<SEC-DOCUMENT>0001178913-21-000678.txt : 20210218
<SEC-HEADER>0001178913-21-000678.hdr.sgml : 20210218
<ACCEPTANCE-DATETIME>20210218090411
ACCESSION NUMBER:		0001178913-21-000678
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		99
CONFORMED PERIOD OF REPORT:	20201231
FILED AS OF DATE:		20210218
DATE AS OF CHANGE:		20210218

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ReWalk Robotics Ltd.
		CENTRAL INDEX KEY:			0001607962
		STANDARD INDUSTRIAL CLASSIFICATION:	ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36612
		FILM NUMBER:		21647796

	BUSINESS ADDRESS:	
		STREET 1:		3 HATNUFA ST.
		STREET 2:		FLOOR 6
		CITY:			YOKNEAM ILIT
		STATE:			L3
		ZIP:			2069203
		BUSINESS PHONE:		97249590123

	MAIL ADDRESS:	
		STREET 1:		3 HATNUFA ST.
		STREET 2:		FLOOR 6
		CITY:			YOKNEAM ILIT
		STATE:			L3
		ZIP:			2069203

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Argo Medical Technologies Ltd.
		DATE OF NAME CHANGE:	20140513
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>zk2125569.htm
<DESCRIPTION>10-K
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: ZKG
         Document created using EDGARfilings PROfile 7.3.2.0
         Copyright 1995 - 2021 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
    <div>
      <div style="text-align: center; line-height: 1.25;">&#160;</div>
      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 14pt; font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">UNITED STATES</div>
      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 14pt; font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">SECURITIES AND EXCHANGE COMMISSION</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">Washington, D.C. 20549</div>
      <div style="text-align: center; line-height: 1.25;">&#160;</div>
      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 14pt; font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">FORM 10-K</div>
      <div style="text-align: center; line-height: 1.25;">&#160;</div>
      <div style="text-align: center; line-height: 1.25;">&#9746; <font style="font-weight: bold;">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</font></div>
      <div style="text-align: center; line-height: 1.25;">&#160;</div>
      <div style="text-align: center; line-height: 1.25;">For the fiscal year ended December&#160;31, 2020</div>
      <div style="text-align: center; line-height: 1.25;">&#160;</div>
      <div style="text-align: center; line-height: 1.25;">or</div>
      <div style="text-align: center; line-height: 1.25;">&#160;</div>
      <div style="text-align: center; line-height: 1.25;">&#9744; <font style="font-weight: bold;">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</font></div>
      <div style="text-align: center; line-height: 1.25;">&#160;</div>
      <div style="text-align: center; line-height: 1.25;">For the transition period from _____ to_____</div>
      <div style="text-align: center; line-height: 1.25;">&#160;</div>
      <div style="text-align: center; line-height: 1.25;">Commission File Number: 001-36612</div>
      <div style="text-align: center; line-height: 1.25;">&#160;</div>
      <div style="text-align: center; line-height: 1.25;"><img width="300" height="118" src="image0.jpg"></div>
      <div style="text-align: center; line-height: 1.25;">&#160;</div>
      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 16pt; font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">ReWalk Robotics Ltd.</div>
      <div style="text-align: center; line-height: 1.25;">(Exact name of registrant as specified in charter)</div>
      <div style="line-height: 1.25;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z61529064c2874335969f28afdd5b5dc4">

          <tr>
            <td style="width: 49.01%; vertical-align: top; border-bottom: #000000 2px solid;">
              <div style="text-align: center; line-height: 1.25;">Israel</div>
            </td>
            <td style="width: 2%; vertical-align: top;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 49%; vertical-align: top; border-bottom: #000000 2px solid;">
              <div style="text-align: center; line-height: 1.25;">Not applicable</div>
            </td>
          </tr>
          <tr>
            <td style="width: 49.01%; vertical-align: top;">
              <div style="text-align: center; line-height: 1.25;">(State or other jurisdiction of<br>
                incorporation or organization)</div>
            </td>
            <td style="width: 2%; vertical-align: top;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 49%; vertical-align: top;">
              <div style="text-align: center; line-height: 1.25;">(I.R.S. employer<br>
                identification no.)</div>
            </td>
          </tr>
          <tr>
            <td style="width: 49.01%; vertical-align: top;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 2%; vertical-align: top;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 49%; vertical-align: top;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 49.01%; vertical-align: top; border-bottom: #000000 2px solid;">
              <div style="text-align: center; line-height: 1.25;">3 Hatnufa Street, Floor 6, Yokneam Ilit, Israel</div>
            </td>
            <td style="width: 2%; vertical-align: top;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 49%; vertical-align: bottom; border-bottom: #000000 2px solid;">
              <div style="text-align: center; line-height: 1.25;">2069203</div>
            </td>
          </tr>
          <tr>
            <td style="width: 49.01%; vertical-align: top;">
              <div style="text-align: center; line-height: 1.25;">(Address of principal executive offices)</div>
            </td>
            <td style="width: 2%; vertical-align: top;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 49%; vertical-align: top;">
              <div style="text-align: center; line-height: 1.25;">(Zip Code)</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;">&#160;</div>
      <div style="text-align: center; line-height: 1.25;">Registrant&#8217;s telephone number, including area code: <u>+972.4.959.0123</u></div>
      <div style="text-align: center; line-height: 1.25;">&#160;</div>
      <div style="text-align: center; line-height: 1.25;">Securities registered pursuant to Section&#160;12(b) of the Act:</div>
      <div style="line-height: 1.25;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z4e69a43ba1b944bb96ca6ba1b2ed5bc1">

          <tr>
            <td style="width: 34%; vertical-align: bottom; border-bottom: #000000 2px solid;">
              <div style="text-align: center; line-height: 1.25; font-weight: bold;">Title of Each Class</div>
            </td>
            <td style="width: 1%; vertical-align: bottom;">
              <div style="text-align: center; line-height: 1.25; font-weight: bold;">&#160;</div>
            </td>
            <td style="width: 32%; vertical-align: bottom; border-bottom: #000000 2px solid;">
              <div style="text-align: center; line-height: 1.25; font-weight: bold;">Trading Symbol(s)</div>
            </td>
            <td style="width: 1%; vertical-align: bottom;">
              <div style="text-align: center; line-height: 1.25; font-weight: bold;">&#160;</div>
            </td>
            <td style="width: 32%; vertical-align: bottom; border-bottom: #000000 2px solid;">
              <div style="text-align: center; line-height: 1.25; font-weight: bold;">Name of Each Exchange on Which Registered</div>
            </td>
          </tr>
          <tr>
            <td style="width: 34%; vertical-align: top; background-color: #CCEEFF;">
              <div style="text-align: center; line-height: 1.25;">Ordinary Shares, par value NIS 0.25&#160;per share</div>
            </td>
            <td style="width: 1%; vertical-align: middle; background-color: #CCEEFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 32%; vertical-align: top; background-color: #CCEEFF;">
              <div style="text-align: center; line-height: 1.25;">RWLK</div>
            </td>
            <td style="width: 1%; vertical-align: middle; background-color: #CCEEFF;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 32%; vertical-align: top; background-color: #CCEEFF;">
              <div style="text-align: center; line-height: 1.25;">Nasdaq Capital Market</div>
            </td>
          </tr>

      </table>
      <div style="text-align: center; line-height: 1.25;">&#160;</div>
      <div style="text-align: center; line-height: 1.25;">Securities Registered Pursuant to Section&#160;12(g) of the Act: None</div>
      <div style="line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. </div>
      <div style="text-align: justify; line-height: 1.25;"> <br>
      </div>
      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Yes &#9744; No &#9746;</div>
      <div style="text-align: justify; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. </div>
      <div style="text-align: justify; line-height: 1.25;"> <br>
      </div>
      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Yes &#9744; No &#9746;</div>
      <div style="text-align: justify; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">Indicate by a check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12&#160;months (or for
        such shorter period that the Registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90&#160;days. </div>
      <div style="text-align: justify; line-height: 1.25;"> <br>
      </div>
      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Yes &#9746; No &#9744;</div>
      <div style="line-height: 1.25;">&#160;</div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; line-height: 1.25;">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months
        (or for such shorter period that the registrant was required to submit such files). &#160;</div>
      <div style="text-align: justify; line-height: 1.25;"> <br>
      </div>
      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Yes &#9746; No &#9744;</div>
      <div style="text-align: justify; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or emerging growth company. See the
        definitions of&#160;&#8220;large accelerated filer&#8221;, &#8220;accelerated filer&#8221;, &#8220;smaller reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</div>
      <div style="line-height: 1.25;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z2e64cba72c5f47e8b222c7d58c8592f1">

          <tr>
            <td style="width: 50%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">Large&#160;accelerated&#160;filer &#9744;</div>
            </td>
            <td style="width: 50%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">Accelerated&#160;filer &#9744;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">Non-accelerated&#160;filer &#9746;</div>
            </td>
            <td style="width: 50%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">Smaller&#160;reporting&#160;company &#9746;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: bottom;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 50%; vertical-align: bottom;">
              <div style="text-align: justify; line-height: 1.25;">Emerging growth company &#9744;</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
        provided pursuant to Section 13(a) of the Exchange Act.&#160;<font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</font></div>
      <div style="text-align: justify; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).&#160;</div>
      <div style="text-align: justify; line-height: 1.25;"> <br>
      </div>
      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Yes &#9744; No &#9746;</div>
      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"> <br>
      </div>
      <div style="line-height: 1.25;">
        <div style="text-align: justify; line-height: 1.25;">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under
          Section 404(b) of the&#160;Sarbanes-Oxley Act (15 USC. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. <font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</font></div>
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">The aggregate market value of the Ordinary Shares held by non-affiliates of the Registrant based upon the closing price<font style="font-weight: bold;">&#160;</font>of the Ordinary Shares as reported by
        the Nasdaq Capital Market on June 30, 2020 (the last business day of the Registrant&#8217;s most recently completed second fiscal quarter) was $27,393,283.</div>
      <div style="line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">
        <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">As of February&#160;16, 2021, the Registrant had outstanding 33,445,454 Ordinary Shares, par value NIS 0.25 per share.</div>
      </div>
      <div style="text-align: justify; line-height: 1.25;">&#160;</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">DOCUMENTS INCORPORATED BY REFERENCE</div>
      <div style="text-align: justify; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">Portions of our proxy statement for our 2021 Annual Meeting of Shareholders, which is to be filed within 120 days after the end of our 2020 fiscal year, are incorporated by reference into Part III
        of this annual report on Form 10-K.</div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <!--PROfilePageNumberReset%LCR%1%%%-->
      <div style="text-align: center; line-height: 1.25;">&#160;&#160; <br>
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">REWALK ROBOTICS LTD.</div>
      <div style="text-align: center; line-height: 1.25;">&#160;</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">FORM 10-K FOR THE YEAR ENDED DECEMBER&#160;31, 2020</div>
      <div style="text-align: center; line-height: 1.25;">&#160;</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">TABLE OF CONTENTS</div>
      <div style="text-align: center; line-height: 1.25;">&#160;</div>
      <table cellspacing="0" cellpadding="2" border="0" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" id="z903aa88cdbb643e4a7a70ffe393d7f2d">

          <tr>
            <td colspan="2" style="width: 91%; vertical-align: top; padding-bottom: 2px;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#160;</div>
            </td>
            <td style="width: 9%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Page No</div>
            </td>
          </tr>
          <tr>
            <td style="width: 9.01%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#160;</div>
            </td>
            <td style="width: 82%; vertical-align: top;">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;"><a href="#PARTI">PART I</a></div>
            </td>
            <td style="width: 9%; vertical-align: bottom;">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 9.01%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="#ITEM1.BUSINESS">ITEM 1.</a></div>
            </td>
            <td style="width: 82%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="#ITEM1.BUSINESS">BUSINESS</a></div>
            </td>
            <td style="width: 9%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">1</div>
            </td>
          </tr>
          <tr>
            <td style="width: 9.01%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="#ITEM1A.RISKFACTORS">ITEM&#160;1A.</a></div>
            </td>
            <td style="width: 82%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="#ITEM1A.RISKFACTORS">RISK FACTORS</a></div>
            </td>
            <td style="width: 9%; vertical-align: bottom;">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">19</div>
            </td>
          </tr>
          <tr>
            <td style="width: 9.01%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="#ITEM1B">ITEM 1B.</a></div>
            </td>
            <td style="width: 82%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="#ITEM1B">UNRESOLVED STAFF COMMENTS</a></div>
            </td>
            <td style="width: 9%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">56</div>
            </td>
          </tr>
          <tr>
            <td style="width: 9.01%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="#ITEM2">ITEM 2.</a></div>
            </td>
            <td style="width: 82%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="#ITEM2">PROPERTIES</a></div>
            </td>
            <td style="width: 9%; vertical-align: bottom; text-align: center;">56</td>
          </tr>
          <tr>
            <td style="width: 9.01%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="#ITEM3">ITEM 3.</a></div>
            </td>
            <td style="width: 82%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="#ITEM3">LEGAL PROCEEDINGS</a></div>
            </td>
            <td style="width: 9%; vertical-align: bottom; background-color: rgb(204, 238, 255); text-align: center;">57</td>
          </tr>
          <tr>
            <td style="width: 9.01%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="#ITEM4">ITEM 4.</a></div>
            </td>
            <td style="width: 82%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="#ITEM4">MINE SAFETY DISCLOSURES</a></div>
            </td>
            <td style="width: 9%; vertical-align: bottom;">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">57</div>
            </td>
          </tr>
          <tr>
            <td style="width: 9.01%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#160;</div>
            </td>
            <td style="width: 82%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#160;</div>
            </td>
            <td style="width: 9%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 9.01%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#160;</div>
            </td>
            <td style="width: 82%; vertical-align: top;">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;"><a href="#PARTII">PART II</a></div>
            </td>
            <td style="width: 9%; vertical-align: bottom;">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 9.01%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="#ITEM5">ITEM&#160;5.</a></div>
            </td>
            <td style="width: 82%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="#ITEM5">MARKET FOR REGISTRANT&#8217;S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES</a></div>
            </td>
            <td style="width: 9%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">58</div>
            </td>
          </tr>
          <tr>
            <td style="width: 9.01%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="#ITEM6">ITEM 6.</a></div>
            </td>
            <td style="width: 82%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="#ITEM6">SELECTED FINANCIAL DATA</a></div>
            </td>
            <td style="width: 9%; vertical-align: bottom;">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">61</div>
            </td>
          </tr>
          <tr>
            <td style="width: 9.01%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="#ITEM7">ITEM&#160;7.</a></div>
            </td>
            <td style="width: 82%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="#ITEM7">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</a></div>
            </td>
            <td style="width: 9%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">62</div>
            </td>
          </tr>
          <tr>
            <td style="width: 9.01%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="#ITEM7A">ITEM&#160;7A.</a></div>
            </td>
            <td style="width: 82%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="#ITEM7A">QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</a></div>
            </td>
            <td style="width: 9%; vertical-align: bottom;">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">79</div>
            </td>
          </tr>
          <tr>
            <td style="width: 9.01%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="#ITEM8">ITEM 8.</a></div>
            </td>
            <td style="width: 82%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="#ITEM8">FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</a></div>
            </td>
            <td style="width: 9%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">79</div>
            </td>
          </tr>
          <tr>
            <td style="width: 9.01%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="#ITEM9">ITEM 9.</a></div>
            </td>
            <td style="width: 82%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="#ITEM9">CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE</a></div>
            </td>
            <td style="width: 9%; vertical-align: bottom;">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">79</div>
            </td>
          </tr>
          <tr>
            <td style="width: 9.01%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="#ITEM9A">ITEM 9A.</a></div>
            </td>
            <td style="width: 82%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="#ITEM9A">CONTROLS AND PROCEDURES</a></div>
            </td>
            <td style="width: 9%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">80</div>
            </td>
          </tr>
          <tr>
            <td style="width: 9.01%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="#ITEM9B">ITEM 9B.</a></div>
            </td>
            <td style="width: 82%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="#ITEM9B">OTHER INFORMATION</a></div>
            </td>
            <td style="width: 9%; vertical-align: bottom;">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">80</div>
            </td>
          </tr>
          <tr>
            <td style="width: 9.01%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#160;</div>
            </td>
            <td style="width: 82%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#160;</div>
            </td>
            <td style="width: 9%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 9.01%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#160;</div>
            </td>
            <td style="width: 82%; vertical-align: top;">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;"><a href="#PARTIII">PART III</a></div>
            </td>
            <td style="width: 9%; vertical-align: bottom;">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 9.01%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="#ITEM10">ITEM 10.</a></div>
            </td>
            <td style="width: 82%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="#ITEM10">DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE</a></div>
            </td>
            <td style="width: 9%; vertical-align: bottom; background-color: rgb(204, 238, 255); text-align: center;">81</td>
          </tr>
          <tr>
            <td style="width: 9.01%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="#ITEM11">ITEM 11.</a></div>
            </td>
            <td style="width: 82%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="#ITEM11">EXECUTIVE COMPENSATION</a></div>
            </td>
            <td style="width: 9%; vertical-align: bottom;">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">81</div>
            </td>
          </tr>
          <tr>
            <td style="width: 9.01%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="#ITEM12">ITEM 12.</a></div>
            </td>
            <td style="width: 82%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="#ITEM12">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS</a></div>
            </td>
            <td style="width: 9%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">81</div>
            </td>
          </tr>
          <tr>
            <td style="width: 9.01%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="#ITEM13.">ITEM 13.</a></div>
            </td>
            <td style="width: 82%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="#ITEM13.">CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE</a></div>
            </td>
            <td style="width: 9%; vertical-align: bottom;">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">81</div>
            </td>
          </tr>
          <tr>
            <td style="width: 9.01%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="#ITEM14.">ITEM 14.</a></div>
            </td>
            <td style="width: 82%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="#ITEM14.">PRINCIPAL ACCOUNTANT FEES AND SERVICES</a></div>
            </td>
            <td style="width: 9%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">81</div>
            </td>
          </tr>
          <tr>
            <td style="width: 9.01%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#160;</div>
            </td>
            <td style="width: 82%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#160;</div>
            </td>
            <td style="width: 9%; vertical-align: bottom;">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 9.01%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#160;</div>
            </td>
            <td style="width: 82%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;"><a href="#PARTIV">PART IV</a></div>
            </td>
            <td style="width: 9%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 9.01%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="#ITEM15.">ITEM 15.</a></div>
            </td>
            <td style="width: 82%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="#ITEM15.">EXHIBITS AND FINANCIAL STATEMENT SCHEDULES</a></div>
            </td>
            <td style="width: 9%; vertical-align: bottom;">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">82</div>
            </td>
          </tr>
          <tr>
            <td style="width: 9.01%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="#ITEM16.">ITEM 16.</a></div>
            </td>
            <td style="width: 82%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="#ITEM16.">FORM 10-K SUMMARY</a></div>
            </td>
            <td style="width: 9%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">82</div>
            </td>
          </tr>
          <tr>
            <td colspan="2" style="width: 91%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="#SIGNATURES">SIGNATURES</a></div>
            </td>
            <td style="width: 9%; vertical-align: bottom;">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">83</div>
            </td>
          </tr>
          <tr>
            <td colspan="2" style="width: 91%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="#POWEROFATTORNEY">POWER OF ATTORNEY</a></div>
            </td>
            <td style="width: 9%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">83</div>
            </td>
          </tr>
          <tr>
            <td colspan="2" style="width: 91%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="#INDEX">INDEX TO CONSOLIDATED FINANCIAL STATEMENTS</a></div>
            </td>
            <td style="width: 9%; vertical-align: bottom;">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">F-1</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;">&#160;</div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">i</font></div>
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25; font-weight: bold;">Definitions and Introduction</div>
      <div style="line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Our legal and commercial name is ReWalk Robotics Ltd. We are a company limited by shares organized under the laws of the State of Israel and were founded in 2001. In September
        2014, we listed our shares on the Nasdaq Global Market, and in May 2017, we transferred our listing to the Nasdaq Capital Market. We have irrevocably appointed ReWalk Robotics, Inc. as our agent to receive service of process in any action against
        us in any United States federal or state court. The address of ReWalk Robotics, Inc. is 200 Donald Lynch Blvd., Marlborough, Massachusetts 01752. As used herein, and unless the context clearly indicates otherwise, the terms &#8220;ReWalk&#8221;, &#8220;the Company&#8221;,
        &#8220;we&#8221;, &#8220;us&#8221;, &#8220;our&#8221; or &#8220;ours&#8221; refer to ReWalk Robotics Ltd. and its subsidiaries.</div>
      <div style="line-height: 1.25;">&#160;</div>
      <div style="line-height: 1.25;"><font style="font-weight: bold;">Special Note Regarding Forward-Looking Statements</font>&#160;<font style="font-weight: bold;">and Risk Factors Summary</font></div>
      <div style="line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">This annual report on Form 10-K, or annual report, contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, or the
        Securities Act, Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act, and the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, that are based on our management&#8217;s beliefs and
        assumptions and on information currently available to our management. Forward-looking statements include information concerning our possible or assumed future results of operations, business strategies, financing plans, competitive position,
        industry environment, potential growth opportunities, potential market opportunities and the effects of competition. Forward-looking statements may include projections regarding our future performance and, in some cases, can be identified by words
        like &#8220;anticipate,&#8221; &#8220;assume,&#8221; &#8220;believe,&#8221; &#8220;could,&#8221; &#8220;seek,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;plan,&#8221; &#8220;potential,&#8221; &#8220;predict,&#8221; &#8220;project,&#8221; &#8220;future,&#8221; &#8220;should,&#8221; &#8220;will,&#8221; &#8220;would&#8221; or similar expressions that convey uncertainty of future events or
        outcomes and the negatives of those terms. These statements may be found in the sections of this annual report titled &#8220;Part I. Item 1. Business,&#8221; &#8220;Part I. Item 1A. Risk Factors,&#8221; &#8220;Part II. Item 7. Management&#8217;s Discussion and Analysis of Financial
        Condition and Results of Operations&#8221; and elsewhere in this annual report. The statements are based on our beliefs, assumptions and expectations of future performance, taking into account the information currently available to us. These statements
        are only predictions based upon our current expectations and projections about future events. There are important factors that could cause our actual results, levels of activity, performance or achievements to differ materially from the results,
        levels of activity, performance or achievements expressed or implied by the statements.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">These factors include those listed in &#8220;Part I. Item 1A. Risk Factors,&#8221; as summarized below. &#160;</div>
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 2.13%; vertical-align: top;">
              <div style="line-height: 1.25;">&#8226;</div>
            </td>
            <td style="width: 97.87%; vertical-align: top;">
              <div style="line-height: 1.25;">the adverse effect that the current coronavirus (COVID-19) pandemic has had and may continue to have on our business and results of operations;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 2.13%; vertical-align: top;">
              <div style="line-height: 1.25;">&#8226;</div>
            </td>
            <td style="width: 97.87%; vertical-align: top;">
              <div style="line-height: 1.25;">our ability to have sufficient funds to meet certain future capital requirements, which could impair our efforts to develop and commercialize existing and new products;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 2.13%; vertical-align: top;">
              <div style="line-height: 1.25;">&#8226;</div>
            </td>
            <td style="width: 97.87%; vertical-align: top;">
              <div style="line-height: 1.25;">our ability to maintain compliance with the continued listing requirements of the Nasdaq Capital Market and the risk that our ordinary shares will be delisted if we cannot do so;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 2.13%; vertical-align: top;">
              <div style="line-height: 1.25;">&#8226;</div>
            </td>
            <td style="width: 97.87%; vertical-align: top;">
              <div style="line-height: 1.25;">our expectations regarding future growth, including our ability to increase sales in our existing geographic markets and expand to new markets;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 2.13%; vertical-align: top;">
              <div style="line-height: 1.25;">&#8226;</div>
            </td>
            <td rowspan="1" style="width: 97.87%; vertical-align: top;">
              <div style="line-height: 1.25;">our ability to maintain and grow our reputation and the market acceptance of our products;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 2.13%; vertical-align: top;">
              <div style="line-height: 1.25;">&#8226;</div>
            </td>
            <td style="width: 97.87%; vertical-align: top;">
              <div style="line-height: 1.25;">our ability to achieve reimbursement from third-party payors for our products;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 2.13%; vertical-align: top;">
              <div style="line-height: 1.25;">&#8226;</div>
            </td>
            <td style="width: 97.87%; vertical-align: top;">
              <div style="line-height: 1.25;">our limited operating history and our ability to leverage our sales, marketing and training infrastructure;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 2.13%; vertical-align: top;">
              <div style="line-height: 1.25;">&#8226;</div>
            </td>
            <td style="width: 97.87%; vertical-align: top;">
              <div style="line-height: 1.25;">our expectations as to our clinical research program and clinical results;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 2.13%; vertical-align: top;">
              <div style="line-height: 1.25;">&#8226;</div>
            </td>
            <td style="width: 97.87%; vertical-align: top;">
              <div style="line-height: 1.25;">our ability to obtain certain components of our products from third-party suppliers and our continued access to our product manufacturers;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 2.13%; vertical-align: top;">
              <div style="line-height: 1.25;">&#8226;</div>
            </td>
            <td style="width: 97.87%; vertical-align: top;">
              <div style="line-height: 1.25;">our ability to improve our products and develop new products;</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">ii</font></div>
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 2.13%; vertical-align: top;">
              <div style="line-height: 1.25;">&#8226;</div>
            </td>
            <td style="width: 97.87%; vertical-align: top;">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">our compliance with medical device reporting regulations to report adverse events involving our products, which could result in voluntary corrective actions or enforcement actions such as mandatory recalls,
                  and the potential impact of such adverse events on ReWalk&#8217;s ability to market and sell its products;</div>
              </div>
            </td>
          </tr>
          <tr>
            <td style="width: 2.13%; vertical-align: top;">
              <div style="line-height: 1.25;">&#8226;</div>
            </td>
            <td style="width: 97.87%; vertical-align: top;">
              <div style="line-height: 1.25;">our ability to gain and maintain regulatory approvals;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 2.13%; vertical-align: top;">
              <div style="line-height: 1.25;">&#8226;</div>
            </td>
            <td style="width: 97.87%; vertical-align: top;">
              <div style="line-height: 1.25;">our expectations as to the results of the FDA, potential regulatory developments with respect to our mandatory 522 postmarket surveillance study;</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 2.13%; vertical-align: top;">&#8226; <br>
            </td>
            <td rowspan="1" style="width: 97.87%; vertical-align: top;">
              <div style="line-height: 1.25">the risk of a cybersecurity attack or breach of our IT systems significantly disrupting our business operations; <br>
              </div>
            </td>
          </tr>
          <tr>
            <td style="width: 2.13%; vertical-align: top;">
              <div style="line-height: 1.25;">&#8226;</div>
            </td>
            <td style="width: 97.87%; vertical-align: top;">
              <div style="line-height: 1.25;">our ability to maintain adequate protection of our intellectual property and to avoid violation of the intellectual property rights of others;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 2.13%; vertical-align: top;">
              <div style="line-height: 1.25;">&#8226;</div>
            </td>
            <td style="width: 97.87%; vertical-align: top;">
              <div style="line-height: 1.25;">our ability to establish a pathway to commercialize our products in China;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 2.13%; vertical-align: top;">
              <div style="line-height: 1.25;">&#8226;</div>
            </td>
            <td style="width: 97.87%; vertical-align: top;">
              <div style="line-height: 1.25;">the impact of substantial sales of our shares by certain shareholders on the market price of our ordinary shares;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 2.13%; vertical-align: top;">
              <div style="line-height: 1.25;">&#8226;</div>
              <div style="line-height: 1.25;">&#8226;</div>
            </td>
            <td style="width: 97.87%; vertical-align: top;">
              <div style="line-height: 1.25;">our ability to use effectively the proceeds of our offerings of securities;</div>
              <div style="line-height: 1.25;">the risk of substantial dilution resulting from the periodic issuances of our ordinary shares;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 2.13%; vertical-align: top;">
              <div style="line-height: 1.25;">&#8226;</div>
            </td>
            <td style="width: 97.87%; vertical-align: top;">
              <div style="line-height: 1.25;">the impact of the market price of our ordinary shares on the determination of whether we are a passive foreign investment company;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 2.13%; vertical-align: top;">
              <div style="line-height: 1.25;">&#8226;</div>
            </td>
            <td style="width: 97.87%; vertical-align: top;">
              <div style="line-height: 1.25;">market and other conditions; and</div>
            </td>
          </tr>
          <tr>
            <td style="width: 2.13%; vertical-align: top;">
              <div style="line-height: 1.25;">&#8226;</div>
            </td>
            <td style="width: 97.87%; vertical-align: top;">
              <div style="line-height: 1.25;">other factors discussed in &#8220;Part I. Item 1A. Risk Factors.&#8221;</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">You should not rely upon forward-looking statements as predictions of future events. Although we believe that the expectations reflected in the forward-looking statements are
        reasonable, we cannot guarantee that future results, levels of activity, performance and events and circumstances reflected in the forward-looking statements will be achieved or will occur.</div>
      <div style="line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">You should not put undue reliance on any forward-looking statements. Any forward-looking statement in this annual report speaks only as of the date hereof. Except as required by
        law, we undertake no obligation to update publicly any forward-looking statements for any reason after the date of this annual report, to conform these statements to actual results or to changes in our expectations.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 5pt; line-height: 1.25;">&#160;</div>
      <div style="line-height: 1.25; font-weight: bold;">Where You Can Find Other Information</div>
      <div style="line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">Our principal executive offices are located at 3 Hatnufa Street, Floor 6, Yokneam Ilit 2069203, Israel, and our telephone number is +972 (4) 959-0123. Our website is www.rewalk.com<font style="font-style: italic;">. </font>Information contained, or that can be accessed through, our website does not constitute a part of this annual report and is not incorporated by reference herein. We have included our website address in this
          annual report solely for informational purposes. Information that we furnish with or file with the Securities and Exchange Commission, or the SEC, including annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K
          and any amendments to, or exhibits included in, these reports are available for download, free of charge, on our website as soon as reasonably practicable after such materials are filed or furnished with the SEC. The SEC also maintains a website
          at SEC.gov that contains reports, proxy and information statements, and other information regarding&#160;issuers&#160;that file electronically with the SEC.&#160;Our SEC filings, including exhibits filed or furnished therewith, are also available on this
          website.</div>
      </div>
      <div style="line-height: 1.25;">&#160;</div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">iii</font></div>
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%1%%%-->
      <div style="text-align: center; line-height: 1.25;"><br>
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;"><a name="PARTI"><!--Anchor--></a>PART I</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">&#160;</div>
      <div style="line-height: 1.25; font-weight: bold;"><a name="ITEM1.BUSINESS"><!--Anchor--></a>ITEM 1. BUSINESS</div>
      <div style="line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Overview</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We are an innovative medical device company that is designing, developing and commercializing robotic exoskeletons that allow individuals with mobility impairments or other
        medical conditions the ability to stand and walk once again. We have developed and are continuing to commercialize our ReWalk Personal and ReWalk Rehabilitation devices for individuals with spinal cord injury (&#8220;SCI Products&#8221;), which are
        exoskeletons designed for individuals with paraplegia that use our patented tilt-sensor technology and an on-board computer and motion sensors to drive motorized legs that power movement.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We have also developed and began commercializing our ReStore device in June 2019. ReStore is a powered, lightweight soft exo-suit intended for use in the rehabilitation of
        individuals with lower limb disability due to stroke. During the second quarter of 2020 we have finalized and moved to implement two separate agreements to distribute additional product lines in the U.S. market. The Company will be the exclusive
        distributor of the MediTouch Tutor movement biofeedback systems in the United States and will also have distribution rights for the MYOLYN MyoCycle FES cycles to U.S. rehabilitation clinics and personal sales through the U.S. Department of Veterans
        Affairs (&#8220;VA&#8221;) hospitals and other personal sales. These new products will improve our product offering to clinics as well as patients within the VA as they both have similar clinician and patient profile.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Our principal markets are the United States and Europe. In Europe, we have a direct sales operation in Germany and the United Kingdom and work with distribution partners in
        certain other major countries. We have offices in Marlborough, Massachusetts, Berlin, Germany and Yokneam, Israel, where we operate our business from.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We have in the past generated and expect to generate in the future revenues from a combination of third-party payors, self-payors, including private and government employers, and
        institutions. While a broad uniform policy of coverage and reimbursement by third-party commercial payors currently does not exist in the United States for electronic exoskeleton technologies such as the ReWalk Personal, we are pursuing various
        paths of reimbursement and support fundraising efforts by institutions and clinics. In December 2015, the U.S. Department of Veterans Affairs, or the VA, issued a national policy for the evaluation, training and procurement of ReWalk Personal
        exoskeleton systems for all qualifying veterans across the United States. The VA policy is the first national coverage policy in the United States for qualifying individuals who have suffered spinal cord injury. As of December 31, 2020, we had
        placed 24 units as part of the VA policy.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;According to a 2017 report published by the Centers for Medicare and Medicaid Services, or CMS, approximately 55% of the spinal cord injury population which are at least five
        years post their injury date are covered by CMS. In July 2020, a code was issued for ReWalk Personal 6.0 (effective October 1, 2020), which might later be followed by coverage policy of CMS.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Additionally, to date, several private insurers in the United States and Europe have provided reimbursement for ReWalk in certain cases. In Germany, we continue to make progress
        toward achieving ReWalk coverage from the various government, private and worker&#8217;s compensation payors. In September 2017, each of German insurer BARMER GEK (&#8220;Barmer&#8221;) and national social accident insurance provider Deutsche Gesetzliche
        Unfallversicherung (&#8220;DGUV&#8221;), indicated that they will provide coverage to users who meet certain inclusion and exclusion criteria. In February 2018, the head office of German statutory health insurance, or SHI, Spitzenverband (&#8220;GKV&#8221;) confirmed
        their decision to list the ReWalk Personal 6.0 exoskeleton system in the German Medical Device Directory. This decision means that ReWalk will be listed among all medical devices for compensation, which SHI providers can procure for any approved
        beneficiary on a case-by-case basis. During the year 2020 we have announced several new agreements with German SHIs such as TK and DAK Gesundheit and others as well as the first German Private Health Insurer (&#8220;PHI&#8221;) that have chosen to enter into
        an agreement that outlines the process of obtaining a device for eligible insured patient. We are currently working with several additional SHIs and PHIs on securing a formal operating contract that will establish the process of obtaining a ReWalk
        Personal 6.0 device for their beneficiaries within their system.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="color: #000000; font-weight: normal; font-style: normal;" id="DSPFPageNumber">1</font></div>
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%2%%%-->
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">During the second quarter of 2020 we finalized and moved to implement two separate agreements to distribute additional product lines in the U.S. market. The Company will be the
        exclusive distributor of the MediTouch Tutor movement biofeedback systems in the United States and will also have distribution rights for the MYOLYN MyoCycle FES cycles to U.S. rehabilitation clinics and personal sales through the VA hospitals.
        These new products will improve our product offering to clinics as well as patients within the VA as they both have similar clinician and patient profile.</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Evolving COVID-19 Pandemic</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The impact of the novel coronavirus (COVID-19) pandemic has been and will likely continue to be extensive in many aspects of society, which has resulted in and will likely
        continue to result in significant disruptions to the global economy, as well as businesses and capital markets around the world. In an effort to halt the outbreak of COVID-19, a number of countries, including the United States and many countries in
        Europe, have placed significant restrictions on travel, and many businesses have announced extended closures. Although certain of these countries or locales within the countries have begun to allow reopening of certain businesses, it is unclear how
        long total or partial shutdowns may last and whether additional shutdowns will be necessary to the extent future outbreaks occur.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The COVID-19 pandemic has affected our ability to engage with our SCI Products, ReStore and Distributed Products existing customers, trial new candidates, deliver ordered units
        or repair existing systems, and provide training of our products to new patients who have largely remained at home due to local movement restrictions and to rehabilitation centers, which have temporarily shifted priorities and responses to
        pandemic-related medical equipment. As a result, our revenues for the year 2020 were adversely impacted as we had limited market access and we encountered reduced payor attention that affected our results.&#160; The overall impact of the limitations on
        our sales efforts are currently difficult to determine, but we believe that the adverse impact may continue, especially as our ability to trial new patients with our SCI Products is limited and as capital budgets for rehabilitation devices such as
        the ReStore are reduced or currently on-hold in most of the clinics and some are enforcing in-clinic restrictions that effect our ability to demonstrate our devices. We continue to monitor our sales pipeline on a day-to-day basis in order to assess
        the quarterly effect of these limitations as some have short term effects and some affects our future pipeline development.&#160; Limitations on travel and business closures recommended by federal, state, and local governments, could, among other
        things, impact our ability to enroll patients in clinical trials, recruit clinical site investigators, and obtain timely approvals from local regulatory authorities. While our manufacturer, Sanmina Corporation, has not shut down its facilities
        during the COVID-19 pandemic, our manufacturing may also be impacted due to supply chain delays or adverse impacts on our production capacity due to government directives or health protocols that might impact our production facility, and the
        current limitations on our sales activities has made it hard for us to effectively forecast our future requirements for systems. For more information, see &#8220;Part II, Item 1A. Risk Factors-The COVID-19 pandemic has adversely affected and may continue
        to materially and adversely impact our business, our operations and our financial results&#8221; and &#8220;Part II, Item 1A. Risk Factors-We depend on a single third party to manufacture our products, and we rely on a limited number of third-party suppliers
        for certain components of our products.&#8221;</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Our future results of operations and liquidity could be adversely impacted by delays in payments of outstanding receivable amounts beyond normal payment terms, supply chain
        disruptions and operational challenges faced by our customers. Continued outbreaks of COVID-19 could result in a widespread health crisis that could adversely affect the economies and financial markets of many countries, resulting in an economic
        downturn or a global recession that could cause significant volatility or decline in the trading price of our securities, affect our ability to execute strategic business activities, affect demand for our products and likely impact our operating
        results. These may further limit or restrict our ability to access capital on favorable terms, or at all, lead to consolidation that negatively impacts our business, weaken demand, increase competition, cause us to reduce our capital spend further,
        or otherwise disrupt our business.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">2</font></div>
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">To align our expenses with the current business environment, we took measures to adjust our cost structure and anticipated cash usage that have taken effect&#160;in the second quarter of 2020 and
          beyond, which included reducing our personnel costs and deferring our subcontractors costs mainly within the research and development segment as well as short term reduction in employee&#8217;s hours of work in specific areas for a limited period,
          eliminating or reducing non-critical consultants, implementing remote working in the United States and Germany, and establishing in-office measures to contain the spread of COVID-19. These cost actions are designed to retain talent and preserve
          cash returns, while at the same time continuing to invest in strategic goals. These cost actions lasted throughout 2020 as needed, but the Company will continue to monitor the environment and extend or modify these actions, if necessary. Despite
          this current situation and the challenges, it imposes, as the year progressed we have developed methods to continue to engage with our current and prospective customers through video conferencing, virtual training events, and online education
          demos to offer our support and showcase the value of our products.</div>
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25; font-weight: bold;">ReWalk Personal and ReWalk Rehabilitation Products</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Development of our SCI Products took over a decade and was spurred by the experiences of our founder, Dr. Amit Goffer, who became a quadriplegic due to an accident. Current
        ReWalk designs are intended for people with paraplegia, a spinal cord injury resulting in complete or incomplete paralysis of the legs, who have the use of their upper bodies and arms. We currently offer two products: ReWalk Personal and ReWalk
        Rehabilitation.</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">
          <div style="text-indent: 36pt; line-height: 1.25;">ReWalk Personal is a breakthrough product that seeks to fundamentally change the health and life experiences of users. Designed for all-day use, the device is battery-powered and consists of a
            light, wearable exoskeleton with integrated motors at the joints, an array of sensors and a computer-based control system to power knee and hip movement. The device controls movement using subtle shifts in the user&#8217;s center of gravity. A
            forward tilt of the upper body is sensed by the system, which initiates the first step. Repeated body shifting generates a sequence of steps that results in a functional walking speed. Because the exoskeleton supports its own weight and
            facilitates the user&#8217;s gait, users do not expend unnecessary energy while walking. While ReWalk does not allow side-to-side actuation, users are able to turn by shifting their weight to the side. The ReWalk Personal also allows users to sit,
            stand and depending on local regulatory approvals, climb and descend stairs. Use on stairs is currently not cleared by the FDA in the United States; the Company has submitted a 510(k) application in January 2021 to add this feature into our
            U.S. labeling as well. Upon completion of training, which generally consists of approximately 15 one-hour sessions, most users are able to put on and remove the device by themselves while sitting, typically in less than 15 minutes, to operate
            the device independently and most are able to put on and remove the devices by themselves. Safety measures include crutches, which provide additional stability, fall protection, which lowers users slowly and safely in the event of a
            malfunction, and the secure &#8220;stand&#8221; mode, which automatically initiates if the user does not begin walking within two seconds. ReWalk is also equipped with maintenance alarms, warnings, and backup batteries. The rechargeable batteries are
            easily accessible and can be recharged in any standard power outlet. Our safety guidelines and FDA specifications, however, require users to be accompanied by a trained companion at all times when using the ReWalk Personal.</div>
        </div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">3</font></div>
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <br>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z2e968eef625e4a5283ffa1e7745e421e">

          <tr>
            <td style="width: 69%; vertical-align: top;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 1%; vertical-align: bottom;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 30%; vertical-align: top;">
              <div style="text-align: center; line-height: 1.25; font-weight: bold;">ReWalk Personal 6.0</div>
            </td>
          </tr>
          <tr>
            <td style="width: 69%; vertical-align: top;">
              <div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; line-height: 1.25;">&#9679;&#160;&#160;&#160;&#160;<font style="font-style: italic;">ReWalk Personal</font>: intended for everyday use at home, at work or in the community. We began marketing
                ReWalk Personal in Europe with CE mark clearance at the end of 2012. We received FDA clearance to market ReWalk Personal in the United States in June 2014. ReWalk Personal units are all manufactured according to the same mechanical
                specifications. Each unit is then permanently sized to fit the individual user and the software is configured for the user&#8217;s specifications by the rehabilitation center, clinic or distributor.</div>
              <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
              <div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; line-height: 1.25;">&#9679;&#160;&#160;&#160;&#160;<font style="font-style: italic;">ReWalk Rehabilitation</font>: designed for the clinical rehabilitation environment, ReWalk Rehabilitation has
                adjustable sizing enabling multiple patient use. ReWalk Rehabilitation provides a valuable means of exercise and therapy. It also enables individuals to evaluate their capacity for using ReWalk Personal in the future. We began marketing
                ReWalk Rehabilitation for use in hospitals, rehabilitation centers and stand-alone training centers in the United States and Europe in 2011. ReWalk Rehabilitation units are all manufactured according to the same mechanical specifications
                and are equipped with adjustable sizing for multi-patient use and software that can be configured for the user&#8217;s specifications. In December 2020, the Company decided to end the production of this design.</div>
            </td>
            <td style="width: 1%; vertical-align: bottom;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 30%; vertical-align: top;">
              <div style="text-align: center; line-height: 1.25;"><img width="114" height="270" src="image1.jpg"></div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;">&#160;&#160;&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Additionally, we have received regulatory approval to sell the ReWalk device in other countries. In the future we intend to seek approval from the applicable regulatory agencies
        in other jurisdictions where we may seek to market ReWalk.</div>
      <div style="text-align: justify; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; line-height: 1.25; font-style: italic;">Overview of Spinal Anatomy and Spinal Cord Injury</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic;">Spinal Anatomy</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">The spine is the central core of the human skeleton and provides structural support, alignment, and flexibility to the body. It consists of 24 interlocking bones, called vertebrae, which are
          stacked on top of one another. The spine is comprised of five regions, of which there are three primary regions: cervical, thoracic, and lumbar. In addition, there is also the sacral region, or sacrum, a triangular-shaped bone, and the coccyx, or
          &#8220;tailbone,&#8221; the bottom portion of the spine.</div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The spinal cord, housed inside the bony spinal column, is a complex bundle of nerves serving as the main pathway for information connecting the brain and nervous system. The
        spinal cord is divided into 31 segments that feed sensory impulses into the spinal cord, which in turn relays them to the brain. Conversely, motor impulses generated in the brain are relayed by the spinal cord to the spinal nerves, which pass the
        impulses to muscles and glands. The spinal cord mediates the reflex responses to some sensory impulses directly, without recourse to the brain, for example, when a person&#8217;s leg is tapped, producing the knee jerk reflex.</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">4</font></div>
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z7775588d55164de9bc4bebf6e4b2305c">

          <tr>
            <td style="width: 100%; vertical-align: top;">
              <div style="text-indent: 36pt; line-height: 1.25; font-style: italic;">Spinal Cord Injury</div>
              <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
            </td>
          </tr>
          <tr>
            <td style="width: 100%; vertical-align: top;">
              <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Spinal cord injury is the result of a direct trauma to the nerves themselves or damage to the surrounding bones and soft tissues which ultimately impacts the spinal cord.
                Spinal cord damage results in a loss of function, such as mobility or feeling. In most people who have spinal cord injury, the spinal cord is intact. Spinal cord injury is not the same as back injury, which may result from pinched nerves or
                ruptured disks. Even when a person sustains a break in a vertebra or vertebrae, there may not be any spinal cord injury if the spinal cord itself is not affected. There are two types of spinal cord injury &#8211; complete and incomplete. In a
                complete injury, a person loses all ability to feel and voluntarily move below the level of the injury. In an incomplete injury, there is some functioning below the level of the injury.</div>
              <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
              <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Upon examination, a patient is assigned a level of injury depending on the location of the spinal cord injury. Cervical level injuries cause paralysis or weakness in both
                arms and legs and is referred to as quadriplegia. Sometimes this type of injury is accompanied by loss of physical sensation, respiratory issues, bowel, bladder, and sexual dysfunction. Thoracic level injuries can cause paralysis or
                weakness of the legs (paraplegia) along with loss of physical sensation, bowel, bladder, and sexual dysfunction. In most cases, arms and hands are not affected. Lumbar level injuries result in paralysis or weakness of the legs (paraplegia).
                Loss of physical sensation, bowel, bladder, and sexual dysfunction can occur. The shoulder, arm, and hand functions are usually unaffected. Sacral level injuries primarily cause loss of bowel and bladder function as well as sexual
                dysfunction.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25; font-style: italic;">&#160;&#160;</div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">5</font></div>
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      &#160;<br>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic;">Clinical evidence</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Published clinical studies indicate ReWalk Personal&#8217;s ability to deliver a functional walking speed. In addition, our experience working with healthcare practitioners and ReWalk
        users, including reports by study participants, as well as multiple clinical studies, some of which are published in peer-reviewed journals, have been carried out to establish the effectiveness and the potential secondary health benefits achieved
        by using the SCI Products for individuals with spinal cord injuries. Certain of the benefits suggested include:</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7b2cf6ed387c4930b7f0ff36befd67d6">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top; align: right;">&#9679;</td>
              <td style="width: auto; vertical-align: top;">
                <div>reduced pain;</div>
              </td>
            </tr>

        </table>
        <div style="text-align: left; margin-left: 5.65pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z9b4d95792ba64604aa34c46e740fa741">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top; align: right;">&#9679;</td>
              <td style="width: auto; vertical-align: top;">
                <div>improved bowel and urinary tract function;</div>
              </td>
            </tr>

        </table>
        <div style="text-align: left; margin-left: 5.65pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za3db20c0e80d4dca8639df34f618162d">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top; align: right;">&#9679;</td>
              <td style="width: auto; vertical-align: top;">
                <div>reduced spasticity;</div>
              </td>
            </tr>

        </table>
        <div style="text-align: left; margin-left: 5.65pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z33a4a9af59504a10aec372537da78d3f">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top; align: right;">&#9679;</td>
              <td style="width: auto; vertical-align: top;">
                <div>increases in joint range of motion for the hip and ankle joints;</div>
              </td>
            </tr>

        </table>
        <div style="text-align: left; margin-left: 5.65pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7644564db35342cb8bb323c655221782">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top; align: right;">&#9679;</td>
              <td style="width: auto; vertical-align: top;">
                <div>improved sleep and reduced fatigue;</div>
              </td>
            </tr>

        </table>
        <div style="text-align: left; margin-left: 5.65pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7f31638906d946f1bfed50e78d376d4e">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top; align: right;">&#9679;</td>
              <td style="width: auto; vertical-align: top;">
                <div>increase in oxygen uptake and heart rate as a result of walking as opposed to sitting and standing;</div>
              </td>
            </tr>

        </table>
        <div style="text-align: left; margin-left: 5.65pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z46ab5a4cb27b4c7685396013248aa898">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top; align: right;">&#9679;</td>
              <td style="width: auto; vertical-align: top;">
                <div>ability to ambulate at a speed greater than 0.4 meters per second, which is considered to be conducive to outdoor related community ambulation; and</div>
              </td>
            </tr>

        </table>
        <div style="text-align: left; margin-left: 5.65pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z3ede197bf60d46c78c5b76e646535e59">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top; align: right;">&#9679;</td>
              <td style="width: auto; vertical-align: top;">
                <div>reduced hospitalizations.</div>
              </td>
            </tr>

        </table>
        <div style="text-align: left; margin-left: 5.65pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#160;</div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Although study participants and other ReWalk users have reported the secondary health benefits listed above, currently there is no conclusive clinical data establishing any
        secondary health benefits of ReWalk. We believe that using our SCI Products may have the ability to reduce the lifetime healthcare costs of individuals with spinal cord injuries, which we believe will make it economically attractive for individuals
        and third-party payors. While we believe that using the SCI Products could potentially offer significant advantages over competing technologies and therapies, disadvantages include the time it takes for a user to put on the device, the slower pace
        of the device compared to a wheelchair, the weight of it when carried, which makes it more burdensome for a companion to transport than a wheelchair, and the requirement that users be accompanied by a trained companion.</div>
      <div style="line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic;">Market Opportunity</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">ReWalk&#8217;s current and near-term market opportunities include providing a solution for persons with spinal cord injury that can be used in the clinic and/or home settings, and a solution for
          therapists to use during stroke rehabilitation in their clinics. For persons with spinal cord injury, confinement to a wheelchair can cause severe physical and psychological deterioration, resulting in bad health, poor quality of life, low
          self-esteem, and high medical expenses. In addition, the secondary medical consequences of paralysis can include difficulty with bowel and urinary tract function, osteoporosis, loss of lean mass, gain in fat mass, insulin resistance, diabetes,
          and heart disease. The cost of treating these conditions is substantial. The National Spinal Cord Injury Statistical Center, or the NSCISC, estimates that complications related to paraplegia cost, excluding indirect costs such as losses in wages,
          fringe benefits and productivity, approximately $500,000 in the first-year post-injury and significant additional amounts over the course of an individual&#8217;s lifetime. Further, secondary complications related to spinal cord injury can reduce life
          expectancies for spinal cord injury, or SCI, patients. The young average age at time of injury and significant remaining life expectancy, the likelihood of living at home and lifetime cost of treatment highlight the need for an out-of-hospital
          solution with demonstrated health and social benefits.</div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The NSCISC estimates as of 2020 that there were 294,000 people in the United States living with spinal cord injury, or SCI, with an annual incidence of approximately 17,810 new
        cases per year. Approximately 44,000 of such patients are veterans and are eligible for medical care and other benefits from the VA. With 25 VA spinal cord injury centers, the VA has the largest single network of spinal cord injury care in the
        United States.</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The University of Alabama-Birmingham Department of Physical Medicine and Rehabilitation operates the NSCISC, which maintains the world&#8217;s largest database on spinal cord injury
        research. Since 2015, motor vehicle crashes have been the leading cause of reported spinal cord injury cases (39%), followed by falls (32%), acts of violence (14%)&#160;and sports injuries (8%). 78% of spinal cord injuries occur among the male
        population. According to NSCISC data, upon hospital discharge, 87% of persons with spinal cord injuries are sent to private, non-institutional residence (in most cases, their homes prior to injury).</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">6</font></div>
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      &#160;<br>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">Based on information from a 2017 report by the NSCISC, 40.4% of the total U.S. population of SCI patients suffered injuries between levels T4 and L5. Three published ReWalk trials for SCI patients
          had an aggregate screening acceptance rate of 79% considering all current FDA limitations, resulting in an estimated 32% of the total population of SCI patients can be considered as candidates for current ReWalk products. For important qualifying
          information about this determination, see &#8220;Part I, Item 1A. Risk Factors&#8212;Risks Related to our Business and our Industry&#8212;The market for medical exoskeletons, including soft suit devices, remains relatively new and unproven, and important
          assumptions about the potential market for our current and future products may be inaccurate.&#8221;</div>
      </div>
      <div style="text-align: justify; line-height: 1.25; font-style: italic;">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25; font-style: italic;">Sales and Marketing activities</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">Our initial commercialization efforts focused on penetrating rehabilitation centers, hospitals, and similar facilities that treat patients with spinal cord injuries to become an integral part of
          their rehabilitation programs and to develop a broad-based training network with these facilities to prepare users for home and community use. As our business has developed, we have shifted our commercialization efforts to marketing ReWalk
          Personal with insurance companies, physicians, and physiotherapists as a standard of care that can be used routinely at home, at work or in the community.</div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">We market and sell our products directly to third party payers, institutions, including rehabilitation centers, individuals and through third-party distributors. We sell our products directly in
          Germany, the United Kingdom, and the United States and primarily through distributors in our other markets. In our direct markets, we have established relationships with rehabilitation centers and the spinal cord injury community, and in our
          indirect markets, our distributors maintain these relationships. Sales of ReWalk Personal are generated primarily from the patient base at our rehabilitation centers, referrals through the spinal cord injury community and direct inquiries from
          potential users.</div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">As of December 31, 2020, we had placed 119 units in use at rehabilitation centers and 492 personal units in a home or community use, compared to 119 units and 453 units,
        respectively, as of December&#160;31, 2019.&#160;In the near future, we intend to continue focusing on our reimbursement efforts, pursuing insurance claims on a case-by-case basis, managing claims through the review process, and investing in efforts to
        expand commercial reimbursement coverage.&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Although we cannot predict the time it will take to achieve higher acceptance rates of our SCI Products, we believe that further clinical evidence supporting the benefits of
        using the device will be a key element to accelerate it.</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; line-height: 1.25; font-style: italic;">Third-Party Reimbursements</div>
      <div style="margin-left: 36pt; line-height: 1.25;">&#160;</div>
      <div style="margin-left: 36pt; line-height: 1.25; font-style: italic;">United States</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In the United States rehabilitation centers generally purchase the ReWalk Rehabilitation unit and then charge patients for ReWalk therapy on a per-session basis. These
        institutions may then seek reimbursement from insurance companies for each session.</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">In December 2015, the VA issued a national policy for the evaluation, training, and procurement of ReWalk Personal exoskeleton systems for all qualifying veterans across the United States.&#160; The VA
          policy is the first national coverage policy in&#160;the United States&#160;for qualifying individuals who have suffered spinal cord injury. In June 2018 the VA has updated this policy to include more training options for individuals who could not complete
          the training due to distance from a VA site. As of December 31, 2020, we had placed 24 units as part of the VA policy. The VA accounted for 10.0% of our total revenues for the year ended December&#160;31, 2020. We continue to work with the VA to
          accelerate the pace of implementation of the VA policy.</div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">While no broad uniform policy of coverage and reimbursement for electronic exoskeleton medical technology exists among commercial insurance payors in the United States,
        reimbursement may be achieved on a case-by-case basis. To date, payments for the ReWalk Personal device have been made primarily through case-by-case determinations by third-party payors, including commercial insurers in the United States, by
        self-payors and donations and, to a lesser extent, through the use of funds from insurance and/or accident settlements.</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">As of December&#160;31, 2020, we had 14 cases pending in the United States for insurance coverage decisions. For more information, see &#8220;Part I, Item 1A. Risk Factors&#8212;Risks Related to
        our Business and our Industry&#8212; We may fail to secure or maintain adequate insurance coverage or reimbursement for our products by third-party payors, which risk may be heightened if insurers find the products to be investigational or experimental
        or if new government regulations change existing reimbursement policies. Additionally, such coverage or reimbursement, even if maintained, may not produce revenues that are high enough to allow us to sell our products profitably.&#8221;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">7</font></div>
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      &#160;<br>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">According to a 2017 report published by the Centers for Medicare and Medicaid Services, or CMS, approximately 55% of the spinal cord injury population which are at least five
        years post their injury date are covered by CMS. In December 2019, we submitted the first application for code issuance for ReWalk Personal 6.0 and in July 2020, a code was issued for ReWalk Personal 6.0 (effective October 1, 2020), which might
        later be followed by coverage policy of CMS. While we believe that a positive response from CMS may broaden coverage by private insurers, we cannot currently predict how long it would take for us to receive a decision from CMS nor can we predict
        other business elements that will be decided by CMS, such as price per unit or product labeling. For more information, see &#8220;Part I, Item 1A. Risk Factors&#8212;Risks Related to our Business and our Industry&#8212; We may fail to secure or maintain adequate
        insurance coverage or reimbursement for our products by third-party payors, which risk may be heightened if insurers find the products to be investigational or experimental or if new government regulations change existing reimbursement policies.
        Additionally, such coverage or reimbursement, even if maintained, may not produce revenues that are high enough to allow us to sell our products profitably.&#8221;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">As part of our plan for growth, we intend to continue working with both national and regional commercial insurance companies, health care practitioners, physicians, researchers,
        and the SCI community to support efforts to demonstrate the benefits and the case to secure potential coverage policies based on supportive data and appeal rulings that have deemed exoskeleton devices a &#8220;medically necessary&#8221; standard of care for
        individuals with SCI. Our efforts in the future will be focused on continued education of insurers through data application, supporting clinical trials to demonstrate the clinical benefits of using the SCI Products, working with advocacy groups,
        ongoing communication as well as trying to obtain CMS coverage for the ReWalk Personal 6.0 device.</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25; font-style: italic;">Western Europe</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Reimbursement for ReWalk in Europe varies by country and historically certain third-party payors have provided reimbursement for our products in certain cases in Germany and
        Italy.</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">We initially focused our efforts in Europe in Germany where we continue to make progress toward achieving ReWalk coverage from the various government, private, and worker&#8217;s compensation payers.
          Specifically:</div>
      </div>
      <div style="text-align: justify; margin-left: 31.5pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8e147e91118347d2a60d8a4783066a45">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top; align: right;">&#9679;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>In September 2017, Barmer confirmed it will provide ReWalk systems to all qualifying beneficiaries. Barmer provides insurance coverage for nearly ten million people in Germany, as a member of the German Statutory Health Insurance
                  (&#8220;SHI&#8221;) network and one of the most significant national insurers in the country. Exoskeletons will be provided to users that meet certain inclusion criteria and assessment by the German Health Insurance Medical Service (Medizinischer
                  Dienst der Krankenversicherungen) before and after training. Barmer has already begun processing claims with users entering training for in-home use of an exoskeleton. We remain in discussion with Barmer regarding a contract based on
                  their 2017 decision.</div>
              </td>
            </tr>

        </table>
        <div style="text-align: left; margin-left: 37.15pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za98b0dd320384af884da58d6819d217d">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top; align: right;">&#9679;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>
                  <div style="text-align: left; line-height: 1.25;">In September 2017 Germany&#8217;s national social accident insurance provider, DGUV, indicated that the DGUV&#8217;s member payers, including the health insurance association <font style="font-style: italic;">Berufsgenossenschaft </font>(also known as BG) and state insurers, will approve the supply of exoskeleton systems for qualifying beneficiaries on a case-by-case basis. DGUV is comprised of 36 different insurers, which
                    provide coverage for more than 80 million individuals in Germany. Per the agreement, eligible individuals will go to BG clinics for evaluation as a part of the procurement.&#160; In May 2020 the DGUV agreed to a binding offer to the
                    evaluation, training, and supply of the ReWalk Personal 6.0 device to qualified individuals.</div>
                </div>
              </td>
            </tr>

        </table>
        <div style="text-align: left; margin-left: 37.15pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z05cb9cea24594cc78e1e6a7462ff5ddb">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top; align: right;">&#9679;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>In February 2018, the GKV confirmed its decision to list the ReWalk Personal system in the German MDD, a comprehensive list of all medical devices which are principally and regularly reimbursed by German SHI providers. The ReWalk
                  Personal was added to the official German list of medical aids, code number 23.29.01.2001, in June 2018. This decision means that ReWalk Personal will be listed among all medical devices for compensation, which SHI providers can procure
                  for any approved beneficiary on a case-by-case basis.</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z520948cb88474551a6b9d08a6ff29140">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top; align: right;">&#9679;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>
                  <div style="text-align: left; line-height: 1.25;">During the year 2020 we have announced several new agreements with SHIs such as TK and DAK-Gesundheit and others as well as the first German Private Health Insurer (&#8220;PHI&#8221;) that have chosen
                    to enter into an agreement that outlines the process to obtaining a device for eligible insured patients.</div>
                </div>
              </td>
            </tr>

        </table>
      </div>
      <br>
      <div style="text-align: justify; text-indent: 35.45pt; line-height: 1.25;">Patients who are covered under these contracts and policies must be medically evaluated for their eligibility to use the ReWalk Personal device. If medically qualified, the
        patient, along with his or her physician, must apply for coverage of the device. If a patient is found eligible and medically fit to use our Personal 6.0 device, we first enter into a rental agreement which allows the patient the necessary period
        to train on how to use the device and then after approval from the insurer the patient receives a personal device to use at home or in the community. We are currently working with several additional SHIs and PHIs on securing a formal operating
        contract that will establish the process of obtaining a ReWalk Personal 6.0 device for their beneficiaries within their system.,</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">As of December&#160;31, 2020, there were 84 insurance cases pending in Germany. We believe that our recent coverage decisions and the existing claims will eventually lead other German
        insurers, to provide coverage on a broad scale. For more information, see &#8220;Part I, Item 1A. Risk Factors&#8212;Risks Related to our Business and our Industry&#8212; We may fail to secure or maintain adequate insurance coverage or reimbursement for our products
        by third-party payors&#8230;.&#8221;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">8</font></div>
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <br>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We continue to support clinical research and academic publications, which we believe will further support the case for coverage.</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We have also had success with reimbursement by private insurers and worker&#8217;s compensation in other European countries and one of the examples was achieved in March 2018, when the
        Italian Ministry of Labor and Social Policy&#8217;s statutory insurance corporation put in place a coverage policy that will provide exoskeleton systems for all qualifying beneficiaries. This policy, the first of its kind in Italy, will provide
        individuals with spinal cord injury access to obtain their own ReWalk Personal device so that they can stand and walk again. Since the initiation of coverage, we have supplied 9 units through our Italian distributor to individuals covered by this
        policy.</div>
      <div style="text-align: justify; text-indent: 35.45pt; line-height: 1.25; font-style: italic;">&#160;</div>
      <div style="text-align: justify; text-indent: 35.45pt; line-height: 1.25; font-style: italic;">Other Funding Sources</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In addition to being funded by third-party payors, including private insurance plans, government programs such as the VA, and Worker&#8217;s Compensation, ReWalk Personal is also
        funded by self-payers. This includes individuals who purchase ReWalk with funds from legal settlements with insurance companies or third parties.</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="za31bff2e5af74d51afcc79331e84f717">

          <tr>
            <td style="width: 69%; vertical-align: top;">
              <div style="line-height: 1.25; font-weight: bold;">ReStore</div>
              <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
              <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In June 2017 we unveiled our lightweight exo-suit ReStore system designed initially for rehabilitation of stroke patients. The patented soft exo-suit technology was
                originally developed at&#160;Harvard University&#8217;s&#160;Wyss&#160;Institute for Biologically Inspired Engineering, or Harvard, where it also underwent initial clinical testing that demonstrated its potential to improve walking for stroke survivors. ReWalk
                and Harvard&#160;entered into a multi-year research collaboration agreement in 2016 which provides ReWalk license to intellectual property relating to lightweight exo-suit system technologies for lower limb disabilities and provides access to
                future innovations that emerge from this collaboration and may be relevant to additional stroke products or other therapies. The development and regulatory approval of ReStore took us approximately three years and in June 2019 we received
                FDA clearance following CE clearance that was obtained in May 2019. Following the regulatory approvals, we have started to commercialize the ReStore product. For more information on the collaboration with Harvard, see &#8220;Research and
                Development-Research and Development Collaborations.&#8221;.</div>
            </td>
            <td style="width: 1%; vertical-align: top;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 30%; vertical-align: top;">
              <div style="text-align: center; line-height: 1.25;"><img width="96" height="266" src="image2.jpg"></div>
              <div style="text-align: center; line-height: 1.25;">ReStore exo-suit</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">The ReStore product is comprised of a soft, fabric-based design which connects to a lightweight waist pack and mechanical cables that help lift the patient&#8217;s affected leg in synchronized timing
          with their natural walking pattern. The lightweight structure wraps around the waist and supports an actuator with a motor, computer, and cable, along with sensors attached to a stable point on the user&#8217;s calf and footplate in the user&#8217;s shoe.
          This design transfers forces in a controlled manner and targeted assistance to the patient ankle during forward propulsion (plantarflexion) and ground clearance (dorsiflexion), two key phases of the gait cycle. The ReStore system is designed to
          provide advantages to stroke rehabilitation clinics and therapists as compared to other traditional therapies and devices by improving the quality and pace of care, supplying real-time analytics to optimize session productivity, and generating
          ongoing data reports to assist with tracking patient progress. We expect the device may also provide other secondary benefits for rehabilitation clinics, including reducing staffing and/ or equipment requirements, staff fatigue and the risk for
          potential staff injuries.</div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Published clinical trials that were conducted at Harvard using the soft-suit design on stroke patients have shown varying levels of improvements, with the main ones being
        improved forward propulsion, reductions in compensatory behaviors including paretic hip hiking and circumduction as well as reduction in metabolic burden associated with post stroke walking. The Company is currently supporting additional clinical
        trials using the ReStore device.</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The main market for ReStore is rehabilitation clinics with a stroke therapy program or clinics that would like to broaden their stroke presence. This product is marketed and sold
        directly to rehabilitation clinics for use during the course of the treatment of their patients which is generally reimbursed by private payors as well as statutory health insurers and CMS.&#160; During the second half of 2019 we expanded our sales and
        marketing presence in the U.S. in order to accelerate the product penetration, which was affected by the impact of the COVID-19 pandemic, especially on clinics and hospitals as they shifted resources and attention during 2020.&#160; Geographically we
        see our priorities as the United States and Europe.</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">Stroke incidence rate in the United States is 795,000 incidences per year and the survival rate is approximately 80%. Of this stroke population, 80% are left with some type of lower limb
          disability. This patient population seeks treatment in one of the thousands inpatient, outpatient, skilled nursing facilities and rehabilitation clinics providing therapy. With the clinical evidence we have to date on ReStore, its unique design
          and the cost-effective offer compared to other products, we believe the ReStore soft-suit has an opportunity to be considered as a standard of care among clinics during their stroke patients therapy, but we also recognize that the process to
          achieve that might be long and will occur once national or regional healthcare providers include the device within their stroke therapy program. We believe that in order to accelerate adoption, further clinical evidence is required as well as
          continued education on the new ReStore design and its unique advantages compared to current therapies and products.</div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">As of December 31, 2020, and December 31, 2019, we had placed 21 and 16 ReStore units, respectively.</div>
      </div>
      <div style="text-align: justify; text-indent: 35.45pt; line-height: 1.25;">&#160;</div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">9</font></div>
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      &#160;<br>
      <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Competition</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The market in which we operate is characterized by active competition and rapid technological change, and we expect competition to increase. Competition arises from providers of
        other mobility systems and prosthetic devices used in the clinic and/or home settings.</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We are aware of a number of other companies developing competing technology and devices, and some of these competitors may have greater resources, greater name recognition,
        broader product lines, or larger customer bases than we do.</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Our principal competitors in the medical exoskeleton market consist of Ekso Bionics (NASDAQ: EKSO), Rex Bionics Pty, Cyberdyne (Tokyo Stock Exchange: 7779), Parker Hannifin
        (NYSE: PH), FREE Bionics, Hocoma, AlterG, and Bioness. These products may also compete with the ReStore exo-suit, as well as manual forms of gait training which do not involve robotic assistive devices.</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We believe that our ReWalk Personal device possesses key competitive advantages over these companies, such as our tilt-sensor technology that provides a self-initiated walking
        experience, more natural gait and faster functional walking speed, the ability to support its own weight and broad user specifications. ReWalk Personal is the first medical exoskeleton cleared by the FDA for personal use in the United States.</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We believe that our ReStore soft exo-suit device will have key competitive advantages over the products of our competitors, including a design that facilitates a natural,
        functional walking pattern through flexible materials, sensors, and powered plantarflexion as well as dorsiflexion, making it the only solution of its type of which we are aware of that supports such movements, achieving that with a lower cost and
        weight than rigid skeletal devices.</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In addition, we compete with alternative devices and alternative therapies, including treadmill-based gait therapies, such as those offered by Hocoma, AlterG, Aretech and Reha
        Technology. Other medical device or robotics companies, academic and research institutions, or others may develop new technologies or therapies that provide a superior walking experience, are more effective in treating the secondary medical
        conditions that we target or are less expensive than our current or future products. Our technologies and products could be rendered obsolete by such developments.</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We may also compete with other treatments and technologies that address the secondary medical conditions that ReWalk seeks to mitigate.</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Community Engagement and Education</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">We devote significant resources to engagement with and education of the spinal cord injury community with respect to the benefits of our SCI Products. We actively seek opportunities to partner with
          hospitals, rehabilitation centers and key opinion leaders to engage in research and development and clinical activities. We also seek to educate and gain support from organizations such as patient advocacy groups and clinician societies with the
          goal of promoting adoption of exoskeleton technology from patient, clinician, and payor communities. We believe that our success has been and will continue to be driven in part by our reputation and acceptance within the spinal cord injury
          community. We are also looking into ways to promote the ReStore device through different advocacy groups to accelerate adoption and support the uniqueness of this technology when compared to current therapies and products.</div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">To date, multiple advocacy groups have issued public endorsement to cover the ReWalk Personal device, including leading United States-based national organizations such as the
        United Spinal Association and the Dana and Christopher Reeves Foundation, as well as others.</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Services and Customer Support</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Our centers of operations in Marlborough, Massachusetts and Berlin, Germany coordinate all customer support and product service functions for North America and Europe,
        respectively, through dedicated technical service personnel who provide product services and customer support through training to healthcare providers and support to product users.</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">10</font></div>
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      &#160;
      <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Research and Development</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">
          <div style="text-indent: 36pt; line-height: 1.25;">We are committed to investing in a robust research and development program to support our current product line and to potentially develop our pipeline of new and complementary and new products,
            and we believe that ongoing research and development efforts are essential to our success. Our research and development team consists of both in-house and external staff, including engineers, machinists, researchers and marketing, quality,
            manufacturing, regulatory and clinical personnel, which we employ in the most efficient way we can and see fit to our current and future needs, who work closely together to design, enhance, and validate our technologies. This research and
            development team conceptualizes technologies and then builds and tests prototypes before refining and/or redesigning, as necessary. Our regulatory and clinical personnel work in parallel with engineers and researchers, allowing us to anticipate
            and resolve potential issues at early stages in the development cycle. Our level of research and development investment depends on our available resources, business plans, and future needs. For more information, see &#8220;Part I, Item 1A. Risk
            Factors &#8212; Risks Related to Our Business and Our Industry &#8212; Our future growth and operating results will depend on our ability to develop, receive regulatory clearance for, and commercialize new products and penetrate new product and geographic
            markets.</div>
        </div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">
          <div style="text-indent: 36pt; line-height: 1.25;">
            <div style="text-indent: 36pt; line-height: 1.25;">We plan to focus our research and development efforts in the future by continually improving and potentially expanding our functional technological platform, by expanding the indication of use
              of our lightweight &#8220;soft suit&#8221; exoskeleton to other medical conditions as well as home therapy or adding a new indication of use. Regarding our Personal 6.0 product we are working on product improvement, expanding our labeling, and in the
              longer term by developing our next generation device with design improvements. New medical indications that affect the ability to walk may include multiple sclerosis, cerebral palsy, Parkinson&#8217;s disease, and elderly assistance.</div>
          </div>
        </div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We conduct our research and development efforts at our facility in Yokneam, Israel. We believe that the close interaction among our research and development and manufacturing
        groups allows for timely and effective realization of our new product concepts.</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Our research and development efforts have been financed, in part, through funding from the Israel Innovation Authority, or the IIA (formerly known as Office of the Chief
        Scientist in the Israel Ministry of Economy), and from the Israel-U.S. Binational Industrial Research and Development, or BIRD Foundation. From our inception through December&#160;31, 2020, we received funding totaling $1.97 million from the IIA and
        $500 thousand from the BIRD Foundation. For more information regarding our research and development financing arrangements, see &#8220;Part II. Item 7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8212;Liquidity and
        Capital Resources&#8221; and &#8220;&#8212;Grants and Other Funding.&#8221;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold;">Research and Development Collaborations</div>
      <div style="text-align: justify; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">On May 16, 2016, we&#160;entered into the Research Collaboration Agreement, or Collaboration Agreement, and the Exclusive License Agreement, or Harvard License Agreement, with
        Harvard. Under the Collaboration Agreement, we and Harvard agreed to collaborate on research regarding the development of lightweight soft suit exoskeleton system technologies for lower limb disabilities, which are intended to treat stroke,
        multiple sclerosis, mobility limitations for the elderly and other medical applications. Under the Collaboration Agreement, we pay Harvard quarterly installment payments to help fund the research. Subject to the terms of the Collaboration
        Agreement, we and Harvard are required to report our respective research results and findings to each other on a regular basis. The Collaboration Agreement governs ownership of the research results and inventions generated in performance of the
        research collaboration and provides us the option to negotiate with Harvard for a license to certain new inventions of Harvard conceived in performance of the collaboration.</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">
          <div style="text-indent: 36pt; line-height: 1.25;">The Collaboration Agreement was amended on April 1, 2018, to extend the term of the Collaboration Agreement by one year to May 16, 2022, and reallocate the Company&#8217;s quarterly installment
            payments to Harvard through such date, and make certain technical changes. The agreement was further amended on April 30, 2020, to extend the term until February 16, 2023, and with certain adjustments to the quarterly installments, subject to
            payment of a minimum funding commitment which was already paid as of December 31, 2020. Under applicable circumstances, we may terminate the agreement if there is a loss of Harvard&#8217;s principal investigator or if we do not believe that we have
            or can secure sufficient funding to proceed. The Collaboration Agreement may also be terminated by either Harvard or us due to a material uncured breach by the other party or upon termination of the Harvard License Agreement. If such
            termination occurs it does not affect the Harvard License Agreement. We may amend the Collaboration Agreement in the future depending on our commercialization focus, market conditions, spending plan, and other factors.</div>
        </div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">Under the Harvard License Agreement, we are granted an exclusive, worldwide royalty-bearing license under certain patents of Harvard relating to lightweight &#8220;soft suit&#8221; exoskeleton system
          technologies for lower limb disabilities, a royalty-free license under certain related know-how and the option to obtain a license under certain inventions conceived under our joint research collaboration. Harvard retains the right to practice
          the patents for research, educational and scholarly purposes. We are required to use commercially reasonable efforts to develop products under the license in accordance with an agreed-upon development plan and to introduce and market such
          products commercially. In addition to an upfront fee and royalties on net sales, we are obligated to pay Harvard certain milestone payments upon the achievement of certain product development and commercialization milestones. We also agreed to
          reimburse Harvard for expenses incurred in connection with the filing, prosecution, and maintenance of the licensed patents.</div>
      </div>
      <div style="text-align: justify; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The Harvard License Agreement will continue in full force and effect until the expiration of the last-to-expire valid claim of the licensed patents. We may terminate the License
        Agreement for any reason upon 60 days&#8217; prior written notice, while Harvard may terminate the License Agreement if we do not obtain requisite insurance or become insolvent. The Harvard License Agreement may also be terminated by Harvard or us due to
        the other party&#8217;s material uncured breach.&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">11</font></div>
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      &#160;
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">The Collaboration Agreement and Harvard License Agreement contain, as applicable, customary representations and warranties and customary enforcement, indemnification, and insurance provisions. For
          further discussion of the Collaboration Agreement and Harvard License Agreement, see Note 9 to our consolidated financial statements for the fiscal year ended December 31, 2020.</div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;&#160;&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In September 2013, we entered into a strategic alliance with Yaskawa Electric Corporation (&#8220;Yaskawa&#8221;), pursuant to which, among other arrangements, we granted Yaskawa the
        exclusive right to market, distribute and commercialize our products in Japan, China and other East Asian countries. In connection with the closing of the first tranche of the private placement of our ordinary shares to Timwell, on May 15, 2018 we
        terminated the distribution rights granted to Yaskawa in China (including Hong Kong and Macau). We terminated all other distribution rights granted to Yaskawa effective September 24, 2020.&#160; For more information on the Timwell private placement, see
        &#8220;Part II. Item 7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8212;Liquidity and Capital Resources&#8212;Timwell Private Placement.&#8221;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Intellectual Property</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">Protection of our intellectual property is important to our business. We seek to protect our intellectual property through a combination of patents, trademarks, confidentiality, and assignment
          agreements with our employees and certain of our contractors and confidentiality agreements with certain of our consultants, scientific advisors and other vendors and contractors. In addition, we rely on trade secrets law to protect our
          proprietary software and product candidates/products in development.</div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In addition to ReWalk&#8217;s portfolio of issued patents and pending patent applications, the Company licenses certain patented and patented pending technology from a third party as
        described above under the &#8220;Research and Development&#8221; section.</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">As of December 31, 2020, we have 9 issued patents in the United States and 11 issued patents outside of the United States, as well as 13 pending patent applications for our
        technology in the United States, Canada, China, and Europe. As such, in the United States and Europe, we have apparatus patent claims covering aspects of ReWalk and similar devices which use a plurality of sensors to empower tilt-sensor technology,
        as well as method patent claims covering certain methods of user activation and control of systems such as ReWalk. While our apparatus claims focus on protecting ReWalk in terms of its physical and structural characteristics, we believe that our
        method claims provide additional protection for our technology. We do not currently license any of the technology contained in our currently commercialized ReWalk Personal 6.0, other than with respect to technology that is generally publicly
        available, but we may do so in the future.</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Patents filed both in the United States and Europe generally have a life of 20 years from their earliest effective filing date. As the oldest of our issued patents relating to
        our tilt-sensor technology was filed in May 2001, our patents on that technology do not begin to expire until May 2021.</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We currently hold a registered trademark in Israel and the United States, as well as pending trademark applications in Europe and the United Kingdom, for the mark &#8220;ReWalk&#8221;. We
        currently hold a registered trademark in United States, Europe and the United Kingdom for the mark &#8220;Restore&#8221;.</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The employment agreement of our founder and former President and Chief Technology Officer, Dr.&#160;Amit Goffer, provides that a patent pending relating to a standing wheelchair is
        his individual property and that he may independently engage in the development of a standing wheelchair. The agreement also provides that we and any of our affiliates or successors have the royalty-free right to the exclusive use in the field of
        exoskeletons of any intellectual property developed by Dr.&#160;Goffer, alone or jointly with others (whether or not as part of the development of a standing wheelchair and whether or not developed through a company), while he is our employee,
        consultant or board member and for three years thereafter. Mr. Goffer retired from serving as our President and Chief Technology Officer on November 18, 2015, and as a member of our board of directors on December 3, 2015.</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We cannot be sure that our intellectual property will provide us with a competitive advantage or that we will not infringe on the intellectual property rights of others. In
        addition, we cannot be sure that any patents will be granted in a timely manner or at all with respect to any of our patent pending applications. For a more comprehensive discussion of the risks related to our intellectual property, see &#8220;Part I,
        Item 1A. Risk Factors&#8212;Risks Related to Our Intellectual Property.&#8221;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">12</font></div>
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      &#160;<br>
      <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Government Regulation</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 18pt; line-height: 1.25;"><font style="font-weight: bold; font-style: italic;">U.S. Regulation</font>&#160;&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Our medical products and manufacturing operations are regulated by the FDA and other federal and state agencies. Our products are regulated as medical devices in the United
        States under the Federal Food, Drug, and Cosmetic Act, or the FFDCA, as implemented and enforced by the FDA. The FDA regulates the development, testing, manufacturing, labeling, storage, installation, servicing, advertising, promotion, marketing,
        distribution, import, export, and market surveillance of our medical devices.</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 18pt; line-height: 1.25; font-style: italic;">Premarket Regulatory Requirements</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Unless an exemption applies, each medical device commercially distributed in the United States requires either FDA clearance of a 510(k) premarket notification, approval of a
        premarket approval application (PMA), or issuance of a de novo order. Under the FFDCA, medical devices are classified into one of three classes&#8212;Class I, Class II or Class III&#8212;depending on the degree of risk associated with each medical device and
        the extent of control needed to provide reasonable assurance of safety and effectiveness. Classification of a device is important because the class to which a device is assigned determines, among other things, the necessity and type of FDA review
        required prior to marketing the device. Class I devices are those for which reasonable assurance of safety and effectiveness can be assured by adherence to general controls that include compliance with the applicable portions of the FDA&#8217;s Quality
        System Regulation, or QSR, facility registration and product listing, reporting of adverse medical events, and appropriate, truthful and non-misleading labeling, advertising, and promotional materials. Class I also includes devices for which there
        is insufficient information to determine that general controls are sufficient to provide reasonable assurance of the safety and effectiveness of the device or to establish special controls to provide such assurance, but that are not life-supporting
        or life-sustaining or for a use which is of substantial importance in preventing impairment of human health, and that do not present a potential unreasonable risk of illness of injury.</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">Class II devices are those for which general controls alone are insufficient to provide reasonable assurance of safety and effectiveness and there is sufficient information to establish &#8220;special
          controls.&#8221; These special controls can include performance standards, post-market surveillance, patient registries, and FDA guidance documents. While most Class&#160;I devices are exempt from the 510(k) premarket notification requirement, most Class&#160;II
          devices require a 510(k) premarket notification to be marketed in the U.S. As a result, manufacturers of most Class II devices are required to submit to the FDA premarket notifications under Section&#160;510(k) of the FFDCA requesting classification
          of their devices in order to market or commercially distribute those devices. To obtain a 510(k), a substantial equivalence determination for their devices, manufacturers must submit to the FDA premarket notifications demonstrating that the
          proposed device is &#8220;substantially equivalent&#8221; to a predicate device already on the market. A predicate device is a legally marketed device that is not subject to premarket approval, or PMA, meaning, (i) a device that was legally marketed prior to
          May&#160;28, 1976 (pre-amendments device) and for which a PMA is not required, (ii) a device that has been reclassified from Class III to Class II or I, or (iii) a device that was found substantially equivalent through the 510(k) process. If the FDA
          agrees that the device is substantially equivalent to a predicate device currently on the market, it will grant 510(k) clearance to commercially market the device. If the device is not &#8220;substantially equivalent&#8221; to a previously cleared device,
          the device is automatically a Class III device. The device sponsor must then fulfill more rigorous premarket approval requirements or can request a risk-based classification determination for the device in accordance with the &#8220;de novo&#8221; process,
          which is a route to market for medical devices that are low to moderate risk but are not substantially equivalent to a predicate device.</div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Devices that are intended to be life sustaining or life supporting, devices that are implantable, devices that present a potential unreasonable risk of harm or are of substantial
        importance in preventing impairment of health, and devices that are not substantially equivalent to a predicate device are placed in Class III and generally require approval of a PMA, unless the device is a pre-amendment device not yet subject to a
        regulation requiring premarket approval. The PMA process is more demanding than the 510(k) premarket notification process. In a PMA, the manufacturer must demonstrate that the device is safe and effective, and the PMA must be supported by extensive
        data, including data from preclinical studies and clinical trials. The PMA must also contain a full description of the device and its components, a full description of the methods, facilities and controls used for manufacturing, and proposed
        labeling. Following receipt of a PMA, the FDA determines whether the application is sufficiently complete to permit a substantive review. If the FDA accepts the application for review, it has 180&#160;days under the FFDCA to complete its review of a
        PMA, although in practice, the FDA&#8217;s review often takes significantly longer, and can take up to several years.</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Clinical trials are almost always required to support PMAs and are sometimes required to support 510(k) submissions. All clinical investigations of devices to determine safety
        and effectiveness must be conducted in accordance with the FDA&#8217;s investigational device exemption, or IDE, regulations that govern investigational device labeling, prohibit promotion of the investigational device, and specify recordkeeping,
        reporting and monitoring responsibilities of study sponsors and study investigators. If the device presents a &#8220;significant risk,&#8221; as defined by the FDA, the agency requires the device sponsor to submit an IDE application to the FDA, which must
        become effective prior to commencing human clinical trials. The IDE will automatically become effective 30 days after receipt by the FDA, unless the FDA denies the application or notifies the company that the investigation is on hold and may not
        begin. If the FDA determines that there are deficiencies or other concerns with an IDE that require modification of the study, the FDA may permit a clinical trial to proceed under a conditional approval. In addition, the study must be approved by,
        and conducted under the oversight of, an Institutional Review Board, or IRB, for each clinical site. If the device presents a non-significant risk to the patient, a sponsor may begin the clinical trial after obtaining approval for the trial by one
        or more IRBs without separate approval from the FDA, but must still comply with abbreviated IDE requirements, such as monitoring the investigation, ensuring that the investigators obtain informed consent, and labeling and record-keeping
        requirements.</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">13</font></div>
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      &#160;
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In June 2014, the FDA granted our petition for &#8220;de novo&#8221; classification, which provides a route to market for medical devices that are low to moderate risk, but are not
        substantially equivalent to a predicate device, and classified ReWalk as Class II subject to special controls. The ReWalk is intended to enable individuals with spinal cord injuries to perform ambulatory functions under supervision of a specially
        trained companion, and inside rehabilitation institutions. The special controls established in the de novo order include the following: compliance with medical device consensus standards; clinical testing to demonstrate safe and effective use
        considering the level of supervision necessary and the use environment; non-clinical performance testing, including durability testing to demonstrate that the device performs as intended under anticipated conditions of use; a training program; and
        labeling related to device use and user training. The special controls of this de novo order also apply to competing products seeking FDA clearance.</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">
          <div style="text-indent: 36pt; line-height: 1.25;">In June 2019, the FDA issued a 510(k) clearance for ReStore which means that the device can be marketed in the U.S. ReStore is intended to be used to assist ambulatory functions in rehabilitation
            institutions under the supervision of a trained therapist for people with hemiplegia or hemiparesis due to stroke. ReStore complies with special controls includes the following: compliance with medical device consensus standards; clinical
            testing to demonstrate safe and effective use considering the level of supervision necessary and the use environment; non-clinical performance testing, including durability testing, to demonstrate that the device performs as intended under
            anticipated conditions of use; a training program; and labeling related to device use and user training. In order for us to market ReStore, we must comply with both general controls, including controls related to quality, facility registration,
            reporting of adverse events and labeling, and the special controls established for the device. Failure to comply with the general and special controls could lead to removal of ReStore from the market, which would have a material adverse effect
            on our business.</div>
        </div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">For more information, see &#8220;Part I, Item 1A. Risk Factors-Risks Related to Government Regulation-We are subject to extensive governmental regulations relating to the
        manufacturing, labeling and marketing of our products, and a failure to comply with such regulations could lead to withdrawal or recall of our products from the market.&#8221;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;&#160;</div>
      <div style="text-align: justify; text-indent: 18pt; line-height: 1.25; font-style: italic;">Post-market Regulatory Requirements</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">After a device is cleared for marketing, and prior to marketing, numerous regulatory requirements apply. These include:</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z11f0d895989943fc8c04a73f9f5dde5a">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#9679;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>establishment registration and device listing;</div>
            </td>
          </tr>

      </table>
      <div style="margin-left: 5.65pt; line-height: 1.25;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z2027d5a0055c48aab249c73337bcda3c">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#9679;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>development of a quality assurance system, including establishing and implementing procedures to design and manufacture devices;</div>
            </td>
          </tr>

      </table>
      <div style="margin-left: 5.65pt; line-height: 1.25;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z9f424273b517479284b87b5f0ca68594">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#9679;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>labeling regulations that prohibit the promotion of products for unapproved or &#8220;off-label&#8221; uses and impose other restrictions on labeling;</div>
            </td>
          </tr>

      </table>
      <div style="margin-left: 5.65pt; line-height: 1.25;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0fe463ca78504e21b5d88e3b3b5e2c3f">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#9679;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>FDA&#8217;s Unique Device Identification requirements that call for a unique device identifier (UDI) on device labels and packages and submission of data to the FDA&#8217;s Global Unique Device Identification Database (GUDID);</div>
            </td>
          </tr>

      </table>
      <div style="margin-left: 5.65pt; line-height: 1.25;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z259fa3eb5a4440d0a26d41c2ec5296b6">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#9679;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>medical device reporting regulations that require manufacturers to report to the FDA if a device may have caused or contributed to a death or serious injury or malfunctioned in a way that would likely cause or contribute to a death or
                serious injury if it were to recur; and corrections and removal reporting regulations that require manufacturers report to the FDA field corrections and product recalls or removals if undertaken to reduce a risk to health posed by the
                device or to remedy a violation of the FFDCA that may present a risk to health; and</div>
            </td>
          </tr>

      </table>
      <div style="margin-left: 5.65pt; line-height: 1.25;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z091a88a5fd004100b7a2d13cf00bb3b8">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#9679;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Post-market surveillance.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">14</font></div>
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 36pt;">ReWalk is required by an FDA order under Section 522 of the FFDCA to conduct a post-market study of the ReWalk Personal device. We
        launched our post-market surveillance study with Stanford University during the second quarter of 2016 and in March 2020 the FDA approved a protocol modification that is expected to supplement data from the clinical study with real-world evidence.
        For more information on the post-market surveillance study progress, see &#8220;Part I, Item 1A. Risk Factors&#8212;Risks Related to Government Regulation.&#8221;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">
          <div style="text-indent: 36pt; line-height: 1.25;">Our manufacturing processes are required to comply with the applicable portions of the Quality System Regulation that covers the methods and the facilities and controls for the design,
            manufacture, testing, production, processes, controls, quality assurance, labeling, packaging, distribution, installation, and servicing of finished devices intended for human use. We actively maintain compliance with the FDA&#8217;s Quality System
            Regulation, 21 CFR Part 820, and the European Union&#8217;s Quality Management Systems requirements, ENISO&#160;13485:2016. <br>
          </div>
        </div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">As a manufacturer, we are subject to periodic scheduled or unscheduled inspections by the FDA. If the FDA believes we or any of our contract manufacturers are not in compliance
        with the quality system requirements, or other post-market requirements, it has significant enforcement authority. Specifically, if the FDA determines that we failed to comply with applicable regulatory requirements, it can take a variety of
        compliance or enforcement actions, which may result in any of the following sanctions:</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0cf0cfac91dd4e01842270b464907575">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top; align: right;">&#9679;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>untitled letters, warning letters, fines, injunctions, consent decrees and civil penalties;</div>
              </td>
            </tr>

        </table>
        <div style="margin-left: 5.65pt; line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z95b101b1c6934337a6bcabcbb6da4e79">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top; align: right;">&#9679;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>
                  <div style="text-align: left; line-height: 1.25;">customer notifications or repair, replacement, or refunds;</div>
                </div>
              </td>
            </tr>

        </table>
        <div style="margin-left: 5.65pt; line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z2214a0c49dfe4241a75e833a1ca0110b">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top; align: right;">&#9679;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>recalls, withdrawals, or administrative detention or seizure of our products;</div>
              </td>
            </tr>

        </table>
        <div style="margin-left: 5.65pt; line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za72563ee31234abe99e6d4f01477263f">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top; align: right;">&#9679;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>operating restrictions or partial suspension or total shutdown of production;</div>
              </td>
            </tr>

        </table>
        <div style="margin-left: 5.65pt; line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z11e98263fbbb48f5a9b3008cf206f494">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top; align: right;">&#9679;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>refusing or delaying requests for approval of pre-market approval applications relating to new products or modified products;</div>
              </td>
            </tr>

        </table>
        <div style="margin-left: 5.65pt; line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb318bc0697c541b1a446a359df2f9e85">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top; align: right;">&#9679;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>withdrawing PMA approval;</div>
              </td>
            </tr>

        </table>
        <div style="margin-left: 5.65pt; line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4f31dab7856543908d009ca10d796236">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top; align: right;">&#9679;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>refusal to grant export approvals for our products; or</div>
              </td>
            </tr>

        </table>
        <div style="margin-left: 5.65pt; line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf4987fa612f14fe0b5073dbfc024264c">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top; align: right;">&#9679;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>pursuing criminal prosecution.</div>
              </td>
            </tr>

        </table>
      </div>
      <br>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">Any such action by the FDA would have a material adverse effect on our business. In addition, these regulatory controls, as well as any changes in FDA policies, can affect the time and cost
          associated with the development, introduction, and continued availability of new products. Where possible, we anticipate these factors in our product development processes.</div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;&#160;</div>
      <div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold;">Regulation outside of the U.S.</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">In addition to the United States regulations, we are subject to a variety of foreign regulations governing clinical trials and commercial sales and distribution of our products. In particular, we
          are subject to regulation in the E.U., which has directives and standards regulating the design, manufacture, clinical trials, labeling and adverse event (i.e., vigilance) reporting for medical devices. Devices that comply with the requirements
          of a relevant directive are entitled to bear the CE mark, indicating that the device conforms to the essential requirements of the applicable directive and, accordingly, can be commercially distributed throughout the European Economic Area (i.e.,
          the E.U. Member States plus Norway, Iceland, and Lichtenstein). The method of assessing conformity varies depending on the class of the product, but normally involves a combination of self-assessment by the manufacturer and a third-party
          assessment by a &#8220;Notified Body.&#8221; This third-party assessment may consist of an audit of the manufacturer&#8217;s quality system or specific testing of the manufacturer&#8217;s product. We comply with the E.U. requirements and have received the CE mark for
          all of our ReWalk systems distributed in the E.U.</div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">On May 26, 2021, the Medical Device Regulation will repeal and replace the existing E.U. medical device directive. The new regulation does not set out a radically new system, but
        envisages, among other things, stricter controls of medical devices, including strengthening of the conformity assessment procedures, and increased expectations with regard to clinical data for devices. Under transitional provisions, medical
        devices with notified body certificates issued under the existing directive prior to May 26, 2021 may continue to be placed on the market for the remaining validity of the certificate, until May 27, 2024 at the latest. After the expiry of any
        applicable transitional period, only devices that have been CE marked under the new regulation may be placed on the market in the E.U.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Foreign sales outside of the E.U. (including in the United Kingdom) are subject to the foreign government regulations of the relevant jurisdiction, and we must obtain approval by
        the appropriate regulatory authorities before we can commence clinical trials or marketing activities in those countries. The approval process varies from country to country, and the time may be longer or shorter than that required to obtain a
        marketing authorization in the United States or the CE mark in the E.U. The requirements governing the conduct of clinical trials, product licensing, pricing and reimbursement vary greatly from country to country.</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In 2017, the European Union adopted a new Medical Device Regulation, which will repeal and replace the existing directives effective May 26, 2020. The new regulation does not set
        out a radically new system, but envisages, among other things, stricter controls of medical devices, including strengthening of the conformity assessment procedures, increased expectations with regard to clinical data for devices and pre-market
        regulatory review of high-risk devices. Under transitional provisions, medical devices with notified body certificates issued under the existing directives prior to May 26, 2020 may continue to be placed on the market for the remaining validity of
        the certificate, until May 27, 2024 at the latest. After the expiry of any applicable transitional period, only devices that have been CE marked under the new regulation may be placed on the market in the E.U.</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">The policies of the FDA and foreign regulatory authorities may change, and additional government regulations may be enacted that could prevent or delay regulatory approval of our products and could
          also increase the cost of regulatory compliance. We cannot predict the likelihood, nature, or extent of adverse governmental regulation that might arise from future legislative or administrative action, either in the United States or abroad.</div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">15</font></div>
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      &#160;
      <div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold;">U.S. Anti-kickback, False Claims and Other Healthcare Fraud and Abuse Laws</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">In the United States, there are federal and state anti-kickback laws that prohibit the payment or receipt of kickbacks, bribes or other remuneration intended to induce the purchase or
          recommendation of healthcare products and services. Violations of these laws can lead to civil and criminal penalties, including exclusion from participation in federal healthcare programs. These laws apply to manufacturers of products, such as
          us, with respect to our financial relationship with hospitals, physicians and other potential purchasers or acquirers of our products. The U.S. government has published regulations that identify &#8220;safe harbors&#8221; or exemptions for certain practices
          from enforcement actions under the federal anti-kickback statute, and we will seek to comply with the safe harbors where possible. To qualify for a safe harbor, the activity must fit squarely within the safe harbor. Arrangements that do not meet
          a safe harbor are not necessarily illegal but must be evaluated on a case by case basis. Other provisions of state and federal law provide civil and criminal penalties for presenting, or causing to be presented, to third-party payers for
          reimbursement claims that are false or fraudulent, or for items or services that were not provided as claimed. False claims allegations under federal and some state laws may be brought on behalf of the government by private persons,
          &#8220;whistleblowers,&#8221; who then receive a share of any recovery.</div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The Patient Protection and Affordable Care Act, as amended by the Health Care and Education Affordability Reconciliation Act, or collectively, the PPACA, among other things,
        amends the intent requirement of the federal anti-kickback and criminal healthcare fraud statutes. A person or entity no longer needs to have actual knowledge of these statutes or specific intent to violate them. In addition, the PPACA provides
        that the government may assert that a claim that includes items or services resulting from a violation of the federal anti-kickback statute constitutes a false or fraudulent claim for purposes of the False Claims Act. The PPACA also imposes new
        reporting and disclosure requirements on device manufacturers for any &#8220;transfer of value&#8221; made or distributed to physicians and teaching hospitals. Device manufacturers will also be required to report and disclose any investment interests held by
        physicians and their immediate family members during the preceding calendar year. A number of provisions of PPACA also reflect increased focus on and funding of healthcare fraud enforcement.</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In September 2017, members of the U.S. Congress introduced legislation with the announced intention to repeal and replace major provisions of the PPACA. Although this proposed
        legislation ultimately failed to pass, Congress succeeded in repealing the PPACA&#8217;s individual mandate as part of the U.S. Tax Cuts and Jobs Act of 2017. Thus, in light of the stated policies of the new U.S. presidential administration, and actions
        of certain members of the U.S. Congress, there is uncertainty with respect to the impact, if any, on the provisions of the PPACA affecting us. While any legislative and regulatory changes will likely take time to develop, and may or may not have an
        impact on the regulatory regime to which we are subject, we cannot predict the ultimate content, timing or effect of any healthcare reform legislation or the impact of potential legislation on us.</div>
      <div style="text-align: justify; line-height: 1.25;">&#160;&#160;</div>
      <div style="text-align: justify; line-height: 1.25;"><font style="font-weight: bold;">Environmental Matters</font>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">We are subject to various environmental, health and safety laws and regulations, including those governing air emissions, water and wastewater discharges, noise emissions, the use, transport,
          management and disposal of chemicals and hazardous materials, the import, export and registration of chemicals, and the cleanup of contaminated sites. Based on information currently available to us, we do not expect environmental costs and
          contingencies to have a material adverse effect on us. The operation of our business and facilities, however, entails risks in these areas. Significant expenditures could be required in the future to comply with environmental or health and safety
          laws, regulations, or requirements.</div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">In Israel, where our contract manufacturer produces all of our products, businesses storing or using certain hazardous materials (including materials necessary for our manufacturing process) are
          required, pursuant to the Israeli Dangerous Substances Law, 5753-1993, to obtain a toxin permit from the Ministry of Environmental Protection.</div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">In the European marketplace, electrical and electronic equipment is required to comply with the Directive on Waste Electrical and Electronic Equipment, which aims to prevent waste by encouraging
          reuse and recycling, and the Directive on Restriction of Use of Certain Hazardous Substances, which restricts the use of six hazardous substances in electrical and electronic products. Our products and certain components of such products &#8220;put on
          the market&#8221; in the EU (whether or not manufactured in the EU) are subject to these directives. Additionally, we are required to comply with certain laws, regulations, and directives, including the Toxic Substances Control Act in the United States
          and REACH in the EU, governing chemicals. These and similar laws and regulations require the testing, reporting and registration of certain chemicals we use and ship. We believe we are in compliance in all material respects with applicable
          environmental laws and regulations.</div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">16</font></div>
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      &#160;<br>
      <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Manufacturing</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">
          <div style="text-indent: 36pt; line-height: 1.25;">ReWalk includes off-the-shelf and custom-made components produced to our specifications by various third parties, for technical and cost-effectiveness. We have contracted with Sanmina Corporation
            (&#8220;Sanmina&#8221;), a well-established contract manufacturer with expertise in the medical device industry, for the manufacture of all of our products. Pursuant to this contract, Sanmina manufactures SCI Products and ReStore at its facility in
            Ma&#8217;alot, Israel. All ReWalk Personal units are manufactured pursuant to the same set of specifications, and all ReWalk Rehabilitation units are manufactured pursuant to another set although the Company does not intend to manufacture this design
            going forward. We place our manufacturing orders with Sanmina pursuant to purchase orders or by providing forecasts for future requirements. We may terminate our relationship with Sanmina at any time upon written notice. Either we or Sanmina
            may terminate the relationship in the event of a material breach, subject to a 30-day cure period. Our agreement with Sanmina contains a limitation on liability that applies equally to both us and Sanmina.</div>
        </div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We believe that this contract manufacturing relationship allows us to operate our business efficiently by focusing our internal efforts on the development and commercialization
        of our technology and our products and provides us with substantial scale-up capacity. We regularly test quality on-site at Sanmina&#8217;s facility and we obtain full quality inspection reports. We maintain a non-disclosure agreement with Sanmina.</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We develop certain of the software components internally and license other software components that are generally available for commercial use as open-source software.</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We manufacture products based upon internal sales forecasts. We deliver products to customers and distributors based upon purchase orders received, and our goal is to fulfill
        each customer&#8217;s order for products in regular production within two weeks of receipt of the order.</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Suppliers</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">We have contracted with Sanmina for the sourcing of all components and raw materials necessary for the manufacture of our products although there are instances that we purchase raw material
          ourselves. Components of our products and raw materials come from suppliers in the United States, Europe, China, and Israel, and we depend on certain of these components and raw materials, including certain electronic parts, for the manufacture
          of our products. To date, we have not experienced significant volatility in the prices of these components and raw materials. However, such prices are subject to a number of factors, including purchase volumes, general economic conditions,
          currency exchange rates, industry cycles, production levels and scarcity of supply.</div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We believe that our and Sanmina&#8217;s facilities, our contracted manufacturing arrangement, and our supply arrangements are sufficient to support our potential capacity needs for the
        foreseeable future.</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;&#160;</div>
      <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Employees</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">As of December&#160;31, 2020, we had 49 employees (including full-time and hourly employees), of whom 21 were located in the United States, 15 were located in Israel and 13 were
        located in Europe. The majority of our employees are, and have been, engaged in sales and marketing activities. We do not employ a significant number of temporary or part time employees.</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">We are subject to labor laws and regulations within our locations mainly in the U.S., Germany, and Israel. These laws and regulations principally concern matters such as pensions, paid annual
          vacation, paid sick days, length of the workday and work week, minimum wages, overtime pay, insurance for work-related accidents, severance pay and other conditions of employment. Our employees are not represented by a labor union. We consider
          our relationship with our employees to be good. To date, we have not experienced any work stoppages.</div>
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">17</font></div>
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-indent: 36pt; line-height: 1.25;">&#160;<br>
      </div>
      <div style="line-height: 1.25; font-weight: bold;">Financial Information about Geographic Areas and Significant Customer Information</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The following table sets forth the geographical breakdown of our revenues for each of the years ended December&#160;31, 2020 and 2019 (in thousands):</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z9ddebf2746094123b44a5462d23a3362" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;">

          <tr>
            <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
              <div style="text-align: center; line-height: 1.25; font-weight: bold;">Year Ended December 31,</div>
            </td>
            <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
              <div style="text-align: center; line-height: 1.25; font-weight: bold;"> 2020</div>
            </td>
            <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
              <div style="text-align: center; line-height: 1.25; font-weight: bold;">2019</div>
            </td>
            <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">Revenues based on customer&#8217;s location:</div>
            </td>
            <td valign="bottom" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" colspan="2" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" colspan="2" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%;">
              <div style="line-height: 1.25; margin-left: 9pt;">Israel</div>
            </td>
            <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">
              <div style="line-height: 1.25;">$</div>
            </td>
            <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="line-height: 1.25;">-</div>
            </td>
            <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="line-height: 1.25;">2</div>
            </td>
            <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25; margin-left: 9pt;">United States</div>
            </td>
            <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">1,746</div>
            </td>
            <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">2,003</div>
            </td>
            <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%;">
              <div style="line-height: 1.25; margin-left: 9pt;">Europe</div>
            </td>
            <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="line-height: 1.25;">2,631</div>
            </td>
            <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="line-height: 1.25;">2,832</div>
            </td>
            <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25; margin-left: 9pt;">Asia-Pacific</div>
            </td>
            <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">8</div>
            </td>
            <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">36</div>
            </td>
            <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%;">
              <div style="line-height: 1.25; margin-left: 9pt;">Latin America</div>
            </td>
            <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="line-height: 1.25;">6</div>
            </td>
            <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="line-height: 1.25;">&#8212;</div>
            </td>
            <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25; margin-left: 9pt;">Africa</div>
            </td>
            <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">2</div>
            </td>
            <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">&#8212;</div>
            </td>
            <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px;">
              <div style="line-height: 1.25;">Total revenues</div>
            </td>
            <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
            <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
              <div style="line-height: 1.25;">$</div>
            </td>
            <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
              <div style="line-height: 1.25;">4,393</div>
            </td>
            <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
            <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
            <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
              <div style="line-height: 1.25;">$</div>
            </td>
            <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
              <div style="line-height: 1.25;">4,873</div>
            </td>
            <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          </tr>

      </table>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Additional discussion of financial information by reportable segment and geographic area and sales in excess of 10% of total revenues to certain of our customers is contained in
        Note 13 to our consolidated financial statements set forth in &#8220;Part II. Item 8. Financial Statements and Supplementary Data&#8221; of this annual report.</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"> <br>
      </div>
    </div>
  </div>
  <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Recent Developments&#160;</div>
  <div style="text-indent: -14.75pt; margin-left: 23.75pt; line-height: 1.25;">&#160;</div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze3cfa3a1691d472ebf004985b108d94c">

      <tr>
        <td style="width: 36pt;"><br>
        </td>
        <td style="width: 18pt; vertical-align: top; align: right;">&#9679;</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div>
            <div style="text-align: left; line-height: 1.25;">Q4 2020 revenue was $1.2 million and FY 2020 revenue was $4.4 million, compared to $1.2 million in Q4 2019 and $4.9 million in FY 2019;</div>
          </div>
        </td>
      </tr>

  </table>
  <div style="margin-left: 29.4pt; line-height: 1.25;">&#160;</div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7dc9e85dd7614202aa8a5ad7cdc96bd4">

      <tr>
        <td style="width: 36pt;"><br>
        </td>
        <td style="width: 18pt; vertical-align: top; align: right;">&#9679;</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div>
            <div style="text-align: left; line-height: 1.25;">
              <div style="line-height: 1.25;">Going concern qualification removed as our cash at the end of the year was $20.3 million and an additional $13.2 million was received through warrants exercises to date in 2021;</div>
            </div>
          </div>
        </td>
      </tr>

  </table>
  <div style="margin-left: 29.4pt; line-height: 1.25;">&#160;</div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zbe917692c065457a805630fc3e054094">

      <tr>
        <td style="width: 36pt;"><br>
        </td>
        <td style="width: 18pt; vertical-align: top; align: right;">&#9679;</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div>
            <div style="text-align: left; line-height: 1.25;">Continued CMS progress made with issuance of HCPCS Level II Code for ReWalk Exoskeleton enabling an upcoming application for coverage;</div>
          </div>
        </td>
      </tr>

  </table>
  <div style="margin-left: 29.4pt; line-height: 1.25;">&#160;</div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z977d763cbb734efdae80aacde672643b">

      <tr>
        <td style="width: 36pt;"><br>
        </td>
        <td style="width: 18pt; vertical-align: top; align: right;">&#9679;</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div>
            <div style="text-align: left; line-height: 1.25;">Expended German reimbursement contracts with additional insurers;</div>
          </div>
        </td>
      </tr>

  </table>
  <div style="margin-left: 29.4pt; line-height: 1.25;">&#160;</div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7198366da9684281b1c0829707b384d2">

      <tr>
        <td style="width: 36pt;"><br>
        </td>
        <td style="width: 18pt; vertical-align: top; align: right;">&#9679;</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div>FY 2020 operating expenses were $14.2 million compared to $16.8 million in FY 2019.</div>
        </td>
      </tr>

  </table>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">18</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <div style="line-height: 1.25">&#160; <br>
  </div>
  <div style="line-height: 1.25;"><a name="ITEM1A.RISKFACTORS"><!--Anchor--></a><font style="font-weight: bold;">ITEM 1A. RISK FACTORS</font>&#160;</div>
  <div style="text-align: justify; line-height: 1.25; font-style: italic;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic;">Our business faces significant risks. You should carefully consider all of the information set forth in this annual report and in our other filings with the SEC,
    including the following risk factors which we face and which are faced by our industry. Our business, financial condition and results of operations could be materially and adversely affected by any of these risks. In that event, the trading price of
    our ordinary shares would likely decline and you might lose all or part of your investment. This report also contains forward-looking statements that involve risks and uncertainties. Our results could materially differ from those anticipated in these
    forward-looking statements, as a result of certain factors including the risks described below and elsewhere in this report and our other SEC filings. See also &#8220;Special Note Regarding Forward-Looking Statements and Risk Factors Summary&#8221; on page (ii).</div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Risks Related to Our Business and Our Industry</div>
  <div style="text-align: justify; line-height: 1.25;">&#160;</div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold;">The COVID-19 pandemic has adversely affected and may continue to materially and adversely impact our business, our operations and our financial results.</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The impact of the COVID-19 pandemic has resulted in and will likely continue to result in significant disruptions to the global economy, as well as businesses and capital markets
      around the world. In an effort to halt the outbreak of COVID-19, a number of countries, including the United States and Germany where we have key operations, placed significant restrictions on travel, and many businesses announced extended
      closures.&#160;&#160; It is unclear how long total or partial shutdowns may last and whether additional shutdowns will be necessary to the extent future outbreaks occur.</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The COVID-19 outbreak has had, and a continuing outbreak or future outbreaks may have, several adverse effects on our business, results of operations and financial condition.</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-style: italic;">Sales.&#160;&#160;</font>In particular, the steps we have taken to&#160;safeguard employees and patients have curtailed direct sales activities, including our
      ability to train patients and rehabilitation centers on how to use our system, which has adversely impacted our revenues in 2020.&#160; The overall&#160;impact of the limitations on our sales efforts are currently hard to determine because, in addition to the
      short-term impacts, we are unable to interact and test our system with potential new patients at the same levels that we have before the COVID-19 outbreak.&#160; It may take an extended period after current restrictions end for us to engage potential new
      clients.&#160; We continue to monitor our sales pipeline on a day-to-day basis&#160;in order to assess the quarterly effect of these limitations as some have short term effects and some affects our future pipeline development.</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">
          <div style="line-height: 1.25;">
            <div style="text-indent: 36pt; line-height: 1.25;">
              <div style="line-height: 1.25;">
                <div style="text-indent: 36pt; line-height: 1.25;"><font style="font-style: italic;">Repairs.&#160;</font>In addition, when a region is under movement restrictions we are sometimes unable to&#160;repair the device onsite and as a result ship a
                  temporary replacement systems in some cases, provide remote service if possible, deliver service parts directly to our customers or perform the repair onsite when circumstances allow it.&#160; We cannot be certain when social distancing
                  restrictions will be fully lifted and, once they are fully lifted, whether sales of our systems will offset the revenue that we have forgone earlier in the year.&#160; We also cannot be certain that social distancing restrictions or other
                  measures will not be reinstated in the event of a future outbreak of COVID-19 or similar outbreak.</div>
              </div>
            </div>
          </div>
        </div>
      </div>
    </div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: center; line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">
          <div style="line-height: 1.25;">
            <div style="text-indent: 36pt; line-height: 1.25;"><font style="font-style: italic;">Production and Supply Chain.</font> We had several delays in parts shipment and an increase in shipment costs during 2020. These delays have not affected our
              product availability, but<font style="font-style: italic;">&#160;</font>our manufacturing may be impacted due to supply chain delays or adverse impacts on our production capacity due to government directives or health protocols that might impact
              our production facility.&#160;In addition, given the impact of current limitations on our sales activities, it has become hard for us to effectively forecast our future requirements for systems.&#160; Accordingly, there is a greater risk that we may
              overproduce or underproduce compared to sales.</div>
          </div>
        </div>
        <div style="line-height: 1.25">&#160;</div>
      </div>
    </div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-style: italic;">Regulatory and clinical trials.&#160;</font>Limitations on travel and business closures recommended by federal, state, and local governments, could,
      among other things, impact our ability to enroll patients in clinical trials, recruit clinical site investigators, and obtain timely approvals from local regulatory authorities.&#160; In our postmarket study that we continue to conduct, we have faced
      decreased ability to contact patients where a patient&#8217;s COVID-19 status is unknown. Regulatory oversight and actions regarding our products have been and may continue to be disrupted or delayed in regions impacted by COVID-19, including the United
      States and Europe, which have been and may continue to impact review and approval timelines for products in development and/or changes to existing products that need regulatory review and approval.</div>
    <div style="line-height: 1.25">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;"><font style="font-style: italic;">Negative impacts on our suppliers and employees</font>.&#160; COVID-19 may impact the health of our employees, directors, partners, or customers, reduce the
          availability of our workforce or those of companies with which we do business, divert our attention toward succession planning, or create disruptions in our supply or distribution networks. The adverse effects of such events on us may include
          disruption to our operations, or demand for our products in the short and/or long term.</div>
      </div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">19</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Our future results of operations and liquidity could be adversely impacted by delays in payments of outstanding receivable amounts beyond normal payment terms, supply chain
      disruptions and operational challenges faced by our customers.&#160; Continued outbreaks of COVID-19 could result in a widespread health crisis that could adversely affect the economies and financial markets of many countries, resulting in an economic
      downturn or a global recession that could cause significant volatility or decline in the trading price of our securities, affect our ability to execute strategic business activities, affect demand for our products and likely impact our operating
      results. These may further limit or restrict our ability to access capital on favorable terms, or at all, lead to consolidation that negatively impacts our business, weaken demand, increase competition, cause us to reduce our capital spend further,
      or otherwise disrupt our business.</div>
    <div style="line-height: 1.25">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold;">
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25; font-style: italic; font-weight: bold;">We may not have sufficient funds to meet certain future capital requirements, which could impair our efforts to develop and commercialize existing and new products, and may need
          to take advantage of various forms of capital-raising transactions, future equity financings, strategic transactions, or borrowings may also further dilute our shareholders or place us under restrictive covenants limiting our ability to operate.</div>
      </div>
    </div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">
          <div style="line-height: 1.25;">
            <div style="text-indent: 36pt; line-height: 1.25;">We intend to finance operating costs until we reach profitable operation with existing cash on hand, continued close examination of our operating spend and potential reduction in specific
              areas, issuances of equity and/or debt securities, and other future public or private issuances of securities, or through a combination of the foregoing. We raised approximately $23.2 million in net proceeds during 2020. However, we may need
              to seek additional sources of financing if we require more funds than anticipated during the next 12 months or in later periods.</div>
          </div>
        </div>
      </div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">
          <div style="line-height: 1.25;">
            <div style="text-indent: 36pt; line-height: 1.25;">
              <div style="line-height: 1.25;">
                <div style="text-indent: 36pt; line-height: 1.25;">Raising additional capital in the public markets could entail certain downsides. Although we will become eligible to begin using Form S-3 again on April 1, 2021, we could be limited to
                  selling no more than one-third of our unaffiliated market capitalization, or public float, on Form S-3 in a 12-month period if our public float again falls below $75 million. For more information on our inability to use Form S-3, see
                  &#8220;Part II. Item 2, Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8212;Liquidity and Capital Resources&#8212;Equity Raises&#8221; below. Additionally, under our December 2020 purchase agreement with certain investors,
                  we agreed for a period of one year following December 3, 2020, not to (i) issue or agree to issue equity or debt securities convertible into, or exercisable or exchangeable for, ordinary shares at a conversion price, exercise price or
                  exchange price which floats with the trading price of the ordinary shares or which may be adjusted after issuance upon the occurrence of certain events or (ii) enter into any agreement, including an equity line of credit, whereby the
                  Company may issue securities at a future-determined price, other than an at&#8211;the-market facility with the placement agent, H.C. Wainwright &amp; Co, LLC, beginning on February 1, 2021. Such limitations may inhibit our ability to access
                  capital efficiently. Additionally, due to these limitations on our use of Form S-3 and the use of our current at-the-market offering program with a separate bank, Piper Jaffray &amp; Co., we may be required to seek other methods for
                  access to capital, such as a registration statement on Form S-1.&#160; The preparation of a registration statement on Form S-1 is and has in the past been, more time-consuming and costly. We may also conduct fundraising transactions in the
                  form of private placements, potentially with registration rights or priced at a discount to the market value of our ordinary shares (similar to a transaction we conducted in December 2020), which could require shareholder approval under
                  the rules of Nasdaq, or other equity raise transactions such as equity lines of credit. In addition to entailing increased capital costs, any such transactions have historically resulted in and could result in substantial dilution of our
                  shareholders&#8217; interests and may also transfer control to a new investor or diminish the value of an investment in our ordinary shares.</div>
              </div>
            </div>
          </div>
        </div>
      </div>
    </div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">We may also need to pursue strategic transactions, such as joint ventures, in-licensing transactions, or the sale of our business or all or substantially all of our assets. We are in discussions
          routinely with such possible sources of additional funding. These private financings and strategic transactions have in the past and could in the future require significant management attention, disrupt our business, adversely affect our
          financial results, be unsuccessful or fail to achieve the desired results. Agreements governing any borrowing arrangement may also contain covenants that could restrict our operations.</div>
      </div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Overall, if we cannot raise the required funds, or cannot raise them on terms acceptable to us or investors, we may be forced to curtail substantially our current operations or cease
    operations altogether.</div>
  <div style="line-height: 1.25;">
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">20</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold;"><br>
      While we have regained compliance with the quantitative continued listing rules of the Nasdaq Capital Market, we may not be able to maintain the listing of our ordinary shares on the Nasdaq Capital Market going forward, which could adversely affect
      our liquidity and the trading volume and market price of our ordinary shares.</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">As previously disclosed, on March 24, 2020, we received a notification letter from Nasdaq stating that we failed to comply with the closing bid price requirement of Nasdaq Rule 5550(a) (&#8220;Rule
          5550(a)&#8221;). If our closing bid price is less than $1 per share for 30 consecutive business days, we will be deficient with Rule 5550(a). On May 11, 2020, we received a notice from Nasdaq stating that we have regained compliance with Rule 5550(a)
          since our share price was above $1 for 10 consecutive business days and that the matter is now closed.&#160; Our closing share price as of February 16, 2021 was $5.20 If we become non-compliant with Rule 5550(a) in the future (absent any relief, such
          as the temporary relief imposed by Nasdaq during the ongoing COVID-19 pandemic) and we fail to regain compliance with Rule 5550(a) during the rule&#8217;s applicable cure period, Nasdaq will notify us that our ordinary shares are subject to delisting.
          In the case of non-compliance, there can be no assurance that we will be able to regain compliance with the applicable rules.</div>
      </div>
    </div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Additionally, as previously disclosed, in October 2018, we received a notification letter from Nasdaq stating that, under Nasdaq Rule 5550(b), or Rule 5550(b), we failed to comply
      with the minimum $35 million market value of listed securities requirement for continued listing on the Nasdaq Capital Market as of October 26, 2018 and did not meet the rule&#8217;s alternative $2.5 million shareholders&#8217; equity and $500,000 net income
      standards as of applicable balance sheet and income statement dates. We regained compliance with Rule 5550(b) in April 2019. Our shareholders&#8217; equity was $21.8 million as of December 31, 2020. However, if our quarterly or annual report for a
      subsequent fiscal period does not evidence such compliance, we may become immediately subject to delisting without a cure period. For example, if we cannot maintain the requisite cash levels for a compliant amount of shareholders&#8217; equity, our
      ordinary shares may be at serious risk of immediate delisting.</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We would be permitted to appeal any delisting determination to a Nasdaq Hearings Panel, and our ordinary shares would remain listed on the Nasdaq Capital Market pending the panel&#8217;s
      decision after the hearing. If we do not appeal the delisting determination or do not succeed in such an appeal, our ordinary shares would be removed from trading on the Nasdaq Capital Market. Any delisting determination could seriously decrease or
      eliminate the value of an investment in our ordinary shares and other securities linked to our ordinary shares. While an alternative listing on an over-the-counter exchange could maintain some degree of a market in our ordinary shares, we could face
      substantial material adverse consequences, including, but not limited to, the following: limited availability for market quotations for our ordinary shares; reduced liquidity with respect to our ordinary shares; a determination that our ordinary
      shares are &#8220;penny stock&#8221; under SEC rules, subjecting brokers trading our ordinary shares to more stringent rules on disclosure and the class of investors to which the broker may sell the ordinary shares; limited news and analyst coverage, in part due
      to the &#8220;penny stock&#8221; rules; decreased ability to issue additional securities or obtain additional financing in the future; and potential breaches under or terminations of our agreements with current or prospective large shareholders, strategic
      investors and banks. The perception among investors that we are at heightened risk of delisting could also negatively affect the market price of our securities and trading volume of our ordinary shares.</div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;&#160;</div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">21</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  &#160;
  <div style="line-height: 1.25;">
    <div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold;">Our future growth and operating results will depend on our ability to develop, receive regulatory clearance for and commercialize new products and penetrate new
      product and geographic markets.</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We are currently engaged in research and development efforts to address the needs of patients with mobility impairments besides paraplegia, such as stroke, and, in the future, we
      may engage in efforts to address these needs in patients with other conditions such as multiple sclerosis, cerebral palsy Parkinson&#8217;s disease and elderly assistance. We also began commercializing in 2019 our first product for stroke patients, the
      ReStore. For more information, see &#8220;Part, Item 1. Business&#8212;ReStore Products&#8221; below. In addition to other research and development projects, we currently collaborate with Harvard University&#8217;s Wyss Institute for Biologically Inspired Engineering to
      design, research and develop lightweight exoskeleton system technologies for lower limb disabilities intended to treat stroke, multiple sclerosis, mobility limitations for the elderly and other medical applications. As part of the collaboration,
      Harvard has also licensed to us certain of its intellectual property relating to lightweight exoskeleton system technologies for lower limb disabilities. We are obligated to use commercially reasonable efforts to develop products under the license in
      accordance with an agreed-upon development plan and to introduce and market such products commercially.</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We expect that a portion of our revenues will be derived, in the next few years, from the ReStore soft suit exoskeleton product and, in later years, if we chose to advance the
      current designs, from other new products such as a home use device for stroke patients or new products of ours aimed at addressing other medical indications which affect the ability to walk, including multiple sclerosis, cerebral palsy, Parkinson&#8217;s
      disease and elderly assistance. As such, our future results will depend on our ability to successfully develop and commercialize such new products. We cannot ensure you that we will be able to introduce new products, products currently under
      development and products contemplated for future development for additional indications in a timely manner, or at all as it depends on our available resources to fund such projects While we received governmental clearance to market our ReStore
      product on the anticipated timetable in 2019, obtaining clearance for any other soft suit exoskeleton products we may develop could involve an extensive, costly and time-consuming process, which would delay any planned commercialization. For more
      information on the clearance processes, see &#8220;Part I, Item 1. Business&#8212;Government Regulation&#8221; below.</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Harvard may also terminate its license agreement with us if we fail to obtain the requisite insurance or become insolvent. Any such termination of this aspect of the collaboration
      with Harvard could impair our research and development efforts into lightweight soft suit exoskeleton system technologies for lower limb disabilities. In addition, we may not be able to clinically demonstrate the medical benefits of our products for
      new indications. We have limited clinical data demonstrating the benefits of our products and we might not be able to support the economic benefits our products have for the customer. We may also be unable to gain necessary regulatory approvals to
      enable us to market new products for additional indications or the regulatory process may be more costly and time-consuming than expected, which could adversely impact us given our cash position and ongoing capital requirements. We might also
      terminate or change our research collaboration agreement with Harvard if we see limited market to the current developed products or seek to focus our available resources to other areas of the business.</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Even if we are successful in the design and development of new products, our growth and results of operations will depend on our ability to penetrate new markets and gain
      acceptance by non-SCI markets such as the stroke rehabilitation market, and, in the longer term, the home use device market for stroke-caused lower limb disability, multiple sclerosis, elderly assist and cerebral palsy patients. We may not be able to
      gain such market acceptance in these communities in a timely manner, or at all.</div>
    <div style="line-height: 1.25">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">While our new products currently under development will share some aspects of the core technology platform in our current products, their design features and components may differ
      from our current products. Accordingly, these products will also be subject to the risks described under &#8220;We rely on sales of our ReWalk and ReStore systems and related service contracts and extended warranties for our revenue. We may not be able to
      achieve or maintain market acceptance or generate sufficient revenues from such contracts.&#8221; To the extent we are unable to successfully develop and commercialize products to address indications other than paraplegia, we will not meet our projected
      results of operations and future growth.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">22</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold;">We rely on sales of our ReWalk and ReStore systems and related service contracts and extended warranties for our revenue. We may not be able to achieve or
      maintain market acceptance of our ReWalk or ReStore systems, or to generate sufficient revenues from these current and future products.</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">We currently rely, and expect in the future to rely, on sales of our ReWalk and ReStore systems and related service contracts and extended warranties for our revenue. We began marketing in 2019 in
          the United States and the EU (following the receipt of FDA and CE mark clearance) the ReStore lightweight soft suit exoskeleton, which is designed to support mobility for individuals suffering from other lower limb disabilities. Several factors
          could negatively affect our ability to achieve and maintain market acceptance of our ReWalk system or our ReStore system, which could in turn materially impair our business, financial condition, and operating results.</div>
      </div>
    </div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;"> <br>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z763203c8c69b4f19a87f8d64e58c078d">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div><font style="font-style: italic;">ReWalk</font>. We have sold only a limited number of ReWalk systems, and market acceptance and adoption depend on educating people with limited upright mobility and health care providers as to the
                distinct features, ease-of-use, positive lifestyle impact and other benefits of ReWalk compared to alternative technologies and treatments. ReWalk may not be perceived to have sufficient potential benefits compared with these alternatives.
                Users may also choose other therapies due to disadvantages of ReWalk, including the time it takes for a user to put on ReWalk, the slower pace of ReWalk compared to a wheelchair, the weight of ReWalk when carried, which makes it more
                burdensome for a companion to transport than a wheelchair, and the requirement that users be accompanied by a trained companion. Also, we believe that healthcare providers tend to be slow to change their medical treatment practices because
                of perceived liability risks arising from the use of new products and the uncertainty of third-party reimbursement. Accordingly, healthcare providers may not recommend ReWalk until there is sufficient evidence to convince them to alter the
                treatment methods they typically recommend, such as prominent healthcare providers or other key opinion leaders in the spinal cord injury community recommending ReWalk as effective in providing identifiable immediate and long-term health
                benefits.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;">&#160;</div>
      </div>
      <div style="line-height: 1.25;">
        <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 54pt;">
          <div style="line-height: 1.25;">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">In addition, we may be unable to sell on a profitable basis current ReWalk systems or other future products for home and community use if third-party payors deny
              coverage, limit reimbursement, or reduce their levels of payment, or if our costs of production increase faster than increases in reimbursement levels. Several private and national insurers in the United States and Europe have provided
              reimbursement for ReWalk in certain cases to date, the VA maintains its policy of covering the cost of ReWalk devices for qualifying veterans across the United States and German insurers such as Germany&#8217;s national social accident insurance
              provider, Deutsche Gesetzliche Unfallversicherung (the &#8220;DGUV&#8221;) indicated that its member payers will approve the supply of exoskeleton systems for qualifying beneficiaries on a case-by-case basis as the ReWalk device was issued a code in the
              medical device directory in Germany and in 2020 we announced that we accepted a binding offer with the DGUV to supply our ReWalk Personal 6.0 to qualified patients as well as with other payors in Germany. However, no broad uniform policy of
              coverage and reimbursement for electronic exoskeleton medical technology exists among third-party payors in the United States and Germany. Health insurance companies and other third-party payors in the future may also not deliver adequate
              coverage or reimbursement for our current or future products designed for home and community use. The VA or DGUV or other payors may cancel or materially curtail their current policy of providing coverage ReWalk devices in the United States
              and Germany for qualifying individuals who have suffered spinal cord injury, or we may not place enough units through to make our sales profitable under their policies. For more information, see &#8220;&#8212;Risks Related to our Business and our
              Industry&#8212; We may fail to secure or maintain adequate insurance coverage or reimbursement for our products by third-party payors, which risk may be heightened if insurers find the products to be investigational or experimental or if new
              government regulations change existing reimbursement policies. Additionally, such coverage or reimbursement, even if maintained, may not produce revenues that are high enough to allow us to sell our products profitably.&#8221;</div>
          </div>
        </div>
      </div>
      <div style="line-height: 1.25;">
        <div style="text-align: center; line-height: 1.25;"> <br>
        </div>
      </div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">23</font></div>
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <br>
      <div style="line-height: 1.25">
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>
                  <div style="line-height: 1.25;"><font style="font-style: italic;">ReStore</font>. The ReStore system is designed to provide advantages to stroke rehabilitation clinics and therapists as compared to other traditional therapies and devices
                    by minimizing setup time, improving patients&#8217; clinical results during therapy, supplying real-time analytics to optimize session productivity, and generating ongoing data reports to assist with tracking patient progress. Other potential
                    secondary benefits for rehabilitation clinics include reducing staffing requirements, staff fatigue and the risk for potential staff injuries. Since the ReStore device is currently being used only in the rehabilitative clinical setting,
                    its market reception will depend heavily on our ability to demonstrate to clinics and therapists the systemic and economic benefits of using the ReStore device, its clinical advantage when compared to other devices or manual therapy,
                    the functionality of the device for a significant portion of the patients that they treat and the overall advantages that the device provides to their patients compared to other technologies.</div>
                </div>
              </td>
            </tr>

        </table>
      </div>
      <div style="line-height: 1.25;">&#160;</div>
    </div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 36pt;">As a general matter, achieving and maintaining market acceptance of our current or future products could be negatively impacted by many
      other factors, including, but not limited to the following: contribution to death or serious injury or malfunction, results of clinical studies relating to our or similar products; claims that our products, or any of their components, infringe on
      patent or other intellectual property rights of third parties; our ability to support financially and leverage our sales, marketing and training infrastructure, as well as our level of research and development efforts; our ability to enhance and
      broaden our research and development efforts and product offerings in response to the evolving demands of people with paraplegia and lower limb disability and healthcare providers; our estimates regarding our current or future addressable market;
      perceived risks associated with the use of our products or similar products or technologies; the introduction of new competitive products or greater acceptance of competitive products; adverse regulatory or legal actions relating to our products or
      similar products or technologies; and problems arising from the outsourcing of our manufacturing capabilities, or our existing manufacturing and supply relationships. Any or all of these factors could materially and negatively impact our business,
      financial condition and operating results.</div>
    <div style="line-height: 1.25">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold;">The market for medical exoskeletons, including soft suit devices, remains relatively new and unproven, and important assumptions about the potential market for
      our current and future products may be inaccurate.</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The market for medical exoskeletons, including lightweight exo-suit devices, remains relatively new and unproven. Accordingly, it is difficult to predict the future size and rate
      of growth of the market. We cannot be certain whether the market will continue to develop or if medical exoskeletons will achieve and sustain a level of market acceptance and demand sufficient for us to continue to generate revenue and achieve
      profitability.</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We obtained FDA clearance for our ReWalk Personal device in June 2014. This clearance permits us to market the device for use by individuals with spinal cord injury at levels T7 to
      L5 and for use by individuals in rehabilitation institutions with spinal cord injury at levels T4 to L5. The FDA&#8217;s clearance requires users of the device to meet the following criteria: healthy hands and shoulders that can support crutches, healthy
      bone density, no skeletal fractures, in good general health, ability to stand with a stander device, weight of less than 220 pounds/100 kilograms and height between 5 feet 3 inches and 6 feet 2 inches/1.60 meters and 1.88 meters. Additionally, the
      FDA clearance contraindicates psychiatric or cognitive conditions that could interfere with a user&#8217;s proper operation of the device and various other clinical conditions, including pregnancy, severe concurrent medical diseases, a history of severe
      neurological injuries other than spinal cord injury, impaired joint mobility, unhealed limbs or pelvic fractures or unstable spine, severe spasticity and significant and chronic loss of joint mobility due to structural changes in non-bony tissue.</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: center; line-height: 1.25;"> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">24</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: center; line-height: 1.25;">&#160; <br>
    </div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We obtained FDA clearance for our ReStore system in June 2019. This clearance permits us to market the device to be used to assist ambulatory functions in rehabilitation
      institutions for people with hemiplegia or hemiparesis due to stroke who can ambulate at least 1.5m (5ft) with no more than minimal to moderate levels of assistance. The FDA&#8217;s clearance requires users of the device to meet the following criteria:
      height between 4 feet 8 inches and 6 feet 3 inches/1.42 meters and 1.92 meters and weight of less than 264 pounds/120 kilograms. Additionally, the FDA clearance contraindicates persons with the following conditions should not use the Restore: serious
      co-morbidities that may interfere with ability to safely use ReStore, severe peripheral artery disease (PAD), unresolved deep vein thrombosis (DVT), range of motion (ROM) restrictions at the ankle that preclude safe walking, cognitive impairments
      that may interfere with safe operation of the device, presence of open wounds or broken skin at device locations, urethane allergy or current pregnancy.</div>
    <div style="line-height: 1.25">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Future products for those with paraplegia or other mobility impairments or spinal cord injuries, may have the same or other restrictions.</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-indent: 36pt; line-height: 1.25;">Our business strategy is based, in part, on our estimates of the number of mobility-impaired individuals and the incurrence of spinal cord injuries and strokes in our target markets, and the
          percentage of those groups that would be able to use our current and future products. Limited sources exist to obtain reliable market data with respect to the number of mobility-impaired individuals and the incurrence of spinal cord injuries and
          strokes in our target markets. In addition, there are no third-party reports or studies regarding what percentage of those with limited mobility, spinal cord injuries would be able to use exoskeletons, in general, or our current or planned future
          products, in particular. Our assumptions may be inaccurate and may change.</div>
      </div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">
          <div style="line-height: 1.25;">
            <div style="text-indent: 36pt; line-height: 1.25;">The National Spinal Cord Injury Statistical Center, or NSCISC, estimates that as of 2019 there were 291,000 people in the United States living with SCI, and that the annual incidence of SCI
              cases is approximately 17,730 new cases per year. Based on information from a 2017 report by the NSCISC, 40.6% of the total U.S. population of SCI patients suffered injuries between levels T4 and L5. Three published ReWalk trials with respect
              to such eligible SCI patients had an aggregate screening acceptance rate of 79% considering all current FDA limitations, resulting in an estimated 32% of the total population of SCI patients being qualified candidates for current ReWalk
              products under its medical labeling criteria. There may be other permanent or short-term factors that affect the market size such as the ability to use the device in the user&#8217;s current home environment and available companion support. With
              regards to our ReStore product for stroke rehabilitation, as the indication of use is currently in rehabilitation clinics our target market is based on the number of current and future clinics who treat stroke patients. Although there are
              thousands of inpatient, outpatient, skilled nursing facilities and rehabilitation clinics providing therapy in the U.S. for example we believe that only a portion of the clinics will decide to include ReStore in their stroke rehab program.
              For more information on our expectations regarding these plans, see &#8220;&#8212;Our future growth and operating results will depend on our ability to develop and commercialize new products and penetrate new markets&#8221; below. For more information
              regarding the potential market for future products, including our lightweight soft suit exoskeleton, see &#8220;Part I, Item 1. Business&#8212;ReWalk Personal and ReWalk Rehabilitation Products&#8212;Market Opportunity&#8221; above.</div>
          </div>
        </div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="line-height: 1.25;"></div>
      </div>
    </div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">We cannot assure you that our estimate regarding our current products is accurate or that our estimate regarding future products will remain the same. FDA or CE mark clearance for such products, if
          received at all, may contain different limitations from the ones the FDA or EU has placed on the devices we currently market for paraplegia. If our estimates of our current or future addressable market are incorrect, our business may not develop
          as we expect, and the price of our securities may suffer.</div>
        <div style="line-height: 1.25">&#160;</div>
      </div>
    </div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold;">We may fail to secure or maintain adequate insurance coverage or reimbursement for our products by third-party payors, which risk may be heightened if insurers
      find the products to be investigational or experimental or if new government regulations change existing reimbursement policies. Additionally, such coverage or reimbursement, even if maintained, may not produce revenues that are high enough to allow
      us to sell our products profitably.</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">We expect that in the future a significant source of payment for ReWalk systems will be private insurance plans and managed care programs, government programs such as the VA, Medicare and Medicaid,
          worker&#8217;s compensation, and other third-party payors. We have similar expectations for our ReStore product, although we possess less information regarding the payment by third-party payors for this product as we only began commercializing it in
          2019.</div>
      </div>
    </div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In December 2015, the VA issued a national reimbursement policy for the ReWalk system, which entails the evaluation, training and procurement of ReWalk Personal exoskeleton systems
      for all qualifying veterans across the United States. Additionally, in September 2017, German insurer BARMER GEK (&#8220;Barmer&#8221;) signed a confirmation and letter of agreement regarding the provision of ReWalk systems for all qualifying beneficiaries and
      the German national social accident insurance provider DGUV indicated that its member payers will approve the supply of exoskeleton systems for qualifying beneficiaries on a case-by-case basis. However, no broad uniform policy of coverage and
      reimbursement for electronic exoskeleton medical technology exists among third-party payors in the United States, although reimbursement may be achieved on a case-by-case basis. To date, payments for our products, which are largely for our ReWalk
      systems, have been made primarily through case-by-case determinations by third-party payors (including several private insurers in the United States), by self-payors and, to a lesser extent, through the use of funds from insurance and/or accident
      settlements.</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">25</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Generally, private insurance companies do not cover or provide reimbursement for any medical exoskeleton products for personal use, including ReWalk Personal, and may ultimately
      provide no coverage at all. For instance, during 2017 we submitted a proposal to a large U.S. national insurance provider for a broader coverage policy for the ReWalk Personal device. While we believe there was support for a change, the insurer was
      unable to reach internal consensus and therefore elected not change its existing non-coverage policy. Additionally, there is limited clinical data related to the ReWalk and ReStore systems, and third-party payors may consider use of them to be
      experimental and therefore refuse to cover any or all of them. For example, Aetna has determined that certain lower-limb prostheses, including ReWalk, are experimental and investigational because there is inadequate evidence of their effectiveness.
      Additionally, the majority of independent medical review decisions made following the denial of ReWalk coverage have determined that ReWalk is experimental and/or investigational, citing a lack of clinical data.</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">Many private third-party payors use coverage decisions and payment amounts determined by the Center for Medicare and Medicaid Services (the &#8220;CMS&#8221;), which administers the Medicare program, as
          guidelines in setting their coverage and reimbursement policies. We have started the process of obtaining reimbursement coverage from CMS, and in July 2020, CMS issued a Healthcare Common Procedure Coding System Level II Code&#160;for ReWalk Personal
          6.0 (effective October 1, 2020). These codes are used to identify medical products and supplies and to facilitate insurance claim submissions and processing for these items. However, while we believe that any ultimate positive reimbursement
          response by CMS will broaden coverage by private insurers, we cannot currently predict how long it would take for us to receive a coverage decision from CMS for any of our products nor can we predict other business elements that will be decided
          by CMS such as the price per unit or product labeling requirements. Even with a positive decision from CMS regarding a product of ours, future action by CMS or other government agencies may diminish possible payments to physicians, outpatient
          centers and/or hospitals that purchase our products for use by their patients and possible payments to individuals who purchase the ReWalk Personal for their own use. Additionally, a decision by CMS to provide reimbursement could influence other
          payors, including private insurers. If CMS declines to provide for reimbursements of our products or if its reimbursement price is lower than that of other payors, our products may not be reimbursed at a cost-effective level or at all. Those
          private third-party payors that do not follow the Medicare guidelines may adopt different coverage and reimbursement policies for purchase of our products or their use in a hospital or rehabilitative setting. In addition, we expect that the
          purchase of ReWalk Rehabilitation systems and the ReStore system, as it is currently being sold for use in rehabilitative settings, will require the approval of senior management at hospitals or rehabilitation facilities, inclusion in the
          hospitals&#8217; or rehabilitation facilities&#8217; budget process for capital expenditures, and in the case of ReWalk Personal, fundraising, and financial planning or assistance.</div>
      </div>
    </div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">Third-party payors are developing increasingly sophisticated methods of controlling healthcare costs. These cost control methods include prospective payment systems, capitated rates, benefit
          redesigns and an exploration of other cost-effective methods of delivering healthcare. These cost control methods potentially limit the amount that healthcare providers may be willing to pay for electronic exoskeleton medical technology if they
          provide coverage at all. We may be unable to sell our products on a profitable basis if third-party payors deny coverage or provide insufficient levels of reimbursement.</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="line-height: 1.25;"></div>
      </div>
    </div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Future legislation could result in modifications to the existing public and private health care insurance systems that would have a material adverse effect on the reimbursement
      policies discussed above. If enacted and implemented, any measures to restrict health care spending could result in decreased revenue from our products and decrease potential returns from our research and development initiatives.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">26</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold;">We have a limited operating history upon which you can evaluate our business plan and prospects.</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Although we were incorporated in 2001, we did not begin selling ReWalk Rehabilitation until 2011, and we did not begin selling ReWalk Personal in Europe until 2012. We began
      selling ReWalk Personal in the United States in the third quarter of 2014, as we received FDA clearance to do so in June 2014. We began selling our ReStore product in the United States and Europe in June 2019 following receipt of FDA and CE mark
      clearance, respectively. Therefore, we have limited operating history upon which you can evaluate our business plan and prospects. Our business plan and prospects must be considered in light of the potential problems, delays, uncertainties and
      complications encountered in connection with a more newly established business. The risks include, but are not limited to, that:</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z1f88c52f77214511a2d01a4ae29d7630">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>a market will not sufficiently develop for our products;</div>
          </td>
        </tr>

    </table>
    <div style="margin-left: 5.65pt; line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8ae2fba89c4a49428fa45b2bf32891c0">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>we will not be able to develop scalable products and services, or that, although scalable, our products and services will not be economical to market;</div>
          </td>
        </tr>

    </table>
    <div style="margin-left: 5.65pt; line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8dcbca78e0a34dc5a1cb3a9fe318677b">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>we will not be able to establish brand recognition and competitive advantages for our products;</div>
          </td>
        </tr>

    </table>
    <div style="margin-left: 5.65pt; line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z66c8770bdf5a4758a7b317dbee294d04">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>we will not receive necessary regulatory clearances or approvals for our products; and</div>
          </td>
        </tr>

    </table>
    <div style="margin-left: 5.65pt; line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0ade1c218c5d48fb938522c863e60838">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>our competitors market an equivalent or superior product or hold proprietary rights that preclude us from marketing our products.</div>
          </td>
        </tr>

    </table>
  </div>
  <br>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">There are no assurances that we can successfully address these challenges. If we are unsuccessful, our business, financial condition and operating results could be materially and
      adversely affected.</div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">27</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold;">&#160;</div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold;">If we are unable to leverage our sales, marketing and training infrastructure, including in light of our reduced corporate spending, we may fail to increase our
      sales.</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">A key element of our long-term business strategy is the continued leveraging of our sales, marketing, training, and reimbursement infrastructure, through the training, retaining and motivating of
          skilled sales and marketing representatives and reimbursement personnel with industry experience and knowledge. Our ability to derive revenue from sales of our products depends largely on our ability to market the products and obtain
          reimbursements for them. In order to continue growing our business efficiently, we must therefore coordinate the development of our sales, marketing, training and reimbursement infrastructure with the timing of regulatory approvals, decisions
          regarding reimbursements, limited resources consideration and other factors in various geographies. Managing and maintaining our sales and marketing infrastructure is expensive and time consuming, and an inability to leverage such an organization
          effectively, or in coordination with regulatory or other developments, could inhibit potential sales and the penetration and adoption of our products into both existing and new markets. However, certain decisions we make regarding staffing in
          these areas in our efforts to maintain an adequate spending level could have unintended negative effects on our revenues, such as by weakening our sales infrastructure, impairing our reimbursement efforts and/or harming the quality of our
          customer service. As we have done throughout the past several years, we intend to continue to evaluate our spending throughout 2020 and focus our resources in areas we believe will support our growth.</div>
      </div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">Additionally, we expect to face significant challenges as we manage and continue to improve our sales and marketing infrastructure and work to retain the individuals who make up those networks.
          Newly hired sales representatives require training and take time to achieve full productivity. If we fail to train new hires adequately, or if we experience high turnover in our sales force in the future, we cannot be certain that new hires will
          become as productive as may be necessary to maintain or increase our sales. In addition, if we are not able to retain, subject to our plans to cut operating expenses, and continue to recruit our network of internal trainers, we may not be able to
          successfully train customers on the use of ReWalk or ReStore, which could inhibit new sales and harm our reputation. If we are unable to expand our sales, marketing, and training capabilities, we may not be able to effectively commercialize our
          products, or enhance the strength of our brand, which could have a material adverse effect on our operating results.</div>
      </div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold;">The health benefits of our products have not been substantiated by long-term clinical data, which could limit sales.</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Although study participants and other ReWalk users have reported the secondary health benefits of our ReWalk products such as a reduction in pain and spasticity, improved bowel and
      urinary tract functions and emotional and psychosocial benefits, among others, currently there is no conclusive clinical data establishing any secondary health benefits of ReWalk. There is also a lack of conclusive clinical data for such health
      benefits of the ReStore specifically its long-term benefits following the usage of the product within the clinic and the trials conducted to date using this product are limited.</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">As a result, potential customers and healthcare providers may be slower to adopt or recommend ReWalk or ReStore and third-party payors may not be willing to provide coverage or
      reimbursement for our products. In addition, future studies or clinical experience may indicate that treatment with our current or future products is not superior to treatment with alternative products or therapies. Such results could slow the
      adoption of our products and significantly reduce our sales.</div>
  </div>
  <div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold;">&#160;</div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold;">We depend on a single third party to manufacture our products, and we rely on a limited number of third-party suppliers for certain components of our products.</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We have contracted with Sanmina Corporation, a well-established contract manufacturer with expertise in the medical device industry, for the manufacture of all of our products and
      the sourcing of all of our components and raw materials. Pursuant to this contract, Sanmina manufactures ReWalk and ReStore, pursuant to our specifications, at its facility in Ma&#8217;alot, Israel. We may terminate our relationship with Sanmina at any
      time upon written notice. In addition, either we or Sanmina may terminate the relationship in the event of a material breach, subject to a 30-day cure period. For our business strategy to be successful, Sanmina must be able to manufacture our
      products in sufficient quantities, in compliance with regulatory requirements and quality control standards, in accordance with agreed upon specifications, at acceptable costs and on a timely basis. Increases in our product sales, whether forecasted
      or unanticipated, could strain the ability of Sanmina to manufacture an increasingly large supply of our current or future products in a manner that meets these various requirements. In addition, although we are not restricted from engaging an
      alternative manufacturer, and potentially have the capabilities to manufacture our products in-house, the process of moving our manufacturing activities would be time consuming and costly, and may limit our ability to meet our sales commitments,
      which could harm our reputation and could have a material adverse effect on our business.</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">28</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">
          <div style="line-height: 1.25;">
            <div style="text-indent: 36pt; line-height: 1.25;">We also rely on third-party suppliers, which contract directly with Sanmina, to supply certain components of our products, and in some cases, we purchase these components ourselves. Sanmina
              does not have long-term supply agreements with most of its suppliers and, in many cases, makes purchases on a purchase order basis. Sanmina&#8217;s ability to secure adequate quantities of such products may be limited. Suppliers may encounter
              problems that limit their ability to manufacture components for our products, including financial difficulties or damage to their manufacturing equipment or facilities. If Sanmina fails to obtain sufficient quantities of high-quality
              components to meet demand on a timely basis, we could lose customer orders, our reputation may be harmed, and our business could suffer.</div>
          </div>
        </div>
      </div>
    </div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
    <div style="text-indent: 36pt; line-height: 1.25;">Our results of operations and liquidity could be adversely impacted by supply chain disruptions and operational challenges faced by our manufacturer or suppliers. Sanmina generally uses a small number
      of suppliers for ReWalk and ReStore. Depending on a limited number of suppliers exposes us to risks, including limited control over pricing, availability, quality, and delivery schedules. Such risks are heightened in light of the interruptions in
      supply chains and distribution networks related to the COVID-19 pandemic. If any one or more of our suppliers ceases to provide sufficient quantities of components in a timely manner or on acceptable terms, Sanmina would have to seek alternative
      sources of supply. It may be difficult to engage additional or replacement suppliers in a timely manner. Failure of these suppliers to deliver products at the level our business requires would limit our ability to meet our sales commitments, which
      could harm our reputation and could have a material adverse effect on our business. Sanmina also may have difficulty obtaining similar components from other suppliers that are acceptable to the FDA or other regulatory agencies, and the failure of
      Sanmina&#8217;s suppliers to comply with strictly enforced regulatory requirements could expose us to regulatory action including warning letters, product recalls, termination of distribution, product seizures or civil penalties. It could also require
      Sanmina to cease using the components, seek alternative components or technologies and we could be forced to modify our products to incorporate alternative components or technologies, which could result in a requirement to seek additional regulatory
      approvals. Any disruption of this nature or increased expenses could harm our commercialization efforts and adversely affect our operating results. <br>
    </div>
  </div>
  <div style="line-height: 1.25; font-style: italic; font-weight: bold;"> <br>
  </div>
  <div style="line-height: 1.25; font-style: italic; font-weight: bold;">We operate in a competitive industry that is subject to rapid technological change, and we expect competition to increase.</div>
  <div style="line-height: 1.25;">&#160; <br>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">There are several other companies developing technology and devices that compete with our products. Our principal competitors in the medical exoskeleton market consist of Ekso
      Bionics, Parker Hannifin, FREE Bionics, Rex Bionics, Cyberdyne, and others. These companies have products currently available for institutional use and in some cases personal use. We expect some of such products to become available for personal use
      in the next few years especially as we continue to expand coverage by different payors and geographies. In addition, we compete with alternative devices and alternative therapies, including treadmill-based gait therapies, such as those offered by
      Hocoma, AlterG, Aretech, Reha Technology and Bioness. Our competitor base may change or expand as we continue to develop and commercialize our soft suit exoskeleton product in the future. These or other medical device or robotics companies, academic
      and research institutions, or others, may develop new technologies or therapies that provide a superior walking experience, are more effective in treating the secondary medical conditions that we target or are less expensive than ReWalk, ReStore or
      future products. Our technologies and products could be rendered obsolete by such developments. We may also compete with other treatments and technologies that address the secondary medical conditions that our products seek to mitigate.</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">Our competitors may respond more quickly to new or emerging technologies, undertake more extensive marketing campaigns, have greater financial, marketing, and other resources than we do or may be
          more successful in attracting potential customers, employees, and strategic partners. In addition, potential customers, such as hospitals and rehabilitation centers, could have long-standing or contractual relationships with competitors or other
          medical device companies. Potential customers may be reluctant to adopt ReWalk or ReStore, particularly if it competes with or has the potential to compete with or diminish the need/utilization of products or treatments supported through these
          existing relationships. If we are not able to compete effectively, our business and results of operations will be negatively impacted.</div>
      </div>
    </div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In addition, because we operate in a new market, the actions of our competitors could adversely affect our business. Adverse events such as product defects or legal claims with
      respect to competing or similar products could cause reputational harm to the exoskeleton market on the whole. Further, adverse regulatory findings or reimbursement-related decisions with respect to other exoskeleton products could negatively impact
      the entire market and, accordingly, our business.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">29</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160; <br>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold;">We utilize independent distributors who are free to market products that compete with ours.</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">While we expect that the percentage of our sales generated from independent distributors will decrease over time as we continue to focus our resources on achieving reimbursement
      within our direct markets in the United States and Europe, we believe that some percentage of our sales will continue to be generated by independent distributors in the future. None of our independent distributors has been required to sell our
      products exclusively. Our distributor agreements generally have one-year initial terms and automatic renewals for an additional year. If any of our key independent distributors were to cease to distribute our products, our sales could be adversely
      affected. In such a situation, we may need to seek alternative independent distributors or increase our reliance on our other independent distributors or our direct sales representatives, which may not prevent our sales from being adversely affected.
      Additionally, to the extent that we enter into additional arrangements with independent distributors to perform sales, marketing, or distribution services, the terms of the arrangements could cause our product margins to be lower than if we directly
      marketed and sold our products.</div>
  </div>
  <div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold;">&#160;</div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold;">We are dependent on a single facility for the manufacturing and assembly of our products.</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">All manufacturing and assembly of our products is conducted at a single facility of our contract manufacturer, Sanmina, located in Ma&#8217;alot, Israel. Accordingly, we are highly
      dependent on the uninterrupted and efficient operation of this facility. If operations at this facility were to be disrupted as a result of equipment failures, earthquakes and other natural disasters, fires, accidents, work stoppages, power outages,
      acts of war or terrorism or other reasons, our business, financial condition and results of operations could be materially adversely affected. In particular, this facility is located in the north of Israel within range of rockets that have from time
      to time been fired into the country during armed conflicts with Hezbollah and other armed groups in Lebanon, Syria or other countries in the region. Although our manufacturing and assembly operations could be transferred elsewhere, either in-house or
      to an alternative Sanmina facility, the process of relocating these operations would cause delays in production. Lost sales or increased costs that we may experience during the disruption, or a forced relocation, of operations may not be recoverable
      under our insurance policies, and longer-term business disruptions could result in a loss of customers. If this were to occur, our business, financial condition and operations could be materially negatively impacted. Additionally, our reliance on
      Sanmina as a contract manufacturer or any other contract manufacturer makes us vulnerable to possible capacity constraints and reduced control over component availability, delivery schedules, manufacturing yields and costs.</div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold;">We may receive a significant number of warranty claims or our ReWalk and ReStore systems may require significant amounts of service after sale.</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">Sales of ReWalk generally include a two-year warranty for parts and services, other than for normal wear and tear. We also provide customers with the option to purchase an extended warranty for up
          to an additional three years. In the beginning of 2018, we updated our service policy for new devices sold to include a 5-year warranty. Our ReStore product offering includes a two-year warranty for parts and services. If product returns or
          warranty claims are significant or exceed our expectations, we could incur unanticipated expenditures for parts and services, which could have a material adverse effect on our operating results.</div>
      </div>
    </div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold;">Defects in our products or the software that drives them could adversely affect the results of our operations.</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The design, manufacture and marketing of our products involve certain inherent risks. Manufacturing or design defects, unanticipated use of ReWalk or ReStore, or inadequate
      disclosure of risks relating to the use of our products can lead to injury or other adverse events. In addition, because the manufacturing of our products is outsourced to Sanmina, our original equipment manufacturer, we may not be aware of
      manufacturing defects that could occur. Such adverse events could lead to recalls or safety alerts relating to our products (either voluntary or required by the FDA or similar governmental authorities in other countries), and could result, in certain
      cases, in the removal of our products from the market. A recall could result in significant costs. To the extent any manufacturing defect occurs, our agreement with Sanmina contains a limitation on Sanmina&#8217;s liability, and therefore we could be
      required to incur the majority of related costs. Product defects or recalls could also result in negative publicity, damage to our reputation or, in some circumstances, delays in new product approvals.</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">When an exoskeleton is used by a paralyzed individual to walk, the individual relies completely on the exoskeleton to hold him or her upright. In addition, our products incorporate sophisticated
          computer software. Complex software frequently contains errors, especially when first introduced. Our software may experience errors or performance problems in the future. If any part of our product&#8217;s hardware or software were to fail, the user
          could experience death or serious injury. Additionally, users may not use our or maintain our products in accordance with safety, storage and training protocols, which could enhance the risk of death or injury. Any such occurrence could cause
          delay in market acceptance of our products, damage to our reputation, additional regulatory filings, product recalls, increased service and warranty costs, product liability claims and loss of revenue relating to such hardware or software
          defects.</div>
      </div>
    </div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">The medical device industry has historically been subject to extensive litigation over product liability claims. We have been, and anticipate that as part of our ordinary course of business we may
          be, subject to product liability claims alleging defects in the design, manufacture, or labeling of our products. A product liability claim, regardless of its merit or eventual outcome, could result in significant legal defense costs and high
          punitive damage payments. Although we maintain product liability insurance, the coverage is subject to deductibles and limitations, and may not be adequate to cover future claims. Additionally, we may be unable to maintain our existing product
          liability insurance in the future at satisfactory rates or adequate amounts.</div>
      </div>
    </div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">30</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  &#160;<br>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold;">We may not be able to enhance our product offerings through our research and development efforts.</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In order to increase our sales and our market share in the exoskeleton market, it is best to enhance and broaden our research and development efforts and product offerings in
      response to the evolving demands of people with paraplegia or paralysis and healthcare providers, as well as competitive technologies. We are also currently involved in ongoing research and development efforts directed to the needs of patients with
      other mobility impairments, such as stroke, and began commercializing our ReStore product for stroke patients in 2019. Depending on our future resources and business focus, we plan to address these needs in patients with other conditions or devices
      for stroke patients to be used at home, improving our current products, or developing products to address additional medical conditions such as multiple sclerosis, Parkinson&#8217;s disease or cerebral palsy and support elderly assistance. We may decide to
      invest our business development resources in partnerships, licensing agreements and other ways that will provide us new product offerings without significant research and development activities. We may not be successful in developing, obtaining
      regulatory approval for, or marketing our currently proposed products and products proposed to be created in the future. In addition, notwithstanding our market research efforts, our future products may not be accepted by consumers, their caregivers,
      healthcare providers or third-party payors who reimburse consumers for our products. The success of any proposed product offerings will depend on numerous factors, including our ability to:</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
    <div style="line-height: 1.25;">
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z500389f2c617412aa2a225b39d8681a1">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>
                <div style="text-align: left; line-height: 1.25;">identify the product features that people with paraplegia or paralysis, their caregivers, and healthcare providers are seeking in a medical device that restores upright mobility and
                  successfully incorporate those features into our products;</div>
              </div>
            </td>
          </tr>

      </table>
      <div style="margin-left: 5.65pt; line-height: 1.25;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z67e511e54f6744c9b230a2f455fe2506">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>identify the product features that people with stroke, multiple sclerosis or other similar indications require while the products are used at home as well as what items are valuable to the clinics that provide them rehabilitation;</div>
            </td>
          </tr>

      </table>
      <div style="margin-left: 5.65pt; line-height: 1.25;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z501b75acef76486ba32a3ff4744a76a5">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>develop and introduce proposed products in sufficient quantities and in a timely manner;</div>
            </td>
          </tr>

      </table>
      <div style="margin-left: 5.65pt; line-height: 1.25;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb30252b5fed1421f8f06ba2d0b9d9032">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>adequately protect our intellectual property and avoid infringing upon the intellectual property rights of third-parties;</div>
            </td>
          </tr>

      </table>
      <div style="margin-left: 5.65pt; line-height: 1.25;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z6e1672b26ff04ff2b42adfeb0cf74e4e">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>
                <div style="text-align: left; line-height: 1.25;">demonstrate the safety, efficacy, and health benefits of proposed products; and</div>
              </div>
            </td>
          </tr>

      </table>
      <div style="margin-left: 5.65pt; line-height: 1.25;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z24fb418b74fb4c1ea56a00a632989aa1">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>obtain the necessary regulatory approvals for proposed products.</div>
            </td>
          </tr>

      </table>
    </div>
    &#160;</div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">If we fail to generate demand by developing products that incorporate features desired by consumers, their caregivers or healthcare providers, or if we do not obtain regulatory clearance or
          approval for proposed products in time to meet market demand, we may fail to generate sales sufficient to achieve or maintain profitability. We have in the past experienced, and we may in the future experience, delays in various phases of product
          development, including during research and development, manufacturing, limited release testing, marketing, and customer education efforts. Such delays could cause customers to delay or forgo purchases of our products, or to purchase our
          competitors&#8217; products. Even if we are able to successfully develop proposed products when anticipated, these products may not produce sales in excess of the costs of development, and they may be quickly rendered obsolete by changing consumer
          preferences or the introduction by our competitors of products embodying new technologies or features.</div>
      </div>
    </div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><br>
  </div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">31</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold;">
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25; font-style: italic; font-weight: bold;">&#160;We may enter into collaborations, in-licensing arrangements, joint ventures, strategic alliances, or partnerships with third&#160;parties that may not result in the development of
          commercially viable products or the generation of significant future revenues.</div>
      </div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
    <div style="text-indent: 36pt; line-height: 1.25;">
      <div style="text-indent: 36pt; line-height: 1.25;">In the ordinary course of our business, we may enter into collaborations, in-licensing arrangements, joint ventures, strategic alliances or partnerships to develop our products and to pursue new
        geographic or product markets. Proposing, negotiating, and implementing collaborations, in-licensing arrangements, joint ventures, strategic alliances, or partnerships may be a lengthy and complex process. We may not identify, secure, or complete
        any such transactions or arrangements in a timely manner, on a cost-effective basis, on acceptable terms or at all. We have limited institutional knowledge and experience with respect to these business development activities, and we may also not
        realize the anticipated benefits of any such transaction or arrangement. In particular, these collaborations may not result in the development of products that achieve commercial success or result in significant revenues and could be terminated
        prior to developing any products. For example, we have entered into agreements with MediTouch and Myolyn for the distribution of their products in the U.S. We also collaborate with Harvard University&#8217;s Wyss Institute for Biologically Inspired
        Engineering for the research, design, development, and commercialization of lightweight exoskeleton system technologies for lower limb disabilities, aimed to treat stroke, multiple sclerosis, mobility limitations for the elderly and other medical
        applications. Our arrangements with MediTouch, Myolyn and Harvard, may not be as productive or successful as we hope. <br>
      </div>
    </div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"> <br>
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
    <div style="text-indent: 36pt; line-height: 1.25;">Additionally, as we pursue these arrangements and choose to pursue other collaborations, in-licensing arrangements, joint ventures, strategic alliances, or partnerships in the future, we may not be in
      a position to exercise sole decision-making authority regarding the transaction or arrangement. This could create the potential risk of creating impasses on decisions, and our collaborators may have economic or business interests or goals that are,
      or that may become, inconsistent with our business interests or goals. It is possible that conflicts may arise with our collaborators. Our collaborators may act in their self-interest, which may be adverse to our best interest, and they may breach
      their obligations to us. Any such disputes could result in litigation or arbitration which would increase our expenses and divert the attention of our management. Further, these transactions and arrangements are contractual in nature and may be
      terminated or dissolved under the terms of the applicable agreements. <br>
    </div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"> <br>
  </div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">32</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <div style="text-align: center; line-height: 1.25;"><br>
  </div>
  <div style="text-align: justify; line-height: 1.25;"><font style="font-weight: bold;">Risks Related to Government Regulation</font>&#160;</div>
  <div style="text-align: justify; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic; font-weight: bold;">
    <div style="text-indent: 36pt; line-height: 1.25; font-style: italic; font-weight: bold;">
      <div style="line-height: 1.25; font-style: italic; font-weight: bold; text-indent: 0px;">We have submitted medical device reports, or MDRs, to the FDA (and equivalent authorities outside of the United States) for numerous serious injuries relating to
        use of the ReWalk Personal system, and conducted a voluntary correction related to certain use instructions in the device&#8217;s labeling, which the FDA classified as a Class II recall. If our product may have caused or contributed to a death or a
        serious injury, or if our product malfunctioned and the malfunction&#8217;s recurrence would be likely to cause or contribute to a death or serious injury, we must submit an MDR to the FDA (and equivalent authorities outside of the United States), which
        could result in voluntary corrective actions or enforcement actions, such as mandatory recalls.</div>
    </div>
  </div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Under the FDA&#8217;s MDR regulations, we are required to report to the FDA information that reasonably suggests a product we market may have caused or contributed to a death or serious
      injury or malfunctioned and our product or a similar device marketed by us would be likely to cause or contribute to death or serious injury if the malfunction were to recur. In addition, all manufacturers placing medical devices on the market in the
      European Union are legally bound to report any serious or potentially serious incidents involving devices they produce or sell to the relevant authority in whose jurisdiction the incident occurred. Between 2013 and 2017, we submitted a number of MDRs
      to the FDA to report incidents in which ReWalk Personal users sustained falls or fractures. The FDA sent us letters requesting additional information relating to these MDRs submitted in 2017, including a request for a failure analysis. In August
      2017, we initiated a voluntary correction for the ReWalk device that related to certain use instructions to reduce the risk of tibia/fibula fractures and submitted a report to the FDA under 21 CFR Part 806. Under Part 806, manufacturers and importers
      are required to make a report to the FDA of any correction or removal of a device if the correction or removal was initiated to reduce a risk to health posed by the device or to remedy a violation of the U.S. Federal Food, Drug, and Cosmetic Act
      caused by the device that may present a risk to health.</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">In June 2018, we received a letter from the FDA agreeing with our decision to initiate a corrective action for the ReWalk, classifying the recall action as a Class II recall, and requesting that we
          make regular status reports to the FDA regarding our progress. While the FDA has statutory authority to require a recall, most recalls are undertaken voluntarily when a medical device is defective, when it could present a risk to health, or when
          it is both defective and presents a risk to health. In January 2019, we submitted a recall termination request to the FDA. In November 2019, the FDA informed us that it considered the recall action terminated. In September 2018, we submitted to
          the FDA revised labeling that incorporates the revised use instructions intended to prevent the tibia/fibula fractures as a special 510(k). The special 510(k) was not accepted by FDA because it was administratively incomplete, and we withdrew the
          submission. In January 2020 we submitted a new 510(k) to the FDA for both the revised labeling/use instructions and additional changes to the device. This new 510(k) was not accepted by FDA because it was administratively incomplete and,
          accordingly, FDA notified ReWalk on January 22, 2020 of the Refuse-to-Accept (RTA) designation. The company was in communication with the FDA and has resubmitted an updated 510(k) in February 2020 which was cleared on May 27, 2020. In September
          2019, we also submitted a revised technical file with the additional device changes to the EU notified body and were notified in December 2019 that the extension of our certification had been granted.</div>
      </div>
    </div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In 2018, we submitted additional MDRs for tibia/fibula fractures that occurred in foreign countries between 2015 and 2018. In addition, in 2018 and 2019 we submitted MDRs for
      tibia/fibula fractures that occurred in the United States and Europe. In 2020 we submitted an MDR for tibial fractures that occurred in the United States. Additional fractures or other adverse events may occur in the future that may require us to
      report to the FDA pursuant to the MDR regulations (or other governmental authorities pursuant to equivalent outside of the United States regulations), and/or to initiate a removal, correction, or other action. Any adverse event involving our products
      could result in future voluntary corrective actions, such as recalls or customer letters, or in an FDA enforcement action, such as a mandatory recall, notification to healthcare professionals and users, warning letter, seizure, injunction or import
      alert. In addition, failure to report such adverse events to appropriate government authorities on a timely basis, or at all, could result in enforcement action against us. Any action, whether voluntary or involuntary, as well as defending ourselves
      in a lawsuit, will require financial resources and distract management, and may harm our reputation and financial results.</div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">33</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  &#160;
  <div style="line-height: 1.25;">
    <div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold;">U.S. healthcare reform measures and other potential legislative initiatives could adversely affect our business.</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">Recent political changes in the United States could result in significant changes in, and uncertainty with respect to, legislation, regulation, global trade, and government policy that could
          substantially impact our business and the medical device industry generally. Certain proposals, if enacted into law, could impose limitations on the prices we will be able to charge for our ReWalk system or any products we may develop and offer
          in the future, or the amounts of reimbursement available for such products from governmental agencies or third-party payers. Additionally, any reduction in reimbursement from Medicare or other government-funded federal programs, including the VA,
          or state healthcare programs could lead to a similar reduction in payments from private commercial payors. The FDA&#8217;s policies may also change, and additional government regulations may be issued that could prevent, limit, or delay regulatory
          approval of our future products, or impose more stringent product labeling and post-marketing testing and other requirements. For instance, in September 2017, members of the U.S. Congress introduced legislation with the announced intention to
          repeal and replace major provisions of the PPACA. Although this proposed legislation ultimately failed to pass, Congress succeeded in repealing the PPACA&#8217;s individual mandate as part of the U.S. Tax Cuts and Jobs Act of 2017 (TCJA).&#160;</div>
        <div style="text-indent: 36pt; line-height: 1.25;"> <br>
        </div>
        <div style="text-indent: 36pt; line-height: 1.25;">
          <div style="line-height: 1.25;">
            <div style="text-indent: 36pt; line-height: 1.25;">In January 2018, President Trump signed a continuing resolution on appropriations for fiscal year 2018 that delayed the implementation of certain ACA-mandated fees, including the 2.3% excise
              tax imposed on manufacturers and importers for certain sales of medical devices through December 31, 2019. Absent further legislative action, the device excise tax was to be reinstated on medical device sales starting January 1, 2020.&#160; The
              Further Consolidated Appropriations Act, 2020 H.R. 1865 (Pub.L.116-94), signed into law on December 20, 2019, repealed the medical device excise tax previously imposed by Internal Revenue Code Section 4191.</div>
          </div>
        </div>
      </div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">On December 14, 2018, a Texas U.S. District Court Judge ruled that the ACA is unconstitutional in its entirety because the &#8220;individual mandate&#8221; was repealed by Congress as part of
      the TCJA.&#160; In December 2019, the U.S. Court of Appeals for the Fifth Circuit affirmed the ruling regarding the individual mandate but remanded the case to the district court for additional analysis of the question of severability and whether portions
      of the law remain invalid. The case is currently under consideration by the U.S. Supreme Court, and a decision is expected by the summer of 2021. It is unclear what effect this decision and other efforts to repeal and replace the ACA will have on our
      business.</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The implementation of cost containment measures or other healthcare reforms may thus prevent us from being able to generate revenue, attain profitability or further commercialize
      our existing ReWalk systems or future ReWalk products. We are currently unable to predict what additional legislation or regulation, if any, relating to the health care industry may be enacted in the future or what effect recently enacted federal
      legislation or any such additional legislation or regulation would have on our business. The pendency or approval of such proposals or reforms could result in a decrease in our stock price or limit our ability to raise capital or to enter into
      collaboration agreements for the further development and commercialization of our programs and products.</div>
  </div>
  <div style="line-height: 1.25; font-style: italic; font-weight: bold;">&#160;</div>
  <div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold;">While we addressed the observations that the FDA cited in a 2015 warning letter related to our mandatory post-market surveillance study and initiated the study,
    we are currently experiencing enrollment issues that make our study progress inadequate and our modified protocol (intended to overcome the enrollment issues so that we may complete the study, as required) has not yet been approved by FDA. Going
    forward, if we cannot meet certain FDA requirements and enrollment criteria for the study or otherwise satisfy FDA requests promptly, or if our study produces unfavorable results, we could be subject to additional FDA warnings letters or more
    significant enforcement action, which could materially and adversely affect our commercial success.&#160;</div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We are conducting an ongoing mandatory FDA postmarket surveillance study on our ReWalk Personal 6.0, which began in June 2016. Before we began the current study, the FDA sent us a
    warning letter on September 30, 2015, (&#8220;the September 2015 Warning Letter&#8221;), threatening potential regulatory action against us for violations of Section 522 of the U.S. Federal Food, Drug, and Cosmetic Act, based on our failure to initiate a
    postmarket surveillance study by the September 28, 2015 deadline, our allegedly deficient protocol for that study, and the lack of progress and communication regarding the study. Between June 2014 and our receipt of the September 2015 Warning Letter,
    we had responded late to certain of the FDA&#8217;s requests related to our study protocol. In February 2016, the FDA sent us an additional information request, or the February 2016 Letter, requesting additional changes to our study protocol and asking that
    we amend the study within 30 days. This letter also discussed the FDA&#8217;s request, as further discussed in later communications with the FDA, for a new premarket notification for our ReWalk device, or a special 510(k), linked to what the FDA viewed as
    changes to the labeling and the device, including to a computer included with the device. In late March 2016, following multiple discussions with the FDA, including an in-person meeting, the FDA confirmed that the agency would permit the continued
    marketing of the ReWalk device conditioned upon our timely submitting a special 510(k) and initiating our postmarket surveillance study by June 1, 2016. The special 510(k) was timely submitted on April 8, 2016, and the FDA&#8217;s substantial equivalence
    determination was received by us on July 22, 2016, granting us permission to continue marketing the ReWalk device. Additionally, we submitted a protocol to the FDA for the postmarket surveillance study that was approved by the FDA on May 5, 2016.&#160;</div>
  <div style="text-align: center; line-height: 1.25;"> <br>
  </div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">34</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <br>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">We began the study on June 13, 2016, with Stanford University as the lead investigational site. In August 2016, the FDA sent us a letter stating that, based on its evaluation
      of our corrective and preventive actions in response to the September 2015 Warning Letter, it appeared we had adequately addressed the violations cited in the September 2015 Warning Letter. As part of our study, we provided the FDA with the required
      periodic reports on the study&#8217;s progress, in a few cases with delay, and we intend to continue providing the FDA with periodic reports as required. Through these reports, we made the FDA aware that due to enrollment issues, we were unable to satisfy
      the target enrollment specified in the original study protocol.&#160; As of December 31, 2020, we had three active centers participating in the study (one site is closed and another site is on hold), but only two sites have successfully enrolled
      patients.&#160; Twelve subjects have enrolled in the study, three have completed the study, and one is using the device in the community. This is substantially below the required number of patients included in our original study protocol.</div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"> <br>
  </div>
  <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 36pt;">In March 2020, FDA approved a modified postmarket study protocol that will supplement data from the clinical study with real-world
    evidence and the study status was updated to progress adequate in September 2020. ReWalk is actively collecting the real-world evidence in order to fulfill the postmarket study order requirements.&#160; However, despite the revised study protocol there can
    be no assurance that we will be able to satisfy the post-market study requirements. Additionally, we are experiencing some study disruptions due to COVID-19 pandemic. The Company has been engaging with FDA on how to manage and address these study
    disruptions.If we cannot meet FDA requirements for the post-market study or timely address requests from the FDA related to the study, or if the results of the study are not as favorable as we expect, the FDA may issue additional warning letters to us,
    impose limitations on the labeling of our device or require us to stop marketing the ReWalk Personal device in the United States. We derived 40% of our revenues in the year ended December 31, 2020 from sales of the ReWalk device in the United States
    and, if we are unable to market the ReWalk device in the United States, we expect that these sales would be adversely impacted, which could materially adversely affect our business and overall results of operations.<font style="font-weight: bold; font-style: italic;">&#160;</font></div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold;">Our devices are subject to the FDA&#8217;s regulations pertaining to marketing and promotional communications, among others. Failure to comply with such regulations
      may give rise to a number of potential FDA enforcement actions, any of which could have a material adverse effect on our business.</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Our sales and marketing efforts, as well as promotions, are subject to various laws and regulations. Medical device promotions must be consistent with and not contrary to labeling,
      be truthful and not false or misleading, and be adequately substantiated. In addition to the requirements applicable to 510(k)-cleared products, we may also be subject to enforcement action in connection with any promotion of an investigational new
      device. A sponsor or investigator, or any person acting on behalf of a sponsor or investigator, may not represent in a promotional context that an investigational new device is safe or effective for the purposes for which it is under investigation or
      otherwise promote the device.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Our marketing and promotional materials are subject to FDA scrutiny to ensure that the device is being marketed in compliance with these requirements. If the FDA investigates our
      marketing and promotional materials and finds that any of our current or future commercial products were being marketed for unapproved or uncleared uses or in a false or misleading manner, we could be subject to FDA enforcement and/or false
      advertising consumer lawsuits, each of which could have a material adverse effect on our business.</div>
  </div>
  <div style="line-height: 1.25;">&#160;&#160;<font style="font-weight: bold; font-style: italic;">&#160;</font></div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold;">
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25; font-style: italic; font-weight: bold;">We are subject to extensive governmental regulations relating to the manufacturing, labeling, and marketing of our products, and a failure to comply with such regulations could
          lead to withdrawal or recall of our products from the market.</div>
      </div>
    </div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Our medical products and manufacturing operations are subject to regulation by the FDA, the European Union, and other governmental authorities both inside and outside of the United
      States. These agencies enforce laws and regulations that govern the development, testing, manufacturing, labeling, storage, installation, servicing, advertising, promoting, marketing, distribution, import, export and market surveillance of our
      products.</div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Our products are regulated as medical devices in the United States under the FFDCA as implemented and enforced by the FDA. Under the FFDCA, medical devices are classified into one of
    three classes (Class I, Class II or Class III) depending on the degree of risk associated with the medical device, what is known about the type of device, and the extent of control needed to provide reasonable assurance of safety and effectiveness.
    Classification of a device is important because the class to which a device is assigned determines, among other things, the necessity and type of FDA review required prior to marketing the device. For more information, see &#8220;Part I, Item 1.
    Business&#8212;Government Regulation&#8221; above</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"> <br>
  </div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">35</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In June 2014, the FDA granted our petition for &#8220;<font style="font-style: italic;">de novo</font>&#8221; classification, which provides a route to market for medical devices that are low
      to moderate risk, but are not substantially equivalent to a predicate device, and classified ReWalk as Class II subject to certain special controls. The ReWalk is intended to enable individuals with spinal cord injuries to perform ambulatory
      functions under supervision of a specially trained companion, and inside rehabilitation institutions. The special controls established in the&#160;<font style="font-style: italic;">de novo</font>&#160;order include the following: compliance with medical device
      consensus standards; clinical testing to demonstrate safe and effective use considering the level of supervision necessary and the use environment; non-clinical performance testing, including durability testing to demonstrate that the device performs
      as intended under anticipated conditions of use; a training program; and labeling related to device use and user training. In order for us to market ReWalk, we must comply with both general controls, including controls related to quality, facility
      registration, reporting of adverse events and labeling, and the special controls established for the device. Failure to comply with these requirements could lead to an FDA enforcement action, which would have a material adverse effect on our
      business.</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="text-indent: 36pt; line-height: 1.25;">In June 2019, the FDA issued a 510(k) clearance for our ReStore device. ReStore is intended to be used to assist ambulatory functions in rehabilitation institutions under the supervision of a trained
    therapist for people with hemiplegia or hemiparesis due to stroke who have a specified amount of ambulatory function. In order for us to market ReStore, we must comply with both general controls, including controls related to quality, facility
    registration, reporting of adverse events and labeling, and the special controls established for the device that include clinical testing, non-clinical performance testing, and a training program. Failure to comply with these requirements could lead to
    an FDA enforcement action, which would have a material adverse effect on our business.&#160;</div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
    <div style="text-indent: 36pt; line-height: 1.25;">Following the introduction of a product, the governmental agencies will periodically review our manufacturing processes and quality controls, and we are under a continuing obligation to ensure that all
      applicable regulatory requirements continue to be met. The process of complying with the applicable good manufacturing practices, adverse event reporting and other requirements can be costly and time consuming, and could delay or prevent the
      production, manufacturing, or sale of our devices. In addition, if we fail to comply with applicable regulatory requirements, it could result in fines or delays of regulatory clearances, closure of manufacturing sites, seizures or recalls of products
      and damage to our reputation, as well as enforcement actions against us.<br>
    </div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">For example, the FDA could request that we recall our ReWalk Personal 6.0 or ReStore device. For more information on certain deficiencies previously identified by the FDA in our
      mandatory post-market surveillance study on our ReWalk Personal 6.0, see &#8220;&#8212;Risks Related to Government Regulation&#8212;While we addressed the observations that FDA cited in a 2015 warning letter related to our mandatory post-market surveillance study and
      initiated the study, we are currently experiencing enrollment issues that make our study progress inadequate. Going forward, if we cannot meet certain FDA requirements and enrollment criteria for the study or otherwise satisfy FDA requests promptly,
      or if our study produces unfavorable results, we could receive additional FDA warnings, which could materially and adversely affect our commercial success.&#8221;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">In addition, governmental agencies may impose new requirements regarding registration or labeling that may require us to modify or re-register our products or otherwise impact our ability to market
          our products in those countries. The process of complying with these governmental regulations can be costly and time consuming, and could delay or prevent the production, manufacturing, or sale of our products. In the European Union, for example,
          a new Medical Device Regulation includes additional premarket and post-market requirements, as well as potential product reclassifications or more stringent commercialization requirements that could adversely affect our CE mark. Penalties for
          regulatory non-compliance with the Medical Device Regulation could also be substantial, including fines, revocation or suspension of CE mark and criminal sanctions.</div>
      </div>
    </div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic; font-weight: bold;">&#160;</div>
  <div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold;">If we or our third-party manufacturers fail to comply with the FDA&#8217;s Quality System Regulation, or QSR, our manufacturing operations could be interrupted.</div>
  <div style="text-align: justify; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
    <div style="text-indent: 36pt; line-height: 1.25;">We and our manufacturer Sanmina are required to comply with the FDA&#8217;s QSR which covers the methods and documentation of the design, testing, production, control, quality assurance, labeling, packaging,
      sterilization, storage, and shipping of our products. We, Sanmina, and our suppliers are also subject to the regulations of foreign jurisdictions regarding the manufacturing process if we or our distributors market our products abroad. We continue to
      monitor our quality management in order to improve our overall level of compliance. Our facilities are subject to periodic and unannounced inspection by U.S. and foreign regulatory agencies to audit compliance with the QSR and comparable foreign
      regulations. If our facilities or those of Sanmina or our suppliers are found to be in violation of applicable laws and regulations, or if we, Sanmina, or our suppliers fail to take satisfactory corrective action in response to an adverse inspection,
      the regulatory authority could take enforcement action, including any of the following sanctions: <br>
    </div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"> <br>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z15924a5b18ce40a494d4000d75a6c5c4">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#9679;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>untitled letters, warning letters, fines, injunctions, consent decrees and civil penalties;</div>
          </td>
        </tr>

    </table>
    <div style="text-align: left; line-height: 1.25;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z3f7ea6a4baff44e1b556b1020b3465a9">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#9679;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>
              <div style="text-align: left; line-height: 1.25;">customer notifications or repair, replacement, or refunds;</div>
            </div>
          </td>
        </tr>

    </table>
    <br>
  </div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">36</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <div style="line-height: 1.25;">&#160;
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z3fc0921a9e5f4cc59209021614ef8894">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#9679;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>operating restrictions or partial suspension or total shutdown of production;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z13ec2ecb2e1244d485630b0b02f34256">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#9679;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>recalls, withdrawals, or administrative detention or seizure of our products;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze60fe873ac854a0581b0da6b85a758a7">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#9679;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>refusing or delaying requests for approval of pre-market approval applications relating to new products or modified products;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0d64934ee5dd415f85f041d236562937">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#9679;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>withdrawing a PMA approval;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z2edd94f9150842f1b9cbc33c0cb1b3f1">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#9679;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>refusing to provide Certificates for Foreign Government;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb2543586bbfa4f86838d66f5cfa54b0e">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#9679;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>refusing to grant export approval for our products; or</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze49fe2fec2d54577a1a86e688741c1c0">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#9679;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>pursuing criminal prosecution.&#160;</div>
          </td>
        </tr>

    </table>
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
    <div style="text-indent: 36pt; line-height: 1.25;">
      <div style="text-indent: 36pt; line-height: 1.25;">Any of these sanctions could impair our ability to produce our products in a cost-effective and timely manner in order to meet our customers&#8217; demands and could have a material adverse effect on our
        reputation, business, results of operations, and financial condition. We may also be required to bear other costs or take other actions that may have a negative impact on our future sales and our ability to generate profits.</div>
    </div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold;">We are subject to various laws and regulations, including &#8220;fraud and abuse&#8221; laws and anti-bribery laws, which, if violated, could subject us to substantial
    penalties.</div>
  <div style="text-align: justify; line-height: 1.25;">&#160;</div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">Medical device companies such as ours have faced lawsuits and investigations pertaining to alleged violations of numerous statutes and regulations, including anti-corruption laws and health care
          &#8220;fraud and abuse&#8221; laws, such as the federal False Claims Act, the federal Anti-Kickback Statute, and the U.S. Foreign Corrupt Practices Act, or the FCPA. See &#8220;Business-Government Regulation&#8221; above.</div>
        <div style="line-height: 1.25">&#160;</div>
      </div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">U.S. federal and state laws, including the federal Physician Payments Sunshine Act, or the Sunshine Act, and the implementation of Open Payments regulations under the Sunshine Act,
      require medical device companies to disclose certain payments or other transfers of value made to healthcare providers and teaching hospitals or funds spent on marketing and promotion of medical device products. It is widely believed that public
      reporting under the Sunshine Act and implementing Open Payments regulations results in increased scrutiny of the financial relationships between industry, physicians and teaching hospitals. Further, some state laws require medical device companies to
      report information related to payments to physicians and other health care providers or marketing expenditures. These anti-kickback, anti-bribery, public reporting and aggregate spending laws affect our sales, marketing and other promotional
      activities by limiting the kinds of financial arrangements, including sales programs, we may have with hospitals, rehabilitation centers, physicians or other potential purchasers or users of ReWalk or ReStore. They also impose additional
      administrative and compliance burdens on us. In particular, these laws influence, among other things, how we structure our sales offerings, including discount practices, customer support, education and training programs and physician consulting and
      other service arrangements, including those with marketers and sales agents. We may face significant costs in attempting to comply with these laws and regulations. If we are found to be in violation of any of these requirements or any actions or
      investigations are instituted against us, those actions could be costly to defend and could have a significant impact on our business, including the imposition of significant criminal and civil fines and penalties, exclusion from federal healthcare
      programs or other sanctions, and damage to our reputation or business.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">37</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
  </div>
  <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 36pt;">
    <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">
      <div style="line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;"><br>
          &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The FCPA applies to companies, including ours, with a class of securities registered under the Exchange Act. The FCPA and other anti-bribery laws to which various aspects of our operations may be subject generally prohibit companies
          and their intermediaries from making improper payments to officials for the purpose of obtaining or retaining business. In various jurisdictions, our operations require that we and third parties acting on our behalf routinely interact with
          government officials, including medical personnel who may be considered government officials for purposes of these laws because they are employees of state-owned or controlled facilities. Other anti-bribery laws to which various aspects of our
          operations may be subject, including the United Kingdom Bribery Act, also prohibit improper payments to private parties and prohibit receipt of improper payments. Our policies prohibit our employees from making or receiving corrupt payments,
          including, among other things, to require compliance by third parties engaged to act on our behalf. Our policies mandate compliance with these anti-bribery laws; however, we operate in many parts of the world that have experienced governmental
          and/or private corruption to some degree. As a result, the existence and implementation of a robust anti-corruption program cannot eliminate all risk that unauthorized reckless or criminal acts have been or will be committed by our employees or
          agents. Violations of these laws, or allegations of such violations, could disrupt our business and harm our financial condition, results of operations, cash flows and reputation.&#160;&#160;</div>
      </div>
    </div>
  </div>
  <div style="line-height: 1.25;">&#160;</div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold;">If we are found to have violated laws protecting the confidentiality of patient health information, we could be subject to civil or criminal penalties, which
      could increase our liabilities and harm our reputation or our business.</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">There are a number of federal, state and foreign laws protecting the confidentiality of certain patient health information, including patient records, and restricting the use and
      disclosure of that protected information. In particular, the U.S. Department of Health and Human Services, or HHS, promulgated patient privacy rules under the Health Insurance Portability and Accountability Act of 1996, or HIPAA. These privacy rules
      protect medical records and other personal health information by limiting their use and disclosure, giving individuals the right to access, amend and seek accounting of their own health information and limiting most use and disclosures of health
      information to the minimum amount reasonably necessary to accomplish the intended purpose. Additionally, the E.U. General Data Protection Regulation (the &#8220;GDPR&#8221;), which took effect in 2018, imposes more stringent data protection requirements and will
      provide for greater penalties for noncompliance. Thus with respect to our operations in Europe, the GDPR may increase our responsibility and liability in relation to personal data that we process and we may be required to put in place additional
      mechanisms ensuring compliance with the GDPR. This may be onerous and adversely affect our business, financial condition, results of operations and prospects. Additionally, if we or any of our service providers are found to be in violation of the
      promulgated patient privacy rules under HIPAA or, once enforced, the GDPR, we could be subject to civil or criminal penalties, which could be substantial and could increase our liabilities, harm our reputation and have a material adverse effect on
      our business, financial condition and operating results.</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In addition, a number of U.S. states have enacted data privacy and security laws and regulations that govern the collection, use, disclosure, transfer, storage, disposal, and
      protection of sensitive personal information, such as social security numbers, financial information and other personal information. For example, several U.S. territories and all 50 states now have data breach laws that require timely notification to
      individual victims, and at times regulators, if a company has experienced the unauthorized access or acquisition of sensitive personal data. Other state laws include the California Consumer Privacy Act (&#8220;CCPA&#8221;) which, among other things, contains new
      obligations for businesses that collect personal information about California residents and affords those individuals new rights relating to their personal information that may affect our ability to use personal information or share it with our
      business partners. Meanwhile, other states have considered privacy laws like the CCPA. &#160;We will continue to monitor and assess the impact of state law developments, which may impose substantial penalties for violations, impose significant costs for
      investigations and compliance, allow private class-action litigation and carry significant potential liability for our business.</div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
    <div style="text-indent: 36pt; line-height: 1.25;">The interpretation and enforcement of the laws and regulations described above are uncertain and subject to change and may require substantial costs to monitor and implement compliance with any
      additional requirements. Failure to comply with U.S. or international data protection laws and regulations could result in government enforcement actions (which could include substantial civil and/or criminal penalties), private litigation, and/or
      adverse publicity and could negatively affect our operating results and business.&#160;&#160; <br>
    </div>
  </div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold; font-style: italic;">Compliance with various regulations, including those related to our status as a U.S. public company and the manufacturing,
      labeling and marketing of our products, may result in heightened general and administrative expenses and costs, divert management&#8217;s attention from revenue-generating activities and pose challenges for our management team, which has limited time,
      personnel and finances to devote to regulatory compliance.</font>&#160;</div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">As a U.S. public company, we are subject to various regulatory and reporting requirements, including those imposed by the SEC, the Sarbanes-Oxley Act of 2002, or the Sarbanes-Oxley
    Act, the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, or the Dodd-Frank Act, the listing requirements of the Nasdaq Capital Market and other applicable securities rules and regulations. Additionally, our medical products and
    manufacturing operations are regulated by the FDA, the European Union and other governmental authorities both inside and outside of the United States. Compliance with the rules and regulations applicable to us as a publicly traded company in the United
    States and medical device manufacturer has greatly increased, and may continue to increase, our legal, general and administrative and financial compliance costs and has made, and may continue to make, some activities more difficult, time-consuming or
    costly. Additionally, these regulatory requirements have diverted, and may continue to divert, management&#8217;s attention from revenue-generating activities and may increase demands on management&#8217;s already-limited resources.&#160;</div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">38</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">Our management team consists of few employees, as the majority of our employees are engaged in sales and marketing and research and development activities. For more information, see &#8220;Part I, Item
          1. Business&#8212;Employees&#8221; above. In light of such constraints on its time, personnel and finances, our management may not be able to implement programs and policies in an effective and timely manner to respond adequately to the heightened legal,
          regulatory and reporting requirements applicable to us. In the past, for example, we have not always been able to respond on a timely basis to requests from regulators, although we have not to date experienced any long-term material adverse
          consequences as a result. For more information, see &#8220;&#8212;Risks Related to Government Regulation&#8212;While we addressed the observations that FDA cited in a 2015 warning letter related to our mandatory post-market surveillance study and initiated the
          study, we are currently experiencing enrollment issues that make our study progress inadequate. Going forward, if we cannot meet certain FDA requirements and enrollment criteria for the study or otherwise satisfy FDA requests promptly, or if our
          study produces unfavorable results, we could receive additional FDA warnings, which could materially and adversely affect our commercial success&#8221; above. Similar deficiencies, weaknesses, or lack of compliance with public company, medical device
          and other regulations could harm our reputation in the capital markets or for quality and safety, negatively affect our ability to maintain our public company status and to develop, commercialize or continue selling our products on a timely and
          effective basis, and cause us to incur sanctions, including fines, injunctions, and penalties.</div>
      </div>
    </div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In addition, complying with public disclosure rules makes our business more visible, which we believe may result in threatened or actual litigation, including by competitors and
      other third parties. If such claims are successful, our business and operating results could be harmed, and even if the claims do not result in litigation or are resolved in our favor, these claims, and the time and resources necessary to resolve
      them, could divert the resources of our management and harm our business and operating results.</div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;&#160;</div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">39</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  &#160;
  <div style="text-align: justify; line-height: 1.25; font-weight: bold;">
    <div style="text-align: left; line-height: 1.25; font-weight: bold;">Risks Related to Our Intellectual Property and Information Technology</div>
  </div>
  <div style="text-align: justify; line-height: 1.25;">&#160;</div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold;">We depend on computer and telecommunications systems we do not own or control and failures in our systems or a cybersecurity attack or breach of our IT systems
      or technology could significantly disrupt our business operations or result in sensitive customer information being compromised which would negatively materially affect our reputation and/or results of operations.</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We have entered into agreements with third parties for hardware, software, telecommunications, and other information technology services in connection with the operation of our
        business. It is possible we or a third party that we rely on could incur interruptions from a loss of communications, hardware or software failures, a cybersecurity attack or a breach of our IT systems or technology, computer viruses or malware. We
        believe that we have positive relations with our vendors and maintain adequate anti-virus and malware software and controls; however, any interruptions to our arrangements with third parties, to our computing and communications infrastructure, or
        to our information systems or any of those operated by a third party that we rely on could significantly disrupt our business operations.</div>
    </div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">In the current environment, there are numerous and evolving risks to cybersecurity and privacy, including criminal hackers, hacktivists, state-sponsored intrusions, industrial espionage, employee
          malfeasance and human or technological error. High-profile security breaches at other companies and in government agencies have increased in recent years, and security industry experts and government officials have warned about the risks of
          hackers and cyberattacks targeting businesses such as ours. Computer hackers and others routinely attempt to breach the security of technology products, services, and systems, and to fraudulently induce employees, customers, or others to
          disclosure information or unwittingly provide access to systems or data. A cyberattack of our systems or networks that impairs our information technology systems could disrupt our business operations and result in loss of service to customers,
          including technical support for our ReWalk devices. While we have certain cybersecurity safeguards in place designed to protect and preserve the integrity of our information technology systems, we have experienced and expect to continue to
          experience actual or attempted cyberattacks of our IT systems or networks. However, none of these actual or attempted cyberattacks has had a material effect on our operations or financial condition.</div>
      </div>
    </div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Additionally, we have access to sensitive customer information in the ordinary course of business. If a significant data breach occurred, our reputation may be adversely affected,
      customer confidence may be diminished, or we may be subject to legal claims, any of which may contribute to the loss of customers and have a material adverse effect on us. For more information, see &#8220;&#8212;Risks Related to Government Regulation&#8212;If we are
      found to have violated laws protecting the confidentiality of patient health information, we could be subject to civil or criminal penalties, which could increase our liabilities and harm our reputation or our business.&#8221; above.</div>
  </div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold;">Our success depends in part on our ability to obtain and maintain protection for the intellectual property relating to or incorporated into our products.</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">Our success depends in part on our ability to obtain and maintain protection for the intellectual property relating to or incorporated into our products. We seek to protect our intellectual
          property through a combination of patents, trademarks, confidentiality, and assignment agreements with our employees and certain of our contractors, and confidentiality agreements with certain of our consultants, scientific advisors, and other
          vendors and contractors. In addition, we rely on trade secret law to protect our proprietary software and product candidates/products in development. For more information, see Business&#8212;Intellectual Property.</div>
      </div>
    </div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">The patent position of robotic and exoskeleton inventions can be highly uncertain and involves many new and evolving complex legal, factual, and technical issues. Patent laws and interpretations of
          those laws are subject to change and any such changes may diminish the value of our patents or narrow the scope of our right to exclude others. In addition, we may fail to apply for or be unable to obtain patents necessary to protect our
          technology or products from competition or fail to enforce our patents due to lack of information about the exact use of technology or processes by third parties. Also, we cannot be sure that any patents will be granted in a timely manner or at
          all with respect to any of our patent pending applications or that any patents that are granted will be adequate to exclude others for any significant period of time or at all. Given the foregoing and in order to continue reducing operational
          expenses in the future, we may invest fewer resources in filing and prosecuting new patents and on maintaining and enforcing various patents, especially in regions where we currently do not focus our market growth strategy.</div>
      </div>
    </div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
    <div style="text-indent: 36pt; line-height: 1.25;">Litigation to establish or challenge the validity of patents, or to defend against or assert against others infringement, unauthorized use, enforceability, or invalidity, can be lengthy and expensive
      and may result in our patents being invalidated or interpreted narrowly and restricting our ability to be granted new patents related to our pending patent applications. Even if we prevail, litigation may be time consuming, force us to incur
      significant costs, and could divert management&#8217;s attention from managing our business while any damages or other remedies awarded to us may not be valuable. In addition, U.S. patents and patent applications may be subject to interference proceedings,
      and U.S. patents may be subject to re-examination and review proceedings in the U.S. Patent and Trademark Office. Foreign patents may also be subject to opposition or comparable proceedings in the corresponding foreign patent offices. Any of these
      proceedings may be expensive and could result in the loss of a patent or denial of a patent application, or the loss or reduction in the scope of one or more of the claims of a patent or patent application.&#160;&#160; <br>
    </div>
  </div>
  <div style="text-align: center; line-height: 1.25;"> </div>
  <br>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">40</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In addition, we seek to protect our trade secrets, know-how, and confidential information that is not patentable by entering into confidentiality and assignment agreements with our
    employees and certain of our contractors and confidentiality agreements with certain of our consultants, scientific advisors, and other vendors and contractors. However, we may fail to enter into the necessary agreements, and even if entered into,
    these agreements may be breached or otherwise fail to prevent disclosure, third-party infringement, or misappropriation of our proprietary information, may be limited as to their term and may not provide an adequate remedy in the event of unauthorized
    disclosure or use of proprietary information. Enforcing a claim that a third party illegally obtained or is using our trade secrets without authorization may be expensive and time consuming, and the outcome is unpredictable. Some of our employees or
    consultants may own certain technology which they license to us for a set term. If these technologies are material to our business after the term of the license, our inability to use them could adversely affect our business and profitability.&#160;</div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We also have taken precautions to initiate reasonable safeguards to protect our information technology systems. However, these measures may not be adequate to safeguard our
      proprietary information, which could lead to the loss or impairment thereof or to expensive litigation to defend our rights against competitors who may be better funded and have superior resources. In addition, unauthorized parties may attempt to
      copy or reverse engineer certain aspects of our products that we consider proprietary or our proprietary information may otherwise become known or may be independently developed by our competitors or other third parties. If other parties are able to
      use our proprietary technology or information, our ability to compete in the market could be harmed. Further, unauthorized use of our intellectual property may have occurred, or may occur in the future, without our knowledge.</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">If we are unable to obtain or maintain adequate protection for intellectual property, or if any protection is reduced or eliminated, competitors may be able to use our
      technologies, resulting in harm to our competitive position.</div>
  </div>
  <div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold;">&#160;</div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold;">Our patents and proprietary technology and processes may not provide us with a competitive advantage.</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Robotics and exoskeleton technologies have been developing rapidly in recent years. We are aware of several other companies developing competing exoskeleton devices for individuals
      with limited mobility and we expect the level of competition and the pace of development in our industry to increase. For more information, see &#8220;Part I, Item 1. Business&#8212;Competition&#8221; above. While we believe our tilt-sensor technology provides a more
      natural and superior method of exoskeleton activation, which creates a better user experience, as well as that our licensed technology used in our ReStore device is unique and provides better results when compared to other products, a variety of
      other activation and control methods exist for exoskeletons, several of which are being developed by our competitors, or may be developed in the future. As a result, our patent portfolio and proprietary technology and processes may not provide us
      with a significant advantage over our competitors, and competitors may be able to design and sell alternative products that are equal to or superior to our products without infringing on our patents. In addition, upon the expiration of our current
      patents, we may be unable to adequately develop new technologies and obtain future patent protection to preserve our competitive advantage. If we are unable to maintain a competitive advantage, our business and results of operations may be materially
      adversely affected.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;Even in instances where others are found to infringe on our patents, many countries have laws under which a patent owner may be compelled to grant licenses for the use of the
      patented technology to other parties. In addition, many countries limit the enforceability of patents against other parties, including government agencies or government contractors. In these countries, a patent owner may have limited remedies, which
      could diminish the value of a patent in those countries. Further, the laws of some countries do not protect intellectual property rights to the same extent as the laws of the United States, particularly in the field of medical products, and effective
      enforcement in those countries may not be available. The ability of others to market comparable products could adversely affect our business.</div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">41</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold;">We are not able to protect our intellectual property rights in all countries.</div>
  <div style="text-align: justify; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
    <div style="text-indent: 36pt; line-height: 1.25;">Filing, prosecuting, maintaining, and defending patents on each of our products in all countries throughout the world would be prohibitively expensive, and thus our intellectual property rights outside
      the United States are limited. In addition, the laws of some foreign countries, especially developing countries, such as China, do not protect intellectual property rights to the same extent as federal and state laws in the United States. Also, it
      may not be possible to effectively enforce intellectual property rights in some countries at all or to the same extent as in the United States and other countries. Consequently, we are unable to prevent third parties from using our inventions in all
      countries, or from selling or importing products made using our inventions in the jurisdictions in which we do not have (or are unable to effectively enforce) patent protection. Competitors may use our technologies in jurisdictions where we have not
      obtained patent protection to develop, market or otherwise commercialize their own products, and we may be unable to prevent those competitors from importing those infringing products into territories where we have patent protection, but enforcement
      may not be as strong as in the United States. These products may compete with our products and our patents and other intellectual property rights may not be effective or sufficient to prevent them from competing in those jurisdictions. Moreover,
      strategic partners, competitors, or others in the chain of commerce may raise legal challenges against our intellectual property rights or may infringe upon our intellectual property rights, including through means that may be difficult to prevent or
      detect.&#160; <br>
    </div>
  </div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="text-align: justify; line-height: 1.25;">
    <div style="text-indent: 36pt; line-height: 1.25;">Many companies have encountered significant problems in protecting and defending intellectual property rights in foreign jurisdictions. Proceedings to enforce our patent rights in the United States or
      foreign jurisdictions could result in substantial costs and divert our efforts and attention from other aspects of our business, could put our patents at risk of being invalidated or interpreted narrowly and our patent applications at risk of not
      issuing, and could provoke third parties to assert patent infringement or other claims against us. We may not prevail in any lawsuits that we initiate, and the damages or other remedies awarded, if any, may not be commercially meaningful.
      Accordingly, our efforts to enforce our intellectual property rights in the United States and around the world may be inadequate to obtain a significant commercial advantage from the intellectual property that we develop or license from third
      parties.<font style="font-weight: bold; font-style: italic;"> <br>
      </font></div>
  </div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold;">We may be subject to patent infringement claims, which could result in substantial costs and liability and prevent us from commercializing our current and future
    products.</div>
  <div style="text-align: justify; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The medical device industry is characterized by competing intellectual property and a substantial amount of litigation over patent rights. In particular, our competitors in both the
    United States and abroad, many of which have substantially greater resources and have made substantial investments in competing technologies, have been issued patents and filed patent applications with respect to their products and processes and may
    apply for other patents in the future. The large number of patents, the rapid rate of new patent issuances, and the complexities of the technology involved increase the risk of patent litigation.&#160;</div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
    <div style="text-indent: 36pt; line-height: 1.25;">Determining whether a product infringes a patent involves complex legal and factual issues and the outcome of patent litigation is often uncertain. Even though we have conducted research of issued
      patents, no assurance can be given that patents containing claims covering our products, technology or methods do not exist, have not been filed or could not be filed or issued. In addition, because patent applications can take years to issue and
      because publication schedules for pending applications vary by jurisdiction, there may be applications now pending of which we are unaware, and which may result in issued patents that our current or future products infringe. Also, because the claims
      of published patent applications can change between publication and patent grant, published applications that initially do not appear to be problematic may issue with claims that potentially cover our products, technology, or methods.&#160; <br>
    </div>
  </div>
  <div style="text-align: center; line-height: 1.25;"> <br>
  </div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">42</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  &#160;
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Infringement actions and other intellectual property claims brought against us, whether with or without merit, may cause us to incur substantial costs and could place a significant
    strain on our financial resources, divert the attention of management, and harm our reputation. We cannot be certain that we will successfully defend against any allegations of infringement. If we are found to infringe another party&#8217;s patents, we could
    be required to pay damages. We could also be prevented from selling our infringing products, unless we can obtain a license to use the technology covered by such patents or can redesign our products so that they do not infringe. A license may be
    available on commercially reasonable terms or none at all, and we may not be able to redesign our products to avoid infringement. Further, any modification to our products could require us to conduct clinical trials and revise our filings with the FDA
    and other regulatory bodies, which would be time consuming and expensive. In these circumstances, we may not be able to sell our products at competitive prices or at all, and our business and operating results could be harmed.&#160;</div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold;">We rely on trademark protection to distinguish our products from the products of our competitors.</div>
  <div style="text-align: justify; line-height: 1.25;">&#160;</div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We rely on trademark protection to distinguish our products from the products of our competitors. We have registered the trademark &#8220;ReWalk&#8221; in Israel and in the United States. The
      trademark &#8220;Restore&#8221; is already registered in Europe and allowed in the United States. In jurisdictions where we have not registered our trademark and are using it, and as permitted by applicable local law, we rely on common law trademark protection.
      Third parties may oppose our trademark applications, or otherwise challenge our use of the trademarks, and may be able to use our trademarks in jurisdictions where they are not registered or otherwise protected by law. If our trademarks are
      successfully challenged or if a third party is using confusingly similar or identical trademarks in particular jurisdictions before we do, we could be forced to rebrand our products, which could result in loss of brand recognition, and could require
      us to devote additional resources to marketing new brands. If others are able to use our trademarks, our ability to distinguish our products may be impaired, which could adversely affect our business. Further, we cannot assure you that competitors
      will not infringe upon our trademarks, or that we will have adequate resources to enforce our trademarks.</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold;">We may be subject to damages resulting from claims that our employees or we have wrongfully used or disclosed alleged trade secrets of their former employers.</div>
  <div style="text-align: justify; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; line-height: 1.25; text-indent: 36pt;">Many of our employees were previously employed at other medical device companies, including our competitors or potential competitors, and we may hire employees in the future that are
    so employed. We could in the future be subject to claims that these employees, or we, have inadvertently or otherwise used or disclosed trade secrets or other proprietary information of their former employers. If we fail in defending against such
    claims, a court could order us to pay substantial damages and prohibit us from using technologies or features that are found to incorporate or be derived from the trade secrets or other proprietary information of the former employers. If any of these
    technologies or features that are important to our products, this could prevent us from selling those products and could have a material adverse effect on our business. Even if we are successful in defending against these claims, such litigation could
    result in substantial costs and divert the attention of management.<font style="font-weight: bold; font-style: italic;">&#160;</font></div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="line-height: 1.25; font-weight: bold;">Risks Related to an Investment in Our Ordinary Shares</div>
  <div style="line-height: 1.25;">&#160;</div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold;">Sales of a substantial number of ordinary shares by us or our large shareholders, certain of whom may have registration rights, or dilutive exercises of a
      substantial number of warrants by our warrant-holders could adversely affect the value of our ordinary shares.</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Sales by us or our shareholders of a substantial number of ordinary shares in the public market, or the perception that these sales might occur, could cause the value of our
      ordinary shares to decline or could impair our ability to raise capital through a future sale of our equity securities. Additionally, dilutive exercises of a substantial number of warrants by our warrant-holders, or the perception that such exercises
      may occur, could put downward price on the market price of our ordinary shares.</div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
    <div style="text-indent: 36pt; line-height: 1.25;">As of February 16, 2021, 5,752,726 ordinary shares were issuable pursuant to the exercise of warrants, with exercise prices ranging from $1.25 to $118.75 per warrant, issued in private and registered
      offerings of ordinary shares and warrants in November 2016, November 2018, February 2019, April 2019, June 2019, February 2020, July 2020 and December 2020. We have registered with the SEC all of these warrants and/or the resale of the shares
      issuable upon their exercise. There were also 6,679 ordinary shares issuable pursuant to the exercise of warrants granted to Kreos Capital V (Expert Fund) Limited (&#8220;Kreos&#8221;), in connection with the December 30, 2015 signed loan agreement (the &#8220;Loan
      Agreement&#8221;) in January and December 2016, with an exercise price that is now set to $7.50 per warrant. For more information, see &#8220;Part I, Item 2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8212;Liquidity and
      Capital Resources&#8212;Loan Agreement with Kreos and Related Warrant to Purchase Ordinary Shares&#8221; and &#8220;Part I, Item 2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8212;Liquidity and Capital Resources&#8212;Equity Raises&#8221;, in
      each case below.</div>
  </div>
  <div style="line-height: 1.25">&#160;</div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">43</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <div style="line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
    <div style="text-indent: 36pt; line-height: 1.25;">
      <div style="text-indent: 36pt; line-height: 1.25;">All shares sold pursuant to an offering covered by a registration statement would be freely transferable. With respect to the outstanding warrants, there may be certain restrictions on the holders to
        sell the underlying ordinary shares to the extent they are restricted securities, held by &#8220;affiliates&#8221; or would exceed certain ownership thresholds. Certain of our largest shareholders, may also have limitations under Rule 144 under the Securities
        Act on the resale of certain ordinary shares they hold unless they are registered for resale under the Securities Act. Despite these limitations and the liquidity we may gain from cash exercises of outstanding warrants, if we, our existing
        shareholders, or their affiliates sell a substantial number of the above-mentioned ordinary shares in the public market, the market price of our ordinary shares could decrease significantly. Shareholders may also incur substantial dilution if
        holders of our warrants exercise their warrants to purchase ordinary shares, which could lower the market price of our ordinary shares. Any such decrease could impair the value of your investment in us.</div>
    </div>
  </div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold;">Future grants of ordinary shares under our equity incentive plans to our employees, non-employee directors and consultants, or sales by these individuals in the
      public market, could result in substantial dilution, thus decreasing the value of your investment in our ordinary shares, and certain grants may also require shareholder approval.</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">We have historically used, and continue to use, our ordinary shares as a means of both rewarding our employees, non-employee directors, and consultants and aligning their interests with those of
          our shareholders. As of December 31, 2020, 1,925,237 ordinary shares remained available for issuance to our and our affiliates&#8217; respective employees, non-employee directors, and consultants under our equity incentive plans, including 1,320,917
          ordinary shares subject to outstanding awards (consisting of outstanding options to purchase 69,606 ordinary shares and 1,251,311 ordinary shares underlying unvested RSUs. For more information, see Note 8c to our consolidated financial statements
          for the year ended December 31, 2020 below.</div>
      </div>
    </div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">Additionally, to the extent registered on a Form S-8, ordinary shares granted or issued under our equity incentive plans will, subject to vesting provisions, lock-up restrictions, and Rule 144
          volume limitations applicable to our &#8220;affiliates,&#8221; be available for sale in the open market immediately upon registration. Sales of a substantial number of the above-mentioned ordinary shares in the public market could result in a significant
          decrease in the market price of our ordinary shares and have a material adverse effect on an investment in our ordinary shares.</div>
      </div>
    </div>
  </div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold;">&#160;If we do not meet the expectations of equity research analysts, if any, if the sole remaining equity analyst following our business does not continue to
      publish research or reports about our business or if the analyst issues unfavorable commentary or downgrade our ordinary shares, the price of our ordinary shares could decline. Additionally, we may fail to meet publicly announced financial guidance
      or other expectations about our business, which would cause our ordinary shares to decline in value.</div>
    <div style="line-height: 1.25">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">There is currently one equity analyst publishing research reports about our business. If our results of operations are below the estimates or expectations of our sole analyst and
      investors, our share price could decline. Moreover, the price of our ordinary shares could decline if one or more securities analysts downgrade our ordinary shares or if analysts issue other unfavorable commentary or stop publishing research or
      reports about us or our business (as has occurred over time, with a decrease in the number of analysts following us from five in 2014 to one in 2020).</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">From time to time, we have also faced difficulty accurately projecting our earnings and have missed certain of our publicly announced guidance. If our financial results for a
      particular period do not meet our guidance or if we reduce our guidance for future periods, the market price of our ordinary shares may decline.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold;">We are a &#8220;smaller reporting company&#8221; and we cannot be certain whether the reduced requirements applicable to smaller reporting companies will make our ordinary
      shares less attractive to investors.</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We are a &#8220;smaller reporting company&#8221; under the rules of the Securities Act and the Exchange Act. As a result, we may choose to take advantage of certain scaled disclosure
      requirements available specifically to smaller reporting companies. For example, we are not required to provide market risk disclosures, a contractual obligations table in our management&#8217;s discussion and analysis of our financial condition and
      results of operations or selected financial data in our annual report. Additionally, as long as we continue to be a smaller reporting company, we may continue to use reduced compensation disclosure obligations, and, provided we are also a
      &#8220;non-accelerated filer,&#8221; we will not be obligated to follow the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act. We will remain both (i) a smaller reporting company and &#8220;non-accelerated filer&#8221; until the last day of the
      fiscal year in which we have at least $100 million in revenue and at least $700 million in aggregate market value of ordinary shares held by non-affiliated persons and entities (known as &#8220;public float&#8221;), or, alternatively, if our revenues exceed $100
      million, (ii) a smaller reporting company until the last day of the fiscal year in which our public float was at least $250.0 million and a &#8220;non-accelerated filer&#8221; until the last day of the fiscal year in which our public float was at least $75.0
      million (in each case, with respect to public float, as measured as of the last business day of the second quarter of such fiscal year).</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">44</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We cannot predict or otherwise determine if investors will find our securities less attractive as a result of our reliance on exemptions as a smaller reporting company and/or
      &#8220;non-accelerated filer.&#8221; If some investors find our securities less attractive as a result, there may be a less active trading market for our ordinary shares and the price of our ordinary shares may be more volatile.</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold;">We are subject to ongoing costs and risks associated with determining whether our existing internal controls over financial reporting systems are compliant with
      Section 404 of the Sarbanes-Oxley Act, and if we fail to achieve and maintain adequate internal controls it could have a material adverse effect on our stated results of operations and harm our reputation.</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We are required to comply with the internal control, evaluation, and certification requirements of Section 404 of the Sarbanes-Oxley Act and the Public Company Accounting Oversight
      Board. Once we no longer qualify as a &#8220;smaller reporting company&#8221; and &#8220;non-accelerated filer,&#8221; our independent registered public accounting firm will need to attest to the effectiveness of our internal control over financial reporting under Section
      404.</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The process of determining whether our existing internal controls over financial reporting systems are compliant with Section 404 and whether there are any material weaknesses or
      significant deficiencies in our existing internal controls requires the investment of substantial time and resources, including by our Chief Financial Officer and other members of our senior management. This determination and any remedial actions
      required could divert internal resources and take a significant amount of time and effort to complete and could result in us incurring additional costs that we did not anticipate, including the hiring of outside consultants. We could experience
      higher than anticipated operating expenses and higher independent auditor fees during and after the implementation of these changes.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">Irrespective of compliance with Section 404, any failure of our internal controls could have a material adverse effect on our stated results of operations and harm our reputation. If we are unable
          to implement any of the required changes to our internal control over financial reporting effectively or efficiently or are required to do so earlier than anticipated, it could adversely affect our operations, financial reporting and/or results
          of operations and could result in an adverse opinion on internal controls from our management and our independent auditors. Further, if our internal control over financial reporting is not effective, the reliability of our financial statements
          may be questioned, and our share price may suffer.</div>
      </div>
    </div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="text-align: justify; line-height: 1.25;">
    <div style="line-height: 1.25;"><font style="font-weight: bold; font-style: italic;">U.S. holders of our ordinary shares may suffer adverse U.S. tax consequences if we are characterized as a passive foreign investment company, or a PFIC</font>,<font style="font-weight: bold; font-style: italic;"> under Section 1297(a) of the Code.</font> <br>
    </div>
  </div>
  <div style="text-align: justify; line-height: 1.25;">&#160;</div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">Generally, if for any taxable year 75% or more of our gross income is passive income, or at least 50% of the average quarterly value of our assets (which may be determined in part by the market
          value of our ordinary shares, which is subject to change) are held for the production of, or produce passive income, we would be characterized as a passive foreign investment company, or PFIC, for U.S. federal income tax purposes. Passive income
          for this purpose generally includes, among other things, certain dividends, interest, royalties, rents, and gains from commodities and securities transactions and from the sale or exchange of property that gives rise to passive income. Passive
          income also includes amounts derived by reason of the temporary investment of funds, including those raised in an offering. In determining whether a non-U.S. corporation is a PFIC, a proportionate share of the income and assets of each
          corporation in which it owns, directly or indirectly, at least a 25% interest (by value) is taken into account.</div>
      </div>
    </div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">45</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">
          <div style="line-height: 1.25;">
            <div style="text-indent: 36pt; line-height: 1.25;">
              <div style="line-height: 1.25;">
                <div style="text-indent: 36pt; line-height: 1.25;">The determination of whether we are a PFIC will depend on the nature and composition of our income and the nature, composition, and value of our assets from time to time. The 50% passive
                  asset test described above is generally based on the fair market value of each asset, with the value of goodwill and going concern value determined in large part by reference to the market value of our ordinary shares, which may be
                  volatile. If we are characterized as a &#8220;controlled foreign corporation,&#8221; or a &#8220;CFC&#8221;, under Section 957(a) of the Code and not considered publicly traded throughout the relevant taxable year, however, the passive asset test may be applied
                  based on the adjusted tax bases of our assets instead of the fair market value of each asset (as described above). Under recently released final Treasury Regulations, however, if we are treated as publicly traded for at least 20 trading
                  days during the relevant taxable year, our assets would generally be required to be measured at their fair market value, even if we are a CFC.</div>
              </div>
            </div>
          </div>
        </div>
      </div>
    </div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">
          <div style="line-height: 1.25;">
            <div style="text-indent: 36pt; line-height: 1.25;">Based on our gross income and assets, the market price of our ordinary shares, and the nature of our business, we believe that we may have been a PFIC for the taxable year ended December&#160;31,
              2020. However, this determination is subject to uncertainty. In addition, there is a significant risk that we may be a PFIC for future taxable years, unless the market price of our ordinary shares increases, or we reduce the amount of cash
              and other passive assets we hold relative to the amount of non-passive assets we hold. Accordingly, no assurances can be made regarding our PFIC status in one or more subsequent years, and our U.S. counsel expresses no opinion with respect to
              our PFIC status in the taxable year ended December 31, 2020, and also expresses no opinion with respect to our predictions or past determinations regarding our PFIC status in the past or in the future.</div>
          </div>
        </div>
      </div>
    </div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">If we are characterized as a PFIC, U.S. holders of our ordinary shares may suffer adverse tax consequences, including having gains realized on the sale of our ordinary shares
      treated as ordinary income, rather than capital gain, the loss of the preferential tax rate applicable to dividends received on our ordinary shares by individuals who are U.S. holders and having interest charges apply to distributions by us and to
      the proceeds of sales of our ordinary shares. In addition, special information reporting may be required. Certain elections exist that may alleviate some of the adverse consequences of PFIC status and would result in an alternative treatment (such as
      mark-to-market treatment or being able to make a qualified electing fund election). However, we do not intend to provide the information necessary for U.S. Holders to make qualified electing fund elections if we are classified as a PFIC.</div>
  </div>
  <div style="text-align: justify; line-height: 1.25;">&#160;&#160;</div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">46</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <br>
  <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 36pt;">Additionally, if we are characterized as a PFIC, for any taxable year during which a U.S. Holder holds ordinary shares, we generally will
    continue to be treated as a PFIC with respect to such U.S. holder for all succeeding years during which such U.S. holder holds ordinary shares unless we cease to be a PFIC and such U.S. holder makes a &#8220;deemed sale&#8221; election with respect to such
    ordinary shares. If such election is made, such U.S. holder will be deemed to have sold such ordinary shares held by such U.S. holder at their fair market value on the last day of the last taxable year in which we qualified as a PFIC, and any gain from
    such deemed sale would be treated as described above.&#160;</div>
  <div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold;">&#160;</div>
  <div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold;">The price of our ordinary shares may be volatile, and you may lose all or part of your investment.</div>
  <div style="text-align: justify; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
    <div style="text-indent: 36pt; line-height: 1.25;">
      <div style="text-indent: 36pt; line-height: 1.25;">Our ordinary shares were first publicly offered in our initial public offering in September 2014, at a price of $300.00 per share, and our ordinary shares have subsequently traded as high as
        $1,092.75 per share and as low as $0.41 per share through February 16, 2021. All prices have been adjusted to reflect our 25-to-1 reverse stock split, which we effected in 2019. The market price of our ordinary shares could be highly volatile and
        may fluctuate substantially as a result of many factors. Moreover, while there is no established public trading market for the warrants offered in our follow-on public offerings, and we do not expect one to develop, our ordinary shares will be
        issuable pursuant to exercise of these warrants. Because the warrants are exercisable into our ordinary shares, volatility, or a reduction in the market price of our ordinary shares could have an adverse effect on the trading price of the warrants.
        Factors which may cause fluctuations in the price of our ordinary shares include, but are not limited to:</div>
    </div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z3020fda91f474906903b6ed66848c169">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#9679;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>actual or anticipated fluctuations in our growth rate or results of operations or those of our competitors;</div>
          </td>
        </tr>

    </table>
    <div style="text-align: left; line-height: 1.25;"><font style="font-family: 'Times New Roman', Times, serif;">&#160;</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z63cfd4c789c74ce6bca03060701f0d70">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#9679;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>customer acceptance of our products;</div>
          </td>
        </tr>

    </table>
    <div style="text-align: left; line-height: 1.25;"><font style="font-family: 'Times New Roman', Times, serif;">&#160;</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z49a55ec96f104359a0e8df899b524b0a">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#9679;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>
              <div style="line-height: 1.25;"> announcements by us or our competitors of new products or services, commercial relationships, acquisitions, or expansion plans;</div>
            </div>
          </td>
        </tr>

    </table>
    <div style="text-align: left; line-height: 1.25;"><font style="font-family: 'Times New Roman', Times, serif;">&#160;</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zdd07ef0e78394d21826901496d88e0d0">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#9679;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>announcements by us or our competitors of other material developments;</div>
          </td>
        </tr>

    </table>
    <div style="text-align: left; line-height: 1.25;"><font style="font-family: 'Times New Roman', Times, serif;">&#160;</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7b83941b257747e3a654bf60cd59e4b2">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#9679;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>our involvement in litigation;</div>
          </td>
        </tr>

    </table>
    <div style="text-align: left; line-height: 1.25;"><font style="font-family: 'Times New Roman', Times, serif;">&#160;</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0f2d39644a4545699acf176b9c4b394c">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#9679;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>changes in government regulation applicable to us and our products;</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zecc94d4ff8644f3f97fa8dc8fcc922a5">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#9679;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>sales, or the anticipation of sales, of our ordinary shares, warrants and debt securities by us, or sales of our ordinary shares by our insiders or other shareholders, including upon expiration of contractual lock-up agreements;</div>
            </td>
          </tr>

      </table>
      <div style="text-align: left; line-height: 1.25;"><font style="font-family: 'Times New Roman', Times, serif;">&#160;</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zadcfe330b41a496f95c76b1ed48edeec">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#9679;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>developments with respect to intellectual property rights;</div>
            </td>
          </tr>

      </table>
      <div style="text-align: left; line-height: 1.25;"><font style="font-family: 'Times New Roman', Times, serif;">&#160;</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z09a1662f5b0f4b0a8b56a0a31a8a4541">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#9679;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>competition from existing or new technologies and products;</div>
            </td>
          </tr>

      </table>
      <div style="text-align: left; line-height: 1.25;"><font style="font-family: 'Times New Roman', Times, serif;">&#160;</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z9c76b3f92b0446d5ac41f27c440d91df">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#9679;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>changes in key personnel;</div>
            </td>
          </tr>

      </table>
      <div style="text-align: left; line-height: 1.25;"><font style="font-family: 'Times New Roman', Times, serif;">&#160;</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z71a80528c16f4d36938a2f2c265fa15f">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#9679;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>the trading volume of our ordinary shares;</div>
            </td>
          </tr>

      </table>
      <div style="text-align: left; line-height: 1.25;"><font style="font-family: 'Times New Roman', Times, serif;">&#160;</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z1adfa4e1f4a04f82b5e012627580f45d">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#9679;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>changes in the estimation of the future size and growth rate of our markets;</div>
            </td>
          </tr>

      </table>
      <div style="text-align: left; line-height: 1.25;"><font style="font-family: 'Times New Roman', Times, serif;">&#160;</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z492e11c50af8479bbd1f410f775fb5ee">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#9679;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>changes in our quarterly or annual forecasts with respect to operating results and financial conditions; and</div>
            </td>
          </tr>

      </table>
      <div style="text-align: left; line-height: 1.25;"><font style="font-family: 'Times New Roman', Times, serif;">&#160;</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z5708a664c29140caa2e0a657d3f931b6">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#9679;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>general economic and market conditions.</div>
            </td>
          </tr>

      </table>
    </div>
    &#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
    <div style="text-indent: 36pt; line-height: 1.25;">In addition, the stock markets have experienced extreme price and volume fluctuations. Broad market and industry factors may materially harm the market price of our ordinary shares, regardless of our
      operating performance. Technical factors in the public trading market for our ordinary shares may produce price movements that may or may not comport with macro, industry or Company-specific&#160;fundamentals, including, without limitation, the sentiment
      of retail investors (including as may be expressed on financial trading and other social media sites), the amount and status of short interest in our securities, access to margin debt, trading in options and other derivatives on our ordinary shares
      and any related hedging or other technical trading factors.&#160;In the past, following periods of volatility in the market price of a company&#8217;s securities, securities class action litigation has often been instituted against that company, as was the case
      for ReWalk in a securities class action dismissed in full in November 2020. If we become involved in any similar litigation, we could incur substantial costs and our management&#8217;s attention and resources could be diverted.</div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">47</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <div style="text-align: justify; line-height: 1.25;"><font style="font-weight: bold; font-style: italic;">&#160;</font>&#160;<font style="font-weight: bold; font-style: italic;">&#160;</font></div>
  <div style="line-height: 1.25;"><font style="font-weight: bold;">Risks Related to Our Incorporation and Location in Israel</font></div>
  <div style="line-height: 1.25">&#160;</div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold;">Our technology development and quality headquarters and the manufacturing facility for our products are located in Israel and, therefore, our results may be
      adversely affected by economic restrictions imposed on, and political and military instability in, Israel.</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">
          <div style="line-height: 1.25;">
            <div style="text-indent: 36pt; line-height: 1.25;">Our technology development and quality headquarters, which houses substantially all of our research and development and our core research and development team, including engineers, machinists,
              and quality and regulatory personnel, as well as the facility of our contract manufacturer, Sanmina, are located in Israel. Many of our employees, directors and officers are residents of Israel. Accordingly, political, economic, and military
              conditions in Israel and the surrounding region may directly affect our business. Since the establishment of the State of Israel in 1948, a number of armed conflicts have taken place between Israel and its Arab neighbors, Hamas (an Islamist
              militia and political group in the Gaza Strip), Hezbollah (an Islamist militia and political group in Lebanon) and other armed groups. Any hostilities involving Israel or the interruption or curtailment of trade within Israel or between
              Israel and its trading partners could materially and adversely affect our business, financial condition and results of operations and could make it more difficult for us to raise capital. In particular, an interruption of operations at the
              Tel Aviv airport related to the conflict in the Gaza Strip or otherwise could prevent or delay shipments of our components or products. Although we maintain inventory in the United States and Germany, an extended interruption could materially
              and adversely affect our business, financial condition, and results of operations.</div>
          </div>
        </div>
      </div>
    </div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">Recent political uprisings, social unrest, and violence in various countries in the Middle East and North Africa, including Israel&#8217;s neighbors Egypt and Syria, are affecting the political stability
          of those countries. This instability may lead to deterioration of the political relationships that exist between Israel and these countries and has raised concerns regarding security in the region and the potential for armed conflict. Our
          commercial insurance does not cover losses that may occur as a result of an event associated with the security situation in the Middle East. Any losses or damages incurred by us could have a material adverse effect on our business. In addition,
          Iran has threatened to attack Israel and is widely believed to be developing nuclear weapons. Iran is also believed to have a strong influence among parties hostile to Israel in areas that neighbor Israel, such as the Syrian government, Hamas in
          Gaza and Hezbollah in Lebanon. Any armed conflicts, terrorist activities or political instability in the region could materially and adversely affect our business, financial condition, and results of operations.</div>
      </div>
    </div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold;">Our operations and the operations of our contract manufacturer, Sanmina, may be disrupted as a result of the obligation of Israeli citizens to perform military
      service.</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">Many Israeli citizens are obligated to perform one month, and in some cases more, of annual military reserve duty until they reach the age of 45 (or older, for reservists with certain occupations)
          and, in the event of a military conflict, may be called to active duty. In response to terrorist activity, there have been periods of significant call-ups of military reservists. It is possible that there will be additional military reserve duty
          call-ups in the future in connection with this conflict or otherwise. Some of our executive officers and employees, as well as those of Sanmina, the manufacturer of all of our products, are required to perform annual military reserve duty in
          Israel and may be called to active duty at any time under emergency circumstances. Although these call-ups have not had a material impact on our operations or on Sanmina&#8217;s ability to manufacture our products, our operations and the operations of
          Sanmina could be disrupted by such call-ups.</div>
      </div>
    </div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;&#160;</div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">48</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <div style="text-align: center; line-height: 1.25;"><br>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold;">Our sales may be adversely affected by boycotts of Israel.</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Several countries, principally in the Middle East, restrict doing business with Israel and Israeli companies, and additional countries may impose restrictions on doing business
      with Israel and Israeli companies whether as a result of hostilities in the region or otherwise. In addition, there have been increased efforts by activists to cause companies and consumers to boycott Israeli goods based on Israeli government
      policies. Such actions, particularly if they become more widespread, may adversely impact our ability to sell our products.</div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold;">The tax benefits that are available to us require us to continue to meet various conditions and may be terminated or reduced in the future, which could increase
      our costs and taxes.</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">Some of our operations in Israel, referred to as &#8220;Beneficiary Enterprises,&#8221; carry certain tax benefits under the Israeli Law for the Encouragement of Capital Investments, 5719-1959, or the
          Investment Law. Substantially all of our future income before taxes can be attributed to these programs. If we do not meet the requirements for maintaining these benefits or if our assumptions regarding the key elements affecting our tax rates
          are rejected by the tax authorities, they may be reduced or cancelled, and the relevant operations would be subject to Israeli corporate tax at the standard rate. In addition to being subject to the standard corporate tax rate, we could be
          required to refund any tax benefits that we may receive in the future, plus interest and penalties thereon. Even if we continue to meet the relevant requirements, the tax benefits that our current &#8220;Beneficiary Enterprises&#8221; receive may not be
          continued in the future at their current levels or at all. If these tax benefits were reduced or eliminated, the amount of taxes that we pay would likely increase, as all of our Israeli operations would consequently be subject to corporate tax at
          the standard rate, which could adversely affect our results of operations. Additionally, if we increase our activities outside of Israel, for example, by way of acquisitions, our increased activities may not be eligible for inclusion in Israeli
          tax benefit programs. For a discussion of our current tax obligations, see &#8220;Part II. Item 7, Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.&#8221;</div>
      </div>
    </div>
  </div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold;">We have received Israeli government grants for certain of our research and development activities and we may receive additional grants in the future. The terms of
    those grants restrict our ability to manufacture products or transfer technologies outside of Israel, and we may be required to pay penalties in such cases or upon the sale of our company.</div>
  <div style="text-align: justify; line-height: 1.25;">&#160;</div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">From our inception through December 31, 2020, we received a total of $1.97 million from the Israel Innovation Authority, or the IIA. We may in the future apply to receive additional grants from the
          IIA to support our research and development activities. With respect to such grants, we are committed to paying royalties at a rate of 3.0% on sales proceeds up to the total amount of grants received, linked to the dollar, and bearing interest at
          an annual rate of LIBOR applicable to dollar deposits. Even after payment in full of these amounts, we will still be required to comply with the requirements of the Israeli Encouragement of Industrial Research, Development and Technological
          Innovation Law, 1984, or the R&amp;D Law, and related regulations, with respect to those past grants. When a company develops know-how, technology or products using IIA grants, the terms of these grants and the R&amp;D Law restrict the transfer
          outside of Israel of such know-how, and of the manufacturing or manufacturing rights of such products, technologies, or know-how, without the prior approval of the IIA. Therefore, if aspects of our technologies are deemed to have been developed
          with IIA funding, the discretionary approval of an IIA committee would be required for any transfer to third parties outside of Israel of know-how or manufacturing or manufacturing rights related to those aspects of such technologies.
          Furthermore, the IIA may impose certain conditions on any arrangement under which it permits us to transfer technology or development out of Israel or may not grant such approvals at all.</div>
      </div>
    </div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Furthermore, the consideration available to our shareholders in a future transaction involving the transfer outside of Israel of technology or know-how developed with IIA funding
      (such as a merger or similar transaction) may be reduced by any amounts that we are required to pay to the IIA.</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In addition to the above, any non-Israeli citizen, resident or entity that, among other things, (i) becomes a holder of 5% or more of our share capital or voting rights, (ii) is
      entitled to appoint one or more of our directors or our chief executive officer or (iii) serves as one of our directors or as our chief executive officer (including holders of 25% or more of the voting power, equity or the right to nominate directors
      in such direct holder, if applicable) is required to notify the IIA and undertake to comply with the rules and regulations applicable to the grant programs of the IIA, including the restrictions on transfer described above. Such notification will be
      required in connection with the investment being made by an investor.</div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;&#160;</div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">49</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  &#160;
  <div style="line-height: 1.25;">
    <div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold;">We may become subject to claims for remuneration or royalties for assigned service invention rights by our employees, which could result in litigation and
      adversely affect our business.</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">A significant portion of our intellectual property has been developed by our employees in the course of their employment for us. Under the Israeli Patent Law, 5727-1967, or the
      Patent Law, and recent decisions by the Israeli Supreme Court and the Israeli Compensation and Royalties Committee, a body constituted under the Patent Law, employees may be entitled to remuneration for intellectual property that they develop for us
      unless they explicitly waive any such rights, although the validity of any such waivers remains open to judicial review. Although we enter into agreements with our employees pursuant to which they agree that any inventions created in the scope of
      their employment or engagement are owned exclusively by us, we may face claims demanding remuneration. As a consequence of such claims, we could be required to pay additional remuneration or royalties to our current and former employees, or be forced
      to litigate such claims, which could negatively affect our business.</div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold;">
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25; font-style: italic; font-weight: bold;">Provisions of Israeli law and our Articles of Association may delay, prevent, or otherwise impede a merger with, or an acquisition of, us, even when the terms of such a
          transaction are favorable to us and our shareholders.</div>
      </div>
    </div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">Israeli corporate law regulates mergers, requires tender offers for acquisitions of shares above specified thresholds, requires special approvals for transactions involving directors, officers or
          significant shareholders and regulates other matters that may be relevant to such types of transactions. For example, a tender offer for all of a company&#8217;s issued and outstanding shares can only be completed if the acquirer receives positive
          responses from the holders of at least 95% of the issued share capital. Completion of the tender offer also requires approval of a majority of the offerees that do not have a personal interest in the tender offer, unless at least 98% of the
          company&#8217;s outstanding shares are tendered. Furthermore, the shareholders, including those who indicated their acceptance of the tender offer (unless the acquirer stipulated in its tender offer that a shareholder that accepts the offer may not
          seek appraisal rights), may, at any time within six months following the completion of the tender offer, petition an Israeli court to alter the consideration for the acquisition. Israeli law also requires a &#8220;special tender offer&#8221; in certain cases
          where a shareholder crosses the 25% or 45% holding threshold, and it imposes procedural and special voting requirements for the approval of a merger in certain cases.</div>
      </div>
    </div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">Our Articles of Association provide that our directors (other than external directors, a requirement of Israeli corporate law from which we have opted out in accordance with an exemption for which
          we are currently eligible) are elected on a staggered basis, such that a potential acquirer cannot readily replace our entire board of directors at a single annual general shareholder meeting. This could prevent a potential acquirer from
          receiving board approval for an acquisition proposal that our board of directors opposes.</div>
      </div>
    </div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Furthermore, Israeli tax considerations may make potential transactions unappealing to us or to our shareholders whose country of residence does not have a tax treaty with Israel
      exempting such shareholders from Israeli tax. For example, Israeli tax law does not recognize tax-free share exchanges to the same extent as U.S. tax law. With respect to mergers involving an exchange of shares, Israeli tax law allows for tax
      deferral in certain circumstances but makes the deferral contingent on the fulfillment of a number of conditions, including, in some cases, a holding period of two years from the date of the transaction during which sales and dispositions of shares
      of the participating companies are subject to certain restrictions. Moreover, with respect to certain share swap transactions, the tax deferral is limited in time, and when such time expires, the tax becomes payable even if no disposition of the
      shares has occurred. These and other similar provisions could delay, prevent or impede an acquisition of us or our merger with another company, even if such an acquisition or merger would be beneficial to us or to our shareholders.</div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold;">We recently amended our articles of association to increase our authorized share capital. There are certain risks associated with this increase.</div>
  <div style="line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
    <div style="text-indent: 36pt; line-height: 1.25;">In late March 2019, following the receipt of shareholder approval, we filed the Third Amended and Restated Articles of Association of the Company with the Registrar of Companies of the State of Israel
      to reflect a 1-for-25 reverse share split increase and to increase the Company&#8217;s authorized share capital after the effect of the reverse share split. As a result, the Company is now authorized to issue 60,000,000 ordinary shares, of which 33,445,454
      ordinary shares were outstanding as of February 16, 2021. The objective of the increase in authorized share capital was to maintain our flexibility following the reverse share split to conduct future issuances of our ordinary shares, in the ordinary
      course from time to time, to fund our operations, consistent with our historical practice of raising financing through equity and debt issuances.</div>
  </div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Although the purpose of the increase in authorized share capital was to preserve our capital-raising position, these additional shares may also be issued in the future for other
      purposes, such as compensation, giving rise to further opportunities for dilution. Future issuances of ordinary shares will dilute the voting power and ownership of our existing shareholders, and, depending on the amount of consideration received in
      connection with the issuance, could also reduce shareholders&#8217; equity on a per-share basis. Due to the increase in authorized capital, the dilution to the ownership interest of our existing shareholders may be greater than would occur had the increase
      not been effected.</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">50</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
  </div>
  <div style="text-align: center; line-height: 1.25;">&#160; <br>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">The newly&#160;available authorized shares resulting from the reverse share split may have the potential to limit the opportunity for our shareholders to dispose of their ordinary shares at a premium.
          We currently do not have any acquisitions or other major transactions planned that would require us to increase our authorized share capital, and our board does not intend to use the increase of the newly&#160;authorized reserve as an anti-takeover
          device. However, the authorized shares could, in theory, also be used to resist or frustrate a third-party transaction that is favored by a majority of the independent shareholders (for example, by permitting issuances that would dilute the share
          ownership of a person seeking to effect a change in the composition of the board or management of the Company or contemplating a tender offer or other transaction for the combination of the Company with another company).</div>
      </div>
    </div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold;">
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25; font-style: italic; font-weight: bold;">It may be difficult to enforce a judgment of a U.S. court against us, our officers, and directors, to assert U.S. securities laws claims in Israel or to serve process on our
          officers and directors.</div>
      </div>
    </div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We are incorporated in Israel. Although the majority of our directors and executive officers reside within the United States and most of the assets of these persons are also likely
      located within the United States, some of our directors and executive officers reside and may have the majority of their assets outside the United States. Additionally, most of our assets are located outside of the United States. Therefore, a
      judgment obtained against us, or those of our directors and executive officers residing outside of the United States, including a judgment based on the civil liability provisions of the U.S. federal securities laws, may not be collectible in the
      United States and may not be enforced by an Israeli court. It also may be difficult for you to effect service of process in the United States on those directors and executive officers residing outside of the United States or to assert U.S. securities
      law claims in original actions instituted in Israel. Israeli courts may refuse to hear a claim based on an alleged violation of U.S. securities laws reasoning that Israel is not the most appropriate forum in which to bring such a claim. In addition,
      even if an Israeli court agrees to hear a claim, it may determine that Israeli law and not U.S. law is applicable to the claim. If U.S. law is found to be applicable, the content of applicable U.S. law must be proven as a fact by expert witnesses,
      which can be a time-consuming and costly process. Certain matters of procedure will also be governed by Israeli law. There is little binding case law in Israel that addresses the matters described above. As a result of the difficulty associated with
      enforcing a judgment against us in Israel, you may be able to collect only limited, or may be unable to collect any, damages awarded by either a U.S. or foreign court.</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold;">Your rights and responsibilities as a shareholder will be governed by Israeli law which differs in some material respects from the rights and responsibilities
      of shareholders of U.S. companies.</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The rights and responsibilities of the holders of our ordinary shares are governed by our Articles of Association and by Israeli law. These rights and responsibilities differ in
      some material respects from the rights and responsibilities of shareholders in U.S.-based corporations. In particular, a shareholder of an Israeli company has a duty to act in good faith and in a customary manner in exercising its rights and
      performing its obligations towards the company and other shareholders, and to refrain from abusing its power in the company, including, among other things, in voting at a general meeting of shareholders on matters such as amendments to a company&#8217;s
      articles of association, increases in a company&#8217;s authorized share capital, mergers and acquisitions and related party transactions requiring shareholder approval. In addition, a shareholder who is aware that it possesses the power to determine the
      outcome of a shareholder vote or to appoint or prevent the appointment of a director or executive officer in the company has a duty of fairness toward the company. There is limited case law available to assist us in understanding the nature of this
      duty or the implications of these provisions. These provisions may be interpreted to impose additional obligations and liabilities on holders of our ordinary shares that are not typically imposed on shareholders of U.S. corporations.</div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold;">Our business could be negatively affected as a result of actions of activist shareholders, and such activism could impact the trading value of our securities.</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In recent years, certain Israeli issuers listed on United States exchanges have been faced with governance-related demands from activist shareholders, unsolicited tender offers and
      proxy contests. Responding to these types of actions by activist shareholders could be costly and time-consuming, disrupting our operations and diverting the attention of management and our employees. Such activities could interfere with our ability
      to execute our strategic plan. In addition, a proxy contest for the election of directors at our annual meeting would require us to incur significant legal fees and proxy solicitation expenses and require significant time and attention by management
      and our board of directors. The perceived uncertainties as to our future direction also could affect the market price and volatility of our securities.</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">51</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
  </div>
  <div style="text-align: justify; line-height: 1.25; font-weight: bold;">General Risks</div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold;">Exchange rate fluctuations between the U.S. dollar, the Euro and the NIS may negatively affect our earnings.</div>
  <div style="text-align: justify; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The U.S. dollar is our functional and reporting currency. Since 2015, most of our expenses were denominated in U.S. dollars and the remaining expenses were denominated in NIS and
    euros. Until 2018, most of our revenues were denominated in U.S. dollars and the remainder of our revenues was denominated in euros and British pound, whereas in the last two years our euro revenues are higher than our U.S dollar revenues. Accordingly,
    any appreciation of the NIS or Euro relative to the U.S. dollar would adversely impact our net loss or net income, if any. For example, we are exposed to the risks that the shekel may appreciate relative to the dollar, or, if the shekel instead
    devalues relative to the dollar, that the inflation rate in Israel may exceed such rate of devaluation of the shekel, or that the timing of such devaluation may lag behind inflation in Israel. In any such event, the dollar cost of our operations in
    Israel would increase and our dollar-denominated results of operations would be adversely affected.</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We cannot predict any future trends in the rate of inflation in Israel or the rate of devaluation (if any) of the shekel against the dollar. For example, while the shekel appreciated
    against the dollar at a rate of approximately 7% during the fiscal year 2020 and 8% during the fiscal year of 2019, the rate of devaluation of the shekel against the dollar was approximately 7% in 2017. This had the effect of increasing the dollar cost
    of our operations in Israel. If the dollar cost of our operations in Israel increases once again, our dollar-measured results of operations will be adversely affected. Our operations also could be adversely affected if we are unable to effectively
    hedge against currency fluctuations in the future.</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We have in the past engaged in limited hedging activities, and we may enter into other hedging arrangements with financial institutions from time to time. Any hedging strategies that
    we may implement in the future to mitigate currency risks, such as forward contracts, options and foreign exchange swaps related to transaction exposures may not eliminate our exposure to foreign exchange fluctuations. For further information, see
    &#8220;Part I, Item 1A. Risk Factors&#8212;The economic effects of &#8216;Brexit&#8217; may affect relationships with existing and future customers and could have an adverse impact on our business and operating results<font style="font-style: italic;">.</font>&#8221;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;&#160;</div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold;">We are subject to certain regulatory regimes that may affect the way that we conduct business internationally, and our failure to comply with applicable laws
      and regulations could materially adversely affect our reputation and result in penalties and increased costs.</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">
          <div style="line-height: 1.25;">
            <div style="text-indent: 36pt; line-height: 1.25;">
              <div style="line-height: 1.25;">
                <div style="text-indent: 36pt; line-height: 1.25;">We are subject to a complex system of laws and regulations related to international trade, including economic sanctions and export control laws and regulations.&#160;We also depend on our
                  distributors and agents for compliance and adherence to local laws and regulations in the markets in which they operate. Significant political or regulatory developments in the jurisdictions in which we sell our products, such as those
                  stemming from the presidential administration in the United States or the U.K.&#8217;s exit from the E.U. (known as &#8220;Brexit&#8221;), are difficult to predict and may have a material adverse effect on us.&#160;For example, in the United States, the Trump
                  administration imposed tariffs on imports from China, Mexico, Canada, and other countries, and expressed support for greater restrictions on free trade and increase tariffs on goods imported into the United States. Changes in U.S.
                  political, regulatory, and economic conditions or in its policies governing international trade and foreign manufacturing and investment in the United States could adversely affect our sales in the United States.</div>
              </div>
            </div>
          </div>
        </div>
      </div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We are also subject to the U.S. Foreign Corrupt Practices&#160;Act and may be subject to similar worldwide anti-bribery&#160;laws that generally prohibit companies and their intermediaries
      from making improper payments to government officials for the purpose of obtaining or retaining business.&#160; Despite our compliance and training programs, we cannot be certain that our procedures will be sufficient to ensure consistent compliance with
      all applicable international trade and anti-corruption laws, or that our employees or channel partners will strictly follow all policies and requirements to which we subject them.&#160;Any alleged or actual violations of these laws may subject us to
      government scrutiny, investigation, debarment, and civil and criminal penalties, which may have an adverse effect on our results of operations, financial condition and reputation.</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">52</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
  </div>
  <div style="text-align: justify; margin-left: 5.5pt; line-height: 1.25; font-style: italic;">&#160; <br>
    <font style="font-weight: bold;">Our operations may be adversely impacted by the U.K.&#8217;s recent exit from the European Union.</font></div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-right: 5.45pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
      <div style="line-height: 1.25;">
        <div style="text-indent: 36pt; margin-right: 5.45pt; margin-left: 5.5pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">
          <div style="line-height: 1.25;">
            <div style="text-indent: 36pt; margin-right: 5.45pt; margin-left: 5.5pt; line-height: 1.25;">The U.K.&#8217;s June 2016 referendum, in which voters approved an exit from the European Union (commonly referred to as &#8220;Brexit&#8221;), and subsequent
              negotiations related to Brexit have caused and may continue to cause volatility in the global stock markets, currency exchange rate fluctuations and global economic uncertainty, which could adversely affect our ability to transact business in
              the U.K. and in countries in the EU. On January 31, 2020, the U.K. formally ceased to be part of the EU. Although the U.K. has passed legislation regarding the immediate impact of the U.K.&#8217;s withdrawal from the EU, it is still unclear what
              terms, if any, may be agreed within the U.K. and between the U.K. and other countries on many aspects of fiscal policy, cross-border trade, and international relations, both in the final outcome and for any transitional period. Because this
              is an unprecedented event, it is also unclear what long-term economic, financial, trade and legal implications the withdrawal of the U.K. from the EU would have and how such withdrawal would affect our customers and our operations in the U.K.
              and Europe. It may also be time-consuming and expensive for us to alter our internal operations in order to comply with new regulations.</div>
            <div style="line-height: 1.25">&#160;</div>
          </div>
        </div>
      </div>
    </div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">As a result of Brexit, the global markets and currencies have been adversely impacted, including a decline in the value of the British pound as compared to the U.S. dollar. A potential devaluation
          of the local currencies of our international buyers relative to the U.S. dollar may impair the purchasing power of our international buyers and could cause international buyers to decrease their participation in our marketplaces or use of our
          products. Further, volatility in exchange rates resulting from Brexit is expected to continue in the short term as the U.K. negotiates its exit from the E.U. We translate sales and other results of our activities in the U.K. denominated in
          British pounds into U.S. dollars for our financial statements. During periods of a strengthening dollar, our reported international sales and earnings could be reduced because foreign currencies may translate into fewer U.S. dollars. Finally,
          Brexit could lead to legal uncertainty and potentially divergent national laws and regulations as the U.K. determines which E.U. laws to replace or replicate, and those laws and regulations may be cumbersome, difficult, or costly in terms of
          compliance. In addition, Brexit may lead other E.U. member countries to consider referendums regarding their E.U. membership. Any of these effects of Brexit, among others, could adversely affect our business, financial condition, operating
          results and cash flows.</div>
        <div style="line-height: 1.25">&#160;</div>
      </div>
    </div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold;">Our business may be materially affected by changes to fiscal and tax policies. Potentially negative or unexpected tax consequences of these policies, or the
      uncertainty surrounding their potential effects, could adversely affect our results of operations and share price.</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The U.S. Tax Cuts and Jobs Act of 2017 (the &#8220;TCJA&#8221;) made significant changes to the U.S. Internal Revenue Code of 1986, as amended (the &#8220;IRC&#8221;). Such changes include a reduction in
      the corporate tax rate from a top marginal rate of 35% to a flat rate of 21% and limitations on certain corporate deductions and credits, among other changes. In addition, the TCJA requires complex computations to be performed that were not
      previously required in U.S. tax law, significant judgments to be made in interpretation of the provisions of the TCJA and significant estimates in calculations, and the preparation and analysis of information not previously relevant or regularly
      produced.</div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">While to date we believe the effect of the TCJA in our Consolidated Financial Statements the application of accounting guidance for various items, and the ultimate impact of the TCJA
    on our business are not material, the final impacts of the TCJA could be materially different from our analysis. For example, adverse changes in the underlying profitability and financial outlook of our operations or changes in tax law could lead to
    changes in our valuation allowances against deferred tax assets on our consolidated balance sheets, which could materially affect our results of operations. The U.S. Treasury Department, the Internal Revenue Service (the &#8220;IRS&#8221;), and other
    standard-setting bodies could interpret or issue guidance on how provisions of the TCJA will be applied or otherwise administered that is different from our interpretation which may materially affect our results of operations.&#160; In addition, the Biden
    presidential administration may implement further changes to U.S. tax policy, including an increase in the U.S. corporate income tax rate. If any or all of these (or similar) proposals are ultimately enacted into law, in whole or in part, they could
    have a negative impact to the Company&#8217;s effective tax rate.</div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Finally, foreign governments may enact tax laws in response to the TCJA that could result in further changes to global taxation and materially affect our financial position and
    results of operations. The uncertainty surrounding the effect of the reforms on our financial results and business could also weaken confidence among investors in our financial condition. This could, in turn, have a materially adverse effect on the
    price of our ordinary shares.&#160;</div>
  <div style="text-align: center; line-height: 1.25;"> <br>
  </div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">53</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  &#160;
  <div style="line-height: 1.25;">
    <div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold;">
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25; font-style: italic; font-weight: bold;">We may seek to grow our business through acquisitions of complementary products or technologies, and the failure to manage acquisitions, or the failure to integrate them with
          our existing business, could have a material adverse effect on our business, financial condition, and operating results.</div>
      </div>
    </div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">From time to time, we may consider opportunities to acquire or license other products or technologies that may enhance our product platform or technology, expand the breadth of our
      markets or customer base, or advance our business strategies. Potential acquisitions involve numerous risks, including:</div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf871ea829bed473e93370a50909bcb76">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#9679;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>problems assimilating the acquired products or technologies;</div>
          </td>
        </tr>

    </table>
    <div style="text-align: left; line-height: 1.25;"><font style="font-family: 'Times New Roman', Times, serif;">&#160;</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8aecf4b6d564426bbde48fdfe586079e">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#9679;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>issues maintaining uniform standards, procedures, controls and policies;</div>
          </td>
        </tr>

    </table>
    <div style="text-align: left; line-height: 1.25;"><font style="font-family: 'Times New Roman', Times, serif;">&#160;</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z5e2e52583dbf4edba7c47d626ff453b0">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#9679;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>unanticipated costs associated with acquisitions;</div>
          </td>
        </tr>

    </table>
    <div style="text-align: left; line-height: 1.25;"><font style="font-family: 'Times New Roman', Times, serif;">&#160;</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z762686a295064c93ad4430c8dd61d8d6">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#9679;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>diversion of management&#8217;s attention from our existing business;</div>
          </td>
        </tr>

    </table>
    <div style="text-align: left; line-height: 1.25;"><font style="font-family: 'Times New Roman', Times, serif;">&#160;</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z2943525277a243a0b62392d67b43350a">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#9679;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>risks associated with entering new markets in which we have limited or no experience; and</div>
          </td>
        </tr>

    </table>
    <div style="text-align: left; line-height: 1.25;"><font style="font-family: 'Times New Roman', Times, serif;">&#160;</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4bf449fef794452b94ec9b63116015d3">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#9679;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>increased legal and accounting costs relating to the acquisitions or compliance with regulatory matters.&#160;</div>
          </td>
        </tr>

    </table>
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"> <br>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">We have no current commitments with respect to any acquisition or licensing. We do not know if we will be able to identify such acquisitions or licensing we deem suitable, whether we will be able
          to successfully complete any such transactions on favorable terms or at all, or whether we will be able to successfully integrate any acquired products or technologies. Our potential inability to integrate any acquired products or technologies
          effectively may adversely affect our business, operating results, and financial condition.</div>
      </div>
    </div>
  </div>
  <div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold;">&#160;</div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold;">If there are significant disruptions in our information technology systems, our business, financial condition and operating results could be adversely affected.</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The efficient operation of our business depends on our information technology systems. We rely on our information technology systems to effectively manage sales and marketing data,
      accounting and financial functions, inventory management, product development tasks, research and development data, customer service and technical support functions. Our information technology systems are vulnerable to damage or interruption from
      earthquakes, fires, floods and other natural disasters, terrorist attacks, attacks by computer viruses or hackers, power losses, and computer system or data network failures. In addition, our data management application is hosted by a third-party
      service provider whose security and information technology systems are subject to similar risks, and our products&#8217; systems contain software which could be subject to computer virus or hacker attacks or other failures.</div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">The failure of our or our service providers&#8217; information technology systems or our products&#8217; software to perform as we anticipate or our failure to effectively implement new information technology
          systems could disrupt our entire operation or adversely affect our software products and could result in decreased sales, increased overhead costs, and product shortages, all of which could have a material adverse effect on our reputation,
          business, financial condition, and operating results.</div>
      </div>
    </div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold;">If we fail to properly manage our anticipated growth, our business could suffer.</div>
  <div style="text-align: justify; line-height: 1.25;">&#160;</div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Our growth and product expansion has placed, and we expect that it will continue to place, a significant strain on our management team and on our financial resources. Failure to
      manage our growth effectively could cause us to misallocate management or financial resources, and result in losses or weaknesses in our infrastructure, which could materially adversely affect our business. Additionally, our anticipated growth will
      increase the demands placed on our suppliers, resulting in an increased need for us to manage our suppliers and monitor for quality assurance. Any failure by us to manage our growth effectively could have an adverse effect on our ability to achieve
      our business objectives.</div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold;">We depend on the knowledge and skills of our senior management.</div>
  <div style="text-align: justify; line-height: 1.25;">&#160;</div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">We have benefited substantially from the leadership and performance of our senior management. For example, we depend on our Chief Executive Officer&#8217;s experience successfully scaling an early-stage
          medical device company, as well as the experience of other members of management. Our success will depend on our ability to retain our current management. Competition for senior management in our industry is intense and we cannot guarantee that
          we will be able to retain our personnel. Additionally, we do not carry key man insurance on any of our current executive officers. The loss of the services of certain members of our senior management could prevent or delay the implementation and
          completion of our strategic objectives or divert management&#8217;s attention to seeking qualified replacements.</div>
      </div>
    </div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;&#160;</div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">54</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; line-height: 1.25;">&#160;<font style="font-weight: bold; font-style: italic;">Shutdowns of the U.S. federal government could materially impair our business and financial condition.</font></div>
    <div style="line-height: 1.25">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">Development of our product candidates and/or regulatory approval may be delayed for reasons beyond our control. For example, over the last several years the U.S. government has shut down several
          times and certain regulatory agencies, such as the FDA and the SEC, have had to furlough critical FDA, SEC, and other government employees and stop critical activities. If a prolonged government shutdown or budget sequestration occurs, it could
          significantly impact the ability of the FDA to timely review and process our regulatory submissions, which could have a material adverse effect on our business. Further, in our operations as a public company, future government shutdowns could
          impact our ability to access the public markets, such as through the declaration of effectiveness of registration statements and obtain necessary capital in order to properly capitalize and continue our operations.</div>
      </div>
    </div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
  </div>
  <div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold;">Uncertainty relating to the LIBOR calculation process and potential phasing out of LIBOR in the future may adversely affect the value of any outstanding debt
    instruments.</div>
  <div style="text-align: justify; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
    <div style="text-indent: 36pt; line-height: 1.25;">LIBOR, the London Interbank Offered Rate, is the basic rate of interest used in lending between banks on the London interbank market and is widely used as a reference for setting the interest rate on
      loans globally. We typically use LIBOR as a reference rate in our term loans such that the interest due to our creditors pursuant to a term loan extended to us is calculated using LIBOR. Most of our term loan agreements contain a stated minimum value
      for LIBOR.</div>
    <div style="line-height: 1.25">&#160;</div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In 2017, the United Kingdom&#8217;s Financial Conduct Authority, which regulates LIBOR, announced that it intends to phase out LIBOR by the end of 2021. It is unclear if at that time
    whether or not LIBOR will cease to exist, or if new methods of calculating LIBOR will be established such that it continues to exist after 2021 or if replacement conventions will be developed. The U.S. Federal Reserve, in conjunction with the
    Alternative Reference Rates Committee, a steering committee comprised of large U.S. financial institutions, is considering replacing U.S. dollar LIBOR with a new index calculated by short-term repurchase agreements, backed by Treasury securities
    (&#8220;SOFR&#8221;). SOFR is observed and backward-looking, which stands in contrast with LIBOR under the current methodology, which is an estimated forward-looking rate and relies, to some degree, on the expert judgment of submitting panel members. Given that
    SOFR is a secured rate backed by government securities, it will be a rate that does not take into account bank credit risk (as is the case with LIBOR). Whether or not SOFR attains market traction as a LIBOR replacement tool remains in question. As
    such, the future of LIBOR at this time is uncertain. At this time, due to a lack of consensus existing as to what rate or rates may become accepted alternatives to LIBOR, it is impossible to predict the effect of any such alternatives on our liquidity.
    However, if LIBOR ceases to exist, we may need to renegotiate our credit agreements that utilize LIBOR as a factor in determining the interest rate to replace LIBOR with the new standard that is established. Additionally, these changes may have an
    adverse impact on the value of or interest earned on any LIBOR-based marketable securities, loans, and derivatives that are included in our financial assets and liabilities.</div>
  <div style="line-height: 1.25">&#160;</div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">55</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;<br>
  </div>
  <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><a name="ITEM1B"><!--Anchor--></a>ITEM 1B. UNRESOLVED STAFF COMMENTS</div>
  <div style="text-align: justify; line-height: 1.25; font-weight: bold;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">None.</div>
  <div style="text-align: justify; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><a name="ITEM2"><!--Anchor--></a>ITEM 2. PROPERTIES</div>
  <div style="line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Our corporate headquarters are located in Yokneam, Israel, our U.S. headquarters are located in Marlborough, Massachusetts, and our European headquarters are located in Berlin,
    Germany.</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
    <div style="text-indent: 36pt; line-height: 1.25;">All of our facilities are leased, and we do not own any real property. The table below sets forth details of the square footage of our current leased properties, all of which are fully utilized. We
      have no material tangible fixed assets apart from the properties described below.</div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <table cellspacing="0" cellpadding="0" id="z4146103e0a1a464fa0e644c50b9cec0f" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;">

      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">Square<br>
            feet (approximate)</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 88%;">
          <div style="line-height: 1.25;">Marlborough, Massachusetts</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">11,850</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 88%;">
          <div style="line-height: 1.25;">Yokneam, Israel</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">11,500</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 88%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">Berlin, Germany</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
          <div style="line-height: 1.25;">753</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 88%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">Total</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">24,103</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
      </tr>

  </table>
  <div style="text-align: justify; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We believe our facilities are adequate and suitable for our current needs.</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;&#160;</div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">56</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <div style="text-align: justify; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><a name="ITEM3"><!--Anchor--></a>ITEM 3. LEGAL PROCEEDINGS</div>
  <div style="line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Occasionally the Company is involved in various claims, lawsuits, regulatory examinations, investigations and other legal matters arising, for the most part, in the ordinary course
    of business. The outcome of litigation and other legal matters is inherently uncertain. In making a determination regarding accruals, using available information, the Company evaluates the likelihood of an unfavorable outcome in legal or regulatory
    proceedings to which the Company is a party and records a loss contingency when it is probable a liability has been incurred and the amount of the loss can be reasonably estimated.</div>
  <div style="text-align: justify; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
    <div style="text-indent: 36pt; line-height: 1.25;">Where the Company determines an unfavorable outcome is not probable or reasonably estimable, the Company does not accrue for any potential litigation loss. These subjective determinations are based on
      the status of such legal or regulatory proceedings, the merits of our defenses and consultation with legal counsel. Actual outcomes of these legal and regulatory proceedings may materially differ from the Company&#8217;s current estimates. It is possible
      that resolution of one or more of the legal matters currently pending or threatened could result in losses material to the Company&#8217;s consolidated results of operations, liquidity, or financial condition.</div>
  </div>
  <div style="line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
    <div style="text-indent: 36pt; line-height: 1.25;">
      <div style="text-indent: 36pt; line-height: 1.25;">As previously disclosed, between September 2016 and January 2017, eight putative class actions on behalf of alleged shareholders that purchased or acquired the Company&#8217;s ordinary shares pursuant
        and/or traceable to its registration statement on Form F-1 (File No. 333-197344) used in connection with the Company&#8217;s initial public offering (the &#8220;IPO&#8221;) were commenced in the following courts: (i) the Superior Court of the State of California,
        County of San Mateo; (ii) the Superior Court of the Commonwealth of Massachusetts, Suffolk County; (iii) the United States District Court for the Northern District of California; and (iv) the United States District Court for the District of
        Massachusetts. The actions involved claims under various sections of the Securities Act and the Exchange Act against the Company, certain of its current and former directors and officers, the underwriters of the Company&#8217;s IPO and certain other
        defendants. The four actions commenced in the Superior Court of the State of California, County of San Mateo were dismissed in January 2017 for lack of personal jurisdiction, and the action commenced in the United States District Court for the
        Northern District of California was voluntarily dismissed in March 2017. Additionally, the two actions commenced in the Superior Court of the Commonwealth of Massachusetts, Suffolk County (the &#8220;Superior Court&#8221;) were consolidated in December 2017,
        and voluntarily dismissed with prejudice in November 2018, after the District Court for the District of Massachusetts partially dismissed the related claims in that court and the parties in the Superior Court entered a stipulation of dismissal with
        prejudice.</div>
    </div>
  </div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
    <div style="text-indent: 36pt; line-height: 1.25;">The action commenced in the United States District Court for the District of Massachusetts (the &#8220;District Court&#8221;), alleging violations of Sections 11 and 15 of the Securities Act and Sections 10(b) and
      20(a) of the Exchange Act, was partially dismissed in August 2018. In particular, the District Court granted the motion to dismiss the claims under Sections 11 and 15 of the Securities Act, finding that the plaintiff failed to plead a false or
      misleading statement in the IPO registration statement. In May 2019, the court subsequently denied the plaintiff&#8217;s motion to amend to pursue Exchange Act claims and the complaint was dismissed. Thereafter, the plaintiff timely appealed to the United
      States Court of Appeals for the First Circuit, which subsequently affirmed the dismissal and the denial of the plaintiff&#8217;s motion to amend in August 2020. The plaintiff did not file a petition for certiorari for appeal of the case to the Supreme
      Court of the United States by the deadline on November 24, 2020. Thus, as of December 31, 2020, all eight actions had been dismissed, with such judgments being final and non-appealable.</div>
  </div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
    <div style="text-indent: 36pt; line-height: 1.25;">For more information, see Note 2t and Note 7e to the Company&#8217;s consolidated financial statements set forth in &#8220;Part II, Item 8. Financial Statements and Supplementary Data&#8221; of this annual report.</div>
  </div>
  <div style="line-height: 1.25;">&#160;&#160;</div>
  <div style="text-align: justify; line-height: 1.25;"><font style="font-weight: bold;"><a name="ITEM4"><!--Anchor--></a>ITEM 4. MINE SAFETY DISCLOSURES</font>.</div>
  <div style="text-align: justify; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Not applicable.</div>
  <div style="line-height: 1.25;">&#160;&#160;</div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">57</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <br>
  <div style="text-align: center; line-height: 1.25; font-weight: bold;"><a name="PARTII"><!--Anchor--></a>PART II</div>
  <div style="text-align: center; line-height: 1.25; font-weight: bold;">&#160;</div>
  <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><a name="ITEM5"><!--Anchor--></a>ITEM 5. MARKET FOR REGISTRANT&#8217;S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES</div>
  <div style="text-align: justify; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Market Information</div>
  <div style="line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Our ordinary shares began trading publicly on The Nasdaq Global Market on September 12, 2014 under the symbol &#8220;RWLK&#8221; and were transferred for listing on The Nasdaq Capital Market
    effective May 25, 2017.</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Dividend Policy</div>
  <div style="line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We have never declared or paid any cash dividends on our ordinary shares. We do not anticipate paying any cash dividends in the foreseeable future. We currently intend to retain
    future earnings, if any, to finance operations and expand our business. Any future determination relating to our dividend policy will be made at the discretion of our board of directors and will depend on a number of factors, including future earnings,
    capital requirements, financial condition and future prospects and other factors our board of directors may deem relevant. The distribution of dividends may also be limited by Israeli law, which permits the distribution of dividends only out of
    retained earnings or otherwise upon the permission of an Israeli court.</div>
  <div style="line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; line-height: 1.25;"><font style="font-weight: bold;">Israeli Taxes Applicable to U.S. Holders</font>&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">A non-Israeli resident who derives capital gains from the sale of shares in an Israeli resident company that were purchased after the company was listed for trading on a stock
    exchange outside of Israel will be exempt from Israeli tax so long as the shares were not held through a permanent establishment that the non-resident maintains in Israel. A partial exemption may be available for non-Israeli resident shareholders who
    acquired their shares prior to the issuer&#8217;s initial public offering.</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
    <div style="text-indent: 36pt; line-height: 1.25;">However, non-Israeli corporations will not be entitled to the foregoing exemption if Israeli residents (i) have a controlling interest of more than 25% in such non-Israeli corporation or (ii) are the
      beneficiaries of, or are entitled to, 25% or more of the revenues or profits of such non-Israeli corporation, whether directly or indirectly. Such exemption is not applicable to a person whose gains from selling or otherwise disposing of the shares
      are deemed to be a business income. Additionally, under the United States-Israel Tax Treaty, or the treaty, the disposition of shares by a shareholder who (i) is a U.S. resident (for purposes of the treaty), (ii) holds the shares as a capital asset,
      and (iii) is entitled to claim the benefits afforded to such person by the treaty, is generally exempt from Israeli capital gains tax. Such exemption will not apply if: (i)&#160;the capital gain arising from the disposition can be attributed to a
      permanent establishment in Israel; (ii)&#160;the shareholder holds, directly or indirectly, shares representing 10% or more of the voting capital during any part of the 12-month period preceding the disposition, subject to certain conditions; or
      (iii)&#160;such U.S. resident is an individual and was present in Israel for 183 days or more during the relevant taxable year. In such case, the sale, exchange, or disposition of our ordinary shares should be subject to Israeli tax, to the extent
      applicable; however, under the treaty, the taxpayer would be permitted to claim a credit for such taxes against the U.S. federal income tax imposed with respect to such sale, exchange, or disposition, subject to the limitations under U.S. law
      applicable to foreign tax credits. If the above exemptions from capital gains tax are not available, corporations will be subject to the corporate tax rate (23%) on capital gains derived from the sale of shares.&#160; The treaty does not relate to U.S.
      state or local taxes.</div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;&#160;</div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">58</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  &#160;
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
    <div style="text-indent: 36pt; line-height: 1.25;">In some instances where our shareholders may be liable for Israeli tax on the sale of their ordinary shares, the payment of the consideration may be subject to the withholding of Israeli tax at source.
      If the above exemptions from capital gains tax are not available, individuals will be subject to a 25% tax rate on real capital gains derived from the sale of shares as long as the individual is not a substantial shareholder of the corporation
      issuing the shares (in which case the individual will be subject to a 30% tax rate), and corporations will be subject to a 23% corporate tax rate. A substantial shareholder is generally a person who alone or together with such person&#8217;s relative or
      another person who collaborates with such person on a permanent basis, holds, directly or indirectly, at least 10% of any of the means of control of the corporation, including the right to vote, receive profits, nominate a director or an executive
      officer, receive assets upon liquidation, or order someone who holds any of the aforesaid rights how to act, regardless of the source of such right. A substantial shareholder will be subject to tax at a rate of 30% in respect of capital gains derived
      from the sale of shares issued by a corporation in which he or she is a substantial shareholder. The determination of whether the individual is a substantial shareholder will be made on the date on which the securities are sold. In addition, the
      individual will be deemed to be a substantial shareholder if at any time during the 12 months preceding the date of the sale he or she was a substantial shareholder.</div>
  </div>
  <div style="text-align: justify; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Dividends paid on publicly traded shares, like our ordinary shares, to non-Israeli residents are generally subject to Israeli withholding tax at a rate of 25%, unless a different
    rate is provided under an applicable tax treaty, provided that a certificate from the Israeli Tax Authority allowing for a reduced withholding tax rate is obtained in advance. Under the United States-Israel Tax Treaty, the maximum rate of tax withheld
    at source in Israel on dividends paid to a holder of our ordinary shares who is a U.S. resident (for purposes of the treaty) is 25%. The treaty provides for reduced tax rates on dividends if (a) the shareholder is a U.S. corporation holding at least
    10% of our issued voting power during the part of the tax year that precedes the date of payment of the dividend and held such minimal percentage during the whole of its prior tax year, and (b) not more than 25% of the Israeli company&#8217;s gross income
    consists of interest or dividends, other than dividends or interest received from subsidiary corporations or corporations 50% or more of the outstanding voting shares of which is owned by the Israeli company. The reduced treaty rate, if applicable, is
    15% in the case of dividends paid from income derived from a Beneficiary or Preferred Enterprise (which is entitled to corporate tax benefits) or 12.5% otherwise. We cannot assure you that in the event we declare a dividend we will designate the income
    out of which the dividend is paid in a manner that will reduce shareholders&#8217; tax liability. If the dividend is attributable partly to income derived from a Beneficiary or Preferred Enterprise and partly to other sources of income, the withholding rate
    will be a blended rate reflecting the relative portions of the two types of income. U.S. residents who are subject to Israeli withholding tax on a dividend may be entitled to a credit or deduction for U.S. federal income tax purposes in the amount of
    the taxes withheld.</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
    <div style="text-indent: 36pt; line-height: 1.25;">Individuals who are subject to tax in Israel are also subject to an additional tax at the rate of 3% on annual income exceeding a certain threshold (NIS 647,640 for 2021, linked to the annual change in
      the Israeli Consumer Price Index), including, but not limited to, income derived from dividends, interest, and capital gains.</div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;&#160;</div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">59</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <br>
  <div style="text-align: center; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: -14pt; margin-left: 14pt; line-height: 1.25;"><font style="font-weight: bold;">Stock Performance Graph</font>&#160;</div>
  <div style="text-align: justify; text-indent: 24pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The following stock performance graph represents the cumulative total shareholder return for the period September 12, 2014 (the date upon which trading of our ordinary shares
    commenced) through December 31, 2020 for our ordinary shares, compared to the Nasdaq Composite Index and the Nasdaq Medical Equipment Index. The returns shown in the graph below may not be indicative of future performance.</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;&#160;</div>
  <div style="text-align: center; line-height: 1.25;">
    <div style="line-height: 1.25;"><font style="font-weight: bold;">COMPARISON OF 65 MONTH CUMULATIVE TOTAL RETURN*</font><br>
      Among ReWalk Robotics, the NASDAQ Composite Index<br>
      and the NASDAQ Medical Equipment Index</div>
  </div>
  <div style="text-align: center; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;&#160; <img src="image6.jpg"></div>
  <div style="text-align: center; line-height: 1.25;">&#160;&#160; <br>
  </div>
  <div style="margin-left: 36pt; line-height: 1.25;">*$100 invested on 9/12/14 in stock or 8/31/14 in index, including reinvestment of dividends.<br>
    Fiscal year ending December 31.</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The above stock performance graph shall not be deemed to be soliciting material or to be filed with the SEC under the Securities Act and the Exchange Act except to the extent that we
    specifically request that such information be treated as soliciting material or specifically incorporate it by reference into a filing under the Securities Act or the Exchange Act.</div>
  <div style="text-align: justify; line-height: 1.25; font-weight: bold;">&#160;</div>
  <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Recent Sales of Unregistered Equity Securities</div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">All sales of unregistered equity securities during the covered period were disclosed on a Current Report on Form 8-K or a Quarterly Report on Form 10-Q.</div>
  <div style="text-align: justify; line-height: 1.25; font-weight: bold;">&#160;</div>
  <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Purchases of Equity Securities by the Issuer and Affiliated Purchasers</div>
  <div style="line-height: 1.25;">&#160;</div>
  <div style="text-indent: 36pt; line-height: 1.25;">None.</div>
  <div style="line-height: 1.25;">&#160;&#160;</div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">60</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  &#160;
  <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><a name="ITEM6"><!--Anchor--></a>ITEM 6.&#160;&#160; SELECTED FINANCIAL DATA</div>
  <div style="text-align: justify; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The following table presents our selected historical consolidated financial data, which is derived from our consolidated financial statements, which have been prepared in accordance
    with U.S. Generally Accepted Accounting Principles, or U.S. GAAP. The selected consolidated statements of operations data for the years ended December&#160;31, 2020, 2019, and 2018 and the selected consolidated balance sheet data as of December&#160;31, 2020,
    and 2019 are derived from our audited consolidated financial statements set forth in &#8220;Part II. Item 8. Financial Statements and Supplementary Data&#8221; of this annual report. The selected consolidated statement of operations data for the years ended
    December 31, 2017 and December 31, 2016 and the selected consolidated balance sheet data as of December 31, 2018, 2017 and 2016 has been derived from our audited consolidated financial statements not included in this annual report.</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">You should read the following selected consolidated financial data in conjunction with &#8220;Part II. Item 7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of
    Operations,&#8221; and it is qualified in its entirety by, reference to our consolidated financial statements and the related notes set forth in &#8220;Part II. Item 8. Financial Statements and Supplementary Data&#8221; of this annual report. The historical results set
    forth below are not necessarily indicative of the results to be expected in future periods.</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <table cellspacing="0" cellpadding="0" id="zf28ffb29e9604c6c822256857fc97cbc" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;">

      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="18" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">Year ended December 31</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="18" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">(In thousands, except share and per share data)</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;"> 2020</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">2019</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">2018</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">2017</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">2016</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 40%;">
          <div style="line-height: 1.25;">Revenues</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">4,393</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">4,873</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">6,545</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">7,753</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">5,869</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 40%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">Cost of revenues</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">2,204</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">2,147</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">3,720</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">4,652</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">5,133</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 40%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">Gross profit</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
          <div style="line-height: 1.25;">2,189</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
          <div style="line-height: 1.25;">2,726</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
          <div style="line-height: 1.25;">2,825</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
          <div style="line-height: 1.25;">3,101</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
          <div style="line-height: 1.25;">736</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 40%;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 40%;">
          <div style="line-height: 1.25;">Operating expenses:</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 40%;">
          <div style="line-height: 1.25;">Research and development, net</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">3,459</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">5,348</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">7,349</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">6,042</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">9,028</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 40%;">
          <div style="line-height: 1.25;">Sales and marketing</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">5,754</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">6,167</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">7,897</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">11,360</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">13,961</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 40%;">
          <div style="line-height: 1.25;">General and administrative</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">4,980</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">5,259</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">6,793</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">7,691</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">8,188</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 40%;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 40%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">Total operating expenses</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">14,193</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">16,774</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">22,039</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">25,093</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">31,177</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 40%;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 40%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">Operating loss</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">(12,004</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">(14,048</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">(19,214</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">(21,992</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">(30,441</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">)</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 40%;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 40%;">
          <div style="line-height: 1.25;">Loss on extinguishment of debt</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">313</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 40%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">Financial expenses, net</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
          <div style="line-height: 1.25;">921</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
          <div style="line-height: 1.25;">1,496</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
          <div style="line-height: 1.25;">2,466</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
          <div style="line-height: 1.25;">2,293</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
          <div style="line-height: 1.25;">2,059</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 40%;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 40%;">
          <div style="line-height: 1.25;">Loss before income taxes</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">(12,925</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">(15,544</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">(21,680</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">(24,598</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">(32,500</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">)</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 40%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">
            <div style="line-height: 1.25;">Taxes on income (tax benefit)</div>
          </div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">51</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">7</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">(5</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">119</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">3</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 40%;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 40%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">Net loss</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">(12,976</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">(15,551</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">(21,675</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">(24,717</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">(32,503</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">)</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 40%;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 40%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">
            <div style="line-height: 1.25;">Net loss per ordinary share, basic and diluted (1)</div>
          </div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">(0.82</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">(2.70</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">(14.72</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">(30.57</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">(61.66</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">)</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 40%;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 40%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">Weighted average number of shares used in computing net loss per ordinary share, basic and diluted</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">15,764,980</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">5,763,317</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">1,472,499</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">808,557</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">527,096</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
      </tr>

  </table>
  <div style="line-height: 1.25;">&#160;&#160;</div>
  <table cellspacing="0" cellpadding="0" id="zb9eb61c5e673405793622cd4bb985e44" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;">

      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="18" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">As of December 31,</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="18" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">(in thousands)</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;"> 2020</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">2019</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">2018</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">2017</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">2016</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25; font-weight: bold;">Balance Sheet Data:</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 40%;">
          <div style="line-height: 1.25;">Cash and cash equivalents</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">20,350</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">16,253</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">9,546</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">14,567</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">23,678</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 40%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">Total assets</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">28,067</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">24,372</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">14,962</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">22,863</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">31,763</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 40%;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 40%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">Accumulated deficit</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">(181,<font style="font-family: 'Times New Roman',Times,serif;">445</font></div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">(168,469</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">(152,918</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">(131,220</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">(106,492</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">)</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 40%;">
          <div style="line-height: 1.25;">Total shareholders&#8217; equity</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">21,774</div>
          </div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">10,780</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">1,945</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">3,707</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">8,260</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>

  </table>
  <div style="line-height: 1.25;">&#160;&#160;</div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zb773412973884595a52e4257e7ead2db">

      <tr>
        <td style="width: 3.85%; vertical-align: top;">
          <div style="line-height: 1.25;">(1)</div>
        </td>
        <td style="width: 96.15%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25;">
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Net loss per ordinary share, basic and diluted, is calculated by dividing our net loss excluding dividends accrued on our convertible preferred shares outstanding
              during the period presented by the weighted average number of shares outstanding during the period presented. See Note 2s to our consolidated financial statements set forth in &#8220;Part II. Item 8. Financial Statements and Supplementary Data&#8221; of
              this annual report.</div>
          </div>
        </td>
      </tr>

  </table>
  <div style="line-height: 1.25;">&#160;&#160;&#160;</div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">61</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <div style="text-align: center; line-height: 1.25;"><br>
  </div>
  <div style="line-height: 1.25;">&#160;<font style="font-weight: bold;"><a name="ITEM7"><!--Anchor--></a>ITEM 7. MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</font></div>
  <div style="line-height: 1.25">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic;">The following discussion and analysis should be read in conjunction with &#8220;Part I. Item 6. Selected Financial Data&#8221; and our consolidated financial statements and
    the related notes included elsewhere in this annual report. This discussion contains forward-looking statements that are based on our management&#8217;s current expectations, estimates and projections for our business, which are subject to a number of risks
    and uncertainties. Our actual results may differ materially from those anticipated in these forward-looking statements as a result of many factors, including those set forth under &#8220;Special Note Regarding Forward-Looking Statements and &#8220;Part I. Item 1A.
    Risk Factors.&#8221;</div>
  <div style="text-align: justify; line-height: 1.25; font-weight: bold;">&#160;</div>
  <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Overview</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
    <div style="text-indent: 36pt; line-height: 1.25;">We are an innovative medical device company that is designing, developing, and commercializing robotic exoskeletons that allow individuals with mobility impairments or other medical conditions the
      ability to stand and walk once again. We have developed and are continuing to commercialize our ReWalk Personal and ReWalk Rehabilitation devices for individuals with spinal cord injury (&#8220;SCI Products&#8221;), which are exoskeletons designed for
      individuals with paraplegia that use our patented tilt-sensor technology and an on-board computer and motion sensors to drive motorized legs that power movement.</div>
  </div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We have also developed and began commercializing our ReStore device in June 2019. ReStore is a powered, lightweight soft exo-suit intended for use in the rehabilitation of
    individuals with lower limb disability due to stroke. During the second quarter of 2020 we have finalized and moved to implement two separate agreements to distribute additional product lines in the U.S. market. The Company will be the exclusive
    distributor of the MediTouch Tutor movement biofeedback systems in the United States and will also have distribution rights for the MYOLYN MyoCycle FES cycles to U.S. rehabilitation clinics and personal sales through the U.S. Department of Veterans
    Affairs (&#8220;VA&#8221;) hospitals and other personal sales. These new products will improve our product offering to clinics as well as patients within the VA as they both have similar clinician and patient profile.</div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Our principal markets are the United States and Europe. In Europe, we have a direct sales operation in Germany and the United Kingdom and work with distribution partners in certain
    other major countries. We have offices in Marlborough, Massachusetts, Berlin, Germany and Yokneam, Israel, where we operate our business from.</div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We have in the past generated and expect to generate in the future revenues from a combination of third-party payors, self-payors, including private and government employers, and
    institutions. While a broad uniform policy of coverage and reimbursement by third-party commercial payors currently does not exist in the United States for electronic exoskeleton technologies such as the ReWalk Personal, we are pursuing various paths
    of reimbursement and support fundraising efforts by institutions and clinics. In December 2015, the U.S. Department of Veterans Affairs, or the VA, issued a national policy for the evaluation, training and procurement of ReWalk Personal exoskeleton
    systems for all qualifying veterans across the United States. The VA policy is the first national coverage policy in the United States for qualifying individuals who have suffered spinal cord injury. As of December 31, 2020, we had placed 24 units as
    part of the VA policy.</div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;According to a 2017 report published by the Centers for Medicare and Medicaid Services, or CMS, approximately 55% of the spinal cord injury population which are at least five years
    post their injury date are covered by CMS. In July 2020, a code was issued for ReWalk Personal 6.0 (effective October 1, 2020), which might later be followed by coverage policy of CMS.</div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
    <div style="text-indent: 36pt; line-height: 1.25;">Additionally, to date, several private insurers in the United States and Europe have provided reimbursement for ReWalk in certain cases. In Germany, we continue to make progress toward achieving ReWalk
      coverage from the various government, private and worker&#8217;s compensation payors. In September 2017, each of German insurer BARMER GEK (&#8220;Barmer&#8221;) and national social accident insurance provider Deutsche Gesetzliche Unfallversicherung (&#8220;DGUV&#8221;),
      indicated that they will provide coverage to users who meet certain inclusion and exclusion criteria. In February 2018, the head office of German statutory health insurance, or SHI, Spitzenverband (&#8220;GKV&#8221;) confirmed their decision to list the ReWalk
      Personal 6.0 exoskeleton system in the German Medical Device Directory. This decision means that ReWalk will be listed among all medical devices for compensation, which SHI providers can procure for any approved beneficiary on a case-by-case basis.
      During the year 2020 we announced several new agreements with German SHIs such as TK and DAK Gesundheit and others as well as the first German Private Health Insurer (&#8220;PHI&#8221;) that have chosen to enter into an agreement that outlines the process of
      obtaining a device for eligible insured patient. We are currently working with several additional SHIs and PHIs on securing a formal operating contract that will establish the process of obtaining a ReWalk Personal 6.0 device for their beneficiaries
      within their system.</div>
  </div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
    <div style="text-indent: 36pt; line-height: 1.25;">During the second quarter of 2020 we finalized and moved to implement two separate agreements to distribute additional product lines in the U.S. market. The Company will be the exclusive distributor of
      the MediTouch Tutor movement biofeedback systems in the United States and will also have distribution rights for the MYOLYN MyoCycle FES cycles to U.S. rehabilitation clinics and personal sales through the VA hospitals. These new products will
      improve our product offering to clinics as well as patients within the VA as they both have similar clinician and patient profile. We have incurred net losses and negative cash flow from operations since inception and anticipate this to continue in
      the near term. We will continue to evaluate spending while continuing to focus resources on activities to commercialize the Restore device for stroke patients, achieving additional commercial reimbursement coverage decisions for our ReWalk Personal
      device, continued research and development activities related mainly to our product line maintenance as well as our soft exo-suit design and activities related to our FDA 522 postmarket study.</div>
  </div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">For information on the effects to our Company from the ongoing COVID-19 pandemic, see &#8220;Part I, Item 1. Business&#8212;Evolving COVID-19 Pandemic.&#8221;</div>
  <div style="text-align: justify; line-height: 1.25;">&#160;&#160;</div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">62</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <div style="text-align: center; line-height: 1.25;"><br>
  </div>
  <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Components of Our Statements of Operations</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic; font-weight: bold;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic; font-weight: bold;">Revenues</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
    <div style="text-indent: 36pt; line-height: 1.25;">We currently rely, and in the future will rely, on sales and rentals of our ReWalk Personal 6.0 device, our ReStore device, additional devices such as MyoCycle and MediTouch which we are distributing
      (&#8220;Distributed Products&#8221;) and related service contracts and extended warranties for our revenue. Our revenue is generated from a combination of third-party payors, institutions, and self-payors, including private and government employers. Payments for
      our products by third party payors have been made primarily through case-by-case determinations. Third-party payors include, without limitation, private insurance plans and managed care programs, government programs including the VA, and worker&#8217;s
      compensation payments. We expect that third-party payors will be an increasingly important source of revenue in the future as well as clinics that will be interested in the ReStore device. In December 2015, the VA issued a national policy for the
      evaluation, training and procurement of ReWalk Personal exoskeleton systems for all qualifying veterans across the United States. The VA policy is the first national coverage policy in the United States for qualifying individuals who have suffered
      spinal cord injury.</div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
    <div style="text-indent: 36pt; line-height: 1.25;">All of our ReWalk Personal and ReWalk Rehabilitation systems sold until the end of 2017 were covered by a two-year warranty from the date of purchase, which is included in the purchase price. We offer
      customers the ability to purchase, any time during the initial warranty period, an extended warranty for up to three additional years. Both warranties cover all elements of the systems, including the batteries, other than normal wear and tear. In the
      beginning of 2018, we updated our service policy for new devices sold to include a five-year warranty. Our ReStore device is sold with a two-year warranty. The Distributed Products warranty ranges between one year to ten years depending on the
      specific product and part.</div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic; font-weight: bold;">Cost of Revenues and Gross Profit</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
    <div style="text-indent: 36pt; line-height: 1.25;">
      <div style="text-indent: 36pt; line-height: 1.25;">Cost of revenue consists primarily of systems purchased from our outsourced manufacturer, Sanmina, salaries, personnel costs including non-cash share-based compensation, associated with manufacturing
        and inventory management, training and inspection, warranty and service costs, shipping and handling and manufacturing startup and transition costs. Cost of revenues also includes royalties and expenses related to royalty-bearing research and
        development grants and sales and marketing grants.</div>
    </div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Our gross profit and gross margin as a percentage of sales is influenced by a number of factors, including primarily the volume and price of our products sold and fluctuations in our
    cost of revenues. We expect gross profit as a percentage of sales will improve in the future as we increase our sales volumes and decrease the product manufacturing costs.</div>
  <div style="text-align: justify; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic; font-weight: bold;">Operating Expenses</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic;">Research and Development Expenses, Net</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
    <div style="text-indent: 36pt; line-height: 1.25;">Research and development expenses, net consist primarily of salaries, related personnel costs including share-based compensation, supplies, materials and consulting expenses related to product design
      and development, clinical studies, regulatory submissions, patent costs, sponsored research costs and other expenses related to our product development and research programs. We expense all research and development expenses as they are incurred.</div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Research and development expenses are presented net of the amount of any grants we receive for research and development in the period in which we receive the grant. We previously
    received grants and other funding from the BIRD Foundation and the Israel Innovation Authority, or &#8220;IIA&#8221; (formerly known as the Office of the Chief Scientist). Certain of those grants require us to pay royalties on sales of ReWalk systems, which are
    recorded as cost of revenues. We may receive additional funding from these entities or others in the future. See &#8220;Grants and Other Funding&#8221; below.</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic;">&#160;&#160;</div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">63</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  &#160;
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic;">Sales and Marketing Expenses</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
    <div style="text-indent: 36pt; line-height: 1.25;">Our sales and marketing expenses consist primarily of salaries, related personnel costs including share-based compensation for sales, marketing and reimbursement personnel, travel, marketing,
      advertisement, public relations activities, and consulting costs. Also included in the sales and marketing expenses are the costs associated with our reimbursement activities in the United States and Germany.</div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic;">General and Administrative Expenses</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
    <div style="text-indent: 36pt; line-height: 1.25;">Our general and administrative expenses consist primarily of salaries, related personnel costs including share-based compensation for our administrative, finance, and general management personnel,
      professional services, and insurance.</div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic;">Financial Income (Expenses), Net</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Financial income and expenses consist of bank commissions, foreign exchange gains and losses, interest earned on investments in short term deposits, interest expenses related to the
    Loan Agreement with kreos..&#160;</div>
  <div style="text-align: justify; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Interest income consists of interest earned on our cash and cash equivalent balances. Interest expense consists of interest accrued on, and certain other costs with respect to any
    indebtedness. Foreign currency exchange changes reflect gains or losses related to transactions denominated in currencies other than the U.S. dollar.</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
    <div style="text-indent: 36pt; line-height: 1.25;">On December 30, 2015, we entered into the Loan Agreement&#160;with Kreos pursuant to which Kreos extended a line of credit to us in the amount of $20.0 million. In connection with the Loan Agreement we
      issued to Kreos a warrant to purchase up to 4,771 of our ordinary shares at an exercise price of $241.00 as we drew down $12.0 million under the Loan Agreement, which amount was increased to 6,679 ordinary shares upon an additional drawdown of $8.0
      million. On June 9, 2017, $3.0 million of the outstanding principal amount was extended by an additional three years with the same interest rate and became subject to repayment in accordance with, and subject to the terms of a secured convertible
      promissory note (the &#8220;Kreos Convertible Note&#8221;). On November 20, 2018, the Company agreed to repay $3.6 million to Kreos in satisfaction of all outstanding indebtedness under the Kreos Convertible Note and other related payments, including prepayment
      costs and end of loan payments and Kreos agreed to terminate the Kreos Convertible Note. The Company repaid Kreos the $3.6 million by issuing to Kreos 192,000 units and 288,000 pre-funded units at the applicable public offering prices for an
      aggregate price of $3.6 million (including the aggregate exercise price for the ordinary shares to be received upon exercise of the pre-funded warrants, assuming Kreos exercises all of the pre-funded warrants it purchased as part of the Company&#8217;s
      public offering. The Company and Kreos also agreed to revise the principal and the repayment schedule under the Kreos Loan Agreement. Additionally, Kreos and the Company entered into the Kreos Warrant Amendment, which amended the exercise price of
      the warrant to purchase 6,679 ordinary shares currently held by Kreos from $241.00 to $7.50. On December 29, 2020, the Company repaid in full the remaining loan principal amount to Kreos including the end of loan payments, and by that discharged all
      of its obligations to Kreos.</div>
  </div>
  <div style="line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">For further discussion of the Loan Agreement with Kreos, see &#8220;-Liquidity and Capital Resources&#8221; below and also Note 6 to our audited consolidated financial statements below.</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic;">Taxes on Income</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
    <div style="text-indent: 36pt; line-height: 1.25;">As of December&#160;31, 2020, we had not yet generated taxable income in Israel. As of that date, our net operating loss carry forwards for Israeli tax purposes amounted to approximately $182.4 million and
      our net operating loss carry forwards for U.S. tax purposes amounted to approximately $291 thousands After we utilize our net operating loss carry forwards, we are eligible for certain tax benefits in Israel under the Law for the Encouragement of
      Capital Investments, 1959. Our benefit period currently ends ten years after the year in which we first have taxable income in Israel provided that the benefit period will not extend beyond 2024.</div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Our taxable income generated outside of Israel will be subject to the regular corporate tax rate in the applicable jurisdictions. As a result, our effective tax rate will be a
    function of the relative proportion of our taxable income that is generated in those locations compared to our overall net income.</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;&#160;</div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">64</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  &#160;<br>
  <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Grants and Other Funding</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic; font-weight: bold;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic; font-weight: bold;">Israel Innovation Authority (formerly known as Office of the Chief Scientist)</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
    <div style="text-indent: 36pt; line-height: 1.25;">From our inception through December&#160;31, 2020, we have received a total of $1.97 million in funding from the IIA, $1.57 million of which are royalty-bearing grants, while $400 thousand were received in
      consideration for an investment in our preferred shares. Out of the royalty-bearing grants received, we have paid royalties to the IIA in the total amount of $88 thousand. The agreements with IIA require us to pay royalties at a rate of 3% on sales
      of ReWalk systems and related services up to the total amount of funding received, linked to the dollar, and bearing interest at an annual rate of LIBOR applicable to dollar deposits. If we transfer IIA-supported technology or know-how outside of
      Israel, we will be liable for additional payments to IIA depending upon the value of the transferred technology or know-how, the amount of IIA support, the time of completion of the IIA-supported research project and other factors. As of December&#160;31,
      2020, the aggregate contingent liability to the IIA was $1.6 million. For more information, see &#8220;Part I, Item 1A. Risk Factors-We have received Israeli government grants for certain of our research and development activities and we may receive
      additional grants in the future. The terms of those grants restrict our ability to manufacture products or transfer technologies outside of Israel...&#8221;</div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Results of Operations</div>
  <div style="text-align: justify; line-height: 1.25; font-weight: bold;">&#160;</div>
  <div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold;">Year Ended December&#160;31, 2020 Compared to Year Ended December&#160;31, 2019</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic; font-weight: bold;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic; font-weight: bold;">Revenues</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Our revenues for 2020 and 2019 were as follows (dollars in thousands, except unit amounts)</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <table cellspacing="0" cellpadding="0" id="z05958cdb3aed4261aeaaab05458995cc" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;">

      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">Years Ended December 31,</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;"> 2020</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">2019</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 76%;">
          <div style="line-height: 1.25;">Personal unit revenues</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">4,220</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">4,674</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">Rehabilitation unit revenues</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">173</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">199</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">Revenues</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">4,393</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">4,873</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
      </tr>

  </table>
  <div style="text-align: justify; line-height: 1.25;">&#160;&#160;</div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">65</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  &#160;
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Revenues decreased by $480 thousand, or 10%, during 2020 compared to 2019. The decrease in revenues for was driven primarily by the impact of the COVID-19 pandemic, as we had limited
    market access which resulted in volume reduction of our Personal 6.0 devices.</div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In the future we expect our growth to be driven by sales of our ReWalk Personal device to third-party payors as we continue to focus our resources on broader commercial coverage
    policies with third-party payors as well as sales of the ReStore and other products to rehabilitation clinics and personal users.</div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic; font-weight: bold;">Gross Profit</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Our gross profit for 2020 and 2019 were as follows (in thousands):&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <table cellspacing="0" cellpadding="0" id="zb13a15b7fe574a30bf3a2c4e8bb7f6a7" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;">

      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">Years Ended December 31,</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;"> 2020</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">2019</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 76%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">Gross profit</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
          <div style="line-height: 1.25;">2,189</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
          <div style="line-height: 1.25;">2,726</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
      </tr>

  </table>
  <div style="text-align: justify; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Gross profit was 50% of revenue for 2020, compared to gross profit of 56% of revenue for 2019. Our gross profit declined as our volume reduced due to the impact from COVID-19 (as
    discussed under &#8220;Evolving COVID-19 Pandemic&#8221; and higher inventory write-off of our older designs that have reached end of production offset with increase in our average selling price.</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We expect our gross profit to improve assuming we increase our sales volumes which could also decrease the product manufacturing costs. Improvements may be partially offset by the
    lower margins we expect upon the launch period of our new ReStore and Distributed Products as well as due to an increase in the cost of product parts.&#160;<font style="font-weight: bold; font-style: italic;">&#160;</font></div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic; font-weight: bold;"> <br>
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic; font-weight: bold;">Research and Development Expenses, Net</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Our research and development expenses, net for 2020 and 2019 were as follows (in thousands):&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <table cellspacing="0" cellpadding="0" id="za840f53ca1fd4d10ac43d121d8836f77" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;">

      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">Years Ended December 31,</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;"> 2019</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">2018</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 76%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">Research and development expenses, net</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
          <div style="line-height: 1.25;">3,459</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
          <div style="line-height: 1.25;">5,348</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
      </tr>

  </table>
  <div style="text-align: justify; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
    <div style="text-indent: 36pt; line-height: 1.25;">Research and development expenses, net, decreased by $1.9 million, or 35%, during 2020 compared to 2019. The decrease is attributable to decreased personnel and personnel related expenses and decreased
      consulting costs associated with the development and clinical study costs of our ReStore soft suit exoskeleton.</div>
  </div>
  <div style="text-align: justify; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
    <div style="text-indent: 36pt; line-height: 1.25;">We intend to focus our research and development expenses mainly on our current products maintenance as well as developing our &#8220;soft suit&#8221; exoskeleton for additional indications affecting the ability to
      walk or a home use design.<font style="font-weight: bold; font-style: italic;">&#160; <br>
      </font></div>
  </div>
  <div style="text-align: center; line-height: 1.25;"> <br>
  </div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">66</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <div style="text-align: center; line-height: 1.25; font-style: italic; font-weight: bold;">&#160; <br>
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic; font-weight: bold;">Sales and Marketing Expenses</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Our sales and marketing expenses for 2020 and 2019 were as follows (in thousands):&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <table cellspacing="0" cellpadding="0" id="z077cd703d0734b009580fd865e966a48" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;">

      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">Years Ended December 31,</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;"> 2020</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">2019</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 76%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">Sales and marketing expenses</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
          <div style="line-height: 1.25;">5,754</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
          <div style="line-height: 1.25;">6,167</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
      </tr>

  </table>
  <div style="text-align: justify; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
    <div style="text-indent: 36pt; line-height: 1.25;">Sales and marketing expenses decreased by $413 thousand, or 7%, during 2020 compared to 2019. The decrease is due to our Payment Protection Program (&#8220;PPP&#8221;) grant forgiveness that supported mainly our
      U.S. personnel and personnel related costs.</div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 36pt;">In the near term our sales and marketing expenses are expected to be driven by our efforts to commercialize our current products and to increase reimbursement
    coverage of the ReWalk Personal device.&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic; font-weight: bold;"> <br>
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic; font-weight: bold;">General and Administrative Expenses</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Our general and administrative expenses for 2020 and 2019 were as follows (in thousands):&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <table cellspacing="0" cellpadding="0" id="zf1f8810e44124886b3142f546831fdbb" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;">

      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">Years Ended December 31,</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;"> 2020</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">2019</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 76%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">General and administrative</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
          <div style="line-height: 1.25;">4,980</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
          <div style="line-height: 1.25;">5,259</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
      </tr>

  </table>
  <div style="text-align: justify; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
    <div style="text-indent: 36pt; line-height: 1.25;">General and administrative expenses decreased by $279 thousand, or 5%, during 2020 compared to 2019. The decrease was driven by lower non-cash compensation expenses and professional services costs
      offset by higher insurance costs.</div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic; font-weight: bold;">Financial Expenses, Net</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Our financial expenses, net for 2020 and 2019 were as follows (in thousands):&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <table cellspacing="0" cellpadding="0" id="z243b7436559341b39968196024916287" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;">

      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">Years Ended December 31,</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;"> 2020</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">2019</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 76%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">Financial expenses, net</div>
        </td>
        <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
          <div style="line-height: 1.25;">921</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
          <div style="line-height: 1.25;">1,496</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
      </tr>

  </table>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
    <div style="text-indent: 36pt; line-height: 1.25;">Financial expenses, net, decreased by $575 thousand, or 62% during 2020 compared to 2019. The decrease is attributable to lower interest expenses related to the Loan Agreement, as amended, with Kreos.
      For further discussion of the Loan Agreement with Kreos, see &#8220;-Liquidity and Capital Resources&#8221; below and also Note 6 to our audited consolidated financial statements below.</div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic; font-weight: bold;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic; font-weight: bold;">Income Tax</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Our income tax for 2020 and 2019 was as follows (in thousands):&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <table cellspacing="0" cellpadding="0" id="z3392bbd1d1834c21a0da4c2e7c3a6ffe" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;">

      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">Years Ended December 31,</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;"> 2020</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">2019</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 76%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">Taxes on income (tax benefit)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
          <div style="line-height: 1.25;">51</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
          <div style="line-height: 1.25;">7</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
      </tr>

  </table>
  <div style="text-align: justify; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
    <div style="text-indent: 36pt; line-height: 1.25;">Income taxes increased by $44 thousand or 629% during 2020 compared to 2019 mainly due to temporary differences booked to deferred tax expense.</div>
  </div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="line-height: 1.25; font-style: italic; font-weight: bold;">Year Ended December 31, 2019 Compared to Year Ended December 31, 2018</div>
  <div style="line-height: 1.25">&#160;</div>
  <div style="line-height: 1.25; text-indent: 36pt; text-align: justify;">
    <div style="text-indent: 36pt; line-height: 1.25;">A discussion of changes in our results of operations in 2019 compared to 2018 has been omitted from this annual report on Form 10-K, but may be found in &#8220;Item 7. Management's Discussion and Analysis of
      Financial Condition and Results of Operations&#8221; of our Form 10-K for the fiscal year ended December 31, 2019, filed with the SEC on February 20, 2020, which is available free of charge on the SECs website at <u>www.sec.gov</u> and at <u>www.rewalk.com</u>,
      and is incorporated by reference herein.</div>
  </div>
  <div style="line-height: 1.25">&#160;</div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">67</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <div style="text-align: center; line-height: 1.25;">&#160;&#160; <br>
  </div>
  <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Critical Accounting Policies</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Our consolidated financial statements are prepared in accordance with United States generally accepted accounting principles. The preparation of our financial statements requires us
    to make estimates, judgments and assumptions that can affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses
    during the reporting period. We base our estimates, judgments and assumptions on historical experience and other factors that we believe to be reasonable under the circumstances. Materially different results can occur as circumstances change and
    additional information becomes known. Besides the estimates identified above that are considered critical, we make many other accounting estimates in preparing our financial statements and related disclosures. See Note&#160;2 to our audited consolidated
    financial statements presented elsewhere in this annual report for a description of the significant accounting policies that we used to prepare our consolidated financial statements. The critical accounting policies that were impacted by the estimates,
    judgments and assumptions used in the preparation of our consolidated financial statements are discussed below.</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic; font-weight: bold;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic; font-weight: bold;">Revenue Recognition</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">On January 1, 2018, we adopted Topic 606 using the modified retrospective method for contracts that were not completed as of January 1, 2018. Under the modified retrospective method,
    we recognized the cumulative effect of initially applying the new revenue standard as an adjustment to the opening balance of retained earnings. This adjustment did not have a material impact on our consolidated financial statements. Results for
    reporting periods beginning after January 1, 2018 are presented under Topic 606, while prior period amounts are not adjusted and continue to be reported in accordance with our historic accounting under Revenue Recognition (&#8220;Topic 605&#8221;).</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">68</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  &#160;
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The adoption of Topic 606 represents a change in accounting principle that will provide financial statement readers with enhanced revenue recognition disclosures. In accordance with
    Topic 606, revenue is recognized when obligations under the terms of a contract with our customer are satisfied; generally this occurs with the transfer of control of our products or services. Revenue is measured as the amount of consideration to which
    we expect to be entitled in exchange for transferring products or providing services. To achieve this core principle, the Company applies the following five steps:</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">1. Identify the contract with a customer</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">2. Identify the performance obligations in the contract</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">3. Determine the transaction price</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">4. Allocate the transaction price to performance obligations in the contract</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">5. Recognize revenue when or as the Company satisfies a performance obligation</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Provisions are made at the time of revenue recognition for any applicable warranty cost expected to be incurred. The timing for revenue recognition among the various products and
    customers is dependent upon satisfaction of such criteria and generally varies from either shipment or delivery to the customer depending on the specific shipping terms of a given transaction, as stipulated in the agreement with each customer. Other
    than pricing terms which may differ due to the different volumes of purchases between distributors and end-users, there are no material differences in the terms and arrangements involving direct and indirect customers. Our products sold through
    agreements with distributors are non-exchangeable, non-refundable, non-returnable and without any rights of price protection or stock rotation. Accordingly, we consider all the distributors as end-users. We generally do not grant a right of return for
    our products. There have been a few occasions in which we experienced a return of our products. Therefore, we recorded reductions to revenue for expected future product returns based on our historical experience.</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">For the majority of sales of Rehabilitation systems, we include training and consider the elements in the arrangement to be a single unit of accounting. In accordance with ASC 606,
    we have concluded that the training is essential to the functionality of our systems. Therefore, we recognize revenue for the system and training only after delivery, in accordance with the agreement delivery terms, to the customer and after the
    training has been completed, once all other revenue recognition criteria have been met. For sales of Personal systems to end users, and for sales of Personal or Rehabilitation systems to third party distributors, we do not provide training to the end
    user as this training is completed by the rehabilitation centers or by the distributor that have previously completed the ReWalk Training program.</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Warranties are classified as either assurance type or service type warranty. A warranty is considered an assurance type warranty if it provides the consumer with assurance that the
    product will function as intended for a limited period of time.</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In the beginning of 2018, we updated our service policy to include a five-year warranty compared to a period of two years that were included in the past for parts and services. The
    first two years are considered as assurance type warranty and the additional period is considered an extended service arrangement, which is a service type warranty. An assurance type warranty is not accounted for as separate performance obligations
    under the revenue model. A service type warranty is either sold with a unit or separately for units for which the warranty has expired. Revenue is then recognized ratably over the life of the warranty.</div>
  <div style="line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The Company also offers a rent-to-purchase option for its ReWalk Personal device. Those transactions provide potential customers the option to use the device for a short term, after
    which they can choose whether to purchase it. In such cases we recognize revenue ratably according to the agreed rental monthly fee. For units placed, we transfer control and recognize a sale when title has passed to our customer and rental revenue
    ratably according to the agreed rental monthly fee. Each unit placed is considered an independent, unbundled performance obligation.</div>
  <div style="line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic; font-weight: bold;">Share-Based Compensation &#8211; Option and Restricted Stock Units (&#8220;RSUs&#8221;) Valuations</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We account for share-based compensation in accordance with ASC No.&#160;718, &#8220;Compensation-Stock Compensation.&#8221; ASC No.&#160;718 requires companies to estimate the fair value of equity-based
    payment awards on the date of grant using an Option-Pricing Model, or OPM. The value of the portion of the award that is ultimately expected to vest is recognized as an expense over the requisite service periods in our consolidated statements of
    operations.</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We selected the Black-Scholes-Merton option pricing model as the most appropriate method for determining the estimated fair value of options. The resulting cost of an equity
    incentive award is recognized as an expense over the requisite service period of the award, which is usually the vesting period. We recognize compensation expense over the vesting period using the straight-line method and classify these amounts in the
    consolidated financial statements based on the department to which the related employee reports.</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;&#160;</div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">69</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  &#160;
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The determination of the grant date fair value of options using the Black-Scholes-Merton option pricing model is affected by estimates and assumptions regarding a number of complex
    and subjective variables. These variables include the expected volatility of our share price over the expected term of the options, share option exercise and cancellation behaviors, risk-free interest rates and expected dividends, which are estimated
    as follows:</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-style: italic;">Risk-free Interest Rate.</font> The risk-free interest rate is based on the yield from U.S. Treasury zero-coupon bonds with a term equivalent to the
    contractual life of the options.</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-style: italic;">Dividend Yield. </font>We have never declared or paid any cash dividends and do not presently plan to pay cash dividends in the foreseeable future.
    Consequently, we used an expected dividend yield of zero.</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-style: italic;">Expected Volatility. </font>We estimated the expected share price volatility for our ordinary shares by considering the historic price volatility
    for industry peers based on price observations over a period equivalent to the expected term of the share option grants. Industry peers consist of public companies in the medical device and healthcare industries. We intend to continue to consistently
    apply this process using the same or similar industry peers until a sufficient amount of historical information regarding the volatility of our ordinary share price becomes available, or unless circumstances change such that the identified companies
    are no longer similar to us, in which case, more suitable companies whose share prices are publicly available would be utilized in the calculation.</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
    <div style="text-indent: 36pt; line-height: 1.25;"><font style="font-style: italic;">Expected Term</font>. The expected term of options granted represents the period of time that options granted are expected to be outstanding and is determined based on
      the simplified method in accordance with ASC No.&#160;718-10-S99-1 (SAB No.&#160;110), as adequate historical experience is not available to provide a reasonable estimate. ASC No.&#160;718 requires forfeitures to be estimated at the time of grant and revised,
      if&#160;necessary, in subsequent periods if actual forfeitures differ from those estimates.</div>
  </div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The fair value of RSUs granted is determined based on the price of the Company&#8217;s ordinary shares on the date of grant.</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic; font-weight: bold;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic; font-weight: bold;">Income Taxes</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">As part of the process of preparing our consolidated financial statements, we are required to estimate our taxes in each of the jurisdictions in which we operate. We account for
    income taxes in accordance with ASC Topic 740, &#8220;Income Taxes,&#8221; or ASC Topic 740. ASC Topic 740 prescribes the use of an asset and liability method whereby deferred tax asset and liability account balances are determined based on the difference between
    book value and the tax bases of assets and liabilities and carryforward tax losses. Deferred taxes are measured using the enacted tax rates and laws that are expected to be in effect when the differences are expected to reverse. We exercise judgment
    and provide a valuation allowance, if necessary, to reduce deferred tax assets to their estimated realizable value if it is more likely than not that some portion or all of the deferred tax asset will not be realized. We have established a full
    valuation allowance with respect to our deferred tax assets.</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">ASU 2015-17, &#8220;Balance Sheet Classification of Deferred Taxes&#8221; provides presentation requirements to classify deferred tax assets and liabilities, along with any related valuation
    allowance, are classified as non-current on the balance sheet. We account for uncertain tax positions in accordance with ASC&#160;740 and recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will
    be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position should be measured based on the largest benefit that has a greater than
    50% likelihood of being realized upon ultimate settlement. Accordingly, we report a liability for unrecognized tax benefits resulting from uncertain tax positions taken or expected to be taken in a tax return. We recognize interest and penalties, if
    any, related to unrecognized tax benefits in tax expense.</div>
  <div style="text-align: justify; line-height: 1.25; font-weight: bold;">&#160;</div>
  <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Recently Issued and Adopted Accounting Pronouncements</div>
  <div style="text-align: justify; line-height: 1.25; font-weight: bold;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
    <div style="text-indent: 36pt; line-height: 1.25;">A discussion of recent accounting pronouncements is included&#160;in&#160;Note&#160;2v,&#160;New Accounting Pronouncements&#160;to our consolidated financial statements in this annual report.</div>
  </div>
  <div style="text-align: justify; line-height: 1.25; font-weight: bold;">&#160;&#160;</div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">70</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  &#160;
  <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Liquidity and Capital Resources</div>
  <div style="line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: -4.5pt; margin-left: 5pt; line-height: 1.25; font-style: italic;">Sources of Liquidity and Outlook</div>
  <div style="text-align: justify; text-indent: -4.5pt; margin-left: 5pt; line-height: 1.25; font-style: italic;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
    <div style="text-indent: 36pt; line-height: 1.25;">Since inception, we have funded our operations primarily through the sale of our equity securities and convertible notes to investors in private placements, the sale of our equity securities in public
      offerings, cash exercises of outstanding warrants and the incurrence of bank debt.</div>
  </div>
  <div><br>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">For the full year ended December 31, 2020, the Company incurred a consolidated net loss of $13 million and has an accumulated deficit in the total amount of $181.4 million.
          Our cash and cash equivalent on December 31, 2020, totaled $20.3 million, and in subsequent warrants exercise transactions the Company received a total of an additional $13.2 million in the beginning of 2021. The Company&#8217;s negative operating cash
          flow for the full year ended December 31, 2020, was $12.6 million. The Company has sufficient funds to support its operation for more than 12 months following the approval of our consolidated financial statements for the fiscal year ended
          December 31, 2020.</div>
      </div>
    </div>
    <br>
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">We expect to incur future net losses and our transition to profitability is dependent upon, among other things, the successful development and commercialization of our
        products and product candidates, the achievement of a level of revenues adequate to support our cost structure.&#160;&#160;Until we achieve profitability or generate positive cash flows, we will continue to need to raise additional cash. We intend to fund
        future operations through cash on hand, additional private and/or public offerings of debt or equity securities, cash exercises of outstanding warrants or a combination of the foregoing. In addition, we may seek additional capital through
        arrangements with strategic partners or from other sources and we will continue to address our cost structure. Notwithstanding, there can be no assurance that we will be able to raise additional funds or achieve or sustain profitability or positive
        cash flows from operations.</div>
    </div>
  </div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We previously considered the Investment Agreement with Timwell as a potential source of ongoing liquidity. However, Timwell notified us that it would not invest the second and third
    tranches under the Investment Agreement. For more information, see &#8220;Timwell Private Placement&#8221; below.&#160;</div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Our anticipated primary uses of cash are (i) sales, marketing and reimbursement expenses related to market development activities of our ReStore device and our Distributed Products
    as well as broadening third-party payor coverage to our SCI Products, and (ii) research and development costs related to our current products maintenance and potential expansion of the indication of use of our lightweight &#8220;soft suit&#8221; exoskeleton to
    other medical conditions as well as home therapy. New medical indications that affect the ability to walk may include multiple sclerosis, cerebral palsy, Parkinson&#8217;s disease, and elderly assistance. Our future cash requirements will depend on many
    factors, including our rate of revenue growth, the expansion of our sales and marketing activities, the timing and extent of our spending on research and development efforts and international expansion. If our current estimates of revenue, expenses or
    capital or liquidity requirements change or are inaccurate, we may seek to sell additional equity or debt securities, arrange for additional bank debt financing, or refinance our indebtedness. There can be no assurance that we will be able to raise
    such funds on acceptable terms.</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;&#160;</div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">71</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  &#160;<br>
  <div style="text-align: justify; text-indent: -4.5pt; margin-left: 5pt; line-height: 1.25; font-style: italic;">Loan Agreement with Kreos and Related Warrant to Purchase Ordinary Shares</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
    <div style="text-align: left; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">On December 30, 2015, we entered into the Loan Agreement with Kreos pursuant to which Kreos extended a line of credit to us in the amount
      of $20.0 million, with interest payable monthly in arrears on any amounts drawn down at a rate of 10.75% per year from the applicable drawdown date through the date on which all principal is repaid. As of June 30, 2017, the Company raised more than
      $20.0 million in connection with the issuance of its share capital and, therefore, in accordance with the terms of the Loan Agreement, the repayment period was extended from 24 months to 36 months. The principal was also reduced in connection with
      the issuance of the Kreos Convertible Note on June 9, 2017. Pursuant to the Loan Agreement, we granted Kreos a first priority security interest over all of our assets, including certain intellectual property and equity interests in its subsidiaries,
      subject to certain permitted security interests.</div>
  </div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Pursuant to the terms of the warrant, in connection with the $20.0 million drawdown under the Loan Agreement on January 4, 2016, we issued
    to Kreos the warrant to purchase up to 4,771 of our ordinary shares at an exercise price of $241.0 per share, increased to 6,679 ordinary shares on December 28, 2016. Subject to the terms of the warrant, the warrant is exercisable, in whole or in part,
    at any time prior to the earlier of (i) December 30, 2025, or (ii) immediately prior to the consummation of a merger, consolidation, or reorganization of us with or into, or the sale or license of all or substantially all our assets or shares to, any
    other entity or person, other than a wholly-owned subsidiary of us, excluding any transaction in which our shareholders prior to the transaction will hold more than 50% of the voting and economic rights of the surviving entity after the transaction.</div>
  <div style="text-indent: 36pt; line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">On June 9, 2017, the Company and Kreos entered into the First Amendment, under which $3.0 million of the outstanding principal under the
    Loan Agreement became subject to repayment pursuant to the senior secured Kreos Convertible Note issued on June 9, 2017.</div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 36pt;">On November 20, 2018, the Company and Kreos entered into the Second Amendment of the Loan Agreement, in which the Company repaid Kreos the
    $3.6 million other related payments, including prepayment costs and end of loan payments, terminating the Kreos Note, by issuing to Kreos 192,000 units and 288,000 pre-funded units as part of an underwritten public offering at the public offering
    prices, and the parties agreed to revise the principal and the repayment schedule under the Kreos Loan. Additionally, Kreos and the Company entered into the Kreos Warrant Amendment, which amended the exercise price of the warrant to purchase 6,679
    ordinary shares currently held by Kreos from $241 to $7.5.</div>
  <div style="line-height: 1.25; text-align: justify;">&#160;</div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">72</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <div style="text-align: center; line-height: 1.25;">&#160;<br>
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">On June 5, 2019 and June 6, 2019, the Company entered into warrant exercise agreements with certain institutional investors of warrants to purchase the Company&#8217;s ordinary shares,
    pursuant to which, Kreos agreed to exercise in cash their November 2018 warrants at the then-effective exercise price of $7.50 per share. Under the exercise agreements, the Company also agreed to issue to Kreos new warrants to purchase up to 480,000
    ordinary shares at an exercise price of $7.50 per share with an exercise period of five years.</div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
    <div style="text-indent: 36pt; line-height: 1.25;">On December 29, 2020, the Company repaid in full the remaining loan principal amount to Kreos including end of loan payments and by that discharged all of its obligation to Kreos Accordingly, as of
      December 31, 2020 the outstanding principal amount under the Kreos Loan Agreement was zero.</div>
  </div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; line-height: 1.25; font-style: italic;">Paycheck Protection Program Loan Agreement</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">On April 21, 2020, RRI entered into a Note agreement evidencing an unsecured loan in the amount of $392 thousand&#160;under the PPP as part of the CARES Act enacted on March 27, 2020.
      The Note provides for an interest rate of&#160;1.00% per year and matures&#160;two years&#160;after the date of initial disbursement. Beginning on the seventh month following the date of initial disbursement, RRI is required to make&#160;18&#160;monthly payments of principal
      and interest. The Note may be used for payroll costs, costs related to certain group health care benefits and insurance premiums, rent payments, utility payments, mortgage interest payments and interest payments on any other debt obligation that were
      incurred before February 15, 2020. Under the terms of the CARES Act, PPP loan recipients can apply for and be granted forgiveness for all or a portion of loan granted under the PPP, with such forgiveness to be determined, subject to limitations,
      based on the use of the loan proceeds for payment of payroll costs and any payments of mortgage interest, rent, and utilities. The terms of any forgiveness may also be subject to further requirements in any regulations and guidelines the Small
      Business Administration may adopt.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">On September 29, 2020, the Company submitted an application for loan forgiveness and on November 6, 2020 the Company received confirmation of its PPP Note forgiveness. For more
      information see Note 10 to our consolidated financial statements set forth in &#8220;Part II. Item 8. Financial Statements and Supplementary Data&#8221; of this annual report.</div>
  </div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="text-align: justify; line-height: 1.25; font-style: italic;">Equity Raises</div>
  <div style="text-align: justify; line-height: 1.25; font-style: italic;">&#160;</div>
  <div style="text-align: justify; line-height: 1.25; font-style: italic;">Use of Form S-3</div>
  <div style="text-align: justify; line-height: 1.25; font-style: italic;">&#160;</div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Beginning with the filing of our Form 10-K on February 17, 2017, we were subject to limitations under the applicable rules of Form S-3, which constrained our ability to secure
      capital pursuant to our ATM Offering Program or other public offerings pursuant to our effective Form S-3. These rules limit the size of primary securities offerings conducted by issuers with a public float of less than $75 million to no more than
      one-third of their public float in any 12-month period. As of February 16, 2021, since our public float has reached at least $75 million in the preceding 60 days, these limitations will no longer apply to our primary offerings under Form S-3 until
      the filing of our annual report on Form 10-K in 2022, when we will re-test our status under these rules. If our public float subsequently drops below $75 million as of the filing of that or a subsequent annual report on Form 10-K, or at the time we
      file a new Form S-3, we will become subject to these limitations again, until the date that our public float again reaches $75 million. Additionally, we may not use our currently effective Form S-3 until April 1, 2021. These limitations do not apply
      to secondary offerings for the resale of our ordinary shares or other securities by selling shareholders or to the issuance of ordinary shares upon conversion by holders of convertible securities, such as warrants. Our currently effective Form S-3
      expires on May 23, 2022. We have registered up to $100 million of ordinary shares&#160;warrants and/or debt securities and certain other outstanding securities with registration rights on the Form S-3.</div>
  </div>
  <div style="text-align: justify; line-height: 1.25;">&#160;</div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">73</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  &#160;
  <div style="text-align: justify; line-height: 1.25; font-style: italic;">
    <div style="line-height: 1.25;"><font style="font-style: italic;">Equity Offerings</font>&#160;<font style="font-style: italic;">and Subsequent Warrant Exercises</font></div>
  </div>
  <div style="text-align: justify; line-height: 1.25; font-style: italic;"> <br>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div id="DSPFPageHeader"></div>
      <div style="line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">On November 20, 2018, the Company completed a follow-on underwritten public offering in which the Company issued and sold 728,019 units, each consisting of&#160;one&#160;ordinary share and&#160;one warrant to
          purchase&#160;one&#160;ordinary share. Each unit was sold to the public at a price of $7.5 per unit, additionally the Company issued and sold 1,050,373 pre-funded units, each unit was sold to the public at a price of $7.25 per unit. Each unit containing
          one pre-funded warrant with an exercise price of $0.25 per share and one warrant to purchase one ordinary share. The total gross proceeds received from the&#160;follow-on public offering, before deducting commissions, discounts and expenses, were
          $13.1 million (including proceeds from the exercise of 90,691 pre-funded warrants at the closing of the offering).&#160;As of December&#160;31, 2018, additional pre-funded warrants to purchase an aggregate 562,466 ordinary shares had been exercised, for
          additional proceeds of $140,617. During the nine months ended September 30, 2019 additional pre-funded warrants and warrants to purchase an aggregate 2,048,752 ordinary shares had been exercised, for additional proceeds of $12.4 million. As
          compensation for their role in the offering, the Company also issued to the underwriters warrants to purchase up to 106,680 ordinary shares, which are immediately exercisable starting on November 20, 2018 until November 15, 2023 at $9.375 per
          share.</div>
      </div>
    </div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; line-height: 1.25;">&#160;</div>
  </div>
  <div style="text-indent: 36pt; line-height: 1.25;">
    <div style="text-indent: 36pt; line-height: 1.25;">&#160;On February 15, 2019, the Company entered into an exclusive placement agent Agreement with H.C. Wainwright, on a reasonable best-efforts basis in connection with a public offering of 760,000 ordinary
      shares at a price of $5.75 per Share. The total gross proceeds received from the follow-on public offering, before deducting commissions, discounts, and expenses, were $4.37 million. The Company also issued to H.C. Wainwright and/or its designees
      warrants to purchase up to 45,600 ordinary shares, which are immediately exercisable starting on February 25, 2019 until February 21, 2024 at $7.1875 per share. <br>
    </div>
  </div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">On April 3, 2019, the Company entered into an exclusive placement agent Agreement with H.C. Wainwright in connection with a registered direct offering of the Company&#8217;s ordinary
    shares, par value NIS 0.25 per share and a concurrent private placement of warrants to purchase ordinary shares. The ordinary shares were offered pursuant to our Form S-3. The Company signed a purchase agreement with certain institutional investors for
    the issuance and sale of 816,914 ordinary shares at $5.2025 per ordinary share and warrants to purchase up to 408,457 ordinary shares at an exercise price of $5.14. The warrants issued to these purchasers will be exercisable at any time and from time
    to time, in whole or in part, following the date of issuance and ending five and one-half years from the date of issuance, at an exercise price of $5.14. The Company also issued to H.C. Wainwright and/or its designees warrants to purchase up to 49,015
    ordinary shares. The warrants issued to H.C. Wainwright will be exercisable at any time and from time to time, in whole or in part, following the date of issuance and ending five years from the date of the execution of the purchase agreement, at a
    price per share equal to $6.503125. The gross proceeds from the offering, before deducting placement agent fees and offering expenses, were approximately&#160;$4.25 million.&#160;&#160;</div>
  <div style="text-align: center; line-height: 1.25;"> <br>
  </div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">74</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  &#160;
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">On June 5, 2019 and June 6, 2019, the Company entered into warrant exercise agreements with certain institutional investors whereby the Company issued warrants to purchase up to
    1,464,665 ordinary shares with an exercise price of $7.50 per share, exercisable from June 5, 2019 or June 6, 2019 until June 5, 2024 or June 6, 2024, respectively. Additionally, the Company issued warrants to purchase up to 87,880 ordinary shares,
    with an exercise price of $9.375 per share, exercisable from June 5, 2019 until June 5, 2024, to certain representatives of H.C. Wainwright as compensation for its role as the placement agent in our June 2019 warrant exercise agreement and concurrent
    private placement of warrants.&#160;</div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">On June 12, 2019, the Company entered into a purchase agreement with certain institutional investors for the issuance and sale of 833,334 ordinary shares, par value NIS 0.25 per
      share,&#160;at $6.00 per ordinary share and warrants to purchase up to 416,667 ordinary shares with an exercise price of $6.00 per share, exercisable from June 12, 2019 until December 12, 2024, in a private placement that took place concurrently with our
      registered direct offering of ordinary shares in June 2019. Additionally, the Company issued warrants to purchase up to 50,000 ordinary shares, with an exercise price of $7.50 per share, exercisable from June 12, 2019 until June 10, 2024, to certain
      representatives of H.C. Wainwright as compensation for its role as the placement agent in our June 2019 registered direct offering and concurrent private placement of warrants.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">
          <div style="line-height: 1.25;">
            <div style="text-indent: 36pt; line-height: 1.25;">On February 10, 2020, the Company closed a &#8220;best efforts&#8221; public offering whereby the Company issued an aggregate of 5,600,000 of common units and pre-funded units at a public offering price of
              $1.25 per common unit and $1.249 per pre-funded unit. As part of the public offering, the Company entered into a securities purchase agreement with certain institutional purchasers. Each common unit consisted of one ordinary share, par value
              NIS 0.25 per share, and one common warrant to purchase one ordinary share. Each pre-funded unit consisted of one pre-funded warrant to purchase one ordinary share and one common warrant. Additionally, the Company issued warrants to purchase
              up to 336,000 ordinary shares, with an exercise price of $1.5625 per share, to representatives of H.C. Wainwright as compensation for its role as the placement agent in the Company&#8217;s February 2020 offering. As of December 31, 2020, all
              pre-funded warrants to purchase ordinary shares had been exercised and 1,831,500 common warrants to purchase ordinary shares had been exercised.</div>
            <div style="line-height: 1.25">&#160;</div>
          </div>
        </div>
      </div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">On July 6, 2020, the Company entered into a purchase agreement with certain institutional investors for the issuance and sale of 4,938,278 ordinary shares, par value NIS 0.25 per share,&#160;at $1.8225
          per ordinary share and warrants to purchase up to 2,469,139 ordinary shares with an exercise price of $1.76 per share, exercisable from July 6, 2020 until January 6, 2026. Additionally, the Company issued warrants to purchase up to 296,297
          ordinary shares, with an exercise price of $2.2781 per share, exercisable from July 6, 2020 until July 2, 2025, to certain representatives of H.C. Wainwright as compensation for its role as the placement agent in our July 2020 registered direct
          offering.</div>
        <div style="line-height: 1.25">&#160;</div>
      </div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">On December 8, 2020, the Company entered into a private placement with certain institutional investors for the issuance and sale of 5,579,776 ordinary shares, par value NIS 0.25
      per share, at $1.43375 per ordinary and warrants to purchase up to 4,184,832 ordinary shares with exercise price of $1.34 per share, exercisable from December 8, 2020 until June 8, 2026. Additionally, the Company issued warrants to purchase up to
      334,787 ordinary shares, with an exercise price of $1.7922 per share, exercisable from December 8, 2020 until June 8, 2026, to certain representatives of H.C. Wainwright as compensation for its role as the placement agent in our December 2020 private
      placement.</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"> <br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">&#160;For information regarding exercises of these warrants after December 31, 2020, please see &#8220;&#8212;Subsequent Events.&#8221;</div>
      </div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160; <br>
    </div>
  </div>
  <div style="text-align: justify; line-height: 1.25; font-style: italic;">ATM Offering Program</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">On May 10, 2016, we entered into our Equity Distribution Agreement with Piper Jaffray, as amended on May 9, 2019, pursuant to which we may offer and sell, from time to time, ordinary shares having
          an aggregate offering price of up to $25.0 million through Piper Jaffray acting as our agent. Subject to the terms and conditions of the Equity Distribution Agreement, Piper Jaffray will use its commercially reasonable efforts to sell on our
          behalf all of the ordinary shares requested to be sold by us, consistent with its normal trading and sales practices. Piper Jaffray may also act as principal in the sale of ordinary shares under the Equity Distribution Agreement. Such sales may
          be made under our Form S-3 in what may be deemed &#8220;at-the-market&#8221; equity offerings as defined in Rule&#160;415 promulgated under the Securities Act, directly on or through the Nasdaq Capital Market, to or through a market maker other than on an
          exchange or otherwise, in negotiated transactions at market prices prevailing at the time of sale or at prices related to such prevailing market prices, and/or any other method permitted by law, including in privately negotiated transactions.</div>
      </div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">75</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Piper Jaffray is entitled to compensation at a fixed commission rate of 3% of the gross sales price per share sold through it as agent under the Equity Distribution Agreement.
      Where Piper Jaffray acts as principal in the sale of ordinary shares under the Equity Distribution Agreement, such rate of compensation will not apply, but in no event will the total compensation of Piper Jaffray, when combined with the reimbursement
      of Piper Jaffray for the out-of-pocket fees and disbursements of its legal counsel, exceed 8.0% of the gross proceeds received from the sale of the ordinary shares.</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">We may instruct Piper Jaffray not to sell ordinary shares if the sales cannot be effected at or above the price designated by us in any instruction. We or Piper Jaffray may suspend an offering of
          ordinary shares under the ATM Offering Program upon proper notice and subject to other conditions, as further described in the Equity Distribution Agreement. Additionally, the ATM Offering Program will terminate on the earlier of (i) the sale of
          all ordinary shares subject to the Equity Distribution Agreement, (ii) the date that is three years after a new registration statement on Form S-3 goes effective, (iii) our becoming ineligible to use Form S-3 and (iv) termination of the Equity
          Distribution Agreement by the parties. The Equity Distribution Agreement may be terminated by Piper Jaffray or us at any time on the close of business on the date of receipt of written notice, and by Piper Jaffray at any time in certain
          circumstances, including any suspension or limitation on the trading of our ordinary shares on the Nasdaq Capital Market, as further described in the Equity Distribution Agreement. We temporarily suspended use of the ATM Offering Program on
          February 20, 2019 to facilitate our February 2019 &#8220;best efforts&#8221; public offering. As of September&#160;30, 2020, we had sold 302,092 ordinary shares under the ATM Offering Program for net proceeds to us of $14.5 million (after commissions, fees, and
          expenses). Additionally, as of that date, we had paid Piper Jaffray compensation of $471 thousand and had incurred total expenses (including such commissions) of approximately $1.2 million in connection with the ATM Offering Program.</div>
      </div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We intend to continue using the at-the-market offering or similar continuous offering programs opportunistically to raise additional funds, although we are currently subject to
      restrictions on using the ATM Offering Program with Piper Jaffray. Under our December 2020 purchase agreement with certain investors, we agreed for a period of one year following December 3, 2020 not to (i) issue or agree to issue equity or debt
      securities convertible into, or exercisable or exchangeable for, ordinary shares at a conversion price, exercise price or exchange price which floats with the trading price of the ordinary shares or which may be adjusted after issuance upon the
      occurrence of certain events or (ii) enter into any agreement, including an equity line of credit, whereby the Company may issue securities at a future-determined price, other than an at&#8211;the-market facility with the placement agent, H.C. Wainwright
      &amp; Co, LLC, beginning on February 1, 2021. Such limitations may inhibit our ability to access capital efficiently.</div>
  </div>
  <div style="text-align: center; line-height: 1.25;"> <br>
  </div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">76</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  &#160;
  <div style="text-align: justify; line-height: 1.25; font-style: italic;">Timwell Private Placement</div>
  <div style="text-align: justify; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">On March 6, 2018, we entered into an investment agreement with Timwell Corporation Limited, a Hong Kong corporation (&#8220;Timwell&#8221;), as amended on May 15, 2018 (the &#8220;Investment
    Agreement&#8221;), pursuant to which we agreed, in return for aggregate gross proceeds to us of $20 million, to issue to Timwell an aggregate of 640,000 of our ordinary shares, at a price per share of $1.25. The Investment Agreement contemplates issuances in
    three tranches, including $5 million for 160,000 shares in the first tranche, $10 million for 320,000 shares in the second tranche and $5 million for 160,000 shares in the third tranche.&#160;</div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The first tranche, consisting of&#160;$5 million&#160;for&#160;160,000&#160;shares,&#160;closed on May 15, 2018. The net aggregate proceeds after deducting commissions, fees and offering expenses in the
      amount of approximately $705 thousand&#160;were approximately $4.3 million.</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The closings of the Second Tranche and Third Tranche were subject to specified closing conditions, including the formation of a joint venture, the signing of a license agreement
      and a supply agreement, and the successful production of certain ReWalk products. The Third Tranche Closing was to have occurred by December 31, 2018 and no later than April 1, 2019. We believe that Timwell committed various material breaches of the
      Investment Agreement, including failure to consummate its second and third investment tranches in the Company for a total of $15 million, failure to enter into a detailed joint venture with the Company, and failure to make payments for
      product-related commitments. Nevertheless, until March 2020 we continued to engage in a dialogue with Timwell (and its affiliate RealCan) on alternative pathways to allow us to commercialize our products in China through RealCan and its affiliates,
      and also provide for RealCan or an affiliate to invest in us.</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In late March 2020, Timwell notified us that it would not invest the second and third tranches under the Investment Agreement. In response, in early April 2020, our Board of
      Directors also removed Timwell&#8217;s designee, who was appointed pursuant to the Investment Agreement, from the Board of Directors, due to this breach pursuant to the terms of the Investment Agreement. We continue to view China as a market with key
      opportunities for products designed for stroke patients, and therefore we continue to evaluate potential relationships with other groups to penetrate the Chinese market.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic; font-weight: bold;">Cash Flows</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic;">&#160;</div>
  <table cellspacing="0" cellpadding="0" id="zde930ef602ab485b89964d812f2fdd47" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;">

      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="10" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">Years Ended December 31,</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;"> 2020</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">2019</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">2018</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 64%;">
          <div style="line-height: 1.25;">Net cash used in operating activities</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">(12,589</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">(14,815</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">(14,774</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">)</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 64%;">
          <div style="line-height: 1.25;">Net cash provided by used in investing activities</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">(73</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">(22</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">(13</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">)</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 64%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">Net cash provided by financing activities</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
          <div style="line-height: 1.25;">16,724</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
          <div style="line-height: 1.25;">21,482</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
          <div style="line-height: 1.25;">9,711</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">Net cash flow</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">4,062</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">6,645</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">(5,076</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">)</div>
        </td>
      </tr>

  </table>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;<font style="font-style: italic;">&#160;</font></div>
  <div style="line-height: 1.25; font-style: italic; font-weight: bold;">Year Ended December 31, 2020 to Year Ended December 31, 2019</div>
  <div style="line-height: 1.25">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic;">Net Cash Used in Operating Activities</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
    <div style="text-indent: 36pt; line-height: 1.25;">Net cash used in operating activities decreased by $2.2 million in 2020 compared to 2019 mainly due to our reduction in our net loss.</div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic;">Net Cash Used in Investing Activities</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Net cash used in investing activities increased from $22 thousand in 2019 to $73 thousand in 2020, primarily as a result of increased use of cash for the purchase of property and
    equipment.</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic;">Net Cash Provided by Financing Activities</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We generated $16.7 million from financing activities in 2020 compared to $21.5 million in 2019. Our fundraising activities remained generally flat with $23.3 million raised in 2020
    and 2019 and the overall decrease is due to our Kreos loan repayment which was higher by $5.2 million in 2020.</div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="line-height: 1.25; font-style: italic; font-weight: bold;">Year Ended December 31, 2019 Compared to Year Ended December 31, 2018</div>
  <div style="line-height: 1.25">&#160;</div>
  <div style="line-height: 1.25; text-align: justify; text-indent: 36pt;">A discussion of changes in our cash flows in 2019 compared to 2018 has been omitted from this annual report on Form 10-K, but may be found in &#8220;Item 7. Management's Discussion and
    Analysis of Financial Condition and Results of Operations&#8221; of our Form 10-K for the fiscal year ended December 30, 2019, filed with the SEC on February 20, 2020, which is available free of charge on the SECs website at <u>www.sec.go</u>v and at <u>www.rewalk.com</u>,
    and is incorporated by reference herein.</div>
  <div style="line-height: 1.25">&#160;</div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">77</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  &#160;<br>
  <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Obligations and Commercial Commitments</div>
  <div style="line-height: 1.25;">&#160;</div>
  <div style="text-indent: 36pt; line-height: 1.25;">Set forth below is a summary of our contractual obligations as of December&#160;31, 2020:</div>
  <div style="text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <table cellspacing="0" cellpadding="0" id="zcb0c6de1d7a340958226ee5a1cf25850" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;">

      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="10" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">Payments due by period (in dollars, in thousands)</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25; font-weight: bold;">Contractual obligations</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">Total</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">Less than<br>
            1 year</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">1-3 years</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 64%;">
          <div style="line-height: 1.25;">Purchase obligations (1)</div>
        </td>
        <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">683</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">683</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 64%;">
          <div style="line-height: 1.25;">Collaboration Agreement and License Agreement obligations (2)</div>
        </td>
        <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">2,319</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">1,000</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">1,319</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 64%;">
          <div style="line-height: 1.25;">Operating lease obligations (3)</div>
        </td>
        <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">1,877</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">710</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">1,167</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 4px;">
          <div style="line-height: 1.25; font-weight: bold;">Total</div>
        </td>
        <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">4,879</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">2,393</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">2,486</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
      </tr>

  </table>
  <div style="text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z3ed2b8ae06624eb0a0782b6a9f0dff35">

      <tr>
        <td style="width: 3.88%; vertical-align: top;">
          <div style="line-height: 1.25;">(1)</div>
        </td>
        <td style="width: 96.12%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25;">The Company depends on one contract manufacturer, Sanmina, for both the ReStore products and the SCI Products. We place our manufacturing orders with Sanmina pursuant to purchase orders or by
            providing forecasts for future requirements. Additionally, we have purchase obligations to our raw material vendors related to the ReStore production, which began in the second quarter of 2019 following regulatory clearance.</div>
        </td>
      </tr>
      <tr>
        <td style="width: 3.88%; vertical-align: top;">
          <div style="line-height: 1.25;">(2)</div>
        </td>
        <td style="width: 96.12%; vertical-align: top;">
          <div style="line-height: 1.25;">
            <div id="DSPFPageHeader"></div>
            <div style="line-height: 1.25;">Our Collaboration Agreement was originally signed for a period of six years and as of December 31, 2020 has a remaining term of approximately 2.16 years, it requires us to pay in quarterly installments for the
              funding of our joint research collaboration with Harvard, subject to a minimum funding commitment under applicable circumstances. Our License Agreement consists of patent reimbursement expenses payments and of a license upfront fee payment.
              There are also several milestone payments contingent upon the achievement of certain product development and commercialization milestones and royalty payments on net sales from certain patents licensed to Harvard. These product development
              milestones have been met as of December 31, 2020. There are commercialization milestones which depend on us reaching certain sales amounts some or all of which may not occur.</div>
          </div>
        </td>
      </tr>
      <tr>
        <td style="width: 3.88%; vertical-align: top;">
          <div style="line-height: 1.25;">(3)</div>
        </td>
        <td style="width: 96.12%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25;">Our operating leases consist of leases for our facilities and motor vehicles.</div>
        </td>
      </tr>

  </table>
  <div style="text-align: justify; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We calculated the payments due under our operating lease obligation for our Israeli office that are to be paid in NIS at a rate of exchange of NIS 3.215:$1.00, and the payments due
    under our operating lease obligation for our German subsidiary that are to be paid in euros at a rate of exchange of &#8364;1.00:$1.227, both of which were the applicable exchange rates as of December&#160;31, 2020. We calculated the payments due under our Loan
    Agreement with Kreos according to the current schedule of repayment of principal and interest, taking into account the two tranches of debt drawn down under the Loan Agreement. For information on this repayment schedule, see &#8220;-Liquidity and Capital
    Resources-Loan Agreement with Kreos and Related Warrant to Purchase Ordinary Shares&#8221; above.</div>
  <div style="text-align: justify; line-height: 1.25; font-weight: bold;">&#160;</div>
  <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Off-Balance Sheet Arrangements</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
    <div style="text-indent: 36pt; line-height: 1.25;">We had no off-balance sheet arrangements or guarantees of third-party obligations during the periods presented.</div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Trend Information</div>
  <div style="text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-indent: 36pt; line-height: 1.25;">
    <div style="text-indent: 36pt; line-height: 1.25;">For information on significant known trends, please see &#8220;Part I-Item 1. &#8220;Business &#8211; Overview&#8221; in this annual report.</div>
  </div>
  <div style="text-indent: 36pt; line-height: 1.25; font-weight: bold;">&#160;</div>
  <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Subsequent Events</div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">Following December 31, 2020, a total of 9,372,954 outstanding warrants with exercise prices ranging from $1.25 to $1.79 were exercised, for total gross proceeds to us of approximately $13.2
          million.</div>
        <div style="line-height: 1.25">&#160;</div>
      </div>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">78</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
  </div>
  <div style="line-height: 1.25; font-weight: bold;">ITEM 7A<a name="ITEM7A"><!--Anchor--></a>. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</div>
  <div style="line-height: 1.25; font-weight: bold;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; margin-left: 5pt; line-height: 1.25; font-style: italic; font-weight: bold;">Currency Exchange Risk</div>
  <div style="line-height: 1.25; font-weight: bold;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Our results of operations and cash flows are affected by fluctuations in foreign currency exchange rates.&#160;Since 2015, most of our expenses were denominated in U.S. dollars and the
    remaining expenses were denominated in NIS and euros, until 2018 most of our revenues were denominated in U.S. dollars and the remainder of our revenues was denominated in euros and British pound whereas in the last two years our euro revenues are
    higher than our U.S dollar revenues. Accordingly, changes in the value of the NIS and euro relative to the U.S. dollar in each of the years 2020, 2019, and 2018 impacted amounts recorded on our consolidated statements of operations for those periods.
    We expect that the denominations of our revenue and expenses in 2021 will be consistent with what we experienced in 2020.</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The following table presents information about the changes in the exchange rates of the NIS and euro against the U.S. dollar in 2020, 2019 and 2018:</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <table cellspacing="0" cellpadding="0" id="zff34203f284d43d8b5caf7a3aa52ff41" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;">

      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">Change in Average Exchange Rate</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25; font-weight: bold;">Period</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">NIS against the<br>
            U.S. Dollar (%)</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">Euro against the<br>
            U.S. Dollar (%)</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 76%;">
          <div style="line-height: 1.25;">2020</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">3.76</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">2.07</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 76%;">
          <div style="line-height: 1.25;">2019</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">0.87</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">(5.16</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">)</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 76%;">
          <div style="line-height: 1.25;">2018</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">0.11</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">4.57</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>

  </table>
  <div style="text-align: center; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The figures above represent the change in the average exchange rate in the given period compared to the average exchange rate in the immediately preceding period. Negative figures
    represent depreciation of the U.S. dollar compared to the NIS or the euro. A 10% increase or decrease in the value of the NIS against the U.S. dollar would have decreased or increased our net loss by approximately $408 thousand in 2020. A 10% increase
    or decrease in the value of the euro against the U.S. dollar would have decreased or increased our net loss by approximately $75 thousand in 2020.</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">From time to time, we enter into limited short term hedging arrangements with financial institutions. We do not use derivative financial instruments for speculative or trading
    purposes.</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic; font-weight: bold;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic; font-weight: bold;">Other Market Risks</div>
  <div style="text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-indent: 36pt; line-height: 1.25;">We do not believe that we have material exposure to interest rate risks or to inflationary risks.</div>
  <div style="line-height: 1.25;">&#160;</div>
  <div style="line-height: 1.25;"><font style="font-weight: bold;"><a name="ITEM8"><!--Anchor--></a>ITEM 8.</font>&#160; <font style="font-weight: bold;">FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</font></div>
  <div style="line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The information required hereunder is set forth under Report of Independent Registered Public Accounting Firm, Consolidated Balance Sheets, Consolidated Statements of Operations,
    Statements of Changes in Shareholders&#8217; Equity, Consolidated Statements of Cash Flows and Notes to Consolidated Financial Statements included in the Consolidated Financial Statements that are a part of this annual report. Other financial information is
    included in the Consolidated Financial Statements that are a part of this annual report.</div>
  <div style="line-height: 1.25;">&#160;&#160;</div>
  <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><a name="ITEM9"><!--Anchor--></a>ITEM 9.&#160; CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE</div>
  <div style="text-align: justify; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">None.</div>
  <div style="line-height: 1.25;">&#160;&#160;</div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">79</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  &#160;
  <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><a name="ITEM9A"><!--Anchor--></a>ITEM 9A. CONTROLS AND PROCEDURES</div>
  <div style="text-align: justify; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Disclosure Controls and Procedures</div>
  <div style="text-align: justify; margin-left: 56pt; line-height: 1.25; font-style: italic;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
    <div style="text-indent: 36pt; line-height: 1.25;">We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our Exchange Act reports is recorded, processed, summarized, and reported within
      the time periods specified in the SEC&#8217;s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions
      regarding required financial disclosure.</div>
  </div>
  <div style="text-align: justify; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">As of the end of the period covered by this Report, we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive
    Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) and Rule 15d-15(e) of the Exchange Act). Based upon, and as of the date of, this evaluation,
    the Chief Executive Officer and the Chief Financial Officer concluded that our disclosure controls and procedures were effective such that the information required to be disclosed by us in our SEC reports is recorded, processed, summarized and reported
    within the time periods specified in SEC rules and forms, and is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.</div>
  <div style="text-align: justify; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Management&#8217;s Report on Internal Control over Financial Reporting</div>
  <div style="text-align: justify; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act.
    Our internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. GAAP.</div>
  <div style="text-align: justify; text-indent: 24pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Our internal control over financial reporting includes those policies and procedures that:</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z5f39bdb8eae24f399bac0611a578824d">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#9679;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of our assets;</div>
          </td>
        </tr>

    </table>
    <div style="margin-left: 5.65pt; line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zcabd94ba4548421d8817cff8ff7a4616">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#9679;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with U.S. GAAP, and that our receipts and expenditures are being made only in accordance with
              authorizations of our management and directors; and</div>
          </td>
        </tr>

    </table>
    <div style="margin-left: 5.65pt; line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb19609b62ae0403f9f60e771b8b38013">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#9679;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of our assets that could have a material effect on our financial statements.</div>
          </td>
        </tr>

    </table>
  </div>
  <br>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Management has assessed the effectiveness of our internal control over financial reporting as of December&#160;31, 2020. In making its assessment, management used the criteria described
    in Internal Control &#8212; Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission.</div>
  <div style="text-align: justify; text-indent: 24pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Based on management&#8217;s assessment, management has concluded that our internal control over financial reporting was effective as of December&#160;31, 2020 to provide reasonable assurance
    regarding the reliability of financial reporting and the preparation of consolidated financial statements for external reporting purposes in accordance with U.S. GAAP.</div>
  <div style="text-align: justify; text-indent: 18pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">This annual report does not include an attestation report of our independent registered public accounting firm regarding internal controls over financial reporting because we are
    exempt from this requirement as a smaller reporting company and non-accelerated filer.</div>
  <div style="text-align: justify; line-height: 1.25; font-weight: bold;">&#160;</div>
  <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Changes in Internal Control over Financial Reporting</div>
  <div style="text-align: justify; line-height: 1.25; font-weight: bold;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">During the fourth quarter of the fiscal year ended December&#160;31, 2020, there were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and
    15d-15(f) of the Exchange Act) that materially affected, or that are reasonably likely to materially affect, our internal control over financial reporting.</div>
  <div style="line-height: 1.25;">&#160;</div>
  <div style="line-height: 1.25;"><font style="font-weight: bold;"><a name="ITEM9B"><!--Anchor--></a>ITEM 9B.</font> &#160; <font style="font-weight: bold;">OTHER INFORMATION</font></div>
  <div style="text-align: justify; line-height: 1.25; font-weight: bold;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Not applicable</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;&#160;</div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">80</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  &#160;
  <div style="text-align: center; line-height: 1.25; font-weight: bold;"><a name="PARTIII"><!--Anchor--></a>PART III</div>
  <div style="text-align: center; line-height: 1.25; font-weight: bold;">&#160;</div>
  <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><a name="ITEM10"><!--Anchor--></a>ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE</div>
  <div style="line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Information About Our Executive Officers</div>
  <div style="line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The following table sets forth the name, age and position of each of our executive officers as of February 18, 2021:</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z42e374e1b21e45d4b19dbf9bb434e653">

      <tr>
        <td style="width: 45.99%; vertical-align: bottom; border-bottom: #000000 2px solid;">
          <div style="line-height: 1.25; font-weight: bold;">Name</div>
        </td>
        <td style="width: 1%; vertical-align: bottom;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 7%; vertical-align: bottom; border-bottom: #000000 2px solid;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">Age</div>
        </td>
        <td style="width: 1%; vertical-align: bottom;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 45%; vertical-align: bottom; border-bottom: #000000 2px solid;">
          <div style="line-height: 1.25; font-weight: bold;">Position</div>
        </td>
      </tr>
      <tr>
        <td style="width: 45.99%; vertical-align: bottom; background-color: #CCEEFF;">
          <div style="line-height: 1.25;">Larry Jasinski</div>
        </td>
        <td style="width: 1%; vertical-align: bottom; background-color: #CCEEFF;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 7%; vertical-align: bottom; background-color: #CCEEFF;">
          <div style="text-align: center; line-height: 1.25;">63</div>
        </td>
        <td style="width: 1%; vertical-align: bottom; background-color: #CCEEFF;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 45%; vertical-align: bottom; background-color: #CCEEFF;">
          <div style="line-height: 1.25;">Chief Executive Officer and Director</div>
        </td>
      </tr>
      <tr>
        <td style="width: 45.99%; vertical-align: bottom;">
          <div style="line-height: 1.25;">Ori Gon</div>
        </td>
        <td style="width: 1%; vertical-align: bottom;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 7%; vertical-align: bottom;">
          <div style="text-align: center; line-height: 1.25;">39</div>
        </td>
        <td style="width: 1%; vertical-align: bottom;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 45%; vertical-align: bottom;">
          <div style="line-height: 1.25;">Chief Financial Officer</div>
        </td>
      </tr>

  </table>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-style: italic;">Larry Jasinski </font>has served as our Chief Executive Officer and as a member of our board since February 2012. From 2005 until 2012,
    Mr.&#160;Jasinski served as the President and Chief Executive Officer of Soteira, Inc., a&#160;company engaged in development and commercialization of products used to treat individuals with vertebral compression fractures, which was acquired by Globus Medical
    in 2012. From 2001 to 2005, Mr.&#160;Jasinski was President and Chief Executive Officer of Cortek, Inc., a company that developed next-generation treatments for degenerative disc disease, which was acquired by Alphatec in 2005. From 1985 until 2001,
    Mr.&#160;Jasinski served in multiple sales, research and development, and general management roles at Boston Scientific Corporation. Mr. Jasinski has served on the board of directors of Massachusetts Bay Lines since 2015 and of LeMaitre Vascular, Inc. since
    2003. Mr.&#160;Jasinski holds a B.Sc. in marketing from Providence College and an MBA from the University of Bridgeport.</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-style: italic;">Ori Gon</font> became our Chief Financial Officer effective February 22, 2018. From 2015 to 2018, Mr. Gon served as our Corporate Controller. Prior
    to ReWalk Robotics Mr. Gon served as Corporate Controller at Oti Ltd from 2012 to 2015. Mr. Gon is a Certified Public Accountant in Israel and holds a B.A. in Economics from Hebrew University of Jerusalem.</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-style: italic;">&#160;</font>&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The remaining information required by this Item will be included in, and is incorporated herein by reference from, our definitive proxy statement for our 2020 Annual Meeting of
    Shareholders to be filed with the SEC pursuant to Regulation 14A within 120 days after the end of our fiscal year ended December&#160;31, 2020 (the &#8220;Proxy Statement&#8221;).</div>
  <div style="text-align: justify; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><a name="ITEM11"><!--Anchor--></a>ITEM 11. EXECUTIVE COMPENSATION</div>
  <div style="text-align: justify; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The information required by this Item 11 will be included in, and is incorporated herein by reference from, our Proxy Statement.</div>
  <div style="text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><a name="ITEM12"><!--Anchor--></a>ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS</div>
  <div style="line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The information required by this Item 12 will be included in and is incorporated herein by reference from, our Proxy Statement.</div>
  <div style="line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><a name="ITEM13."><!--Anchor--></a>ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE</div>
  <div style="line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The information required by this Item 13 will be included in and is incorporated herein by reference, from our Proxy Statement.</div>
  <div style="text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><a name="ITEM14."><!--Anchor--></a>ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES</div>
  <div style="text-align: justify; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The information required by this Item 14 will be included in and is incorporated herein by reference, from our Proxy Statement.</div>
  <div style="text-indent: 36pt; line-height: 1.25;">&#160;&#160;&#160;</div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">81</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  &#160;<br>
  <div style="text-align: center; line-height: 1.25; font-weight: bold;"><a name="PARTIV"><!--Anchor--></a>PART IV</div>
  <div style="text-align: center; line-height: 1.25; font-weight: bold;">&#160;</div>
  <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><a name="ITEM15."><!--Anchor--></a>ITEM 15.&#160;&#160; EXHIBITS, FINANCIAL STATEMENT SCHEDULES</div>
  <div style="line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; line-height: 1.25;">(a)(1) Financial Statements.</div>
  <div style="line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The Consolidated Financial Statements filed as part of this annual report are identified in the Index to Consolidated Financial Statements on page F-1 hereto.</div>
  <div style="line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; line-height: 1.25;">(a)(2) Financial Statement Schedules.</div>
  <div style="line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;Financial Statement Schedules have been omitted because the information required to be set forth therein is not applicable or is shown in the financial statements or notes thereto.</div>
  <div style="text-align: justify; text-indent: 45pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; line-height: 1.25;">(a)(3) Exhibits.</div>
  <div style="text-align: justify; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">See accompanying Exhibit Index included after the signature page of this report for a list of the exhibits filed or furnished with or incorporated by reference in this report.</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;&#160;</div>
  <div style="line-height: 1.25; font-weight: bold;"><a name="ITEM16."><!--Anchor--></a>ITEM 16. FORM 10-K SUMMARY</div>
  <div style="line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Not applicable.</div>
  <div style="line-height: 1.25;">&#160;&#160;</div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">82</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  &#160;
  <div style="text-align: center; line-height: 1.25; font-weight: bold;"><a name="SIGNATURES"><!--Anchor--></a>SIGNATURES</div>
  <div style="text-align: center; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned,
    thereunto duly authorized.</div>
  <div style="line-height: 1.25;">&#160;</div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zfeb1a439aee9493ba795958adc422543">

      <tr>
        <td style="width: 50%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td colspan="2" style="vertical-align: top;">
          <div style="line-height: 1.25; font-weight: bold;">ReWalk Robotics Ltd.</div>
        </td>
        <td colspan="1" style="width: 20%; vertical-align: top;">&#160;</td>
      </tr>
      <tr>
        <td style="width: 50%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td colspan="2" style="vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td colspan="1" style="width: 20%; vertical-align: top;">&#160;</td>
      </tr>
      <tr>
        <td style="width: 50%; vertical-align: top; padding-bottom: 2px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 3%; vertical-align: top; padding-bottom: 2px;">
          <div style="line-height: 1.25;">By:</div>
        </td>
        <td style="width: 27%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">/s/ Larry Jasinski</div>
        </td>
        <td colspan="1" style="width: 20%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td style="width: 50%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 3%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 27%; vertical-align: top;">
          <div style="line-height: 1.25;">Name: Larry Jasinski</div>
        </td>
        <td colspan="1" style="width: 20%; vertical-align: top;">&#160;</td>
      </tr>
      <tr>
        <td style="width: 50%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 3%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 27%; vertical-align: top;">
          <div style="line-height: 1.25;">Title: Chief Executive Officer</div>
        </td>
        <td colspan="1" style="width: 20%; vertical-align: top;">&#160;</td>
      </tr>

  </table>
  <div style="line-height: 1.25;">&#160;</div>
  <div style="line-height: 1.25;">Date: February&#160;18, 2021</div>
  <div style="text-align: center; line-height: 1.25;">&#160;</div>
  <div style="text-align: center; line-height: 1.25; font-weight: bold;"><a name="POWEROFATTORNEY"><!--Anchor--></a>POWER OF ATTORNEY</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">KNOW ALL PERSONS BY THESE PRESENT: That the undersigned officers and directors of ReWalk Robotics Ltd. do hereby constitute and appoint Larry Jasinski and Ori Gon the lawful attorney
    and agent with power and authority to do any and all acts and things and to execute any and all instruments which said attorney and agent determines may be necessary or advisable or required to enable ReWalk Robotics Ltd. to comply with the Securities
    and Exchange Act of 1934, as amended, and any rules or regulations or requirements of the Securities and Exchange Commission in connection with this report. Without limiting the generality of the foregoing power and authority, the powers granted
    include the power and authority to sign the names of the undersigned officers and directors in the capacities indicated below to this report or amendments or supplements thereto, and each of the undersigned hereby ratifies and confirms all that said
    attorneys and agents, or either of them, shall do or cause to be done by virtue hereof. This Power of Attorney may be signed in several counterparts.</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed by the following persons on behalf of the registrant and in the capacities and on the
    dates indicated.</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z67cc245cd0a14de1a9c3697ff8112d6b">

      <tr>
        <td style="width: 24.99%; vertical-align: bottom; border-bottom: #000000 2px solid;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">Signature</div>
        </td>
        <td style="width: 5%; vertical-align: bottom;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 39%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">Title</div>
        </td>
        <td style="width: 5%; vertical-align: bottom;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 26%; vertical-align: bottom; border-bottom: #000000 2px solid;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">Date</div>
        </td>
      </tr>
      <tr>
        <td style="width: 24.99%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 5%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 39%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 5%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 26%; vertical-align: top;">
          <div style="text-align: center; line-height: 1.25;">&#160;</div>
        </td>
      </tr>
      <tr>
        <td style="width: 24.99%; vertical-align: top; border-bottom: #000000 2px solid;">
          <div style="text-align: justify; line-height: 1.25;">/s/ Larry Jasinski</div>
        </td>
        <td style="width: 5%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td rowspan="2" style="width: 39%; vertical-align: middle;">
          <div style="line-height: 1.25;">Director and Chief Executive Officer<br>
            (Principal Executive Officer)</div>
        </td>
        <td style="width: 5%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 26%; vertical-align: bottom;">
          <div style="text-align: center; line-height: 1.25;">February 18, 2021</div>
        </td>
      </tr>
      <tr>
        <td style="width: 24.99%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25;">Larry Jasinski</div>
        </td>
        <td style="width: 5%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 5%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 26%; vertical-align: bottom;">
          <div style="text-align: center; line-height: 1.25;">&#160;</div>
        </td>
      </tr>
      <tr>
        <td style="width: 24.99%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 5%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 39%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 5%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 26%; vertical-align: top;">
          <div style="text-align: center; line-height: 1.25;">&#160;</div>
        </td>
      </tr>
      <tr>
        <td style="width: 24.99%; vertical-align: top; border-bottom: #000000 2px solid;">
          <div style="text-align: justify; line-height: 1.25;">/s/ Ori Gon</div>
        </td>
        <td style="width: 5%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td rowspan="2" style="width: 39%; vertical-align: middle;">
          <div style="line-height: 1.25;">Chief Financial Officer<br>
            (Principal Financial Officer and Principal Accounting Officer)</div>
        </td>
        <td style="width: 5%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 26%; vertical-align: bottom;">
          <div style="text-align: center; line-height: 1.25;">February 18, 2021</div>
        </td>
      </tr>
      <tr>
        <td style="width: 24.99%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25;">Ori Gon</div>
        </td>
        <td style="width: 5%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 5%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 26%; vertical-align: bottom;">
          <div style="text-align: center; line-height: 1.25;">&#160;</div>
        </td>
      </tr>
      <tr>
        <td style="width: 24.99%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 5%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 39%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 5%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 26%; vertical-align: top;">
          <div style="text-align: center; line-height: 1.25;">&#160;</div>
        </td>
      </tr>
      <tr>
        <td style="width: 24.99%; vertical-align: top; border-bottom: #000000 2px solid;">
          <div style="text-align: justify; line-height: 1.25;">/s/ Jeff Dykan</div>
        </td>
        <td style="width: 5%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 39%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25;">Chairman of the Board</div>
        </td>
        <td style="width: 5%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 26%; vertical-align: bottom;">
          <div style="text-align: center; line-height: 1.25;">February 18, 2021</div>
        </td>
      </tr>
      <tr>
        <td style="width: 24.99%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25;">Jeff Dykan</div>
        </td>
        <td style="width: 5%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 39%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 5%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 26%; vertical-align: bottom;">
          <div style="text-align: center; line-height: 1.25;">&#160;</div>
        </td>
      </tr>
      <tr>
        <td style="width: 24.99%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 5%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 39%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 5%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 26%; vertical-align: bottom;">
          <div style="text-align: center; line-height: 1.25;"><br>
          </div>
        </td>
      </tr>
      <tr>
        <td style="width: 24.99%; vertical-align: top; border-bottom: #000000 2px solid;">
          <div style="text-align: justify; line-height: 1.25;">/s/ Yohanan R Engelhardt</div>
        </td>
        <td style="width: 5%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 39%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25;">Director</div>
        </td>
        <td style="width: 5%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 26%; vertical-align: bottom;">
          <div style="text-align: center; line-height: 1.25;">February 18, 2021</div>
        </td>
      </tr>
      <tr>
        <td style="width: 24.99%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25;">Yohanan R Engelhardt</div>
        </td>
        <td style="width: 5%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 39%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 5%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 26%; vertical-align: top;">
          <div style="text-align: center; line-height: 1.25;">&#160;</div>
        </td>
      </tr>
      <tr>
        <td style="width: 24.99%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 5%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 39%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 5%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 26%; vertical-align: top;">
          <div style="text-align: center; line-height: 1.25;">&#160;</div>
        </td>
      </tr>
      <tr>
        <td style="width: 24.99%; vertical-align: top; border-bottom: #000000 2px solid;">
          <div style="line-height: 1.25;">/s/ Dr. John William Poduska</div>
        </td>
        <td style="width: 5%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 39%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25;">Director</div>
        </td>
        <td style="width: 5%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 26%; vertical-align: bottom;">
          <div style="text-align: center; line-height: 1.25;">February 18, 2021</div>
        </td>
      </tr>
      <tr>
        <td style="width: 24.99%; vertical-align: top;">
          <div style="line-height: 1.25;">Dr. John William Poduska</div>
        </td>
        <td style="width: 5%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 39%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 5%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 26%; vertical-align: bottom;">
          <div style="text-align: center; line-height: 1.25;">&#160;</div>
        </td>
      </tr>
      <tr>
        <td style="width: 24.99%; vertical-align: top;">&#160;</td>
        <td style="width: 5%; vertical-align: top;">&#160;</td>
        <td style="width: 39%; vertical-align: top;">&#160;</td>
        <td style="width: 5%; vertical-align: top;">&#160;</td>
        <td style="width: 26%; vertical-align: top;">&#160;</td>
      </tr>
      <tr>
        <td style="width: 24.99%; vertical-align: top; border-bottom: #000000 2px solid;">
          <div style="text-align: justify; line-height: 1.25;">/s/ Wayne B. Weisman</div>
        </td>
        <td style="width: 5%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 39%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25;">Director</div>
        </td>
        <td style="width: 5%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 26%; vertical-align: bottom;">
          <div style="text-align: center; line-height: 1.25;">February 18, 2021</div>
        </td>
      </tr>
      <tr>
        <td style="width: 24.99%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25;">Wayne&#160;B.&#160;Weisman</div>
        </td>
        <td style="width: 5%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 39%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 5%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 26%; vertical-align: top;">
          <div style="text-align: center; line-height: 1.25;">&#160;</div>
        </td>
      </tr>
      <tr>
        <td style="width: 24.99%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 5%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 39%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 5%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 26%; vertical-align: top;">
          <div style="text-align: center; line-height: 1.25;">&#160;</div>
        </td>
      </tr>
      <tr>
        <td style="width: 24.99%; vertical-align: top; border-bottom: #000000 2px solid;">
          <div style="text-align: justify; line-height: 1.25;">/s/ Yasushi Ichiki</div>
        </td>
        <td style="width: 5%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 39%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25;">Director</div>
        </td>
        <td style="width: 5%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 26%; vertical-align: bottom;">
          <div style="text-align: center; line-height: 1.25;">February 18, 2021</div>
        </td>
      </tr>
      <tr>
        <td style="width: 24.99%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25;">Yasushi Ichiki</div>
        </td>
        <td style="width: 5%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 39%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 5%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 26%; vertical-align: top;">
          <div style="text-align: center; line-height: 1.25;">&#160;</div>
        </td>
      </tr>
      <tr>
        <td style="width: 24.99%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 5%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 39%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 5%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 26%; vertical-align: top;">
          <div style="text-align: center; line-height: 1.25;">&#160;</div>
        </td>
      </tr>
      <tr>
        <td style="width: 24.99%; vertical-align: top; border-bottom: #000000 2px solid;">
          <div style="text-align: justify; line-height: 1.25;">/s/ Aryeh Dan</div>
        </td>
        <td style="width: 5%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 39%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25;">Director</div>
        </td>
        <td style="width: 5%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 26%; vertical-align: bottom;">
          <div style="text-align: center; line-height: 1.25;">February 18, 2021</div>
        </td>
      </tr>
      <tr>
        <td style="width: 24.99%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25;">Aryeh Dan</div>
        </td>
        <td style="width: 5%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 39%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 5%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 26%; vertical-align: top;">
          <div style="text-align: center; line-height: 1.25;">&#160;</div>
        </td>
      </tr>
      <tr>
        <td style="width: 24.99%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 5%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 39%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 5%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 26%; vertical-align: top;">
          <div style="text-align: center; line-height: 1.25;">&#160;</div>
        </td>
      </tr>
      <tr>
        <td style="width: 24.99%; vertical-align: top; border-bottom: #000000 2px solid;">
          <div style="line-height: 1.25;">/s/ Randel Richner</div>
        </td>
        <td style="width: 5%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 39%; vertical-align: top;">
          <div style="line-height: 1.25;">Director</div>
        </td>
        <td style="width: 5%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 26%; vertical-align: bottom;">
          <div style="text-align: center; line-height: 1.25;">February 18, 2021</div>
        </td>
      </tr>
      <tr>
        <td style="width: 24.99%; vertical-align: top;">
          <div style="line-height: 1.25;">Randel Richner</div>
        </td>
        <td style="width: 5%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 39%; vertical-align: bottom;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 5%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 26%; vertical-align: bottom;">
          <div style="text-align: center; line-height: 1.25;">&#160;</div>
        </td>
      </tr>

  </table>
  <div style="line-height: 1.25;">&#160;&#160;</div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">83</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  &#160;
  <div style="text-align: center; line-height: 1.25; font-weight: bold;">EXHIBIT INDEX</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <table cellspacing="0" cellpadding="2" border="0" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" id="z0b163bddf9b6435da61cae855bf87fd0">

      <tr>
        <td style="width: 10%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Number</div>
        </td>
        <td style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#160;</div>
        </td>
        <td style="width: 89%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Description</div>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390019005541/f8k032719ex3-1_rewalkrobot.htm">3.1</a></div>
        </td>
        <td style="width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255);"><br>
        </td>
        <td style="width: 89%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390019005541/f8k032719ex3-1_rewalkrobot.htm">Third Amended and Restated Articles of
              Association of the Company (incorporated by reference to Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on April 1, 2019).</a></div>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000119312514315654/d724635dex41.htm">4.1</a></div>
        </td>
        <td style="width: 1%; vertical-align: bottom;"><br>
        </td>
        <td style="width: 89%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000119312514315654/d724635dex41.htm">Specimen share certificate (incorporated by reference
              to Exhibit 4.1 to the Company&#8217;s registration statement on Form F-1/A (File No. 333-197344), filed with the SEC on August 20, 2014).</a></div>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390020004363/f10k2019ex4-2_rewalk.htm">4.2</a></div>
        </td>
        <td style="width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255);"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390020004363/f10k2019ex4-2_rewalk.htm"><br>
          </a></td>
        <td style="width: 89%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">
            <div style="text-align: left; line-height: 1.25;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390020004363/f10k2019ex4-2_rewalk.htm"><u>Description of the registrant&#8217;s securities registered pursuant to Section 12 of the
                  Securities Exchange Act of 1934</u><u> (incorporated by reference to Exhibit 4.2 to the Company&#8217;s Annual Report on Form 10-K, filed with the SEC on February 20, 2020).</u></a></div>
          </div>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000117891316003859/exhibit_10-2.htm">4.3</a></div>
        </td>
        <td style="width: 1%; vertical-align: bottom;"><br>
        </td>
        <td style="width: 89%; vertical-align: bottom;">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000117891316003859/exhibit_10-2.htm">Warrant, dated December 30, 2015, between the Company
              and Kreos Capital V (Expert Fund) Limited (incorporated by reference to Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on January 4, 2016).</a></div>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000114420416130384/v451434_ex4-1.htm">4.4</a></div>
        </td>
        <td style="width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255);"><br>
        </td>
        <td style="width: 89%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000114420416130384/v451434_ex4-1.htm">Form of warrant issued in connection with the
              Company&#8217;s follow-on offering in November 2016 (incorporated by reference to Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on October 31, 2016).</a></div>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390018015029/fs12018a1ex4-7_rewalk.htm">4.5</a></div>
        </td>
        <td style="width: 1%; vertical-align: bottom;"><br>
        </td>
        <td style="width: 89%; vertical-align: bottom;">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390018015029/fs12018a1ex4-7_rewalk.htm">Form of common warrant to purchase ordinary
              shares in November 2018 follow-on offering (incorporated by reference to Exhibit 4.7 to the Company&#8217;s registration statement on Form S-1/A (File No. 333-227852), filed with the SEC on November 14, 2018).&#160;&#160;</a></div>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390018015029/fs12018a1ex4-8_rewalk.htm">4.6</a></div>
        </td>
        <td style="width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255);"><br>
        </td>
        <td style="width: 89%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390018015029/fs12018a1ex4-8_rewalk.htm">Form of underwriter warrant from November
              2018 follow-on offering (incorporated by reference to Exhibit 4.8 to the Company&#8217;s registration statement on Form S-1/A (File No. 333-227852), filed with the SEC on November 14, 2018).</a></div>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390018016422/f8k111618ex4-1_rewalkrob.htm">4.7</a></div>
        </td>
        <td style="width: 1%; vertical-align: bottom;"><br>
        </td>
        <td style="width: 89%; vertical-align: bottom;">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390018016422/f8k111618ex4-1_rewalkrob.htm">First Amendment to Warrant to Purchase
              Shares between the Company and Kreos Capital V (Expert Fund) Limited, dated November 20, 2018 (incorporated by reference to Exhibit 4.1 to the Company&#8217;s current report on Form 8-K filed with the SEC on November 21, 2018).</a></div>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390019003063/f8k0219ex4-1_rewalkrobo.htm">4.8</a></div>
        </td>
        <td style="width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255);"><br>
        </td>
        <td style="width: 89%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390019003063/f8k0219ex4-1_rewalkrobo.htm">Form of placement agent warrant from
              February 2019 &#8220;best efforts&#8221; public offering (incorporated by reference to Exhibit 4.1 of the Company&#8217;s Current Report on Form 8-K filed with the SEC on February 25, 2019).</a></div>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390019005819/f8k040319bex4-1_rewalk.htm">4.9</a></div>
        </td>
        <td style="width: 1%; vertical-align: top;"><br>
        </td>
        <td style="width: 89%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390019005819/f8k040319bex4-1_rewalk.htm">Form of purchaser warrant from April 2019
              registered direct offering and concurrent private placement of warrants (incorporated by reference to Exhibit 4.1 of the Company&#8217;s Current Report on Form 8-K filed with the SEC on April 5, 2019).</a></div>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390019005819/f8k040319bex4-2_rewalk.htm">4.10</a></div>
        </td>
        <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);"><br>
        </td>
        <td style="width: 89%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390019005819/f8k040319bex4-2_rewalk.htm">Form of placement agent warrant from April
              2019 registered direct offering and concurrent private placement of warrants (incorporated by reference to Exhibit 4.2 of the Company&#8217;s Current Report on Form 8-K filed with the SEC on April 5, 2019).</a></div>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390018006939/sc13d0518ex99-4tim_rewalk.htm">4.11</a></div>
        </td>
        <td style="width: 1%; vertical-align: top;"><br>
        </td>
        <td style="width: 89%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390018006939/sc13d0518ex99-4tim_rewalk.htm">Registration Rights Agreement, dated May
              15, 2018, between the Company and Timwell Corporation Limited (incorporated by reference to Exhibit 99.4 to the Schedule 13D filed by Timwell Corporation Limited with the SEC on May 29, 2018).</a></div>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390019010476/f8k060519ex4-1_rewalkrobo.htm">4.12</a></div>
        </td>
        <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);"><br>
        </td>
        <td style="width: 89%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390019010476/f8k060519ex4-1_rewalkrobo.htm">Form of private placement warrant from
              June 2019 private placement of warrants (incorporated by reference to Exhibit 4.1 of the Company&#8217;s Current Report on Form 8-K filed with the SEC on June 11, 2019).</a></div>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390019010476/f8k060519ex4-2_rewalkrobo.htm">4.13</a></div>
        </td>
        <td style="width: 1%; vertical-align: top;"><br>
        </td>
        <td style="width: 89%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390019010476/f8k060519ex4-2_rewalkrobo.htm">Form of placement agent warrant from
              June 2019 private placement of warrants (incorporated by reference to Exhibit 4.2 of the Company&#8217;s Current Report on Form 8-K filed with the SEC on June 11, 2019).</a></div>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390019010548/f8k061019bex4-1_rewalkrobo.htm">4.14</a></div>
        </td>
        <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);"><br>
        </td>
        <td style="width: 89%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390019010548/f8k061019bex4-1_rewalkrobo.htm">Form of purchaser warrant from June
              2019 registered direct offering and concurrent private placement of warrants (incorporated by reference to Exhibit 4.1 of the Company&#8217;s Current Report on Form 8-K filed with the SEC on June 12, 2019).</a></div>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390019010548/f8k061019bex4-2_rewalkrobo.htm">4.15</a></div>
        </td>
        <td style="width: 1%; vertical-align: top;"><br>
        </td>
        <td style="width: 89%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390019010548/f8k061019bex4-2_rewalkrobo.htm">Form of placement agent warrant from
              June 2019 registered direct offering and concurrent private placement of warrants (incorporated by reference to Exhibit 4.2 of the Company&#8217;s Current Report on Form 8-K filed with the SEC on June 12, 2019).</a></div>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390020003105/f8k0220ex4-1_rewalk.htm">4.16</a></div>
        </td>
        <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);"><br>
        </td>
        <td style="width: 89%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390020003105/f8k0220ex4-1_rewalk.htm">Form of common warrant from February 2020 best
              efforts offering (incorporated by reference to Exhibit 4.1 of the Company&#8217;s Current Report on Form 8-K filed with the SEC on February 10, 2020).</a></div>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390020003105/f8k0220ex4-3_rewalk.htm">4.17</a></div>
        </td>
        <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);"><br>
        </td>
        <td style="width: 89%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390020003105/f8k0220ex4-3_rewalk.htm">Form of placement agent warrant from February
              2020 best efforts offering (incorporated by reference to Exhibit 4.3 of the Company&#8217;s Current Report on Form 8-K filed with the SEC on February 10, 2020).</a></div>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000117891320001968/exhibit_4-1.htm">4.18</a></div>
        </td>
        <td style="width: 1%; vertical-align: top;"><br>
        </td>
        <td style="width: 89%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000117891320001968/exhibit_4-1.htm">Form of purchaser warrant from July 2020 registered
              direct offering (incorporated by reference to Exhibit 4.1 of the Company&#8217;s Current Report on Form 8-K filed on July 6, 2020).</a></div>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000117891320001968/exhibit_4-2.htm">4.19</a></div>
        </td>
        <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);"><br>
        </td>
        <td style="width: 89%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000117891320001968/exhibit_4-2.htm">Form of placement agent agreement from July 2020
              registered direct offering (incorporated by reference to Exhibit 4.2 of the Company&#8217;s Current Report on Form 8-K filed on July 6, 2020).</a></div>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000117891320003336/exhibit_4-1.htm">4.20</a></div>
        </td>
        <td style="width: 1%; vertical-align: top;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000117891320003336/exhibit_4-1.htm"><br>
          </a></td>
        <td style="width: 89%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000117891320003336/exhibit_4-1.htm">Form of purchaser warrant from December 2020 private
              placement (incorporated by reference to Exhibit 4.1 of the Company&#8217;s Current Report on Form 8-K filed with the SEC on December 8, 2020).</a></div>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000117891320003336/exhibit_4-2.htm">4.21</a></div>
        </td>
        <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000117891320003336/exhibit_4-2.htm"><br>
          </a></td>
        <td style="width: 89%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000117891320003336/exhibit_4-2.htm">Form of placement agent warrant from December 2020
              private placement (incorporated by reference to Exhibit 4.2 of the Company&#8217;s Current Report on Form 8-K filed with the SEC on December 8, 2020).</a></div>
        </td>
      </tr>

  </table>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;&#160;&#160;</div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">84</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  &#160;
  <table cellspacing="0" cellpadding="2" border="0" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" id="z39f3cc564a1e49fa88e5cf83ddeb92cd">

      <tr>
        <td style="width: 10.13%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="exhibit_10-1.htm">10.1</a></div>
        </td>
        <td style="width: 0.94%; vertical-align: bottom; background-color: rgb(204, 238, 255);"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000119312514265404/d724635dex101.htm"><br>
          </a></td>
        <td style="width: 88.93%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">
            <div style="text-align: left; line-height: 1.25;"><a href="exhibit_10-1.htm"><u>Letter of Agreement, dated July 11, 2013, between the Company and
                  Sanmina Corporation.^</u></a></div>
          </div>
        </td>
      </tr>
      <tr>
        <td style="width: 10.13%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000119312514265404/d724635dex102.htm">10.2</a></div>
        </td>
        <td style="width: 0.94%; vertical-align: bottom;"><br>
        </td>
        <td style="width: 88.93%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000119312514265404/d724635dex102.htm">Strategic Alliance Agreement, dated September 24,
              2013, between the Company and Yaskawa Electric Corporation (incorporated by reference to Exhibit 10.2 to the Company&#8217;s registration statement on Form F-1 (File No. 333-197344), filed with the SEC on July 10, 2014).</a></div>
        </td>
      </tr>
      <tr>
        <td style="width: 10.13%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000119312514265404/d724635dex104.htm">10.3</a></div>
        </td>
        <td style="width: 0.94%; vertical-align: bottom; background-color: rgb(204, 238, 255);"><br>
        </td>
        <td style="width: 88.93%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000119312514265404/d724635dex104.htm">Confidentiality and Non-Disclosure Agreement, dated
              September 24, 2013, between the Company and Yaskawa Electric Corporation (incorporated by reference to Exhibit 10.4 to the Company&#8217;s registration statement on Form F-1 (File No. 333-197344), filed with the SEC on July 10, 2014).</a></div>
        </td>
      </tr>
      <tr>
        <td style="width: 10.13%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000119312514265404/d724635dex105.htm">10.4</a></div>
        </td>
        <td style="width: 0.94%; vertical-align: bottom;"><br>
        </td>
        <td style="width: 88.93%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000119312514265404/d724635dex105.htm">Side Letter, dated September 30, 2013, between the
              Company and Yaskawa Electric Corporation (incorporated by reference to Exhibit 10.5 to the Company&#8217;s registration statement on Form F-1 (File No. 333-197344), filed with the SEC on July 10, 2014).</a></div>
        </td>
      </tr>
      <tr>
        <td style="width: 10.13%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000117891316003859/exhibit_10-1.htm">10.5</a></div>
        </td>
        <td style="width: 0.94%; vertical-align: bottom; background-color: rgb(204, 238, 255);"><br>
        </td>
        <td style="width: 88.93%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000117891316003859/exhibit_10-1.htm">Loan Agreement, dated December 30, 2015, between the
              Company and Kreos Capital V (Expert Fund) Limited (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on January 4, 2016).</a></div>
        </td>
      </tr>
      <tr>
        <td style="width: 10.13%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000162828017007920/rwlk10-q06302017exhibit101.htm">10.6</a></div>
        </td>
        <td style="width: 0.94%; vertical-align: bottom;"><br>
        </td>
        <td style="width: 88.93%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000162828017007920/rwlk10-q06302017exhibit101.htm">First Amendment, dated June 9, 2017, to
              the Loan Agreement, dated December 30, 2015, between ReWalk Robotics, Ltd. and Kreos Capital V (Expert Fund) Limited (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Quarterly Report on Form 10-Q filed with the SEC on August 3,
              2017).</a></div>
        </td>
      </tr>
      <tr>
        <td style="width: 10.13%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="exhibit_10-7.htm">10.7</a></div>
        </td>
        <td style="width: 0.94%; vertical-align: bottom; background-color: rgb(204, 238, 255);"><br>
        </td>
        <td style="width: 88.93%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">
            <div style="text-align: left; line-height: 1.25;"><a href="exhibit_10-7.htm"><u>Research Collaboration Agreement, dated May 16, 2016, between the
                  Company and the President and Fellows of Harvard College.^</u></a></div>
          </div>
        </td>
      </tr>
      <tr>
        <td style="width: 10.13%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="exhibit_10-8.htm">10.8</a></div>
        </td>
        <td style="width: 0.94%; vertical-align: bottom;"><br>
        </td>
        <td style="width: 88.93%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">
            <div style="text-align: left; line-height: 1.25;"><a href="exhibit_10-8.htm">License Agreement, dated May 16, 2016, between the Company and the
                President and Fellows of Harvard College.^</a></div>
          </div>
        </td>
      </tr>
      <tr>
        <td style="width: 10.13%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000119312514315654/d724635dex1011.htm">10.9</a></div>
        </td>
        <td style="width: 0.94%; vertical-align: bottom; background-color: rgb(204, 238, 255);"><br>
        </td>
        <td style="width: 88.93%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000119312514315654/d724635dex1011.htm">Form of indemnification agreement between the
              Company and each of its directors and executive officers (incorporated by reference to Exhibit 10.11 to the Company&#8217;s registration statement on Form F-1/A (File No. 333-197344), filed with the SEC on August 20, 2014).**</a></div>
        </td>
      </tr>
      <tr>
        <td style="width: 10.13%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000119312514265404/d724635dex1012.htm">10.10</a></div>
        </td>
        <td style="width: 0.94%; vertical-align: bottom;"><br>
        </td>
        <td style="width: 88.93%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000119312514265404/d724635dex1012.htm">2012 Equity Incentive Plan (incorporated by
              reference to Exhibit 10.12 to the Company&#8217;s registration statement on Form F-1 (File No. 333-197344), filed with the SEC on July 10, 2014).**</a></div>
        </td>
      </tr>
      <tr>
        <td style="width: 10.13%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000119312514265404/d724635dex1013.htm">10.11</a></div>
        </td>
        <td style="width: 0.94%; vertical-align: bottom; background-color: rgb(204, 238, 255);"><br>
        </td>
        <td style="width: 88.93%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000119312514265404/d724635dex1013.htm">2012 Israeli Equity Incentive Sub Plan
              (incorporated by reference to Exhibit 10.13 to the Company&#8217;s registration statement on Form F-1 (File No. 333-197344), filed with the SEC on July 10, 2014).**</a></div>
        </td>
      </tr>
      <tr>
        <td style="width: 10.13%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000119312514265404/d724635dex1014.htm">10.12</a></div>
        </td>
        <td style="width: 0.94%; vertical-align: bottom;"><br>
        </td>
        <td style="width: 88.93%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000119312514265404/d724635dex1014.htm">2012 U.S. Equity Incentive Sub Plan (incorporated
              by reference to Exhibit 10.14 to the Company&#8217;s registration statement on Form F-1 (File No. 333-197344), filed with the SEC on July 10, 2014).**</a></div>
        </td>
      </tr>
      <tr>
        <td style="width: 10.13%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000119312514265404/d724635dex1015.htm">10.13</a></div>
        </td>
        <td style="width: 0.94%; vertical-align: bottom; background-color: rgb(204, 238, 255);"><br>
        </td>
        <td style="width: 88.93%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000119312514265404/d724635dex1015.htm">2006 Stock Option Plan (incorporated by reference
              to Exhibit 10.15 to the Company&#8217;s registration statement on Form F-1 (File No. 333-197344), filed with the SEC on July 10, 2014).**</a></div>
        </td>
      </tr>
      <tr>
        <td style="width: 10.13%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000117891320001836/exhibit_99-1.htm">10.14</a></div>
        </td>
        <td style="width: 0.94%; vertical-align: bottom;"><br>
        </td>
        <td style="width: 88.93%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">
            <div style="line-height: 1.25;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000117891320001836/exhibit_99-1.htm">2014 Incentive Compensation Plan, as amended (incorporated by reference to Exhibit 99.1 to the Company&#8217;s registration
                statement on Form S-8 (File No. 333-239258), filed with the SEC on June 18, 2020).** </a><br>
            </div>
            <a href="https://www.sec.gov/Archives/edgar/data/1607962/000114420417056327/tv478568_ex99-1.htm"> </a></div>
        </td>
      </tr>
      <tr>
        <td style="width: 10.13%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000160796216000007/rwlk10-k12312015exhibit1016.htm">10.15</a></div>
        </td>
        <td style="width: 0.94%; vertical-align: bottom; background-color: rgb(204, 238, 255);"><br>
        </td>
        <td style="width: 88.93%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000160796216000007/rwlk10-k12312015exhibit1016.htm">Executive Employment Agreement, dated
              as of January 17, 2011, between the Company and Larry Jasinski (incorporated by reference to Exhibit 10.16 to the Company&#8217;s Annual Report on Form 10-K filed with the SEC on February 29, 2016, as amended on May 6, 2016).**</a></div>
        </td>
      </tr>
      <tr>
        <td style="width: 10.13%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000160796216000007/rwlk10-k12312015exhibit1018.htm">10.16</a></div>
        </td>
        <td style="width: 0.94%; vertical-align: bottom;"><br>
        </td>
        <td style="width: 88.93%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000160796216000007/rwlk10-k12312015exhibit1018.htm">2014 Incentive Compensation Plan Form
              of Option Award Agreement for employees and executives (incorporated by reference to Exhibit 10.18 to the Company&#8217;s Annual Report on Form 10-K filed with the SEC on February 29, 2016, as amended on May 6, 2016).**</a></div>
        </td>
      </tr>
      <tr>
        <td style="width: 10.13%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000160796216000007/rwlk10-k12312015exhibit1019.htm">10.17</a></div>
        </td>
        <td style="width: 0.94%; vertical-align: bottom; background-color: rgb(204, 238, 255);"><br>
        </td>
        <td style="width: 88.93%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000160796216000007/rwlk10-k12312015exhibit1019.htm">2014 Incentive Compensation Plan Form
              of Restricted Share Unit Award Agreement for non-Israeli employees, and executives (incorporated by reference to Exhibit 10.19 to the Company&#8217;s Annual Report on Form 10-K filed with the SEC on February 29, 2016, as amended on May 6, 2016).**</a></div>
        </td>
      </tr>
      <tr>
        <td style="width: 10.13%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390018013947/fs12018ex10-20i_rewalkrobot.htm">10.18</a></div>
        </td>
        <td style="width: 0.94%; vertical-align: bottom;"><br>
        </td>
        <td style="width: 88.93%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390018013947/fs12018ex10-20i_rewalkrobot.htm">2014 Incentive Compensation Plan Form
              of Restricted Share Unit Award Agreement for Israeli non-employee directors, employees and executives (incorporated by reference to Exhibit 10.20.1 to the Company&#8217;s registration statement on Form S-1 (File No. 333-227852), filed with the SEC
              on October 15, 2018).**</a></div>
        </td>
      </tr>
      <tr>
        <td style="width: 10.13%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390018013947/fs12018ex10-20ii_rewalkrobot.htm">10.19</a></div>
        </td>
        <td style="width: 0.94%; vertical-align: bottom; background-color: rgb(204, 238, 255);"><br>
        </td>
        <td style="width: 88.93%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390018013947/fs12018ex10-20ii_rewalkrobot.htm">2014 Incentive Compensation Plan Form
              of Restricted Share Unit Award Agreement between the Company and Jeffrey Dykan, as director (incorporated by reference to Exhibit 10.20.2 to the Company&#8217;s registration statement on Form S-1 (File No. 333-227852), filed with the SEC on October
              15, 2018).**</a></div>
        </td>
      </tr>
      <tr>
        <td style="width: 10.13%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000160796216000007/rwlk10-k12312015exhibit1020.htm">10.20</a></div>
        </td>
        <td style="width: 0.94%; vertical-align: bottom;"><br>
        </td>
        <td style="width: 88.93%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000160796216000007/rwlk10-k12312015exhibit1020.htm">2014 Incentive Compensation Plan Prior
              Form of Restricted Share Unit Award Agreement for non-Israeli non-employee directors (incorporated by reference to Exhibit 10.20 to the Company&#8217;s Annual Report on Form 10-K filed with the SEC on February 29, 2016, as amended on May 6,
              2016).**</a></div>
        </td>
      </tr>

  </table>
  <div style="line-height: 1.25;">&#160;&#160;&#160;</div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">85</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  &#160;
  <table cellspacing="0" cellpadding="2" border="0" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" id="z69acedf36bc746d2981bf18547c3d9d8">

      <tr>
        <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390018013947/fs12018ex10-22_rewalkrobot.htm">10.21</a></div>
        </td>
        <td style="width: 0.54%; vertical-align: bottom; background-color: rgb(204, 238, 255);"><br>
        </td>
        <td style="width: 89%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390018013947/fs12018ex10-22_rewalkrobot.htm">2014 Incentive Compensation Plan New
              Form of Restricted Share Unit Award Agreement for non-Israeli non-employee directors (incorporated by reference to Exhibit 10.22 to the Company&#8217;s registration statement on Form S-1 (File No. 333-227852), filed with the SEC on October 15,
              2018).**</a></div>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000160796217000006/rwlk10-k12312016exhibit1021.htm">10.22</a></div>
        </td>
        <td style="width: 0.54%; vertical-align: bottom;"><br>
        </td>
        <td style="width: 89%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000160796217000006/rwlk10-k12312016exhibit1021.htm">2014 Incentive Compensation Plan Prior
              Form of Option Award Agreement for Israeli non-employee directors (incorporated by reference to Exhibit 10.21 to the Company&#8217;s Annual Report on Form 10-K filed with the SEC on February 17, 2017, as amended on April 27, 2017).**</a></div>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000160796217000006/rwlk10-k12312016exhibit1022.htm">10.23</a></div>
        </td>
        <td style="width: 0.54%; vertical-align: bottom; background-color: rgb(204, 238, 255);"><br>
        </td>
        <td style="width: 89%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000160796217000006/rwlk10-k12312016exhibit1022.htm">2014 Incentive Compensation Plan Prior
              Form of Option Award Agreement for non-Israeli non-employee directors (incorporated by reference to Exhibit 10.22 to the Company&#8217;s Annual Report on Form 10-K filed with the SEC on February 17, 2017, as amended on April 27, 2017).**</a></div>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000162828017007920/rwlk10-q06302017exhibit102.htm">10.24</a></div>
        </td>
        <td style="width: 0.54%; vertical-align: bottom;"><br>
        </td>
        <td style="width: 89%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000162828017007920/rwlk10-q06302017exhibit102.htm">ReWalk Robotics Ltd. Compensation
              Policy for Executive Officers and Non-Executive Directors, as amended (incorporated by reference to Exhibit 10.2 of the Company&#8217;s Quarterly Report on Form 10-Q filed with the SEC on August 3, 2017).**</a></div>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000114420416100138/v439415_ex1-1.htm">10.25</a></div>
        </td>
        <td style="width: 0.54%; vertical-align: bottom; background-color: rgb(204, 238, 255);"><br>
        </td>
        <td style="width: 89%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000114420416100138/v439415_ex1-1.htm">Equity Distribution Agreement, dated May 10, 2016,
              between the Company and Piper Jaffray &amp; Co., as Agent (incorporated by reference to Exhibit 1.1 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on May 10, 2016).</a></div>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390019008098/f8k050919ex10-1_rewalk.htm">10.26</a></div>
        </td>
        <td style="width: 0.54%; vertical-align: bottom;"><br>
        </td>
        <td style="width: 89%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390019008098/f8k050919ex10-1_rewalk.htm">Amendment No. 1 to Equity Distribution
              Agreement, dated May 9, 2019, between the Company and Piper Jaffray &amp; Co., as Agent (incorporated by reference to Exhibit 10.1 to the Company&#8217;s current report on Form 8-K filed with the SEC on May 9, 2019).</a></div>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000160796218000007/rwlk10-k12312017exhibit1026.htm">10.27</a></div>
        </td>
        <td style="width: 0.54%; vertical-align: bottom; background-color: rgb(204, 238, 255);"><br>
        </td>
        <td style="width: 89%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000160796218000007/rwlk10-k12312017exhibit1026.htm">Employment Agreement, dated as of
              January 15, 2013, between the Company and Ofir Koren (incorporated by reference to Exhibit 10.26 to the Company&#8217;s annual report on Form 10-K filed with the SEC on March 8, 2018).**</a></div>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390018002652/f8k0318ex10-1_rewalk.htm">10.28</a></div>
        </td>
        <td style="width: 0.54%; vertical-align: bottom;"><br>
        </td>
        <td style="width: 89%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390018002652/f8k0318ex10-1_rewalk.htm">Amendment to Employment Agreement, dated
              March 1, 2018, between the Company and Ori Gon (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K, filed with the SEC on March 7, 2018).**</a></div>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390018002652/f8k0318ex10-2_rewalk.htm">10.29</a></div>
        </td>
        <td style="width: 0.54%; vertical-align: bottom; background-color: rgb(204, 238, 255);"><br>
        </td>
        <td style="width: 89%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390018002652/f8k0318ex10-2_rewalk.htm">Employment Agreement, dated May 25, 2015,
              between the Company and Ori Gon (incorporated by reference to Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K, filed with the SEC on March 7, 2018).**</a></div>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390018003384/f8k0318bex10-1_rewalk.htm">10.30</a></div>
        </td>
        <td style="width: 0.54%; vertical-align: bottom;"><br>
        </td>
        <td style="width: 89%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390018003384/f8k0318bex10-1_rewalk.htm">Investment Agreement, dated March 6, 2018,
              by and between the Company and Timwell Corporation Limited (incorporated by reference to Exhibit 10.1 of the Company&#8217;s Current Report on Form 8-K filed with the SEC on March 23, 2018).*</a></div>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390018003384/f8k0318bex10-2_rewalk.htm">10.31</a></div>
        </td>
        <td style="width: 0.54%; vertical-align: bottom; background-color: rgb(204, 238, 255);"><br>
        </td>
        <td style="width: 89%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390018003384/f8k0318bex10-2_rewalk.htm">Framework Agreement Regarding a Potential
              Joint Venture, dated March 6, 2018, between the Company and RealCan Ambrum Healthcare Industry Investment (Shenzhen) Partnership Enterprise (Limited Partnership) (incorporated by reference to Exhibit 10.2 of the Company&#8217;s Current Report on
              Form 8-K filed with the SEC on March 23, 2018).*</a></div>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390018006939/sc13d0518ex99-3tim_rewalk.htm">10.32</a></div>
        </td>
        <td style="width: 0.54%; vertical-align: bottom;"><br>
        </td>
        <td style="width: 89%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390018006939/sc13d0518ex99-3tim_rewalk.htm">Amendment No. 1 to Investment Agreement,
              dated May 15, 2018, between the Company and Timwell Corporation Limited (incorporated by reference to Exhibit 99.3 to the Schedule 13D filed by Timwell Corporation Limited with the SEC on May 29, 2018).</a></div>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390018008531/f8k062918ex10-1_rewalkrobot.htm">10.33</a></div>
        </td>
        <td style="width: 0.54%; vertical-align: bottom; background-color: rgb(204, 238, 255);"><br>
        </td>
        <td style="width: 89%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390018008531/f8k062918ex10-1_rewalkrobot.htm">Amendment No. 1 to the Research
              Collaboration Agreement, dated May 1, 2017, between the Company and the President and Fellows of Harvard College (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on June 29, 2018).*</a></div>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390018008531/f8k062918ex10-2_rewalkrobot.htm">10.34</a></div>
        </td>
        <td style="width: 0.54%; vertical-align: bottom;"><br>
        </td>
        <td style="width: 89%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390018008531/f8k062918ex10-2_rewalkrobot.htm">Amendment No. 1 to the Exclusive
              License Agreement and Amendment No. 2 to the Research Collaboration Agreement, dated April 1, 2018, between the Company and the President and Fellows of Harvard College (incorporated by reference to Exhibit 10.2 to the Company&#8217;s Current
              Report on Form 8-K filed with the SEC on June 29, 2018).*</a></div>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390018013947/fs12018ex10-38_rewalkrobot.htm">10.35</a></div>
        </td>
        <td style="width: 0.54%; vertical-align: bottom; background-color: rgb(204, 238, 255);"><br>
        </td>
        <td style="width: 89%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390018013947/fs12018ex10-38_rewalkrobot.htm">Waiver, dated September 3, 2018,
              between the Company and Kreos Capital V (Expert Fund) L.P. (incorporated by reference to Exhibit 10.38 to the Company&#8217;s registration statement on Form S-1 (File No. 333-227852), filed with the SEC on October 15, 2018).</a></div>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390018016422/f8k111618ex10-1_rewalkrob.htm">10.36</a></div>
        </td>
        <td style="width: 0.54%; vertical-align: bottom;"><br>
        </td>
        <td style="width: 89%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390018016422/f8k111618ex10-1_rewalkrob.htm">Second Amendment to Loan Agreement
              between the Company and Kreos Capital V (Expert Fund) Limited, dated November 20, 2018 (incorporated by reference to Exhibit 10.1 to the Company&#8217;s current report on Form 8-K filed with the SEC on November 21, 2018).</a></div>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390019003063/f8k0219ex10-1_rewalkrobo.htm">10.37</a></div>
        </td>
        <td style="width: 0.54%; vertical-align: top; background-color: rgb(204, 238, 255);"><br>
        </td>
        <td style="width: 89%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390019003063/f8k0219ex10-1_rewalkrobo.htm">Form of securities purchase agreement
              from February 2019 &#8220;best efforts&#8221; public offering (incorporated by reference to Exhibit 10.1 of the Company&#8217;s Current Report on Form 8-K filed on February 25, 2019).</a></div>
        </td>
      </tr>

  </table>
  <div style="line-height: 1.25;">&#160;&#160;</div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">86</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  &#160;
  <table cellspacing="0" cellpadding="2" border="0" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" id="z3c1a43a294d54115857a51a3c4959b86">

      <tr>
        <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390019005819/f8k040319bex10-1_rewalk.htm">10.38</a></div>
        </td>
        <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);"> <br>
        </td>
        <td style="width: 89%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
          <div style="text-align: justify; line-height: 1.25;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390019005819/f8k040319bex10-1_rewalk.htm"> </a>
            <div style="line-height: 1.25;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390019005819/f8k040319bex10-1_rewalk.htm">Form of securities purchase agreement from April 2019 registered direct offering and concurrent private
                placement of warrants (incorporated by reference to Exhibit 10.1 of the Company&#8217;s Current Report on Form 8-K filed on April 5, 2019).</a></div>
          </div>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390019010476/f8k060519ex10-1_rewalkrobo.htm">10.39</a></div>
        </td>
        <td style="width: 1%; vertical-align: top;"> <br>
        </td>
        <td style="width: 89%; vertical-align: bottom;">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390019010476/f8k060519ex10-1_rewalkrobo.htm">Form of warrant exercise agreement from
              June 2019 private placement of warrants (incorporated by reference to Exhibit 10.1 of the Company&#8217;s Current Report on Form 8-K filed with the SEC on June 11, 2019).</a></div>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390019010548/f8k061019bex10-1_rewalkrobo.htm">10.40</a></div>
        </td>
        <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);"> <br>
        </td>
        <td style="width: 89%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390019010548/f8k061019bex10-1_rewalkrobo.htm">Form of securities purchase agreement
              from June 2019 registered direct offering and concurrent private placement of warrants (incorporated by reference to Exhibit 10.1 of the Company&#8217;s Current Report on Form 8-K filed with the SEC on June 12, 2019).</a></div>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390020003105/f8k0220ex10-1_rewalk.htm">10.41</a></div>
        </td>
        <td style="width: 1%; vertical-align: top;"> <br>
        </td>
        <td style="width: 89%; vertical-align: bottom;">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390020003105/f8k0220ex10-1_rewalk.htm">Form of securities purchase agreement from
              February 2020 best efforts offering (incorporated by reference to Exhibit 10.1 of the Company&#8217;s Current Report on Form 8-K filed with the SEC on February 10, 2020) for the units offered hereby.^</a></div>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390020003105/f8k0220ex10-2_rewalk.htm">10.42</a></div>
        </td>
        <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);"> <br>
        </td>
        <td style="width: 89%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390020003105/f8k0220ex10-2_rewalk.htm">Amendment No. 1 to the Securities Purchase
              Agreement, dated February 7, 2020, by and among the Company and the purchasers party thereto (incorporated by reference to Exhibit 10.2 of the Company&#8217;s Current Report on Form 8-K filed with the SEC on February 10, 2020).^</a></div>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000117891320001968/exhibit_10-1.htm">10.43</a></div>
        </td>
        <td style="width: 1%; vertical-align: top;"><br>
        </td>
        <td style="width: 89%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000117891320001968/exhibit_10-1.htm">Form of securities purchase agreement from July 2020
              registered direct offering (incorporated by reference to Exhibit 10.1 of the Company&#8217;s Current Report on Form 8-K filed on July 6, 2020).</a></div>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000117891320001968/exhibit_10-2.htm">10.44</a></div>
        </td>
        <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);"><br>
        </td>
        <td style="width: 89%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000117891320001968/exhibit_10-2.htm">Engagement Letter, dated June 2, 2020, between the
              Company and H.C. Wainwright &amp; Co., LLC from July 2020 registered direct offering (incorporated by reference to Exhibit 10.2 of the Company&#8217;s Current Report on Form 8-K filed on July 6, 2020).</a></div>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000117891320003336/exhibit_10-1.htm">10.45</a></div>
        </td>
        <td style="width: 1%; vertical-align: top;"><br>
        </td>
        <td style="width: 89%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000117891320003336/exhibit_10-1.htm">Form of securities purchase agreement from December
              2020 private placement, by and among the Company and the purchasers party thereto (incorporated by reference to Exhibit 10.1 of the Company&#8217;s Current Report on Form 8-K filed with the SEC on December 8, 2020).^#</a></div>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000117891320003336/exhibit_10-2.htm">10.46</a></div>
        </td>
        <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);"><br>
        </td>
        <td style="width: 89%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000117891320003336/exhibit_10-2.htm">Form of registration rights agreement from December
              2020 private placement (incorporated by reference to Exhibit 10.2 of the Company&#8217;s Current Report on Form 8-K filed with the SEC on December 8, 2020).</a></div>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000117891320003336/exhibit_10-3.htm">10.47</a></div>
        </td>
        <td style="width: 1%; vertical-align: top;"><br>
        </td>
        <td style="width: 89%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000117891320003336/exhibit_10-3.htm">Engagement Letter, dated December 2, 2020, by and
              among the Company and H.C. Wainwright &amp; Co., LLC (incorporated by reference to Exhibit 10.3 of the Company&#8217;s Current Report on Form 8-K filed with the SEC on December 8, 2020).^</a></div>
        </td>
      </tr>
      <tr>
        <td rowspan="1" style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000117891320001992/exhibit_10-34.htm">10.48</a></div>
        </td>
        <td rowspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);"><br>
        </td>
        <td rowspan="1" style="width: 89%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="text-align: justify; line-height: 1.25;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000117891320001992/exhibit_10-34.htm"><u>Amendment No. 3 to the Research Collaboration Agreement, dated April 30, 2020, between the
                Company and the President and Fellows of Harvard College (incorporated by reference to Exhibit 10.34 to the Company&#8217;s Registration Statement on Form S-1 (File No. 333-239733) filed with the SEC on July 7, 2020).^</u></a></div>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390018015029/fs12018a1ex21-1_rewalk.htm">21.1</a></div>
        </td>
        <td style="width: 1%; vertical-align: bottom;"> <br>
        </td>
        <td style="width: 89%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390018015029/fs12018a1ex21-1_rewalk.htm">List of subsidiaries of the Company
              (incorporated by reference to Exhibit 21.1 to the Company&#8217;s registration statement on Form S-1/A (File No. 333-227852), filed with the SEC on November 7, 2018).</a></div>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="exhibit_23-1.htm">23.1</a></div>
        </td>
        <td style="width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255);"> <br>
        </td>
        <td style="width: 89%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="exhibit_23-1.htm">Consent of Kost Forer
              Gabbay &amp; Kasierer, a member of Ernst &amp; Young Global Limited.</a></div>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top;">
          <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="exhibit_31-1.htm">31.1</a></div>
        </td>
        <td style="width: 1%; vertical-align: middle;"> <br>
        </td>
        <td style="width: 89%; vertical-align: top;">
          <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="exhibit_31-1.htm">Certification of Principal Executive Officer
              pursuant to Section 302 of the Sarbanes-Oxley Act 2002.</a></div>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="exhibit_31-2.htm">31.2</a></div>
        </td>
        <td style="width: 1%; vertical-align: middle; background-color: rgb(204, 238, 255);"> <br>
        </td>
        <td style="width: 89%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="exhibit_31-2.htm">Certification of Principal Financial Officer
              pursuant to Section 302 of the Sarbanes-Oxley Act 2002.</a></div>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top;">
          <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="exhibit_32-1.htm">32.1</a></div>
        </td>
        <td style="width: 1%; vertical-align: middle;"> <br>
        </td>
        <td style="width: 89%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="exhibit_32-1.htm">Certification of Principal
              Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.***</a></div>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="exhibit_32-2.htm">32.2</a></div>
        </td>
        <td style="width: 1%; vertical-align: middle; background-color: rgb(204, 238, 255);"> <br>
        </td>
        <td style="width: 89%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="exhibit_32-2.htm">Certification of Principal
              Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.***</a></div>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top;">
          <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">101.INS</div>
        </td>
        <td style="width: 1%; vertical-align: top;">
          <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#160;</div>
        </td>
        <td style="width: 89%; vertical-align: top;">
          <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">XBRL Instance Document.</div>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">101.SCH</div>
        </td>
        <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#160;</div>
        </td>
        <td style="width: 89%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">XBRL Taxonomy Extension Schema Document.</div>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top;">
          <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">101.PRE</div>
        </td>
        <td style="width: 1%; vertical-align: top;">
          <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#160;</div>
        </td>
        <td style="width: 89%; vertical-align: top;">
          <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">XBRL Taxonomy Presentation Linkbase Document.</div>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">101.CAL</div>
        </td>
        <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#160;</div>
        </td>
        <td style="width: 89%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">XBRL Taxonomy Calculation Linkbase Document.</div>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top;">
          <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">101.LAB</div>
        </td>
        <td style="width: 1%; vertical-align: top;">
          <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#160;</div>
        </td>
        <td style="width: 89%; vertical-align: top;">
          <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">XBRL Taxonomy Label Linkbase Document.</div>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">101.DEF</div>
        </td>
        <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#160;</div>
        </td>
        <td style="width: 89%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">XBRL Taxonomy Extension Definition Linkbase Document.</div>
        </td>
      </tr>

  </table>
  <div style="text-align: justify; line-height: 1.25;">&#160;&#160;</div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z3a3cd019972248f2b2f4a761358cc325">

      <tr>
        <td style="width: 5.45%; vertical-align: top;">
          <div style="line-height: 1.25;">*</div>
        </td>
        <td style="width: 94.55%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25;">Portions of the agreement were omitted and a complete copy of the agreement has been provided separately to the Securities and Exchange Commission pursuant to the Company&#8217;s application
            requesting confidential treatment under, as applicable, Rule&#160;406&#160;of the&#160;Securities Act of 1933, as amended and/or Rule&#160;24b-2&#160;of the&#160;Securities Exchange Act of 1934, as amended, which application was subsequently granted.</div>
        </td>
      </tr>
      <tr>
        <td style="width: 5.45%; vertical-align: top;">
          <div style="line-height: 1.25;">**</div>
        </td>
        <td style="width: 94.55%; vertical-align: top;">
          <div style="line-height: 1.25;">Management contract or compensatory plan, contract or arrangement.</div>
        </td>
      </tr>
      <tr>
        <td style="width: 5.45%; vertical-align: top;">
          <div style="line-height: 1.25;">***</div>
        </td>
        <td style="width: 94.55%; vertical-align: top;">
          <div style="line-height: 1.25;">Furnished herewith.</div>
        </td>
      </tr>
      <tr>
        <td style="width: 5.45%; vertical-align: top;">
          <div style="line-height: 1.25;">^</div>
        </td>
        <td style="width: 94.55%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25;">Portions of this exhibit (indicated by asterisks) have been omitted under rules of the U.S. Securities and Exchange Commission permitting the confidential treatment of select information.</div>
        </td>
      </tr>
      <tr>
        <td style="width: 5.45%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25;">#</div>
        </td>
        <td style="width: 94.55%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25;">The schedules to this exhibit have been omitted pursuant to Item 601(a)(5) of Regulation S-K.</div>
        </td>
      </tr>

  </table>
  <div style="text-align: center; line-height: 1.25;">&#160;&#160;</div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">87</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <br>
  <div style="text-align: center; line-height: 1.25;">&#160;&#160;</div>
  <div style="text-align: center; line-height: 1.25; font-weight: bold;">REWALK ROBOTICS LTD</div>
  <div style="text-align: center; line-height: 1.25;">&#160;</div>
  <div style="text-align: center; line-height: 1.25; font-weight: bold;">CONSOLIDATED FINANCIAL STATEMENTS</div>
  <div style="text-align: center; line-height: 1.25;">&#160;</div>
  <div style="text-align: center; line-height: 1.25; font-weight: bold;">U.S. DOLLARS IN THOUSANDS</div>
  <div style="text-align: center; line-height: 1.25;">&#160;</div>
  <div style="text-align: center; line-height: 1.25; font-weight: bold;"><a name="INDEX"><!--Anchor--></a>INDEX</div>
  <div style="line-height: 1.25;">&#160;</div>
  <table cellspacing="0" cellpadding="2" border="0" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" id="z76cdb7de084e42fab452168e62076fa3">

      <tr>
        <td style="width: 90%; vertical-align: bottom; padding-bottom: 2px;">
          <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#160;</div>
        </td>
        <td style="width: 10%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Page</div>
        </td>
      </tr>
      <tr>
        <td style="width: 90%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="#REPORT">Report of Registered Public Accounting Firm</a></div>
        </td>
        <td style="width: 10%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
          <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">F-2</div>
        </td>
      </tr>
      <tr>
        <td style="width: 90%; vertical-align: top;">
          <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="#BALANCE">Consolidated Balance Sheets</a></div>
        </td>
        <td style="width: 10%; vertical-align: bottom;">
          <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">F-3</div>
        </td>
      </tr>
      <tr>
        <td style="width: 90%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="#STATEMENTS">Consolidated Statements of Operations</a></div>
        </td>
        <td style="width: 10%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
          <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">F-5</div>
        </td>
      </tr>
      <tr>
        <td style="width: 90%; vertical-align: top;">
          <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="#EQUITY">Statements of Changes in Shareholders&#8217; Equity</a></div>
        </td>
        <td style="width: 10%; vertical-align: bottom;">
          <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">F-6</div>
        </td>
      </tr>
      <tr>
        <td style="width: 90%; vertical-align: top; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="#CASH">Consolidated Statements of Cash Flows</a></div>
        </td>
        <td style="width: 10%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
          <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">F-7</div>
        </td>
      </tr>
      <tr>
        <td style="width: 90%; vertical-align: top;">
          <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="#NOTE">Notes to Consolidated Financial Statements</a></div>
        </td>
        <td style="width: 10%; vertical-align: bottom;">
          <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">F-9</div>
        </td>
      </tr>

  </table>
  <div style="line-height: 1.25;">&#160;&#160;</div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <!--PROfilePageNumberReset%Num%2%F - %%-->&#160;
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z8ada268fdd194a2693737d68e07b131b">

      <tr>
        <td style="width: 20%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;<img width="53" height="63" src="image5.jpg"></div>
        </td>
        <td style="width: 30%; vertical-align: bottom;">
          <div style="line-height: 1.25;"><font style="font-weight: bold;">Kost&#160;Forer&#160;Gabbay&#160;&amp;&#160;Kasierer</font><br>
            2 Pal-Yam Blvd.<br>
            Haifa 3309502, Israel</div>
        </td>
        <td style="width: 50%; vertical-align: bottom;">
          <div style="text-align: right; line-height: 1.25;">Tel: +972-4-8654000<br>
            Fax: +972-3-5633439<br>
            ey.com</div>
        </td>
      </tr>

  </table>
  <div style="line-height: 1.25;">&#160;</div>
  <div style="text-align: center; line-height: 1.25; font-weight: bold;"><a name="REPORT"><!--Anchor--></a>REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</div>
  <div style="text-align: center; line-height: 1.25;">&#160;</div>
  <div style="text-align: center; line-height: 1.25; font-weight: bold;">To the Shareholders and Board of Directors of</div>
  <div style="text-align: center; line-height: 1.25;">&#160;</div>
  <div style="text-align: center; line-height: 1.25; font-weight: bold;">REWALK ROBOTICS LTD.</div>
  <div style="text-align: center; line-height: 1.25; font-weight: bold;">&#160;</div>
  <div style="line-height: 1.25; font-weight: bold;">Opinion on the Financial Statements</div>
  <div style="text-align: justify; line-height: 1.25;">
    <div style="line-height: 1.25;">We have audited the accompanying consolidated balance sheets of Rewalk Robotics Ltd. (the &#8220;Company&#8221;) as of December 31, 2020 and 2019, and the related consolidated statements of operations, changes in shareholders&#8217;
      equity and cash flows for each of the three years in the period ended December 31, 2020, and the related notes (collectively referred to as the &#8220;Consolidated financial statements&#8221;). In our opinion, the consolidated financial statements present
      fairly, in all material respects, the financial position of the Company at December 31, 2020 and 2019, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2020, in conformity with U.S.
      generally accepted accounting principles.</div>
  </div>
  <div style="line-height: 1.25; font-weight: bold;">&#160;</div>
  <div style="line-height: 1.25; font-weight: bold;">Basis for Opinion</div>
  <div style="text-align: justify; line-height: 1.25;">
    <div style="line-height: 1.25;">These financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audits. We are a public accounting firm
      registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the
      Securities and Exchange Commission and the PCAOB.</div>
  </div>
  <div style="text-align: justify; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; line-height: 1.25;">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements
    are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an
    understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.&#160;</div>
  <div style="line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; line-height: 1.25;">Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks.
    Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as
    evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</div>
  <div style="text-align: justify; line-height: 1.25;"> <br>
  </div>
  <div style="text-align: justify; line-height: 1.25;">
    <div style="text-align: left; line-height: 1.25; font-weight: bold;">Critical Audit Matter</div>
    <div style="line-height: 1.25;">The critical audit matter communicated below is a matter arising from the current period audit of the financial statements that was communicated or required to be communicated to the audit committee and that (1) relates
      to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matter does not alter in any way our opinion on the
      consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing separate opinions on the critical audit matter or on the account or disclosure to which they relate.</div>
    <div style="line-height: 1.25;"> <br>
    </div>
    <div style="line-height: 1.25;">
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;" id="z4ba8d6e9efc6457eba9eed70ada192fd">

          <tr>
            <td style="width: 30%;" rowspan="1">&#160;</td>
            <td style="width: 70%;" rowspan="1">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">Revenue recognition</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%;" rowspan="1">&#160;</td>
            <td style="width: 70%;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 30%; text-align: left; vertical-align: top;">
              <div>
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-style: italic;">Description of the Matter</div>
              </div>
            </td>
            <td style="width: 70%;">
              <div>
                <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">As described in Note 2 to the consolidated financial statements, the Company generates revenues from sales of products. Revenue is recognized
                  when obligations under the terms of a contract with the Company customer are satisfied. Revenue is measured as the amount of consideration to which the Company expects to be entitled in exchange for transferring products or providing
                  services.&#160;In addition, the Company provides a service type warranty which is accounted for as a separate performance obligation. Revenue is then recognized ratably over the life of the warranty.</div>
                <div style="line-height: 1.25;"><br style="line-height: 1.25;">
                </div>
                <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Auditing the Company&#8217;s revenue recognition involves subjective assumptions used in determining the standalone selling price of distinct
                  performance obligations.</div>
              </div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; text-align: left; vertical-align: top;" rowspan="1">&#160;</td>
            <td style="width: 70%;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 30%; text-align: left; vertical-align: top;" rowspan="1">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-style: italic;">How We Addressed the Matter in Our Audit</div>
            </td>
            <td style="width: 70%;" rowspan="1">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
                <div style="line-height: 1.25;">Our audit procedures included, among others, reading the executed contract and purchase order to understand the contract, identify the performance obligations and evaluate management&#8217;s identification of the
                  distinct performance obligations for a sample of contracts. To test the management&#8217;s determination of standalone selling prices for each performance obligation, our audit procedures included, among others, evaluating the methodology
                  applied and testing the calculations as well as the completeness and accuracy of the underlying data and assumptions used by the Company in its estimates. We also evaluated the Company&#8217;s disclosures included in notes to the consolidated
                  financial statements.</div>
              </div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25;"><br>
    </div>
  </div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z3cd44968df804e05af3bf1bf12616bbf">

      <tr>
        <td style="width: 100%; vertical-align: bottom;">
          <div style="line-height: 1.25;">
            <div style="line-height: 1.25;">/s/ KOST FORER GABBAY &amp; KASIERER</div>
          </div>
        </td>
      </tr>
      <tr>
        <td style="width: 100%; vertical-align: bottom;">
          <div style="line-height: 1.25;">A Member of Ernst &amp; Young Global</div>
        </td>
      </tr>
      <tr>
        <td style="width: 100%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
      </tr>
      <tr>
        <td style="width: 100%; vertical-align: bottom;">
          <div style="line-height: 1.25;">We have served as the Company&#8217;s auditor since 2014.</div>
        </td>
      </tr>
      <tr>
        <td style="width: 100%; vertical-align: top;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
      </tr>
      <tr>
        <td style="width: 100%; vertical-align: top;">
          <div style="line-height: 1.25;">Haifa, Israel</div>
        </td>
      </tr>
      <tr>
        <td style="width: 100%; vertical-align: bottom;">
          <div style="line-height: 1.25;">February 18, 2021</div>
        </td>
      </tr>

  </table>
  <div style="text-align: justify; line-height: 1.25;">&#160;&#160;</div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">F - 2</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  &#160;
  <div style="line-height: 1.25;">
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">REWALK ROBOTICS LTD. AND SUBSIDIARIES</div>
  </div>
  <div style="line-height: 1.25; font-weight: bold;">CONSOLIDATED <a name="BALANCE"><!--Anchor--></a>BALANCE SHEETS&#160;</div>
  <div style="line-height: 1.25; font-weight: bold;">U.S. dollars in thousands</div>
  <div style="line-height: 1.25;">&#160;&#160;</div>
  <table cellspacing="0" cellpadding="0" id="z9a1fe77e252a49afab7ead7ee19bf146" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;">

      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">December 31,</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;"> 2020</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">2019</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
          <div style="text-align: center; line-height: 1.25;">ASSETS</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom;">
          <div style="line-height: 1.25;">CURRENT ASSETS:</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 76%;">
          <div style="line-height: 1.25;">Cash and cash equivalents</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">20,350</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">16,253</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 76%;">
          <div style="line-height: 1.25;">Trade receivable, net</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">684</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">794</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 76%;">
          <div style="line-height: 1.25;">Prepaid expenses and other current assets</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">672</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">903</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">Inventories</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">3,542</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">3,123</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 76%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">Total current assets</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
          <div style="line-height: 1.25;">25,248</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
          <div style="line-height: 1.25;">21,073</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 76%;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 76%;">
          <div style="line-height: 1.25;">LONG-TERM ASSETS</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 76%;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 76%;">
          <div style="line-height: 1.25;">Restricted cash and other long term assets</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">1,033</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">1,061</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 76%;">
          <div style="line-height: 1.25;">Operating lease right-of-use assets</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">1,349</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">1,737</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 76%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">Property and equipment, net</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
          <div style="line-height: 1.25;">437</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
          <div style="line-height: 1.25;">501</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">Total long-term assets</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">2,819</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">3,299</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 76%;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">Total assets</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">28,067</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">24,372</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
      </tr>

  </table>
  <div style="line-height: 1.25;">&#160;&#160;</div>
  <div style="line-height: 1.25;">The accompanying notes are an integral part of these consolidated financial statements.</div>
  <div style="line-height: 1.25;">&#160;&#160;</div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">F - 3</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <br>
  <div style="line-height: 1.25; font-weight: bold;">REWALK ROBOTICS LTD. AND SUBSIDIARIES</div>
  <div style="line-height: 1.25; font-weight: bold;">CONSOLIDATED BALANCE SHEETS&#160;</div>
  <div style="line-height: 1.25; font-weight: bold;">U.S. dollars in thousands (except share and per share data)</div>
  <div style="line-height: 1.25;">&#160;</div>
  <table cellspacing="0" cellpadding="0" id="z6406b0fd6a6c41c093222c7371836be1" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;">

      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">December 31,</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;"> 2020</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">2019</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
          <div style="text-align: center; line-height: 1.25;">LIABILITIES AND SHAREHOLDERS&#8217; EQUITY</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom;">
          <div style="line-height: 1.25;">CURRENT LIABILITIES:</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 76%;">
          <div style="line-height: 1.25;">Current maturities of long-term loan</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">5,438</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 76%;">
          <div style="line-height: 1.25;">Current maturities of operating leases liability</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">660</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">637</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 76%;">
          <div style="line-height: 1.25;">Trade payables</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">2,268</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">2,698</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 76%;">
          <div style="line-height: 1.25;">Employees and payroll accruals</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">867</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">670</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 76%;">
          <div style="line-height: 1.25;">Deferred revenues</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">441</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">323</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">Other current liabilities</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">432</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">402</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 76%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">Total current liabilities</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
          <div style="line-height: 1.25;">4,668</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
          <div style="line-height: 1.25;">10,168</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 76%;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 76%;">
          <div style="line-height: 1.25;">LONG-TERM LIABILITIES</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 76%;">
          <div style="line-height: 1.25;">Long term loan, net of current maturities</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">1,527</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 76%;">
          <div style="line-height: 1.25;">Deferred revenues</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">667</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">521</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 76%;">
          <div style="line-height: 1.25;">Non-current operating leases liability</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">923</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">1,315</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 76%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">Other long-term liabilities</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">35</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">61</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">Total long-term liabilities</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">1,625</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">3,424</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">Total liabilities</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">6,293</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">13,592</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 76%;">
          <div style="line-height: 1.25;">COMMITMENTS AND CONTINGENT LIABILITIES</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25; margin-left: 9pt;">Shareholders&#8217; equity:</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 76%;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25; margin-left: 9pt;">Share capital</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 76%;">
          <div style="line-height: 1.25; margin-left: 18pt;">Ordinary share of NIS 0.25 par value-Authorized: 60,000,000 shares at December 31, 2020 and 2019; Issued and outstanding: 25,332,225 and 7,319,560 shares at December 31, 2020 and December 31,
            2019, respectively</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">1,827</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">504</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">Additional paid-in capital</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">201,392</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">178,745</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">Accumulated deficit</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">(181,445</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">(168,469</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">)</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">Total shareholders&#8217; equity</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">21,774</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">10,780</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">Total liabilities and shareholders&#8217; equity</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">28,067</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">24,372</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
      </tr>

  </table>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="line-height: 1.25;">The accompanying notes are an integral part of these consolidated financial statements.</div>
  <div style="text-align: justify; line-height: 1.25;">&#160;&#160;</div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">F - 4</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <br>
  <div style="line-height: 1.25; font-weight: bold;">REWALK ROBOTICS LTD. AND SUBSIDIARIES</div>
  <div style="line-height: 1.25; font-weight: bold;">CONSOLIDATED <a name="STATEMENTS"><!--Anchor--></a>STATEMENTS OF OPERATIONS&#160;</div>
  <div style="line-height: 1.25; font-weight: bold;">U.S. dollars in thousands (except share and per share data)</div>
  <div style="line-height: 1.25;">&#160;</div>
  <table cellspacing="0" cellpadding="0" id="z825f5580f10747ca875f0c1dd204dd41" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;">

      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="10" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">Year ended December 31,</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;"> 2020</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">2019</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">2018</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 64%;">
          <div style="line-height: 1.25;">Revenues</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">4,393</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">4,873</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">6,545</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">Cost of revenues</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">2,204</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">2,147</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">3,720</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 64%;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">Gross profit</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">2,189</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">2,726</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">2,825</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 64%;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 64%;">
          <div style="line-height: 1.25;">Operating expenses:</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 64%;">
          <div style="line-height: 1.25;">Research and development, net</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">3,459</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">5,348</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">7,349</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 64%;">
          <div style="line-height: 1.25;">Sales and marketing</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">5,754</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">6,167</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">7,897</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 64%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">General and administrative</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
          <div style="line-height: 1.25;">4,980</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
          <div style="line-height: 1.25;">5,259</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
          <div style="line-height: 1.25;">6,793</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 64%;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 64%;">
          <div style="line-height: 1.25;">Total operating expenses</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">14,193</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">16,774</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">22,039</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 64%;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 64%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">Operating loss</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
          <div style="line-height: 1.25;">(12,004</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
          <div style="line-height: 1.25;">(14,048</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
          <div style="line-height: 1.25;">(19,214</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">)</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 64%;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 64%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">Financial expenses, net</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
          <div style="line-height: 1.25;">921</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
          <div style="line-height: 1.25;">1,496</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
          <div style="line-height: 1.25;">2,466</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 64%;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 64%;">
          <div style="line-height: 1.25;">Loss before income taxes</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">(12,925</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">(15,544</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">(21,680</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">)</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">Taxes on income (tax benefit)&#160;&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">51</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">7</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">(5</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">)</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 64%;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">Net loss</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">(12,976</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">(15,551</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">(21,675</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">)</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 64%;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">Net loss per ordinary share, basic and diluted</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">(0.82</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">(2.70</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">(14.72</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">)</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 64%;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">Weighted average number of shares used in computing net loss per ordinary share, basic and diluted</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">15,764,980</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">5,763,317</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">1,472,499</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
      </tr>

  </table>
  <div style="text-align: justify; line-height: 1.25;">&#160;</div>
  <div style="line-height: 1.25;">The accompanying notes are an integral part of these consolidated financial statements.</div>
  <div style="line-height: 1.25;">&#160;&#160;</div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">F - 5</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <br>
  <div style="line-height: 1.25; font-weight: bold;">REWALK ROBOTICS LTD. AND SUBSIDIARIES</div>
  <div style="line-height: 1.25; font-weight: bold;">STATEMENTS OF CHANGES IN SHAREHOLDERS&#8217; <a name="EQUITY"><!--Anchor--></a>EQUITY</div>
  <div style="line-height: 1.25; font-weight: bold;">U.S. dollars in thousands (except share data)</div>
  <div style="line-height: 1.25;">&#160;&#160;</div>
  <table cellspacing="0" cellpadding="0" id="ze3bf8689985e423eb881d588b4025710" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;">

      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">Ordinary Share</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">Additional<br>
            paid-in</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">Accumulated</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">Total<br>
            shareholders&#8217;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">Number</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">Amount</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">capital</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">deficit</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">equity</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 40%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">Balance as of December 31, 2017</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">1,200,146</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">84</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">134,843</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">(131,220</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">3,707</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 40%;">
          <div style="line-height: 1.25; text-indent: -9pt; margin-left: 9pt;">Cumulative effect to accumulated deficit from adoption of a new accounting standard</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">(23</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">(23</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">)</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 40%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25; text-indent: -9pt; margin-left: 9pt;">Share-based compensation to employees and non-employees</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">2,766</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">2,766</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 40%;">
          <div style="line-height: 1.25; text-indent: -9pt; margin-left: 9pt;">Issuance of ordinary shares upon exercise of options to purchase ordinary shares and RSUs by employees and non-employees</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">17,181</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">*</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 40%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25; text-indent: -9pt; margin-left: 9pt;">Issuance of ordinary shares in investing agreement, net of issuance expenses in an amount of $830 (1)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">164,715</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">12</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">4,283</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">4,295</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 40%;">
          <div style="line-height: 1.25; text-indent: -9pt; margin-left: 9pt;">Issuance of ordinary shares in at-the-market offering, net of issuance expenses in the amount of $236 (1)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">49,882</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">4</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">1,113</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">1,117</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 40%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25; text-indent: -9pt; margin-left: 9pt;">Issuance of ordinary shares, warrants and pre-funded warrants in follow-on public offering, net of issuance expenses in an amount of $1,505 (1)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">728,019</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">49</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">11,528</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">11,577</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 40%;">
          <div style="line-height: 1.25; text-indent: -9pt; margin-left: 9pt;">Modification of warrants to purchase ordinary shares (2)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">18</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">18</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 40%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25; text-indent: -9pt; margin-left: 9pt;">Exercise of pre-funded warrants (1)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">653,144</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">44</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">119</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">163</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 40%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">Net loss</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">(21,675</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">(21,675</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">)</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 40%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">Balance as of December 31, 2018</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">2,813,087</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">193</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">154,670</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">(152,918</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">1,945</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 40%;">
          <div style="line-height: 1.25; text-indent: -9pt; margin-left: 9pt;">Share-based compensation to employees and non-employees</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">1,108</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">1,108</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 40%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25; text-indent: -9pt; margin-left: 9pt;">Issuance of ordinary shares upon exercise of options to purchase ordinary shares and RSUs by employees and non-employees</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">47,473</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">2</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">2</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 40%;">
          <div style="line-height: 1.25; text-indent: -9pt; margin-left: 9pt;">
            <div style="line-height: 1.25;">Issuance of ordinary shares in a &#8220;best effort&#8221; offering, net of issuance expenses in the amount of $686 (1)</div>
          </div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">760,000</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">52</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">3,632</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">3,684</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 40%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25; text-indent: -9pt; margin-left: 9pt;">Exercise of pre-funded warrants and warrants (1)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">584,087</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">40</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">1,461</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">1,501</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 40%;">
          <div style="line-height: 1.25; text-indent: -9pt; margin-left: 9pt;">
            <div style="line-height: 1.25;">Issuance of ordinary shares in a &#8220;Registered Direct&#8221; offering, net of issuance expenses in the amount of $ 1,125 (1)</div>
          </div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">1,650,248</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">115</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">8,010</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">8,125</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 40%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25; text-indent: -9pt; margin-left: 9pt;">Issuance of ordinary shares in a &#8220;Warrant exercise&#8221; agreement, net of issuance expenses in the amount of $ 1,019 (1)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">1,464,665</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">102</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">9,864</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">9,966</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 40%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">Net loss</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">(15,551</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">(15,551</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">)</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 40%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 40%;">
          <div style="line-height: 1.25;">Balance as of December 31, 2019</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">7,319,560</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">504</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">178,745</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">(168,469</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">10,780</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 40%;">
          <div style="line-height: 1.25; text-indent: -9pt; margin-left: 9pt;">Share-based compensation to employees and non-employees</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">749</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">749</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 40%;">
          <div style="line-height: 1.25; text-indent: -9pt; margin-left: 9pt;">Issuance of ordinary shares upon exercise of options to purchase ordinary shares and RSUs by employees and non-employees</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">63,111</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">3</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">(3</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 40%;">
          <div style="line-height: 1.25; text-indent: -9pt; margin-left: 9pt;">Issuance of ordinary shares in a &#8220;Best Efforts&#8221; offering, net of issuance expenses in the amount of $ 1,056 (1)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">4,053,172</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">290</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">3,720</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">4,010</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 40%;">
          <div style="line-height: 1.25;">Exercise of pre-funded warrants and warrants (1)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">3,378,328</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">244</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">3,979</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">4,223</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 40%;">
          <div style="line-height: 1.25; text-indent: -9pt; margin-left: 9pt;">
            <div style="line-height: 1.25;">Issuance of ordinary shares in a &#8220;registered direct&#8221; offering, net of issuance expenses in the amount of $ 1,019 (1)</div>
          </div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">4,938,278</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">357</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">7,624</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">7,981</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 40%;">
          <div style="line-height: 1.25; text-indent: -9pt; margin-left: 9pt;">Issuance of ordinary shares in a private placement, net of issuance expenses in the amount of $ 993 (1)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">5,579,776</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">429</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">6,578</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">7,007</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 40%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">Net loss</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
          <div style="line-height: 1.25;">(12,976</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
          <div style="line-height: 1.25;">(12,976</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">)</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 40%;">
          <div style="line-height: 1.25;">Balance as of December 31, 2020</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">25,332,225</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">1,827</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">201,392</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">(181,445</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">21,774</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>

  </table>
  <div style="line-height: 1.25;">&#160;</div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z8547981cc1224394aca41f0934555978">

      <tr>
        <td style="width: 3.85%; vertical-align: top;">
          <div style="line-height: 1.25;">*)</div>
        </td>
        <td style="width: 96.15%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25;">Represents an amount lower than $1.</div>
        </td>
      </tr>

  </table>
  <div style="margin-left: 18pt; line-height: 1.25;">&#160;</div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z75451759bc794e49b5803c73fc2f1466">

      <tr>
        <td style="width: 3.85%; vertical-align: top;">
          <div style="line-height: 1.25;">(1)</div>
        </td>
        <td style="width: 96.15%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25;">See note 8b.</div>
        </td>
      </tr>

  </table>
  <div style="line-height: 1.25;">&#160;</div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="za85b1de3b6e04ba8a56b6382fdbff03f">

      <tr>
        <td style="width: 3.85%; vertical-align: top;">
          <div style="line-height: 1.25;">(2)</div>
        </td>
        <td style="width: 96.15%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25;">See note 8f.</div>
        </td>
      </tr>

  </table>
  <div style="margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-indent: -36pt; margin-left: 36pt; line-height: 1.25;">The accompanying notes are an integral part of these consolidated financial statements.</div>
  <div style="text-indent: -36pt; margin-left: 36pt; line-height: 1.25;">&#160;&#160;</div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">F - 6</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <br>
  <div style="line-height: 1.25; font-weight: bold;">REWALK ROBOTICS LTD. AND&#160;SUBSIDIARIES</div>
  <div style="line-height: 1.25; font-weight: bold;">CONSOLIDATED STATEMENTS OF <a name="CASH"><!--Anchor--></a>CASH FLOWS</div>
  <div style="line-height: 1.25; font-weight: bold;">U.S. dollars in thousands</div>
  <div style="line-height: 1.25;">&#160;</div>
  <div style="line-height: 1.25;">
    <table cellspacing="0" cellpadding="0" id="z077a91bd800e463f99ca3f75665d4ac6" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;">

        <tr>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="10" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">Year ended December 31,</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;"> 2020</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">2019</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">2018</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;"><u>Cash flows used in operating activities:</u></div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 64%;">
            <div style="line-height: 1.25;">Net loss</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">(12,976</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">(15,551</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">(21,675</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">
            <div style="line-height: 1.25;">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 64%;">
            <div style="line-height: 1.25;">Adjustments to reconcile net loss to net cash used in operating activities:</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 64%;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 64%;">
            <div style="line-height: 1.25;">Depreciation</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">285</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">321</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">463</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 64%;">
            <div style="line-height: 1.25;">Share-based compensation to employees and non-employees</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">749</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">1,108</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">2,766</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 64%;">
            <div style="line-height: 1.25;">Deferred taxes</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">(44</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">(57</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">(107</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">
            <div style="line-height: 1.25;">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 64%;">
            <div style="line-height: 1.25;">Gain on PPP forgiveness</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">(392</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">&#8212;</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">&#8212;</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 64%;">
            <div style="line-height: 1.25;">Loss on inducement of debt (2)</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">&#8212;</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">&#8212;</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">600</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 64%;">
            <div style="line-height: 1.25;">Financial expenses related to long term loan</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">&#8212;</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">&#8212;</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">224</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 64%;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 64%;">
            <div style="line-height: 1.25;">Changes in assets and liabilities:</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 64%;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 64%;">
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 9pt;">Trade receivables, net</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">110</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">(36</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">322</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 64%;">
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 9pt;">Prepaid expenses, operating lease right-of-use assets and other assets</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">166</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">64</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">734</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 64%;">
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 9pt;">Inventories</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">(469</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">(1,221</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">1,403</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 64%;">
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 9pt;">Trade payables</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">(506</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">370</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">492</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 64%;">
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 9pt;">Employees and payroll accruals</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">197</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">20</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">(222</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">
            <div style="line-height: 1.25;">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 64%;">
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 9pt;">Deferred revenues and advance from customers</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">264</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">176</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">283</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px;">
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 9pt;">Operating lease liabilities and other liabilities</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">27</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">(9</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">(57</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">
            <div style="line-height: 1.25;">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 64%; padding-bottom: 2px;">
            <div style="line-height: 1.25;">Net cash used in operating activities</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">(12,589</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%; padding-bottom: 2px;">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">(14,815</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%; padding-bottom: 2px;">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">(14,774</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%; padding-bottom: 2px;">
            <div style="line-height: 1.25;">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 64%;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 64%;">
            <div style="line-height: 1.25;"><u>Cash flows used in investing activities:</u></div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px;">
            <div style="line-height: 1.25;">Purchase of property and equipment</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">(73</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">(22</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">(13</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">
            <div style="line-height: 1.25;">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 64%; padding-bottom: 2px;">
            <div style="line-height: 1.25;">Net cash used in investing activities</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">(73</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%; padding-bottom: 2px;">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">(22</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%; padding-bottom: 2px;">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">(13</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%; padding-bottom: 2px;">
            <div style="line-height: 1.25;">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 64%;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 64%;">
            <div style="line-height: 1.25;"><u>Cash flows from financing activities:</u></div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 64%;">
            <div style="line-height: 1.25;">Repayment of long-term loan</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">(6,965</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">(1,722</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">(3,866</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">
            <div style="line-height: 1.25;">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 64%;">
            <div style="line-height: 1.25;">Proceeds from PPP loan (3)</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">392</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">&#8212;</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 64%;">
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: -9pt; margin-left: 9pt;">Issuance of ordinary shares in investment agreement, net of issuance expenses in an amount of $830 (1)</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">&#8212;</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">&#8212;</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">4,295</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 64%;">
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: -9pt; margin-left: 9pt;">Issuance of ordinary shares in at-the-market offering, net of issuance expenses paid in the amount of $211 (1)</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">&#8212;</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">&#8212;</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">1,142</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 64%;">
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: -9pt; margin-left: 9pt;">Issuance of ordinary shares and exercise of pre-funded warrants into ordinary shares in follow-on offering, net of issuance
              expenses in an amount of $1,505 and net of long-term loan conversion in the amount of $3,600 (1) (2)</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">&#8212;</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">&#8212;</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">8,140</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 64%;">
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: -9pt; margin-left: 9pt;">Issuance of ordinary shares in a &#8220;best effort&#8221; offering, net of issuance expenses in the amount of $ 686 (1)</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">&#8212;</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">3,684</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">&#8212;</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 64%;">
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: -9pt; margin-left: 9pt;">Issuance of ordinary shares in a &#8220;registered direct&#8221; offering, net of issuance expenses in the amount of $ 1,035 (1)</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">&#8212;</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">8,125</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">&#8212;</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 64%;">
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: -9pt; margin-left: 9pt;">Issuance of ordinary shares in a &#8220;best effort&#8221; offering, net of issuance expenses in the amount of $1,056 (1)</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">4,010</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">&#8212;</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">&#8212;</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 64%;">
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: -9pt; margin-left: 9pt;">Issuance of ordinary shares in a &#8220;registered direct&#8221; offering, net of issuance expenses in the amount of $977 (1)</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">8,023</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">&#8212;</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">&#8212;</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 64%;">
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: -9pt; margin-left: 9pt;">Issuance of ordinary shares in a &#8220;warrant exercise&#8221; agreement, net of issuance expenses in the amount of $1,019 (1)</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">&#8212;</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">9,966</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">&#8212;</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 64%;">
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: -9pt; margin-left: 9pt;">Issuance of ordinary shares in a private placement, net of issuance expenses in the amount of $959 (1)</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">7,041</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">&#8212;</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">&#8212;</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 64%; padding-bottom: 2px;">
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: -9pt; margin-left: 9pt;">Exercise of pre-funded warrants and warrants (1)</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">4,223</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">1,429</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">&#8212;</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px;">
            <div style="line-height: 1.25;">Net cash provided by financing activities</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">16,724</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">21,482</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">9,711</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 64%;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 64%;">
            <div style="line-height: 1.25;">Increase (decrease) in cash, cash equivalents, and restricted cash</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">4,062</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">6,645</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">(5,076</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">
            <div style="line-height: 1.25;">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 64%; padding-bottom: 2px;">
            <div style="line-height: 1.25;">Cash, cash equivalents, and restricted cash at beginning of period</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">16,992</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">10,347</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">15,423</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 4px;">
            <div style="line-height: 1.25;">Cash, cash equivalents, and restricted cash at end of period</div>
          </td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="line-height: 1.25;">21,054</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="line-height: 1.25;">16,992</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="line-height: 1.25;">10,347</div>
          </td>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        </tr>

    </table>
  </div>
  <div style="line-height: 1.25;"> <br>
  </div>
  <div style="line-height: 1.25;"> </div>
  <div style="line-height: 1.25;">The accompanying notes are an integral part of these consolidated financial statements.</div>
  <div style="line-height: 1.25;">&#160;&#160;</div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">F - 7</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <br>
  <div style="line-height: 1.25; font-weight: bold;">REWALK ROBOTICS LTD. AND SUBSIDIARIES<br>
    CONSOLIDATED STATEMENTS OF CASH FLOWS&#160;</div>
  <div style="line-height: 1.25; font-weight: bold;">U.S. dollars in thousands</div>
  <div style="line-height: 1.25;">&#160;</div>
  <table cellspacing="0" cellpadding="0" id="z4aab71094c134fabbf5f79c2729debb5" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;">

      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="10" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">Year ended December 31,</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;"> 2020</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">2019</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">2018</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25; font-weight: bold;"><u>Supplemental disclosures of non-cash flow information</u></div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">Expenses related to offerings not yet paid (1)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">76</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 64%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">Repayment of long-term loan by issuance of units and pre-funded units (2)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">3,000</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">At-the-market offering expenses not yet paid (1)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">25</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 64%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">Classification of other current assets to property and equipment, net</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">98</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">236</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">Classification of inventory to other current assets</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">164</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 64%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">Classification of inventory to property and equipment</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">50</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">174</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">Cashless exercise of pre-funded warrants</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">72</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 64%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">Initial recognition of operating lease right-of-use assets</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">2,099</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">Initial recognition of operating lease liabilities</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">(2,249</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 64%;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 64%;">
          <div style="line-height: 1.25; font-weight: bold;"><u>Supplemental disclosures of cash flow information:</u></div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 64%;">
          <div style="line-height: 1.25;">Cash and cash equivalents</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">20,350</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">16,253</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">9,546</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">Restricted cash included in other long term assets</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">704</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">739</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">801</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 64%;">
          <div style="line-height: 1.25;">Total Cash, cash equivalents, and restricted cash</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">21,054</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">16,992</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">10,347</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 64%;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 64%;">
          <div style="line-height: 1.25; font-weight: bold;"><u>Supplemental disclosures of cash flow information:</u></div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: rgb(204, 238, 255); vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">Cash paid for income taxes</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">13</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">21</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">25</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 64%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">Cash paid for interest</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
          <div style="line-height: 1.25;">862</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
          <div style="line-height: 1.25;">1,499</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
          <div style="line-height: 1.25;">1,501</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
      </tr>

  </table>
  <div style="line-height: 1.25; font-weight: bold;">&#160;</div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z9ce5a40f220b4d9c8be1e95c1d79acbf">

      <tr>
        <td style="width: 3.85%; vertical-align: top;">
          <div style="line-height: 1.25;">(1)</div>
        </td>
        <td style="width: 96.15%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25;">See note 8b.</div>
        </td>
      </tr>

  </table>
  <div style="line-height: 1.25;">&#160;</div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z4a11bfc25cdf4d6089174b3a329e3f36">

      <tr>
        <td style="width: 3.85%; vertical-align: top;">
          <div style="line-height: 1.25;">(2)</div>
        </td>
        <td style="width: 96.15%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25;">See note 6.</div>
        </td>
      </tr>

  </table>
  <div style="text-align: justify; line-height: 1.25;">&#160;</div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z5bc0833fe3d1452c80b578170e09f45b">

      <tr>
        <td style="width: 3.85%; vertical-align: top;">
          <div style="line-height: 1.25;">(3)</div>
        </td>
        <td style="width: 96.15%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25;">See note 10.</div>
        </td>
      </tr>

  </table>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="line-height: 1.25;">The accompanying notes are an integral part of these consolidated financial statements.</div>
  <div style="line-height: 1.25;">&#160;&#160;</div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">F - 8</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <br>
  <div style="line-height: 1.25;"><font style="font-weight: bold;"><a name="NOTE"><!--Anchor--></a>NOTE&#160;1:-</font>&#160;&#160;&#160;&#160; <font style="font-weight: bold;">GENERAL</font></div>
  <div style="line-height: 1.25">&#160;</div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z73c0f9ba04994c84a372c43778daec8f">

      <tr>
        <td style="width: 17pt;"><br>
        </td>
        <td style="width: 19pt; vertical-align: top; align: right;">a.</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div>ReWalk Robotics Ltd. (&#8220;RRL&#8221;, and together with its subsidiaries, the &#8220;Company&#8221;) was incorporated under the laws of the State of Israel on June&#160;20, 2001 and commenced operations on the&#160;same&#160;date.</div>
        </td>
      </tr>

  </table>
  <div style="margin-left: 5.65pt; line-height: 1.25;">&#160;</div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc22defa361944b118ba6d1e12f0f7460">

      <tr>
        <td style="width: 17pt;"><br>
        </td>
        <td style="width: 19pt; vertical-align: top; align: right;">b.</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div>RRL has two wholly owned subsidiaries: (i)&#160;ReWalk Robotics Inc. (&#8220;RRI&#8221;) incorporated under the laws of Delaware on February&#160;15, 2012 and (ii)&#160;ReWalk Robotics GMBH. (&#8220;RRG&#8221;) (formerly Argo Medical Technologies GmbH) incorporated under the laws
            of Germany on January&#160;14, 2013.</div>
        </td>
      </tr>

  </table>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z33476b6ad2094d83a4499124edf1bbae">

      <tr>
        <td style="width: 17pt;"><br>
        </td>
        <td style="width: 19pt; vertical-align: top; align: right;">c.</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div>The Company is designing, developing, and commercializing robotic&#160;exoskeletons that allow individuals with mobility impairments or other medical conditions the ability to stand and walk once again. The Company has developed and is continuing
            to commercialize the ReWalk, an exoskeleton designed for individuals with paraplegia that uses its patented tilt-sensor technology and an on-board computer and motion sensors to drive motorized legs that power movement. The ReWalk system
            consists of a light wearable brace support suit which integrates motors at the joints, rechargeable batteries, an array of sensors and a computer-based control system to power knee and hip movement. Additionally, the Company developed and, in
            June 2019, started to commercialize the ReStore following receipt of European Union CE mark and United States Food and Drug Administration (&#8220;FDA&#8221;). The ReStore is a powered, lightweight soft exo-suit intended for use in the rehabilitation of
            individuals with lower limb disability due to stroke. The Company markets and sells its products directly to institutions and individuals and through third-party distributors. The Company sells its products directly primarily in Germany and the
            United States, and primarily through distributors in other markets. In its direct markets, the Company has established relationships with rehabilitation centers and the spinal cord injury community, and in its indirect markets, the Company&#8217;s
            distributors maintain these relationships. RRI markets and sells products mainly in the United States. RRG sell the Company&#8217;s products mainly in Germany and Europe.</div>
        </td>
      </tr>

  </table>
  <div style="text-align: justify; text-indent: -36pt; margin-left: 36pt; line-height: 1.25;"> <br>
  </div>
  <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 36pt;">During the second quarter of 2020, we have finalized two separate agreements to distribute additional product lines in the U.S. market.
    The Company will be the exclusive distributor of the MediTouch Tutor movement biofeedback systems in the United States and will also have distribution rights for the MYOLYN MyoCycle FES cycles to U.S. rehabilitation clinics and personal sales through
    the U.S. Department of Veterans Affairs (&#8220;VA&#8221;) hospitals. These new products will improve our product offering to clinics as well as patients within the VA as they both have similar clinician and patient profiles.</div>
  <div style="margin-left: 5.65pt; line-height: 1.25;">&#160;</div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd8d054c208944b989ab9ecba87bbe556">

      <tr>
        <td style="width: 17pt;"><br>
        </td>
        <td style="width: 19pt; vertical-align: top; align: right;">d.</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div>The Company depends on one contract manufacturer, Sanmina. Reliance on this vendor makes the Company vulnerable to possible capacity constraints and reduced control over component availability, delivery schedules, manufacturing yields and
            costs.</div>
        </td>
      </tr>

  </table>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb9e19c9d63534b00a0e37875220c4a2f">

      <tr>
        <td style="width: 17pt;"><br>
        </td>
        <td style="width: 19pt; vertical-align: top; align: right;">e.</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div>The worldwide spread of COVID-19 has resulted in a global economic slowdown and is expected to continue to disrupt general business operations until the disease is contained. This has had a negative impact on the Company's sales and results
            of operations during 2020, and the Company expects that it will continue to negatively affect its sales and results of operations, but the Company is currently unable to predict the scale and duration of that impact. As of the date of issuance
            of these financial statements, the Company is not aware of any specific event or circumstance that would require an update of its accounting estimates or judgments or revision of the carrying value of its assets or liabilities. This
            determination may change as new events occur and additional information is obtained. Actual results could differ from our estimates and judgments, and any such differences may be material to our financial statements.</div>
        </td>
      </tr>

  </table>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">F - 9</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <!--PROfilePageNumberReset%Num%10%F - %%-->
  <div style="line-height: 1.25">&#160;<br>
  </div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc4e92d2381e3411498c1d949f78ba407">

      <tr>
        <td style="width: 17pt;"><br>
        </td>
        <td style="width: 19pt; vertical-align: top; align: right;">f.</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div>
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;">For the full year ended December 31 ,2020 the Company incurred a consolidated net loss of $13 million and has an accumulated deficit in the total amount of $181.4 million. The Company&#8217;s negative operating cash
                flow for the full year ended December 31, 2020 was $12.6 million. Our cash and cash equivalent on December 31, 2020 totaled $20.3 million and in subsequent warrants exercise transactions the Company received a total of additional $13.2
                million in the beginning of 2021. The Company has sufficient funds to support its operation for more than 12 months following the approval of its consolidated financial statements for the fiscal year ended December 31, 2020.</div>
            </div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;">The Company expect to incur future net losses and our transition to profitability is dependent upon, among other things, the successful development and commercialization of the Company&#8217;s products and product
                candidates, the achievement of a level of revenues adequate to support the cost structure.&#160;&#160;Until the Company achieve profitability or generate positive cash flows, it will continue to need to raise additional cash. The Company intend to
                fund future operations through cash on hand, additional private and/or public offerings of debt or equity securities, cash exercises of outstanding warrants or a combination of the foregoing. In addition, the Company may seek additional
                capital through arrangements with strategic partners or from other sources and will continue to address its cost structure. Notwithstanding, there can be no assurance that the Company will be able to raise additional funds or achieve or
                sustain profitability or positive cash flows from operations.</div>
            </div>
          </div>
        </td>
      </tr>

  </table>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="line-height: 1.25;"><font style="font-weight: bold;">NOTE&#160;2:-</font>&#160;&#160;&#160;&#160; <font style="font-weight: bold;">SIGNIFICANT ACCOUNTING POLICIES</font></div>
  <div style="text-align: justify; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">The consolidated financial statements are prepared according to United States generally accepted accounting principles (&#8220;U.S. GAAP&#8221;),
    applied on a consistent basis, as follows:</div>
  <div style="text-align: justify; line-height: 1.25;">&#160;</div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0a33e389668f457b9b7e6bf33704bbef">

      <tr>
        <td style="width: 17pt;"><br>
        </td>
        <td style="width: 19pt; vertical-align: top; align: right;">a.</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div>Use of Estimates</div>
        </td>
      </tr>

  </table>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">The preparation of the consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates, judgments, and
      assumptions. The Company&#8217;s management believes that the estimates, judgments, and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts
      of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
      On an ongoing basis, the Company&#8217;s management evaluates estimates, including those related to inventories, fair values of share-based awards and warrants, contingent liabilities, provision for warranty, allowance for doubtful account and sales return
      reserve. Such estimates are based on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. <br>
    </div>
  </div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
    <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">F - 10</font></div>
    <div style="page-break-after: always;" id="DSPFPageBreak">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc0dba15ad360421690d3148bb5e25a82">

      <tr>
        <td style="width: 17pt;"><br>
        </td>
        <td style="width: 19pt; vertical-align: top; align: right;">b.</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div>Financial Statements in U.S. Dollars:</div>
        </td>
      </tr>

  </table>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">Since 2015, most of the Company&#8217;s expenses were denominated in United States dollars (&#8220;dollars&#8221;) and the remaining expenses were denominated in New Israeli Shekel (&#8220;NIS&#8221;) and Euros.
    Until 2018 most of the Company&#8217;s revenues were denominated in U.S. dollars and the remainder of our revenues was denominated in euros and British pound whereas in the last two years our Euro revenues are higher than the ones in dollars.&#160; &#160;however, the
    selling prices are linked to the Company&#8217;s price list which is determined in dollars, the budget is managed in dollars, financing activities including loans and cash investments, are made in U.S. dollars and the Company&#8217;s management believes that the
    dollar is the primary currency of the economic environment in which the Company and each of its subsidiaries operate. Thus, the dollar is the Company&#8217;s and its subsidiaries&#8217; functional and reporting currency.</div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Accordingly, transactions denominated in currencies other than the functional currency are re-measured to the functional currency in accordance with Accounting Standards
        Codification (&#8220;ASC&#8221;) No. 830, &#8220;Foreign Currency Matters&#8221; at the exchange rate at the date of the transaction or the average exchange rate in the relevant reporting period. At the end of each reporting period, financial assets and liabilities are
        re-measured to the functional currency using exchange rates in effect at the balance sheet date. Non-financial assets and liabilities are re-measured at historical exchange rates. Gains and losses related to re-measurement are recorded as financial
        income (expense) in the consolidated statements of operations as appropriate.</div>
    </div>
  </div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z3d72edf84d57490a93185381c32117fb">

      <tr>
        <td style="width: 17pt;"><br>
        </td>
        <td style="width: 19pt; vertical-align: top; align: right;">c.</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div>Principles of Consolidation:</div>
        </td>
      </tr>

  </table>
  <div style="text-align: justify; text-indent: 54pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
      <div style="line-height: 1.25;">The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, RRI and RRG. All intercompany transactions and balances have been eliminated upon consolidation.</div>
    </div>
  </div>
  <div style="text-align: center; line-height: 1.25;">&#160;&#160;</div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal; font-family: 'Times New Roman',Times,serif;">F - 11</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <div style="line-height: 1.25">&#160; <br>
  </div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd955c270d10444e99907c61dd04aa49f">

      <tr>
        <td style="width: 17pt;"><br>
        </td>
        <td style="width: 19pt; vertical-align: top; align: right;">d.</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div>Cash Equivalents:</div>
        </td>
      </tr>

  </table>
  <div style="text-align: justify; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">Cash equivalents are short-term highly liquid investments that are readily convertible to cash with original maturities of three months or less, at the date acquired.</div>
  <div style="margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z5788efea516d48349aa7e6fb3ab915c9">

      <tr>
        <td style="width: 17pt;"><br>
        </td>
        <td style="width: 19pt; vertical-align: top; align: right;">e.</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div>Inventories:</div>
        </td>
      </tr>

  </table>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">Inventories are stated at the lower of cost or market value. Inventory reserves are provided to cover risks arising from slow-moving items or technological obsolescence.</div>
  <div style="margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">The Company periodically evaluates the quantities on hand relative to historical, current and projected sales volume. Based on this evaluation, an impairment charge is recorded when
    required to write-down inventory to its market value.</div>
  <div style="margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-indent: 36pt; line-height: 1.25;">Cost is determined as follows:</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">Finished products - on the basis of raw materials and manufacturing costs on an average basis.</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">Raw materials - The weighted average cost method.</div>
  <div style="margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">The Company regularly evaluates the ability to realize the value of inventory based on a combination of factors, including historical usage rates and forecasted sales according
      to outstanding backlogs. Purchasing requirements and alternative usage are explored within these processes to mitigate inventory exposure. When recorded, the reserves are intended to reduce the carrying value of inventory to its net realizable value.
      In the years ended December&#160;31, 2020, 2019 and 2018, the Company wrote off inventory in the amount of $215 thousand, $64 thousand, and $562 thousand, respectively. The write off inventory were recorded in cost of revenue. If actual demand for the
      Company&#8217;s products deteriorates, or market conditions are less favorable than those projected, additional inventory reserves may be required.</div>
  </div>
  <div style="text-align: justify; line-height: 1.25;">&#160;</div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4aa8c8c1d0024f7b92595ce5d2e64e86">

      <tr>
        <td style="width: 17pt;"><br>
        </td>
        <td style="width: 19pt; vertical-align: top; align: right;">f.</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div>Related parties transactions and balances:&#160;</div>
        </td>
      </tr>

  </table>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">The Company has a related party shareholder named Yaskawa Electric Corporation (&#8220;YEC&#8221;).</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">In September 2013, the Company entered into a share purchase agreement and a strategic alliance with YEC, pursuant to which YEC has agreed to distribute the Company&#8217;s products, in
    addition to providing sales, marketing, service and training functions, in Japan, China (including Hong-Kong and Macau), Taiwan, South Korea, Singapore and Thailand.</div>
  <div style="margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
      <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">As of December 31, 2020, and 2019, the related party receivable were 0% of trade receivable, net, in both years. Revenues from YEC during the years ended
        December&#160;31, 2020, 2019, and 2018 amounted to $0 thousand, $41 thousand, and $13, respectively.</div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
  </div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal; font-family: 'Times New Roman',Times,serif;">F - 12</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  &#160;
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z05a82daea43b40e2b33b8f576d65c3b7">

      <tr>
        <td style="width: 17pt;"><br>
        </td>
        <td style="width: 19pt; vertical-align: top; align: right;">g.</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div>Property and Equipment:</div>
        </td>
      </tr>

  </table>
  <div style="text-align: justify; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets at
    the following annual rates:&#160;</div>
  <div style="line-height: 1.25;">&#160;</div>
  <table align="right" cellspacing="0" cellpadding="0" border="0" style="width: 95%; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;" id="z251bfdcae9e14e5e93cd117615991b47">

      <tr>
        <td style="width: 75.84%; vertical-align: bottom;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td style="width: 24.16%; vertical-align: bottom; border-bottom: #000000 2px solid;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">%</div>
        </td>
      </tr>
      <tr>
        <td style="width: 75.84%; vertical-align: top; background-color: #CCEEFF;">
          <div style="line-height: 1.25;">Computer equipment</div>
        </td>
        <td style="width: 24.16%; vertical-align: top; background-color: #CCEEFF;">
          <div style="text-align: center; line-height: 1.25;">20-33 (mainly 33)</div>
        </td>
      </tr>
      <tr>
        <td style="width: 75.84%; vertical-align: top;">
          <div style="line-height: 1.25;">Office furniture and equipment</div>
        </td>
        <td style="width: 24.16%; vertical-align: top;">
          <div style="text-align: center; line-height: 1.25;">6 - 10&#160;(mainly 10)</div>
        </td>
      </tr>
      <tr>
        <td style="width: 75.84%; vertical-align: top; background-color: #CCEEFF;">
          <div style="line-height: 1.25;">Machinery and laboratory equipment</div>
        </td>
        <td style="width: 24.16%; vertical-align: top; background-color: #CCEEFF;">
          <div style="text-align: center; line-height: 1.25;">15</div>
        </td>
      </tr>
      <tr>
        <td style="width: 75.84%; vertical-align: bottom;">
          <div style="line-height: 1.25;">Field service units</div>
        </td>
        <td style="width: 24.16%; vertical-align: top;">
          <div style="text-align: center; line-height: 1.25;">50</div>
        </td>
      </tr>
      <tr>
        <td style="width: 75.84%; vertical-align: top; background-color: #CCEEFF;">
          <div style="line-height: 1.25;">Leasehold improvements</div>
        </td>
        <td style="width: 24.16%; vertical-align: top; background-color: #CCEEFF;">
          <div style="text-align: center; line-height: 1.25;">Over&#160;the&#160;shorter&#160;of&#160;the&#160;lease<br>
            term or estimated useful life</div>
        </td>
      </tr>

  </table>
  <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; clear: both;">&#160;</div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z9443fa13dcbe4ce6b1b64bf17f939507">

      <tr>
        <td style="width: 17pt;"><br>
        </td>
        <td style="width: 19pt; vertical-align: top; align: right;">h.</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div>Impairment of Long-Lived Assets:</div>
        </td>
      </tr>

  </table>
  <div style="line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">The Company&#8217;s long-lived assets are reviewed for impairment in accordance with ASC No.&#160;360, &#8220;Property, Plant and Equipment&#8221; whenever events or changes in circumstances indicate that
    the carrying amount of an asset (or asset group) may not be recoverable. Recoverability of assets (or asset group) to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted cash flows expected to be
    generated by the assets. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. During the years ended December&#160;31, 2020,
    2019 and 2018, no impairment losses have been recorded.</div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z6146e80aa19e400b986403f2498b419f">

      <tr>
        <td style="width: 17pt;"><br>
        </td>
        <td style="width: 19pt; vertical-align: top; align: right;">i.</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div>Restricted cash and Other long-term assets:</div>
        </td>
      </tr>

  </table>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">Other long-term assets include long-term prepaid expenses and restricted cash deposits for offices and cars leasing based upon the term of the remaining restrictions.</div>
  <div style="text-align: justify; line-height: 1.25;">&#160;</div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z67e623d200a64464ac03f67293e01e52">

      <tr>
        <td style="width: 17pt;"><br>
        </td>
        <td style="width: 19pt; vertical-align: top; align: right;">j.</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div>Revenue Recognition:&#160;</div>
        </td>
      </tr>

  </table>
  <div style="line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">The Company generates revenues from sales of products. The Company sells its products directly to end customers and through distributors. The Company sells its products to private
    individuals (who finance the purchases by themselves, through fundraising or reimbursement coverage from insurance companies), rehabilitation facilities and distributors.</div>
  <div style="text-align: justify; text-indent: -13.5pt; margin-left: 31.5pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">On January 1, 2018, the Company adopted Topic 606 using the modified retrospective method for contracts that were not completed as of January 1, 2018. Under the modified
    retrospective method, the Company recognized the cumulative effect of initially applying the new revenue standard as an adjustment to the opening balance of retained earnings. This adjustment did not have a material impact on the Company consolidated
    financial statements. Results for reporting periods beginning after January 1, 2018 are presented under Topic 606, while prior period amounts are not adjusted and continue to be reported in accordance with the Company historic accounting under Revenue
    Recognition (&#8220;Topic 605&#8221;).</div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal; font-family: 'Times New Roman',Times,serif;">F - 13</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <div style="line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 34.2pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">The adoption of Topic 606 represents a change in accounting principle that will provide financial statement readers with enhanced
    revenue recognition disclosures. In accordance with Topic 606, revenue is recognized when obligations under the terms of a contract with the Company customer are satisfied; generally this occurs with the transfer of control of the Company products or
    services. Revenue is measured as the amount of consideration to which the Company expect to be entitled in exchange for transferring products or providing services. To achieve this core principle, the Company applies the following five steps:</div>
  <div style="text-align: justify; text-indent: -13.5pt; margin-left: 31.5pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">1. Identify the contract with a customer</div>
  <div style="text-align: justify; margin-left: 72pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 43.2pt; line-height: 1.25;">A contract with a customer exists when (i) the Company enters into a written agreement with a customer that defines each party&#8217;s rights regarding the products or services to be
    transferred and identifies the payment terms related to these products or services, (ii) both parties to the contract are committed to perform their respective obligations, (iii) the contract has commercial substance, and (iv) the Company determines
    that collection of substantially all consideration for products or services that are transferred is probable based on the customer&#8217;s intent and ability to pay the promised consideration. The Company applies judgment in determining the customer&#8217;s
    ability and intention to pay, which is based on a variety of factors including the customer&#8217;s payment history or, in the case of a new customer, published credit and financial information pertaining to the customer.</div>
  <div style="text-align: justify; text-indent: -40.5pt; margin-left: 72pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">2. Identify the performance obligations in the contract</div>
  <div style="text-align: justify; margin-left: 40.5pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 43.2pt; line-height: 1.25;">Performance obligations promised in a contract are identified based on the products or services that will be transferred to the customer that are both capable of being distinct,
    whereby the customer can benefit from the product or service either on its own or together with other resources that are readily available from the Company, and are distinct in the context of the contract, whereby the transfer of the products or
    services is separately identifiable from other promises in the contract.</div>
  <div style="text-align: justify; margin-left: 40.5pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">3. Determine the transaction price</div>
  <div style="text-align: justify; margin-left: 40.5pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 43.2pt; line-height: 1.25;">The transaction price is determined based on the consideration to which the Company will be entitled in exchange for transferring products or services to the customer. To the
    extent the transaction price is variable, revenue is recognized at an amount equal the consideration to which the Company expects to be entitled. This estimate includes customer sales incentives which are accounted for as a reduction to revenue and
    estimated using either the expected value method or the most likely amount method, depending on the nature of the program.</div>
  <div style="text-align: justify; margin-left: 40.5pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 43.2pt; line-height: 1.25;">As a result of the Company&#8217;s adoption of this standard, the majority of the amounts that were historically classified as bad debt expense, primarily related to self-payers
    customers, are now considered an implicit price concession in determining net revenue. Accordingly, the Company recognized uncollectible balances associated with self-payers customers as a reduction of the transaction price and therefore as a reduction
    in net revenues when historically these amounts were classified as bad debt expense within general and administrative expenses.</div>
  <div style="text-align: justify; margin-left: 40.5pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 43.2pt; line-height: 1.25;">Shipping and handling costs charged to customers are included in net sales. Determining the transaction price requires significant judgment, which is discussed by revenue category
    in further detail below.</div>
  <div style="text-align: justify; margin-left: 40.5pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 43.2pt; line-height: 1.25;">
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">In practice, the Company does not offer extended payment terms beyond one year to customers.</div>
  </div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">4. Allocate the transaction price to performance obligations in the contract</div>
  <div style="text-align: justify; text-indent: -40.5pt; margin-left: 72pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 43.2pt; line-height: 1.25;">If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. Contracts that contain multiple
    performance obligations require an allocation of the transaction price to each performance obligation based on a relative standalone selling price basis unless a portion of the variable consideration related to the contract is allocated entirely to a
    performance obligation. The Company determines standalone selling price based on the price at which the performance obligation is sold separately.</div>
  <div style="text-align: justify; text-indent: -40.5pt; margin-left: 72pt; line-height: 1.25;">&#160;&#160;</div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal; font-family: 'Times New Roman',Times,serif;">F - 14</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  &#160;<br>
  <div style="text-align: justify; text-indent: -40.5pt; margin-left: 72pt; line-height: 1.25;">5. Recognize revenue when or as the Company satisfies a performance obligation</div>
  <div style="text-align: justify; margin-left: 40.5pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 43.2pt; line-height: 1.25;">The Company generally satisfies performance obligations at a point in time, once the customer has obtained the legal title to the items purchased or service provided.</div>
  <div style="text-align: justify; margin-left: 40.5pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 43.2pt; line-height: 1.25;">
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">For systems sold to rehabilitation facilities, the Company includes training and considers the elements in the arrangement to be a single performance obligation. In accordance
      with ASC 606, the Company has concluded that the training is essential to the functionality of the Company&#8217;s systems. Therefore, the Company recognizes revenue for the system and training only after delivery in accordance with the agreement delivery
      terms to the customer and after the training has been completed.</div>
  </div>
  <div style="text-align: justify; margin-left: 40.5pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 43.2pt; line-height: 1.25;">
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">For sales of Personal systems to end users, and for sales of Personal or Rehabilitation systems to third party distributors, the Company does not provide training to the end
      user as this training is completed by the Rehabilitation centers or by the distributor that have previously completed the ReWalk Training program. Therefore, the Company recognizes revenue in such sales upon delivery.</div>
  </div>
  <div style="text-align: justify; margin-left: 40.5pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 43.2pt; line-height: 1.25;">Revenue is recognized based on the transaction price at the time the related performance obligation is satisfied by transferring a promised product or service to a customer.</div>
  <div style="text-align: justify; margin-left: 40.5pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 43.2pt; line-height: 1.25;">The Company generally does not grant a right of return for its products. There have been isolated cases in which the Company experienced a return of its products. Therefore, the
    Company records reductions to revenue for expected future product returns based on the Company&#8217;s historical experience.</div>
  <div style="text-align: justify; margin-left: 40.5pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 43.2pt; line-height: 1.25;"><u>Disaggregation of Revenues (in thousands)</u></div>
  <div style="text-align: justify; margin-left: 40.5pt; line-height: 1.25;">&#160;</div>
  <table align="right" cellspacing="0" cellpadding="0" border="0" id="z244734cb0e59414b81b34ea77097c036" style="width: 93%; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">

      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="text-align: center; line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="10" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">Year Ended December 31,</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;"> 2020</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">2019</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">2018</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 64%;">
          <div style="line-height: 1.25;">Units placed</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">3,620</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">4,385</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">6,237</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">Spare parts and warranties</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">773</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">488</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">308</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 64%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">Total Revenues</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
          <div style="line-height: 1.25;">4,393</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
          <div style="line-height: 1.25;">4,873</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
          <div style="line-height: 1.25;">6,545</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
      </tr>

  </table>
  <div style="margin-left: 90pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif; clear: both;">&#160;</div>
  <div style="text-align: justify; margin-left: 43.2pt; line-height: 1.25;"><u>Units placed</u></div>
  <div style="text-align: justify; margin-left: 43.2pt; line-height: 1.25;">&#160;<br>
    The Company currently offer five products: (1) ReWalk Personal, (2) ReWalk Rehabilitation, (3) ReStore, (4) MyoCycle and (5) MediTouch.</div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="text-align: justify; margin-left: 43.2pt; line-height: 1.25;">ReWalk Personal and ReWalk Rehabilitation are units for spinal cord injuries (&#8220;SCI Products&#8221;). SCI Products are currently designed for everyday use by paraplegic individuals at
    home and in their communities, and are custom fitted for each user, as well as for use by paraplegia patients in the clinical rehabilitation environment, where they provide individuals access to valuable exercise and therapy. ReWalk Rehabilitation
    current design is dated and will not be produced in the future.</div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="text-align: justify; margin-left: 43.2pt; line-height: 1.25;">ReStore is a powered, lightweight soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation
    environment.</div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="text-align: justify; margin-left: 43.2pt; line-height: 1.25;">MyoCycle which uses Functional Electrical Stimulation (&#8220;FES&#8221;) technology and MediTouch tutor movement biofeedback devices (&#8220;Distributed Products&#8221;).&#160; The Company markets the
    Distributed Products in the United States for use at home or in clinic.</div>
  <div style="text-align: justify; margin-left: 43.2pt; line-height: 1.25;"> <br>
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;&#160;&#160;Units placed includes revenue from sales of SCI Products, ReStore and Distributed Products.</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"> <br>
  </div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal; font-family: 'Times New Roman',Times,serif;">F - 15</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"> <br>
  </div>
  <br>
  <div style="text-align: justify; margin-left: 43.2pt; line-height: 1.25;">For units placed, the Company recognizes revenues when it transfers control and title has passed to the customer.&#160; Each unit placed is considered an independent, unbundled
    performance obligation. The Company also offers a rent-to-purchase model in which the Company recognizes revenue ratably according to the agreed rental monthly fee.</div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="text-align: justify; margin-left: 43.2pt; line-height: 1.25;"><u>Spare parts and warranties</u></div>
  <div style="text-align: justify; margin-left: 43.2pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 43.2pt; line-height: 1.25;">Spare parts are sold to private individuals, rehabilitation facilities and distributors. Revenue is recognized when the Company satisfies a performance obligation by transferring
    control over promised goods or services to the customer. Each part sold is considered an independent, unbundled performance obligation.</div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="text-align: justify; margin-left: 43.2pt; line-height: 1.25;">Warranties are classified as either assurance type or service type warranty. A warranty is considered an assurance type warranty if it provides the consumer with assurance that the
    product will function as intended for a limited period of time.</div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="text-align: justify; margin-left: 43.2pt; line-height: 1.25;">In the beginning of 2018, the Company updated its service policy for SCI Products to include a five- year warranty compared to a period of two years that were included in the past
    for parts and services. The first two years are considered as assurance type warranty and the additional period is considered an extended service arrangement, which is a service type warranty. An assurance type warranty is not accounted for as separate
    performance obligations under the revenue model. A service type warranty is either sold with a unit or separately for units for which the warranty has expired. Revenue is then recognized ratably over the life of the warranty.</div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="text-align: justify; margin-left: 43.2pt; line-height: 1.25;">The ReStore device is offered with a two-year warranty which is considered as assurance type warranty.</div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="text-align: justify; margin-left: 43.2pt; line-height: 1.25;">The Distributed Products are offered with assurance type warranty ranging between one year to ten years depending on the specific product and part.</div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="text-align: justify; margin-left: 43.2pt; line-height: 1.25;">
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><u>Contract balances</u><u> (in thousands)</u></div>
  </div>
  <div style="text-align: justify; margin-left: 40.5pt; line-height: 1.25;">&#160;</div>
  <table align="right" cellspacing="0" cellpadding="0" border="0" id="z5c799b2fe8f0464797acfbb534d43627" style="width: 93%; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">

      <tr>
        <td valign="bottom" style="vertical-align: bottom;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">December 31,</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">December 31,</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;"> 2020</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">2019</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 76%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">Trade receivable, net (1)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
          <div style="line-height: 1.25;">684</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
          <div style="line-height: 1.25;">794</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">Deferred revenues (1) (2)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">1,108</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">844</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
      </tr>

  </table>
  <div style="margin-left: 72pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif; clear: both;">&#160;</div>
  <table align="right" cellspacing="0" cellpadding="0" border="0" style="width: 93%; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;" id="z17cb99861cfd43fcbaa9360391eba714">

      <tr>
        <td style="width: 3.85%; vertical-align: top;">
          <div style="line-height: 1.25;">(1)</div>
        </td>
        <td style="width: 96.15%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Balance presented net of unrecognized revenues that were not yet collected.</div>
        </td>
      </tr>

  </table>
  <div style="margin-left: 72pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif; clear: both;">&#160;</div>
  <table align="right" cellspacing="0" cellpadding="0" border="0" style="width: 93%; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;" id="z3161792d8d93450192807264069a7a74">

      <tr>
        <td style="width: 3.85%; vertical-align: top;">
          <div style="line-height: 1.25;">(2)</div>
        </td>
        <td style="width: 96.15%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25;">$330 thousand of December&#160;31, 2019 deferred revenues balance were recognized as revenues during the year ended December 31, 2020.</div>
        </td>
      </tr>

  </table>
  <div style="text-align: justify; margin-left: 40.5pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif; clear: both;">&#160;</div>
  <div style="text-align: justify; margin-left: 43.2pt; line-height: 1.25;"><u>Typical timing of payment</u></div>
  <div style="margin-left: 43.2pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 43.2pt; line-height: 1.25;">Deferred revenue is comprised mainly of unearned revenue related to service type warranty but also includes other offerings for which the Company has been paid in advance and earns
    revenue when the Company transfers control of the product or service.</div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="text-align: justify; margin-left: 43.2pt; line-height: 1.25;">The Company&#8217;s unfilled performance obligations as of December 31, 2020 and the estimated revenue expected to be recognized in the future related to the service type warranty
    amounts to $1,108 thousand, which is fulfilled over one to five years. &#160;</div>
  <div style="text-align: justify; margin-left: 43.2pt; line-height: 1.25;">&#160;</div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal; font-family: 'Times New Roman',Times,serif;">F - 16</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  &#160;
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z6ad9a3b4411a480fb5186fe382453b4c">

      <tr>
        <td style="width: 17pt;"><br>
        </td>
        <td style="width: 19pt; vertical-align: top; align: right;">k.</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div>Accounting for Share-Based Compensation:</div>
        </td>
      </tr>

  </table>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">The Company accounts for share-based compensation in accordance with ASC No.&#160;718, &#8220;Compensation-Stock Compensation&#8221; (&#8220;ASC No. 718&#8221;). ASC No. 718 requires companies to estimate the
    fair value of equity-based payment awards on the date of grant using an Option-Pricing Model (&#8220;OPM&#8221;). The value of the portion of the award that is ultimately expected to vest is recognized as an expense over the requisite service periods in the
    Company&#8217;s consolidated statements of operations.</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">The Company recognizes compensation expenses for the value of its awards granted based on the straight-line method over the requisite service period of each of the awards.</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">Effective as of January 1, 2017, the Company adopted Accounting Standards Update 2016-09, &#8220;Compensation-Stock Compensation (Topic 718)&#8221; (&#8220;ASU 2016-09&#8221;) on a modified, retrospective
    basis. ASU 2016-09 permits entities to make an accounting policy election related to how forfeitures will impact the recognition of compensation cost for stock-based compensation: to estimate the total number of awards for which the requisite service
    period will not be rendered or to account for forfeitures as they occur. Upon adoption of ASU 2016-09, the Company elected to change its accounting policy to account for forfeitures as they occur. The change was applied on a modified, retrospective
    basis with a cumulative-effect adjustment to retained earnings of $11 thousand (which increased the accumulated deficit) as of January 1, 2017.</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">ASU 2016-09 also eliminates the requirement that excess tax benefits be realized as a reduction in current taxes payable before the associated tax benefit can be recognized as an
    increase in paid in capital. The implementation resulted with no cumulative-effect adjustment to retained earnings as of January 1, 2017.</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;"> <br>
  </div>
  <div style="margin-left: 36pt; line-height: 1.25;">Additionally, ASU 2016-09 addresses the presentation of excess tax benefits and employee taxes paid on the statement of cash flows. The Company is now required to present excess tax benefits as an
    operating activity on the statement of cash flows rather than as a financing activity. The Company adopted this change prospectively.</div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">In June 2018, the FASB issued ASU No.&#160;2018-07 Compensation&#8212;Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting. ASU 2018-07 was issued to
    simplify several aspects of the accounting for nonemployee share-based payment transactions resulting from expanding the scope of Topic 718, "Compensation &#8211; Stock Compensation", to include share-based payment transactions for acquiring goods and
    services from nonemployees. The amendments specify that Topic 718 applies to all share-based payment transactions in which a grantor acquires goods or services to be used or consumed in a grantor&#8217;s own operations by issuing share-based payment awards.
    As a result of ASU 2018-07, grants awarded to non-employees are accounted for under ASC 718. The Company adopted ASU 2018-07 as of January 1, 2019. The adoption did not have a material impact on the consolidated financial statements.</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">The Company selected the Black-Scholes-Merton option pricing model as the most appropriate fair value method for its share-option awards. The option-pricing model requires a number
    of assumptions, of which the most significant are the fair market value of the underlying ordinary share, expected share price volatility and the expected option term. Expected volatility was calculated based upon certain peer companies that the
    Company considered to be comparable. The expected option term represents the period of time that options granted are expected to be outstanding. The expected option term is determined based on the simplified method in accordance with Staff Accounting
    Bulletin No.&#160;110, as adequate historical experience is not available to provide a reasonable estimate. The simplified method will continue to apply until enough historical experience is available to provide a reasonable estimate of the expected term.
    The risk-free interest rate is based on the yield from U.S. treasury bonds with an equivalent term. The Company has historically not paid dividends and has no foreseeable plans to pay dividends.</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">Following the IPO in September 2014, the fair value of ordinary shares is observable as they are publicly traded.</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;"> <br>
  </div>
  <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 36pt;">The fair value of Restricted Stock Units (RSUs) granted is determined based on the price of the Company&#8217;s ordinary shares on the date of
    grant.<br>
    <div><br>
    </div>
  </div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal; font-family: 'Times New Roman',Times,serif;">F - 17</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">The fair value for options granted in 2019, 2018 is estimated at the date of grant using a Black-Scholes-Merton option pricing model with the following assumptions:</div>
  <div style="line-height: 1.25;">&#160;</div>
  <table align="right" cellspacing="0" cellpadding="0" border="0" id="zcfac848f1c7c4ec8be5afff37beb22e7" style="width: 95%; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">

      <tr>
        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td colspan="6" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center;">
          <div style="line-height: 1.25; font-weight: bold;">
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">Year Ended December 31,</div>
          </div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;"> 2019</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">2018</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; background-color: #CCEEFF; width: 76%;">
          <div style="line-height: 1.25;">Expected volatility</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">57.5</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">%</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">57% - 61</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">%</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 76%;">
          <div style="line-height: 1.25;">Risk-free rate</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">2.22</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">%</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">2.74% - 2.83</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">%</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; background-color: #CCEEFF; width: 76%;">
          <div style="line-height: 1.25;">Dividend yield</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">%</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">%</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 76%;">
          <div style="line-height: 1.25;">Expected term (in years)</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">6.11</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">6.11</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; background-color: #CCEEFF; width: 76%;">
          <div style="line-height: 1.25;">Share price</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">5.37</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">25.5 - $28.75</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>

  </table>
  <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; clear: both;">&#160;&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">There were no options granted during the twelve months ended December 31, 2020.</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;"> <br>
  </div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">The Company accounts for options granted to consultants and other service providers under ASC No. 718. The fair value of these options was estimated using a
      Black-Scholes-Merton option-pricing model.</div>
  </div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
      <div style="line-height: 1.25;">The non-cash compensation expenses related to employees and non- employees for the years ended December&#160;31, 2020, 2019 and 2018 amounted to $749 thousand, $1,108 thousand, and $2,766 thousand, respectively.</div>
    </div>
  </div>
  <div style="text-align: justify; line-height: 1.25;"> <font lang="AR-SA" style="font-size:10.0pt;font-family:'Times New Roman',serif; mso-fareast-font-family:'Times New Roman'" dir="RTL">&#160;</font>
    <table width="100%" cellspacing="0" cellpadding="0" border="0" style="width:100.0%;mso-cellspacing:0cm;mso-yfti-tbllook:1184;mso-padding-alt: 0cm 0cm 0cm 0cm" class="MsoNormalTable">

        <tr style="mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes">
          <td width="24" valign="top" style="width:18.0pt;padding:0cm 0cm 0cm 0cm">
            <p style="margin-bottom:0cm;margin-bottom:.0001pt;line-height: normal" class="MsoNormal"><font dir="LTR"></font><font dir="LTR"></font><font style="font-size: 10.0pt;font-family:'Times New Roman',serif;mso-fareast-font-family:'Times New Roman'"><font dir="LTR"></font><font dir="LTR"></font>&#160;</font></p>
          </td>
          <td width="24" valign="top" style="width:18.0pt;padding:0cm 0cm 0cm 0cm">
            <p style="margin-bottom:0cm;margin-bottom:.0001pt;line-height: normal" class="MsoNormal"><font style="font-size:10.0pt;font-family:'Times New Roman',serif; mso-fareast-font-family:'Times New Roman'">l.</font></p>
          </td>
          <td valign="top" style="padding:0cm 0cm 0cm 0cm">
            <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Warrants to Acquire Ordinary Shares:</div>
          </td>
        </tr>

    </table>
    <p style="margin-top: 0cm; margin-right: 0cm; margin-left: 36.0pt; margin-bottom: .0001pt; line-height: normal;" class="MsoNormal"><font lang="AR-SA" style="font-size:10.0pt;font-family:'Times New Roman',serif; mso-fareast-font-family:'Times New Roman'" dir="RTL">&#160;</font></p>
    <div style="margin-left: 36pt; line-height: 1.25;">During the twelve-month ended 31, 2020, and 2019, respectively, the Company issued warrants to acquire up to 11,389,555 and 2,522,284 ordinary shares. The Company assessed the warrants pursuant to ASC
      480 "Distinguishing Liabilities from Equity" and ASC 815 "Derivatives and Hedging" and determine that the warrants should be accounted for as equity and not as a derivative liability. Refer to Note 8f for additional information.</div>
  </div>
  <div style="text-align: justify; line-height: 1.25;"> <br>
  </div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8db205dbbcfb4efaa93a391fce4c3d64">

      <tr>
        <td style="width: 17pt;"><br>
        </td>
        <td style="width: 19pt; vertical-align: top; align: right;">m.</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div>Research and Development Costs:</div>
        </td>
      </tr>

  </table>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">Research and development costs are charged to the consolidated statement of operations as incurred and are presented net of the amount of any grants the company receive for research
    and development in the period in which the grant was received.</div>
  <div style="text-align: justify; line-height: 1.25;">&#160;</div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z842b410387424176bf5d892651c42ab0">

      <tr>
        <td style="width: 17pt;"><br>
        </td>
        <td style="width: 19pt; vertical-align: top; align: right;">n.</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div>Income Taxes</div>
        </td>
      </tr>

  </table>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">The Company accounts for income taxes in accordance with ASC No.&#160;740, &#8220;Income Taxes&#8221; (&#8220;ASC No. 740&#8221;), using the liability method whereby deferred tax assets and liability account
    balances are determined based on the differences between financial reporting and the tax basis for assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The
    Company provides a valuation allowance, if necessary, to reduce deferred tax assets to the amounts that are more likely-than-not to be realized.</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">ASC No. 740 contains a two-step approach to recognizing and measuring a liability for uncertain tax positions. The first step is to evaluate the tax position taken or expected to be
    taken in a tax return by determining if the weight of available evidence indicates that it is more likely than not that, on an evaluation of the technical merits, the tax position will be sustained on audit, including resolution of any related appeals
    or litigation processes. The second step is to measure the tax benefit as the largest amount that is more than 50% likely to be realized upon ultimate settlement. The Company accrues interest and penalties related to unrecognized tax benefits in its
    taxes on income. As of December 31, 2020, and 2019, the Company did not identify any significant uncertain tax positions.&#160;</div>
  <div style="text-align: justify; line-height: 1.25;">&#160;&#160;</div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal; font-family: 'Times New Roman',Times,serif;">F - 18</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  &#160;
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze6bf0cf2a2aa4cc3b679ca44928b857c">

      <tr>
        <td style="width: 17pt;"><br>
        </td>
        <td style="width: 19pt; vertical-align: top; align: right;">o.</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div>Warranty:</div>
        </td>
      </tr>

  </table>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">The Company provided a two-year standard warranty for its products. In the beginning of 2018, we updated our service policy for new devices sold to include five-year warranties.&#160; The
    Company determined that the first two years of warranty is an assurance-type warranty and records a provision for the estimated cost to repair or replace products under warranty at the time of sale. Factors that affect the Company&#8217;s warranty reserve
    include the number of units sold, historical and anticipated rates of warranty repairs and the cost per repair.</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <table align="right" cellspacing="0" cellpadding="0" border="0" id="z24e95ed7a2ee4f738f16153ac66d9200" style="width: 95%; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">

      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="text-align: center; line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">US Dollars<br>
            in<br>
            thousands</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 88%;">
          <div style="line-height: 1.25;">Balance at December 31, 2019</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">227</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 88%;">
          <div style="line-height: 1.25;">Provision</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">125</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 88%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">Usage</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
          <div style="line-height: 1.25;">(212</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">)</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 88%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">Balance at December 31, 2020</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">140</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
      </tr>

  </table>
  <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; clear: both;">&#160;</div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z1a8f598a777d49a5b354da4c89c73b12">

      <tr>
        <td style="width: 17pt;"><br>
        </td>
        <td style="width: 19pt; vertical-align: top; align: right;">p.</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div>Concentrations of Credit Risks:</div>
        </td>
      </tr>

  </table>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash, cash equivalents and trade receivables.</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">The Company&#8217;s cash and cash equivalents are deposited in major banks in Israel, the United States and Germany. Such deposits in the United States may be in excess of insured limits
    and are not insured in other jurisdictions. The Company maintains cash and cash equivalents with diverse financial institutions and monitors the amount of credit exposure to each financial institution.</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">Concentration of credit risk with respect to trade receivable is primarily limited to a customer to which the Company makes substantial sales.</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <table align="right" cellspacing="0" cellpadding="0" border="0" id="z6023b00ba79a4ef29192bf73408506a9" style="width: 95%; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">

      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">December 31,</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;"> 2020</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">2019</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 76%;">
          <div style="text-align: justify; line-height: 1.25;">Customer A</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">15</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">%</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">*</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">)</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 76%;">
          <div style="line-height: 1.25;">Customer B</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">15</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">%</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">*</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">)</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 76%;">
          <div style="text-align: justify; line-height: 1.25;">Customer C</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">15</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">%</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">*</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">)</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 76%;">
          <div style="text-align: justify; line-height: 1.25;">Customer D</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">14</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">%</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">*</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">)</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 76%;">
          <div style="text-align: justify; line-height: 1.25;">Customer E</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">12</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">%</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">12</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">%</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 76%;">
          <div style="text-align: justify; line-height: 1.25;">Customer F</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">11</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">%</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">*</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">)</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 76%;">
          <div style="text-align: justify; line-height: 1.25;">Customer G</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">*</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">14</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">%</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 76%;">
          <div style="line-height: 1.25;">Customer H</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">*</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">13</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">%</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 76%;">
          <div style="line-height: 1.25;">Customer I</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">*</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">13</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">%</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 76%;">
          <div style="text-align: justify; line-height: 1.25;">Customer J</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">*</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">12</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">%</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 76%;">
          <div style="text-align: justify; line-height: 1.25;">Customer K</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">*</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">12</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">%</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 76%;">
          <div style="line-height: 1.25;">Customer L</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">*</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">12</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">%</div>
        </td>
      </tr>

  </table>
  <div style="text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif; clear: both;">&#160;</div>
  <table align="right" cellspacing="0" cellpadding="0" border="0" style="width: 95%; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;" id="z134b78bbeb3144378ee804552ff51346">

      <tr>
        <td style="width: 3.85%; vertical-align: top;">
          <div style="line-height: 1.25;">*)</div>
        </td>
        <td style="width: 96.15%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25;">Less than 10%</div>
        </td>
      </tr>

  </table>
  <div style="text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif; clear: both;">&#160;&#160;</div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal; font-family: 'Times New Roman',Times,serif;">F - 19</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  &#160;
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">The Company&#8217;s trade receivables are geographically diversified and derived primarily from sales to customers in various countries, mainly in the United States and Europe.
    Concentration of credit risk with respect to trade receivables is limited by credit limits, ongoing credit evaluation and account monitoring procedures. The Company performs ongoing credit evaluations of its distributors based upon a specific review of
    all significant outstanding invoices. The Company writes off receivables when they are deemed uncollectible and having exhausted all collection efforts. As of December 31, 2020, and 2019 trade receivables are presented net of $102 thousand and $31
    thousand allowance for doubtful accounts, respectively, and net of sales return reserve of $0 thousand and $86 thousand, respectively.</div>
  <div style="text-align: justify; line-height: 1.25;">&#160;</div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4e14dd2dffa44865bb3145074fd5b07a">

      <tr>
        <td style="width: 17pt;"><br>
        </td>
        <td style="width: 19pt; vertical-align: top; align: right;">q.</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div>Accrued Severance Pay:</div>
        </td>
      </tr>

  </table>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">Pursuant to Israel&#8217;s Severance Pay Law, Israeli employees are entitled to severance pay equal to one month&#8217;s salary for each year of employment, or a portion thereof. All of the
    employees of the RRL elected to be included under section 14 of the Severance Pay Law, 1963 (&#8220;section 14&#8221;). According to this section, these employees are entitled only to monthly deposits, at a rate of 8.33% of their monthly salary, made in their name
    with insurance companies. Payments in accordance with section 14 release the Company from any future severance payments (under the above Israeli Severance Pay Law) in respect of those employees; therefore, related assets and liabilities are not
    presented in the balance sheet.&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">Total Company expenses related to severance pay amounted to $125 thousand, $156 thousand and $169 thousand for the years ended December&#160;31, 2020, 2019 and 2018, respectively.</div>
  <div style="text-align: justify; line-height: 1.25;">&#160;</div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z6bf8ea3b08384d14b0ccf4afddd571ac">

      <tr>
        <td style="width: 17pt;"><br>
        </td>
        <td style="width: 19pt; vertical-align: top; align: right;">r.</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div>Fair Value Measurements:</div>
        </td>
      </tr>

  </table>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the
    asset or liability in an orderly transaction between market participants on the measurement date.&#160; The Company uses a three-tier fair value hierarchy to classify and disclose all assets and liabilities measured at fair value on a recurring basis, as
    well as assets and liabilities measured at fair value on a non-recurring basis, in periods subsequent to their initial measurement.&#160; The hierarchy requires the Company to use observable inputs when available, and to minimize the use of unobservable
    inputs when determining fair value. If a financial instrument uses inputs that fall in different levels of the hierarchy, the instrument will be categorized based upon the lowest level of input that is significant to the fair value calculation. The
    three-tiers are defined as follows:</div>
  <div style="margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <div>
    <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zdcbd6ac918d047b7b0ce02f1923b2381" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">

        <tr style="vertical-align: top;">
          <td style="width: 36pt;">&#160;</td>
          <td style="vertical-align: top; width: 27pt;">
            <div style="text-align: left; line-height: 1.25;">&#9679;</div>
          </td>
          <td style="align: left; vertical-align: top; width: auto;">
            <div style="text-align: left; line-height: 1.25;"><font style="font-weight: bold;">Level 1.&#160;</font>Observable inputs based on unadjusted quoted prices in active markets for identical assets or liabilities;</div>
          </td>
        </tr>

    </table>
  </div>
  <div style="line-height: 1.25;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
  <div>
    <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zd17ba00465ad44acbc00c8c632d833f1" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">

        <tr style="vertical-align: top;">
          <td style="width: 36pt;">&#160;</td>
          <td style="vertical-align: top; width: 27pt;">
            <div style="text-align: left; line-height: 1.25;">&#9679;</div>
          </td>
          <td style="align: left; vertical-align: top; width: auto;">
            <div style="text-align: left; line-height: 1.25;"><font style="font-weight: bold;">Level 2.&#160;</font>Inputs, other than quoted prices in active markets, that are observable either directly or indirectly; and</div>
          </td>
        </tr>

    </table>
  </div>
  <div style="line-height: 1.25;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
  <div>
    <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z7971363fdc984e908a793fa67f2f12af" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">

        <tr style="vertical-align: top;">
          <td style="width: 36pt;">&#160;</td>
          <td style="vertical-align: top; width: 27pt;">
            <div style="text-align: left; line-height: 1.25;">&#9679;</div>
          </td>
          <td style="align: left; vertical-align: top; width: auto;">
            <div style="text-align: left; line-height: 1.25;"><font style="font-weight: bold;">Level 3.&#160;</font>Unobservable inputs for which there is little or no market data requiring the Company to develop its own assumptions.</div>
          </td>
        </tr>

    </table>
  </div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">The carrying amounts of cash and cash equivalents, short term deposits, trade receivables and trade payables approximate their fair value due to the short-term maturity of such
    instruments.</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">&#160;&#160;</div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal; font-family: 'Times New Roman',Times,serif;">F - 20</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <div style="text-align: center; line-height: 1.25;"><br>
  </div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z147735070f9745478837e094cfe351cf">

      <tr>
        <td style="width: 17pt;"><br>
        </td>
        <td style="width: 19pt; vertical-align: top; align: right;">s.</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div>Basic and Diluted Net Loss Per Share:</div>
        </td>
      </tr>

  </table>
  <div style="margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">Basic net loss per share is computed by dividing the net loss by the weighted-average number of shares of ordinary shares outstanding during the period.</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">Diluted net loss per share is computed by giving effect to all potential shares of ordinary shares, including stock options, convertible preferred share warrants, to the extent
    dilutive, all in accordance with ASC No.&#160;260, &#8220;Earning Per Share&#8221;.</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">The following table sets forth the computation of the Company&#8217;s basic and diluted net loss per ordinary share (in thousands, except share and per share data):</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <table align="right" cellspacing="0" cellpadding="0" border="0" id="zf3292f75d1664a6e9a65631d4d24c1c5" style="width: 95%; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">

      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="10" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">Year ended December 31,</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;"> 2020</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">2019</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">2018</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 64%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">Net loss</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
          <div style="line-height: 1.25;">(12,976</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
          <div style="line-height: 1.25;">(15,551</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
          <div style="line-height: 1.25;">(21,675</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">)</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 64%;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 64%;">
          <div style="line-height: 1.25;">Net loss attributable to ordinary shares</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">(12,976</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">(15,551</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">(21,675</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">)</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">Shares used in computing net loss per ordinary shares, basic and diluted</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">15,764,980</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">5,763,317</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">1,472,499</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 64%;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 64%;">
          <div style="line-height: 1.25;">Net loss per ordinary share, basic and diluted</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">(0.82</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">(2.70</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">(14.72</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">)</div>
        </td>
      </tr>

  </table>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif; clear: both;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">
    <div style="text-align: left; line-height: 1.25;">Basic and diluted net loss per share was the same for each period presented as the inclusion of all potential shares of ordinary shares and warrants outstanding would have been anti-dilutive.</div>
    <div style="line-height: 1.25">&#160;</div>
  </div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z84c18d6253bf4238bc62601cb23e7efb">

      <tr>
        <td style="width: 17pt;"><br>
        </td>
        <td style="width: 19pt; vertical-align: top; align: right;">t.</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div>Contingent liabilities</div>
        </td>
      </tr>

  </table>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">The Company accounts for its contingent liabilities in accordance with ASC No.&#160;450, &#8220;Contingencies&#8221;. A provision is recorded when it is both probable that a liability has been
    incurred and the amount of the loss can be reasonably estimated.</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">With respect to legal matters, provisions are reviewed and adjusted to reflect the impact of negotiations, estimated settlements, legal rulings, advice of legal counsel and other
    information and events pertaining to a particular matter.</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;"> <br>
  </div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">See note 7e for further information.</div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4e6e8ddef3724ce7868cf6b53b989b16">

      <tr>
        <td style="width: 17pt;"><br>
        </td>
        <td style="width: 19pt; vertical-align: top; align: right;">u.</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div>Government grants</div>
        </td>
      </tr>

  </table>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">Government grants received by the Company relating to categories of operating expenditures are credited to the consolidated statements of operations during the period in which the
    expenditure to which they relate is charged. Royalty and non-royalty-bearing grants from the Israel Innovation Authority, or the IIA, (formerly known as the Israeli Office of the Chief Scientist), from the Israel-U.S. Binational Industrial Research and
    Development Foundation (&#8220;BIRD&#8221;) and from the Israeli Fund for Promoting Overseas Marketing for funding certain approved research and development projects and sales and marketing activities are recognized at the time when the Company is entitled to such
    grants, on the basis of the related costs incurred, and are included as a deduction from research and development or sales and marketing expenses (see Note&#160;7c).</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">No royalty-bearing grants were recorded for the years ended December 31, 2020, and December 31, 2019, the Company received royalty-bearing grants in the amount of $198 thousand for
    the year ended December 31, 2018, as part of the research and development expenses.</div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal; font-family: 'Times New Roman',Times,serif;">F - 21</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <div style="line-height: 1.25">&#160;<br>
  </div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">Total Company expenses related to royalties amounted to $46 thousand, $15 thousand for the years ended December&#160;31, 2020, 2019, respectively, no royalty expenses were recorded for
    the year ended December&#160;31, 2018.</div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zedb0b2f971494d55a06e892aae3c3b76">

      <tr>
        <td style="width: 17pt;"><br>
        </td>
        <td style="width: 19pt; vertical-align: top; align: right;">v.</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div>New Accounting Pronouncements</div>
        </td>
      </tr>

  </table>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-indent: 36pt; line-height: 1.25; font-style: italic;">Recently Implemented Accounting Pronouncements</div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z53e58c161f4e4c0d9e1cfc8d00371b44">

      <tr>
        <td style="width: 72pt;"><br>
        </td>
        <td style="width: 36pt; vertical-align: top; align: right;">i.</td>
        <td style="width: auto; vertical-align: top;">
          <div>Leases:</div>
        </td>
      </tr>

  </table>
  <div style="line-height: 1.25">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">In February 2016, the FASB&#160;issued Accounting Standard Update, or ASU, No. 2016-02, Leases (Topic 842), to enhance the transparency and comparability of financial reporting related to
    leasing arrangements. The Company adopted the standard effective January 1, 2019. At the inception of an arrangement, the Company determines whether the arrangement is or contains a lease based on the unique facts and circumstances present. Operating
    lease liabilities and their corresponding right-of-use assets are recorded based on the present value of lease payments over the expected lease term. The interest rate implicit in lease contracts is typically not readily determinable. As such, the
    Company utilizes its incremental borrowing rate, which is the rate incurred to borrow on a collateralized basis over a similar term an amount equal to the lease payments in a similar economic environment.</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">Prior to the Company&#8217;s adoption of ASU 2016-02, when its lease agreements contained rent payment relief and rent escalation clauses, the Company recorded a deferred rent asset or
    liability equal to the difference between the rent expense and the future minimum lease payments due. Operating leases are recognized on the balance sheet as right-of-use assets, current maturities of operating leases and noncurrent operating lease
    liabilities.</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">The Company used the modified retrospective transition method, under which the Company applied the standard as a cumulative effect adjustment to each lease that had commenced as of
    the beginning of January 1, 2019 and did not apply the standard to comparative historical periods. In addition, the Company elected to apply the package of practical expedients permitted under the transition guidance, which among other things, allowed
    the Company to carry forward the historical lease classification. The Company has elected, as of the adoption date, not to reassess whether expired or existing contracts contain leases under the new definition of a lease, not to reassess the lease
    classification for expired or existing leases, and not to reassess whether previously capitalized initial direct costs would qualify for capitalization under ASC 842.</div>
  <div style="text-align: center; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Leases with an initial term of 12 months or less are not recorded on the balance sheet. The Company recognizes the lease expense for such leases on a straight-line basis in the
      statement of operations over the lease term. As a result, the Company no longer recognizes deferred rent on the balance sheet.</div>
    <div style="margin-left: 36pt; line-height: 1.25;"> <br>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">The Company has elected to apply the practical expedient and combine lease and non-lease components.&#160; <br>
    </div>
  </div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Upon adoption of this standard on January 1, 2019, the Company recorded right&#8211;of&#8211;use assets and corresponding lease liabilities of&#160;$2,099 thousand&#160;and&#160;$2,249 thousand,
      respectively. As of&#160;December&#160;31, 2020, the right&#8211;of&#8211;use assets and corresponding lease liabilities in the Company&#8217;s consolidated balance sheets were&#160;$1,349 thousand&#160;and&#160;$1,583 thousand, respectively. The adoption of this standard did not have a
      material impact on the Company&#8217;s consolidated statements of operations or cash flows. See also note 7b - Lease commitment.</div>
  </div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal; font-family: 'Times New Roman',Times,serif;">F - 22</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic;">Recent Accounting Pronouncements Not Yet Adopted</div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z50e182fa759e4e5db0765d46b3042523">

      <tr>
        <td style="width: 70.8pt;"><br>
        </td>
        <td style="width: 36pt; vertical-align: top; align: right;">i.</td>
        <td style="width: auto; vertical-align: top;">
          <div>Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity</div>
        </td>
      </tr>

  </table>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">In August 2020, the FASB issued ASU No. 2020-06, Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity (ASU&#160; 2020-06), which simplifies the accounting for
    certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts in an entity&#8217;s own equity.&#160; Among other changes, ASU 2020-06 removes from GAAP the liability and equity separation model for
    convertible instruments with a cash conversion feature and a beneficial conversion feature, and as a result, after adoption, entities will no longer separately present in equity an embedded conversion feature for such debt. Similarly, the embedded
    conversion feature will no longer be amortized into income as interest expense over the life of the instrument. Instead, entities will account for a convertible debt instrument wholly as debt unless (1) a convertible instrument contains features that
    require bifurcation as a derivative under ASC Topic 815, Derivatives and Hedging, or (2) a convertible debt instrument was issued at a substantial premium. Additionally, ASU 2020-06 requires the application of the if-converted method to calculate the
    impact of convertible instruments on diluted earnings per share (EPS). ASU&#160; 2020-06 is effective for fiscal years beginning after December 15, 2021, with early adoption permitted for fiscal years beginning after December 15, 2020 and can be adopted on
    either a fully retrospective or modified retrospective basis. The adoption of this standard is not expected to result in a material impact to the Company&#8217;s financial statements.</div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z70dbcad0e59447bfa3b078cc6c5a1e76">

      <tr>
        <td style="width: 70.8pt;"><br>
        </td>
        <td style="width: 36pt; vertical-align: top; align: right;">ii.</td>
        <td style="width: auto; vertical-align: top;">
          <div>Financial Instruments&#160;</div>
        </td>
      </tr>

  </table>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">In June 2016, FASB issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. ASU 2016-13 amends the impairment
    model to utilize an expected loss methodology in place of the currently used incurred loss methodology, which will result in the more timely recognition of losses. Topic 326 was adopted by the Company on January 1, 2020. The adoption did not have a
    material impact on the Company&#8217;s consolidated financial statements.</div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="line-height: 1.25;"><font style="font-weight: bold;">NOTE&#160;3:-</font>&#160;&#160;&#160; <font style="font-weight: bold;">PREPAID EXPENSES AND OTHER CURRENT ASSETS</font></div>
  <div style="line-height: 1.25;">&#160;</div>
  <div style="text-indent: 36pt; line-height: 1.25;">The components of prepaid expenses and other current assets are as follows (in thousands):</div>
  <div style="line-height: 1.25;">&#160;</div>
  <table align="right" cellspacing="0" cellpadding="0" border="0" id="zc6efca7e7e844e46a25c6bd8d55ca9ea" style="width: 95%; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">

      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">December 31,</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;"> 2020</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">2019</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 76%;">
          <div style="line-height: 1.25;">Government institutions</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">87</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">175</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 76%;">
          <div style="line-height: 1.25;">Prepaid expenses</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">311</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">318</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 76%;">
          <div style="line-height: 1.25;">Advances to vendors</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">241</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">246</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">Other assets</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">33</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">164</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 76%;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">672</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">903</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
      </tr>

  </table>
  <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; clear: both;">&#160;</div>
  <div style="line-height: 1.25;"><font style="font-weight: bold;">NOTE&#160;4:-</font>&#160;&#160;&#160;&#160; <font style="font-weight: bold;">INVENTORIES</font></div>
  <div style="line-height: 1.25; font-weight: bold;">&#160;</div>
  <div style="text-indent: 36pt; line-height: 1.25;">The components of inventories are as follows (in thousands):</div>
  <div style="text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <table align="right" cellspacing="0" cellpadding="0" border="0" id="z4334ea3338be48a1a507c3302b556507" style="width: 95%; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">

      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">December 31,</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;"> 2020</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">2019</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 76%;">
          <div style="line-height: 1.25;">Finished products</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">2,764</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">2,394</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">Raw materials</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">778</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">729</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 76%;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">3,542</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">3,123</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
      </tr>

  </table>
  <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; clear: both;">&#160;</div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal; font-family: 'Times New Roman',Times,serif;">F - 23</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <div style="text-align: center; line-height: 1.25;"><br>
  </div>
  <div style="line-height: 1.25;"><font style="font-weight: bold;">NOTE&#160;5:-</font>&#160;&#160;&#160; <font style="font-weight: bold;">PROPERTY AND EQUIPMENT, NET</font></div>
  <div style="line-height: 1.25; font-weight: bold;">&#160;</div>
  <div style="text-indent: 36pt; line-height: 1.25;">The components of property and equipment, net are as follows (in thousands):</div>
  <div style="line-height: 1.25; font-weight: bold;">&#160;</div>
  <table align="right" cellspacing="0" cellpadding="0" border="0" id="z40bab54ebb0e4397aeb5637d012e1e87" style="width: 95%; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">

      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">December 31,</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;"> 2020</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">2019</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">Cost:</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 76%;">
          <div style="line-height: 1.25;">Computer equipment</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">725</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">723</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">Office furniture and equipment</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">298</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">293</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 76%;">
          <div style="line-height: 1.25;">Machinery and laboratory equipment</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">612</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">604</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">Field service units</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">1,626</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">1,420</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">Leasehold improvements</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">333</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">333</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">3,594</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">3,373</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
      </tr>

  </table>
  <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; clear: both;">&#160;</div>
  <table align="right" cellspacing="0" cellpadding="0" border="0" id="z840539bb6b7f46bea160bf1f1c4d9228" style="width: 95%; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">

      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">December 31,</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;"> 2020</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">2019</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 76%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">Accumulated depreciation</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
          <div style="line-height: 1.25;">3,157</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
          <div style="line-height: 1.25;">2,872</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 76%;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 76%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">Property and equipment, net</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
          <div style="line-height: 1.25;">437</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
          <div style="line-height: 1.25;">501</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
      </tr>

  </table>
  <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; clear: both;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Depreciation expenses amounted to $285 thousand, $321 thousand, and $463 thousand for the years ended December&#160;31, 2020, 2019 and 2018, respectively.&#160;</div>
  <div style="text-align: justify; text-indent: 54pt; line-height: 1.25;">&#160;</div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal; font-family: 'Times New Roman',Times,serif;">F - 24</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <br>
  <div style="line-height: 1.25; font-weight: bold;">NOTE&#160;6: -&#160;&#160; LOAN AGREEMENT WITH KREOS AND RELATED WARRANT TO PURCHASE ORDINARY SHARES</div>
  <div style="line-height: 1.25">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">On December 30, 2015, the Company entered into the loan agreement (the &#8220;Loan Agreement&#8221;) with Kreos Capital V (Expert Fund) Limited (&#8220;Kreos&#8221;), pursuant to which Kreos extended a line
    of credit to us in the amount of $20 million, with interest payable monthly in arrears on any amounts drawn down at a rate of 10.75% per year from the applicable drawdown date through the date on which all principal is repaid. As of June 30, 2017, the
    Company raised more than $20 million in connection with the issuance of its share capital and, therefore, in accordance with the terms of the Loan Agreement, the repayment period was extended from 24 months to 36 months. The principal was also reduced
    in connection with the issuance of the Kreos Convertible Note on June 9, 2017. Pursuant to the Loan Agreement, we granted Kreos a first priority security interest over all of our assets, including certain intellectual property and equity interests in
    its subsidiaries, subject to certain permitted security interests.</div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="text-indent: 36pt; line-height: 1.25;">Pursuant to the terms of the warrant, in connection with the $20.0 million drawdown under the Loan Agreement on January 4, 2016, we issued to Kreos the warrant to purchase up to 4,771 of our ordinary
    shares at an exercise price of $241.0 per share, increased to 6,679 ordinary shares on December 28, 2016. Subject to the terms of the warrant, the warrant is exercisable, in whole or in part, at any time prior to the earlier of (i) December 30, 2025,
    or (ii) immediately prior to the consummation of a merger, consolidation, or reorganization of us with or into, or the sale or license of all or substantially all our assets or shares to, any other entity or person, other than a wholly-owned subsidiary
    of us, excluding any transaction in which our shareholders prior to the transaction will hold more than 50% of the voting and economic rights of the surviving entity after the transaction.</div>
  <div style="text-indent: 36pt; line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="text-indent: 36pt; line-height: 1.25;">On June 9, 2017, the Company and Kreos entered into the First Amendment, under which $3.0 million of the outstanding principal under the Loan Agreement became subject to repayment pursuant to the senior
    secured Kreos Convertible Note issued on June 9, 2017.</div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
    <div style="text-indent: 36pt; line-height: 1.25;">&#160;On November 20, 2018, the Company and Kreos entered into the Second Amendment of the Loan Agreement, in which the Company repaid Kreos the $3.6 million other related payments, including prepayment
      costs and end of loan payments, terminating the Kreos Note, by issuing to Kreos 192,000 units and 288,000 pre-funded units as part of an underwritten public offering at the public offering prices, and the parties agreed to revise the principal and
      the repayment schedule under the Kreos Loan. Additionally, Kreos and the Company entered into the Kreos Warrant Amendment, which amended the exercise price of the warrant to purchase 6,679 ordinary shares currently held by Kreos from $241.0 to $7.50.</div>
  </div>
  <div style="text-align: justify; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">On June 5, 2019 and June 6, 2019, the Company entered into warrant exercise agreements with certain institutional investors of warrants to purchase the Company&#8217;s ordinary shares,
    pursuant to which, Kreos agreed to exercise in cash their November 2018 warrants at the existing exercise price of $7.50 per share. Under the exercise agreements, the Company also agreed to issue to Kreos new warrants to purchase up to 480,000 ordinary
    shares at an exercise price of $7.50 per share and exercise period of five years.&#160;</div>
  <div style="line-height: 1.25">&#160;<br>
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">On December 29, 2020, the Company repaid in full the remaining loan principal amount to Kreos including the end of loan payments, and by that discharged all of its obligations to
    Kreos and as of December 31, 2020, the outstanding principal amount under the Kreos Loan Agreement was zero.&#160;</div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The Company recorded interest expense in the amount of $907 thousand during the fiscal year ended December&#160;31, 2020.</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal; font-family: 'Times New Roman',Times,serif;">F - 25</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <div style="text-align: center; line-height: 1.25;"><br>
  </div>
  <div style="line-height: 1.25;"><font style="font-weight: bold;">NOTE&#160;7:-</font>&#160;&#160;&#160;&#160; <font style="font-weight: bold;">COMMITMENTS AND CONTINGENT LIABILITIES</font></div>
  <div style="line-height: 1.25">&#160;</div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z71631782f67c4ba1a807e8892c46a8cd">

      <tr>
        <td style="width: 17pt;"><br>
        </td>
        <td style="width: 19pt; vertical-align: top; align: right;">a.</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div>Purchase commitment:</div>
        </td>
      </tr>

  </table>
  <div style="margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">The Company has contractual obligations to purchase goods from its contract manufacturer as well as raw materials from different vendors. Purchase obligations do not include
    contracts that may be canceled without penalty. As of December&#160;31, 2020, non-cancelable outstanding obligations amounted to approximately $0.7 million.</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7114fb01bfff49ba95b76036a53bccf9">

      <tr>
        <td style="width: 17pt;"><br>
        </td>
        <td style="width: 19pt; vertical-align: top; align: right;">b.</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div>Operating lease commitment:</div>
        </td>
      </tr>

  </table>
  <div style="text-align: justify; text-indent: -18pt; margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <div>
    <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z98b9924a313d4ceea15de6d760b03ddd" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">

        <tr style="vertical-align: top;">
          <td style="width: 36pt;">&#160;</td>
          <td style="vertical-align: top; width: 18pt;">
            <div style="text-align: left; line-height: 1.25;">(i)</div>
          </td>
          <td style="align: left; vertical-align: top; width: auto;">
            <div style="text-align: justify; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif;">The Company operates from leased facilities in Israel, the United States and Germany. These leases expire between 2021 and 2023. A
                portion of the Company&#8217;s facilities leases is generally subject to annual changes in the Consumer Price Index (CPI). The changes to the CPI are treated as variable lease payments and recognized in the period in which the obligation for
                those payments was incurred.</font></div>
          </td>
        </tr>

    </table>
  </div>
  <div style="margin-left: 36pt; line-height: 1.25;">&#160;&#160;</div>
  <div>
    <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zcbd9492150d64f1f856ef88201ec8098" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">

        <tr style="vertical-align: top;">
          <td style="width: 36pt;">&#160;</td>
          <td style="vertical-align: top; width: 18pt;">
            <div style="text-align: left; line-height: 1.25;">(ii)</div>
          </td>
          <td style="align: left; vertical-align: top; width: auto;">
            <div style="text-align: justify; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif;">RRL and RRG lease cars for their employees under cancelable operating lease agreements expiring at various dates in between 2021 and
                2023. A subset of the Company&#8217;s cars leases is considered variable. The variable lease payments for such cars leases are based on actual mileage incurred at the stated contractual rate. RRL and RRG have an option to be released from these
                agreements, which may result in penalties in a maximum amount of approximately $26 thousand as of December&#160;31, 2020.</font></div>
          </td>
        </tr>

    </table>
  </div>
  <div style="text-align: justify; text-indent: -18pt; margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">The Company&#8217;s future lease payments for its facilities and cars, which are presented as current maturities of operating leases and non-current operating leases liabilities on the
    Company&#8217;s consolidated balance sheets as of&#160;December&#160;31, 2020&#160;are as follows (in thousands):</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <table align="right" cellspacing="0" cellpadding="0" border="0" id="zdb7695d55aa043a5a1fe0885ee1a4249" style="width: 95%; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">

      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">2021</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">710</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 88%;">
          <div style="line-height: 1.25;">2022</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">676</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 88%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">2023</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">491</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 88%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">Total lease payments</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">1,877</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 88%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">Less: imputed interest</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">(294</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">)</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 88%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">Present value of future lease payments</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">1,583</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">Less: current maturities of operating leases</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">(660</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">)</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 88%;">
          <div style="line-height: 1.25;">Non-current operating leases</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">923</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">Weighted-average remaining lease term (in years)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">2.69</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 88%;">
          <div style="line-height: 1.25;">Weighted-average discount rate</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">12.6</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">%</div>
        </td>
      </tr>

  </table>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif; clear: both;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">Total rent expenses for the years ended December&#160;31, 2020, 2019 and 2018 were $764 thousand, $739 thousand, and $695 thousand, respectively.</div>
  <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf560b39bfd6e411487b434ff352a82c6">

      <tr>
        <td style="width: 17pt;"><br>
        </td>
        <td style="width: 19pt; vertical-align: top; align: right;">c.</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div>Royalties:</div>
        </td>
      </tr>

  </table>
  <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">The Company&#8217;s research and development efforts are financed, in part, through funding from the IIA and BIRD. Since the Company&#8217;s inception through December&#160;31, 2020, the Company
    received funding from the IIA and BIRD in the total amount of $1.97 million and $500 thousand, respectively. Out of the $1.97 million in funding from the IIA, a total amount of $1.57 million were royalty-bearing grants (as of December&#160;31, 2020, the
    Company paid royalties to the IIA in the total amount of $88 thousand), while a total amount of $400 thousand was received in consideration of 209 convertible preferred A shares, which converted after the Company&#8217;s initial public offering in September
    2014 into ordinary shares in a conversion ratio of 1 to 1. The Company is obligated to pay royalties to the IIA, amounting to 3% of the sales of the products and other related revenues generated from such projects, up to 100% of the grants received.
    The royalty payment obligations also bear interest at the LIBOR rate. The obligation to pay these royalties is contingent on actual sales of the applicable products and in the absence of such sales, no payment is required.</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;"> <br>
  </div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal; font-family: 'Times New Roman',Times,serif;">F - 26</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">Additionally, the License Agreement requires the Company to pay Harvard royalties on net sales, See note 9 below for more information about the Collaboration Agreement and the
    License Agreement.</div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">Royalties expenses in cost of revenue were&#160;$46 thousand and $15 thousand&#160;for the years ended December&#160;31, 2020, and 2019 respectively, no royalties&#8217; expenses recorded for the year
    ended December&#160;31, 2018.</div>
  <div style="margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">As of December&#160;31, 2020, the contingent liability to the IIA amounted to $1.6 million. The Israeli Research and Development Law provides that know-how developed under an approved
    research and development program may not be transferred to third parties without the approval of the IIA. Such approval is not required for the sale or export of any products resulting from such research or development. The IIA, under special
    circumstances, may approve the transfer of IIA-funded know-how outside Israel, in the following cases:</div>
  <div style="margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">(a)&#160;the grant recipient pays to the IIA a portion of the sale price paid in consideration for such IIA-funded know-how or in consideration for the sale of the grant recipient itself,
    as the case may be, which portion will not exceed six times the amount of the grants received plus interest (or three times the amount of the grant received plus interest, in the event that the recipient of the know-how has committed to retain the
    R&amp;D activities of the grant recipient in Israel after the transfer); (b)&#160;the grant recipient receives know-how from a third party in exchange for its IIA-funded know-how; (c)&#160;such transfer of IIA-funded know-how arises in connection with certain
    types of cooperation in research and development activities; or (d)&#160;If such transfer of know-how arises in connection with a liquidation by reason of insolvency or receivership of the grant recipient.</div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z67642dacf86542d184c5e455ae2e25fb">

      <tr>
        <td style="width: 17pt;"><br>
        </td>
        <td style="width: 19pt; vertical-align: top; align: right;">d.</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div>Liens</div>
        </td>
      </tr>

  </table>
  <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">&#160;&#160;</div>
  <div style="margin-left: 36pt; line-height: 1.25; text-align: justify;">
    <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">As part of the Company&#8217;s other long-term assets and restricted cash, an amount of $704 thousand has been pledged as security in respect of a guarantee granted
      to a third party. Such deposit cannot be pledged to others or withdrawn without the consent of such third party.</div>
  </div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal; font-family: 'Times New Roman',Times,serif;">F - 27</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <br>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z2e53269c7f3c45bd88bece20968e6c92">

      <tr>
        <td style="width: 17pt;"><br>
        </td>
        <td style="width: 19pt; vertical-align: top; align: right;">e.</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div>Legal Claims:</div>
        </td>
      </tr>

  </table>
  <div style="text-align: justify; text-indent: -18pt; margin-left: 36pt; line-height: 1.25;">&#160;&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
      <div style="line-height: 1.25;">As previously disclosed, between September 2016 and January 2017, eight putative class actions on behalf of alleged shareholders that purchased or acquired the Company&#8217;s ordinary shares pursuant and/or traceable to its
        registration statement on Form F-1 (File No. 333-197344) used in connection with the Company&#8217;s initial public offering (the &#8220;IPO&#8221;) were commenced in the following courts: (i) the Superior Court of the State of California, County of San Mateo; (ii)
        the Superior Court of the Commonwealth of Massachusetts, Suffolk County; (iii) the United States District Court for the Northern District of California; and (iv) the United States District Court for the District of Massachusetts. The actions
        involved claims under various sections of the Securities Act and the Exchange Act against the Company, certain of its current and former directors and officers, the underwriters of the Company&#8217;s IPO and certain other defendants. The four actions
        commenced in the Superior Court of the State of California, County of San Mateo were dismissed in January 2017 for lack of personal jurisdiction, and the action commenced in the United States District Court for the Northern District of California
        was voluntarily dismissed in March 2017. Additionally, the two actions commenced in the Superior Court of the Commonwealth of Massachusetts, Suffolk County (he &#8220;Superior Court&#8221;), were consolidated in December 2017, and voluntarily dismissed with
        prejudice in November 2018, after the District Court for the District of Massachusetts partially dismissed the related claims in that court and the parties in the Superior Court entered a stipulation of dismissal with prejudice.</div>
    </div>
  </div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="margin-left: 36pt; line-height: 1.25; text-align: justify;">
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">The action commenced in the United States District Court for the District of Massachusetts (the &#8220;District Court&#8221;), alleging violations of Sections 11 and 15 of the Securities
      Act and Sections 10(b) and 20(a) of the Exchange Act, was partially dismissed in August 2018. In particular, the District Court granted the motion to dismiss the claims under Sections 11 and 15 of the Securities Act, finding that the plaintiff failed
      to plead a false or misleading statement in the IPO registration statement. In May 2019, the court subsequently denied the plaintiff&#8217;s motion to amend to pursue Exchange Act claims and the complaint was dismissed. Thereafter, the plaintiff timely
      appealed to the United States Court of Appeals for the First Circuit, which subsequently affirmed the dismissal and the denial of the plaintiff&#8217;s motion to amend in August 2020. The plaintiff did not file a petition for certiorari for appeal of the
      case to the Supreme Court of the United States by the deadline on November 24, 2020. Thus, as of December 31, 2020, all eight actions had been dismissed, with such judgments being final and non-appealable.</div>
  </div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal; font-family: 'Times New Roman',Times,serif;">F - 28</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  &#160;
  <div style="line-height: 1.25; font-weight: bold;">NOTE&#160;8: - &#160; SHAREHOLDERS&#8217; EQUITY&#160;</div>
  <div style="line-height: 1.25">&#160;</div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zbce2f39981044abe95f83348d9a27c09">

      <tr>
        <td style="width: 17pt;"><br>
        </td>
        <td style="width: 19pt; vertical-align: top; align: right;">a.</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div>Reverse share split:&#160;</div>
        </td>
      </tr>

  </table>
  <div style="line-height: 1.25; font-weight: bold;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">On&#160;March&#160;27, 2019, the&#160;Company&#8217;s shareholders approved (i) a reverse share split within a range of 1:8 to 1:32, to be effective at the ratio and on a date to be determined by
      the Board of Directors, and (ii) amendments to the Company&#8217;s Articles of Association authorizing an increase in the Company&#8217;s authorized share capital (and corresponding authorized number of ordinary shares, proportionally adjusting such number for
      the reverse share split) by up to NIS 17.5 million. Following the shareholder approval, an authorized committee of the Board of Directors of the Company approved a one-for-twenty-five reverse share split of the Company&#8217;s ordinary shares, and the
      Company filed the Third Amended and Restated Articles of Association of the Company with the Israeli Corporations Authority to effect the reverse share split and to increase the Company&#8217;s authorized share capital after the effect of the reverse share
      split. The reverse share split became effective on April 1, 2019. Additionally, effective at the same time, the total number of ordinary shares the Company is authorized to issue changed from 250,000,000 shares to 60,000,000 shares, the par value per
      share of the ordinary shares changed to NIS 0.25 and the authorized share capital of the Company changed from NIS 2,500,000 to NIS 15,000,000. All share and per share data included in these consolidated financial statements, for periods before
      December 31, 2019, give retroactive effect to the reverse stock split.</div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">Upon the effectiveness of the reverse share split, every twenty-five shares were automatically combined and converted into one ordinary share. Appropriate adjustments were also made
    to all outstanding derivative securities of the Company, including all outstanding equity awards and warrants.</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">No fractional shares were issued in connection with the reverse share split. Instead, all fractional shares (including shares underlying outstanding equity awards and warrants) were
    rounded down to the nearest whole number.</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">&#160;&#160;</div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z23594874992e43fc97f02f13de087636">

      <tr>
        <td style="width: 17pt;"><br>
        </td>
        <td style="width: 19pt; vertical-align: top; align: right;">b.</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div>Equity raise:</div>
        </td>
      </tr>

  </table>
  <div style="line-height: 1.25;">&#160;</div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z964929ec1f6f4ccb991d72651bfdec3f">

      <tr>
        <td style="width: 17pt;"><br>
        </td>
        <td style="width: 19pt; vertical-align: top; align: right;">1.</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div>At-the-market offering program:</div>
        </td>
      </tr>

  </table>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">On May 10, 2016, the Company entered into an equity distribution agreement (the &#8220;Equity Distribution Agreement&#8221;) with Piper Jaffray &amp; Co. (&#8220;Piper Jaffray&#8221;), as amended on May 9,
    2019, pursuant to which it may offer and sell, from time to time, ordinary shares having an aggregate offering price of up to $25 million, through Piper Jaffray acting as its agent. Subject to the terms and conditions of the Equity Distribution
    Agreement, Piper Jaffray will use its commercially reasonable efforts to sell on the Company&#8217;s behalf all of the ordinary shares requested to be sold by the Company, consistent with its normal trading and sales practices. Piper Jaffray may also act as
    principal in the sale of ordinary shares under the Equity Distribution Agreement. Sales may be made under the Company&#8217;s shelf registration statement on Form S-3, which was declared effective by the&#160;SEC on&#160;May 9, 2016, or the Company&#8217;s shelf
    registration statement on Form S-3, which was declared effective by the SEC on May 23, 2019 (the &#8220;Form S-3&#8221;), in what may be deemed &#8220;at-the-market&#8221; equity offerings as defined in Rule 415 promulgated under the Securities Act of 1933, as amended (the
    &#8220;ATM Offering Program&#8221;). Sales may be made directly on or through the NASDAQ Capital Market, the existing trading market for the Company&#8217;s ordinary shares, to or through a market maker other than on an exchange or otherwise, in negotiated transactions
    at market prices prevailing at the time of sale or at prices related to such prevailing market prices, and/or any other method permitted by law, including in privately negotiated transactions. Piper Jaffray is entitled to compensation at a fixed
    commission rate of 3.0% of the gross sales price per share sold through it as agent under the Equity Distribution Agreement. Where Piper Jaffray acts as principal in the sale of ordinary shares under the Equity Distribution Agreement, such rate of
    compensation will not apply, but in no event will the total compensation of Piper Jaffray, when combined with the reimbursement of Piper Jaffray for the out-of-pocket fees and disbursements of its legal counsel, exceed 8.0% of the gross proceeds
    received from the sale of the ordinary shares. The Company is not required to sell any of its ordinary shares at any time.</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">From the inception of the ATM Offering Program in May 2016 until December 31, 2020, the Company had sold 302,092 ordinary shares under the ATM Offering Program for gross
      proceeds of $15.7 million and net proceeds to the Company of $14.5 million (after commissions, fees, and expenses). Additionally, as of that date, the Company had paid Piper Jaffray compensation for the fixed commission rate of 3.0% in the aggregated
      amount of $471 thousand and had incurred total expenses (including such commissions) of approximately $1.2 million in connection with the ATM Offering Program.</div>
  </div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal; font-family: 'Times New Roman',Times,serif;">F - 29</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0e6420828f00419fb2d007983c5ac23b">

      <tr>
        <td style="width: 17pt;"><br>
        </td>
        <td style="width: 19pt; vertical-align: top; align: right;">2.</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div>Follow-on offerings&#160;&#160;&#160;</div>
        </td>
      </tr>

  </table>
  <div style="text-align: justify; line-height: 1.25;">&#160;&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">In November 2018, the Company entered into an underwriting agreement with H.C. Wainwright &amp; Co., LLC (&#8220;H.C. Wainwright&#8221;), in connection with the Company&#8217;s follow-on public
    offering of 496,055 units, each consisting of one ordinary share and one common warrant to purchase one ordinary share with an exercise price of $7.5 per warrant. Each unit was sold to the public at a price of $7.50 per unit. On November 18, 2018, H.C.
    Wainwright exercised in full its option to purchase 231,964 ordinary shares for $7.25 per share and/or common warrants to purchase up to an additional 231,964 ordinary shares for $0.25 per warrant.</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">&#160;&#160;&#160;&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Additionally, the Company issued and sold 1,050,372 pre-funded units at a price to the public of $7.25 per unit. Each unit containing one pre-funded warrant with an exercise
      price of $0.25 per share and one warrant to purchase one ordinary share with an exercise price of $7.50 per warrant. The total gross proceeds received from the November 2018 follow-on public offering, before deducting commissions, discounts, and
      expenses, were $13.1 million (including proceeds from the exercise of 90,691 pre-funded warrants at the closing of the offering). As of December&#160;31, 2018, additional pre-funded warrants to purchase an aggregate 562,466 ordinary shares had been
      exercised, for additional proceeds of $140,617. During the year ended December 31, 2019 additional 288,000 pre-funded warrants and 296,087 warrants to purchase an aggregate 584,087 ordinary shares had been exercised, for additional proceeds of $1.5
      million. As compensation for their role in the offering, the Company also issued to the Underwriters warrants to purchase up to 106,680 ordinary shares, which became immediately exercisable starting on November 20, 2018 until November 15, 2023 at
      $9.375 per share.</div>
  </div>
  <div style="text-align: justify; line-height: 1.25;">&#160;&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">In February 2019, the Company entered into an exclusive placement agent agreement with H.C. Wainwright, on a reasonable best-efforts basis in connection with a public offering of
    760,000 ordinary shares at a price of $5.75 per share.</div>
  <div style="text-align: justify; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">The total gross proceeds received from the February 2019 follow-on public offering, before deducting commissions, discounts, and expenses, were $4.37 million. The Company also
      issued to H.C Wainwright and/or its designees warrants to purchase up to 45,600 ordinary shares, which are immediately exercisable starting on February 25, 2019 until February 21, 2024 at $7.1875 per share.</div>
  </div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">In April 2019, the Company entered into securities purchase agreements with certain institutional purchasers whereby the Company issued 816,914 ordinary shares at $5.2025 per
    ordinary share and warrants to purchase up to 408,457 ordinary shares with an exercise price of $5.14 per share, exercisable from April 5, 2019 until October 7, 2024, in a private placement that took place concurrently with the Company&#8217;s registered
    direct offering of ordinary shares in April 2019. Additionally, the Company issued warrants to purchase up to 49,015 ordinary shares, with an exercise price of $6.503125 per share, exercisable from April 5, 2019 until April 3, 2024, to representatives
    of H.C. Wainwright as compensation for its role as the placement agent in the Company&#8217;s April 2019 registered direct offering and concurrent private placement of warrants.</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">On June 5, 2019 and June 6, 2019, the Company entered into warrant exercise agreements with certain institutional investors whereby the Company issued warrants to purchase up to
    1,464,665 ordinary shares with an exercise price of $7.50 per share, exercisable from June 5, 2019 or June 6, 2019 until June 5, 2024 or June 6, 2024, respectively. Additionally, the Company issued warrants to purchase up to 87,880 ordinary shares,
    with an exercise price of $9.375 per share, exercisable from June 5, 2019 until June 5, 2024, to certain representatives of H.C. Wainwright as compensation for its role as the placement agent in the Company&#8217;s June 2019 warrant exercise agreement and
    concurrent private placement of warrants.</div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal; font-family: 'Times New Roman',Times,serif;">F - 30</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">On June 12, 2019, the Company entered into a purchase agreement with certain institutional investors for the issuance and sale of 833,334 ordinary shares, par value NIS 0.25 per
    share&#160;at $6.00 per ordinary share and warrants to purchase up to 416,667 ordinary shares with an exercise price of $6.00 per share, exercisable from June 12, 2019 until December 12, 2024, in a private placement that took place concurrently with the
    Company&#8217;s registered direct offering of ordinary shares in June 2019. Additionally, the Company issued warrants to purchase up to 50,000 ordinary shares, with an exercise price of $7.50 per share, exercisable from June 12, 2019 until June 10, 2024, to
    certain representatives of H.C. Wainwright as compensation for its role as the placement agent in the Company&#8217;s June 2019 registered direct offering and concurrent private placement of warrants.</div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">
    <div style="text-align: left; line-height: 1.25;">On February 10, 2020, the Company closed a &#8220;best efforts&#8221; public offering whereby the Company issued an aggregate of 5,600,000 of common units and pre-funded units at a public offering price of $1.25
      per common unit and $1.249 per pre-funded unit. As part of the public offering, the Company entered into a securities purchase agreement with certain institutional purchasers. Each common unit consisted of one ordinary share, par value NIS 0.25 per
      share, and one common warrant to purchase one ordinary share. Each of the 1,546,828 pre-funded unit consisted of one pre-funded warrant to purchase one ordinary share and one common warrant. Additionally, the Company issued warrants to purchase up to
      336,000 ordinary shares, with an exercise price of $1.5625 per share, to representatives of H.C. Wainwright as compensation for its role as the placement agent in the Company&#8217;s February 2020 offering.&#160; During the three months ended March 31, 2020,
      all pre-funded warrants to purchase ordinary shares were exercised.</div>
    <div style="line-height: 1.25">&#160;</div>
  </div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">As of December 31, 2020, a total of 1,831,500 common warrants to purchase ordinary shares were exercised.</div>
  </div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">On July 6,2020, the Company entered into a purchase agreement with certain institutional investors for the issuance and sale of (i) 4,938,278 ordinary shares, par value NIS 0.25 per
    share, at a price of $1.8225 per ordinary share and (ii) warrants to purchase up to 2,469,139 ordinary shares with an exercise price of $1.76 per share, exercisable from July 6, 2020 until January 6, 2026. Additionally, the Company issued warrants to
    purchase up to 296,297 ordinary shares, with an exercise price of $2.2781 per share, exercisable from July 6, 2020 until July 2, 2025, to certain representatives of H.C. Wainwright as compensation for its role as the placement agent in its July 2020
    registered direct offering.</div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">On December 3,2020, the Company entered into a purchase agreement with certain institutional investors for the issuance and sale of (i) 5,579,776 ordinary shares, par value NIS 0.25
    per share, at a price of $1.4337 per ordinary share and (ii) warrants to purchase up to 4,184,832 ordinary shares with an exercise price of $1.34 per share, exercisable from December 8, 2020 until June 8, 2026. Additionally, the Company issued warrants
    to purchase up to 334,787 ordinary shares, with an exercise price of $1.7922 per share, exercisable from December 8, 2020 until June 8, 2026, to certain representatives of H.C. Wainwright as compensation for its role as the placement agent in its
    December 2020 registered direct offering.</div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf1a1ca111b0c4711a3ec7bf9ad55065d">

      <tr>
        <td style="width: 17pt;"><br>
        </td>
        <td style="width: 19pt; vertical-align: top; align: right;">3.</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div>Investment agreement</div>
        </td>
      </tr>

  </table>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">On March 6, 2018, the Company entered into an investment agreement with Timwell Corporation Limited, a Hong Kong corporation (&#8220;Timwell&#8221;), as amended on May 15, 2018 (the &#8220;Investment
    Agreement&#8221;), pursuant to which the Company agreed to issue to Timwell, in three different tranches, an aggregate of 640,000 ordinary shares in return for aggregate gross proceeds of $20 million. The closing of each tranche is subject to certain closing
    conditions. The closing of the first tranche (the &#8220;First Tranche Closing&#8221;) took place on May 15, 2018, upon which Timwell received 160,000 ordinary shares for an aggregate purchase price of $5,000,000, and Timwell and the Company signed a registration
    rights agreement in the form attached to the Investment Agreement. The net aggregate proceeds of the First Tranche Closing after deducting fees and other related expenses in the amount of approximately $705 thousands were approximately $4.3 million.
    The remaining investment is to occur in two tranches, including $10 million for the issuance to Timwell of 320,000 ordinary shares (the &#8220;Second Tranche&#8221;) and $5 million for the issuance to Timwell of 160,000 ordinary shares (the &#8220;Third Tranch&#8221;). The
    closing of the second and third tranches is subject to specified closing conditions, including, with respect to the second tranche, the signing of a license agreement and a supply agreement and the formation of the China JV (the &#8220;China JV&#8221;) based on
    the JV Framework Agreement, and, with respect to the third tranche, the successful production of certain ReWalk products by the China JV. The second tranche closing was initially expected to occur by July 1, 2018 and the third tranche closing was
    initially expected to occur by December 31, 2018 and no later than April 1, 2019.</div>
  <div style="text-align: justify; line-height: 1.25;">&#160;</div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal; font-family: 'Times New Roman',Times,serif;">F - 31</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">In late March 2020, Timwell notified the Company that it would not invest the second and third tranches under the Investment Agreement. In response, in early April 2020, the
    Company&#8217;s Board of Directors also removed Timwell&#8217;s designee, who was appointed pursuant to the Investment Agreement, from the Board of Directors, due to this breach pursuant to the terms of the Investment Agreement. As the Company continues to view
    China as a market with key opportunities for products designed for stroke patients, the Company continues to evaluate potential relationships with other groups to penetrate the Chinese market.</div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">In May 2018, the Company entered into a fee and release agreement with Canaccord Genuity LLC (&#8220;Canaccord Genuity&#8221;) requiring the Company to pay to Canaccord Genuity, in connection
    with a settlement, in addition to certain cash amounts, (i) $125 thousand in ordinary shares of the Company after the First Tranche Closing of the Timwell transaction and (ii) $225 thousand in ordinary shares of the Company after the closing of the
    Second Tranche of the Timwell transaction (or such lower amount if the Second Tranche Closing is less than $10.0 million). The price per share used for calculation of the number of ordinary shares issued by the Company to Canaccord Genuity is based on
    the volume weighted average price of the Company&#8217;s ordinary shares as reported on the Nasdaq Capital Market for the five consecutive trading days prior to the date of issuance. The Company is also obligated to pay $100 thousand in cash following the
    closing of the Third Tranche of $5.0 million (or such lower amount if the Third Tranche Closing is less than $5.0 million). Following the First Tranche Closing on May 15, 2018, the Company issued 4,715 ordinary shares to Canaccord Genuity.&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za59e12d1ab6b42a189bf8ea686629c55">

      <tr>
        <td style="width: 17pt;"><br>
        </td>
        <td style="width: 19pt; vertical-align: top; align: right;">c.</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div>Share option plans:</div>
        </td>
      </tr>

  </table>
  <div style="line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">On March&#160;30, 2012, the Company&#8217;s board of directors adopted the ReWalk Robotics Ltd. 2012 Equity Incentive Plan.</div>
  <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">On August 19, 2014, the Company&#8217;s board of directors adopted the ReWalk Robotics Ltd. 2014 Incentive Compensation Plan or the &#8220;Plan&#8221;. The Plan provides for the grant of stock
    options, stock appreciation rights, restricted stock awards, restricted stock units, cash-based awards, other stock-based awards and dividend equivalents to the Company&#8217;s and its affiliates&#8217; respective employees, non-employee directors and consultants.</div>
  <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">Starting in 2014, the Company&#160;grants to directors and employees also Restricted Stock Units (&#8220;RSUs&#8217;&#8217;) under this Plan. An RSU award is an agreement to issue shares of the company&#8217;s
    ordinary shares at the time the award is vested.</div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">As of December 31, 2020, and 2019, the Company had reserved 604,320 and 12,409 shares of ordinary shares, respectively, available for issuance to employees, directors, officers, and
    non-employees of the Company.</div>
  <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">&#160;&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">The options generally vest over four years, with certain options granted to non-employee directors during the fiscal year ended December&#160;31, 2019, vesting over&#160;one&#160;year.</div>
  <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">Any option that is forfeited or canceled before expiration becomes available for future grants under the Plan.</div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal; font-family: 'Times New Roman',Times,serif;">F - 32</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt; line-height: 1.25;">&#160;<br>
  </div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
      <div style="line-height: 1.25;">A summary of employee and non-employee&#160;shares options activity during the fiscal year ended 2020 is as follows:</div>
    </div>
  </div>
  <div style="text-align: justify; margin-left: 72pt; line-height: 1.25;">&#160;</div>
  <table align="right" cellspacing="0" cellpadding="0" border="0" id="z333a780dd513489ea483da9d96b10a52" style="width: 95%; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">

      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">Number</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">Average</div>
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">exercise</div>
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">price</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">Average</div>
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">remaining</div>
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">contractual</div>
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">life (years)</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">Aggregate</div>
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">intrinsic</div>
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">value (in</div>
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">thousands)</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 52%;">
          <div style="line-height: 1.25;">Options outstanding at the beginning of the year</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">74,713</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">41.6</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">6.34</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">135</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 52%;">
          <div style="line-height: 1.25;">Granted</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 52%;">
          <div style="line-height: 1.25;">Exercised</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">Forfeited</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">(5,107</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">91.59</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 52%;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">Options outstanding at the end of the year</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">69,606</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">37.9</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">5.59</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 52%;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">Options exercisable at the end of the year</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">52,997</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">43.76</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">4.94</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
      </tr>

  </table>
  <div style="text-align: justify; margin-left: 72pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif; clear: both;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
      <div style="line-height: 1.25;">A summary of employee and non-employee RSUs activity during the fiscal year ended 2020 is as follows:</div>
    </div>
  </div>
  <div style="text-align: justify; line-height: 1.25;">&#160;</div>
  <table align="right" cellspacing="0" cellpadding="0" border="0" id="z08c2cc9952cf4a269ef65b9e027ffd67" style="width: 95%; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">

      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">Number of</div>
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">shares underlying</div>
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">outstanding</div>
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">RSUs</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">Weighted-</div>
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">average</div>
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">grant date</div>
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">fair value</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 76%;">
          <div style="line-height: 1.25;">Unvested RSUs at the beginning of the year</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">62,378</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">44.61</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 76%;">
          <div style="line-height: 1.25;">Granted</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">1,266,185</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">1.44</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 76%;">
          <div style="line-height: 1.25;">Vested</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">(63,111</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">7.83</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">Forfeited</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">(14,141</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">6.05</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 76%;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">Unvested RSUs at the end of the year</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">1,251,311</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">3.20</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
      </tr>

  </table>
  <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; clear: both;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">The weighted average grant date fair values of options granted during the fiscal year ended December&#160;31, 2019, 2018 were $2.98, $15.25, respectively. The weighted average grant date
    fair values of RSUs granted during the fiscal year ended December&#160;31, 2020, 2019 and 2018, were $1.44, $4.67and $26.75, respectively.</div>
  <div style="text-align: justify; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">The aggregate intrinsic value in the table above represents the total intrinsic value that would have been received by the option holders had all option holders, which hold options
    with positive intrinsic value, exercised their options on the last date of the exercise period. During the years ended December&#160;31, 2020 and December&#160;31, 2019, no options were exercised. Total fair value of shares vested during the year ended
    December&#160;31, 2020, 2019 and 2018 were $676 thousand, $1,175 thousand, and $2,918 thousand, respectively. As of December&#160;31, 2020, there were $2 million of total unrecognized compensation cost related to non-vested share-based compensation arrangements
    granted under the 2014 Plan. This cost is expected to be recognized over a period of approximately 3.2 years.</div>
  <div style="text-align: justify; text-indent: 54pt; line-height: 1.25;">&#160;</div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal; font-family: 'Times New Roman',Times,serif;">F - 33</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <br>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">The number of options and RSUs outstanding as of December&#160;31, 2020 is set forth below, with options separated by range of exercise price:</div>
  <div style="text-align: justify; text-indent: 54pt; line-height: 1.25;">&#160;</div>
  <table align="right" cellspacing="0" cellpadding="0" border="0" id="z6f11344252224499ad65c066a0b989e8" style="width: 95%; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">

      <tr>
        <td style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">Range of exercise&#160;price</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">Options and RSUs<br>
            Outstanding as of<br>
            December 31,<br>
            2020</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">Weighted</div>
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">average</div>
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">remaining</div>
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">contractual</div>
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">life (years) (1)</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">Options Exercisable as of December 31,<br>
            2020</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">Weighted</div>
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">average</div>
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">remaining</div>
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">contractual</div>
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">life (years) (1)</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 52%;">
          <div style="line-height: 1.25;">RSUs only</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">1,251,311</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 52%;">
          <div style="line-height: 1.25;">$5.37</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">12,425</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">8.24</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">5,435</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">8.24</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 52%;">
          <div style="line-height: 1.25;">$20.42- $33.75</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">36,292</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">5.26</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">27,598</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">4.60</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 52%;">
          <div style="line-height: 1.25;">$37.14-$38.75</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">9,992</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">2.99</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">9,992</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">2.99</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 52%;">
          <div style="line-height: 1.25;">$50-$52.5</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">8,231</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">6.43</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">7,306</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">6.44</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">$182.5-$524.25</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">2,666</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">4.84</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">2,666</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">4.84</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 52%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
          <div style="line-height: 1.25;">1,320,917</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
          <div style="line-height: 1.25;">5.59</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
          <div style="line-height: 1.25;">52,997</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
          <div style="line-height: 1.25;">4.94</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
      </tr>

  </table>
  <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; clear: both;">&#160;</div>
  <table align="right" cellspacing="0" cellpadding="0" border="0" style="width: 95%; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;" id="z0880807c2442494481d433b408f422c8">

      <tr>
        <td style="width: 3.85%; vertical-align: top;">
          <div style="line-height: 1.25;">(1)</div>
        </td>
        <td style="width: 96.09%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25;">Calculation of weighted average remaining contractual term does not include the RSUs that were granted, which have an indefinite contractual term.</div>
        </td>
      </tr>

  </table>
  <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; clear: both;">&#160;</div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf8331be665c64e619344e46cc4d93093">

      <tr>
        <td style="width: 17pt;"><br>
        </td>
        <td style="width: 19pt; vertical-align: top; align: right;">d.</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div>Equity compensation issued to consultants:</div>
        </td>
      </tr>

  </table>
  <div style="text-align: justify; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">The Company granted 6,680 fully vested RSUs during the fiscal year ended December&#160;31, 2019 to non-employee consultants. As of December&#160;31, 2020, there are no outstanding options or
    RSUs held by non-employee consultants.</div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd31e7a8bb09f4dd380ed3659c480e191">

      <tr>
        <td style="width: 17pt;"><br>
        </td>
        <td style="width: 19pt; vertical-align: top; align: right;">e.</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div>Share-based compensation expense for employees and non-employees:</div>
        </td>
      </tr>

  </table>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">The Company recognized non-cash share-based compensation expense in the consolidated statements of operations as follows (in thousands):</div>
  </div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <table align="right" cellspacing="0" cellpadding="0" border="0" id="zedd6cc7efe2d49be877f8a188016ed3a" style="width: 95%; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">

      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="10" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">Year Ended December 31,</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;"> 2020</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">2019</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">2018</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 64%;">
          <div style="line-height: 1.25;">Cost of revenues</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">8</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">13</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">16</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 64%;">
          <div style="line-height: 1.25;">Research and development, net</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">136</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">204</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">435</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 64%;">
          <div style="line-height: 1.25;">Sales and marketing, net</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">163</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">166</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">467</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">General and administrative</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">442</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">725</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">1,848</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 64%;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">Total</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">749</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">1,108</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">2,766</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
      </tr>

  </table>
  <div style="line-height: 1.25; clear: both;"><br style="line-height: 1.25;">
  </div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal; font-family: 'Times New Roman',Times,serif;">F - 34</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  &#160;
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zece8f1ea1f6d4bc0a3b21fc81312ccac">

      <tr>
        <td style="width: 17pt;"><br>
        </td>
        <td style="width: 19pt; vertical-align: top; align: right;">f.</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div>Warrants to purchase ordinary shares:</div>
        </td>
      </tr>

  </table>
  <div style="line-height: 1.25;">&#160;</div>
  <div style="margin-left: 36pt; line-height: 1.25;">The following table summarizes information about warrants outstanding and exercisable as of December&#160;31, 2020:</div>
  <div style="text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <table align="right" cellspacing="0" cellpadding="0" border="0" id="z10fa5c8f5fd64ea58708475ca56d3205" style="width: 95%; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">

      <tr>
        <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25; font-weight: bold;">Issuance date</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">Warrants<br>
            outstanding</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">Exercise price per warrant</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">Warrants outstanding and exercisable</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">Contractual<br>
            term</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">(number)</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">(number)</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="text-align: center; line-height: 1.25;">&#160;</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 32%;">
          <div style="line-height: 1.25;">December 31, 2015 (1)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">4,771</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">7.500</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">4,771</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 32%;">
          <div style="text-align: center; line-height: 1.25;">See footnote (1)</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 32%;">
          <div style="line-height: 1.25;">November 1, 2016 (2)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">97,496</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">118.750</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">97,496</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" style="vertical-align: bottom; width: 32%;">
          <div style="text-align: center; line-height: 1.25;">November 1, 2021</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 32%;">
          <div style="line-height: 1.25;">December 28, 2016 (3)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">1,908</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">7.500</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">1,908</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 32%;">
          <div style="text-align: center; line-height: 1.25;">See footnote (1)</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 32%;">
          <div style="line-height: 1.25;">November 20, 2018 (4)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">126,839</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">7.500</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">126,839</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" style="vertical-align: bottom; width: 32%;">
          <div style="text-align: center; line-height: 1.25;">November 20, 2023</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 32%;">
          <div style="line-height: 1.25;">November 20, 2018 (5)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">106,680</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">9.375</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">106,680</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 32%;">
          <div style="text-align: center; line-height: 1.25;">November 15, 2023</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 32%;">
          <div style="line-height: 1.25;">February 25, 2019 (6)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">45,600</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">7.187</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">45,600</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" style="vertical-align: bottom; width: 32%;">
          <div style="text-align: center; line-height: 1.25;">February 21, 2024</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 32%;">
          <div style="line-height: 1.25;">April 5, 2019 (7)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">408,457</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">5.140</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">408,457</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 32%;">
          <div style="text-align: center; line-height: 1.25;">October 7, 2024</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 32%;">
          <div style="line-height: 1.25;">April 5, 2019 (8)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">49,015</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">6.503</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">49,015</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" style="vertical-align: bottom; width: 32%;">
          <div style="text-align: center; line-height: 1.25;">April 3, 2024</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 32%;">
          <div style="line-height: 1.25;">June 5, 2019 and June 6, 2019 (9)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">1,464,665</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">7.500</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">1,464,665</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 32%;">
          <div style="text-align: center; line-height: 1.25;">June 5, 2024</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 32%;">
          <div style="line-height: 1.25;">June 5, 2019 (10)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">87,880</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">9.375</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">87,880</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" style="vertical-align: bottom; width: 32%;">
          <div style="text-align: center; line-height: 1.25;">June 5, 2024</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 32%;">
          <div style="line-height: 1.25;">June 12, 2019 (11)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">416,667</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">6.000</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">416,667</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 32%;">
          <div style="text-align: center; line-height: 1.25;">December 12, 2024</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 32%;">
          <div style="line-height: 1.25;">June 10, 2019 (12)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">50,000</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">7.500</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">50,000</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" style="vertical-align: bottom; width: 32%;">
          <div style="text-align: center; line-height: 1.25;">June 10, 2024</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 32%;">
          <div style="line-height: 1.25;">February 10, 2020 (13)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">3,768,500</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">1.250</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">4,343,500</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 32%;">
          <div style="text-align: center; line-height: 1.25;">February 10, 2025</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 32%;">
          <div style="line-height: 1.25;">February 10, 2020 (14)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">336,000</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">1.5625</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">336,000</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" style="vertical-align: bottom; width: 32%;">
          <div style="text-align: center; line-height: 1.25;">February 10, 2025</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 32%;">
          <div style="line-height: 1.25;">July 6, 2020 (15)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">2,469,139</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">1.76</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">2,469,139</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 32%;">
          <div style="text-align: center; line-height: 1.25;">July 2, 2025</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 32%;">
          <div style="line-height: 1.25;">July 6, 2020 (16)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">296,297</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">2.2781</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">296,297</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" style="vertical-align: bottom; width: 32%;">
          <div style="text-align: center; line-height: 1.25;">July 2, 2025</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 32%;">
          <div style="line-height: 1.25;">December 3, 2020 (17)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">4,184,832</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">1.34</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">4,184,832</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 32%;">
          <div style="text-align: center; line-height: 1.25;">June 8, 2026</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 32%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">December 3, 2020 (18)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">334,787</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">1.7922</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">334,787</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" style="vertical-align: bottom; width: 32%; padding-bottom: 2px;">
          <div style="text-align: center; line-height: 1.25;">June 8, 2026</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 32%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
          <div style="line-height: 1.25;">14,249,533</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
          <div style="line-height: 1.25;">14,249,533</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 32%; padding-bottom: 4px;">
          <div style="text-align: center; line-height: 1.25;">&#160;</div>
        </td>
      </tr>

  </table>
  <div style="clear: both;"><br>
  </div>
  <table align="right" cellspacing="0" cellpadding="0" border="0" style="width: 95%; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">

      <tr>
        <td style="width: 3.88%; vertical-align: top;">
          <div style="line-height: 1.25;">(1)</div>
        </td>
        <td style="width: 96.12%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25;">Represents warrants for ordinary shares issuable upon an exercise price of $7.5 per share, which were granted on December 31, 2015 to Kreos Capital V (Expert) Fund Limited, or Kreos, in
            connection with a loan made by Kreos to us and are currently exercisable (in whole or in part) until the earlier of (i) December 30, 2025 or (ii) immediately prior to the consummation of a merger, consolidation, or reorganization of us with or
            into, or the sale or license of all or substantially all the assets or shares of us to, any other entity or person, other than a wholly-owned subsidiary of us, excluding any transaction in which the Company&#8217;s shareholders prior to the
            transaction will hold more than 50% of the voting and economic rights of the surviving entity after the transaction. None of these warrants had been exercised as of December 31, 2020.</div>
        </td>
      </tr>

  </table>
  <div style="line-height: 1.25; clear: both;"><br style="line-height: 1.25;">
  </div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal; font-family: 'Times New Roman',Times,serif;">F - 35</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <table align="right" cellspacing="0" cellpadding="0" border="0" style="width: 100%; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;" id="ze5403d3ed0b34b878e19f68e7a78deb7">

      <tr>
        <td style="width: 5%; vertical-align: top;" colspan="1">&#160;</td>
        <td style="width: 4%; vertical-align: top;">
          <div style="line-height: 1.25;">(2)</div>
        </td>
        <td style="width: 91%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25;">Represents warrants issued as part of the Company&#8217;s follow-on offering in November 2016. At any time, the board of directors may reduce the exercise price of the warrants to any amount and for
            any period of time it deems appropriate.</div>
        </td>
      </tr>
      <tr>
        <td style="width: 5%; vertical-align: top;" colspan="1">&#160;</td>
        <td style="width: 4%; vertical-align: top;">
          <div style="line-height: 1.25;">(3)</div>
        </td>
        <td style="width: 91%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25;">Represents common warrants that were issued as part of the $8.0 million drawdown under the Loan Agreement which occurred on December 28, 2016. See footnote 1 for exercisability terms.</div>
        </td>
      </tr>
      <tr>
        <td style="width: 5%; vertical-align: top;" colspan="1">&#160;</td>
        <td style="width: 4%; vertical-align: top;">
          <div style="line-height: 1.25;">(4)</div>
        </td>
        <td style="width: 91%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25;">Represents common warrants that were issued as part of the Company&#8217;s follow-on offering in November 2018. As of September 30, 2019, warrants to purchase an aggregate 1,651,537 ordinary shares
            had been exercised.</div>
        </td>
      </tr>

  </table>
  <table align="right" cellspacing="0" cellpadding="0" border="0" style="width: 100%; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 10pt; text-align: left; clear: both;">

      <tr>
        <td style="width: 5%; vertical-align: top;" colspan="1">&#160;</td>
        <td style="width: 4%; vertical-align: top;">
          <div style="line-height: 1.25;">(5)</div>
        </td>
        <td style="width: 91%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25;">Represents common warrants that were issued to the underwriters as compensation for their role in the Company&#8217;s follow-on offering in November 2018.</div>
        </td>
      </tr>
      <tr>
        <td style="width: 5%; vertical-align: top;" colspan="1">&#160;</td>
        <td style="width: 4%; vertical-align: top;">
          <div style="line-height: 1.25;">(6)</div>
        </td>
        <td style="width: 91%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25;">Represents warrants that were issued to the exclusive placement agent as compensation for its role in the Company&#8217;s follow-on offering in February 2019.</div>
        </td>
      </tr>
      <tr>
        <td style="width: 5%; vertical-align: top;" colspan="1">&#160;</td>
        <td style="width: 4%; vertical-align: top;">
          <div style="line-height: 1.25;">(7)</div>
        </td>
        <td style="width: 91%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25;">Represents warrants that were issued to certain institutional purchasers in a private placement in the Company&#8217;s registered direct offering of ordinary shares in April 2019.</div>
        </td>
      </tr>
      <tr>
        <td style="width: 5%; vertical-align: top;" colspan="1">&#160;</td>
        <td style="width: 4%; vertical-align: top;">
          <div style="line-height: 1.25;">(8)</div>
        </td>
        <td style="width: 91%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25;">Represents warrants that were issued to the placement agent as compensation for its role in the Company&#8217;s April 2019 registered direct offering.</div>
        </td>
      </tr>
      <tr>
        <td style="width: 5%; vertical-align: top;" colspan="1">&#160;</td>
        <td style="width: 4%; vertical-align: top;">
          <div style="line-height: 1.25;">(9)</div>
        </td>
        <td style="width: 91%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25;">Represents warrants that were issued to certain institutional investors in a warrant exercise agreement on June 5, 2019 and June 6, 2019, respectively.</div>
        </td>
      </tr>
      <tr>
        <td style="width: 5%; vertical-align: top;" colspan="1">&#160;</td>
        <td style="width: 4%; vertical-align: top;">
          <div style="line-height: 1.25;">(10)</div>
        </td>
        <td style="width: 91%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25;">Represents warrants that were issued to the placement agent as compensation for its role in the Company&#8217;s June 2019 warrant exercise agreement and concurrent private placement of warrants.</div>
        </td>
      </tr>
      <tr>
        <td style="width: 5%; vertical-align: top;" colspan="1">&#160;</td>
        <td style="width: 4%; vertical-align: top;">
          <div style="line-height: 1.25;">(11)</div>
        </td>
        <td style="width: 91%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25;">Represents warrants that were issued to certain institutional investors in a warrant exercise agreement in June 2019.</div>
        </td>
      </tr>
      <tr>
        <td style="width: 5%; vertical-align: top;" colspan="1">&#160;</td>
        <td style="width: 4%; vertical-align: top;">
          <div style="line-height: 1.25;">(12)</div>
        </td>
        <td style="width: 91%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25;">Represents warrants that were issued to the placement agent as compensation for its role in the Company&#8217;s June 2019 registered direct offering and concurrent private placement of warrants.</div>
        </td>
      </tr>
      <tr>
        <td style="width: 5%; vertical-align: top;" colspan="1">&#160;</td>
        <td style="width: 4%; vertical-align: top;">
          <div style="line-height: 1.25;">(13)</div>
        </td>
        <td style="width: 91%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25;">Represents warrants that were issued to certain institutional purchasers in a private placement in the Company&#8217;s best efforts offering of ordinary shares in February 2020.</div>
        </td>
      </tr>
      <tr>
        <td style="width: 5%; vertical-align: top;" colspan="1">&#160;</td>
        <td style="width: 4%; vertical-align: top;">
          <div style="line-height: 1.25;">(14)</div>
        </td>
        <td style="width: 91%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25;">Represents warrants that were issued to the placement agent as compensation for its role in the Company&#8217;s February 2020 best efforts offering.</div>
        </td>
      </tr>
      <tr>
        <td style="width: 5%; vertical-align: top;" colspan="1">&#160;</td>
        <td style="width: 4%; vertical-align: top;">
          <div style="line-height: 1.25;">(15)</div>
        </td>
        <td style="width: 91%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25;">Represents warrants that were issued to certain institutional purchasers in a private placement in our registered direct offering of ordinary shares in July 2020</div>
        </td>
      </tr>
      <tr>
        <td style="width: 5%; vertical-align: top;" colspan="1">&#160;</td>
        <td style="width: 4%; vertical-align: top;">
          <div style="line-height: 1.25;">(16)</div>
        </td>
        <td style="width: 91%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25;">Represents warrants that were issued to the placement agent as compensation for its role in the Company&#8217;s July 2020 registered direct offering.</div>
        </td>
      </tr>
      <tr>
        <td style="width: 5%; vertical-align: top;" colspan="1">&#160;</td>
        <td style="width: 4%; vertical-align: top;">
          <div style="line-height: 1.25;">(17)</div>
        </td>
        <td style="width: 91%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25;">Represents warrants that were issued to certain institutional purchasers in a private placement in our private placement offering of ordinary shares in December 2020</div>
        </td>
      </tr>
      <tr>
        <td style="width: 5%; vertical-align: top;" colspan="1">&#160;</td>
        <td style="width: 4%; vertical-align: top;">
          <div style="line-height: 1.25;">(18)</div>
        </td>
        <td style="width: 91%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25;">Represents warrants that were issued to the placement agent as compensation for its role in the Company&#8217;s December 2020 private placement.</div>
        </td>
      </tr>

  </table>
  <div style="clear: both;"> <br>
  </div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
    <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">F - 36</font></div>
    <div style="page-break-after: always;" id="DSPFPageBreak">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <div style="line-height: 1.25;">&#160;<font style="font-weight: bold;">NOTE&#160; 9:-&#160; RESEARCH COLLABORATION AGREEMENT AND LICENSE AGREEMENT</font></div>
  <div style="line-height: 1.25">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">On May 16, 2016, the Company entered into a Research Collaboration Agreement (&#8220;Collaboration Agreement&#8221;) and an Exclusive License Agreement (&#8220;License Agreement&#8221;) with Harvard. The
    Research Collaboration Agreement was amended on May 1, 2017 and April 1, 2018 (as amended, the &#8220;Collaboration Agreement&#8221;), and the Exclusive License Agreement was amended on April 1, 2018 (as amended, the &#8220;License Agreement&#8221;), to extend the term of the
    Collaboration Agreement by one year to May 16, 2022 and reallocate the Company&#8217;s quarterly installment payments to Harvard through such date, and to make certain technical changes. On April 30, 2020, the Company and Harvard amended the Collaboration
    Agreement, which included certain adjustments to the quarterly installments and extended the term an additional three quarters until February 2023.</div>
  <div style="line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Under the Collaboration Agreement, Harvard and the Company have agreed to collaborate on research regarding the development of lightweight &#8220;soft suit&#8221; exoskeleton system technologies
    for lower limb disabilities, which are intended to treat stroke, multiple sclerosis, mobility limitations for the elderly and other medical applications. The Company has committed to pay in quarterly installments for the funding of this research,
    subject to a minimum funding commitment under applicable circumstances. The Collaboration Agreement will expire on February 16, 2023.</div>
  <div style="line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Under the License Agreement, Harvard has granted the Company an exclusive, worldwide royalty-bearing license under certain patents of Harvard relating to lightweight &#8220;soft suit&#8221;
    exoskeleton system technologies for lower limb disabilities, a royalty-free license under certain related know-how and the option to obtain a license under certain inventions conceived under the joint research collaboration.</div>
  <div style="text-align: justify; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The License Agreement requires the Company to pay Harvard an upfront fee, reimbursements for expenses that Harvard incurred in connection with the licensed patents, royalties on net
    sales and several milestone payments contingent upon the achievement of certain product development and commercialization milestones. The Harvard License Agreement will continue in full force and effect until the expiration of the last-to-expire valid
    claim of the licensed patents. As of December 31,2020, the Company achieved three of the milestones which represent all development milestones under the License Agreement. The Company continues to evaluate the likelihood that the other milestones will
    be achieved on a quarterly basis.</div>
  <div style="text-align: justify; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The Company&#8217;s total payment obligation under the Collaboration Agreement and the Harvard License Agreement is $7.2 &#160;&#160;million, some of which is subject to a minimum funding commitment
    under applicable circumstances as indicated above.</div>
  <div style="text-align: justify; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
    <div style="text-indent: 36pt; line-height: 1.25;">The Company has recorded expenses in the amount of $0.8 million, $1.6 million, and $0.9 million for the years ended December&#160;31, 2020, 2019, and 2018, respectively, which are part of the total payment
      obligation indicated above, as research and development expenses related to the Harvard License Agreement and to the Collaboration Agreement. No withholding tax was deducted from the Company&#8217;s payments to Harvard in respect of the Collaboration
      Agreement and License Agreement since this is not taxable income in Israel in accordance with Section 170 of the Israel Income Tax Ordinance 1961-5721.</div>
  </div>
  <div style="text-align: justify; line-height: 1.25;">&#160;&#160;&#160;</div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal; font-family: 'Times New Roman',Times,serif;">F - 37</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="text-align: justify; line-height: 1.25; font-weight: bold;">NOTE 10: - PAYCHECK PROTECTION PROGRAM LOAN</div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 36pt;">On April 21, 2020, RRI received an unsecured loan in the principal amount of $392 under the Paycheck Protection Program (the &#8220;PPP&#8221;)
    administered by the U.S. Small Business Administration, or the SBA, pursuant to the Coronavirus Aid, Relief, and Economic Security Act (the &#8220;CARES Act&#8221;), or the PPP loan. The terms of the PPP Loan were subsequently revised in accordance with the
    provisions of the Paycheck Protection Flexibility Act of 2020, or the PPP Flexibility Act, which was enacted on June 5, 2020. The PPP loan provides for an interest rate of 1.00% per year and matures two years after the date of initial disbursement,
    with initial principal and interest payments coming due late in fiscal 2021. The PPP loan may be used for payroll costs, costs related to certain group health care benefits and insurance premiums, rent payments, utility payments, mortgage interest
    payments and interest payments on any other debt obligation that were incurred before February 15, 2020. Under the terms of the CARES Act and the PPP Flexibility Act, the Company may apply for and be granted forgiveness for all or a portion of loan
    granted under the PPP loan, with such forgiveness to be determined, subject to limitations (including where employees of the Company have been terminated and not re-hired by a certain date), based on the use of the loan proceeds for payment of payroll
    costs and any payments of mortgage interest, rent, and utilities. The terms of any forgiveness may also be subject to further requirements in regulations and guidelines adopted by the SBA.</div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 36pt;">On September 29, 2020, the Company applied for loan forgiveness and on November 6, 2020 the Company received confirmation of its PPP Note
    forgiveness.</div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 36pt;">
    <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;">Forgiveness is booked as other income within the marketing and sales expenses because it was granted and used for payroll, rent, and utility costs related to sales efforts.</div>
      </div>
    </div>
  </div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="text-align: justify; line-height: 1.25; font-weight: bold;">NOTE 11: - INCOME TAXES</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 18pt;">The Company&#8217;s subsidiaries are separately taxed under the domestic tax laws of the jurisdiction of incorporation of each entity.</div>
  <div style="text-align: justify; line-height: 1.25;">&#160;</div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z495f2ff54edb43c9b12ed00e41577015">

      <tr>
        <td style="width: 17pt;"><br>
        </td>
        <td style="width: 19pt; vertical-align: top; align: right;">a.</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div>Corporate tax rates in Israel:</div>
        </td>
      </tr>

  </table>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">Presented hereunder are the tax rates relevant to the Company in the years 2018-2020:</div>
  <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">The Israeli statutory corporate tax rate and real capital gains were 23% in the years 2018-2020.</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z563e6c146a774b7c840fb8537d035ac8">

      <tr>
        <td style="width: 17pt;"><br>
        </td>
        <td style="width: 19pt; vertical-align: top; align: right;">b.</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div>
            <div style="text-align: left; line-height: 1.25;">Income (loss) before taxes on income is comprised as follows (in thousands):</div>
          </div>
        </td>
      </tr>

  </table>
  <div style="margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <table align="right" cellspacing="0" cellpadding="0" border="0" id="z2ba3a7d1752c4363bc6e2cd6ff3d455b" style="width: 95%; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">

      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="10" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">Year Ended December 31,</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;"> 2020</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">2019</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">2018</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 64%;">
          <div style="line-height: 1.25;">Domestic</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">(12,992</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">(15,599</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">(21,784</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">)</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">Foreign</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">67</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">55</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">104</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 64%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
          <div style="line-height: 1.25;">(12,925</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
          <div style="line-height: 1.25;">(15,544</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
          <div style="line-height: 1.25;">(21,680</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">)</div>
        </td>
      </tr>

  </table>
  <div style="margin-left: 36pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif; clear: both;">&#160;</div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z081375363046492ba85434cf4fe097b1">

      <tr>
        <td style="width: 17pt;"><br>
        </td>
        <td style="width: 19pt; vertical-align: top; align: right;">c.</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div>
            <div style="text-align: left; line-height: 1.25;">Taxes on income are comprised as follows (in thousands):&#160;</div>
          </div>
        </td>
      </tr>

  </table>
  <div style="line-height: 1.25;">&#160;</div>
  <table align="right" cellspacing="0" cellpadding="0" border="0" id="zcdc58fc524c440858a57748de7edc2b3" style="width: 95%; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">

      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="10" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">Year Ended December 31,</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;"> 2020</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">2019</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">2018</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 64%;">
          <div style="line-height: 1.25;">Current</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">95</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">64</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">102</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">Deferred</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">(44</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">(57</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">(107</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">)<br>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 64%;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">51</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">7</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">(5</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">)</div>
        </td>
      </tr>

  </table>
  <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; clear: both;">&#160;</div>
  <table align="right" cellspacing="0" cellpadding="0" border="0" id="zdf4592310e5f4e58871a824057235746" style="width: 95%; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">

      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="10" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">Year Ended December 31,</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;"> 2020</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">2019</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">2018</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 64%;">
          <div style="line-height: 1.25;">Domestic</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">Foreign</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">51</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">7</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">(5</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">)</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 64%;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">51</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">7</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">(5</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">)</div>
        </td>
      </tr>

  </table>
  <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; clear: both;">&#160;</div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zab90f7c8c6824db28e51a5ff35678e0b">

      <tr>
        <td style="width: 17pt;"><br>
        </td>
        <td style="width: 19pt; vertical-align: top; align: right;">d.</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div>
            <div style="text-align: left; line-height: 1.25;">Deferred income taxes (in thousands):</div>
          </div>
        </td>
      </tr>

  </table>
  <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts
    used for income tax purposes. The Company&#8217;s deferred tax assets as of December&#160;31, 2020 and 2019 are derived from temporary differences.</div>
  <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">In assessing the realization of deferred tax assets, the Company considers whether it is more likely than not that all or some portion of the deferred tax assets will not be
    realized. Based on the Company&#8217;s history of losses, the Company established a full valuation allowance for RRL.</div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal; font-family: 'Times New Roman',Times,serif;">F - 38</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <div style="line-height: 1.25">&#160; <br>
  </div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">Undistributed earnings of certain subsidiaries as of December&#160;31, 2020 were immaterial. The Company intends to reinvest these earnings indefinitely in the foreign subsidiaries. As a
    result, the Company has not provided for any&#160;deferred income taxes.</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <table align="right" cellspacing="0" cellpadding="0" border="0" id="za1a0ca5d98ce48fcbd64c50f98f02c7d" style="width: 95%; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">

      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">December 31,</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;"> 2020</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">2019</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">Deferred tax assets:</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 76%;">
          <div style="line-height: 1.25;">Carry forward tax losses</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">41,941</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">35,051</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">Research and development carry forward expenses-temporary differences</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">946</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">1,294</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 76%;">
          <div style="line-height: 1.25;">Accrual and reserves</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">341</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">290</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">
            <div style="line-height: 1.25;">Lease liabilities</div>
          </div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">390</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">433</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 76%;">
          <div style="line-height: 1.25;">Total deferred tax assets</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">43,618</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">37,068</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">Deferred tax liabilities:</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 76%;">
          <div style="line-height: 1.25;">
            <div style="line-height: 1.25;">Right-of-use asset</div>
          </div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">(390</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">(433</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">)</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">Net deferred tax assets</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">43,228</div>
          </div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">36,635</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">Valuation allowance</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">(42,941</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">(36,392</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">)</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">Net deferred tax assets</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">287</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">243</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
      </tr>

  </table>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif; clear: both;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">
    <div style="line-height: 1.25;">The net changes in the total valuation allowance for each of the years ended December&#160;31, 2020, 2019 and 2018, are comprised as follows (in thousands):</div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <table align="right" cellspacing="0" cellpadding="0" border="0" id="z35a053d4f75348c6b77902f0ea14916a" style="width: 95%; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">

      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="10" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">Year Ended December 31,</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;"> 2020</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">2019</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">2018</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 64%;">
          <div style="line-height: 1.25;">Balance at beginning of year</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">(36,392</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">(29,655</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">(26,311</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">)</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 64%;">
          <div style="line-height: 1.25;">Changes due to amendments to tax laws and exchange rate differences</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">(2,929</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">(2,055</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">1,393</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 64%;">
          <div style="line-height: 1.25;">Adjustment previous year loss</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">(735</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">Additions during the year</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">(3,620</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">(3,947</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">(4,737</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">)</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 64%;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">Balance at end of year</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">(42,941 <br>
          </div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">(36,392</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">(29,655</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">)</div>
        </td>
      </tr>

  </table>
  <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif; clear: both;">&#160;</div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal; font-family: 'Times New Roman',Times,serif;">F - 39</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <br>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z51e8a038c406441d816c571ae27c4ac3">

      <tr>
        <td style="width: 17pt;"><br>
        </td>
        <td style="width: 19pt; vertical-align: top; align: right;">e.</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div>Reconciliation of the theoretical tax expenses:</div>
        </td>
      </tr>

  </table>
  <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">A reconciliation between the theoretical tax expense, assuming all income is taxed at the statutory tax rate applicable to income of the Company, and the actual tax expense
      (benefit) as reported in the consolidated statements of operations is as follows (in thousands):</div>
  </div>
  <div style="text-align: justify; line-height: 1.25;">&#160;</div>
  <table align="right" cellspacing="0" cellpadding="0" border="0" id="z4ab1a317623746aa8f3e7b4ad9ead3cd" style="width: 95%; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">

      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="10" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">Year Ended December 31,</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;"> 2020</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">2019</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">2018</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 64%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">Loss before taxes, as reported in the consolidated statements of operations</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
          <div style="line-height: 1.25;">(12,925</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
          <div style="line-height: 1.25;">(15,544</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
          <div style="line-height: 1.25;">(21,680</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">)</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 64%;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 64%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">Statutory tax rate</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
          <div style="line-height: 1.25;">23.0</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">%</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
          <div style="line-height: 1.25;">23.0</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">%</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
          <div style="line-height: 1.25;">23.0</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">%</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 64%;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 64%;">
          <div style="line-height: 1.25;">Theoretical tax benefits on the above amount at the Israeli statutory tax rate</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">(2,973</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">(3,575</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">(4,986</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">)</div>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 64%;">
          <div style="line-height: 1.25;">Income tax at rate other than the Israeli statutory tax rate</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">3</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">(1</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">5</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 64%;">
          <div style="line-height: 1.25;">
            <div style="line-height: 1.25;">Non-deductible expenses including equity-based compensation expenses and other</div>
          </div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">185</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">255</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">631</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 64%;">
          <div style="line-height: 1.25;">Operating losses and other temporary differences for which valuation allowance was provided</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">3,620</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">3,947</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">4,737</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 64%;">
          <div style="line-height: 1.25;">Permanent differences</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">(706</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">(651</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">(427</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">)</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">Other</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">(78</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">32</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">35</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 64%;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">Actual tax expense</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">51</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">7</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">(5</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">)</div>
        </td>
      </tr>

  </table>
  <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; clear: both;">&#160;&#160;</div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z791cb6555109419f8bfa57802578bca1">

      <tr>
        <td style="width: 17pt;"><br>
        </td>
        <td style="width: 19pt; vertical-align: top; align: right;">f.</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div>Foreign tax rates:</div>
        </td>
      </tr>

  </table>
  <div style="text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <div style="margin-left: 36pt; line-height: 1.25;">Taxable income of RRI was subject to tax at the rate of 21% in 2020, 2019 and 2018.</div>
  <div style="text-indent: 36pt; line-height: 1.25;">&#160;&#160;</div>
  <div style="text-indent: 36pt; line-height: 1.25;">Taxable income of RRG was subject to tax at the rate of 30% in 2020, 2019, and 2018.</div>
  <div style="text-align: justify; text-indent: 54pt; line-height: 1.25;">&#160;</div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z43d53d1b59844e8196d75da61ea03d04">

      <tr>
        <td style="width: 17pt;"><br>
        </td>
        <td style="width: 19pt; vertical-align: top; align: right;">g.</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div>Tax benefits under the Law for the Encouragement of Capital Investments, 1959 (the &#8220;Investment Law&#8221;):&#160;</div>
        </td>
      </tr>

  </table>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">Conditions for entitlement to the benefits:</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">Under the Investment Law, in 2012 the Company elected &#8220;Beneficiary Enterprise&#8221; status which provides certain benefits, including tax exemptions and reduced tax rates. Income not
    eligible for Beneficiary Enterprise benefits is taxed at a regular rate.</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">Income derived from Beneficiary Enterprise from productive activity will be exempt from tax for ten years from the year in which the Company first has taxable income, providing that
    12 years have not passed from the beginning of the year of election. In the event of a dividend distribution from income that is exempt from company tax, as aforementioned, the Company will be required to pay tax of 10%- 25% on that income.</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">In the event of distribution of dividends from the said tax-exempt income, the amount distributed will be subject to corporate tax at the rate ordinarily applicable to the
    Beneficiary Enterprise&#8217;s income. Tax-exempt income generated under the Company&#8217;s &#8220;Beneficiary Enterprise&#8221; program will be subject to taxes upon dividend distribution or complete liquidation.</div>
  <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal; font-family: 'Times New Roman',Times,serif;">F - 40</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  &#160;
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">The entitlement to the above benefits is conditional upon the Company&#8217;s fulfilling the conditions stipulated by the Law and regulations published thereunder.</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">On December 29, 2010, the Knesset approved an additional amendment to the Law for the Encouragement of Capital Investments, 1959. According to the amendment, a reduced uniform
    corporate tax rate for exporting industrial enterprises (over 25%) was established. The reduced tax rate will not be program dependent and will apply to the industrial enterprise&#8217;s entire income. The tax rates for industrial enterprises have been
    reduced. In August 2013, the Israeli Knesset approved an amendment to the Investment Law, pursuant to which the rates for development area A will be 9% and for the rest of the country- 16% in 2014 and thereafter. The Amendment also prescribes that any
    dividends distributed to individuals or foreign residents from a preferred enterprise&#8217;s earnings as above will be subject to taxes at a rate of 20% (subject to tax treaty benefits)</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">In December 2016, the Economic Efficiency Law (Legislative Amendments for Applying the Economic Policy for the 2017 and 2018 Budget Years), 2016 which includes Amendment 73 to the
    Law for the Encouragement of Capital Investments (&#8220;the Amendment&#8221;) was published. According to the Amendment, a preferred enterprise located in development area A will be subject to a tax rate of 7.5% instead of 9% effective from January 1, 2017 (and
    thereafter the tax rate applicable to preferred enterprises located in other areas remains at 16%).</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">The Company has examined the effect of the adoption of the Amendment on its financial statements, and as of the date of the publication of the financial statements, the Company
    estimates that it will not apply the Amendment. The Company&#8217;s estimate may change in the future.</div>
  <div style="text-align: justify; line-height: 1.25;">&#160;</div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf1b0aeaf3ca64a2486b1d0930669f1c3">

      <tr>
        <td style="width: 17pt;"><br>
        </td>
        <td style="width: 19pt; vertical-align: top; align: right;">h.</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div>Tax assessments:</div>
        </td>
      </tr>

  </table>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <div style="margin-left: 36pt; line-height: 1.25;">RRL has had final tax assessments up to and including the 2015 tax year.</div>
  <div style="margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <div style="margin-left: 36pt; line-height: 1.25;">
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Each RRI and RRG have not had a final tax assessment&#160;since its inception.</div>
  </div>
  <div style="text-align: justify; line-height: 1.25;">&#160;</div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zdab1f9ce80b04eac8acaec28821c7cce">

      <tr>
        <td style="width: 17pt;"><br>
        </td>
        <td style="width: 19pt; vertical-align: top; align: right;">i.</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div>Net operating carry-forward losses for tax purposes:</div>
        </td>
      </tr>

  </table>
  <div style="text-align: justify; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">As of December&#160;31, 2020, RRL has carry-forward losses amounting to approximately $182.4 million, which can be carried forward for an indefinite period, and RRI has
      carry-forward losses amounting to approximately $291 thousands, which can be carried forward for a period of 20 years.</div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <div style="line-height: 1.25; font-weight: bold;">NOTE&#160;12: - FINANCIAL EXPENSES, NET</div>
  <div style="text-align: justify; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">The components of financial expenses, net were as follows (in thousands):</div>
  </div>
  <div style="margin-left: 36pt; line-height: 1.25;">&#160;</div>
  <table align="right" cellspacing="0" cellpadding="0" border="0" id="z5c91740d842e4334816c9648efa53c90" style="width: 95%; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">

      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="10" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">Year Ended December 31,</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;"> 2020</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">2019</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">2018</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 64%;">
          <div style="line-height: 1.25;">Foreign currency transactions and other</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">(9</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">(34</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">)</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">42</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 64%;">
          <div style="line-height: 1.25;">Financial expenses related to loan agreement with Kreos</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">907</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">1,499</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">2,398</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 64%; padding-bottom: 2px;">
          <div style="line-height: 1.25;">Bank commissions</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
          <div style="line-height: 1.25;">23</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
          <div style="line-height: 1.25;">31</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
          <div style="line-height: 1.25;">26</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 64%;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 64%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
          <div style="line-height: 1.25;">921</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
          <div style="line-height: 1.25;">1,496</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
          <div style="line-height: 1.25;">2,466</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
      </tr>

  </table>
  <div style="margin-left: 36pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif; clear: both;">&#160;</div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal; font-family: 'Times New Roman',Times,serif;">F - 41</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <br>
  <div style="line-height: 1.25; font-weight: bold;">NOTE 13: -&#160; GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA</div>
  <div style="line-height: 1.25">&#160;</div>
  <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 36pt;">Summary information about geographic areas:</div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 36pt;">
    <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">
      <div style="line-height: 1.25;">ASC 280, &#8220;Segment Reporting&#8221; establishes standards for reporting information about operating segments. Operating segments are defined as components of an enterprise about which separate financial information is
        available that is evaluated regularly by the chief operating decision maker in deciding how to allocate resources and in assessing performance. The Company manages its business on the basis of one reportable segment and derives revenues from
        selling systems and services (see Note 1 for a brief description of the Company&#8217;s business). The following is a summary of revenues within geographic areas (in thousands):</div>
    </div>
  </div>
  <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
  <table align="right" cellspacing="0" cellpadding="0" border="0" id="zec3d7aa5328f4b0f84320dfdfed923e6" style="width: 95%; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">

      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="10" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">Year Ended December 31,</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;"> 2020</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">2019</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">2018</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">Revenues based on customer&#8217;s location:</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 64%;">
          <div style="line-height: 1.25; margin-left: 9pt;">Israel</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">2</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25; margin-left: 9pt;">United States</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">1,746</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">2,003</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">3,558</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 64%;">
          <div style="line-height: 1.25; margin-left: 9pt;">Europe</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">2,631</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">2,832</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">2,807</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25; margin-left: 9pt;">Asia-Pacific</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">8</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">36</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">22</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 64%;">
          <div style="line-height: 1.25; margin-left: 9pt;">Latin America</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">6</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">58</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25; margin-left: 9pt;">Africa</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">2</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">&#8212;</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">100</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 64%;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">Total revenues</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">4,393</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">4,873</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
          <div style="line-height: 1.25;">6,545</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
      </tr>

  </table>
  <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; clear: both;">&#160;</div>
  <table align="right" cellspacing="0" cellpadding="0" border="0" id="z2ef27552142e4f388dcac51bf5575d3f" style="width: 95%; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">

      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">December 31,</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;"> 2020</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">2019</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF;">
          <div style="line-height: 1.25;">Long-lived assets by geographic region:</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 76%;">
          <div style="line-height: 1.25; margin-left: 9pt;">Israel</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">145</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">179</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 76%;">
          <div style="line-height: 1.25; margin-left: 9pt;">United States</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">249</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">244</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
          <div style="line-height: 1.25; margin-left: 9pt;">Germany</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">43</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="line-height: 1.25;">78</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 76%;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">437</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">$</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
          <div style="line-height: 1.25;">501</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
      </tr>

  </table>
  <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; clear: both;">&#160;</div>
  <table align="right" cellspacing="0" cellpadding="0" border="0" style="width: 95%; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;" id="zf6398c4ec5504e8a93132307dffabbba">

      <tr>
        <td style="width: 3.88%; vertical-align: top;">
          <div style="line-height: 1.25;">(*)</div>
        </td>
        <td style="width: 96.12%; vertical-align: top;">
          <div style="text-align: justify; line-height: 1.25;">Long-lived assets are comprised of property and equipment, net.</div>
        </td>
      </tr>

  </table>
  <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; clear: both;">&#160;&#160;</div>
  <div style="margin-left: 36pt; line-height: 1.25;">Major customer data as a percentage of total revenues:</div>
  <div style="line-height: 1.25;">&#160;</div>
  <table align="right" cellspacing="0" cellpadding="0" border="0" id="zbbad66930d1b49dbb2d56aacfee26f04" style="width: 95%; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">

      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="10" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">Year Ended December 31,</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
          <div style="line-height: 1.25;">&#160;</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;"> 2020</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">2019</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">2018</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
      </tr>
      <tr>
        <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 64%;">
          <div style="line-height: 1.25;">Customer A</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">10.0</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">%</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">15.0</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">%</div>
        </td>
        <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">&#160;</td>
        <td valign="bottom" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;">
          <div style="line-height: 1.25;">38.0</div>
        </td>
        <td valign="bottom" nowrap="nowrap" colspan="1" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;">
          <div style="line-height: 1.25;">%</div>
        </td>
      </tr>

  </table>
  <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; clear: both;">&#160;&#160;</div>
  <div style="text-align: justify; line-height: 1.25; font-weight: bold;">NOTE&#160;14: - SUBSEQUENT EVENTS</div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; line-height: 1.25;">&#160;</div>
  </div>
  <div style="line-height: 1.25;">
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 36pt;">
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">
          <div style="line-height: 1.25;">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">Following December 31, 2020, a total of 9,372,954 outstanding warrants with exercise prices ranging from $1.25 to $1.79 were exercised, for total gross proceeds to us of approximately $13.2 million.</div>
                <div style="line-height: 1.25;"><br style="line-height: 1.25;">
                </div>
              </div>
            </div>
          </div>
        </div>
      </div>
    </div>
  </div>
  <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal; font-family: 'Times New Roman',Times,serif;">F - 42</font></div>
  <div style="text-align: center;">
    <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; margin-left: auto; margin-right: auto;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal; font-family: 'Times New Roman',Times,serif;"><br>
    </font></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>exhibit_10-1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: ZKG
         Document created using EDGARfilings PROfile 7.3.2.0
         Copyright 1995 - 2021 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div style="text-align: right; line-height: 1.25; font-weight: bold;">
      <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"><u>Exhibit 10.1</u></div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">Certain confidential information contained in this document, marked by brackets and asterisk, has been </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">omitted pursuant to Item 601(b)(10)(iv) of Regulation S-K, because it (i) is not material and (ii) would be </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">competitively harmful if publicly disclosed.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">LETTER OF AGREEMENT</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">This Letter of Agreement (&#8220;<font style="font-weight: bold;">LOA</font>&#8221;) is made and entered into as of this 11th day of July 2013 (&#8220;<font style="font-weight: bold;">Effective Date</font>&#8221;) between <font style="font-weight: bold;">Argo Medical Technologies Ltd</font>, an Israeli corporation having its principal place of business at Cohav Yokneam Building, Yokneam Ilit P.O.B 161, Israel 20692 (&#8220;<font style="font-weight: bold;">Customer</font>&#8221;) and
      <font style="font-weight: bold;">Sanmina Corporation </font>and its subsidiaries, (collectively &#8220;<font style="font-weight: bold;">Sanmina</font>&#8221;), a Delaware corporation having its principal place of business at 2700 North First Street, San Jose,
      California 95134.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">1. Customer and Sanmina are establishing a business relationship under which Customer may, among other things, have Sanmina procure components, parts, and raw material (collectively &#8220;<font style="font-weight: bold;">Components</font>&#8221;)
      to manufacture, assemble, test, inspect configure and ship products detailed in documentation provided by Customer to Sanmina from time to time (&#8220;<font style="font-weight: bold;">Products</font>&#8221;) in accordance with Customer&#8217;s purchase orders (&#8220;<font style="font-weight: bold;">Orders</font>&#8221;) submitted by Customer from time to time and accepted by Sanmina. The unit prices for the Products (&#8220;<font style="font-weight: bold;">Prices</font>&#8221;) and the related financial liability for the procurement
      of Components for such Products (&#8220;<font style="font-weight: bold;">Component Liability</font>&#8221;) are as demonstrated in <font style="font-weight: bold;"><u>Appendix A</u></font> hereto, as may be amended in writing by mutual consent of the parties
      from time to time. This LOA is for the purpose of authorizing Sanmina to begin work immediately in lieu of a fully negotiated manufacturing services agreement (&#8220;<font style="font-weight: bold;">MSA</font>&#8221;). This LOA implies no commitment to enter
      into a MSA. Both parties acknowledge that the execution of a MSA is contingent upon the mutual consent of the parties, and that should the MSA not be executed, the terms of this LOA shall be the sole governing agreement until terminated by either
      party. The parties agree that all Orders accepted by Sanmina shall be based on the terms contained in this LOA, unless replaced by a MSA. Customer shall provide Sanmina&#8217;s Credit Department upon request a completed credit application. Sanmina shall
      provide Customer with an initial credit limit, which shall be reviewed (and, if necessary, adjusted) from time to time with periodic financial updates from Customer in order to maintain a credit limit. The credit limit may be reduced upon five (5)
      days&#8217; prior written notice to Customer. In the event Customer exceeds its credit limit, Sanmina shall have the right to stop shipments of Product and stop loading new Orders and Forecasts until Customer makes a sufficient payment to bring its account
      within the credit limit provided.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">2. Prices are in U.S. Dollars and are subject to change by mutual consent. Prices were agreed by the parties based on (i) the specifications, (ii) the projected volumes and run rates and other assumptions agreed by the
      parties and (iii) shipment FCA Sanmina&#8217;s facility of manufacture (Incoterms 2010). Prices specifically exclude (1) export licensing of the Product and payment of broker&#8217;s fees, duties, tariffs or other similar charges, (2) taxes (other than those
      based on the net income of Sanmina); and (3) tooling or non-recurring expenses. Payment terms for Products are net thirty (30) days after the date of the invoice which shall not be issued prior to shipment of such Product, <font style="font-style: italic;"><u>provided</u></font><font style="font-style: italic;">&#160;</font><font style="font-style: italic;"><u>that</u></font> if Customer has no credit from Sanmina, such payment shall be made upon shipment (but subject always to receipt of
      invoice). Customer shall pay Sanmina in advance for its Component Liability and Customer acknowledges that Sanmina will not place any orders for Components until such time as Sanmina has received the advance payment in full from Customer to cover its
      Component Liability. It is clarified that Component Liability pre-paid by Customer for any Product shall be deducted from the Price payable for such Product.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">3. Customer may also provide Sanmina with forecasts for future requirements of Products (&#8220;<font style="font-weight: bold;">Forecasts</font>&#8221;). Provided that Sanmina has received an advanced payment from Customer to cover
      its Component Liability in full, Sanmina will procure the quantity and type of Components necessary to manufacture the quantities of Product set forth in the Order and Forecast in accordance with its standard material ordering policies available at <u>www.sanmina-sci.com</u>
      (&#8220;<font style="font-weight: bold;">Policies</font>&#8221;), and agrees to be financially responsible for all Components ordered in accordance with the Policies. Customer guarantees the obligations of each of its subsidiaries or affiliates that places
      Orders or Forecasts pursuant to this LOA, and agrees to be jointly liable for all such obligations.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">4. Sanmina warrants that, for a period of one year from the date of manufacture of the Product, the Product will be free from defects in workmanship. Products shall be considered free from defects in workmanship if they
      are manufactured in accordance with the most current version of IPC-A-600 or IPC-A-610. Sanmina shall, at its option and at its expense (and as Customer&#8217;s sole and exclusive remedy for breach of any warranty), repair, replace or issue a credit for
      Product found to have defective workmanship during the warranty period. In addition, Sanmina will administer and pass through to Customer (to the extent that they are transferable) manufacturers&#8217; Component warranties and manage such warranties on
      Customer&#8217;s behalf, but does not independently warrant Components. THE SOLE REMEDY UNDER THIS WARRANTY SHALL BE THE REPAIR, REPLACEMENT, OR CREDIT FOR DEFECTS AS STATED ABOVE. THIS WARRANTY IS THE SOLE WARRANTY GIVEN BY SANMINA AND IS IN LIEU OF ANY
      OTHER WARRANTIES EITHER EXPRESS OR IMPLIED, INCLUDING BUT NOT LIMITED TO WARRANTIES OF MERCHANTABILITY, NON INFRINGEMENT, AND FITNESS FOR A PARTICULAR PURPOSE, EACH OF WHICH IS SPECIFICALLY DISCLAIMED. Compliance with &#8220;RoHS&#8221;, &#8220;REACH&#8221; and other
      environmental legislation worldwide shall be as separately agreed by the parties.</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <!--PROfilePageNumberReset%Num%2%%%-->
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">5. Customer may terminate this LOA or cancel an Order hereunder upon written notice to Sanmina. Sanmina will make commercially reasonable efforts to return Components to vendors (provided that Sanmina shall not be so
      obligated for Components which have a line item value of less than $1000). <font style="font-weight: bold;"><u>Termination for Cause:</u></font> either party may terminate this LOA or an Order for default if the other party materially breaches and
      has not cured within thirty (30) days after the defaulting party is notified in writing of the material breach. Cure period for payment-related breaches shall be five (5) business days from receipt of notice. <font style="font-weight: bold;"><u>Termination
          Based on other than Sanmina Breach:</u></font> if this LOA or an Order is terminated by Customer for any reason <font style="font-style: italic;">other than</font> a breach by Sanmina (including but not limited to a force majeure or termination
      for convenience), Customer shall pay Sanmina: (1) the Order price for all finished Product existing at the time of termination; (2) Sanmina&#8217;s cost (including labor, Components, and mark-up on Components and labor as set forth in <u>Appendix A</u>
      hereto) for work in process; and (3) Component inventory pursuant to Section 3 above. <font style="font-weight: bold;"><u>Termination Based on Sanmina&#8217;s Breach:</u></font> if Customer terminates this LOA or cancels an Order as a result of an uncured
      breach by Sanmina, Customer shall pay (1) the Order price for finished Product at the time of termination; (2) Sanmina&#8217;s cost (including labor, Components) for work in process; and (3) Component inventory pursuant to <u>Appendix A</u> hereto and
      Section 3 <font style="font-weight: bold; font-style: italic;">excluding</font> Sanmina markup or acquisition cost on Components relating to such uncured breach. Sanmina remains liable to Customer for damages pursuant to this LOA. Customer shall be
      responsible for Sanmina&#8217;s documented cost to perform Customer-authorized non-recurring engineering or associated program duties. Provided that the Customer has no outstanding receivable, upon termination, Sanmina will deliver to Customer all Products
      and Components. Further, upon termination Sanmina will promptly deliver to Customer any and all documentation and other property owned by Customer or for which Customer has paid under this LOA.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">6. IN NO EVENT SHALL EITHER PARTY BE LIABLE TO THE OTHER FOR ANY INDIRECT, CONSEQUENTIAL, INCIDENTAL, PUNITIVE OR SPECIAL DAMAGES, OR ANY DAMAGES WHATSOEVER RESULTING FROM LOSS OF USE, DATA OR PROFITS, EVEN IF SUCH OTHER
      PARTY HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. FOR THE PURPOSE OF THIS SECTION, BOTH LOST PROFITS AND DAMAGES RESULTING FROM VALUE ADDED TO THE PRODUCT BY CUSTOMER SHALL BE CONSIDERED CONSEQUENTIAL DAMAGES. IN NO EVENT SHALL SANMINA&#8217;S
      LIABILITY FOR A PRODUCT (WHETHER ASSERTED AS A TORT OR CONTRACT CLAIM) EXCEED THE AMOUNTS PAID TO SANMINA FOR SUCH PRODUCT HEREUNDER. IN NO EVENT SHALL EITHER PARTY&#8217;S LIABILITY FOR ALL CLAIMS ARISING OUT OF OR RELATING TO THIS LOA EXCEED THE LESSER
      OF EITHER $[***] OR [***] PERCENT ([***]%) OF THE TRAILING 12 MONTHS OF REVENUE FOR PRODUCT PAID FOR UNDER THIS LOA (THE &#8220;<font style="font-weight: bold;">CAP</font>&#8221;). THESE LIMITATIONS SHALL APPLY NOTWITHSTANDING ANY FAILURE OF ESSENTIAL PURPOSE OF
      ANY LIMITED REMEDY. THE CAP SHALL NOT APPLY TO LIMIT (i) CUSTOMER&#8217;S OBLIGATIONS HEREUNDER FOR TERMINATION/CANCELLATION PAYMENTS, AND (ii) THERE SHALL BE NO LIMITATIONS UNDER THIS SECTION ON A PARTY&#8217;S INDEMNIFICATION OBLIGATIONS. THE LIMITATIONS SET
      FORTH IN THIS SECTION SHALL APPLY WHERE THE DAMAGES ARISE OUT OF OR RELATE TO THIS LOA.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">7. Sanmina shall promptly indemnify, defend, and hold Customer and its affiliates, shareholders, directors, officers, employees, contractors, agents, and other representatives harmless from all third party demands,
      claims, actions, causes of action, proceedings, suits, assessments, losses, damages, liabilities, settlements, judgments, fines, penalties, interest, costs and expenses (including fees and disbursements of counsel) of every kind (collectively, &#8220;<font style="font-weight: bold;">Claim</font>(<font style="font-weight: bold;">s</font>)&#8221;) (a) based upon personal injury or death or injury to property (other than damage to the Product itself, which is handled in accordance with Sanmina&#8217;s warranty) to
      the extent caused by the negligent or willful acts or omissions of Sanmina or its officers, employees, subcontractors or agents and/or (b) arising from or relating to any actual or alleged infringement, misappropriation, or alleged violation of any
      intellectual property rights relating to Sanmina&#8217;s manufacturing processes.</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">2</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">8. Customer shall promptly indemnify, defend, and hold Sanmina harmless from and against every Claim (a) based upon personal injury or death or injury to property to the extent caused by the negligent or willful acts or
      omissions of Customer or its officers, employees, subcontractors, or agents, (b) arising from or relating to any actual or alleged infringement, misappropriation or alleged violation of any intellectual property rights relating to a Product or
      portion of a Product, or (c) that the Product has a design defect or fails to comply with &#8220;RoHS&#8221;, &#8220;WEEE&#8221;, &#8220;REACH&#8221;&#8217; (or other environmental legislation) where such failure was not the responsibility of Sanmina.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">9. The parties hereby agree to amend the Non-Disclosure Agreement (&#8220;<font style="font-weight: bold;">NDA</font>&#8221;) entered into between the parties on April 25, 2013 such that the meaning of &#8220;<font style="font-style: italic;">Information</font>&#8221; (as defined therein) shall also include (without derogation from any other meaning included therein) any information related to Company&#8217;s shareholders (as the terms &#8220;<font style="font-style: italic;">Company</font>&#8221; is
      defined therein). The NDA (as herein amended) is hereby incorporated herein by reference. A copy of the NDA (prior to the above amendment) is annexed hereto as <font style="font-weight: bold;">Appendix B</font>.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">10. Any and all intellectual property rights and other rights in and to the Products and its underlying technology, including without limitation any derivatives thereof, and including further any changes or improvements
      therein made following contribution by Sanmina, shall be retained by Customer at all times, and no right therein is granted to Sanmina by virtue of this LOA or otherwise.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">11. This LOA and its attachments make up the entire agreement between the parties and supersede prior discussions, except for the NDA incorporated in this LOA (as amended hereby). The parties expressly reject any
      pre-printed terms and conditions of any Order, acknowledgment, or any other form document of either party. The terms hereof may be amended only by a writing executed by authorized representatives of the parties. This LOA will not be assigned by
      either party without the other party&#8217;s prior written consent except that subject to Section 3, Customer may assign its rights and obligations hereunder without the need for consent to any affiliate or successor. Customer shall be the exporter of
      record for all Products shipped hereunder, and shall comply with all applicable export control statutes and regulations. This LOA shall be construed in accordance with the substantive laws of California (excluding its conflicts of laws principles).
      The parties acknowledge and agree that the state courts of Santa Clara County or federal courts of the Northern District of California shall have exclusive jurisdiction and venue to adjudicate any and all disputes in connection with this LOA. The
      provisions of the United Nations Conventions on Contracts for the International Sale of Goods shall not apply to this LOA.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">ACCEPTED AND AGREED TO:</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z45481933db96408f881bb6f9e813a448">

        <tr>
          <td colspan="3" style="width: 50.36%; vertical-align: top;">
            <div style="line-height: 1.25;">SANMINA CORPORATION</div>
          </td>
          <td style="width: 0.28%; vertical-align: bottom;">&#160;</td>
          <td colspan="3" style="width: 49.36%; vertical-align: top;">
            <div style="line-height: 1.25;">CUSTOMER</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5.81%; vertical-align: middle;">&#160;</td>
          <td colspan="2" style="width: 44.56%; vertical-align: middle;">&#160;</td>
          <td colspan="2" style="width: 6.08%; vertical-align: middle;">&#160;</td>
          <td colspan="2" style="width: 43.55%; vertical-align: middle;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 5.81%; vertical-align: top;">
            <div style="line-height: 1.25;">By:</div>
          </td>
          <td style="width: 0.3%; vertical-align: bottom;">&#160;</td>
          <td style="width: 44.26%; vertical-align: top; border-bottom: 2px solid #000000;">
            <div style="line-height: 1.25;">
              <div style="text-align: center; line-height: 1.25;">/s/ Mark Kraizer</div>
            </div>
          </td>
          <td style="width: 0.28%; vertical-align: bottom;">&#160;</td>
          <td style="width: 5.81%; vertical-align: top;">
            <div style="line-height: 1.25;">By:</div>
          </td>
          <td style="width: 0.28%; vertical-align: bottom;">&#160;</td>
          <td style="width: 43.28%; vertical-align: top; border-bottom: 2px solid #000000;">
            <div style="line-height: 1.25;">
              <div style="text-align: center; line-height: 1.25;">/s/ Ami Kraft</div>
            </div>
          </td>
        </tr>
        <tr>
          <td style="width: 5.81%; vertical-align: middle;">&#160;</td>
          <td colspan="2" style="width: 44.56%; vertical-align: middle;">&#160;</td>
          <td colspan="2" style="width: 6.08%; vertical-align: middle;">&#160;</td>
          <td colspan="2" style="width: 43.55%; vertical-align: middle;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 5.81%; vertical-align: top;">
            <div style="line-height: 1.25;">Name:</div>
          </td>
          <td style="width: 0.3%; vertical-align: bottom;">&#160;</td>
          <td style="width: 44.26%; vertical-align: top; border-bottom: 2px solid #000000;">
            <div style="line-height: 1.25;">
              <div style="text-align: center; line-height: 1.25;">Mark Kraizer</div>
            </div>
          </td>
          <td style="width: 0.28%; vertical-align: bottom;">&#160;</td>
          <td style="width: 5.81%; vertical-align: top;">
            <div style="line-height: 1.25;">Name:</div>
          </td>
          <td style="width: 0.28%; vertical-align: bottom;">&#160;</td>
          <td style="width: 43.28%; vertical-align: top; border-bottom: 2px solid #000000;">
            <div style="line-height: 1.25;">
              <div style="text-align: center; line-height: 1.25;">Ami Kraft</div>
            </div>
          </td>
        </tr>
        <tr>
          <td style="width: 5.81%; vertical-align: middle;">&#160;</td>
          <td colspan="2" style="width: 44.56%; vertical-align: middle;">&#160;</td>
          <td colspan="2" style="width: 6.08%; vertical-align: middle;">&#160;</td>
          <td colspan="2" style="width: 43.55%; vertical-align: middle;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 5.81%; vertical-align: top;">
            <div style="line-height: 1.25;">Title:</div>
          </td>
          <td style="width: 0.3%; vertical-align: bottom;">&#160;</td>
          <td style="width: 44.26%; vertical-align: top; border-bottom: 2px solid #000000;">
            <div style="line-height: 1.25;">
              <div style="text-align: center; line-height: 1.25;">VP &amp; General Manager</div>
            </div>
          </td>
          <td style="width: 0.28%; vertical-align: bottom;">&#160;</td>
          <td style="width: 5.81%; vertical-align: top;">
            <div style="line-height: 1.25;">Title:</div>
          </td>
          <td style="width: 0.28%; vertical-align: bottom;">&#160;</td>
          <td style="width: 43.28%; vertical-align: top; border-bottom: 2px solid #000000;">
            <div style="line-height: 1.25;">
              <div style="text-align: center; line-height: 1.25;">CFO</div>
            </div>
          </td>
        </tr>
        <tr>
          <td style="width: 5.81%; vertical-align: middle;">&#160;</td>
          <td colspan="2" style="width: 44.56%; vertical-align: middle;">&#160;</td>
          <td colspan="2" style="width: 6.08%; vertical-align: middle;">&#160;</td>
          <td colspan="2" style="width: 43.55%; vertical-align: middle;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 5.81%; vertical-align: top;">&#160;</td>
          <td style="width: 0.3%; vertical-align: bottom;">&#160;</td>
          <td style="width: 44.26%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">Sanmina Israel</div>
          </td>
          <td style="width: 0.28%; vertical-align: bottom;">&#160;</td>
          <td style="width: 5.81%; vertical-align: top;">&#160;</td>
          <td style="width: 0.28%; vertical-align: bottom;">&#160;</td>
          <td style="width: 43.28%; vertical-align: top;">
            <div style="text-indent: 20pt; line-height: 1.25;">Argo</div>
            <div style="text-indent: 20pt; line-height: 1.25;">Medical Technologies Ltd.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">3</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">LOA Appendix A</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">Pricing</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; font-weight: bold;"><u>The price model agreed between Sanmina and Argo Medical Technologies is as follows:</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">[***]</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; font-style: italic; font-weight: bold;"><u>The price model above and the Qty of the system refers to minimum order quantities (&#8220;MOQs&#8221;) to be agreed by the parties from time to time.</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; font-style: italic; font-weight: bold;"><u>Numerical Examples:</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">[***]</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; font-style: italic; font-weight: bold;"><u>NRE Charges:</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">[***]</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;"><font style="font-weight: bold;">For extra engineering services Sanmina will charge </font>[***]<font style="font-weight: bold;"> USD per hour.</font></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; font-weight: bold;">Component Liability:</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">Liability for Components shall be determined between the Parties on a case-by-case basis.</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">4</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">NDA</div>
    <div style="text-align: center; line-height: 1.25;"><img width="610" height="87" src="image00007.jpg"></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;"><u>CONFIDENTIALITY AND NON-DISCLOSURE AGREEMENT</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">WHEREAS, Argo Medical Technologies Ltd., having an address at Kochav Yokneam Building, POB 161, Yokneam 20692, Israel (hereinafter, together with any affiliate thereof, &#8220;<font style="font-weight: bold;">Company</font>&#8221;),
      possesses confidential and proprietary information, methods and technology in connection with a device and methods for overcoming impeded locomotion disability, and related devices that utilize similar principles and technology (hereinafter &#8220;<font style="font-weight: bold;">Product</font>&#8221;);</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">WHEREAS, Sanmina- having an address at P.O.B 102 Maa&#8217;lot 24952 Israel (hereinafter &#8220;<font style="font-weight: bold;">Recipient</font>&#8221;), desires to provide to the Company certain out sourcing services, as may be agreed
      in writing between the Company and Recipient form time to time (the &#8220;<font style="font-weight: bold;">Services</font>&#8221;); and</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">WHEREAS, the Company may disclose to Recipient from time to time, at its discretion, certain Information (as defined below) to enable Recipient to provide the Services (the &#8220;<font style="font-weight: bold;">Purpose</font>&#8221;)
      and,;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">NOW, THEREFORE, to induce disclosure by the Company of such Information, Recipient hereby undertakes and agrees as follows (the &#8220;<font style="font-weight: bold;">Undertaking</font>&#8221;):</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">1. The term &#8220;<font style="font-weight: bold;">Information</font>&#8221; means any and all confidential and proprietary information of, or related to, the Company, including but not limited to any and all specifications,
      methods, prototypes, technology (including production technology), computer programs, and any and all records, data, methods, techniques, processes, projections, plans, marketing and/or pricing information, materials, financial statements, memoranda,
      analyses, notes and any other data or information (in whatever form), as well as improvements and know-how related thereto, relating to or concerning the Company, the Company&#8217;s suppliers or products, irrespective of form, but shall not include
      information that (i) was already known to or independently developed by the Recipient prior to its disclosure as demonstrated by reasonable and tangible evidence satisfactory to the Company; (ii) shall have appeared in any printed publication or
      patent or shall have become a part of the public knowledge except as a result of breach of this Undertaking by the Recipient; (iii) shall have been received by the Recipient from another person or entity having no obligation to the Company or the
      Company&#8217;s suppliers; or (iv) is approved in writing by the Company for release by the Recipient.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">2. Recipient (i) shall treat all Information as strictly confidential, (ii) shall not disclose any Information to any other person or entity, other than Recipient&#8217;s employees, officers and directors, with a need to know
      who have confidentiality obligations at least as restrictive as those contained herein, without the prior written consent of the Company, (iii) shall protect the Information with at least the same degree of care and confidentiality as it affords its
      own confidential information, at all times exercising at least a high degree of care in such protection, and (iv) shall not use any Information in any manner except for Purpose.</div>
    <div style="line-height: 1.25;"><img width="190" height="46" src="image00008.jpg"></div>
    <div style="line-height: 1.25;">3. The Recipient acknowledges and agrees that the Information is and shall remain proprietary to the Company. All copies of the Information shall be returned to the Company immediately upon request without retaining
      copies thereof.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">4. It is understood and agreed that any disclosure of Information shall not grant the Recipient any express, implied or other license or rights to patents or trade secrets of the Company, whether or not patentable, nor
      shall it constitute or be deemed to create a partnership, joint venture or other like engagement. Further, Recipient agrees that it shall not remove or otherwise alter any of the trademarks or service marks, serial numbers, logos, copyrights, notices
      or other proprietary notices, if any, fixed or attached to Information or any part thereof.</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">5</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">5. Neither this Undertaking nor the disclosure or receipt of Information shall constitute or imply any promise or intention by Company to receive Services from the Recipient, or any commitment by Company with respect to
      present or future relationship with Recipient.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">6. The Recipient&#8217;s Undertakings herein shall be binding upon it and its affiliates, subsidiaries or successors and shall continue until permission is specifically granted in writing to the Recipient by the Company to
      release the Information.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">7. Recipient acknowledges that violation of its obligations hereunder could cause the Company irreparable harm (including, but not limited to, the loss of patent rights) which could not be reasonably or adequately
      compensated for in damages resulting from an action of law and, therefore, that Recipient&#8217;s agreements hereunder shall be enforceable both under law or in equity, by injunction or otherwise, without the necessity of posting a bond.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">8. This Undertaking shall be exclusively governed by, construed and enforced in accordance with the laws of the State of Israel, the courts of which shall have exclusive jurisdiction over any dispute hereunder. A
      determination that any term of this Undertaking is void or unenforceable shall not affect the validity or enforceability of any other term or condition and any such invalid provision shall be construed and enforced (to the extent possible) in
      accordance with the original intent of the parties as herein expressed.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;"><font style="font-weight: bold;">IN WITNESS WHEREOF</font>, the Recipient has executed this Undertaking on April <u>25</u> , 2013.</div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zfca254c66f2b4e74a3cff86d70050b66">

        <tr>
          <td style="width: 4%; vertical-align: middle;">&#160;</td>
          <td style="width: 25%; vertical-align: middle;">&#160;</td>
          <td colspan="1" style="width: 71%; vertical-align: middle;">&#160;</td>
        </tr>
        <tr>
          <td colspan="2" style="vertical-align: top;">
            <div style="line-height: 1.25;">RECIPIENT</div>
          </td>
          <td colspan="1" style="width: 71%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 4%; vertical-align: middle;">&#160;</td>
          <td style="vertical-align: middle; width: 25%;">&#160;</td>
          <td colspan="1" style="width: 71%; vertical-align: middle;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 4%; vertical-align: top; padding-bottom: 2px;">
            <div style="line-height: 1.25;">By:</div>
          </td>
          <td style="width: 25%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">/s/ Nir Marko</div>
            </div>
          </td>
          <td colspan="1" style="width: 71%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 4%; vertical-align: middle;">&#160;</td>
          <td style="vertical-align: middle; width: 25%;">&#160;</td>
          <td colspan="1" style="width: 71%; vertical-align: middle;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 4%; vertical-align: top; padding-bottom: 2px;">
            <div style="line-height: 1.25;">Title:</div>
          </td>
          <td style="width: 25%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">
              <div style="text-align: center; line-height: 1.25;">Director Business Development</div>
            </div>
          </td>
          <td colspan="1" style="width: 71%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 4%; vertical-align: middle;">&#160;</td>
          <td style="vertical-align: middle; width: 25%;">&#160;</td>
          <td colspan="1" style="width: 71%; vertical-align: middle;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 4%; vertical-align: top;">&#160;</td>
          <td style="width: 25%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">Sanmina -Sci</div>
          </td>
          <td colspan="1" style="width: 71%; vertical-align: top;">&#160;</td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
  </div>
  <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">6</font>
    <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; margin-left: auto; margin-right: auto;"></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.7
<SEQUENCE>3
<FILENAME>exhibit_10-7.htm
<DESCRIPTION>EXHIBIT 10.7
<TEXT>
<html style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; text-align: left;">
  <head>
    <!-- Licensed to: ZKG
         Document created using EDGARfilings PROfile 7.3.2.0
         Copyright 1995 - 2021 Broadridge -->
  </head>
<body bgcolor="#ffffff">
  <div style="text-align: right; margin-right: 6.05pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"><u>Exhibit 10.7</u></div>
  <div style="line-height: 1.25">&#160;</div>
  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
  </div>
  <div style="text-align: center; margin-right: 5.5pt; margin-left: 4.5pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Certain confidential information contained in this document, marked by brackets
    and asterisk, has </div>
  <div style="text-align: center; margin-right: 5.5pt; margin-left: 4.5pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">been omitted &#160;pursuant to Item 601(b)(10)(iv) of Regulation S-K, because it (i)
    is not material and (ii) </div>
  <div style="text-align: center; margin-right: 5.5pt; margin-left: 4.5pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">would be competitively harmful if publicly disclosed.</div>
  <div style="line-height: 1.25">&#160;</div>
  <div style="text-align: center; margin-right: 117.05pt; margin-left: 116.75pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">RESEARCH COLLABORATION AGREEMENT</div>
  <div style="line-height: 1.25">&#160;</div>
  <div style="text-align: justify; text-indent: 30.3pt; margin-right: 5.75pt; margin-left: 6pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">This Research Collaboration Agreement (together with all Exhibits hereto,
    this &#8220;<font style="font-weight: bold;">Agreement</font>&#8221;), effective as of May 16, 2016 (the &#8220;<font style="font-weight: bold;">Effective Date</font>&#8221;), is entered into by and between <font style="font-weight: bold;">President and Fellows of Harvard
      College</font>, a charitable corporation of Massachusetts having an office at Richard A. and Susan F. Smith Campus Center, Suite 727, 1350 Massachusetts Avenue, Cambridge, Massachusetts 02138 (&#8220;<font style="font-weight: bold;">Harvard</font>&#8221;), and <font style="font-weight: bold;">ReWalk Robotics</font>, <font style="font-weight: bold;">Ltd. </font>a company existing under the laws of the State of Israel, having a place of business at 200 Donald Lynch Blvd., Marlborough, MA 01752 (&#8220;<font style="font-weight: bold;">Company</font>&#8221;). Harvard and Company each shall be referred to herein as a &#8220;<font style="font-weight: bold;">Party</font>&#8221; and together as the &#8220;<font style="font-weight: bold;">Parties</font>.&#8221;</div>
  <div style="line-height: 1.25">&#160;</div>
  <div style="text-align: left; margin-left: 36.3pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-weight: bold;">WHEREAS</font>, Harvard and Company desire to collaborate in the performance of
    research to be described in a research plan&#894; and</div>
  <div style="line-height: 1.25">&#160;</div>
  <div style="text-align: justify; text-indent: 30.3pt; margin-right: 5.65pt; margin-left: 6pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-weight: bold;">WHEREAS</font>, Harvard and Company believe
    that collaborating with each other in the performance of such research will be of mutual benefit, will further the instructional and research objectives of Harvard and will foster the development of scientific knowledge.</div>
  <div style="line-height: 1.25">&#160;</div>
  <div style="text-align: left; margin-left: 36.3pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-weight: bold;">NOW, THEREFORE, </font>in consideration of the promises and mutual covenants set forth
    herein, Harvard and Company agree as follows:</div>
  <div style="line-height: 1.25">&#160;
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7c699c42f218458cbc2ab3fa887bdcf8">

          <tr>
            <td style="width: 36.35pt; vertical-align: top; align: right;">
              <div style="margin-left: 6.05pt; line-height: 1.25; font-weight: bold;">1.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="line-height: 1.25; font-weight: bold;">Definitions.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 30.3pt; margin-right: 5.85pt; margin-left: 6pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Whenever used in this Agreement with an initial capital letter, the terms
      defined in this <u>Article 1</u>, whether used in the singular or the plural, shall have the meanings specified below.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf9b1188d941b41399fcc49733ebed5be">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">1.1</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;">&#8220;<font style="font-weight: bold;">Active</font>&#8221; shall mean, with respect to a Soft Exosuit, technology that
                commands motors to apply torques at joint(s) beyond adjusting pretension levels.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z496ef0b725d04f5fa7e17458d297abce">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">1.2</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;">&#8220;<font style="font-weight: bold;">Calendar Quarter</font>&#8221; shall mean each of the periods of three (3)
                consecutive calendar months ending on March 31, June 30, September 30 and December 31 during the Term.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7ae04a5f0afa42c89a06a58a4fe2257d">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">1.3</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;">&#8220;<font style="font-weight: bold;">Company Invention</font>&#8221; shall mean any patentable invention that is
                conceived and/or reduced to practice in the performance of the Research Plan during the Term for which at least one inventor is a member of the Company Team (but no inventor is a member of the Harvard Team).</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z5fe3bfc119ce40c89f50bd818df6237f">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">1.4</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;">&#8220;<font style="font-weight: bold;">Company Patent Rights</font>&#8221; shall mean any patents and patent
                applications that claim any Company Invention, in each case solely to the extent the claims are directed to the subject matter of such Company Invention.</div>
            </td>
          </tr>

      </table>
      <div>
        <div>
          <div> <br>
          </div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

              <tr>
                <td style="width: 6.05pt; vertical-align: top; align: right;">
                  <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">1.5</div>
                </td>
                <td style="width: auto; vertical-align: top;">
                  <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
                    <div style="line-height: 1.25; text-indent: 9pt;">&#8220;<font style="font-weight: bold;">Company Principal Investigator</font>&#8221; shall mean Ofir Koren, or such other principal investigator who may replace him pursuant to <u>Section 2.2</u>.</div>
                  </div>
                </td>
              </tr>

          </table>
        </div>
        <div style="line-height: 1.25">&#160;</div>
      </div>
    </div>
    <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">
      <div>
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

              <tr>
                <td style="width: 6.05pt; vertical-align: top; align: right;">
                  <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">1.6</div>
                </td>
                <td style="width: auto; vertical-align: top;">
                  <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
                    <div style="line-height: 1.25;">
                      <div style="line-height: 1.25; text-indent: 0pt; margin-left: 9pt;">&#8220;<font style="font-weight: bold;">Company Results</font>&#8221; shall mean Results generated by the Company
                        Team.</div>
                    </div>
                  </div>
                </td>
              </tr>

          </table>
        </div>
        <div style="line-height: 1.25">&#160;</div>
      </div>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zdfb6d188de01429abb0f6dee74b3e305">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">1.7</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;">&#8220;<font style="font-weight: bold;">Company Team</font>&#8221; shall mean the Company Principal Investigator and
                those technicians, scientists and/or other individuals employed (or otherwise retained) by Company to work on behalf of Company under <font style="font-weight: bold;">[</font>his/her<font style="font-weight: bold;">] </font>direction on
                the Research.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z5da9eb3bcca147cd8b6e6f15709c2a7b">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">1.8</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;">&#8220;<font style="font-weight: bold;">Control</font>&#8221; shall mean, with respect to any Patent Rights,
                other intellectual property rights or trade secrets, the legal authority or right (whether by license or otherwise) of a Party to grant a license or a sublicense of or under such Patent Rights, or other intellectual property rights to
                another Person, or to otherwise disclose such trade secrets to another Person, without breaching the terms of any agreement with a third party, or misappropriating the trade secrets of a third party.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">
        <div>
          <div>
            <div> <br>
            </div>
            <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
              <div id="DSPFPageBreak" style="page-break-after: always;">
                <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
            </div>
            <!--PROfilePageNumberReset%Num%2%%%--></div>
          <div style="line-height: 1.25">&#160;</div>
          <div style="line-height: 1.25">
            <div style="line-height: 1.25;">
              <div>
                <div style="line-height: 1.25">
                  <div>
                    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

                        <tr>
                          <td style="width: 6.05pt; vertical-align: top; align: right;">
                            <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">1.9&#160; <br>
                            </div>
                          </td>
                          <td style="width: auto; vertical-align: top;">
                            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
                              <div style="line-height: 1.25;">
                                <div style="line-height: 1.25;">
                                  <div style="line-height: 1.25; text-indent: 0pt; margin-left: 9pt;">&#8220;<font style="font-weight: bold;">Field</font>&#8221; shall mean Active Medical Lower Limb Soft
                                    Exosuits.</div>
                                </div>
                              </div>
                            </div>
                          </td>
                        </tr>

                    </table>
                  </div>
                  <div style="line-height: 1.25">&#160;</div>
                </div>
              </div>
            </div>
          </div>
        </div>
      </div>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze4e16d3ed18049ff841956ac13c70122">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">1.10</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;">&#8220;<font style="font-weight: bold;">Governmental Authority</font>&#8221; means any transnational, domestic or foreign
                federal, state or local governmental, regulatory or administrative authority, department, court, agency or official, including any political subdivision thereof.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z2c533b6ef0884997a6e391c9b790944b">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">1.11</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;">&#8220;<font style="font-weight: bold;">Harvard Background Patents</font>&#8221; shall mean, in each case to the extent
                owned or Controlled by Harvard, all of the Patent Rights for the patents and patent applications listed in <u>Exhibit C</u>.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd7f1fc8836ac4820af28642e10c0214f">

          <tr>
            <td style="width: 83.65pt; vertical-align: top; align: right;">
              <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">1.12</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;">&#8220;<font style="font-weight: bold;">Harvard Inventions</font>&#8221; shall mean Harvard Type A Inventions and Harvard
                Type B Inventions, collectively.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zab6e27e8fb43424dbc58243ba9a0e9d3">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">1.13</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;">&#8220;<font style="font-weight: bold;">Harvard Principal Investigator</font>&#8221; shall mean Conor Walsh, Ph.D., or
                such other principal investigator who may replace Dr. Walsh pursuant to <u>Section 2.2</u>.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z30620bcdd87e42a6baff0621de2cb6df">

          <tr>
            <td style="width: 83.65pt; vertical-align: top; align: right;">
              <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">1.14</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;">&#8220;<font style="font-weight: bold;">Harvard Results</font>&#8221; shall mean Results generated by the Harvard Team.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0.05pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z2093c78d38b540768ee092d76b4afc16">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">1.15</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;">&#8220;<font style="font-weight: bold;">Harvard Team</font>&#8221; shall mean the Harvard Principal Investigator and
                those faculty members, research fellows, students, technicians, scientists and/or other individuals employed (or otherwise retained) by Harvard to work on behalf of Harvard under his/her direction on the Research.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0.05pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zad1caa3771aa4c2f85b0584e068564de">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">1.16</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;">&#8220;<font style="font-weight: bold;">Harvard Type A Invention</font>&#8221; shall mean any patentable invention that
                either (a) is conceived and reduced to practice (i)(x) in the performance of the Research Plan during the Term or (y) conceived in the performance of the Research Plan during the Term and reduced to practice within one (1) year after
                termination or expiration of the Term, (ii) for which at least one inventor is a member of the Harvard Team (but no inventor is a member of the Company Team) and (iii) which is dominated by a Valid Claim within the Harvard Background
                Patents (regardless of whether or not such Valid Claim ultimately issues)&#894; or (b) is deemed a Harvard Type A Invention pursuant to <u>Section 5.2.4</u>.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0.05pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4ed853b17cf44e1aa76f4b09d1d74eae">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">1.17</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;">&#8220;<font style="font-weight: bold;">Harvard Type A Patent Rights</font>&#8221; shall mean all of the Patents Rights
                for any patents or patent applications that claim any Harvard Type A Invention, in each case solely to the extent the claims are directed to the subject matter of such Harvard Type A Invention.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0.05pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z39215535146b4da1816f6976e5e773b6">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">1.18</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;"><font style="font-weight: bold;">&#8220;Harvard Type B Invention&#8221; </font>shall mean any patentable invention (i)
                conceived and reduced to practice during the Term or (ii) conceived in the performance of the Research Plan during the Term and reduced to practice within one (1) year after termination or expiration of the Term (a) that is not a Harvard
                Type A Invention, (b) for which an inventor is a member of the Harvard Team (but no inventor is a member of the Company Team). Harvard Type B Inventions shall exclude new actuator and sensor components.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zbd02496ac32e42f29e2fc273a123c588">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">1.19</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;">&#8220;<font style="font-weight: bold;">Harvard Type B Patent Rights</font>&#8221; shall mean all of the Patent Rights
                for any patents or patent applications that claim any Harvard Type B Invention, in each case solely to the extent the claims are directed to the subject matter of such Harvard Type B Invention.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z326da21104004f22b19a6151d3634715">

          <tr>
            <td style="width: 83.65pt; vertical-align: top; align: right;">
              <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">1.20</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;">&#8220;<font style="font-weight: bold;">Invention</font>&#8221; shall mean a Company Invention, Harvard Invention or
                Joint Invention, as the case may be.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 3.4pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z919a0019ead441fb8be734e813238306">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">1.21</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;">&#8220;<font style="font-weight: bold;">Joint Invention</font>&#8221; shall mean any patentable invention that is (i)
                conceived and reduced to practice in the performance of a Research Plan during the Term or (ii) conceived in the performance of the Research Plan during the Term and reduced to practice within [**] after termination or expiration of the
                Term, for which one or more inventors are members of the Company Team and one or more inventors are members of the Harvard Team.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; font-weight: normal; font-style: normal;">2</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z2257a4ae369a4ffa819d9f053d5b57fe">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">1.22</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;">&#8220;<font style="font-weight: bold;">Joint Patents</font>&#8221; shall mean any patents and patent applications that
                claim any Joint Invention, in each case solely to the extent the claims are directed to the subject matter of such Joint Invention.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze65375c7d2224c3c9d018bfc904ab506">

          <tr>
            <td style="width: 83.65pt; vertical-align: top; align: right;">
              <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">1.23</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;">&#8220;<font style="font-weight: bold;">License Agreement</font>&#8221; shall mean the agreement entered into by the
                Parties as of the Effective Date.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z06229405501c4e88b905c669e2f16b2a">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">1.24</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;">&#8220;<font style="font-weight: bold;">Medical Lower Limb</font>&#8221; shall mean actively affecting leg movement in
                patients with gait impairments resulting from the lack of proper muscle function due to neurological impairment, muscular degeneration or advanced aging.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z15547a68686641a58fc2ba2ceebd8b95">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">1.25</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;">&#8220;<font style="font-weight: bold;">Person</font>&#8221; shall mean an individual, corporation, partnership, limited
                liability company, association, trust or other entity or organization, including a Governmental Authority.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd7ec76c80cb5470992339bb129fce6b8">

          <tr>
            <td style="width: 83.65pt; vertical-align: top; align: right;">
              <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">1.26</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;">&#8220;<font style="font-weight: bold;">Principal Investigators</font>&#8221; shall mean the Company Principal
                Investigator and the Harvard Principal Investigator.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z94be820e3999407da48e3082e85f53b3">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">1.27</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;">&#8220;<font style="font-weight: bold;">Patent Rights</font>&#8221; shall mean, with respect to any patents or patent
                applications, all of the following: (a) such patents and patent applications (including the PCT and/or U.S. utility application claiming priority to such application(s) that are filed on or before the one year conversion date of such
                application(s))&#894; (b) any patent or patent application that claims priority to and is a divisional, continuation, reissue, renewal, reexamination, substitution or extension of any patent application identified in (a)&#894; (c) any patents issuing
                on any patent application identified in (a) or (b), including any reissues, renewals, reexaminations, substitutions or extensions thereof&#894; (d) any claim of a continuation-in-part application or patent (including any reissues, renewals,
                reexaminations, substitutions or extensions thereof) that is entitled to the priority date of, and is directed specifically to subject matter specifically described in, at least one of the patents or patent applications identified in (a),
                (b) or (c)&#894; (e) any foreign counterpart (including PCTs) of any patent or patent application identified in (a), (b) or (c) or of the claims identified in (d)&#894; and (f) any supplementary protection certificates, pediatric exclusivity periods,
                any other patent term extensions and exclusivity periods and the like of any patents and patent applications identified in (a) through (e).</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z960ac0d141284aaca4d17b3632327999">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">1.28</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;">&#8220;<font style="font-weight: bold;">Research</font>&#8221; shall mean the research actually conducted during the Term
                by the Company Team and/or Harvard Team under the terms of this Agreement in accordance with the Research Plan.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze9217fa72b2c489481fa627a51f25b8d">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">1.29</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;">&#8220;<font style="font-weight: bold;">Research Plan</font>&#8221; shall mean the research plan attached hereto as <u>Exhibit
                  A </u>(as may be amended from time to time by mutual agreement of the Parties), which sets forth the scope, timing and details of the research to be performed by the Company Team and Harvard Team under the direction of their respective
                Principal Investigators during the Term.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25">
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

            <tr>
              <td style="width: 6.05pt; vertical-align: top; align: right;">
                <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">1.30</div>
              </td>
              <td style="width: auto; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
                  <div style="line-height: 1.25; text-indent: 0pt; margin-left: 9pt;">&#8220;<font style="font-weight: bold;">Results</font>&#8221; shall mean all data, materials, compositions, methods,
                    processes, analyses, formulae, know-how, trade secrets, unpatented inventions (whether patentable or unpatentable and whether or not reduced to practice), technology, and information generated in the performance of the Research, but
                    excluding Inventions.</div>
                </div>
              </td>
            </tr>

        </table>
      </div>
      <div style="line-height: 1.25">&#160;
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

              <tr>
                <td style="width: 6.05pt; vertical-align: top; align: right;">
                  <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">1.31</div>
                </td>
                <td style="width: auto; vertical-align: top;">
                  <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
                    <div style="line-height: 1.25; text-indent: 0pt; margin-left: 9pt;">&#8220;<font style="font-weight: bold;">Soft Exosuit</font>&#8221; shall mean assistive technology comprised of (a)
                      a motor/gear-driven actuation system, (b) Bowden-cable-based transmission, (c) a textile-based human interface, (d) wearable sensors and (e) algorithms to control assistance.</div>
                  </div>
                </td>
              </tr>

          </table>
        </div>
        <div style="line-height: 1.25">&#160;
          <div>
            <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

                <tr>
                  <td style="width: 6.05pt; vertical-align: top;">
                    <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">1.32</div>
                  </td>
                  <td style="width: auto; vertical-align: top;">
                    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
                      <div style="line-height: 1.25; text-indent: 0pt; margin-left: 9pt;">&#8220;<font style="font-weight: bold;">Valid Claim</font>&#8221; shall mean: (a) a claim of an issued and
                        unexpired patent that has not been (i) held permanently revoked, unenforceable, unpatentable or invalid by a decision of a Governmental Authority of competent jurisdiction, unappealable or unappealed within the time allowed for
                        appeal, (ii) rendered unenforceable through disclaimer or otherwise, (iii) abandoned or (iv) permanently lost through an interference or opposition proceeding without any right of appeal or review&#894; or (b) a pending claim of a
                        pending patent application that (i) has been asserted and continues to be prosecuted in good faith and (ii) has not been abandoned or finally rejected without the possibility of appeal or refiling.</div>
                    </div>
                  </td>
                </tr>

            </table>
          </div>
          <div style="line-height: 1.25">&#160;</div>
          <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; font-weight: normal; font-style: normal;">3</font></div>
            <div id="DSPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
        </div>
      </div>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z43044f453d6041abb94895d960f88b85">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">1.33</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;"><font style="font-weight: bold;">Additional Defined Terms</font>. The following capitalized terms shall have
                the meanings ascribed to them in the following sections of this Agreement:</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" border="0" align="center" style="width: 70%; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 10pt; text-align: left;" id="z9d66a5d3e65c4418818206832c9fa504">

        <tr>
          <td style="width: 58.13%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Abandoned Joint Patent</div>
          </td>
          <td style="width: 41.87%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 6.2.5.2</div>
          </td>
        </tr>
        <tr>
          <td style="width: 58.13%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Agreement</div>
          </td>
          <td style="width: 41.87%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Preamble</div>
          </td>
        </tr>
        <tr>
          <td style="width: 58.13%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Company</div>
          </td>
          <td style="width: 41.87%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Preamble</div>
          </td>
        </tr>
        <tr>
          <td style="width: 58.13%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Company Confidential Information</div>
          </td>
          <td style="width: 41.87%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 7.1</div>
          </td>
        </tr>
        <tr>
          <td style="width: 58.13%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Company Visiting Scientist</div>
          </td>
          <td style="width: 41.87%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 2.3</div>
          </td>
        </tr>
        <tr>
          <td style="width: 58.13%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Confidential Information</div>
          </td>
          <td style="width: 41.87%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 7.1</div>
          </td>
        </tr>
        <tr>
          <td style="width: 58.13%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Ex-Field Licensee</div>
          </td>
          <td style="width: 41.87%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 10.16</div>
          </td>
        </tr>
        <tr>
          <td style="width: 58.13%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Harvard</div>
          </td>
          <td style="width: 41.87%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Preamble</div>
          </td>
        </tr>
        <tr>
          <td style="width: 58.13%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Harvard Confidential Information</div>
          </td>
          <td style="width: 41.87%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 7.1</div>
          </td>
        </tr>
        <tr>
          <td style="width: 58.13%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Harvard Names</div>
          </td>
          <td style="width: 41.87%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 10.5</div>
          </td>
        </tr>
        <tr>
          <td style="width: 58.13%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Harvard Visiting Scientist</div>
          </td>
          <td style="width: 41.87%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 2.3</div>
          </td>
        </tr>
        <tr>
          <td style="width: 58.13%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">MS</div>
          </td>
          <td style="width: 41.87%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Exhibit A</div>
          </td>
        </tr>
        <tr>
          <td style="width: 58.13%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Negotiation Period</div>
          </td>
          <td style="width: 41.87%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 6.2.3</div>
          </td>
        </tr>
        <tr>
          <td style="width: 58.13%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Option Activation Period</div>
          </td>
          <td style="width: 41.87%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 6.2.2</div>
          </td>
        </tr>
        <tr>
          <td style="width: 58.13%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Option Exercise Period</div>
          </td>
          <td style="width: 41.87%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 6.2.3</div>
          </td>
        </tr>
        <tr>
          <td style="width: 58.13%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Party or Parties</div>
          </td>
          <td style="width: 41.87%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Preamble</div>
          </td>
        </tr>
        <tr>
          <td style="width: 58.13%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Reimbursed Costs</div>
          </td>
          <td style="width: 41.87%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 10.16</div>
          </td>
        </tr>
        <tr>
          <td style="width: 58.13%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Suit</div>
          </td>
          <td style="width: 41.87%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 10.10</div>
          </td>
        </tr>
        <tr>
          <td style="width: 58.13%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Term</div>
          </td>
          <td style="width: 41.87%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 9.1</div>
          </td>
        </tr>
        <tr>
          <td style="width: 58.13%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Visiting Scientist</div>
          </td>
          <td style="width: 41.87%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
            <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 2.3</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze22988596f1745b3824246b6a05e2e23">

          <tr>
            <td style="width: 74.85pt; vertical-align: top; align: right;">
              <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">2.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt; font-weight: bold;">Research.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25">
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0.05pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

            <tr>
              <td style="width: 6.05pt; vertical-align: top; align: right;">
                <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">2.1</div>
              </td>
              <td style="width: auto; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
                  <div style="line-height: 1.25; text-indent: 0pt; margin-left: 9pt;"><font style="font-weight: bold;">Performance of Research</font>. The Parties shall use good faith efforts
                    to perform the Research in accordance with the Research Plan&#894; however, neither Party makes any warranties or representations regarding completion of the Research or the achievement of any particular results.</div>
                </div>
              </td>
            </tr>

        </table>
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0.05pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z502f47e006324ae491e7723fb8945151">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">2.2</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;"><font style="font-weight: bold;">Principal Investigators</font>. The part of the Research to be performed by
                Harvard will be directed and supervised by the Harvard Principal Investigator, who shall have primary responsibility for the performance of such Research. The part of the Research to be performed by Company will be directed and supervised
                by the Company Principal Investigator, who shall have primary responsibility for the performance of such Research. The Principal Investigators shall maintain regular contact with each other, at least monthly, and shall facilitate the
                coordination of the Parties&#8217; activities under the Research Plan. Company may replace the named Company Principal Investigator upon prior written notice to Harvard. If the Harvard Principal Investigator ceases to supervise the Research for
                any reason, Harvard will notify Company promptly and may endeavor to find a substitute acceptable to Company. If Harvard declines or is unable to find a substitute acceptable to Company within [**] after the Harvard Principal Investigator
                ceases to supervise the Research, Company may terminate this Agreement immediately upon written notice to Harvard.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 3.4pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zfd7814fa6a334925b06877abcae9ca9d">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">2.3</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;"><font style="font-weight: bold;">Visiting Scientists</font>. The Parties agree that one or more scientists
                from Company (each, a &#8220;<font style="font-weight: bold;">Company Visiting Scientist</font>&#8221;) may perform or otherwise participate in Research at Harvard&#8217;s facilities, and one or more scientists from Harvard (each, a &#8220;<font style="font-weight: bold;">Harvard Visiting Scientist</font>&#8221;, and together with Company Visiting Scientists, the &#8220;<font style="font-weight: bold;">Visiting Scientists</font>&#8221;) may perform or otherwise participate in Research at Company&#8217;s
                facilities. Company shall provide Harvard with prior written notice of each Company Visiting Scientist that Company intends to have perform or otherwise participate in Research at Harvard&#8217;s facilities. Each Visiting Scientist from Company
                shall execute a Visitor Participation Agreement, in the form attached hereto as <u>Exhibit D</u>), prior to his/her visit. Notwithstanding the terms of the Visitor Participation Agreement or any other provision of this Agreement to the
                contrary, the Parties hereby agree that if a Company Visiting Scientist conceives and reduces to practice any patentable invention&#160; in the performance of the Research Plan during the Term outside of Harvard&#8217;s premises and facilities, then
                he/she shall assign his/her entire right, title and interest in and to such invention to Company. Company shall provide all necessary information and documentation required by the U.S. Department of Homeland Security, if any is required,
                and shall ensure that its Visiting Scientist has the appropriate visa for his/her visit(s) to Harvard. Each Party will endeavor to apprise the other Party&#8217;s Visiting Scientists of any rules, regulations, procedures and policies that may be
                applicable to the Visiting Scientist&#8217;s activities at its facilities. In any event, however, the Visiting Scientist shall comply with all applicable rules, regulations, procedures and policies at all times during the term of this Agreement.
                Neither Party shall compensate or reimburse the other Party or&#160; the other Party&#8217;s Visiting Scientist in connection with the Visiting Scientist&#8217;s visit(s) under this Agreement. Each Party shall pay and administer all compensation and fringe
                benefits, if any, due to its Visiting Scientists. Neither Party shall provide housing, meals, travel or any other personal expenses for the other Party&#8217;s Visiting Scientists. Instead, all such expenses shall be the responsibility of the
                Visiting Scientist or his/her employer. Each Party shall provide health insurance for its Visiting Scientists. Each Company Visiting Scientist shall sign and deliver to Harvard, prior to the commencement of his/her visit, the
                &#8220;Acknowledgement of Risk and Release for Non-Harvard Personnel Using Harvard Research and Instructional Laboratory Facilities,&#8221; in the form attached hereto as <u>Exhibit E</u>).</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; font-weight: normal; font-style: normal;">4</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0.05pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z79458f173585490aa6bf6fd2cd64dc71">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 72pt; line-height: 1.25; font-weight: bold;">2.4</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;">Harvard Team. Within [**] of the Effective Date, Harvard will identify in writing to Company all of the
                members of the Harvard Team. Harvard shall use reasonable efforts to ensure that the continued inclusion of such individuals on the Harvard Team. If any member&#160; of the Harvard Team will be removed or replaced, Harvard shall provide
                reasonable advance notice thereof to Company and shall provide Company with a qualified replacement member, having qualifications and experience at least equal to the former member, who is reasonably satisfactory to Company. If for any
                reason, Company objects to any new proposed member of the Harvard Team, the Parties shall work together in good faith to identify an alternative new member. At no point during the Term will there be less than [**] members of the Harvard
                Team.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z224ef0c278af44f2b0da63babb9c8a8f">

          <tr>
            <td style="width: 36.35pt; vertical-align: top; align: right;">
              <div style="margin-left: 67.5pt; line-height: 1.25; font-weight: bold;">3.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt; font-weight: bold;">Costs and Expenses.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 3.4pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z5f42d02e6d094d2eacad9b2d2407a1d5">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">3.1</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;">Subject to <u>Section 9.6.1</u>, Company agrees to pay Harvard the total amount of [**] United States
                Dollars (US $[**]), as follows:</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb7a19434aa7941dd9e68065a97477a98">

          <tr>
            <td style="width: 36.35pt; vertical-align: top; align: right;">
              <div style="margin-left: 96.95pt; line-height: 1.25; font-weight: bold;">3.1.1</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;">[**] United States Dollars (US $[**]) for 2016 to be paid in [**] equal installments of [**] United States
                Dollars (US $[**]) each, each of which shall be payable within forty-five (45) days of receipt of the invoice from Harvard for such amount. Harvard shall issue each invoice to Company at least [**] prior to the start of each Calendar
                Quarter in 2016 after the Effective Date.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z927db716011a4ca09c00f92806752c39">

          <tr>
            <td style="width: 36.35pt; vertical-align: top; align: right;">
              <div style="margin-left: 96.95pt; line-height: 1.25; font-weight: bold;">3.1.2</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;">[**] United States Dollars for 2017 ($[**]) to be paid as follows: (a) a first installment of [**] United
                States Dollars (US $[**]) and (b) [**] subsequent equal installments of [**] United States Dollars (US $[**]) each, each of which shall be payable within [**] of receipt of the invoice from Harvard for such amount. Harvard shall issue each
                invoice to Company at least [**] prior to the start of each Calendar Quarter in 2017.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze9b0fafaeed140788e2334ab89b3d541">

          <tr>
            <td style="width: 36.35pt; vertical-align: top; align: right;">
              <div style="margin-left: 96.95pt; line-height: 1.25; font-weight: bold;">3.1.3</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;">[**] United States Dollars ($[**]) for 2018 to be paid as follows: (a) a first installment of [**] United
                States Dollars (US $[**]) and (b) [**] subsequent equal installments of [**] United States Dollars (US $[**]) each, each of which shall be payable within [**] of receipt of the invoice from Harvard for such amount. Harvard shall issue each
                invoice to Company at least [**] prior to the start of each Calendar Quarter in 2018.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z13ade2c8da6b4e729819db8de2c320ff">

          <tr>
            <td style="width: 36.35pt; vertical-align: top; align: right;">
              <div style="margin-left: 96.95pt; line-height: 1.25; font-weight: bold;">3.1.4</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;">[**] United States Dollars for 2019 ($[**]) to be paid as follows: (a) a first installment of [**] United
                States Dollars (US $[**]) and (b) [**] subsequent equal installments of [**] United States Dollars (US $[**]) each, each of which shall be payable within [**] of receipt of the invoice from Harvard for such amount. Harvard shall issue each
                invoice to Company at least [**] prior to the start of each Calendar Quarter in 2019.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf371d208ac194c7aa3eecf0921e4e62b">

          <tr>
            <td style="width: 36.35pt; vertical-align: top; align: right;">
              <div style="margin-left: 96.95pt; line-height: 1.25; font-weight: bold;">3.1.5</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;">[**] United States Dollars ($[**]) for 2020 to be paid as follows: (a) a first installment of [**] United
                States Dollars (US $[**]) and (b) [**] subsequent equal installments of [**] United States Dollars (US $[**]) each, each of which shall be payable within [**] of receipt of the invoice from Harvard for such amount. Harvard shall issue each
                invoice to Company at least [**] prior to the start of each Calendar Quarter in 2020.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; font-weight: normal; font-style: normal;">5</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z26da9586a8064e238071a31e270cca0d">

          <tr>
            <td style="width: 115.85pt; vertical-align: top; align: right;">
              <div style="margin-left: 96.95pt; line-height: 1.25; font-weight: bold;">3.1.6</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;">[**] United States Dollars ($[**]) for 2021 to be paid in [**] equal installments of [**] United States
                Dollars (US $[**]) each, each of which shall be payable within [**] of receipt of the invoice from Harvard for such amount. Harvard shall issue each invoice to Company at least [**] prior to the start of the [**] Calendar Quarters of 2021.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z226f3df60ebf4c49a90e3f2340c3be50">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">3.2</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;">Harvard shall use the amounts paid by Company to Harvard pursuant to this Article 3 solely for the conduct of
                the Research pursuant to the terms of this Agreement in accordance with the Research Plan. Harvard shall not be obligated to incur costs or expend funds to conduct the Research in excess of the total amount paid by Company under this
                Agreement.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z15ea7d9eebe64874a566123b484edda7">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 67.5pt; line-height: 1.25; font-weight: bold;">3.3</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;">Harvard will provide Company with a fixed-price invoice in the form set forth in <u>Exhibit B </u>hereto
                prior to each scheduled Calendar Quarterly payment&#894; provided that Harvard&#8217;s failure to do so will not relieve Company from its obligation to make the corresponding payment, but instead will entitle Company to delay the due date of such
                payment until the date that is [**] after the date of Harvard&#8217;s invoice. All payments due under this Agreement will be paid in United States dollars and will be without deduction or withholding of any kind. To the extent&#160; that any terms or
                conditions of any invoice issued by Company in connection with Harvard&#8217;s invoices under this <u>Section 3.3 </u>conflict with the terms and conditions of this Agreement, the terms and conditions of this Agreement will prevail and govern.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z54e3aa9c27ce40f3be7992734a2fc8f0">

          <tr>
            <td style="width: 36.35pt; vertical-align: top; align: right;">
              <div style="margin-left: 67.5pt; line-height: 1.25; font-weight: bold;">4.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt; font-weight: bold;">Results.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd0641db5076e452a96719921781147b6">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">4.1</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt; font-weight: bold;">Reports&#894; Use&#894; License.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zfe3c1845a596492aacf7693173f984e5">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">
              <div style="margin-left: 96.95pt; line-height: 1.25; font-weight: bold;">4.1.1</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;">Each Party shall provide the other with reports summarizing its Results, no less frequently than once each
                Calendar Quarter. After each such exchange, the Parties shall meet either in person or by teleconference to review the Results. Within [**] after the earlier of the completion of the Research or the termination of this Agreement, each Party
                will provide the other with a final report summarizing its Results.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf57386e998934837beffca7ca709ba47">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">
              <div style="margin-left: 96.95pt; line-height: 1.25; font-weight: bold;">4.1.2</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;">Subject to <u>Articles 7 </u>and 8 of this Agreement and without limiting any rights or licenses expressly
                granted by Harvard to Company pursuant to this Agreement or the License Agreement, Harvard shall have the right to use Company&#8217;s Results for internal research purposes only.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z36d66d5a5c2645459d2324ac0c2216a6">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">
              <div style="margin-left: 96.95pt; line-height: 1.25; font-weight: bold;">4.1.3</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;">Subject to <u>Articles 7 </u>and 8 of this Agreement and without limiting any rights or licenses expressly
                granted by Harvard to Company pursuant to this Agreement or the License Agreement, Harvard hereby grants to Company a perpetual, non- exclusive, royalty-free license to use any Harvard Results both (a) for internal research purposes and (b)
                to make, have made, offer for sale, sell, have sold, repair, service and import products and services within the Field in the Territory.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z969b3590789246188dcee7b1900f4aa4">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">4.2</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;"><font style="font-weight: bold;">Confidentiality. </font>Without regard to the marking requirement described
                in <u>Section 7.1 </u>or the disclosure mechanism described in <u>Section 7.2 </u>and subject to the exceptions set forth in <u>Section 7.1 </u>(i) &#8211; (iv), each Party (a) shall treat as Confidential Information (as otherwise defined
                in <u>Section 7.1</u>) of the other Party the contents of any report provided to it under <u>Section 4.1 </u>that discloses Results generated solely by the other Party and (b) shall treat as Confidential Information of the Parties
                jointly the contents of any report provided to it under <u>Section 4.1 </u>that discloses Results generated jointly by the Parties until publication of such joint Results in accordance with <u>Article 8 </u>(except that patent filings
                in accordance with <u>Section 5.4 </u>shall be permitted).</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; font-weight: normal; font-style: normal;">6</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div>
      <div> <br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zda099e40c67f403caaf7f00b7a8d604e">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 67.5pt; line-height: 1.25; font-weight: bold;">4.3</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;"><font style="font-weight: bold;">Meet and Confer. </font>If, during the Term, Company notifies Harvard
                Principal Investigator that Company believes that certain Harvard Results are competitively sensitive or would provide Company with a discernible competitive or market advantage that would be adversely affected if publicly used, disclosed
                or published, then the Parties shall use good faith efforts to meet and confer to discuss such Harvard Results and the concerns of Company regarding the use, disclosure and publication thereof by Harvard, the Harvard Principal Investigator
                or the Harvard Team.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z204aec86fb6b4eebb62c8876374e61b4">

          <tr>
            <td style="width: 36.35pt; vertical-align: top; align: right;">
              <div style="margin-left: 67.5pt; line-height: 1.25; font-weight: bold;">5.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt; font-weight: bold;">Inventions.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z169cd01363b24b699f00b9ecaf74d33f">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">5.1</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;"><font style="font-weight: bold;">Inventorship. </font>Inventorship of Inventions shall be determined in
                accordance with United States patent law.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z471fc0a90d6642c299ac4d565741888c">

          <tr>
            <td style="width: 79.25pt; vertical-align: top; align: right;">
              <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">5.2</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold; text-indent: 9pt;">Ownership.</div>
            </td>
          </tr>

      </table>
      <div>
        <div style="text-align: left; text-indent: 31.8pt; margin-left: 4.5pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"> <br>
        </div>
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 3.4pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7a05b3ece7924c8180915afeb2ee002b">

              <tr>
                <td style="width: 36pt; vertical-align: top; align: right;">
                  <div style="margin-left: 99pt; line-height: 1.25; font-weight: bold;">5.2.1</div>
                </td>
                <td style="width: auto; vertical-align: top;">
                  <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
                    <div style="line-height: 1.25; text-indent: 0pt; margin-left: 9pt;"><font style="font-weight: bold;">Company Inventions</font>. The entire right, title and interest in and
                      to all Company Inventions shall be owned solely by Company.</div>
                  </div>
                </td>
              </tr>

          </table>
        </div>
      </div>
    </div>
    <div style="text-align: left; text-indent: 31.8pt; margin-left: 4.5pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"> <br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 3.4pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7a05b3ece7924c8180915afeb2ee002b">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">
              <div style="margin-left: 99pt; line-height: 1.25; font-weight: bold;">5.2.2</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;"><font style="font-weight: bold;">Harvard Inventions</font>. The entire right, title and interest in and to
                all Harvard Inventions shall be owned solely by Harvard.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z91effb2083f245d0b72785ff36735904">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">
              <div style="margin-left: 99pt; line-height: 1.25; font-weight: bold;">5.2.3</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;"><font style="font-weight: bold;">Joint Inventions.</font> The entire right, title and interest in and to all
                Joint Inventions shall be owned jointly by Company and Harvard. Subject to Section 6.2, Company and Harvard each shall have the full right in any jurisdiction to grant licenses under its interest in Joint Patents without any obligation to
                seek the consent of the other or to account for any profits made as a result of any such license.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z61e5c1cf16234cbc9fdc061aecac5c80">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">
              <div style="margin-left: 99pt; line-height: 1.25; font-weight: bold;">5.2.4</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;"><font style="font-weight: bold;">Inventions Made by Company Visiting Scientists</font>. Notwithstanding
                anything to the contrary herein (but consistent with the fourth (4th) sentence of <u>Section 2.3</u>), patentable inventions conceived and reduced to practice by a Company Visiting Scientist solely during the period that such Company
                Visiting Scientist is performing or otherwise participating in Research at Harvard&#8217;s facilities in the performance of the Research Plan will be deemed to be a Harvard Type A Invention.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4ee3a53dfcbe468e9179b1ca3c32fb00">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">
              <div style="margin-left: 99pt; line-height: 1.25; font-weight: bold;">5.2.5</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;"><font style="font-weight: bold;">Inventions Made by Harvard Visiting Scientists</font>. Notwithstanding
                anything to the contrary herein, patentable inventions conceived and reduced to practice by a Harvard Visiting Scientist (other than Dr. Walsh) solely during the period that such Harvard Visiting Scientist is performing or otherwise
                participating in Research at Company&#8217;s facilities in the performance of the Research Plan will be deemed to be a Joint Invention.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z388974369dcb435c9ef09297abe294d0">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 67.5pt; line-height: 1.25; font-weight: bold;">5.3</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;"><font style="font-weight: bold;">Disclosure</font>. Harvard shall notify Company, promptly and in writing, of
                any Invention with respect to which its Office of Technology Development has received a written invention disclosure form and (in the case of Harvard Inventions and Joint Inventions) filed a patent application&#894; provided, however, that
                subject to and without limiting Sections 2.6.4 (with respect to Consulting Inventions and Joint Consulting Inventions (as such terms are defined in the License Agreement)) and 6.1 <u>(</u>with respect to any Inventions included in the
                Licensed Patent Rights (as such term is defined in the License Agreement)) of the License Agreement, Harvard may elect to notify Company prior to filing. Company shall notify Harvard, promptly and in writing, of any Company Invention for
                which it has filed a patent application&#894; provided, however,&#160; that Company may elect to notify Harvard prior to filing. Without regard to the marking requirement described in <u>Section 7.1 </u>or the disclosure mechanism described in <u>Section

                  7.2</u>, and subject to the exceptions set forth in <u>Section 7.1 </u>(i) &#8211; (iv), each Party (a) shall treat as Confidential Information of the other Party the contents of any notice provided to it under this <u>Section 5.3 </u>that
                discloses an Invention owned solely by the other Party and (b) shall treat as Confidential Information of the Parties jointly the contents of any notice provided to it under this <u>Section 5.3 </u>that discloses a Joint Invention until
                publication of such Joint Invention in accordance with <u>Article 8 </u>(except that patent filings in accordance with <u>Section 5.4 </u>shall be permitted).</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; font-weight: normal; font-style: normal;">7</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z2dc498d5ddb445da96d2023c4074098a">

          <tr>
            <td style="width: 79.25pt; vertical-align: top; align: right;">
              <div style="margin-left: 67.5pt; line-height: 1.25; font-weight: bold;">5.4</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt; font-weight: bold;">Patent Filing and Prosecution.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4e76f9e5519248d6852e3f1eacacfba3">

          <tr>
            <td style="width: 36.35pt; vertical-align: top; align: right;">
              <div style="margin-left: 96.95pt; line-height: 1.25; font-weight: bold;">5.4.1</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;"><font style="font-weight: bold;">Sole Inventions</font>. Company shall be responsible, at its sole expense
                and discretion, for the preparation, filing, prosecution and maintenance of Company Patent Rights. Subject to and without limiting Section 6 of the License Agreement with respect&#160; to any Inventions included in the Licensed Patent Rights (as
                such term is defined in the License Agreement), Harvard shall be responsible,&#160; at its sole expense and discretion, for the preparation, filing, prosecution and maintenance of Harvard Patent Rights.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 3.4pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0232709df02e48fba78d018156d10402">

          <tr>
            <td style="width: 36.35pt; vertical-align: top; align: right;">
              <div style="margin-left: 96.95pt; line-height: 1.25; font-weight: bold;">5.4.2</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;"><font style="font-weight: bold;">Joint Inventions. </font>Harvard shall be responsible for the preparation,
                filing, prosecution and maintenance of Joint Patents&#894; provided, however, that Harvard may elect to waive such right on a case-by-case basis, in which case Harvard shall notify Company promptly in writing and Company shall have the right,
                but not the obligation, to take responsibility for such Joint Patents at its own expense. The responsible Party shall: (a) use outside patent counsel reasonably acceptable to the other Party and instruct such patent counsel to furnish the
                other Party with copies of all correspondence relating to Joint Patents from all patent offices, as well as copies of all proposed responses to such correspondence in time for the other Party to review and comment on such responses&#894; (b)
                give the other Party an opportunity to review the text of each patent application before filing&#894; (c) consult with the other Party with respect thereto&#894; (d) supply the other Party with a copy of the application as filed, together with notice
                of its filing date and serial number&#894; and (e) keep the other Party advised of the status of actual and prospective patent filings. The responsible Party shall give the other Party the opportunity to provide comments on and make requests of
                the responsible Party concerning the preparation, filing, prosecution and maintenance of Joint Patents, and shall consider such comments and requests in good faith.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7f51077733ef4966913c5fcbac9f5508">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">5.5</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;"><font style="font-weight: bold;">No License or Grant of Rights</font>. Except as expressly provided in <u>Section
                  4.1 </u>or <u>Article 6</u>, nothing in this Agreement shall be construed to confer any ownership interest, license or other rights upon a Party by implication, estoppel or otherwise as to any technology, intellectual property rights,
                products or biological materials of the other Party or any other entity.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb45139f7b38543b6b567ab91eeacc218">

          <tr>
            <td style="width: 36.35pt; vertical-align: top; align: right;">
              <div style="margin-left: 63pt; line-height: 1.25; font-weight: bold;">6.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt; font-weight: bold;">Intellectual Property.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z2a8964ebfcb144428706facc425cebf9">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 67.5pt; line-height: 1.25; font-weight: bold;">6.1</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;"><font style="font-weight: bold;">Harvard Type A Inventions</font>. Harvard shall grant a license to Company
                under Harvard&#8217;s interest under the Harvard Type A Inventions pursuant to and in accordance with the License Agreement.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zfb742f077e3e4082bb535cffbf41585e">

          <tr>
            <td style="width: 79.25pt; vertical-align: top; align: right;">
              <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">6.2</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold; text-indent: 9pt;">Grant of Option Under Harvard Type B Inventions and Harvard&#8217;s Interest in Joint Patents.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zdfe7ad94b6aa4a70a3db271344c2cd66">

          <tr>
            <td style="width: 36.35pt; vertical-align: top; align: right;">
              <div style="margin-left: 96.95pt; line-height: 1.25; font-weight: bold;">6.2.1</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;"><font style="font-weight: bold;">Option</font>. With respect to each Harvard Type B Invention, Harvard shall
                notify Company of such Harvard Type B Invention prior to notifying any third party and Harvard hereby grants to Company the first option to negotiate in good faith with Harvard for a non-exclusive or an exclusive (at Company&#8217;s discretion),
                royalty-bearing, worldwide license under the Harvard Type B Patent Rights to develop, make, have made, offer for sale, sell, have sold and import products and services in the Field on terms that are commercially reasonable to the industry&#894;
                provided, however, that no such license will include any grant of exclusive rights that would violate the National Institutes of Health&#8217;s Principles and Guidelines for Recipients of NIH Research Grants and Contracts on Obtaining and
                Disseminating Biomedical Research Resources, as published at 64 Fed. Reg. 72090, and as may be amended from time to time. With respect to each Joint Invention, Harvard shall notify Company of its intent to file any application for a Joint
                Patent and Harvard hereby grants to Company the first option to negotiate in good faith with Harvard for an exclusive license under Harvard&#8217;s interest in the Joint Patent to develop, make, have made, offer for sale, sell, have sold and
                import products and services in the Field on terms that are commercially reasonable to the industry.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; font-weight: normal; font-style: normal;">8</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z14a1411f853048098760db0932b036bf">

          <tr>
            <td style="width: 36.35pt; vertical-align: top; align: right;">
              <div style="margin-left: 96.95pt; line-height: 1.25; font-weight: bold;">6.2.2</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;"><font style="font-weight: bold;">Activation&#894; Patent Costs</font>. If Company chooses to activate such option
                to negotiate with Harvard for a license under a Harvard Type B Invention (or, if applicable, an exclusive license under Harvard&#8217;s interest in a Joint Invention), it shall provide Harvard with written notice thereof within [**] after
                disclosure of the relevant Harvard Type B Invention (or relevant Joint Invention) under <u>Section 5.3 </u>(the &#8220;<font style="font-weight: bold;">Option Activation Period</font>&#8221;). If Company activates an option during the relevant Option
                Activation Period, then subject to <u>Section 10.16</u>, it shall reimburse Harvard for all reasonable documented, out-of-pocket costs relating to the preparation, filing, prosecution and maintenance of the relevant Harvard Type B Patent
                Rights (or relevant Joint Patent) incurred by Harvard prior to activation of the option, as well as those incurred during the Option Exercise Period and Negotiation Period. Harvard shall submit periodic invoices and Company shall make
                payment within [**] after the date of each such invoice.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 3.4pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z16daa80db4dd423d9886164790c71aee">

          <tr>
            <td style="width: 36.35pt; vertical-align: top; align: right;">
              <div style="margin-left: 96.95pt; line-height: 1.25; font-weight: bold;">6.2.3</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;"><font style="font-weight: bold;">Exercise</font>. If Company chooses to exercise its option to negotiate with
                Harvard for a license under a Harvard Type&#160; B Invention (or, if applicable, an exclusive license under Harvard&#8217;s interest in a Joint Invention) that Company has activated under <u>Section 6.2.2</u>, Company must provide Harvard with
                written notice of such decision at any time during the Term or within [**] after expiration or termination of the Term (collectively, the &#8220;<font style="font-weight: bold;">Option Exercise Period</font>&#8221;). If Company exercises an option to
                negotiate with Harvard for a license under a Harvard Type B Invention within the Option Exercise Period, it shall have [**] after such exercise within which to execute a license agreement with Harvard (the &#8220;<font style="font-weight: bold;">Negotiation

                  Period</font>&#8221;)&#894; provided that the Negotiation Period may be extended by mutual agreement of the Parties. Each of Harvard and Company shall use good faith efforts to negotiate and execute such mutually-agreeable license agreement. If
                Company exercises an option for an exclusive license under Harvard&#8217;s interest in a Joint Invention, then upon receipt by Harvard of the written request of Company, the Parties shall immediately amend <u>Exhibit 1.25 </u>of the License
                Agreement to add Harvard&#8217;s interest in such Joint Patent and upon such amendment, each such Joint Patent shall automatically (and without any action of the Parties) be deemed to be &#8220;<font style="font-weight: bold;">Licensed Patent Rights</font>&#8221;
                licensed pursuant to the License Agreement by Harvard to Licensee on the same terms as those set forth therein, including, without limitation, subject to <u>Section 11.17 </u>thereof, reimbursement to Harvard for all documented, out-of-
                pocket expenses incurred by Harvard in connection with such Licensed Patent Rights in accordance with <u>Article 6 </u>thereof.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zcb5af0f5150342dd83628b2c7a9de531">

          <tr>
            <td style="width: 36.35pt; vertical-align: top; align: right;">
              <div style="margin-left: 96.95pt; line-height: 1.25; font-weight: bold;">6.2.4</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;"><font style="font-weight: bold;">Terms</font>. Except as otherwise expressly agreed by the Parties in
                writing, such license agreement for a license under a Harvard Type B Invention shall include, without limitation, (a) in the case of an exclusive license, terms consistent with the provisions of&#160; 35 U.S.C. &#167;&#167; 200-212 and 37 C.F.R. &#167; 401 et
                seq., and a reservation of the rights of Harvard and other not-for-profit research organizations to practice the subject matter of the licensed Harvard Type B Patent Rights for research, teaching and other educational purposes only, (b) the
                indemnity, insurance, limitations on liability, patent cost reimbursement (subject to a provision consistent with <u>Section 10.16</u>) and other provisions customary to patent and technology licenses normally granted by Harvard (i.e.,
                consistent with those as set forth in the License Agreement), and (c) commercially reasonable due diligence obligations for the development and commercialization of products or processes covered by the relevant Harvard Type B Patent Rights
                (i.e., consistent with those set forth in the License Agreement).</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z5ceeb3885b0445659bf3b0c8aec96ff3">

          <tr>
            <td style="width: 115.85pt; vertical-align: top; align: right;">
              <div style="margin-left: 96.95pt; line-height: 1.25; font-weight: bold;">6.2.5</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;"><font style="font-weight: bold;">Expiration</font>.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8a372f7b9c044cbf9238771a4999492e">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 96.95pt; line-height: 1.25; font-weight: bold;">6.2.5.1</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;">With respect to each Harvard Type B Invention, if Company (a) does not activate its option during the
                relevant Option Activation Period, (b) provides written notice to Harvard during the relevant Option Activation Period that it waives its option in whole or in part, (c) activates its option during the relevant Option Activation Period but
                does not exercise the Option during the Option Exercise Period or (d) exercises its Option during the Option Exercise Period and the Parties fail to reach agreement on terms and conditions of a license agreement within the Negotiation
                Period, then Company&#8217;s rights under this <u>Article 6 </u>with respect to such Harvard Type B Invention shall expire.</div>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; font-weight: normal; font-style: normal;">9</font></div>
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 3.4pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z18bd30b755d7421fae8f17a6c6fd54ef">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 96.95pt; line-height: 1.25; font-weight: bold;">6.2.5.2</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;">With respect to each Joint Invention, if Company decides that it does not wish to pay for the preparation,
                filing, prosecution or maintenance of a Joint Patent in a particular country (each, an &#8220;<font style="font-weight: bold;">Abandoned Joint Patent</font>&#8221;), Company shall provide Harvard with prompt written notice of such election. Upon
                Harvard&#8217;s receipt of such notice, Company shall be released from its obligation to reimburse Harvard&#160; for the expenses incurred thereafter as to such Abandoned Joint Patents&#894; provided, however, that expenses authorized prior to the receipt
                by Harvard of such notice shall be deemed incurred prior to the notice. For clarity, Company&#8217;s right thereafter under such Abandoned Joint Patents shall be limited to a non-exclusive license in the Field in the relevant territory solely to
                the extent necessary for Company to practice other Patent Rights dominated by a Valid Claim within such Abandoned Joint Patent.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf08bb770f9094815be2bf9dec9b9086e">

          <tr>
            <td style="width: 36.35pt; vertical-align: top; align: right;">
              <div style="margin-left: 63pt; line-height: 1.25; font-weight: bold;">7.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt; font-weight: bold;">Confidential Information.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zea77ca732d9748fcb3fbe1f8d1635971">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 67.5pt; line-height: 1.25; font-weight: bold;">7.1</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;"><font style="font-weight: bold;">Definitions. &#8220;Confidential Information&#8221; </font>shall mean all information
                (including Results, but only until publication in accordance with Article 8 hereof) that is marked as confidential (or, if disclosed orally or in intangible form, that is summarized in a writing that is marked as confidential and delivered
                to the recipient within thirty (30) days after disclosure) and that is disclosed (a) by or on behalf of Harvard (including by any member of the Harvard Team) to Company hereunder (&#8220;<font style="font-weight: bold;">Harvard Confidential
                  Information</font>&#8221;) or (b) by or on behalf of Company (including by any member of the Company Team) to Harvard or the Harvard Principal Investigator hereunder (&#8220;<font style="font-weight: bold;">Company Confidential Information</font>&#8221;).
                Notwithstanding the above, the obligations set forth in Sections 7.2, 7.3 and 8.2 shall not apply to Confidential Information to the extent that it: (i) was known to the recipient at the time it was disclosed, other than by previous
                disclosure by or on behalf of the discloser, as evidenced by written records at the time of disclosure&#894; (ii) is at the time of disclosure or later becomes publicly known under circumstances involving no breach of this Agreement&#894; (iii) is
                lawfully and in good faith made available to the recipient by a third party who is not subject to obligations of confidentiality to the discloser with respect to such information&#894; or (iv) is independently developed by the recipient without
                the use of or reference to Confidential Information, as demonstrated by documentary evidence.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z6202980918584510b1b86c6fe4776dce">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">7.2</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;"><font style="font-weight: bold;">Disclosure Limitation. </font>Pursuant to Harvard policy, the Harvard
                Principal Investigator is not supposed to receive information that is subject to confidentiality obligations, including any Company Confidential Information, if doing so would affect his ability to publish research results or the ability of
                other scholars to replicate the published results. Accordingly, Company agrees to disclose Company Confidential Information to the Harvard Principal Investigator only if (a) it first notifies the Harvard Principal Investigator of the nature
                of such information and (b) the Harvard Principal Investigator, in his sole discretion, notifies Company that he wishes to accept the specified information, or a portion thereof. For clarity the obligations of the Harvard Principal
                Investigator set forth in <u>Sections 7.3 </u>and <u>8.2 </u>shall only apply to Company Confidential Information accepted by the Harvard Principal Investigator in accordance with this <u>Section 7.2</u>.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0f05f339167a4fe6ab405184a0a2061f">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">7.3</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;"><font style="font-weight: bold;">Obligations. </font>Company, Harvard, and the Harvard Principal
                Investigator each agree that, without the prior written consent of Harvard (in the case of Company being the recipient) or Company (in the case of Harvard or the Harvard Principal Investigator being the recipient)&#160; in each case, during the
                Term of this Agreement, and for five (5) years thereafter, it/he (a) will not disclose Confidential Information that it/he has received hereunder to any third party and (b) will not use Confidential Information that it/he has received
                hereunder except for the purposes of performing the Research and, in the case of Company, evaluating whether to exercise an option under Article 6 of this Agreement. Company, Harvard, and the Harvard Principal Investigator each shall treat
                Confidential Information that it/he has received hereunder with the same degree of confidentiality as it/he treats its/his own confidential and proprietary information, but in all events no less than a reasonable degree of confidentiality.
                Company, Harvard and the Harvard Principal Investigator each may disclose Confidential Information that it/he has received hereunder only to members of the Company Team or Harvard Team, respectively, who have a need to know such information
                for the purposes specified above and who agree in writing to protect such Confidential Information in accordance with the terms set forth in this Agreement.</div>
            </td>
          </tr>

      </table>
    </div>
    <div id="DSPFPageHeader">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; font-weight: normal; font-style: normal;">10</font></div>
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 3.4pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z747830e145f44892b31c8afb1abb1c0d">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">7.4</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;"><font style="font-weight: bold;">Agreement. </font>The terms (but not the existence) of this Agreement
                constitute the Confidential Information of both Parties and neither Party shall disclose the terms of this Agreement to any third party except (a) to its Affiliates, Distributors and Sublicensees (as such terms are defined in the License
                Agreement) and their respective officers, directors, members, employees, agents and outside advisors who reasonably need to know such information for exercising such Party&#8217;s rights or performing such Party&#8217;s obligations under this Agreement
                or the License Agreement, (b) with the prior written approval of the other Party, (c) the Parties may issue a press release substantially in the form set forth in <u>Exhibit F</u>, which press release has been approved in advance by
                Harvard, or (d) this restriction shall not apply to any information required by law to&#160; be disclosed to any Governmental Authority or required to be disclosed publicly pursuant to applicable law, including, without limitation, pursuant&#160; to
                or in connection with securities law reporting obligations or the rules of any securities exchange, provided that the Party disclosing such information shall seek confidential treatment of such Confidential Information to the extent
                permitted under applicable law. Notwithstanding the foregoing, Harvard may publicly acknowledge Company&#8217;s support for the investigations being pursued under this Agreement and in such statement, may disclose a high-level description of the
                research project (without disclosing specific timelines or deadlines), the relevant Harvard school/researchers, and the identity of Company as the sponsor).</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf84d203209dd474898a807f22ccb20e1">

          <tr>
            <td style="width: 36.35pt; vertical-align: top; align: right;">
              <div style="margin-left: 63pt; line-height: 1.25; font-weight: bold;">8.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt; font-weight: bold;">Publications.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 3.4pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z5c1ddda5ab514a2da3cc664e2f898d9b">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">8.1</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;">It is possible that Harvard and Company will publish the Results jointly. Nonetheless, subject to the
                provisions of this Agreement (including Article 7), each Party reserves the right to publish its Results separately. Harvard shall provide Company with a copy of any manuscript or other publication disclosing Results at least [**] prior to
                submission for publication for the purpose of enabling Company to review the manuscript or other publication for potentially patentable Inventions with respect to which it wishes to exercise its option rights under Article 6 and/or for
                Company Confidential Information. Company shall provide Harvard with a copy of any manuscript or other publication disclosing Results at least [**] prior to submission for publication for the purpose of enabling Harvard to review the
                manuscript or other publication for potentially patentable Joint Inventions with respect to which it would like to file a patent application and/or for Harvard Confidential Information.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 3.4pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za34dde1a8d60427dbff1152b7b75077a">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">8.2</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;">The Party wishing to publish shall delete from its manuscript or other publication prior to submission all
                Confidential Information of the other Party that the other Party identifies and requests the Party wishing to publish to delete within the [**] period specified in Section 8.1.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 3.4pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zbc74edb3daba401cb274247f1f4f2975">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">8.3</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;">If, during the [**] period specified in Section 8.1, Company notifies Harvard that a manuscript or other
                publication reveals a potentially patentable Harvard Type B Invention or Joint Invention for which it wishes to exercise an option pursuant to Article 6, or Harvard notifies Company that a manuscript or other publication reveals a
                potentially patentable Joint Invention with respect to which it would like to file a patent application, the Party wishing to publish shall delay publication for the purpose of enabling a patent application to be filed in accordance with
                Section 5.4 until the earliest to occur of: (a) a patent application has been filed with respect to such Harvard Type B Invention or Joint Invention&#894; (b) Harvard&#8217;s Office of Technology Development and Company have determined that the
                relevant Harvard Type B Invention or Joint Invention is not patentable&#894; or (c) [**] have elapsed from the date of notification under this Section 8.3.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 3.4pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc643f3b160f249369768eb4e16083053">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">8.4</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;">Notwithstanding anything to the contrary herein, the Parties agree to abide by the policies of journals in
                which publications will appear as to such matters as the public release or availability of data or biological materials relating to the manuscript or other publication. Proper acknowledgment will be made for the contributions of each Party
                to the Results being published. In addition, to the extent required by applicable journal policies, each Party shall use reasonable efforts to make samples of its research materials disclosed in the manuscript or other publication available
                upon request (supplies permitting) to scientists at non-profit institutions, provided that the recipient scientist agrees in writing that such research materials (a) will be used for research in the recipient scientist&#8217;s laboratory only,
                (b) will not be used for any commercial purpose, (c) will not be used for work on human subjects, and (d) will not be distributed to other laboratories.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; font-weight: normal; font-style: normal;">11</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z6e3bd097aebe4e5aaeaa5f37c66d4e91">

          <tr>
            <td style="width: 36.35pt; vertical-align: top; align: right;">
              <div style="margin-left: 63pt; line-height: 1.25; font-weight: bold;">9.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt; font-weight: bold;">Term and Termination.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0.05pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z93cdbc4fa87c4f5daf422034414015a9">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 67.5pt; line-height: 1.25; font-weight: bold;">9.1</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;"><font style="font-weight: bold;">Term. </font>This Agreement shall commence on the Effective Date and shall
                remain in effect for a period of five (5) years (the &#8220;<font style="font-weight: bold;">Term</font>&#8221;), unless earlier terminated in accordance with the provisions of this <u>Article 9</u>.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0.05pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf2f4196cdf8b41cb905c2bb42cd25c42">

          <tr>
            <td style="width: 79.25pt; vertical-align: top; align: right;">
              <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">9.2</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold; text-indent: 9pt;">Termination.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc52e1deb49494c6ebbb9d0afd30dc35b">

          <tr>
            <td style="width: 36.35pt; vertical-align: top; align: right;">
              <div style="margin-left: 96.95pt; line-height: 1.25; font-weight: bold;">9.2.1</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;"><font style="font-weight: bold;">Loss of Harvard Principal Investigator. </font>In the event that Dr. Walsh
                ceases to supervise the Research and Harvard declines or is unable to find a substitute the Harvard Principal Investigator acceptable to Company as provided in <u>Section 2.2</u>, Company may terminate this Agreement in accordance with <u>Section

                  2.2</u>.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za7f9b27fa4c842bca33c039e8a267609">

          <tr>
            <td style="width: 36.35pt; vertical-align: top; align: right;">
              <div style="margin-left: 96.95pt; line-height: 1.25; font-weight: bold;">9.2.2</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;"><font style="font-weight: bold;">Termination for Default. </font>In the event that either Party commits a
                material breach of its obligations under this Agreement and fails to cure that breach within thirty (30) days after receiving a written demand to cure from the non-breaching Party, the non-breaching Party may terminate this Agreement
                immediately upon written notice of termination to the breaching Party.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z80cfacd541c84bc9b9621815742295d4">

          <tr>
            <td style="width: 36.35pt; vertical-align: top; align: right;">
              <div style="margin-left: 96.95pt; line-height: 1.25; font-weight: bold;">9.2.3</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;"><font style="font-weight: bold;">Termination for Convenience. </font>Subject to provisions of <u>Section
                  9.6.1 </u>regarding the payment by Company of any minimum commitment, Company may terminate this Agreement if the Company does not believe that it either has sufficient finances to proceed or can otherwise secure sufficient funding to
                proceed, upon sixty (60) days prior written notice to Harvard.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z6eb02b76f0b548ec92198d15129bbf0b">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">9.3</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;"><font style="font-weight: bold;">Cross-Termination. </font>This Agreement shall automatically (and without
                any action of the Parties) terminate upon termination of the License Agreement in accordance with <u>Section 9.2 </u>thereof.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z5f415f1d412f4d0abb192d2e604ff223">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">9.4</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;"><font style="font-weight: bold;">Force Majeure. </font>Neither Party will be responsible for delays
                resulting from causes beyond its reasonable control, including, without limitation, fire, explosion, flood, war, strike or riot&#894; provided that the non-performing Party uses commercially reasonable efforts to avoid or remove such causes of
                non-performance and continues performance under this Agreement with reasonable dispatch whenever such causes are removed.</div>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 3.4pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za7445a31427042cfa2941fb8d5775412">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 67.5pt; line-height: 1.25; font-weight: bold;">9.5</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;"><font style="font-weight: bold;">Survival. </font>The following provisions, as well as any rights,
                obligations and duties which by their nature extend beyond the expiration or termination of this Agreement, shall survive the expiration or termination of this Agreement: <u>Article 7 </u>and 9 and <u>Sections 4.1.2</u>, <u>4.2</u>, <u>5.2</u>,
                <u>5.3</u>, <u>10.2</u>, <u>10.3</u>, <u>10.4</u>, and <u>10.5</u>. In addition, the provisions of <u>Article 6 </u>shall survive termination of this Agreement as necessary to effectuate the rights of Company, unless Harvard has
                terminated this Agreement because of a material uncured breach by Company. In addition, <u>Sections 4.1.3 </u>and <u>10.6 </u>shall survive the expiration or termination of this Agreement but solely until expiration or termination of
                the License Agreement.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z5980f04fe47247328717cb7dc3248232">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">9.6</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;"><font style="font-weight: bold;">Effect of Termination. </font>Except as otherwise expressly set forth in <u>Section
                  9.5 </u>or this <u>Section 9.6</u>, all rights and obligations of the Parties shall cease immediately upon expiration or termination of this Agreement.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc0aacf298e88493082f09d9b8ba5b63e">

          <tr>
            <td style="width: 115.85pt; vertical-align: top; align: right;">
              <div style="margin-left: 96.95pt; line-height: 1.25; font-weight: bold;">9.6.1</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold; text-indent: 9pt;">Payment Obligations.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za8f72f3a7bf548a6b567462da1c08c30">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 96.95pt; line-height: 1.25; font-weight: bold;">9.6.1.1</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;"><font style="font-weight: bold;">Payment of Minimum Commitment for Certain Terminations Prior to April 1,
                  2018. </font>In the event that (a) Harvard terminates this Agreement in accordance with <u>Section 9.2.2 </u>for the uncured material breach of Company, or (b) Company terminates this Agreement in accordance with <u>Section 9.2.3</u>,
                where, in either case of (a) or (b), the effective date of such termination is prior to [**] then notwithstanding that such termination may predate the dates for invoicing and payment set forth in <u>Section 3.1</u>, Company&#8217;s obligation
                to pay Harvard all amounts due pursuant to <u>Sections 3.1.1</u>, <u>3.1.2 </u>and <u>3.1.3(a) </u>hereof (which, for clarity, equals [**] U.S. Dollars ($[**])) shall expressly survive such termination and Company shall pay Harvard all
                such amounts due no later than the respective deadlines set forth therein. For clarity, if this Agreement is terminated for any reason specified in this <u>Section 9.6.1.1</u>, Company shall have no obligation to pay any other amounts due
                or payable under <u>Section 3.1 </u>from and after the effective date of such termination.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; font-weight: normal; font-style: normal;">12</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z97c936492cf245dfa2d02cc7b2318129">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 96.95pt; line-height: 1.25; font-weight: bold;">9.6.1.2</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;"><font style="font-weight: bold;">Payment Obligations with respect to All Other Terminations. </font>For
                clarity, in the event that this Agreement is terminated for any other reason (including, (a) the Company terminates this Agreement in accordance with (i) <u>Section 9.2.1 </u>for loss of Harvard Principal Investigator, or (ii) <u>Section
                  9.2.2 </u>for the uncured material breach of Harvard, (b) the Company terminates this Agreement in accordance with <u>Section 9.2.3 </u>(where the effective date of such termination for convenience is on or after [**]), (c) Harvard
                terminates this Agreement in accordance with <u>Section 9.2.2 </u>for the uncured material breach of Company (where the effective date of such termination is on or after [**]), or (d) this Agreement automatically terminates in accordance
                with <u>Section 9.3 </u>due to termination of the License Agreement), then, in each such case, Company shall have no obligation to pay any amounts due or payable under <u>Section 3.1 </u>from and after the effective date of such
                termination. Notwithstanding anything to the contrary herein, in the event that this Agreement is terminated for the reasons specified in subparts (b) or (c) of this <u>Section 9.6.1.2</u>, Company shall pay Harvard the amount of any
                financial commitments reasonably incurred by Harvard prior to termination in connection with the Research that cannot be canceled, including, without limitation, graduate student and post-doctoral stipends provided that (x) Harvard shall
                use reasonable efforts not to incur any financial commitments that cannot be canceled with thirty (30) (or more) days prior written notice and (y) Harvard shall notify Company of any such material financial commitments periodically during
                the Term and upon Company&#8217;s reasonable request.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z2ed40f3fd5fc4d96b5935992d47144af">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 96.95pt; line-height: 1.25; font-weight: bold;">9.6.1.3</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;"><font style="font-weight: bold;">Title to Equipment and Materials.</font> Upon termination or expiration of
                this Agreement for any reason, Harvard shall retain title to all equipment or material purchased or fabricated by Harvard, the Principal Investigator or the Harvard Team (regardless of whether such equipment or materials were purchase or
                fabricated with funds provided by Company hereunder).</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zfac87238c79f4f88a9731c043cedda86">

          <tr>
            <td style="width: 36.35pt; vertical-align: top; align: right;">
              <div style="margin-left: 63pt; line-height: 1.25; font-weight: bold;">10.&#160; <br>
              </div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt; font-weight: bold;">Miscellaneous.</div>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb9409edbe5de4d53945bbb3177c31572">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">10.1</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 9pt;"><font style="font-weight: bold;">Representations and Warranties</font>.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc7d65ccaa3a642daa41c64a4bf195dfe">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 96.95pt; line-height: 1.25; font-weight: bold;">10.1.1.1</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;"><font style="font-weight: bold;">Mutual Representations. </font>Each Party represents and warrants to the
                other Party as follows:</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z726c7650e4084c10bf35d09ff2e59e30">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">(a)</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;"><font style="font-weight: bold;">Duly Organized</font>. Such Party is a corporation duly organized, validly
                existing and in good standing under the laws of the jurisdiction of its incorporation, is qualified to do business and is in good standing as a foreign corporation in each jurisdiction in which the conduct of its business or the ownership
                of its properties requires such qualification and failure to have such would prevent such Party from performing its obligations under this Agreement.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z34de1220b5c94a659e032fcadbba0d2c">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">(b)</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;"><font style="font-weight: bold;">Due Authorization&#894; Binding Agreement</font>. The execution, delivery and
                performance of this Agreement by such Party have been duly authorized by all necessary corporate action. This Agreement is a legal and valid obligation binding on such Party and enforceable in accordance with its terms and does not: (i) to
                such Party&#8217;s knowledge and belief, violate any law, rule, regulation, order, writ, judgment, decree, determination or award of any court, governmental body or administrative or other agency having jurisdiction over such Party&#894; nor (ii)
                conflict with, or constitute a default under, any agreement, instrument or understanding, oral or written, to which such Party is a party or by which it is bound.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc3f10641b1944fa9b823e71ac8a247e4">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">(c)</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;"><font style="font-weight: bold;">Employee/Contractor Agreements</font>. All of such Party&#8217;s and its employees
                acting on its behalf pursuant to this Agreement are and will be obligated under a binding written agreement to assign to such Party or its designee all inventions and to comply with obligations of confidentiality and non-use consistent in
                scope with those set forth herein.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z039835982a7741cf9112c735e81934a1">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 96.95pt; line-height: 1.25; font-weight: bold;">10.1.1.2</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;"><font style="font-weight: bold;">Representations by Harvard.</font> OTD, on behalf of Harvard, represents,
                warrants and covenants to Company that as follows:</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; font-weight: normal; font-style: normal;">13</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 4.85pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7f3a73a355b8425580a4e79b7a3ca304">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">(a)</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;"><font style="font-weight: bold;">Third Party Rights</font>. As of the Effective Date, to the knowledge of
                OTD, Harvard has not received any funding, participation or other rights from any third Person or other Governmental Authority that conflicts or is inconsistent with the rights, licenses and options granted to Company hereunder. As of the
                Effective Date, Harvard has the right to grant the licenses and rights as contemplated under this Agreement and&#160; has not granted any right to any third Person which would conflict or be inconsistent with the licenses and rights granted to
                Company hereunder. Harvard will not during the Term grant any right to any third Person which would conflict or be inconsistent with the licenses and rights granted to Company hereunder.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z73aa604ac4574b778d1e6dd8777fd312">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">(b)</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;"><font style="font-weight: bold;">Patents</font>. Harvard is the sole and exclusive owner of all right, title
                and interest in and to the Harvard Background Patents, including all of the patents and patent applications identified as &#8220;Harvard Background Patents&#8221; in <u>Exhibit 1.25</u>. All official fees, maintenance fees&#160; and annuities for the
                Licensed Patent Rights have been paid through the Effective Date.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0e75cd518a7b4414982ae88430cceee2">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">(c)</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;"><font style="font-weight: bold;">Non-Infringement of Third Party Rights</font>. OTD has not received any
                written notice from any Person of any actual or threatened claim that the use or practice of the Licensed Patent Rights or Licensed Know-How infringes or otherwise violates the intellectual property rights of a third Person.</div>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 3.4pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z33bb179e73934d219a00f2c164d82949">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">(d)</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;"><font style="font-weight: bold;">Patent and Technology Status</font>. As of the Effective Date, none of the
                Licensed Patent Rights is currently involved in any interference, reissue, reexamination, or opposition proceeding and OTD has not received any written notice from any Person of such actual or threatened proceeding.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z2942fede9c124dbc921887513cca5d8e">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">(e)</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;"><font style="font-weight: bold;">Non-Infringement by Third Parties</font>. As of the Effective Date, to the
                knowledge of OTD, no third Persons are infringing the Licensed Patent Rights or Licensed Know-How.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4dcf799aa1c541b982a9c268f7df0887">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">10.2</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;"><font style="font-weight: bold;">Warranty Disclaimer. </font>EXCEPT AS EXPRESSLY SET FORTH IN THIS ARTICLE
                10, NEITHER PARTY MAKES ANY WARRANTIES, EXPRESS OR IMPLIED, AS TO ANY MATTER RELATING TO THIS AGREEMENT, INCLUDING, WITHOUT LIMITATION: RESULTS&#894; THE PERFORMANCE, CONDITION, ORIGINALITY OR ACCURACY OF THE RESEARCH OR MATERIALS&#894; THE
                AVAILABILITY OF LEGAL PROTECTION FOR INVENTIONS OR ANY OTHER WORK PRODUCT OF THE RESEARCH&#894; OR THE VALIDITY OR ENFORCEABILITY OF ANY PATENT RIGHTS. EXCEPT AS EXPRESSLY SET FORTH IN THIS ARTICLE 10, ALL MATERIALS PROVIDED HEREUNDER ARE
                PROVIDED &#8220;AS IS,&#8221; AND NEITHER PARTY MAKES ANY WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE FOR ANY RESULTS OR MATERIALS PROVIDED HEREUNDER, OR THAT THE USE OF THE RESULTS OR MATERIALS WILL NOT INFRINGE ANY PATENT RIGHTS
                OR OTHER INTELLECTUAL PROPERTY RIGHT</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z96791927aa004bac9773952988dce109">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">10.3</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;"><font style="font-weight: bold;">Responsibilities and Indemnification. </font>Each Party shall be
                responsible for its own acts in the performance of the Research, its use of Results, and its use, storage and disposal of any materials. Company shall indemnify, defend and hold harmless Harvard and its current and former directors,
                governing board members, trustees, officers, faculty, medical and professional staff, employees, students, and agents and their respective successors, heirs and assigns from and against any third party claim, liability, cost, expense,
                damage, deficiency, loss or obligation&#160; of any kind or nature (including, without limitation, reasonable attorneys&#8217; fees and other costs and expenses of litigation) based upon, arising out of, or otherwise relating to Company&#8217;s use of
                Results, including without limitation any cause of action relating to product liability, except to the extent caused by or resulting from the gross negligence or willful misconduct of Harvard.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z38639a49581248be84bacab19fd230f1">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">10.4</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;"><font style="font-weight: bold;">Limitation of Liability</font>. Except with respect to Company&#8217;s
                indemnification obligations under <u>Section 10.3</u>, neither Party will be liable to the other with respect to any subject matter of this Agreement under any contract, negligence, strict liability or other legal or equitable theory for
                (a) any indirect, incidental, consequential or punitive damages or lost profits or (b) cost of procurement of substitute goods, technology or services. Except with respect to Company&#8217;s indemnification obligations under <u>Section 10.3</u>,
                each Party&#8217;s aggregate liability for all damages of any kind arising out of or relating to this Agreement or its subject matter shall not exceed the amounts paid by Company to Harvard under this Agreement.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; font-weight: normal; font-style: normal;">14</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf33dc86bd90945d19f025414f765b8b3">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">10.5</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;"><font style="font-weight: bold;">Use of Names</font>. Except as provided below, Company shall not, and shall
                ensure that its affiliates shall not, use or register the name &#8220;Harvard&#8221; or &#8220;Wyss Institute&#8221; (alone or as part of another name) or any logos, seals, insignia or other words, names, symbols or other indicia&#160; of origin owned by Harvard that,
                in each case, identify Harvard or the Wyss Institute or any other Harvard school, unit, division or affiliate (collectively, &#8220;<font style="font-weight: bold;">Harvard Names</font>&#8221;) for any purpose as a trademark except with the prior
                written approval of, and in accordance with restrictions required by, Harvard, provided, however that Company may issue a press release substantially in the form set forth in <u>Exhibit F</u>, which press release has been approved in
                advance by Harvard. This restriction shall not apply to any information required by law to be disclosed to any Governmental Authority, including, without limitation, information required to be disclosed pursuant to or in connection with
                securities reporting. If, notwithstanding this prohibition, Company or any of its affiliates registers any Harvard Name as a trademark, service mark, domain name, trade name, business or company name or otherwise anywhere in the world,
                then, in addition to any other remedies Harvard may have, Harvard shall have the right to compel Company or such affiliate to assign its rights in such registration to Harvard and Company shall take such steps as may be necessary to
                transfer record ownership of such registration to Harvard, at Company&#8217;s cost.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 3.4pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z125a404035564b70aa9f018feb8a7b15">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">10.6</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;"><font style="font-weight: bold;">Research Partially Funded by Grants. </font>To the extent that any
                Invention has been partially funded by the federal government (including any of its agencies), this Agreement and the grant of any rights in such Invention is subject to and governed by federal law, such as the provisions of 35 U.S.C. &#167;&#167;
                200-212 and all associated implementing regulations, as well as all applicable terms and conditions of such grant, provided, however that neither Harvard, the Harvard Principal Investigator nor any member of the Harvard Team shall accept
                any funding that would conflict or otherwise be inconsistent with the rights and licenses granted to Company hereunder or in the License Agreement.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze0356f4f9e7e4ea3a2cf07929c10e153">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">10.7</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;"><font style="font-weight: bold;">Independent Contractors</font>. Company will not have the right to direct or
                control the activities of Harvard or the Harvard Principal Investigator in performing the Research. Harvard will not have the right to direct or control the activities of Company or the Company Principal Investigator in performing the
                Research. Harvard and Company shall act hereunder only as independent contractors, and nothing herein contained shall give either Party the right to bind the other, be deemed to constitute either Party as agent for or partner of the other
                or any third party, or be construed or fiduciary relationship between the Parties.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd78201e783574b09b2f38e002cc2ef9b">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">10.8</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;"><font style="font-weight: bold;">Notices</font>. Any notices to be given hereunder shall be sufficient if
                signed by the Party giving same and delivered in one of the following manners: (a) hand delivery&#894; (b) certified mail, return receipt requested&#894; (c) expedited delivery via a nationally recognized courier service&#894; (d) facsimile if the sender
                retains evidence of successful transmission and if the sender promptly sends the original by ordinary mail, or (e) email, if the sender retains evidence of the sent transmission and if the sender promptly sends the original by ordinary
                mail, in any event to the following addresses:</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z63031edfb8e74c5ca531604745f604a9">

        <tr>
          <td style="width: 22.78%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;&#160;&#160; &#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; If to Licensee:</div>
          </td>
          <td style="width: 77.22%; vertical-align: bottom;">
            <div style="margin-right: 62.65pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 9pt;">ReWalk Robotics, Ltd.</div>
            <div style="margin-right: 62.65pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 9pt;">200 Donald Lynch Blvd.</div>
            <div style="margin-right: 62.65pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 9pt;">Marlborough, Massachusetts 01752</div>
            <div style="margin-right: 62.65pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 9pt;"><font style="font-family: 'Times New Roman', Times, serif;">Email: </font><font style="font-family: 'Times New Roman', Times, serif;"><u>larry.jasinski@rewalk.com</u> </font><font style="font-family: 'Times New Roman', Times, serif;">and </font><u><font style="font-family: 'Times New Roman', Times, serif;">ofir@rewalk.com</font></u></div>
            <div style="margin-right: 62.65pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 9pt;">Facsimile: 508 251-2970</div>
            <div style="margin-right: 62.65pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 9pt;">Attn.: Larry Jasinski and Ofir Koren</div>
          </td>
        </tr>
        <tr>
          <td style="width: 22.78%; vertical-align: top;">&#160;</td>
          <td style="width: 77.22%; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 22.78%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;&#160;&#160; &#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; With copy to the following (if a technical notice):</div>
          </td>
          <td style="width: 77.22%; vertical-align: bottom;">
            <div style="text-align: justify; margin-right: 62.65pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 9pt;">ReWalk Robotics, Ltd.</div>
            <div style="text-align: justify; margin-right: 62.65pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 9pt;">Hatnufa st. 3, floor 6</div>
            <div style="text-align: justify; margin-right: 62.65pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 9pt;">Yokneaam, POB 161, 2069203</div>
            <div style="text-align: justify; margin-right: 62.65pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 9pt;">Israel</div>
            <div style="text-align: justify; margin-right: 62.65pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 9pt;">Facsimile: +972-4-959 0125</div>
            <div style="margin-right: 62.65pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 9pt;"><font style="font-family: 'Times New Roman', Times, serif;">Email: </font><font style="font-family: 'Times New Roman', Times, serif;"><u>larry.jasinski@rewalk.com</u> </font><font style="font-family: 'Times New Roman', Times, serif;">and </font><u><font style="font-family: 'Times New Roman', Times, serif;">ofir@rewalk.com</font></u></div>
            <div style="text-align: justify; margin-right: 62.65pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 9pt;">Attn.: Larry Jasinski and Ofir Koren</div>
          </td>
        </tr>
        <tr>
          <td style="width: 22.78%; vertical-align: top;">&#160;</td>
          <td style="width: 77.22%; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 22.78%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;&#160;&#160; &#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; If to Harvard:</div>
          </td>
          <td style="width: 77.22%; vertical-align: bottom;">
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 9pt;">Office of Technology Development<font style="font-family: 'Times New Roman', Times, serif;"><br>
              </font>Harvard University<font style="font-family: 'Times New Roman', Times, serif;"><br>
              </font>Richard A. and Susan F. Smith Campus Center, Suite 727<font style="font-family: 'Times New Roman', Times, serif;"><br>
              </font>1350 Massachusetts Avenue<font style="font-family: 'Times New Roman', Times, serif;"><br>
              </font>Cambridge, Massachusetts 02138</div>
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 9pt;">Facsimile: (617) 495-9568</div>
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 9pt;">Attn.: Chief Technology Development Officer</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; font-weight: normal; font-style: normal;">15</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-right: 5.75pt; margin-left: 4.5pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">By such notice, either Party may change its address for future notices.
      Notices mailed shall be deemed given on the date postmarked on the envelope. Notices sent by expedited delivery shall be deemed given on the date received by the courier, as indicated on the shipping manifest&#160; or waybill. Notices sent by fax shall be
      deemed given on the date faxed.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zfbb8dfa1720b4856bfdadf3db458de9b">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">10.9&#160; <br>
              </div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;"><font style="font-weight: bold;">Modification</font>. No modification or waiver of this Agreement or of any
                covenant, condition or limitation herein contained shall be valid unless in writing and executed by duly-authorized representatives of both Parties. A failure by a Party to assert its rights under, including upon any breach or default of,
                this Agreement shall not be deemed a waiver of such rights. No such failure or waiver in writing by either Party with respect to any rights shall extend to or affect any subsequent breach or impair any right consequent thereon.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zee2c655e8ed54930bf837abfe1cd413a">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">10.10</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;"><font style="font-weight: bold;">Governing Law and Venue</font>. This Agreement will be governed by, and
                construed in accordance with, the substantive laws of the Commonwealth of Massachusetts, without giving effect to any choice or conflict of law provision, except that questions affecting the construction and effect of any patent shall be
                determined by the law of the country in which the patent shall have been granted. Any action, suit or other proceeding arising out of or relating to this Agreement, its subject matter, any document or instrument delivered pursuant to, or a
                breach of this Agreement or any such document or instrument (a &#8220;<font style="font-weight: bold;">Suit</font>&#8221;) shall be brought in a court of competent jurisdiction in the Commonwealth of Massachusetts, and the Parties hereby consent to the
                sole jurisdiction of the state and federal courts sitting in the Commonwealth of Massachusetts. Each Party agrees not to raise any objection at any time to the laying or maintaining of the venue of any Suit in any of the specified courts,
                irrevocably waives any claim that Suit has been brought in any inconvenient forum and further irrevocably waives the right to object, with respect to any Suit, that such court does not have any jurisdiction over such Party.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0fd2fd7002254ec1bf0a4c8d93ebfd82">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">10.11</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;"><font style="font-weight: bold;">Severability</font>. If any provision of this Agreement is or becomes
                invalid or is ruled invalid by any court of competent jurisdiction or is deemed unenforceable, such invalidity shall not render the entire Agreement unenforceable or invalid but rather the Agreement shall be read and construed as if the
                invalid or unenforceable provision(s) are not contained herein, and the rights and obligations of the Parties shall be construed and enforced accordingly.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z68d6ed5a5b5c494e8c6c6984db7cbb44">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">10.12</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;"><font style="font-weight: bold;">Assignment</font>. This Agreement shall be binding upon and inure to the
                benefit of the respective successors and assigns of the Parties hereto&#894; provided, however that neither Party may assign any of its rights or obligations under this Agreement to any other person or entity without the prior written consent of
                the other except that Company may, without such consent, assign this Agreement, in its entirety, and its rights, obligations and interests to (a) to any affiliate or (b) to any purchaser of all of Company&#8217;s equity or all or substantially
                all of Company&#8217;s assets or business to which this Agreement relates, or (c) to any successor corporation resulting from any merger or consolidation of Company with or into such corporation, provided, in each case, that the assignee agrees
                in writing to be bound by the terms of this Agreement. Any assignment purported or attempted to be made in violation of the terms of this <u>Section 10.12 </u>shall be null and void and of no legal effect.</div>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; font-weight: normal; font-style: normal;">16</font></div>
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 3.4pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zec526dbd9bbd4a5a86fc79cc7f73238c">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">10.13</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;"><font style="font-weight: bold;">Entire Agreement</font>. This Agreement is the sole agreement with respect
                to the subject matter hereof and supersedes all other agreements and understandings between the Parties with respect to the same.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z5d3cf71e666542e389da1f4a7803c0a2">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">10.14</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;"><font style="font-weight: bold;">Counterparts. </font>The Parties may execute this Agreement in two or more
                counterparts, each of which shall be deemed an original, but both of which together shall constitute one and the same instrument. Transmission by facsimile or electronic mail of an executed counterpart of this Agreement shall be deemed to
                constitute due and sufficient delivery of such counterpart. If by electronic mail, the executed Agreement must be delivered in a .pdf format.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd6c833008fed4f70a7f961aa10cad9ab">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">10.15</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;"><font style="font-weight: bold;">No Third-Party Beneficiaries</font>. This Agreement is for the sole benefit
                of the Parties hereto and their respective successors and permitted assigns and nothing herein, express or implied, is intended to or shall confer upon any other individual, corporation, partnership, joint venture, limited liability
                company, Governmental Authority, unincorporated organization, trust, association or other entity any legal or equitable right, benefit or remedy of any nature whatsoever, under or by reason of this Agreement.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z847c47d88ae34c99a5fe094493007fe6">

          <tr>
            <td style="width: 6.05pt; vertical-align: top; align: right;">
              <div style="margin-left: 66.65pt; line-height: 1.25; font-weight: bold;">10.16</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 0pt; margin-left: 9pt;"><font style="font-weight: bold;">Reimbursement</font>. To the extent that Company reimburses Harvard for any
                costs incurred by Harvard for the preparation, filing, prosecution and maintenance of any Patent Rights hereunder (such costs, &#8220;<font style="font-weight: bold;">Reimbursed Costs</font>&#8221;), then if Harvard grants a license under such Patent
                Rights to a third Person outside the Field (each, an &#8220;<font style="font-weight: bold;">Ex-Field Licensee</font>&#8221;) and receives reimbursement from such Ex-Field Licensee for Reimbursed Costs, then Company shall only be responsible for
                reimbursing an appropriate portion of such Reimbursed Costs based on the scope and type of license (i.e., non-exclusive vs. exclusive) granted to such Ex-Field Licensee and Harvard shall credit Company&#8217;s portion of the Reimbursed Costs to
                amounts owed under the License Agreement.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; margin-right: 117.05pt; margin-left: 117.2pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">[Signature page follows]</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; font-weight: normal; font-style: normal;">17</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: left; margin-left: 6pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-weight: bold;"> <br>
      </font></div>
    <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><font style="font-weight: bold;">IN WITNESS WHEREOF, </font>each Party has caused this Agreement to be executed by its duly authorized
      representative as of the Effective Date.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25">
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 45.26%; vertical-align: bottom;" colspan="2">
              <div style="text-align: justify; line-height: 1.25; font-weight: bold;">
                <div style="text-align: left; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;">President and Fellows of Harvard College</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <br>
                </div>
              </div>
              <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
            </td>
            <td style="width: 9.47%; vertical-align: bottom;">&#160;</td>
            <td style="width: 45.27%; vertical-align: bottom;" colspan="2">
              <div style="text-align: justify; line-height: 1.25; font-weight: bold;">ReWalk Robotics, Ltd.</div>
              <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
            </td>
          </tr>
          <tr>
            <td style="width: 5.81%; vertical-align: bottom;">
              <div style="text-align: justify; line-height: 1.25;">By:</div>
            </td>
            <td style="width: 39.46%; vertical-align: bottom; border-bottom: 2px solid #000000;">
              <div style="line-height: 1.25;">
                <div style="text-align: justify; line-height: 1.25;">/s/ Isaac T. Kohlberg</div>
              </div>
            </td>
            <td style="width: 9.47%; vertical-align: bottom;">&#160;</td>
            <td style="width: 5.81%; vertical-align: bottom;">
              <div style="text-align: justify; line-height: 1.25;">By:</div>
            </td>
            <td style="width: 39.47%; vertical-align: bottom; border-bottom: 2px solid #000000;">
              <div style="line-height: 1.25;">
                <div style="text-align: justify; line-height: 1.25;">/s/ Larry Jasinski</div>
              </div>
            </td>
          </tr>
          <tr>
            <td style="width: 5.81%; vertical-align: bottom;">
              <div style="text-align: justify; line-height: 1.25;">Name:</div>
            </td>
            <td style="width: 39.46%; vertical-align: bottom;">
              <div style="line-height: 1.25;">
                <div style="text-align: justify; line-height: 1.25;">Isaac T. Kohlberg</div>
              </div>
            </td>
            <td style="width: 9.47%; vertical-align: bottom;">&#160;</td>
            <td style="width: 5.81%; vertical-align: bottom;">
              <div style="text-align: justify; line-height: 1.25;">Name:</div>
            </td>
            <td style="width: 39.47%; vertical-align: bottom;">
              <div style="line-height: 1.25;">
                <div style="text-align: justify; line-height: 1.25;">Larry Jasinski</div>
              </div>
            </td>
          </tr>
          <tr>
            <td style="width: 5.81%; vertical-align: bottom;">
              <div style="text-align: justify; line-height: 1.25;">Title:</div>
            </td>
            <td style="width: 39.46%; vertical-align: bottom;">
              <div style="text-align: justify; line-height: 1.25;">
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Senior Associate Provost</div>
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Chief Technology Development Officer Office of Technology Development</div>
              </div>
            </td>
            <td style="width: 9.47%; vertical-align: bottom;">&#160;</td>
            <td style="width: 5.81%; vertical-align: bottom;">
              <div style="text-align: justify; line-height: 1.25;">Title:</div>
            </td>
            <td style="width: 39.47%; vertical-align: bottom;">
              <div style="line-height: 1.25;">
                <div style="text-align: justify; line-height: 1.25;">CEO</div>
              </div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">I, the undersigned, hereby confirm that I have read the Agreement, that its contents are acceptable to me and that I will act in accordance
        with its terms, including the provisions of <u>Article 7</u>.</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 44.99%; vertical-align: top; border-bottom: #000000 2px solid;">
              <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
              <div style="text-align: justify; line-height: 1.25;">/s/ Conor Walsh</div>
            </td>
            <td style="width: 55.01%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 44.99%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Conor Walsh, Ph.D.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25"> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; font-weight: normal; font-style: normal;">18</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <!--PROfilePageNumberReset%Num%19%%%-->
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; margin-right: 117.05pt; margin-left: 117.05pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">EXHIBIT A</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; margin-right: 117.05pt; margin-left: 117.05pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Research Plan</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: left; margin-right: 27.55pt; margin-left: 6pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-weight: bold;"><u>Aim</u></font><font style="font-weight: bold;">: </font>Harvard


      expects to perform research to support Company&#8217;s development of both stroke and multiple sclerosis (&#8220;MS&#8221;) specific Soft Exosuits as follows:</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: left; margin-left: 6pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">[**]</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">19</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; margin-right: 117.05pt; margin-left: 117.05pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Exhibit B</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; margin-right: 117.05pt; margin-left: 117.05pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Form of Harvard Invoice</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; margin-right: 116.8pt; margin-left: 117.65pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Attached.</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; font-weight: normal; font-style: normal;">20</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;">
      <div> <br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" id="z79b77eb477bc4800810bbd789b13711d" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

          <tr>
            <td style="width: 10%;">
              <div>
                <div style="text-align: left; line-height: 1.25;"><img width="67" height="58" src="image00010.jpg"></div>
              </div>
            </td>
            <td style="width: 75%; text-align: left; vertical-align: top;">
              <div>
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">HARVARD</div>
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Office for Sponsored Programs</div>
              </div>
            </td>
            <td style="width: 15%; text-align: right; vertical-align: top;">
              <div style="font-weight: bold;">&#160;INVOICE</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z5ecc2334fd3f4d96ab545e840512b2a3">

          <tr>
            <td style="width: 31.16%; vertical-align: top;">
              <div style="margin-right: 75.75pt; margin-left: 2.5pt; line-height: 1.25;">SPONSOR </div>
              <div style="margin-right: 75.75pt; margin-left: 2.5pt; line-height: 1.25;">NAME </div>
              <div style="margin-right: 75.75pt; margin-left: 2.5pt; line-height: 1.25;">SPONSOR </div>
              <div style="margin-right: 75.75pt; margin-left: 2.5pt; line-height: 1.25;">ADDRESS</div>
            </td>
            <td style="width: 38.83%; vertical-align: top; text-align: center;">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">HU PI:</div>
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Prime PI:</div>
            </td>
            <td style="width: 30.01%; vertical-align: top; text-align: right;">
              <div style="margin-right: 0.35pt; margin-left: 99.5pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">PI Name </div>
              <div style="margin-right: 0.35pt; margin-left: 99.5pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Prime PI </div>
              <div style="margin-right: 0.35pt; margin-left: 99.5pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Name &#160; &#160; <br>
              </div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 31.16%; vertical-align: top;">&#160;</td>
            <td rowspan="1" style="width: 38.83%; vertical-align: bottom; text-align: center;">&#160;</td>
            <td rowspan="1" style="width: 30.01%; vertical-align: bottom; text-align: right;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 31.16%; vertical-align: top;">
              <div style="margin-left: 2.5pt; line-height: 1.25;">City, State Zip</div>
            </td>
            <td style="width: 38.83%; vertical-align: top;">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Award #:</div>
            </td>
            <td style="width: 30.01%; vertical-align: top;">
              <div style="text-align: right; margin-right: 2.4pt; line-height: 1.25;">Award_No.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 31.16%; vertical-align: top;">
              <div style="margin-left: 2.5pt; line-height: 1.25;">Line 3</div>
            </td>
            <td style="width: 38.83%; vertical-align: top;">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Grant #:</div>
            </td>
            <td style="width: 30.01%; vertical-align: top;">
              <div style="text-align: right; margin-right: 2.4pt; line-height: 1.25;">Grant_No.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 31.16%; vertical-align: top;">
              <div style="margin-left: 2.5pt; line-height: 1.25;">Line 4</div>
            </td>
            <td style="width: 38.83%; vertical-align: top;">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Obligated $:</div>
            </td>
            <td style="width: 30.01%; vertical-align: top;">
              <div style="text-align: right; margin-right: 2.75pt; line-height: 1.25;">$0.00</div>
            </td>
          </tr>
          <tr>
            <td style="width: 31.16%; vertical-align: top;">
              <div style="margin-left: 2.5pt; line-height: 1.25;">Line 5</div>
            </td>
            <td style="width: 38.83%; vertical-align: top;">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Period:</div>
            </td>
            <td style="width: 30.01%; vertical-align: top;">
              <div style="text-align: right; margin-right: 2.65pt; line-height: 1.25;">00<font style="font-weight: bold;">/</font>00/0000 <font style="font-weight: bold;">- </font>00<font style="font-weight: bold;">/</font>00/0000</div>
            </td>
          </tr>
          <tr>
            <td style="width: 31.16%; vertical-align: top;">
              <div style="margin-left: 2.5pt; line-height: 1.25;">Email Address</div>
            </td>
            <td style="width: 38.83%; vertical-align: top;">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">PO #</div>
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Extra Header Field1 </div>
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Extra Header Field2</div>
            </td>
            <td style="width: 30.01%; vertical-align: top;">
              <div style="text-align: right; text-indent: 33.45pt; margin-right: 2.4pt; margin-left: 87.55pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">PO_No. misc header field1 </div>
              <div style="text-align: right; text-indent: 33.45pt; margin-right: 2.4pt; margin-left: 87.55pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">misc header field2</div>
            </td>
          </tr>
          <tr>
            <td style="width: 31.16%; vertical-align: top; border-bottom: #000000 2px solid;">&#160;</td>
            <td style="width: 38.83%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Project Title: PROJECT TITLE</div>
            </td>
            <td style="width: 30.01%; vertical-align: top; border-bottom: #000000 2px solid;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 31.16%; vertical-align: top;">
              <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">Invoice Number</div>
            </td>
            <td style="width: 38.83%; vertical-align: top;">
              <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
              <div style="text-align: center; margin-right: 48.15pt; margin-left: 34.75pt; line-height: 1.25; font-weight: bold;">Invoice Date</div>
            </td>
            <td style="width: 30.01%; vertical-align: top;">
              <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">Terms</div>
            </td>
          </tr>
          <tr>
            <td style="width: 31.16%; vertical-align: top;">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">123456-01</div>
            </td>
            <td style="width: 38.83%; vertical-align: top;">
              <div style="text-align: center; margin-right: 48.15pt; margin-left: 34.05pt; line-height: 1.25;">TBD</div>
            </td>
            <td style="width: 30.01%; vertical-align: top;">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">NET 45</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25">
        <table cellspacing="0" cellpadding="0" border="0" id="z45982063aa21485cade9f78e2ee314a7" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td style="width: 50%;">
                <div>
                  <div style="text-align: left; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;">Amount Due Per Terms of Agreement:</font> <br>
                  </div>
                </div>
              </td>
              <td style="width: 50.00%;">
                <div style="text-align: right;">&#160;<font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;">$0.00</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="line-height: 1.25"> <br>
      </div>
      <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;"></font>
      <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;">Space is provided here for a couple of lines of custom text, if required</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: right; margin-left: 354.6pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Approved by: OSP Approver Name</div>
      <div style="line-height: 1.25; text-align: right;">_____________________________ <br>
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">
        <table cellspacing="0" cellpadding="0" border="0" id="z80cb68e5b8e54c59838f634b7331bb00" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td colspan="2" rowspan="1" style="width: 50%; border-bottom: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; margin-right: 9.65pt; margin-left: 10.45pt; line-height: 1.25; font-style: italic;">Remittance stub if paying by check</div>
                </div>
              </td>
            </tr>

        </table>
      </div>
      <div style="line-height: 1.25"><br>
        <div style="line-height: 1.25;">
          <div style="text-align: left; margin-left: 61.7pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Please indicate the HU Acct# <font style="font-weight: bold;">000-00000-000000 </font>as reference with your
            payment.</div>
          <div style="line-height: 1.25">&#160;</div>
          <div style="line-height: 1.25">
            <table cellspacing="0" cellpadding="0" border="0" id="zb2121626f1fa4117894988b420a9cf55" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

                <tr>
                  <td style="width: 33.33%;">
                    <div style="text-align: center;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;">Invoice Number</font> <br>
                    </div>
                  </td>
                  <td style="width: 33.33%;">
                    <div style="text-align: center;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;"><font style="font-weight: bold;">Invoice Date</font> <br>
                      </font></div>
                  </td>
                  <td style="width: 33.33%;">
                    <div style="text-align: center;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;">Terms</font></div>
                  </td>
                </tr>
                <tr>
                  <td rowspan="1" style="width: 33.33%; text-align: center;"><font style="font-family: 'Times New Roman',Times,serif;">123456-01</font></td>
                  <td rowspan="1" style="width: 33.33%; text-align: center;"><font style="font-family: 'Times New Roman',Times,serif;">TDB</font></td>
                  <td rowspan="1" style="width: 33.33%; text-align: center;"><font style="font-family: 'Times New Roman',Times,serif;">NET 45</font></td>
                </tr>

            </table>
          </div>
          <div style="line-height: 1.25"> <br>
          </div>
          <div style="line-height: 1.25">
            <table cellspacing="0" cellpadding="0" border="0" id="z42cffb8554b54f4c98229e66a6d0aaca" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

                <tr>
                  <td style="width: 33.33%; text-align: left; vertical-align: top;">
                    <div>
                      <div style="margin-left: 8pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">PLEASE SEND REMITTANCE TO:</div>
                      <div style="margin-left: 8pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">President &amp; Fellows of Harvard College</div>
                      <div style="margin-right: 50.9pt; margin-left: 8pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">P.O. Box 415649 Boston, MA 02241-5649</div>
                    </div>
                  </td>
                  <td style="width: 33.33%; text-align: center; vertical-align: top;">
                    <div><font style="font-family: 'Times New Roman',Times,serif;">or</font></div>
                  </td>
                  <td style="width: 33.33%; text-align: center; vertical-align: top;">
                    <div>
                      <div style="line-height: 1.25;">&#160;&#160;&#160; <font style="font-family: 'Times New Roman',Times,serif;">By WireTransfer/ACH Transfer to:</font> <br>
                      </div>
                      <div style="line-height: 1.25;">Bank of America <br>
                      </div>
                      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-style: italic;">Harvard University Account #898-</div>
                      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-style: italic;">41099 (WIRE) ABA 026009593</div>
                      <div style="line-height: 1.25;">(ACH) ABA 011000138 <br>
                      </div>
                      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-style: italic;">Swift Code: BOFAUS3N</div>
                    </div>
                  </td>
                </tr>

            </table>
          </div>
          <div style="line-height: 1.25"> <br>
          </div>
          <div style="text-align: left; margin-left: 8pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">For questions, please contact: OSP-FRAP@Harvard.edu</div>
          <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">21</font></div>
            <div id="DSPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div style="line-height: 1.25;"><br style="line-height: 1.25;">
          </div>
        </div>
        <div style="text-align: center; margin-right: 117.05pt; margin-left: 117.05pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Exhibit C</div>
        <div style="text-align: center; margin-right: 117.05pt; margin-left: 117.05pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Harvard Background Patents</div>
        <div style="line-height: 1.25">&#160;</div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

            <tr>
              <td style="width: 8.04%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 11.35pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Case</div>
              </td>
              <td style="width: 10.09%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 10.7pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Country</div>
              </td>
              <td style="width: 16.99%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="text-align: center; margin-right: 31.95pt; margin-left: 31.95pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Type</div>
              </td>
              <td style="width: 44.96%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="text-align: center; margin-right: 91.35pt; margin-left: 91.3pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Appl. Title</div>
              </td>
              <td style="width: 19.93%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 23.35pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Serial Number</div>
              </td>
            </tr>
            <tr>
              <td style="width: 8.04%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 10.09%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 16.99%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 44.96%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 19.93%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
            </tr>
            <tr>
              <td style="width: 8.04%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 10.09%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 16.99%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 44.96%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 19.93%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
            </tr>
            <tr>
              <td style="width: 8.04%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 10.09%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 16.99%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 44.96%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 19.93%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
            </tr>
            <tr>
              <td style="width: 8.04%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 10.09%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 16.99%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 44.96%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 19.93%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
            </tr>
            <tr>
              <td style="width: 8.04%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 10.09%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 16.99%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 44.96%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 19.93%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
            </tr>
            <tr>
              <td style="width: 8.04%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 10.09%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 16.99%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 44.96%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 19.93%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
            </tr>
            <tr>
              <td style="width: 8.04%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 10.09%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 16.99%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 44.96%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 19.93%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
            </tr>
            <tr>
              <td style="width: 8.04%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 10.09%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 16.99%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 44.96%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 19.93%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
            </tr>
            <tr>
              <td style="width: 8.04%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 10.09%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 16.99%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 44.96%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 19.93%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
            </tr>
            <tr>
              <td style="width: 8.04%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 10.09%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 16.99%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 44.96%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 19.93%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
            </tr>
            <tr>
              <td style="width: 8.04%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 10.09%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 16.99%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 44.96%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 19.93%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
            </tr>
            <tr>
              <td style="width: 8.04%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 10.09%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 16.99%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 44.96%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 19.93%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
            </tr>
            <tr>
              <td style="width: 8.04%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 10.09%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 16.99%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 44.96%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 19.93%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
            </tr>
            <tr>
              <td style="width: 8.04%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 10.09%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 16.99%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 44.96%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 19.93%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
            </tr>
            <tr>
              <td style="width: 8.04%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 10.09%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 16.99%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 44.96%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 19.93%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
            </tr>
            <tr>
              <td style="width: 8.04%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 10.09%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 16.99%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 44.96%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 19.93%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
            </tr>
            <tr>
              <td style="width: 8.04%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 10.09%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 16.99%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 44.96%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 19.93%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
            </tr>
            <tr>
              <td style="width: 8.04%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 10.09%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 16.99%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 44.96%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 19.93%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
            </tr>
            <tr>
              <td style="width: 8.04%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 10.09%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 16.99%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 44.96%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 19.93%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
            </tr>
            <tr>
              <td style="width: 8.04%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 10.09%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 16.99%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 44.96%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 19.93%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
            </tr>
            <tr>
              <td style="width: 8.04%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 10.09%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 16.99%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 44.96%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 19.93%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
            </tr>
            <tr>
              <td style="width: 8.04%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 10.09%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 16.99%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 44.96%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 19.93%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
            </tr>
            <tr>
              <td style="width: 8.04%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 10.09%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 16.99%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 44.96%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 19.93%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
            </tr>
            <tr>
              <td style="width: 8.04%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 10.09%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 16.99%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 44.96%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 19.93%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
            </tr>
            <tr>
              <td style="width: 8.04%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 10.09%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 16.99%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 44.96%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 19.93%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
            </tr>
            <tr>
              <td style="width: 8.04%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 10.09%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 16.99%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 44.96%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 19.93%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
            </tr>
            <tr>
              <td style="width: 8.04%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 10.09%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 16.99%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 44.96%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 19.93%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
            </tr>
            <tr>
              <td style="width: 8.04%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 10.09%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 16.99%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 44.96%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 19.93%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
            </tr>
            <tr>
              <td style="width: 8.04%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 10.09%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 16.99%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 44.96%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 19.93%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
            </tr>
            <tr>
              <td style="width: 8.04%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 10.09%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 16.99%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 44.96%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
              <td style="width: 19.93%; vertical-align: top; background-color: rgb(242, 242, 242); border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
                <div style="margin-left: 1.25pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="line-height: 1.25">&#160;</div>
        <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">22</font></div>
          <div id="DSPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: center; margin-right: 117.05pt; margin-left: 117.05pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Exhibit D</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: center; margin-right: 117.05pt; margin-left: 117.05pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Visitor Participation Agreement</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: center; margin-right: 116.8pt; margin-left: 117.65pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Attached.</div>
        <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">23</font></div>
          <div id="DSPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
        <div id="DSPFPageHeader">
          <div style="line-height: 1.25;"><br style="line-height: 1.25;">
          </div>
        </div>
        <div style="text-align: center; margin-right: 117.05pt; margin-left: 117.3pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">HARVARD UNIVERSITY VISITOR PARTICIPATION </div>
        <div style="text-align: center; margin-right: 117.05pt; margin-left: 117.3pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">AGREEMENT</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: center; margin-right: 117pt; margin-left: 117.65pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">for visitors from for-profit organizations (U.S. and foreign)</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: left; margin-right: 22.35pt; margin-left: 6.65pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">In consideration of my participation in research or other projects of President and Fellows
          of Harvard College ("Harvard" or the "University") and/or my use of funds, facilities or other resources provided by or through Harvard (collectively, "Harvard Activities"), I agree as follows:</div>
        <div style="line-height: 1.25">&#160;</div>
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

              <tr>
                <td style="width: 6.65pt; vertical-align: top; align: right;">
                  <div style="margin-left: 6.65pt; line-height: 1.25;">1)</div>
                </td>
                <td style="width: auto; vertical-align: top;">
                  <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;With respect to my Harvard Activities, I acknowledge that I am bound by and will comply with Harvard's research policies (among them, the
                    "Statement of Policy in Regard to Intellectual Property," or "IP Policy"), as they may be amended from time to time and made available by Harvard at <u>http://vpr.harvard.edu/pages/research-policies-guidance </u>or otherwise.</div>
                </td>
              </tr>

          </table>
        </div>
        <div style="line-height: 1.25">&#160;</div>
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

              <tr>
                <td style="width: 6.65pt; vertical-align: top; align: right;">
                  <div style="margin-left: 6.65pt; line-height: 1.25;">2)</div>
                </td>
                <td style="width: auto; vertical-align: top;">
                  <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;If any agreement between Harvard and a third party <font style="font-style: italic;">(e.g., </font>with respect to research funding or
                    collaboration, or the use of materials, data, rights, equipment or the like) pertains to my Harvard Activities, I will abide that agreement, to the extent its terms apply and are made known to me.</div>
                </td>
              </tr>

          </table>
        </div>
        <div style="line-height: 1.25">&#160;</div>
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

              <tr>
                <td style="width: 6.65pt; vertical-align: top; align: right;">
                  <div style="margin-left: 6.65pt; line-height: 1.25;">3)</div>
                </td>
                <td style="width: auto; vertical-align: top;">
                  <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;I will report promptly to Harvard's Office of Technology Development ("OTD") any Invention, Sponsored Computer Software and/or Unpatented
                    Material, as those capitalized terms are defined in the IP Policy, here referred to together as "Developments", that the IP Policy requires me to disclose to Harvard. I hereby assign and agree to assign to Harvard all my right, title
                    and interest in all Developments that Harvard is entitled to own under the IP Policy, and all patent rights, copyrights and other intellectual property rights in those Developments throughout the world. I&#160; hereby grant to Harvard any
                    rights required to be granted to Harvard under the IP Policy with respect to Incidental Inventions (as defined in the IP Policy) or other Developments I am entitled to own.</div>
                </td>
              </tr>

          </table>
        </div>
        <div style="line-height: 1.25">&#160;</div>
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

              <tr>
                <td style="width: 6.65pt; vertical-align: top; align: right;">
                  <div style="margin-left: 6.65pt; line-height: 1.25;">4)</div>
                </td>
                <td style="width: auto; vertical-align: top;">
                  <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;If any agreement between Harvard and a third party requires that my copyrights in works of authorship (for example, research reports or
                    articles) be assigned or licensed to Harvard or a third party, I hereby assign or license to Harvard the copyrights that are needed in order to fulfill the agreement.</div>
                </td>
              </tr>

          </table>
        </div>
        <div style="line-height: 1.25">&#160;</div>
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

              <tr>
                <td style="width: 6.65pt; vertical-align: top; align: right;">
                  <div style="margin-left: 6.65pt; line-height: 1.25;">5)</div>
                </td>
                <td style="width: auto; vertical-align: top;">
                  <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;I will cooperate with Harvard in such reasonable steps as may be needed to carry out its research policies and to confirm, establish or
                    protect the rights of Harvard or its designees. This may include, for example, executing additional documents, assisting in the filing, prosecution or defense of patent applications, and letting Harvard see my research data or materials
                    as needed to respond to inquiries or conduct internal and external&#160; oversight activities.</div>
                </td>
              </tr>

          </table>
        </div>
        <div style="line-height: 1.25">&#160;</div>
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

              <tr>
                <td style="width: 6.65pt; vertical-align: top; align: right;">
                  <div style="margin-left: 6.65pt; line-height: 1.25;">6)</div>
                </td>
                <td style="width: auto; vertical-align: top;">
                  <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;I have not made with any third party, except the organization by which I am primarily employed and whose duly-authorized representative has
                    signed this Agreement in the space provided below, any agreement that conflicts or reasonably could be construed as conflicting with the terms of this Agreement, and will not in future make any such agreement.</div>
                </td>
              </tr>

          </table>
        </div>
        <div style="line-height: 1.25">&#160;</div>
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

              <tr>
                <td style="width: 6.65pt; vertical-align: top; align: right;">
                  <div style="margin-left: 6.65pt; line-height: 1.25;">7)</div>
                </td>
                <td style="width: auto; vertical-align: top;">
                  <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;The obligations of this Agreement relating to my Harvard Activities will continue after the end of those Activities. This Agreement is
                    binding on me, my estate, heirs and assigns.</div>
                </td>
              </tr>

          </table>
        </div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: justify; margin-left: 1pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">By signing in the space provided below, I hereby accept and agree to the terms and conditions of this Agreement:</div>
        <div style="text-align: justify; margin-left: 1pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"> <br>
        </div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 7.99%; vertical-align: top;">&#160;</td>
              <td style="width: 12%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;">Signature:</div>
              </td>
              <td style="width: 45%; vertical-align: top; border-bottom: #000000 2px solid;">&#160;</td>
              <td style="width: 35%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 7.99%; vertical-align: top;">&#160;</td>
              <td style="width: 12%; vertical-align: top;">&#160;</td>
              <td style="width: 45%; vertical-align: top;">&#160;</td>
              <td style="width: 35%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 7.99%; vertical-align: top;">&#160;</td>
              <td style="width: 12%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;">Name:</div>
              </td>
              <td style="width: 45%; vertical-align: top; border-bottom: #000000 2px solid;">&#160;</td>
              <td style="width: 35%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 7.99%; vertical-align: top;">&#160;</td>
              <td style="width: 12%; vertical-align: top;">&#160;</td>
              <td style="width: 45%; vertical-align: top;">&#160;</td>
              <td style="width: 35%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 7.99%; vertical-align: top;">&#160;</td>
              <td style="width: 12%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;">Date:</div>
              </td>
              <td style="width: 45%; vertical-align: top; border-bottom: #000000 2px solid;">&#160;</td>
              <td style="width: 35%; vertical-align: top;">&#160;</td>
            </tr>

        </table>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: left; margin-right: 22.35pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The organization named below acknowledges and agrees that the individual whose signature appears above is
          released from any obligation to it and/or its affiliates as regards any rights in inventions, discoveries, copyrightable materials or other developments, which obligation is or reasonably could be construed to be in conflict with the terms of
          this Agreement. The person signing below represents and warrants that he/she is duly authorized to sign this Agreement on behalf of such organization.</div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 7.99%; vertical-align: top;">&#160;</td>
              <td style="width: 12%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;">Signature:</div>
              </td>
              <td style="width: 45%; vertical-align: top; border-bottom: #000000 2px solid;">&#160;</td>
              <td style="width: 35%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 7.99%; vertical-align: top;">&#160;</td>
              <td style="width: 12%; vertical-align: top;">&#160;</td>
              <td style="width: 45%; vertical-align: top;">&#160;</td>
              <td style="width: 35%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 7.99%; vertical-align: top;">&#160;</td>
              <td style="width: 12%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;">Name:</div>
              </td>
              <td style="width: 45%; vertical-align: top; border-bottom: #000000 2px solid;">&#160;</td>
              <td style="width: 35%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 7.99%; vertical-align: top;">&#160;</td>
              <td style="width: 12%; vertical-align: top;">&#160;</td>
              <td style="width: 45%; vertical-align: top;">&#160;</td>
              <td style="width: 35%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 7.99%; vertical-align: top;">&#160;</td>
              <td style="width: 12%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;">Title:</div>
              </td>
              <td style="width: 45%; vertical-align: top; border-bottom: #000000 2px solid;">&#160;</td>
              <td style="width: 35%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 7.99%; vertical-align: top;">&#160;</td>
              <td style="width: 12%; vertical-align: top;">&#160;</td>
              <td style="width: 45%; vertical-align: top;">&#160;</td>
              <td style="width: 35%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 7.99%; vertical-align: top;">&#160;</td>
              <td style="width: 12%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;">Organization:</div>
              </td>
              <td style="width: 45%; vertical-align: top; border-bottom: #000000 2px solid;">&#160;</td>
              <td style="width: 35%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 7.99%; vertical-align: top;">&#160;</td>
              <td style="width: 12%; vertical-align: top;">&#160;</td>
              <td style="width: 45%; vertical-align: top;">&#160;</td>
              <td style="width: 35%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 7.99%; vertical-align: top;">&#160;</td>
              <td style="width: 12%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;">Date:</div>
              </td>
              <td style="width: 45%; vertical-align: top; border-bottom: #000000 2px solid;">&#160;</td>
              <td style="width: 35%; vertical-align: top;">&#160;</td>
            </tr>

        </table>
        <div style="line-height: 1.25">&#160;</div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">24</font></div>
          <div id="DSPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
        <div id="DSPFPageHeader">
          <div style="line-height: 1.25;"><br style="line-height: 1.25;">
          </div>
        </div>
        <div style="text-align: center; margin-right: 117.05pt; margin-left: 117.05pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Exhibit E</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: center; margin-right: 117.05pt; margin-left: 117.05pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Acknowledgment of Risk and Release</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: center; margin-right: 116.8pt; margin-left: 117.65pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Attached.</div>
        <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">25</font></div>
          <div id="DSPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: center; margin-right: 117.05pt; margin-left: 116.75pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">ACKNOWLEDGEMENT OF RISK AND </div>
        <div style="text-align: center; margin-right: 117.05pt; margin-left: 116.75pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">RELEASE</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: center; margin-right: 117.05pt; margin-left: 117.05pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold;">for</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: center; margin-right: 117.05pt; margin-left: 117.05pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Non-Harvard Personnel Using Harvard Research <br>
          and Instructional Laboratory Facilities</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: center; margin-left: 6.65pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><font style="font-style: italic;">THIS IS A RELEASE OF LEGAL RIGHTS </font>- <font style="font-style: italic;">PLEASE


            READ AND UNDERSTAND BEFORE SIGNING</font></div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: left; text-indent: 30.3pt; margin-right: 27.55pt; margin-left: 6pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">I, the undersigned, accept and agree to the following terms and
          conditions in consideration for my use of Harvard's research and instructional laboratory facilities.</div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

              <tr>
                <td style="width: 21.2pt; vertical-align: top; align: right;">
                  <div style="margin-left: 6.05pt; line-height: 1.25;">1.</div>
                </td>
                <td style="width: auto; vertical-align: top;">
                  <div style="text-align: justify; line-height: 1.25;"><u>Access to Facilities</u>. The facilities are being made available to me as an educational or research opportunity. I am not a student, employee or affiliate of Harvard.</div>
                </td>
              </tr>

          </table>
        </div>
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

              <tr>
                <td style="width: 21.2pt; vertical-align: top; align: right;">
                  <div style="margin-left: 6.05pt; line-height: 1.25;">2.</div>
                </td>
                <td style="width: auto; vertical-align: top;">
                  <div style="text-align: justify; line-height: 1.25;"><u>Health and Safety Risks</u>. I understand that Harvard laboratories may contain hazardous substances and equipment. I will take every precaution necessary to protect my health and
                    safety, and the health and safety of others. I will acquaint myself with and conduct my activities in accordance with all safety rules and safe operational procedures. If I am not familiar with or I do not know how to handle safely a
                    substance or piece of equipment, I will seek assistance from qualified Harvard personnel. I recognize that I may be subjected to potential risks, illnesses and injuries. I have made my own investigation of these risks, understand these
                    risks and assume them knowingly and willingly.</div>
                </td>
              </tr>

          </table>
        </div>
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

              <tr>
                <td style="width: 21.2pt; vertical-align: top; align: right;">
                  <div style="margin-left: 6.05pt; line-height: 1.25;">3.</div>
                </td>
                <td style="width: auto; vertical-align: top;">
                  <div style="text-align: justify; line-height: 1.25;"><u>No Medical Coverage</u>. I understand that if I am injured as a result of my activities at Harvard, I am not covered by Harvard insurance of any kind. It will be my responsibility to
                    pay for emergency room care, doctors' services, hospitalization, and any other related costs, medical or non- medical. I will not be eligible to participate in Harvard's health, disability or life insurance program.</div>
                </td>
              </tr>

          </table>
        </div>
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

              <tr>
                <td style="width: 21.2pt; vertical-align: top; align: right;">
                  <div style="margin-left: 6.05pt; line-height: 1.25;">4.</div>
                </td>
                <td style="width: auto; vertical-align: top;">
                  <div style="text-align: justify; line-height: 1.25;"><u>Appropriate Conduc</u>t. I agree to observe all applicable governmental, University and departmental policies, rules and regulations that pertain to my conduct on campus and in the
                    facilities. I agree that Harvard officials may require me to leave the facilities if they believe that I have violated a policy, rule or regulation or if they believe that my conduct is inappropriate.</div>
                </td>
              </tr>

          </table>
        </div>
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

              <tr>
                <td style="width: 21.2pt; vertical-align: top; align: right;">
                  <div style="margin-left: 6.05pt; line-height: 1.25;">5.</div>
                </td>
                <td style="width: auto; vertical-align: top;">
                  <div style="text-align: justify; line-height: 1.25;"><u>Confidentiality</u>. I agree not to disclose or to use, directly or indirectly, any proprietary or confidential research, data, trade secrets, personal data, or other similar
                    information of which I may become aware as a result of my activities in Harvard's facilities.</div>
                </td>
              </tr>

          </table>
        </div>
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

              <tr>
                <td style="width: 21.2pt; vertical-align: top; align: right;">
                  <div style="margin-left: 6.05pt; line-height: 1.25;">6.</div>
                </td>
                <td style="width: auto; vertical-align: top;">
                  <div style="text-align: justify; line-height: 1.25;"><u>ASSUMPTION OF RISK AND RELEASE OF CLAIMS</u>. Knowing the risks described above, I agree, on behalf of my family, heirs and personal representative(s), to assume all the risks and
                    responsibilities surrounding my use of and access to Harvard's laboratories and equipment. To the maximum extent permitted by law, I release Harvard, its current and former members of its governing boards, officers, faculty, staff,
                    representatives, volunteers, employees, students, other trainees and agents, and their respective heirs and assigns, from any and all claims, losses, expenses, damages, or liabilities which I may incur or suffer, arising out of or
                    related to my use of- or access to the laboratories or equipment and resulting from any cause, including but not limited to negligence by Harvard, its current or former members of governing boards, officers, faculty, staff,
                    representatives, volunteers, employees, students, other trainees or agents.</div>
                </td>
              </tr>

          </table>
        </div>
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

              <tr>
                <td style="width: 21.2pt; vertical-align: top; align: right;">
                  <div style="margin-left: 6.05pt; line-height: 1.25; font-style: italic;">7.</div>
                </td>
                <td style="width: auto; vertical-align: top;">
                  <div style="text-align: justify; line-height: 1.25;"><u>INDEMNIFICATION</u>. <font style="font-style: italic;">I agree to indemnify Harvard, its current and former members of its governing boards officers, faculty, staff,
                      representatives, volunteers, employees, students, other trainees, and agents, and their respective heirs and assigns, against any and all claims, actions, suits, procedures, costs, expenses, damages, and liabilities (including
                      reasonable attorneys' fees) (collectively "Claims"), arising out of or related to my use of or access to Harvard's laboratories or equipment, but only in proportion to and to the extent that such Claims result from or are caused by my
                      own negligent or intentional acts or omissions.</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: left; margin-right: 22.35pt; margin-left: 6.65pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">I have carefully read this Acknowledgement of Risk and Release before signing it. This
          agreement shall be governed by the laws of the Commonwealth of Massachusetts (excluding its conflict of laws principles), which shall be the forum for any lawsuits filed under or incident to this document or the attached Harvard University
          Visitor Participation Agreement.</div>
        <div style="line-height: 1.25">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 34.94%; vertical-align: top;">
                <div style="text-align: justify; margin-left: 6.65pt; line-height: 1.25;">Signed:________________________</div>
              </td>
              <td style="width: 65.06%; vertical-align: top;">
                <div style="text-align: justify; margin-left: 6.65pt; line-height: 1.25;">Date:_____________________________</div>
              </td>
            </tr>
            <tr>
              <td style="width: 34.94%; vertical-align: top;">&#160;</td>
              <td style="width: 65.06%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td colspan="2" style="width: 100%; vertical-align: top;">
                <div style="text-align: justify; margin-left: 6.65pt; line-height: 1.25;">Name (print)_______________________________</div>
              </td>
            </tr>
            <tr>
              <td colspan="2" style="width: 100%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td colspan="2" style="width: 100%; vertical-align: top;">
                <div style="text-align: justify; margin-left: 6.65pt; line-height: 1.25;">Date of Arrival: ____________________ Anticipated Date of Departure:_________</div>
              </td>
            </tr>

        </table>
        <div style="text-align: justify; margin-left: 6.65pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Version: 5/2015</div>
        <div style="line-height: 1.25">&#160;</div>
        <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">26</font></div>
          <div id="DSPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: center; margin-right: 117.05pt; margin-left: 117.05pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">&#160;Exhibit F</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: center; margin-right: 117.05pt; margin-left: 117.05pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Press Release</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: center; margin-right: 116.8pt; margin-left: 117.65pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Attached.</div>
        <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">27</font></div>
          <div id="DSPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: left; margin-left: 6.65pt; line-height: 1.25;"><img width="120" height="53" src="image3.jpg"></div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">FOR IMMEDIATE RELEASE</div>
        <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">May 17, 2016</div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: center; margin-right: 1pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">ReWalk Announces Collaboration with Harvard University&#8217;s Wyss Institute to Develop Lightweight
          and Soft </div>
        <div style="text-align: center; margin-right: 1pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Exoskeleton Systems for the Treatment of Stroke, Multiple Sclerosis and Limited Mobility
          Patients</div>
        <div style="text-align: center; margin-right: 1pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">Five-Year Agreement Establishes Unique Collaboration and Extensive IP Licensing for &#8220;Soft
          Suit&#8221; Exoskeleton </div>
        <div style="text-align: center; margin-right: 1pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">Systems</div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: left; margin-right: 1pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">YOKNEAM ILIT, Israel and MARLBOROUGH, MA &#8212; ReWalk Robotics Ltd. (Nasdaq: RWLK) (&#8220;ReWalk&#8221; or &#8220;Company&#8221;), the leading
          global exoskeleton developer and manufacturer today announced a collaboration with Harvard University&#8217;s Wyss Institute for Biologically Inspired Engineering for the licensing of Intellectual Property (IP), and development of concepts and designs
          of lightweight exoskeleton system&#160; technologies for lower limb disabilities. This exclusive licensing and collaboration agreement will focus on the development of &#8220;soft suit&#8221; systems for the treatment of stroke, Multiple Sclerosis (MS), mobility
          limitations for the elderly and other medical applications.</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: left; margin-right: 1pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8220;There is a great need in the health care system for lightweight, lower-cost wearable exoskeleton designs to support
          stroke patients, individuals diagnosed with Multiple Sclerosis and senior citizens who require mechanical mobility assistance. This collaboration will help create the next generation of exoskeleton systems, making life-changing technology
          available to millions of consumers across a host of patient populations,&#8221; said Larry Jasinski, CEO of ReWalk.</div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: left; margin-right: 1pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8220;This is a very exciting day for the soft suit technology,&#8221; said Conor Walsh, who is a Core Faculty Member at the
          Wyss Institute, the John L. Loeb Associate Professor of Engineering and Applied Sciences at Harvard&#8217;s John A. Paulson School of Engineering and Applied Sciences and Founder&#160; of the Harvard Biodesign Lab. &#8220;ReWalk brings commercialization expertise
          and experience in the area of wearable robotics and complements our translation-focused research. Ultimately this deal paves the way for this technology to make its way to patients.&#8221;</div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: left; margin-right: 1pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The majority of Stroke and MS patients as well as the elderly do not require the structural support of current
          market rigid exoskeleton systems for individuals with spinal cord injury. The soft suit prototypes from the Wyss Institute transmit power to key joints of the legs with cable&#160; technologies powered with software and mechanics that are similar to
          the technologies used in the ReWalk system. The cables are connected to fabric-based designs that attach to the legs and foot, thus lending the name &#8220;soft suit.&#8221;</div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: left; margin-right: 1pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">"Our collaboration with ReWalk is a wonderful example of the Wyss Institute model in action," said Wyss Institute
          Founding Director Don Ingber, M.D., Ph.D. "We work with industry to help de-risk the technologies we develop, both technically and commercially, and thereby expedite their translation into real world applications."</div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: left; margin-right: 1pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Initial pilot studies with stroke patients run at Harvard&#8217;s Wyss Institute in collaboration with faculty and
          researchers from Boston University have demonstrated the function of the soft suit exoskeleton technology. ReWalk will work in concert with the Wyss Institute on the continued development of lightweight designs to complete clinical studies,
          pursue regulatory approvals and commercialize the systems on a global scale. The first commercial application is expected to be stroke, followed by MS and then additional applications. There are an estimated 3 million stroke patients with lower
          limb disability in the U.S., and approximately 400,000 individuals with Multiple Sclerosis.</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: left; margin-right: 1pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8220;Harvard and its Wyss Institute are pioneers in the development of technology in this space. The licensed Harvard
          patent portfolio currently includes 19 patent applications, which includes applications in at least six countries. The applications cover the soft suit, control systems and methods of treating patients. Harvard and the Wyss Institute have built
          comprehensive research expertise in addition to the worldwide patent portfolio. There is no better partner than these renowned institutions with which to pursue the mission of bringing cutting-edge technology to disabled individuals around the
          world,&#8221; Jasinski added.</div>
        <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">28</font></div>
          <div id="DSPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: left; margin-right: 1pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Coordinated by Harvard&#8217;s Office of Technology Development, this collaboration includes funding for continued
          research and technology development at the Wyss Institute and transfer of knowledge and research results to ReWalk.</div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: left; margin-right: 1pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The agreement is effective May 16, 2016, with anticipated commercialization before 2019. For more about Harvard&#8217;s
          Wyss Institute, please visit: http://wyss.harvard.edu/</div>
        <div style="text-align: left; margin-right: 1pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">For more about Harvard&#8217;s Office of Technology Development, please visit: <u>http://otd.harvard.edu/</u></div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: left; margin-right: 1pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">For more about ReWalk, please visit: <u>www.rewalk.com</u></div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: left; margin-right: 1pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;"><u>About ReWalk Personal 6.0</u></div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: left; margin-right: 1pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">ReWalk Personal 6.0 is a wearable robotic exoskeleton that provides powered hip and knee motion to enable
          individuals with spinal cord injury to stand upright and walk. The system provides user-initiated mobility through the integration of a wearable brace support, a computer-based control system and motion sensors. The system allows independent,
          controlled walking similar to a natural gait pattern of the legs. The ReWalk device is&#160; the most studied exoskeleton in the industry</div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: left; margin-right: 1pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;"><u>About ReWalk Robotics Ltd.</u></div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: left; margin-right: 1pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">ReWalk Robotics Ltd. develops, manufactures and markets wearable robotic exoskeletons for individuals with spinal
          cord injury. Our mission is to fundamentally change the quality of life for individuals with lower limb disability through the creation and development of market leading robotic technologies. Founded in 2001, ReWalk has headquarters in the U.S.,
          Israel and Germany. For more information on the ReWalk systems, please visit http://www.rewalk.com.</div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: left; margin-right: 1pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">ReWalk&#174; is a registered trademark of ReWalk Robotics Ltd. in Israel.</div>
        <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">29</font></div>
          <div id="DSPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: left; margin-right: 27.55pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;"><u>Forward Looking Statements</u></div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: left; margin-right: 1pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">In addition to historical information, this press release contains forward-looking statements within the meaning of
          the U.S. Private Securities Litigation Reform Act of 1995, Section 27A of the U.S. Securities Act of 1933, and Section 21E of the U.S. Securities Exchange Act of 1934. Such forward-looking statements may include projections regarding ReWalk&#8217;s
          future performance and, in some cases, may be identified by words like &#8220;anticipate,&#8221; &#8220;assume,&#8221; &#8220;believe,&#8221; &#8220;continue,&#8221; &#8220;could,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;plan,&#8221; &#8220;potential,&#8221; &#8220;predict,&#8221; &#8220;project,&#8221; &#8220;future,&#8221; &#8220;will,&#8221; &#8220;seek&#8221; and similar
          terms or phrases. The forward-looking statements contained in this press release are based on management&#8217;s current expectations, which are subject to uncertainty, risks and changes in circumstances that are difficult to predict and many of which
          are outside of ReWalk&#8217;s control. Important factors that could cause ReWalk&#8217;s actual results to differ materially from those indicated in the forward-looking statements include, among others: ReWalk&#8217;s expectations regarding future growth,
          including its ability to increase sales in its existing geographic markets and to expand to new markets&#894; ReWalk&#8217;s ability to maintain and grow its reputation and to achieve and maintain market acceptance of its products&#894; ReWalk&#8217;s ability to
          achieve reimbursement from third-party payors for its products&#894; ReWalk&#8217;s expectations as to its clinical research program and clinical results&#894; ReWalk&#8217;s ability to improve its products, develop new products&#894; ReWalk&#8217;s ability to maintain adequate
          protection of its intellectual property and to avoid violation of the intellectual property rights of others&#894; ReWalk&#8217;s ability to repay its secured indebtedness&#894; ReWalk&#8217;s ability to gain and maintain regulatory approvals&#894; ReWalk&#8217;s ability to
          maintain relationships with existing customers and develop relationships with new customers&#894; and other factors discussed under the heading &#8220;Risk Factors&#8221; in ReWalk&#8217;s Annual Report on Form 10-K for the year ended December 31, 2015 filed with the
          U.S. Securities and Exchange Commission on February 29, 2016 and other documents subsequently filed with or furnished to the U.S. Securities and Exchange Commission. Any forward-looking statement made in this press release speaks only as of the
          date hereof. Factors or events that could cause ReWalk&#8217;s actual results to differ from the statements contained herein may emerge from time to time, and it is not possible for ReWalk to predict all of them. Except as required by law, ReWalk
          undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future developments or otherwise.</div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: left; margin-right: 27.55pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><u>Media Contact:</u></div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: left; margin-right: 27.55pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">ReWalk Robotics</div>
        <div style="text-align: left; margin-right: 27.55pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Jennifer Wlach</div>
        <div style="text-align: left; margin-right: 27.55pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">202-261-4000</div>
        <div style="text-align: left; margin-right: 27.55pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><u>j</u><u>wlach@mercuryllc.com</u></div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: left; margin-right: 27.55pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Wyss Institute at Harvard University</div>
        <div style="text-align: left; margin-right: 27.55pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Mary Tolikas</div>
        <div style="text-align: left; margin-right: 27.55pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">617-432-7733</div>
        <div style="text-align: left; margin-right: 27.55pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><u>mary.tolikas@wyss.harvard.edu</u></div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: left; margin-right: 27.55pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><u>Investor Relations Contact:</u></div>
        <div style="text-align: left; margin-right: 27.55pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Lisa M. Wilson</div>
        <div style="text-align: left; margin-right: 27.55pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">In-Site Communications, Inc.</div>
        <div style="text-align: left; margin-right: 27.55pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">917-543-9932</div>
        <div style="text-align: left; margin-right: 27.55pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><u>lwilson@insitecony.com</u></div>
        <div style="text-align: left; margin-right: 27.55pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><u> <br>
          </u></div>
      </div>
    </div>
  </div>
  <div style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">30</font>
    <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; margin-left: auto; margin-right: auto;"></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.8
<SEQUENCE>4
<FILENAME>exhibit_10-8.htm
<DESCRIPTION>EXHIBIT 10.8
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: ZKG
         Document created using EDGARfilings PROfile 7.3.2.0
         Copyright 1995 - 2021 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div style="text-align: right; line-height: 1.25; font-weight: bold;">
      <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"><u>Exhibit 10.8</u></div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: right; line-height: 1.25; font-weight: bold;">EXECUTION VERSION</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">Certain confidential information contained in this document, marked by brackets and asterisk, has been </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">omitted&#160; pursuant to Item 601(b)(10)(iv) of Regulation S-K, because it (i) is not material and (ii) would be </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">competitively harmful if publicly disclosed.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">LICENSE AGREEMENT</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">This License Agreement (together with all Exhibits hereto, this &#8220;<font style="font-weight: bold;">Agreement</font>&#8221;) is entered into as of this 16th day of May, 2016 (the &#8220;<font style="font-weight: bold;">Effective Date</font>&#8221;), by and between <font style="font-weight: bold;">President and Fellows of Harvard College</font>, a charitable corporation of Massachusetts having an office at Richard A. and Susan F. Smith Campus
      Center, Suite 727, 1350 Massachusetts Avenue, Cambridge, Massachusetts 02138 (&#8220;<font style="font-weight: bold;">Harvard</font>&#8221;), and <font style="font-weight: bold;">ReWalk Robotics</font>, <font style="font-weight: bold;">Ltd</font>. a company
      existing under the laws of the State of Israel, having a place of business at 200 Donald Lynch Blvd., Marlborough, MA 01752 (&#8220;<font style="font-weight: bold;">Licensee</font>&#8221;). Harvard and Licensee each shall be referred to herein as a &#8220;<font style="font-weight: bold;">Party</font>&#8221; and together as the &#8220;<font style="font-weight: bold;">Parties</font>.&#8221;</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">WHEREAS</font>, certain technology claimed in the Licensed Patent Rights (as defined below) and included in the Licensed Know-How was developed in
      research conducted by Harvard researcher Dr. Conor Walsh, together with others at the Wyss Institute for Biologically Inspired Engineering at Harvard University; and</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">WHEREAS</font>, Licensee wishes to obtain a license under the Licensed Patent Rights and Licensed Know-How; and</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">WHEREAS</font>, Harvard desires to have products based on the inventions described in the Licensed Patent Rights developed and commercialized to
      benefit the public; and</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">WHEREAS</font>, Licensee has represented to Harvard, in order to induce Harvard to enter into this Agreement, that Licensee shall commit itself to
      commercially reasonable efforts to develop, obtain regulatory approval for and commercialize such products in accordance with the terms and conditions set forth herein.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">NOW, THEREFORE,</font> the Parties hereto, intending to be legally bound, hereby agree as follows:</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">
      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36.35pt; vertical-align: top; align: right;">
                <div style="margin-left: 6.05pt; line-height: 1.25; font-weight: bold;">1.</div>
              </td>
              <td style="width: auto; vertical-align: top;">
                <div style="line-height: 1.25; font-weight: bold;">Definitions.</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Whenever used in this Agreement with an initial capital letter, the terms defined in this <u>Article 1</u>, whether used in the singular or the plural, will have the meanings
      specified below. Terms with an initial capital letter used in this Agreement that are not defined below will have the meaning set forth in the Collaboration Agreement.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">1.1</font> &#8220;<font style="font-weight: bold;">Active</font>&#8221; means, with respect to a Soft Exosuit, technology that commands motors to apply torques
      at joint(s) beyond adjusting pretension levels.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">1.2 </font>&#8220;<font style="font-weight: bold;">Affiliate</font>&#8221; means, with respect to a person, organization or entity, any person, organization
      or entity controlling, controlled by or under common control with, such person, organization or entity. For purposes of this definition only, &#8220;control&#8221; of another person, organization or entity will mean the possession, directly or indirectly, of the
      power to direct or cause the direction of the activities, management or policies of such person, organization or entity, whether through the ownership of voting securities, by contract or otherwise. Without limiting the foregoing, control will be
      presumed to exist when a person, organization or entity (a) owns or directly controls fifty percent (50%) or more of the outstanding voting stock or other ownership interest of the other organization or entity or (b) possesses, directly or
      indirectly, the power to elect or appoint fifty percent (50%) or more of the members of the governing body of the other organization or entity. The Parties acknowledge that in the case of certain entities organized under the laws of certain countries
      outside of the United States, the maximum percentage ownership permitted by law for a foreign investor may be less than fifty percent (50%), and that in such cases such lower percentage will be substituted in the preceding sentence.</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <!--PROfilePageNumberReset%Num%2%%%-->
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">1.3 </font>&#8220;<font style="font-weight: bold;">Calendar Quarter</font>&#8221; means each of the periods of three (3) consecutive calendar months ending on
      March 31, June 30, September 30 and December 31 during the Term.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">1.4 </font>&#8220;<font style="font-weight: bold;">Clinical Data</font>&#8221;<font style="font-weight: bold;">&#160;</font>means all records, reports, data and
      information and other Know-How concerning the Licensed Products that is or was created as a result of or in connection with the conduct of a clinical trial.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">1.5 </font>&#8220;<font style="font-weight: bold;">Collaboration Agreement</font>&#8221;<font style="font-weight: bold;">&#160;</font>means the research
      collaboration agreement entered into by the Parties as of the Effective Date under which the Parties will perform a Research Plan as defined therein.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">1.6 </font>&#8220;<font style="font-weight: bold;">Consulting Invention</font>&#8221; means any patentable invention (other than a Joint Consulting Invention)
      conceived and/or reduced to practice solely by Dr. Walsh within three (3) years after the Effective Date (so long as he is employed by Harvard during such three (3) year period) in his performance of consulting or other services for Licensee which is
      dominated by a Valid Claim within the Harvard Background Patents.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">1.7 </font>&#8220;<font style="font-weight: bold;">Consulting Patent Rights</font>&#8221; means any Patent Rights for any patent application or patent that
      claim any Consulting Invention, in each case solely to the extent the claims are directed to the subject matter of such Consulting Invention.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">1.8 </font>&#8220;<font style="font-weight: bold;">Control</font>&#8221;<font style="font-weight: bold;">&#160;</font>means, with respect to any Know-How, Patent
      Rights, other intellectual property rights or trade secrets, the legal authority or right (whether by license or otherwise) of a Party to grant a license or a sublicense of or under such Know-How, Patent Rights, or other intellectual property rights
      to another Person, or to otherwise disclose such trade secrets to another Person, without breaching the terms of any agreement with a third party, or misappropriating the trade secrets of a third party.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">1.9 </font>&#8220;<font style="font-weight: bold;">Design Freeze</font>&#8221; means the date that the design specifications of a Licensed Product have been
      achieved in accordance with the Licensee&#8217;s quality system, which date shall be indicated in a written notice provided by Licensee to Harvard.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">1.10 </font>&#8220;<font style="font-weight: bold;">Developing Country</font>&#8221; means any low-income or lower-middle-income country, as defined by the
      World Bank, except for India.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">1.11 </font>&#8220;<font style="font-weight: bold;">Development Milestones</font>&#8221;<font style="font-weight: bold;">&#160;</font>means the development and
      commercialization milestones set forth in <u>Exhibit 1.11</u> hereto.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">1.12 </font>&#8220;<font style="font-weight: bold;">Development Plan</font>&#8221;<font style="font-weight: bold;">&#160;</font>means the plan for the development
      and commercialization of Licensed Products attached hereto as <u>Exhibit 1.12</u>, as such plan may be adjusted from time to time pursuant to Section 3.2.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">1.13 </font>&#8220;<font style="font-weight: bold;">Distributor</font>&#8221;<font style="font-weight: bold;">&#160;</font>means a third party whom Licensee, its
      Affiliate or a Sublicensee engages to offer for sale, sell and/or import Licensed Products purchased from Licensee, such Affiliate or such Sublicensee, as applicable, for resale by such third party under the label of Licensee, such Affiliate or such
      Sublicensee, as applicable; provided that the term &#8220;Distributor&#8221; shall not include any person or entity who pays Licensee, its Affiliate or a Sublicensee any consideration (in any form) with respect to such engagement other than the consideration
      paid for the purchase of such Licensed Products.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">1.14 </font>&#8220;<font style="font-weight: bold;">European Economic Area</font>&#8221; or &#8220;<font style="font-weight: bold;">EEA</font>&#8221; means the
      twenty-eight members of the European Union, Iceland, Liechtenstein, Norway, Switzerland and Turkey.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">1.15 </font>&#8220;<font style="font-weight: bold;">Field</font>&#8221;<font style="font-weight: bold;">&#160;</font>means Active Medical Lower Limb Soft Exosuits.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">1.16 </font>&#8220;<font style="font-weight: bold;">First Commercial Sale</font>&#8221; means the date of the first sale or lease by Licensee, its Affiliate
      or a Sublicensee of a Licensed Product to a third party for end use (or use by a lease) or consumption of such Licensed Product following receipt of any required Marketing Clearance in the country in which such Licensed Product is sold or leased,
      excluding, however, any sale or other distribution (including leases) for use in a clinical study.</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;" id="DSPFPageNumber">2</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">1.17 </font>&#8220;<font style="font-weight: bold;">Governmental Authority</font>&#8221; means any transnational, domestic or foreign federal, state or local
      governmental, regulatory or administrative authority, department, court, agency or official, including any political subdivision thereof.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">1.18 </font>&#8220;<font style="font-weight: bold;">Harvard Background Patents</font>&#8221; means, in each case to the extent owned or Controlled by Harvard
      as of the Effective Date, all of the Patent Rights for the patents and patent applications identified as &#8220;Harvard Background Patents&#8221; in <u>Exhibit 1.25</u>.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">1.19 </font>&#8220;<font style="font-weight: bold;">Harvard Type A Invention</font>&#8221;<font style="font-weight: bold;">&#160;</font>means any patentable
      invention that either (a) is conceived and reduced to practice (i) (x) in the performance of the Research Plan during the Research Term or (y) conceived in the performance of the Research Plan during the Term and reduced to practice within one (1)
      year after termination or expiration of the Research Term, (ii) for which at least one inventor is a member of the Harvard Team (but no inventor is a member of the Company Team) and (iii) which is dominated by a Valid Claim within the Harvard
      Background Patents (regardless of whether or not such Valid Claim ultimately issues); or (b) is deemed a Harvard Type A Invention pursuant to <u>Section 5.2.4</u> of the Collaboration Agreement.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">1.20 </font>&#8220;<font style="font-weight: bold;">Harvard Type A Patent Rights</font>&#8221;<font style="font-weight: bold;">&#160;</font>means all of the Patent
      Rights for any patents or patent applications that claim any Harvard Type A Invention, in each case solely to the extent the claims are directed to the subject matter of such Harvard Type A Invention.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">1.21 </font>&#8220;<font style="font-weight: bold;">Joint Consulting Invention</font>&#8221; means any patentable invention conceived and/or reduced to
      practice jointly by (a) one or more employees or consultants of Licensee and (b) Dr. Walsh within [**] after the Effective Date (for so long as Dr. Walsh is employed by Harvard during such [**] period) in the performance of consulting or other
      services for Licensee which is dominated by a Valid Claim within the Harvard Background Patents.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">1.22 </font>&#8220;<font style="font-weight: bold;">Joint Consulting Patent Rights</font>&#8221; means any Patent Rights for any patent or patent application
      that claim any Joint Consulting Invention, in each case solely to the extent the claims are directed to the subject matter of such Joint Consulting Invention.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">1.23 </font>&#8220;<font style="font-weight: bold;">Know-How</font>&#8221;<font style="font-weight: bold;">&#160;</font>means all data, materials, compositions,
      methods, processes, analyses, formulae, know-how, trade secrets, unpatented inventions (whether patentable or unpatentable and whether or not reduced to practice), technology, and information generated in the performance of the Research, but
      excluding Inventions.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">1.24 </font>&#8220;<font style="font-weight: bold;">Licensed Know-How</font>&#8221;<font style="font-weight: bold;">&#160;</font>means all Know-How that is owned
      or Controlled by Harvard as of the Effective Date that (a) is set forth on <u>Exhibit 1.24</u> hereto; or (b) the Parties both (i) mutually agree was known by a member of the Harvard Team or Dr. Walsh as of the Effective Date and is necessary for an
      individual who is reasonably skilled in the relevant art to enable him/her to practice the Harvard Background Patents; and (ii) mutually agree to add to <u>Exhibit 1.24</u>.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">1.25 </font>&#8220;<font style="font-weight: bold;">Licensed Patent Rights</font>&#8221; means (a) the Harvard Background Patents and (b) any Licensed Type A
      Patents, Consulting Patent Rights and Joint Consulting Patent Rights subsequently added to <u>Exhibit 1.25</u> pursuant to <u>Sections 2.5</u> or <u>2.6</u>, as applicable.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">1.26 </font>&#8220;<font style="font-weight: bold;">Licensed Product</font>&#8221;<font style="font-weight: bold;">&#160;</font>means on a country-by-country
      basis, any product, the making, using, selling, offering for sale, importing or exporting in the country in question would (without the license granted hereunder) infringe directly, indirectly by inducement of infringement, or indirectly by
      contributory infringement, at least one pending Valid Claim or issued Valid Claim in that country.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">1.27 </font>&#8220;<font style="font-weight: bold;">Marketing Clearance</font>&#8221; means all approvals from the relevant Regulatory Authority of a country
      necessary to market and sell a Licensed Product in such country.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">1.28 </font>&#8220;<font style="font-weight: bold;">Medical Lower Limb</font>&#8221;<font style="font-weight: bold;">&#160;</font>means actively affecting leg
      movement in patients with gait impairments resulting from lack of proper muscle function due to neurological impairment, muscular degeneration or advanced aging.</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;" id="DSPFPageNumber">3</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">1.29 </font>&#8220;<font style="font-weight: bold;">Net Sales</font>&#8221; means the gross amount billed or invoiced by or on behalf of Licensee, its
      Affiliates or Sublicensees (in each case, the &#8220;<font style="font-weight: bold;">Invoicing Entity</font>&#8221;) on sales, leases or other transfers of Licensed Products, less the following to the extent applicable with respect to such sales, leases or
      other transfers and not previously deducted from the gross invoice price: (a) customary trade, quantity or cash discounts to the extent actually allowed and taken; (b) amounts actually repaid or credited by reason of rejection or return of any
      previously sold, leased or otherwise transferred Licensed Products; (c) customer freight charges that are paid by or on behalf of the Invoicing Entity; and (d) to the extent separately stated on purchase orders, invoices or other documents of sale,
      any sales, value added or similar taxes, custom duties or other similar governmental charges levied directly on the production, sale, transportation, delivery or use of a Licensed Product that are paid by or on behalf of the Invoicing Entity, but not
      including any tax levied with respect to income; provided that:</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;"><font style="font-weight: bold;">1.29.1 </font>in any transfers of Licensed Products between an Invoicing Entity and an Affiliate or Sublicensee of such Invoicing Entity not for
      the purpose of resale by such Affiliate or Sublicensee, Net Sales will be equal to the fair market value of the Licensed Products so transferred, assuming an arm&#8217;s length transaction made in the ordinary course of business, and</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;"><font style="font-weight: bold;">1.29.2 </font>in the event that an Invoicing Entity receives non-cash consideration for any Licensed Products or in the case of transactions not
      at arm&#8217;s length with a non-Affiliate of an Invoicing Entity, Net Sales will be calculated based on the fair market value of such consideration or transaction, assuming an arm&#8217;s length transaction made in the ordinary course of business. Sales of
      Licensed Products by an Invoicing Entity to its Affiliate or a Sublicensee for resale by such Affiliate or Sublicensee will not be deemed Net Sales. Instead, Net Sales will be determined based on the gross amount billed or invoiced by such Affiliate
      or Sublicensee upon resale of such Licensed Products to a third party purchaser.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">1.30 </font>&#8220;<font style="font-weight: bold;">Non-Royalty Sublicense Income</font>&#8221;<font style="font-weight: bold;">&#160;</font>means any payments or
      other consideration that Licensee or any of its Affiliates receives in connection with a Sublicense, other than royalties based on Net Sales. If Licensee or its Affiliate receives non-cash consideration in connection with a Sublicense or in the case
      of transactions not at arm&#8217;s length, Non-Royalty Sublicense Income will be calculated based on the fair market value of such consideration or transaction, at the time of the transaction, assuming an arm&#8217;s length transaction made in the ordinary
      course of business.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">1.31 </font>&#8220;<font style="font-weight: bold;">Patent Rights</font>&#8221; means, with respect to any patents or patent applications, all of the
      following: (a) such patents and patent applications (including the PCT and/or U.S. utility application claiming priority to such application(s) that are filed on or before the one year conversion date of such application(s)); (b) any patent or patent
      application that claims priority to and is a divisional, continuation, reissue, renewal, reexamination, substitution or extension of any patent application identified in (a); (c) any patents issuing on any patent application identified in (a) or (b),
      including any reissues, renewals, reexaminations, substitutions or extensions thereof; (d) any claim of a continuation-in-part application or patent (including any reissues, renewals, reexaminations, substitutions or extensions thereof) that is
      entitled to the priority date of, and is directed specifically to subject matter specifically described in, at least one of the patents or patent applications identified in (a), (b) or (c); (e) any foreign counterpart (including PCTs) of any patent
      or patent application identified in (a), (b) or (c) or of the claims identified in (d); and (f) any supplementary protection certificates, pediatric exclusivity periods, any other patent term extensions and exclusivity periods and the like of any
      patents and patent applications identified in (a) through (e).</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">1.32 </font>&#8220;<font style="font-weight: bold;">Person</font>&#8221;<font style="font-weight: bold;">&#160;</font>means<font style="font-weight: bold;">&#160;</font>an

      individual, corporation, partnership, limited liability company, association, trust or other entity or organization, including a Governmental Authority.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">1.33 </font>&#8220;<font style="font-weight: bold;">Regulatory Authority</font>&#8221;<font style="font-weight: bold;">&#160;</font>means any applicable government
      regulatory authority involved in granting approvals for the manufacturing and marketing of a Licensed Product, including the Food and Drug Administration in the United States and any foreign equivalent.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">1.34 </font>&#8220;<font style="font-weight: bold;">Research Term</font>&#8221;<font style="font-weight: bold;">&#160;</font>means the term of the Collaboration
      Agreement.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">1.35 </font>&#8220;<font style="font-weight: bold;">Soft Exosuit</font>&#8221;<font style="font-weight: bold;">&#160;</font>means assistive technology comprised of
      (i) a motor/gear-driven actuation system, (ii) Bowden-cable-based transmission, (iii) a textile-based human interface, (iv) wearable sensors and (v) algorithms to control assistance.</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;" id="DSPFPageNumber">4</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">1.36 </font>&#8220;<font style="font-weight: bold;">Sublicense</font>&#8221;<font style="font-weight: bold;">&#160;</font>means: (a) any right granted, license
      given or agreement entered into by Licensee to or with any other person or entity, under or with respect to or permitting any use or exploitation of any of the Licensed Patent Rights or otherwise permitting the development, manufacture, marketing,
      distribution, use and/or sale of Licensed Products;<font style="font-weight: bold;">&#160;</font>(b) any option or other right granted by Licensee to any other person or entity to negotiate for or receive any of the rights described under clause (a); or
      (c) any standstill or similar obligation undertaken by Licensee toward any other person or entity not to grant any of the rights described in clause (a) or (b) to any third party; in each case regardless of whether such grant of rights, license given
      or agreement entered into is referred to or is described as a sublicense.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">1.37 </font>&#8220;<font style="font-weight: bold;">Sublicensee</font>&#8221; means any person or entity granted a Sublicense.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">1.38 </font>&#8220;<font style="font-weight: bold;">Territory</font>&#8221;<font style="font-weight: bold;">&#160;</font>means worldwide.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">1.39 </font>&#8220;<font style="font-weight: bold;">Third Party Proposed Product</font>&#8221;<font style="font-weight: bold;">&#160;</font>means an actual or
      potential<font style="font-weight: bold;">&#160;</font>Licensed Product that is for an application or market segment for which Harvard reasonably believes a Licensed Product is not being actively developed and commercialized by Licensee, its Affiliates or
      any Sublicensee hereunder.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">1.40 </font>&#8220;<font style="font-weight: bold;">Valid Claim</font>&#8221; means, on a country-by-country basis: (a) a claim of an issued and unexpired
      patent within the Licensed Patent Rights that has not been (i) held permanently revoked, unenforceable, unpatentable or invalid by a decision of a court or governmental body of competent jurisdiction, unappealable or unappealed within the time
      allowed for appeal, (ii) rendered unenforceable through disclaimer or otherwise, (iii) abandoned or (iv) permanently lost through an interference or opposition proceeding without any right of appeal or review; or (b) a pending claim of a pending
      patent application within the Licensed Patent Rights that (i) has been asserted and continues to be prosecuted in good faith and (ii) has not been abandoned or finally rejected without the possibility of appeal or refiling.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">1.41 Additional Defined Terms.</font> The following capitalized terms shall have the meanings ascribed to them in the following sections of this
      Agreement:</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="2" border="0" align="center" id="z5b0dba8c7e9144fc8a9678736c55e013" style="width: 70%; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 10pt; text-align: left;">

        <tr>
          <td style="width: 66.08%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Abandoned Patent Rights</div>
          </td>
          <td style="width: 33.92%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 6.3</div>
          </td>
        </tr>
        <tr>
          <td style="width: 66.08%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Agreement</div>
          </td>
          <td style="width: 33.92%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Preamble</div>
          </td>
        </tr>
        <tr>
          <td style="width: 66.08%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Bankruptcy Code</div>
          </td>
          <td style="width: 33.92%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 11.18</div>
          </td>
        </tr>
        <tr>
          <td style="width: 66.08%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Challenging Party</div>
          </td>
          <td style="width: 33.92%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 4.6</div>
          </td>
        </tr>
        <tr>
          <td style="width: 66.08%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Challenge Proceeding</div>
          </td>
          <td style="width: 33.92%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 4.6</div>
          </td>
        </tr>
        <tr>
          <td style="width: 66.08%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Claims</div>
          </td>
          <td style="width: 33.92%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 9.1</div>
          </td>
        </tr>
        <tr>
          <td style="width: 66.08%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Effective Date</div>
          </td>
          <td style="width: 33.92%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Preamble</div>
          </td>
        </tr>
        <tr>
          <td style="width: 66.08%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Ex-Field Licensee</div>
          </td>
          <td style="width: 33.92%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 11.17</div>
          </td>
        </tr>
        <tr>
          <td style="width: 66.08%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Explanation</div>
          </td>
          <td style="width: 33.92%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 3.4</div>
          </td>
        </tr>
        <tr>
          <td style="width: 66.08%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">[**]</div>
          </td>
          <td style="width: 33.92%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Exhibit 11</div>
          </td>
        </tr>
        <tr>
          <td style="width: 66.08%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Harvard</div>
          </td>
          <td style="width: 33.92%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Preamble</div>
          </td>
        </tr>
        <tr>
          <td style="width: 66.08%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Harvard Names</div>
          </td>
          <td style="width: 33.92%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 11.3</div>
          </td>
        </tr>
        <tr>
          <td style="width: 66.08%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Indemnitees</div>
          </td>
          <td style="width: 33.92%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 9.1</div>
          </td>
        </tr>
        <tr>
          <td style="width: 66.08%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Infringement</div>
          </td>
          <td style="width: 33.92%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 7.1</div>
          </td>
        </tr>
        <tr>
          <td style="width: 66.08%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Initial Deadline</div>
          </td>
          <td style="width: 33.92%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 3.4.2</div>
          </td>
        </tr>
        <tr>
          <td style="width: 66.08%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Licensed Type A Patents</div>
          </td>
          <td style="width: 33.92%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 2.5</div>
          </td>
        </tr>
        <tr>
          <td style="width: 66.08%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Licensee</div>
          </td>
          <td style="width: 33.92%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Preamble</div>
          </td>
        </tr>
        <tr>
          <td style="width: 66.08%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">OTD</div>
          </td>
          <td style="width: 33.92%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 2.6.4</div>
          </td>
        </tr>
        <tr>
          <td style="width: 66.08%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Party or Parties</div>
          </td>
          <td style="width: 33.92%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Preamble</div>
          </td>
        </tr>
        <tr>
          <td style="width: 66.08%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Plan</div>
          </td>
          <td style="width: 33.92%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 3.4</div>
          </td>
        </tr>
        <tr>
          <td style="width: 66.08%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Reimbursed Costs</div>
          </td>
          <td style="width: 33.92%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 11.17</div>
          </td>
        </tr>
        <tr>
          <td style="width: 66.08%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Second Deadline</div>
          </td>
          <td style="width: 33.92%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 3.4.4</div>
          </td>
        </tr>
        <tr>
          <td style="width: 66.08%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Suit</div>
          </td>
          <td style="width: 33.92%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 11.6</div>
          </td>
        </tr>
        <tr>
          <td style="width: 66.08%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Term</div>
          </td>
          <td style="width: 33.92%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 10.1</div>
          </td>
        </tr>
        <tr>
          <td style="width: 66.08%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Third Deadline</div>
          </td>
          <td style="width: 33.92%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Section 3.4.5</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="color: #000000; font-weight: normal; font-style: normal;" id="DSPFPageNumber">5</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div>
      <div>
        <div> <br>
        </div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36.35pt; vertical-align: top; align: right;">
                <div style="margin-left: 6.05pt; line-height: 1.25; font-weight: bold;">2.</div>
              </td>
              <td style="width: auto; vertical-align: top;">
                <div style="line-height: 1.25; font-weight: bold;"><font style="font-weight: bold;">License</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">2.1 License Grants</font>. Subject to the terms and conditions set forth in this Agreement, Harvard hereby grants to Licensee (a) an exclusive,
      royalty-bearing license under the Licensed Patent Rights (and (x) if an option for an exclusive license thereunder has been exercised in accordance with <u>Section 6.2.3</u> of the Collaboration Agreement, under Harvard&#8217;s interest in and to the
      Joint Patents Rights; and (y) if an option for an exclusive license thereunder has been exercised in accordance with <u>Section 2.6.6</u>, under Harvard&#8217;s interest in and to the Joint Consulting Patents Rights) solely to make, have made, offer for
      sale, sell, have sold, repair, service and import Licensed Products solely within the Field and in the Territory; and (b) a non-exclusive, royalty-free license to use any Licensed Know-How both (i) for internal research purposes and (ii) to make,
      have made, offer for sale, sell, have sold, repair, service, and import Licensed Products solely within the Field in the Territory; provided, however, that:</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;"><font style="font-weight: bold;">2.1.1 </font>Harvard retains the right, for itself and for other not-for-profit research organizations to practice the Licensed Patent Rights and
      use the Licensed Know-How, in each case, within the scope of the licenses granted above, solely for research, educational and scholarly purposes; and</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;"><font style="font-weight: bold;">2.1.2 </font>the United States federal government retains rights in the Licensed Patent Rights and Licensed Know-How pursuant to 35 U.S.C. &#167;&#167;
      200-212 and 37 C.F.R. &#167; 401 et seq., and any right granted in this Agreement greater than that permitted under 35 U.S.C. &#167;&#167; 200-212 or 37 C.F.R. &#167; 401 et seq. will be subject to modification as may be required to conform to the provisions of those
      statutes and regulations.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;"><font style="font-weight: bold;">2.2 Affiliates; Sublicensees; Distributors</font>. The license granted to Licensee under <u>Section 2.1</u> includes the right to have some or all
      of Licensee&#8217;s rights or obligations under this Agreement exercised or performed by one or more of Licensee&#8217;s Affiliates; Sublicensees or Distributors on Licensee&#8217;s behalf; provided, however, that:</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;"><font style="font-weight: bold;">2.2.1 </font>no such Affiliate, Sublicensee or Distributor shall be entitled to grant, directly or indirectly, to any third party any right of
      whatever nature under, or with respect to, or permitting any use or exploitation of, any of the Licensed Patent Rights or Licensed Know-How, including any right to develop, manufacture, market or sell Licensed Products; and</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;"><font style="font-weight: bold;">2.2.2 </font>any act or omission taken or made by an Affiliate, Sublicensee or Distributor of Licensee under this Agreement will be deemed an act
      or omission by Licensee.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">2.3 Sublicenses</font>.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;"><font style="font-weight: bold;">2.3.1 Sublicense Grant</font>. Licensee will be entitled to grant Sublicenses to third parties under the license granted pursuant to <u>Section
        2.1</u> subject to the terms of this <u>Section 2.3</u>. Any such Sublicense shall be on terms and conditions in compliance with and not inconsistent with the terms of this Agreement.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;"><font style="font-weight: bold;">2.3.2 Sublicense Agreements</font>. Licensee shall grant Sublicenses pursuant to written agreements, which will be subject and subordinate to the
      terms and conditions of this Agreement. Such Sublicense agreements will contain, among other things, the following:</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 108pt; line-height: 1.25;"><font style="font-weight: bold;">2.3.2.1 </font>all provisions necessary to ensure Licensee&#8217;s ability to perform its obligations under this Agreement;</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 108pt; line-height: 1.25;"><font style="font-weight: bold;">2.3.2.2 </font>a section substantially the same as <u>Article 9</u> of this Agreement, which also will state that the Indemnitees (as defined in
      <u>Section 9.1</u>) are intended third party beneficiaries of such Sublicense agreement for the purpose of enforcing such indemnification;</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 108pt; line-height: 1.25;"><font style="font-weight: bold;">2.3.2.3 </font>a provision clarifying that, in the event of termination of the license set forth in <u>Section 2.1</u> (in whole or in part
      (e.g., termination in a particular country)), any existing Sublicense agreement shall terminate to the extent of such terminated license;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;" id="DSPFPageNumber">6</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 108pt; line-height: 1.25;"><font style="font-weight: bold;">2.3.2.4 </font>a provision prohibiting the Sublicensee from sublicensing its rights under such Sublicense agreement; and</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 108pt; line-height: 1.25;"><font style="font-weight: bold;">2.3.2.5 </font>a provision prohibiting the<font style="font-weight: bold;">&#160;</font>Sublicensee from assigning the Sublicense agreement without
      the prior written consent of Harvard, except that Sublicensee may assign the Sublicense agreement to an affiliate of Sublicensee or to a successor in connection with the merger, consolidation or sale of all or substantially all of its assets or that
      portion of its business to which the Sublicense agreement relates; provided, however, that any permitted assignee agrees in writing to be bound by the terms of such Sublicense agreement.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;"><font style="font-weight: bold;">2.3.3 Delivery of Sublicense Agreement</font>. Licensee shall furnish Harvard with a fully executed copy of any Sublicense agreement, promptly
      after its execution. Harvard shall keep all such copies in its confidential files and shall use them solely for the purpose of monitoring Licensee&#8217;s and Sublicensees&#8217; compliance with their obligations hereunder and enforcing Harvard&#8217;s rights under
      this Agreement.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;"><font style="font-weight: bold;">2.3.4 Breach by Sublicensee</font>. Licensee shall be responsible for any breach of a Sublicense agreement by any Sublicensee that results in a
      material breach of this Agreement. Licensee shall either (a) cure such breach in accordance with <u>Section 10.2.2</u> of this Agreement or (b) enforce its rights by terminating such Sublicense agreement in accordance with the terms thereof.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-weight: bold;">2.4 Third Party Proposed Products.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;"><font style="font-weight: bold;">2.4.1 </font>If a Third Party makes a bona fide proposal to Harvard for developing a Third Party Proposed Product and Harvard is interested in
      having such Third Party Proposed Product developed and commercialized, Harvard may notify Licensee of the Third Party&#8217;s proposal, and shall include in such notification non-confidential information regarding the Third Party proposal. Within [**]
      after the receipt of such notification from Harvard, Licensee shall notify Harvard whether it is interested in developing such Third Party Proposed Product. Licensee&#8217;s decision shall be in its sole discretion.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;"><font style="font-weight: bold;">2.4.2 </font>If Licensee (in its sole discretion) notifies Harvard within such [**] period that it is interested in developing such Third Party
      Proposed Product, the Parties will negotiate in good faith and agree, during the [**] following such notification, upon a development plan with respect to such Third Party Proposed Product, which development plan will be similar to the Development
      Plan with respect to other Licensed Products developed by Licensee, subject to necessary adjustments, and will include reasonable milestones. If the Parties agree on such development plan and milestones within such [**] period, Licensee shall
      maintain its exclusive license(s) hereunder with respect to such Third Party Proposed Product, but shall be obligated (a) to use commercially reasonable efforts to develop and commercialize the Third Party Proposed Product in accordance with such new
      development plan and (b) to meet the milestones with respect to the Third Party Proposed Product.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;"><font style="font-weight: bold;">2.4.3 </font>If (a) License (in its sole discretion) notifies Harvard that it is not interested in develping such Third Party Proposed Product, or
      (b) the Parties do not agree on a development plan and milestones, then neither Harvard nor any other Person (other than Licensee) shall have the right to (nor license nor authorize any third Person to) make, have made, offer for sale, sell, have
      sold and/or import any such Third Party Proposed Product without the prior written consent of Licensee in its sole discretion.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">2.5 Harvard Type A Patent Rights</font>. Subject to the agreement of the inventors of the inventions claimed in the relevant Harvard Type A Patent
      Rights, upon receipt by Harvard of (a) a [**] dollar ($[**]) license fee for worldwide rights under each family of Harvard Type A Patent Rights and (b) the written request of Licensee identifying the relevant family of Harvard Type A Patent Rights,
      the Parties shall immediately amend <u>Exhibit 1.25</u> to add such Harvard Type A Patent Rights and upon such amendment, such Harvard Type A Patent Rights shall automatically (and without any additional action of the Parties) be deemed to be &#8220;<font style="font-weight: bold;">Licensed Type A Patents</font>&#8221; licensed pursuant to this Agreement by Harvard to Licensee on the same terms as those set forth herein, including, without limitation, subject to <u>Section 11.17</u>, reimbursement to
      Harvard for all documented, out-of-pocket expenses incurred by Harvard in connection with such Harvard Type A Patent Rights in accordance with <u>Article 6</u>.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">2.6 Ownership of Consulting Inventions</font>.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;"><font style="font-weight: bold;">2.6.1 </font>Dr. Walsh&#8217;s consulting agreements for the performing of consulting or other services to Licensee shall comply with all applicable
      Harvard policies with respect thereto. Therefore the entire right, title and interest in and to each Consulting Invention, and all corresponding Consulting Patent Rights, will be owned solely by Harvard. The Parties and Dr. Walsh agree that Dr. Walsh
      shall assign his entire right, title and interest in any such Consulting Invention to Harvard.</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;" id="DSPFPageNumber">7</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;"><font style="font-weight: bold;">2.6.2 </font>The entire right, title and interest in and to each Joint Consulting Invention, and all corresponding Joint Patent Rights, will be
      owned jointly by Licensee and Harvard. The parties and Dr. Walsh agree that Dr. Walsh shall assign his entire right, title and interest in any such Joint Consulting Invention to Harvard and Licensee jointly. Subject to the terms and conditions of
      this Agreement (including, without limitation, the exclusive license granted by Harvard to Licensee pursuant to <u>Section 2.1</u> hereof), each Party shall be free to use and license its undivided share of any and all Joint Consulting Inventions or
      any and all Joint Patent Rights without having to (i) obtain the agreement or consent of the other Party, (ii) provide notice of such use or licensing to the other Party or (iii) make any accounting to the other Party for such use or licensing or any
      revenues or profits derived from such use or licensing.</div>
    <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;"> <br>
    </div>
    <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;"><font style="font-weight: bold;">2.6.3 </font>All determinations of inventorship under this Agreement shall be made in accordance with United States patent law. In case of dispute
      over inventorship, a mutually acceptable outside patent counsel shall make the determination of the inventor(s) by applying the standards contained in United States patent law.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;"><font style="font-weight: bold;">2.6.4 </font>Dr. Walsh shall disclose to Licensee and Harvard&#8217;s Office of Technology Development (&#8220;<font style="font-weight: bold;">OTD</font>&#8221;)
      in a confidential writing the conception and/or reduction to practice of any Consulting Invention and Joint Consulting Invention promptly after he becomes aware thereof. Harvard shall disclose to Licensee in a confidential writing the conception
      and/or reduction to practice of any Consulting Invention and Joint Consulting Invention of which it becomes aware, promptly after OTD&#8217;s receipt of an invention disclosure form from Dr. Walsh.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;"><font style="font-weight: bold;">2.6.5 </font>Any consulting or other agreement pursuant to which Dr. Walsh (for so long as he is an employee of Harvard) performs services for or
      on behalf of Licensee shall be consistent with and subordinate to the provisions of this <u>Section 2.6</u>. Any such consulting agreement shall require Dr. Walsh to assign his rights in Consulting Inventions and Joint Consulting Inventions, but not
      in other inventions, in a manner consistent with the provisions of this <u>Section 2.6</u>, and shall allow Dr. Walsh to make the disclosures contemplated by <u>Section 2.6.4</u>. In the case of any discrepancy between <u>Section 2.6</u> of this
      Agreement and any such consulting agreement, the terms of this Agreement shall prevail.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;"><font style="font-weight: bold;">2.6.6 </font>Solely at the option of Licensee and upon its written request (at Licensee&#8217;s sole discretion), the Parties shall immediately amend <u>Exhibit

        1.25</u> to add each family of Consulting Patent Rights (or Harvard&#8217;s interest in each family of Joint Consulting Patent Rights) that Licensee identifies and upon such amendment, such Consulting Patent Rights (or Harvard&#8217;s interest in such Joint
      Consulting Patent Rights) shall automatically (and without any additional action of the Parties) be deemed to be &#8220;<font style="font-weight: bold;">Licensed Patents</font>&#8221; licensed pursuant to this Agreement by Harvard to Licensee on the same terms
      as set forth herein, including, without limitation, subject to <u>Section 11.17</u>, reimbursement to Harvard for all documented, out-of-pocket expenses incurred by Harvard in connection with such Consulting Patent Rights or Joint Consulting Patent
      Rights in accordance with <u>Article 6</u>.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">2.7 No Other Grant of Rights</font>. Except as expressly provided herein, nothing in this Agreement will be construed to confer any ownership
      interest, license or other rights upon Licensee by implication, estoppel or otherwise as to any technology, intellectual property rights, products or biological materials of Harvard, or any other entity, regardless of whether such technology,
      intellectual property rights, products or biological materials are dominant, subordinate or otherwise related to any Licensed Patent Rights or Licensed Know-How.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">2.8 Know-How Transfer</font>. Without limiting the Parties&#8217; obligations under the Collaboration Agreement, as soon as reasonably practicable after
      the Effective Date and in any event by no later than [**] after the Effective Date, Harvard will, at no additional cost or expense to Licensee, (a) transfer and deliver to Licensee tangible copies of all documents and materials contained within
      subpart (a) of the definition of Licensed Know-How and (b) upon reasonable request and during normal business hours, provide technical assistance and have regular knowledge transfer discussions reasonably sufficent to transfer the Licensed Know-How
      to Licensee time.</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;" id="DSPFPageNumber">8</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">
      <div><br>
      </div>
      <div>
        <div>
          <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 36.35pt; vertical-align: top; align: right;">
                  <div style="margin-left: 6.05pt; line-height: 1.25; font-weight: bold;">3.</div>
                </td>
                <td style="width: auto; vertical-align: top;">
                  <div style="text-align: justify; line-height: 1.25;"><font style="font-weight: bold;">Development and Commercialization</font>.</div>
                </td>
              </tr>

          </table>
        </div>
        <div style="line-height: 1.25">&#160;</div>
      </div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">3.1 Diligence</font>. Licensee shall use commercially reasonable efforts and shall cause its Sublicensees to use commercially reasonable efforts:
      (a) to develop Licensed Products in accordance with the Development Plan; (b) to introduce Licensed Products into the commercial market; and (c) to market Licensed Products following such introduction into the market. In addition, Licensee, by itself
      or through its Affiliates or Sublicensees, shall achieve each of the Development Milestones by the deadlines specified in <u>Exhibit 1.11</u>.</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"> <br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">3.2 </font><font style="font-weight: bold;">Adjustments of Development Plan</font>. Licensee will be entitled, from time to time, to make such
      adjustments to the then applicable Development Plan as Licensee believes, in its good faith judgment, are needed in order to improve Licensee&#8217;s ability to meet the Development Milestones.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">3.3 Reporting</font>. Within [**] after the end of each calendar year, Licensee shall furnish Harvard with a written report summarizing its, its
      Affiliates&#8217; and its Sublicensees&#8217; efforts during the prior year to develop and commercialize Licensed Products, including: (a) research and development activities; (b) commercialization efforts; and (c) marketing efforts. Each report must contain a
      sufficient level of detail for Harvard to assess whether Licensee is in compliance with its obligations under <u>Section 3.1</u> and a discussion of intended efforts for the then current year. Together with each report, Licensee shall provide
      Harvard with a copy of the then current Development Plan.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">3.4 Failure to Meet Development Milestone; Opportunity to Cure</font>.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;"><font style="font-weight: bold;">3.4.1 </font>If Licensee believes that it will not achieve a Development Milestone, it may notify Harvard in writing in advance of the relevant
      deadline. Licensee shall include with such notice (a) a reasonable explanation of the reasons for such failure (&#8220;<font style="font-weight: bold;">Explanation</font>&#8221;) and (b) a reasonable, detailed, written plan for promptly achieving a reasonable
      extended deadline and/or amended milestone (&#8220;<font style="font-weight: bold;">Plan</font>&#8221;).</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;"><font style="font-weight: bold;">3.4.2 </font>If Licensee so notifies Harvard, but fails to provide Harvard with both an Explanation and Plan, then Licensee will have an
      additional [**] from such notice or until the original deadline of the relevant Development Milestone, whichever is later (the &#8220;<font style="font-weight: bold;">Initial Deadline</font>&#8221;), to meet such milestone. Licensee&#8217;s failure to provide Harvard
      with both an Explanation and Plan by the Initial Deadline shall constitute a material breach of this Agreement and Harvard shall have the right to terminate this Agreement forthwith.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;"><font style="font-weight: bold;">3.4.3 </font>If Licensee so notifies Harvard and provides Harvard with an Explanation and Plan by the Initial Deadline, both of which are
      acceptable to Harvard in its reasonable discretion, then if Harvard agrees in writing or fails to provide written notice of its objection Licensee within [**] of the Initial Deadline, then <u>Exhibit 1.11</u> will be amended automatically to
      incorporate the extended deadline and/or amended milestone set forth in the Plan.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;"><font style="font-weight: bold;">3.4.4 </font>If Licensee so notifies Harvard and provides Harvard with an Explanation and Plan, but the Explanation is not acceptable to Harvard
      in its reasonable discretion (e.g., Licensee asserts development preference for a non-Licensed Product) then Harvard will provide written notice of its objection to Licensee explaining why the Explanation is not acceptable within [**] of the Initial
      Deadline, and Licensee will have an additional [**] from receipt of Harvard&#8217;s written notice or until the original deadline of the relevant Development Milestone, whichever is later (the &#8220;<font style="font-weight: bold;">Second Deadline</font>&#8221;), to
      meet such milestone or to persuade Harvard that the Explanation is reasonable. Licensee&#8217;s failure to meet such milestone or to persuade Harvard that the Explanation is reasonable by the Second Deadline shall constitute a material breach of this
      Agreement and Harvard shall have the right to terminate this Agreement forthwith.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;"><font style="font-weight: bold;">3.4.5 </font>If Licensee so notifies Harvard and provides Harvard with an Explanation and Plan, but the Plan is not acceptable to Harvard in its
      reasonable discretion, then Harvard will provide written notice of its objection to Licensee explaining why the Plan is not acceptable and providing Licensee with suggestions for an acceptable Plan within [**] of the Initial Deadline. Licensee will
      then have one opportunity to provide Harvard with a reasonably acceptable Plan (or to persuade Harvard that its Plan is reasonable) within [**] after receipt of Harvard&#8217;s written notice and suggestions, during which time Harvard agrees to work in
      good faith with Licensee in its effort to develop a reasonably acceptable Plan. If, within such [**], Licensee provides Harvard with a reasonably acceptable Plan, then <u>Exhibit 1.11</u> will be amended automatically to incorporate the extended
      deadline and/or amended milestone set forth in the Plan. If, within such [**], Licensee fails to provide a reasonably acceptable Plan, then Licensee will have an additional [**] or until the original deadline of the relevant Development Milestone,
      whichever is later (the &#8220;<font style="font-weight: bold;">Third Deadline</font>&#8221;), to meet such milestone. Licensee&#8217;s failure to provide such acceptable Plan or meet such milestone by the Third Deadline shall constitute a material breach of this
      Agreement and Harvard shall have the right to terminate this Agreement forthwith.</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;" id="DSPFPageNumber">9</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;"><font style="font-weight: bold;">3.4.6 </font>For clarity, if Licensee fails to achieve a Development Milestone and did not avail itself of the procedure set forth in this <u>Section

        3.4</u>, such failure shall constitute a material breach of this Agreement and Harvard shall have the right to terminate this Agreement forthwith.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">3.5 Regulatory Filings</font>. Licensee shall have the exclusive right to prepare and present all regulatory filings necessary or appropriate in
      any country and to obtain and maintain any regulatory approval (including Marketing Clearances) required to market Licensed Products in any such country. Licensee shall solely own all right, title and interest in and to all such regulatory approvals
      and filings. In the event of any undisputed termination of this Agreement (other than termination by Licensee pursuant to <u>Section 10.2.2.1</u> for the uncured material breach of Harvard), upon receipt of a written request from Harvard, (a)
      Licensee shall promptly provide Harvard with the right to reference, cross-reference, review, have access to, incorporate and use all documents and other materials (other than Clinical Data) filed by or on behalf of Licensee and its Affiliates with
      any Regulatory Authority in furtherance of applications for regulatory approval in the relevant country with respect to Licensed Products (<font style="font-weight: bold;">&#8220;Regulatory Documents</font>&#8221;); (b) Harvard shall be entitled to freely use
      solely for research, educational and scholarly purposes any Regulatory Documents delivered by Licensee to Harvard pursuant to this <u>Section 3.5</u>; and (c) Harvard may grant third Persons the royalty-bearing right to use any Regulatory Documents
      (as well as, to the extent permitted by applicable law, any Clinical Data that has been depersonalized to the reasonable satisfaction of Licensee), provided that the Parties mutually agree on a reasonable allocation between Harvard and Licensee of
      all royalties paid by such third Persons as a result of the use of such Regulatory Documents.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div>
          <div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 36.35pt; vertical-align: top; align: right;">
                    <div style="margin-left: 6.05pt; line-height: 1.25; font-weight: bold;">4.</div>
                  </td>
                  <td style="width: auto; vertical-align: top;">
                    <div style="text-align: justify; line-height: 1.25;">
                      <div style="line-height: 1.25;"><font style="font-weight: bold;">Consideration for Grant of License</font>.</div>
                    </div>
                  </td>
                </tr>

            </table>
          </div>
          <div style="line-height: 1.25">&#160;</div>
        </div>
      </div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">4.1 License Fee</font>. In partial consideration for the rights and licenses to the Licensed Patent Rights granted hereunder, within [**] after
      execution of the Agreement, Licensee shall pay Harvard a [**] U.S. Dollars (US $[**]) license fee.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">4.2 Milestone Payments</font>. In partial consideration for the rights and licenses granted hereunder, Licensee shall pay Harvard the following
      milestone payments upon the first Licensed Product of Licensee to reach each of the following Development Milestones, regardless of whether such Development Milestone is achieved by Licensee, an Affiliate of Licensee or a Sublicensee:</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;"><font style="font-weight: bold;">4.2.1 </font>[**] U.S. Dollars (US $[**]) upon [**];</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;"><font style="font-weight: bold;">4.2.2 </font>[**] U.S. Dollars (US $[**]) upon [**];</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;"><font style="font-weight: bold;">4.2.3 </font>[**] U.S. Dollars (US $[**]) upon [**].</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;"><font style="font-weight: bold;">4.2.4 </font>Licensee shall notify Harvard in writing within [**] following the achievement of each milestone described above, and shall make the
      appropriate milestone payment within [**] after the achievement of such milestone.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">4.3 Royalty on Net Sales</font>. In partial consideration for the rights and licenses granted hereunder, Licensee shall pay Harvard royalties on
      Net Sales as follows:</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;"><font style="font-weight: bold;">4.3.1 </font>an amount equal to [**] percent ([**]%) of Net Sales until achieving cumulative aggregate Net Sales of [**] U.S. Dollars (US $[**]);</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;"><font style="font-weight: bold;">4.3.2 </font>an amount equal to [**] percent ([**]%) of Net Sales while the cumulative aggregate of Net Sales is greater than [**] U.S. Dollars
      (US $[**]) but less than [**] U.S. Dollars (US $[**]); and</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;"><font style="font-weight: bold;">4.3.3 </font>an amount equal to [**] percent ([**]%) of Net Sales after achieving cumulative aggregate Net Sales of [**] U.S. Dollars (US $[**])
      until the expiration or termination of the Term.</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;" id="DSPFPageNumber">10</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">4.4 Commercial Milestone</font>.<font style="font-weight: bold;">&#160;</font>In partial consideration for the rights and licenses granted hereunder,
      Licensee shall pay Harvard a commercial milestone payment in the amount of [**] U.S. Dollars (US $[**]) when cumulative, gross, worldwide sales exceed [**] U.S. Dollars (US $[**]).</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">4.5 Non-Royalty Sublicense Income</font>. In partial consideration for the rights and licenses granted hereunder, Licensee will pay Harvard an
      amount equal to [**] percent ([**]%) of all Non-Royalty Sublicense Income.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">4.6 Patent Challenge</font>. If Licensee, its Affiliate or a Sublicensee (&#8220;<font style="font-weight: bold;">Challenging Party</font>&#8221;) commences an
      action in which it challenges the validity, enforceability or scope of any of the Licensed Patent Rights (a &#8220;<font style="font-weight: bold;">Challenge Proceeding</font>&#8221;), the royalty rates specified in <u>Section 4.3</u> will be doubled with
      respect to Net Sales of Licensed Products that are sold during the pendency of such Challenge Proceeding. If the outcome of such Challenge Proceeding is a determination against the Challenging Party, (a) the royalty rate specified in <u>Section 4.3</u>
      with respect to Net Sales of Licensed Products that are covered by the Licensed Patent Rights that are the subject of such Challenge Proceeding shall remain at such doubled rate and (b) Licensee shall reimburse Harvard for all expenses incurred by
      Harvard (including reasonable attorneys&#8217; fees) in connection with such Challenge Proceeding. If the outcome of such Challenge Proceeding is a determination in favor of the Challenging Party, Harvard shall reimburse Licensee [**] of all royalties paid
      by Licensee to Harvard during the pendency of such Challenge Proceeding and the royalty rate specified in <u>Section 4.3</u> with respect to Net Sales of Licensed Products that are covered by the Licensed Patent Rights that are the subject of such
      Challenge Proceeding shall revert to the original (i.e., not doubled) rate.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;">
          <div>
            <div>
              <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                  <tr>
                    <td style="width: 36.35pt; vertical-align: top; align: right;">
                      <div style="margin-left: 6.05pt; line-height: 1.25; font-weight: bold;">5.</div>
                    </td>
                    <td style="width: auto; vertical-align: top;">
                      <div style="text-align: justify; line-height: 1.25;">
                        <div style="line-height: 1.25;">
                          <div style="line-height: 1.25;"><font style="font-weight: bold;">Reports; Payments; Records</font>.</div>
                        </div>
                      </div>
                    </td>
                  </tr>

              </table>
            </div>
            <div style="line-height: 1.25">&#160;</div>
          </div>
        </div>
      </div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">5.1 Reports and Payments</font>.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;"><font style="font-weight: bold;">5.1.1 Reports</font>. Within [**] after the conclusion of each Calendar Quarter commencing with the first Calendar Quarter in which Net Sales are
      generated or Non-Royalty Sublicense Income is received, Licensee shall deliver to Harvard a report containing the following information (in each instance, with a Licensed Product-by-Licensed Product and country-by-country breakdown):</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 108pt; line-height: 1.25;"><font style="font-weight: bold;">5.1.1.1 </font>the number of units of Licensed Products sold, leased or otherwise transferred by Invoicing Entities for the applicable Calendar
      Quarter;</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 108pt; line-height: 1.25;"><font style="font-weight: bold;">5.1.1.2 </font>the gross amount billed or invoiced for Licensed Products sold, leased or otherwise transferred by Invoicing Entities during the
      applicable Calendar Quarter;</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 108pt; line-height: 1.25;"><font style="font-weight: bold;">5.1.1.3 </font>a calculation of Net Sales for the applicable Calendar Quarter, including an itemized listing of allowable deductions;</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 108pt; line-height: 1.25;"><font style="font-weight: bold;">5.1.1.4 </font>a detailed accounting of all Non-Royalty Sublicense Income received during the applicable Calendar Quarter;</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 108pt; line-height: 1.25;"><font style="font-weight: bold;">5.1.1.5 </font>the total amount payable to Harvard in U.S. Dollars on Net Sales and Non-Royalty Sublicense Income for the applicable Calendar
      Quarter, together with the exchange rates used for conversion;</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 108pt; line-height: 1.25;"><font style="font-weight: bold;">5.1.1.6 </font>a list of Harvard Case numbers for all Licensed Patent Rights that have Valid Claims covering the Licensed Products; and</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 108pt; line-height: 1.25;"><font style="font-weight: bold;">5.1.1.7 </font>A list of Licensed Products which incorporate or comprise the Licensed Know-How.</div>
    <div style="text-align: justify; text-indent: 108pt; line-height: 1.25;"> <br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Each such quarterly report shall be certified on behalf of Licensee by its chief financial officer as true, correct and complete in all material respects. If no amounts are due to
      Harvard for a particular Calendar Quarter, the report shall so state. In addition to the above-described quarterly reports, within sixty (60) days after the end of each calendar year, Licensee shall provide Harvard with an annual report containing
      the above-described information for such calendar year. Each such annual report shall be prepared on behalf of Licensee by an independent, certified public accountant and certified by such accountant as true, correct and complete in all material
      respects.</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;" id="DSPFPageNumber">11</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;"><font style="font-weight: bold;">5.1.2 Payment</font>. Within [**] after the end of each Calendar Quarter, Licensee shall pay Harvard all amounts due with respect to Net Sales and
      Non-Royalty Sublicense Income for the applicable Calendar Quarter.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">5.2 Payment Currency</font>. All payments due under this Agreement will be paid in U.S. Dollars. Conversion of foreign currency to U.S. Dollars
      will be made at the conversion rate existing in the United States (as reported in the <font style="font-style: italic;">Wall Street Journal</font>) on the last working day of the applicable Calendar Quarter. Such payments due will be paid without
      deduction of exchange, collection or other charges.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">5.3 Records</font>.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;"><font style="font-weight: bold;">5.3.1 Licensee Records</font>. Licensee shall maintain, and shall cause its Affiliates and Sublicensees to maintain, complete and accurate records
      of Licensed Products that are made, used, sold, leased or transferred under this Agreement, any amounts payable to Harvard in relation to such Licensed Products, and all Non-Royalty Sublicense Income received by Licensee and its Affiliates, which
      records shall contain sufficient information to permit Harvard to confirm the accuracy of any reports or notifications delivered to Harvard under <u>Section 5.1</u>. Licensee, its Affiliates and/or its Sublicensees, as applicable, shall retain such
      records relating to a given Calendar Quarter for at least [**] after the conclusion of that Calendar Quarter, during which time Harvard will have the right, at its expense, to cause an independent, certified public accountant reasonably acceptable to
      Licensee to inspect such records during normal business hours for the purposes of verifying the accuracy of any reports and payments delivered under this Agreement and Licensee&#8217;s compliance with the terms hereof. Such accountant shall not disclose to
      Harvard any information other than information necessary to confirm the accuracy of reports and payments delivered under this Agreement. The Parties shall reconcile any underpayment or overpayment within [**] after the accountant delivers the results
      of the audit. If any audit performed under this <u>Section 5.3</u> reveals an underpayment in excess of [**] percent ([**]%) in any calendar year, Licensee shall reimburse Harvard for all amounts incurred in connection with such audit. Harvard may
      exercise its rights under this <u>Section 5.3</u> [**] every year per audited entity and only with at least [**] prior written notice to the audited entity.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;"><font style="font-weight: bold;">5.3.2 Harvard Records</font>. Harvard shall maintain complete and accurate records of its costs and expenses incurred under this Agreement, which
      records shall contain sufficient information to permit Licensee to confirm the accuracy of any reimbursable expenses paid by Licensee hereunder.<u>&#160;</u>Harvard shall retain such records relating to a given Calendar Quarter for at least [**] after the
      conclusion of that Calendar Quarter, during which time Licensee will have the right, at its expense, to cause an independent, certified public accountant reasonably acceptable to Harvard to inspect such records during normal business hours for the
      purposes of verifying the accuracy of any invoices delivered under this Agreement and Harvard&#8217;s compliance with the terms hereof. Such accountant shall not disclose to Licensee any information other than information necessary to confirm the accuracy
      of such invoices and the reimbursable costs and expenses claimed by Harvard under this Agreement. The Parties shall reconcile any underpayment or overpayment within [**] after the accountant delivers the results of the audit. If any audit performed
      under this <u>Section 5.3.2</u> reveals an overpayment by Licensee in excess of [**] percent ([**]%) in any calendar year, Harvard shall reimburse Licensee for all amounts incurred in connection with such audit. Licensee may exercise its rights
      under this <u>Section 5.3.2</u> [**] every year and only with at least [**] prior written notice to Harvard.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">5.4 Late Payments</font>. Any payments by Licensee that are not paid on or before the date such payments are due under this Agreement will bear
      interest at the lower of (a) [**] percent ([**]%) per month and (b) the maximum rate allowed by law. Interest will accrue beginning on the first day following the due date for payment and will be compounded quarterly.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">5.5 Payment Method</font>. Each payment due to Harvard under this Agreement shall be paid by check or wire transfer of funds to Harvard&#8217;s account
      in accordance with written instructions provided by Harvard. If made by wire transfer, such payments shall be marked so as to refer to this Agreement.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">5.6 Withholding and Similar Taxes</font>. Licensee shall be responsible for all non-U.S. taxes related to payments due to Harvard hereunder. All
      such payments due to Harvard will be paid without deduction of such taxes.</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;" id="DSPFPageNumber">12</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;">
          <div style="line-height: 1.25;">
            <div>
              <div>
                <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36.35pt; vertical-align: top; align: right;">
                        <div style="margin-left: 6.05pt; line-height: 1.25; font-weight: bold;">6.</div>
                      </td>
                      <td style="width: auto; vertical-align: top;">
                        <div style="text-align: justify; line-height: 1.25;">
                          <div style="line-height: 1.25;">
                            <div style="line-height: 1.25;">
                              <div style="line-height: 1.25;"><font style="font-weight: bold;">Patent Filing, Prosecution and Maintenance</font>.</div>
                            </div>
                          </div>
                        </div>
                      </td>
                    </tr>

                </table>
              </div>
              <div style="line-height: 1.25">&#160;</div>
            </div>
          </div>
        </div>
      </div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">6.1 Control</font>.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;"><font style="font-weight: bold;">(a) Control by Harvard</font>. Harvard will be responsible for the preparation, filing, prosecution, protection, defense and maintenance of all
      Licensed Patent Rights, using independent patent counsel reasonably acceptable to Licensee. Harvard will: (i) instruct such patent counsel to furnish the Licensee with copies of all correspondence relating to the Licensed Patent Rights from the
      United States Patent and Trademark Office (USPTO) and any other patent office, as well as copies of all proposed responses to such correspondence in time for Licensee to review and comment on such response; (ii) give Licensee an opportunity to review
      the text of each patent application before filing; (iii) consult with Licensee with respect thereto; (iv) supply Licensee with a copy of the application as filed, together with notice of its filing date and serial number; and (v) keep Licensee
      advised of the status of actual and prospective patent filings. Harvard shall give Licensee the opportunity to provide comments on and make requests of Harvard concerning the preparation, filing, prosecution, protection, defense and maintenance of
      the Licensed Patent Rights, and shall seriously consider such comments and requests; however, final decision-making authority shall vest in Harvard (except where Licensee is responsible pursuant to <u>Section 6.1(b)</u>). Notwithstanding the
      foregoing, if Licensee requests that Harvard prepare, file and/or prosecute (or continue to prepare, file and/or prosecute) an application for any Licensed Patent Rights, then Harvard shall prepare, file and prosecute such application (or continue to
      prepare, file and/or prosecute) such application subject to Company&#8217;s reimbursement to Harvard for all documented, out-of-pocket expenses incurred by Harvard in connection therewith in accordance with <u>Article 6</u> (but <u>Section 11.17</u>),
      provided, however, that Harvard expressly reserves the right to decline Licensee&#8217;s request to file, prosecute, maintain or defend any of the Licensed Patent Rights in any Developing Country(ies) unless (A) Licensee demonstrates to Harvard&#8217;s
      reasonable satisfaction that the filing, prosecution, maintenance or defense of such Licensed Patent Rights in such Developing Country(ies) would materially increase the locally-affordable availability of Licensed Products or equivalents thereof (<font style="font-style: italic;">e.g.,</font> generic products) in those and/or other Developing Country(ies) and (B) the provisions of <u>Section 7</u> notwithstanding, Licensee agrees that Harvard shall hold final decision-making authority, on a
      case-by-case basis, as to whether Licensee will be permitted to enforce such Licensed Patent Rights in such Developing Country(ies).</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;"><font style="font-weight: bold;">(b) </font>So long as Licensee is performing its obligation to reimburse Harvard for all documented, out-of-pocket expenses incurred by Harvard in
      connection with such Licensed Patent Rights in accordance with <u>Article 6</u> (but subject to <u>Section 11.17</u>), Harvard will not abandon, withdraw, surrender or otherwise seek to no longer be responsible for the preparation, filing,
      prosecution, protection, defense and maintenance of any Licensed Patent Rights.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">6.2 Expenses</font>. Subject to <u>Sections 6.3</u> and <u>11.20</u>, below, Licensee shall reimburse Harvard for all documented, out-of-pocket
      expenses incurred by Harvard pursuant to this <u>Article 6</u> within [**] after the date of each valid and accurate invoice from Harvard for such expenses. In addition, within [**] after the Effective Date and subject to <u>Section 11.17</u>,
      Licensee shall reimburse Harvard for all documented, out-of-pocket expenses incurred by Harvard prior to the Effective Date with respect to the preparation, filing, prosecution, protection, and maintenance of the Harvard Background Patents, the
      billed amount of which is, as of the Effective Date, equal to [**] United States Dollars (US $[**]). License shall pay such amount as follows: (a) [**] United States Dollars (US $[**]) to be paid within [**] of the Effective Date and (b) the
      remaining balance to be paid on or before [**].</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">6.3 </font><font style="font-weight: bold;">Abandonment</font>. If Licensee decides that it does not wish to pay for the preparation, filing,
      prosecution, protection, maintenance or defense of any Licensed Patent Rights (other than Joint Patent Rights) in a particular country (&#8220;<font style="font-weight: bold;">Abandoned Patent Rights</font>&#8221;), Licensee shall provide Harvard with prompt
      written notice of such election. Upon receipt of such notice by Harvard, Licensee shall be released from its obligation to reimburse Harvard for the expenses incurred thereafter as to such Abandoned Patent Rights; provided, however, that expenses
      authorized prior to the receipt by Harvard of such notice shall be deemed incurred prior to the notice. In the event of Licensee&#8217;s abandonment of any Licensed Patent Rights, any license granted by Harvard to Licensee hereunder with respect to such
      Abandoned Patent Rights will terminate, and Licensee will have no rights whatsoever to exploit such Abandoned Patent Rights. Harvard will then be free, without further notice or obligation to Licensee, to grant rights in and to such Abandoned Patent
      Rights to third parties.</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;" id="DSPFPageNumber">13</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">6.4 Small Entity Designation</font>. If Licensee, its Affiliates, any Sublicensee and/or any holder of an option to obtain a Sublicense does not
      qualify, or at any point during the Term ceases to qualify, as an entity entitled to pay lesser fees as provided by the USPTO (i.e., a &#8220;small entity&#8221;) or the patent office of any other country, Licensee shall so notify Harvard immediately, in order
      to enable Harvard to comply with regulations regarding payment of fees with respect to Licensed Patent Rights.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">6.5 Marking</font>. Licensee shall, and shall cause its Affiliates and Sublicensees to, mark all Licensed Products sold or otherwise disposed of in
      such a manner as to conform with the patent laws and practice of the country to which such products are shipped or in which such products are sold for purposes of ensuring maximum enforceability of Licensed Patent Rights in such country.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;">
          <div style="line-height: 1.25;">
            <div style="line-height: 1.25;">
              <div>
                <div>
                  <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                      <tr>
                        <td style="width: 36.35pt; vertical-align: top; align: right;">
                          <div style="margin-left: 6.05pt; line-height: 1.25; font-weight: bold;">7.</div>
                        </td>
                        <td style="width: auto; vertical-align: top;">
                          <div style="text-align: justify; line-height: 1.25;">
                            <div style="line-height: 1.25;">
                              <div style="line-height: 1.25;">
                                <div style="line-height: 1.25;">
                                  <div style="line-height: 1.25;"><font style="font-weight: bold;">Enforcement of Patent Rights</font>.</div>
                                </div>
                              </div>
                            </div>
                          </div>
                        </td>
                      </tr>

                  </table>
                </div>
                <div style="line-height: 1.25">&#160;</div>
              </div>
            </div>
          </div>
        </div>
      </div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">7.1 Notice</font>. In the event either party becomes aware of any possible or actual infringement of any Licensed Patent Rights with respect to
      Licensed Products in the Field (an &#8220;<font style="font-weight: bold;">Infringement</font>&#8221;), that Party shall promptly notify the other Party and provide it with details regarding such Infringement.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">7.2 Suit by Licensee.</font> Licensee shall have the first right, but not the obligation, to take action in the prosecution, prevention, or
      termination of any Infringement. Before Licensee commences an action with respect to any Infringement, Licensee shall consider in good faith the views of Harvard and potential effects on the public interest in making its decision whether to sue,
      especially with regard to the locally-affordable availability of Licensed Products or equivalents thereof, <font style="font-style: italic;">e.g., </font>generic products, in Developing Countries, provided, however, that Licensee shall not be in
      breach of this Agreement if Licensee makes a commercially reasonable decision to take or not take action. Should Licensee elect to bring suit against an infringer, Licensee shall keep Harvard reasonably informed of the progress of the action and
      shall give Harvard a reasonable opportunity in advance to consult with Licensee and offer its views about major decisions affecting the litigation. Licensee shall give careful consideration to those views, but shall have the right to control the
      action; provided, however, that if Licensee fails to defend in good faith the validity and/or enforceability of the Licensed Patent Rights in the action or, or if Licensee&#8217;s license to a Valid Claim in the suit terminates, Harvard may elect to take
      control of the action pursuant to <u>Section 7.3</u>. Any and all expenses, including reasonable attorneys&#8217; fees, incurred by Harvard with respect to the prosecution, adjudication and/or settlement of such suit, including any related appeals, shall
      be paid for entirely by Licensee and Licensee shall hold Harvard free, clear and harmless from and against any and all such expenses. The expenses of such suit or suits that Licensee elects to bring, including any expenses of Harvard incurred in
      conjunction with the prosecution of such suits or the settlement thereof, shall be paid for entirely by Licensee and Licensee shall hold Harvard free, clear and harmless from and against any and all costs of such litigation, including reasonable
      attorneys&#8217; fees. Licensee shall not compromise or settle such litigation without the prior written consent of Harvard, which consent shall not be unreasonably withheld or delayed. In the event Licensee exercises its right to sue pursuant to this <u>Section

        7.2</u>, it shall first reimburse itself out of any sums recovered in such suit or in settlement thereof for all costs and expenses of every kind and character, including reasonable attorneys&#8217; fees, necessarily incurred in the prosecution of any
      such suit. If, after such reimbursement, any funds shall remain from said recovery, then Harvard shall receive an amount equal to [**] percent ([**]%) of such funds and the remaining [**] percent ([**]%) of such funds shall be retained by Licensee.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">7.3 Suit by Harvard</font>. If Licensee does not take action in the prosecution, prevention, or termination of any Infringement pursuant to <u>Section

        7.2</u> above, and has not commenced negotiations with the infringer for the discontinuance of said Infringement, within [**] after receipt of notice to Licensee by Harvard of the existence of an Infringement, Harvard may elect to do so. Should
      Harvard elect to bring suit against an infringer and Licensee is joined as party plaintiff in any such suit, Licensee shall have the right to approve the counsel selected by Harvard to represent Harvard and Licensee, such approval not to be
      unreasonably withheld. Any and all expenses, including reasonable attorneys&#8217; fees, incurred by Licensee with respect to the prosecution, adjudication and/or settlement of such suit, including any related appeals, shall be paid for entirely by Harvard
      and Harvard shall hold Licensee free, clear and harmless from and against any and all such expenses. Harvard shall not compromise or settle such litigation without the prior written consent of Licensee, which consent shall not be unreasonably
      withheld or delayed. In the event Harvard exercises its right to sue pursuant to this <u>Section 7.3</u>, it shall first reimburse itself out of any sums recovered in such suit or in settlement thereof for all costs and expenses of every kind and
      character, including reasonable attorneys&#8217; fees, necessarily incurred in the prosecution of any such suit. If, after such reimbursement, any funds shall remain from said recovery, then Licensee shall receive an amount equal to [**] percent ([**]%) of
      such funds and the remaining [**] percent ([**]%) of such funds shall be retained by Harvard.</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;" id="DSPFPageNumber">14</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">7.4 Own Counsel</font>. Each Party shall always have the right to be represented by counsel of its own selection and at its own expense in any suit
      instituted under this <u>Article 7</u> by the other Party for Infringement.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">7.5 Cooperation</font>. Each Party agrees to cooperate fully in any action under this <u>Article 7</u> that is controlled by the other Party,
      including joining as a party to the action, provided that the controlling Party reimburses the cooperating Party promptly for any costs and expenses incurred by the cooperating Party in connection with providing such assistance.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">7.6 Declaratory Judgment</font>. If a declaratory judgment action is brought naming Licensee and/or any of its Affiliates or Sublicensees as a
      defendant and alleging invalidity or unenforceability of any claims within the Licensed Patent Rights, Licensee shall promptly notify Harvard in writing and Harvard may elect, upon written notice to Licensee within [**] after Harvard receives notice
      of the commencement of such action, to take over the sole defense of the invalidity and/or unenforceability aspect of the action at its own expense.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;">
          <div style="line-height: 1.25;">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;">
                <div>
                  <div>
                    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                        <tr>
                          <td style="width: 36.35pt; vertical-align: top; align: right;">
                            <div style="margin-left: 6.05pt; line-height: 1.25; font-weight: bold;">8.</div>
                          </td>
                          <td style="width: auto; vertical-align: top;">
                            <div style="text-align: justify; line-height: 1.25;">
                              <div style="line-height: 1.25;">
                                <div style="line-height: 1.25;">
                                  <div style="line-height: 1.25;">
                                    <div style="line-height: 1.25;">
                                      <div style="line-height: 1.25;"><font style="font-weight: bold;">Warranties; Limitation of Liability</font>.</div>
                                    </div>
                                  </div>
                                </div>
                              </div>
                            </div>
                          </td>
                        </tr>

                    </table>
                  </div>
                  <div style="line-height: 1.25">&#160;</div>
                </div>
              </div>
            </div>
          </div>
        </div>
      </div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">8.1 Representations and Warranties</font>.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;"><font style="font-weight: bold;">8.1.1 Reciprocal Representations and Warranties</font>. Each Party represents and warrants to the other Party as follows:</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;"><font style="font-weight: bold;">(a) Duly Organized</font>. Such Party is a corporation duly organized, validly existing and in good standing under the laws of the jurisdiction of
      its incorporation, is qualified to do business and is in good standing as a foreign corporation in each jurisdiction in which the conduct of its business or the ownership of its properties requires such qualification and failure to have such would
      prevent such Party from performing its obligations under this Agreement.</div>
    <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;"> <br>
    </div>
    <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;"><font style="font-weight: bold;">(b) Due Authorization; Binding Agreement</font>. The execution, delivery and performance of this Agreement by such Party have been duly authorized
      by all necessary corporate action. This Agreement is a legal and valid obligation binding on such Party and enforceable in accordance with its terms and does not: (i) to such Party&#8217;s knowledge and belief, violate any law, rule, regulation, order,
      writ, judgment, decree, determination or award of any court, governmental body or administrative or other agency having jurisdiction over such Party; nor (ii) conflict with, or constitute a default under, any agreement, instrument or understanding,
      oral or written, to which such Party is a party or by which it is bound.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;"><font style="font-weight: bold;">8.1.2 Representations by Licensee.</font> Licensee represents and warrants that it will comply in all material respects, and will ensure that its
      Affiliates and Sublicensees comply in all material respects, with all local, state, federal and international laws and regulations relating to the development, manufacture, use, sale and importation of Licensed Products. Without limiting the
      foregoing, Licensee represents and warrants, on behalf of itself and its Affiliates and Sublicensees, that it shall comply with all United States laws and regulations controlling the export of certain commodities and technical data, including without
      limitation all Export Administration Regulations of the United States Department of Commerce. Among other things, these laws and regulations prohibit or require a license for the export of certain types of commodities and technical data to specified
      countries. Licensee hereby gives written assurance that it will comply with, and will cause its Affiliates to comply with (and will contractually obligate its Sublicensees to comply with), all United States export control laws and regulations, that
      it bears sole responsibility for any violation of such laws and regulations by itself or its Affiliates or Sublicensees, and that it will indemnify, defend, and hold Harvard harmless (in accordance with <u>Section 9.1</u>) for the consequences of
      any such violation.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;"><font style="font-weight: bold;">8.1.3 Representations by Harvard</font>. OTD, on behalf of Harvard, represents, warrants and covenants to Licensee as follows:</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;"><font style="font-weight: bold;">(a) Third Party Rights</font>. As of the Effective Date, to the knowledge of OTD, Harvard has not received any funding, participation or other
      rights from any third Person or other Governmental Authority that conflicts or is inconsistent with the rights, licenses and options granted to Licensee hereunder. As of the Effective Date, Harvard has the right to grant the licenses and rights as
      contemplated under this Agreement and has not granted any right to any third Person which would conflict or be inconsistent with the licenses and rights granted to Licensee hereunder. Harvard will not during the Term grant any right to any third
      Person which would conflict or be inconsistent with the licenses and rights granted to Licensee hereunder.</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;" id="DSPFPageNumber">15</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;"><font style="font-weight: bold;">(b) Patents</font>. Harvard is the sole and exclusive owner of all right, title and interest in and to the Harvard Background Patents, including
      all of the patents and patent applications identified as &#8220;Harvard Background Patents&#8221; in <u>Exhibit 1.25</u>. All official fees, maintenance fees and annuities for the Licensed Patent Rights have been paid through the Effective Date.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;"><font style="font-weight: bold;">(c) Non-Infringement of Third Party Rights</font>. OTD has not received any written notice from any Person of any actual or threatened claim that
      the use or practice of the Licensed Patent Rights or Licensed Know-How infringes or otherwise violates the intellectual property rights of a third Person.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;"><font style="font-weight: bold;">(d) Patent and Technology Status</font>. As of the Effective Date, none of the Licensed Patent Rights is currently involved in any interference,
      reissue, reexamination, or opposition proceeding and OTD has not received any written notice from any Person of such actual or threatened proceeding.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;"><font style="font-weight: bold;">(e) Non-Infringement by Third Parties</font>. As of the Effective Date, to the knowledge of OTD, no third Persons are infringing the Licensed
      Patent Rights or Licensed Know-How.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">8.2 No Other Warranties</font>.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;"><font style="font-weight: bold;">8.2.1 </font>NOTHING CONTAINED HEREIN SHALL BE DEEMED TO BE A WARRANTY BY HARVARD THAT PATENTS WILL ISSUE ON PATENT APPLICATIONS INCLUDED IN THE
      LICENSED PATENT RIGHTS, OR THAT ANY OF THE LICENSED PATENT RIGHTS WILL AFFORD ADEQUATE OR COMMERCIALLY WORTHWHILE PROTECTION.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;"><font style="font-weight: bold;">8.2.2 </font>HARVARD MAKES NO WARRANTIES WHATSOEVER AS TO THE COMMERCIAL OR SCIENTIFIC VALUE OF THE LICENSED PATENT RIGHTS OR LICENSED KNOW-HOW.
      HARVARD MAKES NO REPRESENTATION THAT THE PRACTICE OF THE LICENSED PATENT RIGHTS OR THE DEVELOPMENT, MANUFACTURE, USE, SALE OR IMPORTATION OF ANY LICENSED PRODUCT, OR ANY ELEMENT THEREOF, WILL NOT INFRINGE ANY PATENT OR PROPRIETARY RIGHTS.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;"><font style="font-weight: bold;">8.2.3 </font>EXCEPT AS OTHERWISE EXPRESSLY PROVIDED IN THIS AGREEMENT, NEITHER PARTY MAKES ANY WARRANTY WITH RESPECT TO ANY TECHNOLOGY, PATENTS,
      GOODS, SERVICES, RIGHTS OR OTHER SUBJECT MATTER OF THIS AGREEMENT AND EACH PARTY HEREBY DISCLAIMS WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE AND NONINFRINGEMENT WITH RESPECT TO ANY AND ALL OF THE FOREGOING.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">8.3 Limitation of Liability</font>.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;"><font style="font-weight: bold;">8.3.1 </font>Except with respect to matters for which Licensee is obligated to indemnify Harvard under <u>Article 9</u>,<font style="font-weight: bold;">&#160;</font>neither Party will be liable to the other with respect to any subject matter of this Agreement under any contract, negligence, strict liability or other legal or equitable theory for (a) any indirect, incidental, consequential or
      punitive damages or lost profits or (b) cost of procurement of substitute goods, technology or services.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;"><font style="font-weight: bold;">8.3.2 </font>Except with respect to matters for which Licensee is obligated to indemnify Harvard under <u>Article 9</u>,<font style="font-weight: bold;">&#160;</font>each Party&#8217;s aggregate liability for all damages of any kind arising out of or relating to this Agreement or its subject matter under any contract, negligence, strict liability or other legal or equitable theory shall not exceed the
      amounts paid by Licensee to Harvard under this Agreement.</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;" id="DSPFPageNumber">16</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;">
          <div style="line-height: 1.25;">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">
                  <div>
                    <div>
                      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                          <tr>
                            <td style="width: 36.35pt; vertical-align: top; align: right;">
                              <div style="margin-left: 6.05pt; line-height: 1.25; font-weight: bold;">9.</div>
                            </td>
                            <td style="width: auto; vertical-align: top;">
                              <div style="text-align: justify; line-height: 1.25;">
                                <div style="line-height: 1.25;">
                                  <div style="line-height: 1.25;">
                                    <div style="line-height: 1.25;">
                                      <div style="line-height: 1.25;">
                                        <div style="line-height: 1.25;">
                                          <div style="line-height: 1.25;"><font style="font-weight: bold;">Indemnification and Insurance</font>.</div>
                                        </div>
                                      </div>
                                    </div>
                                  </div>
                                </div>
                              </div>
                            </td>
                          </tr>

                      </table>
                    </div>
                  </div>
                </div>
              </div>
            </div>
          </div>
        </div>
      </div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">9.1 Indemnity</font>.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;"><font style="font-weight: bold;">9.1.1 Indemnity</font>. Licensee shall indemnify, defend and hold harmless Harvard and its current and former directors, governing board members,
      trustees, officers, faculty, medical and professional staff, employees, students, and agents and their respective successors, heirs and assigns (collectively, the &#8220;<font style="font-weight: bold;">Indemnitees</font>&#8221;) from and against any third party
      claim, liability, cost, expense, damage, deficiency, loss or obligation of any kind or nature (including, without limitation, reasonable attorneys&#8217; fees and other costs and expenses of litigation) based upon, arising out of, or otherwise relating to
      the rights or licenses granted to Licensee under this Agreement or any Sublicense, including any cause of action relating to product liability concerning any product, process, or service made, used, sold or performed pursuant to any right or license
      granted under this Agreement (collectively, &#8220;<font style="font-weight: bold;">Claims</font>&#8221;). Neither Licensee nor Harvard shall settle any Claim without the prior written consent of the other, which consent shall not be unreasonably withheld.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;"><font style="font-weight: bold;">9.2 Insurance</font>.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;"><font style="font-weight: bold;">9.2.1 </font>Beginning at the time any Licensed Product is being commercially distributed or sold (other than for the purpose of obtaining
      regulatory approvals) by Licensee, or by an Affiliate, Sublicensee or agent of Licensee, Licensee shall, at its sole cost and expense, procure and maintain commercial general liability insurance in amounts not less than [**] U.S. Dollars (US $[**])
      per incident and [**] U.S. Dollars (US $[**]) annual aggregate and naming the Indemnitees as additional insureds. During clinical trials of any such Licensed Product, Licensee shall, at its sole cost and expense, procure and maintain commercial
      general liability insurance in such equal or lesser amount as Harvard shall require, naming the Indemnitees as additional insureds. Such commercial general liability insurance shall provide: (a) product liability coverage and (b) broad form
      contractual liability coverage for Licensee&#8217;s indemnification obligations under this Agreement.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;"><font style="font-weight: bold;">9.2.2 </font>If Licensee elects to self-insure all or part of the limits described above in <u>Section 9.2.1</u> (including deductibles or
      retentions that are in excess of [**] (US $[**]) annual aggregate) such self-insurance program must be acceptable to Harvard and CRICO/RMF (Harvard&#8217;s insurer) in their sole discretion. The minimum amounts of insurance coverage required shall not be
      construed to create a limit of Licensee&#8217;s liability with respect to its indemnification obligations under this Agreement.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;"><font style="font-weight: bold;">9.2.3 </font>Licensee shall provide Harvard with written evidence of such insurance upon request of Harvard. Licensee shall provide Harvard with
      written notice at least fifteen (15) days prior to the cancellation, non-renewal or material change in such insurance. If Licensee does not obtain replacement insurance providing comparable coverage within such fifteen (15) day period, Harvard shall
      have the right to terminate this Agreement effective at the end of such fifteen (15) day period without notice or any additional waiting periods.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;"><font style="font-weight: bold;">9.2.4 </font>Licensee shall maintain such commercial general liability insurance beyond the expiration or termination of this Agreement during:
      (a) the period that any Licensed Product is being commercially distributed or sold by Licensee, or an Affiliate, Sublicensee or agent of Licensee; and (b) a reasonable period after the period referred to in (a)<font style="font-weight: bold;">&#160;</font>above

      which in no event shall be less than fifteen (15) years.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;">
          <div style="line-height: 1.25;">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">
                  <div style="line-height: 1.25;">
                    <div>
                      <div>
                        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                            <tr>
                              <td style="width: 36.35pt; vertical-align: top; align: right;">
                                <div style="margin-left: 6.05pt; line-height: 1.25; font-weight: bold;">10.</div>
                              </td>
                              <td style="width: auto; vertical-align: top;">
                                <div style="text-align: justify; line-height: 1.25;">
                                  <div style="line-height: 1.25;">
                                    <div style="line-height: 1.25;">
                                      <div style="line-height: 1.25;">
                                        <div style="line-height: 1.25;">
                                          <div style="line-height: 1.25;">
                                            <div style="line-height: 1.25;">
                                              <div style="line-height: 1.25;"><font style="font-weight: bold;">Term and Termination</font>.</div>
                                            </div>
                                          </div>
                                        </div>
                                      </div>
                                    </div>
                                  </div>
                                </div>
                              </td>
                            </tr>

                        </table>
                      </div>
                    </div>
                  </div>
                </div>
              </div>
            </div>
          </div>
        </div>
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">10.1 Term</font>. The term of this Agreement shall commence on the Effective Date and, unless earlier terminated as provided in this <u>Article 10</u>,
      shall continue in full force and effect until the expiration of the last to expire Valid Claim (the &#8220;<font style="font-weight: bold;">Term</font>&#8221;).</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">10.2 Termination</font>.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;"><font style="font-weight: bold;">10.2.1 Termination Without Cause</font>. Licensee may terminate this Agreement for any or no reason upon sixty (60) days prior written notice to
      Harvard.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;"><font style="font-weight: bold;">10.2.2 Termination for Default</font>.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 108pt; line-height: 1.25;"><font style="font-weight: bold;">10.2.2.1 </font>In the event that either Party commits a material breach of its obligations under this Agreement and fails to cure that breach
      within thirty (30) days after receiving written notice thereof, the other Party may terminate this Agreement immediately upon written notice to the Party in breach.</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;" id="DSPFPageNumber">17</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 108pt; line-height: 1.25;"><font style="font-weight: bold;">10.2.2.2 </font>If Licensee defaults in its obligations under <u>Section 9.2</u> to procure and maintain insurance or, if Licensee has in any
      event failed to comply with the notice requirements contained therein, then Harvard may terminate this Agreement immediately without notice or additional waiting period.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 108pt; line-height: 1.25;"><font style="font-weight: bold;">10.2.2.3 </font>Harvard shall be entitled to terminate this Agreement in accordance with the provisions of <u>Section 3.4</u>.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;"><font style="font-weight: bold;">10.2.3 Bankruptcy</font>. Harvard may terminate this Agreement upon notice to Licensee if Licensee becomes insolvent, is adjudged bankrupt, applies
      for judicial or extra-judicial settlement with its creditors, makes an assignment for the benefit of its creditors, voluntarily files for bankruptcy or has a receiver or trustee (or the like) in bankruptcy appointed by reason of its insolvency, or in
      the event an involuntary bankruptcy action is filed against Licensee and not dismissed within ninety (90) days, or if Licensee becomes the subject of liquidation or dissolution proceedings or otherwise discontinues business.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">10.3 Effect of Termination</font>.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;"><font style="font-weight: bold;">10.3.1 Termination of Rights</font>. Upon expiration or termination of this Agreement by either Party pursuant to any of the provisions of <u>Section

        10.2</u>: (a) the rights and licenses granted to Licensee under <u>Article 2</u> shall terminate, all rights in and to and under the Licensed Patent Rights and Licensed Know-How will revert to Harvard and neither Licensee nor its Affiliates may
      make any further use or exploitation of the Licensed Patent Rights or Licensed Know-How; and (b) any existing agreements that contain a Sublicense shall terminate to the extent of such Sublicense; provided, however, that, for each Sublicensee, upon
      termination of the Sublicense agreement with such Sublicensee, if the Sublicensee is not then in breach of its Sublicense agreement with Licensee such that Licensee would have the right to terminate such Sublicense, such Sublicensee shall have the
      right to seek a license from Harvard. Harvard agrees to negotiate such licenses in good faith under reasonable terms and conditions, which shall not impose any representations, warranties, obligations or liabilities on Harvard that are not included
      in this Agreement.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;"><font style="font-weight: bold;">10.3.2 Accruing Obligations</font>. Termination or expiration of this Agreement shall not relieve the Parties of obligations accruing prior to such
      termination or expiration, including obligations to pay amounts accruing hereunder up to the date of termination or expiration, which shall be paid to Harvard within forty-five (45) days after such termination or expiration. Notwithstanding any other
      provision of this Agreement, after the date of termination or expiration (except in the case of termination by Harvard pursuant to <u>Section 10.2</u>), Licensee, its Affiliates and Sublicensees (a) may sell or otherwise dispose of all Licensed
      Products then in stock and (b) may complete the production of Licensed Products then in the process of production and sell or otherwise dispose of the same, in each case, in accordance with the terms and conditions of this Agreement, including that
      in the case of both (a) and (b), Licensee shall pay the applicable royalties and payments to Harvard in accordance with <u>Article 4</u> within thirty (30) days after the end of each Calendar Quarter after the Term during which such sales or other
      dispositions are made, provide reports and audit rights to Harvard pursuant to <u>Article 5</u> and maintain insurance in accordance with the requirements of <u>Section 9.2</u>.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">10.4 Survival</font>. The Parties&#8217; respective rights, obligations and duties under <u>Articles 5</u>,<u> 9</u>, <u>10</u> and <u>11</u> and <u>Sections

        8.2 </u>and <u>8.3</u>, as well as any rights, obligations and duties which by their nature extend beyond the expiration or termination of this Agreement, shall survive any expiration or termination of this Agreement. In addition, Licensee&#8217;s
      obligations under <u>Section 4.5</u> with respect to Sublicenses granted prior to expiration or termination of the Agreement shall survive such expiration or termination.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;">
          <div style="line-height: 1.25;">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">
                  <div style="line-height: 1.25;">
                    <div style="line-height: 1.25;">
                      <div>
                        <div>
                          <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                              <tr>
                                <td style="width: 36.35pt; vertical-align: top; align: right;">
                                  <div style="margin-left: 6.05pt; line-height: 1.25; font-weight: bold;">11.</div>
                                </td>
                                <td style="width: auto; vertical-align: top;">
                                  <div style="text-align: justify; line-height: 1.25;">
                                    <div style="line-height: 1.25;">
                                      <div style="line-height: 1.25;">
                                        <div style="line-height: 1.25;">
                                          <div style="line-height: 1.25;">
                                            <div style="line-height: 1.25;">
                                              <div style="line-height: 1.25;">
                                                <div style="line-height: 1.25;">
                                                  <div style="line-height: 1.25;"><font style="font-weight: bold;">Miscellaneous</font>.</div>
                                                </div>
                                              </div>
                                            </div>
                                          </div>
                                        </div>
                                      </div>
                                    </div>
                                  </div>
                                </td>
                              </tr>

                          </table>
                        </div>
                      </div>
                    </div>
                  </div>
                </div>
              </div>
            </div>
          </div>
        </div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">11.1 Preference for United States Industry</font>. During the period of exclusivity of this license in the United States, Licensee shall comply
      with 37 C.F.R. &#167; 401.14(i) or any successor rule or regulation. Upon Licensee&#8217;s request, and at Licensee&#8217;s expense, Harvard shall apply to the applicable United States governmental agency for a waiver to such requirements; provided, however, that all
      reasonable costs incurred by Harvard related to the preparation and application of the waiver shall be paid by Licensee within forty-five (45) days following receipt of Harvard&#8217;s valid and accurate invoice for such costs. In the event that Harvard is
      unable to obtain such waiver, then subject to the Parties mutually agreeing upon reduced royalty rates and other appropriate modifications to this Agreement to address Licensee&#8217;s loss of exclusivity, the license granted to Licensee under <u>Section
        2.1</u> shall become non-exclusive.</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;" id="DSPFPageNumber">18</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">11.2 No Security Interest</font>. Licensee shall not enter into any agreement under which Licensee grants to or otherwise creates in any third
      party a security interest in this Agreement or any of the rights granted to Licensee herein. Any grant or creation of a security interest purported or attempted to be made in violation of the terms of this <u>Section 11.2</u> shall be null and void
      and of no legal effect.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">11.3 Use of Name</font>. Except as provided below, Licensee shall not, and shall ensure that its Affiliates and Sublicensees shall not, use or
      register the name &#8220;Harvard&#8221; or &#8220;Wyss Institute&#8221; (alone or as part of another name) or any logos, seals, insignia or other words, names, symbols or other indicia of origin owned by Harvard that, in each case, identify Harvard or the Wyss Institute or
      any other Harvard school, unit, division or affiliate (collectively, &#8220;<font style="font-weight: bold;">Harvard Names</font>&#8221;) for any purpose as a trademark except with the prior written approval of, and in accordance with restrictions required by,
      Harvard, provided, however that Company may issue a press release substantially in the form set forth in <u>Exhibit F</u> to the Collaboration Agreement, which press release has been approved in advance by Harvard. This restriction shall not apply
      to any information required by law to be disclosed to any Governmental Authority, including, without limitation, to satisfy any securities reporting requirements. If, notwithstanding this prohibition, Licensee registers any Harvard Name as a
      trademark, service mark, domain name, trade name, business or company name or otherwise anywhere in the world, then, in addition to any other remedies Harvard may have, Harvard shall have the right to compel Licensee to assign Licensee rights in such
      registration to Harvard and Licensee shall take such steps as may be necessary to transfer record ownership of such registration to Harvard, at Licensee cost.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">11.4 Entire Agreement</font>. This Agreement is the sole agreement with respect to the subject matter hereof and except as expressly set forth
      herein, supersedes all other agreements and understandings between the Parties with respect to the same.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">11.5 Notices</font>. Unless otherwise specifically provided, all notices required or permitted by this Agreement shall be in writing and may be
      delivered personally, or may be sent by facsimile (if applicable), expedited delivery or certified mail, return receipt requested, to the following addresses or by email (with confirmatory copy sent by regular mail), unless the Parties are
      subsequently notified of any change of address in accordance with this <u>Section 11.5</u>:</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="z026a887409644d62a3882e146776bd60" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 31%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;&#160;&#160; &#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; If to Licensee:</div>
          </td>
          <td style="width: 69%; vertical-align: bottom;">
            <div style="text-align: justify; margin-right: 62.65pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 9pt;">ReWalk Robotics, Ltd.</div>
            <div style="text-align: justify; margin-right: 62.65pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 9pt;">200 Donald Lynch Blvd.</div>
            <div style="text-align: justify; margin-right: 62.65pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 9pt;">Marlborough, Massachusetts 01752</div>
            <div style="margin-right: 62.65pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 9pt;">Email: <u><font style="font-family: 'Times New Roman', Times, serif;">larry.jasinski@rewalk.com</font></u> and<font style="font-family: 'Times New Roman', Times, serif;"><br>
              </font><u><font style="font-family: 'Times New Roman', Times, serif;">ofir@rewalk.com</font></u></div>
            <div style="text-align: justify; margin-right: 62.65pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 9pt;">Facsimile: +1 (508) 251-2970</div>
            <div style="text-align: justify; margin-right: 62.65pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 9pt;">Attn.: Larry Jasinski and Ofir Koren</div>
          </td>
        </tr>
        <tr>
          <td style="width: 31%; vertical-align: top;">&#160;</td>
          <td style="width: 69%; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 31%; vertical-align: top;">
            <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
            <div style="line-height: 1.25;">&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; &#160; &#160;&#160; With copy to the following (if a technical notice):</div>
          </td>
          <td style="width: 69%; vertical-align: bottom;">
            <div style="text-align: justify; margin-right: 62.65pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 9pt;">ReWalk Robotics, Ltd.</div>
            <div style="text-align: justify; margin-right: 62.65pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 9pt;">Hatnufa st. 3, floor 6</div>
            <div style="text-align: justify; margin-right: 62.65pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 9pt;">Yokneaam, POB 161, 2069203</div>
            <div style="text-align: justify; margin-right: 62.65pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 9pt;">Israel</div>
            <div style="text-align: justify; margin-right: 62.65pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 9pt;">Facsimile: +972-4-959 0125</div>
            <div style="margin-right: 62.65pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 9pt;">Email: <u><font style="font-family: 'Times New Roman', Times, serif;">larry.jasinski@rewalk.com</font></u> and<font style="font-family: 'Times New Roman', Times, serif;"><br>
              </font><u><font style="font-family: 'Times New Roman', Times, serif;">ofir@rewalk.com</font></u></div>
            <div style="text-align: justify; margin-right: 62.65pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 9pt;">Attn.: Larry Jasinski and Ofir Koren</div>
            <div style="text-align: justify; margin-right: 62.65pt; line-height: 1.25;"> <br>
            </div>
          </td>
        </tr>
        <tr>
          <td style="width: 31%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; &#160;&#160; If to Harvard:</div>
          </td>
          <td style="width: 69%; vertical-align: bottom;">
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 9pt;">Office of Technology Development<font style="font-family: 'Times New Roman', Times, serif;"><br>
              </font>Harvard University<font style="font-family: 'Times New Roman', Times, serif;"><br>
              </font>Richard A. and Susan F. Smith Campus Center, Suite 727<font style="font-family: 'Times New Roman', Times, serif;"><br>
              </font>1350 Massachusetts Avenue<font style="font-family: 'Times New Roman', Times, serif;"><br>
              </font>Cambridge, Massachusetts 02138</div>
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 9pt;">Facsimile: +1 (617) 495-9568</div>
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 9pt;">Attn.: Chief Technology Development Officer</div>
            <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
          </td>
        </tr>

    </table>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;" id="DSPFPageNumber">19</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Any notice shall be deemed to have been received as follows: (a) by personal delivery or expedited delivery, upon receipt; (b) by facsimile, one business day after transmission or
      dispatch; (c) by certified mail, as evidenced by the return receipt. If notice is sent by facsimile, a confirming copy of the same shall be sent by mail to the same address.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">11.6 Governing Law and Jurisdiction</font>. This Agreement will be governed by, and construed in accordance with, the substantive laws of the
      Commonwealth of Massachusetts, without giving effect to any choice or conflict of law provision, except that questions affecting the construction and effect of any patent shall be determined by the law of the country in which the patent shall have
      been granted. Any action, suit or other proceeding arising under or relating to this Agreement, its subject matter, any document or instrument delivered pursuant to, or a breach of this Agreement or any such document or instrument (a &#8220;<font style="font-weight: bold;">Suit</font>&#8221;) shall be brought in a court of competent jurisdiction in the Commonwealth of Massachusetts, and the Parties hereby consent to the sole jurisdiction of the state and federal courts sitting in the Commonwealth
      of Massachusetts. Each Party agrees not to raise any objection at any time to the laying or maintaining of the venue of any Suit in any of the specified courts, irrevocably waives any claim that Suit has been brought in any inconvenient forum and
      further irrevocably waives the right to object, with respect to any Suit, that such court does not have any jurisdiction over such Party.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">11.7 Binding Effect</font>. This Agreement shall be binding upon and inure to the benefit of the Parties and their respective legal
      representatives, successors and permitted assigns.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">11.8 Headings</font>. Section and subsection headings are inserted for convenience of reference only and do not form a part of this Agreement.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">11.9 Counterparts</font>. The Parties may execute this Agreement in two or more counterparts, each of which shall be deemed an original, but both
      of which together shall constitute one and the same instrument. Transmission by facsimile or electronic mail of an executed counterpart of this Agreement shall be deemed to constitute due and sufficient delivery of such counterpart. If by electronic
      mail, the executed Agreement must be delivered in a .pdf format.</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">11.10 Amendment; Waiver</font>. This Agreement may be amended, modified, superseded or cancelled, and any of the terms may be waived, only by a
      written instrument executed by each Party or, in the case of waiver, by the Party waiving compliance. The delay or failure of either Party at any time or times to require performance of any provisions hereof shall in no manner affect the rights at a
      later time to enforce the same. No waiver by either Party of any condition or of the breach of any term contained in this Agreement, whether by conduct, or otherwise, in any one or more instances, shall be deemed to be, or considered as, a further or
      continuing waiver of any such condition or of the breach of such term or any other term of this Agreement.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">11.11 No Agency or Partnership</font>. Nothing contained in this Agreement shall give either Party the right to bind the other, be deemed to
      constitute either Party as agent for or partner of the other or any third party, or be construed or fiduciary relationship between the Parties. The relationship between the Parties is that of independent contractors.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">11.12 Assignment and Successors</font>.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;"><font style="font-weight: bold;">11.12.1</font> This Agreement may not be assigned by either Party without the consent of the other, which consent shall not be unreasonably
      withheld, except that each Party may, without such consent, assign this Agreement, in its entirety, and the rights, obligations and interests of such Party (a) to any affiliate or (b) to any purchaser of all of such Party&#8217;s equity or all or
      substantially all of such Party&#8217;s assets or business to which this Agreement relates, or (c) to any successor corporation resulting from any merger or consolidation of such Party with or into such corporation, provided, in each case, that the
      assignee agrees in writing to be bound by the terms of this Agreement. Any assignment purported or attempted to be made in violation of the terms of this <u>Section 11.12</u> shall be null and void and of no legal effect.</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;" id="DSPFPageNumber">20</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;"><font style="font-weight: bold;">11.12.2</font> The rights and licenses granted to Licensee hereunder shall run with the Licensed Patent Rights and Licensed Know-How and Harvard
      shall not license, encumber, convey or otherwise transfer its rights in or to the Licensed Patent Rights or Licensed Know-How in any way that conflicts with the terms of this Agreement or the rights and licenses granted to Licensee hereunder without
      the prior written consent of Licensee (in its sole discretion). Any assignment, conveyance, license, encumbrance, transfer or other disposition of Harvard&#8217;s rights in or to the Licensed Patent Rights or Licensed Know-How shall be expressly subject to
      this Agreement and the rights and licenses granted to Licensee hereunder.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">11.13 Force Majeure</font>. Except for monetary obligations hereunder, neither Party will be responsible for delays resulting from causes beyond
      the reasonable control of such Party, including fire, explosion, flood, war, strike, or riot, provided that the nonperforming Party uses commercially reasonable efforts to avoid or remove such causes of nonperformance and continues performance under
      this Agreement with reasonable dispatch whenever such causes are removed.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">11.14 Interpretation</font>. Each Party hereto acknowledges and agrees that: (a) it and/or its counsel reviewed and negotiated the terms and
      provisions of this Agreement and has contributed to its revision; (b) the rule of construction to the effect that any ambiguities are resolved against the drafting Party shall not be employed in the interpretation of this Agreement; (c) the terms and
      provisions of this Agreement shall be construed fairly as to both Parties hereto and not in favor of or against either Party, regardless of which Party was generally responsible for the preparation of this Agreement; and (d) the use of &#8220;include,&#8221;
      &#8220;includes,&#8221; or &#8220;including&#8221; herein shall not be limiting and &#8220;or&#8221; shall not be exclusive.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">11.15 Severability</font>. If any provision of this Agreement is or becomes invalid or is ruled invalid by any court of competent jurisdiction or
      is deemed unenforceable, such invalidity shall not render the entire Agreement unenforceable or invalid but rather the Agreement shall be read and construed as if the invalid or unenforceable provision(s) are not contained herein, and the rights and
      obligations of the Parties shall be construed and enforced accordingly.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">11.16 No Third-Party Beneficiaries</font>. This Agreement is for the sole benefit of the Parties hereto and their respective successors and
      permitted assigns and nothing herein, express or implied, is intended to or shall confer upon any other individual, corporation, partnership, joint venture, limited liability company, Governmental Authority, unincorporated organization, trust,
      association or other entity any legal or equitable right, benefit or remedy of any nature whatsoever, under or by reason of this Agreement.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">11.17 Reimbursement</font>. To the extent that Licensee reimburses Harvard for any costs incurred by Harvard for the preparation, filing,
      prosecution and maintenance of any Patent Rights hereunder (such costs, &#8220;<font style="font-weight: bold;">Reimbursed Costs</font>&#8221;), then if Harvard grants a license under such Patent Rights to a third Person outside the Field (each, an &#8220;<font style="font-weight: bold;">Ex-Field Licensee</font>&#8221;) and receives reimbursement from such Ex-Field Licensee for Reimbursed Costs, then Licensee shall only be responsible for reimbursing an appropriate portion of such Reimbursed Costs based on the
      scope and type of license (i.e., non-exclusive vs. exclusive) granted to such Ex-Field Licensee and Harvard shall credit Company&#8217;s portion of the Reimbursed Costs to amounts owed to Harvard hereunder.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">11.18 Licenses of Intellectual Property</font>. Each Party acknowledges and agrees that all rights and licenses under the Licensed Patent Rights
      and Licensed Know-How granted by Harvard to Licensee under this Agreement are, and shall otherwise be deemed to be, for purposes of the United States Bankruptcy Code (the &#8220;<font style="font-weight: bold;">Bankruptcy Code</font>&#8221;), including Section
      365(n) thereof, licenses of rights to &#8220;intellectual property&#8221; as defined under Section 101(35A) of the Bankruptcy Code and in connection therewith, Section 365(n) shall apply. The Parties acknowledge and agree that Licensee shall retain and may fully
      exercise all of its respective rights and elections under the Bankruptcy Code, including, without limitation, Licensee&#8217;s election to continue receiving the benefit of the licenses granted hereunder in consideration for the royalties due and payable
      hereunder. Without limiting the foregoing, if Harvard makes a general assignment for the benefit of creditors, if a receiver for Harvard&#8217;s assets is appointed, if Harvard becomes insolvent, makes a filing in bankruptcy or ceases operations, or if any
      of Harvard&#8217;s lenders forecloses upon or otherwise exercises any of its rights under or with respect to any liens or security interests on any of the Licensed Patent Rights, Licensed Know-How and/or this Agreement, then Harvard acknowledges and agrees
      that such foreclosure and exercise shall be expressly subject to this Agreement and all rights and licenses under the Licensed Patent Rights and Licensed Know-How granted by Harvard to Licensee under this Agreement and the license granted to Licensee
      hereunder shall, in consideration for the royalties due and payable hereunder, continue in full force and effect.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">11.19 Confidentiality</font>. The terms (but not the existence) of this Agreement constitute the Confidential Information of both Parties pursuant
      to Article VII of the Collaboration Agreement and neither Party shall disclose the terms of this Agreement to any third party except (a) to its Affiliates, Distributors and Sublicensees and their respective officers, directors, members, employees,
      agents and outside advisors who reasonably need to know such information for exercising such Party&#8217;s rights or performing such Party&#8217;s obligations under this Agreement or the Collaboration Agreement, (b) with the prior written approval of the other
      Party, (c) the Company may issue a press release substantially in the form set forth in Exhibit F to the Collaboration Agreement, which press release has been approved in advance by Harvard, or (d) this restriction shall not apply to any information
      required by law to be disclosed to any Governmental Authority or required to be disclosed publicly pursuant to applicable law, including, without limitation, pursuant to or in connection with securities law reporting obligations or the rules of any
      securities exchange, provided that the Party disclosing such information shall seek confidential treatment of such Confidential Information to the extent permitted under applicable law.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-style: italic;">[Signature page follows]</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;" id="DSPFPageNumber">21</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;"><font style="font-weight: bold;">IN WITNESS WHEREOF,</font> the Parties have caused this Agreement to be executed by their duly authorized representatives as of the date first written above.</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z9a8b72d9532c488e84f7140e001521c3" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 45.26%; vertical-align: bottom;" colspan="2">
            <div style="text-align: justify; line-height: 1.25; font-weight: bold;">President and Fellows of Harvard College</div>
            <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
          </td>
          <td style="width: 9.47%; vertical-align: bottom;">&#160;</td>
          <td style="width: 45.27%; vertical-align: bottom;" colspan="2">
            <div style="text-align: justify; line-height: 1.25; font-weight: bold;">ReWalk Robotics, Ltd.</div>
            <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
          </td>
        </tr>
        <tr>
          <td style="width: 5.81%; vertical-align: bottom;">
            <div style="text-align: justify; line-height: 1.25;">By:</div>
          </td>
          <td style="width: 39.46%; vertical-align: bottom; border-bottom: 2px solid #000000;">
            <div style="line-height: 1.25;">
              <div style="text-align: justify; line-height: 1.25;">/s/ Isaac T. Kohlberg</div>
            </div>
          </td>
          <td style="width: 9.47%; vertical-align: bottom;">&#160;</td>
          <td style="width: 5.81%; vertical-align: bottom;">
            <div style="text-align: justify; line-height: 1.25;">By:</div>
          </td>
          <td style="width: 39.47%; vertical-align: bottom; border-bottom: 2px solid #000000;">
            <div style="line-height: 1.25;">
              <div style="text-align: justify; line-height: 1.25;">/s/ Larry Jasinski</div>
            </div>
          </td>
        </tr>
        <tr>
          <td style="width: 5.81%; vertical-align: bottom;">
            <div style="text-align: justify; line-height: 1.25;">Name:</div>
          </td>
          <td style="width: 39.46%; vertical-align: bottom; border-bottom: 2px solid #000000;">
            <div style="line-height: 1.25;">
              <div style="text-align: justify; line-height: 1.25;">Isaac T. Kohlberg</div>
            </div>
          </td>
          <td style="width: 9.47%; vertical-align: bottom;">&#160;</td>
          <td style="width: 5.81%; vertical-align: bottom;">
            <div style="text-align: justify; line-height: 1.25;">Name:</div>
          </td>
          <td style="width: 39.47%; vertical-align: bottom; border-bottom: 2px solid #000000;">
            <div style="line-height: 1.25;">
              <div style="text-align: justify; line-height: 1.25;">Larry Jasinski</div>
            </div>
          </td>
        </tr>
        <tr>
          <td style="width: 5.81%; vertical-align: bottom;">
            <div style="text-align: justify; line-height: 1.25;">Title:</div>
          </td>
          <td style="width: 39.46%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div style="text-align: justify; line-height: 1.25;">Senior Associate Provost</div>
            <div style="text-align: justify; line-height: 1.25;">Chief Technology Development Officer Office of Technology Development </div>
            <div style="text-align: justify; line-height: 1.25;">Harvard University</div>
          </td>
          <td style="width: 9.47%; vertical-align: bottom;">&#160;</td>
          <td style="width: 5.81%; vertical-align: bottom;">
            <div style="text-align: justify; line-height: 1.25;">Title:</div>
          </td>
          <td style="width: 39.47%; vertical-align: bottom; border-bottom: 2px solid #000000;">
            <div style="line-height: 1.25;">
              <div style="text-align: justify; line-height: 1.25;">CEO</div>
            </div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">I, the undersigned, hereby confirm that I have read the Agreement, that its contents are acceptable to me and that I will act in accordance with its terms, including the provisions of <u>Section 2.6</u>.</div>
    <table cellspacing="0" cellpadding="0" id="z56f238a962d2439993adf174d68a39b4" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 44.99%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
            <div style="text-align: justify; line-height: 1.25;">/s/ Conor Walsh</div>
          </td>
          <td style="width: 55.01%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 44.99%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Conor Walsh, Ph.D.</div>
          </td>
          <td style="width: 55.01%; vertical-align: top;">&#160;</td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;" id="DSPFPageNumber">22</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">Exhibit 1.11</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">Development Milestones</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;"> <br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" id="z394613c9e8ab41669504d31be98f51ae" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="width: 50%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Development Milestone</div>
          </td>
          <td style="width: 50%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Deadline</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#9679; [**]</div>
          </td>
          <td style="width: 50%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">On or before [**].</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#9679; [**]</div>
          </td>
          <td style="width: 50%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">On or before [**].</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#9679; [**]</div>
          </td>
          <td style="width: 50%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">On or before [**].</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#9679; [**]</div>
          </td>
          <td style="width: 50%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">On or before [**].</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#9679; [**]</div>
          </td>
          <td style="width: 50%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">On or before [**].</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#9679; [**]</div>
          </td>
          <td style="width: 50%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">On or before [**].</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;" id="DSPFPageNumber">23</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">Exhibit 1.12</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">Development Plan</div>
    <div style="line-height: 1.25;">[**].</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;" id="DSPFPageNumber">24</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">Exhibit 1.24</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">Licensed Know-How</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;"> <br>
    </div>
    <table cellspacing="0" cellpadding="0" id="z3873a880d69e44b59e9f6c995b6f1827" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">
            <div style="line-height: 1.25;">&#8226;</div>
          </td>
          <td style="width: 96.09%; vertical-align: top;">
            <div style="line-height: 1.25;">[**]</div>
          </td>
        </tr>
        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">
            <div style="line-height: 1.25;">&#8226;</div>
          </td>
          <td style="width: 96.09%; vertical-align: top;">
            <div style="line-height: 1.25;">[**]</div>
          </td>
        </tr>
        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">
            <div style="line-height: 1.25;">&#8226;</div>
          </td>
          <td style="width: 96.09%; vertical-align: top;">
            <div style="line-height: 1.25;">[**]</div>
          </td>
        </tr>
        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">
            <div style="line-height: 1.25;">&#8226;</div>
          </td>
          <td style="width: 96.09%; vertical-align: top;">
            <div style="line-height: 1.25;">[**]</div>
          </td>
        </tr>
        <tr>
          <td style="width: 0.06%; vertical-align: top;">&#160;</td>
          <td style="width: 3.85%; vertical-align: top;">
            <div style="line-height: 1.25;">&#8226;</div>
          </td>
          <td style="width: 96.09%; vertical-align: top;">
            <div style="line-height: 1.25;">[**]</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;" id="DSPFPageNumber">25</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">Exhibit 1.25</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">Licensed Patent Rights</div>
    <div style="line-height: 1.25; font-weight: bold;">Harvard Background Patents</div>
    <table cellspacing="0" cellpadding="3" border="0" id="z34a9a072e7924ac189ca3e0664f46b62" style="background-color: #FFFFFF; width: 100%; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">

        <tr>
          <td nowrap="nowrap" style="width: 8%; vertical-align: middle; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">Case</div>
          </td>
          <td nowrap="nowrap" style="width: 10%; vertical-align: middle; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">Country</div>
          </td>
          <td style="width: 17%; vertical-align: middle; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">Type</div>
          </td>
          <td style="width: 45%; vertical-align: middle; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">Appl. Title</div>
          </td>
          <td nowrap="nowrap" style="width: 20%; vertical-align: middle; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">Serial Number</div>
          </td>
        </tr>
        <tr>
          <td style="width: 8%; vertical-align: middle; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td style="width: 10%; vertical-align: middle; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td style="width: 17%; vertical-align: middle; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td style="width: 45%; vertical-align: middle; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td style="width: 20%; vertical-align: middle; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
        </tr>
        <tr>
          <td nowrap="nowrap" style="width: 8%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td nowrap="nowrap" style="width: 10%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td style="width: 17%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td style="width: 45%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td nowrap="nowrap" style="width: 20%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
        </tr>
        <tr>
          <td nowrap="nowrap" style="width: 8%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td nowrap="nowrap" style="width: 10%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td style="width: 17%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td style="width: 45%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td nowrap="nowrap" style="width: 20%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
        </tr>
        <tr>
          <td nowrap="nowrap" style="width: 8%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td nowrap="nowrap" style="width: 10%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td style="width: 17%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td style="width: 45%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td nowrap="nowrap" style="width: 20%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
        </tr>
        <tr>
          <td nowrap="nowrap" style="width: 8%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td nowrap="nowrap" style="width: 10%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td style="width: 17%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td style="width: 45%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td nowrap="nowrap" style="width: 20%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
        </tr>
        <tr>
          <td nowrap="nowrap" style="width: 8%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td nowrap="nowrap" style="width: 10%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td style="width: 17%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td style="width: 45%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td nowrap="nowrap" style="width: 20%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
        </tr>
        <tr>
          <td nowrap="nowrap" style="width: 8%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td nowrap="nowrap" style="width: 10%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td style="width: 17%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td style="width: 45%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td nowrap="nowrap" style="width: 20%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
        </tr>
        <tr>
          <td nowrap="nowrap" style="width: 8%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td nowrap="nowrap" style="width: 10%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td style="width: 17%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td style="width: 45%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td nowrap="nowrap" style="width: 20%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
        </tr>
        <tr>
          <td nowrap="nowrap" style="width: 8%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td nowrap="nowrap" style="width: 10%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td style="width: 17%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td style="width: 45%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td nowrap="nowrap" style="width: 20%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
        </tr>
        <tr>
          <td nowrap="nowrap" style="width: 8%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td nowrap="nowrap" style="width: 10%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td style="width: 17%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td style="width: 45%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td nowrap="nowrap" style="width: 20%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="3" border="0" style="background-color: #FFFFFF; width: 100%; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">

        <tr>
          <td nowrap="nowrap" style="width: 8%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td nowrap="nowrap" style="width: 10%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td style="width: 17%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td style="width: 45%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td nowrap="nowrap" style="width: 20%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
        </tr>
        <tr>
          <td nowrap="nowrap" style="width: 8%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td nowrap="nowrap" style="width: 10%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td style="width: 17%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td style="width: 45%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td nowrap="nowrap" style="width: 20%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
        </tr>
        <tr>
          <td nowrap="nowrap" style="width: 8%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td nowrap="nowrap" style="width: 10%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td style="width: 17%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td style="width: 45%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td nowrap="nowrap" style="width: 20%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
        </tr>
        <tr>
          <td nowrap="nowrap" style="width: 8%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td nowrap="nowrap" style="width: 10%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td style="width: 17%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td style="width: 45%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td nowrap="nowrap" style="width: 20%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
        </tr>
        <tr>
          <td nowrap="nowrap" style="width: 8%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td nowrap="nowrap" style="width: 10%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td style="width: 17%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td style="width: 45%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td nowrap="nowrap" style="width: 20%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
        </tr>
        <tr>
          <td nowrap="nowrap" style="width: 8%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td nowrap="nowrap" style="width: 10%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td style="width: 17%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td style="width: 45%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td nowrap="nowrap" style="width: 20%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
        </tr>
        <tr>
          <td nowrap="nowrap" style="width: 8%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td nowrap="nowrap" style="width: 10%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td style="width: 17%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td style="width: 45%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td nowrap="nowrap" style="width: 20%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
        </tr>
        <tr>
          <td nowrap="nowrap" style="width: 8%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td nowrap="nowrap" style="width: 10%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td style="width: 17%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td style="width: 45%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td nowrap="nowrap" style="width: 20%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
        </tr>
        <tr>
          <td nowrap="nowrap" style="width: 8%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td nowrap="nowrap" style="width: 10%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td style="width: 17%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td style="width: 45%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td nowrap="nowrap" style="width: 20%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
        </tr>
        <tr>
          <td nowrap="nowrap" style="width: 8%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td nowrap="nowrap" style="width: 10%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td style="width: 17%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td style="width: 45%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
          <td nowrap="nowrap" style="width: 20%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">[**]</div>
          </td>
        </tr>

    </table>
    <div>
      <table cellspacing="0" cellpadding="3" border="0" style="background-color: #FFFFFF; width: 100%; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">

          <tr>
            <td nowrap="nowrap" style="width: 8%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">[**]</div>
            </td>
            <td nowrap="nowrap" style="width: 10%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">[**]</div>
            </td>
            <td style="width: 17%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">[**]</div>
            </td>
            <td style="width: 45%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">[**]</div>
            </td>
            <td nowrap="nowrap" style="width: 20%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">[**]</div>
            </td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 8%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">[**]</div>
            </td>
            <td nowrap="nowrap" style="width: 10%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">[**]</div>
            </td>
            <td style="width: 17%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">[**]</div>
            </td>
            <td style="width: 45%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">[**]</div>
            </td>
            <td nowrap="nowrap" style="width: 20%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">[**]</div>
            </td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 8%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">[**]</div>
            </td>
            <td nowrap="nowrap" style="width: 10%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">[**]</div>
            </td>
            <td style="width: 17%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">[**]</div>
            </td>
            <td style="width: 45%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">[**]</div>
            </td>
            <td nowrap="nowrap" style="width: 20%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">[**]</div>
            </td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 8%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">[**]</div>
            </td>
            <td nowrap="nowrap" style="width: 10%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">[**]</div>
            </td>
            <td style="width: 17%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">[**]</div>
            </td>
            <td style="width: 45%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">[**]&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <br>
              </div>
            </td>
            <td nowrap="nowrap" style="width: 20%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">[**]</div>
            </td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 8%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">[**]</div>
            </td>
            <td nowrap="nowrap" style="width: 10%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">[**]</div>
            </td>
            <td style="width: 17%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">[**]</div>
            </td>
            <td style="width: 45%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">[**]</div>
            </td>
            <td nowrap="nowrap" style="width: 20%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">[**]</div>
            </td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 8%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">[**]</div>
            </td>
            <td nowrap="nowrap" style="width: 10%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">[**]</div>
            </td>
            <td style="width: 17%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">[**]</div>
            </td>
            <td style="width: 45%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">[**]</div>
            </td>
            <td nowrap="nowrap" style="width: 20%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">[**]</div>
            </td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 8%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">[**]</div>
            </td>
            <td nowrap="nowrap" style="width: 10%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">[**]</div>
            </td>
            <td style="width: 17%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">[**]</div>
            </td>
            <td style="width: 45%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">[**]</div>
            </td>
            <td nowrap="nowrap" style="width: 20%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">[**]</div>
            </td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 8%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">[**]</div>
            </td>
            <td nowrap="nowrap" style="width: 10%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">[**]</div>
            </td>
            <td style="width: 17%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">[**]</div>
            </td>
            <td style="width: 45%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">[**]</div>
            </td>
            <td nowrap="nowrap" style="width: 20%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">[**]</div>
            </td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 8%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">[**]</div>
            </td>
            <td nowrap="nowrap" style="width: 10%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">[**]</div>
            </td>
            <td style="width: 17%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">[**]</div>
            </td>
            <td style="width: 45%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">[**]</div>
            </td>
            <td nowrap="nowrap" style="width: 20%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">[**]</div>
            </td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 8%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">[**]</div>
            </td>
            <td nowrap="nowrap" style="width: 10%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">[**]</div>
            </td>
            <td style="width: 17%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">[**]</div>
            </td>
            <td style="width: 45%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">[**]</div>
            </td>
            <td nowrap="nowrap" style="width: 20%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0) rgb(0, 0, 0) rgb(0, 0, 0);">
              <div style="line-height: 1.25;">[**]</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
    </div>
    <div style="line-height: 1.25; font-weight: bold;">Licensed Type A Patent Rights</div>
    <div style="line-height: 1.25;">[**]</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25; font-weight: bold;">Consulting Patent Rights</div>
    <div style="line-height: 1.25;">[**]</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25; font-weight: bold;">Joint Consulting Patent Rights</div>
    <div style="line-height: 1.25;">[**]</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
  </div>
  <div style="text-align: center;"><font style="font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;" id="DSPFPageNumber">26</font>
    <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; margin-left: auto; margin-right: auto;"></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>5
<FILENAME>exhibit_23-1.htm
<DESCRIPTION>EXHIBIT 23.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: ZKG
         Document created using EDGARfilings PROfile 7.3.2.0
         Copyright 1995 - 2021 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
    <div style="text-align: right;"><u><font style="font-weight: bold;">Exhibit 23.1</font></u><br>
    </div>
    <div> <br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;" id="zc923ecabd69745f6ba2b6e90c1e71364">

          <tr>
            <td style="width: 33.33%;" rowspan="6" colspan="1">
              <div>&#160;<img src="image00004.jpg"></div>
            </td>
            <td style="width: 33.33%; font-weight: bold;">
              <div>&#160;Kost Forer Gabbay &amp; Kasierer</div>
            </td>
            <td style="width: 33.33%;">
              <div>
                <div style="text-align: left; line-height: 1.25;">Tel: +972-4-8654000</div>
              </div>
            </td>
          </tr>
          <tr>
            <td style="width: 33.33%;">
              <div>
                <div style="text-align: left; line-height: 1.25;">2 Pal-Yam Blvd. Brosh Bldg.</div>
              </div>
            </td>
            <td style="width: 33.33%;">
              <div>
                <div style="text-align: left; line-height: 1.25;">Fax: +972-3-5633439</div>
              </div>
            </td>
          </tr>
          <tr>
            <td style="width: 33.33%;">
              <div>
                <div style="text-align: left; line-height: 1.25;">Haifa 3309502, Israel</div>
              </div>
            </td>
            <td style="width: 33.33%;">
              <div>
                <div style="text-align: left; line-height: 1.25;">ey.com</div>
              </div>
            </td>
          </tr>
          <tr>
            <td style="width: 33.33%;" rowspan="1">&#160;</td>
            <td style="width: 33.33%;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 33.33%;" rowspan="1">&#160;</td>
            <td style="width: 33.33%;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 33.33%;" rowspan="1">&#160;</td>
            <td style="width: 33.33%;" rowspan="1">&#160;</td>
          </tr>

      </table>
    </div>
    <br>
    <div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">We consent to the incorporation by reference in the
          Registration Statements on Form S-8 (File Nos. 333-199688, 333-221357, 333-230485 and 333-239258) pertaining to ReWalk Robotics Ltd. 2006 Stock Option Plan, ReWalk Robotics Ltd. 2012 Equity Incentive Plan and ReWalk Robotics Ltd. 2014 Incentive
          Compensation Plan, as applicable, the Registration Statements on Form S-1 (File Nos. 333-235931,&#160;333-235932,&#160;333-239733 and 333-251454) and the Registration Statement on Form S-3 (File No. 333-231305) of our report dated February 18, 2021, with respect to the consolidated financial statements of ReWalk Robotics Ltd.
          included in the annual report (Form 10-K) for the year ended December 31, 2020.&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" id="z57f752ff78084bb1891199f33018f602" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 67%; vertical-align: top;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 33%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          </tr>
          <tr>
            <td style="width: 67%; vertical-align: top;">
              <div style="line-height: 1.25;">Haifa, Israel</div>
            </td>
            <td style="width: 33%; vertical-align: top;">
              <div style="text-align: center; line-height: 1.25;">/s/ KOST FORER GABBAY &amp; KASIERER</div>
            </td>
          </tr>
          <tr>
            <td style="width: 67%; vertical-align: top;">
              <div style="line-height: 1.25;">February 18, 2021</div>
            </td>
            <td style="width: 33%; vertical-align: top;">
              <div style="text-align: center; line-height: 1.25;">A Member of EY Global</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;">&#160;</div>
      <div style="line-height: 1.25">
        <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>6
<FILENAME>exhibit_31-1.htm
<DESCRIPTION>EXHIBIT 31.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: ZKG
         Document created using EDGARfilings PROfile 7.3.2.0
         Copyright 1995 - 2021 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
    <div>
      <div id="DSPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
      <div style="text-align: right; line-height: 1.25; font-weight: bold;"><u>EXHIBIT&#160;31.1</u></div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">EXCHANGE ACT RULE&#160;13A-14(A)/15D-14(A)</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">AS ADOPTED PURSUANT TO SECTION&#160;302</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">OF THE SARBANES-OXLEY ACT OF 2002</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">I, Larry Jasinski, certify that:</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">1.&#160;I have reviewed this annual report on Form&#160;10-K of ReWalk Robotics Ltd. (the &#8220;registrant&#8221;);</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">2.&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact
        necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">3.&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all
        material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">4.&#160;The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and
        procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-left: 18pt; line-height: 1.25;">(a)&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be
        designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is
        being prepared;</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-left: 18pt; line-height: 1.25;">(b) Designed such internal control over financial reporting, or caused such internal control over financial
        reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting
        principles;</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-left: 18pt; line-height: 1.25;">(c)&#160;Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report
        our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;&#160;and</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-left: 18pt; line-height: 1.25;">(d)&#160;Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred
        during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report)that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial
        reporting; and</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">5.&#160;The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over
        financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions):</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-left: 18pt; line-height: 1.25;">(a)&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over
        financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information;&#160;and</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-left: 18pt; line-height: 1.25;">(b)&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in
        the registrant&#8217;s internal control over financial reporting.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zdabc7e1c62d14b3fb39803ad67a60d34" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 50%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
            <td style="width: 25%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; line-height: 1.25;">/s/ Larry Jasinski</div>
            </td>
            <td style="width: 25%; vertical-align: top; padding-bottom: 2px;" colspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 25%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">Larry Jasinski</div>
            </td>
            <td style="width: 25%; vertical-align: top;" colspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 25%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">Chief Executive Officer</div>
            </td>
            <td style="width: 25%; vertical-align: top;" colspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 25%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">(Principal Executive Officer)</div>
            </td>
            <td style="width: 25%; vertical-align: top;" colspan="1">&#160;</td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">Date: February 18, 2021</div>
      <div style="text-align: justify; line-height: 1.25;"> <br>
      </div>
      <div style="text-align: justify; line-height: 1.25;">
        <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"> </div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>7
<FILENAME>exhibit_31-2.htm
<DESCRIPTION>EXHIBIT 31.2
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: ZKG
         Document created using EDGARfilings PROfile 7.3.2.0
         Copyright 1995 - 2021 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
    <div>
      <div id="DSPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
      <div style="text-align: right; line-height: 1.25; font-weight: bold;"><u>EXHIBIT&#160;31.2</u></div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">EXCHANGE ACT RULE&#160;13A-14(A)/15D-14(A)</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">AS ADOPTED PURSUANT TO SECTION&#160;302</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">OF THE SARBANES-OXLEY ACT OF 2002</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">I, Ori Gon, certify that:</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">1.&#160;I have reviewed this annual report on Form&#160;10-K of ReWalk Robotics Ltd. (the &#8220;registrant&#8221;);</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">2.&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact
        necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">3.&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all
        material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">4.&#160;The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and
        procedures (as defined in Exchange Act Rules&#160;13a-15(e) and 15d-15(e)) and&#160; internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-left: 18pt; line-height: 1.25;">(a)&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be
        designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is
        being prepared;</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-left: 18pt; line-height: 1.25;">(b)&#160;Designed such internal control over financial reporting, or caused such internal control over financial
        reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting
        principles;</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-left: 18pt; line-height: 1.25;">(c) Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report
        our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-left: 18pt; line-height: 1.25;">(d)&#160;Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred
        during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial
        reporting; and</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">5.&#160;The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over
        financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions):</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-left: 18pt; line-height: 1.25;">(a)&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over
        financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information;&#160;and</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-left: 18pt; line-height: 1.25;">(b)&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in
        the registrant&#8217;s internal control over financial reporting.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z44824238b3d04cf7827412de63331800" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 50%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
            <td style="width: 25%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; line-height: 1.25;">/s/ Ori Gon</div>
            </td>
            <td style="width: 25%; vertical-align: top; padding-bottom: 2px;" colspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 25%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">Ori Gon</div>
            </td>
            <td style="width: 25%; vertical-align: top;" colspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 25%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">Chief Financial Officer</div>
            </td>
            <td style="width: 25%; vertical-align: top;" colspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 25%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">(Principal Financial Officer)</div>
            </td>
            <td style="width: 25%; vertical-align: top;" colspan="1">&#160;</td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">Date: February 18, 2021</div>
      <div style="text-align: justify; line-height: 1.25;"> <br>
      </div>
      <div style="text-align: justify; line-height: 1.25;">
        <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"> </div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>8
<FILENAME>exhibit_32-1.htm
<DESCRIPTION>EXHIBIT 32.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: ZKG
         Document created using EDGARfilings PROfile 7.3.2.0
         Copyright 1995 - 2021 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
    <div>
      <div id="DSPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
      <div style="text-align: right; line-height: 1.25;">&#160;<font style="font-weight: bold;"><u>EXHIBIT&#160;32.1</u></font></div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">18&#160;U.S.C. SECTION&#160;1350</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">AS ADOPTED PURSUANT TO SECTION&#160;906</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">OF THE SARBANES-OXLEY ACT OF 2002</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">In connection with the Annual Report of ReWalk Robotics Ltd. (the &#8220;Company&#8221;) on Form&#160;10-K for the period ended December&#160;31, 2020, as
        filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;),&#160;I, Larry Jasinski, do hereby certify, pursuant to 18&#160;U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that, to my
        knowledge:</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zb3ed5b2cffc84ec9ad7768d6e518618c" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" id="z503db4db6e1247cabfb61a834423d7bb" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zb5a8854552114338a28dbace16de6beb" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 50%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
            <td style="width: 25%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; line-height: 1.25;">/s/ Larry Jasinski</div>
            </td>
            <td style="width: 25%; vertical-align: top; padding-bottom: 2px;" colspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 25%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">Larry Jasinski</div>
            </td>
            <td style="width: 25%; vertical-align: top;" colspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 25%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">Chief Executive Officer</div>
            </td>
            <td style="width: 25%; vertical-align: top;" colspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 25%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">(Principal Executive Officer)</div>
            </td>
            <td style="width: 25%; vertical-align: top;" colspan="1">&#160;</td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">Date: February 18, 2021</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company
        and furnished to the Securities and Exchange Commission or its staff upon request.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">
        <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>9
<FILENAME>exhibit_32-2.htm
<DESCRIPTION>EXHIBIT 32.2
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: ZKG
         Document created using EDGARfilings PROfile 7.3.2.0
         Copyright 1995 - 2021 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
    <div>
      <div id="DSPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
      <div style="text-align: right; line-height: 1.25; font-weight: bold;"><u>EXHIBIT&#160;32.2</u></div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">18&#160;U.S.C. SECTION&#160;1350</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">AS ADOPTED PURSUANT TO SECTION&#160;906</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">OF THE SARBANES-OXLEY ACT OF 2002</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">In connection with the Annual Report of ReWalk Robotics Ltd. (the &#8220;Company&#8221;) on Form&#160;10-K for the period ended December&#160;31, 2020, as
        filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;),&#160;I, Ori Gon, do hereby certify, pursuant to 18&#160;U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zb37629ff5cdf413bbffaf52400a06990" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" id="z8471ba82b0a743e99add5f4d443a2116" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z9a0c13b52ec34955991785720348fd3a" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 50%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
            <td style="width: 25%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; line-height: 1.25;">/s/ Ori Gon</div>
            </td>
            <td style="width: 25%; vertical-align: top; padding-bottom: 2px;" colspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 25%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">Ori Gon</div>
            </td>
            <td style="width: 25%; vertical-align: top;" colspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 25%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">Chief Financial Officer</div>
            </td>
            <td style="width: 25%; vertical-align: top;" colspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 25%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">(Principal Financial Officer)</div>
            </td>
            <td style="width: 25%; vertical-align: top;" colspan="1">&#160;</td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">Date: February 18, 2021</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company
        and furnished to the Securities and Exchange Commission or its staff upon request.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">
        <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>10
<FILENAME>rwlk-20201231.xml
<DESCRIPTION>XBRL INSTANCE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoXBRL; Version: 5.6b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Source; Value: RWLK 1220 10K.xfr; Date: 2021%2D02%2D18T13:24:26Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<xbrli:xbrl xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:us-roles="http://fasb.org/us-roles/2020-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:us-types="http://fasb.org/us-types/2020-01-31" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:rwlk="http://rewalk.com/20201231">
    <link:schemaRef xlink:href="rwlk-20201231.xsd" xlink:type="simple" />
    <xbrli:context id="Context_As_Of_30_Sep_2017T00_00_00_TO_30_Sep_2017T00_00_00">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_country_IL">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="Context_As_Of_30_Sep_2017T00_00_00_TO_30_Sep_2017T00_00_00_StatementGeographicalAxis_US">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="Context_As_Of_30_Sep_2017T00_00_00_TO_30_Sep_2017T00_00_00_StatementGeographicalAxis_DE">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_country_IL">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="Context_9ME_01_Jan_2016T00_00_00_TO_30_Sep_2016T00_00_00_StatementGeographicalAxis_US">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="Context_9ME_01_Jan_2016T00_00_00_TO_30_Sep_2016T00_00_00_StatementGeographicalAxis_EuropeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="Context_9ME_01_Jan_2016T00_00_00_TO_30_Sep_2016T00_00_00_StatementGeographicalAxis_AsiaPacificMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_country_IL">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00_StatementGeographicalAxis_US">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00_StatementGeographicalAxis_EuropeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00_StatementGeographicalAxis_AsiaPacificMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_LatinAmericaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:LatinAmericaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_us-gaap_LatinAmericaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:LatinAmericaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_UnitsPlacedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="rwlk:RevenueObligationAxis">rwlk:UnitsPlacedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_SparePartsAndWarrantiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="rwlk:RevenueObligationAxis">rwlk:SparePartsAndWarrantiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_UnitsPlacedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="rwlk:RevenueObligationAxis">rwlk:UnitsPlacedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_SparePartsAndWarrantiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="rwlk:RevenueObligationAxis">rwlk:SparePartsAndWarrantiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_srt_AfricaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AfricaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_srt_AfricaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AfricaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00_AgreementAxis_LicenseAgreementAndCollaborationAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="rwlk:AgreementAxis">rwlk:LicenseAgreementAndCollaborationAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_CustomerAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">rwlk:CustomerAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_CustomerBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">rwlk:CustomerBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_CustomerCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">rwlk:CustomerCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_CustomerDMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">rwlk:CustomerDMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_CustomerEMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">rwlk:CustomerEMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_CustomerFMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">rwlk:CustomerFMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_CustomerGMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">rwlk:CustomerGMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_CustomerHMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">rwlk:CustomerHMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_CustomerIMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">rwlk:CustomerIMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_CustomerJMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">rwlk:CustomerJMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_CustomerKMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">rwlk:CustomerKMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_YaskawaElectricCorporationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">rwlk:YaskawaElectricCorporationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_YaskawaElectricCorporationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">rwlk:YaskawaElectricCorporationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_us-gaap_SalesRevenueNetMember_custom_CustomerAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">rwlk:CustomerAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_SalesRevenueNetMember_custom_CustomerAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">rwlk:CustomerAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_CustomerLMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">rwlk:CustomerLMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="Context_As_Of_30_Sep_2017T00_00_00_TO_30_Sep_2017T00_00_00_AwardTypeAxis_EmployeeStockOptionAndRestrictedStockUnitsRsuMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rwlk:EmployeeStockOptionAndRestrictedStockUnitsRsuMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">rwlk:ExercisePriceRangeTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">rwlk:ExercisePriceRangeThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeFiveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">rwlk:ExercisePriceRangeFiveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeFourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">rwlk:ExercisePriceRangeFourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_EmployeeStockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">rwlk:ExercisePriceRangeTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">rwlk:ExercisePriceRangeThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeFiveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">rwlk:ExercisePriceRangeFiveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeFourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">rwlk:ExercisePriceRangeFourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">rwlk:ExercisePriceRangeOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">rwlk:ExercisePriceRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_EmployeeStockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">rwlk:ExercisePriceRangeOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">rwlk:ExercisePriceRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwoThousandSixteenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rwlk:WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwoThousandSixteenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandSixteenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rwlk:WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandSixteenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandFifteenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rwlk:WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandFifteenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rwlk:WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rwlk:WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentyFiveTwoThousandNineteenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rwlk:WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentyFiveTwoThousandNineteenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rwlk:WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rwlk:WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveAndSixTwoThousandNineteenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rwlk:WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveAndSixTwoThousandNineteenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveTwoThousandNineteenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rwlk:WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveTwoThousandNineteenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTweleveTwoThousandNineteenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rwlk:WarrantsToPurchaseOrdinarySharesIssuedOnJuneTweleveTwoThousandNineteenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTenTwoThousandNineteenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rwlk:WarrantsToPurchaseOrdinarySharesIssuedOnJuneTenTwoThousandNineteenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31_custom_KreosCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">rwlk:KreosCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-06-12_custom_SecuritiesPurchaseAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="rwlk:AgreementAxis">rwlk:SecuritiesPurchaseAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-06-12</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-04-30_custom_SecuritiesPurchaseAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="rwlk:AgreementAxis">rwlk:SecuritiesPurchaseAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="Context_9ME_01_Jan_2016T00_00_00_TO_30_Sep_2016T00_00_00_IncomeStatementLocationAxis_SellingAndMarketingExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="Context_9ME_01_Jan_2016T00_00_00_TO_30_Sep_2016T00_00_00_IncomeStatementLocationAxis_ResearchAndDevelopmentExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="Context_9ME_01_Jan_2016T00_00_00_TO_30_Sep_2016T00_00_00_IncomeStatementLocationAxis_CostOfSalesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="Context_9ME_01_Jan_2016T00_00_00_TO_30_Sep_2016T00_00_00_IncomeStatementLocationAxis_GeneralAndAdministrativeExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00_IncomeStatementLocationAxis_SellingAndMarketingExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00_IncomeStatementLocationAxis_ResearchAndDevelopmentExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00_IncomeStatementLocationAxis_CostOfSalesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00_IncomeStatementLocationAxis_GeneralAndAdministrativeExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_EmployeesAndNonEmployeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">rwlk:EmployeesAndNonEmployeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_EmployeesAndNonEmployeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">rwlk:EmployeesAndNonEmployeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-02-01to2019-02-28_us-gaap_PrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-02-01</xbrli:startDate>
        <xbrli:endDate>2019-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwoThousandSixteenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rwlk:WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwoThousandSixteenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rwlk:WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rwlk:WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentyFiveTwoThousandNineteenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rwlk:WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentyFiveTwoThousandNineteenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rwlk:WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rwlk:WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveAndSixTwoThousandNineteenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rwlk:WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveAndSixTwoThousandNineteenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveTwoThousandNineteenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rwlk:WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveTwoThousandNineteenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTweleveTwoThousandNineteenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rwlk:WarrantsToPurchaseOrdinarySharesIssuedOnJuneTweleveTwoThousandNineteenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTenTwoThousandNineteenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rwlk:WarrantsToPurchaseOrdinarySharesIssuedOnJuneTenTwoThousandNineteenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-12-31_custom_KreosCapitalVMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rwlk:KreosCapitalVMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-12-28_custom_KreosCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">rwlk:KreosCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-12-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-02-22to2018-03-06_custom_TimwellCorporationLimitedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">rwlk:TimwellCorporationLimitedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-02-22</xbrli:startDate>
        <xbrli:endDate>2018-03-06</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-05-10_custom_AtmOfferingProgramMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">rwlk:AtmOfferingProgramMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-05-10</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="Context_As_Of_31_Dec_2016T00_00_00_TO_31_Dec_2016T00_00_00">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00_AwardTypeAxis_RestrictedStockUnitsRSUMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="Context_9ME_01_Jan_2016T00_00_00_TO_30_Sep_2016T00_00_00_AwardTypeAxis_RestrictedStockUnitsRSUMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-05-04to2018-05-31_custom_TimwellCorporationLimitedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">rwlk:TimwellCorporationLimitedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-05-04</xbrli:startDate>
        <xbrli:endDate>2018-05-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-09_custom_FirstAmendmentMember_us-gaap_SecuredDebtMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rwlk:FirstAmendmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-09</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-03-01to2019-03-27">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-03-01</xbrli:startDate>
        <xbrli:endDate>2019-03-27</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-04-01to2019-04-30_custom_SecuritiesPurchaseAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="rwlk:AgreementAxis">rwlk:SecuritiesPurchaseAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-04-01</xbrli:startDate>
        <xbrli:endDate>2019-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-04-01to2019-04-30_custom_SecuritiesPurchaseAgreementsMember_custom_WarrantsToPurchaseOrdinarySharesIssuedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="rwlk:AgreementAxis">rwlk:SecuritiesPurchaseAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rwlk:WarrantsToPurchaseOrdinarySharesIssuedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-04-01</xbrli:startDate>
        <xbrli:endDate>2019-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-05-14to2019-06-05_custom_SecuritiesPurchaseAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="rwlk:AgreementAxis">rwlk:SecuritiesPurchaseAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-05-14</xbrli:startDate>
        <xbrli:endDate>2019-06-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-05-14to2019-06-05_custom_SecuritiesPurchaseAgreementsMember_custom_WarrantsToPurchaseOrdinarySharesIssuedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="rwlk:AgreementAxis">rwlk:SecuritiesPurchaseAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rwlk:WarrantsToPurchaseOrdinarySharesIssuedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-05-14</xbrli:startDate>
        <xbrli:endDate>2019-06-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-05-14to2019-06-06_custom_SecuritiesPurchaseAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="rwlk:AgreementAxis">rwlk:SecuritiesPurchaseAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-05-14</xbrli:startDate>
        <xbrli:endDate>2019-06-06</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-05-14to2019-06-06_custom_SecuritiesPurchaseAgreementsMember_custom_WarrantsToPurchaseOrdinarySharesIssuedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="rwlk:AgreementAxis">rwlk:SecuritiesPurchaseAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rwlk:WarrantsToPurchaseOrdinarySharesIssuedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-05-14</xbrli:startDate>
        <xbrli:endDate>2019-06-06</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-05-22to2019-06-12_custom_SecuritiesPurchaseAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="rwlk:AgreementAxis">rwlk:SecuritiesPurchaseAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-05-22</xbrli:startDate>
        <xbrli:endDate>2019-06-12</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-05-22to2019-06-12_custom_SecuritiesPurchaseAgreementsMember_custom_WarrantsToPurchaseOrdinarySharesIssuedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="rwlk:AgreementAxis">rwlk:SecuritiesPurchaseAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rwlk:WarrantsToPurchaseOrdinarySharesIssuedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-05-22</xbrli:startDate>
        <xbrli:endDate>2019-06-12</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-11-02to2018-11-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-11-02</xbrli:startDate>
        <xbrli:endDate>2018-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-04-30_custom_SecuritiesPurchaseAgreementsMember_custom_WarrantsToPurchaseOrdinarySharesIssuedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="rwlk:AgreementAxis">rwlk:SecuritiesPurchaseAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rwlk:WarrantsToPurchaseOrdinarySharesIssuedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-06-05_custom_SecuritiesPurchaseAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="rwlk:AgreementAxis">rwlk:SecuritiesPurchaseAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-06-05</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-06-05_custom_SecuritiesPurchaseAgreementsMember_custom_WarrantsToPurchaseOrdinarySharesIssuedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="rwlk:AgreementAxis">rwlk:SecuritiesPurchaseAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rwlk:WarrantsToPurchaseOrdinarySharesIssuedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-06-05</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-06-06_custom_SecuritiesPurchaseAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="rwlk:AgreementAxis">rwlk:SecuritiesPurchaseAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-06-06</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-06-06_custom_SecuritiesPurchaseAgreementsMember_custom_WarrantsToPurchaseOrdinarySharesIssuedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="rwlk:AgreementAxis">rwlk:SecuritiesPurchaseAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rwlk:WarrantsToPurchaseOrdinarySharesIssuedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-06-06</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-06-12_custom_SecuritiesPurchaseAgreementsMember_custom_WarrantsToPurchaseOrdinarySharesIssuedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="rwlk:AgreementAxis">rwlk:SecuritiesPurchaseAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rwlk:WarrantsToPurchaseOrdinarySharesIssuedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-06-12</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-06-12_custom_SecuritiesPurchaseAgreementsMember_custom_IsraeliMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="rwlk:AgreementAxis">rwlk:SecuritiesPurchaseAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="rwlk:TypeofCurrencyAxis">rwlk:IsraeliMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-06-12</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00_StatementEquityComponentsAxis_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00_StatementEquityComponentsAxis_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_FieldServiceUnitsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rwlk:FieldServiceUnitsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_ComputerEquipmentMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_ComputerEquipmentMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_FurnitureAndFixturesMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_FurnitureAndFixturesMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_MachineryAndLaboratoryEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rwlk:MachineryAndLaboratoryEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-12-31_us-gaap_AccountingStandardsUpdate201609Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201609Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_ComputerEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_FurnitureAndFixturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_MachineryAndLaboratoryEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rwlk:MachineryAndLaboratoryEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_FieldServiceUnitsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rwlk:FieldServiceUnitsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-12-26to2015-12-30_us-gaap_SecuredDebtMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-12-26</xbrli:startDate>
        <xbrli:endDate>2015-12-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="I2015Q4Dec30_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-11-01to2018-11-20_custom_SecondAmendmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rwlk:SecondAmendmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-11-01</xbrli:startDate>
        <xbrli:endDate>2018-11-20</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_RrlAndRrgMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rwlk:RrlAndRrgMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="FD2016Q4YTD">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="FD2018Q4YTD_us-gaap_IncomeTaxAuthorityNameAxis_us-gaap_IsraelTaxAuthorityMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:IsraelTaxAuthorityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_ReWalkRoboticsGMBHMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rwlk:ReWalkRoboticsGMBHMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_ReWalkRoboticsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rwlk:ReWalkRoboticsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_ReWalkRoboticsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rwlk:ReWalkRoboticsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_ReWalkRoboticsGMBHMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rwlk:ReWalkRoboticsGMBHMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_IsraelTaxAuthorityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:IsraelTaxAuthorityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2010-12-25to2010-12-29">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2010-12-25</xbrli:startDate>
        <xbrli:endDate>2010-12-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_us-gaap_EmployeeStockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="Context_As_Of_31_Dec_2016T00_00_00_TO_31_Dec_2016T00_00_00_StatementEquityComponentsAxis_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="Context_As_Of_31_Dec_2016T00_00_00_TO_31_Dec_2016T00_00_00_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="Context_As_Of_31_Dec_2016T00_00_00_TO_31_Dec_2016T00_00_00_StatementEquityComponentsAxis_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="Context_As_Of_30_Sep_2017T00_00_00_TO_30_Sep_2017T00_00_00_StatementEquityComponentsAxis_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="Context_As_Of_30_Sep_2017T00_00_00_TO_30_Sep_2017T00_00_00_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="Context_As_Of_30_Sep_2017T00_00_00_TO_30_Sep_2017T00_00_00_StatementEquityComponentsAxis_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_BestOfferingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">rwlk:BestOfferingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_AtmOfferingProgramMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">rwlk:AtmOfferingProgramMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_RegisteredDirectMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">rwlk:RegisteredDirectMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_WarrantExerciseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">rwlk:WarrantExerciseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_InvestmentAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">rwlk:InvestmentAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_RegisteredDirectOfferingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">rwlk:RegisteredDirectOfferingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_PublicStockOfferingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">rwlk:PublicStockOfferingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_BestOfferingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">rwlk:BestOfferingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_RegisteredDirectOfferingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">rwlk:RegisteredDirectOfferingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_PrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_RegisteredDirectMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">rwlk:RegisteredDirectMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_AtmOfferingProgramMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">rwlk:AtmOfferingProgramMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_UnitsPlacedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="rwlk:RevenueObligationAxis">rwlk:UnitsPlacedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_SparePartsAndWarrantiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="rwlk:RevenueObligationAxis">rwlk:SparePartsAndWarrantiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_CustomerAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">rwlk:CustomerAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_CustomerBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">rwlk:CustomerBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_CustomerCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">rwlk:CustomerCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_CustomerDMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">rwlk:CustomerDMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_CustomerEMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">rwlk:CustomerEMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_CustomerFMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">rwlk:CustomerFMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_CustomerGMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">rwlk:CustomerGMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_CustomerHMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">rwlk:CustomerHMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_CustomerIMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">rwlk:CustomerIMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_CustomerJMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">rwlk:CustomerJMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_CustomerKMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">rwlk:CustomerKMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_CustomerLMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">rwlk:CustomerLMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_EmployeesAndNonEmployeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">rwlk:EmployeesAndNonEmployeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_YaskawaElectricCorporationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">rwlk:YaskawaElectricCorporationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_ReStoreProductMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rwlk:ReStoreProductMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_SCIProductsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rwlk:SCIProductsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_FieldServiceUnitsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rwlk:FieldServiceUnitsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_MachineryAndLaboratoryEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rwlk:MachineryAndLaboratoryEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_FurnitureAndFixturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_ComputerEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_IsraelUSBinationalIndustrialResearchAndDevelopmentFoundationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rwlk:IsraelUSBinationalIndustrialResearchAndDevelopmentFoundationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_IsraelInnovationAuthorityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rwlk:IsraelInnovationAuthorityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_IsraelInnovationAuthorityMember_us-gaap_ConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rwlk:IsraelInnovationAuthorityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_IPOMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_IsraelInnovationAuthorityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rwlk:IsraelInnovationAuthorityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_EmployeeStockOptionAndRestrictedStockUnitsRsuMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rwlk:EmployeeStockOptionAndRestrictedStockUnitsRsuMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_EmployeeStockOptionAndRestrictedStockUnitsRsuMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rwlk:EmployeeStockOptionAndRestrictedStockUnitsRsuMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_GeneralAndAdministrativeExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_SellingAndMarketingExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_ResearchAndDevelopmentExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_CostOfSalesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_LicenseAgreementAndCollaborationAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="rwlk:AgreementAxis">rwlk:LicenseAgreementAndCollaborationAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_ReWalkRoboticsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rwlk:ReWalkRoboticsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_IsraelTaxAuthorityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:IsraelTaxAuthorityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_ReWalkRoboticsGMBHMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rwlk:ReWalkRoboticsGMBHMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_country_IL">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_country_US">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_srt_EuropeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_srt_AsiaPacificMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_srt_LatinAmericaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:LatinAmericaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_srt_AfricaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AfricaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_country_IL">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_country_US">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_country_DE">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_SalesRevenueNetMember_custom_CustomerAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">rwlk:CustomerAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_EmployeeStockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2020-12-31_custom_EquityExchangeProgramMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="rwlk:AgreementAxis">rwlk:EquityExchangeProgramMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_ReWalkRoboticsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rwlk:ReWalkRoboticsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandFifteenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rwlk:WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandFifteenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandSixteenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rwlk:WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandSixteenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_IsraelInnovationAuthorityMember_us-gaap_ConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rwlk:IsraelInnovationAuthorityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-04-21_custom_PaycheckProtectionProgramLoanMember_custom_SiliconValleyBankMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rwlk:PaycheckProtectionProgramLoanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rwlk:SiliconValleyBankMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-04-21</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-04-01to2020-04-21_custom_PaycheckProtectionProgramLoanMember_custom_SiliconValleyBankMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rwlk:PaycheckProtectionProgramLoanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rwlk:SiliconValleyBankMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-04-01</xbrli:startDate>
        <xbrli:endDate>2020-04-21</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rwlk:WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rwlk:WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rwlk:WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rwlk:WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberThreeTwoThousandTwentyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rwlk:WarrantsToPurchaseOrdinarySharesIssuedOnDecemberThreeTwoThousandTwentyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberThreeTwoThousandTwentyOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rwlk:WarrantsToPurchaseOrdinarySharesIssuedOnDecemberThreeTwoThousandTwentyOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rwlk:WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rwlk:WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rwlk:WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rwlk:WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberThreeTwoThousandTwentyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rwlk:WarrantsToPurchaseOrdinarySharesIssuedOnDecemberThreeTwoThousandTwentyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberThreeTwoThousandTwentyOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rwlk:WarrantsToPurchaseOrdinarySharesIssuedOnDecemberThreeTwoThousandTwentyOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_RestrictedStockUnitsRSUMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_EmployeeStockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-02-01to2021-02-10_custom_CommonUnitsAndPreFundedUnitsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">rwlk:CommonUnitsAndPreFundedUnitsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-02-01</xbrli:startDate>
        <xbrli:endDate>2021-02-10</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-02-10_custom_CommonUnitsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">rwlk:CommonUnitsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-02-10</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-02-10_custom_PreFundedUnitsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">rwlk:PreFundedUnitsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-02-10</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-02-10_custom_CommonUnitsAndPreFundedUnitsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">rwlk:CommonUnitsAndPreFundedUnitsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-02-10</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_CommonUnitsAndPreFundedUnits1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">rwlk:CommonUnitsAndPreFundedUnits1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-01to2020-07-06_custom_PurchaseAgreementWithCertainInstitutionalInvestorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">rwlk:PurchaseAgreementWithCertainInstitutionalInvestorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-07-06</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-07-06_custom_PurchaseAgreementWithCertainInstitutionalInvestorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">rwlk:PurchaseAgreementWithCertainInstitutionalInvestorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-07-06</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-07-06_custom_PurchaseAgreementWithCertainInstitutionalInvestorsMember_custom_AdditionallyWarrantsIssuedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">rwlk:PurchaseAgreementWithCertainInstitutionalInvestorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">rwlk:AdditionallyWarrantsIssuedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-07-06</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-12-01to2020-12-03_custom_PurchaseAgreementWithCertainInstitutionalInvestorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">rwlk:PurchaseAgreementWithCertainInstitutionalInvestorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-12-01</xbrli:startDate>
        <xbrli:endDate>2020-12-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-03_custom_PurchaseAgreementWithCertainInstitutionalInvestorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">rwlk:PurchaseAgreementWithCertainInstitutionalInvestorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-03_custom_PurchaseAgreementWithCertainInstitutionalInvestorsMember_custom_AdditionallyWarrantsIssuedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">rwlk:PurchaseAgreementWithCertainInstitutionalInvestorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">rwlk:AdditionallyWarrantsIssuedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_LicenseAgreementAndCollaborationAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="rwlk:AgreementAxis">rwlk:LicenseAgreementAndCollaborationAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-02-16">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-02-16</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30_us-gaap_SecuredDebtMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-12-26to2016-01-04_us-gaap_SecuredDebtMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-12-26</xbrli:startDate>
        <xbrli:endDate>2016-01-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-01-04_us-gaap_SecuredDebtMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-01-04</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-12-28_us-gaap_SecuredDebtMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-12-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-11-20_custom_SecondAmendmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rwlk:SecondAmendmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-11-20</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-11-01to2018-11-20_custom_SecondAmendmentMember_custom_PreFundedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rwlk:SecondAmendmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">rwlk:PreFundedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-11-01</xbrli:startDate>
        <xbrli:endDate>2018-11-20</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-06-06_us-gaap_SecuredDebtMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-06-06</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_SecuredDebtMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-06-01to2017-06-30_us-gaap_SecuredDebtMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-06-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-01-02_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-01-02</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-01-02_us-gaap_SubsequentEventMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-01-02</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-01-02_us-gaap_SubsequentEventMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-01-02</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-01to2021-01-02_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-01-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USD_per_Share">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="segment">
      <xbrli:measure>rwlk:segment</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="ILS_Per_Share">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:ILS</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="Context_As_Of_30_Sep_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">501000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2019-12-31_country_IL" unitRef="USD" decimals="-3">179000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="Context_As_Of_30_Sep_2017T00_00_00_TO_30_Sep_2017T00_00_00_StatementGeographicalAxis_US" unitRef="USD" decimals="-3">244000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="Context_As_Of_30_Sep_2017T00_00_00_TO_30_Sep_2017T00_00_00_StatementGeographicalAxis_DE" unitRef="USD" decimals="-3">78000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2020-12-31" unitRef="USD" decimals="-3">437000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2020-12-31_country_IL" unitRef="USD" decimals="-3">145000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2020-12-31_country_US" unitRef="USD" decimals="-3">249000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2020-12-31_country_DE" unitRef="USD" decimals="-3">43000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Revenues contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">4873000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2018-01-01to2018-12-31_country_IL" unitRef="USD" xsi:nil="true" />
    <us-gaap:Revenues contextRef="Context_9ME_01_Jan_2016T00_00_00_TO_30_Sep_2016T00_00_00_StatementGeographicalAxis_US" unitRef="USD" decimals="-3">3558000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="Context_9ME_01_Jan_2016T00_00_00_TO_30_Sep_2016T00_00_00_StatementGeographicalAxis_EuropeMember" unitRef="USD" decimals="-3">2807000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="Context_9ME_01_Jan_2016T00_00_00_TO_30_Sep_2016T00_00_00_StatementGeographicalAxis_AsiaPacificMember" unitRef="USD" decimals="-3">22000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2019-01-01to2019-12-31_country_IL" unitRef="USD" decimals="-3">2000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00_StatementGeographicalAxis_US" unitRef="USD" decimals="-3">2003000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00_StatementGeographicalAxis_EuropeMember" unitRef="USD" decimals="-3">2832000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00_StatementGeographicalAxis_AsiaPacificMember" unitRef="USD" decimals="-3">36000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2019-01-01to2019-12-31_us-gaap_LatinAmericaMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:Revenues contextRef="From2018-01-01to2018-12-31_us-gaap_LatinAmericaMember" unitRef="USD" decimals="-3">58000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2019-01-01to2019-12-31_custom_UnitsPlacedMember" unitRef="USD" decimals="-3">4385000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2019-01-01to2019-12-31_custom_SparePartsAndWarrantiesMember" unitRef="USD" decimals="-3">488000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2018-01-01to2018-12-31_custom_UnitsPlacedMember" unitRef="USD" decimals="-3">6237000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2018-01-01to2018-12-31_custom_SparePartsAndWarrantiesMember" unitRef="USD" decimals="-3">308000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">6545000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2019-01-01to2019-12-31_srt_AfricaMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:Revenues contextRef="From2018-01-01to2018-12-31_srt_AfricaMember" unitRef="USD" decimals="-3">100000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="-3">4393000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2020-01-01to2020-12-31_custom_UnitsPlacedMember" unitRef="USD" decimals="-3">3620000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2020-01-01to2020-12-31_custom_SparePartsAndWarrantiesMember" unitRef="USD" decimals="-3">773000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2020-01-01to2020-12-31_country_IL" unitRef="USD" xsi:nil="true" />
    <us-gaap:Revenues contextRef="From2020-01-01to2020-12-31_country_US" unitRef="USD" decimals="-3">1746000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2020-01-01to2020-12-31_srt_EuropeMember" unitRef="USD" decimals="-3">2631000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2020-01-01to2020-12-31_srt_AsiaPacificMember" unitRef="USD" decimals="-3">8000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2020-01-01to2020-12-31_srt_LatinAmericaMember" unitRef="USD" decimals="-3">6000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2020-01-01to2020-12-31_srt_AfricaMember" unitRef="USD" decimals="-3">2000</us-gaap:Revenues>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">5348000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">7349000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00_AgreementAxis_LicenseAgreementAndCollaborationAgreementMember" unitRef="USD" decimals="-3">1600000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="-3">3459000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2020-01-01to2020-12-31_custom_LicenseAgreementAndCollaborationAgreementMember" unitRef="USD" decimals="-3">800000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2018-01-01to2018-12-31_custom_LicenseAgreementAndCollaborationAgreementMember" unitRef="USD" decimals="-3">900000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="Context_As_Of_30_Sep_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">31000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="AsOf2020-12-31" unitRef="USD" decimals="-3">102000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <rwlk:AllowanceForSalesReturns contextRef="Context_As_Of_30_Sep_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">86000</rwlk:AllowanceForSalesReturns>
    <rwlk:AllowanceForSalesReturns contextRef="AsOf2020-12-31" unitRef="USD" decimals="-3">0</rwlk:AllowanceForSalesReturns>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2019-01-01to2019-12-31_custom_CustomerAMember" unitRef="pure" id="Foot-00-0" xsi:nil="true" />
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2019-01-01to2019-12-31_custom_CustomerBMember" unitRef="pure" id="Foot-00-1" xsi:nil="true" />
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2019-01-01to2019-12-31_custom_CustomerCMember" unitRef="pure" id="Foot-00-2" xsi:nil="true" />
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2019-01-01to2019-12-31_custom_CustomerDMember" unitRef="pure" id="Foot-00-3" xsi:nil="true" />
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2019-01-01to2019-12-31_custom_CustomerEMember" unitRef="pure" id="Foot-00-4" decimals="INF">0.12</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2019-01-01to2019-12-31_custom_CustomerFMember" unitRef="pure" id="Foot-00-5" xsi:nil="true" />
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2019-01-01to2019-12-31_custom_CustomerGMember" unitRef="pure" decimals="INF">0.14</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2019-01-01to2019-12-31_custom_CustomerHMember" unitRef="pure" id="Foot-00-6" decimals="INF">0.13</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2019-01-01to2019-12-31_custom_CustomerIMember" unitRef="pure" id="Foot-00-7" decimals="INF">0.13</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2019-01-01to2019-12-31_custom_CustomerJMember" unitRef="pure" id="Foot-00-8" decimals="INF">0.12</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2019-01-01to2019-12-31_custom_CustomerKMember" unitRef="pure" id="Foot-00-9" decimals="INF">0.12</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2019-01-01to2019-12-31_custom_YaskawaElectricCorporationMember" unitRef="pure" decimals="INF">0.00</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2018-01-01to2018-12-31_us-gaap_SalesRevenueNetMember_custom_CustomerAMember" unitRef="pure" decimals="INF">0.380</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2019-01-01to2019-12-31_us-gaap_SalesRevenueNetMember_custom_CustomerAMember" unitRef="pure" decimals="INF">0.150</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2019-01-01to2019-12-31_custom_CustomerLMember" unitRef="pure" id="Foot-00-10" decimals="INF">0.12</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2020-01-01to2020-12-31_custom_CustomerAMember" unitRef="pure" decimals="INF">0.15</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2020-01-01to2020-12-31_custom_CustomerBMember" unitRef="pure" decimals="INF">0.15</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2020-01-01to2020-12-31_custom_CustomerCMember" unitRef="pure" decimals="INF">0.15</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2020-01-01to2020-12-31_custom_CustomerDMember" unitRef="pure" decimals="INF">0.14</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2020-01-01to2020-12-31_custom_CustomerEMember" unitRef="pure" decimals="INF">0.12</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2020-01-01to2020-12-31_custom_CustomerFMember" unitRef="pure" decimals="INF">0.11</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2020-01-01to2020-12-31_custom_CustomerGMember" unitRef="pure" id="Foot-00-11" xsi:nil="true" />
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2020-01-01to2020-12-31_custom_CustomerHMember" unitRef="pure" id="Foot-00-12" xsi:nil="true" />
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2020-01-01to2020-12-31_custom_CustomerIMember" unitRef="pure" id="Foot-00-13" xsi:nil="true" />
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2020-01-01to2020-12-31_custom_CustomerJMember" unitRef="pure" id="Foot-00-14" xsi:nil="true" />
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2020-01-01to2020-12-31_custom_CustomerKMember" unitRef="pure" id="Foot-00-15" xsi:nil="true" />
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2020-01-01to2020-12-31_custom_CustomerLMember" unitRef="pure" id="Foot-00-16" xsi:nil="true" />
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2020-01-01to2020-12-31_custom_YaskawaElectricCorporationMember" unitRef="pure" decimals="INF">0.00</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2020-01-01to2020-12-31_us-gaap_SalesRevenueNetMember_custom_CustomerAMember" unitRef="pure" decimals="INF">0.100</us-gaap:ConcentrationRiskPercentage1>
    <rwlk:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstandingNumber contextRef="Context_As_Of_30_Sep_2017T00_00_00_TO_30_Sep_2017T00_00_00_AwardTypeAxis_EmployeeStockOptionAndRestrictedStockUnitsRsuMember" unitRef="shares" decimals="INF">62378</rwlk:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstandingNumber>
    <rwlk:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstandingNumber contextRef="AsOf2020-12-31_custom_EmployeeStockOptionAndRestrictedStockUnitsRsuMember" unitRef="shares" decimals="INF">1251311</rwlk:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures contextRef="From2020-01-01to2020-12-31_custom_EmployeeStockOptionAndRestrictedStockUnitsRsuMember" unitRef="shares" decimals="INF">14141</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures>
    <rwlk:SharebasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeOutstandingOptionsAndEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice contextRef="Context_As_Of_30_Sep_2017T00_00_00_TO_30_Sep_2017T00_00_00_AwardTypeAxis_EmployeeStockOptionAndRestrictedStockUnitsRsuMember" unitRef="USD_per_Share" decimals="INF">44.61</rwlk:SharebasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeOutstandingOptionsAndEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice>
    <rwlk:SharebasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeOutstandingOptionsAndEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice contextRef="AsOf2020-12-31_custom_EmployeeStockOptionAndRestrictedStockUnitsRsuMember" unitRef="USD_per_Share" decimals="INF">3.20</rwlk:SharebasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeOutstandingOptionsAndEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="From2020-01-01to2020-12-31" unitRef="USD_per_Share" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit contextRef="From2020-01-01to2020-12-31_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeTwoMember" unitRef="USD_per_Share" decimals="INF">20.42</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit contextRef="From2020-01-01to2020-12-31_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeThreeMember" unitRef="USD_per_Share" decimals="INF">37.14</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit contextRef="From2020-01-01to2020-12-31_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeFiveMember" unitRef="USD_per_Share" decimals="INF">182.5</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit contextRef="From2020-01-01to2020-12-31_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeFourMember" unitRef="USD_per_Share" decimals="INF">50</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit contextRef="From2020-01-01to2020-12-31_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeTwoMember" unitRef="USD_per_Share" decimals="INF">33.75</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit contextRef="From2020-01-01to2020-12-31_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeThreeMember" unitRef="USD_per_Share" decimals="INF">38.75</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit contextRef="From2020-01-01to2020-12-31_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeFiveMember" unitRef="USD_per_Share" decimals="INF">524.25</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit contextRef="From2020-01-01to2020-12-31_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeFourMember" unitRef="USD_per_Share" decimals="INF">52.5</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="AsOf2020-12-31_us-gaap_EmployeeStockOptionMember" unitRef="shares" decimals="INF">1320917</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="AsOf2020-12-31_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeTwoMember" unitRef="shares" decimals="INF">36292</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="AsOf2020-12-31_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeThreeMember" unitRef="shares" decimals="INF">9992</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="AsOf2020-12-31_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeFiveMember" unitRef="shares" decimals="INF">2666</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="AsOf2020-12-31_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeFourMember" unitRef="shares" decimals="INF">8231</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="AsOf2020-12-31_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeOneMember" unitRef="shares" decimals="INF">12425</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="From2020-01-01to2020-12-31_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeTwoMember" id="Foot-01-0">P5Y3M4D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="From2020-01-01to2020-12-31_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeThreeMember" id="Foot-01-1">P2Y11M26D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="From2020-01-01to2020-12-31_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeFiveMember" id="Foot-01-2">P4Y10M3D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="From2020-01-01to2020-12-31_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeFourMember" id="Foot-01-3">P6Y5M5D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="From2020-01-01to2020-12-31_us-gaap_EmployeeStockOptionMember" id="Foot-01-4">P5Y7M2D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="From2020-01-01to2020-12-31_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeOneMember" id="Foot-01-5">P8Y2M27D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="From2020-01-01to2020-12-31_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeMember" id="Foot-01-6">P0Y</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="AsOf2020-12-31_us-gaap_EmployeeStockOptionMember" unitRef="shares" decimals="INF">52997</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="AsOf2020-12-31_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeTwoMember" unitRef="shares" decimals="INF">27598</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="AsOf2020-12-31_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeThreeMember" unitRef="shares" decimals="INF">9992</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="AsOf2020-12-31_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeFiveMember" unitRef="shares" decimals="INF">2666</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="AsOf2020-12-31_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeFourMember" unitRef="shares" decimals="INF">7306</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="AsOf2020-12-31_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeOneMember" unitRef="shares" decimals="INF">5435</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2 contextRef="From2020-01-01to2020-12-31_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeTwoMember" id="Foot-01-7">P4Y7M6D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2 contextRef="From2020-01-01to2020-12-31_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeThreeMember" id="Foot-01-8">P2Y11M26D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2 contextRef="From2020-01-01to2020-12-31_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeFiveMember" id="Foot-01-9">P4Y10M3D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2 contextRef="From2020-01-01to2020-12-31_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeFourMember" id="Foot-01-10">P6Y5M9D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2 contextRef="From2020-01-01to2020-12-31_us-gaap_EmployeeStockOptionMember" id="Foot-01-11">P4Y11M8D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2 contextRef="From2020-01-01to2020-12-31_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeOneMember" id="Foot-01-12">P8Y2M27D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2 contextRef="From2020-01-01to2020-12-31_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeMember" id="Foot-01-13">P0Y</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwoThousandSixteenMember" unitRef="USD_per_Share" id="Foot-02-0" decimals="INF">118.750</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandSixteenMember" unitRef="USD_per_Share" id="Foot-03-0" decimals="INF">7.500</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandFifteenMember" unitRef="USD_per_Share" id="Foot-04-0" decimals="INF">7.500</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenMember" unitRef="USD_per_Share" id="Foot-05-0" decimals="INF">7.500</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenOneMember" unitRef="USD_per_Share" id="Foot-06-0" decimals="INF">9.375</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentyFiveTwoThousandNineteenMember" unitRef="USD_per_Share" id="Foot-07-0" decimals="INF">7.187</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenMember" unitRef="USD_per_Share" id="Foot-08-0" decimals="INF">5.140</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenOneMember" unitRef="USD_per_Share" id="Foot-09-0" decimals="INF">6.503</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveAndSixTwoThousandNineteenMember" unitRef="USD_per_Share" id="Foot-10-0" decimals="INF">7.500</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveTwoThousandNineteenMember" unitRef="USD_per_Share" id="Foot-11-0" decimals="INF">9.375</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTweleveTwoThousandNineteenMember" unitRef="USD_per_Share" id="Foot-12-0" decimals="INF">6.000</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTenTwoThousandNineteenMember" unitRef="USD_per_Share" id="Foot-13-0" decimals="INF">7.500</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2015-12-31_custom_KreosCapitalMember" unitRef="USD_per_Share" decimals="INF">7.5</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2019-06-12_custom_SecuritiesPurchaseAgreementsMember" unitRef="USD_per_Share" decimals="INF">6.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2019-04-30_custom_SecuritiesPurchaseAgreementsMember" unitRef="USD_per_Share" decimals="INF">5.14</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyMember" unitRef="USD_per_Share" id="Foot-14-0" decimals="INF">1.250</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyOneMember" unitRef="USD_per_Share" id="Foot-15-0" decimals="INF">1.5625</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyMember" unitRef="USD_per_Share" id="Foot-16-0" decimals="INF">1.76</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyOneMember" unitRef="USD_per_Share" id="Foot-17-0" decimals="INF">2.2781</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberThreeTwoThousandTwentyMember" unitRef="USD_per_Share" id="Foot-18-0" decimals="INF">1.34</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberThreeTwoThousandTwentyOneMember" unitRef="USD_per_Share" id="Foot-19-0" decimals="INF">1.7922</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2020-02-10_custom_CommonUnitsAndPreFundedUnitsMember" unitRef="USD_per_Share" decimals="INF">1.5625</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2020-07-06_custom_PurchaseAgreementWithCertainInstitutionalInvestorsMember" unitRef="USD_per_Share" decimals="INF">1.76</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2020-07-06_custom_PurchaseAgreementWithCertainInstitutionalInvestorsMember_custom_AdditionallyWarrantsIssuedMember" unitRef="USD_per_Share" decimals="INF">2.2781</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2020-12-03_custom_PurchaseAgreementWithCertainInstitutionalInvestorsMember" unitRef="USD_per_Share" decimals="INF">1.34</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2020-12-03_custom_PurchaseAgreementWithCertainInstitutionalInvestorsMember_custom_AdditionallyWarrantsIssuedMember" unitRef="USD_per_Share" decimals="INF">1.7922</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2016-01-04_us-gaap_SecuredDebtMember" unitRef="USD_per_Share" decimals="INF">241.0</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2018-11-20_custom_SecondAmendmentMember" unitRef="USD_per_Share" decimals="INF">7.5</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2019-06-06_us-gaap_SecuredDebtMember" unitRef="USD_per_Share" decimals="INF">7.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2021-01-02_us-gaap_SubsequentEventMember_srt_MinimumMember" unitRef="ILS_Per_Share" decimals="INF">1.25</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2021-01-02_us-gaap_SubsequentEventMember_srt_MaximumMember" unitRef="ILS_Per_Share" decimals="INF">1.79</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">1108000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">2766000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="Context_9ME_01_Jan_2016T00_00_00_TO_30_Sep_2016T00_00_00_IncomeStatementLocationAxis_SellingAndMarketingExpenseMember" unitRef="USD" decimals="-3">467000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="Context_9ME_01_Jan_2016T00_00_00_TO_30_Sep_2016T00_00_00_IncomeStatementLocationAxis_ResearchAndDevelopmentExpenseMember" unitRef="USD" decimals="-3">435000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="Context_9ME_01_Jan_2016T00_00_00_TO_30_Sep_2016T00_00_00_IncomeStatementLocationAxis_CostOfSalesMember" unitRef="USD" decimals="-3">16000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="Context_9ME_01_Jan_2016T00_00_00_TO_30_Sep_2016T00_00_00_IncomeStatementLocationAxis_GeneralAndAdministrativeExpenseMember" unitRef="USD" decimals="-3">1848000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00_IncomeStatementLocationAxis_SellingAndMarketingExpenseMember" unitRef="USD" decimals="-3">166000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00_IncomeStatementLocationAxis_ResearchAndDevelopmentExpenseMember" unitRef="USD" decimals="-3">204000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00_IncomeStatementLocationAxis_CostOfSalesMember" unitRef="USD" decimals="-3">13000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00_IncomeStatementLocationAxis_GeneralAndAdministrativeExpenseMember" unitRef="USD" decimals="-3">725000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2018-01-01to2018-12-31_custom_EmployeesAndNonEmployeesMember" unitRef="USD" decimals="-3">2766000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2019-01-01to2019-12-31_custom_EmployeesAndNonEmployeesMember" unitRef="USD" decimals="-3">1108000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="-3">749000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2020-01-01to2020-12-31_custom_EmployeesAndNonEmployeesMember" unitRef="USD" decimals="-3">749000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2020-01-01to2020-12-31_us-gaap_GeneralAndAdministrativeExpenseMember" unitRef="USD" decimals="-3">442000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2020-01-01to2020-12-31_us-gaap_SellingAndMarketingExpenseMember" unitRef="USD" decimals="-3">163000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2020-01-01to2020-12-31_us-gaap_ResearchAndDevelopmentExpenseMember" unitRef="USD" decimals="-3">136000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2020-01-01to2020-12-31_us-gaap_CostOfSalesMember" unitRef="USD" decimals="-3">8000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:NumberOfReportableSegments contextRef="From2020-01-01to2020-12-31" unitRef="segment" decimals="INF">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:InventoryFinishedGoods contextRef="Context_As_Of_30_Sep_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">2394000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryFinishedGoods contextRef="AsOf2020-12-31" unitRef="USD" decimals="-3">2764000</us-gaap:InventoryFinishedGoods>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="pure" decimals="INF">0.575</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="From2018-01-01to2018-12-31_srt_MinimumMember" unitRef="pure" decimals="INF">0.57</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="From2018-01-01to2018-12-31_srt_MaximumMember" unitRef="pure" decimals="INF">0.61</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00">P6Y1M9D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2018-01-01to2018-12-31">P6Y1M9D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2020-01-01to2020-12-31_us-gaap_EmployeeStockOptionMember">P3Y2M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2020-01-01to2020-12-31">P0Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="pure" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="From2018-01-01to2018-12-31" unitRef="pure" xsi:nil="true" />
    <rwlk:InvestmentOptionsExercisePrices contextRef="From2020-01-01to2020-12-31_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeOneMember" unitRef="USD_per_Share" decimals="INF">5.37</rwlk:InvestmentOptionsExercisePrices>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="pure" decimals="INF">0.0222</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="From2018-01-01to2018-12-31_srt_MinimumMember" unitRef="pure" decimals="INF">0.0274</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="From2018-01-01to2018-12-31_srt_MaximumMember" unitRef="pure" decimals="INF">0.0283</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2020-01-01to2020-12-31" unitRef="shares" xsi:nil="true" />
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="Context_As_Of_30_Sep_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="ILS_Per_Share" decimals="INF">0.25</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2020-12-31" unitRef="ILS_Per_Share" decimals="INF">0.25</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2020-02-10_custom_CommonUnitsAndPreFundedUnitsMember" unitRef="ILS_Per_Share" decimals="INF">0.25</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2020-07-06_custom_PurchaseAgreementWithCertainInstitutionalInvestorsMember" unitRef="ILS_Per_Share" decimals="INF">0.25</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2020-12-03_custom_PurchaseAgreementWithCertainInstitutionalInvestorsMember" unitRef="ILS_Per_Share" decimals="INF">0.25</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:SharePrice contextRef="Context_As_Of_30_Sep_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD_per_Share" decimals="INF">5.37</us-gaap:SharePrice>
    <us-gaap:SharePrice contextRef="AsOf2018-12-31_srt_MinimumMember" unitRef="USD_per_Share" decimals="INF">25.5</us-gaap:SharePrice>
    <us-gaap:SharePrice contextRef="AsOf2018-12-31_srt_MaximumMember" unitRef="USD_per_Share" decimals="INF">28.75</us-gaap:SharePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod contextRef="From2020-01-01to2020-12-31_custom_EmployeeStockOptionAndRestrictedStockUnitsRsuMember" unitRef="shares" decimals="INF">63111</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="AsOf2020-12-31" unitRef="shares" decimals="INF">52997</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 contextRef="AsOf2020-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2020-01-01to2020-12-31_custom_LicenseAgreementAndCollaborationAgreementMember">2023-02-16</us-gaap:DebtInstrumentMaturityDate>
    <rwlk:ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsGrantedInPeriodWeightedAverageExercisePrice contextRef="From2020-01-01to2020-12-31_custom_EmployeeStockOptionAndRestrictedStockUnitsRsuMember" unitRef="USD_per_Share" decimals="INF">1.44</rwlk:ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsGrantedInPeriodWeightedAverageExercisePrice>
    <rwlk:ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsvestedInPeriodWeightedAverageExercisePrice contextRef="From2020-01-01to2020-12-31_custom_EmployeeStockOptionAndRestrictedStockUnitsRsuMember" unitRef="USD_per_Share" decimals="INF">7.83</rwlk:ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsvestedInPeriodWeightedAverageExercisePrice>
    <rwlk:ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsForfeitedInPeriodWeightedAverageExercisePrice contextRef="From2020-01-01to2020-12-31_custom_EmployeeStockOptionAndRestrictedStockUnitsRsuMember" unitRef="USD_per_Share" decimals="INF">6.05</rwlk:ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsForfeitedInPeriodWeightedAverageExercisePrice>
    <us-gaap:InventoryRawMaterials contextRef="Context_As_Of_30_Sep_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">729000</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryRawMaterials contextRef="AsOf2020-12-31" unitRef="USD" decimals="-3">778000</us-gaap:InventoryRawMaterials>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="Context_As_Of_30_Sep_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="shares" decimals="INF">74713</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2020-12-31" unitRef="shares" decimals="INF">69606</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="Context_As_Of_30_Sep_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD_per_Share" decimals="INF">41.6</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2020-12-31" unitRef="USD_per_Share" decimals="INF">37.9</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice contextRef="AsOf2020-12-31" unitRef="USD_per_Share" decimals="INF">43.76</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="Context_As_Of_30_Sep_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">135000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="AsOf2020-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" id="Foot-20-0" xsi:nil="true" />
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement contextRef="From2018-01-01to2018-12-31" unitRef="USD" id="Foot-20-1" xsi:nil="true" />
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement contextRef="From2019-02-01to2019-02-28_us-gaap_PrivatePlacementMember" unitRef="USD" decimals="-3">4370000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement contextRef="From2020-01-01to2020-12-31" unitRef="USD" id="Foot-20-2" decimals="-3">7041000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="From2020-01-01to2020-12-31" unitRef="shares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice contextRef="From2020-01-01to2020-12-31" unitRef="USD_per_Share" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice contextRef="From2020-01-01to2020-12-31" unitRef="USD_per_Share" decimals="INF">91.59</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:RoyaltyExpense contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">15000</us-gaap:RoyaltyExpense>
    <us-gaap:RoyaltyExpense contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="-3">46000</us-gaap:RoyaltyExpense>
    <rwlk:FinancialExpensesIncomeNet contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">1496000</rwlk:FinancialExpensesIncomeNet>
    <rwlk:FinancialExpensesIncomeNet contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">2466000</rwlk:FinancialExpensesIncomeNet>
    <rwlk:FinancialExpensesIncomeNet contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="-3">921000</rwlk:FinancialExpensesIncomeNet>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">7000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">-5000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="-3">51000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">-15551000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">-21675000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2018-01-01to2018-12-31_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2018-01-01to2018-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2018-01-01to2018-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="-3">-21675000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="USD" decimals="-3">-15551000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="-3">-12976000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2020-01-01to2020-12-31_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2020-01-01to2020-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2020-01-01to2020-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="-3">-12976000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD_per_Share" decimals="INF">-2.70</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2018-01-01to2018-12-31" unitRef="USD_per_Share" decimals="INF">-14.72</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2020-01-01to2020-12-31" unitRef="USD_per_Share" decimals="INF">-0.82</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="shares" decimals="INF">5763317</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="From2018-01-01to2018-12-31" unitRef="shares" decimals="INF">1472499</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="From2020-01-01to2020-12-31" unitRef="shares" decimals="INF">15764980</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:Depreciation contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">321000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">463000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="-3">285000</us-gaap:Depreciation>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">-57000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">-107000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="-3">-44000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="From2020-01-01to2020-12-31">P4Y11M8D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives contextRef="From2020-01-01to2020-12-31_custom_FieldServiceUnitsMember">50%</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
    <us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives contextRef="From2020-01-01to2020-12-31_us-gaap_LeaseholdImprovementsMember">Over&#160;the&#160;shorter&#160;of&#160;the&#160;lease  term or estimated useful life</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
    <us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives contextRef="From2020-01-01to2020-12-31_us-gaap_ComputerEquipmentMember_srt_MinimumMember">20%</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
    <us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives contextRef="From2020-01-01to2020-12-31_us-gaap_ComputerEquipmentMember_srt_MaximumMember">33%</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
    <us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives contextRef="From2020-01-01to2020-12-31_us-gaap_FurnitureAndFixturesMember_srt_MinimumMember">6%</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
    <us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives contextRef="From2020-01-01to2020-12-31_us-gaap_FurnitureAndFixturesMember_srt_MaximumMember">10%</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
    <us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives contextRef="From2020-01-01to2020-12-31_custom_MachineryAndLaboratoryEquipmentMember">15%</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
    <us-gaap:StandardProductWarrantyAccrual contextRef="Context_As_Of_30_Sep_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">227000</us-gaap:StandardProductWarrantyAccrual>
    <us-gaap:StandardProductWarrantyAccrual contextRef="AsOf2020-12-31" unitRef="USD" decimals="-3">140000</us-gaap:StandardProductWarrantyAccrual>
    <us-gaap:StandardProductWarrantyAccrualWarrantiesIssued contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="-3">125000</us-gaap:StandardProductWarrantyAccrualWarrantiesIssued>
    <us-gaap:StandardProductWarrantyAccrualPayments contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="-3">212000</us-gaap:StandardProductWarrantyAccrualPayments>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">-15551000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">-21675000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="-3">-12976000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:DeferredRevenue contextRef="Context_As_Of_30_Sep_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" id="Foot-21-0" decimals="-3">844000</us-gaap:DeferredRevenue>
    <us-gaap:DeferredRevenue contextRef="AsOf2020-12-31" unitRef="USD" id="Foot-21-1" decimals="-3">1108000</us-gaap:DeferredRevenue>
    <us-gaap:InventoryWriteDown contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">64000</us-gaap:InventoryWriteDown>
    <us-gaap:InventoryWriteDown contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">562000</us-gaap:InventoryWriteDown>
    <us-gaap:InventoryWriteDown contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="-3">215000</us-gaap:InventoryWriteDown>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" xsi:nil="true" />
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="From2018-01-01to2018-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="From2020-01-01to2020-12-31_custom_YaskawaElectricCorporationMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:RevenueFromRelatedParties contextRef="From2018-01-01to2018-12-31_custom_YaskawaElectricCorporationMember" unitRef="USD" decimals="-3">13000</us-gaap:RevenueFromRelatedParties>
    <us-gaap:RevenueFromRelatedParties contextRef="From2019-01-01to2019-12-31_custom_YaskawaElectricCorporationMember" unitRef="USD" decimals="-3">41000</us-gaap:RevenueFromRelatedParties>
    <us-gaap:RevenueFromRelatedParties contextRef="From2020-01-01to2020-12-31_custom_YaskawaElectricCorporationMember" unitRef="USD" decimals="-3">0</us-gaap:RevenueFromRelatedParties>
    <rwlk:RevenueRecognitionRecognized contextRef="From2020-01-01to2020-12-31">The estimated revenue expected to be recognized in the future related to the service type warranty amounts to $1,108 thousand, which is fulfilled over one to five years.</rwlk:RevenueRecognitionRecognized>
    <rwlk:CumulativeEffectOnRetainedEarningsNetOfTax contextRef="From2016-01-01to2016-12-31_us-gaap_AccountingStandardsUpdate201609Member" unitRef="USD" decimals="-3">11000</rwlk:CumulativeEffectOnRetainedEarningsNetOfTax>
    <rwlk:SeverancePayMonthlyDepositByEmployeesPercentage contextRef="From2020-01-01to2020-12-31" unitRef="pure" decimals="INF">0.0833</rwlk:SeverancePayMonthlyDepositByEmployeesPercentage>
    <us-gaap:PostemploymentBenefitsPeriodExpense contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">156000</us-gaap:PostemploymentBenefitsPeriodExpense>
    <us-gaap:PostemploymentBenefitsPeriodExpense contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">169000</us-gaap:PostemploymentBenefitsPeriodExpense>
    <us-gaap:PostemploymentBenefitsPeriodExpense contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="-3">125000</us-gaap:PostemploymentBenefitsPeriodExpense>
    <rwlk:RoyaltyBearingGrantsExpenses contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" xsi:nil="true" />
    <rwlk:RoyaltyBearingGrantsExpenses contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">198000</rwlk:RoyaltyBearingGrantsExpenses>
    <rwlk:RoyaltyBearingGrantsExpenses contextRef="From2020-01-01to2020-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:IncomeTaxExaminationLikelihoodOfUnfavorableSettlement contextRef="From2020-01-01to2020-12-31">50%</us-gaap:IncomeTaxExaminationLikelihoodOfUnfavorableSettlement>
    <rwlk:PrepaidExpensesToGovernmentInstitutionsCurrent contextRef="Context_As_Of_30_Sep_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">175000</rwlk:PrepaidExpensesToGovernmentInstitutionsCurrent>
    <rwlk:PrepaidExpensesToGovernmentInstitutionsCurrent contextRef="AsOf2020-12-31" unitRef="USD" decimals="-3">87000</rwlk:PrepaidExpensesToGovernmentInstitutionsCurrent>
    <us-gaap:PrepaidExpenseCurrent contextRef="Context_As_Of_30_Sep_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">318000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent contextRef="AsOf2020-12-31" unitRef="USD" decimals="-3">311000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:Supplies contextRef="Context_As_Of_30_Sep_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">246000</us-gaap:Supplies>
    <us-gaap:Supplies contextRef="AsOf2020-12-31" unitRef="USD" decimals="-3">241000</us-gaap:Supplies>
    <us-gaap:OtherAssetsCurrent contextRef="Context_As_Of_30_Sep_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">164000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent contextRef="AsOf2020-12-31" unitRef="USD" decimals="-3">33000</us-gaap:OtherAssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="Context_As_Of_30_Sep_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">3373000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2019-12-31_us-gaap_ComputerEquipmentMember" unitRef="USD" decimals="-3">723000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2019-12-31_us-gaap_FurnitureAndFixturesMember" unitRef="USD" decimals="-3">293000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2019-12-31_custom_MachineryAndLaboratoryEquipmentMember" unitRef="USD" decimals="-3">604000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2019-12-31_custom_FieldServiceUnitsMember" unitRef="USD" decimals="-3">1420000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2019-12-31_us-gaap_LeaseholdImprovementsMember" unitRef="USD" decimals="-3">333000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2020-12-31" unitRef="USD" decimals="-3">3594000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2020-12-31_custom_FieldServiceUnitsMember" unitRef="USD" decimals="-3">1626000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2020-12-31_custom_MachineryAndLaboratoryEquipmentMember" unitRef="USD" decimals="-3">612000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2020-12-31_us-gaap_FurnitureAndFixturesMember" unitRef="USD" decimals="-3">298000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2020-12-31_us-gaap_ComputerEquipmentMember" unitRef="USD" decimals="-3">725000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2020-12-31_us-gaap_LeaseholdImprovementsMember" unitRef="USD" decimals="-3">333000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="Context_As_Of_30_Sep_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">2872000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2020-12-31" unitRef="USD" decimals="-3">3157000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" id="Foot-22-0" xsi:nil="true" />
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt contextRef="From2020-01-01to2020-12-31" unitRef="USD" id="Foot-22-1" decimals="-3">392000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt contextRef="From2015-12-26to2016-01-04_us-gaap_SecuredDebtMember" unitRef="USD" decimals="-3">20000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:DebtInstrumentTerm contextRef="From2015-12-26to2015-12-30_us-gaap_SecuredDebtMember">P24M</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentTerm contextRef="From2020-04-01to2020-04-21_custom_PaycheckProtectionProgramLoanMember_custom_SiliconValleyBankMember">P2Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentTerm contextRef="From2017-06-01to2017-06-30_us-gaap_SecuredDebtMember">P36M</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="I2015Q4Dec30_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember" unitRef="pure" decimals="INF">0.1075</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="AsOf2020-04-21_custom_PaycheckProtectionProgramLoanMember_custom_SiliconValleyBankMember" unitRef="pure" decimals="INF">0.01</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <rwlk:DebtInstrumentProceedsfromIssuanceofCommonStockRequiredforRepaymentPeriodtobeExtended contextRef="AsOf2017-06-30_us-gaap_SecuredDebtMember" unitRef="USD" decimals="-3">20000000</rwlk:DebtInstrumentProceedsfromIssuanceofCommonStockRequiredforRepaymentPeriodtobeExtended>
    <rwlk:LongtermDebtMaturitiesPortionofPrincipalSubjecttoRepaymentExtension contextRef="AsOf2017-06-09_custom_FirstAmendmentMember_us-gaap_SecuredDebtMember" unitRef="USD" decimals="-3">3000000</rwlk:LongtermDebtMaturitiesPortionofPrincipalSubjecttoRepaymentExtension>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent contextRef="AsOf2020-12-31" unitRef="USD" decimals="-3">710000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears contextRef="AsOf2020-12-31" unitRef="USD" decimals="-3">676000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears contextRef="AsOf2020-12-31" unitRef="USD" decimals="-3">491000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDue contextRef="AsOf2020-12-31" unitRef="USD" decimals="-3">1877000</us-gaap:OperatingLeasesFutureMinimumPaymentsDue>
    <rwlk:ImputedInterest contextRef="AsOf2020-12-31" unitRef="USD" decimals="-3">-294000</rwlk:ImputedInterest>
    <us-gaap:PresentValueOfFutureMinimumLeasePaymentsSaleLeasebackTransactions contextRef="AsOf2020-12-31" unitRef="USD" decimals="-3">1583000</us-gaap:PresentValueOfFutureMinimumLeasePaymentsSaleLeasebackTransactions>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="AsOf2020-12-31">P2Y8M9D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="AsOf2020-12-31" unitRef="pure" decimals="INF">0.126</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:PurchaseObligation contextRef="AsOf2020-12-31" unitRef="USD" decimals="-3">700000</us-gaap:PurchaseObligation>
    <us-gaap:ProceedsFromRoyaltiesReceived contextRef="From2020-01-01to2020-12-31_custom_IsraelUSBinationalIndustrialResearchAndDevelopmentFoundationMember" unitRef="USD" decimals="-3">500000</us-gaap:ProceedsFromRoyaltiesReceived>
    <us-gaap:ProceedsFromRoyaltiesReceived contextRef="From2020-01-01to2020-12-31_custom_IsraelInnovationAuthorityMember" unitRef="USD" decimals="-3">1970000</us-gaap:ProceedsFromRoyaltiesReceived>
    <rwlk:ResearchAndDevelopmentRoyaltyBearingGrants contextRef="From2020-01-01to2020-12-31_custom_IsraelInnovationAuthorityMember" unitRef="USD" decimals="-3">1570000</rwlk:ResearchAndDevelopmentRoyaltyBearingGrants>
    <us-gaap:PaymentsForRoyalties contextRef="From2020-01-01to2020-12-31_custom_IsraelInnovationAuthorityMember" unitRef="USD" decimals="-3">88000</us-gaap:PaymentsForRoyalties>
    <rwlk:ResearchAndDevelopmentAmountReceivedInConsiderationOfConvertiblePreferredShares contextRef="From2020-01-01to2020-12-31_custom_IsraelInnovationAuthorityMember_us-gaap_ConvertiblePreferredStockMember" unitRef="USD" decimals="-3">400000</rwlk:ResearchAndDevelopmentAmountReceivedInConsiderationOfConvertiblePreferredShares>
    <us-gaap:ConversionOfStockDescription contextRef="From2020-01-01to2020-12-31_us-gaap_IPOMember">Ordinary shares in a conversion ratio of 1 to 1.</us-gaap:ConversionOfStockDescription>
    <rwlk:PercentageOfGrantReceivedConsideredToDetermineRoyaltyFees contextRef="From2020-01-01to2020-12-31_custom_IsraelInnovationAuthorityMember" unitRef="pure" decimals="INF">1.00</rwlk:PercentageOfGrantReceivedConsideredToDetermineRoyaltyFees>
    <us-gaap:DescriptionOfLessorLeasingArrangementsOperatingLeases contextRef="From2018-01-01to2018-12-31_custom_RrlAndRrgMember">RRL and RRG lease cars for their employees under cancelable operating lease agreements expiring at various dates in between 2021 and 2023.</us-gaap:DescriptionOfLessorLeasingArrangementsOperatingLeases>
    <us-gaap:DescriptionOfLessorLeasingArrangementsOperatingLeases contextRef="From2020-01-01to2020-12-31">These leases expire between 2021 and 2023.</us-gaap:DescriptionOfLessorLeasingArrangementsOperatingLeases>
    <us-gaap:OperatingLeasesRentExpenseNet contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">739000</us-gaap:OperatingLeasesRentExpenseNet>
    <us-gaap:OperatingLeasesRentExpenseNet contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">695000</us-gaap:OperatingLeasesRentExpenseNet>
    <us-gaap:OperatingLeasesRentExpenseNet contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="-3">764000</us-gaap:OperatingLeasesRentExpenseNet>
    <us-gaap:OtherLongTermDebt contextRef="AsOf2020-12-31" unitRef="USD" decimals="-3">704000</us-gaap:OtherLongTermDebt>
    <us-gaap:DebtInstrumentPeriodicPayment contextRef="From2020-01-01to2020-12-31_custom_LicenseAgreementAndCollaborationAgreementMember" unitRef="USD" decimals="-3">7200000</us-gaap:DebtInstrumentPeriodicPayment>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">-15599000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">-21784000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="-3">-12992000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">55000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">104000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="-3">67000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">-15544000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">-21680000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="-3">-12925000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">64000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">102000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="-3">95000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" xsi:nil="true" />
    <us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations contextRef="From2018-01-01to2018-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations contextRef="From2020-01-01to2020-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">7000</us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">-5000</us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="-3">51000</us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="Context_As_Of_30_Sep_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">35051000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="AsOf2020-12-31" unitRef="USD" decimals="-3">41941000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment contextRef="Context_As_Of_30_Sep_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">1294000</us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment>
    <us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment contextRef="AsOf2020-12-31" unitRef="USD" decimals="-3">946000</us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals contextRef="Context_As_Of_30_Sep_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">290000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals contextRef="AsOf2020-12-31" unitRef="USD" decimals="-3">341000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals>
    <us-gaap:DeferredTaxAssetsGross contextRef="Context_As_Of_30_Sep_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">36635000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross contextRef="AsOf2020-12-31" unitRef="USD" decimals="-3">43228000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsNet contextRef="Context_As_Of_30_Sep_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">243000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet contextRef="AsOf2020-12-31" unitRef="USD" decimals="-3">287000</us-gaap:DeferredTaxAssetsNet>
    <rwlk:ValuationAllowanceDeferredTaxAssetChangesDuetoAmendmentsinTaxLawsandExchangeRateDifferencesAmount contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">-2055000</rwlk:ValuationAllowanceDeferredTaxAssetChangesDuetoAmendmentsinTaxLawsandExchangeRateDifferencesAmount>
    <rwlk:ValuationAllowanceDeferredTaxAssetChangesDuetoAmendmentsinTaxLawsandExchangeRateDifferencesAmount contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">1393000</rwlk:ValuationAllowanceDeferredTaxAssetChangesDuetoAmendmentsinTaxLawsandExchangeRateDifferencesAmount>
    <rwlk:ValuationAllowanceDeferredTaxAssetChangesDuetoAmendmentsinTaxLawsandExchangeRateDifferencesAmount contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="-3">-2929000</rwlk:ValuationAllowanceDeferredTaxAssetChangesDuetoAmendmentsinTaxLawsandExchangeRateDifferencesAmount>
    <rwlk:ValuationAllowanceDeferredTaxAssetAdjustmentsAmount contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">735000</rwlk:ValuationAllowanceDeferredTaxAssetAdjustmentsAmount>
    <rwlk:ValuationAllowanceDeferredTaxAssetAdjustmentsAmount contextRef="From2018-01-01to2018-12-31" unitRef="USD" xsi:nil="true" />
    <rwlk:ValuationAllowanceDeferredTaxAssetAdjustmentsAmount contextRef="From2020-01-01to2020-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">3947000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">4737000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="-3">3620000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="pure" decimals="INF">0.23</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="From2018-01-01to2018-12-31" unitRef="pure" decimals="INF">0.23</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="FD2018Q4YTD_us-gaap_IncomeTaxAuthorityNameAxis_us-gaap_IsraelTaxAuthorityMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" unitRef="pure" decimals="INF">0.23</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="From2018-01-01to2018-12-31_custom_ReWalkRoboticsGMBHMember" unitRef="pure" decimals="INF">0.30</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="From2018-01-01to2018-12-31_custom_ReWalkRoboticsIncMember" unitRef="pure" decimals="INF">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="From2019-01-01to2019-12-31_custom_ReWalkRoboticsIncMember" unitRef="pure" decimals="INF">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="From2019-01-01to2019-12-31_custom_ReWalkRoboticsGMBHMember" unitRef="pure" decimals="INF">0.30</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="From2019-01-01to2019-12-31_us-gaap_IsraelTaxAuthorityMember" unitRef="pure" decimals="INF">0.23</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="From2020-01-01to2020-12-31" unitRef="pure" decimals="INF">0.23</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="From2020-01-01to2020-12-31_custom_ReWalkRoboticsIncMember" unitRef="pure" decimals="INF">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="From2020-01-01to2020-12-31_us-gaap_IsraelTaxAuthorityMember" unitRef="pure" decimals="INF">0.23</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="From2020-01-01to2020-12-31_custom_ReWalkRoboticsGMBHMember" unitRef="pure" decimals="INF">0.30</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">-3575000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">-4986000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="-3">-2973000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">-1000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">5000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="-3">3000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpense contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">255000</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpense contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">631000</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpense contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="-3">185000</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">3947000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">4737000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="-3">3620000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">32000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">35000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="-3">-78000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <rwlk:BeneficiaryEnterprisefromProductiveActivityTaxRateonDividendDistributionsfromTaxExemptIncome contextRef="From2018-01-01to2018-12-31_srt_MinimumMember" unitRef="pure" decimals="INF">0.1</rwlk:BeneficiaryEnterprisefromProductiveActivityTaxRateonDividendDistributionsfromTaxExemptIncome>
    <rwlk:BeneficiaryEnterprisefromProductiveActivityTaxRateonDividendDistributionsfromTaxExemptIncome contextRef="From2018-01-01to2018-12-31_srt_MaximumMember" unitRef="pure" decimals="INF">0.25</rwlk:BeneficiaryEnterprisefromProductiveActivityTaxRateonDividendDistributionsfromTaxExemptIncome>
    <us-gaap:OperatingLossCarryforwards contextRef="AsOf2020-12-31" unitRef="USD" decimals="-3">291000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="AsOf2020-12-31_custom_ReWalkRoboticsIncMember" unitRef="USD" decimals="-3">182400000</us-gaap:OperatingLossCarryforwards>
    <rwlk:DescriptionOfIncomeTaxLawForEncouragementOfCapitalInvestments contextRef="FD2016Q4YTD">The Economic Policy for the 2017 and 2018 Budget Years), 2016 which includes Amendment 73 to the Law for the Encouragement of Capital Investments (&#8220;the Amendment&#8221;) was published. According to the Amendment, a preferred enterprise located in development area A will be subject to a tax rate of 7.5% instead of 9% effective from January 1, 2017 (and thereafter the tax rate applicable to preferred enterprises located in other areas remains at 16%).</rwlk:DescriptionOfIncomeTaxLawForEncouragementOfCapitalInvestments>
    <rwlk:DescriptionOfIncomeTaxLawForEncouragementOfCapitalInvestments contextRef="From2010-12-25to2010-12-29">The Knesset approved an additional amendment to the Law for the Encouragement of Capital Investments, 1959. According to the amendment, a reduced uniform corporate tax rate for exporting industrial enterprises (over 25%) was established. The reduced tax rate will not be program dependent and will apply to the industrial enterprise&#8217;s entire income. The tax rates for industrial enterprises have been reduced. In August 2013, the Israeli Knesset approved an amendment to the Investment Law, pursuant to which the rates for development area A will be 9% and for the rest of the country- 16% in 2014 and thereafter. The Amendment also prescribes that any dividends distributed to individuals or foreign residents from a preferred enterprise&#8217;s earnings as above will be subject to taxes at a rate of 20% (subject to tax treaty benefits)</rwlk:DescriptionOfIncomeTaxLawForEncouragementOfCapitalInvestments>
    <rwlk:NetOperatingCarryForwardLossesTerms contextRef="From2020-01-01to2020-12-31_custom_ReWalkRoboticsIncMember">P20Y</rwlk:NetOperatingCarryForwardLossesTerms>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">-34000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">42000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="-3">-9000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:RepaymentsOfBankDebt contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">1499000</us-gaap:RepaymentsOfBankDebt>
    <us-gaap:RepaymentsOfBankDebt contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">2398000</us-gaap:RepaymentsOfBankDebt>
    <us-gaap:RepaymentsOfBankDebt contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="-3">907000</us-gaap:RepaymentsOfBankDebt>
    <rwlk:BankCommissions contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">31000</rwlk:BankCommissions>
    <rwlk:BankCommissions contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">26000</rwlk:BankCommissions>
    <rwlk:BankCommissions contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="-3">23000</rwlk:BankCommissions>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="From2020-01-01to2020-12-31" unitRef="shares" decimals="INF">5107</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00">P6Y4M2D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2020-01-01to2020-12-31">P5Y7M2D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="Context_As_Of_30_Sep_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">903000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2020-12-31" unitRef="USD" decimals="-3">672000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:InventoryNet contextRef="Context_As_Of_30_Sep_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">3123000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="AsOf2020-12-31" unitRef="USD" decimals="-3">3542000</us-gaap:InventoryNet>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted contextRef="From2020-01-01to2020-12-31_custom_EmployeeStockOptionAndRestrictedStockUnitsRsuMember" unitRef="shares" decimals="INF">1266185</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
    <dei:EntityRegistrantName contextRef="From2020-01-01to2020-12-31">ReWalk Robotics Ltd.</dei:EntityRegistrantName>
    <dei:EntityCentralIndexKey contextRef="From2020-01-01to2020-12-31">0001607962</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2020-01-01to2020-12-31">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="From2020-01-01to2020-12-31">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentType contextRef="From2020-01-01to2020-12-31">10-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2020-01-01to2020-12-31">2020-12-31</dei:DocumentPeriodEndDate>
    <dei:DocumentFiscalPeriodFocus contextRef="From2020-01-01to2020-12-31">FY</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentFiscalYearFocus contextRef="From2020-01-01to2020-12-31">2020</dei:DocumentFiscalYearFocus>
    <dei:EntityWellKnownSeasonedIssuer contextRef="From2020-01-01to2020-12-31">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="From2020-01-01to2020-12-31">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="From2020-01-01to2020-12-31">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityFilerCategory contextRef="From2020-01-01to2020-12-31">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntityShellCompany contextRef="From2020-01-01to2020-12-31">false</dei:EntityShellCompany>
    <dei:EntitySmallBusiness contextRef="From2020-01-01to2020-12-31">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="From2020-01-01to2020-12-31">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityFileNumber contextRef="From2020-01-01to2020-12-31">001-36612</dei:EntityFileNumber>
    <dei:EntityInteractiveDataCurrent contextRef="From2020-01-01to2020-12-31">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityIncorporationStateCountryCode contextRef="From2020-01-01to2020-12-31">L3</dei:EntityIncorporationStateCountryCode>
    <us-gaap:AccountsReceivableNetCurrent contextRef="Context_As_Of_30_Sep_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" id="Foot-23-0" decimals="-3">794000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="AsOf2020-12-31" unitRef="USD" id="Foot-23-1" decimals="-3">684000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AssetsCurrent contextRef="Context_As_Of_30_Sep_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">21073000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2020-12-31" unitRef="USD" decimals="-3">25248000</us-gaap:AssetsCurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="Context_As_Of_30_Sep_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">1061000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="AsOf2020-12-31" unitRef="USD" decimals="-3">1033000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="Context_As_Of_30_Sep_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">1737000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="AsOf2020-12-31" unitRef="USD" decimals="-3">1349000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:AssetsNoncurrent contextRef="Context_As_Of_30_Sep_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">3299000</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent contextRef="AsOf2020-12-31" unitRef="USD" decimals="-3">2819000</us-gaap:AssetsNoncurrent>
    <us-gaap:Assets contextRef="Context_As_Of_30_Sep_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">24372000</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2020-12-31" unitRef="USD" decimals="-3">28067000</us-gaap:Assets>
    <us-gaap:LiabilitiesCurrent contextRef="Context_As_Of_30_Sep_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">10168000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2020-12-31" unitRef="USD" decimals="-3">4668000</us-gaap:LiabilitiesCurrent>
    <us-gaap:Liabilities contextRef="Context_As_Of_30_Sep_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">13592000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="AsOf2020-12-31" unitRef="USD" decimals="-3">6293000</us-gaap:Liabilities>
    <us-gaap:StockholdersEquity contextRef="Context_As_Of_30_Sep_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">10780000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2018-12-31" unitRef="USD" decimals="-3">1945000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="Context_As_Of_31_Dec_2016T00_00_00_TO_31_Dec_2016T00_00_00" unitRef="USD" decimals="-3">3707000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="Context_As_Of_31_Dec_2016T00_00_00_TO_31_Dec_2016T00_00_00_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="USD" decimals="-3">-131220000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="Context_As_Of_31_Dec_2016T00_00_00_TO_31_Dec_2016T00_00_00_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">134843000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="Context_As_Of_31_Dec_2016T00_00_00_TO_31_Dec_2016T00_00_00_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">84000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="Context_As_Of_30_Sep_2017T00_00_00_TO_30_Sep_2017T00_00_00_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="USD" decimals="-3">-168469000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="Context_As_Of_30_Sep_2017T00_00_00_TO_30_Sep_2017T00_00_00_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">178745000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="Context_As_Of_30_Sep_2017T00_00_00_TO_30_Sep_2017T00_00_00_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">504000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2018-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="-3">193000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2018-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">154670000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2018-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="-3">-152918000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-12-31" unitRef="USD" decimals="-3">21774000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="-3">1827000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">201392000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="-3">-181445000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesAuthorized contextRef="Context_As_Of_30_Sep_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="shares" decimals="INF">60000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2020-12-31" unitRef="shares" decimals="INF">60000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="Context_As_Of_30_Sep_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="shares" decimals="INF">7319560</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2020-12-31" unitRef="shares" decimals="INF">25332225</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="Context_As_Of_30_Sep_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="shares" decimals="INF">7319560</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2020-12-31" unitRef="shares" decimals="INF">25332225</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CostOfRevenue contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">2147000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">3720000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="-3">2204000</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">2726000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">2825000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="-3">2189000</us-gaap:GrossProfit>
    <us-gaap:SellingAndMarketingExpense contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">6167000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">7897000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="-3">5754000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">5259000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">6793000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="-3">4980000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">16774000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">22039000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="-3">14193000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">-14048000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">-19214000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="-3">-12004000</us-gaap:OperatingIncomeLoss>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" xsi:nil="true" />
    <us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="From2018-01-01to2018-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="-3">392000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">-15544000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">-21680000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="-3">-12925000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ShareBasedCompensation contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">1108000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">2766000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="-3">749000</us-gaap:ShareBasedCompensation>
    <rwlk:GainsLossesOnInducementOfDebt1 contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" id="Foot-24-0" xsi:nil="true" />
    <rwlk:GainsLossesOnInducementOfDebt1 contextRef="From2018-01-01to2018-12-31" unitRef="USD" id="Foot-24-1" decimals="-3">-600000</rwlk:GainsLossesOnInducementOfDebt1>
    <rwlk:GainsLossesOnInducementOfDebt1 contextRef="From2020-01-01to2020-12-31" unitRef="USD" id="Foot-24-2" xsi:nil="true" />
    <rwlk:FinancialExpensesRelatedToLongTermLoan contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" xsi:nil="true" />
    <rwlk:FinancialExpensesRelatedToLongTermLoan contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">224000</rwlk:FinancialExpensesRelatedToLongTermLoan>
    <rwlk:FinancialExpensesRelatedToLongTermLoan contextRef="From2020-01-01to2020-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">36000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">-322000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="-3">-110000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">-64000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">-734000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="-3">-166000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInInventories contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">1221000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">-1403000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="-3">469000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">370000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">492000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="-3">-506000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">20000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">-222000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="-3">197000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInDeferredLiabilities contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">176000</us-gaap:IncreaseDecreaseInDeferredLiabilities>
    <us-gaap:IncreaseDecreaseInDeferredLiabilities contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">283000</us-gaap:IncreaseDecreaseInDeferredLiabilities>
    <us-gaap:IncreaseDecreaseInDeferredLiabilities contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="-3">264000</us-gaap:IncreaseDecreaseInDeferredLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">-9000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">-57000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="-3">27000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">-14815000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">-14774000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="-3">-12589000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">22000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">13000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="-3">73000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">-22000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">-13000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="-3">-73000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:RepaymentsOfLongTermDebt contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">1722000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">3866000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="-3">6965000</us-gaap:RepaymentsOfLongTermDebt>
    <rwlk:IssuanceOfOrdinarySharesInInvestmentAgreement contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" id="Foot-20-3" xsi:nil="true" />
    <rwlk:IssuanceOfOrdinarySharesInInvestmentAgreement contextRef="From2018-01-01to2018-12-31" unitRef="USD" id="Foot-20-4" decimals="-3">4295000</rwlk:IssuanceOfOrdinarySharesInInvestmentAgreement>
    <rwlk:IssuanceOfOrdinarySharesInInvestmentAgreement contextRef="From2020-01-01to2020-12-31" unitRef="USD" id="Foot-20-5" xsi:nil="true" />
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" id="Foot-20-6" xsi:nil="true" />
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="From2018-01-01to2018-12-31" unitRef="USD" id="Foot-20-7" decimals="-3">1142000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="From2020-01-01to2020-12-31" unitRef="USD" id="Foot-20-8" xsi:nil="true" />
    <rwlk:ProceedsFromIssuanceofPreFundedWarrants contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" id="Foot-25-0" xsi:nil="true" />
    <rwlk:ProceedsFromIssuanceofPreFundedWarrants contextRef="From2018-01-01to2018-12-31" unitRef="USD" id="Foot-25-1" decimals="-3">8140000</rwlk:ProceedsFromIssuanceofPreFundedWarrants>
    <rwlk:ProceedsFromIssuanceofPreFundedWarrants contextRef="From2020-01-01to2020-12-31" unitRef="USD" id="Foot-25-2" xsi:nil="true" />
    <rwlk:ProceedsFromOfferingCost contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" id="Foot-20-9" xsi:nil="true" />
    <rwlk:ProceedsFromOfferingCost contextRef="From2018-01-01to2018-12-31" unitRef="USD" id="Foot-20-10" xsi:nil="true" />
    <rwlk:ProceedsFromOfferingCost contextRef="From2020-01-01to2020-12-31" unitRef="USD" id="Foot-20-11" decimals="-3">4010000</rwlk:ProceedsFromOfferingCost>
    <rwlk:ProceedsFromIssuanceOfRegistrationCost contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" id="Foot-20-12" xsi:nil="true" />
    <rwlk:ProceedsFromIssuanceOfRegistrationCost contextRef="From2018-01-01to2018-12-31" unitRef="USD" id="Foot-20-13" xsi:nil="true" />
    <rwlk:ProceedsFromIssuanceOfRegistrationCost contextRef="From2020-01-01to2020-12-31" unitRef="USD" id="Foot-20-14" decimals="-3">8023000</rwlk:ProceedsFromIssuanceOfRegistrationCost>
    <rwlk:IssuanceOfOrdinarySharesInWarrantExerciseAgreementNetOfIssuanceExpensesInAmountOf10191 contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" id="Foot-20-15" decimals="-3">9966000</rwlk:IssuanceOfOrdinarySharesInWarrantExerciseAgreementNetOfIssuanceExpensesInAmountOf10191>
    <rwlk:IssuanceOfOrdinarySharesInWarrantExerciseAgreementNetOfIssuanceExpensesInAmountOf10191 contextRef="From2018-01-01to2018-12-31" unitRef="USD" id="Foot-20-16" xsi:nil="true" />
    <rwlk:IssuanceOfOrdinarySharesInWarrantExerciseAgreementNetOfIssuanceExpensesInAmountOf10191 contextRef="From2020-01-01to2020-12-31" unitRef="USD" id="Foot-20-17" xsi:nil="true" />
    <rwlk:ExerciseOfPreFundedWarrants contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" id="Foot-20-18" decimals="-3">1429000</rwlk:ExerciseOfPreFundedWarrants>
    <rwlk:ExerciseOfPreFundedWarrants contextRef="From2018-01-01to2018-12-31" unitRef="USD" id="Foot-20-19" xsi:nil="true" />
    <rwlk:ExerciseOfPreFundedWarrants contextRef="From2020-01-01to2020-12-31" unitRef="USD" id="Foot-20-20" decimals="-3">4223000</rwlk:ExerciseOfPreFundedWarrants>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">21482000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">9711000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="-3">16724000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">6645000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">-5076000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="-3">4062000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="Context_As_Of_30_Sep_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">16992000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2018-12-31" unitRef="USD" decimals="-3">10347000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="Context_As_Of_31_Dec_2016T00_00_00_TO_31_Dec_2016T00_00_00" unitRef="USD" decimals="-3">15423000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2020-12-31" unitRef="USD" decimals="-3">21054000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <rwlk:RepaymentOfLongTermLoanByIssuanceOfUnitsAndPrefundedUnits contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" id="Foot-24-3" xsi:nil="true" />
    <rwlk:RepaymentOfLongTermLoanByIssuanceOfUnitsAndPrefundedUnits contextRef="From2018-01-01to2018-12-31" unitRef="USD" id="Foot-24-4" decimals="-3">3000000</rwlk:RepaymentOfLongTermLoanByIssuanceOfUnitsAndPrefundedUnits>
    <rwlk:RepaymentOfLongTermLoanByIssuanceOfUnitsAndPrefundedUnits contextRef="From2020-01-01to2020-12-31" unitRef="USD" id="Foot-24-5" xsi:nil="true" />
    <rwlk:CommonStockIssuanceCostsIncurredNotYetPaid contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" id="Foot-20-21" xsi:nil="true" />
    <rwlk:CommonStockIssuanceCostsIncurredNotYetPaid contextRef="From2018-01-01to2018-12-31" unitRef="USD" id="Foot-20-22" decimals="-3">25000</rwlk:CommonStockIssuanceCostsIncurredNotYetPaid>
    <rwlk:CommonStockIssuanceCostsIncurredNotYetPaid contextRef="From2020-01-01to2020-12-31" unitRef="USD" id="Foot-20-23" xsi:nil="true" />
    <rwlk:ClassificationOfOtherCurrentAssetsToPropertyAndEquipmentNet contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" xsi:nil="true" />
    <rwlk:ClassificationOfOtherCurrentAssetsToPropertyAndEquipmentNet contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">236000</rwlk:ClassificationOfOtherCurrentAssetsToPropertyAndEquipmentNet>
    <rwlk:ClassificationOfOtherCurrentAssetsToPropertyAndEquipmentNet contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="-3">98000</rwlk:ClassificationOfOtherCurrentAssetsToPropertyAndEquipmentNet>
    <rwlk:ClassificationOfInventoryToPropertyAndEquipmentNet contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">174000</rwlk:ClassificationOfInventoryToPropertyAndEquipmentNet>
    <rwlk:ClassificationOfInventoryToPropertyAndEquipmentNet contextRef="From2018-01-01to2018-12-31" unitRef="USD" xsi:nil="true" />
    <rwlk:ClassificationOfInventoryToPropertyAndEquipmentNet contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="-3">50000</rwlk:ClassificationOfInventoryToPropertyAndEquipmentNet>
    <rwlk:CashlessExerciseOfPrefundedWarrants contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">72000</rwlk:CashlessExerciseOfPrefundedWarrants>
    <rwlk:CashlessExerciseOfPrefundedWarrants contextRef="From2018-01-01to2018-12-31" unitRef="USD" xsi:nil="true" />
    <rwlk:CashlessExerciseOfPrefundedWarrants contextRef="From2020-01-01to2020-12-31" unitRef="USD" xsi:nil="true" />
    <rwlk:SupplementalCashFlowCashAndCashEquivalents contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">16253000</rwlk:SupplementalCashFlowCashAndCashEquivalents>
    <rwlk:SupplementalCashFlowCashAndCashEquivalents contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">9546000</rwlk:SupplementalCashFlowCashAndCashEquivalents>
    <rwlk:SupplementalCashFlowCashAndCashEquivalents contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="-3">20350000</rwlk:SupplementalCashFlowCashAndCashEquivalents>
    <rwlk:RestrictedCashIncludedInOtherNoncurrentAssets contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">739000</rwlk:RestrictedCashIncludedInOtherNoncurrentAssets>
    <rwlk:RestrictedCashIncludedInOtherNoncurrentAssets contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">801000</rwlk:RestrictedCashIncludedInOtherNoncurrentAssets>
    <rwlk:RestrictedCashIncludedInOtherNoncurrentAssets contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="-3">704000</rwlk:RestrictedCashIncludedInOtherNoncurrentAssets>
    <rwlk:CashAndCashEquivalentsRestrictedCashAndRestrictedCashEquivalent contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">16992000</rwlk:CashAndCashEquivalentsRestrictedCashAndRestrictedCashEquivalent>
    <rwlk:CashAndCashEquivalentsRestrictedCashAndRestrictedCashEquivalent contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">10347000</rwlk:CashAndCashEquivalentsRestrictedCashAndRestrictedCashEquivalent>
    <rwlk:CashAndCashEquivalentsRestrictedCashAndRestrictedCashEquivalent contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="-3">21054000</rwlk:CashAndCashEquivalentsRestrictedCashAndRestrictedCashEquivalent>
    <us-gaap:InterestPaidNet contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">1499000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">1501000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="-3">862000</us-gaap:InterestPaidNet>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" xsi:nil="true" />
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">1505000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="From2019-01-01to2019-12-31_custom_BestOfferingMember" unitRef="USD" decimals="-3">686000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="From2018-01-01to2018-12-31_custom_AtmOfferingProgramMember" unitRef="USD" decimals="-3">211000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="From2019-01-01to2019-12-31_custom_RegisteredDirectMember" unitRef="USD" decimals="-3">1035000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="From2019-01-01to2019-12-31_custom_WarrantExerciseMember" unitRef="USD" decimals="-3">1019000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="From2018-01-01to2018-12-31_custom_InvestmentAgreementMember" unitRef="USD" decimals="-3">830000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="From2020-01-01to2020-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="From2020-01-01to2020-12-31_custom_BestOfferingMember" unitRef="USD" decimals="-3">1056000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="From2020-01-01to2020-12-31_us-gaap_PrivatePlacementMember" unitRef="USD" decimals="-3">959000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="From2020-01-01to2020-12-31_custom_RegisteredDirectMember" unitRef="USD" decimals="-3">977000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="From2020-01-01to2020-12-31_custom_AtmOfferingProgramMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:SharesOutstanding contextRef="Context_As_Of_31_Dec_2016T00_00_00_TO_31_Dec_2016T00_00_00_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="INF">1200146</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding contextRef="Context_As_Of_30_Sep_2017T00_00_00_TO_30_Sep_2017T00_00_00_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="INF">7319560</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding contextRef="AsOf2018-12-31_us-gaap_CommonStockMember" unitRef="shares" decimals="INF">2813087</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding contextRef="AsOf2020-12-31_us-gaap_CommonStockMember" unitRef="shares" decimals="INF">25332225</us-gaap:SharesOutstanding>
    <us-gaap:AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">-23000</us-gaap:AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet>
    <us-gaap:AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet contextRef="From2018-01-01to2018-12-31_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet contextRef="From2018-01-01to2018-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet contextRef="From2018-01-01to2018-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="-3">-23000</us-gaap:AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">1108000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">2766000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="From2018-01-01to2018-12-31_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="From2018-01-01to2018-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">2766000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="From2018-01-01to2018-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">1108000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="-3">749000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="From2020-01-01to2020-12-31_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="From2020-01-01to2020-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">749000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="From2020-01-01to2020-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">2000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="From2018-01-01to2018-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="From2018-01-01to2018-12-31_us-gaap_CommonStockMember" unitRef="USD" id="Foot-26-0" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="From2018-01-01to2018-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="From2018-01-01to2018-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">2000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="From2020-01-01to2020-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="From2020-01-01to2020-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="-3">3000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="From2020-01-01to2020-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">-3000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="From2020-01-01to2020-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="From2018-01-01to2018-12-31_us-gaap_CommonStockMember" unitRef="shares" decimals="INF">17181</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="INF">47473</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="From2020-01-01to2020-12-31_us-gaap_CommonStockMember" unitRef="shares" decimals="INF">63111</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <rwlk:StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInInvestingAgreementNetOfIssuanceExpenses contextRef="From2018-01-01to2018-12-31" unitRef="USD" id="Foot-20-24" decimals="-3">4295000</rwlk:StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInInvestingAgreementNetOfIssuanceExpenses>
    <rwlk:StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInInvestingAgreementNetOfIssuanceExpenses contextRef="From2018-01-01to2018-12-31_us-gaap_CommonStockMember" unitRef="USD" id="Foot-20-25" decimals="-3">12000</rwlk:StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInInvestingAgreementNetOfIssuanceExpenses>
    <rwlk:StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInInvestingAgreementNetOfIssuanceExpenses contextRef="From2018-01-01to2018-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" id="Foot-20-26" decimals="-3">4283000</rwlk:StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInInvestingAgreementNetOfIssuanceExpenses>
    <rwlk:StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInInvestingAgreementNetOfIssuanceExpenses contextRef="From2018-01-01to2018-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" id="Foot-20-27" xsi:nil="true" />
    <rwlk:StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInInvestingAgreementNetOfIssuanceExpenses contextRef="From2018-01-01to2018-12-31_us-gaap_CommonStockMember" unitRef="shares" id="Foot-20-28" decimals="INF">164715</rwlk:StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInInvestingAgreementNetOfIssuanceExpenses>
    <rwlk:StockIssuedDuringPeriodValueNewIssuesTwo contextRef="From2018-01-01to2018-12-31" unitRef="USD" id="Foot-20-29" decimals="-3">1117000</rwlk:StockIssuedDuringPeriodValueNewIssuesTwo>
    <rwlk:StockIssuedDuringPeriodValueNewIssuesTwo contextRef="From2018-01-01to2018-12-31_us-gaap_CommonStockMember" unitRef="USD" id="Foot-20-30" decimals="-3">4000</rwlk:StockIssuedDuringPeriodValueNewIssuesTwo>
    <rwlk:StockIssuedDuringPeriodValueNewIssuesTwo contextRef="From2018-01-01to2018-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" id="Foot-20-31" decimals="-3">1113000</rwlk:StockIssuedDuringPeriodValueNewIssuesTwo>
    <rwlk:StockIssuedDuringPeriodValueNewIssuesTwo contextRef="From2018-01-01to2018-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" id="Foot-20-32" xsi:nil="true" />
    <rwlk:StockIssuedDuringPeriodSharesNewIssuesTwo contextRef="From2018-01-01to2018-12-31_us-gaap_CommonStockMember" unitRef="shares" id="Foot-20-33" decimals="INF">49882</rwlk:StockIssuedDuringPeriodSharesNewIssuesTwo>
    <rwlk:StockDuringPeriodOrdinarySharesAndWarrantsValuePurchaseOrdinarySharesInFollowOnPublicOfferingTwo contextRef="From2018-01-01to2018-12-31" unitRef="USD" id="Foot-20-34" decimals="-3">11577000</rwlk:StockDuringPeriodOrdinarySharesAndWarrantsValuePurchaseOrdinarySharesInFollowOnPublicOfferingTwo>
    <rwlk:StockDuringPeriodOrdinarySharesAndWarrantsValuePurchaseOrdinarySharesInFollowOnPublicOfferingTwo contextRef="From2018-01-01to2018-12-31_us-gaap_CommonStockMember" unitRef="USD" id="Foot-20-35" decimals="-3">49000</rwlk:StockDuringPeriodOrdinarySharesAndWarrantsValuePurchaseOrdinarySharesInFollowOnPublicOfferingTwo>
    <rwlk:StockDuringPeriodOrdinarySharesAndWarrantsValuePurchaseOrdinarySharesInFollowOnPublicOfferingTwo contextRef="From2018-01-01to2018-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" id="Foot-20-36" decimals="-3">11528000</rwlk:StockDuringPeriodOrdinarySharesAndWarrantsValuePurchaseOrdinarySharesInFollowOnPublicOfferingTwo>
    <rwlk:StockDuringPeriodOrdinarySharesAndWarrantsValuePurchaseOrdinarySharesInFollowOnPublicOfferingTwo contextRef="From2018-01-01to2018-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" id="Foot-20-37" xsi:nil="true" />
    <rwlk:StockDuringPeriodOrdinarySharesAndWarrantsSharesPurchaseOrdinarySharesInFollowOnPublicOfferingTwo contextRef="From2018-01-01to2018-12-31_us-gaap_CommonStockMember" unitRef="shares" id="Foot-20-38" decimals="INF">728019</rwlk:StockDuringPeriodOrdinarySharesAndWarrantsSharesPurchaseOrdinarySharesInFollowOnPublicOfferingTwo>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="From2018-01-01to2018-12-31" unitRef="USD" id="Foot-27-0" decimals="-3">18000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="From2018-01-01to2018-12-31_us-gaap_CommonStockMember" unitRef="USD" id="Foot-27-1" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="From2018-01-01to2018-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" id="Foot-27-2" decimals="-3">18000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="From2018-01-01to2018-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" id="Foot-27-3" xsi:nil="true" />
    <rwlk:ExerciseOfPreFundedWarrantsValue contextRef="From2018-01-01to2018-12-31" unitRef="USD" id="Foot-20-39" decimals="-3">163000</rwlk:ExerciseOfPreFundedWarrantsValue>
    <rwlk:ExerciseOfPreFundedWarrantsValue contextRef="From2018-01-01to2018-12-31_us-gaap_CommonStockMember" unitRef="USD" id="Foot-20-40" decimals="-3">44000</rwlk:ExerciseOfPreFundedWarrantsValue>
    <rwlk:ExerciseOfPreFundedWarrantsValue contextRef="From2018-01-01to2018-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" id="Foot-20-41" decimals="-3">119000</rwlk:ExerciseOfPreFundedWarrantsValue>
    <rwlk:ExerciseOfPreFundedWarrantsValue contextRef="From2018-01-01to2018-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" id="Foot-20-42" xsi:nil="true" />
    <rwlk:ExerciseOfPreFundedWarrantsShares contextRef="From2018-01-01to2018-12-31_us-gaap_CommonStockMember" unitRef="shares" id="Foot-20-43" decimals="INF">653144</rwlk:ExerciseOfPreFundedWarrantsShares>
    <rwlk:StockIssuedDuringPeriodValueOrdinaryShares contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" id="Foot-20-44" decimals="-3">3684000</rwlk:StockIssuedDuringPeriodValueOrdinaryShares>
    <rwlk:StockIssuedDuringPeriodValueOrdinaryShares contextRef="From2018-01-01to2018-12-31" unitRef="USD" xsi:nil="true" />
    <rwlk:StockIssuedDuringPeriodValueOrdinaryShares contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="USD" id="Foot-20-45" xsi:nil="true" />
    <rwlk:StockIssuedDuringPeriodValueOrdinaryShares contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" id="Foot-20-46" decimals="-3">3632000</rwlk:StockIssuedDuringPeriodValueOrdinaryShares>
    <rwlk:StockIssuedDuringPeriodValueOrdinaryShares contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" id="Foot-20-47" decimals="-3">52000</rwlk:StockIssuedDuringPeriodValueOrdinaryShares>
    <rwlk:StockIssuedDuringPeriodValueOrdinaryShares contextRef="From2020-01-01to2020-12-31" unitRef="USD" xsi:nil="true" />
    <rwlk:StockIssuedDuringPeriodSharesOrdinaryShares contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" id="Foot-20-48" decimals="INF">760000</rwlk:StockIssuedDuringPeriodSharesOrdinaryShares>
    <rwlk:ExerciseOfPrefundedWarrantsAndWarrantsValue contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" id="Foot-20-49" decimals="-3">1501000</rwlk:ExerciseOfPrefundedWarrantsAndWarrantsValue>
    <rwlk:ExerciseOfPrefundedWarrantsAndWarrantsValue contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="USD" id="Foot-20-50" xsi:nil="true" />
    <rwlk:ExerciseOfPrefundedWarrantsAndWarrantsValue contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" id="Foot-20-51" decimals="-3">1461000</rwlk:ExerciseOfPrefundedWarrantsAndWarrantsValue>
    <rwlk:ExerciseOfPrefundedWarrantsAndWarrantsValue contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" id="Foot-20-52" decimals="-3">40000</rwlk:ExerciseOfPrefundedWarrantsAndWarrantsValue>
    <rwlk:ExerciseOfPrefundedWarrantsAndWarrantsValue contextRef="From2020-01-01to2020-12-31" unitRef="USD" id="Foot-20-53" decimals="-3">4223000</rwlk:ExerciseOfPrefundedWarrantsAndWarrantsValue>
    <rwlk:ExerciseOfPrefundedWarrantsAndWarrantsValue contextRef="From2020-01-01to2020-12-31_us-gaap_CommonStockMember" unitRef="USD" id="Foot-20-54" decimals="-3">244000</rwlk:ExerciseOfPrefundedWarrantsAndWarrantsValue>
    <rwlk:ExerciseOfPrefundedWarrantsAndWarrantsValue contextRef="From2020-01-01to2020-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" id="Foot-20-55" decimals="-3">3979000</rwlk:ExerciseOfPrefundedWarrantsAndWarrantsValue>
    <rwlk:ExerciseOfPrefundedWarrantsAndWarrantsValue contextRef="From2020-01-01to2020-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" id="Foot-20-56" xsi:nil="true" />
    <rwlk:ExerciseOfPreFundedWarrantsAndWarrantsShares contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" id="Foot-20-57" decimals="INF">584087</rwlk:ExerciseOfPreFundedWarrantsAndWarrantsShares>
    <rwlk:ExerciseOfPreFundedWarrantsAndWarrantsShares contextRef="From2020-01-01to2020-12-31_us-gaap_CommonStockMember" unitRef="shares" id="Foot-20-58" decimals="INF">3378328</rwlk:ExerciseOfPreFundedWarrantsAndWarrantsShares>
    <rwlk:StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" id="Foot-20-59" decimals="-3">8125000</rwlk:StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses>
    <rwlk:StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="USD" id="Foot-20-60" xsi:nil="true" />
    <rwlk:StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" id="Foot-20-61" decimals="-3">8010000</rwlk:StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses>
    <rwlk:StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" id="Foot-20-62" decimals="-3">115000</rwlk:StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses>
    <rwlk:StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" id="Foot-20-63" decimals="INF">1650248</rwlk:StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses>
    <rwlk:StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" id="Foot-20-64" decimals="-3">9966000</rwlk:StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses>
    <rwlk:StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="USD" id="Foot-20-65" xsi:nil="true" />
    <rwlk:StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" id="Foot-20-66" decimals="-3">9864000</rwlk:StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses>
    <rwlk:StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" id="Foot-20-67" decimals="-3">102000</rwlk:StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="From2019-01-01to2019-12-31_custom_BestOfferingMember" unitRef="USD" decimals="-3">686000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="From2018-01-01to2018-12-31_custom_AtmOfferingProgramMember" unitRef="USD" decimals="-3">236000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="From2019-01-01to2019-12-31_custom_WarrantExerciseMember" unitRef="USD" decimals="-3">1019000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="From2018-01-01to2018-12-31_custom_InvestmentAgreementMember" unitRef="USD" decimals="-3">830000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="From2019-01-01to2019-12-31_custom_RegisteredDirectOfferingMember" unitRef="USD" decimals="-3">1125000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="From2018-01-01to2018-12-31_custom_PublicStockOfferingMember" unitRef="USD" decimals="-3">1505000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="From2020-01-01to2020-12-31_custom_BestOfferingMember" unitRef="USD" decimals="-3">1056000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="From2020-01-01to2020-12-31_custom_RegisteredDirectOfferingMember" unitRef="USD" decimals="-3">1019000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="From2020-01-01to2020-12-31_us-gaap_PrivatePlacementMember" unitRef="USD" decimals="-3">993000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:ProfitLoss contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">-15551000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">-21675000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="-3">-12976000</us-gaap:ProfitLoss>
    <rwlk:DeferredIncometax contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">-57000</rwlk:DeferredIncometax>
    <rwlk:DeferredIncometax contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">-107000</rwlk:DeferredIncometax>
    <rwlk:DeferredIncometax contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="-3">-44000</rwlk:DeferredIncometax>
    <us-gaap:LessorOperatingLeaseDescription contextRef="From2020-01-01to2020-12-31">Upon adoption of this standard on January 1, 2019, the Company recorded right&#8211;of&#8211;use assets and corresponding lease liabilities of $2,099 thousand and $2,249 thousand, respectively. As of December 31, 2020, the right&#8211;of&#8211;use assets and corresponding lease liabilities in the Company&#8217;s consolidated balance sheets were $1,349 thousand and $1,583 thousand, respectively.</us-gaap:LessorOperatingLeaseDescription>
    <us-gaap:OtherTaxExpenseBenefit contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">7000</us-gaap:OtherTaxExpenseBenefit>
    <us-gaap:OtherTaxExpenseBenefit contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">-5000</us-gaap:OtherTaxExpenseBenefit>
    <us-gaap:OtherTaxExpenseBenefit contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="-3">51000</us-gaap:OtherTaxExpenseBenefit>
    <rwlk:TaxesIncome contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">7000</rwlk:TaxesIncome>
    <rwlk:TaxesIncome contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">-5000</rwlk:TaxesIncome>
    <rwlk:TaxesIncome contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="-3">51000</rwlk:TaxesIncome>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="AsOf2020-12-31_custom_ReStoreProductMember">P2Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="AsOf2020-12-31_custom_SCIProductsMember">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <rwlk:TaxesOnIncome contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">7000</rwlk:TaxesOnIncome>
    <rwlk:TaxesOnIncome contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">-5000</rwlk:TaxesOnIncome>
    <rwlk:TaxesOnIncome contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="-3">51000</rwlk:TaxesOnIncome>
    <us-gaap:FinanceLeaseRightOfUseAsset contextRef="Context_As_Of_30_Sep_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">433000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset contextRef="AsOf2020-12-31" unitRef="USD" decimals="-3">390000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet contextRef="Context_As_Of_30_Sep_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">37068000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet contextRef="AsOf2020-12-31" unitRef="USD" decimals="-3">43618000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <rwlk:RightofuseLiability contextRef="Context_As_Of_30_Sep_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">-433000</rwlk:RightofuseLiability>
    <rwlk:RightofuseLiability contextRef="AsOf2020-12-31" unitRef="USD" decimals="-3">-390000</rwlk:RightofuseLiability>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">-651000</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">-427000</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="-3">-706000</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <rwlk:InitialRecognitionOfOperatingLeaseRightofuseAssets contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">2099000</rwlk:InitialRecognitionOfOperatingLeaseRightofuseAssets>
    <rwlk:InitialRecognitionOfOperatingLeaseRightofuseAssets contextRef="From2018-01-01to2018-12-31" unitRef="USD" xsi:nil="true" />
    <rwlk:InitialRecognitionOfOperatingLeaseRightofuseAssets contextRef="From2020-01-01to2020-12-31" unitRef="USD" xsi:nil="true" />
    <rwlk:InitialRecognitionOfOperatingLeaseLiabilities contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">-2249000</rwlk:InitialRecognitionOfOperatingLeaseLiabilities>
    <rwlk:InitialRecognitionOfOperatingLeaseLiabilities contextRef="From2018-01-01to2018-12-31" unitRef="USD" xsi:nil="true" />
    <rwlk:InitialRecognitionOfOperatingLeaseLiabilities contextRef="From2020-01-01to2020-12-31" unitRef="USD" xsi:nil="true" />
    <rwlk:ClassificationOfInventoryToOtherCurrentAssets contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">164000</rwlk:ClassificationOfInventoryToOtherCurrentAssets>
    <rwlk:ClassificationOfInventoryToOtherCurrentAssets contextRef="From2018-01-01to2018-12-31" unitRef="USD" xsi:nil="true" />
    <rwlk:ClassificationOfInventoryToOtherCurrentAssets contextRef="From2020-01-01to2020-12-31" unitRef="USD" xsi:nil="true" />
    <dei:EntityPublicFloat contextRef="AsOf2020-06-30" unitRef="USD" decimals="-3">27393283000</dei:EntityPublicFloat>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="Context_As_Of_30_Sep_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">36392000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="AsOf2018-12-31" unitRef="USD" decimals="-3">29655000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="Context_As_Of_31_Dec_2016T00_00_00_TO_31_Dec_2016T00_00_00" unitRef="USD" decimals="-3">26311000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="AsOf2020-12-31" unitRef="USD" decimals="-3">42941000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <rwlk:IssuanceExpensesOfOfferingSharesAmount contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" xsi:nil="true" />
    <rwlk:IssuanceExpensesOfOfferingSharesAmount contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">3600000</rwlk:IssuanceExpensesOfOfferingSharesAmount>
    <rwlk:IssuanceExpensesOfOfferingSharesAmount contextRef="From2020-01-01to2020-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:IncomeTaxesPaid contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">21000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">25000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="-3">13000</us-gaap:IncomeTaxesPaid>
    <rwlk:StockIssuedDuringPeriodSharesOrdinaryShares1 contextRef="From2020-01-01to2020-12-31_us-gaap_CommonStockMember" unitRef="shares" id="Foot-20-68" decimals="INF">4053172</rwlk:StockIssuedDuringPeriodSharesOrdinaryShares1>
    <rwlk:StockIssuedDuringPeriodValueOrdinaryShares1 contextRef="From2020-01-01to2020-12-31" unitRef="USD" id="Foot-20-69" decimals="-3">4010000</rwlk:StockIssuedDuringPeriodValueOrdinaryShares1>
    <rwlk:StockIssuedDuringPeriodValueOrdinaryShares1 contextRef="From2020-01-01to2020-12-31_us-gaap_CommonStockMember" unitRef="USD" id="Foot-20-70" decimals="-3">290000</rwlk:StockIssuedDuringPeriodValueOrdinaryShares1>
    <rwlk:StockIssuedDuringPeriodValueOrdinaryShares1 contextRef="From2020-01-01to2020-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" id="Foot-20-71" decimals="-3">3720000</rwlk:StockIssuedDuringPeriodValueOrdinaryShares1>
    <rwlk:StockIssuedDuringPeriodValueOrdinaryShares1 contextRef="From2020-01-01to2020-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" id="Foot-20-72" xsi:nil="true" />
    <rwlk:StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1 contextRef="From2020-01-01to2020-12-31" unitRef="USD" id="Foot-20-73" decimals="-3">7981000</rwlk:StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1>
    <rwlk:StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1 contextRef="From2020-01-01to2020-12-31_us-gaap_CommonStockMember" unitRef="USD" id="Foot-20-74" decimals="-3">357000</rwlk:StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1>
    <rwlk:StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1 contextRef="From2020-01-01to2020-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" id="Foot-20-75" decimals="-3">7624000</rwlk:StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1>
    <rwlk:StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1 contextRef="From2020-01-01to2020-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" id="Foot-20-76" xsi:nil="true" />
    <rwlk:StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1 contextRef="From2020-01-01to2020-12-31_us-gaap_CommonStockMember" unitRef="shares" id="Foot-20-77" decimals="INF">4938278</rwlk:StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1>
    <rwlk:StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="INF">1464665</rwlk:StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses>
    <rwlk:StockIssuedDuringPeriodSharesPrivatePlacement contextRef="From2020-01-01to2020-12-31_us-gaap_CommonStockMember" unitRef="shares" id="Foot-20-78" decimals="INF">5579776</rwlk:StockIssuedDuringPeriodSharesPrivatePlacement>
    <rwlk:StockIssuedDuringPeriodValuePrivatePlacement contextRef="From2020-01-01to2020-12-31" unitRef="USD" id="Foot-20-79" decimals="-3">7007000</rwlk:StockIssuedDuringPeriodValuePrivatePlacement>
    <rwlk:StockIssuedDuringPeriodValuePrivatePlacement contextRef="From2020-01-01to2020-12-31_us-gaap_CommonStockMember" unitRef="USD" id="Foot-20-80" decimals="-3">429000</rwlk:StockIssuedDuringPeriodValuePrivatePlacement>
    <rwlk:StockIssuedDuringPeriodValuePrivatePlacement contextRef="From2020-01-01to2020-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" id="Foot-20-81" decimals="-3">6578000</rwlk:StockIssuedDuringPeriodValuePrivatePlacement>
    <rwlk:StockIssuedDuringPeriodValuePrivatePlacement contextRef="From2020-01-01to2020-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" id="Foot-20-82" xsi:nil="true" />
    <rwlk:RegisteredDirectOfferingsIssuanceCostIncurredNotYetPaid contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" id="Foot-20-83" xsi:nil="true" />
    <rwlk:RegisteredDirectOfferingsIssuanceCostIncurredNotYetPaid contextRef="From2018-01-01to2018-12-31" unitRef="USD" id="Foot-20-84" xsi:nil="true" />
    <rwlk:RegisteredDirectOfferingsIssuanceCostIncurredNotYetPaid contextRef="From2020-01-01to2020-12-31" unitRef="USD" id="Foot-20-85" decimals="-3">76000</rwlk:RegisteredDirectOfferingsIssuanceCostIncurredNotYetPaid>
    <us-gaap:CommitmentsAndContingencies contextRef="Context_As_Of_30_Sep_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" xsi:nil="true" />
    <us-gaap:CommitmentsAndContingencies contextRef="AsOf2020-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:InterestExpenseDebt contextRef="From2020-01-01to2020-12-31_us-gaap_SecuredDebtMember" unitRef="USD" decimals="-3">907000</us-gaap:InterestExpenseDebt>
    <rwlk:ContingentLiabilityRelatedToGrantsReceived contextRef="AsOf2020-12-31_custom_IsraelInnovationAuthorityMember" unitRef="USD" decimals="-3">1600000</rwlk:ContingentLiabilityRelatedToGrantsReceived>
    <rwlk:BeneficiaryEnterprisefromProductiveActivityTaxExemptionPeriod contextRef="From2020-01-01to2020-12-31">P10Y</rwlk:BeneficiaryEnterprisefromProductiveActivityTaxExemptionPeriod>
    <rwlk:BeneficiaryEnterprisefromProductiveActivityMaximumTimefromPeriodofElectionforTaxExemption contextRef="From2020-01-01to2020-12-31">P12Y</rwlk:BeneficiaryEnterprisefromProductiveActivityMaximumTimefromPeriodofElectionforTaxExemption>
    <rwlk:OperatingLeasesMaximumPenaltiesPayableOnEarlyReleaseOfAgreement contextRef="AsOf2020-12-31" unitRef="USD" decimals="-3">26000</rwlk:OperatingLeasesMaximumPenaltiesPayableOnEarlyReleaseOfAgreement>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="Context_As_Of_30_Sep_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">24372000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2020-12-31" unitRef="USD" decimals="-3">28067000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="Context_As_Of_30_Sep_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">-168469000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2020-12-31" unitRef="USD" decimals="-3">-181445000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AdditionalPaidInCapital contextRef="Context_As_Of_30_Sep_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">178745000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2020-12-31" unitRef="USD" decimals="-3">201392000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:LiabilitiesNoncurrent contextRef="Context_As_Of_30_Sep_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">3424000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent contextRef="AsOf2020-12-31" unitRef="USD" decimals="-3">1625000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="Context_As_Of_30_Sep_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">61000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="AsOf2020-12-31" unitRef="USD" decimals="-3">35000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="Context_As_Of_30_Sep_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">1315000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="AsOf2020-12-31" unitRef="USD" decimals="-3">923000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:DeferredRevenueNoncurrent contextRef="Context_As_Of_30_Sep_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">521000</us-gaap:DeferredRevenueNoncurrent>
    <us-gaap:DeferredRevenueNoncurrent contextRef="AsOf2020-12-31" unitRef="USD" decimals="-3">667000</us-gaap:DeferredRevenueNoncurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="Context_As_Of_30_Sep_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">1527000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="AsOf2020-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:OtherLiabilitiesCurrent contextRef="Context_As_Of_30_Sep_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">402000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="AsOf2020-12-31" unitRef="USD" decimals="-3">432000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:DeferredRevenueCurrent contextRef="Context_As_Of_30_Sep_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">323000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueCurrent contextRef="AsOf2020-12-31" unitRef="USD" decimals="-3">441000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="Context_As_Of_30_Sep_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">670000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="AsOf2020-12-31" unitRef="USD" decimals="-3">867000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="Context_As_Of_30_Sep_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">2698000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2020-12-31" unitRef="USD" decimals="-3">2268000</us-gaap:AccountsPayableCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="Context_As_Of_30_Sep_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">637000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="AsOf2020-12-31" unitRef="USD" decimals="-3">660000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LongTermDebtCurrent contextRef="Context_As_Of_30_Sep_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">5438000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent contextRef="AsOf2020-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="Context_As_Of_30_Sep_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">16253000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2020-12-31" unitRef="USD" decimals="-3">20350000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ProceedsFromWarrantExercises contextRef="From2021-01-01to2021-01-02_us-gaap_SubsequentEventMember" unitRef="USD" decimals="-3">13200000</us-gaap:ProceedsFromWarrantExercises>
    <rwlk:RoyaltyFeesPercentage contextRef="From2020-01-01to2020-12-31_custom_IsraelInnovationAuthorityMember" unitRef="pure" decimals="INF">0.03</rwlk:RoyaltyFeesPercentage>
    <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion contextRef="AsOf2020-12-31_custom_IsraelInnovationAuthorityMember_us-gaap_ConvertiblePreferredStockMember" unitRef="shares" decimals="INF">209</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
    <us-gaap:UnsecuredDebt contextRef="AsOf2020-04-21_custom_PaycheckProtectionProgramLoanMember_custom_SiliconValleyBankMember" unitRef="USD" decimals="-3">392000</us-gaap:UnsecuredDebt>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="AsOf2020-12-31_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeMember" unitRef="shares" decimals="INF">1251311</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="-3">330000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:StockholdersEquityReverseStockSplit contextRef="From2019-03-01to2019-03-27">The Company&#8217;s shareholders approved (i) a reverse share split within a range of 1:8 to 1:32, to be effective at the ratio and on a date to be determined by the Board of Directors, and (ii) amendments to the Company&#8217;s Articles of Association authorizing an increase in the Company&#8217;s authorized share capital (and corresponding authorized number of ordinary shares, proportionally adjusting such number for the reverse share split) by up to NIS 17.5 million. Following the shareholder approval, an authorized committee of the Board of Directors of the Company approved a one-for-twenty-five reverse share split of the Company&#8217;s ordinary shares, and the Company filed the Third Amended and Restated Articles of Association of the Company with the Registrar of Companies of the State of Israel to effect the reverse share split and to increase the Company&#8217;s authorized share capital after the effect of the reverse share split. The reverse share split became effective on April 1, 2019. Additionally, effective at the same time, the total number of ordinary shares the Company is authorized to issue changed from 250,000,000 shares to 60,000,000 shares, the par value per share of the ordinary shares changed to NIS 0.25 and the authorized share capital of the Company changed from NIS 2,500,000 to NIS 15,000,000. All share and per share data included in these consolidated financial statements, for periods before December 31, 2019, give retroactive effect to the reverse stock split.</us-gaap:StockholdersEquityReverseStockSplit>
    <rwlk:CommonStockAggregateOfferingPriceAuthorizedUnderEquityDistributionAgreement contextRef="AsOf2016-05-10_custom_AtmOfferingProgramMember" unitRef="USD" decimals="-3">25000000</rwlk:CommonStockAggregateOfferingPriceAuthorizedUnderEquityDistributionAgreement>
    <rwlk:CommonStockIssuanceCostsUnderEquityDistributionAgreementAsPercentOfGrossProceeds contextRef="AsOf2016-05-10_custom_AtmOfferingProgramMember" unitRef="pure" decimals="INF">0.03</rwlk:CommonStockIssuanceCostsUnderEquityDistributionAgreementAsPercentOfGrossProceeds>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2019-02-01to2019-02-28_us-gaap_PrivatePlacementMember" unitRef="shares" decimals="INF">760000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2020-01-01to2020-12-31_custom_AtmOfferingProgramMember" unitRef="shares" decimals="INF">302092</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2020-02-01to2021-02-10_custom_CommonUnitsAndPreFundedUnitsMember" unitRef="shares" decimals="INF">5600000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2020-07-01to2020-07-06_custom_PurchaseAgreementWithCertainInstitutionalInvestorsMember" unitRef="shares" decimals="INF">4938278</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2020-12-01to2020-12-03_custom_PurchaseAgreementWithCertainInstitutionalInvestorsMember" unitRef="shares" decimals="INF">5579776</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare contextRef="AsOf2020-02-10_custom_CommonUnitsMember" unitRef="USD_per_Share" decimals="INF">1.25</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SharesIssuedPricePerShare contextRef="AsOf2020-02-10_custom_PreFundedUnitsMember" unitRef="USD_per_Share" decimals="INF">1.249</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SharesIssuedPricePerShare contextRef="AsOf2020-07-06_custom_PurchaseAgreementWithCertainInstitutionalInvestorsMember" unitRef="USD_per_Share" decimals="INF">1.8225</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SharesIssuedPricePerShare contextRef="AsOf2020-12-03_custom_PurchaseAgreementWithCertainInstitutionalInvestorsMember" unitRef="USD_per_Share" decimals="INF">1.4337</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight contextRef="AsOf2020-02-10_custom_CommonUnitsAndPreFundedUnitsMember" unitRef="shares" decimals="INF">1546828</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <rwlk:StockIssuedDuringPeriodValueNewIssuesGross contextRef="From2020-01-01to2020-12-31_custom_AtmOfferingProgramMember" unitRef="USD" decimals="-3">15700000</rwlk:StockIssuedDuringPeriodValueNewIssuesGross>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2020-01-01to2020-12-31_custom_AtmOfferingProgramMember" unitRef="USD" decimals="-3">14500000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <rwlk:FixedCommissionRate contextRef="From2020-01-01to2020-12-31_custom_AtmOfferingProgramMember" unitRef="pure" decimals="INF">0.03</rwlk:FixedCommissionRate>
    <rwlk:FixedCommissionAmount contextRef="From2020-01-01to2020-12-31_custom_AtmOfferingProgramMember" unitRef="USD" decimals="-3">471000</rwlk:FixedCommissionAmount>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="USD_per_Share" decimals="INF">4.67</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="Context_9ME_01_Jan_2016T00_00_00_TO_30_Sep_2016T00_00_00_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="USD_per_Share" decimals="INF">26.75</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="From2020-01-01to2020-12-31_us-gaap_RestrictedStockUnitsRSUMember" unitRef="USD_per_Share" decimals="INF">1.44</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="USD_per_Share" decimals="INF">2.98</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="Context_9ME_01_Jan_2016T00_00_00_TO_30_Sep_2016T00_00_00_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="USD_per_Share" decimals="INF">15.25</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance contextRef="AsOf2020-12-31_us-gaap_EmployeeStockOptionMember" unitRef="shares" decimals="INF">604320</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance contextRef="AsOf2019-12-31_us-gaap_EmployeeStockOptionMember" unitRef="shares" decimals="INF">12409</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <rwlk:AggregateNumberOfOrdinaryShares contextRef="From2018-02-22to2018-03-06_custom_TimwellCorporationLimitedMember" unitRef="shares" decimals="INF">640000</rwlk:AggregateNumberOfOrdinaryShares>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="Context_As_Of_30_Sep_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="shares" decimals="INF">2522284</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="AsOf2019-06-12_custom_SecuritiesPurchaseAgreementsMember" unitRef="shares" decimals="INF">416667</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="AsOf2019-04-30_custom_SecuritiesPurchaseAgreementsMember" unitRef="shares" decimals="INF">408457</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="AsOf2020-12-31" unitRef="shares" decimals="INF">11389555</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="AsOf2020-02-10_custom_CommonUnitsAndPreFundedUnitsMember" unitRef="shares" decimals="INF">336000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="AsOf2020-07-06_custom_PurchaseAgreementWithCertainInstitutionalInvestorsMember" unitRef="shares" decimals="INF">2469139</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="AsOf2020-07-06_custom_PurchaseAgreementWithCertainInstitutionalInvestorsMember_custom_AdditionallyWarrantsIssuedMember" unitRef="shares" decimals="INF">296297</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="AsOf2020-12-03_custom_PurchaseAgreementWithCertainInstitutionalInvestorsMember" unitRef="shares" decimals="INF">4184832</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="AsOf2020-12-03_custom_PurchaseAgreementWithCertainInstitutionalInvestorsMember_custom_AdditionallyWarrantsIssuedMember" unitRef="shares" decimals="INF">334787</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="AsOf2016-01-04_us-gaap_SecuredDebtMember" unitRef="shares" decimals="INF">4771</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="AsOf2016-12-28_us-gaap_SecuredDebtMember" unitRef="shares" decimals="INF">6679</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="AsOf2019-06-06_us-gaap_SecuredDebtMember" unitRef="shares" decimals="INF">480000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="AsOf2020-12-31_us-gaap_EmployeeStockOptionMember" unitRef="USD" decimals="-3">2000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable contextRef="From2015-01-01to2015-12-31_custom_KreosCapitalVMember">2015-12-31</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
    <rwlk:WarrantsExercisableDescrition contextRef="From2015-01-01to2015-12-31_custom_KreosCapitalVMember">Currently exercisable (in whole or in part) until the earlier of (i) December 30, 2025 or (ii) immediately prior to the consummation of a merger, consolidation, or reorganization of us with or into, or the sale or license of all or substantially all the assets or shares of us to, any other entity or person, other than a wholly-owned subsidiary of us, excluding any transaction in which the Company&#8217;s shareholders prior to the transaction will hold more than 50% of the voting and economic rights of the surviving entity after the transaction.</rwlk:WarrantsExercisableDescrition>
    <rwlk:WarrantsExercisableDescrition contextRef="From2019-04-01to2019-04-30_custom_SecuritiesPurchaseAgreementsMember">Exercisable from April 5, 2019 until October 7, 2024.</rwlk:WarrantsExercisableDescrition>
    <rwlk:WarrantsExercisableDescrition contextRef="From2019-04-01to2019-04-30_custom_SecuritiesPurchaseAgreementsMember_custom_WarrantsToPurchaseOrdinarySharesIssuedMember">Exercisable from April 5, 2019 until April 3, 2024.</rwlk:WarrantsExercisableDescrition>
    <rwlk:WarrantsExercisableDescrition contextRef="From2019-05-14to2019-06-05_custom_SecuritiesPurchaseAgreementsMember">Exercisable from June 5, 2019 or June 6, 2019 until June 5, 2024 or June 6, 2024.</rwlk:WarrantsExercisableDescrition>
    <rwlk:WarrantsExercisableDescrition contextRef="From2019-05-14to2019-06-05_custom_SecuritiesPurchaseAgreementsMember_custom_WarrantsToPurchaseOrdinarySharesIssuedMember">Exercisable from June 5, 2019 until June 5, 2024.</rwlk:WarrantsExercisableDescrition>
    <rwlk:WarrantsExercisableDescrition contextRef="From2019-05-14to2019-06-06_custom_SecuritiesPurchaseAgreementsMember">Exercisable from June 5, 2019 or June 6, 2019 until June 5, 2024 or June 6, 2024.</rwlk:WarrantsExercisableDescrition>
    <rwlk:WarrantsExercisableDescrition contextRef="From2019-05-14to2019-06-06_custom_SecuritiesPurchaseAgreementsMember_custom_WarrantsToPurchaseOrdinarySharesIssuedMember">Exercisable from June 5, 2019 until June 5, 2024.</rwlk:WarrantsExercisableDescrition>
    <rwlk:WarrantsExercisableDescrition contextRef="From2019-05-22to2019-06-12_custom_SecuritiesPurchaseAgreementsMember">Exercisable from June 12, 2019 until December 12, 2024.</rwlk:WarrantsExercisableDescrition>
    <rwlk:WarrantsExercisableDescrition contextRef="From2019-05-22to2019-06-12_custom_SecuritiesPurchaseAgreementsMember_custom_WarrantsToPurchaseOrdinarySharesIssuedMember">Exercisable from June 12, 2019 until June 10, 2024.</rwlk:WarrantsExercisableDescrition>
    <us-gaap:DebtInstrumentCollateralAmount contextRef="AsOf2016-12-28_custom_KreosCapitalMember" unitRef="USD" decimals="-3">8000000</us-gaap:DebtInstrumentCollateralAmount>
    <us-gaap:CostsAndExpensesRelatedParty contextRef="From2018-01-01to2020-12-31_custom_EquityExchangeProgramMember" unitRef="USD" decimals="-3">0</us-gaap:CostsAndExpensesRelatedParty>
    <us-gaap:ProceedsFromStockPlans contextRef="From2018-02-22to2018-03-06_custom_TimwellCorporationLimitedMember" unitRef="USD" decimals="-3">20000000</us-gaap:ProceedsFromStockPlans>
    <us-gaap:AcceleratedShareRepurchasesFinalPricePaidPerShare contextRef="From2019-02-01to2019-02-28_us-gaap_PrivatePlacementMember" unitRef="USD_per_Share" decimals="INF">5.75</us-gaap:AcceleratedShareRepurchasesFinalPricePaidPerShare>
    <rwlk:FeesAndOtherRelatedExpenses contextRef="From2018-02-22to2018-03-06_custom_TimwellCorporationLimitedMember" unitRef="USD" decimals="-3">705000</rwlk:FeesAndOtherRelatedExpenses>
    <rwlk:FeesAndOtherRelatedExpenses contextRef="From2020-01-01to2020-12-31_custom_AtmOfferingProgramMember" unitRef="USD" decimals="-3">1200000</rwlk:FeesAndOtherRelatedExpenses>
    <rwlk:NetAggregateProceedsOfAfterDeductingFeesAndOtherRelatedExpenses contextRef="From2018-02-22to2018-03-06_custom_TimwellCorporationLimitedMember" unitRef="USD" decimals="-3">4300000</rwlk:NetAggregateProceedsOfAfterDeductingFeesAndOtherRelatedExpenses>
    <us-gaap:SecuritiesLoanedMeasurementDifferenceDescription contextRef="From2018-02-22to2018-03-06_custom_TimwellCorporationLimitedMember">The Company entered into an investment agreement with Timwell Corporation Limited, a Hong Kong corporation (&#8220;Timwell&#8221;), as amended on May 15, 2018 (the &#8220;Investment Agreement&#8221;), pursuant to which the Company agreed to issue to Timwell, in three different tranches, an aggregate of 640,000 ordinary shares in return for aggregate gross proceeds of $20 million. The closing of each tranche is subject to certain closing conditions. The closing of the first tranche (the &#8220;First Tranche Closing&#8221;) took place on May 15, 2018, upon which Timwell received 160,000 ordinary shares for an aggregate purchase price of $5,000,000, and Timwell and the Company signed a registration rights agreement in the form attached to the Investment Agreement. The net aggregate proceeds of the First Tranche Closing after deducting fees and other related expenses in the amount of approximately $705 thousands were approximately $4.3 million. The remaining investment is to occur in two tranches, including $10 million for the issuance to Timwell of 320,000 ordinary shares (the &#8220;Second Tranche&#8221;) and $5 million for the issuance to Timwell of 160,000 ordinary shares (the &#8220;Third Tranch&#8221;). The closing of the second and third tranches is subject to specified closing conditions, including, with respect to the second tranche, the signing of a license agreement and a supply agreement and the formation of the China JV (the &#8220;China JV&#8221;) based on the JV Framework Agreement, and, with respect to the third tranche, the successful production of certain ReWalk products by the China JV. The second tranche closing was initially expected to occur by July 1, 2018 and the third tranche closing was initially expected to occur by December 31, 2018 and no later than April 1, 2019.</us-gaap:SecuritiesLoanedMeasurementDifferenceDescription>
    <us-gaap:SecuritiesLoanedMeasurementDifferenceDescription contextRef="From2018-05-04to2018-05-31_custom_TimwellCorporationLimitedMember">The Company entered into a fee and release agreement with Canaccord Genuity LLC (&#8220;Canaccord Genuity&#8221;) requiring the Company to pay to Canaccord Genuity, in connection with a settlement, in addition to certain cash amounts, (i) $125 thousand in ordinary shares of the Company after the First Tranche Closing of the Timwell transaction and (ii) $225 thousand in ordinary shares of the Company after the closing of the Second Tranche of the Timwell transaction (or such lower amount if the Second Tranche Closing is less than $10.0 million). The price per share used for calculation of the number of ordinary shares issued by the Company to Canaccord Genuity is based on the volume weighted average price of the Company&#8217;s ordinary shares as reported on the Nasdaq Capital Market for the five consecutive trading days prior to the date of issuance. The Company is also obligated to pay $100 thousand in cash following the closing of the Third Tranche of $5.0 million (or such lower amount if the Third Tranche Closing is less than $5.0 million). Following the First Tranche Closing in May 15, 2018, the Company issued 4,715 ordinary shares to Canaccord Genuity.</us-gaap:SecuritiesLoanedMeasurementDifferenceDescription>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="AsOf2020-12-31" unitRef="USD" decimals="-3">1651537000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="AsOf2020-12-31_custom_CommonUnitsAndPreFundedUnits1Member" unitRef="USD" decimals="-3">1831500000</us-gaap:WarrantsAndRightsOutstanding>
    <rwlk:DescriptionOfUnderwritingAgreement contextRef="From2018-11-02to2018-11-30">The Company entered into an underwriting agreement with H.C. Wainwright &amp; Co., LLC (&#8220;H.C. Wainwright&#8221;), in connection with the Company&#8217;s follow-on public offering of 496,055 units, each consisting of one ordinary share and one common warrant to purchase one ordinary share with an exercise price of $7.5 per warrant. Each unit was sold to the public at a price of $7.50 per unit. On November 18, 2018, H.C. Wainwright exercised in full its option to purchase 231,964 ordinary shares for $7.25 per share and/or common warrants to purchase up to an additional 231,964 ordinary shares for $0.25 per warrant.</rwlk:DescriptionOfUnderwritingAgreement>
    <rwlk:DescriptionOfUnderwritersWarrantsToPurchase contextRef="From2018-11-02to2018-11-30">The Company issued and sold 1,050,372 pre-funded units at a price to the public of $7.25 per unit. Each unit containing one pre-funded warrant with an exercise price of $0.25 per share and one warrant to purchase one ordinary share with an exercise price of $7.50 per warrant. The total gross proceeds received from the November 2018 follow-on public offering, before deducting commissions, discounts and expenses, were $13.1 million (including proceeds from the exercise of 90,691 pre-funded warrants at the closing of the offering). As of December 31, 2018, additional pre-funded warrants to purchase an aggregate 562,466 ordinary shares had been exercised, for additional proceeds of $140,617. During the year ended December 31, 2019 additional 288,000 pre-funded warrants and 296,087 warrants to purchase an aggregate 584,087 ordinary shares had been exercised, for additional proceeds of $1.5 million. As compensation for their role in the offering, the Company also issued to the Underwriters warrants to purchase up to 106,680 ordinary shares, which became immediately exercisable starting on November 20, 2018 until November 15, 2023 at $9.375 per share.</rwlk:DescriptionOfUnderwritersWarrantsToPurchase>
    <rwlk:DescriptionOfWainwrightOrItsDesigneesWarrantsToPurchase contextRef="From2019-02-01to2019-02-28_us-gaap_PrivatePlacementMember">The Company also issued to H.C Wainwright and/or its designees warrants to purchase up to 45,600 ordinary shares, which are immediately exercisable starting on February 25, 2019 until February 21, 2024 at $7.1875 per share.</rwlk:DescriptionOfWainwrightOrItsDesigneesWarrantsToPurchase>
    <rwlk:StockIssuedDuringPeriodShareOrdinaryShares contextRef="From2019-04-01to2019-04-30_custom_SecuritiesPurchaseAgreementsMember" unitRef="shares" decimals="INF">816914</rwlk:StockIssuedDuringPeriodShareOrdinaryShares>
    <rwlk:StockIssuedDuringPeriodShareOrdinaryShares contextRef="From2019-04-01to2019-04-30_custom_SecuritiesPurchaseAgreementsMember_custom_WarrantsToPurchaseOrdinarySharesIssuedMember" unitRef="shares" decimals="INF">49015</rwlk:StockIssuedDuringPeriodShareOrdinaryShares>
    <rwlk:StockIssuedDuringPeriodShareOrdinaryShares contextRef="From2019-05-14to2019-06-05_custom_SecuritiesPurchaseAgreementsMember" unitRef="shares" decimals="INF">1464665</rwlk:StockIssuedDuringPeriodShareOrdinaryShares>
    <rwlk:StockIssuedDuringPeriodShareOrdinaryShares contextRef="From2019-05-14to2019-06-05_custom_SecuritiesPurchaseAgreementsMember_custom_WarrantsToPurchaseOrdinarySharesIssuedMember" unitRef="shares" decimals="INF">87880</rwlk:StockIssuedDuringPeriodShareOrdinaryShares>
    <rwlk:StockIssuedDuringPeriodShareOrdinaryShares contextRef="From2019-05-14to2019-06-06_custom_SecuritiesPurchaseAgreementsMember" unitRef="shares" decimals="INF">1464665</rwlk:StockIssuedDuringPeriodShareOrdinaryShares>
    <rwlk:StockIssuedDuringPeriodShareOrdinaryShares contextRef="From2019-05-14to2019-06-06_custom_SecuritiesPurchaseAgreementsMember_custom_WarrantsToPurchaseOrdinarySharesIssuedMember" unitRef="shares" decimals="INF">87880</rwlk:StockIssuedDuringPeriodShareOrdinaryShares>
    <rwlk:StockIssuedDuringPeriodShareOrdinaryShares contextRef="From2019-05-22to2019-06-12_custom_SecuritiesPurchaseAgreementsMember" unitRef="shares" decimals="INF">833334</rwlk:StockIssuedDuringPeriodShareOrdinaryShares>
    <rwlk:StockIssuedDuringPeriodShareOrdinaryShares contextRef="From2019-05-22to2019-06-12_custom_SecuritiesPurchaseAgreementsMember_custom_WarrantsToPurchaseOrdinarySharesIssuedMember" unitRef="shares" decimals="INF">50000</rwlk:StockIssuedDuringPeriodShareOrdinaryShares>
    <rwlk:OrdinarySharesExercisePrice contextRef="AsOf2019-06-12_custom_SecuritiesPurchaseAgreementsMember" unitRef="USD_per_Share" decimals="INF">6.00</rwlk:OrdinarySharesExercisePrice>
    <rwlk:OrdinarySharesExercisePrice contextRef="AsOf2019-04-30_custom_SecuritiesPurchaseAgreementsMember" unitRef="USD_per_Share" decimals="INF">5.2025</rwlk:OrdinarySharesExercisePrice>
    <rwlk:OrdinarySharesExercisePrice contextRef="AsOf2019-04-30_custom_SecuritiesPurchaseAgreementsMember_custom_WarrantsToPurchaseOrdinarySharesIssuedMember" unitRef="USD_per_Share" decimals="INF">6.503125</rwlk:OrdinarySharesExercisePrice>
    <rwlk:OrdinarySharesExercisePrice contextRef="AsOf2019-06-05_custom_SecuritiesPurchaseAgreementsMember" unitRef="USD_per_Share" decimals="INF">7.50</rwlk:OrdinarySharesExercisePrice>
    <rwlk:OrdinarySharesExercisePrice contextRef="AsOf2019-06-05_custom_SecuritiesPurchaseAgreementsMember_custom_WarrantsToPurchaseOrdinarySharesIssuedMember" unitRef="USD_per_Share" decimals="INF">9.375</rwlk:OrdinarySharesExercisePrice>
    <rwlk:OrdinarySharesExercisePrice contextRef="AsOf2019-06-06_custom_SecuritiesPurchaseAgreementsMember" unitRef="USD_per_Share" decimals="INF">7.50</rwlk:OrdinarySharesExercisePrice>
    <rwlk:OrdinarySharesExercisePrice contextRef="AsOf2019-06-06_custom_SecuritiesPurchaseAgreementsMember_custom_WarrantsToPurchaseOrdinarySharesIssuedMember" unitRef="USD_per_Share" decimals="INF">9.375</rwlk:OrdinarySharesExercisePrice>
    <rwlk:OrdinarySharesExercisePrice contextRef="AsOf2019-06-12_custom_SecuritiesPurchaseAgreementsMember_custom_WarrantsToPurchaseOrdinarySharesIssuedMember" unitRef="USD_per_Share" decimals="INF">7.50</rwlk:OrdinarySharesExercisePrice>
    <rwlk:OrdinarySharesExercisePrice contextRef="AsOf2019-06-12_custom_SecuritiesPurchaseAgreementsMember_custom_IsraeliMember" unitRef="USD_per_Share" decimals="INF">0.25</rwlk:OrdinarySharesExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares contextRef="From2020-01-01to2020-12-31_us-gaap_EmployeeStockOptionMember" unitRef="shares" decimals="INF">676</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares contextRef="From2018-01-01to2018-12-31_us-gaap_EmployeeStockOptionMember" unitRef="shares" decimals="INF">2918</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares contextRef="From2019-01-01to2019-12-31_us-gaap_EmployeeStockOptionMember" unitRef="shares" decimals="INF">1175</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <rwlk:WarrantsToPurchaseOrdinaryShares contextRef="From2020-01-01to2020-12-31" unitRef="shares" decimals="INF">6680</rwlk:WarrantsToPurchaseOrdinaryShares>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="AsOf2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwoThousandSixteenMember" unitRef="shares" id="Foot-02-1" decimals="INF">97496</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="AsOf2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandSixteenMember" unitRef="shares" id="Foot-03-1" decimals="INF">1908</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="AsOf2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandFifteenMember" unitRef="shares" id="Foot-04-1" decimals="INF">4771</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="AsOf2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenMember" unitRef="shares" id="Foot-05-1" decimals="INF">126839</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="AsOf2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenOneMember" unitRef="shares" id="Foot-06-1" decimals="INF">106680</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="AsOf2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentyFiveTwoThousandNineteenMember" unitRef="shares" id="Foot-07-1" decimals="INF">45600</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="AsOf2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenMember" unitRef="shares" id="Foot-08-1" decimals="INF">408457</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="AsOf2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenOneMember" unitRef="shares" id="Foot-09-1" decimals="INF">49015</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="AsOf2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveAndSixTwoThousandNineteenMember" unitRef="shares" id="Foot-10-1" decimals="INF">1464665</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="AsOf2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveTwoThousandNineteenMember" unitRef="shares" id="Foot-11-1" decimals="INF">87880</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="AsOf2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTweleveTwoThousandNineteenMember" unitRef="shares" id="Foot-12-1" decimals="INF">416667</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="AsOf2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTenTwoThousandNineteenMember" unitRef="shares" id="Foot-13-1" decimals="INF">50000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="AsOf2020-12-31" unitRef="shares" decimals="INF">14249533</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="AsOf2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyMember" unitRef="shares" id="Foot-14-1" decimals="INF">3768500</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="AsOf2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyOneMember" unitRef="shares" id="Foot-15-1" decimals="INF">336000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="AsOf2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyMember" unitRef="shares" id="Foot-16-1" decimals="INF">2469139</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="AsOf2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyOneMember" unitRef="shares" id="Foot-17-1" decimals="INF">296297</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="AsOf2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberThreeTwoThousandTwentyMember" unitRef="shares" id="Foot-18-1" decimals="INF">4184832</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="AsOf2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberThreeTwoThousandTwentyOneMember" unitRef="shares" id="Foot-19-1" decimals="INF">334787</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="AsOf2021-01-02_us-gaap_SubsequentEventMember" unitRef="shares" decimals="INF">9372954</us-gaap:ClassOfWarrantOrRightOutstanding>
    <rwlk:ClassOfWarrantOrRightExercisable contextRef="AsOf2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwoThousandSixteenMember" unitRef="shares" id="Foot-02-2" decimals="INF">97496</rwlk:ClassOfWarrantOrRightExercisable>
    <rwlk:ClassOfWarrantOrRightExercisable contextRef="AsOf2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandSixteenMember" unitRef="shares" id="Foot-03-2" decimals="INF">1908</rwlk:ClassOfWarrantOrRightExercisable>
    <rwlk:ClassOfWarrantOrRightExercisable contextRef="AsOf2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandFifteenMember" unitRef="shares" id="Foot-04-2" decimals="INF">4771</rwlk:ClassOfWarrantOrRightExercisable>
    <rwlk:ClassOfWarrantOrRightExercisable contextRef="AsOf2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenMember" unitRef="shares" id="Foot-05-2" decimals="INF">126839</rwlk:ClassOfWarrantOrRightExercisable>
    <rwlk:ClassOfWarrantOrRightExercisable contextRef="AsOf2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenOneMember" unitRef="shares" id="Foot-06-2" decimals="INF">106680</rwlk:ClassOfWarrantOrRightExercisable>
    <rwlk:ClassOfWarrantOrRightExercisable contextRef="AsOf2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentyFiveTwoThousandNineteenMember" unitRef="shares" id="Foot-07-2" decimals="INF">45600</rwlk:ClassOfWarrantOrRightExercisable>
    <rwlk:ClassOfWarrantOrRightExercisable contextRef="AsOf2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenMember" unitRef="shares" id="Foot-08-2" decimals="INF">408457</rwlk:ClassOfWarrantOrRightExercisable>
    <rwlk:ClassOfWarrantOrRightExercisable contextRef="AsOf2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenOneMember" unitRef="shares" id="Foot-09-2" decimals="INF">49015</rwlk:ClassOfWarrantOrRightExercisable>
    <rwlk:ClassOfWarrantOrRightExercisable contextRef="AsOf2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveAndSixTwoThousandNineteenMember" unitRef="shares" id="Foot-10-2" decimals="INF">1464665</rwlk:ClassOfWarrantOrRightExercisable>
    <rwlk:ClassOfWarrantOrRightExercisable contextRef="AsOf2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveTwoThousandNineteenMember" unitRef="shares" id="Foot-11-2" decimals="INF">87880</rwlk:ClassOfWarrantOrRightExercisable>
    <rwlk:ClassOfWarrantOrRightExercisable contextRef="AsOf2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTweleveTwoThousandNineteenMember" unitRef="shares" id="Foot-12-2" decimals="INF">416667</rwlk:ClassOfWarrantOrRightExercisable>
    <rwlk:ClassOfWarrantOrRightExercisable contextRef="AsOf2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTenTwoThousandNineteenMember" unitRef="shares" id="Foot-13-2" decimals="INF">50000</rwlk:ClassOfWarrantOrRightExercisable>
    <rwlk:ClassOfWarrantOrRightExercisable contextRef="AsOf2020-12-31" unitRef="shares" decimals="INF">14249533</rwlk:ClassOfWarrantOrRightExercisable>
    <rwlk:ClassOfWarrantOrRightExercisable contextRef="AsOf2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyMember" unitRef="shares" id="Foot-14-2" decimals="INF">4343500</rwlk:ClassOfWarrantOrRightExercisable>
    <rwlk:ClassOfWarrantOrRightExercisable contextRef="AsOf2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyOneMember" unitRef="shares" id="Foot-15-2" decimals="INF">336000</rwlk:ClassOfWarrantOrRightExercisable>
    <rwlk:ClassOfWarrantOrRightExercisable contextRef="AsOf2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyMember" unitRef="shares" id="Foot-16-2" decimals="INF">2469139</rwlk:ClassOfWarrantOrRightExercisable>
    <rwlk:ClassOfWarrantOrRightExercisable contextRef="AsOf2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyOneMember" unitRef="shares" id="Foot-17-2" decimals="INF">296297</rwlk:ClassOfWarrantOrRightExercisable>
    <rwlk:ClassOfWarrantOrRightExercisable contextRef="AsOf2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberThreeTwoThousandTwentyMember" unitRef="shares" id="Foot-18-2" decimals="INF">4184832</rwlk:ClassOfWarrantOrRightExercisable>
    <rwlk:ClassOfWarrantOrRightExercisable contextRef="AsOf2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberThreeTwoThousandTwentyOneMember" unitRef="shares" id="Foot-19-2" decimals="INF">334787</rwlk:ClassOfWarrantOrRightExercisable>
    <rwlk:WarrantsExpitationDate contextRef="From2020-01-01to2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwoThousandSixteenMember" id="Foot-02-3">2021-11-01</rwlk:WarrantsExpitationDate>
    <rwlk:WarrantsExpitationDate contextRef="From2020-01-01to2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenMember" id="Foot-05-3">2023-11-20</rwlk:WarrantsExpitationDate>
    <rwlk:WarrantsExpitationDate contextRef="From2020-01-01to2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenOneMember" id="Foot-06-3">2023-11-15</rwlk:WarrantsExpitationDate>
    <rwlk:WarrantsExpitationDate contextRef="From2020-01-01to2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentyFiveTwoThousandNineteenMember" id="Foot-07-3">2024-02-21</rwlk:WarrantsExpitationDate>
    <rwlk:WarrantsExpitationDate contextRef="From2020-01-01to2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenMember" id="Foot-08-3">2024-10-07</rwlk:WarrantsExpitationDate>
    <rwlk:WarrantsExpitationDate contextRef="From2020-01-01to2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenOneMember" id="Foot-09-3">2024-04-03</rwlk:WarrantsExpitationDate>
    <rwlk:WarrantsExpitationDate contextRef="From2020-01-01to2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveAndSixTwoThousandNineteenMember" id="Foot-10-3">2024-06-05</rwlk:WarrantsExpitationDate>
    <rwlk:WarrantsExpitationDate contextRef="From2020-01-01to2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveTwoThousandNineteenMember" id="Foot-11-3">2024-06-05</rwlk:WarrantsExpitationDate>
    <rwlk:WarrantsExpitationDate contextRef="From2020-01-01to2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTweleveTwoThousandNineteenMember" id="Foot-12-3">2024-12-12</rwlk:WarrantsExpitationDate>
    <rwlk:WarrantsExpitationDate contextRef="From2020-01-01to2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTenTwoThousandNineteenMember" id="Foot-13-3">2024-06-10</rwlk:WarrantsExpitationDate>
    <rwlk:WarrantsExpitationDate contextRef="From2020-01-01to2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandFifteenMember" id="Foot-04-3">2025-12-30</rwlk:WarrantsExpitationDate>
    <rwlk:WarrantsExpitationDate contextRef="From2020-01-01to2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandSixteenMember" id="Foot-03-3">2025-12-30</rwlk:WarrantsExpitationDate>
    <rwlk:WarrantsExpitationDate contextRef="From2020-01-01to2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyMember" id="Foot-14-3">2020-02-10</rwlk:WarrantsExpitationDate>
    <rwlk:WarrantsExpitationDate contextRef="From2020-01-01to2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyOneMember" id="Foot-15-3">2020-02-10</rwlk:WarrantsExpitationDate>
    <rwlk:WarrantsExpitationDate contextRef="From2020-01-01to2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyMember" id="Foot-16-3">2020-07-06</rwlk:WarrantsExpitationDate>
    <rwlk:WarrantsExpitationDate contextRef="From2020-01-01to2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyOneMember" id="Foot-17-3">2020-07-06</rwlk:WarrantsExpitationDate>
    <rwlk:WarrantsExpitationDate contextRef="From2020-01-01to2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberThreeTwoThousandTwentyMember" id="Foot-18-3">2020-12-03</rwlk:WarrantsExpitationDate>
    <rwlk:WarrantsExpitationDate contextRef="From2020-01-01to2020-12-31_custom_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberThreeTwoThousandTwentyOneMember" id="Foot-19-3">2020-12-03</rwlk:WarrantsExpitationDate>
    <us-gaap:CommonStockValue contextRef="Context_As_Of_30_Sep_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">504000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2020-12-31" unitRef="USD" decimals="-3">1827000</us-gaap:CommonStockValue>
    <rwlk:PrepaidExpenseAndOtherAssetsDisclosureTextBlock contextRef="From2020-01-01to2020-12-31">&lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;font style="font-weight: bold"&gt;NOTE&amp;#160;3:-&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160; &lt;font style="font-weight: bold"&gt;PREPAID EXPENSES AND OTHER CURRENT ASSETS&lt;/font&gt;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-indent: 36pt"&gt;The components of prepaid expenses and other current assets are as follows (in thousands):&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" border="0" align="right" id="zc6efca7e7e844e46a25c6bd8d55ca9ea" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="6" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;December 31,&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt; 2020&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;2019&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Government institutions&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;87&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;175&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Prepaid expenses&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;311&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;318&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Advances to vendors&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;241&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;246&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Other assets&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;33&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;164&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;672&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;903&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</rwlk:PrepaidExpenseAndOtherAssetsDisclosureTextBlock>
    <us-gaap:InventoryDisclosureTextBlock contextRef="From2020-01-01to2020-12-31">&lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;font style="font-weight: bold"&gt;NOTE&amp;#160;4:-&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;font style="font-weight: bold"&gt;INVENTORIES&lt;/font&gt;&lt;/div&gt;&#13;  &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-indent: 36pt"&gt;The components of inventories are as follows (in thousands):&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" border="0" align="right" id="z4334ea3338be48a1a507c3302b556507" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="6" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;December 31,&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt; 2020&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;2019&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Finished products&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;2,764&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;2,394&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Raw materials&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;778&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;729&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;3,542&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;3,123&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="From2020-01-01to2020-12-31">&lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;font style="font-weight: bold"&gt;NOTE&amp;#160;5:-&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160; &lt;font style="font-weight: bold"&gt;PROPERTY AND EQUIPMENT, NET&lt;/font&gt;&lt;/div&gt;&#13;  &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-indent: 36pt"&gt;The components of property and equipment, net are as follows (in thousands):&lt;/div&gt;&#13;  &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" border="0" align="right" id="z40bab54ebb0e4397aeb5637d012e1e87" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="6" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;December 31,&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt; 2020&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;2019&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Cost:&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Computer equipment&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;725&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;723&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Office furniture and equipment&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;298&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;293&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Machinery and laboratory equipment&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;612&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;604&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Field service units&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;1,626&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;1,420&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Leasehold improvements&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;333&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;333&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;3,594&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;3,373&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; clear: both"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" border="0" align="right" id="z840539bb6b7f46bea160bf1f1c4d9228" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="6" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;December 31,&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt; 2020&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;2019&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Accumulated depreciation&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;3,157&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;2,872&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Property and equipment, net&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;437&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;501&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; clear: both"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt"&gt;Depreciation expenses amounted to $285 thousand, $321 thousand, and $463 thousand for the years ended December&amp;#160;31, 2020, 2019 and 2018, respectively.&amp;#160;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2020-01-01to2020-12-31">&lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;font style="font-weight: bold"&gt;NOTE&amp;#160;7:-&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;font style="font-weight: bold"&gt;COMMITMENTS AND CONTINGENT LIABILITIES&lt;/font&gt;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z71631782f67c4ba1a807e8892c46a8cd" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"&gt;&lt;br /&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top"&gt;a.&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;Purchase commitment:&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;The Company has contractual obligations to purchase goods from its contract manufacturer as well as raw materials from different vendors. Purchase obligations do not include&#13;    contracts that may be canceled without penalty. As of December&amp;#160;31, 2020, non-cancelable outstanding obligations amounted to approximately $0.7 million.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z7114fb01bfff49ba95b76036a53bccf9" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"&gt;&lt;br /&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top"&gt;b.&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;Operating lease commitment:&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: -18pt; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;    &lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z98b9924a313d4ceea15de6d760b03ddd" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;      &#13;        &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;&#13;          &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 36pt"&gt;&amp;#160;&lt;/td&gt;&#13;          &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 18pt"&gt;&#13;            &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: left"&gt;(i)&lt;/div&gt;&#13;          &lt;/td&gt;&#13;          &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: auto"&gt;&#13;            &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;&lt;font style="font-family: Times New Roman,Times,serif"&gt;The Company operates from leased facilities in Israel, the United States and Germany. These leases expire between 2021 and 2023. A&#13;                portion of the Company&amp;#8217;s facilities leases is generally subject to annual changes in the Consumer Price Index (CPI). The changes to the CPI are treated as variable lease payments and recognized in the period in which the obligation for&#13;                those payments was incurred.&lt;/font&gt;&lt;/div&gt;&#13;          &lt;/td&gt;&#13;        &lt;/tr&gt;&#13;      &#13;    &lt;/table&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 36pt"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;    &lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zcbd9492150d64f1f856ef88201ec8098" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;      &#13;        &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;&#13;          &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 36pt"&gt;&amp;#160;&lt;/td&gt;&#13;          &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 18pt"&gt;&#13;            &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: left"&gt;(ii)&lt;/div&gt;&#13;          &lt;/td&gt;&#13;          &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: auto"&gt;&#13;            &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;&lt;font style="font-family: Times New Roman,Times,serif"&gt;RRL and RRG lease cars for their employees under cancelable operating lease agreements expiring at various dates in between 2021 and&#13;                2023. A subset of the Company&amp;#8217;s cars leases is considered variable. The variable lease payments for such cars leases are based on actual mileage incurred at the stated contractual rate. RRL and RRG have an option to be released from these&#13;                agreements, which may result in penalties in a maximum amount of approximately $26 thousand as of December&amp;#160;31, 2020.&lt;/font&gt;&lt;/div&gt;&#13;          &lt;/td&gt;&#13;        &lt;/tr&gt;&#13;      &#13;    &lt;/table&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: -18pt; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;The Company&amp;#8217;s future lease payments for its facilities and cars, which are presented as current maturities of operating leases and non-current operating leases liabilities on the&#13;    Company&amp;#8217;s consolidated balance sheets as of&amp;#160;December&amp;#160;31, 2020&amp;#160;are as follows (in thousands):&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" border="0" align="right" id="zdb7695d55aa043a5a1fe0885ee1a4249" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;2021&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;710&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 88%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;2022&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;676&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 88%; padding-bottom: 2px; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;2023&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;491&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 88%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Total lease payments&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;1,877&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 88%; padding-bottom: 2px; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Less: imputed interest&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(294&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 88%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Present value of future lease payments&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;1,583&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Less: current maturities of operating leases&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(660&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 88%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Non-current operating leases&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;923&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Weighted-average remaining lease term (in years)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;2.69&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 88%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Weighted-average discount rate&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;12.6&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;%&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt; clear: both"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;Total rent expenses for the years ended December&amp;#160;31, 2020, 2019 and 2018 were $764 thousand, $739 thousand, and $695 thousand, respectively.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zf560b39bfd6e411487b434ff352a82c6" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"&gt;&lt;br /&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top"&gt;c.&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;Royalties:&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;The Company&amp;#8217;s research and development efforts are financed, in part, through funding from the IIA and BIRD. Since the Company&amp;#8217;s inception through December&amp;#160;31, 2020, the Company&#13;    received funding from the IIA and BIRD in the total amount of $1.97 million and $500 thousand, respectively. Out of the $1.97 million in funding from the IIA, a total amount of $1.57 million were royalty-bearing grants (as of December&amp;#160;31, 2020, the&#13;    Company paid royalties to the IIA in the total amount of $88 thousand), while a total amount of $400 thousand was received in consideration of 209 convertible preferred A shares, which converted after the Company&amp;#8217;s initial public offering in September&#13;    2014 into ordinary shares in a conversion ratio of 1 to 1. The Company is obligated to pay royalties to the IIA, amounting to 3% of the sales of the products and other related revenues generated from such projects, up to 100% of the grants received.&#13;    The royalty payment obligations also bear interest at the LIBOR rate. The obligation to pay these royalties is contingent on actual sales of the applicable products and in the absence of such sales, no payment is required.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt; &lt;br /&gt;&#13;  &lt;/div&gt;&#13;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;Additionally, the License Agreement requires the Company to pay Harvard royalties on net sales, See note 9 below for more information about the Collaboration Agreement and the&#13;    License Agreement.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;Royalties expenses in cost of revenue were&amp;#160;$46 thousand and $15 thousand&amp;#160;for the years ended December&amp;#160;31, 2020, and 2019 respectively, no royalties&amp;#8217; expenses recorded for the year&#13;    ended December&amp;#160;31, 2018.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;As of December&amp;#160;31, 2020, the contingent liability to the IIA amounted to $1.6 million. The Israeli Research and Development Law provides that know-how developed under an approved&#13;    research and development program may not be transferred to third parties without the approval of the IIA. Such approval is not required for the sale or export of any products resulting from such research or development. The IIA, under special&#13;    circumstances, may approve the transfer of IIA-funded know-how outside Israel, in the following cases:&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;(a)&amp;#160;the grant recipient pays to the IIA a portion of the sale price paid in consideration for such IIA-funded know-how or in consideration for the sale of the grant recipient itself,&#13;    as the case may be, which portion will not exceed six times the amount of the grants received plus interest (or three times the amount of the grant received plus interest, in the event that the recipient of the know-how has committed to retain the&#13;    R&amp;#38;D activities of the grant recipient in Israel after the transfer); (b)&amp;#160;the grant recipient receives know-how from a third party in exchange for its IIA-funded know-how; (c)&amp;#160;such transfer of IIA-funded know-how arises in connection with certain&#13;    types of cooperation in research and development activities; or (d)&amp;#160;If such transfer of know-how arises in connection with a liquidation by reason of insolvency or receivership of the grant recipient.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;  &lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z67642dacf86542d184c5e455ae2e25fb" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"&gt;&lt;br /&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top"&gt;d.&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;Liens&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt; margin-left: 36pt"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 36pt; text-align: justify"&gt;As part of the&#13;  Company&amp;#8217;s other long-term assets and restricted cash, an amount of $704 thousand has been pledged as security in&#13;  respect of a guarantee granted to a third party. Such deposit cannot be pledged to others or withdrawn without the consent of&#13;  such third party.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;  &lt;/div&gt;&#13;&#13;  &lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z2e53269c7f3c45bd88bece20968e6c92" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"&gt;&lt;br /&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top"&gt;e.&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;Legal Claims:&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: -18pt; margin-left: 36pt"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;As previously disclosed,&#13;  between September 2016 and January 2017, eight putative class actions on behalf of alleged shareholders that purchased or&#13;  acquired the Company&amp;#8217;s ordinary shares pursuant and/or traceable to its registration statement on Form F-1 (File No.&#13;  333-197344) used in connection with the Company&amp;#8217;s initial public offering (the &amp;#8220;IPO&amp;#8221;) were commenced in the&#13;  following courts: (i) the Superior Court of the State of California, County of San Mateo; (ii) the Superior Court of the&#13;  Commonwealth of Massachusetts, Suffolk County; (iii) the United States District Court for the Northern District of&#13;  California; and (iv) the United States District Court for the District of Massachusetts. The actions involved claims under&#13;  various sections of the Securities Act and the Exchange Act against the Company, certain of its current and former directors&#13;  and officers, the underwriters of the Company&amp;#8217;s IPO and certain other defendants. The four actions commenced in the&#13;  Superior Court of the State of California, County of San Mateo were dismissed in January 2017 for lack of personal&#13;  jurisdiction, and the action commenced in the United States District Court for the Northern District of California was&#13;  voluntarily dismissed in March 2017. Additionally, the two actions commenced in the Superior Court of the Commonwealth of&#13;  Massachusetts, Suffolk County (he &amp;#8220;Superior Court,&amp;#8221;), were consolidated in December 2017, and voluntarily dismissed with&#13;  prejudice in November 2018, after the District Court for the District of Massachusetts partially dismissed the related claims&#13;  in that court and the parties in the Superior Court entered a stipulation of dismissal with prejudice.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 36pt; text-align: justify"&gt;&#13;    &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;The action commenced in the United States District Court for the District of Massachusetts (the &amp;#8220;District Court&amp;#8221;), alleging&#13;      violations of Sections 11 and 15 of the Securities Act and Sections 10(b) and 20(a) of the Exchange Act, was partially dismissed in August 2018. In particular, the District Court granted the motion to dismiss the claims under Sections 11 and 15 of&#13;      the Securities Act, finding that the plaintiff failed to plead a false or misleading statement in the IPO registration statement. In May 2019, the court subsequently denied the plaintiff&amp;#8217;s motion to amend to pursue Exchange Act claims and the&#13;      complaint was dismissed. Thereafter, the plaintiff timely appealed to the United States Court of Appeals for the First Circuit, which subsequently affirmed the dismissal and the denial of the plaintiff&amp;#8217;s motion to amend in August 2020. The plaintiff&#13;      did not file a petition for certiorari for appeal of the case to the Supreme Court of the United States by the deadline on November 24, 2020. Thus, as of December 31, 2020, all eight actions had been dismissed, with such judgments being final and non-appealable.&lt;/div&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock contextRef="From2020-01-01to2020-12-31">&lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;font style="font-weight: bold"&gt;NOTE&amp;#160; 9:-&amp;#160; RESEARCH COLLABORATION AGREEMENT AND LICENSE AGREEMENT&lt;/font&gt;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt"&gt;On May 16, 2016, the Company entered into a Research Collaboration Agreement (&amp;#8220;Collaboration Agreement&amp;#8221;) and an Exclusive License Agreement (&amp;#8220;License Agreement&amp;#8221;) with Harvard. The&#13;    Research Collaboration Agreement was amended on May 1, 2017 and April 1, 2018 (as amended, the &amp;#8220;Collaboration Agreement&amp;#8221;), and the Exclusive License Agreement was amended on April 1, 2018 (as amended, the &amp;#8220;License Agreement&amp;#8221;), to extend the term of the&#13;    Collaboration Agreement by one year to May 16, 2022 and reallocate the Company&amp;#8217;s quarterly installment payments to Harvard through such date, and to make certain technical changes. On April 30, 2020, the Company and Harvard amended the Collaboration&#13;    Agreement, which included certain adjustments to the quarterly installments and extended the term an additional three quarters until February 2023.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt"&gt;Under the Collaboration Agreement, Harvard and the Company have agreed to collaborate on research regarding the development of lightweight &amp;#8220;soft suit&amp;#8221; exoskeleton system technologies&#13;    for lower limb disabilities, which are intended to treat stroke, multiple sclerosis, mobility limitations for the elderly and other medical applications. The Company has committed to pay in quarterly installments for the funding of this research,&#13;    subject to a minimum funding commitment under applicable circumstances. The Collaboration Agreement will expire on February 16, 2023.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt"&gt;Under the License Agreement, Harvard has granted the Company an exclusive, worldwide royalty-bearing license under certain patents of Harvard relating to lightweight &amp;#8220;soft suit&amp;#8221;&#13;    exoskeleton system technologies for lower limb disabilities, a royalty-free license under certain related know-how and the option to obtain a license under certain inventions conceived under the joint research collaboration.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt"&gt;The License Agreement requires the Company to pay Harvard an upfront fee, reimbursements for expenses that Harvard incurred in connection with the licensed patents, royalties on net&#13;    sales and several milestone payments contingent upon the achievement of certain product development and commercialization milestones. The Harvard License Agreement will continue in full force and effect until the expiration of the last-to-expire valid&#13;    claim of the licensed patents. As of December 31,2020, the Company achieved three of the milestones which represent all development milestones under the License Agreement. The Company continues to evaluate the likelihood that the other milestones will&#13;    be achieved on a quarterly basis.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt"&gt;The Company&amp;#8217;s total payment obligation under the Collaboration Agreement and the Harvard License Agreement is $7.2 &amp;#160;&amp;#160;million, some of which is subject to a minimum funding commitment&#13;    under applicable circumstances as indicated above.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt"&gt;The Company has recorded expenses in the amount of $0.8 million, $1.6 million, and $0.9 million for the years ended December&amp;#160;31, 2020, 2019, and 2018, respectively, which are part of&#13;    the total payment obligation indicated above, as research and development expenses related to the Harvard License Agreement and to the Collaboration Agreement. No withholding tax was deducted from the Company&amp;#8217;s payments to Harvard in respect of the&#13;    Collaboration Agreement and License Agreement since this is not taxable income in Israel in accordance with Section 170 of the Israel Income Tax Ordinance 1961-5721.&lt;/div&gt;</us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock>
    <us-gaap:DebtDisclosureTextBlock contextRef="From2020-01-01to2020-12-31">&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;NOTE 10: - PAYCHECK PROTECTION PROGRAM LOAN&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt"&gt;On April 21, 2020, RRI received an unsecured loan in the principal amount of $392 under the Paycheck Protection Program (the &amp;#8220;PPP&amp;#8221;)&#13;    administered by the U.S. Small Business Administration, or the SBA, pursuant to the Coronavirus Aid, Relief, and Economic Security Act (the &amp;#8220;CARES Act&amp;#8221;), or the PPP loan. The terms of the PPP Loan were subsequently revised in accordance with the&#13;    provisions of the Paycheck Protection Flexibility Act of 2020, or the PPP Flexibility Act, which was enacted on June 5, 2020. The PPP loan provides for an interest rate of 1.00% per year and matures two years after the date of initial disbursement,&#13;    with initial principal and interest payments coming due late in fiscal 2021. The PPP loan may be used for payroll costs, costs related to certain group health care benefits and insurance premiums, rent payments, utility payments, mortgage interest&#13;    payments and interest payments on any other debt obligation that were incurred before February 15, 2020. Under the terms of the CARES Act and the PPP Flexibility Act, the Company may apply for and be granted forgiveness for all or a portion of loan&#13;    granted under the PPP loan, with such forgiveness to be determined, subject to limitations (including where employees of the Company have been terminated and not re-hired by a certain date), based on the use of the loan proceeds for payment of payroll&#13;    costs and any payments of mortgage interest, rent, and utilities. The terms of any forgiveness may also be subject to further requirements in regulations and guidelines adopted by the SBA.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt"&gt;On September 29, 2020, the Company applied for loan forgiveness and on November 6, 2020 the Company received confirmation of its PPP Note&#13;    forgiveness.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt"&gt;&#13;    &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Forgiveness is booked as other income within the marketing and&#13;    sales expenses because it was  granted and used for payroll, rent, and utility costs related to sales efforts.&lt;/div&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2020-01-01to2020-12-31">&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;NOTE 11: - INCOME TAXES&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 18pt"&gt;The Company&amp;#8217;s subsidiaries are separately taxed under the domestic tax laws of the jurisdiction of incorporation of each entity.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z495f2ff54edb43c9b12ed00e41577015" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"&gt;&lt;br /&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top"&gt;a.&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;Corporate tax rates in Israel:&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;Presented hereunder are the tax rates relevant to the Company in the years 2018-2020:&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;The Israeli statutory corporate tax rate and real capital gains were 23% in the years 2018-2020.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z563e6c146a774b7c840fb8537d035ac8" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"&gt;&lt;br /&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top"&gt;b.&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;Income (loss) before taxes on income is comprised as follows (in&#13;          thousands):&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" border="0" align="right" id="z2ba3a7d1752c4363bc6e2cd6ff3d455b" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="10" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;Year Ended December 31,&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt; 2020&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;2019&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;2018&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Domestic&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(12,992&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(15,599&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(21,784&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Foreign&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;67&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;55&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;104&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(12,925&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(15,544&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(21,680&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 36pt; clear: both"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z081375363046492ba85434cf4fe097b1" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"&gt;&lt;br /&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top"&gt;c.&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;Taxes on income are comprised as follows (in thousands):&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" border="0" align="right" id="zcdc58fc524c440858a57748de7edc2b3" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="10" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;Year Ended December 31,&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt; 2020&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;2019&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;2018&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Current&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;95&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;64&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;102&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Deferred&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(44&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(57&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(107&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;)&lt;br /&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;51&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;7&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(5&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; clear: both"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" border="0" align="right" id="zdf4592310e5f4e58871a824057235746" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="10" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;Year Ended December 31,&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt; 2020&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;2019&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;2018&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Domestic&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#8212;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#8212;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#8212;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Foreign&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;51&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;7&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(5&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;51&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;7&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(5&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; clear: both"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zab90f7c8c6824db28e51a5ff35678e0b" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"&gt;&lt;br /&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top"&gt;d.&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;Deferred income taxes (in thousands):&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts&#13;    used for income tax purposes. The Company&amp;#8217;s deferred tax assets as of December&amp;#160;31, 2020 and 2019 are derived from temporary differences.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;In assessing the realization of deferred tax assets, the Company considers whether it is more likely than not that all or some portion of the deferred tax assets will not be&#13;    realized. Based on the Company&amp;#8217;s history of losses, the Company established a full valuation allowance for RRL.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;  &lt;/div&gt;&#13;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;Undistributed earnings of certain subsidiaries as of December&amp;#160;31, 2020 were immaterial. The Company intends to reinvest these earnings indefinitely in the foreign subsidiaries. As a&#13;    result, the Company has not provided for any&amp;#160;deferred income taxes.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" border="0" align="right" id="za1a0ca5d98ce48fcbd64c50f98f02c7d" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="6" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;December 31,&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt; 2020&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;2019&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Deferred tax assets:&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Carry forward tax losses&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;41,941&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;35,051&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Research and development carry forward expenses-temporary differences&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;946&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;1,294&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Accrual and reserves&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;341&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;290&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&#13;            &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Lease liabilities&lt;/div&gt;&#13;          &lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;390&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;433&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Total deferred tax assets&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;43,618&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;37,068&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Deferred tax liabilities:&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&#13;            &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Right-of-use asset&lt;/div&gt;&#13;          &lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(390&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(433&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Net deferred tax assets&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;43,228&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;36,635&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Valuation allowance&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(42,941&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(36,392&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Net deferred tax assets&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;287&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;243&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt; clear: both"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;The net changes in the&#13;  total valuation allowance for each of the years ended December&amp;#160;31, 2020, 2019 and 2018, are comprised as follows (in&#13;  thousands):&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" border="0" align="right" id="z35a053d4f75348c6b77902f0ea14916a" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="10" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;Year Ended December 31,&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt; 2020&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;2019&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;2018&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Balance at beginning of year&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(36,392&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(29,655&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(26,311&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Changes due to amendments to tax laws and exchange rate differences&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(2,929&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(2,055&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;1,393&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Adjustment previous year loss&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#8212;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(735&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#8212;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Additions during the year&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(3,620&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(3,947&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(4,737&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Balance at end of year&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(42,941&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(36,392&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(29,655&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt; margin-left: 36pt; clear: both"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;  &lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z51e8a038c406441d816c571ae27c4ac3" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"&gt;&lt;br /&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top"&gt;e.&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;Reconciliation of the theoretical tax expenses:&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;A reconciliation between the theoretical tax expense, assuming all income is taxed at the statutory tax rate applicable to income of the Company, and the actual tax expense (benefit)&#13;    as reported in the consolidated statements of operations is as follows (in thousands):&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" border="0" align="right" id="z4ab1a317623746aa8f3e7b4ad9ead3cd" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="10" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;Year Ended December 31,&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt; 2020&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;2019&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;2018&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Loss before taxes, as reported in the consolidated statements of operations&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(12,925&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(15,544&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(21,680&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Statutory tax rate&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;23.0&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;%&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;23.0&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;%&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;23.0&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;%&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Theoretical tax benefits on the above amount at the Israeli statutory tax rate&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(2,973&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(3,575&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(4,986&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Income tax at rate other than the Israeli statutory tax rate&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;3&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(1&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;5&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Non-deductible expenses including equity-based compensation expenses and other&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;185&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;255&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;631&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Operating losses and other temporary differences for which valuation allowance was provided&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;3,620&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;3,947&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;4,737&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Permanent differences&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(706&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(651&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(427&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;)&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Other&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(78&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;32&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;35&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Actual tax expense&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;51&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;7&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(5&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; clear: both"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z791cb6555109419f8bfa57802578bca1" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"&gt;&lt;br /&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top"&gt;f.&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;Foreign tax rates:&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-indent: 36pt; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 36pt"&gt;Taxable income of RRI was subject to tax at the rate of 21% in 2020, 2019 and 2018.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-indent: 36pt"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-indent: 36pt"&gt;Taxable income of RRG was subject to tax at the rate of 30% in 2020, 2019, and 2018.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 54pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z43d53d1b59844e8196d75da61ea03d04" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"&gt;&lt;br /&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top"&gt;g.&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;Tax benefits under the Law for the Encouragement of Capital Investments, 1959 (the &amp;#8220;Investment Law&amp;#8221;):&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;Conditions for entitlement to the benefits:&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;Under the Investment Law, in 2012 the Company elected &amp;#8220;Beneficiary Enterprise&amp;#8221; status which provides certain benefits, including tax exemptions and reduced tax rates. Income not&#13;    eligible for Beneficiary Enterprise benefits is taxed at a regular rate.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;Income derived from Beneficiary Enterprise from productive activity will be exempt from tax for ten years from the year in which the Company first has taxable income, providing that&#13;    12 years have not passed from the beginning of the year of election. In the event of a dividend distribution from income that is exempt from company tax, as aforementioned, the Company will be required to pay tax of 10%- 25% on that income.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;In the event of distribution of dividends from the said tax-exempt income, the amount distributed will be subject to corporate tax at the rate ordinarily applicable to the&#13;    Beneficiary Enterprise&amp;#8217;s income. Tax-exempt income generated under the Company&amp;#8217;s &amp;#8220;Beneficiary Enterprise&amp;#8221; program will be subject to taxes upon dividend distribution or complete liquidation.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;The entitlement to the above benefits is conditional upon the Company&amp;#8217;s fulfilling the conditions stipulated by the Law and regulations published thereunder.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;On December 29, 2010, the Knesset approved an additional amendment to the Law for the Encouragement of Capital Investments, 1959. According to the amendment, a reduced uniform&#13;    corporate tax rate for exporting industrial enterprises (over 25%) was established. The reduced tax rate will not be program dependent and will apply to the industrial enterprise&amp;#8217;s entire income. The tax rates for industrial enterprises have been&#13;    reduced. In August 2013, the Israeli Knesset approved an amendment to the Investment Law, pursuant to which the rates for development area A will be 9% and for the rest of the country- 16% in 2014 and thereafter. The Amendment also prescribes that any&#13;    dividends distributed to individuals or foreign residents from a preferred enterprise&amp;#8217;s earnings as above will be subject to taxes at a rate of 20% (subject to tax treaty benefits)&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;In December 2016, the Economic Efficiency Law (Legislative Amendments for Applying the Economic Policy for the 2017 and 2018 Budget Years), 2016 which includes Amendment 73 to the&#13;    Law for the Encouragement of Capital Investments (&amp;#8220;the Amendment&amp;#8221;) was published. According to the Amendment, a preferred enterprise located in development area A will be subject to a tax rate of 7.5% instead of 9% effective from January 1, 2017 (and&#13;    thereafter the tax rate applicable to preferred enterprises located in other areas remains at 16%).&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;The Company has examined the effect of the adoption of the Amendment on its financial statements, and as of the date of the publication of the financial statements, the Company&#13;    estimates that it will not apply the Amendment. The Company&amp;#8217;s estimate may change in the future.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zf1b0aeaf3ca64a2486b1d0930669f1c3" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"&gt;&lt;br /&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top"&gt;h.&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;Tax assessments:&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 36pt"&gt;RRL has had final tax assessments up to and including the 2015 tax year.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 36pt"&gt;Each RRI and RRG have not had a final tax&#13;  assessment since its inception.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zdab1f9ce80b04eac8acaec28821c7cce" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"&gt;&lt;br /&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top"&gt;i.&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;Net operating carry-forward losses for tax purposes:&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;As of December&amp;#160;31, 2020, RRL has carry-forward losses amounting to approximately $182.4 million, which can be carried forward for an indefinite period, and RRI has carry-forward&#13;    losses amounting to approximately $291 thousands, which can be carried forward for a period of 20 years.&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock contextRef="From2020-01-01to2020-12-31">&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif"&gt;NOTE&amp;#160;12: - FINANCIAL EXPENSES, NET&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;The components of&#13;  financial expenses, net were as follows (in thousands):&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" border="0" align="right" id="z5c91740d842e4334816c9648efa53c90" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="10" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;Year Ended December 31,&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt; 2020&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;2019&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;2018&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Foreign currency transactions and other&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(9&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(34&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;42&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Financial expenses related to loan agreement with Kreos&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;907&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;1,499&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;2,398&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Bank commissions&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;23&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;31&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;26&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;921&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;1,496&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;2,466&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="From2020-01-01to2020-12-31">&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif"&gt;NOTE 13: -&amp;#160; GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt"&gt;Summary information about geographic areas:&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt"&gt;ASC 280, &amp;#8220;Segment&#13;  Reporting&amp;#8221; establishes standards for reporting information about operating segments. Operating segments are defined as&#13;  components of an enterprise about which separate financial information is available that is evaluated regularly by the chief&#13;  operating decision maker in deciding how to allocate resources and in assessing performance. The Company manages its business&#13;  on the basis of one reportable segment and derives revenues from selling systems and services (see Note 1 for a brief&#13;  description of the Company&amp;#8217;s business). The following is a summary of revenues within geographic areas (in thousands):&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" border="0" align="right" id="zec3d7aa5328f4b0f84320dfdfed923e6" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="10" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;Year Ended December 31,&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt; 2020&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;2019&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;2018&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Revenues based on customer&amp;#8217;s location:&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 9pt"&gt;Israel&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#8212;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;2&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#8212;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 9pt"&gt;United States&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;1,746&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;2,003&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;3,558&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 9pt"&gt;Europe&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;2,631&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;2,832&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;2,807&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 9pt"&gt;Asia-Pacific&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;8&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;36&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;22&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 9pt"&gt;Latin America&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;6&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#8212;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;58&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 9pt"&gt;Africa&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;2&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#8212;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;100&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Total revenues&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;4,393&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;4,873&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;6,545&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; clear: both"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" border="0" align="right" id="z2ef27552142e4f388dcac51bf5575d3f" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="6" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;December 31,&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt; 2020&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;2019&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Long-lived assets by geographic region:&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 9pt"&gt;Israel&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;145&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;179&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 9pt"&gt;United States&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;249&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;244&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 9pt"&gt;Germany&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;43&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;78&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;437&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;501&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; clear: both"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" border="0" align="right" id="zf6398c4ec5504e8a93132307dffabbba" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 3.88%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(*)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 96.12%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;Long-lived assets are comprised of property and equipment, net.&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; clear: both"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 36pt"&gt;Major customer data as a percentage of total revenues:&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" border="0" align="right" id="zbbad66930d1b49dbb2d56aacfee26f04" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="10" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;Year Ended December 31,&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt; 2020&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;2019&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;2018&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Customer A&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;10.0&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;%&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;15.0&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;%&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;38.0&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;%&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:UseOfEstimates contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z0a33e389668f457b9b7e6bf33704bbef" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"&gt;&lt;br /&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top"&gt;a.&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;Use of Estimates&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&#13;    &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;The preparation of the consolidated financial statements in conformity with U.S. generally accepted accounting principles&#13;      requires management to make estimates, judgments, and assumptions. The Company&amp;#8217;s management believes that the estimates, judgments, and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of&#13;      assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. On&#13;      an ongoing basis, the Company&amp;#8217;s management evaluates estimates, including those related to inventories, fair values of share-based awards and warrants, contingent liabilities, provision for warranty, allowance for doubtful account and sales return&#13;      reserve. Such estimates are based on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. &lt;/div&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zc0dba15ad360421690d3148bb5e25a82" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"&gt;&lt;br /&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top"&gt;b.&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;Financial Statements in U.S. Dollars:&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;Since 2015, most of the Company&amp;#8217;s expenses were denominated in United States dollars (&amp;#8220;dollars&amp;#8221;) and the remaining expenses were denominated in New Israeli Shekel (&amp;#8220;NIS&amp;#8221;) and Euros.&#13;    Until 2018 most of the Company&amp;#8217;s revenues were denominated in U.S. dollars and the remainder of our revenues was denominated in euros and British pound whereas in the last two years our Euro revenues are higher than the ones in dollars.&amp;#160; &amp;#160;however, the&#13;    selling prices are linked to the Company&amp;#8217;s price list which is determined in dollars, the budget is managed in dollars, financing activities including loans and cash investments, are made in U.S. dollars and the Company&amp;#8217;s management believes that the&#13;    dollar is the primary currency of the economic environment in which the Company and each of its subsidiaries operate. Thus, the dollar is the Company&amp;#8217;s and its subsidiaries&amp;#8217; functional and reporting currency.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;Accordingly, transactions denominated in currencies other than the functional currency are re-measured to the functional currency in accordance with Accounting Standards Codification&#13;    (&amp;#8220;ASC&amp;#8221;) No. 830, &amp;#8220;Foreign Currency Matters&amp;#8221; at the exchange rate at the date of the transaction or the average exchange rate in the relevant reporting period. At the end of each reporting period, financial assets and liabilities are re-measured to the&#13;    functional currency using exchange rates in effect at the balance sheet date. Non-financial assets and liabilities are re-measured at historical exchange rates. Gains and losses related to re-measurement are recorded as financial income (expense) in&#13;    the consolidated statements of operations as appropriate.&lt;/div&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z3d72edf84d57490a93185381c32117fb" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"&gt;&lt;br /&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top"&gt;c.&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;Principles of Consolidation:&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 54pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&#13;    &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, RRI and RRG. All&#13;      intercompany transactions and balances have been eliminated upon consolidation.&lt;/div&gt;&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zd955c270d10444e99907c61dd04aa49f" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"&gt;&lt;br /&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top"&gt;d.&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;Cash Equivalents:&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;Cash equivalents are short-term highly liquid investments that are readily convertible to cash with original maturities of three months or less, at the date acquired.&lt;/div&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:InventoryPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z5788efea516d48349aa7e6fb3ab915c9" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"&gt;&lt;br /&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top"&gt;e.&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;Inventories:&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;Inventories are stated at the lower of cost or market value. Inventory reserves are provided to cover risks arising from slow-moving items or technological obsolescence.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;The Company periodically evaluates the quantities on hand relative to historical, current and projected sales volume. Based on this evaluation, an impairment charge is recorded when&#13;    required to write-down inventory to its market value.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-indent: 36pt"&gt;Cost is determined as follows:&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;Finished products - on the basis of raw materials and manufacturing costs on an average basis.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;Raw materials - The weighted average cost method.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&#13;    &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;The Company regularly evaluates the ability to realize the value of inventory based on a combination of factors, including&#13;      historical usage rates and forecasted sales according to outstanding backlogs. Purchasing requirements and alternative usage are explored within these processes to mitigate inventory exposure. When recorded, the reserves are intended to reduce the&#13;      carrying value of inventory to its net realizable value. In the years ended December&amp;#160;31, 2020, 2019 and 2018, the Company wrote off inventory in the amount of $215 thousand, $64 thousand, and $562 thousand, respectively. The write off inventory were recorded in cost of revenue. If actual demand for the Company&amp;#8217;s products deteriorates, or market conditions are less favorable than those projected,&#13;      additional inventory reserves may be required.&lt;/div&gt;&lt;/div&gt;</us-gaap:InventoryPolicyTextBlock>
    <rwlk:RelatedPartiesTransactionsAndBalancesPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z4aa8c8c1d0024f7b92595ce5d2e64e86" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"&gt;&lt;br /&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top"&gt;f.&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;Related parties transactions and balances:&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;The Company has a related party shareholder named Yaskawa Electric Corporation (&amp;#8220;YEC&amp;#8221;).&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;In September 2013, the Company entered into a share purchase agreement and a strategic alliance with YEC, pursuant to which YEC has agreed to distribute the Company&amp;#8217;s products, in&#13;    addition to providing sales, marketing, service and training functions, in Japan, China (including Hong-Kong and Macau), Taiwan, South Korea, Singapore and Thailand.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&#13;    &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;As of December 31, 2020, and 2019,&#13;      the related party receivable were 0% of trade receivable, net, in both years. Revenues from YEC during the years ended December&amp;#160;31, 2020, 2019, and 2018&#13;      amounted to $0 thousand, $41 thousand, and $13, respectively.&lt;/div&gt;&lt;/div&gt;</rwlk:RelatedPartiesTransactionsAndBalancesPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z05a82daea43b40e2b33b8f576d65c3b7" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"&gt;&lt;br /&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top"&gt;g.&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;Property and Equipment:&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets at&#13;    the following annual rates:&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" border="0" align="right" id="z251bfdcae9e14e5e93cd117615991b47" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 75.84%; vertical-align: bottom"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; width: 24.16%; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;%&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 75.84%; vertical-align: top; background-color: #CCEEFF"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Computer equipment&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 24.16%; vertical-align: top; background-color: #CCEEFF"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;20-33 (mainly 33)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 75.84%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Office furniture and equipment&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 24.16%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;6 - 10&amp;#160;(mainly 10)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 75.84%; vertical-align: top; background-color: #CCEEFF"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Machinery and laboratory equipment&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 24.16%; vertical-align: top; background-color: #CCEEFF"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;15&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 75.84%; vertical-align: bottom"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Field service units&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 24.16%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;50&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 75.84%; vertical-align: top; background-color: #CCEEFF"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Leasehold improvements&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 24.16%; vertical-align: top; background-color: #CCEEFF"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;Over&amp;#160;the&amp;#160;shorter&amp;#160;of&amp;#160;the&amp;#160;lease&lt;br /&gt;&#13;            term or estimated useful life&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z9443fa13dcbe4ce6b1b64bf17f939507" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"&gt;&lt;br /&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top"&gt;h.&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;Impairment of Long-Lived Assets:&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;The Company&amp;#8217;s long-lived assets are reviewed for impairment in accordance with ASC No.&amp;#160;360, &amp;#8220;Property, Plant and Equipment&amp;#8221; whenever events or changes in circumstances indicate that&#13;    the carrying amount of an asset (or asset group) may not be recoverable. Recoverability of assets (or asset group) to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted cash flows expected to be&#13;    generated by the assets. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. During the years ended December&amp;#160;31, 2020,&#13;    2019 and 2018, no impairment losses have been recorded.&lt;/div&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <rwlk:OtherLongTermAssetsPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z6146e80aa19e400b986403f2498b419f" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"&gt;&lt;br /&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top"&gt;i.&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;Restricted cash and Other long-term assets:&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;Other long-term assets include long-term prepaid expenses and restricted cash deposits for offices and cars leasing based upon the term of the remaining restrictions.&lt;/div&gt;</rwlk:OtherLongTermAssetsPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z67e623d200a64464ac03f67293e01e52" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"&gt;&lt;br /&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top"&gt;j.&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;Revenue Recognition:&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;The Company generates revenues from sales of products. The Company sells its products directly to end customers and through distributors. The Company sells its products to private&#13;    individuals (who finance the purchases by themselves, through fundraising or reimbursement coverage from insurance companies), rehabilitation facilities and distributors.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: -13.5pt; margin-left: 31.5pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;On January 1, 2018, the Company adopted Topic 606 using the modified retrospective method for contracts that were not completed as of January 1, 2018. Under the modified&#13;    retrospective method, the Company recognized the cumulative effect of initially applying the new revenue standard as an adjustment to the opening balance of retained earnings. This adjustment did not have a material impact on the Company consolidated&#13;    financial statements. Results for reporting periods beginning after January 1, 2018 are presented under Topic 606, while prior period amounts are not adjusted and continue to be reported in accordance with the Company historic accounting under Revenue&#13;    Recognition (&amp;#8220;Topic 605&amp;#8221;).&lt;/div&gt;&#13;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 34.2pt"&gt;The adoption of Topic 606 represents a change in accounting principle that will provide financial statement readers with enhanced&#13;    revenue recognition disclosures. In accordance with Topic 606, revenue is recognized when obligations under the terms of a contract with the Company customer are satisfied; generally this occurs with the transfer of control of the Company products or&#13;    services. Revenue is measured as the amount of consideration to which the Company expect to be entitled in exchange for transferring products or providing services. To achieve this core principle, the Company applies the following five steps:&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: -13.5pt; margin-left: 31.5pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;1. Identify the contract with a customer&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 72pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt"&gt;A contract with a customer exists when (i) the Company enters into a written agreement with a customer that defines each party&amp;#8217;s rights regarding the products or services to be&#13;    transferred and identifies the payment terms related to these products or services, (ii) both parties to the contract are committed to perform their respective obligations, (iii) the contract has commercial substance, and (iv) the Company determines&#13;    that collection of substantially all consideration for products or services that are transferred is probable based on the customer&amp;#8217;s intent and ability to pay the promised consideration. The Company applies judgment in determining the customer&amp;#8217;s&#13;    ability and intention to pay, which is based on a variety of factors including the customer&amp;#8217;s payment history or, in the case of a new customer, published credit and financial information pertaining to the customer.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: -40.5pt; margin-left: 72pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;2. Identify the performance obligations in the contract&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 40.5pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt"&gt;Performance obligations promised in a contract are identified based on the products or services that will be transferred to the customer that are both capable of being distinct,&#13;    whereby the customer can benefit from the product or service either on its own or together with other resources that are readily available from the Company, and are distinct in the context of the contract, whereby the transfer of the products or&#13;    services is separately identifiable from other promises in the contract.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 40.5pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;3. Determine the transaction price&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 40.5pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt"&gt;The transaction price is determined based on the consideration to which the Company will be entitled in exchange for transferring products or services to the customer. To the&#13;    extent the transaction price is variable, revenue is recognized at an amount equal the consideration to which the Company expects to be entitled. This estimate includes customer sales incentives which are accounted for as a reduction to revenue and&#13;    estimated using either the expected value method or the most likely amount method, depending on the nature of the program.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 40.5pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt"&gt;As a result of the Company&amp;#8217;s adoption of this standard, the majority of the amounts that were historically classified as bad debt expense, primarily related to self-payers&#13;    customers, are now considered an implicit price concession in determining net revenue. Accordingly, the Company recognized uncollectible balances associated with self-payers customers as a reduction of the transaction price and therefore as a reduction&#13;    in net revenues when historically these amounts were classified as bad debt expense within general and administrative expenses.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 40.5pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt"&gt;Shipping and handling costs charged to customers are included in net sales. Determining the transaction price requires significant judgment, which is discussed by revenue category&#13;    in further detail below.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 40.5pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt"&gt;In practice, the Company does not offer extended payment terms beyond one year to customers.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;4. Allocate the transaction price to performance obligations in the contract&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: -40.5pt; margin-left: 72pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt"&gt;If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. Contracts that contain multiple&#13;    performance obligations require an allocation of the transaction price to each performance obligation based on a relative standalone selling price basis unless a portion of the variable consideration related to the contract is allocated entirely to a&#13;    performance obligation. The Company determines standalone selling price based on the price at which the performance obligation is sold separately.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: -40.5pt; margin-left: 72pt"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&#13;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: -40.5pt; margin-left: 72pt"&gt;5. Recognize revenue when or as the Company satisfies a performance obligation&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 40.5pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt"&gt;The Company generally satisfies performance obligations at a point in time, once the customer has obtained the legal title to the items purchased or service provided.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 40.5pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt"&gt;&#13;    &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;For systems sold to rehabilitation facilities, the Company includes training and considers the elements in the arrangement to be&#13;      a single performance obligation. In accordance with ASC 606, the Company has concluded that the training is essential to the functionality of the Company&amp;#8217;s systems. Therefore, the Company recognizes revenue for the system and training only after delivery in accordance with the agreement delivery terms to the customer and after the training has been completed.&lt;/div&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 40.5pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt"&gt;&#13;    &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;For sales of Personal systems to end users, and for sales of Personal or Rehabilitation systems to third party distributors, the&#13;      Company does not provide training to the end user as this training is completed by the Rehabilitation centers or by the distributor that have previously completed the ReWalk Training program. Therefore, the Company recognizes revenue in such sales upon delivery.&lt;/div&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 40.5pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt"&gt;Revenue is recognized based on the transaction price at the time the related performance obligation is satisfied by transferring a promised product or service to a customer.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 40.5pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt"&gt;The Company generally does not grant a right of return for its products. There have been isolated cases in which the Company experienced a return of its products. Therefore, the&#13;    Company records reductions to revenue for expected future product returns based on the Company&amp;#8217;s historical experience.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 40.5pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt"&gt;&lt;u&gt;Disaggregation of Revenues (in thousands)&lt;/u&gt;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 40.5pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" border="0" align="right" id="z244734cb0e59414b81b34ea77097c036" style="font: 10pt Times New Roman, Times, Serif; width: 93%; color: #000000; text-align: left"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="10" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;Year Ended December 31,&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt; 2020&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;2019&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;2018&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Units placed&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;3,620&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;4,385&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;6,237&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Spare parts and warranties&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;773&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;488&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;308&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Total Revenues&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;4,393&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;4,873&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;6,545&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 90pt; clear: both"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt"&gt;&lt;u&gt;Units placed&lt;/u&gt;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt"&gt;&amp;#160;&lt;br /&gt;&#13;    The Company currently offer five products: (1) ReWalk Personal, (2) ReWalk Rehabilitation, (3) ReStore, (4) MyoCycle and (5) MediTouch.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt"&gt;ReWalk Personal and ReWalk Rehabilitation are units for spinal cord injuries (&amp;#8220;SCI Products&amp;#8221;). SCI Products are currently designed for everyday use by paraplegic individuals at&#13;    home and in their communities, and are custom fitted for each user, as well as for use by paraplegia patients in the clinical rehabilitation environment, where they provide individuals access to valuable exercise and therapy. ReWalk Rehabilitation&#13;    current design is dated and will not be produced in the future.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt"&gt;ReStore is a powered, lightweight soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation&#13;    environment.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt"&gt;MyoCycle which uses Functional Electrical Stimulation (&amp;#8220;FES&amp;#8221;) technology and MediTouch tutor movement biofeedback devices (&amp;#8220;Distributed Products&amp;#8221;).&amp;#160; The Company markets the&#13;    Distributed Products in the United States for use at home or in clinic.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt"&gt; &lt;br /&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt"&gt;&amp;#160;&amp;#160;&amp;#160;Units placed includes revenue from sales of SCI Products, ReStore and Distributed Products.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt"&gt; &lt;br /&gt;&#13;  &lt;/div&gt;&#13;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt"&gt;For units placed, the Company recognizes revenues when it transfers control and title has passed to the customer.&amp;#160; Each unit placed is considered an independent, unbundled&#13;    performance obligation. The Company also offers a rent-to-purchase model in which the Company recognizes revenue ratably according to the agreed rental monthly fee.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt"&gt;&lt;u&gt;Spare parts and warranties&lt;/u&gt;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt"&gt;Spare parts are sold to private individuals, rehabilitation facilities and distributors. Revenue is recognized when the Company satisfies a performance obligation by transferring&#13;    control over promised goods or services to the customer. Each part sold is considered an independent, unbundled performance obligation.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt"&gt;Warranties are classified as either assurance type or service type warranty. A warranty is considered an assurance type warranty if it provides the consumer with assurance that the&#13;    product will function as intended for a limited period of time.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt"&gt;In the beginning of 2018, the Company updated its service policy for SCI Products to include a five- year warranty compared to a period of two years that were included in the past&#13;    for parts and services. The first two years are considered as assurance type warranty and the additional period is considered an extended service arrangement, which is a service type warranty. An assurance type warranty is not accounted for as separate&#13;    performance obligations under the revenue model. A service type warranty is either sold with a unit or separately for units for which the warranty has expired. Revenue is then recognized ratably over the life of the warranty.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt"&gt;The ReStore device is offered with a two-year warranty which is considered as assurance type warranty.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt"&gt;The Distributed Products are offered with assurance type warranty ranging between one year to ten years depending on the specific product and part.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt"&gt;&#13;    &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;u&gt;Contract balances&lt;/u&gt;&lt;u&gt; (in thousands)&lt;/u&gt;&lt;/div&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 40.5pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" border="0" align="right" id="z5c799b2fe8f0464797acfbb534d43627" style="font: 10pt Times New Roman, Times, Serif; width: 93%; color: #000000; text-align: left"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;December 31,&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;December 31,&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt; 2020&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;2019&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Trade receivable, net (1)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;684&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;794&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Deferred revenues (1) (2)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;1,108&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;844&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 72pt; clear: both"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" border="0" align="right" id="z17cb99861cfd43fcbaa9360391eba714" style="font: 10pt Times New Roman, Times, Serif; width: 93%; color: #000000; text-align: left"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 3.85%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(1)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 96.15%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;Balance presented net of unrecognized revenues that were not yet collected.&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 72pt; clear: both"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" border="0" align="right" id="z3161792d8d93450192807264069a7a74" style="font: 10pt Times New Roman, Times, Serif; width: 93%; color: #000000; text-align: left"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 3.85%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(2)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 96.15%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;$330 thousand of December&amp;#160;31, 2019 deferred revenues balance were recognized as revenues during the year ended December 31, 2020.&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 40.5pt; clear: both"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt"&gt;&lt;u&gt;Typical timing of payment&lt;/u&gt;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 43.2pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt"&gt;Deferred revenue is comprised mainly of unearned revenue related to service type warranty but also includes other offerings for which the Company has been paid in advance and earns&#13;    revenue when the Company transfers control of the product or service.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt"&gt;The Company&amp;#8217;s unfilled performance obligations as of December 31, 2020 and the estimated revenue expected to be recognized in the future related to the service type warranty&#13;    amounts to $1,108 thousand, which is fulfilled over one to five years.&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z6ad9a3b4411a480fb5186fe382453b4c" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"&gt;&lt;br /&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top"&gt;k.&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;Accounting for Share-Based Compensation:&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;The Company accounts for share-based compensation in accordance with ASC No.&amp;#160;718, &amp;#8220;Compensation-Stock Compensation&amp;#8221; (&amp;#8220;ASC No. 718&amp;#8221;). ASC No. 718 requires companies to estimate the&#13;    fair value of equity-based payment awards on the date of grant using an Option-Pricing Model (&amp;#8220;OPM&amp;#8221;). The value of the portion of the award that is ultimately expected to vest is recognized as an expense over the requisite service periods in the&#13;    Company&amp;#8217;s consolidated statements of operations.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;The Company recognizes compensation expenses for the value of its awards granted based on the straight-line method over the requisite service period of each of the awards.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;Effective as of January 1, 2017, the Company adopted Accounting Standards Update 2016-09, &amp;#8220;Compensation-Stock Compensation (Topic 718)&amp;#8221; (&amp;#8220;ASU 2016-09&amp;#8221;) on a modified, retrospective&#13;    basis. ASU 2016-09 permits entities to make an accounting policy election related to how forfeitures will impact the recognition of compensation cost for stock-based compensation: to estimate the total number of awards for which the requisite service&#13;    period will not be rendered or to account for forfeitures as they occur. Upon adoption of ASU 2016-09, the Company elected to change its accounting policy to account for forfeitures as they occur. The change was applied on a modified, retrospective&#13;    basis with a cumulative-effect adjustment to retained earnings of $11 thousand (which increased the accumulated deficit) as of January 1, 2017.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;ASU 2016-09 also eliminates the requirement that excess tax benefits be realized as a reduction in current taxes payable before the associated tax benefit can be recognized as an&#13;    increase in paid in capital. The implementation resulted with no cumulative-effect adjustment to retained earnings as of January 1, 2017.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt; &lt;br /&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 36pt"&gt;Additionally, ASU 2016-09 addresses the presentation of excess tax benefits and employee taxes paid on the statement of cash flows. The Company is now required to present excess tax benefits as an&#13;    operating activity on the statement of cash flows rather than as a financing activity. The Company adopted this change prospectively.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;In June 2018, the FASB issued ASU No.&amp;#160;2018-07 Compensation&amp;#8212;Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting. ASU 2018-07 was issued to&#13;    simplify several aspects of the accounting for nonemployee share-based payment transactions resulting from expanding the scope of Topic 718, "Compensation &amp;#8211; Stock Compensation", to include share-based payment transactions for acquiring goods and&#13;    services from nonemployees. The amendments specify that Topic 718 applies to all share-based payment transactions in which a grantor acquires goods or services to be used or consumed in a grantor&amp;#8217;s own operations by issuing share-based payment awards.&#13;    As a result of ASU 2018-07, grants awarded to non-employees are accounted for under ASC 718. The Company adopted ASU 2018-07 as of January 1, 2019. The adoption did not have a material impact on the consolidated financial statements.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;The Company selected the Black-Scholes-Merton option pricing model as the most appropriate fair value method for its share-option awards. The option-pricing model requires a number&#13;    of assumptions, of which the most significant are the fair market value of the underlying ordinary share, expected share price volatility and the expected option term. Expected volatility was calculated based upon certain peer companies that the&#13;    Company considered to be comparable. The expected option term represents the period of time that options granted are expected to be outstanding. The expected option term is determined based on the simplified method in accordance with Staff Accounting&#13;    Bulletin No.&amp;#160;110, as adequate historical experience is not available to provide a reasonable estimate. The simplified method will continue to apply until enough historical experience is available to provide a reasonable estimate of the expected term.&#13;    The risk-free interest rate is based on the yield from U.S. treasury bonds with an equivalent term. The Company has historically not paid dividends and has no foreseeable plans to pay dividends.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;Following the IPO in September 2014, the fair value of ordinary shares is observable as they are publicly traded.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt; &lt;br /&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;The fair value of Restricted Stock Units (RSUs) granted is determined based on the price of the Company&amp;#8217;s ordinary shares on the date of&#13;    grant.&lt;br /&gt;&#13;    &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;br /&gt;&#13;    &lt;/div&gt;&#13;  &lt;/div&gt;&#13;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;The fair value for options granted in 2019, 2018 is estimated at the date of grant using a Black-Scholes-Merton option pricing model with the following assumptions:&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" border="0" align="right" id="zcfac848f1c7c4ec8be5afff37beb22e7" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="6" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;Year Ended December 31,&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt; 2019&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;2018&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: #CCEEFF; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Expected volatility&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;57.5&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;%&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;57% - 61&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;%&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Risk-free rate&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;2.22&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;%&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;2.74% - 2.83&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;%&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: #CCEEFF; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Dividend yield&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#8212;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;%&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#8212;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;%&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Expected term (in years)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;6.11&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;6.11&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: #CCEEFF; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Share price&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;5.37&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;25.5 - $28.75&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; clear: both"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;There were no options granted during the twelve months ended December 31, 2020.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt; &lt;br /&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;The Company accounts for&#13;  options granted to consultants and other service providers under ASC No. 718. The fair value of these options was estimated&#13;  using a Black-Scholes-Merton option-pricing model.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&#13;    &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;The non-cash compensation expenses related to employees and non- employees for the years ended December&amp;#160;31, 2020, 2019 and 2018&#13;      amounted to $749 thousand, $1,108 thousand, and $2,766 thousand, respectively.&lt;/div&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z8db205dbbcfb4efaa93a391fce4c3d64" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"&gt;&lt;br /&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top"&gt;m.&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;Research and Development Costs:&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;Research and development costs are charged to the consolidated statement of operations as incurred and are presented net of the amount of any grants the company receive for research&#13;    and development in the period in which the grant was received.&lt;/div&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z842b410387424176bf5d892651c42ab0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"&gt;&lt;br /&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top"&gt;n.&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;Income Taxes&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;The Company accounts for income taxes in accordance with ASC No.&amp;#160;740, &amp;#8220;Income Taxes&amp;#8221; (&amp;#8220;ASC No. 740&amp;#8221;), using the liability method whereby deferred tax assets and liability account&#13;    balances are determined based on the differences between financial reporting and the tax basis for assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The&#13;    Company provides a valuation allowance, if necessary, to reduce deferred tax assets to the amounts that are more likely-than-not to be realized.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;ASC No. 740 contains a two-step approach to recognizing and measuring a liability for uncertain tax positions. The first step is to evaluate the tax position taken or expected to be&#13;    taken in a tax return by determining if the weight of available evidence indicates that it is more likely than not that, on an evaluation of the technical merits, the tax position will be sustained on audit, including resolution of any related appeals&#13;    or litigation processes. The second step is to measure the tax benefit as the largest amount that is more than 50% likely to be realized upon ultimate settlement. The Company accrues interest and penalties related to unrecognized tax benefits in its&#13;    taxes on income. As of December 31, 2020, and 2019, the Company did not identify any significant uncertain tax positions.&amp;#160;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:StandardProductWarrantyPolicy contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="ze6bf0cf2a2aa4cc3b679ca44928b857c" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"&gt;&lt;br /&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top"&gt;o.&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;Warranty:&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;The Company provided a two-year standard warranty for its products. In the beginning of 2018, we updated our service policy for new devices sold to include five-year warranties.&amp;#160; The&#13;    Company determined that the first two years of warranty is an assurance-type warranty and records a provision for the estimated cost to repair or replace products under warranty at the time of sale. Factors that affect the Company&amp;#8217;s warranty reserve&#13;    include the number of units sold, historical and anticipated rates of warranty repairs and the cost per repair.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" border="0" align="right" id="z24e95ed7a2ee4f738f16153ac66d9200" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;US Dollars&lt;br /&gt;&#13;            in&lt;br /&gt;&#13;            thousands&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 88%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Balance at December 31, 2019&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;227&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 88%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Provision&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;125&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 88%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Usage&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(212&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 88%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Balance at December 31, 2020&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;140&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:StandardProductWarrantyPolicy>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z1a8f598a777d49a5b354da4c89c73b12" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"&gt;&lt;br /&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top"&gt;p.&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;Concentrations of Credit Risks:&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash, cash equivalents and trade receivables.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;The Company&amp;#8217;s cash and cash equivalents are deposited in major banks in Israel, the United States and Germany. Such deposits in the United States may be in excess of insured limits&#13;    and are not insured in other jurisdictions. The Company maintains cash and cash equivalents with diverse financial institutions and monitors the amount of credit exposure to each financial institution.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;Concentration of credit risk with respect to trade receivable is primarily limited to a customer to which the Company makes substantial sales.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" border="0" align="right" id="z6023b00ba79a4ef29192bf73408506a9" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="6" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;December 31,&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt; 2020&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;2019&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;Customer A&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;15&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;%&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;*&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Customer B&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;15&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;%&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;*&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;Customer C&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;15&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;%&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;*&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;Customer D&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;14&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;%&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;*&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;Customer E&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;12&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;%&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;12&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;%&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;Customer F&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;11&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;%&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;*&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;Customer G&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;*&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;14&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;%&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Customer H&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;*&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;13&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;%&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Customer I&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;*&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;13&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;%&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;Customer J&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;*&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;12&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;%&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;Customer K&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;*&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;12&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;%&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Customer L&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;*&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;12&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;%&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-indent: 36pt; clear: both"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" border="0" align="right" id="z134b78bbeb3144378ee804552ff51346" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 3.85%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;*)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 96.15%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;Less than 10%&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-indent: 36pt; clear: both"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;The Company&amp;#8217;s trade receivables are geographically diversified and derived primarily from sales to customers in various countries, mainly in the United States and Europe.&#13;    Concentration of credit risk with respect to trade receivables is limited by credit limits, ongoing credit evaluation and account monitoring procedures. The Company performs ongoing credit evaluations of its distributors based upon a specific review of&#13;    all significant outstanding invoices. The Company writes off receivables when they are deemed uncollectible and having exhausted all collection efforts. As of December 31, 2020, and 2019 trade receivables are presented net of $102 thousand and $31&#13;    thousand allowance for doubtful accounts, respectively, and net of sales return reserve of $0 thousand and $86 thousand, respectively.&lt;/div&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:PostemploymentBenefitPlansPolicy contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z4e14dd2dffa44865bb3145074fd5b07a" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"&gt;&lt;br /&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top"&gt;q.&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;Accrued Severance Pay:&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;Pursuant to Israel&amp;#8217;s Severance Pay Law, Israeli employees are entitled to severance pay equal to one month&amp;#8217;s salary for each year of employment, or a portion thereof. All of the&#13;    employees of the RRL elected to be included under section 14 of the Severance Pay Law, 1963 (&amp;#8220;section 14&amp;#8221;). According to this section, these employees are entitled only to monthly deposits, at a rate of 8.33% of their monthly salary, made in their name&#13;    with insurance companies. Payments in accordance with section 14 release the Company from any future severance payments (under the above Israeli Severance Pay Law) in respect of those employees; therefore, related assets and liabilities are not&#13;    presented in the balance sheet.&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;Total Company expenses related to severance pay amounted to $125 thousand, $156 thousand and $169 thousand for the years ended December&amp;#160;31, 2020, 2019 and 2018, respectively.&lt;/div&gt;</us-gaap:PostemploymentBenefitPlansPolicy>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z6bf8ea3b08384d14b0ccf4afddd571ac" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"&gt;&lt;br /&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top"&gt;r.&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;Fair Value Measurements:&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the&#13;    asset or liability in an orderly transaction between market participants on the measurement date.&amp;#160; The Company uses a three-tier fair value hierarchy to classify and disclose all assets and liabilities measured at fair value on a recurring basis, as&#13;    well as assets and liabilities measured at fair value on a non-recurring basis, in periods subsequent to their initial measurement.&amp;#160; The hierarchy requires the Company to use observable inputs when available, and to minimize the use of unobservable&#13;    inputs when determining fair value. If a financial instrument uses inputs that fall in different levels of the hierarchy, the instrument will be categorized based upon the lowest level of input that is significant to the fair value calculation. The&#13;    three-tiers are defined as follows:&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;    &lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zdcbd6ac918d047b7b0ce02f1923b2381" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;      &#13;        &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;&#13;          &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 36pt"&gt;&amp;#160;&lt;/td&gt;&#13;          &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 27pt"&gt;&#13;            &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: left"&gt;&amp;#9679;&lt;/div&gt;&#13;          &lt;/td&gt;&#13;          &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: auto"&gt;&#13;            &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: left"&gt;&lt;font style="font-weight: bold"&gt;Level 1.&amp;#160;&lt;/font&gt;Observable inputs based on unadjusted quoted prices in active markets for identical assets or liabilities;&lt;/div&gt;&#13;          &lt;/td&gt;&#13;        &lt;/tr&gt;&#13;      &#13;    &lt;/table&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;    &lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zd17ba00465ad44acbc00c8c632d833f1" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;      &#13;        &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;&#13;          &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 36pt"&gt;&amp;#160;&lt;/td&gt;&#13;          &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 27pt"&gt;&#13;            &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: left"&gt;&amp;#9679;&lt;/div&gt;&#13;          &lt;/td&gt;&#13;          &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: auto"&gt;&#13;            &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: left"&gt;&lt;font style="font-weight: bold"&gt;Level 2.&amp;#160;&lt;/font&gt;Inputs, other than quoted prices in active markets, that are observable either directly or indirectly; and&lt;/div&gt;&#13;          &lt;/td&gt;&#13;        &lt;/tr&gt;&#13;      &#13;    &lt;/table&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;    &lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z7971363fdc984e908a793fa67f2f12af" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;      &#13;        &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;&#13;          &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 36pt"&gt;&amp;#160;&lt;/td&gt;&#13;          &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 27pt"&gt;&#13;            &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: left"&gt;&amp;#9679;&lt;/div&gt;&#13;          &lt;/td&gt;&#13;          &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: auto"&gt;&#13;            &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: left"&gt;&lt;font style="font-weight: bold"&gt;Level 3.&amp;#160;&lt;/font&gt;Unobservable inputs for which there is little or no market data requiring the Company to develop its own assumptions.&lt;/div&gt;&#13;          &lt;/td&gt;&#13;        &lt;/tr&gt;&#13;      &#13;    &lt;/table&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;The carrying amounts of cash and cash equivalents, short term deposits, trade receivables and trade payables approximate their fair value due to the short-term maturity of such&#13;    instruments.&lt;/div&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:CommitmentsAndContingenciesPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z84c18d6253bf4238bc62601cb23e7efb" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top"&gt;t.&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;Contingent liabilities&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;The Company accounts for its contingent liabilities in accordance with ASC No.&amp;#160;450, &amp;#8220;Contingencies&amp;#8221;. A provision is recorded when it is both probable that a liability has been&#13;    incurred and the amount of the loss can be reasonably estimated.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;With respect to legal matters, provisions are reviewed and adjusted to reflect the impact of negotiations, estimated settlements, legal rulings, advice of legal counsel and other&#13;    information and events pertaining to a particular matter.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt; &lt;br /&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;See note 7e for further information.&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesPolicyTextBlock>
    <rwlk:GovernmentGrantsPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z4e6e8ddef3724ce7868cf6b53b989b16" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"&gt;&lt;br /&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top"&gt;u.&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;Government grants&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;Government grants received by the Company relating to categories of operating expenditures are credited to the consolidated statements of operations during the period in which the&#13;    expenditure to which they relate is charged. Royalty and non-royalty-bearing grants from the Israel Innovation Authority, or the IIA, (formerly known as the Israeli Office of the Chief Scientist), from the Israel-U.S. Binational Industrial Research and&#13;    Development Foundation (&amp;#8220;BIRD&amp;#8221;) and from the Israeli Fund for Promoting Overseas Marketing for funding certain approved research and development projects and sales and marketing activities are recognized at the time when the Company is entitled to such&#13;    grants, on the basis of the related costs incurred, and are included as a deduction from research and development or sales and marketing expenses (see Note&amp;#160;7c).&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;No royalty-bearing grants were recorded for the years ended December 31, 2020, and December 31, 2019, the Company received royalty-bearing grants in the amount of $198 thousand for&#13;    the year ended December 31, 2018, as part of the research and development expenses.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;  &lt;/div&gt;&#13;&#13; &#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;Total Company expenses related to royalties amounted to $46 thousand, $15 thousand for the years ended December&amp;#160;31, 2020, 2019, respectively, no royalty expenses were recorded for&#13;    the year ended December&amp;#160;31, 2018.&lt;/div&gt;</rwlk:GovernmentGrantsPolicyTextBlock>
    <us-gaap:ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock contextRef="From2020-01-01to2020-12-31">&lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets at&#13;    the following annual rates:&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" border="0" align="right" id="z251bfdcae9e14e5e93cd117615991b47" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 75.84%; vertical-align: bottom"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; width: 24.16%; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;%&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 75.84%; vertical-align: top; background-color: #CCEEFF"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Computer equipment&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 24.16%; vertical-align: top; background-color: #CCEEFF"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;20-33 (mainly 33)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 75.84%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Office furniture and equipment&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 24.16%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;6 - 10&amp;#160;(mainly 10)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 75.84%; vertical-align: top; background-color: #CCEEFF"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Machinery and laboratory equipment&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 24.16%; vertical-align: top; background-color: #CCEEFF"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;15&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 75.84%; vertical-align: bottom"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Field service units&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 24.16%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;50&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 75.84%; vertical-align: top; background-color: #CCEEFF"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Leasehold improvements&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 24.16%; vertical-align: top; background-color: #CCEEFF"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;Over&amp;#160;the&amp;#160;shorter&amp;#160;of&amp;#160;the&amp;#160;lease&lt;br /&gt;&#13;            term or estimated useful life&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" border="0" align="right" id="z244734cb0e59414b81b34ea77097c036" style="font: 10pt Times New Roman, Times, Serif; width: 93%; color: #000000; text-align: left"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="10" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;Year Ended December 31,&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt; 2020&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;2019&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;2018&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Units placed&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;3,620&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;4,385&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;6,237&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Spare parts and warranties&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;773&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;488&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;308&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Total Revenues&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;4,393&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;4,873&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;6,545&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock>
    <rwlk:ScheduleOfTradeReceivablesAndDeferredRevenuesTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" border="0" align="right" id="z5c799b2fe8f0464797acfbb534d43627" style="font: 10pt Times New Roman, Times, Serif; width: 93%; color: #000000; text-align: left"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;December 31,&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;December 31,&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt; 2020&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;2019&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Trade receivable, net (1)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;684&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;794&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Deferred revenues (1) (2)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;1,108&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;844&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 72pt; clear: both"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" border="0" align="right" id="z17cb99861cfd43fcbaa9360391eba714" style="font: 10pt Times New Roman, Times, Serif; width: 93%; color: #000000; text-align: left"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 3.85%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(1)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 96.15%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;Balance presented net of unrecognized revenues that were not yet collected.&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 72pt; clear: both"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" border="0" align="right" id="z3161792d8d93450192807264069a7a74" style="font: 10pt Times New Roman, Times, Serif; width: 93%; color: #000000; text-align: left"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 3.85%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(2)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 96.15%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;$330 thousand of December&amp;#160;31, 2019 deferred revenues balance were recognized as revenues during the year ended December 31, 2020.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</rwlk:ScheduleOfTradeReceivablesAndDeferredRevenuesTableTextBlock>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;The fair value for options granted in 2019, 2018 is estimated at the date of grant using a Black-Scholes-Merton option pricing model with the following assumptions:&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" border="0" align="right" id="zcfac848f1c7c4ec8be5afff37beb22e7" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="6" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;Year Ended December 31,&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt; 2019&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;2018&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: #CCEEFF; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Expected volatility&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;57.5&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;%&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;57% - 61&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;%&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Risk-free rate&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;2.22&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;%&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;2.74% - 2.83&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;%&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: #CCEEFF; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Dividend yield&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#8212;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;%&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#8212;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;%&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Expected term (in years)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;6.11&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;6.11&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: #CCEEFF; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Share price&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;5.37&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;25.5 - $28.75&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" border="0" align="right" id="z24e95ed7a2ee4f738f16153ac66d9200" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;US Dollars&lt;br /&gt;&#13;            in&lt;br /&gt;&#13;            thousands&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 88%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Balance at December 31, 2019&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;227&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 88%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Provision&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;125&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 88%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Usage&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(212&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 88%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Balance at December 31, 2020&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;140&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock>
    <us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock contextRef="From2020-01-01to2020-12-31">&lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;Concentration of credit risk with respect to trade receivable is primarily limited to a customer to which the Company makes substantial sales.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" border="0" align="right" id="z6023b00ba79a4ef29192bf73408506a9" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="6" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;December 31,&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt; 2020&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;2019&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;Customer A&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;15&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;%&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;*&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Customer B&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;15&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;%&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;*&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;Customer C&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;15&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;%&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;*&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;Customer D&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;14&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;%&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;*&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;Customer E&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;12&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;%&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;12&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;%&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;Customer F&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;11&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;%&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;*&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;Customer G&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;*&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;14&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;%&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Customer H&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;*&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;13&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;%&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Customer I&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;*&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;13&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;%&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;Customer J&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;*&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;12&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;%&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;Customer K&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;*&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;12&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;%&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Customer L&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;*&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;12&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;%&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-indent: 36pt; clear: both"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" border="0" align="right" id="z134b78bbeb3144378ee804552ff51346" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 3.85%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;*)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 96.15%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;Less than 10%&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;The following table sets forth the computation of the Company&amp;#8217;s basic and diluted net loss per ordinary share (in thousands, except share and per share data):&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" border="0" align="right" id="zf3292f75d1664a6e9a65631d4d24c1c5" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="10" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;Year ended December 31,&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt; 2020&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;2019&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;2018&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Net loss&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(12,976&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(15,551&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(21,675&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Net loss attributable to ordinary shares&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(12,976&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(15,551&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(21,675&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Shares used in computing net loss per ordinary shares, basic and diluted&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;15,764,980&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;5,763,317&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;1,472,499&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Net loss per ordinary share, basic and diluted&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(0.82&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(2.70&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(14.72&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock contextRef="From2020-01-01to2020-12-31">&lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-indent: 36pt"&gt;The components of prepaid expenses and other current assets are as follows (in thousands):&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" border="0" align="right" id="zc6efca7e7e844e46a25c6bd8d55ca9ea" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="6" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;December 31,&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt; 2020&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;2019&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Government institutions&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;87&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;175&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Prepaid expenses&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;311&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;318&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Advances to vendors&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;241&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;246&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Other assets&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;33&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;164&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;672&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;903&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-indent: 36pt"&gt;The components of inventories are as follows (in thousands):&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" border="0" align="right" id="z4334ea3338be48a1a507c3302b556507" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="6" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;December 31,&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt; 2020&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;2019&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Finished products&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;2,764&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;2,394&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Raw materials&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;778&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;729&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;3,542&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;3,123&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="From2020-01-01to2020-12-31">&lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-indent: 36pt"&gt;The components of property and equipment, net are as follows (in thousands):&lt;/div&gt;&#13;  &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" border="0" align="right" id="z40bab54ebb0e4397aeb5637d012e1e87" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="6" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;December 31,&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt; 2020&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;2019&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Cost:&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Computer equipment&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;725&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;723&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Office furniture and equipment&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;298&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;293&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Machinery and laboratory equipment&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;612&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;604&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Field service units&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;1,626&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;1,420&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Leasehold improvements&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;333&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;333&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;3,594&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;3,373&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; clear: both"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" border="0" align="right" id="z840539bb6b7f46bea160bf1f1c4d9228" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="6" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;December 31,&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt; 2020&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;2019&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Accumulated depreciation&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;3,157&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;2,872&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Property and equipment, net&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;437&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;501&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;The Company&amp;#8217;s future lease payments for its facilities and cars, which are presented as current maturities of operating leases and non-current operating leases liabilities on the&#13;    Company&amp;#8217;s consolidated balance sheets as of&amp;#160;December&amp;#160;31, 2020&amp;#160;are as follows (in thousands):&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" border="0" align="right" id="zdb7695d55aa043a5a1fe0885ee1a4249" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;2021&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;710&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 88%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;2022&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;676&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 88%; padding-bottom: 2px; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;2023&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;491&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 88%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Total lease payments&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;1,877&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 88%; padding-bottom: 2px; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Less: imputed interest&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(294&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 88%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Present value of future lease payments&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;1,583&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Less: current maturities of operating leases&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(660&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 88%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Non-current operating leases&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;923&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Weighted-average remaining lease term (in years)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;2.69&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 88%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Weighted-average discount rate&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;12.6&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;%&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;A summary of employee and&amp;#160;non-employee shares options activity during the fiscal year ended 2020 is as follows:&lt;/div&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 72pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" border="0" align="right" id="z333a780dd513489ea483da9d96b10a52" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;Number&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;Average&lt;/div&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;exercise&lt;/div&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;price&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;Average&lt;/div&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;remaining&lt;/div&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;contractual&lt;/div&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;life (years)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;Aggregate&lt;/div&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;intrinsic&lt;/div&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;value (in&lt;/div&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;thousands)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 52%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Options outstanding at the beginning of the year&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;74,713&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;41.6&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;6.34&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;135&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 52%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Granted&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#8212;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#8212;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#8212;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#8212;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 52%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Exercised&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#8212;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#8212;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#8212;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#8212;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 52%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Forfeited&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(5,107&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;91.59&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#8212;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#8212;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 52%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 52%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Options outstanding at the end of the year&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;69,606&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;37.9&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;5.59&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#8212;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 52%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 52%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Options exercisable at the end of the year&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;52,997&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;43.76&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;4.94&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#8212;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock>
    <us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;A summary of employee and&amp;#160;non-employee RSUs activity during the fiscal year ended 2020 is as follows:&lt;/div&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" border="0" align="right" id="z08c2cc9952cf4a269ef65b9e027ffd67" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;Number of&lt;/div&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;shares underlying&lt;/div&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;outstanding&lt;/div&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;RSUs&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;Weighted-&lt;/div&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;average&lt;/div&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;grant date&lt;/div&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;fair value&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Unvested RSUs at the beginning of the year&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;62,378&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;44.61&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Granted&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;1,266,185&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;1.44&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Vested&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(63,111&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;7.83&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Forfeited&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(14,141&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;6.05&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Unvested RSUs at the end of the year&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;1,251,311&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;3.20&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock contextRef="From2020-01-01to2020-12-31">&lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;The number of options and RSUs outstanding as of December&amp;#160;31, 2020 is set forth below, with options separated by range of exercise price:&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 54pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" border="0" align="right" id="z6f11344252224499ad65c066a0b989e8" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif"&gt;Range of exercise&amp;#160;price&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;Options and RSUs&lt;br /&gt;&#13;            Outstanding as of&lt;br /&gt;&#13;            December 31,&lt;br /&gt;&#13;            2020&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;Weighted&lt;/div&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;average&lt;/div&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;remaining&lt;/div&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;contractual&lt;/div&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;life (years) (1)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;Options Exercisable as of December 31,&lt;br /&gt;&#13;            2020&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;Weighted&lt;/div&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;average&lt;/div&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;remaining&lt;/div&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;contractual&lt;/div&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;life (years) (1)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 52%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;RSUs only&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;1,251,311&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#8212;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#8212;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#8212;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 52%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$5.37&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;12,425&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;8.24&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;5,435&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;8.24&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 52%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$20.42- $33.75&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;36,292&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;5.26&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;27,598&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;4.60&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 52%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$37.14-$38.75&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;9,992&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;2.99&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;9,992&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;2.99&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 52%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$50-$52.5&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;8,231&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;6.43&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;7,306&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;6.44&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 52%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$182.5-$524.25&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;2,666&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;4.84&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;2,666&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;4.84&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 52%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;1,320,917&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;5.59&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;52,997&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;4.94&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; clear: both"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" border="0" align="right" id="z0880807c2442494481d433b408f422c8" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 3.85%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(1)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 96.09%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;Calculation of weighted average remaining contractual term does not include the RSUs that were granted, which have an indefinite contractual term.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z563e6c146a774b7c840fb8537d035ac8" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"&gt;&lt;br /&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top"&gt;&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;Income (loss) before taxes on income is comprised as follows (in&#13;          thousands):&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" border="0" align="right" id="z2ba3a7d1752c4363bc6e2cd6ff3d455b" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="10" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;Year Ended December 31,&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt; 2020&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;2019&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;2018&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Domestic&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(12,992&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(15,599&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(21,784&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Foreign&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;67&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;55&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;104&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(12,925&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(15,544&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(21,680&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z081375363046492ba85434cf4fe097b1" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"&gt;&lt;br /&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top"&gt;&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;Taxes on income are comprised as follows (in thousands):&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" border="0" align="right" id="zcdc58fc524c440858a57748de7edc2b3" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="10" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;Year Ended December 31,&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt; 2020&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;2019&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;2018&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Current&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;95&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;64&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;102&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Deferred&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(44&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(57&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(107&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;)&lt;br /&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;51&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;7&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(5&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; clear: both"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" border="0" align="right" id="zdf4592310e5f4e58871a824057235746" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="10" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;Year Ended December 31,&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt; 2020&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;2019&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;2018&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Domestic&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#8212;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#8212;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#8212;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Foreign&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;51&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;7&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(5&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;51&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;7&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(5&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" border="0" align="right" id="za1a0ca5d98ce48fcbd64c50f98f02c7d" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="6" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;December 31,&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt; 2020&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;2019&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Deferred tax assets:&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Carry forward tax losses&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;41,941&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;35,051&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Research and development carry forward expenses-temporary differences&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;946&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;1,294&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Accrual and reserves&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;341&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;290&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&#13;            &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Lease liabilities&lt;/div&gt;&#13;          &lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;390&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;433&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Total deferred tax assets&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;43,618&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;37,068&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Deferred tax liabilities:&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&#13;            &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Right-of-use asset&lt;/div&gt;&#13;          &lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(390&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(433&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Net deferred tax assets&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;43,228&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;36,635&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Valuation allowance&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(42,941&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(36,392&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Net deferred tax assets&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;287&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;243&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:SummaryOfValuationAllowanceTextBlock contextRef="From2020-01-01to2020-12-31">&lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;The net changes in the&#13;total valuation allowance for each of the years ended December&amp;#160;31, 2020, 2019 and 2018, are comprised as follows (in&#13;thousands):&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" border="0" align="right" id="z35a053d4f75348c6b77902f0ea14916a" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="10" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;Year Ended December 31,&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt; 2020&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;2019&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;2018&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Balance at beginning of year&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(36,392&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(29,655&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(26,311&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Changes due to amendments to tax laws and exchange rate differences&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(2,929&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(2,055&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;1,393&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Adjustment previous year loss&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#8212;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(735&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#8212;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Additions during the year&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(3,620&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(3,947&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(4,737&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Balance at end of year&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(42,941&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(36,392&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(29,655&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:SummaryOfValuationAllowanceTextBlock>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;A reconciliation between the theoretical tax expense, assuming all income is taxed at the statutory tax rate applicable to income of the Company, and the actual tax expense (benefit)&#13;    as reported in the consolidated statements of operations is as follows (in thousands):&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" border="0" align="right" id="z4ab1a317623746aa8f3e7b4ad9ead3cd" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="10" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;Year Ended December 31,&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt; 2020&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;2019&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;2018&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Loss before taxes, as reported in the consolidated statements of operations&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(12,925&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(15,544&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(21,680&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Statutory tax rate&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;23.0&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;%&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;23.0&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;%&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;23.0&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;%&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Theoretical tax benefits on the above amount at the Israeli statutory tax rate&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(2,973&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(3,575&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(4,986&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Income tax at rate other than the Israeli statutory tax rate&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;3&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(1&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;5&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Non-deductible expenses including equity-based compensation expenses and other&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;185&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;255&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;631&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Operating losses and other temporary differences for which valuation allowance was provided&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;3,620&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;3,947&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;4,737&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Permanent differences&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(706&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(651&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(427&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;)&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Other&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(78&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;32&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;35&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Actual tax expense&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;51&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;7&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(5&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;The components of&#13;financial expenses, net were as follows (in thousands):&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" border="0" align="right" id="z5c91740d842e4334816c9648efa53c90" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="10" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;Year Ended December 31,&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt; 2020&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;2019&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;2018&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Foreign currency transactions and other&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(9&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(34&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;42&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Financial expenses related to loan agreement with Kreos&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;907&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;1,499&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;2,398&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Bank commissions&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;23&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;31&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;26&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;921&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;1,496&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;2,466&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock>
    <us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt"&gt;The following is a summary&#13;of revenues within geographic areas (in thousands):&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" border="0" align="right" id="zec3d7aa5328f4b0f84320dfdfed923e6" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="10" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;Year Ended December 31,&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt; 2020&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;2019&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;2018&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Revenues based on customer&amp;#8217;s location:&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 9pt"&gt;Israel&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#8212;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;2&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#8212;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 9pt"&gt;United States&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;1,746&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;2,003&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;3,558&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 9pt"&gt;Europe&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;2,631&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;2,832&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;2,807&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 9pt"&gt;Asia-Pacific&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;8&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;36&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;22&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 9pt"&gt;Latin America&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;6&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#8212;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;58&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 9pt"&gt;Africa&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;2&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#8212;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;100&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Total revenues&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;4,393&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;4,873&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;6,545&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; clear: both"&gt;&amp;#160;&lt;/div&gt;</us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock>
    <us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" border="0" align="right" id="z2ef27552142e4f388dcac51bf5575d3f" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="6" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;December 31,&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt; 2020&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;2019&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Long-lived assets by geographic region:&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 9pt"&gt;Israel&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;145&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;179&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 9pt"&gt;United States&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;249&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;244&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 9pt"&gt;Germany&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;43&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;78&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;437&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;501&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; clear: both"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" border="0" align="right" id="zf6398c4ec5504e8a93132307dffabbba" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 3.88%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(*)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 96.12%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;Long-lived assets are comprised of property and equipment, net.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock>
    <us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 36pt"&gt;Major customer data as a percentage of total revenues:&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" border="0" align="right" id="zbbad66930d1b49dbb2d56aacfee26f04" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="10" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;Year Ended December 31,&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt; 2020&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;2019&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;2018&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Customer A&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;10.0&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;%&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;15.0&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;%&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;38.0&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;%&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock>
    <dei:EntityCommonStockSharesOutstanding contextRef="AsOf2021-02-16" unitRef="shares" decimals="INF">33445454</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:RepaymentsOfDebt contextRef="From2018-11-01to2018-11-20_custom_SecondAmendmentMember" unitRef="USD" decimals="-3">3600000</us-gaap:RepaymentsOfDebt>
    <us-gaap:StockIssuedDuringPeriodSharesOther contextRef="From2018-11-01to2018-11-20_custom_SecondAmendmentMember" unitRef="shares" decimals="INF">192000</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:StockIssuedDuringPeriodSharesOther contextRef="From2018-11-01to2018-11-20_custom_SecondAmendmentMember_custom_PreFundedMember" unitRef="shares" decimals="INF">288000</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:DebtInstrumentFaceAmount contextRef="I2015Q4Dec30_us-gaap_LongtermDebtTypeAxis_us-gaap_SecuredDebtMember" unitRef="USD" decimals="-3">20000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2020-01-01to2020-12-31">&lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;font style="font-weight: bold"&gt;NOTE&amp;#160;2:-&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;font style="font-weight: bold"&gt;SIGNIFICANT ACCOUNTING POLICIES&lt;/font&gt;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 18pt"&gt;The consolidated financial statements are prepared according to United States generally accepted accounting principles (&amp;#8220;U.S. GAAP&amp;#8221;),&#13;    applied on a consistent basis, as follows:&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z0a33e389668f457b9b7e6bf33704bbef" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"&gt;&lt;br /&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top"&gt;a.&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;Use of Estimates&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&#13;    &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;The preparation of the consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates, judgments, and&#13;      assumptions. The Company&amp;#8217;s management believes that the estimates, judgments, and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts&#13;      of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.&#13;      On an ongoing basis, the Company&amp;#8217;s management evaluates estimates, including those related to inventories, fair values of share-based awards and warrants, contingent liabilities, provision for warranty, allowance for doubtful account and sales return&#13;      reserve. Such estimates are based on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. &lt;br /&gt;&#13;    &lt;/div&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &#13;  &lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zc0dba15ad360421690d3148bb5e25a82" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"&gt;&lt;br /&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top"&gt;b.&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;Financial Statements in U.S. Dollars:&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;Since 2015, most of the Company&amp;#8217;s expenses were denominated in United States dollars (&amp;#8220;dollars&amp;#8221;) and the remaining expenses were denominated in New Israeli Shekel (&amp;#8220;NIS&amp;#8221;) and Euros.&#13;    Until 2018 most of the Company&amp;#8217;s revenues were denominated in U.S. dollars and the remainder of our revenues was denominated in euros and British pound whereas in the last two years our Euro revenues are higher than the ones in dollars.&amp;#160; &amp;#160;however, the&#13;    selling prices are linked to the Company&amp;#8217;s price list which is determined in dollars, the budget is managed in dollars, financing activities including loans and cash investments, are made in U.S. dollars and the Company&amp;#8217;s management believes that the&#13;    dollar is the primary currency of the economic environment in which the Company and each of its subsidiaries operate. Thus, the dollar is the Company&amp;#8217;s and its subsidiaries&amp;#8217; functional and reporting currency.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;Accordingly, transactions denominated in currencies other than the functional currency are re-measured to the functional currency in accordance with Accounting Standards Codification&#13;    (&amp;#8220;ASC&amp;#8221;) No. 830, &amp;#8220;Foreign Currency Matters&amp;#8221; at the exchange rate at the date of the transaction or the average exchange rate in the relevant reporting period. At the end of each reporting period, financial assets and liabilities are re-measured to the&#13;    functional currency using exchange rates in effect at the balance sheet date. Non-financial assets and liabilities are re-measured at historical exchange rates. Gains and losses related to re-measurement are recorded as financial income (expense) in&#13;    the consolidated statements of operations as appropriate.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;  &lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z3d72edf84d57490a93185381c32117fb" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"&gt;&lt;br /&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top"&gt;c.&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;Principles of Consolidation:&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 54pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&#13;    &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&#13;      &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, RRI and RRG. All&#13;        intercompany transactions and balances have been eliminated upon consolidation.&lt;/div&gt;&#13;    &lt;/div&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt Times New Roman, Times, Serif; clear: both; margin-top: 10pt; margin-bottom: 10pt"&gt;&#13;    &#13;  &#13;  &lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zd955c270d10444e99907c61dd04aa49f" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"&gt;&lt;br /&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top"&gt;d.&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;Cash Equivalents:&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;Cash equivalents are short-term highly liquid investments that are readily convertible to cash with original maturities of three months or less, at the date acquired.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z5788efea516d48349aa7e6fb3ab915c9" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"&gt;&lt;br /&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top"&gt;e.&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;Inventories:&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;Inventories are stated at the lower of cost or market value. Inventory reserves are provided to cover risks arising from slow-moving items or technological obsolescence.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;The Company periodically evaluates the quantities on hand relative to historical, current and projected sales volume. Based on this evaluation, an impairment charge is recorded when&#13;    required to write-down inventory to its market value.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-indent: 36pt"&gt;Cost is determined as follows:&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;Finished products - on the basis of raw materials and manufacturing costs on an average basis.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;Raw materials - The weighted average cost method.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&#13;    &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;The Company regularly evaluates the ability to realize the value of inventory based on a combination of factors, including historical usage rates and forecasted sales according&#13;      to outstanding backlogs. Purchasing requirements and alternative usage are explored within these processes to mitigate inventory exposure. When recorded, the reserves are intended to reduce the carrying value of inventory to its net realizable value.&#13;      In the years ended December&amp;#160;31, 2020, 2019 and 2018, the Company wrote off inventory in the amount of $215 thousand, $64 thousand, and $562 thousand, respectively. The write off inventory were recorded in cost of revenue. If actual demand for the&#13;      Company&amp;#8217;s products deteriorates, or market conditions are less favorable than those projected, additional inventory reserves may be required.&lt;/div&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z4aa8c8c1d0024f7b92595ce5d2e64e86" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"&gt;&lt;br /&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top"&gt;f.&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;Related parties transactions and balances:&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;The Company has a related party shareholder named Yaskawa Electric Corporation (&amp;#8220;YEC&amp;#8221;).&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;In September 2013, the Company entered into a share purchase agreement and a strategic alliance with YEC, pursuant to which YEC has agreed to distribute the Company&amp;#8217;s products, in&#13;    addition to providing sales, marketing, service and training functions, in Japan, China (including Hong-Kong and Macau), Taiwan, South Korea, Singapore and Thailand.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&#13;    &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&#13;      &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: left"&gt;As of December 31, 2020, and 2019, the related party receivable were 0% of trade receivable, net, in both years. Revenues from YEC during&#13;        the years ended December&amp;#160;31, 2020, 2019, and 2018 amounted to $0 thousand, $41 thousand, and $13, respectively.&lt;/div&gt;&#13;      &#13;    &lt;/div&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt Times New Roman, Times, Serif; clear: both; margin-top: 10pt; margin-bottom: 10pt"&gt;&#13;    &#13;  &amp;#160;&#13;  &lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z05a82daea43b40e2b33b8f576d65c3b7" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"&gt;&lt;br /&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top"&gt;g.&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;Property and Equipment:&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets at&#13;    the following annual rates:&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" border="0" align="right" id="z251bfdcae9e14e5e93cd117615991b47" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 75.84%; vertical-align: bottom"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; width: 24.16%; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;%&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 75.84%; vertical-align: top; background-color: #CCEEFF"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Computer equipment&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 24.16%; vertical-align: top; background-color: #CCEEFF"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;20-33 (mainly 33)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 75.84%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Office furniture and equipment&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 24.16%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;6 - 10&amp;#160;(mainly 10)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 75.84%; vertical-align: top; background-color: #CCEEFF"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Machinery and laboratory equipment&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 24.16%; vertical-align: top; background-color: #CCEEFF"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;15&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 75.84%; vertical-align: bottom"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Field service units&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 24.16%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;50&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 75.84%; vertical-align: top; background-color: #CCEEFF"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Leasehold improvements&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 24.16%; vertical-align: top; background-color: #CCEEFF"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;Over&amp;#160;the&amp;#160;shorter&amp;#160;of&amp;#160;the&amp;#160;lease&lt;br /&gt;&#13;            term or estimated useful life&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center; clear: both"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z9443fa13dcbe4ce6b1b64bf17f939507" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"&gt;&lt;br /&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top"&gt;h.&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;Impairment of Long-Lived Assets:&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;The Company&amp;#8217;s long-lived assets are reviewed for impairment in accordance with ASC No.&amp;#160;360, &amp;#8220;Property, Plant and Equipment&amp;#8221; whenever events or changes in circumstances indicate that&#13;    the carrying amount of an asset (or asset group) may not be recoverable. Recoverability of assets (or asset group) to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted cash flows expected to be&#13;    generated by the assets. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. During the years ended December&amp;#160;31, 2020,&#13;    2019 and 2018, no impairment losses have been recorded.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;  &lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z6146e80aa19e400b986403f2498b419f" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"&gt;&lt;br /&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top"&gt;i.&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;Restricted cash and Other long-term assets:&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;Other long-term assets include long-term prepaid expenses and restricted cash deposits for offices and cars leasing based upon the term of the remaining restrictions.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z67e623d200a64464ac03f67293e01e52" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"&gt;&lt;br /&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top"&gt;j.&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;Revenue Recognition:&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;The Company generates revenues from sales of products. The Company sells its products directly to end customers and through distributors. The Company sells its products to private&#13;    individuals (who finance the purchases by themselves, through fundraising or reimbursement coverage from insurance companies), rehabilitation facilities and distributors.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: -13.5pt; margin-left: 31.5pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;On January 1, 2018, the Company adopted Topic 606 using the modified retrospective method for contracts that were not completed as of January 1, 2018. Under the modified&#13;    retrospective method, the Company recognized the cumulative effect of initially applying the new revenue standard as an adjustment to the opening balance of retained earnings. This adjustment did not have a material impact on the Company consolidated&#13;    financial statements. Results for reporting periods beginning after January 1, 2018 are presented under Topic 606, while prior period amounts are not adjusted and continue to be reported in accordance with the Company historic accounting under Revenue&#13;    Recognition (&amp;#8220;Topic 605&amp;#8221;).&lt;/div&gt;&#13;  &lt;div style="font: 10pt Times New Roman, Times, Serif; clear: both; margin-top: 10pt; margin-bottom: 10pt"&gt;&#13;    &#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 34.2pt"&gt;The adoption of Topic 606 represents a change in accounting principle that will provide financial statement readers with enhanced&#13;    revenue recognition disclosures. In accordance with Topic 606, revenue is recognized when obligations under the terms of a contract with the Company customer are satisfied; generally this occurs with the transfer of control of the Company products or&#13;    services. Revenue is measured as the amount of consideration to which the Company expect to be entitled in exchange for transferring products or providing services. To achieve this core principle, the Company applies the following five steps:&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: -13.5pt; margin-left: 31.5pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;1. Identify the contract with a customer&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 72pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt"&gt;A contract with a customer exists when (i) the Company enters into a written agreement with a customer that defines each party&amp;#8217;s rights regarding the products or services to be&#13;    transferred and identifies the payment terms related to these products or services, (ii) both parties to the contract are committed to perform their respective obligations, (iii) the contract has commercial substance, and (iv) the Company determines&#13;    that collection of substantially all consideration for products or services that are transferred is probable based on the customer&amp;#8217;s intent and ability to pay the promised consideration. The Company applies judgment in determining the customer&amp;#8217;s&#13;    ability and intention to pay, which is based on a variety of factors including the customer&amp;#8217;s payment history or, in the case of a new customer, published credit and financial information pertaining to the customer.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: -40.5pt; margin-left: 72pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;2. Identify the performance obligations in the contract&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 40.5pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt"&gt;Performance obligations promised in a contract are identified based on the products or services that will be transferred to the customer that are both capable of being distinct,&#13;    whereby the customer can benefit from the product or service either on its own or together with other resources that are readily available from the Company, and are distinct in the context of the contract, whereby the transfer of the products or&#13;    services is separately identifiable from other promises in the contract.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 40.5pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;3. Determine the transaction price&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 40.5pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt"&gt;The transaction price is determined based on the consideration to which the Company will be entitled in exchange for transferring products or services to the customer. To the&#13;    extent the transaction price is variable, revenue is recognized at an amount equal the consideration to which the Company expects to be entitled. This estimate includes customer sales incentives which are accounted for as a reduction to revenue and&#13;    estimated using either the expected value method or the most likely amount method, depending on the nature of the program.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 40.5pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt"&gt;As a result of the Company&amp;#8217;s adoption of this standard, the majority of the amounts that were historically classified as bad debt expense, primarily related to self-payers&#13;    customers, are now considered an implicit price concession in determining net revenue. Accordingly, the Company recognized uncollectible balances associated with self-payers customers as a reduction of the transaction price and therefore as a reduction&#13;    in net revenues when historically these amounts were classified as bad debt expense within general and administrative expenses.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 40.5pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt"&gt;Shipping and handling costs charged to customers are included in net sales. Determining the transaction price requires significant judgment, which is discussed by revenue category&#13;    in further detail below.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 40.5pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt"&gt;&#13;    &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;In practice, the Company does not offer extended payment terms beyond one year to customers.&lt;/div&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;4. Allocate the transaction price to performance obligations in the contract&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: -40.5pt; margin-left: 72pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt"&gt;If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. Contracts that contain multiple&#13;    performance obligations require an allocation of the transaction price to each performance obligation based on a relative standalone selling price basis unless a portion of the variable consideration related to the contract is allocated entirely to a&#13;    performance obligation. The Company determines standalone selling price based on the price at which the performance obligation is sold separately.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: -40.5pt; margin-left: 72pt"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt Times New Roman, Times, Serif; clear: both; margin-top: 10pt; margin-bottom: 10pt"&gt;&#13;    &#13;  &amp;#160;&lt;br /&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: -40.5pt; margin-left: 72pt"&gt;5. Recognize revenue when or as the Company satisfies a performance obligation&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 40.5pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt"&gt;The Company generally satisfies performance obligations at a point in time, once the customer has obtained the legal title to the items purchased or service provided.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 40.5pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt"&gt;&#13;    &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;For systems sold to rehabilitation facilities, the Company includes training and considers the elements in the arrangement to be a single performance obligation. In accordance&#13;      with ASC 606, the Company has concluded that the training is essential to the functionality of the Company&amp;#8217;s systems. Therefore, the Company recognizes revenue for the system and training only after delivery in accordance with the agreement delivery&#13;      terms to the customer and after the training has been completed.&lt;/div&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 40.5pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt"&gt;&#13;    &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;For sales of Personal systems to end users, and for sales of Personal or Rehabilitation systems to third party distributors, the Company does not provide training to the end&#13;      user as this training is completed by the Rehabilitation centers or by the distributor that have previously completed the ReWalk Training program. Therefore, the Company recognizes revenue in such sales upon delivery.&lt;/div&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 40.5pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt"&gt;Revenue is recognized based on the transaction price at the time the related performance obligation is satisfied by transferring a promised product or service to a customer.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 40.5pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt"&gt;The Company generally does not grant a right of return for its products. There have been isolated cases in which the Company experienced a return of its products. Therefore, the&#13;    Company records reductions to revenue for expected future product returns based on the Company&amp;#8217;s historical experience.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 40.5pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt"&gt;&lt;u&gt;Disaggregation of Revenues (in thousands)&lt;/u&gt;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 40.5pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" border="0" align="right" id="z244734cb0e59414b81b34ea77097c036" style="font: 10pt Times New Roman, Times, Serif; width: 93%; color: #000000; text-align: left"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="10" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;Year Ended December 31,&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt; 2020&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;2019&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;2018&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Units placed&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;3,620&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;4,385&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;6,237&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Spare parts and warranties&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;773&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;488&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;308&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Total Revenues&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;4,393&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;4,873&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;6,545&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 90pt; clear: both"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt"&gt;&lt;u&gt;Units placed&lt;/u&gt;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt"&gt;&amp;#160;&lt;br /&gt;&#13;    The Company currently offer five products: (1) ReWalk Personal, (2) ReWalk Rehabilitation, (3) ReStore, (4) MyoCycle and (5) MediTouch.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt"&gt;ReWalk Personal and ReWalk Rehabilitation are units for spinal cord injuries (&amp;#8220;SCI Products&amp;#8221;). SCI Products are currently designed for everyday use by paraplegic individuals at&#13;    home and in their communities, and are custom fitted for each user, as well as for use by paraplegia patients in the clinical rehabilitation environment, where they provide individuals access to valuable exercise and therapy. ReWalk Rehabilitation&#13;    current design is dated and will not be produced in the future.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt"&gt;ReStore is a powered, lightweight soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation&#13;    environment.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt"&gt;MyoCycle which uses Functional Electrical Stimulation (&amp;#8220;FES&amp;#8221;) technology and MediTouch tutor movement biofeedback devices (&amp;#8220;Distributed Products&amp;#8221;).&amp;#160; The Company markets the&#13;    Distributed Products in the United States for use at home or in clinic.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt"&gt; &lt;br /&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt"&gt;&amp;#160;&amp;#160;&amp;#160;Units placed includes revenue from sales of SCI Products, ReStore and Distributed Products.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt"&gt; &lt;br /&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt Times New Roman, Times, Serif; clear: both; margin-top: 10pt; margin-bottom: 10pt"&gt;&#13;      &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt"&gt; &lt;br /&gt;&#13;  &lt;/div&gt;&#13;  &lt;br /&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt"&gt;For units placed, the Company recognizes revenues when it transfers control and title has passed to the customer.&amp;#160; Each unit placed is considered an independent, unbundled&#13;    performance obligation. The Company also offers a rent-to-purchase model in which the Company recognizes revenue ratably according to the agreed rental monthly fee.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt"&gt;&lt;u&gt;Spare parts and warranties&lt;/u&gt;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt"&gt;Spare parts are sold to private individuals, rehabilitation facilities and distributors. Revenue is recognized when the Company satisfies a performance obligation by transferring&#13;    control over promised goods or services to the customer. Each part sold is considered an independent, unbundled performance obligation.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt"&gt;Warranties are classified as either assurance type or service type warranty. A warranty is considered an assurance type warranty if it provides the consumer with assurance that the&#13;    product will function as intended for a limited period of time.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt"&gt;In the beginning of 2018, the Company updated its service policy for SCI Products to include a five- year warranty compared to a period of two years that were included in the past&#13;    for parts and services. The first two years are considered as assurance type warranty and the additional period is considered an extended service arrangement, which is a service type warranty. An assurance type warranty is not accounted for as separate&#13;    performance obligations under the revenue model. A service type warranty is either sold with a unit or separately for units for which the warranty has expired. Revenue is then recognized ratably over the life of the warranty.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt"&gt;The ReStore device is offered with a two-year warranty which is considered as assurance type warranty.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt"&gt;The Distributed Products are offered with assurance type warranty ranging between one year to ten years depending on the specific product and part.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt"&gt;&#13;    &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;u&gt;Contract balances&lt;/u&gt;&lt;u&gt; (in thousands)&lt;/u&gt;&lt;/div&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 40.5pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" border="0" align="right" id="z5c799b2fe8f0464797acfbb534d43627" style="font: 10pt Times New Roman, Times, Serif; width: 93%; color: #000000; text-align: left"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;December 31,&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;December 31,&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt; 2020&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;2019&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Trade receivable, net (1)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;684&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;794&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Deferred revenues (1) (2)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;1,108&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;844&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 72pt; clear: both"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" border="0" align="right" id="z17cb99861cfd43fcbaa9360391eba714" style="font: 10pt Times New Roman, Times, Serif; width: 93%; color: #000000; text-align: left"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 3.85%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(1)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 96.15%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;Balance presented net of unrecognized revenues that were not yet collected.&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 72pt; clear: both"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" border="0" align="right" id="z3161792d8d93450192807264069a7a74" style="font: 10pt Times New Roman, Times, Serif; width: 93%; color: #000000; text-align: left"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 3.85%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(2)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 96.15%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;$330 thousand of December&amp;#160;31, 2019 deferred revenues balance were recognized as revenues during the year ended December 31, 2020.&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 40.5pt; clear: both"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt"&gt;&lt;u&gt;Typical timing of payment&lt;/u&gt;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 43.2pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt"&gt;Deferred revenue is comprised mainly of unearned revenue related to service type warranty but also includes other offerings for which the Company has been paid in advance and earns&#13;    revenue when the Company transfers control of the product or service.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt"&gt;The Company&amp;#8217;s unfilled performance obligations as of December 31, 2020 and the estimated revenue expected to be recognized in the future related to the service type warranty&#13;    amounts to $1,108 thousand, which is fulfilled over one to five years. &amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt Times New Roman, Times, Serif; clear: both; margin-top: 10pt; margin-bottom: 10pt"&gt;&#13;    &#13;  &amp;#160;&#13;  &lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z6ad9a3b4411a480fb5186fe382453b4c" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"&gt;&lt;br /&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top"&gt;k.&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;Accounting for Share-Based Compensation:&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;The Company accounts for share-based compensation in accordance with ASC No.&amp;#160;718, &amp;#8220;Compensation-Stock Compensation&amp;#8221; (&amp;#8220;ASC No. 718&amp;#8221;). ASC No. 718 requires companies to estimate the&#13;    fair value of equity-based payment awards on the date of grant using an Option-Pricing Model (&amp;#8220;OPM&amp;#8221;). The value of the portion of the award that is ultimately expected to vest is recognized as an expense over the requisite service periods in the&#13;    Company&amp;#8217;s consolidated statements of operations.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;The Company recognizes compensation expenses for the value of its awards granted based on the straight-line method over the requisite service period of each of the awards.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;Effective as of January 1, 2017, the Company adopted Accounting Standards Update 2016-09, &amp;#8220;Compensation-Stock Compensation (Topic 718)&amp;#8221; (&amp;#8220;ASU 2016-09&amp;#8221;) on a modified, retrospective&#13;    basis. ASU 2016-09 permits entities to make an accounting policy election related to how forfeitures will impact the recognition of compensation cost for stock-based compensation: to estimate the total number of awards for which the requisite service&#13;    period will not be rendered or to account for forfeitures as they occur. Upon adoption of ASU 2016-09, the Company elected to change its accounting policy to account for forfeitures as they occur. The change was applied on a modified, retrospective&#13;    basis with a cumulative-effect adjustment to retained earnings of $11 thousand (which increased the accumulated deficit) as of January 1, 2017.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;ASU 2016-09 also eliminates the requirement that excess tax benefits be realized as a reduction in current taxes payable before the associated tax benefit can be recognized as an&#13;    increase in paid in capital. The implementation resulted with no cumulative-effect adjustment to retained earnings as of January 1, 2017.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt; &lt;br /&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 36pt"&gt;Additionally, ASU 2016-09 addresses the presentation of excess tax benefits and employee taxes paid on the statement of cash flows. The Company is now required to present excess tax benefits as an&#13;    operating activity on the statement of cash flows rather than as a financing activity. The Company adopted this change prospectively.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;In June 2018, the FASB issued ASU No.&amp;#160;2018-07 Compensation&amp;#8212;Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting. ASU 2018-07 was issued to&#13;    simplify several aspects of the accounting for nonemployee share-based payment transactions resulting from expanding the scope of Topic 718, "Compensation &amp;#8211; Stock Compensation", to include share-based payment transactions for acquiring goods and&#13;    services from nonemployees. The amendments specify that Topic 718 applies to all share-based payment transactions in which a grantor acquires goods or services to be used or consumed in a grantor&amp;#8217;s own operations by issuing share-based payment awards.&#13;    As a result of ASU 2018-07, grants awarded to non-employees are accounted for under ASC 718. The Company adopted ASU 2018-07 as of January 1, 2019. The adoption did not have a material impact on the consolidated financial statements.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;The Company selected the Black-Scholes-Merton option pricing model as the most appropriate fair value method for its share-option awards. The option-pricing model requires a number&#13;    of assumptions, of which the most significant are the fair market value of the underlying ordinary share, expected share price volatility and the expected option term. Expected volatility was calculated based upon certain peer companies that the&#13;    Company considered to be comparable. The expected option term represents the period of time that options granted are expected to be outstanding. The expected option term is determined based on the simplified method in accordance with Staff Accounting&#13;    Bulletin No.&amp;#160;110, as adequate historical experience is not available to provide a reasonable estimate. The simplified method will continue to apply until enough historical experience is available to provide a reasonable estimate of the expected term.&#13;    The risk-free interest rate is based on the yield from U.S. treasury bonds with an equivalent term. The Company has historically not paid dividends and has no foreseeable plans to pay dividends.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;Following the IPO in September 2014, the fair value of ordinary shares is observable as they are publicly traded.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt; &lt;br /&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;The fair value of Restricted Stock Units (RSUs) granted is determined based on the price of the Company&amp;#8217;s ordinary shares on the date of&#13;    grant.&lt;br /&gt;&#13;    &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;br /&gt;&#13;    &lt;/div&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt Times New Roman, Times, Serif; clear: both; margin-top: 10pt; margin-bottom: 10pt"&gt;&#13;    &#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;The fair value for options granted in 2019, 2018 is estimated at the date of grant using a Black-Scholes-Merton option pricing model with the following assumptions:&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" border="0" align="right" id="zcfac848f1c7c4ec8be5afff37beb22e7" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="6" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;Year Ended December 31,&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt; 2019&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;2018&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: #CCEEFF; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Expected volatility&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;57.5&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;%&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;57% - 61&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;%&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Risk-free rate&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;2.22&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;%&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;2.74% - 2.83&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;%&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: #CCEEFF; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Dividend yield&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#8212;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;%&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#8212;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;%&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Expected term (in years)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;6.11&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;6.11&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: #CCEEFF; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Share price&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;5.37&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;25.5 - $28.75&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; clear: both"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;There were no options granted during the twelve months ended December 31, 2020.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt; &lt;br /&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;The Company accounts for options granted to consultants and other service providers under ASC No. 718.        The fair value of&#13;    these options was estimated using a Black-Scholes-Merton option-pricing model.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&#13;    &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;The non-cash compensation expenses related to employees and non- employees for the years ended December&amp;#160;31, 2020, 2019 and 2018 amounted to $749 thousand, $1,108 thousand, and&#13;      $2,766 thousand, respectively.&lt;/div&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;&#13;    &lt;font lang="AR-SA" dir="rtl" style="font: 10pt Times New Roman,serif; mso-fareast-font-family: Times New Roman"&gt;&amp;#160;&lt;/font&gt;&#13;    &lt;table cellspacing="0" cellpadding="0" border="0" class="MsoNormalTable" style="font: 10pt Times New Roman, Times, Serif; width: 100%; width: 100%; mso-padding-alt: 0cm 0cm 0cm 0cm"&gt;&#13;      &#13;        &lt;tr style="font: 10pt Times New Roman, Times, Serif; mso-yfti-irow: 0; mso-yfti-firstrow: yes; mso-yfti-lastrow: yes"&gt;&#13;          &lt;td style="font: 10pt Times New Roman, Times, Serif; padding: 0cm; width: 24px; vertical-align: top; width: 18pt"&gt;&#13;            &lt;p class="MsoNormal" style="font: 10pt/normal Times New Roman, Times, Serif; margin-bottom: 0cm; margin-bottom: 0pt"&gt;&lt;font dir="ltr"&gt;&lt;/font&gt;&lt;font dir="ltr"&gt;&lt;/font&gt;&lt;font style="font: 10pt Times New Roman,serif; mso-fareast-font-family: Times New Roman"&gt;&lt;font dir="ltr"&gt;&lt;/font&gt;&lt;font dir="ltr"&gt;&lt;/font&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;          &lt;/td&gt;&#13;          &lt;td style="font: 10pt Times New Roman, Times, Serif; padding: 0cm; width: 24px; vertical-align: top; width: 18pt"&gt;&#13;            &lt;p class="MsoNormal" style="font: 10pt/normal Times New Roman, Times, Serif; margin-bottom: 0cm; margin-bottom: 0pt"&gt;&lt;font style="font: 10pt Times New Roman,serif; mso-fareast-font-family: Times New Roman"&gt;l.&lt;/font&gt;&lt;/p&gt;&#13;          &lt;/td&gt;&#13;          &lt;td style="font: 10pt Times New Roman, Times, Serif; padding: 0cm; vertical-align: top"&gt;&#13;            &lt;p class="MsoNormal" style="font: 10pt/normal Times New Roman, Times, Serif; margin-bottom: 0cm; margin-bottom: 0pt"&gt;&lt;font style="font: 10pt Times New Roman,serif; mso-fareast-font-family: Times New Roman"&gt;Warrants to Acquire&#13;                Ordinary Shares:&lt;/font&gt;&lt;/p&gt;&#13;          &lt;/td&gt;&#13;        &lt;/tr&gt;&#13;      &#13;    &lt;/table&gt;&#13;    &lt;p class="MsoNormal" style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0cm 0cm 0pt 36pt"&gt;&lt;font lang="AR-SA" dir="rtl" style="font: 10pt Times New Roman,serif; mso-fareast-font-family: Times New Roman"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;    &lt;p class="MsoNormal" style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0cm 0cm 0pt 36pt"&gt;&lt;font style="font: 10pt Times New Roman,serif; mso-fareast-font-family: Times New Roman"&gt;D&lt;/font&gt;&lt;font style="font: 10pt Times New Roman,serif; mso-fareast-font-family: Times New Roman; mso-bidi-language: HE"&gt;uring&#13;    the twelve-month ended&lt;/font&gt;&lt;font style="font: 10pt Times New Roman,serif; mso-fareast-font-family: Times New Roman"&gt; 31,&#13;    2020, and 2019, respectively, the Company issued warrants to acquire up to &lt;/font&gt;&lt;font dir="rtl"&gt;&lt;/font&gt;&lt;font dir="rtl"&gt;&lt;/font&gt;&lt;font lang="HE" dir="rtl" style="font: 10pt Times New Roman,serif; mso-fareast-font-family: Times New Roman; mso-bidi-language: HE"&gt;&lt;font dir="rtl"&gt;&lt;/font&gt;&lt;font dir="rtl"&gt;&lt;/font&gt;11,389,555&lt;/font&gt;&lt;font dir="ltr"&gt;&lt;/font&gt;&lt;font dir="ltr"&gt;&lt;/font&gt;&lt;font style="font: 10pt Times New Roman,serif; mso-fareast-font-family: Times New Roman"&gt;&lt;font dir="ltr"&gt;&lt;/font&gt;&lt;font dir="ltr"&gt;&lt;/font&gt;&#13;    and &lt;/font&gt;&lt;font dir="rtl"&gt;&lt;/font&gt;&lt;font dir="rtl"&gt;&lt;/font&gt;&lt;font lang="HE" dir="rtl" style="font: 10pt Times New Roman,serif; mso-fareast-font-family: Times New Roman; mso-bidi-language: HE"&gt;&lt;font dir="rtl"&gt;&lt;/font&gt;&lt;font dir="rtl"&gt;&lt;/font&gt;2,522,284&lt;/font&gt;&lt;font dir="ltr"&gt;&lt;/font&gt;&lt;font dir="ltr"&gt;&lt;/font&gt;&lt;font style="font: 10pt Times New Roman,serif; mso-fareast-font-family: Times New Roman"&gt;&lt;font dir="ltr"&gt;&lt;/font&gt;&lt;font dir="ltr"&gt;&lt;/font&gt;&#13;    ordinary shares. The Company assessed the warrants pursuant to ASC 480 "Distinguishing Liabilities from Equity" and ASC 815&#13;    "Derivatives and Hedging" and determine that the warrants should be accounted for as equity and not as a derivative&#13;    liability. Refer to Note &lt;/font&gt;&lt;font dir="rtl"&gt;&lt;/font&gt;&lt;font dir="rtl"&gt;&lt;/font&gt;&lt;font lang="HE" dir="rtl" style="font: 10pt Times New Roman,serif; mso-fareast-font-family: Times New Roman; mso-bidi-language: HE"&gt;&lt;font dir="rtl"&gt;&lt;/font&gt;&lt;font dir="rtl"&gt;&lt;/font&gt;8&lt;/font&gt;&lt;font style="font: 10pt Times New Roman,serif; mso-fareast-font-family: Times New Roman; mso-bidi-language: HE"&gt;f&lt;/font&gt;&lt;font style="font: 10pt Times New Roman,serif; mso-fareast-font-family: Times New Roman"&gt;&#13;    for additional information.&lt;font style="mso-spacerun: yes"&gt;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&#13;    &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt; &lt;br /&gt;&#13;  &lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z8db205dbbcfb4efaa93a391fce4c3d64" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"&gt;&lt;br /&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top"&gt;m.&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;Research and Development Costs:&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;Research and development costs are charged to the consolidated statement of operations as incurred and are presented net of the amount of any grants the company receive for research&#13;    and development in the period in which the grant was received.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z842b410387424176bf5d892651c42ab0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"&gt;&lt;br /&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top"&gt;n.&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;Income Taxes&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;The Company accounts for income taxes in accordance with ASC No.&amp;#160;740, &amp;#8220;Income Taxes&amp;#8221; (&amp;#8220;ASC No. 740&amp;#8221;), using the liability method whereby deferred tax assets and liability account&#13;    balances are determined based on the differences between financial reporting and the tax basis for assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The&#13;    Company provides a valuation allowance, if necessary, to reduce deferred tax assets to the amounts that are more likely-than-not to be realized.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;ASC No. 740 contains a two-step approach to recognizing and measuring a liability for uncertain tax positions. The first step is to evaluate the tax position taken or expected to be&#13;    taken in a tax return by determining if the weight of available evidence indicates that it is more likely than not that, on an evaluation of the technical merits, the tax position will be sustained on audit, including resolution of any related appeals&#13;    or litigation processes. The second step is to measure the tax benefit as the largest amount that is more than 50% likely to be realized upon ultimate settlement. The Company accrues interest and penalties related to unrecognized tax benefits in its&#13;    taxes on income. As of December 31, 2020, and 2019, the Company did not identify any significant uncertain tax positions.&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt Times New Roman, Times, Serif; clear: both; margin-top: 10pt; margin-bottom: 10pt"&gt;&#13;    &#13;  &lt;/div&gt;&#13;  &amp;#160;&#13;  &lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="ze6bf0cf2a2aa4cc3b679ca44928b857c" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"&gt;&lt;br /&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top"&gt;o.&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;Warranty:&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;The Company provided a two-year standard warranty for its products. In the beginning of 2018, we updated our service policy for new devices sold to include five-year warranties.&amp;#160; The&#13;    Company determined that the first two years of warranty is an assurance-type warranty and records a provision for the estimated cost to repair or replace products under warranty at the time of sale. Factors that affect the Company&amp;#8217;s warranty reserve&#13;    include the number of units sold, historical and anticipated rates of warranty repairs and the cost per repair.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" border="0" align="right" id="z24e95ed7a2ee4f738f16153ac66d9200" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;US Dollars&lt;br /&gt;&#13;            in&lt;br /&gt;&#13;            thousands&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 88%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Balance at December 31, 2019&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;227&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 88%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Provision&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;125&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 88%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Usage&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(212&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 88%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Balance at December 31, 2020&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;140&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; clear: both"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z1a8f598a777d49a5b354da4c89c73b12" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"&gt;&lt;br /&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top"&gt;p.&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;Concentrations of Credit Risks:&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash, cash equivalents and trade receivables.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;The Company&amp;#8217;s cash and cash equivalents are deposited in major banks in Israel, the United States and Germany. Such deposits in the United States may be in excess of insured limits&#13;    and are not insured in other jurisdictions. The Company maintains cash and cash equivalents with diverse financial institutions and monitors the amount of credit exposure to each financial institution.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;Concentration of credit risk with respect to trade receivable is primarily limited to a customer to which the Company makes substantial sales.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" border="0" align="right" id="z6023b00ba79a4ef29192bf73408506a9" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="6" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;December 31,&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt; 2020&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;2019&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;Customer A&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;15&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;%&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;*&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Customer B&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;15&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;%&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;*&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;Customer C&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;15&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;%&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;*&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;Customer D&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;14&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;%&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;*&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;Customer E&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;12&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;%&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;12&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;%&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;Customer F&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;11&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;%&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;*&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;Customer G&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;*&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;14&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;%&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Customer H&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;*&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;13&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;%&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Customer I&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;*&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;13&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;%&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;Customer J&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;*&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;12&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;%&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;Customer K&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;*&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;12&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;%&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Customer L&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;*&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;12&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;%&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-indent: 36pt; clear: both"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" border="0" align="right" id="z134b78bbeb3144378ee804552ff51346" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 3.85%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;*)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 96.15%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;Less than 10%&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-indent: 36pt; clear: both"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt Times New Roman, Times, Serif; clear: both; margin-top: 10pt; margin-bottom: 10pt"&gt;&#13;    &#13;  &lt;/div&gt;&#13;  &amp;#160;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;The Company&amp;#8217;s trade receivables are geographically diversified and derived primarily from sales to customers in various countries, mainly in the United States and Europe.&#13;    Concentration of credit risk with respect to trade receivables is limited by credit limits, ongoing credit evaluation and account monitoring procedures. The Company performs ongoing credit evaluations of its distributors based upon a specific review of&#13;    all significant outstanding invoices. The Company writes off receivables when they are deemed uncollectible and having exhausted all collection efforts. As of December 31, 2020, and 2019 trade receivables are presented net of $102 thousand and $31&#13;    thousand allowance for doubtful accounts, respectively, and net of sales return reserve of $0 thousand and $86 thousand, respectively.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z4e14dd2dffa44865bb3145074fd5b07a" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"&gt;&lt;br /&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top"&gt;q.&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;Accrued Severance Pay:&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;Pursuant to Israel&amp;#8217;s Severance Pay Law, Israeli employees are entitled to severance pay equal to one month&amp;#8217;s salary for each year of employment, or a portion thereof. All of the&#13;    employees of the RRL elected to be included under section 14 of the Severance Pay Law, 1963 (&amp;#8220;section 14&amp;#8221;). According to this section, these employees are entitled only to monthly deposits, at a rate of 8.33% of their monthly salary, made in their name&#13;    with insurance companies. Payments in accordance with section 14 release the Company from any future severance payments (under the above Israeli Severance Pay Law) in respect of those employees; therefore, related assets and liabilities are not&#13;    presented in the balance sheet.&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;Total Company expenses related to severance pay amounted to $125 thousand, $156 thousand and $169 thousand for the years ended December&amp;#160;31, 2020, 2019 and 2018, respectively.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z6bf8ea3b08384d14b0ccf4afddd571ac" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"&gt;&lt;br /&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top"&gt;r.&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;Fair Value Measurements:&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the&#13;    asset or liability in an orderly transaction between market participants on the measurement date.&amp;#160; The Company uses a three-tier fair value hierarchy to classify and disclose all assets and liabilities measured at fair value on a recurring basis, as&#13;    well as assets and liabilities measured at fair value on a non-recurring basis, in periods subsequent to their initial measurement.&amp;#160; The hierarchy requires the Company to use observable inputs when available, and to minimize the use of unobservable&#13;    inputs when determining fair value. If a financial instrument uses inputs that fall in different levels of the hierarchy, the instrument will be categorized based upon the lowest level of input that is significant to the fair value calculation. The&#13;    three-tiers are defined as follows:&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;    &lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zdcbd6ac918d047b7b0ce02f1923b2381" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;      &#13;        &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;&#13;          &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 36pt"&gt;&amp;#160;&lt;/td&gt;&#13;          &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 27pt"&gt;&#13;            &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: left"&gt;&amp;#9679;&lt;/div&gt;&#13;          &lt;/td&gt;&#13;          &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: auto"&gt;&#13;            &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: left"&gt;&lt;font style="font-weight: bold"&gt;Level 1.&amp;#160;&lt;/font&gt;Observable inputs based on unadjusted quoted prices in active markets for identical assets or liabilities;&lt;/div&gt;&#13;          &lt;/td&gt;&#13;        &lt;/tr&gt;&#13;      &#13;    &lt;/table&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;    &lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zd17ba00465ad44acbc00c8c632d833f1" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;      &#13;        &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;&#13;          &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 36pt"&gt;&amp;#160;&lt;/td&gt;&#13;          &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 27pt"&gt;&#13;            &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: left"&gt;&amp;#9679;&lt;/div&gt;&#13;          &lt;/td&gt;&#13;          &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: auto"&gt;&#13;            &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: left"&gt;&lt;font style="font-weight: bold"&gt;Level 2.&amp;#160;&lt;/font&gt;Inputs, other than quoted prices in active markets, that are observable either directly or indirectly; and&lt;/div&gt;&#13;          &lt;/td&gt;&#13;        &lt;/tr&gt;&#13;      &#13;    &lt;/table&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;    &lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z7971363fdc984e908a793fa67f2f12af" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;      &#13;        &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;&#13;          &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 36pt"&gt;&amp;#160;&lt;/td&gt;&#13;          &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 27pt"&gt;&#13;            &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: left"&gt;&amp;#9679;&lt;/div&gt;&#13;          &lt;/td&gt;&#13;          &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: auto"&gt;&#13;            &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: left"&gt;&lt;font style="font-weight: bold"&gt;Level 3.&amp;#160;&lt;/font&gt;Unobservable inputs for which there is little or no market data requiring the Company to develop its own assumptions.&lt;/div&gt;&#13;          &lt;/td&gt;&#13;        &lt;/tr&gt;&#13;      &#13;    &lt;/table&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;The carrying amounts of cash and cash equivalents, short term deposits, trade receivables and trade payables approximate their fair value due to the short-term maturity of such&#13;    instruments.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt Times New Roman, Times, Serif; clear: both; margin-top: 10pt; margin-bottom: 10pt"&gt;&#13;    &#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;&lt;br /&gt;&#13;  &lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z147735070f9745478837e094cfe351cf" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"&gt;&lt;br /&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top"&gt;s.&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;Basic and Diluted Net Loss Per Share:&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;Basic net loss per share is computed by dividing the net loss by the weighted-average number of shares of ordinary shares outstanding during the period.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;Diluted net loss per share is computed by giving effect to all potential shares of ordinary shares, including stock options, convertible preferred share warrants, to the extent&#13;    dilutive, all in accordance with ASC No.&amp;#160;260, &amp;#8220;Earning Per Share&amp;#8221;.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;The following table sets forth the computation of the Company&amp;#8217;s basic and diluted net loss per ordinary share (in thousands, except share and per share data):&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" border="0" align="right" id="zf3292f75d1664a6e9a65631d4d24c1c5" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="10" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;Year ended December 31,&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt; 2020&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;2019&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;2018&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Net loss&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(12,976&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(15,551&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(21,675&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Net loss attributable to ordinary shares&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(12,976&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(15,551&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(21,675&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Shares used in computing net loss per ordinary shares, basic and diluted&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;15,764,980&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;5,763,317&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;1,472,499&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Net loss per ordinary share, basic and diluted&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(0.82&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(2.70&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(14.72&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt; clear: both"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&#13;    &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: left"&gt;Basic and diluted net loss per share was the same for each period presented as the inclusion of all potential shares of ordinary shares and&#13;      warrants outstanding would have been anti-dilutive.&lt;/div&gt;&#13;    &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z84c18d6253bf4238bc62601cb23e7efb" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"&gt;&lt;br /&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top"&gt;t.&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;Contingent liabilities&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;The Company accounts for its contingent liabilities in accordance with ASC No.&amp;#160;450, &amp;#8220;Contingencies&amp;#8221;. A provision is recorded when it is both probable that a liability has been&#13;    incurred and the amount of the loss can be reasonably estimated.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;With respect to legal matters, provisions are reviewed and adjusted to reflect the impact of negotiations, estimated settlements, legal rulings, advice of legal counsel and other&#13;    information and events pertaining to a particular matter.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt; &lt;br /&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;See note 7e for further information.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;  &lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z4e6e8ddef3724ce7868cf6b53b989b16" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"&gt;&lt;br /&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top"&gt;u.&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;Government grants&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;Government grants received by the Company relating to categories of operating expenditures are credited to the consolidated statements of operations during the period in which the&#13;    expenditure to which they relate is charged. Royalty and non-royalty-bearing grants from the Israel Innovation Authority, or the IIA, (formerly known as the Israeli Office of the Chief Scientist), from the Israel-U.S. Binational Industrial Research and&#13;    Development Foundation (&amp;#8220;BIRD&amp;#8221;) and from the Israeli Fund for Promoting Overseas Marketing for funding certain approved research and development projects and sales and marketing activities are recognized at the time when the Company is entitled to such&#13;    grants, on the basis of the related costs incurred, and are included as a deduction from research and development or sales and marketing expenses (see Note&amp;#160;7c).&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;No royalty-bearing grants were recorded for the years ended December 31, 2020, and December 31, 2019, the Company received royalty-bearing grants in the amount of $198 thousand for&#13;    the year ended December 31, 2018, as part of the research and development expenses.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt Times New Roman, Times, Serif; clear: both; margin-top: 10pt; margin-bottom: 10pt"&gt;&#13;    &#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;br /&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;Total Company expenses related to royalties amounted to $46 thousand, $15 thousand for the years ended December&amp;#160;31, 2020, 2019, respectively, no royalty expenses were recorded for&#13;    the year ended December&amp;#160;31, 2018.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;  &lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zedb0b2f971494d55a06e892aae3c3b76" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"&gt;&lt;br /&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top"&gt;v.&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;New Accounting Pronouncements&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: italic 10pt/1.25 Times New Roman, Times, Serif; text-indent: 36pt"&gt;Recently Implemented Accounting Pronouncements&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;  &lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z53e58c161f4e4c0d9e1cfc8d00371b44" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 72pt"&gt;&lt;br /&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 36pt; vertical-align: top"&gt;i.&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;Leases:&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;In February 2016, the FASB&amp;#160;issued Accounting Standard Update, or ASU, No. 2016-02, Leases (Topic 842), to enhance the transparency and comparability of financial reporting related to&#13;    leasing arrangements. The Company adopted the standard effective January 1, 2019. At the inception of an arrangement, the Company determines whether the arrangement is or contains a lease based on the unique facts and circumstances present. Operating&#13;    lease liabilities and their corresponding right-of-use assets are recorded based on the present value of lease payments over the expected lease term. The interest rate implicit in lease contracts is typically not readily determinable. As such, the&#13;    Company utilizes its incremental borrowing rate, which is the rate incurred to borrow on a collateralized basis over a similar term an amount equal to the lease payments in a similar economic environment.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;Prior to the Company&amp;#8217;s adoption of ASU 2016-02, when its lease agreements contained rent payment relief and rent escalation clauses, the Company recorded a deferred rent asset or&#13;    liability equal to the difference between the rent expense and the future minimum lease payments due. Operating leases are recognized on the balance sheet as right-of-use assets, current maturities of operating leases and noncurrent operating lease&#13;    liabilities.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;The Company used the modified retrospective transition method, under which the Company applied the standard as a cumulative effect adjustment to each lease that had commenced as of&#13;    the beginning of January 1, 2019 and did not apply the standard to comparative historical periods. In addition, the Company elected to apply the package of practical expedients permitted under the transition guidance, which among other things, allowed&#13;    the Company to carry forward the historical lease classification. The Company has elected, as of the adoption date, not to reassess whether expired or existing contracts contain leases under the new definition of a lease, not to reassess the lease&#13;    classification for expired or existing leases, and not to reassess whether previously capitalized initial direct costs would qualify for capitalization under ASC 842.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&#13;    &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Leases with an initial term of 12 months or less are not recorded on the balance sheet. The Company recognizes the lease expense&#13;      for such leases on a straight-line basis in the statement of operations over the lease term. As a result, the Company no longer recognizes deferred rent on the balance sheet.&lt;/div&gt;&#13;    &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 36pt"&gt; &lt;br /&gt;&#13;    &lt;/div&gt;&#13;    &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;The Company has elected to apply the practical expedient and combine lease and non-lease components.&amp;#160; &lt;br /&gt;&#13;    &lt;/div&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;Upon adoption of this&#13;  standard on January 1, 2019, the Company recorded right&amp;#8211;of&amp;#8211;use assets and corresponding lease liabilities&#13;  of&amp;#160;$2,099&amp;#160;thousand and&amp;#160;$2,249 thousand, respectively. As of&amp;#160;December&amp;#160;31, 2020, the&#13;  right&amp;#8211;of&amp;#8211;use assets and corresponding lease liabilities in the Company&amp;#8217;s consolidated balance sheets&#13;  were&amp;#160;$1,349 thousand&amp;#160;and&amp;#160;$1,583 thousand, respectively. The adoption of this standard did not have a material impact&#13;  on the Company&amp;#8217;s consolidated statements of operations or cash flows. See also note 7b - Lease commitment.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt Times New Roman, Times, Serif; clear: both; margin-top: 10pt; margin-bottom: 10pt"&gt;&#13;    &#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: italic 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt"&gt;Recent Accounting Pronouncements Not Yet Adopted&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;  &lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z50e182fa759e4e5db0765d46b3042523" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 70.8pt"&gt;&lt;br /&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 36pt; vertical-align: top"&gt;i.&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;Accounting for Convertible Instruments and Contracts in an Entity&amp;#8217;s Own Equity&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;In August 2020, the FASB issued ASU No. 2020-06, Accounting for Convertible Instruments and Contracts in an Entity&amp;#8217;s Own Equity (ASU&amp;#160; 2020-06), which simplifies the accounting for&#13;    certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts in an entity&amp;#8217;s own equity.&amp;#160; Among other changes, ASU 2020-06 removes from GAAP the liability and equity separation model for&#13;    convertible instruments with a cash conversion feature and a beneficial conversion feature, and as a result, after adoption, entities will no longer separately present in equity an embedded conversion feature for such debt. Similarly, the embedded&#13;    conversion feature will no longer be amortized into income as interest expense over the life of the instrument. Instead, entities will account for a convertible debt instrument wholly as debt unless (1) a convertible instrument contains features that&#13;    require bifurcation as a derivative under ASC Topic 815, Derivatives and Hedging, or (2) a convertible debt instrument was issued at a substantial premium. Additionally, ASU 2020-06 requires the application of the if-converted method to calculate the&#13;    impact of convertible instruments on diluted earnings per share (EPS). ASU&amp;#160; 2020-06 is effective for fiscal years beginning after December 15, 2021, with early adoption permitted for fiscal years beginning after December 15, 2020 and can be adopted on&#13;    either a fully retrospective or modified retrospective basis. The adoption of this standard is not expected to result in a material impact to the Company&amp;#8217;s financial statements.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;  &lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z70dbcad0e59447bfa3b078cc6c5a1e76" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 70.8pt"&gt;&lt;br /&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 36pt; vertical-align: top"&gt;ii.&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;Financial Instruments&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;In June 2016, FASB issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. ASU 2016-13 amends the impairment&#13;    model to utilize an expected loss methodology in place of the currently used incurred loss methodology, which will result in the more timely recognition of losses. Topic 326 was adopted by the Company on January 1, 2020. The adoption did not have a&#13;    material impact on the Company&amp;#8217;s consolidated financial statements.&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zedb0b2f971494d55a06e892aae3c3b76" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"&gt;&lt;br /&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top"&gt;v.&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;New Accounting Pronouncements&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: italic 10pt/1.25 Times New Roman, Times, Serif; text-indent: 36pt"&gt;Recently Implemented Accounting Pronouncements&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;  &lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z53e58c161f4e4c0d9e1cfc8d00371b44" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 72pt"&gt;&lt;br /&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 36pt; vertical-align: top"&gt;i.&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;Leases:&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;In February 2016, the FASB&amp;#160;issued Accounting Standard Update, or ASU, No. 2016-02, Leases (Topic 842), to enhance the transparency and comparability of financial reporting related to&#13;    leasing arrangements. The Company adopted the standard effective January 1, 2019. At the inception of an arrangement, the Company determines whether the arrangement is or contains a lease based on the unique facts and circumstances present. Operating&#13;    lease liabilities and their corresponding right-of-use assets are recorded based on the present value of lease payments over the expected lease term. The interest rate implicit in lease contracts is typically not readily determinable. As such, the&#13;    Company utilizes its incremental borrowing rate, which is the rate incurred to borrow on a collateralized basis over a similar term an amount equal to the lease payments in a similar economic environment.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;Prior to the Company&amp;#8217;s adoption of ASU 2016-02, when its lease agreements contained rent payment relief and rent escalation clauses, the Company recorded a deferred rent asset or&#13;    liability equal to the difference between the rent expense and the future minimum lease payments due. Operating leases are recognized on the balance sheet as right-of-use assets, current maturities of operating leases and noncurrent operating lease&#13;    liabilities.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;The Company used the modified retrospective transition method, under which the Company applied the standard as a cumulative effect adjustment to each lease that had commenced as of&#13;    the beginning of January 1, 2019 and did not apply the standard to comparative historical periods. In addition, the Company elected to apply the package of practical expedients permitted under the transition guidance, which among other things, allowed&#13;    the Company to carry forward the historical lease classification. The Company has elected, as of the adoption date, not to reassess whether expired or existing contracts contain leases under the new definition of a lease, not to reassess the lease&#13;    classification for expired or existing leases, and not to reassess whether previously capitalized initial direct costs would qualify for capitalization under ASC 842.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&#13;    &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Leases with an initial term of 12 months or less are not recorded on the balance sheet. The Company recognizes the lease expense&#13;      for such leases on a straight-line basis in the statement of operations over the lease term. As a result, the Company no longer recognizes deferred rent on the balance sheet.&lt;/div&gt;&#13;    &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 36pt"&gt; &lt;br /&gt;&#13;    &lt;/div&gt;&#13;    &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;The Company has elected to apply the practical expedient and combine lease and non-lease components.&amp;#160; &lt;br /&gt;&#13;    &lt;/div&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;Upon adoption of this&#13;  standard on January 1, 2019, the Company recorded right&amp;#8211;of&amp;#8211;use assets and corresponding lease liabilities&#13;  of&amp;#160;$2,099&amp;#160;thousand and&amp;#160;$2,249 thousand , respectively. As of&amp;#160;December&amp;#160;31, 2020, the&#13;  right&amp;#8211;of&amp;#8211;use assets and corresponding lease liabilities in the Company&amp;#8217;s consolidated balance sheets&#13;  were&amp;#160;$1,349 thousand&amp;#160;and&amp;#160;$1,583 thousand, respectively. The adoption of this standard did not have a material impact&#13;  on the Company&amp;#8217;s consolidated statements of operations or cash flows. See also note 7b - Lease commitment.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;  &lt;/div&gt;&#13;  &lt;div id="DSPFPageBreakArea" style="font: 10pt Times New Roman, Times, Serif; clear: both; margin-top: 10pt; margin-bottom: 10pt"&gt;&#13;    &#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: italic 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt"&gt;Recent Accounting Pronouncements Not Yet Adopted&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;  &lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z50e182fa759e4e5db0765d46b3042523" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 70.8pt"&gt;&lt;br /&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 36pt; vertical-align: top"&gt;i.&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;Accounting for Convertible Instruments and Contracts in an Entity&amp;#8217;s Own Equity&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;In August 2020, the FASB issued ASU No. 2020-06, Accounting for Convertible Instruments and Contracts in an Entity&amp;#8217;s Own Equity (ASU&amp;#160; 2020-06), which simplifies the accounting for&#13;    certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts in an entity&amp;#8217;s own equity.&amp;#160; Among other changes, ASU 2020-06 removes from GAAP the liability and equity separation model for&#13;    convertible instruments with a cash conversion feature and a beneficial conversion feature, and as a result, after adoption, entities will no longer separately present in equity an embedded conversion feature for such debt. Similarly, the embedded&#13;    conversion feature will no longer be amortized into income as interest expense over the life of the instrument. Instead, entities will account for a convertible debt instrument wholly as debt unless (1) a convertible instrument contains features that&#13;    require bifurcation as a derivative under ASC Topic 815, Derivatives and Hedging, or (2) a convertible debt instrument was issued at a substantial premium. Additionally, ASU 2020-06 requires the application of the if-converted method to calculate the&#13;    impact of convertible instruments on diluted earnings per share (EPS). ASU&amp;#160; 2020-06 is effective for fiscal years beginning after December 15, 2021, with early adoption permitted for fiscal years beginning after December 15, 2020 and can be adopted on&#13;    either a fully retrospective or modified retrospective basis. The adoption of this standard is not expected to result in a material impact to the Company&amp;#8217;s financial statements.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;  &lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z70dbcad0e59447bfa3b078cc6c5a1e76" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 70.8pt"&gt;&lt;br /&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 36pt; vertical-align: top"&gt;ii.&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;Financial Instruments&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;In June 2016, FASB issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. ASU 2016-13 amends the impairment&#13;    model to utilize an expected loss methodology in place of the currently used incurred loss methodology, which will result in the more timely recognition of losses. Topic 326 was adopted by the Company on January 1, 2020. The adoption did not have a&#13;    material impact on the Company&amp;#8217;s consolidated financial statements.&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z147735070f9745478837e094cfe351cf" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"&gt;&lt;br /&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top"&gt;s.&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;Basic and Diluted Net Loss Per Share:&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;Basic net loss per share is computed by dividing the net loss by the weighted-average number of shares of ordinary shares outstanding during the period.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;Diluted net loss per share is computed by giving effect to all potential shares of ordinary shares, including stock options, convertible preferred share warrants, to the extent&#13;    dilutive, all in accordance with ASC No.&amp;#160;260, &amp;#8220;Earning Per Share&amp;#8221;.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;The following table sets forth the computation of the Company&amp;#8217;s basic and diluted net loss per ordinary share (in thousands, except share and per share data):&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" border="0" align="right" id="zf3292f75d1664a6e9a65631d4d24c1c5" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="10" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;Year ended December 31,&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt; 2020&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;2019&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;2018&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Net loss&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(12,976&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(15,551&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(21,675&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Net loss attributable to ordinary shares&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(12,976&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(15,551&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(21,675&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Shares used in computing net loss per ordinary shares, basic and diluted&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;15,764,980&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;5,763,317&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;1,472,499&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Net loss per ordinary share, basic and diluted&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(0.82&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(2.70&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(14.72&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt; clear: both"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&#13;    &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: left"&gt;Basic and diluted net loss per share was the same for each period presented as the inclusion of all potential shares of ordinary shares and&#13;      warrants outstanding would have been anti-dilutive.&lt;/div&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <rwlk:ClassOfWarrantOrRightPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;    &lt;table cellspacing="0" cellpadding="0" border="0" class="MsoNormalTable" style="font: 10pt Times New Roman, Times, Serif; width: 100%; width: 100%; mso-padding-alt: 0cm 0cm 0cm 0cm"&gt;&#13;      &#13;        &lt;tr style="font: 10pt Times New Roman, Times, Serif; mso-yfti-irow: 0; mso-yfti-firstrow: yes; mso-yfti-lastrow: yes"&gt;&#13;          &lt;td style="font: 10pt Times New Roman, Times, Serif; padding: 0cm; width: 24px; vertical-align: top; width: 18pt"&gt;&#13;            &lt;p class="MsoNormal" style="font: 10pt/normal Times New Roman, Times, Serif; margin-bottom: 0cm; margin-bottom: 0pt"&gt;&lt;font dir="ltr"&gt;&lt;/font&gt;&lt;font dir="ltr"&gt;&lt;/font&gt;&lt;font style="font: 10pt Times New Roman,serif; mso-fareast-font-family: Times New Roman"&gt;&lt;font dir="ltr"&gt;&lt;/font&gt;&lt;font dir="ltr"&gt;&lt;/font&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;          &lt;/td&gt;&#13;          &lt;td style="font: 10pt Times New Roman, Times, Serif; padding: 0cm; width: 24px; vertical-align: top; width: 18pt"&gt;&#13;            &lt;p class="MsoNormal" style="font: 10pt/normal Times New Roman, Times, Serif; margin-bottom: 0cm; margin-bottom: 0pt"&gt;&lt;font style="font: 10pt Times New Roman,serif; mso-fareast-font-family: Times New Roman"&gt;l.&lt;/font&gt;&lt;/p&gt;&#13;          &lt;/td&gt;&#13;          &lt;td style="font: 10pt Times New Roman, Times, Serif; padding: 0cm; vertical-align: top"&gt;&#13;            &lt;p class="MsoNormal" style="font: 10pt/normal Times New Roman, Times, Serif; margin-bottom: 0cm; margin-bottom: 0pt"&gt;&lt;font style="font: 10pt Times New Roman,serif; mso-fareast-font-family: Times New Roman"&gt;Warrants to Acquire&#13;                Ordinary Shares:&lt;/font&gt;&lt;/p&gt;&#13;          &lt;/td&gt;&#13;        &lt;/tr&gt;&#13;      &#13;    &lt;/table&gt;&#13;    &lt;p class="MsoNormal" style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0cm 0cm 0pt 36pt"&gt;&lt;font lang="AR-SA" dir="rtl" style="font: 10pt Times New Roman,serif; mso-fareast-font-family: Times New Roman"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;    &lt;p class="MsoNormal" style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0cm 0cm 0pt 36pt"&gt;&lt;font style="font: 10pt Times New Roman,serif; mso-fareast-font-family: Times New Roman"&gt;D&lt;/font&gt;&lt;font style="font: 10pt Times New Roman,serif; mso-fareast-font-family: Times New Roman; mso-bidi-language: HE"&gt;uring&#13;    the twelve-month ended&lt;/font&gt;&lt;font style="font: 10pt Times New Roman,serif; mso-fareast-font-family: Times New Roman"&gt; 31,&#13;    2020, and 2019, respectively, the Company issued warrants to acquire up to &lt;/font&gt;&lt;font dir="rtl"&gt;&lt;/font&gt;&lt;font dir="rtl"&gt;&lt;/font&gt;&lt;font lang="HE" dir="rtl" style="font: 10pt Times New Roman,serif; mso-fareast-font-family: Times New Roman; mso-bidi-language: HE"&gt;&lt;font dir="rtl"&gt;&lt;/font&gt;&lt;font dir="rtl"&gt;&lt;/font&gt;11,389,555&lt;/font&gt;&lt;font dir="ltr"&gt;&lt;/font&gt;&lt;font dir="ltr"&gt;&lt;/font&gt;&lt;font style="font: 10pt Times New Roman,serif; mso-fareast-font-family: Times New Roman"&gt;&lt;font dir="ltr"&gt;&lt;/font&gt;&lt;font dir="ltr"&gt;&lt;/font&gt;&#13;    and &lt;/font&gt;&lt;font dir="rtl"&gt;&lt;/font&gt;&lt;font dir="rtl"&gt;&lt;/font&gt;&lt;font lang="HE" dir="rtl" style="font: 10pt Times New Roman,serif; mso-fareast-font-family: Times New Roman; mso-bidi-language: HE"&gt;&lt;font dir="rtl"&gt;&lt;/font&gt;&lt;font dir="rtl"&gt;&lt;/font&gt;2,522,284&lt;/font&gt;&lt;font dir="ltr"&gt;&lt;/font&gt;&lt;font dir="ltr"&gt;&lt;/font&gt;&lt;font style="font: 10pt Times New Roman,serif; mso-fareast-font-family: Times New Roman"&gt;&lt;font dir="ltr"&gt;&lt;/font&gt;&lt;font dir="ltr"&gt;&lt;/font&gt;&#13;    ordinary shares. The Company assessed the warrants pursuant to ASC 480 "Distinguishing Liabilities from Equity" and ASC 815&#13;    "Derivatives and Hedging" and determine that the warrants should be accounted for as equity and not as a derivative&#13;    liability. Refer to Note &lt;/font&gt;&lt;font dir="rtl"&gt;&lt;/font&gt;&lt;font dir="rtl"&gt;&lt;/font&gt;&lt;font lang="HE" dir="rtl" style="font: 10pt Times New Roman,serif; mso-fareast-font-family: Times New Roman; mso-bidi-language: HE"&gt;&lt;font dir="rtl"&gt;&lt;/font&gt;&lt;font dir="rtl"&gt;&lt;/font&gt;8&lt;/font&gt;&lt;font style="font: 10pt Times New Roman,serif; mso-fareast-font-family: Times New Roman; mso-bidi-language: HE"&gt;f&lt;/font&gt;&lt;font style="font: 10pt Times New Roman,serif; mso-fareast-font-family: Times New Roman"&gt;&#13;    for additional information.&lt;font style="mso-spacerun: yes"&gt;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</rwlk:ClassOfWarrantOrRightPolicyTextBlock>
    <rwlk:DisclosureofTermLoansandWarrantstoPurchaseOrdinarySharesTextBlock contextRef="From2020-01-01to2020-12-31">&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif"&gt;NOTE&amp;#160;6: -&amp;#160;&amp;#160; LOAN AGREEMENT WITH KREOS AND RELATED WARRANT TO PURCHASE ORDINARY SHARES&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt"&gt;On December 30, 2015, the Company entered into the loan agreement (the &amp;#8220;Loan Agreement&amp;#8221;) with Kreos Capital V (Expert Fund) Limited (&amp;#8220;Kreos&amp;#8221;), pursuant to which Kreos extended a line&#13;    of credit to us in the amount of $20 million, with interest payable monthly in arrears on any amounts drawn down at a rate of 10.75% per year from the applicable drawdown date through the date on which all principal is repaid. As of June 30, 2017, the&#13;    Company raised more than $20 million in connection with the issuance of its share capital and, therefore, in accordance with the terms of the Loan Agreement, the repayment period was extended from 24 months to 36 months. The principal was also reduced&#13;    in connection with the issuance of the Kreos Convertible Note on June 9, 2017. Pursuant to the Loan Agreement, we granted Kreos a first priority security interest over all of our assets, including certain intellectual property and equity interests in&#13;    its subsidiaries, subject to certain permitted security interests.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-indent: 36pt"&gt;Pursuant to the terms of the warrant, in connection with the $20.0 million drawdown under the Loan Agreement on January 4, 2016, we issued to Kreos the warrant to purchase up to 4,771 of our ordinary&#13;    shares at an exercise price of $241.0 per share, increased to 6,679 ordinary shares on December 28, 2016. Subject to the terms of the warrant, the warrant is exercisable, in whole or in part, at any time prior to the earlier of (i) December 30, 2025,&#13;    or (ii) immediately prior to the consummation of a merger, consolidation, or reorganization of us with or into, or the sale or license of all or substantially all our assets or shares to, any other entity or person, other than a wholly-owned subsidiary&#13;    of us, excluding any transaction in which our shareholders prior to the transaction will hold more than 50% of the voting and economic rights of the surviving entity after the transaction.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-indent: 36pt"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-indent: 36pt"&gt;On June 9, 2017, the Company and Kreos entered into the First Amendment, under which $3.0 million of the outstanding principal under the Loan Agreement became subject to repayment pursuant to the senior&#13;    secured Kreos Convertible Note issued on June 9, 2017.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt"&gt;&amp;#160;On November 20, 2018, the Company and Kreos entered into the Second Amendment of the Loan Agreement, in which the Company repaid Kreos the $3.6 million other related payments,&#13;    including prepayment costs and end of loan payments, terminating the Kreos Note, by issuing to Kreos 192,000 units and 288,000 pre-funded units as part of an underwritten public offering at the public offering prices, and the parties agreed to revise&#13;    the principal and the repayment schedule under the Kreos Loan. Additionally, Kreos and the Company entered into the Kreos Warrant Amendment, which amended the exercise price of the warrant to purchase 6,679 ordinary shares currently held by Kreos from&#13;    $241.0 to $7.50.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt"&gt;On June 5, 2019 and June 6, 2019, the Company entered into warrant exercise agreements with certain institutional investors of warrants to purchase the Company&amp;#8217;s ordinary shares,&#13;    pursuant to which, Kreos agreed to exercise in cash their November 2018 warrants at the existing exercise price of $7.50 per share. Under the exercise agreements, the Company also agreed to issue to Kreos new warrants to purchase up to 480,000 ordinary&#13;    shares at an exercise price of $7.50 per share and exercise period of five years.&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;br /&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt"&gt;On December 29, 2020, the Company repaid in full the remaining loan principal amount to Kreos including the end of loan payments, and by that discharged all of its obligations to&#13;    Kreos and as of December 31, 2020, the outstanding principal amount under the Kreos Loan Agreement was zero.&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt"&gt;The Company recorded interest expense in the amount of $907 thousand during the fiscal year ended December&amp;#160;31, 2020.&lt;/div&gt;</rwlk:DisclosureofTermLoansandWarrantstoPurchaseOrdinarySharesTextBlock>
    <rwlk:ProceedsFromStockTwo contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">8125000</rwlk:ProceedsFromStockTwo>
    <rwlk:ProceedsFromStockTwo contextRef="From2018-01-01to2018-12-31" unitRef="USD" xsi:nil="true" />
    <rwlk:ProceedsFromStockTwo contextRef="From2020-01-01to2020-12-31" unitRef="USD" xsi:nil="true" />
    <rwlk:ProceedsFromStockOne contextRef="Context_9ME_01_Jan_2017T00_00_00_TO_30_Sep_2017T00_00_00" unitRef="USD" decimals="-3">3684000</rwlk:ProceedsFromStockOne>
    <rwlk:ProceedsFromStockOne contextRef="From2018-01-01to2018-12-31" unitRef="USD" xsi:nil="true" />
    <rwlk:ProceedsFromStockOne contextRef="From2020-01-01to2020-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock contextRef="From2020-01-01to2020-12-31">&lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;The Company recognized&#13;non-cash share-based compensation expense in the consolidated statements of operations as follows (in thousands):&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;  &lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" border="0" align="right" id="zedd6cc7efe2d49be877f8a188016ed3a" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="10" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;Year Ended December 31,&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt; 2020&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;2019&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;2018&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Cost of revenues&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;8&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;13&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;16&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Research and development, net&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;136&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;204&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;435&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Sales and marketing, net&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;163&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;166&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;467&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;General and administrative&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;442&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;725&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;1,848&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Total&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;749&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;1,108&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;2,766&lt;/div&gt;&#13;        &lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock contextRef="From2020-01-01to2020-12-31">&lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 36pt"&gt;The following table summarizes information about warrants outstanding and exercisable as of December&amp;#160;31, 2020:&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" border="0" align="right" id="z10fa5c8f5fd64ea58708475ca56d3205" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif"&gt;Issuance date&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;Warrants&lt;br /&gt;&#13;            outstanding&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;Exercise price per warrant&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;Warrants outstanding and exercisable&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;Contractual&lt;br /&gt;&#13;            term&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;(number)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;(number)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;December 31, 2015 (1)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;4,771&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;7.500&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;4,771&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;See footnote (1)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 32%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;November 1, 2016 (2)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;97,496&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;118.750&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;97,496&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 32%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;November 1, 2021&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;December 28, 2016 (3)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;1,908&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;7.500&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;1,908&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;See footnote (1)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 32%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;November 20, 2018 (4)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;126,839&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;7.500&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;126,839&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 32%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;November 20, 2023&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;November 20, 2018 (5)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;106,680&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;9.375&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;106,680&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;November 15, 2023&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 32%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;February 25, 2019 (6)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;45,600&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;7.187&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;45,600&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 32%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;February 21, 2024&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;April 5, 2019 (7)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;408,457&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;5.140&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;408,457&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;October 7, 2024&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 32%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;April 5, 2019 (8)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;49,015&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;6.503&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;49,015&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 32%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;April 3, 2024&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;June 5, 2019 and June 6, 2019 (9)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;1,464,665&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;7.500&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;1,464,665&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;June 5, 2024&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 32%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;June 5, 2019 (10)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;87,880&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;9.375&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;87,880&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 32%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;June 5, 2024&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;June 12, 2019 (11)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;416,667&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;6.000&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;416,667&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;December 12, 2024&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 32%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;June 10, 2019 (12)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;50,000&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;7.500&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;50,000&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 32%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;June 10, 2024&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;February 10, 2020 (13)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;3,768,500&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;1.250&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;4,343,500&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;February 10, 2025&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 32%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;February 10, 2020 (14)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;336,000&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;1.5625&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;336,000&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 32%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;February 10, 2025&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;July 6, 2020 (15)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;2,469,139&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;1.76&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;2,469,139&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;July 2, 2025&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 32%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;July 6, 2020 (16)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;296,297&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;2.2781&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;296,297&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 32%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;July 2, 2025&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;December 3, 2020 (17)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;4,184,832&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;1.34&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;4,184,832&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;June 8, 2026&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 32%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;December 3, 2020 (18)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;334,787&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;1.7922&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;334,787&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 32%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;June 8, 2026&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;14,249,533&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;14,249,533&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt Times New Roman, Times, Serif; clear: both"&gt;&lt;br /&gt;&#13;  &lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" border="0" align="right" style="font: 10pt Times New Roman, Times, Serif; width: 100%; color: #000000; text-align: left"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="width: 5%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 4%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(1)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 91%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;Represents warrants for ordinary shares issuable upon an exercise price of $7.5 per share, which were granted on December 31, 2015 to Kreos Capital V (Expert) Fund Limited, or Kreos, in&#13;            connection with a loan made by Kreos to us and are currently exercisable (in whole or in part) until the earlier of (i) December 30, 2025 or (ii) immediately prior to the consummation of a merger, consolidation, or reorganization of us with or&#13;            into, or the sale or license of all or substantially all the assets or shares of us to, any other entity or person, other than a wholly-owned subsidiary of us, excluding any transaction in which the Company&amp;#8217;s shareholders prior to the&#13;            transaction will hold more than 50% of the voting and economic rights of the surviving entity after the transaction. None of these warrants had been exercised as of December 31, 2020.&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;&#13;  &lt;table cellspacing="0" cellpadding="0" border="0" align="right" id="ze5403d3ed0b34b878e19f68e7a78deb7" style="font: 10pt Times New Roman, Times, Serif; width: 100%; color: #000000; text-align: left"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; width: 5%; vertical-align: top"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 4%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(2)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 91%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;Represents warrants issued as part of the Company&amp;#8217;s follow-on offering in November 2016. At any time, the board of directors may reduce the exercise price of the warrants to any amount and for&#13;            any period of time it deems appropriate.&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; width: 5%; vertical-align: top"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 4%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(3)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 91%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;Represents common warrants that were issued as part of the $8.0 million drawdown under the Loan Agreement which occurred on December 28, 2016. See footnote 1 for exercisability terms.&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; width: 5%; vertical-align: top"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 4%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(4)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 91%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;Represents common warrants that were issued as part of the Company&amp;#8217;s follow-on offering in November 2018. As of September 30, 2019, warrants to purchase an aggregate 1,651,537 ordinary shares&#13;            had been exercised.&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" border="0" align="right" style="font: 10pt Times New Roman, Times, Serif; width: 100%; color: rgb(0, 0, 0); text-align: left; clear: both"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; width: 5%; vertical-align: top"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 4%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(5)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 91%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;Represents common warrants that were issued to the underwriters as compensation for their role in the Company&amp;#8217;s follow-on offering in November 2018.&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; width: 5%; vertical-align: top"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 4%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(6)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 91%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;Represents warrants that were issued to the exclusive placement agent as compensation for its role in the Company&amp;#8217;s follow-on offering in February 2019.&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; width: 5%; vertical-align: top"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 4%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(7)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 91%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;Represents warrants that were issued to certain institutional purchasers in a private placement in the Company&amp;#8217;s registered direct offering of ordinary shares in April 2019.&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; width: 5%; vertical-align: top"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 4%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(8)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 91%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;Represents warrants that were issued to the placement agent as compensation for its role in the Company&amp;#8217;s April 2019 registered direct offering.&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; width: 5%; vertical-align: top"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 4%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(9)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 91%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;Represents warrants that were issued to certain institutional investors in a warrant exercise agreement on June 5, 2019 and June 6, 2019, respectively.&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; width: 5%; vertical-align: top"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 4%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(10)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 91%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;Represents warrants that were issued to the placement agent as compensation for its role in the Company&amp;#8217;s June 2019 warrant exercise agreement and concurrent private placement of warrants.&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; width: 5%; vertical-align: top"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 4%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(11)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 91%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;Represents warrants that were issued to certain institutional investors in a warrant exercise agreement in June 2019.&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; width: 5%; vertical-align: top"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 4%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(12)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 91%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;Represents warrants that were issued to the placement agent as compensation for its role in the Company&amp;#8217;s June 2019 registered direct offering and concurrent private placement of warrants.&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; width: 5%; vertical-align: top"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 4%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(13)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 91%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;Represents warrants that were issued to certain institutional purchasers in a private placement in the Company&amp;#8217;s best efforts offering of ordinary shares in February 2020.&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; width: 5%; vertical-align: top"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 4%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(14)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 91%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;Represents warrants that were issued to the placement agent as compensation for its role in the Company&amp;#8217;s February 2020 best efforts offering.&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; width: 5%; vertical-align: top"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 4%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(15)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 91%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;Represents warrants that were issued to certain institutional purchasers in a private placement in our registered direct offering of ordinary shares in July 2020&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; width: 5%; vertical-align: top"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 4%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(16)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 91%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;Represents warrants that were issued to the placement agent as compensation for its role in the Company&amp;#8217;s July 2020 registered direct offering.&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; width: 5%; vertical-align: top"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 4%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(17)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 91%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;Represents warrants that were issued to certain institutional purchasers in a private placement in our private placement offering of ordinary shares in December 2020&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; width: 5%; vertical-align: top"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 4%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(18)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 91%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;Represents warrants that were issued to the placement agent as compensation for its role in the Company&amp;#8217;s December 2020 private placement.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2020-01-01to2020-12-31">&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;NOTE&amp;#160;14: - SUBSEQUENT EVENTS&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&#13;    &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&#13;    &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt"&gt;&#13;      &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&#13;        &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&#13;            &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&#13;              &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&#13;                &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Following December 31, 2020, a total of 9,372,954 outstanding warrants with exercise prices ranging from $1.25 to $1.79 were&#13;                  exercised, for total gross proceeds to us of approximately $13.2 million.&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2020-01-01to2020-12-31">&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif"&gt;NOTE&amp;#160;8: - &amp;#160; SHAREHOLDERS&amp;#8217; EQUITY&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zbce2f39981044abe95f83348d9a27c09" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"&gt;&lt;br /&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top"&gt;a.&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;Reverse share split:&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&#13;    &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;On&amp;#160;March&amp;#160;27, 2019, the&amp;#160;Company&amp;#8217;s shareholders approved (i) a reverse share split within a range of 1:8 to 1:32, to be effective at the ratio and on a date to be determined by&#13;      the Board of Directors, and (ii) amendments to the Company&amp;#8217;s Articles of Association authorizing an increase in the Company&amp;#8217;s authorized share capital (and corresponding authorized number of ordinary shares, proportionally adjusting such number for&#13;      the reverse share split) by up to NIS 17.5 million. Following the shareholder approval, an authorized committee of the Board of Directors of the Company approved a one-for-twenty-five reverse share split of the Company&amp;#8217;s ordinary shares, and the&#13;      Company filed the Third Amended and Restated Articles of Association of the Company with the Israeli Corporations Authority to effect the reverse share split and to increase the Company&amp;#8217;s authorized share capital after the effect of the reverse share&#13;      split. The reverse share split became effective on April 1, 2019. Additionally, effective at the same time, the total number of ordinary shares the Company is authorized to issue changed from 250,000,000 shares to 60,000,000 shares, the par value per&#13;      share of the ordinary shares changed to NIS 0.25 and the authorized share capital of the Company changed from NIS 2,500,000 to NIS 15,000,000. All share and per share data included in these consolidated financial statements, for periods before&#13;      December 31, 2019, give retroactive effect to the reverse stock split.&lt;/div&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;Upon the effectiveness of the reverse share split, every twenty-five shares were automatically combined and converted into one ordinary share. Appropriate adjustments were also made&#13;    to all outstanding derivative securities of the Company, including all outstanding equity awards and warrants.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;No fractional shares were issued in connection with the reverse share split. Instead, all fractional shares (including shares underlying outstanding equity awards and warrants) were&#13;    rounded down to the nearest whole number.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z23594874992e43fc97f02f13de087636" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"&gt;&lt;br /&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top"&gt;b.&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;Equity raise:&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z964929ec1f6f4ccb991d72651bfdec3f" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"&gt;&lt;br /&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top"&gt;1.&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;At-the-market offering program:&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;On May 10, 2016, the Company entered into an equity distribution agreement (the &amp;#8220;Equity Distribution Agreement&amp;#8221;) with Piper Jaffray &amp;#38; Co. (&amp;#8220;Piper Jaffray&amp;#8221;), as amended on May 9,&#13;    2019, pursuant to which it may offer and sell, from time to time, ordinary shares having an aggregate offering price of up to $25 million, through Piper Jaffray acting as its agent. Subject to the terms and conditions of the Equity Distribution&#13;    Agreement, Piper Jaffray will use its commercially reasonable efforts to sell on the Company&amp;#8217;s behalf all of the ordinary shares requested to be sold by the Company, consistent with its normal trading and sales practices. Piper Jaffray may also act as&#13;    principal in the sale of ordinary shares under the Equity Distribution Agreement. Sales may be made under the Company&amp;#8217;s shelf registration statement on Form S-3, which was declared effective by the&amp;#160;SEC on&amp;#160;May 9, 2016, or the Company&amp;#8217;s shelf&#13;    registration statement on Form S-3, which was declared effective by the SEC on May 23, 2019 (the &amp;#8220;Form S-3&amp;#8221;), in what may be deemed &amp;#8220;at-the-market&amp;#8221; equity offerings as defined in Rule 415 promulgated under the Securities Act of 1933, as amended (the&#13;    &amp;#8220;ATM Offering Program&amp;#8221;). Sales may be made directly on or through the NASDAQ Capital Market, the existing trading market for the Company&amp;#8217;s ordinary shares, to or through a market maker other than on an exchange or otherwise, in negotiated transactions&#13;    at market prices prevailing at the time of sale or at prices related to such prevailing market prices, and/or any other method permitted by law, including in privately negotiated transactions. Piper Jaffray is entitled to compensation at a fixed&#13;    commission rate of 3.0% of the gross sales price per share sold through it as agent under the Equity Distribution Agreement. Where Piper Jaffray acts as principal in the sale of ordinary shares under the Equity Distribution Agreement, such rate of&#13;    compensation will not apply, but in no event will the total compensation of Piper Jaffray, when combined with the reimbursement of Piper Jaffray for the out-of-pocket fees and disbursements of its legal counsel, exceed 8.0% of the gross proceeds&#13;    received from the sale of the ordinary shares. The Company is not required to sell any of its ordinary shares at any time.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&#13;    &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;From the inception of the ATM Offering Program in May 2016 until December 31, 2020, the Company had sold 302,092 ordinary shares under the ATM Offering Program for gross&#13;      proceeds of $15.7 million and net proceeds to the Company of $14.5 million (after commissions, fees, and expenses). Additionally, as of that date, the Company had paid Piper Jaffray compensation for the fixed commission rate of 3.0% in the aggregated&#13;      amount of $471 thousand and had incurred total expenses (including such commissions) of approximately $1.2 million in connection with the ATM Offering Program.&lt;/div&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z0e6420828f00419fb2d007983c5ac23b" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"&gt;&lt;br /&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top"&gt;2.&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;Follow-on offerings&amp;#160;&amp;#160;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;In November 2018, the Company entered into an underwriting agreement with H.C. Wainwright &amp;#38; Co., LLC (&amp;#8220;H.C. Wainwright&amp;#8221;), in connection with the Company&amp;#8217;s follow-on public&#13;    offering of 496,055 units, each consisting of one ordinary share and one common warrant to purchase one ordinary share with an exercise price of $7.5 per warrant. Each unit was sold to the public at a price of $7.50 per unit. On November 18, 2018, H.C.&#13;    Wainwright exercised in full its option to purchase 231,964 ordinary shares for $7.25 per share and/or common warrants to purchase up to an additional 231,964 ordinary shares for $0.25 per warrant.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&#13;    &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Additionally, the Company issued and sold 1,050,372 pre-funded units at a price to the public of $7.25 per unit. Each unit containing one pre-funded warrant with an exercise&#13;      price of $0.25 per share and one warrant to purchase one ordinary share with an exercise price of $7.50 per warrant. The total gross proceeds received from the November 2018 follow-on public offering, before deducting commissions, discounts, and&#13;      expenses, were $13.1 million (including proceeds from the exercise of 90,691 pre-funded warrants at the closing of the offering). As of December&amp;#160;31, 2018, additional pre-funded warrants to purchase an aggregate 562,466 ordinary shares had been&#13;      exercised, for additional proceeds of $140,617. During the year ended December 31, 2019 additional 288,000 pre-funded warrants and 296,087 warrants to purchase an aggregate 584,087 ordinary shares had been exercised, for additional proceeds of $1.5&#13;      million. As compensation for their role in the offering, the Company also issued to the Underwriters warrants to purchase up to 106,680 ordinary shares, which became immediately exercisable starting on November 20, 2018 until November 15, 2023 at&#13;      $9.375 per share.&lt;/div&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;In February 2019, the Company entered into an exclusive placement agent agreement with H.C. Wainwright, on a reasonable best-efforts basis in connection with a public offering of&#13;    760,000 ordinary shares at a price of $5.75 per share.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&#13;    &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;The total gross proceeds received from the February 2019 follow-on public offering, before deducting commissions, discounts, and expenses, were $4.37 million. The Company also&#13;      issued to H.C Wainwright and/or its designees warrants to purchase up to 45,600 ordinary shares, which are immediately exercisable starting on February 25, 2019 until February 21, 2024 at $7.1875 per share.&lt;/div&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;In April 2019, the Company entered into securities purchase agreements with certain institutional purchasers whereby the Company issued 816,914 ordinary shares at $5.2025 per&#13;    ordinary share and warrants to purchase up to 408,457 ordinary shares with an exercise price of $5.14 per share, exercisable from April 5, 2019 until October 7, 2024, in a private placement that took place concurrently with the Company&amp;#8217;s registered&#13;    direct offering of ordinary shares in April 2019. Additionally, the Company issued warrants to purchase up to 49,015 ordinary shares, with an exercise price of $6.503125 per share, exercisable from April 5, 2019 until April 3, 2024, to representatives&#13;    of H.C. Wainwright as compensation for its role as the placement agent in the Company&amp;#8217;s April 2019 registered direct offering and concurrent private placement of warrants.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;On June 5, 2019 and June 6, 2019, the Company entered into warrant exercise agreements with certain institutional investors whereby the Company issued warrants to purchase up to&#13;    1,464,665 ordinary shares with an exercise price of $7.50 per share, exercisable from June 5, 2019 or June 6, 2019 until June 5, 2024 or June 6, 2024, respectively. Additionally, the Company issued warrants to purchase up to 87,880 ordinary shares,&#13;    with an exercise price of $9.375 per share, exercisable from June 5, 2019 until June 5, 2024, to certain representatives of H.C. Wainwright as compensation for its role as the placement agent in the Company&amp;#8217;s June 2019 warrant exercise agreement and&#13;    concurrent private placement of warrants.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;On June 12, 2019, the Company entered into a purchase agreement with certain institutional investors for the issuance and sale of 833,334 ordinary shares, par value NIS 0.25 per&#13;    share&amp;#160;at $6.00 per ordinary share and warrants to purchase up to 416,667 ordinary shares with an exercise price of $6.00 per share, exercisable from June 12, 2019 until December 12, 2024, in a private placement that took place concurrently with the&#13;    Company&amp;#8217;s registered direct offering of ordinary shares in June 2019. Additionally, the Company issued warrants to purchase up to 50,000 ordinary shares, with an exercise price of $7.50 per share, exercisable from June 12, 2019 until June 10, 2024, to&#13;    certain representatives of H.C. Wainwright as compensation for its role as the placement agent in the Company&amp;#8217;s June 2019 registered direct offering and concurrent private placement of warrants.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&#13;    &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: left"&gt;On February 10, 2020, the Company closed a &amp;#8220;best efforts&amp;#8221; public offering whereby the Company issued an aggregate of 5,600,000 of common&#13;      units and pre-funded units at a public offering price of $1.25 per common unit and $1.249 per pre-funded unit. As part of the public offering, the Company entered into a securities purchase agreement with certain institutional purchasers. Each common&#13;      unit consisted of one ordinary share, par value NIS 0.25 per share, and one common warrant to purchase one ordinary share. Each of the 1,546,828 pre-funded unit consisted of one pre-funded warrant to purchase one ordinary share and one common&#13;      warrant. Additionally, the Company issued warrants to purchase up to 336,000 ordinary shares, with an exercise price of $1.5625 per share, to representatives of H.C. Wainwright as compensation for its role as the placement agent in the Company&amp;#8217;s&#13;      February 2020 offering.&amp;#160; During the three months ended March 31, 2020, all pre-funded warrants to purchase ordinary shares were exercised.&lt;/div&gt;&#13;    &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&#13;    &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;As of December 31, 2020, a total of 1,831,500 common warrants to purchase ordinary shares were exercised.&lt;/div&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;On July 6,2020, the Company entered into a purchase agreement with certain institutional investors for the issuance and sale of (i) 4,938,278 ordinary shares, par value NIS 0.25 per&#13;    share, at a price of $1.8225 per ordinary share and (ii) warrants to purchase up to 2,469,139 ordinary shares with an exercise price of $1.76 per share, exercisable from July 6, 2020 until January 6, 2026. Additionally, the Company issued warrants to&#13;    purchase up to 296,297 ordinary shares, with an exercise price of $2.2781 per share, exercisable from July 6, 2020 until July 2, 2025, to certain representatives of H.C. Wainwright as compensation for its role as the placement agent in its July 2020&#13;    registered direct offering.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;On December 3,2020, the Company entered into a purchase agreement with certain institutional investors for the issuance and sale of (i) 5,579,776 ordinary shares, par value NIS 0.25&#13;    per share, at a price of $1.4337 per ordinary share and (ii) warrants to purchase up to 4,184,832 ordinary shares with an exercise price of $1.34 per share, exercisable from December 8, 2020 until June 8, 2026. Additionally, the Company issued warrants&#13;    to purchase up to 334,787 ordinary shares, with an exercise price of $1.7922 per share, exercisable from December 8, 2020 until June 8, 2026, to certain representatives of H.C. Wainwright as compensation for its role as the placement agent in its&#13;    December 2020 registered direct offering.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;  &lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zf1a1ca111b0c4711a3ec7bf9ad55065d" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"&gt;&lt;br /&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top"&gt;3.&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;Investment agreement&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;On March 6, 2018, the Company entered into an investment agreement with Timwell Corporation Limited, a Hong Kong corporation (&amp;#8220;Timwell&amp;#8221;), as amended on May 15, 2018 (the &amp;#8220;Investment&#13;    Agreement&amp;#8221;), pursuant to which the Company agreed to issue to Timwell, in three different tranches, an aggregate of 640,000 ordinary shares in return for aggregate gross proceeds of $20 million. The closing of each tranche is subject to certain closing&#13;    conditions. The closing of the first tranche (the &amp;#8220;First Tranche Closing&amp;#8221;) took place on May 15, 2018, upon which Timwell received 160,000 ordinary shares for an aggregate purchase price of $5,000,000, and Timwell and the Company signed a registration&#13;    rights agreement in the form attached to the Investment Agreement. The net aggregate proceeds of the First Tranche Closing after deducting fees and other related expenses in the amount of approximately $705 thousands were approximately $4.3 million.&#13;    The remaining investment is to occur in two tranches, including $10 million for the issuance to Timwell of 320,000 ordinary shares (the &amp;#8220;Second Tranche&amp;#8221;) and $5 million for the issuance to Timwell of 160,000 ordinary shares (the &amp;#8220;Third Tranch&amp;#8221;). The&#13;    closing of the second and third tranches is subject to specified closing conditions, including, with respect to the second tranche, the signing of a license agreement and a supply agreement and the formation of the China JV (the &amp;#8220;China JV&amp;#8221;) based on&#13;    the JV Framework Agreement, and, with respect to the third tranche, the successful production of certain ReWalk products by the China JV. The second tranche closing was initially expected to occur by July 1, 2018 and the third tranche closing was&#13;    initially expected to occur by December 31, 2018 and no later than April 1, 2019.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;In late March 2020, Timwell notified the Company that it would not invest the second and third tranches under the Investment Agreement. In response, in early April 2020, the&#13;    Company&amp;#8217;s Board of Directors also removed Timwell&amp;#8217;s designee, who was appointed pursuant to the Investment Agreement, from the Board of Directors, due to this breach pursuant to the terms of the Investment Agreement. As the Company continues to view&#13;    China as a market with key opportunities for products designed for stroke patients, the Company continues to evaluate potential relationships with other groups to penetrate the Chinese market.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;In May 2018, the Company entered into a fee and release agreement with Canaccord Genuity LLC (&amp;#8220;Canaccord Genuity&amp;#8221;) requiring the Company to pay to Canaccord Genuity, in connection&#13;    with a settlement, in addition to certain cash amounts, (i) $125 thousand in ordinary shares of the Company after the First Tranche Closing of the Timwell transaction and (ii) $225 thousand in ordinary shares of the Company after the closing of the&#13;    Second Tranche of the Timwell transaction (or such lower amount if the Second Tranche Closing is less than $10.0 million). The price per share used for calculation of the number of ordinary shares issued by the Company to Canaccord Genuity is based on&#13;    the volume weighted average price of the Company&amp;#8217;s ordinary shares as reported on the Nasdaq Capital Market for the five consecutive trading days prior to the date of issuance. The Company is also obligated to pay $100 thousand in cash following the&#13;    closing of the Third Tranche of $5.0 million (or such lower amount if the Third Tranche Closing is less than $5.0 million). Following the First Tranche Closing on May 15, 2018, the Company issued 4,715 ordinary shares to Canaccord Genuity.&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="za59e12d1ab6b42a189bf8ea686629c55" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"&gt;&lt;br /&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top"&gt;c.&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;Share option plans:&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;On March&amp;#160;30, 2012, the Company&amp;#8217;s board of directors adopted the ReWalk Robotics Ltd. 2012 Equity Incentive Plan.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt; margin-left: 72pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;On August 19, 2014, the Company&amp;#8217;s board of directors adopted the ReWalk Robotics Ltd. 2014 Incentive Compensation Plan or the &amp;#8220;Plan&amp;#8221;. The Plan provides for the grant of stock&#13;    options, stock appreciation rights, restricted stock awards, restricted stock units, cash-based awards, other stock-based awards and dividend equivalents to the Company&amp;#8217;s and its affiliates&amp;#8217; respective employees, non-employee directors and consultants.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt; margin-left: 72pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;Starting in 2014, the Company&amp;#160;grants to directors and employees also Restricted Stock Units (&amp;#8220;RSUs&amp;#8217;&amp;#8217;) under this Plan. An RSU award is an agreement to issue shares of the company&amp;#8217;s&#13;    ordinary shares at the time the award is vested.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;As of December 31, 2020, and 2019, the Company had reserved 604,320 and 12,409 shares of ordinary shares, respectively, available for issuance to employees, directors, officers, and&#13;    non-employees of the Company.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt; margin-left: 36pt"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;The options generally vest over four years, with certain options granted to non-employee directors during the fiscal year ended December&amp;#160;31, 2019, vesting over&amp;#160;one&amp;#160;year.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt; margin-left: 72pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;Any option that is forfeited or canceled before expiration becomes available for future grants under the Plan.&lt;/div&gt;&#13;  &#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt; margin-left: 72pt"&gt;&amp;#160;&lt;br /&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&#13;    &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&#13;      &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;A summary of employee and non-employee&amp;#160;shares options activity during the fiscal year ended 2020 is as follows:&lt;/div&gt;&#13;    &lt;/div&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 72pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" border="0" align="right" id="z333a780dd513489ea483da9d96b10a52" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;Number&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;Average&lt;/div&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;exercise&lt;/div&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;price&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;Average&lt;/div&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;remaining&lt;/div&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;contractual&lt;/div&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;life (years)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;Aggregate&lt;/div&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;intrinsic&lt;/div&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;value (in&lt;/div&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;thousands)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 52%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Options outstanding at the beginning of the year&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;74,713&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;41.6&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;6.34&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;135&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 52%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Granted&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#8212;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#8212;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#8212;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#8212;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 52%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Exercised&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#8212;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#8212;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#8212;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#8212;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 52%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Forfeited&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(5,107&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;91.59&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#8212;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#8212;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 52%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 52%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Options outstanding at the end of the year&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;69,606&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;37.9&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;5.59&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#8212;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 52%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 52%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Options exercisable at the end of the year&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;52,997&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;43.76&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;4.94&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#8212;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 72pt; clear: both"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&#13;    &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&#13;      &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;A summary of employee and non-employee RSUs activity during the fiscal year ended 2020 is as follows:&lt;/div&gt;&#13;    &lt;/div&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" border="0" align="right" id="z08c2cc9952cf4a269ef65b9e027ffd67" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;Number of&lt;/div&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;shares underlying&lt;/div&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;outstanding&lt;/div&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;RSUs&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;Weighted-&lt;/div&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;average&lt;/div&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;grant date&lt;/div&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;fair value&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Unvested RSUs at the beginning of the year&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;62,378&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;44.61&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Granted&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;1,266,185&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;1.44&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Vested&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(63,111&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;7.83&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Forfeited&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(14,141&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;6.05&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Unvested RSUs at the end of the year&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;1,251,311&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;3.20&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; clear: both"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;The weighted average grant date fair values of options granted during the fiscal year ended December&amp;#160;31, 2019, 2018 were $2.98, $15.25, respectively. The weighted average grant date&#13;    fair values of RSUs granted during the fiscal year ended December&amp;#160;31, 2020, 2019 and 2018, were $1.44, $4.67and $26.75, respectively.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;The aggregate intrinsic value in the table above represents the total intrinsic value that would have been received by the option holders had all option holders, which hold options&#13;    with positive intrinsic value, exercised their options on the last date of the exercise period. During the years ended December&amp;#160;31, 2020 and December&amp;#160;31, 2019, no options were exercised. Total fair value of shares vested during the year ended&#13;    December&amp;#160;31, 2020, 2019 and 2018 were $676 thousand, $1,175 thousand, and $2,918 thousand, respectively. As of December&amp;#160;31, 2020, there were $2 million of total unrecognized compensation cost related to non-vested share-based compensation arrangements&#13;    granted under the 2014 Plan. This cost is expected to be recognized over a period of approximately 3.2 years.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 54pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;br /&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;The number of options and RSUs outstanding as of December&amp;#160;31, 2020 is set forth below, with options separated by range of exercise price:&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 54pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" border="0" align="right" id="z6f11344252224499ad65c066a0b989e8" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif"&gt;Range of exercise&amp;#160;price&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;Options and RSUs&lt;br /&gt;&#13;            Outstanding as of&lt;br /&gt;&#13;            December 31,&lt;br /&gt;&#13;            2020&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;Weighted&lt;/div&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;average&lt;/div&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;remaining&lt;/div&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;contractual&lt;/div&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;life (years) (1)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;Options Exercisable as of December 31,&lt;br /&gt;&#13;            2020&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;Weighted&lt;/div&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;average&lt;/div&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;remaining&lt;/div&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;contractual&lt;/div&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;life (years) (1)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 52%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;RSUs only&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;1,251,311&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#8212;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#8212;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#8212;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 52%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$5.37&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;12,425&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;8.24&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;5,435&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;8.24&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 52%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$20.42- $33.75&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;36,292&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;5.26&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;27,598&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;4.60&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 52%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$37.14-$38.75&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;9,992&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;2.99&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;9,992&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;2.99&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 52%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$50-$52.5&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;8,231&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;6.43&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;7,306&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;6.44&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 52%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$182.5-$524.25&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;2,666&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;4.84&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;2,666&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;4.84&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 52%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;1,320,917&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;5.59&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;52,997&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;4.94&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; clear: both"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" border="0" align="right" id="z0880807c2442494481d433b408f422c8" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 3.85%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(1)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 96.09%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;Calculation of weighted average remaining contractual term does not include the RSUs that were granted, which have an indefinite contractual term.&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; clear: both"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zf8331be665c64e619344e46cc4d93093" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"&gt;&lt;br /&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top"&gt;d.&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;Equity compensation issued to consultants:&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;The Company granted 6,680 fully vested RSUs during the fiscal year ended December&amp;#160;31, 2019 to non-employee consultants. As of December&amp;#160;31, 2020, there are no outstanding options or&#13;    RSUs held by non-employee consultants.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;  &lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zd31e7a8bb09f4dd380ed3659c480e191" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"&gt;&lt;br /&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top"&gt;e.&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;Share-based compensation expense for employees and non-employees:&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;&#13;    &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;The Company recognized non-cash share-based compensation expense in the consolidated statements of operations as follows (in thousands):&lt;/div&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;  &lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" border="0" align="right" id="zedd6cc7efe2d49be877f8a188016ed3a" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="10" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;Year Ended December 31,&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt; 2020&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;2019&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;2018&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Cost of revenues&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;8&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;13&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;16&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Research and development, net&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;136&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;204&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;435&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Sales and marketing, net&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;163&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;166&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;467&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;General and administrative&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;442&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;725&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;1,848&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;Total&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;749&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;1,108&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;2,766&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; clear: both"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;  &lt;/div&gt;&#13;  &amp;#160;&#13;  &lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zece8f1ea1f6d4bc0a3b21fc81312ccac" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"&gt;&lt;br /&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top"&gt;f.&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;Warrants to purchase ordinary shares:&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 36pt"&gt;The following table summarizes information about warrants outstanding and exercisable as of December&amp;#160;31, 2020:&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-indent: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" border="0" align="right" id="z10fa5c8f5fd64ea58708475ca56d3205" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif"&gt;Issuance date&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;Warrants&lt;br /&gt;&#13;            outstanding&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;Exercise price per warrant&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;Warrants outstanding and exercisable&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;Contractual&lt;br /&gt;&#13;            term&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;(number)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"&gt;&#13;          &lt;div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;(number)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;December 31, 2015 (1)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;4,771&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;7.500&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;4,771&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;See footnote (1)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 32%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;November 1, 2016 (2)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;97,496&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;118.750&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;97,496&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 32%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;November 1, 2021&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;December 28, 2016 (3)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;1,908&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;7.500&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;1,908&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;See footnote (1)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 32%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;November 20, 2018 (4)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;126,839&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;7.500&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;126,839&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 32%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;November 20, 2023&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;November 20, 2018 (5)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;106,680&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;9.375&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;106,680&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;November 15, 2023&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 32%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;February 25, 2019 (6)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;45,600&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;7.187&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;45,600&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 32%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;February 21, 2024&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;April 5, 2019 (7)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;408,457&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;5.140&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;408,457&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;October 7, 2024&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 32%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;April 5, 2019 (8)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;49,015&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;6.503&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;49,015&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 32%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;April 3, 2024&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;June 5, 2019 and June 6, 2019 (9)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;1,464,665&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;7.500&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;1,464,665&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;June 5, 2024&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 32%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;June 5, 2019 (10)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;87,880&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;9.375&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;87,880&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 32%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;June 5, 2024&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;June 12, 2019 (11)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;416,667&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;6.000&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;416,667&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;December 12, 2024&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 32%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;June 10, 2019 (12)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;50,000&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;7.500&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;50,000&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 32%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;June 10, 2024&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;February 10, 2020 (13)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;3,768,500&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;1.250&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;4,343,500&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;February 10, 2025&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 32%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;February 10, 2020 (14)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;336,000&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;1.5625&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;336,000&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 32%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;February 10, 2025&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;July 6, 2020 (15)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;2,469,139&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;$&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;1.76&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;2,469,139&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;July 2, 2025&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 32%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;July 6, 2020 (16)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;296,297&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;2.2781&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;296,297&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 32%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;July 2, 2025&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;December 3, 2020 (17)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;4,184,832&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;1.34&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;4,184,832&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;June 8, 2026&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 32%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;December 3, 2020 (18)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;334,787&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;1.7922&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;334,787&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 32%; padding-bottom: 2px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;June 8, 2026&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;14,249,533&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;14,249,533&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%; padding-bottom: 4px"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center"&gt;&amp;#160;&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt Times New Roman, Times, Serif; clear: both"&gt;&lt;br /&gt;&#13;  &lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" border="0" align="right" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 3.88%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(1)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 96.12%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;Represents warrants for ordinary shares issuable upon an exercise price of $7.5 per share, which were granted on December 31, 2015 to Kreos Capital V (Expert) Fund Limited, or Kreos, in&#13;            connection with a loan made by Kreos to us and are currently exercisable (in whole or in part) until the earlier of (i) December 30, 2025 or (ii) immediately prior to the consummation of a merger, consolidation, or reorganization of us with or&#13;            into, or the sale or license of all or substantially all the assets or shares of us to, any other entity or person, other than a wholly-owned subsidiary of us, excluding any transaction in which the Company&amp;#8217;s shareholders prior to the&#13;            transaction will hold more than 50% of the voting and economic rights of the surviving entity after the transaction. None of these warrants had been exercised as of December 31, 2020.&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; clear: both"&gt;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" border="0" align="right" id="ze5403d3ed0b34b878e19f68e7a78deb7" style="font: 10pt Times New Roman, Times, Serif; width: 100%; color: #000000; text-align: left"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; width: 5%; vertical-align: top"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 4%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(2)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 91%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;Represents warrants issued as part of the Company&amp;#8217;s follow-on offering in November 2016. At any time, the board of directors may reduce the exercise price of the warrants to any amount and for&#13;            any period of time it deems appropriate.&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; width: 5%; vertical-align: top"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 4%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(3)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 91%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;Represents common warrants that were issued as part of the $8.0 million drawdown under the Loan Agreement which occurred on December 28, 2016. See footnote 1 for exercisability terms.&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; width: 5%; vertical-align: top"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 4%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(4)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 91%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;Represents common warrants that were issued as part of the Company&amp;#8217;s follow-on offering in November 2018. As of September 30, 2019, warrants to purchase an aggregate 1,651,537 ordinary shares&#13;            had been exercised.&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" border="0" align="right" style="font: 10pt Times New Roman, Times, Serif; width: 100%; color: rgb(0, 0, 0); text-align: left; clear: both"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; width: 5%; vertical-align: top"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 4%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(5)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 91%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;Represents common warrants that were issued to the underwriters as compensation for their role in the Company&amp;#8217;s follow-on offering in November 2018.&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; width: 5%; vertical-align: top"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 4%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(6)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 91%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;Represents warrants that were issued to the exclusive placement agent as compensation for its role in the Company&amp;#8217;s follow-on offering in February 2019.&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; width: 5%; vertical-align: top"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 4%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(7)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 91%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;Represents warrants that were issued to certain institutional purchasers in a private placement in the Company&amp;#8217;s registered direct offering of ordinary shares in April 2019.&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; width: 5%; vertical-align: top"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 4%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(8)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 91%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;Represents warrants that were issued to the placement agent as compensation for its role in the Company&amp;#8217;s April 2019 registered direct offering.&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; width: 5%; vertical-align: top"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 4%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(9)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 91%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;Represents warrants that were issued to certain institutional investors in a warrant exercise agreement on June 5, 2019 and June 6, 2019, respectively.&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; width: 5%; vertical-align: top"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 4%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(10)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 91%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;Represents warrants that were issued to the placement agent as compensation for its role in the Company&amp;#8217;s June 2019 warrant exercise agreement and concurrent private placement of warrants.&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; width: 5%; vertical-align: top"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 4%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(11)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 91%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;Represents warrants that were issued to certain institutional investors in a warrant exercise agreement in June 2019.&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; width: 5%; vertical-align: top"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 4%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(12)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 91%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;Represents warrants that were issued to the placement agent as compensation for its role in the Company&amp;#8217;s June 2019 registered direct offering and concurrent private placement of warrants.&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; width: 5%; vertical-align: top"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 4%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(13)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 91%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;Represents warrants that were issued to certain institutional purchasers in a private placement in the Company&amp;#8217;s best efforts offering of ordinary shares in February 2020.&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; width: 5%; vertical-align: top"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 4%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(14)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 91%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;Represents warrants that were issued to the placement agent as compensation for its role in the Company&amp;#8217;s February 2020 best efforts offering.&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; width: 5%; vertical-align: top"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 4%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(15)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 91%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;Represents warrants that were issued to certain institutional purchasers in a private placement in our registered direct offering of ordinary shares in July 2020&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; width: 5%; vertical-align: top"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 4%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(16)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 91%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;Represents warrants that were issued to the placement agent as compensation for its role in the Company&amp;#8217;s July 2020 registered direct offering.&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; width: 5%; vertical-align: top"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 4%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(17)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 91%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;Represents warrants that were issued to certain institutional purchasers in a private placement in our private placement offering of ordinary shares in December 2020&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td colspan="1" style="font: 10pt Times New Roman, Times, Serif; width: 5%; vertical-align: top"&gt;&amp;#160;&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 4%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;(18)&lt;/div&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 91%; vertical-align: top"&gt;&#13;          &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"&gt;Represents warrants that were issued to the placement agent as compensation for its role in the Company&amp;#8217;s December 2020 private placement.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="From2020-01-01to2020-12-31">&lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;font style="font-weight: bold"&gt;NOTE&amp;#160;1:-&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;font style="font-weight: bold"&gt;GENERAL&lt;/font&gt;&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z73c0f9ba04994c84a372c43778daec8f" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"&gt;&lt;br /&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top"&gt;a.&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;ReWalk Robotics Ltd. (&amp;#8220;RRL&amp;#8221;, and together with its subsidiaries, the &amp;#8220;Company&amp;#8221;) was incorporated under the laws of the State of Israel on June&amp;#160;20, 2001 and commenced operations on the&amp;#160;same&amp;#160;date.&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 5.65pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zc22defa361944b118ba6d1e12f0f7460" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"&gt;&lt;br /&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top"&gt;b.&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;RRL has two wholly owned subsidiaries: (i)&amp;#160;ReWalk Robotics Inc. (&amp;#8220;RRI&amp;#8221;) incorporated under the laws of Delaware on February&amp;#160;15, 2012 and (ii)&amp;#160;ReWalk Robotics GMBH. (&amp;#8220;RRG&amp;#8221;) (formerly Argo Medical Technologies GmbH) incorporated under the laws&#13;            of Germany on January&amp;#160;14, 2013.&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;  &lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z33476b6ad2094d83a4499124edf1bbae" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"&gt;&lt;br /&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top"&gt;c.&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;The Company is designing, developing, and commercializing robotic&amp;#160;exoskeletons that allow individuals with mobility impairments or other medical conditions the ability to stand and walk once again. The Company has developed and is continuing&#13;            to commercialize the ReWalk, an exoskeleton designed for individuals with paraplegia that uses its patented tilt-sensor technology and an on-board computer and motion sensors to drive motorized legs that power movement. The ReWalk system&#13;            consists of a light wearable brace support suit which integrates motors at the joints, rechargeable batteries, an array of sensors and a computer-based control system to power knee and hip movement. Additionally, the Company developed and, in&#13;            June 2019, started to commercialize the ReStore following receipt of European Union CE mark and United States Food and Drug Administration (&amp;#8220;FDA&amp;#8221;). The ReStore is a powered, lightweight soft exo-suit intended for use in the rehabilitation of&#13;            individuals with lower limb disability due to stroke. The Company markets and sells its products directly to institutions and individuals and through third-party distributors. The Company sells its products directly primarily in Germany and the&#13;            United States, and primarily through distributors in other markets. In its direct markets, the Company has established relationships with rehabilitation centers and the spinal cord injury community, and in its indirect markets, the Company&amp;#8217;s&#13;            distributors maintain these relationships. RRI markets and sells products mainly in the United States. RRG sell the Company&amp;#8217;s products mainly in Germany and Europe.&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: -36pt; margin-left: 36pt"&gt; &lt;br /&gt;&#13;  &lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"&gt;During the second quarter of 2020, we have finalized two separate agreements to distribute additional product lines in the U.S. market.&#13;    The Company will be the exclusive distributor of the MediTouch Tutor movement biofeedback systems in the United States and will also have distribution rights for the MYOLYN MyoCycle FES cycles to U.S. rehabilitation clinics and personal sales through&#13;    the U.S. Department of Veterans Affairs (&amp;#8220;VA&amp;#8221;) hospitals. These new products will improve our product offering to clinics as well as patients within the VA as they both have similar clinician and patient profiles.&lt;/div&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 5.65pt"&gt;&amp;#160;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zd8d054c208944b989ab9ecba87bbe556" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"&gt;&lt;br /&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top"&gt;d.&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;The Company depends on one contract manufacturer, Sanmina. Reliance on this vendor makes the Company vulnerable to possible capacity constraints and reduced control over component availability, delivery schedules, manufacturing yields and&#13;            costs.&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;  &lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zb9e19c9d63534b00a0e37875220c4a2f" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"&gt;&lt;br /&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top"&gt;e.&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;The worldwide spread of COVID-19 has resulted in a global economic slowdown and is expected to continue to disrupt general business operations until the disease is contained. This has had a negative impact on the Company's sales and results&#13;            of operations during 2020, and the Company expects that it will continue to negatively affect its sales and results of operations, but the Company is currently unable to predict the scale and duration of that impact. As of the date of issuance&#13;            of these financial statements, the Company is not aware of any specific event or circumstance that would require an update of its accounting estimates or judgments or revision of the carrying value of its assets or liabilities. This&#13;            determination may change as new events occur and additional information is obtained. Actual results could differ from our estimates and judgments, and any such differences may be material to our financial statements.&lt;/div&gt;&#13;        &lt;/td&gt;&#13;      &lt;/tr&gt;&#13;    &#13;  &lt;/table&gt;&#13;  &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&amp;#160;&lt;br /&gt;&lt;/div&gt;&#13;  &lt;table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zc4e92d2381e3411498c1d949f78ba407" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"&gt;&#13;    &#13;      &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"&gt;&lt;br /&gt;&#13;        &lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top"&gt;f.&lt;/td&gt;&#13;        &lt;td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify"&gt;&#13;          &lt;div style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;            &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&#13;              &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;For the full year ended December 31 ,2020 the Company incurred a consolidated net loss of $13 million and has an accumulated&#13;                deficit in the total amount of $181.4 million. The Company&amp;#8217;s negative operating cash flow for the full year ended December 31, 2020 was $12.6 million. Our cash and cash equivalent on December 31, 2020 totaled $20.3 million and in subsequent&#13;                warrants exercise transactions the Company received a total of additional $13.2 million in the beginning of 2021. The Company has sufficient funds to support its operation for more than 12 months following the approval of its consolidated&#13;                financial statements for the fiscal year ended December 31, 2020.&lt;/div&gt;&#13;            &lt;/div&gt;&#13;            &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;            &lt;/div&gt;&#13;            &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;&#13;              &lt;div style="font: 10pt/1.25 Times New Roman, Times, Serif"&gt;The Company expect to incur future net losses and our transition to profitability is dependent upon, among other things, the successful development and commercialization of the Company&amp;#8217;s products and product candidates, the achievement of a level of revenues adequate to support&#13;                  the cost structure.&amp;#160;&amp;#160;Until the Company achieve profitability or generate positive cash flows, it will continue to need to raise additional cash. The Company intend to fund future operations through cash on hand, additional private and/or&#13;                  public offerings of debt or equity securities, cash exercises of outstanding warrants or a combination of the foregoing. In addition, the Company may seek additional capital through arrangements with strategic partners or from other&#13;                  sources and will continue to address its cost structure. Notwithstanding, there can be no assurance that the Company will be able to raise additional funds or achieve or sustain profitability or positive cash flows from operations.&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <link:footnoteLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="#Foot-00-0" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-1" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-2" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-3" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-4" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-5" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-6" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-7" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-8" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-9" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-10" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-11" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-12" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-13" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-14" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-15" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-16" xlink:label="Foot-00_loc" />
      <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Foot-00_loc" xlink:to="Footnote-05" order="1" />
      <link:loc xlink:type="locator" xlink:href="#Foot-01-0" xlink:label="Foot-01_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-01-1" xlink:label="Foot-01_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-01-2" xlink:label="Foot-01_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-01-3" xlink:label="Foot-01_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-01-4" xlink:label="Foot-01_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-01-5" xlink:label="Foot-01_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-01-6" xlink:label="Foot-01_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-01-7" xlink:label="Foot-01_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-01-8" xlink:label="Foot-01_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-01-9" xlink:label="Foot-01_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-01-10" xlink:label="Foot-01_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-01-11" xlink:label="Foot-01_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-01-12" xlink:label="Foot-01_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-01-13" xlink:label="Foot-01_loc" />
      <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Foot-01_loc" xlink:to="Footnote-06" order="1" />
      <link:loc xlink:type="locator" xlink:href="#Foot-02-0" xlink:label="Foot-02_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-02-1" xlink:label="Foot-02_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-02-2" xlink:label="Foot-02_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-02-3" xlink:label="Foot-02_loc" />
      <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Foot-02_loc" xlink:to="Footnote-09" order="1" />
      <link:loc xlink:type="locator" xlink:href="#Foot-03-0" xlink:label="Foot-03_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-03-1" xlink:label="Foot-03_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-03-2" xlink:label="Foot-03_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-03-3" xlink:label="Foot-03_loc" />
      <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Foot-03_loc" xlink:to="Footnote-10" order="1" />
      <link:loc xlink:type="locator" xlink:href="#Foot-04-0" xlink:label="Foot-04_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-04-1" xlink:label="Foot-04_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-04-2" xlink:label="Foot-04_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-04-3" xlink:label="Foot-04_loc" />
      <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Foot-04_loc" xlink:to="Footnote-08" order="1" />
      <link:loc xlink:type="locator" xlink:href="#Foot-05-0" xlink:label="Foot-05_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-05-1" xlink:label="Foot-05_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-05-2" xlink:label="Foot-05_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-05-3" xlink:label="Foot-05_loc" />
      <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Foot-05_loc" xlink:to="Footnote-11" order="1" />
      <link:loc xlink:type="locator" xlink:href="#Foot-06-0" xlink:label="Foot-06_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-06-1" xlink:label="Foot-06_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-06-2" xlink:label="Foot-06_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-06-3" xlink:label="Foot-06_loc" />
      <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Foot-06_loc" xlink:to="Footnote-12" order="1" />
      <link:loc xlink:type="locator" xlink:href="#Foot-07-0" xlink:label="Foot-07_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-07-1" xlink:label="Foot-07_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-07-2" xlink:label="Foot-07_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-07-3" xlink:label="Foot-07_loc" />
      <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Foot-07_loc" xlink:to="Footnote-13" order="1" />
      <link:loc xlink:type="locator" xlink:href="#Foot-08-0" xlink:label="Foot-08_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-08-1" xlink:label="Foot-08_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-08-2" xlink:label="Foot-08_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-08-3" xlink:label="Foot-08_loc" />
      <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Foot-08_loc" xlink:to="Footnote-14" order="1" />
      <link:loc xlink:type="locator" xlink:href="#Foot-09-0" xlink:label="Foot-09_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-09-1" xlink:label="Foot-09_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-09-2" xlink:label="Foot-09_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-09-3" xlink:label="Foot-09_loc" />
      <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Foot-09_loc" xlink:to="Footnote-15" order="1" />
      <link:loc xlink:type="locator" xlink:href="#Foot-10-0" xlink:label="Foot-10_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-10-1" xlink:label="Foot-10_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-10-2" xlink:label="Foot-10_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-10-3" xlink:label="Foot-10_loc" />
      <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Foot-10_loc" xlink:to="Footnote-16" order="1" />
      <link:loc xlink:type="locator" xlink:href="#Foot-11-0" xlink:label="Foot-11_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-11-1" xlink:label="Foot-11_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-11-2" xlink:label="Foot-11_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-11-3" xlink:label="Foot-11_loc" />
      <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Foot-11_loc" xlink:to="Footnote-17" order="1" />
      <link:loc xlink:type="locator" xlink:href="#Foot-12-0" xlink:label="Foot-12_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-12-1" xlink:label="Foot-12_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-12-2" xlink:label="Foot-12_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-12-3" xlink:label="Foot-12_loc" />
      <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Foot-12_loc" xlink:to="Footnote-18" order="1" />
      <link:loc xlink:type="locator" xlink:href="#Foot-13-0" xlink:label="Foot-13_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-13-1" xlink:label="Foot-13_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-13-2" xlink:label="Foot-13_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-13-3" xlink:label="Foot-13_loc" />
      <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Foot-13_loc" xlink:to="Footnote-19" order="1" />
      <link:loc xlink:type="locator" xlink:href="#Foot-14-0" xlink:label="Foot-14_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-14-1" xlink:label="Foot-14_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-14-2" xlink:label="Foot-14_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-14-3" xlink:label="Foot-14_loc" />
      <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Foot-14_loc" xlink:to="Footnote-20" order="1" />
      <link:loc xlink:type="locator" xlink:href="#Foot-15-0" xlink:label="Foot-15_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-15-1" xlink:label="Foot-15_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-15-2" xlink:label="Foot-15_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-15-3" xlink:label="Foot-15_loc" />
      <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Foot-15_loc" xlink:to="Footnote-21" order="1" />
      <link:loc xlink:type="locator" xlink:href="#Foot-16-0" xlink:label="Foot-16_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-16-1" xlink:label="Foot-16_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-16-2" xlink:label="Foot-16_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-16-3" xlink:label="Foot-16_loc" />
      <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Foot-16_loc" xlink:to="Footnote-22" order="1" />
      <link:loc xlink:type="locator" xlink:href="#Foot-17-0" xlink:label="Foot-17_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-17-1" xlink:label="Foot-17_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-17-2" xlink:label="Foot-17_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-17-3" xlink:label="Foot-17_loc" />
      <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Foot-17_loc" xlink:to="Footnote-23" order="1" />
      <link:loc xlink:type="locator" xlink:href="#Foot-18-0" xlink:label="Foot-18_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-18-1" xlink:label="Foot-18_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-18-2" xlink:label="Foot-18_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-18-3" xlink:label="Foot-18_loc" />
      <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Foot-18_loc" xlink:to="Footnote-24" order="1" />
      <link:loc xlink:type="locator" xlink:href="#Foot-19-0" xlink:label="Foot-19_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-19-1" xlink:label="Foot-19_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-19-2" xlink:label="Foot-19_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-19-3" xlink:label="Foot-19_loc" />
      <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Foot-19_loc" xlink:to="Footnote-25" order="1" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-0" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-1" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-2" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-3" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-4" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-5" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-6" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-7" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-8" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-9" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-10" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-11" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-12" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-13" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-14" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-15" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-16" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-17" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-18" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-19" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-20" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-21" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-22" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-23" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-24" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-25" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-26" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-27" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-28" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-29" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-30" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-31" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-32" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-33" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-34" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-35" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-36" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-37" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-38" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-39" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-40" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-41" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-42" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-43" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-44" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-45" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-46" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-47" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-48" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-49" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-50" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-51" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-52" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-53" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-54" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-55" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-56" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-57" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-58" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-59" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-60" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-61" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-62" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-63" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-64" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-65" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-66" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-67" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-68" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-69" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-70" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-71" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-72" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-73" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-74" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-75" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-76" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-77" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-78" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-79" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-80" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-81" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-82" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-83" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-84" xlink:label="Foot-20_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-20-85" xlink:label="Foot-20_loc" />
      <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Foot-20_loc" xlink:to="Footnote-02" order="1" />
      <link:loc xlink:type="locator" xlink:href="#Foot-21-0" xlink:label="Foot-21_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-21-1" xlink:label="Foot-21_loc" />
      <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Foot-21_loc" xlink:to="Footnote-04" order="1" />
      <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Foot-21_loc" xlink:to="Footnote-07" order="2" />
      <link:loc xlink:type="locator" xlink:href="#Foot-22-0" xlink:label="Foot-22_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-22-1" xlink:label="Foot-22_loc" />
      <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Foot-22_loc" xlink:to="Footnote-26" order="1" />
      <link:loc xlink:type="locator" xlink:href="#Foot-23-0" xlink:label="Foot-23_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-23-1" xlink:label="Foot-23_loc" />
      <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Foot-23_loc" xlink:to="Footnote-04" order="1" />
      <link:loc xlink:type="locator" xlink:href="#Foot-24-0" xlink:label="Foot-24_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-24-1" xlink:label="Foot-24_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-24-2" xlink:label="Foot-24_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-24-3" xlink:label="Foot-24_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-24-4" xlink:label="Foot-24_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-24-5" xlink:label="Foot-24_loc" />
      <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Foot-24_loc" xlink:to="Footnote-03" order="1" />
      <link:loc xlink:type="locator" xlink:href="#Foot-25-0" xlink:label="Foot-25_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-25-1" xlink:label="Foot-25_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-25-2" xlink:label="Foot-25_loc" />
      <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Foot-25_loc" xlink:to="Footnote-02" order="1" />
      <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Foot-25_loc" xlink:to="Footnote-03" order="2" />
      <link:loc xlink:type="locator" xlink:href="#Foot-26-0" xlink:label="Foot-26_loc" />
      <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Foot-26_loc" xlink:to="Footnote-01" order="1" />
      <link:loc xlink:type="locator" xlink:href="#Foot-27-0" xlink:label="Foot-27_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-27-1" xlink:label="Foot-27_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-27-2" xlink:label="Foot-27_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-27-3" xlink:label="Foot-27_loc" />
      <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Foot-27_loc" xlink:to="Footnote-27" order="1" />
      <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-01" xml:lang="en-US">Represents an amount lower than $1.</link:footnote>
      <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-02" xml:lang="en-US">See note 8b.</link:footnote>
      <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-03" xml:lang="en-US">See note 6.</link:footnote>
      <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-04" xml:lang="en-US">Balance presented net of unrecognized revenues that were not yet collected.</link:footnote>
      <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-05" xml:lang="en-US">Less than 10%</link:footnote>
      <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-06" xml:lang="en-US">Calculation of weighted average remaining contractual term does not include the RSUs that were granted, which have an indefinite contractual term.</link:footnote>
      <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-07" xml:lang="en-US">$330 thousand of December 31, 2019 deferred revenues balance were recognized as revenues during the year ended December 31, 2020.</link:footnote>
      <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-08" xml:lang="en-US">Represents warrants for ordinary shares issuable upon an exercise price of $7.5 per share, which were granted on December 31, 2015 to Kreos Capital V (Expert) Fund Limited, or Kreos, in connection with a loan made by Kreos to us and are currently exercisable (in whole or in part) until the earlier of (i) December 30, 2025 or (ii) immediately prior to the consummation of a merger, consolidation, or reorganization of us with or into, or the sale or license of all or substantially all the assets or shares of us to, any other entity or person, other than a wholly-owned subsidiary of us, excluding any transaction in which the Company's shareholders prior to the transaction will hold more than 50% of the voting and economic rights of the surviving entity after the transaction. None of these warrants had been exercised as of December 31, 2020.</link:footnote>
      <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-09" xml:lang="en-US">Represents warrants issued as part of the Company's follow-on offering in November 2016. At any time, the board of directors may reduce the exercise price of the warrants to any amount and for any period of time it deems appropriate.</link:footnote>
      <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-10" xml:lang="en-US">Represents common warrants that were issued as part of the $8.0 million drawdown under the Loan Agreement which occurred on December 28, 2016. See footnote 1 for exercisability terms.</link:footnote>
      <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-11" xml:lang="en-US">Represents common warrants that were issued as part of the Company's follow-on offering in November 2018. As of September 30, 2019, warrants to purchase an aggregate 1,651,537 ordinary shares had been exercised.</link:footnote>
      <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-12" xml:lang="en-US">Represents common warrants that were issued to the underwriters as compensation for their role in the Company's follow-on offering in November 2018.</link:footnote>
      <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-13" xml:lang="en-US">Represents warrants that were issued to the exclusive placement agent as compensation for its role in the Company's follow-on offering in February 2019.</link:footnote>
      <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-14" xml:lang="en-US">Represents warrants that were issued to certain institutional purchasers in a private placement in the Company's registered direct offering of ordinary shares in April 2019.</link:footnote>
      <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-15" xml:lang="en-US">Represents warrants that were issued to the placement agent as compensation for its role in the Company's April 2019 registered direct offering.</link:footnote>
      <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-16" xml:lang="en-US">Represents warrants that were issued to certain institutional investors in a warrant exercise agreement on June 5, 2019 and June 6, 2019, respectively.</link:footnote>
      <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-17" xml:lang="en-US">Represents warrants that were issued to the placement agent as compensation for its role in the Company's June 2019 warrant exercise agreement and concurrent private placement of warrants.</link:footnote>
      <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-18" xml:lang="en-US">Represents warrants that were issued to certain institutional investors in a warrant exercise agreement in June 2019.</link:footnote>
      <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-19" xml:lang="en-US">Represents warrants that were issued to the placement agent as compensation for its role in the Company's June 2019 registered direct offering and concurrent private placement of warrants.</link:footnote>
      <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-20" xml:lang="en-US">Represents warrants that were issued to certain institutional purchasers in a private placement in the Company's best efforts offering of ordinary shares in February 2020.</link:footnote>
      <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-21" xml:lang="en-US">Represents warrants that were issued to the placement agent as compensation for its role in the Company's February 2020 best efforts offering.</link:footnote>
      <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-22" xml:lang="en-US">Represents warrants that were issued to certain institutional purchasers in a private placement in our registered direct offering of ordinary shares in July 2020</link:footnote>
      <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-23" xml:lang="en-US">Represents warrants that were issued to the placement agent as compensation for its role in the Company's July 2020 registered direct offering.</link:footnote>
      <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-24" xml:lang="en-US">Represents warrants that were issued to certain institutional purchasers in a private placement in our private placement offering of ordinary shares in December 2020</link:footnote>
      <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-25" xml:lang="en-US">Represents warrants that were issued to the placement agent as compensation for its role in the Company's December 2020 private placement.</link:footnote>
      <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-26" xml:lang="en-US">See note 10.</link:footnote>
      <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-27" xml:lang="en-US">See note 8f.</link:footnote>
    </link:footnoteLink>
</xbrli:xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>11
<FILENAME>rwlk-20201231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoXBRL; Version: 5.6b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Source; Value: RWLK 1220 10K.xfr; Date: 2021%2D02%2D18T13:24:26Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: /apZo7xRiXgOn8uHanFcWa6EibPty5t7SZkxu2h9ffnaTyomDtE30SefxRg2gbkG -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:us-roles="http://fasb.org/us-roles/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:srt-types="http://fasb.org/srt-types/2020-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:us-types="http://fasb.org/us-types/2020-01-31" xmlns:rwlk="http://rewalk.com/20201231" elementFormDefault="qualified" targetNamespace="http://rewalk.com/20201231">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://rewalk.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
	  <link:definition>00000001 - Document - Document and Entity Information</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://rewalk.com/role/ConsolidatedBalanceSheets" id="ConsolidatedBalanceSheets">
	  <link:definition>00000002 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://rewalk.com/role/ConsolidatedBalanceSheetsParenthetical" id="ConsolidatedBalanceSheetsParenthetical">
	  <link:definition>00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://rewalk.com/role/ConsolidatedStatementsOfOperations" id="ConsolidatedStatementsOfOperations">
	  <link:definition>00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://rewalk.com/role/StatementsOfChangesInShareholdersEquity" id="StatementsOfChangesInShareholdersEquity">
	  <link:definition>00000005 - Statement - STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://rewalk.com/role/StatementsOfChangesInShareholdersEquityParenthetical" id="StatementsOfChangesInShareholdersEquityParenthetical">
	  <link:definition>00000006 - Statement - STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Parenthetical)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://rewalk.com/role/ConsolidatedStatementsOfCashFlows" id="ConsolidatedStatementsOfCashFlows">
	  <link:definition>00000007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://rewalk.com/role/ConsolidatedStatementsOfCashFlowsParenthetical" id="ConsolidatedStatementsOfCashFlowsParenthetical">
	  <link:definition>00000008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://rewalk.com/role/General" id="General">
	  <link:definition>00000009 - Disclosure - GENERAL</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://rewalk.com/role/SignificantAccountingPolicies" id="SignificantAccountingPolicies">
	  <link:definition>00000010 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://rewalk.com/role/PrepaidExpensesAndOtherCurrentAssets" id="PrepaidExpensesAndOtherCurrentAssets">
	  <link:definition>00000011 - Disclosure - PREPAID EXPENSES AND OTHER CURRENT ASSETS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://rewalk.com/role/Inventories" id="Inventories">
	  <link:definition>00000012 - Disclosure - INVENTORIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://rewalk.com/role/PropertyAndEquipmentNet" id="PropertyAndEquipmentNet">
	  <link:definition>00000013 - Disclosure - PROPERTY AND EQUIPMENT, NET</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://rewalk.com/role/LoanAgreementWithKreosAndRelatedWarrantToPurchaseOrdinaryShares" id="LoanAgreementWithKreosAndRelatedWarrantToPurchaseOrdinaryShares">
	  <link:definition>00000014 - Disclosure - LOAN AGREEMENT WITH KREOS AND RELATED WARRANT TO PURCHASE ORDINARY SHARES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://rewalk.com/role/CommitmentsAndContingentLiabilities" id="CommitmentsAndContingentLiabilities">
	  <link:definition>00000015 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://rewalk.com/role/ShareholdersEquity" id="ShareholdersEquity">
	  <link:definition>00000016 - Disclosure - SHAREHOLDERS' EQUITY</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://rewalk.com/role/ResearchCollaborationAgreementAndLicenseAgreement" id="ResearchCollaborationAgreementAndLicenseAgreement">
	  <link:definition>00000017 - Disclosure - RESEARCH COLLABORATION AGREEMENT AND LICENSE AGREEMENT</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://rewalk.com/role/PaycheckProtectionProgramLoan" id="PaycheckProtectionProgramLoan">
	  <link:definition>00000018 - Disclosure - PAYCHECK PROTECTION PROGRAM LOAN</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://rewalk.com/role/IncomeTaxes" id="IncomeTaxes">
	  <link:definition>00000019 - Disclosure - INCOME TAXES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://rewalk.com/role/FinancialExpensesNet" id="FinancialExpensesNet">
	  <link:definition>00000020 - Disclosure - FINANCIAL EXPENSES, NET</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://rewalk.com/role/GeographicInformationAndMajorCustomerAndProductData" id="GeographicInformationAndMajorCustomerAndProductData">
	  <link:definition>00000021 - Disclosure - GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://rewalk.com/role/SubsequentEvents" id="SubsequentEvents">
	  <link:definition>00000022 - Disclosure - SUBSEQUENT EVENTS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://rewalk.com/role/SignificantAccountingPoliciesPolicies" id="SignificantAccountingPoliciesPolicies">
	  <link:definition>00000023 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://rewalk.com/role/SignificantAccountingPoliciesTables" id="SignificantAccountingPoliciesTables">
	  <link:definition>00000024 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://rewalk.com/role/PrepaidExpensesAndOtherCurrentAssetsTables" id="PrepaidExpensesAndOtherCurrentAssetsTables">
	  <link:definition>00000025 - Disclosure - PREPAID EXPENSES AND OTHER CURRENT ASSETS (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://rewalk.com/role/InventoriesTables" id="InventoriesTables">
	  <link:definition>00000026 - Disclosure - INVENTORIES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://rewalk.com/role/PropertyAndEquipmentNetTables" id="PropertyAndEquipmentNetTables">
	  <link:definition>00000027 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://rewalk.com/role/CommitmentsAndContingentLiabilitiesTables" id="CommitmentsAndContingentLiabilitiesTables">
	  <link:definition>00000028 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://rewalk.com/role/ShareholdersEquityTables" id="ShareholdersEquityTables">
	  <link:definition>00000029 - Disclosure - SHAREHOLDERS' EQUITY (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://rewalk.com/role/IncomeTaxesTables" id="IncomeTaxesTables">
	  <link:definition>00000030 - Disclosure - INCOME TAXES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://rewalk.com/role/FinancialExpensesNetTables" id="FinancialExpensesNetTables">
	  <link:definition>00000031 - Disclosure - FINANCIAL EXPENSES, NET (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataTables" id="GeographicInformationAndMajorCustomerAndProductDataTables">
	  <link:definition>00000032 - Disclosure - GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://rewalk.com/role/GeneralDetails" id="GeneralDetails">
	  <link:definition>00000033 - Disclosure - GENERAL (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://rewalk.com/role/SignificantAccountingPoliciesDetails" id="SignificantAccountingPoliciesDetails">
	  <link:definition>00000034 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://rewalk.com/role/SignificantAccountingPoliciesDetails1" id="SignificantAccountingPoliciesDetails1">
	  <link:definition>00000035 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details 1)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://rewalk.com/role/SignificantAccountingPoliciesDetails2" id="SignificantAccountingPoliciesDetails2">
	  <link:definition>00000036 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details 2)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://rewalk.com/role/SignificantAccountingPoliciesDetails3" id="SignificantAccountingPoliciesDetails3">
	  <link:definition>00000037 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details 3)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://rewalk.com/role/SignificantAccountingPoliciesDetails4" id="SignificantAccountingPoliciesDetails4">
	  <link:definition>00000038 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details 4)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://rewalk.com/role/SignificantAccountingPoliciesDetails5" id="SignificantAccountingPoliciesDetails5">
	  <link:definition>00000039 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details 5)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://rewalk.com/role/SignificantAccountingPoliciesDetails6" id="SignificantAccountingPoliciesDetails6">
	  <link:definition>00000040 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details 6)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://rewalk.com/role/SignificantAccountingPoliciesDetails7" id="SignificantAccountingPoliciesDetails7">
	  <link:definition>00000041 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details 7)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://rewalk.com/role/SignificantAccountingPoliciesDetailsTextual" id="SignificantAccountingPoliciesDetailsTextual">
	  <link:definition>00000042 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details Textual)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://rewalk.com/role/PrepaidExpensesAndOtherCurrentAssetsDetails" id="PrepaidExpensesAndOtherCurrentAssetsDetails">
	  <link:definition>00000043 - Disclosure - PREPAID EXPENSES AND OTHER CURRENT ASSETS (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://rewalk.com/role/InventoriesDetails" id="InventoriesDetails">
	  <link:definition>00000044 - Disclosure - INVENTORIES (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://rewalk.com/role/PropertyAndEquipmentNetDetails" id="PropertyAndEquipmentNetDetails">
	  <link:definition>00000045 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://rewalk.com/role/PropertyAndEquipmentNetDetailsTextual" id="PropertyAndEquipmentNetDetailsTextual">
	  <link:definition>00000046 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details Textual)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://rewalk.com/role/LoanAgreementWithKreosAndRelatedWarrantToPurchaseOrdinarySharesDetails" id="LoanAgreementWithKreosAndRelatedWarrantToPurchaseOrdinarySharesDetails">
	  <link:definition>00000047 - Disclosure - LOAN AGREEMENT WITH KREOS AND RELATED WARRANT TO PURCHASE ORDINARY SHARES (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://rewalk.com/role/CommitmentsAndContingentLiabilitiesDetails" id="CommitmentsAndContingentLiabilitiesDetails">
	  <link:definition>00000048 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://rewalk.com/role/CommitmentsAndContingentLiabilitiesDetailsTextual" id="CommitmentsAndContingentLiabilitiesDetailsTextual">
	  <link:definition>00000049 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES (Details Textual)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://rewalk.com/role/ShareholdersEquityDetails" id="ShareholdersEquityDetails">
	  <link:definition>00000050 - Disclosure - SHAREHOLDERS' EQUITY (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://rewalk.com/role/ShareholdersEquityDetails1" id="ShareholdersEquityDetails1">
	  <link:definition>00000051 - Disclosure - SHAREHOLDERS' EQUITY (Details 1)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://rewalk.com/role/ShareholdersEquityDetails2" id="ShareholdersEquityDetails2">
	  <link:definition>00000052 - Disclosure - SHAREHOLDERS' EQUITY (Details 2)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://rewalk.com/role/ShareholdersEquityDetails3" id="ShareholdersEquityDetails3">
	  <link:definition>00000053 - Disclosure - SHAREHOLDERS' EQUITY (Details 3)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://rewalk.com/role/ShareholdersEquityDetails4" id="ShareholdersEquityDetails4">
	  <link:definition>00000054 - Disclosure - SHAREHOLDERS' EQUITY (Details 4)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://rewalk.com/role/ShareholdersEquityDetailsTextual" id="ShareholdersEquityDetailsTextual">
	  <link:definition>00000055 - Disclosure - SHAREHOLDERS' EQUITY (Details Textual)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://rewalk.com/role/ResearchCollaborationAgreementAndLicenseAgreementDetails" id="ResearchCollaborationAgreementAndLicenseAgreementDetails">
	  <link:definition>00000056 - Disclosure - RESEARCH COLLABORATION AGREEMENT AND LICENSE AGREEMENT (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://rewalk.com/role/PaycheckProtectionProgramLoanDetailsTextual" id="PaycheckProtectionProgramLoanDetailsTextual">
	  <link:definition>00000057 - Disclosure - PAYCHECK PROTECTION PROGRAM LOAN (Details Textual)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://rewalk.com/role/IncomeTaxesDetails" id="IncomeTaxesDetails">
	  <link:definition>00000058 - Disclosure - INCOME TAXES (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://rewalk.com/role/IncomeTaxesDetails1" id="IncomeTaxesDetails1">
	  <link:definition>00000059 - Disclosure - INCOME TAXES (Details 1)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://rewalk.com/role/IncomeTaxesDetails2" id="IncomeTaxesDetails2">
	  <link:definition>00000060 - Disclosure - INCOME TAXES (Details 2)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://rewalk.com/role/IncomeTaxesDetails3" id="IncomeTaxesDetails3">
	  <link:definition>00000061 - Disclosure - INCOME TAXES (Details 3)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://rewalk.com/role/IncomeTaxesDetails4" id="IncomeTaxesDetails4">
	  <link:definition>00000062 - Disclosure - INCOME TAXES (Details 4)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://rewalk.com/role/IncomeTaxesDetailsTextual" id="IncomeTaxesDetailsTextual">
	  <link:definition>00000063 - Disclosure - INCOME TAXES (Details Textual)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://rewalk.com/role/FinancialExpensesNetDetails" id="FinancialExpensesNetDetails">
	  <link:definition>00000064 - Disclosure - FINANCIAL EXPENSES, NET (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails" id="GeographicInformationAndMajorCustomerAndProductDataDetails">
	  <link:definition>00000065 - Disclosure - GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails1" id="GeographicInformationAndMajorCustomerAndProductDataDetails1">
	  <link:definition>00000066 - Disclosure - GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA (Details 1)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails2" id="GeographicInformationAndMajorCustomerAndProductDataDetails2">
	  <link:definition>00000067 - Disclosure - GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA (Details 2)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetailsTextual" id="GeographicInformationAndMajorCustomerAndProductDataDetailsTextual">
	  <link:definition>00000068 - Disclosure - GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA (Details Textual)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://rewalk.com/role/SubsequentEventsDetails" id="SubsequentEventsDetails">
	  <link:definition>00000069 - Disclosure - SUBSEQUENT EVENTS (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="rwlk-20201231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="rwlk-20201231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="rwlk-20201231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="rwlk-20201231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd" />
    <import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2020-01-31" schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd" />
    <import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd" />
    <element id="rwlk_AllowanceForSalesReturns" name="AllowanceForSalesReturns" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstandingNumber" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstandingNumber" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_SharebasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeOutstandingOptionsAndEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice" name="SharebasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeOutstandingOptionsAndEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice" nillable="true" xbrli:periodType="instant" type="num:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_InvestmentOptionsExercisePrices" name="InvestmentOptionsExercisePrices" nillable="true" xbrli:periodType="duration" type="num:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsGrantedInPeriodWeightedAverageExercisePrice" name="ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsGrantedInPeriodWeightedAverageExercisePrice" nillable="true" xbrli:periodType="duration" type="num:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsvestedInPeriodWeightedAverageExercisePrice" name="ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsvestedInPeriodWeightedAverageExercisePrice" nillable="true" xbrli:periodType="duration" type="num:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsForfeitedInPeriodWeightedAverageExercisePrice" name="ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsForfeitedInPeriodWeightedAverageExercisePrice" nillable="true" xbrli:periodType="duration" type="num:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_FinancialExpensesIncomeNet" name="FinancialExpensesIncomeNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_RevenueRecognitionRecognized" name="RevenueRecognitionRecognized" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_CumulativeEffectOnRetainedEarningsNetOfTax" name="CumulativeEffectOnRetainedEarningsNetOfTax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_SeverancePayMonthlyDepositByEmployeesPercentage" name="SeverancePayMonthlyDepositByEmployeesPercentage" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_RoyaltyBearingGrantsExpenses" name="RoyaltyBearingGrantsExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_PrepaidExpensesToGovernmentInstitutionsCurrent" name="PrepaidExpensesToGovernmentInstitutionsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_DebtInstrumentProceedsfromIssuanceofCommonStockRequiredforRepaymentPeriodtobeExtended" name="DebtInstrumentProceedsfromIssuanceofCommonStockRequiredforRepaymentPeriodtobeExtended" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_LongtermDebtMaturitiesPortionofPrincipalSubjecttoRepaymentExtension" name="LongtermDebtMaturitiesPortionofPrincipalSubjecttoRepaymentExtension" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_ImputedInterest" name="ImputedInterest" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_ResearchAndDevelopmentRoyaltyBearingGrants" name="ResearchAndDevelopmentRoyaltyBearingGrants" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_ResearchAndDevelopmentAmountReceivedInConsiderationOfConvertiblePreferredShares" name="ResearchAndDevelopmentAmountReceivedInConsiderationOfConvertiblePreferredShares" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_PercentageOfGrantReceivedConsideredToDetermineRoyaltyFees" name="PercentageOfGrantReceivedConsideredToDetermineRoyaltyFees" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_ValuationAllowanceDeferredTaxAssetChangesDuetoAmendmentsinTaxLawsandExchangeRateDifferencesAmount" name="ValuationAllowanceDeferredTaxAssetChangesDuetoAmendmentsinTaxLawsandExchangeRateDifferencesAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_ValuationAllowanceDeferredTaxAssetAdjustmentsAmount" name="ValuationAllowanceDeferredTaxAssetAdjustmentsAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_BeneficiaryEnterprisefromProductiveActivityTaxRateonDividendDistributionsfromTaxExemptIncome" name="BeneficiaryEnterprisefromProductiveActivityTaxRateonDividendDistributionsfromTaxExemptIncome" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_DescriptionOfIncomeTaxLawForEncouragementOfCapitalInvestments" name="DescriptionOfIncomeTaxLawForEncouragementOfCapitalInvestments" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_NetOperatingCarryForwardLossesTerms" name="NetOperatingCarryForwardLossesTerms" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_BankCommissions" name="BankCommissions" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_GainsLossesOnInducementOfDebt1" name="GainsLossesOnInducementOfDebt1" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_FinancialExpensesRelatedToLongTermLoan" name="FinancialExpensesRelatedToLongTermLoan" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_IssuanceOfOrdinarySharesInInvestmentAgreement" name="IssuanceOfOrdinarySharesInInvestmentAgreement" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_ProceedsFromIssuanceofPreFundedWarrants" name="ProceedsFromIssuanceofPreFundedWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_ProceedsFromOfferingCost" name="ProceedsFromOfferingCost" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_ProceedsFromIssuanceOfRegistrationCost" name="ProceedsFromIssuanceOfRegistrationCost" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_IssuanceOfOrdinarySharesInWarrantExerciseAgreementNetOfIssuanceExpensesInAmountOf10191" name="IssuanceOfOrdinarySharesInWarrantExerciseAgreementNetOfIssuanceExpensesInAmountOf10191" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_ExerciseOfPreFundedWarrants" name="ExerciseOfPreFundedWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_RepaymentOfLongTermLoanByIssuanceOfUnitsAndPrefundedUnits" name="RepaymentOfLongTermLoanByIssuanceOfUnitsAndPrefundedUnits" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_CommonStockIssuanceCostsIncurredNotYetPaid" name="CommonStockIssuanceCostsIncurredNotYetPaid" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_ClassificationOfOtherCurrentAssetsToPropertyAndEquipmentNet" name="ClassificationOfOtherCurrentAssetsToPropertyAndEquipmentNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_ClassificationOfInventoryToPropertyAndEquipmentNet" name="ClassificationOfInventoryToPropertyAndEquipmentNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_CashlessExerciseOfPrefundedWarrants" name="CashlessExerciseOfPrefundedWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_SupplementalCashFlowCashAndCashEquivalents" name="SupplementalCashFlowCashAndCashEquivalents" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_RestrictedCashIncludedInOtherNoncurrentAssets" name="RestrictedCashIncludedInOtherNoncurrentAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_CashAndCashEquivalentsRestrictedCashAndRestrictedCashEquivalent" name="CashAndCashEquivalentsRestrictedCashAndRestrictedCashEquivalent" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInInvestingAgreementNetOfIssuanceExpenses" name="StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInInvestingAgreementNetOfIssuanceExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInInvestingAgreementNetOfIssuanceExpenses" name="StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInInvestingAgreementNetOfIssuanceExpenses" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_StockIssuedDuringPeriodValueNewIssuesTwo" name="StockIssuedDuringPeriodValueNewIssuesTwo" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_StockIssuedDuringPeriodSharesNewIssuesTwo" name="StockIssuedDuringPeriodSharesNewIssuesTwo" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_StockDuringPeriodOrdinarySharesAndWarrantsValuePurchaseOrdinarySharesInFollowOnPublicOfferingTwo" name="StockDuringPeriodOrdinarySharesAndWarrantsValuePurchaseOrdinarySharesInFollowOnPublicOfferingTwo" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_StockDuringPeriodOrdinarySharesAndWarrantsSharesPurchaseOrdinarySharesInFollowOnPublicOfferingTwo" name="StockDuringPeriodOrdinarySharesAndWarrantsSharesPurchaseOrdinarySharesInFollowOnPublicOfferingTwo" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_ExerciseOfPreFundedWarrantsValue" name="ExerciseOfPreFundedWarrantsValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_ExerciseOfPreFundedWarrantsShares" name="ExerciseOfPreFundedWarrantsShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_StockIssuedDuringPeriodValueOrdinaryShares" name="StockIssuedDuringPeriodValueOrdinaryShares" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_StockIssuedDuringPeriodSharesOrdinaryShares" name="StockIssuedDuringPeriodSharesOrdinaryShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_ExerciseOfPrefundedWarrantsAndWarrantsValue" name="ExerciseOfPrefundedWarrantsAndWarrantsValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_ExerciseOfPreFundedWarrantsAndWarrantsShares" name="ExerciseOfPreFundedWarrantsAndWarrantsShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses" name="StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses" name="StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses" name="StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_DeferredIncometax" name="DeferredIncometax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_TaxesIncome" name="TaxesIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_TaxesOnIncome" name="TaxesOnIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_RightofuseLiability" name="RightofuseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_InitialRecognitionOfOperatingLeaseRightofuseAssets" name="InitialRecognitionOfOperatingLeaseRightofuseAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_InitialRecognitionOfOperatingLeaseLiabilities" name="InitialRecognitionOfOperatingLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_ClassificationOfInventoryToOtherCurrentAssets" name="ClassificationOfInventoryToOtherCurrentAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_IssuanceExpensesOfOfferingSharesAmount" name="IssuanceExpensesOfOfferingSharesAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_StockIssuedDuringPeriodSharesOrdinaryShares1" name="StockIssuedDuringPeriodSharesOrdinaryShares1" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_StockIssuedDuringPeriodValueOrdinaryShares1" name="StockIssuedDuringPeriodValueOrdinaryShares1" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1" name="StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1" name="StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses" name="StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_StockIssuedDuringPeriodSharesPrivatePlacement" name="StockIssuedDuringPeriodSharesPrivatePlacement" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_StockIssuedDuringPeriodValuePrivatePlacement" name="StockIssuedDuringPeriodValuePrivatePlacement" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_RegisteredDirectOfferingsIssuanceCostIncurredNotYetPaid" name="RegisteredDirectOfferingsIssuanceCostIncurredNotYetPaid" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_ContingentLiabilityRelatedToGrantsReceived" name="ContingentLiabilityRelatedToGrantsReceived" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_BeneficiaryEnterprisefromProductiveActivityTaxExemptionPeriod" name="BeneficiaryEnterprisefromProductiveActivityTaxExemptionPeriod" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_BeneficiaryEnterprisefromProductiveActivityMaximumTimefromPeriodofElectionforTaxExemption" name="BeneficiaryEnterprisefromProductiveActivityMaximumTimefromPeriodofElectionforTaxExemption" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_OperatingLeasesMaximumPenaltiesPayableOnEarlyReleaseOfAgreement" name="OperatingLeasesMaximumPenaltiesPayableOnEarlyReleaseOfAgreement" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_RoyaltyFeesPercentage" name="RoyaltyFeesPercentage" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_CommonStockAggregateOfferingPriceAuthorizedUnderEquityDistributionAgreement" name="CommonStockAggregateOfferingPriceAuthorizedUnderEquityDistributionAgreement" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_CommonStockIssuanceCostsUnderEquityDistributionAgreementAsPercentOfGrossProceeds" name="CommonStockIssuanceCostsUnderEquityDistributionAgreementAsPercentOfGrossProceeds" nillable="true" xbrli:periodType="instant" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_StockIssuedDuringPeriodValueNewIssuesGross" name="StockIssuedDuringPeriodValueNewIssuesGross" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_FixedCommissionRate" name="FixedCommissionRate" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_FixedCommissionAmount" name="FixedCommissionAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_AggregateNumberOfOrdinaryShares" name="AggregateNumberOfOrdinaryShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_WarrantsExercisableDescrition" name="WarrantsExercisableDescrition" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_FeesAndOtherRelatedExpenses" name="FeesAndOtherRelatedExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_NetAggregateProceedsOfAfterDeductingFeesAndOtherRelatedExpenses" name="NetAggregateProceedsOfAfterDeductingFeesAndOtherRelatedExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_DescriptionOfUnderwritingAgreement" name="DescriptionOfUnderwritingAgreement" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_DescriptionOfUnderwritersWarrantsToPurchase" name="DescriptionOfUnderwritersWarrantsToPurchase" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_DescriptionOfWainwrightOrItsDesigneesWarrantsToPurchase" name="DescriptionOfWainwrightOrItsDesigneesWarrantsToPurchase" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_StockIssuedDuringPeriodShareOrdinaryShares" name="StockIssuedDuringPeriodShareOrdinaryShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_OrdinarySharesExercisePrice" name="OrdinarySharesExercisePrice" nillable="true" xbrli:periodType="instant" type="num:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_WarrantsToPurchaseOrdinaryShares" name="WarrantsToPurchaseOrdinaryShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_ClassOfWarrantOrRightExercisable" name="ClassOfWarrantOrRightExercisable" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_WarrantsExpitationDate" name="WarrantsExpitationDate" nillable="true" xbrli:periodType="duration" type="xbrli:dateItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_PrepaidExpenseAndOtherAssetsDisclosureTextBlock" name="PrepaidExpenseAndOtherAssetsDisclosureTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_RelatedPartiesTransactionsAndBalancesPolicyTextBlock" name="RelatedPartiesTransactionsAndBalancesPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_OtherLongTermAssetsPolicyTextBlock" name="OtherLongTermAssetsPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_GovernmentGrantsPolicyTextBlock" name="GovernmentGrantsPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_ScheduleOfTradeReceivablesAndDeferredRevenuesTableTextBlock" name="ScheduleOfTradeReceivablesAndDeferredRevenuesTableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_ClassOfWarrantOrRightPolicyTextBlock" name="ClassOfWarrantOrRightPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_DisclosureofTermLoansandWarrantstoPurchaseOrdinarySharesTextBlock" name="DisclosureofTermLoansandWarrantstoPurchaseOrdinarySharesTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_ProceedsFromStockTwo" name="ProceedsFromStockTwo" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_ProceedsFromStockOne" name="ProceedsFromStockOne" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_UnitsPlacedMember" name="UnitsPlacedMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_SparePartsAndWarrantiesMember" name="SparePartsAndWarrantiesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_LicenseAgreementAndCollaborationAgreementMember" name="LicenseAgreementAndCollaborationAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_AtmOfferingProgramMember" name="AtmOfferingProgramMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_CustomerAMember" name="CustomerAMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_CustomerBMember" name="CustomerBMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_CustomerCMember" name="CustomerCMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_CustomerDMember" name="CustomerDMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_CustomerEMember" name="CustomerEMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_CustomerFMember" name="CustomerFMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_CustomerGMember" name="CustomerGMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_CustomerHMember" name="CustomerHMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_CustomerIMember" name="CustomerIMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_CustomerJMember" name="CustomerJMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_CustomerKMember" name="CustomerKMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_YaskawaElectricCorporationMember" name="YaskawaElectricCorporationMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_CustomerLMember" name="CustomerLMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_EmployeeStockOptionAndRestrictedStockUnitsRsuMember" name="EmployeeStockOptionAndRestrictedStockUnitsRsuMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_ExercisePriceRangeTwoMember" name="ExercisePriceRangeTwoMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_ExercisePriceRangeThreeMember" name="ExercisePriceRangeThreeMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_ExercisePriceRangeFiveMember" name="ExercisePriceRangeFiveMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_ExercisePriceRangeFourMember" name="ExercisePriceRangeFourMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_ExercisePriceRangeOneMember" name="ExercisePriceRangeOneMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_ExercisePriceRangeMember" name="ExercisePriceRangeMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwoThousandSixteenMember" name="WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwoThousandSixteenMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandSixteenMember" name="WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandSixteenMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandFifteenMember" name="WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandFifteenMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenMember" name="WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenOneMember" name="WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenOneMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentyFiveTwoThousandNineteenMember" name="WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentyFiveTwoThousandNineteenMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenMember" name="WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenOneMember" name="WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenOneMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveAndSixTwoThousandNineteenMember" name="WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveAndSixTwoThousandNineteenMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveTwoThousandNineteenMember" name="WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveTwoThousandNineteenMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTweleveTwoThousandNineteenMember" name="WarrantsToPurchaseOrdinarySharesIssuedOnJuneTweleveTwoThousandNineteenMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTenTwoThousandNineteenMember" name="WarrantsToPurchaseOrdinarySharesIssuedOnJuneTenTwoThousandNineteenMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_KreosCapitalMember" name="KreosCapitalMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_SecuritiesPurchaseAgreementsMember" name="SecuritiesPurchaseAgreementsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_NonEmployeesMember" name="NonEmployeesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_EmployeesAndNonEmployeesMember" name="EmployeesAndNonEmployeesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_KreosCapitalVMember" name="KreosCapitalVMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_TimwellCorporationLimitedMember" name="TimwellCorporationLimitedMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_FirstAmendmentMember" name="FirstAmendmentMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_WarrantsToPurchaseOrdinarySharesIssuedMember" name="WarrantsToPurchaseOrdinarySharesIssuedMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_IsraeliMember" name="IsraeliMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_FieldServiceUnitsMember" name="FieldServiceUnitsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_MachineryAndLaboratoryEquipmentMember" name="MachineryAndLaboratoryEquipmentMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_SecondAmendmentMember" name="SecondAmendmentMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_IsraelUSBinationalIndustrialResearchAndDevelopmentFoundationMember" name="IsraelUSBinationalIndustrialResearchAndDevelopmentFoundationMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_IsraelInnovationAuthorityMember" name="IsraelInnovationAuthorityMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_RrlAndRrgMember" name="RrlAndRrgMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_ReWalkRoboticsGMBHMember" name="ReWalkRoboticsGMBHMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_ReWalkRoboticsIncMember" name="ReWalkRoboticsIncMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_EquityExchangeProgramMember" name="EquityExchangeProgramMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_BestOfferingMember" name="BestOfferingMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_InvestmentAgreementMember" name="InvestmentAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_RegisteredDirectMember" name="RegisteredDirectMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_WarrantExerciseMember" name="WarrantExerciseMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_RegisteredDirectOfferingMember" name="RegisteredDirectOfferingMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_PublicStockOfferingMember" name="PublicStockOfferingMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_SCIProductsMember" name="SCIProductsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_ReStoreProductMember" name="ReStoreProductMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_PaycheckProtectionProgramLoanMember" name="PaycheckProtectionProgramLoanMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_SiliconValleyBankMember" name="SiliconValleyBankMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyMember" name="WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyOneMember" name="WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyOneMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyMember" name="WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyOneMember" name="WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyOneMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberThreeTwoThousandTwentyMember" name="WarrantsToPurchaseOrdinarySharesIssuedOnDecemberThreeTwoThousandTwentyMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberThreeTwoThousandTwentyOneMember" name="WarrantsToPurchaseOrdinarySharesIssuedOnDecemberThreeTwoThousandTwentyOneMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_CommonUnitsAndPreFundedUnitsMember" name="CommonUnitsAndPreFundedUnitsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_CommonUnitsMember" name="CommonUnitsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_PreFundedUnitsMember" name="PreFundedUnitsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_CommonUnitsAndPreFundedUnits1Member" name="CommonUnitsAndPreFundedUnits1Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_PurchaseAgreementWithCertainInstitutionalInvestorsMember" name="PurchaseAgreementWithCertainInstitutionalInvestorsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_AdditionallyWarrantsIssuedMember" name="AdditionallyWarrantsIssuedMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_PreFundedMember" name="PreFundedMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_DocumentAndEntityInformationAbstract" name="DocumentAndEntityInformationAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_CumulativeEffectToStockBasedCompensationFromAdoptionOfNewAccountingStandard" name="CumulativeEffectToStockBasedCompensationFromAdoptionOfNewAccountingStandard" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_CumulativeEffectToAccumulatedDeficitFromAdoptionOfNewAccountingStandard" name="CumulativeEffectToAccumulatedDeficitFromAdoptionOfNewAccountingStandard" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_SupplementalDisclosuresOfCashFlowInformation" name="SupplementalDisclosuresOfCashFlowInformation" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_LongTermLoanConversionAmount" name="LongTermLoanConversionAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_GeneralTextualAbstract" name="GeneralTextualAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_RevenueObligationAxis" name="RevenueObligationAxis" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" />
    <element id="rwlk_RevenueObligationDomain" name="RevenueObligationDomain" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_SignificantAccountingPoliciesDetails4Abstract" name="SignificantAccountingPoliciesDetails4Abstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_SignificantAccountingPoliciesDetails1Abstract" name="SignificantAccountingPoliciesDetails1Abstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_SignificantAccountingPoliciesTextualAbstract" name="SignificantAccountingPoliciesTextualAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_RelatedPartyTransactionOwnershipPercentage" name="RelatedPartyTransactionOwnershipPercentage" nillable="true" xbrli:periodType="instant" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionsQuantification" name="NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionsQuantification" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_PropertyAndEquipmentNetTextualAbstract" name="PropertyAndEquipmentNetTextualAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_LoanAgreementWithKreosAndRelatedWarrantToPurchaseOrdinarySharesTextual" name="LoanAgreementWithKreosAndRelatedWarrantToPurchaseOrdinarySharesTextual" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_CommitmentsAndContingenciesLiabilitiesTextualAbstract" name="CommitmentsAndContingenciesLiabilitiesTextualAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_GuarantorObligationsCollateralPledged" name="GuarantorObligationsCollateralPledged" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingRollForwardAbstract" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingRollForwardAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingWeightedAverageExercisePriceRollForwardAbstract" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingWeightedAverageExercisePriceRollForwardAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_AgreementAxis" name="AgreementAxis" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" />
    <element id="rwlk_AgreementDomain" name="AgreementDomain" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_TypeofCurrencyAxis" name="TypeofCurrencyAxis" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" />
    <element id="rwlk_TypeofCurrencyDomain" name="TypeofCurrencyDomain" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_ShareholdersEquityTextualAbstract" name="ShareholdersEquityTextualAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_StockIssuedDuringPeriodPricePerShare" name="StockIssuedDuringPeriodPricePerShare" nillable="true" xbrli:periodType="duration" type="num:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_SharebasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsVestedAndOptionsNetBasisOfCommonStock" name="SharebasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsVestedAndOptionsNetBasisOfCommonStock" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_PrefundedWarrantsToPurchaseAggregateOrdinarySharesExercised" name="PrefundedWarrantsToPurchaseAggregateOrdinarySharesExercised" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_DescriptionOfEquityExchangePrograms" name="DescriptionOfEquityExchangePrograms" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_ResearchCollaborationAgreementAndLicenseAgreementTextualAbstract" name="ResearchCollaborationAgreementAndLicenseAgreementTextualAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_IncomeTaxesDetailsAbstract" name="IncomeTaxesDetailsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_ScheduleOfIncomeTaxTable" name="ScheduleOfIncomeTaxTable" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" />
    <element id="rwlk_ScheduleOfIncomeTaxLineItems" name="ScheduleOfIncomeTaxLineItems" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_IncomeTaxesTextualAbstract" name="IncomeTaxesTextualAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_GeographicInformationAndMajorCustomerAndProductDataTextualAbstract" name="GeographicInformationAndMajorCustomerAndProductDataTextualAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="rwlk_SubsequentEventsDetailsAbstract" name="SubsequentEventsDetailsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>12
<FILENAME>rwlk-20201231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoXBRL; Version: 5.6b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Source; Value: RWLK 1220 10K.xfr; Date: 2021%2D02%2D18T13:24:26Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://rewalk.com/role/DocumentAndEntityInformation" xlink:href="rwlk-20201231.xsd#DocumentAndEntityInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/ConsolidatedBalanceSheets" xlink:href="rwlk-20201231.xsd#ConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="rwlk-20201231.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/ConsolidatedStatementsOfOperations" xlink:href="rwlk-20201231.xsd#ConsolidatedStatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/StatementsOfChangesInShareholdersEquity" xlink:href="rwlk-20201231.xsd#StatementsOfChangesInShareholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/StatementsOfChangesInShareholdersEquityParenthetical" xlink:href="rwlk-20201231.xsd#StatementsOfChangesInShareholdersEquityParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/ConsolidatedStatementsOfCashFlows" xlink:href="rwlk-20201231.xsd#ConsolidatedStatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/ConsolidatedStatementsOfCashFlowsParenthetical" xlink:href="rwlk-20201231.xsd#ConsolidatedStatementsOfCashFlowsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/General" xlink:href="rwlk-20201231.xsd#General" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/SignificantAccountingPolicies" xlink:href="rwlk-20201231.xsd#SignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/PrepaidExpensesAndOtherCurrentAssets" xlink:href="rwlk-20201231.xsd#PrepaidExpensesAndOtherCurrentAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/Inventories" xlink:href="rwlk-20201231.xsd#Inventories" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/PropertyAndEquipmentNet" xlink:href="rwlk-20201231.xsd#PropertyAndEquipmentNet" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/LoanAgreementWithKreosAndRelatedWarrantToPurchaseOrdinaryShares" xlink:href="rwlk-20201231.xsd#LoanAgreementWithKreosAndRelatedWarrantToPurchaseOrdinaryShares" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/CommitmentsAndContingentLiabilities" xlink:href="rwlk-20201231.xsd#CommitmentsAndContingentLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/ShareholdersEquity" xlink:href="rwlk-20201231.xsd#ShareholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/ResearchCollaborationAgreementAndLicenseAgreement" xlink:href="rwlk-20201231.xsd#ResearchCollaborationAgreementAndLicenseAgreement" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/PaycheckProtectionProgramLoan" xlink:href="rwlk-20201231.xsd#PaycheckProtectionProgramLoan" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/IncomeTaxes" xlink:href="rwlk-20201231.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/FinancialExpensesNet" xlink:href="rwlk-20201231.xsd#FinancialExpensesNet" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/GeographicInformationAndMajorCustomerAndProductData" xlink:href="rwlk-20201231.xsd#GeographicInformationAndMajorCustomerAndProductData" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/SubsequentEvents" xlink:href="rwlk-20201231.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/SignificantAccountingPoliciesPolicies" xlink:href="rwlk-20201231.xsd#SignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/SignificantAccountingPoliciesTables" xlink:href="rwlk-20201231.xsd#SignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/PrepaidExpensesAndOtherCurrentAssetsTables" xlink:href="rwlk-20201231.xsd#PrepaidExpensesAndOtherCurrentAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/InventoriesTables" xlink:href="rwlk-20201231.xsd#InventoriesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/PropertyAndEquipmentNetTables" xlink:href="rwlk-20201231.xsd#PropertyAndEquipmentNetTables" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/CommitmentsAndContingentLiabilitiesTables" xlink:href="rwlk-20201231.xsd#CommitmentsAndContingentLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/ShareholdersEquityTables" xlink:href="rwlk-20201231.xsd#ShareholdersEquityTables" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/IncomeTaxesTables" xlink:href="rwlk-20201231.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/FinancialExpensesNetTables" xlink:href="rwlk-20201231.xsd#FinancialExpensesNetTables" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataTables" xlink:href="rwlk-20201231.xsd#GeographicInformationAndMajorCustomerAndProductDataTables" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/GeneralDetails" xlink:href="rwlk-20201231.xsd#GeneralDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/SignificantAccountingPoliciesDetails" xlink:href="rwlk-20201231.xsd#SignificantAccountingPoliciesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/SignificantAccountingPoliciesDetails1" xlink:href="rwlk-20201231.xsd#SignificantAccountingPoliciesDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/SignificantAccountingPoliciesDetails2" xlink:href="rwlk-20201231.xsd#SignificantAccountingPoliciesDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/SignificantAccountingPoliciesDetails3" xlink:href="rwlk-20201231.xsd#SignificantAccountingPoliciesDetails3" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/SignificantAccountingPoliciesDetails4" xlink:href="rwlk-20201231.xsd#SignificantAccountingPoliciesDetails4" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/SignificantAccountingPoliciesDetails5" xlink:href="rwlk-20201231.xsd#SignificantAccountingPoliciesDetails5" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/SignificantAccountingPoliciesDetails6" xlink:href="rwlk-20201231.xsd#SignificantAccountingPoliciesDetails6" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/SignificantAccountingPoliciesDetails7" xlink:href="rwlk-20201231.xsd#SignificantAccountingPoliciesDetails7" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/SignificantAccountingPoliciesDetailsTextual" xlink:href="rwlk-20201231.xsd#SignificantAccountingPoliciesDetailsTextual" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/PrepaidExpensesAndOtherCurrentAssetsDetails" xlink:href="rwlk-20201231.xsd#PrepaidExpensesAndOtherCurrentAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/InventoriesDetails" xlink:href="rwlk-20201231.xsd#InventoriesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/PropertyAndEquipmentNetDetails" xlink:href="rwlk-20201231.xsd#PropertyAndEquipmentNetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/PropertyAndEquipmentNetDetailsTextual" xlink:href="rwlk-20201231.xsd#PropertyAndEquipmentNetDetailsTextual" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/LoanAgreementWithKreosAndRelatedWarrantToPurchaseOrdinarySharesDetails" xlink:href="rwlk-20201231.xsd#LoanAgreementWithKreosAndRelatedWarrantToPurchaseOrdinarySharesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/CommitmentsAndContingentLiabilitiesDetails" xlink:href="rwlk-20201231.xsd#CommitmentsAndContingentLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/CommitmentsAndContingentLiabilitiesDetailsTextual" xlink:href="rwlk-20201231.xsd#CommitmentsAndContingentLiabilitiesDetailsTextual" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/ShareholdersEquityDetails" xlink:href="rwlk-20201231.xsd#ShareholdersEquityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/ShareholdersEquityDetails1" xlink:href="rwlk-20201231.xsd#ShareholdersEquityDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/ShareholdersEquityDetails2" xlink:href="rwlk-20201231.xsd#ShareholdersEquityDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/ShareholdersEquityDetails3" xlink:href="rwlk-20201231.xsd#ShareholdersEquityDetails3" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/ShareholdersEquityDetails4" xlink:href="rwlk-20201231.xsd#ShareholdersEquityDetails4" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/ShareholdersEquityDetailsTextual" xlink:href="rwlk-20201231.xsd#ShareholdersEquityDetailsTextual" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/ResearchCollaborationAgreementAndLicenseAgreementDetails" xlink:href="rwlk-20201231.xsd#ResearchCollaborationAgreementAndLicenseAgreementDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/PaycheckProtectionProgramLoanDetailsTextual" xlink:href="rwlk-20201231.xsd#PaycheckProtectionProgramLoanDetailsTextual" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/IncomeTaxesDetails" xlink:href="rwlk-20201231.xsd#IncomeTaxesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/IncomeTaxesDetails1" xlink:href="rwlk-20201231.xsd#IncomeTaxesDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/IncomeTaxesDetails2" xlink:href="rwlk-20201231.xsd#IncomeTaxesDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/IncomeTaxesDetails3" xlink:href="rwlk-20201231.xsd#IncomeTaxesDetails3" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/IncomeTaxesDetails4" xlink:href="rwlk-20201231.xsd#IncomeTaxesDetails4" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/IncomeTaxesDetailsTextual" xlink:href="rwlk-20201231.xsd#IncomeTaxesDetailsTextual" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/FinancialExpensesNetDetails" xlink:href="rwlk-20201231.xsd#FinancialExpensesNetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails" xlink:href="rwlk-20201231.xsd#GeographicInformationAndMajorCustomerAndProductDataDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails1" xlink:href="rwlk-20201231.xsd#GeographicInformationAndMajorCustomerAndProductDataDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails2" xlink:href="rwlk-20201231.xsd#GeographicInformationAndMajorCustomerAndProductDataDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetailsTextual" xlink:href="rwlk-20201231.xsd#GeographicInformationAndMajorCustomerAndProductDataDetailsTextual" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/SubsequentEventsDetails" xlink:href="rwlk-20201231.xsd#SubsequentEventsDetails" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://rewalk.com/role/DocumentAndEntityInformation" xlink:title="00000001 - Document - Document and Entity Information" />
    <link:calculationLink xlink:type="extended" xlink:role="http://rewalk.com/role/ConsolidatedBalanceSheets" xlink:title="00000002 - Statement - CONSOLIDATED BALANCE SHEETS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaapAssetsNoncurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaapOtherAssetsNoncurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapOtherAssetsNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaapLongTermDebtCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapLongTermDebtCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaapDeferredRevenueCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapDeferredRevenueCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaapLongTermDebtNoncurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapLongTermDebtNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="loc_us-gaapDeferredRevenueNoncurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapDeferredRevenueNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapOtherLiabilitiesNoncurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapOtherLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://rewalk.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://rewalk.com/role/ConsolidatedStatementsOfOperations" xlink:title="00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapRevenues" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaapCostOfRevenue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapCostOfRevenue" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaapSellingAndMarketingExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapSellingAndMarketingExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_FinancialExpensesIncomeNet" xlink:label="loc_rwlkFinancialExpensesIncomeNet" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_rwlkFinancialExpensesIncomeNet" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://rewalk.com/role/StatementsOfChangesInShareholdersEquity" xlink:title="00000005 - Statement - STATEMENTS OF CHANGES IN SHAREHOLDERS&apos; EQUITY" />
    <link:calculationLink xlink:type="extended" xlink:role="http://rewalk.com/role/StatementsOfChangesInShareholdersEquityParenthetical" xlink:title="00000006 - Statement - STATEMENTS OF CHANGES IN SHAREHOLDERS&apos; EQUITY (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://rewalk.com/role/ConsolidatedStatementsOfCashFlows" xlink:title="00000007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredIncomeTaxExpenseBenefit" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDeferredIncomeTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_GainsLossesOnInducementOfDebt1" xlink:label="loc_rwlkGainsLossesOnInducementOfDebt1" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_rwlkGainsLossesOnInducementOfDebt1" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_FinancialExpensesRelatedToLongTermLoan" xlink:label="loc_rwlkFinancialExpensesRelatedToLongTermLoan" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_rwlkFinancialExpensesRelatedToLongTermLoan" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableTrade" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableTrade" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInEmployeeRelatedLiabilities" />
      <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInEmployeeRelatedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInDeferredLiabilities" />
      <link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInDeferredLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherOperatingLiabilities" />
      <link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherOperatingLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="loc_us-gaapRepaymentsOfLongTermDebt" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapRepaymentsOfLongTermDebt" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:label="loc_us-gaapProceedsFromIssuanceOfLongTermDebt" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_IssuanceOfOrdinarySharesInInvestmentAgreement" xlink:label="loc_rwlkIssuanceOfOrdinarySharesInInvestmentAgreement" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_rwlkIssuanceOfOrdinarySharesInInvestmentAgreement" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ProceedsFromIssuanceofPreFundedWarrants" xlink:label="loc_rwlkProceedsFromIssuanceofPreFundedWarrants" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_rwlkProceedsFromIssuanceofPreFundedWarrants" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ProceedsFromOfferingCost" xlink:label="loc_rwlkProceedsFromOfferingCost" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_rwlkProceedsFromOfferingCost" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ProceedsFromIssuanceOfRegistrationCost" xlink:label="loc_rwlkProceedsFromIssuanceOfRegistrationCost" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_rwlkProceedsFromIssuanceOfRegistrationCost" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_IssuanceOfOrdinarySharesInWarrantExerciseAgreementNetOfIssuanceExpensesInAmountOf10191" xlink:label="loc_rwlkIssuanceOfOrdinarySharesInWarrantExerciseAgreementNetOfIssuanceExpensesInAmountOf10191" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_rwlkIssuanceOfOrdinarySharesInWarrantExerciseAgreementNetOfIssuanceExpensesInAmountOf10191" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ExerciseOfPreFundedWarrants" xlink:label="loc_rwlkExerciseOfPreFundedWarrants" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_rwlkExerciseOfPreFundedWarrants" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ProceedsFromStockOne" xlink:label="loc_rwlkProceedsFromStockOne" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_rwlkProceedsFromStockOne" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ProceedsFromStockTwo" xlink:label="loc_rwlkProceedsFromStockTwo" />
      <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_rwlkProceedsFromStockTwo" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_CashAndCashEquivalentsRestrictedCashAndRestrictedCashEquivalent" xlink:label="loc_rwlkCashAndCashEquivalentsRestrictedCashAndRestrictedCashEquivalent" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_SupplementalCashFlowCashAndCashEquivalents" xlink:label="loc_rwlkSupplementalCashFlowCashAndCashEquivalents" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_rwlkCashAndCashEquivalentsRestrictedCashAndRestrictedCashEquivalent" xlink:to="loc_rwlkSupplementalCashFlowCashAndCashEquivalents" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_RestrictedCashIncludedInOtherNoncurrentAssets" xlink:label="loc_rwlkRestrictedCashIncludedInOtherNoncurrentAssets" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_rwlkCashAndCashEquivalentsRestrictedCashAndRestrictedCashEquivalent" xlink:to="loc_rwlkRestrictedCashIncludedInOtherNoncurrentAssets" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://rewalk.com/role/ConsolidatedStatementsOfCashFlowsParenthetical" xlink:title="00000008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://rewalk.com/role/General" xlink:title="00000009 - Disclosure - GENERAL" />
    <link:calculationLink xlink:type="extended" xlink:role="http://rewalk.com/role/SignificantAccountingPolicies" xlink:title="00000010 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://rewalk.com/role/PrepaidExpensesAndOtherCurrentAssets" xlink:title="00000011 - Disclosure - PREPAID EXPENSES AND OTHER CURRENT ASSETS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://rewalk.com/role/Inventories" xlink:title="00000012 - Disclosure - INVENTORIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://rewalk.com/role/PropertyAndEquipmentNet" xlink:title="00000013 - Disclosure - PROPERTY AND EQUIPMENT, NET" />
    <link:calculationLink xlink:type="extended" xlink:role="http://rewalk.com/role/LoanAgreementWithKreosAndRelatedWarrantToPurchaseOrdinaryShares" xlink:title="00000014 - Disclosure - LOAN AGREEMENT WITH KREOS AND RELATED WARRANT TO PURCHASE ORDINARY SHARES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://rewalk.com/role/CommitmentsAndContingentLiabilities" xlink:title="00000015 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://rewalk.com/role/ShareholdersEquity" xlink:title="00000016 - Disclosure - SHAREHOLDERS&apos; EQUITY" />
    <link:calculationLink xlink:type="extended" xlink:role="http://rewalk.com/role/ResearchCollaborationAgreementAndLicenseAgreement" xlink:title="00000017 - Disclosure - RESEARCH COLLABORATION AGREEMENT AND LICENSE AGREEMENT" />
    <link:calculationLink xlink:type="extended" xlink:role="http://rewalk.com/role/PaycheckProtectionProgramLoan" xlink:title="00000018 - Disclosure - PAYCHECK PROTECTION PROGRAM LOAN" />
    <link:calculationLink xlink:type="extended" xlink:role="http://rewalk.com/role/IncomeTaxes" xlink:title="00000019 - Disclosure - INCOME TAXES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://rewalk.com/role/FinancialExpensesNet" xlink:title="00000020 - Disclosure - FINANCIAL EXPENSES, NET" />
    <link:calculationLink xlink:type="extended" xlink:role="http://rewalk.com/role/GeographicInformationAndMajorCustomerAndProductData" xlink:title="00000021 - Disclosure - GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA" />
    <link:calculationLink xlink:type="extended" xlink:role="http://rewalk.com/role/SubsequentEvents" xlink:title="00000022 - Disclosure - SUBSEQUENT EVENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://rewalk.com/role/SignificantAccountingPoliciesPolicies" xlink:title="00000023 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://rewalk.com/role/SignificantAccountingPoliciesTables" xlink:title="00000024 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://rewalk.com/role/PrepaidExpensesAndOtherCurrentAssetsTables" xlink:title="00000025 - Disclosure - PREPAID EXPENSES AND OTHER CURRENT ASSETS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://rewalk.com/role/InventoriesTables" xlink:title="00000026 - Disclosure - INVENTORIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://rewalk.com/role/PropertyAndEquipmentNetTables" xlink:title="00000027 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://rewalk.com/role/CommitmentsAndContingentLiabilitiesTables" xlink:title="00000028 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://rewalk.com/role/ShareholdersEquityTables" xlink:title="00000029 - Disclosure - SHAREHOLDERS&apos; EQUITY (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://rewalk.com/role/IncomeTaxesTables" xlink:title="00000030 - Disclosure - INCOME TAXES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://rewalk.com/role/FinancialExpensesNetTables" xlink:title="00000031 - Disclosure - FINANCIAL EXPENSES, NET (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataTables" xlink:title="00000032 - Disclosure - GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://rewalk.com/role/GeneralDetails" xlink:title="00000033 - Disclosure - GENERAL (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://rewalk.com/role/SignificantAccountingPoliciesDetails" xlink:title="00000034 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://rewalk.com/role/SignificantAccountingPoliciesDetails1" xlink:title="00000035 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details 1)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://rewalk.com/role/SignificantAccountingPoliciesDetails2" xlink:title="00000036 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details 2)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://rewalk.com/role/SignificantAccountingPoliciesDetails3" xlink:title="00000037 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details 3)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://rewalk.com/role/SignificantAccountingPoliciesDetails4" xlink:title="00000038 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details 4)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://rewalk.com/role/SignificantAccountingPoliciesDetails5" xlink:title="00000039 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details 5)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://rewalk.com/role/SignificantAccountingPoliciesDetails6" xlink:title="00000040 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details 6)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://rewalk.com/role/SignificantAccountingPoliciesDetails7" xlink:title="00000041 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details 7)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://rewalk.com/role/SignificantAccountingPoliciesDetailsTextual" xlink:title="00000042 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details Textual)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://rewalk.com/role/PrepaidExpensesAndOtherCurrentAssetsDetails" xlink:title="00000043 - Disclosure - PREPAID EXPENSES AND OTHER CURRENT ASSETS (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_PrepaidExpensesToGovernmentInstitutionsCurrent" xlink:label="loc_rwlkPrepaidExpensesToGovernmentInstitutionsCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:to="loc_rwlkPrepaidExpensesToGovernmentInstitutionsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Supplies" xlink:label="loc_us-gaapSupplies" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:to="loc_us-gaapSupplies" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="loc_us-gaapOtherAssetsCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:to="loc_us-gaapOtherAssetsCurrent" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://rewalk.com/role/InventoriesDetails" xlink:title="00000044 - Disclosure - INVENTORIES (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://rewalk.com/role/PropertyAndEquipmentNetDetails" xlink:title="00000045 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://rewalk.com/role/PropertyAndEquipmentNetDetailsTextual" xlink:title="00000046 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details Textual)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://rewalk.com/role/LoanAgreementWithKreosAndRelatedWarrantToPurchaseOrdinarySharesDetails" xlink:title="00000047 - Disclosure - LOAN AGREEMENT WITH KREOS AND RELATED WARRANT TO PURCHASE ORDINARY SHARES (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://rewalk.com/role/CommitmentsAndContingentLiabilitiesDetails" xlink:title="00000048 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInTwoYears" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInThreeYears" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInFourYears" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://rewalk.com/role/CommitmentsAndContingentLiabilitiesDetailsTextual" xlink:title="00000049 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES (Details Textual)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://rewalk.com/role/ShareholdersEquityDetails" xlink:title="00000050 - Disclosure - SHAREHOLDERS&apos; EQUITY (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://rewalk.com/role/ShareholdersEquityDetails1" xlink:title="00000051 - Disclosure - SHAREHOLDERS&apos; EQUITY (Details 1)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://rewalk.com/role/ShareholdersEquityDetails2" xlink:title="00000052 - Disclosure - SHAREHOLDERS&apos; EQUITY (Details 2)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://rewalk.com/role/ShareholdersEquityDetails3" xlink:title="00000053 - Disclosure - SHAREHOLDERS&apos; EQUITY (Details 3)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://rewalk.com/role/ShareholdersEquityDetails4" xlink:title="00000054 - Disclosure - SHAREHOLDERS&apos; EQUITY (Details 4)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://rewalk.com/role/ShareholdersEquityDetailsTextual" xlink:title="00000055 - Disclosure - SHAREHOLDERS&apos; EQUITY (Details Textual)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://rewalk.com/role/ResearchCollaborationAgreementAndLicenseAgreementDetails" xlink:title="00000056 - Disclosure - RESEARCH COLLABORATION AGREEMENT AND LICENSE AGREEMENT (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://rewalk.com/role/PaycheckProtectionProgramLoanDetailsTextual" xlink:title="00000057 - Disclosure - PAYCHECK PROTECTION PROGRAM LOAN (Details Textual)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://rewalk.com/role/IncomeTaxesDetails" xlink:title="00000058 - Disclosure - INCOME TAXES (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://rewalk.com/role/IncomeTaxesDetails1" xlink:title="00000059 - Disclosure - INCOME TAXES (Details 1)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://rewalk.com/role/IncomeTaxesDetails2" xlink:title="00000060 - Disclosure - INCOME TAXES (Details 2)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://rewalk.com/role/IncomeTaxesDetails3" xlink:title="00000061 - Disclosure - INCOME TAXES (Details 3)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://rewalk.com/role/IncomeTaxesDetails4" xlink:title="00000062 - Disclosure - INCOME TAXES (Details 4)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://rewalk.com/role/IncomeTaxesDetailsTextual" xlink:title="00000063 - Disclosure - INCOME TAXES (Details Textual)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://rewalk.com/role/FinancialExpensesNetDetails" xlink:title="00000064 - Disclosure - FINANCIAL EXPENSES, NET (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails" xlink:title="00000065 - Disclosure - GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails1" xlink:title="00000066 - Disclosure - GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA (Details 1)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails2" xlink:title="00000067 - Disclosure - GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA (Details 2)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetailsTextual" xlink:title="00000068 - Disclosure - GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA (Details Textual)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://rewalk.com/role/SubsequentEventsDetails" xlink:title="00000069 - Disclosure - SUBSEQUENT EVENTS (Details)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>13
<FILENAME>rwlk-20201231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoXBRL; Version: 5.6b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Source; Value: RWLK 1220 10K.xfr; Date: 2021%2D02%2D18T13:24:26Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://rewalk.com/role/DocumentAndEntityInformation" xlink:href="rwlk-20201231.xsd#DocumentAndEntityInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/ConsolidatedBalanceSheets" xlink:href="rwlk-20201231.xsd#ConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="rwlk-20201231.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/ConsolidatedStatementsOfOperations" xlink:href="rwlk-20201231.xsd#ConsolidatedStatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/StatementsOfChangesInShareholdersEquity" xlink:href="rwlk-20201231.xsd#StatementsOfChangesInShareholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/StatementsOfChangesInShareholdersEquityParenthetical" xlink:href="rwlk-20201231.xsd#StatementsOfChangesInShareholdersEquityParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/ConsolidatedStatementsOfCashFlows" xlink:href="rwlk-20201231.xsd#ConsolidatedStatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/ConsolidatedStatementsOfCashFlowsParenthetical" xlink:href="rwlk-20201231.xsd#ConsolidatedStatementsOfCashFlowsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/General" xlink:href="rwlk-20201231.xsd#General" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/SignificantAccountingPolicies" xlink:href="rwlk-20201231.xsd#SignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/PrepaidExpensesAndOtherCurrentAssets" xlink:href="rwlk-20201231.xsd#PrepaidExpensesAndOtherCurrentAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/Inventories" xlink:href="rwlk-20201231.xsd#Inventories" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/PropertyAndEquipmentNet" xlink:href="rwlk-20201231.xsd#PropertyAndEquipmentNet" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/LoanAgreementWithKreosAndRelatedWarrantToPurchaseOrdinaryShares" xlink:href="rwlk-20201231.xsd#LoanAgreementWithKreosAndRelatedWarrantToPurchaseOrdinaryShares" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/CommitmentsAndContingentLiabilities" xlink:href="rwlk-20201231.xsd#CommitmentsAndContingentLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/ShareholdersEquity" xlink:href="rwlk-20201231.xsd#ShareholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/ResearchCollaborationAgreementAndLicenseAgreement" xlink:href="rwlk-20201231.xsd#ResearchCollaborationAgreementAndLicenseAgreement" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/PaycheckProtectionProgramLoan" xlink:href="rwlk-20201231.xsd#PaycheckProtectionProgramLoan" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/IncomeTaxes" xlink:href="rwlk-20201231.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/FinancialExpensesNet" xlink:href="rwlk-20201231.xsd#FinancialExpensesNet" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/GeographicInformationAndMajorCustomerAndProductData" xlink:href="rwlk-20201231.xsd#GeographicInformationAndMajorCustomerAndProductData" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/SubsequentEvents" xlink:href="rwlk-20201231.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/SignificantAccountingPoliciesPolicies" xlink:href="rwlk-20201231.xsd#SignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/SignificantAccountingPoliciesTables" xlink:href="rwlk-20201231.xsd#SignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/PrepaidExpensesAndOtherCurrentAssetsTables" xlink:href="rwlk-20201231.xsd#PrepaidExpensesAndOtherCurrentAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/InventoriesTables" xlink:href="rwlk-20201231.xsd#InventoriesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/PropertyAndEquipmentNetTables" xlink:href="rwlk-20201231.xsd#PropertyAndEquipmentNetTables" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/CommitmentsAndContingentLiabilitiesTables" xlink:href="rwlk-20201231.xsd#CommitmentsAndContingentLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/ShareholdersEquityTables" xlink:href="rwlk-20201231.xsd#ShareholdersEquityTables" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/IncomeTaxesTables" xlink:href="rwlk-20201231.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/FinancialExpensesNetTables" xlink:href="rwlk-20201231.xsd#FinancialExpensesNetTables" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataTables" xlink:href="rwlk-20201231.xsd#GeographicInformationAndMajorCustomerAndProductDataTables" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/GeneralDetails" xlink:href="rwlk-20201231.xsd#GeneralDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/SignificantAccountingPoliciesDetails" xlink:href="rwlk-20201231.xsd#SignificantAccountingPoliciesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/SignificantAccountingPoliciesDetails1" xlink:href="rwlk-20201231.xsd#SignificantAccountingPoliciesDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/SignificantAccountingPoliciesDetails2" xlink:href="rwlk-20201231.xsd#SignificantAccountingPoliciesDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/SignificantAccountingPoliciesDetails3" xlink:href="rwlk-20201231.xsd#SignificantAccountingPoliciesDetails3" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/SignificantAccountingPoliciesDetails4" xlink:href="rwlk-20201231.xsd#SignificantAccountingPoliciesDetails4" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/SignificantAccountingPoliciesDetails5" xlink:href="rwlk-20201231.xsd#SignificantAccountingPoliciesDetails5" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/SignificantAccountingPoliciesDetails6" xlink:href="rwlk-20201231.xsd#SignificantAccountingPoliciesDetails6" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/SignificantAccountingPoliciesDetails7" xlink:href="rwlk-20201231.xsd#SignificantAccountingPoliciesDetails7" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/SignificantAccountingPoliciesDetailsTextual" xlink:href="rwlk-20201231.xsd#SignificantAccountingPoliciesDetailsTextual" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/PrepaidExpensesAndOtherCurrentAssetsDetails" xlink:href="rwlk-20201231.xsd#PrepaidExpensesAndOtherCurrentAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/InventoriesDetails" xlink:href="rwlk-20201231.xsd#InventoriesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/PropertyAndEquipmentNetDetails" xlink:href="rwlk-20201231.xsd#PropertyAndEquipmentNetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/PropertyAndEquipmentNetDetailsTextual" xlink:href="rwlk-20201231.xsd#PropertyAndEquipmentNetDetailsTextual" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/LoanAgreementWithKreosAndRelatedWarrantToPurchaseOrdinarySharesDetails" xlink:href="rwlk-20201231.xsd#LoanAgreementWithKreosAndRelatedWarrantToPurchaseOrdinarySharesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/CommitmentsAndContingentLiabilitiesDetails" xlink:href="rwlk-20201231.xsd#CommitmentsAndContingentLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/CommitmentsAndContingentLiabilitiesDetailsTextual" xlink:href="rwlk-20201231.xsd#CommitmentsAndContingentLiabilitiesDetailsTextual" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/ShareholdersEquityDetails" xlink:href="rwlk-20201231.xsd#ShareholdersEquityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/ShareholdersEquityDetails1" xlink:href="rwlk-20201231.xsd#ShareholdersEquityDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/ShareholdersEquityDetails2" xlink:href="rwlk-20201231.xsd#ShareholdersEquityDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/ShareholdersEquityDetails3" xlink:href="rwlk-20201231.xsd#ShareholdersEquityDetails3" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/ShareholdersEquityDetails4" xlink:href="rwlk-20201231.xsd#ShareholdersEquityDetails4" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/ShareholdersEquityDetailsTextual" xlink:href="rwlk-20201231.xsd#ShareholdersEquityDetailsTextual" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/ResearchCollaborationAgreementAndLicenseAgreementDetails" xlink:href="rwlk-20201231.xsd#ResearchCollaborationAgreementAndLicenseAgreementDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/PaycheckProtectionProgramLoanDetailsTextual" xlink:href="rwlk-20201231.xsd#PaycheckProtectionProgramLoanDetailsTextual" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/IncomeTaxesDetails" xlink:href="rwlk-20201231.xsd#IncomeTaxesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/IncomeTaxesDetails1" xlink:href="rwlk-20201231.xsd#IncomeTaxesDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/IncomeTaxesDetails2" xlink:href="rwlk-20201231.xsd#IncomeTaxesDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/IncomeTaxesDetails3" xlink:href="rwlk-20201231.xsd#IncomeTaxesDetails3" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/IncomeTaxesDetails4" xlink:href="rwlk-20201231.xsd#IncomeTaxesDetails4" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/IncomeTaxesDetailsTextual" xlink:href="rwlk-20201231.xsd#IncomeTaxesDetailsTextual" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/FinancialExpensesNetDetails" xlink:href="rwlk-20201231.xsd#FinancialExpensesNetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails" xlink:href="rwlk-20201231.xsd#GeographicInformationAndMajorCustomerAndProductDataDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails1" xlink:href="rwlk-20201231.xsd#GeographicInformationAndMajorCustomerAndProductDataDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails2" xlink:href="rwlk-20201231.xsd#GeographicInformationAndMajorCustomerAndProductDataDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetailsTextual" xlink:href="rwlk-20201231.xsd#GeographicInformationAndMajorCustomerAndProductDataDetailsTextual" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/SubsequentEventsDetails" xlink:href="rwlk-20201231.xsd#SubsequentEventsDetails" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://rewalk.com/role/DocumentAndEntityInformation" xlink:title="00000001 - Document - Document and Entity Information" />
    <link:definitionLink xlink:type="extended" xlink:role="http://rewalk.com/role/ConsolidatedBalanceSheets" xlink:title="00000002 - Statement - CONSOLIDATED BALANCE SHEETS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://rewalk.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://rewalk.com/role/ConsolidatedStatementsOfOperations" xlink:title="00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://rewalk.com/role/StatementsOfChangesInShareholdersEquity" xlink:title="00000005 - Statement - STATEMENTS OF CHANGES IN SHAREHOLDERS&apos; EQUITY">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet" xlink:label="loc_us-gaapAdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_50" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation_50" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation_50" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInInvestingAgreementNetOfIssuanceExpenses" xlink:label="loc_rwlkStockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInInvestingAgreementNetOfIssuanceExpenses_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_rwlkStockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInInvestingAgreementNetOfIssuanceExpenses_50" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInInvestingAgreementNetOfIssuanceExpenses" xlink:label="loc_rwlkStockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInInvestingAgreementNetOfIssuanceExpenses_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_rwlkStockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInInvestingAgreementNetOfIssuanceExpenses_50" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalOther_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalOther_50" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_StockIssuedDuringPeriodValueNewIssuesTwo" xlink:label="loc_rwlkStockIssuedDuringPeriodValueNewIssuesTwo_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_rwlkStockIssuedDuringPeriodValueNewIssuesTwo_50" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_StockIssuedDuringPeriodSharesNewIssuesTwo" xlink:label="loc_rwlkStockIssuedDuringPeriodSharesNewIssuesTwo_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_rwlkStockIssuedDuringPeriodSharesNewIssuesTwo_50" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueOther_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueOther_50" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesOther_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesOther_50" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_StockDuringPeriodOrdinarySharesAndWarrantsValuePurchaseOrdinarySharesInFollowOnPublicOfferingTwo" xlink:label="loc_rwlkStockDuringPeriodOrdinarySharesAndWarrantsValuePurchaseOrdinarySharesInFollowOnPublicOfferingTwo_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_rwlkStockDuringPeriodOrdinarySharesAndWarrantsValuePurchaseOrdinarySharesInFollowOnPublicOfferingTwo_50" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_StockDuringPeriodOrdinarySharesAndWarrantsSharesPurchaseOrdinarySharesInFollowOnPublicOfferingTwo" xlink:label="loc_rwlkStockDuringPeriodOrdinarySharesAndWarrantsSharesPurchaseOrdinarySharesInFollowOnPublicOfferingTwo_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_rwlkStockDuringPeriodOrdinarySharesAndWarrantsSharesPurchaseOrdinarySharesInFollowOnPublicOfferingTwo_50" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalWarrantIssued_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalWarrantIssued_50" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ExerciseOfPreFundedWarrantsValue" xlink:label="loc_rwlkExerciseOfPreFundedWarrantsValue_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_rwlkExerciseOfPreFundedWarrantsValue_50" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ExerciseOfPreFundedWarrantsShares" xlink:label="loc_rwlkExerciseOfPreFundedWarrantsShares_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_rwlkExerciseOfPreFundedWarrantsShares_50" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_CumulativeEffectToStockBasedCompensationFromAdoptionOfNewAccountingStandard" xlink:label="loc_rwlkCumulativeEffectToStockBasedCompensationFromAdoptionOfNewAccountingStandard_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_rwlkCumulativeEffectToStockBasedCompensationFromAdoptionOfNewAccountingStandard_50" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_CumulativeEffectToAccumulatedDeficitFromAdoptionOfNewAccountingStandard" xlink:label="loc_rwlkCumulativeEffectToAccumulatedDeficitFromAdoptionOfNewAccountingStandard_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_rwlkCumulativeEffectToAccumulatedDeficitFromAdoptionOfNewAccountingStandard_50" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_StockIssuedDuringPeriodValueOrdinaryShares1" xlink:label="loc_rwlkStockIssuedDuringPeriodValueOrdinaryShares1_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_rwlkStockIssuedDuringPeriodValueOrdinaryShares1_50" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_StockIssuedDuringPeriodSharesOrdinaryShares1" xlink:label="loc_rwlkStockIssuedDuringPeriodSharesOrdinaryShares1_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_rwlkStockIssuedDuringPeriodSharesOrdinaryShares1_50" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_StockIssuedDuringPeriodValueOrdinaryShares" xlink:label="loc_rwlkStockIssuedDuringPeriodValueOrdinaryShares_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_rwlkStockIssuedDuringPeriodValueOrdinaryShares_50" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_StockIssuedDuringPeriodSharesOrdinaryShares" xlink:label="loc_rwlkStockIssuedDuringPeriodSharesOrdinaryShares_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_rwlkStockIssuedDuringPeriodSharesOrdinaryShares_50" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ExerciseOfPrefundedWarrantsAndWarrantsValue" xlink:label="loc_rwlkExerciseOfPrefundedWarrantsAndWarrantsValue_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_rwlkExerciseOfPrefundedWarrantsAndWarrantsValue_50" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ExerciseOfPreFundedWarrantsAndWarrantsShares" xlink:label="loc_rwlkExerciseOfPreFundedWarrantsAndWarrantsShares_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_rwlkExerciseOfPreFundedWarrantsAndWarrantsShares_50" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses" xlink:label="loc_rwlkStockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_rwlkStockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses_50" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses" xlink:label="loc_rwlkStockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_rwlkStockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses_50" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1" xlink:label="loc_rwlkStockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_rwlkStockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1_50" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1" xlink:label="loc_rwlkStockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_rwlkStockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1_50" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses" xlink:label="loc_rwlkStockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_rwlkStockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses_50" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses" xlink:label="loc_rwlkStockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_rwlkStockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses_50" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_StockIssuedDuringPeriodValuePrivatePlacement" xlink:label="loc_rwlkStockIssuedDuringPeriodValuePrivatePlacement_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_rwlkStockIssuedDuringPeriodValuePrivatePlacement_50" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_StockIssuedDuringPeriodSharesPrivatePlacement" xlink:label="loc_rwlkStockIssuedDuringPeriodSharesPrivatePlacement_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_rwlkStockIssuedDuringPeriodSharesPrivatePlacement_50" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_50" xlink:type="arc" order="35" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://rewalk.com/role/StatementsOfChangesInShareholdersEquityParenthetical" xlink:title="00000006 - Statement - STATEMENTS OF CHANGES IN SHAREHOLDERS&apos; EQUITY (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_BestOfferingMember" xlink:label="loc_rwlkBestOfferingMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_rwlkBestOfferingMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_RegisteredDirectOfferingMember" xlink:label="loc_rwlkRegisteredDirectOfferingMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_rwlkRegisteredDirectOfferingMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaapPrivatePlacementMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapPrivatePlacementMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_WarrantExerciseMember" xlink:label="loc_rwlkWarrantExerciseMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_rwlkWarrantExerciseMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_InvestmentAgreementMember" xlink:label="loc_rwlkInvestmentAgreementMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_rwlkInvestmentAgreementMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_AtmOfferingProgramMember" xlink:label="loc_rwlkAtmOfferingProgramMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_rwlkAtmOfferingProgramMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_PublicStockOfferingMember" xlink:label="loc_rwlkPublicStockOfferingMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_rwlkPublicStockOfferingMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_100" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://rewalk.com/role/ConsolidatedStatementsOfCashFlows" xlink:title="00000007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://rewalk.com/role/ConsolidatedStatementsOfCashFlowsParenthetical" xlink:title="00000008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_BestOfferingMember" xlink:label="loc_rwlkBestOfferingMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_rwlkBestOfferingMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_RegisteredDirectMember" xlink:label="loc_rwlkRegisteredDirectMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_rwlkRegisteredDirectMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaapPrivatePlacementMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapPrivatePlacementMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_InvestmentAgreementMember" xlink:label="loc_rwlkInvestmentAgreementMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_rwlkInvestmentAgreementMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_AtmOfferingProgramMember" xlink:label="loc_rwlkAtmOfferingProgramMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_rwlkAtmOfferingProgramMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_WarrantExerciseMember" xlink:label="loc_rwlkWarrantExerciseMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_rwlkWarrantExerciseMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfStockIssuanceCosts_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsOfStockIssuanceCosts_120" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_IssuanceExpensesOfOfferingSharesAmount" xlink:label="loc_rwlkIssuanceExpensesOfOfferingSharesAmount_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_rwlkIssuanceExpensesOfOfferingSharesAmount_120" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_LongTermLoanConversionAmount" xlink:label="loc_rwlkLongTermLoanConversionAmount_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_rwlkLongTermLoanConversionAmount_120" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://rewalk.com/role/General" xlink:title="00000009 - Disclosure - GENERAL" />
    <link:definitionLink xlink:type="extended" xlink:role="http://rewalk.com/role/SignificantAccountingPolicies" xlink:title="00000010 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://rewalk.com/role/PrepaidExpensesAndOtherCurrentAssets" xlink:title="00000011 - Disclosure - PREPAID EXPENSES AND OTHER CURRENT ASSETS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://rewalk.com/role/Inventories" xlink:title="00000012 - Disclosure - INVENTORIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://rewalk.com/role/PropertyAndEquipmentNet" xlink:title="00000013 - Disclosure - PROPERTY AND EQUIPMENT, NET" />
    <link:definitionLink xlink:type="extended" xlink:role="http://rewalk.com/role/LoanAgreementWithKreosAndRelatedWarrantToPurchaseOrdinaryShares" xlink:title="00000014 - Disclosure - LOAN AGREEMENT WITH KREOS AND RELATED WARRANT TO PURCHASE ORDINARY SHARES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://rewalk.com/role/CommitmentsAndContingentLiabilities" xlink:title="00000015 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://rewalk.com/role/ShareholdersEquity" xlink:title="00000016 - Disclosure - SHAREHOLDERS&apos; EQUITY" />
    <link:definitionLink xlink:type="extended" xlink:role="http://rewalk.com/role/ResearchCollaborationAgreementAndLicenseAgreement" xlink:title="00000017 - Disclosure - RESEARCH COLLABORATION AGREEMENT AND LICENSE AGREEMENT" />
    <link:definitionLink xlink:type="extended" xlink:role="http://rewalk.com/role/PaycheckProtectionProgramLoan" xlink:title="00000018 - Disclosure - PAYCHECK PROTECTION PROGRAM LOAN" />
    <link:definitionLink xlink:type="extended" xlink:role="http://rewalk.com/role/IncomeTaxes" xlink:title="00000019 - Disclosure - INCOME TAXES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://rewalk.com/role/FinancialExpensesNet" xlink:title="00000020 - Disclosure - FINANCIAL EXPENSES, NET" />
    <link:definitionLink xlink:type="extended" xlink:role="http://rewalk.com/role/GeographicInformationAndMajorCustomerAndProductData" xlink:title="00000021 - Disclosure - GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA" />
    <link:definitionLink xlink:type="extended" xlink:role="http://rewalk.com/role/SubsequentEvents" xlink:title="00000022 - Disclosure - SUBSEQUENT EVENTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://rewalk.com/role/SignificantAccountingPoliciesPolicies" xlink:title="00000023 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://rewalk.com/role/SignificantAccountingPoliciesTables" xlink:title="00000024 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://rewalk.com/role/PrepaidExpensesAndOtherCurrentAssetsTables" xlink:title="00000025 - Disclosure - PREPAID EXPENSES AND OTHER CURRENT ASSETS (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://rewalk.com/role/InventoriesTables" xlink:title="00000026 - Disclosure - INVENTORIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://rewalk.com/role/PropertyAndEquipmentNetTables" xlink:title="00000027 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://rewalk.com/role/CommitmentsAndContingentLiabilitiesTables" xlink:title="00000028 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://rewalk.com/role/ShareholdersEquityTables" xlink:title="00000029 - Disclosure - SHAREHOLDERS&apos; EQUITY (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://rewalk.com/role/IncomeTaxesTables" xlink:title="00000030 - Disclosure - INCOME TAXES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://rewalk.com/role/FinancialExpensesNetTables" xlink:title="00000031 - Disclosure - FINANCIAL EXPENSES, NET (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataTables" xlink:title="00000032 - Disclosure - GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://rewalk.com/role/GeneralDetails" xlink:title="00000033 - Disclosure - GENERAL (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_GeneralTextualAbstract" xlink:label="loc_rwlkGeneralTextualAbstract_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_rwlkGeneralTextualAbstract_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkGeneralTextualAbstract_40" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkGeneralTextualAbstract_40" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkGeneralTextualAbstract_40" xlink:to="loc_us-gaapNetIncomeLoss_40" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkGeneralTextualAbstract_40" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_40" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaapProceedsFromWarrantExercises_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkGeneralTextualAbstract_40" xlink:to="loc_us-gaapProceedsFromWarrantExercises_40" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://rewalk.com/role/SignificantAccountingPoliciesDetails" xlink:title="00000034 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaapComputerEquipmentMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapComputerEquipmentMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_MachineryAndLaboratoryEquipmentMember" xlink:label="loc_rwlkMachineryAndLaboratoryEquipmentMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_rwlkMachineryAndLaboratoryEquipmentMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_FieldServiceUnitsMember" xlink:label="loc_rwlkFieldServiceUnitsMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_rwlkFieldServiceUnitsMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:label="loc_us-gaapPropertyPlantAndEquipmentEstimatedUsefulLives_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentEstimatedUsefulLives_80" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://rewalk.com/role/SignificantAccountingPoliciesDetails1" xlink:title="00000035 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details 1)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_RevenueObligationAxis" xlink:label="loc_rwlkRevenueObligationAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_rwlkRevenueObligationAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_RevenueObligationDomain" xlink:label="loc_rwlkRevenueObligationDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_rwlkRevenueObligationAxis" xlink:to="loc_rwlkRevenueObligationDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_RevenueObligationDomain" xlink:label="loc_rwlkRevenueObligationDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_rwlkRevenueObligationAxis" xlink:to="loc_rwlkRevenueObligationDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_UnitsPlacedMember" xlink:label="loc_rwlkUnitsPlacedMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkRevenueObligationDomain" xlink:to="loc_rwlkUnitsPlacedMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_SparePartsAndWarrantiesMember" xlink:label="loc_rwlkSparePartsAndWarrantiesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkRevenueObligationDomain" xlink:to="loc_rwlkSparePartsAndWarrantiesMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenues_100" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://rewalk.com/role/SignificantAccountingPoliciesDetails2" xlink:title="00000036 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details 2)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://rewalk.com/role/SignificantAccountingPoliciesDetails3" xlink:title="00000037 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details 3)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_80" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_80" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_80" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_80" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharePrice_80" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://rewalk.com/role/SignificantAccountingPoliciesDetails4" xlink:title="00000038 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details 4)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://rewalk.com/role/SignificantAccountingPoliciesDetails5" xlink:title="00000039 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details 5)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://rewalk.com/role/SignificantAccountingPoliciesDetails6" xlink:title="00000040 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details 6)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis" xlink:label="loc_srtMajorCustomersAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtMajorCustomersAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_CustomerAMember" xlink:label="loc_rwlkCustomerAMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_rwlkCustomerAMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_CustomerBMember" xlink:label="loc_rwlkCustomerBMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_rwlkCustomerBMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_CustomerCMember" xlink:label="loc_rwlkCustomerCMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_rwlkCustomerCMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_CustomerDMember" xlink:label="loc_rwlkCustomerDMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_rwlkCustomerDMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_CustomerEMember" xlink:label="loc_rwlkCustomerEMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_rwlkCustomerEMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_CustomerFMember" xlink:label="loc_rwlkCustomerFMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_rwlkCustomerFMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_CustomerGMember" xlink:label="loc_rwlkCustomerGMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_rwlkCustomerGMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_CustomerHMember" xlink:label="loc_rwlkCustomerHMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_rwlkCustomerHMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_CustomerIMember" xlink:label="loc_rwlkCustomerIMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_rwlkCustomerIMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_CustomerJMember" xlink:label="loc_rwlkCustomerJMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_rwlkCustomerJMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_CustomerKMember" xlink:label="loc_rwlkCustomerKMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_rwlkCustomerKMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_CustomerLMember" xlink:label="loc_rwlkCustomerLMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_rwlkCustomerLMember_110" xlink:type="arc" order="111" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1_250" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://rewalk.com/role/SignificantAccountingPoliciesDetails7" xlink:title="00000041 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details 7)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://rewalk.com/role/SignificantAccountingPoliciesDetailsTextual" xlink:title="00000042 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details Textual)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="loc_us-gaapConcentrationRiskLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTable" xlink:label="loc_us-gaapConcentrationRiskTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskLineItems" xlink:to="loc_us-gaapConcentrationRiskTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_srtProductOrServiceAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ReStoreProductMember" xlink:label="loc_rwlkReStoreProductMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_rwlkReStoreProductMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_SCIProductsMember" xlink:label="loc_rwlkSCIProductsMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_rwlkSCIProductsMember_110" xlink:type="arc" order="111" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_EmployeesAndNonEmployeesMember" xlink:label="loc_rwlkEmployeesAndNonEmployeesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_rwlkEmployeesAndNonEmployeesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="loc_us-gaapAdjustmentsForNewAccountingPronouncementsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_us-gaapAdjustmentsForNewAccountingPronouncementsAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaapTypeOfAdoptionMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAdjustmentsForNewAccountingPronouncementsAxis" xlink:to="loc_us-gaapTypeOfAdoptionMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaapTypeOfAdoptionMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAdjustmentsForNewAccountingPronouncementsAxis" xlink:to="loc_us-gaapTypeOfAdoptionMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201609Member" xlink:label="loc_us-gaapAccountingStandardsUpdate201609Member_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTypeOfAdoptionMember" xlink:to="loc_us-gaapAccountingStandardsUpdate201609Member_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_YaskawaElectricCorporationMember" xlink:label="loc_rwlkYaskawaElectricCorporationMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_rwlkYaskawaElectricCorporationMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_SignificantAccountingPoliciesTextualAbstract" xlink:label="loc_rwlkSignificantAccountingPoliciesTextualAbstract_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskLineItems" xlink:to="loc_rwlkSignificantAccountingPoliciesTextualAbstract_150" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWriteDown" xlink:label="loc_us-gaapInventoryWriteDown_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkSignificantAccountingPoliciesTextualAbstract_150" xlink:to="loc_us-gaapInventoryWriteDown_150" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="loc_us-gaapImpairmentOfLongLivedAssetsHeldForUse_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkSignificantAccountingPoliciesTextualAbstract_150" xlink:to="loc_us-gaapImpairmentOfLongLivedAssetsHeldForUse_150" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_RelatedPartyTransactionOwnershipPercentage" xlink:label="loc_rwlkRelatedPartyTransactionOwnershipPercentage_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkSignificantAccountingPoliciesTextualAbstract_150" xlink:to="loc_rwlkRelatedPartyTransactionOwnershipPercentage_150" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkSignificantAccountingPoliciesTextualAbstract_150" xlink:to="loc_us-gaapConcentrationRiskPercentage1_150" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromRelatedParties" xlink:label="loc_us-gaapRevenueFromRelatedParties_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkSignificantAccountingPoliciesTextualAbstract_150" xlink:to="loc_us-gaapRevenueFromRelatedParties_150" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkSignificantAccountingPoliciesTextualAbstract_150" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent_150" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_AllowanceForSalesReturns" xlink:label="loc_rwlkAllowanceForSalesReturns_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkSignificantAccountingPoliciesTextualAbstract_150" xlink:to="loc_rwlkAllowanceForSalesReturns_150" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkSignificantAccountingPoliciesTextualAbstract_150" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax_150" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_RevenueRecognitionRecognized" xlink:label="loc_rwlkRevenueRecognitionRecognized_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkSignificantAccountingPoliciesTextualAbstract_150" xlink:to="loc_rwlkRevenueRecognitionRecognized_150" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_CumulativeEffectOnRetainedEarningsNetOfTax" xlink:label="loc_rwlkCumulativeEffectOnRetainedEarningsNetOfTax_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkSignificantAccountingPoliciesTextualAbstract_150" xlink:to="loc_rwlkCumulativeEffectOnRetainedEarningsNetOfTax_150" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaapAllocatedShareBasedCompensationExpense_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkSignificantAccountingPoliciesTextualAbstract_150" xlink:to="loc_us-gaapAllocatedShareBasedCompensationExpense_150" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement" xlink:label="loc_us-gaapIncomeTaxExaminationLikelihoodOfUnfavorableSettlement_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkSignificantAccountingPoliciesTextualAbstract_150" xlink:to="loc_us-gaapIncomeTaxExaminationLikelihoodOfUnfavorableSettlement_150" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_SeverancePayMonthlyDepositByEmployeesPercentage" xlink:label="loc_rwlkSeverancePayMonthlyDepositByEmployeesPercentage_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkSignificantAccountingPoliciesTextualAbstract_150" xlink:to="loc_rwlkSeverancePayMonthlyDepositByEmployeesPercentage_150" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PostemploymentBenefitsPeriodExpense" xlink:label="loc_us-gaapPostemploymentBenefitsPeriodExpense_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkSignificantAccountingPoliciesTextualAbstract_150" xlink:to="loc_us-gaapPostemploymentBenefitsPeriodExpense_150" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_RoyaltyBearingGrantsExpenses" xlink:label="loc_rwlkRoyaltyBearingGrantsExpenses_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkSignificantAccountingPoliciesTextualAbstract_150" xlink:to="loc_rwlkRoyaltyBearingGrantsExpenses_150" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RoyaltyExpense" xlink:label="loc_us-gaapRoyaltyExpense_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkSignificantAccountingPoliciesTextualAbstract_150" xlink:to="loc_us-gaapRoyaltyExpense_150" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionsQuantification" xlink:label="loc_rwlkNewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionsQuantification_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkSignificantAccountingPoliciesTextualAbstract_150" xlink:to="loc_rwlkNewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionsQuantification_150" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LessorOperatingLeaseDescription" xlink:label="loc_us-gaapLessorOperatingLeaseDescription_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkSignificantAccountingPoliciesTextualAbstract_150" xlink:to="loc_us-gaapLessorOperatingLeaseDescription_150" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingTerm_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkSignificantAccountingPoliciesTextualAbstract_150" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingTerm_150" xlink:type="arc" order="19" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://rewalk.com/role/PrepaidExpensesAndOtherCurrentAssetsDetails" xlink:title="00000043 - Disclosure - PREPAID EXPENSES AND OTHER CURRENT ASSETS (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://rewalk.com/role/InventoriesDetails" xlink:title="00000044 - Disclosure - INVENTORIES (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://rewalk.com/role/PropertyAndEquipmentNetDetails" xlink:title="00000045 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaapComputerEquipmentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapComputerEquipmentMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_MachineryAndLaboratoryEquipmentMember" xlink:label="loc_rwlkMachineryAndLaboratoryEquipmentMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_rwlkMachineryAndLaboratoryEquipmentMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_FieldServiceUnitsMember" xlink:label="loc_rwlkFieldServiceUnitsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_rwlkFieldServiceUnitsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_130" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://rewalk.com/role/PropertyAndEquipmentNetDetailsTextual" xlink:title="00000046 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details Textual)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://rewalk.com/role/LoanAgreementWithKreosAndRelatedWarrantToPurchaseOrdinarySharesDetails" xlink:title="00000047 - Disclosure - LOAN AGREEMENT WITH KREOS AND RELATED WARRANT TO PURCHASE ORDINARY SHARES (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaapDebtInstrumentLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaapDebtInstrumentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaapLongtermDebtTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapLongtermDebtTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuredDebtMember" xlink:label="loc_us-gaapSecuredDebtMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_us-gaapSecuredDebtMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapDebtInstrumentAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_FirstAmendmentMember" xlink:label="loc_rwlkFirstAmendmentMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_rwlkFirstAmendmentMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_SecondAmendmentMember" xlink:label="loc_rwlkSecondAmendmentMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_rwlkSecondAmendmentMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_srtStatementScenarioAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_PreFundedMember" xlink:label="loc_rwlkPreFundedMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_rwlkPreFundedMember_90" xlink:type="arc" order="92" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_LoanAgreementWithKreosAndRelatedWarrantToPurchaseOrdinarySharesTextual" xlink:label="loc_rwlkLoanAgreementWithKreosAndRelatedWarrantToPurchaseOrdinarySharesTextual_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_rwlkLoanAgreementWithKreosAndRelatedWarrantToPurchaseOrdinarySharesTextual_140" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount_140" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:label="loc_us-gaapProceedsFromIssuanceOfLongTermDebt_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfLongTermDebt_140" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTerm" xlink:label="loc_us-gaapDebtInstrumentTerm_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentTerm_140" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_140" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_DebtInstrumentProceedsfromIssuanceofCommonStockRequiredforRepaymentPeriodtobeExtended" xlink:label="loc_rwlkDebtInstrumentProceedsfromIssuanceofCommonStockRequiredforRepaymentPeriodtobeExtended_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_rwlkDebtInstrumentProceedsfromIssuanceofCommonStockRequiredforRepaymentPeriodtobeExtended_140" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_LongtermDebtMaturitiesPortionofPrincipalSubjecttoRepaymentExtension" xlink:label="loc_rwlkLongtermDebtMaturitiesPortionofPrincipalSubjecttoRepaymentExtension_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_rwlkLongtermDebtMaturitiesPortionofPrincipalSubjecttoRepaymentExtension_140" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseDebt" xlink:label="loc_us-gaapInterestExpenseDebt_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapInterestExpenseDebt_140" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_140" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_140" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfDebt" xlink:label="loc_us-gaapRepaymentsOfDebt_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapRepaymentsOfDebt_140" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesOther_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesOther_140" xlink:type="arc" order="11" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://rewalk.com/role/CommitmentsAndContingentLiabilitiesDetails" xlink:title="00000048 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://rewalk.com/role/CommitmentsAndContingentLiabilitiesDetailsTextual" xlink:title="00000049 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES (Details Textual)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCommitmentsLineItems" xlink:label="loc_us-gaapOtherCommitmentsLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCommitmentsTable" xlink:label="loc_us-gaapOtherCommitmentsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapOtherCommitmentsLineItems" xlink:to="loc_us-gaapOtherCommitmentsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapOtherCommitmentsTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_IsraelInnovationAuthorityMember" xlink:label="loc_rwlkIsraelInnovationAuthorityMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_rwlkIsraelInnovationAuthorityMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_IsraelUSBinationalIndustrialResearchAndDevelopmentFoundationMember" xlink:label="loc_rwlkIsraelUSBinationalIndustrialResearchAndDevelopmentFoundationMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_rwlkIsraelUSBinationalIndustrialResearchAndDevelopmentFoundationMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_RrlAndRrgMember" xlink:label="loc_rwlkRrlAndRrgMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_rwlkRrlAndRrgMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapOtherCommitmentsTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapOtherCommitmentsTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="loc_us-gaapConvertiblePreferredStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapConvertiblePreferredStockMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapOtherCommitmentsTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaapIPOMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapIPOMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_CommitmentsAndContingenciesLiabilitiesTextualAbstract" xlink:label="loc_rwlkCommitmentsAndContingenciesLiabilitiesTextualAbstract_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOtherCommitmentsLineItems" xlink:to="loc_rwlkCommitmentsAndContingenciesLiabilitiesTextualAbstract_120" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligation" xlink:label="loc_us-gaapPurchaseObligation_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkCommitmentsAndContingenciesLiabilitiesTextualAbstract_120" xlink:to="loc_us-gaapPurchaseObligation_120" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_OperatingLeasesMaximumPenaltiesPayableOnEarlyReleaseOfAgreement" xlink:label="loc_rwlkOperatingLeasesMaximumPenaltiesPayableOnEarlyReleaseOfAgreement_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkCommitmentsAndContingenciesLiabilitiesTextualAbstract_120" xlink:to="loc_rwlkOperatingLeasesMaximumPenaltiesPayableOnEarlyReleaseOfAgreement_120" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRoyaltiesReceived" xlink:label="loc_us-gaapProceedsFromRoyaltiesReceived_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkCommitmentsAndContingenciesLiabilitiesTextualAbstract_120" xlink:to="loc_us-gaapProceedsFromRoyaltiesReceived_120" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ResearchAndDevelopmentRoyaltyBearingGrants" xlink:label="loc_rwlkResearchAndDevelopmentRoyaltyBearingGrants_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkCommitmentsAndContingenciesLiabilitiesTextualAbstract_120" xlink:to="loc_rwlkResearchAndDevelopmentRoyaltyBearingGrants_120" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRoyalties" xlink:label="loc_us-gaapPaymentsForRoyalties_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkCommitmentsAndContingenciesLiabilitiesTextualAbstract_120" xlink:to="loc_us-gaapPaymentsForRoyalties_120" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ResearchAndDevelopmentAmountReceivedInConsiderationOfConvertiblePreferredShares" xlink:label="loc_rwlkResearchAndDevelopmentAmountReceivedInConsiderationOfConvertiblePreferredShares_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkCommitmentsAndContingenciesLiabilitiesTextualAbstract_120" xlink:to="loc_rwlkResearchAndDevelopmentAmountReceivedInConsiderationOfConvertiblePreferredShares_120" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:label="loc_us-gaapConvertiblePreferredStockSharesIssuedUponConversion_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkCommitmentsAndContingenciesLiabilitiesTextualAbstract_120" xlink:to="loc_us-gaapConvertiblePreferredStockSharesIssuedUponConversion_120" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_RoyaltyFeesPercentage" xlink:label="loc_rwlkRoyaltyFeesPercentage_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkCommitmentsAndContingenciesLiabilitiesTextualAbstract_120" xlink:to="loc_rwlkRoyaltyFeesPercentage_120" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConversionOfStockDescription" xlink:label="loc_us-gaapConversionOfStockDescription_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkCommitmentsAndContingenciesLiabilitiesTextualAbstract_120" xlink:to="loc_us-gaapConversionOfStockDescription_120" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ContingentLiabilityRelatedToGrantsReceived" xlink:label="loc_rwlkContingentLiabilityRelatedToGrantsReceived_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkCommitmentsAndContingenciesLiabilitiesTextualAbstract_120" xlink:to="loc_rwlkContingentLiabilityRelatedToGrantsReceived_120" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_PercentageOfGrantReceivedConsideredToDetermineRoyaltyFees" xlink:label="loc_rwlkPercentageOfGrantReceivedConsideredToDetermineRoyaltyFees_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkCommitmentsAndContingenciesLiabilitiesTextualAbstract_120" xlink:to="loc_rwlkPercentageOfGrantReceivedConsideredToDetermineRoyaltyFees_120" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RoyaltyExpense" xlink:label="loc_us-gaapRoyaltyExpense_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkCommitmentsAndContingenciesLiabilitiesTextualAbstract_120" xlink:to="loc_us-gaapRoyaltyExpense_120" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_GuarantorObligationsCollateralPledged" xlink:label="loc_rwlkGuarantorObligationsCollateralPledged_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkCommitmentsAndContingenciesLiabilitiesTextualAbstract_120" xlink:to="loc_rwlkGuarantorObligationsCollateralPledged_120" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DescriptionOfLessorLeasingArrangementsOperatingLeases" xlink:label="loc_us-gaapDescriptionOfLessorLeasingArrangementsOperatingLeases_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkCommitmentsAndContingenciesLiabilitiesTextualAbstract_120" xlink:to="loc_us-gaapDescriptionOfLessorLeasingArrangementsOperatingLeases_120" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLongTermDebt" xlink:label="loc_us-gaapOtherLongTermDebt_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkCommitmentsAndContingenciesLiabilitiesTextualAbstract_120" xlink:to="loc_us-gaapOtherLongTermDebt_120" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet" xlink:label="loc_us-gaapOperatingLeasesRentExpenseNet_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkCommitmentsAndContingenciesLiabilitiesTextualAbstract_120" xlink:to="loc_us-gaapOperatingLeasesRentExpenseNet_120" xlink:type="arc" order="16" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://rewalk.com/role/ShareholdersEquityDetails" xlink:title="00000050 - Disclosure - SHAREHOLDERS&apos; EQUITY (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://rewalk.com/role/ShareholdersEquityDetails1" xlink:title="00000051 - Disclosure - SHAREHOLDERS&apos; EQUITY (Details 1)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_EmployeeStockOptionAndRestrictedStockUnitsRsuMember" xlink:label="loc_rwlkEmployeeStockOptionAndRestrictedStockUnitsRsuMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_rwlkEmployeeStockOptionAndRestrictedStockUnitsRsuMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingRollForwardAbstract" xlink:label="loc_rwlkShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingRollForwardAbstract_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_rwlkShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingRollForwardAbstract_20" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstandingNumber" xlink:label="loc_rwlkSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstandingNumber_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingRollForwardAbstract_20" xlink:to="loc_rwlkSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstandingNumber_20" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingRollForwardAbstract_20" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_20" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingRollForwardAbstract_20" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_20" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingRollForwardAbstract_20" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_20" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingWeightedAverageExercisePriceRollForwardAbstract" xlink:label="loc_rwlkShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingWeightedAverageExercisePriceRollForwardAbstract_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_rwlkShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingWeightedAverageExercisePriceRollForwardAbstract_20" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_SharebasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeOutstandingOptionsAndEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice" xlink:label="loc_rwlkSharebasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeOutstandingOptionsAndEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingWeightedAverageExercisePriceRollForwardAbstract_20" xlink:to="loc_rwlkSharebasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeOutstandingOptionsAndEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice_20" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsGrantedInPeriodWeightedAverageExercisePrice" xlink:label="loc_rwlkShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsGrantedInPeriodWeightedAverageExercisePrice_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingWeightedAverageExercisePriceRollForwardAbstract_20" xlink:to="loc_rwlkShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsGrantedInPeriodWeightedAverageExercisePrice_20" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsvestedInPeriodWeightedAverageExercisePrice" xlink:label="loc_rwlkShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsvestedInPeriodWeightedAverageExercisePrice_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingWeightedAverageExercisePriceRollForwardAbstract_20" xlink:to="loc_rwlkShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsvestedInPeriodWeightedAverageExercisePrice_20" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsForfeitedInPeriodWeightedAverageExercisePrice" xlink:label="loc_rwlkShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsForfeitedInPeriodWeightedAverageExercisePrice_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingWeightedAverageExercisePriceRollForwardAbstract_20" xlink:to="loc_rwlkShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsForfeitedInPeriodWeightedAverageExercisePrice_20" xlink:type="arc" order="10" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://rewalk.com/role/ShareholdersEquityDetails2" xlink:title="00000052 - Disclosure - SHAREHOLDERS&apos; EQUITY (Details 2)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaapEmployeeStockOptionMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapEmployeeStockOptionMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ExercisePriceRangeOneMember" xlink:label="loc_rwlkExercisePriceRangeOneMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_rwlkExercisePriceRangeOneMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ExercisePriceRangeTwoMember" xlink:label="loc_rwlkExercisePriceRangeTwoMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_rwlkExercisePriceRangeTwoMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ExercisePriceRangeThreeMember" xlink:label="loc_rwlkExercisePriceRangeThreeMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_rwlkExercisePriceRangeThreeMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ExercisePriceRangeFourMember" xlink:label="loc_rwlkExercisePriceRangeFourMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_rwlkExercisePriceRangeFourMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ExercisePriceRangeFiveMember" xlink:label="loc_rwlkExercisePriceRangeFiveMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_rwlkExercisePriceRangeFiveMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ExercisePriceRangeMember" xlink:label="loc_rwlkExercisePriceRangeMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_rwlkExercisePriceRangeMember_120" xlink:type="arc" order="122" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_InvestmentOptionsExercisePrices" xlink:label="loc_rwlkInvestmentOptionsExercisePrices_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_rwlkInvestmentOptionsExercisePrices_150" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_150" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_150" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_150" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_150" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_150" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_150" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_150" xlink:type="arc" order="7" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://rewalk.com/role/ShareholdersEquityDetails3" xlink:title="00000053 - Disclosure - SHAREHOLDERS&apos; EQUITY (Details 3)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="loc_us-gaapClassOfWarrantOrRightLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="loc_us-gaapClassOfWarrantOrRightTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapClassOfWarrantOrRightTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandFifteenMember" xlink:label="loc_rwlkWarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandFifteenMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_rwlkWarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandFifteenMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwoThousandSixteenMember" xlink:label="loc_rwlkWarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwoThousandSixteenMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_rwlkWarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwoThousandSixteenMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandSixteenMember" xlink:label="loc_rwlkWarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandSixteenMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_rwlkWarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandSixteenMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenMember" xlink:label="loc_rwlkWarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_rwlkWarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenOneMember" xlink:label="loc_rwlkWarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenOneMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_rwlkWarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenOneMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentyFiveTwoThousandNineteenMember" xlink:label="loc_rwlkWarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentyFiveTwoThousandNineteenMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_rwlkWarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentyFiveTwoThousandNineteenMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenMember" xlink:label="loc_rwlkWarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_rwlkWarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenOneMember" xlink:label="loc_rwlkWarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenOneMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_rwlkWarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenOneMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveAndSixTwoThousandNineteenMember" xlink:label="loc_rwlkWarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveAndSixTwoThousandNineteenMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_rwlkWarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveAndSixTwoThousandNineteenMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveTwoThousandNineteenMember" xlink:label="loc_rwlkWarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveTwoThousandNineteenMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_rwlkWarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveTwoThousandNineteenMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTweleveTwoThousandNineteenMember" xlink:label="loc_rwlkWarrantsToPurchaseOrdinarySharesIssuedOnJuneTweleveTwoThousandNineteenMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_rwlkWarrantsToPurchaseOrdinarySharesIssuedOnJuneTweleveTwoThousandNineteenMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTenTwoThousandNineteenMember" xlink:label="loc_rwlkWarrantsToPurchaseOrdinarySharesIssuedOnJuneTenTwoThousandNineteenMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_rwlkWarrantsToPurchaseOrdinarySharesIssuedOnJuneTenTwoThousandNineteenMember_110" xlink:type="arc" order="111" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyMember" xlink:label="loc_rwlkWarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_rwlkWarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyOneMember" xlink:label="loc_rwlkWarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyOneMember_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_rwlkWarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyOneMember_130" xlink:type="arc" order="131" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyMember" xlink:label="loc_rwlkWarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_rwlkWarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyMember_140" xlink:type="arc" order="141" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyOneMember" xlink:label="loc_rwlkWarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyOneMember_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_rwlkWarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyOneMember_150" xlink:type="arc" order="151" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberThreeTwoThousandTwentyMember" xlink:label="loc_rwlkWarrantsToPurchaseOrdinarySharesIssuedOnDecemberThreeTwoThousandTwentyMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_rwlkWarrantsToPurchaseOrdinarySharesIssuedOnDecemberThreeTwoThousandTwentyMember_160" xlink:type="arc" order="161" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberThreeTwoThousandTwentyOneMember" xlink:label="loc_rwlkWarrantsToPurchaseOrdinarySharesIssuedOnDecemberThreeTwoThousandTwentyOneMember_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_rwlkWarrantsToPurchaseOrdinarySharesIssuedOnDecemberThreeTwoThousandTwentyOneMember_170" xlink:type="arc" order="171" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding_380" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_380" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ClassOfWarrantOrRightExercisable" xlink:label="loc_rwlkClassOfWarrantOrRightExercisable_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_rwlkClassOfWarrantOrRightExercisable_380" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_WarrantsExpitationDate" xlink:label="loc_rwlkWarrantsExpitationDate_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_rwlkWarrantsExpitationDate_380" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://rewalk.com/role/ShareholdersEquityDetails4" xlink:title="00000054 - Disclosure - SHAREHOLDERS&apos; EQUITY (Details 4)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="loc_us-gaapScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="loc_us-gaapScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember" xlink:label="loc_us-gaapCostOfSalesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapCostOfSalesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaapResearchAndDevelopmentExpenseMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapResearchAndDevelopmentExpenseMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingAndMarketingExpenseMember" xlink:label="loc_us-gaapSellingAndMarketingExpenseMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapSellingAndMarketingExpenseMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="loc_us-gaapGeneralAndAdministrativeExpenseMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapGeneralAndAdministrativeExpenseMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaapAllocatedShareBasedCompensationExpense_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="loc_us-gaapAllocatedShareBasedCompensationExpense_160" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://rewalk.com/role/ShareholdersEquityDetailsTextual" xlink:title="00000055 - Disclosure - SHAREHOLDERS&apos; EQUITY (Details Textual)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionLineItems" xlink:label="loc_us-gaapShareBasedGoodsAndNonemployeeServicesTransactionLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable" xlink:label="loc_us-gaapScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedGoodsAndNonemployeeServicesTransactionLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_AgreementAxis" xlink:label="loc_rwlkAgreementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable" xlink:to="loc_rwlkAgreementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_AgreementDomain" xlink:label="loc_rwlkAgreementDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_rwlkAgreementAxis" xlink:to="loc_rwlkAgreementDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_AgreementDomain" xlink:label="loc_rwlkAgreementDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_rwlkAgreementAxis" xlink:to="loc_rwlkAgreementDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_SecuritiesPurchaseAgreementsMember" xlink:label="loc_rwlkSecuritiesPurchaseAgreementsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkAgreementDomain" xlink:to="loc_rwlkSecuritiesPurchaseAgreementsMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_EquityExchangeProgramMember" xlink:label="loc_rwlkEquityExchangeProgramMember_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkAgreementDomain" xlink:to="loc_rwlkEquityExchangeProgramMember_240" xlink:type="arc" order="241" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_TimwellCorporationLimitedMember" xlink:label="loc_rwlkTimwellCorporationLimitedMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_rwlkTimwellCorporationLimitedMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_KreosCapitalMember" xlink:label="loc_rwlkKreosCapitalMember_370" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_rwlkKreosCapitalMember_370" xlink:type="arc" order="371" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_WarrantsToPurchaseOrdinarySharesIssuedMember" xlink:label="loc_rwlkWarrantsToPurchaseOrdinarySharesIssuedMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_rwlkWarrantsToPurchaseOrdinarySharesIssuedMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaapPrivatePlacementMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapPrivatePlacementMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_AtmOfferingProgramMember" xlink:label="loc_rwlkAtmOfferingProgramMember_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_rwlkAtmOfferingProgramMember_130" xlink:type="arc" order="131" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_CommonUnitsAndPreFundedUnitsMember" xlink:label="loc_rwlkCommonUnitsAndPreFundedUnitsMember_400" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_rwlkCommonUnitsAndPreFundedUnitsMember_400" xlink:type="arc" order="401" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_CommonUnitsMember" xlink:label="loc_rwlkCommonUnitsMember_410" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_rwlkCommonUnitsMember_410" xlink:type="arc" order="411" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_PreFundedUnitsMember" xlink:label="loc_rwlkPreFundedUnitsMember_420" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_rwlkPreFundedUnitsMember_420" xlink:type="arc" order="421" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_CommonUnitsAndPreFundedUnits1Member" xlink:label="loc_rwlkCommonUnitsAndPreFundedUnits1Member_440" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_rwlkCommonUnitsAndPreFundedUnits1Member_440" xlink:type="arc" order="441" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_PurchaseAgreementWithCertainInstitutionalInvestorsMember" xlink:label="loc_rwlkPurchaseAgreementWithCertainInstitutionalInvestorsMember_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_rwlkPurchaseAgreementWithCertainInstitutionalInvestorsMember_450" xlink:type="arc" order="451" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaapRestrictedStockUnitsRSUMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockUnitsRSUMember_140" xlink:type="arc" order="141" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaapEmployeeStockOptionMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapEmployeeStockOptionMember_160" xlink:type="arc" order="161" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_KreosCapitalVMember" xlink:label="loc_rwlkKreosCapitalVMember_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_rwlkKreosCapitalVMember_230" xlink:type="arc" order="231" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_TypeofCurrencyAxis" xlink:label="loc_rwlkTypeofCurrencyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable" xlink:to="loc_rwlkTypeofCurrencyAxis" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_TypeofCurrencyDomain" xlink:label="loc_rwlkTypeofCurrencyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_rwlkTypeofCurrencyAxis" xlink:to="loc_rwlkTypeofCurrencyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_TypeofCurrencyDomain" xlink:label="loc_rwlkTypeofCurrencyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_rwlkTypeofCurrencyAxis" xlink:to="loc_rwlkTypeofCurrencyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_IsraeliMember" xlink:label="loc_rwlkIsraeliMember_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkTypeofCurrencyDomain" xlink:to="loc_rwlkIsraeliMember_300" xlink:type="arc" order="302" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_AdditionallyWarrantsIssuedMember" xlink:label="loc_rwlkAdditionallyWarrantsIssuedMember_470" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_rwlkAdditionallyWarrantsIssuedMember_470" xlink:type="arc" order="472" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ShareholdersEquityTextualAbstract" xlink:label="loc_rwlkShareholdersEquityTextualAbstract_520" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedGoodsAndNonemployeeServicesTransactionLineItems" xlink:to="loc_rwlkShareholdersEquityTextualAbstract_520" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="loc_us-gaapStockholdersEquityReverseStockSplit_520" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkShareholdersEquityTextualAbstract_520" xlink:to="loc_us-gaapStockholdersEquityReverseStockSplit_520" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_CommonStockAggregateOfferingPriceAuthorizedUnderEquityDistributionAgreement" xlink:label="loc_rwlkCommonStockAggregateOfferingPriceAuthorizedUnderEquityDistributionAgreement_520" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkShareholdersEquityTextualAbstract_520" xlink:to="loc_rwlkCommonStockAggregateOfferingPriceAuthorizedUnderEquityDistributionAgreement_520" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_CommonStockIssuanceCostsUnderEquityDistributionAgreementAsPercentOfGrossProceeds" xlink:label="loc_rwlkCommonStockIssuanceCostsUnderEquityDistributionAgreementAsPercentOfGrossProceeds_520" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkShareholdersEquityTextualAbstract_520" xlink:to="loc_rwlkCommonStockIssuanceCostsUnderEquityDistributionAgreementAsPercentOfGrossProceeds_520" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_520" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkShareholdersEquityTextualAbstract_520" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_520" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare_520" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkShareholdersEquityTextualAbstract_520" xlink:to="loc_us-gaapSharesIssuedPricePerShare_520" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_520" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkShareholdersEquityTextualAbstract_520" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_520" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_520" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkShareholdersEquityTextualAbstract_520" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_520" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_StockIssuedDuringPeriodPricePerShare" xlink:label="loc_rwlkStockIssuedDuringPeriodPricePerShare_520" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkShareholdersEquityTextualAbstract_520" xlink:to="loc_rwlkStockIssuedDuringPeriodPricePerShare_520" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_StockIssuedDuringPeriodValueNewIssuesGross" xlink:label="loc_rwlkStockIssuedDuringPeriodValueNewIssuesGross_520" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkShareholdersEquityTextualAbstract_520" xlink:to="loc_rwlkStockIssuedDuringPeriodValueNewIssuesGross_520" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_520" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkShareholdersEquityTextualAbstract_520" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_520" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_FixedCommissionRate" xlink:label="loc_rwlkFixedCommissionRate_520" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkShareholdersEquityTextualAbstract_520" xlink:to="loc_rwlkFixedCommissionRate_520" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_FixedCommissionAmount" xlink:label="loc_rwlkFixedCommissionAmount_520" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkShareholdersEquityTextualAbstract_520" xlink:to="loc_rwlkFixedCommissionAmount_520" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfStockIssuanceCosts_520" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkShareholdersEquityTextualAbstract_520" xlink:to="loc_us-gaapPaymentsOfStockIssuanceCosts_520" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_520" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkShareholdersEquityTextualAbstract_520" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_520" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_520" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkShareholdersEquityTextualAbstract_520" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_520" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_520" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkShareholdersEquityTextualAbstract_520" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_520" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_520" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkShareholdersEquityTextualAbstract_520" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_520" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardDescription_520" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkShareholdersEquityTextualAbstract_520" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardDescription_520" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance_520" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkShareholdersEquityTextualAbstract_520" xlink:to="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance_520" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_AggregateNumberOfOrdinaryShares" xlink:label="loc_rwlkAggregateNumberOfOrdinaryShares_520" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkShareholdersEquityTextualAbstract_520" xlink:to="loc_rwlkAggregateNumberOfOrdinaryShares_520" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_SharebasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsVestedAndOptionsNetBasisOfCommonStock" xlink:label="loc_rwlkSharebasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsVestedAndOptionsNetBasisOfCommonStock_520" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkShareholdersEquityTextualAbstract_520" xlink:to="loc_rwlkSharebasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsVestedAndOptionsNetBasisOfCommonStock_520" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_520" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkShareholdersEquityTextualAbstract_520" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_520" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_520" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkShareholdersEquityTextualAbstract_520" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_520" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_520" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkShareholdersEquityTextualAbstract_520" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_520" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_520" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkShareholdersEquityTextualAbstract_520" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_520" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_520" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkShareholdersEquityTextualAbstract_520" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_520" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable" xlink:label="loc_us-gaapClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable_520" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkShareholdersEquityTextualAbstract_520" xlink:to="loc_us-gaapClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable_520" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_WarrantsExercisableDescrition" xlink:label="loc_rwlkWarrantsExercisableDescrition_520" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkShareholdersEquityTextualAbstract_520" xlink:to="loc_rwlkWarrantsExercisableDescrition_520" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCollateralAmount" xlink:label="loc_us-gaapDebtInstrumentCollateralAmount_520" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkShareholdersEquityTextualAbstract_520" xlink:to="loc_us-gaapDebtInstrumentCollateralAmount_520" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpensesRelatedParty" xlink:label="loc_us-gaapCostsAndExpensesRelatedParty_520" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkShareholdersEquityTextualAbstract_520" xlink:to="loc_us-gaapCostsAndExpensesRelatedParty_520" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockPlans" xlink:label="loc_us-gaapProceedsFromStockPlans_520" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkShareholdersEquityTextualAbstract_520" xlink:to="loc_us-gaapProceedsFromStockPlans_520" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare" xlink:label="loc_us-gaapAcceleratedShareRepurchasesFinalPricePaidPerShare_520" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkShareholdersEquityTextualAbstract_520" xlink:to="loc_us-gaapAcceleratedShareRepurchasesFinalPricePaidPerShare_520" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction" xlink:label="loc_us-gaapSaleOfStockPercentageOfOwnershipAfterTransaction_520" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkShareholdersEquityTextualAbstract_520" xlink:to="loc_us-gaapSaleOfStockPercentageOfOwnershipAfterTransaction_520" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PartnersCapitalLimitationOfLiability" xlink:label="loc_us-gaapPartnersCapitalLimitationOfLiability_520" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkShareholdersEquityTextualAbstract_520" xlink:to="loc_us-gaapPartnersCapitalLimitationOfLiability_520" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_FeesAndOtherRelatedExpenses" xlink:label="loc_rwlkFeesAndOtherRelatedExpenses_520" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkShareholdersEquityTextualAbstract_520" xlink:to="loc_rwlkFeesAndOtherRelatedExpenses_520" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_NetAggregateProceedsOfAfterDeductingFeesAndOtherRelatedExpenses" xlink:label="loc_rwlkNetAggregateProceedsOfAfterDeductingFeesAndOtherRelatedExpenses_520" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkShareholdersEquityTextualAbstract_520" xlink:to="loc_rwlkNetAggregateProceedsOfAfterDeductingFeesAndOtherRelatedExpenses_520" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuritiesLoanedMeasurementDifferenceDescription" xlink:label="loc_us-gaapSecuritiesLoanedMeasurementDifferenceDescription_520" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkShareholdersEquityTextualAbstract_520" xlink:to="loc_us-gaapSecuritiesLoanedMeasurementDifferenceDescription_520" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="loc_us-gaapWarrantsAndRightsOutstanding_520" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkShareholdersEquityTextualAbstract_520" xlink:to="loc_us-gaapWarrantsAndRightsOutstanding_520" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_PrefundedWarrantsToPurchaseAggregateOrdinarySharesExercised" xlink:label="loc_rwlkPrefundedWarrantsToPurchaseAggregateOrdinarySharesExercised_520" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkShareholdersEquityTextualAbstract_520" xlink:to="loc_rwlkPrefundedWarrantsToPurchaseAggregateOrdinarySharesExercised_520" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_DescriptionOfUnderwritingAgreement" xlink:label="loc_rwlkDescriptionOfUnderwritingAgreement_520" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkShareholdersEquityTextualAbstract_520" xlink:to="loc_rwlkDescriptionOfUnderwritingAgreement_520" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_DescriptionOfUnderwritersWarrantsToPurchase" xlink:label="loc_rwlkDescriptionOfUnderwritersWarrantsToPurchase_520" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkShareholdersEquityTextualAbstract_520" xlink:to="loc_rwlkDescriptionOfUnderwritersWarrantsToPurchase_520" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement_520" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkShareholdersEquityTextualAbstract_520" xlink:to="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement_520" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_DescriptionOfWainwrightOrItsDesigneesWarrantsToPurchase" xlink:label="loc_rwlkDescriptionOfWainwrightOrItsDesigneesWarrantsToPurchase_520" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkShareholdersEquityTextualAbstract_520" xlink:to="loc_rwlkDescriptionOfWainwrightOrItsDesigneesWarrantsToPurchase_520" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_StockIssuedDuringPeriodShareOrdinaryShares" xlink:label="loc_rwlkStockIssuedDuringPeriodShareOrdinaryShares_520" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkShareholdersEquityTextualAbstract_520" xlink:to="loc_rwlkStockIssuedDuringPeriodShareOrdinaryShares_520" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_OrdinarySharesExercisePrice" xlink:label="loc_rwlkOrdinarySharesExercisePrice_520" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkShareholdersEquityTextualAbstract_520" xlink:to="loc_rwlkOrdinarySharesExercisePrice_520" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_520" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkShareholdersEquityTextualAbstract_520" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_520" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_DescriptionOfEquityExchangePrograms" xlink:label="loc_rwlkDescriptionOfEquityExchangePrograms_520" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkShareholdersEquityTextualAbstract_520" xlink:to="loc_rwlkDescriptionOfEquityExchangePrograms_520" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_WarrantsToPurchaseOrdinaryShares" xlink:label="loc_rwlkWarrantsToPurchaseOrdinaryShares_520" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkShareholdersEquityTextualAbstract_520" xlink:to="loc_rwlkWarrantsToPurchaseOrdinaryShares_520" xlink:type="arc" order="48" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://rewalk.com/role/ResearchCollaborationAgreementAndLicenseAgreementDetails" xlink:title="00000056 - Disclosure - RESEARCH COLLABORATION AGREEMENT AND LICENSE AGREEMENT (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:label="loc_us-gaapResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:label="loc_us-gaapScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="loc_us-gaapScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_AgreementAxis" xlink:label="loc_rwlkAgreementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:to="loc_rwlkAgreementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_AgreementDomain" xlink:label="loc_rwlkAgreementDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_rwlkAgreementAxis" xlink:to="loc_rwlkAgreementDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_AgreementDomain" xlink:label="loc_rwlkAgreementDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_rwlkAgreementAxis" xlink:to="loc_rwlkAgreementDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_LicenseAgreementAndCollaborationAgreementMember" xlink:label="loc_rwlkLicenseAgreementAndCollaborationAgreementMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkAgreementDomain" xlink:to="loc_rwlkLicenseAgreementAndCollaborationAgreementMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ResearchCollaborationAgreementAndLicenseAgreementTextualAbstract" xlink:label="loc_rwlkResearchCollaborationAgreementAndLicenseAgreementTextualAbstract_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="loc_rwlkResearchCollaborationAgreementAndLicenseAgreementTextualAbstract_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentPeriodicPayment" xlink:label="loc_us-gaapDebtInstrumentPeriodicPayment_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkResearchCollaborationAgreementAndLicenseAgreementTextualAbstract_40" xlink:to="loc_us-gaapDebtInstrumentPeriodicPayment_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkResearchCollaborationAgreementAndLicenseAgreementTextualAbstract_40" xlink:to="loc_us-gaapResearchAndDevelopmentExpense_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkResearchCollaborationAgreementAndLicenseAgreementTextualAbstract_40" xlink:to="loc_us-gaapDebtInstrumentMaturityDate_40" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://rewalk.com/role/PaycheckProtectionProgramLoanDetailsTextual" xlink:title="00000057 - Disclosure - PAYCHECK PROTECTION PROGRAM LOAN (Details Textual)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaapDebtInstrumentLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaapDebtInstrumentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapDebtInstrumentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_PaycheckProtectionProgramLoanMember" xlink:label="loc_rwlkPaycheckProtectionProgramLoanMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_rwlkPaycheckProtectionProgramLoanMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_SiliconValleyBankMember" xlink:label="loc_rwlkSiliconValleyBankMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_rwlkSiliconValleyBankMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnsecuredDebt" xlink:label="loc_us-gaapUnsecuredDebt_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapUnsecuredDebt_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTerm" xlink:label="loc_us-gaapDebtInstrumentTerm_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentTerm_30" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://rewalk.com/role/IncomeTaxesDetails" xlink:title="00000058 - Disclosure - INCOME TAXES (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://rewalk.com/role/IncomeTaxesDetails1" xlink:title="00000059 - Disclosure - INCOME TAXES (Details 1)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://rewalk.com/role/IncomeTaxesDetails2" xlink:title="00000060 - Disclosure - INCOME TAXES (Details 2)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://rewalk.com/role/IncomeTaxesDetails3" xlink:title="00000061 - Disclosure - INCOME TAXES (Details 3)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://rewalk.com/role/IncomeTaxesDetails4" xlink:title="00000062 - Disclosure - INCOME TAXES (Details 4)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://rewalk.com/role/IncomeTaxesDetailsTextual" xlink:title="00000063 - Disclosure - INCOME TAXES (Details Textual)">
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ScheduleOfIncomeTaxLineItems" xlink:label="loc_rwlkScheduleOfIncomeTaxLineItems" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ScheduleOfIncomeTaxTable" xlink:label="loc_rwlkScheduleOfIncomeTaxTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_rwlkScheduleOfIncomeTaxLineItems" xlink:to="loc_rwlkScheduleOfIncomeTaxTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_rwlkScheduleOfIncomeTaxTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ReWalkRoboticsIncMember" xlink:label="loc_rwlkReWalkRoboticsIncMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_rwlkReWalkRoboticsIncMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ReWalkRoboticsGMBHMember" xlink:label="loc_rwlkReWalkRoboticsGMBHMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_rwlkReWalkRoboticsGMBHMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_rwlkScheduleOfIncomeTaxTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_130" xlink:type="arc" order="131" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis" xlink:label="loc_us-gaapIncomeTaxAuthorityNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_rwlkScheduleOfIncomeTaxTable" xlink:to="loc_us-gaapIncomeTaxAuthorityNameAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeTaxAuthorityNameAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeTaxAuthorityNameAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IsraelTaxAuthorityMember" xlink:label="loc_us-gaapIsraelTaxAuthorityMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeTaxAuthorityNameDomain" xlink:to="loc_us-gaapIsraelTaxAuthorityMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_IncomeTaxesTextualAbstract" xlink:label="loc_rwlkIncomeTaxesTextualAbstract_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkScheduleOfIncomeTaxLineItems" xlink:to="loc_rwlkIncomeTaxesTextualAbstract_190" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkIncomeTaxesTextualAbstract_190" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_190" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCutsAndJobsActOf2017ChangeInTaxRateDeferredTaxAssetIncomeTaxExpense" xlink:label="loc_us-gaapTaxCutsAndJobsActOf2017ChangeInTaxRateDeferredTaxAssetIncomeTaxExpense_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkIncomeTaxesTextualAbstract_190" xlink:to="loc_us-gaapTaxCutsAndJobsActOf2017ChangeInTaxRateDeferredTaxAssetIncomeTaxExpense_190" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_BeneficiaryEnterprisefromProductiveActivityTaxExemptionPeriod" xlink:label="loc_rwlkBeneficiaryEnterprisefromProductiveActivityTaxExemptionPeriod_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkIncomeTaxesTextualAbstract_190" xlink:to="loc_rwlkBeneficiaryEnterprisefromProductiveActivityTaxExemptionPeriod_190" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_BeneficiaryEnterprisefromProductiveActivityMaximumTimefromPeriodofElectionforTaxExemption" xlink:label="loc_rwlkBeneficiaryEnterprisefromProductiveActivityMaximumTimefromPeriodofElectionforTaxExemption_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkIncomeTaxesTextualAbstract_190" xlink:to="loc_rwlkBeneficiaryEnterprisefromProductiveActivityMaximumTimefromPeriodofElectionforTaxExemption_190" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_BeneficiaryEnterprisefromProductiveActivityTaxRateonDividendDistributionsfromTaxExemptIncome" xlink:label="loc_rwlkBeneficiaryEnterprisefromProductiveActivityTaxRateonDividendDistributionsfromTaxExemptIncome_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkIncomeTaxesTextualAbstract_190" xlink:to="loc_rwlkBeneficiaryEnterprisefromProductiveActivityTaxRateonDividendDistributionsfromTaxExemptIncome_190" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaapOperatingLossCarryforwards_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkIncomeTaxesTextualAbstract_190" xlink:to="loc_us-gaapOperatingLossCarryforwards_190" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_DescriptionOfIncomeTaxLawForEncouragementOfCapitalInvestments" xlink:label="loc_rwlkDescriptionOfIncomeTaxLawForEncouragementOfCapitalInvestments_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkIncomeTaxesTextualAbstract_190" xlink:to="loc_rwlkDescriptionOfIncomeTaxLawForEncouragementOfCapitalInvestments_190" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_NetOperatingCarryForwardLossesTerms" xlink:label="loc_rwlkNetOperatingCarryForwardLossesTerms_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rwlkIncomeTaxesTextualAbstract_190" xlink:to="loc_rwlkNetOperatingCarryForwardLossesTerms_190" xlink:type="arc" order="8" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://rewalk.com/role/FinancialExpensesNetDetails" xlink:title="00000064 - Disclosure - FINANCIAL EXPENSES, NET (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails" xlink:title="00000065 - Disclosure - GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:label="loc_us-gaapEntityWideRevenueMajorCustomerLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:label="loc_us-gaapScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapEntityWideRevenueMajorCustomerLineItems" xlink:to="loc_us-gaapScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:to="loc_srtStatementGeographicalAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_IL" xlink:label="loc_countryIL_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryIL_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US" xlink:label="loc_countryUS_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryUS_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EuropeMember" xlink:label="loc_srtEuropeMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_srtEuropeMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_AsiaPacificMember" xlink:label="loc_srtAsiaPacificMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_srtAsiaPacificMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LatinAmericaMember" xlink:label="loc_srtLatinAmericaMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_srtLatinAmericaMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_AfricaMember" xlink:label="loc_srtAfricaMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_srtAfricaMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEntityWideRevenueMajorCustomerLineItems" xlink:to="loc_us-gaapRevenues_220" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails1" xlink:title="00000066 - Disclosure - GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA (Details 1)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="loc_srtStatementGeographicalAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_IL" xlink:label="loc_countryIL_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryIL_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US" xlink:label="loc_countryUS_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryUS_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_DE" xlink:label="loc_countryDE_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryDE_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_90" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails2" xlink:title="00000067 - Disclosure - GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA (Details 2)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:label="loc_us-gaapEntityWideRevenueMajorCustomerLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:label="loc_us-gaapScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapEntityWideRevenueMajorCustomerLineItems" xlink:to="loc_us-gaapScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis" xlink:label="loc_srtMajorCustomersAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:to="loc_srtMajorCustomersAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_CustomerAMember" xlink:label="loc_rwlkCustomerAMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_rwlkCustomerAMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaapSalesRevenueNetMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapSalesRevenueNetMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEntityWideRevenueMajorCustomerLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1_40" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetailsTextual" xlink:title="00000068 - Disclosure - GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA (Details Textual)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://rewalk.com/role/SubsequentEventsDetails" xlink:title="00000069 - Disclosure - SUBSEQUENT EVENTS (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaapProceedsFromWarrantExercises_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromWarrantExercises_50" xlink:type="arc" order="2" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>14
<FILENAME>rwlk-20201231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoXBRL; Version: 5.6b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Source; Value: RWLK 1220 10K.xfr; Date: 2021%2D02%2D18T13:24:26Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_StatementGeographicalAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementGeographicalAxis_lbl" xml:lang="en-US">Geographical [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_IL" xlink:label="country_IL" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_IL" xlink:to="country_IL_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_IL_lbl" xml:lang="en-US">Israel [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US" xlink:label="country_US" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_US" xlink:to="country_US_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_US_lbl" xml:lang="en-US">United States [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_DE" xlink:label="country_DE" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_DE" xlink:to="country_DE_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_DE_lbl" xml:lang="en-US">Germany [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EuropeMember" xlink:label="srt_EuropeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_EuropeMember" xlink:to="srt_EuropeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_EuropeMember_lbl" xml:lang="en-US">Europe [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_AsiaPacificMember" xlink:label="srt_AsiaPacificMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_AsiaPacificMember" xlink:to="srt_AsiaPacificMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_AsiaPacificMember_lbl" xml:lang="en-US">Asia Pacific [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LatinAmericaMember" xlink:label="srt_LatinAmericaMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_LatinAmericaMember" xlink:to="srt_LatinAmericaMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_LatinAmericaMember_lbl" xml:lang="en-US">Latin America [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_RevenueObligationAxis" xlink:label="rwlk_RevenueObligationAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_RevenueObligationAxis" xlink:to="rwlk_RevenueObligationAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_RevenueObligationAxis_lbl" xml:lang="en-US">Revenue Obligation [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_UnitsPlacedMember" xlink:label="rwlk_UnitsPlacedMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_UnitsPlacedMember" xlink:to="rwlk_UnitsPlacedMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_UnitsPlacedMember_lbl" xml:lang="en-US">Units Placed [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_SparePartsAndWarrantiesMember" xlink:label="rwlk_SparePartsAndWarrantiesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_SparePartsAndWarrantiesMember" xlink:to="rwlk_SparePartsAndWarrantiesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_SparePartsAndWarrantiesMember_lbl" xml:lang="en-US">Spare parts and warranties [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_AfricaMember" xlink:label="srt_AfricaMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_AfricaMember" xlink:to="srt_AfricaMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_AfricaMember_lbl" xml:lang="en-US">Africa [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_AgreementAxis" xlink:label="rwlk_AgreementAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_AgreementAxis" xlink:to="rwlk_AgreementAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_AgreementAxis_lbl" xml:lang="en-US">Agreement [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_LicenseAgreementAndCollaborationAgreementMember" xlink:label="rwlk_LicenseAgreementAndCollaborationAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_LicenseAgreementAndCollaborationAgreementMember" xlink:to="rwlk_LicenseAgreementAndCollaborationAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_LicenseAgreementAndCollaborationAgreementMember_lbl" xml:lang="en-US">License Agreement and Collaboration Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis" xlink:label="srt_MajorCustomersAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_MajorCustomersAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MajorCustomersAxis_lbl" xml:lang="en-US">Customer [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_CustomerAMember" xlink:label="rwlk_CustomerAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_CustomerAMember" xlink:to="rwlk_CustomerAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_CustomerAMember_lbl" xml:lang="en-US">Customer A [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_CustomerBMember" xlink:label="rwlk_CustomerBMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_CustomerBMember" xlink:to="rwlk_CustomerBMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_CustomerBMember_lbl" xml:lang="en-US">Customer B [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_CustomerCMember" xlink:label="rwlk_CustomerCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_CustomerCMember" xlink:to="rwlk_CustomerCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_CustomerCMember_lbl" xml:lang="en-US">Customer C [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_CustomerDMember" xlink:label="rwlk_CustomerDMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_CustomerDMember" xlink:to="rwlk_CustomerDMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_CustomerDMember_lbl" xml:lang="en-US">Customer D [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_CustomerEMember" xlink:label="rwlk_CustomerEMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_CustomerEMember" xlink:to="rwlk_CustomerEMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_CustomerEMember_lbl" xml:lang="en-US">Customer E [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_CustomerFMember" xlink:label="rwlk_CustomerFMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_CustomerFMember" xlink:to="rwlk_CustomerFMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_CustomerFMember_lbl" xml:lang="en-US">Customer F [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_CustomerGMember" xlink:label="rwlk_CustomerGMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_CustomerGMember" xlink:to="rwlk_CustomerGMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_CustomerGMember_lbl" xml:lang="en-US">Customer G [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_CustomerHMember" xlink:label="rwlk_CustomerHMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_CustomerHMember" xlink:to="rwlk_CustomerHMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_CustomerHMember_lbl" xml:lang="en-US">Customer H [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_CustomerIMember" xlink:label="rwlk_CustomerIMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_CustomerIMember" xlink:to="rwlk_CustomerIMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_CustomerIMember_lbl" xml:lang="en-US">Customer I [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_CustomerJMember" xlink:label="rwlk_CustomerJMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_CustomerJMember" xlink:to="rwlk_CustomerJMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_CustomerJMember_lbl" xml:lang="en-US">Customer J [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_CustomerKMember" xlink:label="rwlk_CustomerKMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_CustomerKMember" xlink:to="rwlk_CustomerKMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_CustomerKMember_lbl" xml:lang="en-US">Customer K [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xml:lang="en-US">Related Party [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_YaskawaElectricCorporationMember" xlink:label="rwlk_YaskawaElectricCorporationMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_YaskawaElectricCorporationMember" xlink:to="rwlk_YaskawaElectricCorporationMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_YaskawaElectricCorporationMember_lbl" xml:lang="en-US">YEC [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="us-gaap_SalesRevenueNetMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueNetMember" xlink:to="us-gaap_SalesRevenueNetMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesRevenueNetMember_lbl" xml:lang="en-US">Sales Revenue, Net [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_CustomerLMember" xlink:label="rwlk_CustomerLMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_CustomerLMember" xlink:to="rwlk_CustomerLMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_CustomerLMember_lbl" xml:lang="en-US">Customer L [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US">Award Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_EmployeeStockOptionAndRestrictedStockUnitsRsuMember" xlink:label="rwlk_EmployeeStockOptionAndRestrictedStockUnitsRsuMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_EmployeeStockOptionAndRestrictedStockUnitsRsuMember" xlink:to="rwlk_EmployeeStockOptionAndRestrictedStockUnitsRsuMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_EmployeeStockOptionAndRestrictedStockUnitsRsuMember_lbl" xml:lang="en-US">Employee Stock Option And Restricted Stock Units Rsu [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xml:lang="en-US">Employee Stock Option [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lbl" xml:lang="en-US">Exercise Price Range [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ExercisePriceRangeTwoMember" xlink:label="rwlk_ExercisePriceRangeTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ExercisePriceRangeTwoMember" xlink:to="rwlk_ExercisePriceRangeTwoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_ExercisePriceRangeTwoMember_lbl" xml:lang="en-US">$20.42- $33.75 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ExercisePriceRangeThreeMember" xlink:label="rwlk_ExercisePriceRangeThreeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ExercisePriceRangeThreeMember" xlink:to="rwlk_ExercisePriceRangeThreeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_ExercisePriceRangeThreeMember_lbl" xml:lang="en-US">$37.14-$38.75 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ExercisePriceRangeFiveMember" xlink:label="rwlk_ExercisePriceRangeFiveMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ExercisePriceRangeFiveMember" xlink:to="rwlk_ExercisePriceRangeFiveMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_ExercisePriceRangeFiveMember_lbl" xml:lang="en-US">$182.5-$524.25 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ExercisePriceRangeFourMember" xlink:label="rwlk_ExercisePriceRangeFourMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ExercisePriceRangeFourMember" xlink:to="rwlk_ExercisePriceRangeFourMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_ExercisePriceRangeFourMember_lbl" xml:lang="en-US">$50-$52.5 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ExercisePriceRangeOneMember" xlink:label="rwlk_ExercisePriceRangeOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ExercisePriceRangeOneMember" xlink:to="rwlk_ExercisePriceRangeOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_ExercisePriceRangeOneMember_lbl" xml:lang="en-US">5.37 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ExercisePriceRangeMember" xlink:label="rwlk_ExercisePriceRangeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ExercisePriceRangeMember" xlink:to="rwlk_ExercisePriceRangeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_ExercisePriceRangeMember_lbl" xml:lang="en-US">RSUs only [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_lbl" xml:lang="en-US">Class of Warrant or Right [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwoThousandSixteenMember" xlink:label="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwoThousandSixteenMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwoThousandSixteenMember" xlink:to="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwoThousandSixteenMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwoThousandSixteenMember_lbl" xml:lang="en-US">November 1, 2016 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandSixteenMember" xlink:label="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandSixteenMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandSixteenMember" xlink:to="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandSixteenMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandSixteenMember_lbl" xml:lang="en-US">December 28, 2016 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandFifteenMember" xlink:label="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandFifteenMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandFifteenMember" xlink:to="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandFifteenMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandFifteenMember_lbl" xml:lang="en-US">December 31, 2015 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenMember" xlink:label="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenMember" xlink:to="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenMember_lbl" xml:lang="en-US">November 20, 2018 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenOneMember" xlink:label="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenOneMember" xlink:to="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenOneMember_lbl" xml:lang="en-US">November 20, 2018 One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentyFiveTwoThousandNineteenMember" xlink:label="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentyFiveTwoThousandNineteenMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentyFiveTwoThousandNineteenMember" xlink:to="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentyFiveTwoThousandNineteenMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentyFiveTwoThousandNineteenMember_lbl" xml:lang="en-US">February 25, 2019 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenMember" xlink:label="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenMember" xlink:to="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenMember_lbl" xml:lang="en-US">April 5, 2019 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenOneMember" xlink:label="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenOneMember" xlink:to="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenOneMember_lbl" xml:lang="en-US">April 5, 2019 One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveAndSixTwoThousandNineteenMember" xlink:label="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveAndSixTwoThousandNineteenMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveAndSixTwoThousandNineteenMember" xlink:to="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveAndSixTwoThousandNineteenMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveAndSixTwoThousandNineteenMember_lbl" xml:lang="en-US">June 5, 2019 and June 6, 2019 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveTwoThousandNineteenMember" xlink:label="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveTwoThousandNineteenMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveTwoThousandNineteenMember" xlink:to="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveTwoThousandNineteenMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveTwoThousandNineteenMember_lbl" xml:lang="en-US">June 5, 2019 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTweleveTwoThousandNineteenMember" xlink:label="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTweleveTwoThousandNineteenMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTweleveTwoThousandNineteenMember" xlink:to="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTweleveTwoThousandNineteenMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTweleveTwoThousandNineteenMember_lbl" xml:lang="en-US">June 12, 2019 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTenTwoThousandNineteenMember" xlink:label="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTenTwoThousandNineteenMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTenTwoThousandNineteenMember" xlink:to="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTenTwoThousandNineteenMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTenTwoThousandNineteenMember_lbl" xml:lang="en-US">June 10, 2019 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_KreosCapitalMember" xlink:label="rwlk_KreosCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_KreosCapitalMember" xlink:to="rwlk_KreosCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_KreosCapitalMember_lbl" xml:lang="en-US">Kreos Capital [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_SecuritiesPurchaseAgreementsMember" xlink:label="rwlk_SecuritiesPurchaseAgreementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_SecuritiesPurchaseAgreementsMember" xlink:to="rwlk_SecuritiesPurchaseAgreementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_SecuritiesPurchaseAgreementsMember_lbl" xml:lang="en-US">Securities Purchase Agreements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xml:lang="en-US">Income Statement Location [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingAndMarketingExpenseMember" xlink:label="us-gaap_SellingAndMarketingExpenseMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingAndMarketingExpenseMember" xlink:to="us-gaap_SellingAndMarketingExpenseMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingAndMarketingExpenseMember_lbl" xml:lang="en-US">Sales and marketing, net [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xml:lang="en-US">Research and development, net [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember" xlink:label="us-gaap_CostOfSalesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfSalesMember" xlink:to="us-gaap_CostOfSalesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfSalesMember_lbl" xml:lang="en-US">Cost of revenues [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xml:lang="en-US">General and administrative [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_TitleOfIndividualAxis_lbl" xml:lang="en-US">Title of Individual [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_EmployeesAndNonEmployeesMember" xlink:label="rwlk_EmployeesAndNonEmployeesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_EmployeesAndNonEmployeesMember" xlink:to="rwlk_EmployeesAndNonEmployeesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_EmployeesAndNonEmployeesMember_lbl" xml:lang="en-US">Employees and non- employees [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xml:lang="en-US">Sale of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrivatePlacementMember" xlink:to="us-gaap_PrivatePlacementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrivatePlacementMember_lbl" xml:lang="en-US">Private Placement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LegalEntityAxis_lbl" xml:lang="en-US">Legal Entity [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_KreosCapitalVMember" xlink:label="rwlk_KreosCapitalVMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_KreosCapitalVMember" xlink:to="rwlk_KreosCapitalVMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_KreosCapitalVMember_lbl" xml:lang="en-US">Kreos Capital V [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_TimwellCorporationLimitedMember" xlink:label="rwlk_TimwellCorporationLimitedMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_TimwellCorporationLimitedMember" xlink:to="rwlk_TimwellCorporationLimitedMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_TimwellCorporationLimitedMember_lbl" xml:lang="en-US">Timwell Corporation Limited [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_AtmOfferingProgramMember" xlink:label="rwlk_AtmOfferingProgramMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_AtmOfferingProgramMember" xlink:to="rwlk_AtmOfferingProgramMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_AtmOfferingProgramMember_lbl" xml:lang="en-US">Atm Offering Program [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockUnitsRSUMember" xlink:to="us-gaap_RestrictedStockUnitsRSUMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xml:lang="en-US">Debt Instrument [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_FirstAmendmentMember" xlink:label="rwlk_FirstAmendmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_FirstAmendmentMember" xlink:to="rwlk_FirstAmendmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_FirstAmendmentMember_lbl" xml:lang="en-US">First Amendment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongtermDebtTypeAxis_lbl" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuredDebtMember" xlink:label="us-gaap_SecuredDebtMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SecuredDebtMember" xlink:to="us-gaap_SecuredDebtMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SecuredDebtMember_lbl" xml:lang="en-US">Secured Debt [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_WarrantsToPurchaseOrdinarySharesIssuedMember" xlink:label="rwlk_WarrantsToPurchaseOrdinarySharesIssuedMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_WarrantsToPurchaseOrdinarySharesIssuedMember" xlink:to="rwlk_WarrantsToPurchaseOrdinarySharesIssuedMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_WarrantsToPurchaseOrdinarySharesIssuedMember_lbl" xml:lang="en-US">Warrants To Purchase Ordinary Shares[Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_TypeofCurrencyAxis" xlink:label="rwlk_TypeofCurrencyAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_TypeofCurrencyAxis" xlink:to="rwlk_TypeofCurrencyAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_TypeofCurrencyAxis_lbl" xml:lang="en-US">Type of Currency [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_IsraeliMember" xlink:label="rwlk_IsraeliMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_IsraeliMember" xlink:to="rwlk_IsraeliMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_IsraeliMember_lbl" xml:lang="en-US">Israeli [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Ordinary Share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional paid-in capital [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Accumulated deficit [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_FieldServiceUnitsMember" xlink:label="rwlk_FieldServiceUnitsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_FieldServiceUnitsMember" xlink:to="rwlk_FieldServiceUnitsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_FieldServiceUnitsMember_lbl" xml:lang="en-US">Field service units [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xml:lang="en-US">Leasehold improvements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="us-gaap_ComputerEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComputerEquipmentMember" xlink:to="us-gaap_ComputerEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComputerEquipmentMember_lbl" xml:lang="en-US">Computer equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeAxis_lbl" xml:lang="en-US">Range [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MinimumMember_lbl" xml:lang="en-US">Minimum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MaximumMember_lbl" xml:lang="en-US">Maximum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FurnitureAndFixturesMember" xlink:to="us-gaap_FurnitureAndFixturesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xml:lang="en-US">Office furniture and equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_MachineryAndLaboratoryEquipmentMember" xlink:label="rwlk_MachineryAndLaboratoryEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_MachineryAndLaboratoryEquipmentMember" xlink:to="rwlk_MachineryAndLaboratoryEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_MachineryAndLaboratoryEquipmentMember_lbl" xml:lang="en-US">Machinery and laboratory equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl" xml:lang="en-US">Adjustments for New Accounting Pronouncements [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201609Member" xlink:label="us-gaap_AccountingStandardsUpdate201609Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingStandardsUpdate201609Member" xlink:to="us-gaap_AccountingStandardsUpdate201609Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingStandardsUpdate201609Member_lbl" xml:lang="en-US">Accounting Standards Update 2016-09 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_SecondAmendmentMember" xlink:label="rwlk_SecondAmendmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_SecondAmendmentMember" xlink:to="rwlk_SecondAmendmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_SecondAmendmentMember_lbl" xml:lang="en-US">Second Amendment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_RrlAndRrgMember" xlink:label="rwlk_RrlAndRrgMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_RrlAndRrgMember" xlink:to="rwlk_RrlAndRrgMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_RrlAndRrgMember_lbl" xml:lang="en-US">RRL and RRG [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis" xlink:label="us-gaap_IncomeTaxAuthorityNameAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="us-gaap_IncomeTaxAuthorityNameAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxAuthorityNameAxis_lbl" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IsraelTaxAuthorityMember" xlink:label="us-gaap_IsraelTaxAuthorityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IsraelTaxAuthorityMember" xlink:to="us-gaap_IsraelTaxAuthorityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IsraelTaxAuthorityMember_lbl" xml:lang="en-US">Israel Tax Authority [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ReWalkRoboticsGMBHMember" xlink:label="rwlk_ReWalkRoboticsGMBHMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ReWalkRoboticsGMBHMember" xlink:to="rwlk_ReWalkRoboticsGMBHMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_ReWalkRoboticsGMBHMember_lbl" xml:lang="en-US">ReWalk Robotics GMBH [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ReWalkRoboticsIncMember" xlink:label="rwlk_ReWalkRoboticsIncMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ReWalkRoboticsIncMember" xlink:to="rwlk_ReWalkRoboticsIncMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_ReWalkRoboticsIncMember_lbl" xml:lang="en-US">ReWalk Robotics Inc [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_BestOfferingMember" xlink:label="rwlk_BestOfferingMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_BestOfferingMember" xlink:to="rwlk_BestOfferingMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_BestOfferingMember_lbl" xml:lang="en-US">Best Offering [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_RegisteredDirectMember" xlink:label="rwlk_RegisteredDirectMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_RegisteredDirectMember" xlink:to="rwlk_RegisteredDirectMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_RegisteredDirectMember_lbl" xml:lang="en-US">Registered Direct [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_WarrantExerciseMember" xlink:label="rwlk_WarrantExerciseMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_WarrantExerciseMember" xlink:to="rwlk_WarrantExerciseMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_WarrantExerciseMember_lbl" xml:lang="en-US">Warrant Exercise [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_InvestmentAgreementMember" xlink:label="rwlk_InvestmentAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_InvestmentAgreementMember" xlink:to="rwlk_InvestmentAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_InvestmentAgreementMember_lbl" xml:lang="en-US">Investment Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_RegisteredDirectOfferingMember" xlink:label="rwlk_RegisteredDirectOfferingMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_RegisteredDirectOfferingMember" xlink:to="rwlk_RegisteredDirectOfferingMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="rwlk_RegisteredDirectOfferingMember_lbl" xml:lang="en-US">Registered Direct [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_PublicStockOfferingMember" xlink:label="rwlk_PublicStockOfferingMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_PublicStockOfferingMember" xlink:to="rwlk_PublicStockOfferingMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_PublicStockOfferingMember_lbl" xml:lang="en-US">Follow-on Public Offering [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductOrServiceAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ProductOrServiceAxis_lbl" xml:lang="en-US">Product and Service [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ReStoreProductMember" xlink:label="rwlk_ReStoreProductMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ReStoreProductMember" xlink:to="rwlk_ReStoreProductMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_ReStoreProductMember_lbl" xml:lang="en-US">ReStore product [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_SCIProductsMember" xlink:label="rwlk_SCIProductsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_SCIProductsMember" xlink:to="rwlk_SCIProductsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_SCIProductsMember_lbl" xml:lang="en-US">SCI Products [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_IsraelUSBinationalIndustrialResearchAndDevelopmentFoundationMember" xlink:label="rwlk_IsraelUSBinationalIndustrialResearchAndDevelopmentFoundationMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_IsraelUSBinationalIndustrialResearchAndDevelopmentFoundationMember" xlink:to="rwlk_IsraelUSBinationalIndustrialResearchAndDevelopmentFoundationMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_IsraelUSBinationalIndustrialResearchAndDevelopmentFoundationMember_lbl" xml:lang="en-US">Israel US Binational Industrial Research And Development Foundation [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_IsraelInnovationAuthorityMember" xlink:label="rwlk_IsraelInnovationAuthorityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_IsraelInnovationAuthorityMember" xlink:to="rwlk_IsraelInnovationAuthorityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_IsraelInnovationAuthorityMember_lbl" xml:lang="en-US">Israel Innovation Authority [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="us-gaap_ConvertiblePreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertiblePreferredStockMember" xlink:to="us-gaap_ConvertiblePreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertiblePreferredStockMember_lbl" xml:lang="en-US">Convertible preferred A shares [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IPOMember" xlink:to="us-gaap_IPOMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IPOMember_lbl" xml:lang="en-US">IPO [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_EquityExchangeProgramMember" xlink:label="rwlk_EquityExchangeProgramMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_EquityExchangeProgramMember" xlink:to="rwlk_EquityExchangeProgramMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_EquityExchangeProgramMember_lbl" xml:lang="en-US">Equity Exchange Program [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_PaycheckProtectionProgramLoanMember" xlink:label="rwlk_PaycheckProtectionProgramLoanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_PaycheckProtectionProgramLoanMember" xlink:to="rwlk_PaycheckProtectionProgramLoanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_PaycheckProtectionProgramLoanMember_lbl" xml:lang="en-US">Paycheck Protection Program Loan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_SiliconValleyBankMember" xlink:label="rwlk_SiliconValleyBankMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_SiliconValleyBankMember" xlink:to="rwlk_SiliconValleyBankMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_SiliconValleyBankMember_lbl" xml:lang="en-US">Silicon Valley Bank [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyMember" xlink:label="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyMember" xlink:to="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyMember_lbl" xml:lang="en-US">February 10, 2020 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyOneMember" xlink:label="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyOneMember" xlink:to="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyOneMember_lbl" xml:lang="en-US">February 10, 2020 One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyMember" xlink:label="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyMember" xlink:to="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyMember_lbl" xml:lang="en-US">July 6, 2020 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyOneMember" xlink:label="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyOneMember" xlink:to="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyOneMember_lbl" xml:lang="en-US">July 6, 2020 One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberThreeTwoThousandTwentyMember" xlink:label="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberThreeTwoThousandTwentyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberThreeTwoThousandTwentyMember" xlink:to="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberThreeTwoThousandTwentyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberThreeTwoThousandTwentyMember_lbl" xml:lang="en-US">December 3, 2020 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberThreeTwoThousandTwentyOneMember" xlink:label="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberThreeTwoThousandTwentyOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberThreeTwoThousandTwentyOneMember" xlink:to="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberThreeTwoThousandTwentyOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberThreeTwoThousandTwentyOneMember_lbl" xml:lang="en-US">December 3, 2020 One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_CommonUnitsAndPreFundedUnitsMember" xlink:label="rwlk_CommonUnitsAndPreFundedUnitsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_CommonUnitsAndPreFundedUnitsMember" xlink:to="rwlk_CommonUnitsAndPreFundedUnitsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_CommonUnitsAndPreFundedUnitsMember_lbl" xml:lang="en-US">Common units and pre-funded units [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_CommonUnitsMember" xlink:label="rwlk_CommonUnitsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_CommonUnitsMember" xlink:to="rwlk_CommonUnitsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_CommonUnitsMember_lbl" xml:lang="en-US">Common units [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_PreFundedUnitsMember" xlink:label="rwlk_PreFundedUnitsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_PreFundedUnitsMember" xlink:to="rwlk_PreFundedUnitsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_PreFundedUnitsMember_lbl" xml:lang="en-US">Pre-funded units [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_CommonUnitsAndPreFundedUnits1Member" xlink:label="rwlk_CommonUnitsAndPreFundedUnits1Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_CommonUnitsAndPreFundedUnits1Member" xlink:to="rwlk_CommonUnitsAndPreFundedUnits1Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_CommonUnitsAndPreFundedUnits1Member_lbl" xml:lang="en-US">Common units and pre-funded units one [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_PurchaseAgreementWithCertainInstitutionalInvestorsMember" xlink:label="rwlk_PurchaseAgreementWithCertainInstitutionalInvestorsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_PurchaseAgreementWithCertainInstitutionalInvestorsMember" xlink:to="rwlk_PurchaseAgreementWithCertainInstitutionalInvestorsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_PurchaseAgreementWithCertainInstitutionalInvestorsMember_lbl" xml:lang="en-US">Purchase agreement with certain institutional investors [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_AdditionallyWarrantsIssuedMember" xlink:label="rwlk_AdditionallyWarrantsIssuedMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_AdditionallyWarrantsIssuedMember" xlink:to="rwlk_AdditionallyWarrantsIssuedMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_AdditionallyWarrantsIssuedMember_lbl" xml:lang="en-US">Additionally Warrants Issued [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_StatementScenarioAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementScenarioAxis_lbl" xml:lang="en-US">Scenario [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_PreFundedMember" xlink:label="rwlk_PreFundedMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_PreFundedMember" xlink:to="rwlk_PreFundedMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_PreFundedMember_lbl" xml:lang="en-US">Pre-Funded [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US">Subsequent Event [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_DocumentAndEntityInformationAbstract" xlink:label="rwlk_DocumentAndEntityInformationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_DocumentAndEntityInformationAbstract" xlink:to="rwlk_DocumentAndEntityInformationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_DocumentAndEntityInformationAbstract_lbl" xml:lang="en-US">Document and Entity Information [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation State Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">CURRENT ASSETS:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xml:lang="en-US">Trade receivable, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryNet_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="us-gaap_AssetsNoncurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_AssetsNoncurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsNoncurrentAbstract_lbl" xml:lang="en-US">LONG-TERM ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xml:lang="en-US">Restricted cash and other long term assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xml:lang="en-US">Operating lease right-of-use assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Property and equipment, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsNoncurrent" xlink:label="us-gaap_AssetsNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_AssetsNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsNoncurrent_lbl" xml:lang="en-US">Total long-term assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Total assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">LIABILITIES AND SHAREHOLDERS' EQUITY</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">CURRENT LIABILITIES:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="us-gaap_LongTermDebtCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtCurrent" xlink:to="us-gaap_LongTermDebtCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtCurrent_lbl" xml:lang="en-US">Current maturities of long-term loan</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xml:lang="en-US">Current maturities of operating leases liability</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Trade payables</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xml:lang="en-US">Employees and payroll accruals</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="us-gaap_DeferredRevenueCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueCurrent" xlink:to="us-gaap_DeferredRevenueCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRevenueCurrent_lbl" xml:lang="en-US">Deferred revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl" xml:lang="en-US">Other current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xml:lang="en-US">LONG-TERM LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_LongTermDebtNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtNoncurrent" xlink:to="us-gaap_LongTermDebtNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtNoncurrent_lbl" xml:lang="en-US">Long term loan, net of current maturities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="us-gaap_DeferredRevenueNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueNoncurrent" xlink:to="us-gaap_DeferredRevenueNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredRevenueNoncurrent_lbl" xml:lang="en-US">Deferred revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xml:lang="en-US">Non-current operating leases liability</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesNoncurrent" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xml:lang="en-US">Other long-term liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="us-gaap_LiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesNoncurrent_lbl" xml:lang="en-US">Total long-term liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">Total liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US">COMMITMENTS AND CONTINGENT LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">Shareholders' equity:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Share capital Ordinary share of NIS 0.25 par value-Authorized: 60,000,000 shares at December 31, 2020 and 2019; Issued and outstanding: 25,332,225 and 7,319,560 shares at December 31, 2020 and December 31, 2019, respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Additional paid-in capital</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total shareholders' equity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total liabilities and shareholders' equity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Ordinary shares, par value (in NIS per share)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Ordinary shares, authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Ordinary shares, issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Ordinary shares, outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Revenues_lbl" xml:lang="en-US">Revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenue" xlink:label="us-gaap_CostOfRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfRevenue" xlink:to="us-gaap_CostOfRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfRevenue_lbl" xml:lang="en-US">Cost of revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit" xlink:label="us-gaap_GrossProfit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_GrossProfit_lbl" xml:lang="en-US">Gross profit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xml:lang="en-US">Operating expenses:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Research and development, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="us-gaap_SellingAndMarketingExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingAndMarketingExpense" xlink:to="us-gaap_SellingAndMarketingExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingAndMarketingExpense_lbl" xml:lang="en-US">Sales and marketing</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US">General and administrative</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingExpenses_lbl" xml:lang="en-US">Total operating expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">Operating loss</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_FinancialExpensesIncomeNet" xlink:label="rwlk_FinancialExpensesIncomeNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_FinancialExpensesIncomeNet" xlink:to="rwlk_FinancialExpensesIncomeNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_FinancialExpensesIncomeNet_lbl" xml:lang="en-US">Financial expenses, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US">Loss before income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Taxes on income (tax benefit)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net loss</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xml:lang="en-US">Net loss per ordinary share, basic and diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xml:lang="en-US">Weighted average number of shares used in computing net loss per ordinary share, basic and diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US">Balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet" xlink:label="us-gaap_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet" xlink:to="us-gaap_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet_lbl" xml:lang="en-US">Cumulative effect to accumulated deficit from adoption of a new accounting standard</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xml:lang="en-US">Share-based compensation to employees and non-employees</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl" xml:lang="en-US">Issuance of ordinary shares upon exercise of options to purchase ordinary shares and RSUs by employees and non-employees</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl" xml:lang="en-US">Issuance of ordinary shares upon exercise of options to purchase ordinary shares and RSUs by employees and non-employees, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInInvestingAgreementNetOfIssuanceExpenses" xlink:label="rwlk_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInInvestingAgreementNetOfIssuanceExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInInvestingAgreementNetOfIssuanceExpenses" xlink:to="rwlk_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInInvestingAgreementNetOfIssuanceExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInInvestingAgreementNetOfIssuanceExpenses_lbl" xml:lang="en-US">Issuance of ordinary shares in investing agreement, net of issuance expenses in an amount of $830</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInInvestingAgreementNetOfIssuanceExpenses" xlink:label="rwlk_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInInvestingAgreementNetOfIssuanceExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInInvestingAgreementNetOfIssuanceExpenses" xlink:to="rwlk_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInInvestingAgreementNetOfIssuanceExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInInvestingAgreementNetOfIssuanceExpenses_lbl" xml:lang="en-US">Issuance of ordinary shares in investing agreement, net of issuance expenses in an amount of $830, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_lbl" xml:lang="en-US">Issuance of warrants to purchase ordinary shares</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_StockIssuedDuringPeriodValueNewIssuesTwo" xlink:label="rwlk_StockIssuedDuringPeriodValueNewIssuesTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_StockIssuedDuringPeriodValueNewIssuesTwo" xlink:to="rwlk_StockIssuedDuringPeriodValueNewIssuesTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_StockIssuedDuringPeriodValueNewIssuesTwo_lbl" xml:lang="en-US">Issuance of ordinary shares in at-the-market offering, net of issuance expenses in the amount of $236</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_StockIssuedDuringPeriodSharesNewIssuesTwo" xlink:label="rwlk_StockIssuedDuringPeriodSharesNewIssuesTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_StockIssuedDuringPeriodSharesNewIssuesTwo" xlink:to="rwlk_StockIssuedDuringPeriodSharesNewIssuesTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_StockIssuedDuringPeriodSharesNewIssuesTwo_lbl" xml:lang="en-US">Issuance of ordinary shares in at-the-market offering, net of issuance expenses in the amount of $236, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueOther" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther_lbl" xml:lang="en-US">Cashless exercise of warrants into ordinary shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther_lbl" xml:lang="en-US">Cashless exercise of warrants into ordinary shares, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_StockDuringPeriodOrdinarySharesAndWarrantsValuePurchaseOrdinarySharesInFollowOnPublicOfferingTwo" xlink:label="rwlk_StockDuringPeriodOrdinarySharesAndWarrantsValuePurchaseOrdinarySharesInFollowOnPublicOfferingTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_StockDuringPeriodOrdinarySharesAndWarrantsValuePurchaseOrdinarySharesInFollowOnPublicOfferingTwo" xlink:to="rwlk_StockDuringPeriodOrdinarySharesAndWarrantsValuePurchaseOrdinarySharesInFollowOnPublicOfferingTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_StockDuringPeriodOrdinarySharesAndWarrantsValuePurchaseOrdinarySharesInFollowOnPublicOfferingTwo_lbl" xml:lang="en-US">Issuance of ordinary shares, warrants and pre-funded warrants in follow-on public offering, net of issuance expenses in an amount of $1,505</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_StockDuringPeriodOrdinarySharesAndWarrantsSharesPurchaseOrdinarySharesInFollowOnPublicOfferingTwo" xlink:label="rwlk_StockDuringPeriodOrdinarySharesAndWarrantsSharesPurchaseOrdinarySharesInFollowOnPublicOfferingTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_StockDuringPeriodOrdinarySharesAndWarrantsSharesPurchaseOrdinarySharesInFollowOnPublicOfferingTwo" xlink:to="rwlk_StockDuringPeriodOrdinarySharesAndWarrantsSharesPurchaseOrdinarySharesInFollowOnPublicOfferingTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_StockDuringPeriodOrdinarySharesAndWarrantsSharesPurchaseOrdinarySharesInFollowOnPublicOfferingTwo_lbl" xml:lang="en-US">Issuance of ordinary shares, warrants and pre-funded warrants in follow-on public offering, net of issuance expenses in an amount of $1,505, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl" xml:lang="en-US">Modification of warrants to purchase ordinary shares</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ExerciseOfPreFundedWarrantsValue" xlink:label="rwlk_ExerciseOfPreFundedWarrantsValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ExerciseOfPreFundedWarrantsValue" xlink:to="rwlk_ExerciseOfPreFundedWarrantsValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_ExerciseOfPreFundedWarrantsValue_lbl" xml:lang="en-US">Exercise of pre-funded warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ExerciseOfPreFundedWarrantsShares" xlink:label="rwlk_ExerciseOfPreFundedWarrantsShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ExerciseOfPreFundedWarrantsShares" xlink:to="rwlk_ExerciseOfPreFundedWarrantsShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_ExerciseOfPreFundedWarrantsShares_lbl" xml:lang="en-US">Exercise of pre-funded warrants, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_CumulativeEffectToStockBasedCompensationFromAdoptionOfNewAccountingStandard" xlink:label="rwlk_CumulativeEffectToStockBasedCompensationFromAdoptionOfNewAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_CumulativeEffectToStockBasedCompensationFromAdoptionOfNewAccountingStandard" xlink:to="rwlk_CumulativeEffectToStockBasedCompensationFromAdoptionOfNewAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_CumulativeEffectToStockBasedCompensationFromAdoptionOfNewAccountingStandard_lbl" xml:lang="en-US">Cumulative effect to stock based compensation from adoption of a new accounting standard</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_CumulativeEffectToAccumulatedDeficitFromAdoptionOfNewAccountingStandard" xlink:label="rwlk_CumulativeEffectToAccumulatedDeficitFromAdoptionOfNewAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_CumulativeEffectToAccumulatedDeficitFromAdoptionOfNewAccountingStandard" xlink:to="rwlk_CumulativeEffectToAccumulatedDeficitFromAdoptionOfNewAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="rwlk_CumulativeEffectToAccumulatedDeficitFromAdoptionOfNewAccountingStandard_lbl" xml:lang="en-US">Cumulative effect to accumulated deficit from adoption of a new accounting standard</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_StockIssuedDuringPeriodValueOrdinaryShares1" xlink:label="rwlk_StockIssuedDuringPeriodValueOrdinaryShares1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_StockIssuedDuringPeriodValueOrdinaryShares1" xlink:to="rwlk_StockIssuedDuringPeriodValueOrdinaryShares1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_StockIssuedDuringPeriodValueOrdinaryShares1_lbl" xml:lang="en-US">Issuance of ordinary shares in a "Best Efforts" offering, net of issuance expenses in the amount of $ 1,056</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_StockIssuedDuringPeriodSharesOrdinaryShares1" xlink:label="rwlk_StockIssuedDuringPeriodSharesOrdinaryShares1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_StockIssuedDuringPeriodSharesOrdinaryShares1" xlink:to="rwlk_StockIssuedDuringPeriodSharesOrdinaryShares1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_StockIssuedDuringPeriodSharesOrdinaryShares1_lbl" xml:lang="en-US">Issuance of ordinary shares in a "Best Efforts" offering, net of issuance expenses in the amount of $ 1,056, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_StockIssuedDuringPeriodValueOrdinaryShares" xlink:label="rwlk_StockIssuedDuringPeriodValueOrdinaryShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_StockIssuedDuringPeriodValueOrdinaryShares" xlink:to="rwlk_StockIssuedDuringPeriodValueOrdinaryShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_StockIssuedDuringPeriodValueOrdinaryShares_lbl" xml:lang="en-US">Issuance of ordinary shares in a "best effort" offering, net of issuance expenses in the amount of $686</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_StockIssuedDuringPeriodSharesOrdinaryShares" xlink:label="rwlk_StockIssuedDuringPeriodSharesOrdinaryShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_StockIssuedDuringPeriodSharesOrdinaryShares" xlink:to="rwlk_StockIssuedDuringPeriodSharesOrdinaryShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_StockIssuedDuringPeriodSharesOrdinaryShares_lbl" xml:lang="en-US">Issuance of ordinary shares in a "best effort" offering, net of issuance expenses in the amount of $686, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ExerciseOfPrefundedWarrantsAndWarrantsValue" xlink:label="rwlk_ExerciseOfPrefundedWarrantsAndWarrantsValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ExerciseOfPrefundedWarrantsAndWarrantsValue" xlink:to="rwlk_ExerciseOfPrefundedWarrantsAndWarrantsValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_ExerciseOfPrefundedWarrantsAndWarrantsValue_lbl" xml:lang="en-US">Exercise of pre-funded warrants and warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ExerciseOfPreFundedWarrantsAndWarrantsShares" xlink:label="rwlk_ExerciseOfPreFundedWarrantsAndWarrantsShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ExerciseOfPreFundedWarrantsAndWarrantsShares" xlink:to="rwlk_ExerciseOfPreFundedWarrantsAndWarrantsShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_ExerciseOfPreFundedWarrantsAndWarrantsShares_lbl" xml:lang="en-US">Exercise of pre-funded warrants and warrants, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses" xlink:label="rwlk_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses" xlink:to="rwlk_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses_lbl" xml:lang="en-US">Issuance of ordinary shares in a "Registered Direct" offering, net of issuance expenses in the amount of $ 1,125</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses" xlink:label="rwlk_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses" xlink:to="rwlk_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses_lbl" xml:lang="en-US">Issuance of ordinary shares in a "Registered Direct" offering, net of issuance expenses in the amount of $ 1,125, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1" xlink:label="rwlk_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1" xlink:to="rwlk_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1_lbl" xml:lang="en-US">Issuance of ordinary shares in a "registered direct" offering, net of issuance expenses in the amount of $ 1,019</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1" xlink:label="rwlk_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1" xlink:to="rwlk_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1_lbl" xml:lang="en-US">Issuance of ordinary shares in a "registered direct" offering, net of issuance expenses in the amount of $ 1,019, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses" xlink:label="rwlk_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses" xlink:to="rwlk_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses_lbl" xml:lang="en-US">Issuance of ordinary shares in a "Warrant exercise" agreement, net of issuance expenses in the amount of $ 1,019</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses" xlink:label="rwlk_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses" xlink:to="rwlk_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses_lbl" xml:lang="en-US">Issuance of ordinary shares in a "Warrant exercise" agreement, net of issuance expenses in the amount of $ 1,019,shares</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_StockIssuedDuringPeriodValuePrivatePlacement" xlink:label="rwlk_StockIssuedDuringPeriodValuePrivatePlacement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_StockIssuedDuringPeriodValuePrivatePlacement" xlink:to="rwlk_StockIssuedDuringPeriodValuePrivatePlacement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_StockIssuedDuringPeriodValuePrivatePlacement_lbl" xml:lang="en-US">Issuance of ordinary shares in a private placement, net of issuance expenses in the amount of $ 993</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_StockIssuedDuringPeriodSharesPrivatePlacement" xlink:label="rwlk_StockIssuedDuringPeriodSharesPrivatePlacement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_StockIssuedDuringPeriodSharesPrivatePlacement" xlink:to="rwlk_StockIssuedDuringPeriodSharesPrivatePlacement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_StockIssuedDuringPeriodSharesPrivatePlacement_lbl" xml:lang="en-US">Issuance of ordinary shares in a private placement, net of issuance expenses in the amount of $ 993, shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Net loss</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_3_lbl" xml:lang="en-US">Balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesOutstanding_2_lbl" xml:lang="en-US">Balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_lbl" xml:lang="en-US">Issuance expenses, amount</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows used in operating activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Depreciation_lbl" xml:lang="en-US">Depreciation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US">Share-based compensation to employees and non-employees</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Deferred taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" xml:lang="en-US">Gain on PPP forgiveness</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_GainsLossesOnInducementOfDebt1" xlink:label="rwlk_GainsLossesOnInducementOfDebt1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_GainsLossesOnInducementOfDebt1" xlink:to="rwlk_GainsLossesOnInducementOfDebt1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="rwlk_GainsLossesOnInducementOfDebt1_lbl" xml:lang="en-US">Loss on inducement of debt</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_FinancialExpensesRelatedToLongTermLoan" xlink:label="rwlk_FinancialExpensesRelatedToLongTermLoan" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_FinancialExpensesRelatedToLongTermLoan" xlink:to="rwlk_FinancialExpensesRelatedToLongTermLoan_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_FinancialExpensesRelatedToLongTermLoan_lbl" xml:lang="en-US">Financial expenses related to long term loan</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US">Changes in assets and liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xml:lang="en-US">Trade receivables, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xml:lang="en-US">Prepaid expenses, operating lease right-of-use assets and other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableTrade" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableTrade_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableTrade_lbl" xml:lang="en-US">Trade payables</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_lbl" xml:lang="en-US">Employees and payroll accruals</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredLiabilities" xlink:label="us-gaap_IncreaseDecreaseInDeferredLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDeferredLiabilities" xlink:to="us-gaap_IncreaseDecreaseInDeferredLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInDeferredLiabilities_lbl" xml:lang="en-US">Deferred revenues and advance from customers</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_lbl" xml:lang="en-US">Operating lease liabilities and other liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash used in operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows used in investing activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US">Purchase of property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash used in investing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from financing activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="us-gaap_RepaymentsOfLongTermDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfLongTermDebt" xlink:to="us-gaap_RepaymentsOfLongTermDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfLongTermDebt_lbl" xml:lang="en-US">Repayment of long-term loan</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfLongTermDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="us-gaap_ProceedsFromIssuanceOfLongTermDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfLongTermDebt_lbl" xml:lang="en-US">Proceeds from PPP loan</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_IssuanceOfOrdinarySharesInInvestmentAgreement" xlink:label="rwlk_IssuanceOfOrdinarySharesInInvestmentAgreement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_IssuanceOfOrdinarySharesInInvestmentAgreement" xlink:to="rwlk_IssuanceOfOrdinarySharesInInvestmentAgreement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_IssuanceOfOrdinarySharesInInvestmentAgreement_lbl" xml:lang="en-US">Issuance of ordinary shares in investment agreement, net of issuance expenses in an amount of $830</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US">Issuance of ordinary shares in at-the-market offering, net of issuance expenses paid in the amount of $211</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ProceedsFromIssuanceofPreFundedWarrants" xlink:label="rwlk_ProceedsFromIssuanceofPreFundedWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ProceedsFromIssuanceofPreFundedWarrants" xlink:to="rwlk_ProceedsFromIssuanceofPreFundedWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_ProceedsFromIssuanceofPreFundedWarrants_lbl" xml:lang="en-US">Issuance of ordinary shares and exercise of pre-funded warrants into ordinary shares in follow-on offering, net of issuance expenses in an amount of $1,505 and net of long-term loan conversion in the amount of $3,600</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ProceedsFromStockOne" xlink:label="rwlk_ProceedsFromStockOne" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ProceedsFromStockOne" xlink:to="rwlk_ProceedsFromStockOne_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="rwlk_ProceedsFromStockOne_lbl" xml:lang="en-US">Issuance of ordinary shares in a "best effort" offering, net of issuance expenses in the amount of $686</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ProceedsFromStockTwo" xlink:label="rwlk_ProceedsFromStockTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ProceedsFromStockTwo" xlink:to="rwlk_ProceedsFromStockTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_ProceedsFromStockTwo_lbl" xml:lang="en-US">Issuance of ordinary shares in a "registered direct" offering, net of issuance expenses in the amount of $1,035</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ProceedsFromOfferingCost" xlink:label="rwlk_ProceedsFromOfferingCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ProceedsFromOfferingCost" xlink:to="rwlk_ProceedsFromOfferingCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_ProceedsFromOfferingCost_lbl" xml:lang="en-US">Issuance of ordinary shares in a "best effort" offering, net of issuance expenses in the amount of $1,056</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ProceedsFromIssuanceOfRegistrationCost" xlink:label="rwlk_ProceedsFromIssuanceOfRegistrationCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ProceedsFromIssuanceOfRegistrationCost" xlink:to="rwlk_ProceedsFromIssuanceOfRegistrationCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_ProceedsFromIssuanceOfRegistrationCost_lbl" xml:lang="en-US">Issuance of ordinary shares in a "registered direct" offering, net of issuance expenses in the amount of $977</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_IssuanceOfOrdinarySharesInWarrantExerciseAgreementNetOfIssuanceExpensesInAmountOf10191" xlink:label="rwlk_IssuanceOfOrdinarySharesInWarrantExerciseAgreementNetOfIssuanceExpensesInAmountOf10191" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_IssuanceOfOrdinarySharesInWarrantExerciseAgreementNetOfIssuanceExpensesInAmountOf10191" xlink:to="rwlk_IssuanceOfOrdinarySharesInWarrantExerciseAgreementNetOfIssuanceExpensesInAmountOf10191_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_IssuanceOfOrdinarySharesInWarrantExerciseAgreementNetOfIssuanceExpensesInAmountOf10191_lbl" xml:lang="en-US">Issuance of ordinary shares in a "warrant exercise" agreement, net of issuance expenses in the amount of $1,019</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl" xml:lang="en-US">Issuance of ordinary shares in a private placement, net of issuance expenses in the amount of $959</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ExerciseOfPreFundedWarrants" xlink:label="rwlk_ExerciseOfPreFundedWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ExerciseOfPreFundedWarrants" xlink:to="rwlk_ExerciseOfPreFundedWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="rwlk_ExerciseOfPreFundedWarrants_lbl" xml:lang="en-US">Exercise of pre-funded warrants and warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash provided by financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xml:lang="en-US">Increase (decrease) in cash, cash equivalents, and restricted cash</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US">Cash, cash equivalents, and restricted cash at beginning of period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_lbl" xml:lang="en-US">Cash, cash equivalents, and restricted cash at end of period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xml:lang="en-US">Supplemental disclosures of non-cash flow information</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_RegisteredDirectOfferingsIssuanceCostIncurredNotYetPaid" xlink:label="rwlk_RegisteredDirectOfferingsIssuanceCostIncurredNotYetPaid" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_RegisteredDirectOfferingsIssuanceCostIncurredNotYetPaid" xlink:to="rwlk_RegisteredDirectOfferingsIssuanceCostIncurredNotYetPaid_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_RegisteredDirectOfferingsIssuanceCostIncurredNotYetPaid_lbl" xml:lang="en-US">Expenses related to offerings not yet paid</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_RepaymentOfLongTermLoanByIssuanceOfUnitsAndPrefundedUnits" xlink:label="rwlk_RepaymentOfLongTermLoanByIssuanceOfUnitsAndPrefundedUnits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_RepaymentOfLongTermLoanByIssuanceOfUnitsAndPrefundedUnits" xlink:to="rwlk_RepaymentOfLongTermLoanByIssuanceOfUnitsAndPrefundedUnits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_RepaymentOfLongTermLoanByIssuanceOfUnitsAndPrefundedUnits_lbl" xml:lang="en-US">Repayment of long-term loan by issuance of units and pre-funded units</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_CommonStockIssuanceCostsIncurredNotYetPaid" xlink:label="rwlk_CommonStockIssuanceCostsIncurredNotYetPaid" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_CommonStockIssuanceCostsIncurredNotYetPaid" xlink:to="rwlk_CommonStockIssuanceCostsIncurredNotYetPaid_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_CommonStockIssuanceCostsIncurredNotYetPaid_lbl" xml:lang="en-US">At-the-market offering expenses not yet paid</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ClassificationOfOtherCurrentAssetsToPropertyAndEquipmentNet" xlink:label="rwlk_ClassificationOfOtherCurrentAssetsToPropertyAndEquipmentNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ClassificationOfOtherCurrentAssetsToPropertyAndEquipmentNet" xlink:to="rwlk_ClassificationOfOtherCurrentAssetsToPropertyAndEquipmentNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_ClassificationOfOtherCurrentAssetsToPropertyAndEquipmentNet_lbl" xml:lang="en-US">Classification of other current assets to property and equipment, net</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ClassificationOfInventoryToOtherCurrentAssets" xlink:label="rwlk_ClassificationOfInventoryToOtherCurrentAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ClassificationOfInventoryToOtherCurrentAssets" xlink:to="rwlk_ClassificationOfInventoryToOtherCurrentAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_ClassificationOfInventoryToOtherCurrentAssets_lbl" xml:lang="en-US">Classification of inventory to other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ClassificationOfInventoryToPropertyAndEquipmentNet" xlink:label="rwlk_ClassificationOfInventoryToPropertyAndEquipmentNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ClassificationOfInventoryToPropertyAndEquipmentNet" xlink:to="rwlk_ClassificationOfInventoryToPropertyAndEquipmentNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_ClassificationOfInventoryToPropertyAndEquipmentNet_lbl" xml:lang="en-US">Classification of inventory to property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_CashlessExerciseOfPrefundedWarrants" xlink:label="rwlk_CashlessExerciseOfPrefundedWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_CashlessExerciseOfPrefundedWarrants" xlink:to="rwlk_CashlessExerciseOfPrefundedWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_CashlessExerciseOfPrefundedWarrants_lbl" xml:lang="en-US">Cashless exercise of pre-funded warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_InitialRecognitionOfOperatingLeaseRightofuseAssets" xlink:label="rwlk_InitialRecognitionOfOperatingLeaseRightofuseAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_InitialRecognitionOfOperatingLeaseRightofuseAssets" xlink:to="rwlk_InitialRecognitionOfOperatingLeaseRightofuseAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_InitialRecognitionOfOperatingLeaseRightofuseAssets_lbl" xml:lang="en-US">Initial recognition of operating lease right-of-use assets</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_InitialRecognitionOfOperatingLeaseLiabilities" xlink:label="rwlk_InitialRecognitionOfOperatingLeaseLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_InitialRecognitionOfOperatingLeaseLiabilities" xlink:to="rwlk_InitialRecognitionOfOperatingLeaseLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_InitialRecognitionOfOperatingLeaseLiabilities_lbl" xml:lang="en-US">Initial recognition of operating lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US">Supplemental disclosures of cash flow information:</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_SupplementalCashFlowCashAndCashEquivalents" xlink:label="rwlk_SupplementalCashFlowCashAndCashEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_SupplementalCashFlowCashAndCashEquivalents" xlink:to="rwlk_SupplementalCashFlowCashAndCashEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="rwlk_SupplementalCashFlowCashAndCashEquivalents_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_RestrictedCashIncludedInOtherNoncurrentAssets" xlink:label="rwlk_RestrictedCashIncludedInOtherNoncurrentAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_RestrictedCashIncludedInOtherNoncurrentAssets" xlink:to="rwlk_RestrictedCashIncludedInOtherNoncurrentAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_RestrictedCashIncludedInOtherNoncurrentAssets_lbl" xml:lang="en-US">Restricted cash included in other long term assets</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_CashAndCashEquivalentsRestrictedCashAndRestrictedCashEquivalent" xlink:label="rwlk_CashAndCashEquivalentsRestrictedCashAndRestrictedCashEquivalent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_CashAndCashEquivalentsRestrictedCashAndRestrictedCashEquivalent" xlink:to="rwlk_CashAndCashEquivalentsRestrictedCashAndRestrictedCashEquivalent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="rwlk_CashAndCashEquivalentsRestrictedCashAndRestrictedCashEquivalent_lbl" xml:lang="en-US">Total Cash, cash equivalents, and restricted cash</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_SupplementalDisclosuresOfCashFlowInformation" xlink:label="rwlk_SupplementalDisclosuresOfCashFlowInformation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_SupplementalDisclosuresOfCashFlowInformation" xlink:to="rwlk_SupplementalDisclosuresOfCashFlowInformation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="rwlk_SupplementalDisclosuresOfCashFlowInformation_lbl" xml:lang="en-US">Supplemental disclosures of cash flow information:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaid" xlink:label="us-gaap_IncomeTaxesPaid" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaid" xlink:to="us-gaap_IncomeTaxesPaid_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxesPaid_lbl" xml:lang="en-US">Cash paid for income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaidNet_lbl" xml:lang="en-US">Cash paid for interest</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xml:lang="en-US">Issuance expenses paid</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_IssuanceExpensesOfOfferingSharesAmount" xlink:label="rwlk_IssuanceExpensesOfOfferingSharesAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_IssuanceExpensesOfOfferingSharesAmount" xlink:to="rwlk_IssuanceExpensesOfOfferingSharesAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_IssuanceExpensesOfOfferingSharesAmount_lbl" xml:lang="en-US">Issuance expenses in an amount</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_LongTermLoanConversionAmount" xlink:label="rwlk_LongTermLoanConversionAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_LongTermLoanConversionAmount" xlink:to="rwlk_LongTermLoanConversionAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_LongTermLoanConversionAmount_lbl" xml:lang="en-US">Long term loan conversion</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xml:lang="en-US">GENERAL</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">SIGNIFICANT ACCOUNTING POLICIES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_lbl" xml:lang="en-US">Prepaid Expense and Other Assets, Current [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_PrepaidExpenseAndOtherAssetsDisclosureTextBlock" xlink:label="rwlk_PrepaidExpenseAndOtherAssetsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_PrepaidExpenseAndOtherAssetsDisclosureTextBlock" xlink:to="rwlk_PrepaidExpenseAndOtherAssetsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_PrepaidExpenseAndOtherAssetsDisclosureTextBlock_lbl" xml:lang="en-US">PREPAID EXPENSES AND OTHER CURRENT ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="us-gaap_InventoryDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureAbstract_lbl" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="us-gaap_InventoryDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureTextBlock" xlink:to="us-gaap_InventoryDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureTextBlock_lbl" xml:lang="en-US">INVENTORIES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xml:lang="en-US">PROPERTY AND EQUIPMENT, NET</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_DisclosureofTermLoansandWarrantstoPurchaseOrdinarySharesTextBlock" xlink:label="rwlk_DisclosureofTermLoansandWarrantstoPurchaseOrdinarySharesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_DisclosureofTermLoansandWarrantstoPurchaseOrdinarySharesTextBlock" xlink:to="rwlk_DisclosureofTermLoansandWarrantstoPurchaseOrdinarySharesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_DisclosureofTermLoansandWarrantstoPurchaseOrdinarySharesTextBlock_lbl" xml:lang="en-US">LOAN AGREEMENT WITH KREOS AND RELATED WARRANT TO PURCHASE ORDINARY SHARES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">COMMITMENTS AND CONTINGENT LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityAbstract_lbl" xml:lang="en-US">Equity [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US">SHAREHOLDERS' EQUITY</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentAbstract" xlink:label="us-gaap_ResearchAndDevelopmentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentAbstract" xlink:to="us-gaap_ResearchAndDevelopmentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentAbstract_lbl" xml:lang="en-US">Research and Development [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:label="us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:to="us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_lbl" xml:lang="en-US">RESEARCH COLLABORATION AGREEMENT AND LICENSE AGREEMENT</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xml:lang="en-US">PAYCHECK PROTECTION PROGRAM LOAN</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">INCOME TAXES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract" xlink:label="us-gaap_OtherIncomeAndExpensesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="us-gaap_OtherIncomeAndExpensesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherIncomeAndExpensesAbstract_lbl" xml:lang="en-US">Other Income and Expenses [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:label="us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:to="us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock_lbl" xml:lang="en-US">FINANCIAL EXPENSES, NET</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingAbstract_lbl" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xml:lang="en-US">GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">SUBSEQUENT EVENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of Estimates</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xml:lang="en-US">Financial Statements in U.S. Dollars</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xml:lang="en-US">Principles of Consolidation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US">Cash Equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="us-gaap_InventoryPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryPolicyTextBlock" xlink:to="us-gaap_InventoryPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_InventoryPolicyTextBlock_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_RelatedPartiesTransactionsAndBalancesPolicyTextBlock" xlink:label="rwlk_RelatedPartiesTransactionsAndBalancesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_RelatedPartiesTransactionsAndBalancesPolicyTextBlock" xlink:to="rwlk_RelatedPartiesTransactionsAndBalancesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_RelatedPartiesTransactionsAndBalancesPolicyTextBlock_lbl" xml:lang="en-US">Related parties transactions and balances</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xml:lang="en-US">Property and Equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xml:lang="en-US">Impairment of Long-Lived Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_OtherLongTermAssetsPolicyTextBlock" xlink:label="rwlk_OtherLongTermAssetsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_OtherLongTermAssetsPolicyTextBlock" xlink:to="rwlk_OtherLongTermAssetsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_OtherLongTermAssetsPolicyTextBlock_lbl" xml:lang="en-US">Restricted cash and Other long term assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xml:lang="en-US">Revenue Recognition</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xml:lang="en-US">Accounting for Share-Based Compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ClassOfWarrantOrRightPolicyTextBlock" xlink:label="rwlk_ClassOfWarrantOrRightPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ClassOfWarrantOrRightPolicyTextBlock" xlink:to="rwlk_ClassOfWarrantOrRightPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_ClassOfWarrantOrRightPolicyTextBlock_lbl" xml:lang="en-US">Warrants to Acquire Ordinary Shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xml:lang="en-US">Research and Development Costs</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StandardProductWarrantyPolicy" xlink:label="us-gaap_StandardProductWarrantyPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StandardProductWarrantyPolicy" xlink:to="us-gaap_StandardProductWarrantyPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StandardProductWarrantyPolicy_lbl" xml:lang="en-US">Warranty</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xml:lang="en-US">Concentrations of Credit Risks</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PostemploymentBenefitPlansPolicy" xlink:label="us-gaap_PostemploymentBenefitPlansPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PostemploymentBenefitPlansPolicy" xlink:to="us-gaap_PostemploymentBenefitPlansPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PostemploymentBenefitPlansPolicy_lbl" xml:lang="en-US">Accrued Severance Pay</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl" xml:lang="en-US">Fair Value Measurements</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Basic and Diluted Net Loss Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesPolicyTextBlock_lbl" xml:lang="en-US">Contingent liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_GovernmentGrantsPolicyTextBlock" xlink:label="rwlk_GovernmentGrantsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_GovernmentGrantsPolicyTextBlock" xlink:to="rwlk_GovernmentGrantsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_GovernmentGrantsPolicyTextBlock_lbl" xml:lang="en-US">Government grants</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">New Accounting Pronouncements</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock_lbl" xml:lang="en-US">Schedule of property and equipment estimated useful lives</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" xlink:to="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_lbl" xml:lang="en-US">Schedule of disaggregation of revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ScheduleOfTradeReceivablesAndDeferredRevenuesTableTextBlock" xlink:label="rwlk_ScheduleOfTradeReceivablesAndDeferredRevenuesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ScheduleOfTradeReceivablesAndDeferredRevenuesTableTextBlock" xlink:to="rwlk_ScheduleOfTradeReceivablesAndDeferredRevenuesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_ScheduleOfTradeReceivablesAndDeferredRevenuesTableTextBlock_lbl" xml:lang="en-US">Schedule of trade receivables and short and long term deferred revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xml:lang="en-US">Schedule of Black-Scholes-Merton option pricing model assumptions</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:label="us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:to="us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_lbl" xml:lang="en-US">Schedule of product warranty liability</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:label="us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:to="us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_lbl" xml:lang="en-US">Schedule of concentration of credit risk</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xml:lang="en-US">Schedule of basic and diluted net loss per ordinary share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_lbl" xml:lang="en-US">Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:to="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_lbl" xml:lang="en-US">Schedule of prepaid expenses and other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xml:lang="en-US">Schedule of inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xml:lang="en-US">Schedule of components of Property and Equipment, Net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:to="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_lbl" xml:lang="en-US">Schedule of future minimum lease commitments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock_lbl" xml:lang="en-US">Schedule of employee and non-employee shares options activity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_lbl" xml:lang="en-US">Schedule of employee and non-employee RSUs activity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_lbl" xml:lang="en-US">Schedule of options and RSUs outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xml:lang="en-US">Schedule of non-cash share-based compensation expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xml:lang="en-US">Schedule of warrants outstanding and exercisable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" xml:lang="en-US">Schedule of loss before taxes on income</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xml:lang="en-US">Schedule of taxes on income</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of deferred income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:label="us-gaap_SummaryOfValuationAllowanceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:to="us-gaap_SummaryOfValuationAllowanceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SummaryOfValuationAllowanceTextBlock_lbl" xml:lang="en-US">Schedule of net changes in total valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xml:lang="en-US">Schedule of reconciliation between the theoretical tax expense and the actual tax expense (benefit)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:label="us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:to="us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_lbl" xml:lang="en-US">Schedule of financial expenses, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:label="us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:to="us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_lbl" xml:lang="en-US">Schedule of revenues within geographic areas</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:label="us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:to="us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_lbl" xml:lang="en-US">Schedule of long-lived assets by geographic region</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:label="us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:to="us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_lbl" xml:lang="en-US">Schedule of major customer data as a percentage of total revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_GeneralTextualAbstract" xlink:label="rwlk_GeneralTextualAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_GeneralTextualAbstract" xlink:to="rwlk_GeneralTextualAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_GeneralTextualAbstract_lbl" xml:lang="en-US">General (Textual)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xml:lang="en-US">Negative cash flow from operations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="us-gaap_ProceedsFromWarrantExercises" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromWarrantExercises" xlink:to="us-gaap_ProceedsFromWarrantExercises_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromWarrantExercises_lbl" xml:lang="en-US">Proceeds from warrants exercise</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="srt_RangeAxis_2_lbl" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_2_lbl" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:label="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:to="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_lbl" xml:lang="en-US">Property and equipment estimated useful lives</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_Revenues_2_lbl" xml:lang="en-US">Total Revenues</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AccountsReceivableNetCurrent_2_lbl" xml:lang="en-US">Trade receivable, net (1)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenue" xlink:label="us-gaap_DeferredRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenue" xlink:to="us-gaap_DeferredRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRevenue_lbl" xml:lang="en-US">Deferred revenues (1) (2)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xml:lang="en-US">Expected volatility</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xml:lang="en-US">Risk-free rate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xml:lang="en-US">Dividend yield</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xml:lang="en-US">Expected term (in years)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharePrice_lbl" xml:lang="en-US">Share price</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_SignificantAccountingPoliciesDetails4Abstract" xlink:label="rwlk_SignificantAccountingPoliciesDetails4Abstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_SignificantAccountingPoliciesDetails4Abstract" xlink:to="rwlk_SignificantAccountingPoliciesDetails4Abstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_SignificantAccountingPoliciesDetails4Abstract_lbl" xml:lang="en-US">Significant Accounting Policies</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xml:lang="en-US">Warrants to acquire common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_SignificantAccountingPoliciesDetails1Abstract" xlink:label="rwlk_SignificantAccountingPoliciesDetails1Abstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_SignificantAccountingPoliciesDetails1Abstract" xlink:to="rwlk_SignificantAccountingPoliciesDetails1Abstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="rwlk_SignificantAccountingPoliciesDetails1Abstract_lbl" xml:lang="en-US">Significant Accounting Policies</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:label="us-gaap_MovementInStandardProductWarrantyAccrualRollForward" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:to="us-gaap_MovementInStandardProductWarrantyAccrualRollForward_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MovementInStandardProductWarrantyAccrualRollForward_lbl" xml:lang="en-US">Warranty provision:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StandardProductWarrantyAccrual" xlink:label="us-gaap_StandardProductWarrantyAccrual" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StandardProductWarrantyAccrual" xlink:to="us-gaap_StandardProductWarrantyAccrual_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StandardProductWarrantyAccrual_lbl" xml:lang="en-US">Balance at December 31, 2019</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StandardProductWarrantyAccrualWarrantiesIssued" xlink:label="us-gaap_StandardProductWarrantyAccrualWarrantiesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StandardProductWarrantyAccrualWarrantiesIssued" xlink:to="us-gaap_StandardProductWarrantyAccrualWarrantiesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StandardProductWarrantyAccrualWarrantiesIssued_lbl" xml:lang="en-US">Provision</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StandardProductWarrantyAccrualPayments" xlink:label="us-gaap_StandardProductWarrantyAccrualPayments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StandardProductWarrantyAccrualPayments" xlink:to="us-gaap_StandardProductWarrantyAccrualPayments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StandardProductWarrantyAccrualPayments_lbl" xml:lang="en-US">Usage</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StandardProductWarrantyAccrual" xlink:to="us-gaap_StandardProductWarrantyAccrual_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StandardProductWarrantyAccrual_2_lbl" xml:lang="en-US">Balance at December 31, 2020</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl" xml:lang="en-US">Concentration of credit risk</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProfitLoss_lbl" xml:lang="en-US">Net loss</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xml:lang="en-US">Net loss attributable to ordinary shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_lbl" xml:lang="en-US">Shares used in computing net loss per ordinary shares, basic and diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTable" xlink:label="us-gaap_ConcentrationRiskTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskTable" xlink:to="us-gaap_ConcentrationRiskTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskTable_lbl" xml:lang="en-US">Concentration Risk [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="us-gaap_ConcentrationRiskLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskLineItems" xlink:to="us-gaap_ConcentrationRiskLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskLineItems_lbl" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_2_lbl" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_SignificantAccountingPoliciesTextualAbstract" xlink:label="rwlk_SignificantAccountingPoliciesTextualAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_SignificantAccountingPoliciesTextualAbstract" xlink:to="rwlk_SignificantAccountingPoliciesTextualAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_SignificantAccountingPoliciesTextualAbstract_lbl" xml:lang="en-US">Significant Accounting Policies (Textual)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWriteDown" xlink:label="us-gaap_InventoryWriteDown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryWriteDown" xlink:to="us-gaap_InventoryWriteDown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryWriteDown_lbl" xml:lang="en-US">Wrote off inventory amount</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_lbl" xml:lang="en-US">Impairment losses</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_RelatedPartyTransactionOwnershipPercentage" xlink:label="rwlk_RelatedPartyTransactionOwnershipPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_RelatedPartyTransactionOwnershipPercentage" xlink:to="rwlk_RelatedPartyTransactionOwnershipPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_RelatedPartyTransactionOwnershipPercentage_lbl" xml:lang="en-US">Shareholder ownership percentage (greater than)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ConcentrationRiskPercentage1_2_lbl" xml:lang="en-US">Related party receivables as a percent of trade receivables, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromRelatedParties" xlink:label="us-gaap_RevenueFromRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromRelatedParties" xlink:to="us-gaap_RevenueFromRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromRelatedParties_lbl" xml:lang="en-US">Revenues from related party</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" xml:lang="en-US">Allowance for doubtful accounts</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_AllowanceForSalesReturns" xlink:label="rwlk_AllowanceForSalesReturns" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_AllowanceForSalesReturns" xlink:to="rwlk_AllowanceForSalesReturns_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_AllowanceForSalesReturns_lbl" xml:lang="en-US">Net of sales return reserve</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xml:lang="en-US">Deferred revenue recognized</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_RevenueRecognitionRecognized" xlink:label="rwlk_RevenueRecognitionRecognized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_RevenueRecognitionRecognized" xlink:to="rwlk_RevenueRecognitionRecognized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_RevenueRecognitionRecognized_lbl" xml:lang="en-US">Revenue recognition description</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_CumulativeEffectOnRetainedEarningsNetOfTax" xlink:label="rwlk_CumulativeEffectOnRetainedEarningsNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_CumulativeEffectOnRetainedEarningsNetOfTax" xlink:to="rwlk_CumulativeEffectOnRetainedEarningsNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_CumulativeEffectOnRetainedEarningsNetOfTax_lbl" xml:lang="en-US">Cumulative-effect adjustment to retained earnings/accumulated deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xml:lang="en-US">Non-cash compensation expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement" xlink:label="us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement" xlink:to="us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement_lbl" xml:lang="en-US">Maximum percentage of likely to be realized upon ultimate settlement</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_SeverancePayMonthlyDepositByEmployeesPercentage" xlink:label="rwlk_SeverancePayMonthlyDepositByEmployeesPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_SeverancePayMonthlyDepositByEmployeesPercentage" xlink:to="rwlk_SeverancePayMonthlyDepositByEmployeesPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_SeverancePayMonthlyDepositByEmployeesPercentage_lbl" xml:lang="en-US">Percentage of monthly deposit by employees</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PostemploymentBenefitsPeriodExpense" xlink:label="us-gaap_PostemploymentBenefitsPeriodExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PostemploymentBenefitsPeriodExpense" xlink:to="us-gaap_PostemploymentBenefitsPeriodExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PostemploymentBenefitsPeriodExpense_lbl" xml:lang="en-US">Severance pay expense</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_RoyaltyBearingGrantsExpenses" xlink:label="rwlk_RoyaltyBearingGrantsExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_RoyaltyBearingGrantsExpenses" xlink:to="rwlk_RoyaltyBearingGrantsExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_RoyaltyBearingGrantsExpenses_lbl" xml:lang="en-US">Royalty-bearing grants expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RoyaltyExpense" xlink:label="us-gaap_RoyaltyExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RoyaltyExpense" xlink:to="us-gaap_RoyaltyExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RoyaltyExpense_lbl" xml:lang="en-US">Royalty expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionsQuantification" xlink:label="rwlk_NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionsQuantification" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionsQuantification" xlink:to="rwlk_NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionsQuantification_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionsQuantification_lbl" xml:lang="en-US">Addition of lease assets and liabilities related to operating leases</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LessorOperatingLeaseDescription" xlink:label="us-gaap_LessorOperatingLeaseDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LessorOperatingLeaseDescription" xlink:to="us-gaap_LessorOperatingLeaseDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LessorOperatingLeaseDescription_lbl" xml:lang="en-US">Lease, description</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstandingTerm" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm_lbl" xml:lang="en-US">Service policy</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_PrepaidExpensesToGovernmentInstitutionsCurrent" xlink:label="rwlk_PrepaidExpensesToGovernmentInstitutionsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_PrepaidExpensesToGovernmentInstitutionsCurrent" xlink:to="rwlk_PrepaidExpensesToGovernmentInstitutionsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_PrepaidExpensesToGovernmentInstitutionsCurrent_lbl" xml:lang="en-US">Government institutions</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="us-gaap_PrepaidExpenseCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseCurrent" xlink:to="us-gaap_PrepaidExpenseCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseCurrent_lbl" xml:lang="en-US">Prepaid expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Supplies" xlink:label="us-gaap_Supplies" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Supplies" xlink:to="us-gaap_Supplies_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Supplies_lbl" xml:lang="en-US">Advances to vendors</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="us-gaap_OtherAssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsCurrent" xlink:to="us-gaap_OtherAssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsCurrent_lbl" xml:lang="en-US">Other assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_2_lbl" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoods" xlink:label="us-gaap_InventoryFinishedGoods" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryFinishedGoods" xlink:to="us-gaap_InventoryFinishedGoods_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryFinishedGoods_lbl" xml:lang="en-US">Finished products</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterials" xlink:label="us-gaap_InventoryRawMaterials" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryRawMaterials" xlink:to="us-gaap_InventoryRawMaterials_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryRawMaterials_lbl" xml:lang="en-US">Raw materials</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xml:lang="en-US">Property, plant and equipment, gross</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US">Accumulated depreciation</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_PropertyAndEquipmentNetTextualAbstract" xlink:label="rwlk_PropertyAndEquipmentNetTextualAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_PropertyAndEquipmentNetTextualAbstract" xlink:to="rwlk_PropertyAndEquipmentNetTextualAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_PropertyAndEquipmentNetTextualAbstract_lbl" xml:lang="en-US">Property and Equipment, Net (Textual)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_Depreciation_2_lbl" xml:lang="en-US">Depreciation expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentTable_lbl" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentLineItems_lbl" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_LoanAgreementWithKreosAndRelatedWarrantToPurchaseOrdinarySharesTextual" xlink:label="rwlk_LoanAgreementWithKreosAndRelatedWarrantToPurchaseOrdinarySharesTextual" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_LoanAgreementWithKreosAndRelatedWarrantToPurchaseOrdinarySharesTextual" xlink:to="rwlk_LoanAgreementWithKreosAndRelatedWarrantToPurchaseOrdinarySharesTextual_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_LoanAgreementWithKreosAndRelatedWarrantToPurchaseOrdinarySharesTextual_lbl" xml:lang="en-US">Loan Agreement with Kreos and Related Warrant to Purchase Ordinary Shares (Textual)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xml:lang="en-US">Face amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="us-gaap_ProceedsFromIssuanceOfLongTermDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfLongTermDebt_2_lbl" xml:lang="en-US">Proceeds from long term loan</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTerm" xlink:label="us-gaap_DebtInstrumentTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentTerm" xlink:to="us-gaap_DebtInstrumentTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentTerm_lbl" xml:lang="en-US">Loan term</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xml:lang="en-US">Annual interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_DebtInstrumentProceedsfromIssuanceofCommonStockRequiredforRepaymentPeriodtobeExtended" xlink:label="rwlk_DebtInstrumentProceedsfromIssuanceofCommonStockRequiredforRepaymentPeriodtobeExtended" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_DebtInstrumentProceedsfromIssuanceofCommonStockRequiredforRepaymentPeriodtobeExtended" xlink:to="rwlk_DebtInstrumentProceedsfromIssuanceofCommonStockRequiredforRepaymentPeriodtobeExtended_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_DebtInstrumentProceedsfromIssuanceofCommonStockRequiredforRepaymentPeriodtobeExtended_lbl" xml:lang="en-US">Required proceeds from issuance of common stock required for repayment period to be extended</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_LongtermDebtMaturitiesPortionofPrincipalSubjecttoRepaymentExtension" xlink:label="rwlk_LongtermDebtMaturitiesPortionofPrincipalSubjecttoRepaymentExtension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_LongtermDebtMaturitiesPortionofPrincipalSubjecttoRepaymentExtension" xlink:to="rwlk_LongtermDebtMaturitiesPortionofPrincipalSubjecttoRepaymentExtension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_LongtermDebtMaturitiesPortionofPrincipalSubjecttoRepaymentExtension_lbl" xml:lang="en-US">Portion of principal subject to repayment extension</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseDebt" xlink:label="us-gaap_InterestExpenseDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseDebt" xlink:to="us-gaap_InterestExpenseDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpenseDebt_lbl" xml:lang="en-US">Interest expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_2_lbl" xml:lang="en-US">Warrant to purchase ordinary shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xml:lang="en-US">Warrant exercise price</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfDebt" xlink:label="us-gaap_RepaymentsOfDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfDebt" xlink:to="us-gaap_RepaymentsOfDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfDebt_lbl" xml:lang="en-US">Repayments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther_2_lbl" xml:lang="en-US">Units issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_lbl" xml:lang="en-US">2021</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_lbl" xml:lang="en-US">2022</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_lbl" xml:lang="en-US">2023</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_lbl" xml:lang="en-US">2024</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_lbl" xml:lang="en-US">Total lease payments</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ImputedInterest" xlink:label="rwlk_ImputedInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ImputedInterest" xlink:to="rwlk_ImputedInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_ImputedInterest_lbl" xml:lang="en-US">Less: imputed interest</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PresentValueOfFutureMinimumLeasePaymentsSaleLeasebackTransactions" xlink:label="us-gaap_PresentValueOfFutureMinimumLeasePaymentsSaleLeasebackTransactions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PresentValueOfFutureMinimumLeasePaymentsSaleLeasebackTransactions" xlink:to="us-gaap_PresentValueOfFutureMinimumLeasePaymentsSaleLeasebackTransactions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PresentValueOfFutureMinimumLeasePaymentsSaleLeasebackTransactions_lbl" xml:lang="en-US">Present value of future lease payments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_2_lbl" xml:lang="en-US">Less: current maturities of operating leases</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_2_lbl" xml:lang="en-US">Non-current operating leases</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xml:lang="en-US">Weighted-average remaining lease term (in years)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xml:lang="en-US">Weighted-average discount rate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCommitmentsTable" xlink:label="us-gaap_OtherCommitmentsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCommitmentsTable" xlink:to="us-gaap_OtherCommitmentsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherCommitmentsTable_lbl" xml:lang="en-US">Other Commitments [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCommitmentsLineItems" xlink:label="us-gaap_OtherCommitmentsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_OtherCommitmentsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherCommitmentsLineItems_lbl" xml:lang="en-US">Other Commitments [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_CommitmentsAndContingenciesLiabilitiesTextualAbstract" xlink:label="rwlk_CommitmentsAndContingenciesLiabilitiesTextualAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_CommitmentsAndContingenciesLiabilitiesTextualAbstract" xlink:to="rwlk_CommitmentsAndContingenciesLiabilitiesTextualAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_CommitmentsAndContingenciesLiabilitiesTextualAbstract_lbl" xml:lang="en-US">Commitments and Contingent Liabilities (Textual)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligation" xlink:label="us-gaap_PurchaseObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PurchaseObligation" xlink:to="us-gaap_PurchaseObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PurchaseObligation_lbl" xml:lang="en-US">Non-cancelable outstanding obligations</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_OperatingLeasesMaximumPenaltiesPayableOnEarlyReleaseOfAgreement" xlink:label="rwlk_OperatingLeasesMaximumPenaltiesPayableOnEarlyReleaseOfAgreement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_OperatingLeasesMaximumPenaltiesPayableOnEarlyReleaseOfAgreement" xlink:to="rwlk_OperatingLeasesMaximumPenaltiesPayableOnEarlyReleaseOfAgreement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_OperatingLeasesMaximumPenaltiesPayableOnEarlyReleaseOfAgreement_lbl" xml:lang="en-US">Maximum penalties payable on early release of agreement</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRoyaltiesReceived" xlink:label="us-gaap_ProceedsFromRoyaltiesReceived" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRoyaltiesReceived" xlink:to="us-gaap_ProceedsFromRoyaltiesReceived_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromRoyaltiesReceived_lbl" xml:lang="en-US">Total fund received</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ResearchAndDevelopmentRoyaltyBearingGrants" xlink:label="rwlk_ResearchAndDevelopmentRoyaltyBearingGrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ResearchAndDevelopmentRoyaltyBearingGrants" xlink:to="rwlk_ResearchAndDevelopmentRoyaltyBearingGrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_ResearchAndDevelopmentRoyaltyBearingGrants_lbl" xml:lang="en-US">Royalty bearing grants</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRoyalties" xlink:label="us-gaap_PaymentsForRoyalties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRoyalties" xlink:to="us-gaap_PaymentsForRoyalties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForRoyalties_lbl" xml:lang="en-US">Royalties paid</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ResearchAndDevelopmentAmountReceivedInConsiderationOfConvertiblePreferredShares" xlink:label="rwlk_ResearchAndDevelopmentAmountReceivedInConsiderationOfConvertiblePreferredShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ResearchAndDevelopmentAmountReceivedInConsiderationOfConvertiblePreferredShares" xlink:to="rwlk_ResearchAndDevelopmentAmountReceivedInConsiderationOfConvertiblePreferredShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_ResearchAndDevelopmentAmountReceivedInConsiderationOfConvertiblePreferredShares_lbl" xml:lang="en-US">Amount received in consideration of preferred shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:to="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_lbl" xml:lang="en-US">Convertible preferred shares</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_RoyaltyFeesPercentage" xlink:label="rwlk_RoyaltyFeesPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_RoyaltyFeesPercentage" xlink:to="rwlk_RoyaltyFeesPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_RoyaltyFeesPercentage_lbl" xml:lang="en-US">Percentage of obligation to pay royalties</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConversionOfStockDescription" xlink:label="us-gaap_ConversionOfStockDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockDescription" xlink:to="us-gaap_ConversionOfStockDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConversionOfStockDescription_lbl" xml:lang="en-US">Description of conversion ratio</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ContingentLiabilityRelatedToGrantsReceived" xlink:label="rwlk_ContingentLiabilityRelatedToGrantsReceived" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ContingentLiabilityRelatedToGrantsReceived" xlink:to="rwlk_ContingentLiabilityRelatedToGrantsReceived_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_ContingentLiabilityRelatedToGrantsReceived_lbl" xml:lang="en-US">Contingent liability</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_PercentageOfGrantReceivedConsideredToDetermineRoyaltyFees" xlink:label="rwlk_PercentageOfGrantReceivedConsideredToDetermineRoyaltyFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_PercentageOfGrantReceivedConsideredToDetermineRoyaltyFees" xlink:to="rwlk_PercentageOfGrantReceivedConsideredToDetermineRoyaltyFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_PercentageOfGrantReceivedConsideredToDetermineRoyaltyFees_lbl" xml:lang="en-US">Percentage of grant received</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RoyaltyExpense" xlink:to="us-gaap_RoyaltyExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_RoyaltyExpense_2_lbl" xml:lang="en-US">Royalties expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_GuarantorObligationsCollateralPledged" xlink:label="rwlk_GuarantorObligationsCollateralPledged" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_GuarantorObligationsCollateralPledged" xlink:to="rwlk_GuarantorObligationsCollateralPledged_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_GuarantorObligationsCollateralPledged_lbl" xml:lang="en-US">Amount pledged as security</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DescriptionOfLessorLeasingArrangementsOperatingLeases" xlink:label="us-gaap_DescriptionOfLessorLeasingArrangementsOperatingLeases" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DescriptionOfLessorLeasingArrangementsOperatingLeases" xlink:to="us-gaap_DescriptionOfLessorLeasingArrangementsOperatingLeases_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DescriptionOfLessorLeasingArrangementsOperatingLeases_lbl" xml:lang="en-US">Lease expiration, term</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLongTermDebt" xlink:label="us-gaap_OtherLongTermDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLongTermDebt" xlink:to="us-gaap_OtherLongTermDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLongTermDebt_lbl" xml:lang="en-US">Other long-term assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet" xlink:label="us-gaap_OperatingLeasesRentExpenseNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesRentExpenseNet" xlink:to="us-gaap_OperatingLeasesRentExpenseNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesRentExpenseNet_lbl" xml:lang="en-US">Rent expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US">Number, Options outstanding at the beginning of the period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US">Number, Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US">Number, Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xml:lang="en-US">Number, Forfeited</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xml:lang="en-US">Number, Options outstanding at the end of the period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xml:lang="en-US">Number, Options exercisable at the end of the period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Average exercise price, Options outstanding at the beginning of the period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Average exercise price, Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Average exercise price, Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Average exercise price, Forfeited</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Average exercise price, Options outstanding at the end of the period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xml:lang="en-US">Average exercise price, Options exercisable at the end of the period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Average remaining contractual life (in years), Options outstanding at the beginning of the period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xml:lang="en-US">Average remaining contractual life (in years), Options exercisable at the end of the period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xml:lang="en-US">Aggregate intrinsic value (in thousands), Options outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xml:lang="en-US">Aggregate intrinsic value (in thousands), Options exercisable at the end of the period</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingRollForwardAbstract" xlink:label="rwlk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingRollForwardAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingRollForwardAbstract" xlink:to="rwlk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingRollForwardAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingRollForwardAbstract_lbl" xml:lang="en-US">Number of shares underlying outstanding RSUs</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstandingNumber" xlink:label="rwlk_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstandingNumber" xlink:to="rwlk_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="rwlk_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstandingNumber_lbl" xml:lang="en-US">Unvested RSUs at the Beginning of the period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_lbl" xml:lang="en-US">Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xml:lang="en-US">Vested</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_lbl" xml:lang="en-US">Forfeited</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstandingNumber" xlink:to="rwlk_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstandingNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="rwlk_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstandingNumber_2_lbl" xml:lang="en-US">Unvested RSUs at the end of the period</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingWeightedAverageExercisePriceRollForwardAbstract" xlink:label="rwlk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingWeightedAverageExercisePriceRollForwardAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingWeightedAverageExercisePriceRollForwardAbstract" xlink:to="rwlk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingWeightedAverageExercisePriceRollForwardAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingWeightedAverageExercisePriceRollForwardAbstract_lbl" xml:lang="en-US">Weighted average grant date fair value</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_SharebasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeOutstandingOptionsAndEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice" xlink:label="rwlk_SharebasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeOutstandingOptionsAndEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_SharebasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeOutstandingOptionsAndEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice" xlink:to="rwlk_SharebasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeOutstandingOptionsAndEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="rwlk_SharebasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeOutstandingOptionsAndEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice_lbl" xml:lang="en-US">Unvested RSUs at the Beginning of the period</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsGrantedInPeriodWeightedAverageExercisePrice" xlink:label="rwlk_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsGrantedInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsGrantedInPeriodWeightedAverageExercisePrice" xlink:to="rwlk_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsGrantedInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="rwlk_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsGrantedInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsvestedInPeriodWeightedAverageExercisePrice" xlink:label="rwlk_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsvestedInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsvestedInPeriodWeightedAverageExercisePrice" xlink:to="rwlk_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsvestedInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsvestedInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Vested</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsForfeitedInPeriodWeightedAverageExercisePrice" xlink:label="rwlk_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsForfeitedInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsForfeitedInPeriodWeightedAverageExercisePrice" xlink:to="rwlk_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsForfeitedInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsForfeitedInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Forfeited</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_SharebasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeOutstandingOptionsAndEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice" xlink:to="rwlk_SharebasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeOutstandingOptionsAndEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="rwlk_SharebasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeOutstandingOptionsAndEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Unvested RSUs at the end of the period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_lbl" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_lbl" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_InvestmentOptionsExercisePrices" xlink:label="rwlk_InvestmentOptionsExercisePrices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_InvestmentOptionsExercisePrices" xlink:to="rwlk_InvestmentOptionsExercisePrices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_InvestmentOptionsExercisePrices_lbl" xml:lang="en-US">Exercise price</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xml:lang="en-US">RSUs outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_lbl" xml:lang="en-US">Range of exercise price, minimum</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_lbl" xml:lang="en-US">Range of exercise price, maximum</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_lbl" xml:lang="en-US">Options outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Options outstanding weighted average remaining contractual life (years)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_lbl" xml:lang="en-US">Options outstanding and exercisable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Options exercisable weighted average remaining contractual life (years)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="us-gaap_ClassOfWarrantOrRightTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_ClassOfWarrantOrRightTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightTable_lbl" xml:lang="en-US">Class of Warrant or Right [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems_lbl" xml:lang="en-US">Class of Warrant or Right [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xml:lang="en-US">Warrants outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2_lbl" xml:lang="en-US">Exercise price per warrant</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ClassOfWarrantOrRightExercisable" xlink:label="rwlk_ClassOfWarrantOrRightExercisable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ClassOfWarrantOrRightExercisable" xlink:to="rwlk_ClassOfWarrantOrRightExercisable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_ClassOfWarrantOrRightExercisable_lbl" xml:lang="en-US">Warrants outstanding and exercisable</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_WarrantsExpitationDate" xlink:label="rwlk_WarrantsExpitationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_WarrantsExpitationDate" xlink:to="rwlk_WarrantsExpitationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_WarrantsExpitationDate_lbl" xml:lang="en-US">Contractual term</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_2_lbl" xml:lang="en-US">Non-cash share-based compensation expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable" xlink:label="us-gaap_ScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable" xlink:to="us-gaap_ScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable_lbl" xml:lang="en-US">Schedule of Share-based Goods and Nonemployee Services Transaction [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionLineItems" xlink:label="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionLineItems" xlink:to="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionLineItems_lbl" xml:lang="en-US">Share-based Goods and Nonemployee Services Transaction [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ShareholdersEquityTextualAbstract" xlink:label="rwlk_ShareholdersEquityTextualAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ShareholdersEquityTextualAbstract" xlink:to="rwlk_ShareholdersEquityTextualAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_ShareholdersEquityTextualAbstract_lbl" xml:lang="en-US">Shareholders' Equity (Textual)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="us-gaap_StockholdersEquityReverseStockSplit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityReverseStockSplit" xlink:to="us-gaap_StockholdersEquityReverseStockSplit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityReverseStockSplit_lbl" xml:lang="en-US">Reverse share split, description</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_CommonStockAggregateOfferingPriceAuthorizedUnderEquityDistributionAgreement" xlink:label="rwlk_CommonStockAggregateOfferingPriceAuthorizedUnderEquityDistributionAgreement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_CommonStockAggregateOfferingPriceAuthorizedUnderEquityDistributionAgreement" xlink:to="rwlk_CommonStockAggregateOfferingPriceAuthorizedUnderEquityDistributionAgreement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_CommonStockAggregateOfferingPriceAuthorizedUnderEquityDistributionAgreement_lbl" xml:lang="en-US">Aggregate offering price</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_CommonStockIssuanceCostsUnderEquityDistributionAgreementAsPercentOfGrossProceeds" xlink:label="rwlk_CommonStockIssuanceCostsUnderEquityDistributionAgreementAsPercentOfGrossProceeds" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_CommonStockIssuanceCostsUnderEquityDistributionAgreementAsPercentOfGrossProceeds" xlink:to="rwlk_CommonStockIssuanceCostsUnderEquityDistributionAgreementAsPercentOfGrossProceeds_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_CommonStockIssuanceCostsUnderEquityDistributionAgreementAsPercentOfGrossProceeds_lbl" xml:lang="en-US">Stock issuance costs under equity distribution agreement as a percent of gross proceeds</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US">Issuance of ordinary shares (in shares)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl" xml:lang="en-US">Shares issued price per share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_2_lbl" xml:lang="en-US">Par value of shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl" xml:lang="en-US">Warrant to purchase one ordinary share</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_StockIssuedDuringPeriodPricePerShare" xlink:label="rwlk_StockIssuedDuringPeriodPricePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_StockIssuedDuringPeriodPricePerShare" xlink:to="rwlk_StockIssuedDuringPeriodPricePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_StockIssuedDuringPeriodPricePerShare_lbl" xml:lang="en-US">Price per share of shares sold under ATM offering program (in USD per share)</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_StockIssuedDuringPeriodValueNewIssuesGross" xlink:label="rwlk_StockIssuedDuringPeriodValueNewIssuesGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_StockIssuedDuringPeriodValueNewIssuesGross" xlink:to="rwlk_StockIssuedDuringPeriodValueNewIssuesGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_StockIssuedDuringPeriodValueNewIssuesGross_lbl" xml:lang="en-US">Issuance of ordinary shares in an ATM offering of ordinary shares, gross of issuance expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US">Issuance of ordinary shares in an ATM offering of ordinary shares, net of issuance expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_FixedCommissionRate" xlink:label="rwlk_FixedCommissionRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_FixedCommissionRate" xlink:to="rwlk_FixedCommissionRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_FixedCommissionRate_lbl" xml:lang="en-US">Fixed commission rate</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_FixedCommissionAmount" xlink:label="rwlk_FixedCommissionAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_FixedCommissionAmount" xlink:to="rwlk_FixedCommissionAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_FixedCommissionAmount_lbl" xml:lang="en-US">Fixed commission amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_2_lbl" xml:lang="en-US">Issuance expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_lbl" xml:lang="en-US">Options granted (in shares)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted average grant date fair value, restricted stock units (in USD per share)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted average grant date fair value, options (in USD per share)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xml:lang="en-US">Total intrinsic value of options exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription_lbl" xml:lang="en-US">Award vesting period, description</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xml:lang="en-US">Shares reserved for future issuance (in shares)</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_AggregateNumberOfOrdinaryShares" xlink:label="rwlk_AggregateNumberOfOrdinaryShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_AggregateNumberOfOrdinaryShares" xlink:to="rwlk_AggregateNumberOfOrdinaryShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_AggregateNumberOfOrdinaryShares_lbl" xml:lang="en-US">Aggregate number of ordinary shares</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_SharebasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsVestedAndOptionsNetBasisOfCommonStock" xlink:label="rwlk_SharebasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsVestedAndOptionsNetBasisOfCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_SharebasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsVestedAndOptionsNetBasisOfCommonStock" xlink:to="rwlk_SharebasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsVestedAndOptionsNetBasisOfCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_SharebasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsVestedAndOptionsNetBasisOfCommonStock_lbl" xml:lang="en-US">Vested and options exercised net of ordinary shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_3_lbl" xml:lang="en-US">Exercise price per share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_3_lbl" xml:lang="en-US">Number of warrants issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" xml:lang="en-US">Unrecognized cost of shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_2_lbl" xml:lang="en-US">Expected term of shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xml:lang="en-US">Sale of ordinary shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable" xlink:label="us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable" xlink:to="us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable_lbl" xml:lang="en-US">Warrants grant date</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_WarrantsExercisableDescrition" xlink:label="rwlk_WarrantsExercisableDescrition" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_WarrantsExercisableDescrition" xlink:to="rwlk_WarrantsExercisableDescrition_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_WarrantsExercisableDescrition_lbl" xml:lang="en-US">Warrants exercisable, description</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCollateralAmount" xlink:label="us-gaap_DebtInstrumentCollateralAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentCollateralAmount" xlink:to="us-gaap_DebtInstrumentCollateralAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentCollateralAmount_lbl" xml:lang="en-US">Drawdown amount under loan agreement</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpensesRelatedParty" xlink:label="us-gaap_CostsAndExpensesRelatedParty" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpensesRelatedParty" xlink:to="us-gaap_CostsAndExpensesRelatedParty_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostsAndExpensesRelatedParty_lbl" xml:lang="en-US">Compensation payment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockPlans" xlink:label="us-gaap_ProceedsFromStockPlans" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockPlans" xlink:to="us-gaap_ProceedsFromStockPlans_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromStockPlans_lbl" xml:lang="en-US">Gross proceeds</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare" xlink:label="us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare" xlink:to="us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare_lbl" xml:lang="en-US">Sale of stock price per share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction" xlink:label="us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction" xlink:to="us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction_lbl" xml:lang="en-US">Proceeds percentage of sale of the ordinary shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PartnersCapitalLimitationOfLiability" xlink:label="us-gaap_PartnersCapitalLimitationOfLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PartnersCapitalLimitationOfLiability" xlink:to="us-gaap_PartnersCapitalLimitationOfLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PartnersCapitalLimitationOfLiability_lbl" xml:lang="en-US">Limitation on sales, description</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_FeesAndOtherRelatedExpenses" xlink:label="rwlk_FeesAndOtherRelatedExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_FeesAndOtherRelatedExpenses" xlink:to="rwlk_FeesAndOtherRelatedExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_FeesAndOtherRelatedExpenses_lbl" xml:lang="en-US">Fees and other related expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_NetAggregateProceedsOfAfterDeductingFeesAndOtherRelatedExpenses" xlink:label="rwlk_NetAggregateProceedsOfAfterDeductingFeesAndOtherRelatedExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_NetAggregateProceedsOfAfterDeductingFeesAndOtherRelatedExpenses" xlink:to="rwlk_NetAggregateProceedsOfAfterDeductingFeesAndOtherRelatedExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_NetAggregateProceedsOfAfterDeductingFeesAndOtherRelatedExpenses_lbl" xml:lang="en-US">Net aggregate proceeds of after deducting fees and other related expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuritiesLoanedMeasurementDifferenceDescription" xlink:label="us-gaap_SecuritiesLoanedMeasurementDifferenceDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SecuritiesLoanedMeasurementDifferenceDescription" xlink:to="us-gaap_SecuritiesLoanedMeasurementDifferenceDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SecuritiesLoanedMeasurementDifferenceDescription_lbl" xml:lang="en-US">Description of tranche consisting</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="us-gaap_WarrantsAndRightsOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstanding" xlink:to="us-gaap_WarrantsAndRightsOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsOutstanding_lbl" xml:lang="en-US">Warrant exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_PrefundedWarrantsToPurchaseAggregateOrdinarySharesExercised" xlink:label="rwlk_PrefundedWarrantsToPurchaseAggregateOrdinarySharesExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_PrefundedWarrantsToPurchaseAggregateOrdinarySharesExercised" xlink:to="rwlk_PrefundedWarrantsToPurchaseAggregateOrdinarySharesExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_PrefundedWarrantsToPurchaseAggregateOrdinarySharesExercised_lbl" xml:lang="en-US">Pre-funded warrants to purchase an aggregate ordinary shares exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_DescriptionOfUnderwritingAgreement" xlink:label="rwlk_DescriptionOfUnderwritingAgreement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_DescriptionOfUnderwritingAgreement" xlink:to="rwlk_DescriptionOfUnderwritingAgreement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_DescriptionOfUnderwritingAgreement_lbl" xml:lang="en-US">Description of underwriting agreement</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_DescriptionOfUnderwritersWarrantsToPurchase" xlink:label="rwlk_DescriptionOfUnderwritersWarrantsToPurchase" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_DescriptionOfUnderwritersWarrantsToPurchase" xlink:to="rwlk_DescriptionOfUnderwritersWarrantsToPurchase_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_DescriptionOfUnderwritersWarrantsToPurchase_lbl" xml:lang="en-US">Description of underwriters warrants to purchase</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_2_lbl" xml:lang="en-US">Total gross proceeds received from the follow-on public offering</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_DescriptionOfWainwrightOrItsDesigneesWarrantsToPurchase" xlink:label="rwlk_DescriptionOfWainwrightOrItsDesigneesWarrantsToPurchase" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_DescriptionOfWainwrightOrItsDesigneesWarrantsToPurchase" xlink:to="rwlk_DescriptionOfWainwrightOrItsDesigneesWarrantsToPurchase_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_DescriptionOfWainwrightOrItsDesigneesWarrantsToPurchase_lbl" xml:lang="en-US">Description of wainwright or its designees warrants to purchase</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_StockIssuedDuringPeriodShareOrdinaryShares" xlink:label="rwlk_StockIssuedDuringPeriodShareOrdinaryShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_StockIssuedDuringPeriodShareOrdinaryShares" xlink:to="rwlk_StockIssuedDuringPeriodShareOrdinaryShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_StockIssuedDuringPeriodShareOrdinaryShares_lbl" xml:lang="en-US">Issuance of ordinary shares, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_OrdinarySharesExercisePrice" xlink:label="rwlk_OrdinarySharesExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_OrdinarySharesExercisePrice" xlink:to="rwlk_OrdinarySharesExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_OrdinarySharesExercisePrice_lbl" xml:lang="en-US">Exercise price ordinary shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_lbl" xml:lang="en-US">Total fair value of shares vested</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_DescriptionOfEquityExchangePrograms" xlink:label="rwlk_DescriptionOfEquityExchangePrograms" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_DescriptionOfEquityExchangePrograms" xlink:to="rwlk_DescriptionOfEquityExchangePrograms_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_DescriptionOfEquityExchangePrograms_lbl" xml:lang="en-US">Description of equity exchange program</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_WarrantsToPurchaseOrdinaryShares" xlink:label="rwlk_WarrantsToPurchaseOrdinaryShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_WarrantsToPurchaseOrdinaryShares" xlink:to="rwlk_WarrantsToPurchaseOrdinaryShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_WarrantsToPurchaseOrdinaryShares_lbl" xml:lang="en-US">Warrants to purchase ordinary shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:label="us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:to="us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_lbl" xml:lang="en-US">Schedule of Research and Development Arrangement, Contract to Perform for Others [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_lbl" xml:lang="en-US">Research and Development Arrangement, Contract to Perform for Others [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ResearchCollaborationAgreementAndLicenseAgreementTextualAbstract" xlink:label="rwlk_ResearchCollaborationAgreementAndLicenseAgreementTextualAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ResearchCollaborationAgreementAndLicenseAgreementTextualAbstract" xlink:to="rwlk_ResearchCollaborationAgreementAndLicenseAgreementTextualAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_ResearchCollaborationAgreementAndLicenseAgreementTextualAbstract_lbl" xml:lang="en-US">Research Collaboration Agreement and License Agreement (Textual)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentPeriodicPayment" xlink:label="us-gaap_DebtInstrumentPeriodicPayment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentPeriodicPayment" xlink:to="us-gaap_DebtInstrumentPeriodicPayment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentPeriodicPayment_lbl" xml:lang="en-US">Total payment obligation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ResearchAndDevelopmentExpense_2_lbl" xml:lang="en-US">Research and development expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMaturityDate" xlink:to="us-gaap_DebtInstrumentMaturityDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentMaturityDate_lbl" xml:lang="en-US">Research collaboration agreement expire date</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnsecuredDebt" xlink:label="us-gaap_UnsecuredDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnsecuredDebt" xlink:to="us-gaap_UnsecuredDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnsecuredDebt_lbl" xml:lang="en-US">Unsecured promissory note</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_2_lbl" xml:lang="en-US">Interest rate</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentTerm" xlink:to="us-gaap_DebtInstrumentTerm_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentTerm_2_lbl" xml:lang="en-US">Initial period of loan</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_IncomeTaxesDetailsAbstract" xlink:label="rwlk_IncomeTaxesDetailsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_IncomeTaxesDetailsAbstract" xlink:to="rwlk_IncomeTaxesDetailsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_IncomeTaxesDetailsAbstract_lbl" xml:lang="en-US">Income Taxes (Textual)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl" xml:lang="en-US">Domestic</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl" xml:lang="en-US">Foreign</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_lbl" xml:lang="en-US">Income loss before taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Current</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_DeferredIncometax" xlink:label="rwlk_DeferredIncometax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_DeferredIncometax" xlink:to="rwlk_DeferredIncometax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_DeferredIncometax_lbl" xml:lang="en-US">Deferred</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_TaxesOnIncome" xlink:label="rwlk_TaxesOnIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_TaxesOnIncome" xlink:to="rwlk_TaxesOnIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_TaxesOnIncome_lbl" xml:lang="en-US">Taxes on income</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:label="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:to="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_lbl" xml:lang="en-US">Domestic</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" xlink:label="us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" xlink:to="us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations_lbl" xml:lang="en-US">Foreign</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_TaxesIncome" xlink:label="rwlk_TaxesIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_TaxesIncome" xlink:to="rwlk_TaxesIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="rwlk_TaxesIncome_lbl" xml:lang="en-US">Taxes on income</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGrossAbstract" xlink:label="us-gaap_DeferredTaxAssetsGrossAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract" xlink:to="us-gaap_DeferredTaxAssetsGrossAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsGrossAbstract_lbl" xml:lang="en-US">Deferred tax assets:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xml:lang="en-US">Carry forward tax losses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:to="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_lbl" xml:lang="en-US">Research and development carry forward expenses-temporary differences</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_lbl" xml:lang="en-US">Accrual and reserves</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset" xlink:label="us-gaap_FinanceLeaseRightOfUseAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseRightOfUseAsset" xlink:to="us-gaap_FinanceLeaseRightOfUseAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseRightOfUseAsset_lbl" xml:lang="en-US">Lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xml:lang="en-US">Total deferred tax asset</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesAbstract" xlink:label="us-gaap_DeferredTaxLiabilitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilitiesAbstract_lbl" xml:lang="en-US">Deferred tax liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_RightofuseLiability" xlink:label="rwlk_RightofuseLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_RightofuseLiability" xlink:to="rwlk_RightofuseLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_RightofuseLiability_lbl" xml:lang="en-US">Right-of-use liability</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xml:lang="en-US">Net deferred tax assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xml:lang="en-US">Net deferred tax assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xml:lang="en-US">Balance at beginning of year</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ValuationAllowanceDeferredTaxAssetChangesDuetoAmendmentsinTaxLawsandExchangeRateDifferencesAmount" xlink:label="rwlk_ValuationAllowanceDeferredTaxAssetChangesDuetoAmendmentsinTaxLawsandExchangeRateDifferencesAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ValuationAllowanceDeferredTaxAssetChangesDuetoAmendmentsinTaxLawsandExchangeRateDifferencesAmount" xlink:to="rwlk_ValuationAllowanceDeferredTaxAssetChangesDuetoAmendmentsinTaxLawsandExchangeRateDifferencesAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_ValuationAllowanceDeferredTaxAssetChangesDuetoAmendmentsinTaxLawsandExchangeRateDifferencesAmount_lbl" xml:lang="en-US">Changes due to amendments to tax laws and exchange rate differences</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ValuationAllowanceDeferredTaxAssetAdjustmentsAmount" xlink:label="rwlk_ValuationAllowanceDeferredTaxAssetAdjustmentsAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ValuationAllowanceDeferredTaxAssetAdjustmentsAmount" xlink:to="rwlk_ValuationAllowanceDeferredTaxAssetAdjustmentsAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="rwlk_ValuationAllowanceDeferredTaxAssetAdjustmentsAmount_lbl" xml:lang="en-US">Adjustment previous year loss</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl" xml:lang="en-US">Additions during the year</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_3_lbl" xml:lang="en-US">Balance at end of year</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2_lbl" xml:lang="en-US">Loss before taxes, as reported in the consolidated statements of operations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US">Statutory tax rate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US">Theoretical tax benefits on the above amount at the Israeli statutory tax rate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:to="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_lbl" xml:lang="en-US">Income tax at rate other than the Israeli statutory tax rate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpense_lbl" xml:lang="en-US">Non-deductible expenses including equity-based compensation expenses and other</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Operating losses and other temporary differences for which valuation allowance was provided</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:label="us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:to="us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_lbl" xml:lang="en-US">Permanent differences</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:to="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl" xml:lang="en-US">Other</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherTaxExpenseBenefit" xlink:label="us-gaap_OtherTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherTaxExpenseBenefit" xlink:to="us-gaap_OtherTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherTaxExpenseBenefit_lbl" xml:lang="en-US">Actual tax expense</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ScheduleOfIncomeTaxTable" xlink:label="rwlk_ScheduleOfIncomeTaxTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ScheduleOfIncomeTaxTable" xlink:to="rwlk_ScheduleOfIncomeTaxTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_ScheduleOfIncomeTaxTable_lbl" xml:lang="en-US">Schedule of Income Tax [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ScheduleOfIncomeTaxLineItems" xlink:label="rwlk_ScheduleOfIncomeTaxLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ScheduleOfIncomeTaxLineItems" xlink:to="rwlk_ScheduleOfIncomeTaxLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_ScheduleOfIncomeTaxLineItems_lbl" xml:lang="en-US">ScheduleOfIncomeTaxLineItems [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_IncomeTaxesTextualAbstract" xlink:label="rwlk_IncomeTaxesTextualAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_IncomeTaxesTextualAbstract" xlink:to="rwlk_IncomeTaxesTextualAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="rwlk_IncomeTaxesTextualAbstract_lbl" xml:lang="en-US">Income Taxes (Textual)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCutsAndJobsActOf2017ChangeInTaxRateDeferredTaxAssetIncomeTaxExpense" xlink:label="us-gaap_TaxCutsAndJobsActOf2017ChangeInTaxRateDeferredTaxAssetIncomeTaxExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCutsAndJobsActOf2017ChangeInTaxRateDeferredTaxAssetIncomeTaxExpense" xlink:to="us-gaap_TaxCutsAndJobsActOf2017ChangeInTaxRateDeferredTaxAssetIncomeTaxExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TaxCutsAndJobsActOf2017ChangeInTaxRateDeferredTaxAssetIncomeTaxExpense_lbl" xml:lang="en-US">Effect of tax rate change on deferred tax expense</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_BeneficiaryEnterprisefromProductiveActivityTaxExemptionPeriod" xlink:label="rwlk_BeneficiaryEnterprisefromProductiveActivityTaxExemptionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_BeneficiaryEnterprisefromProductiveActivityTaxExemptionPeriod" xlink:to="rwlk_BeneficiaryEnterprisefromProductiveActivityTaxExemptionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_BeneficiaryEnterprisefromProductiveActivityTaxExemptionPeriod_lbl" xml:lang="en-US">Beneficiary enterprise from productive activity, tax exemption period</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_BeneficiaryEnterprisefromProductiveActivityMaximumTimefromPeriodofElectionforTaxExemption" xlink:label="rwlk_BeneficiaryEnterprisefromProductiveActivityMaximumTimefromPeriodofElectionforTaxExemption" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_BeneficiaryEnterprisefromProductiveActivityMaximumTimefromPeriodofElectionforTaxExemption" xlink:to="rwlk_BeneficiaryEnterprisefromProductiveActivityMaximumTimefromPeriodofElectionforTaxExemption_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_BeneficiaryEnterprisefromProductiveActivityMaximumTimefromPeriodofElectionforTaxExemption_lbl" xml:lang="en-US">Beneficiary enterprise from productive activity, maximum time from period of election for tax exemption</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_BeneficiaryEnterprisefromProductiveActivityTaxRateonDividendDistributionsfromTaxExemptIncome" xlink:label="rwlk_BeneficiaryEnterprisefromProductiveActivityTaxRateonDividendDistributionsfromTaxExemptIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_BeneficiaryEnterprisefromProductiveActivityTaxRateonDividendDistributionsfromTaxExemptIncome" xlink:to="rwlk_BeneficiaryEnterprisefromProductiveActivityTaxRateonDividendDistributionsfromTaxExemptIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_BeneficiaryEnterprisefromProductiveActivityTaxRateonDividendDistributionsfromTaxExemptIncome_lbl" xml:lang="en-US">Beneficiary enterprise from productive activity, tax rate on dividend distributions from tax exempt income</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xml:lang="en-US">Carry-forward losses</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_DescriptionOfIncomeTaxLawForEncouragementOfCapitalInvestments" xlink:label="rwlk_DescriptionOfIncomeTaxLawForEncouragementOfCapitalInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_DescriptionOfIncomeTaxLawForEncouragementOfCapitalInvestments" xlink:to="rwlk_DescriptionOfIncomeTaxLawForEncouragementOfCapitalInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_DescriptionOfIncomeTaxLawForEncouragementOfCapitalInvestments_lbl" xml:lang="en-US">Description of income tax law for encouragement of capital investments</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_NetOperatingCarryForwardLossesTerms" xlink:label="rwlk_NetOperatingCarryForwardLossesTerms" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_NetOperatingCarryForwardLossesTerms" xlink:to="rwlk_NetOperatingCarryForwardLossesTerms_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_NetOperatingCarryForwardLossesTerms_lbl" xml:lang="en-US">Net operating carry-forward losses, terms</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_lbl" xml:lang="en-US">Foreign currency transactions and other</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfBankDebt" xlink:label="us-gaap_RepaymentsOfBankDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfBankDebt" xlink:to="us-gaap_RepaymentsOfBankDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfBankDebt_lbl" xml:lang="en-US">Financial expenses related to loan agreement with Kreos</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_BankCommissions" xlink:label="rwlk_BankCommissions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_BankCommissions" xlink:to="rwlk_BankCommissions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_BankCommissions_lbl" xml:lang="en-US">Bank commissions</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:label="us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:to="us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_lbl" xml:lang="en-US">Schedule of Revenue by Major Customers, by Reporting Segments [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:label="us-gaap_EntityWideRevenueMajorCustomerLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:to="us-gaap_EntityWideRevenueMajorCustomerLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EntityWideRevenueMajorCustomerLineItems_lbl" xml:lang="en-US">Revenue, Major Customer [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_Revenues_3_lbl" xml:lang="en-US">Total revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_lbl" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_lbl" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_2_lbl" xml:lang="en-US">Long-lived assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConcentrationRiskPercentage1_3_lbl" xml:lang="en-US">Concentration risk</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_GeographicInformationAndMajorCustomerAndProductDataTextualAbstract" xlink:label="rwlk_GeographicInformationAndMajorCustomerAndProductDataTextualAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_GeographicInformationAndMajorCustomerAndProductDataTextualAbstract" xlink:to="rwlk_GeographicInformationAndMajorCustomerAndProductDataTextualAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_GeographicInformationAndMajorCustomerAndProductDataTextualAbstract_lbl" xml:lang="en-US">Geographic Information and Major Customer and Product Data (Textual)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments" xlink:label="us-gaap_NumberOfReportableSegments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfReportableSegments" xlink:to="us-gaap_NumberOfReportableSegments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NumberOfReportableSegments_lbl" xml:lang="en-US">Number of reportable segments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromWarrantExercises" xlink:to="us-gaap_ProceedsFromWarrantExercises_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromWarrantExercises_2_lbl" xml:lang="en-US">Proceeds From Warrant Exercises</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_AggregateNumberOfOrdinaryShares" xlink:to="rwlk_AggregateNumberOfOrdinaryShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_AggregateNumberOfOrdinaryShares_doc" xml:lang="en-US">Aggregate number of ordinary shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_AgreementAxis" xlink:to="rwlk_AgreementAxis_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_AgreementAxis_doc" xml:lang="en-US">Agreement Axis</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_AgreementDomain" xlink:label="rwlk_AgreementDomain" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_AgreementDomain" xlink:to="rwlk_AgreementDomain_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_AgreementDomain_doc" xml:lang="en-US">Agreement Domain</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_AllowanceForSalesReturns" xlink:to="rwlk_AllowanceForSalesReturns_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_AllowanceForSalesReturns_doc" xml:lang="en-US">Allowance for Sales Returns</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_AtmOfferingProgramMember" xlink:to="rwlk_AtmOfferingProgramMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_AtmOfferingProgramMember_doc" xml:lang="en-US">ATM Offering Program [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_BankCommissions" xlink:to="rwlk_BankCommissions_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_BankCommissions_doc" xml:lang="en-US">Amount of bank commissions.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_BeneficiaryEnterprisefromProductiveActivityMaximumTimefromPeriodofElectionforTaxExemption" xlink:to="rwlk_BeneficiaryEnterprisefromProductiveActivityMaximumTimefromPeriodofElectionforTaxExemption_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_BeneficiaryEnterprisefromProductiveActivityMaximumTimefromPeriodofElectionforTaxExemption_doc" xml:lang="en-US">Beneficiary Enterprise from Productive Activity, Maximum Time from Period of Election for Tax Exemption</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_BeneficiaryEnterprisefromProductiveActivityTaxExemptionPeriod" xlink:to="rwlk_BeneficiaryEnterprisefromProductiveActivityTaxExemptionPeriod_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_BeneficiaryEnterprisefromProductiveActivityTaxExemptionPeriod_doc" xml:lang="en-US">Beneficiary Enterprise from Productive Activity, Tax Exemption Period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_BeneficiaryEnterprisefromProductiveActivityTaxRateonDividendDistributionsfromTaxExemptIncome" xlink:to="rwlk_BeneficiaryEnterprisefromProductiveActivityTaxRateonDividendDistributionsfromTaxExemptIncome_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_BeneficiaryEnterprisefromProductiveActivityTaxRateonDividendDistributionsfromTaxExemptIncome_doc" xml:lang="en-US">Beneficiary Enterprise from Productive Activity, Tax Rate on Dividend Distributions from Tax Exempt Income</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_BestOfferingMember" xlink:to="rwlk_BestOfferingMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_BestOfferingMember_doc" xml:lang="en-US">Best Offering [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_CashAndCashEquivalentsRestrictedCashAndRestrictedCashEquivalent" xlink:to="rwlk_CashAndCashEquivalentsRestrictedCashAndRestrictedCashEquivalent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_CashAndCashEquivalentsRestrictedCashAndRestrictedCashEquivalent_doc" xml:lang="en-US">Amount of total cash, cash equivalents, and restricted cash for the period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_CashlessExerciseOfPrefundedWarrants" xlink:to="rwlk_CashlessExerciseOfPrefundedWarrants_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_CashlessExerciseOfPrefundedWarrants_doc" xml:lang="en-US">Cashless exercise of pre-funded warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ClassOfWarrantOrRightExercisable" xlink:to="rwlk_ClassOfWarrantOrRightExercisable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_ClassOfWarrantOrRightExercisable_doc" xml:lang="en-US">Class of Warrant or Right, Exercisable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ClassificationOfInventoryToOtherCurrentAssets" xlink:to="rwlk_ClassificationOfInventoryToOtherCurrentAssets_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_ClassificationOfInventoryToOtherCurrentAssets_doc" xml:lang="en-US">Classification of inventory to other current assets.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ClassificationOfInventoryToPropertyAndEquipmentNet" xlink:to="rwlk_ClassificationOfInventoryToPropertyAndEquipmentNet_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_ClassificationOfInventoryToPropertyAndEquipmentNet_doc" xml:lang="en-US">Classification of Inventory to Property and Equipment, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ClassificationOfOtherCurrentAssetsToPropertyAndEquipmentNet" xlink:to="rwlk_ClassificationOfOtherCurrentAssetsToPropertyAndEquipmentNet_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_ClassificationOfOtherCurrentAssetsToPropertyAndEquipmentNet_doc" xml:lang="en-US">Classification of other net current assets to property and equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_CommonStockAggregateOfferingPriceAuthorizedUnderEquityDistributionAgreement" xlink:to="rwlk_CommonStockAggregateOfferingPriceAuthorizedUnderEquityDistributionAgreement_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_CommonStockAggregateOfferingPriceAuthorizedUnderEquityDistributionAgreement_doc" xml:lang="en-US">Common Stock, Aggregate Offering Price Authorized Under Equity Distribution Agreement</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_CommonStockIssuanceCostsIncurredNotYetPaid" xlink:to="rwlk_CommonStockIssuanceCostsIncurredNotYetPaid_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_CommonStockIssuanceCostsIncurredNotYetPaid_doc" xml:lang="en-US">Common Stock Issuance Costs Incurred but Not yet Paid</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_CommonStockIssuanceCostsUnderEquityDistributionAgreementAsPercentOfGrossProceeds" xlink:to="rwlk_CommonStockIssuanceCostsUnderEquityDistributionAgreementAsPercentOfGrossProceeds_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_CommonStockIssuanceCostsUnderEquityDistributionAgreementAsPercentOfGrossProceeds_doc" xml:lang="en-US">Stock issuance costs under equity distribution agreement as a percent of gross proceeds.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ContingentLiabilityRelatedToGrantsReceived" xlink:to="rwlk_ContingentLiabilityRelatedToGrantsReceived_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_ContingentLiabilityRelatedToGrantsReceived_doc" xml:lang="en-US">Represents the contingent liability related to grant received as of the balance sheet date.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_CumulativeEffectOnRetainedEarningsNetOfTax" xlink:to="rwlk_CumulativeEffectOnRetainedEarningsNetOfTax_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_CumulativeEffectOnRetainedEarningsNetOfTax_doc" xml:lang="en-US">Cumulative-effect adjustment to retained earnings/accumulated deficit.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_CumulativeEffectToAccumulatedDeficitFromAdoptionOfNewAccountingStandard" xlink:to="rwlk_CumulativeEffectToAccumulatedDeficitFromAdoptionOfNewAccountingStandard_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_CumulativeEffectToAccumulatedDeficitFromAdoptionOfNewAccountingStandard_doc" xml:lang="en-US">Cumulative effect to accumulated deficit from adoption of a new accounting standard.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_CumulativeEffectToStockBasedCompensationFromAdoptionOfNewAccountingStandard" xlink:to="rwlk_CumulativeEffectToStockBasedCompensationFromAdoptionOfNewAccountingStandard_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_CumulativeEffectToStockBasedCompensationFromAdoptionOfNewAccountingStandard_doc" xml:lang="en-US">Cumulative effect to stock based compensation from adoption of a new accounting standard.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_CustomerAMember" xlink:to="rwlk_CustomerAMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_CustomerAMember_doc" xml:lang="en-US">Customer A [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_CustomerBMember" xlink:to="rwlk_CustomerBMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_CustomerBMember_doc" xml:lang="en-US">Customer B [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_CustomerCMember" xlink:to="rwlk_CustomerCMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_CustomerCMember_doc" xml:lang="en-US">Customer C [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_CustomerDMember" xlink:to="rwlk_CustomerDMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_CustomerDMember_doc" xml:lang="en-US">Customer D [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_CustomerEMember" xlink:to="rwlk_CustomerEMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_CustomerEMember_doc" xml:lang="en-US">Customer E [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_CustomerFMember" xlink:to="rwlk_CustomerFMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_CustomerFMember_doc" xml:lang="en-US">Customer F [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_CustomerGMember" xlink:to="rwlk_CustomerGMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_CustomerGMember_doc" xml:lang="en-US">Customer G [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_CustomerHMember" xlink:to="rwlk_CustomerHMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_CustomerHMember_doc" xml:lang="en-US">Customer H [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_CustomerIMember" xlink:to="rwlk_CustomerIMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_CustomerIMember_doc" xml:lang="en-US">Customer I [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_CustomerJMember" xlink:to="rwlk_CustomerJMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_CustomerJMember_doc" xml:lang="en-US">Customer J [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_CustomerKMember" xlink:to="rwlk_CustomerKMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_CustomerKMember_doc" xml:lang="en-US">Customer K [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_CustomerLMember" xlink:to="rwlk_CustomerLMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_CustomerLMember_doc" xml:lang="en-US">Customer L [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_DebtInstrumentProceedsfromIssuanceofCommonStockRequiredforRepaymentPeriodtobeExtended" xlink:to="rwlk_DebtInstrumentProceedsfromIssuanceofCommonStockRequiredforRepaymentPeriodtobeExtended_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_DebtInstrumentProceedsfromIssuanceofCommonStockRequiredforRepaymentPeriodtobeExtended_doc" xml:lang="en-US">Debt Instrument, Proceeds from Issuance of Common Stock Required for Repayment Period to be Extended</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_DeferredIncometax" xlink:to="rwlk_DeferredIncometax_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_DeferredIncometax_doc" xml:lang="en-US">Deferred Income Tax.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_DescriptionOfEquityExchangePrograms" xlink:to="rwlk_DescriptionOfEquityExchangePrograms_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_DescriptionOfEquityExchangePrograms_doc" xml:lang="en-US">Description of equity exchange program.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_DescriptionOfIncomeTaxLawForEncouragementOfCapitalInvestments" xlink:to="rwlk_DescriptionOfIncomeTaxLawForEncouragementOfCapitalInvestments_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_DescriptionOfIncomeTaxLawForEncouragementOfCapitalInvestments_doc" xml:lang="en-US">Description of income tax law for encouragement of capital investments.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_DescriptionOfUnderwritersWarrantsToPurchase" xlink:to="rwlk_DescriptionOfUnderwritersWarrantsToPurchase_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_DescriptionOfUnderwritersWarrantsToPurchase_doc" xml:lang="en-US">Description of underwriters warrants to purchase.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_DescriptionOfUnderwritingAgreement" xlink:to="rwlk_DescriptionOfUnderwritingAgreement_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_DescriptionOfUnderwritingAgreement_doc" xml:lang="en-US">Description of underwriting agreement.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_DescriptionOfWainwrightOrItsDesigneesWarrantsToPurchase" xlink:to="rwlk_DescriptionOfWainwrightOrItsDesigneesWarrantsToPurchase_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_DescriptionOfWainwrightOrItsDesigneesWarrantsToPurchase_doc" xml:lang="en-US">Description of wainwright or its designees warrants to purchase.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_DisclosureofTermLoansandWarrantstoPurchaseOrdinarySharesTextBlock" xlink:to="rwlk_DisclosureofTermLoansandWarrantstoPurchaseOrdinarySharesTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_DisclosureofTermLoansandWarrantstoPurchaseOrdinarySharesTextBlock_doc" xml:lang="en-US">Disclosure of Term Loans and Warrants to Purchase Ordinary Shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_EmployeeStockOptionAndRestrictedStockUnitsRsuMember" xlink:to="rwlk_EmployeeStockOptionAndRestrictedStockUnitsRsuMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_EmployeeStockOptionAndRestrictedStockUnitsRsuMember_doc" xml:lang="en-US">Represents details pertaining to employee share option and RSU.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_EmployeesAndNonEmployeesMember" xlink:to="rwlk_EmployeesAndNonEmployeesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_EmployeesAndNonEmployeesMember_doc" xml:lang="en-US">Employees and non- employees [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_EquityExchangeProgramMember" xlink:to="rwlk_EquityExchangeProgramMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_EquityExchangeProgramMember_doc" xml:lang="en-US">Equity Exchange Program [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ExerciseOfPreFundedWarrants" xlink:to="rwlk_ExerciseOfPreFundedWarrants_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_ExerciseOfPreFundedWarrants_doc" xml:lang="en-US">Exercise of pre-funded warrants and warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ExerciseOfPreFundedWarrantsAndWarrantsShares" xlink:to="rwlk_ExerciseOfPreFundedWarrantsAndWarrantsShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_ExerciseOfPreFundedWarrantsAndWarrantsShares_doc" xml:lang="en-US">Number of shares exercise of pre-funded warrants and warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ExerciseOfPreFundedWarrantsShares" xlink:to="rwlk_ExerciseOfPreFundedWarrantsShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_ExerciseOfPreFundedWarrantsShares_doc" xml:lang="en-US">Number of shares exercise of pre-funded warrants and warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ExerciseOfPreFundedWarrantsValue" xlink:to="rwlk_ExerciseOfPreFundedWarrantsValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_ExerciseOfPreFundedWarrantsValue_doc" xml:lang="en-US">Value of exercise of pre-funded warrants and warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ExerciseOfPrefundedWarrantsAndWarrantsValue" xlink:to="rwlk_ExerciseOfPrefundedWarrantsAndWarrantsValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_ExerciseOfPrefundedWarrantsAndWarrantsValue_doc" xml:lang="en-US">Value of exercise of pre-funded warrants and warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ExercisePriceRangeFiveMember" xlink:to="rwlk_ExercisePriceRangeFiveMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_ExercisePriceRangeFiveMember_doc" xml:lang="en-US">Represents information by five range of option prices pertaining to options granted.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ExercisePriceRangeFourMember" xlink:to="rwlk_ExercisePriceRangeFourMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_ExercisePriceRangeFourMember_doc" xml:lang="en-US">Represents information by four range of option prices pertaining to options granted.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ExercisePriceRangeMember" xlink:to="rwlk_ExercisePriceRangeMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_ExercisePriceRangeMember_doc" xml:lang="en-US">Exercise Price Range [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ExercisePriceRangeOneMember" xlink:to="rwlk_ExercisePriceRangeOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_ExercisePriceRangeOneMember_doc" xml:lang="en-US">Represents information by one range of option prices pertaining to options granted.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ExercisePriceRangeThreeMember" xlink:to="rwlk_ExercisePriceRangeThreeMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_ExercisePriceRangeThreeMember_doc" xml:lang="en-US">Represents information by three range of option prices pertaining to options granted.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ExercisePriceRangeTwoMember" xlink:to="rwlk_ExercisePriceRangeTwoMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_ExercisePriceRangeTwoMember_doc" xml:lang="en-US">Represents information by two range of option prices pertaining to options granted.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_FeesAndOtherRelatedExpenses" xlink:to="rwlk_FeesAndOtherRelatedExpenses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_FeesAndOtherRelatedExpenses_doc" xml:lang="en-US">The amount of fees and other related expenses.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_FieldServiceUnitsMember" xlink:to="rwlk_FieldServiceUnitsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_FieldServiceUnitsMember_doc" xml:lang="en-US">Field service units [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_FinancialExpensesIncomeNet" xlink:to="rwlk_FinancialExpensesIncomeNet_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_FinancialExpensesIncomeNet_doc" xml:lang="en-US">Represents the aggregate amount of financial expense or income from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_FinancialExpensesRelatedToLongTermLoan" xlink:to="rwlk_FinancialExpensesRelatedToLongTermLoan_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_FinancialExpensesRelatedToLongTermLoan_doc" xml:lang="en-US">Financial expenses related to long term loan.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_FirstAmendmentMember" xlink:to="rwlk_FirstAmendmentMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_FirstAmendmentMember_doc" xml:lang="en-US">First Amendment [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_FixedCommissionAmount" xlink:to="rwlk_FixedCommissionAmount_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_FixedCommissionAmount_doc" xml:lang="en-US">Fixed commission amount.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_FixedCommissionRate" xlink:to="rwlk_FixedCommissionRate_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_FixedCommissionRate_doc" xml:lang="en-US">Fixed commission rate.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_GainsLossesOnInducementOfDebt1" xlink:to="rwlk_GainsLossesOnInducementOfDebt1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_GainsLossesOnInducementOfDebt1_doc" xml:lang="en-US">Loss on inducement of debt.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_GovernmentGrantsPolicyTextBlock" xlink:to="rwlk_GovernmentGrantsPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_GovernmentGrantsPolicyTextBlock_doc" xml:lang="en-US">Disclosure of accounting policy for government grants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_GuarantorObligationsCollateralPledged" xlink:to="rwlk_GuarantorObligationsCollateralPledged_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_GuarantorObligationsCollateralPledged_doc" xml:lang="en-US">Guarantor obligations as collateral pledged.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ImputedInterest" xlink:to="rwlk_ImputedInterest_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_ImputedInterest_doc" xml:lang="en-US">Less: imputed interest.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_InitialRecognitionOfOperatingLeaseLiabilities" xlink:to="rwlk_InitialRecognitionOfOperatingLeaseLiabilities_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_InitialRecognitionOfOperatingLeaseLiabilities_doc" xml:lang="en-US">Initial recognition of operating lease liabilities.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_InitialRecognitionOfOperatingLeaseRightofuseAssets" xlink:to="rwlk_InitialRecognitionOfOperatingLeaseRightofuseAssets_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_InitialRecognitionOfOperatingLeaseRightofuseAssets_doc" xml:lang="en-US">Initial recognition of operating lease right-of-use assets.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_InvestmentAgreementMember" xlink:to="rwlk_InvestmentAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_InvestmentAgreementMember_doc" xml:lang="en-US">Investment Agreement.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_InvestmentOptionsExercisePrices" xlink:to="rwlk_InvestmentOptionsExercisePrices_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_InvestmentOptionsExercisePrices_doc" xml:lang="en-US">Exercise price.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_IsraelInnovationAuthorityMember" xlink:to="rwlk_IsraelInnovationAuthorityMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_IsraelInnovationAuthorityMember_doc" xml:lang="en-US">Israeli Innovation Authority [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_IsraelUSBinationalIndustrialResearchAndDevelopmentFoundationMember" xlink:to="rwlk_IsraelUSBinationalIndustrialResearchAndDevelopmentFoundationMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_IsraelUSBinationalIndustrialResearchAndDevelopmentFoundationMember_doc" xml:lang="en-US">Israel US Binational Industrial Research And Development Foundation [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_IsraeliMember" xlink:to="rwlk_IsraeliMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_IsraeliMember_doc" xml:lang="en-US">Israeli Member</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_IssuanceExpensesOfOfferingSharesAmount" xlink:to="rwlk_IssuanceExpensesOfOfferingSharesAmount_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_IssuanceExpensesOfOfferingSharesAmount_doc" xml:lang="en-US">Issuance expenses of offering shares amount.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_IssuanceOfOrdinarySharesInInvestmentAgreement" xlink:to="rwlk_IssuanceOfOrdinarySharesInInvestmentAgreement_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_IssuanceOfOrdinarySharesInInvestmentAgreement_doc" xml:lang="en-US">Issuance of ordinary shares of investment agreement, net of issuance expenses in the amount.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_IssuanceOfOrdinarySharesInWarrantExerciseAgreementNetOfIssuanceExpensesInAmountOf10191" xlink:to="rwlk_IssuanceOfOrdinarySharesInWarrantExerciseAgreementNetOfIssuanceExpensesInAmountOf10191_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_IssuanceOfOrdinarySharesInWarrantExerciseAgreementNetOfIssuanceExpensesInAmountOf10191_doc" xml:lang="en-US">Issuance of ordinary shares of warrant exercise, net of issuance expenses in the amount.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_KreosCapitalMember" xlink:to="rwlk_KreosCapitalMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_KreosCapitalMember_doc" xml:lang="en-US">Kreos Capital [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_KreosCapitalVMember" xlink:to="rwlk_KreosCapitalVMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_KreosCapitalVMember_doc" xml:lang="en-US">Kreos Capital V [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_LicenseAgreementAndCollaborationAgreementMember" xlink:to="rwlk_LicenseAgreementAndCollaborationAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_LicenseAgreementAndCollaborationAgreementMember_doc" xml:lang="en-US">License Agreement and to the Collaboration Agreement member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_LoanAgreementWithKreosAndRelatedWarrantToPurchaseOrdinarySharesTextual" xlink:to="rwlk_LoanAgreementWithKreosAndRelatedWarrantToPurchaseOrdinarySharesTextual_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_LoanAgreementWithKreosAndRelatedWarrantToPurchaseOrdinarySharesTextual_doc" xml:lang="en-US">Loan Agreement with Kreos and Related Warrant to Purchase Ordinary Shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_LongTermLoanConversionAmount" xlink:to="rwlk_LongTermLoanConversionAmount_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_LongTermLoanConversionAmount_doc" xml:lang="en-US">Long term loan conversion amount .</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_LongtermDebtMaturitiesPortionofPrincipalSubjecttoRepaymentExtension" xlink:to="rwlk_LongtermDebtMaturitiesPortionofPrincipalSubjecttoRepaymentExtension_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_LongtermDebtMaturitiesPortionofPrincipalSubjecttoRepaymentExtension_doc" xml:lang="en-US">Long-term Debt, Maturities, Portion of Principal Subject to Repayment Extension</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_MachineryAndLaboratoryEquipmentMember" xlink:to="rwlk_MachineryAndLaboratoryEquipmentMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_MachineryAndLaboratoryEquipmentMember_doc" xml:lang="en-US">Machinery and laboratory equipment [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_NetAggregateProceedsOfAfterDeductingFeesAndOtherRelatedExpenses" xlink:to="rwlk_NetAggregateProceedsOfAfterDeductingFeesAndOtherRelatedExpenses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_NetAggregateProceedsOfAfterDeductingFeesAndOtherRelatedExpenses_doc" xml:lang="en-US">The net aggregate proceeds of the first tranche closing after deducting fees and other related expenses in the amount of approximately.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_NetOperatingCarryForwardLossesTerms" xlink:to="rwlk_NetOperatingCarryForwardLossesTerms_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_NetOperatingCarryForwardLossesTerms_doc" xml:lang="en-US">Net operating carry-forward losses, terms.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionsQuantification" xlink:to="rwlk_NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionsQuantification_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionsQuantification_doc" xml:lang="en-US">Addition of lease assets and liabilities related to operating leases.</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_NonEmployeesMember" xlink:label="rwlk_NonEmployeesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_NonEmployeesMember" xlink:to="rwlk_NonEmployeesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_NonEmployeesMember_doc" xml:lang="en-US">Non-employees [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_OperatingLeasesMaximumPenaltiesPayableOnEarlyReleaseOfAgreement" xlink:to="rwlk_OperatingLeasesMaximumPenaltiesPayableOnEarlyReleaseOfAgreement_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_OperatingLeasesMaximumPenaltiesPayableOnEarlyReleaseOfAgreement_doc" xml:lang="en-US">Represents the maximum amount of penalties payable on early release of lease agreement.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_OrdinarySharesExercisePrice" xlink:to="rwlk_OrdinarySharesExercisePrice_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_OrdinarySharesExercisePrice_doc" xml:lang="en-US">Exercise price ordinary shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_OtherLongTermAssetsPolicyTextBlock" xlink:to="rwlk_OtherLongTermAssetsPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_OtherLongTermAssetsPolicyTextBlock_doc" xml:lang="en-US">Disclosure of accounting policy for other long term assets.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_PercentageOfGrantReceivedConsideredToDetermineRoyaltyFees" xlink:to="rwlk_PercentageOfGrantReceivedConsideredToDetermineRoyaltyFees_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_PercentageOfGrantReceivedConsideredToDetermineRoyaltyFees_doc" xml:lang="en-US">Represents the percentage of grant received considered to determine royalty fees.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_PrefundedWarrantsToPurchaseAggregateOrdinarySharesExercised" xlink:to="rwlk_PrefundedWarrantsToPurchaseAggregateOrdinarySharesExercised_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_PrefundedWarrantsToPurchaseAggregateOrdinarySharesExercised_doc" xml:lang="en-US">Pre-funded warrants to purchase an aggregate ordinary shares exercised.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_PrepaidExpenseAndOtherAssetsDisclosureTextBlock" xlink:to="rwlk_PrepaidExpenseAndOtherAssetsDisclosureTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_PrepaidExpenseAndOtherAssetsDisclosureTextBlock_doc" xml:lang="en-US">The entire disclosure for prepaid expenses and other current assets.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_PrepaidExpensesToGovernmentInstitutionsCurrent" xlink:to="rwlk_PrepaidExpensesToGovernmentInstitutionsCurrent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_PrepaidExpensesToGovernmentInstitutionsCurrent_doc" xml:lang="en-US">Amount of asset related to consideration paid in advance to government institutions.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ProceedsFromIssuanceOfRegistrationCost" xlink:to="rwlk_ProceedsFromIssuanceOfRegistrationCost_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_ProceedsFromIssuanceOfRegistrationCost_doc" xml:lang="en-US">Issuance of ordinary shares of registered direct, net of issuance expenses in the amount.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ProceedsFromIssuanceofPreFundedWarrants" xlink:to="rwlk_ProceedsFromIssuanceofPreFundedWarrants_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_ProceedsFromIssuanceofPreFundedWarrants_doc" xml:lang="en-US">Issuance of ordinary shares and exercise of pre-funded warrants into ordinary shares in follow-on offering, net of issuance expenses.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ProceedsFromOfferingCost" xlink:to="rwlk_ProceedsFromOfferingCost_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_ProceedsFromOfferingCost_doc" xml:lang="en-US">Issuance of ordinary shares in a offering, net of issuance expenses in the amount.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_PublicStockOfferingMember" xlink:to="rwlk_PublicStockOfferingMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_PublicStockOfferingMember_doc" xml:lang="en-US">Follow-on Public Offering [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ReStoreProductMember" xlink:to="rwlk_ReStoreProductMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_ReStoreProductMember_doc" xml:lang="en-US">ReStore product [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ReWalkRoboticsGMBHMember" xlink:to="rwlk_ReWalkRoboticsGMBHMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_ReWalkRoboticsGMBHMember_doc" xml:lang="en-US">ReWalk Robotics GMBH</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ReWalkRoboticsIncMember" xlink:to="rwlk_ReWalkRoboticsIncMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_ReWalkRoboticsIncMember_doc" xml:lang="en-US">Represents information pertaining to the ReWalk Robotics Inc., a wholly-owned subsidiary of the entity.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_RegisteredDirectMember" xlink:to="rwlk_RegisteredDirectMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_RegisteredDirectMember_doc" xml:lang="en-US">Registered Direct.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_RegisteredDirectOfferingMember" xlink:to="rwlk_RegisteredDirectOfferingMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_RegisteredDirectOfferingMember_doc" xml:lang="en-US">Registered Direct [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_RelatedPartiesTransactionsAndBalancesPolicyTextBlock" xlink:to="rwlk_RelatedPartiesTransactionsAndBalancesPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_RelatedPartiesTransactionsAndBalancesPolicyTextBlock_doc" xml:lang="en-US">Disclosure of accounting policy for related parties transactions and balances.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_RelatedPartyTransactionOwnershipPercentage" xlink:to="rwlk_RelatedPartyTransactionOwnershipPercentage_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_RelatedPartyTransactionOwnershipPercentage_doc" xml:lang="en-US">Related party transaction, ownership percentage.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_RepaymentOfLongTermLoanByIssuanceOfUnitsAndPrefundedUnits" xlink:to="rwlk_RepaymentOfLongTermLoanByIssuanceOfUnitsAndPrefundedUnits_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_RepaymentOfLongTermLoanByIssuanceOfUnitsAndPrefundedUnits_doc" xml:lang="en-US">Repayment of long term loan by issuance of units and pre-funded units.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ResearchAndDevelopmentAmountReceivedInConsiderationOfConvertiblePreferredShares" xlink:to="rwlk_ResearchAndDevelopmentAmountReceivedInConsiderationOfConvertiblePreferredShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_ResearchAndDevelopmentAmountReceivedInConsiderationOfConvertiblePreferredShares_doc" xml:lang="en-US">Represents the portion of aggregate amount received in consideration of convertible preferred shares by the entity to fund research and development activity.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ResearchAndDevelopmentRoyaltyBearingGrants" xlink:to="rwlk_ResearchAndDevelopmentRoyaltyBearingGrants_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_ResearchAndDevelopmentRoyaltyBearingGrants_doc" xml:lang="en-US">Represents the portion of aggregate amount received as royalty bearing grants by the entity to fund research and development activity.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_RestrictedCashIncludedInOtherNoncurrentAssets" xlink:to="rwlk_RestrictedCashIncludedInOtherNoncurrentAssets_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_RestrictedCashIncludedInOtherNoncurrentAssets_doc" xml:lang="en-US">Amount of restricted cash included in other long term assets for the period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_RevenueObligationAxis" xlink:to="rwlk_RevenueObligationAxis_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_RevenueObligationAxis_doc" xml:lang="en-US">Revenue Obligation Axis</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_RevenueObligationDomain" xlink:label="rwlk_RevenueObligationDomain" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_RevenueObligationDomain" xlink:to="rwlk_RevenueObligationDomain_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_RevenueObligationDomain_doc" xml:lang="en-US">Revenue Obligation Domain</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_RevenueRecognitionRecognized" xlink:to="rwlk_RevenueRecognitionRecognized_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_RevenueRecognitionRecognized_doc" xml:lang="en-US">Revenue Recognition Recognized</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_RightofuseLiability" xlink:to="rwlk_RightofuseLiability_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_RightofuseLiability_doc" xml:lang="en-US">Right-of-use liability.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_RoyaltyBearingGrantsExpenses" xlink:to="rwlk_RoyaltyBearingGrantsExpenses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_RoyaltyBearingGrantsExpenses_doc" xml:lang="en-US">Represents the expenses related to royalty bearing grants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_RrlAndRrgMember" xlink:to="rwlk_RrlAndRrgMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_RrlAndRrgMember_doc" xml:lang="en-US">RRL and RRG [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_SCIProductsMember" xlink:to="rwlk_SCIProductsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_SCIProductsMember_doc" xml:lang="en-US">SCI Products [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ScheduleOfIncomeTaxLineItems" xlink:to="rwlk_ScheduleOfIncomeTaxLineItems_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_ScheduleOfIncomeTaxLineItems_doc" xml:lang="en-US">Schedule of Income Tax Line Items</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ScheduleOfIncomeTaxTable" xlink:to="rwlk_ScheduleOfIncomeTaxTable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_ScheduleOfIncomeTaxTable_doc" xml:lang="en-US">Disclosure of information about income tax.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ScheduleOfTradeReceivablesAndDeferredRevenuesTableTextBlock" xlink:to="rwlk_ScheduleOfTradeReceivablesAndDeferredRevenuesTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_ScheduleOfTradeReceivablesAndDeferredRevenuesTableTextBlock_doc" xml:lang="en-US">Tabular disclosure of trade receivables and short and long term deferred revenues.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_SecondAmendmentMember" xlink:to="rwlk_SecondAmendmentMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_SecondAmendmentMember_doc" xml:lang="en-US">Second Amendment [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_SecuritiesPurchaseAgreementsMember" xlink:to="rwlk_SecuritiesPurchaseAgreementsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_SecuritiesPurchaseAgreementsMember_doc" xml:lang="en-US">Securities Purchase Agreements [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_SeverancePayMonthlyDepositByEmployeesPercentage" xlink:to="rwlk_SeverancePayMonthlyDepositByEmployeesPercentage_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_SeverancePayMonthlyDepositByEmployeesPercentage_doc" xml:lang="en-US">Represents the percentage of monthly deposit required by employees as per the severance pay law.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsForfeitedInPeriodWeightedAverageExercisePrice" xlink:to="rwlk_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsForfeitedInPeriodWeightedAverageExercisePrice_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsForfeitedInPeriodWeightedAverageExercisePrice_doc" xml:lang="en-US">Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options forfeited.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsGrantedInPeriodWeightedAverageExercisePrice" xlink:to="rwlk_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsGrantedInPeriodWeightedAverageExercisePrice_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsGrantedInPeriodWeightedAverageExercisePrice_doc" xml:lang="en-US">Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options granted.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsvestedInPeriodWeightedAverageExercisePrice" xlink:to="rwlk_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsvestedInPeriodWeightedAverageExercisePrice_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsvestedInPeriodWeightedAverageExercisePrice_doc" xml:lang="en-US">Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options vested.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_SharebasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsVestedAndOptionsNetBasisOfCommonStock" xlink:to="rwlk_SharebasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsVestedAndOptionsNetBasisOfCommonStock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_SharebasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsVestedAndOptionsNetBasisOfCommonStock_doc" xml:lang="en-US">Vested and options exercised net of ordinary shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstandingNumber" xlink:to="rwlk_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstandingNumber_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstandingNumber_doc" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options and Equity Instruments Other than Options, Outstanding, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_SharebasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeOutstandingOptionsAndEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice" xlink:to="rwlk_SharebasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeOutstandingOptionsAndEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_SharebasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeOutstandingOptionsAndEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice_doc" xml:lang="en-US">Share-based Compensation, Shares Authorized under Stock Options Plans, Exercise Price Range, Outstanding Options and Equity Instruments Other than Options, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_SparePartsAndWarrantiesMember" xlink:to="rwlk_SparePartsAndWarrantiesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_SparePartsAndWarrantiesMember_doc" xml:lang="en-US">Spare parts and warranties [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_StockDuringPeriodOrdinarySharesAndWarrantsSharesPurchaseOrdinarySharesInFollowOnPublicOfferingTwo" xlink:to="rwlk_StockDuringPeriodOrdinarySharesAndWarrantsSharesPurchaseOrdinarySharesInFollowOnPublicOfferingTwo_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_StockDuringPeriodOrdinarySharesAndWarrantsSharesPurchaseOrdinarySharesInFollowOnPublicOfferingTwo_doc" xml:lang="en-US">Issuance of ordinary shares, warrants and pre-funded warrants in follow-on public offering, net of issuance expenses shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_StockDuringPeriodOrdinarySharesAndWarrantsValuePurchaseOrdinarySharesInFollowOnPublicOfferingTwo" xlink:to="rwlk_StockDuringPeriodOrdinarySharesAndWarrantsValuePurchaseOrdinarySharesInFollowOnPublicOfferingTwo_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_StockDuringPeriodOrdinarySharesAndWarrantsValuePurchaseOrdinarySharesInFollowOnPublicOfferingTwo_doc" xml:lang="en-US">Issuance of ordinary shares, warrants and pre-funded warrants in follow-on public offering, net of issuance expenses in an amount.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_StockIssuedDuringPeriodPricePerShare" xlink:to="rwlk_StockIssuedDuringPeriodPricePerShare_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_StockIssuedDuringPeriodPricePerShare_doc" xml:lang="en-US">Stock Issued During Period, Price Per Share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_StockIssuedDuringPeriodShareOrdinaryShares" xlink:to="rwlk_StockIssuedDuringPeriodShareOrdinaryShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_StockIssuedDuringPeriodShareOrdinaryShares_doc" xml:lang="en-US">Issuance of ordinary shares, shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInInvestingAgreementNetOfIssuanceExpenses" xlink:to="rwlk_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInInvestingAgreementNetOfIssuanceExpenses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInInvestingAgreementNetOfIssuanceExpenses_doc" xml:lang="en-US">Issuance of ordinary shares in investing agreement, net of issuance expenses in an amount of shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses" xlink:to="rwlk_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses_doc" xml:lang="en-US">Number of shares issuance of ordinary shares in a "Registered Direct" offerings , net of issuance expenses in the amount.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_StockIssuedDuringPeriodSharesNewIssuesTwo" xlink:to="rwlk_StockIssuedDuringPeriodSharesNewIssuesTwo_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_StockIssuedDuringPeriodSharesNewIssuesTwo_doc" xml:lang="en-US">Issuance of ordinary shares in at-the-market offering, net of issuance shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_StockIssuedDuringPeriodSharesOrdinaryShares" xlink:to="rwlk_StockIssuedDuringPeriodSharesOrdinaryShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_StockIssuedDuringPeriodSharesOrdinaryShares_doc" xml:lang="en-US">Number of shares issuance of ordinary shares in a "best efforts" offering, net of issuance expenses in the amount.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInInvestingAgreementNetOfIssuanceExpenses" xlink:to="rwlk_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInInvestingAgreementNetOfIssuanceExpenses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInInvestingAgreementNetOfIssuanceExpenses_doc" xml:lang="en-US">Issuance of ordinary shares in investing agreement, net of issuance expenses in an amount.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses" xlink:to="rwlk_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses_doc" xml:lang="en-US">Value of issuance of ordinary shares in a "Warrant exercise" agreement, net of issuance expenses in the amount.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses" xlink:to="rwlk_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses_doc" xml:lang="en-US">Value of issuance of ordinary shares in a "Registered Direct" offerings , net of issuance expenses in the amount.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_StockIssuedDuringPeriodValueNewIssuesGross" xlink:to="rwlk_StockIssuedDuringPeriodValueNewIssuesGross_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_StockIssuedDuringPeriodValueNewIssuesGross_doc" xml:lang="en-US">Stock Issued During Period, Value, New Issues, Gross</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_StockIssuedDuringPeriodValueNewIssuesTwo" xlink:to="rwlk_StockIssuedDuringPeriodValueNewIssuesTwo_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_StockIssuedDuringPeriodValueNewIssuesTwo_doc" xml:lang="en-US">Issuance of ordinary shares in at-the-market offering, net of issuance expenses in the amount.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_StockIssuedDuringPeriodValueOrdinaryShares" xlink:to="rwlk_StockIssuedDuringPeriodValueOrdinaryShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_StockIssuedDuringPeriodValueOrdinaryShares_doc" xml:lang="en-US">Value of issuance of ordinary shares in a "best efforts" offering, net of issuance expenses.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_SupplementalCashFlowCashAndCashEquivalents" xlink:to="rwlk_SupplementalCashFlowCashAndCashEquivalents_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_SupplementalCashFlowCashAndCashEquivalents_doc" xml:lang="en-US">Amount of cash and cash equivalents for the preiod.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_SupplementalDisclosuresOfCashFlowInformation" xlink:to="rwlk_SupplementalDisclosuresOfCashFlowInformation_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_SupplementalDisclosuresOfCashFlowInformation_doc" xml:lang="en-US">Supplemental Disclosures of Cash Flow Information.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_TaxesIncome" xlink:to="rwlk_TaxesIncome_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_TaxesIncome_doc" xml:lang="en-US">Taxes on income.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_TaxesOnIncome" xlink:to="rwlk_TaxesOnIncome_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_TaxesOnIncome_doc" xml:lang="en-US">Taxes on income.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_TimwellCorporationLimitedMember" xlink:to="rwlk_TimwellCorporationLimitedMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_TimwellCorporationLimitedMember_doc" xml:lang="en-US">Timwell Corporation Limited [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_TypeofCurrencyAxis" xlink:to="rwlk_TypeofCurrencyAxis_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_TypeofCurrencyAxis_doc" xml:lang="en-US">Type of Currency [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_TypeofCurrencyDomain" xlink:label="rwlk_TypeofCurrencyDomain" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_TypeofCurrencyDomain" xlink:to="rwlk_TypeofCurrencyDomain_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_TypeofCurrencyDomain_doc" xml:lang="en-US">Type of Currency Domain</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_UnitsPlacedMember" xlink:to="rwlk_UnitsPlacedMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_UnitsPlacedMember_doc" xml:lang="en-US">Units Placed [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ValuationAllowanceDeferredTaxAssetAdjustmentsAmount" xlink:to="rwlk_ValuationAllowanceDeferredTaxAssetAdjustmentsAmount_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_ValuationAllowanceDeferredTaxAssetAdjustmentsAmount_doc" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Adjustments, Amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ValuationAllowanceDeferredTaxAssetChangesDuetoAmendmentsinTaxLawsandExchangeRateDifferencesAmount" xlink:to="rwlk_ValuationAllowanceDeferredTaxAssetChangesDuetoAmendmentsinTaxLawsandExchangeRateDifferencesAmount_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_ValuationAllowanceDeferredTaxAssetChangesDuetoAmendmentsinTaxLawsandExchangeRateDifferencesAmount_doc" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Changes Due to Amendments in Tax Laws and Exchange Rate Differences, Amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_WarrantExerciseMember" xlink:to="rwlk_WarrantExerciseMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_WarrantExerciseMember_doc" xml:lang="en-US">Warrant Exercise.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_WarrantsExercisableDescrition" xlink:to="rwlk_WarrantsExercisableDescrition_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_WarrantsExercisableDescrition_doc" xml:lang="en-US">Warrants exercisable, description.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_WarrantsExpitationDate" xlink:to="rwlk_WarrantsExpitationDate_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_WarrantsExpitationDate_doc" xml:lang="en-US">Warrants Expitation Date.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_WarrantsToPurchaseOrdinaryShares" xlink:to="rwlk_WarrantsToPurchaseOrdinaryShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_WarrantsToPurchaseOrdinaryShares_doc" xml:lang="en-US">Warrants to purchase ordinary shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_WarrantsToPurchaseOrdinarySharesIssuedMember" xlink:to="rwlk_WarrantsToPurchaseOrdinarySharesIssuedMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_WarrantsToPurchaseOrdinarySharesIssuedMember_doc" xml:lang="en-US">Warrants To Purchase Ordinary Shares[Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenMember" xlink:to="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenMember_doc" xml:lang="en-US">April 5, 2019 [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenOneMember" xlink:to="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenOneMember_doc" xml:lang="en-US">April 5, 2019 One [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandFifteenMember" xlink:to="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandFifteenMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandFifteenMember_doc" xml:lang="en-US">Warrants to Purchase Ordinary Shares Issued on December Two Thousand Fifteen [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandSixteenMember" xlink:to="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandSixteenMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandSixteenMember_doc" xml:lang="en-US">Warrants to Purchase Ordinary Shares Issued on December Two Thousand Sixteen [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentyFiveTwoThousandNineteenMember" xlink:to="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentyFiveTwoThousandNineteenMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentyFiveTwoThousandNineteenMember_doc" xml:lang="en-US">February 25, 2019 [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveAndSixTwoThousandNineteenMember" xlink:to="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveAndSixTwoThousandNineteenMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveAndSixTwoThousandNineteenMember_doc" xml:lang="en-US">June 5, 2019 and June 6, 2019 [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveTwoThousandNineteenMember" xlink:to="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveTwoThousandNineteenMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveTwoThousandNineteenMember_doc" xml:lang="en-US">June 5, 2019 [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTenTwoThousandNineteenMember" xlink:to="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTenTwoThousandNineteenMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTenTwoThousandNineteenMember_doc" xml:lang="en-US">June 10, 2019 [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTweleveTwoThousandNineteenMember" xlink:to="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTweleveTwoThousandNineteenMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTweleveTwoThousandNineteenMember_doc" xml:lang="en-US">June 12, 2019 [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenMember" xlink:to="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenMember_doc" xml:lang="en-US">November 20, 2018 [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenOneMember" xlink:to="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenOneMember_doc" xml:lang="en-US">November 20, 2018 One [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwoThousandSixteenMember" xlink:to="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwoThousandSixteenMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwoThousandSixteenMember_doc" xml:lang="en-US">Warrants to Purchase Ordinary Shares Issued on November Two Thousand Sixteen [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_YaskawaElectricCorporationMember" xlink:to="rwlk_YaskawaElectricCorporationMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_YaskawaElectricCorporationMember_doc" xml:lang="en-US">YEC [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_StockIssuedDuringPeriodValueOrdinaryShares1" xlink:to="rwlk_StockIssuedDuringPeriodValueOrdinaryShares1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_StockIssuedDuringPeriodValueOrdinaryShares1_doc" xml:lang="en-US">Value of further issuance of ordinary shares in a "best efforts" offering, net of issuance expenses.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_StockIssuedDuringPeriodSharesOrdinaryShares1" xlink:to="rwlk_StockIssuedDuringPeriodSharesOrdinaryShares1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_StockIssuedDuringPeriodSharesOrdinaryShares1_doc" xml:lang="en-US">Number of further shares issuance of ordinary shares in a "best efforts" offering, net of issuance expenses in the amount.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1" xlink:to="rwlk_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1_doc" xml:lang="en-US">Value of further issuance of ordinary shares in a registered direct offerings, net of issuance expenses in the amount.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1" xlink:to="rwlk_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1_doc" xml:lang="en-US">Number of further shares issuance of ordinary shares in a registered direct offerings, net of issuance expenses in the amount.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_StockIssuedDuringPeriodValuePrivatePlacement" xlink:to="rwlk_StockIssuedDuringPeriodValuePrivatePlacement_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_StockIssuedDuringPeriodValuePrivatePlacement_doc" xml:lang="en-US">Equity impact of the value of new stock issued during the period under private placement.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses" xlink:to="rwlk_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses_doc" xml:lang="en-US">Number of shares issuance of ordinary shares in a "Warrant exercise" agreement, net of issuance expenses in the amount.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_StockIssuedDuringPeriodSharesPrivatePlacement" xlink:to="rwlk_StockIssuedDuringPeriodSharesPrivatePlacement_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_StockIssuedDuringPeriodSharesPrivatePlacement_doc" xml:lang="en-US">Number of new stock issued during the period under private placement.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_RegisteredDirectOfferingsIssuanceCostIncurredNotYetPaid" xlink:to="rwlk_RegisteredDirectOfferingsIssuanceCostIncurredNotYetPaid_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_RegisteredDirectOfferingsIssuanceCostIncurredNotYetPaid_doc" xml:lang="en-US">"Registered direct" offerings issuance cost incurred not yet paid.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_RoyaltyFeesPercentage" xlink:to="rwlk_RoyaltyFeesPercentage_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_RoyaltyFeesPercentage_doc" xml:lang="en-US">Represents the percentage of royalty fees.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_PaycheckProtectionProgramLoanMember" xlink:to="rwlk_PaycheckProtectionProgramLoanMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_PaycheckProtectionProgramLoanMember_doc" xml:lang="en-US">Paycheck Protection Program Loan [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_SiliconValleyBankMember" xlink:to="rwlk_SiliconValleyBankMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_SiliconValleyBankMember_doc" xml:lang="en-US">Silicon Valley Bank [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyMember" xlink:to="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyMember_doc" xml:lang="en-US">February 10, 2020 [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyOneMember" xlink:to="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyOneMember_doc" xml:lang="en-US">February 10, 2020 One [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyMember" xlink:to="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyMember_doc" xml:lang="en-US">July 6, 2020 [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyOneMember" xlink:to="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyOneMember_doc" xml:lang="en-US">July 6, 2020 One [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberThreeTwoThousandTwentyMember" xlink:to="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberThreeTwoThousandTwentyMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberThreeTwoThousandTwentyMember_doc" xml:lang="en-US">December 3, 2020 [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberThreeTwoThousandTwentyOneMember" xlink:to="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberThreeTwoThousandTwentyOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberThreeTwoThousandTwentyOneMember_doc" xml:lang="en-US">December 3, 2020 One [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_CommonUnitsAndPreFundedUnitsMember" xlink:to="rwlk_CommonUnitsAndPreFundedUnitsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_CommonUnitsAndPreFundedUnitsMember_doc" xml:lang="en-US">Common units and pre-funded units [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_CommonUnitsMember" xlink:to="rwlk_CommonUnitsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_CommonUnitsMember_doc" xml:lang="en-US">Common units [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_PreFundedUnitsMember" xlink:to="rwlk_PreFundedUnitsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_PreFundedUnitsMember_doc" xml:lang="en-US">Pre-funded units [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_CommonUnitsAndPreFundedUnits1Member" xlink:to="rwlk_CommonUnitsAndPreFundedUnits1Member_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_CommonUnitsAndPreFundedUnits1Member_doc" xml:lang="en-US">Common units and pre-funded units one [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_PurchaseAgreementWithCertainInstitutionalInvestorsMember" xlink:to="rwlk_PurchaseAgreementWithCertainInstitutionalInvestorsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_PurchaseAgreementWithCertainInstitutionalInvestorsMember_doc" xml:lang="en-US">Purchase agreement with certain institutional investors [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_AdditionallyWarrantsIssuedMember" xlink:to="rwlk_AdditionallyWarrantsIssuedMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_AdditionallyWarrantsIssuedMember_doc" xml:lang="en-US">Additionally Warrants Issued [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ClassOfWarrantOrRightPolicyTextBlock" xlink:to="rwlk_ClassOfWarrantOrRightPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_ClassOfWarrantOrRightPolicyTextBlock_doc" xml:lang="en-US">Disclosure of accounting policy for warrants or rights.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ProceedsFromStockTwo" xlink:to="rwlk_ProceedsFromStockTwo_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_ProceedsFromStockTwo_doc" xml:lang="en-US">Proceeds from issuance of stock.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ProceedsFromStockOne" xlink:to="rwlk_ProceedsFromStockOne_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rwlk_ProceedsFromStockOne_doc" xml:lang="en-US">Proceeds from issuance of stock.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_RegisteredDirectOfferingMember" xlink:to="rwlk_RegisteredDirectOfferingMember_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_RegisteredDirectOfferingMember_3_lbl" xml:lang="en-US">RegisteredDirectOfferingMember</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Assets, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_AssetsNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsNoncurrent_2_lbl" xml:lang="en-US">Assets, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_2_lbl" xml:lang="en-US">Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueNoncurrent" xlink:to="us-gaap_DeferredRevenueNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRevenueNoncurrent_2_lbl" xml:lang="en-US">Deferred Revenue, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesNoncurrent_2_lbl" xml:lang="en-US">Liabilities, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_2_lbl" xml:lang="en-US">Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_4_lbl" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GrossProfit_2_lbl" xml:lang="en-US">Gross Profit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpenses_2_lbl" xml:lang="en-US">Operating Expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_2_lbl" xml:lang="en-US">Operating Income (Loss)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesOutstanding_3_lbl" xml:lang="en-US">Shares, Outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_CumulativeEffectToAccumulatedDeficitFromAdoptionOfNewAccountingStandard" xlink:to="rwlk_CumulativeEffectToAccumulatedDeficitFromAdoptionOfNewAccountingStandard_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_CumulativeEffectToAccumulatedDeficitFromAdoptionOfNewAccountingStandard_3_lbl" xml:lang="en-US">CumulativeEffectToAccumulatedDeficitFromAdoptionOfNewAccountingStandard</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_2_lbl" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_2_lbl" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_GainsLossesOnInducementOfDebt1" xlink:to="rwlk_GainsLossesOnInducementOfDebt1_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_GainsLossesOnInducementOfDebt1_3_lbl" xml:lang="en-US">GainsLossesOnInducementOfDebt1</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_lbl" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInInventories_2_lbl" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableTrade_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableTrade_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Payable, Trade</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_2_lbl" xml:lang="en-US">Increase (Decrease) in Employee Related Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfLongTermDebt" xlink:to="us-gaap_RepaymentsOfLongTermDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfLongTermDebt_2_lbl" xml:lang="en-US">Repayments of Long-term Debt</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ProceedsFromStockOne" xlink:to="rwlk_ProceedsFromStockOne_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_ProceedsFromStockOne_3_lbl" xml:lang="en-US">ProceedsFromStockOne</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ExerciseOfPreFundedWarrants" xlink:to="rwlk_ExerciseOfPreFundedWarrants_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_ExerciseOfPreFundedWarrants_3_lbl" xml:lang="en-US">ExerciseOfPreFundedWarrants</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_SupplementalCashFlowCashAndCashEquivalents" xlink:to="rwlk_SupplementalCashFlowCashAndCashEquivalents_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_SupplementalCashFlowCashAndCashEquivalents_3_lbl" xml:lang="en-US">SupplementalCashFlowCashAndCashEquivalents</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_CashAndCashEquivalentsRestrictedCashAndRestrictedCashEquivalent" xlink:to="rwlk_CashAndCashEquivalentsRestrictedCashAndRestrictedCashEquivalent_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_CashAndCashEquivalentsRestrictedCashAndRestrictedCashEquivalent_3_lbl" xml:lang="en-US">Total Cash, cash equivalents, and restricted cash</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_2_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryPolicyTextBlock" xlink:to="us-gaap_InventoryPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryPolicyTextBlock_2_lbl" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StandardProductWarrantyAccrual" xlink:to="us-gaap_StandardProductWarrantyAccrual_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StandardProductWarrantyAccrual_3_lbl" xml:lang="en-US">Standard Product Warranty Accrual</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StandardProductWarrantyAccrualPayments" xlink:to="us-gaap_StandardProductWarrantyAccrualPayments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StandardProductWarrantyAccrualPayments_2_lbl" xml:lang="en-US">Standard Product Warranty Accrual, Decrease for Payments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProfitLoss_2_lbl" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstandingNumber" xlink:to="rwlk_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstandingNumber_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstandingNumber_4_lbl" xml:lang="en-US">Options and RSUs outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_SharebasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeOutstandingOptionsAndEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice" xlink:to="rwlk_SharebasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeOutstandingOptionsAndEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_SharebasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeOutstandingOptionsAndEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice_4_lbl" xml:lang="en-US">Sharebased Compensation Shares Authorized Under Stock Options Plans Exercise Price Range Outstanding Options And Equity Instruments Other Than Options Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsGrantedInPeriodWeightedAverageExercisePrice" xlink:to="rwlk_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsGrantedInPeriodWeightedAverageExercisePrice_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsGrantedInPeriodWeightedAverageExercisePrice_3_lbl" xml:lang="en-US">ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsGrantedInPeriodWeightedAverageExercisePrice</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:to="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_2_lbl" xml:lang="en-US">Federal Income Tax Expense (Benefit), Continuing Operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" xlink:to="us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations_2_lbl" xml:lang="en-US">Foreign Income Tax Expense (Benefit), Continuing Operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_TaxesIncome" xlink:to="rwlk_TaxesIncome_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_TaxesIncome_3_lbl" xml:lang="en-US">TaxesIncome</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_4_lbl" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsNet_2_lbl" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rwlk_ValuationAllowanceDeferredTaxAssetAdjustmentsAmount" xlink:to="rwlk_ValuationAllowanceDeferredTaxAssetAdjustmentsAmount_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rwlk_ValuationAllowanceDeferredTaxAssetAdjustmentsAmount_3_lbl" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Adjustments, Amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_2_lbl" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>15
<FILENAME>rwlk-20201231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoXBRL; Version: 5.6b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Source; Value: RWLK 1220 10K.xfr; Date: 2021%2D02%2D18T13:24:26Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://rewalk.com/role/DocumentAndEntityInformation" xlink:href="rwlk-20201231.xsd#DocumentAndEntityInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/ConsolidatedBalanceSheets" xlink:href="rwlk-20201231.xsd#ConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="rwlk-20201231.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/ConsolidatedStatementsOfOperations" xlink:href="rwlk-20201231.xsd#ConsolidatedStatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/StatementsOfChangesInShareholdersEquity" xlink:href="rwlk-20201231.xsd#StatementsOfChangesInShareholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/StatementsOfChangesInShareholdersEquityParenthetical" xlink:href="rwlk-20201231.xsd#StatementsOfChangesInShareholdersEquityParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/ConsolidatedStatementsOfCashFlows" xlink:href="rwlk-20201231.xsd#ConsolidatedStatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/ConsolidatedStatementsOfCashFlowsParenthetical" xlink:href="rwlk-20201231.xsd#ConsolidatedStatementsOfCashFlowsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/General" xlink:href="rwlk-20201231.xsd#General" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/SignificantAccountingPolicies" xlink:href="rwlk-20201231.xsd#SignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/PrepaidExpensesAndOtherCurrentAssets" xlink:href="rwlk-20201231.xsd#PrepaidExpensesAndOtherCurrentAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/Inventories" xlink:href="rwlk-20201231.xsd#Inventories" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/PropertyAndEquipmentNet" xlink:href="rwlk-20201231.xsd#PropertyAndEquipmentNet" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/LoanAgreementWithKreosAndRelatedWarrantToPurchaseOrdinaryShares" xlink:href="rwlk-20201231.xsd#LoanAgreementWithKreosAndRelatedWarrantToPurchaseOrdinaryShares" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/CommitmentsAndContingentLiabilities" xlink:href="rwlk-20201231.xsd#CommitmentsAndContingentLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/ShareholdersEquity" xlink:href="rwlk-20201231.xsd#ShareholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/ResearchCollaborationAgreementAndLicenseAgreement" xlink:href="rwlk-20201231.xsd#ResearchCollaborationAgreementAndLicenseAgreement" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/PaycheckProtectionProgramLoan" xlink:href="rwlk-20201231.xsd#PaycheckProtectionProgramLoan" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/IncomeTaxes" xlink:href="rwlk-20201231.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/FinancialExpensesNet" xlink:href="rwlk-20201231.xsd#FinancialExpensesNet" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/GeographicInformationAndMajorCustomerAndProductData" xlink:href="rwlk-20201231.xsd#GeographicInformationAndMajorCustomerAndProductData" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/SubsequentEvents" xlink:href="rwlk-20201231.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/SignificantAccountingPoliciesPolicies" xlink:href="rwlk-20201231.xsd#SignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/SignificantAccountingPoliciesTables" xlink:href="rwlk-20201231.xsd#SignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/PrepaidExpensesAndOtherCurrentAssetsTables" xlink:href="rwlk-20201231.xsd#PrepaidExpensesAndOtherCurrentAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/InventoriesTables" xlink:href="rwlk-20201231.xsd#InventoriesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/PropertyAndEquipmentNetTables" xlink:href="rwlk-20201231.xsd#PropertyAndEquipmentNetTables" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/CommitmentsAndContingentLiabilitiesTables" xlink:href="rwlk-20201231.xsd#CommitmentsAndContingentLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/ShareholdersEquityTables" xlink:href="rwlk-20201231.xsd#ShareholdersEquityTables" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/IncomeTaxesTables" xlink:href="rwlk-20201231.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/FinancialExpensesNetTables" xlink:href="rwlk-20201231.xsd#FinancialExpensesNetTables" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataTables" xlink:href="rwlk-20201231.xsd#GeographicInformationAndMajorCustomerAndProductDataTables" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/GeneralDetails" xlink:href="rwlk-20201231.xsd#GeneralDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/SignificantAccountingPoliciesDetails" xlink:href="rwlk-20201231.xsd#SignificantAccountingPoliciesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/SignificantAccountingPoliciesDetails1" xlink:href="rwlk-20201231.xsd#SignificantAccountingPoliciesDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/SignificantAccountingPoliciesDetails2" xlink:href="rwlk-20201231.xsd#SignificantAccountingPoliciesDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/SignificantAccountingPoliciesDetails3" xlink:href="rwlk-20201231.xsd#SignificantAccountingPoliciesDetails3" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/SignificantAccountingPoliciesDetails4" xlink:href="rwlk-20201231.xsd#SignificantAccountingPoliciesDetails4" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/SignificantAccountingPoliciesDetails5" xlink:href="rwlk-20201231.xsd#SignificantAccountingPoliciesDetails5" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/SignificantAccountingPoliciesDetails6" xlink:href="rwlk-20201231.xsd#SignificantAccountingPoliciesDetails6" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/SignificantAccountingPoliciesDetails7" xlink:href="rwlk-20201231.xsd#SignificantAccountingPoliciesDetails7" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/SignificantAccountingPoliciesDetailsTextual" xlink:href="rwlk-20201231.xsd#SignificantAccountingPoliciesDetailsTextual" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/PrepaidExpensesAndOtherCurrentAssetsDetails" xlink:href="rwlk-20201231.xsd#PrepaidExpensesAndOtherCurrentAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/InventoriesDetails" xlink:href="rwlk-20201231.xsd#InventoriesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/PropertyAndEquipmentNetDetails" xlink:href="rwlk-20201231.xsd#PropertyAndEquipmentNetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/PropertyAndEquipmentNetDetailsTextual" xlink:href="rwlk-20201231.xsd#PropertyAndEquipmentNetDetailsTextual" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/LoanAgreementWithKreosAndRelatedWarrantToPurchaseOrdinarySharesDetails" xlink:href="rwlk-20201231.xsd#LoanAgreementWithKreosAndRelatedWarrantToPurchaseOrdinarySharesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/CommitmentsAndContingentLiabilitiesDetails" xlink:href="rwlk-20201231.xsd#CommitmentsAndContingentLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/CommitmentsAndContingentLiabilitiesDetailsTextual" xlink:href="rwlk-20201231.xsd#CommitmentsAndContingentLiabilitiesDetailsTextual" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/ShareholdersEquityDetails" xlink:href="rwlk-20201231.xsd#ShareholdersEquityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/ShareholdersEquityDetails1" xlink:href="rwlk-20201231.xsd#ShareholdersEquityDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/ShareholdersEquityDetails2" xlink:href="rwlk-20201231.xsd#ShareholdersEquityDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/ShareholdersEquityDetails3" xlink:href="rwlk-20201231.xsd#ShareholdersEquityDetails3" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/ShareholdersEquityDetails4" xlink:href="rwlk-20201231.xsd#ShareholdersEquityDetails4" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/ShareholdersEquityDetailsTextual" xlink:href="rwlk-20201231.xsd#ShareholdersEquityDetailsTextual" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/ResearchCollaborationAgreementAndLicenseAgreementDetails" xlink:href="rwlk-20201231.xsd#ResearchCollaborationAgreementAndLicenseAgreementDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/PaycheckProtectionProgramLoanDetailsTextual" xlink:href="rwlk-20201231.xsd#PaycheckProtectionProgramLoanDetailsTextual" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/IncomeTaxesDetails" xlink:href="rwlk-20201231.xsd#IncomeTaxesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/IncomeTaxesDetails1" xlink:href="rwlk-20201231.xsd#IncomeTaxesDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/IncomeTaxesDetails2" xlink:href="rwlk-20201231.xsd#IncomeTaxesDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/IncomeTaxesDetails3" xlink:href="rwlk-20201231.xsd#IncomeTaxesDetails3" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/IncomeTaxesDetails4" xlink:href="rwlk-20201231.xsd#IncomeTaxesDetails4" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/IncomeTaxesDetailsTextual" xlink:href="rwlk-20201231.xsd#IncomeTaxesDetailsTextual" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/FinancialExpensesNetDetails" xlink:href="rwlk-20201231.xsd#FinancialExpensesNetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails" xlink:href="rwlk-20201231.xsd#GeographicInformationAndMajorCustomerAndProductDataDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails1" xlink:href="rwlk-20201231.xsd#GeographicInformationAndMajorCustomerAndProductDataDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails2" xlink:href="rwlk-20201231.xsd#GeographicInformationAndMajorCustomerAndProductDataDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetailsTextual" xlink:href="rwlk-20201231.xsd#GeographicInformationAndMajorCustomerAndProductDataDetailsTextual" xlink:type="simple" />
    <link:roleRef roleURI="http://rewalk.com/role/SubsequentEventsDetails" xlink:href="rwlk-20201231.xsd#SubsequentEventsDetails" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://rewalk.com/role/DocumentAndEntityInformation" xlink:title="00000001 - Document - Document and Entity Information">
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_DocumentAndEntityInformationAbstract" xlink:label="loc_rwlkDocumentAndEntityInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkDocumentAndEntityInformationAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkDocumentAndEntityInformationAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkDocumentAndEntityInformationAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkDocumentAndEntityInformationAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkDocumentAndEntityInformationAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkDocumentAndEntityInformationAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://rewalk.com/role/ConsolidatedBalanceSheets" xlink:title="00000002 - Statement - CONSOLIDATED BALANCE SHEETS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="loc_us-gaapAssetsNoncurrentAbstract" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsNoncurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaapOtherAssetsNoncurrent" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapOtherAssetsNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaapAssetsNoncurrent" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapAssetsNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaapLongTermDebtCurrent" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLongTermDebtCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaapDeferredRevenueCurrent" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapDeferredRevenueCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="loc_us-gaapLiabilitiesNoncurrentAbstract" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaapLongTermDebtNoncurrent" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapLongTermDebtNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="loc_us-gaapDeferredRevenueNoncurrent" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapDeferredRevenueNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapOtherLiabilitiesNoncurrent" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapOtherLiabilitiesNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapLiabilitiesNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://rewalk.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://rewalk.com/role/ConsolidatedStatementsOfOperations" xlink:title="00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapRevenues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaapCostOfRevenue" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapCostOfRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaapOperatingExpensesAbstract" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingExpensesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaapSellingAndMarketingExpense" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapSellingAndMarketingExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_FinancialExpensesIncomeNet" xlink:label="loc_rwlkFinancialExpensesIncomeNet" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_rwlkFinancialExpensesIncomeNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_us-gaapEarningsPerShareBasicAndDiluted" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapEarningsPerShareBasicAndDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://rewalk.com/role/StatementsOfChangesInShareholdersEquity" xlink:title="00000005 - Statement - STATEMENTS OF CHANGES IN SHAREHOLDERS&apos; EQUITY">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="40" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet" xlink:label="loc_us-gaapAdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInInvestingAgreementNetOfIssuanceExpenses" xlink:label="loc_rwlkStockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInInvestingAgreementNetOfIssuanceExpenses" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_rwlkStockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInInvestingAgreementNetOfIssuanceExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInInvestingAgreementNetOfIssuanceExpenses" xlink:label="loc_rwlkStockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInInvestingAgreementNetOfIssuanceExpenses" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_rwlkStockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInInvestingAgreementNetOfIssuanceExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalOther" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalOther" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_StockIssuedDuringPeriodValueNewIssuesTwo" xlink:label="loc_rwlkStockIssuedDuringPeriodValueNewIssuesTwo" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_rwlkStockIssuedDuringPeriodValueNewIssuesTwo" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_StockIssuedDuringPeriodSharesNewIssuesTwo" xlink:label="loc_rwlkStockIssuedDuringPeriodSharesNewIssuesTwo" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_rwlkStockIssuedDuringPeriodSharesNewIssuesTwo" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueOther" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueOther" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesOther" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesOther" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_StockDuringPeriodOrdinarySharesAndWarrantsValuePurchaseOrdinarySharesInFollowOnPublicOfferingTwo" xlink:label="loc_rwlkStockDuringPeriodOrdinarySharesAndWarrantsValuePurchaseOrdinarySharesInFollowOnPublicOfferingTwo" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_rwlkStockDuringPeriodOrdinarySharesAndWarrantsValuePurchaseOrdinarySharesInFollowOnPublicOfferingTwo" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_StockDuringPeriodOrdinarySharesAndWarrantsSharesPurchaseOrdinarySharesInFollowOnPublicOfferingTwo" xlink:label="loc_rwlkStockDuringPeriodOrdinarySharesAndWarrantsSharesPurchaseOrdinarySharesInFollowOnPublicOfferingTwo" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_rwlkStockDuringPeriodOrdinarySharesAndWarrantsSharesPurchaseOrdinarySharesInFollowOnPublicOfferingTwo" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalWarrantIssued" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ExerciseOfPreFundedWarrantsValue" xlink:label="loc_rwlkExerciseOfPreFundedWarrantsValue" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_rwlkExerciseOfPreFundedWarrantsValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ExerciseOfPreFundedWarrantsShares" xlink:label="loc_rwlkExerciseOfPreFundedWarrantsShares" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_rwlkExerciseOfPreFundedWarrantsShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_CumulativeEffectToStockBasedCompensationFromAdoptionOfNewAccountingStandard" xlink:label="loc_rwlkCumulativeEffectToStockBasedCompensationFromAdoptionOfNewAccountingStandard" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_rwlkCumulativeEffectToStockBasedCompensationFromAdoptionOfNewAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_CumulativeEffectToAccumulatedDeficitFromAdoptionOfNewAccountingStandard" xlink:label="loc_rwlkCumulativeEffectToAccumulatedDeficitFromAdoptionOfNewAccountingStandard" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_rwlkCumulativeEffectToAccumulatedDeficitFromAdoptionOfNewAccountingStandard" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_StockIssuedDuringPeriodValueOrdinaryShares1" xlink:label="loc_rwlkStockIssuedDuringPeriodValueOrdinaryShares1" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_rwlkStockIssuedDuringPeriodValueOrdinaryShares1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_StockIssuedDuringPeriodSharesOrdinaryShares1" xlink:label="loc_rwlkStockIssuedDuringPeriodSharesOrdinaryShares1" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_rwlkStockIssuedDuringPeriodSharesOrdinaryShares1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_StockIssuedDuringPeriodValueOrdinaryShares" xlink:label="loc_rwlkStockIssuedDuringPeriodValueOrdinaryShares" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_rwlkStockIssuedDuringPeriodValueOrdinaryShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_StockIssuedDuringPeriodSharesOrdinaryShares" xlink:label="loc_rwlkStockIssuedDuringPeriodSharesOrdinaryShares" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_rwlkStockIssuedDuringPeriodSharesOrdinaryShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ExerciseOfPrefundedWarrantsAndWarrantsValue" xlink:label="loc_rwlkExerciseOfPrefundedWarrantsAndWarrantsValue" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_rwlkExerciseOfPrefundedWarrantsAndWarrantsValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ExerciseOfPreFundedWarrantsAndWarrantsShares" xlink:label="loc_rwlkExerciseOfPreFundedWarrantsAndWarrantsShares" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_rwlkExerciseOfPreFundedWarrantsAndWarrantsShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses" xlink:label="loc_rwlkStockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_rwlkStockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses" xlink:label="loc_rwlkStockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_rwlkStockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1" xlink:label="loc_rwlkStockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_rwlkStockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1" xlink:label="loc_rwlkStockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_rwlkStockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses" xlink:label="loc_rwlkStockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_rwlkStockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses" xlink:label="loc_rwlkStockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_rwlkStockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_StockIssuedDuringPeriodValuePrivatePlacement" xlink:label="loc_rwlkStockIssuedDuringPeriodValuePrivatePlacement" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_rwlkStockIssuedDuringPeriodValuePrivatePlacement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_StockIssuedDuringPeriodSharesPrivatePlacement" xlink:label="loc_rwlkStockIssuedDuringPeriodSharesPrivatePlacement" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_rwlkStockIssuedDuringPeriodSharesPrivatePlacement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_2" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_2" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://rewalk.com/role/StatementsOfChangesInShareholdersEquityParenthetical" xlink:title="00000006 - Statement - STATEMENTS OF CHANGES IN SHAREHOLDERS&apos; EQUITY (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_BestOfferingMember" xlink:label="loc_rwlkBestOfferingMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_rwlkBestOfferingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_RegisteredDirectOfferingMember" xlink:label="loc_rwlkRegisteredDirectOfferingMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_rwlkRegisteredDirectOfferingMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaapPrivatePlacementMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapPrivatePlacementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_WarrantExerciseMember" xlink:label="loc_rwlkWarrantExerciseMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_rwlkWarrantExerciseMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_InvestmentAgreementMember" xlink:label="loc_rwlkInvestmentAgreementMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_rwlkInvestmentAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_AtmOfferingProgramMember" xlink:label="loc_rwlkAtmOfferingProgramMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_rwlkAtmOfferingProgramMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_PublicStockOfferingMember" xlink:label="loc_rwlkPublicStockOfferingMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_rwlkPublicStockOfferingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://rewalk.com/role/ConsolidatedStatementsOfCashFlows" xlink:title="00000007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredIncomeTaxExpenseBenefit" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDeferredIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_GainsLossesOnInducementOfDebt1" xlink:label="loc_rwlkGainsLossesOnInducementOfDebt1" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_rwlkGainsLossesOnInducementOfDebt1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_FinancialExpensesRelatedToLongTermLoan" xlink:label="loc_rwlkFinancialExpensesRelatedToLongTermLoan" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_rwlkFinancialExpensesRelatedToLongTermLoan" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableTrade" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableTrade" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInEmployeeRelatedLiabilities" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInEmployeeRelatedLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInDeferredLiabilities" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInDeferredLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherOperatingLiabilities" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherOperatingLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="loc_us-gaapRepaymentsOfLongTermDebt" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapRepaymentsOfLongTermDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:label="loc_us-gaapProceedsFromIssuanceOfLongTermDebt" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_IssuanceOfOrdinarySharesInInvestmentAgreement" xlink:label="loc_rwlkIssuanceOfOrdinarySharesInInvestmentAgreement" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_rwlkIssuanceOfOrdinarySharesInInvestmentAgreement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ProceedsFromIssuanceofPreFundedWarrants" xlink:label="loc_rwlkProceedsFromIssuanceofPreFundedWarrants" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_rwlkProceedsFromIssuanceofPreFundedWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ProceedsFromStockOne" xlink:label="loc_rwlkProceedsFromStockOne" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_rwlkProceedsFromStockOne" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ProceedsFromStockTwo" xlink:label="loc_rwlkProceedsFromStockTwo" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_rwlkProceedsFromStockTwo" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ProceedsFromOfferingCost" xlink:label="loc_rwlkProceedsFromOfferingCost" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_rwlkProceedsFromOfferingCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ProceedsFromIssuanceOfRegistrationCost" xlink:label="loc_rwlkProceedsFromIssuanceOfRegistrationCost" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_rwlkProceedsFromIssuanceOfRegistrationCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_IssuanceOfOrdinarySharesInWarrantExerciseAgreementNetOfIssuanceExpensesInAmountOf10191" xlink:label="loc_rwlkIssuanceOfOrdinarySharesInWarrantExerciseAgreementNetOfIssuanceExpensesInAmountOf10191" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_rwlkIssuanceOfOrdinarySharesInWarrantExerciseAgreementNetOfIssuanceExpensesInAmountOf10191" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ExerciseOfPreFundedWarrants" xlink:label="loc_rwlkExerciseOfPreFundedWarrants" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_rwlkExerciseOfPreFundedWarrants" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_RegisteredDirectOfferingsIssuanceCostIncurredNotYetPaid" xlink:label="loc_rwlkRegisteredDirectOfferingsIssuanceCostIncurredNotYetPaid" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_rwlkRegisteredDirectOfferingsIssuanceCostIncurredNotYetPaid" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_RepaymentOfLongTermLoanByIssuanceOfUnitsAndPrefundedUnits" xlink:label="loc_rwlkRepaymentOfLongTermLoanByIssuanceOfUnitsAndPrefundedUnits" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_rwlkRepaymentOfLongTermLoanByIssuanceOfUnitsAndPrefundedUnits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_CommonStockIssuanceCostsIncurredNotYetPaid" xlink:label="loc_rwlkCommonStockIssuanceCostsIncurredNotYetPaid" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_rwlkCommonStockIssuanceCostsIncurredNotYetPaid" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ClassificationOfOtherCurrentAssetsToPropertyAndEquipmentNet" xlink:label="loc_rwlkClassificationOfOtherCurrentAssetsToPropertyAndEquipmentNet" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_rwlkClassificationOfOtherCurrentAssetsToPropertyAndEquipmentNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ClassificationOfInventoryToOtherCurrentAssets" xlink:label="loc_rwlkClassificationOfInventoryToOtherCurrentAssets" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_rwlkClassificationOfInventoryToOtherCurrentAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ClassificationOfInventoryToPropertyAndEquipmentNet" xlink:label="loc_rwlkClassificationOfInventoryToPropertyAndEquipmentNet" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_rwlkClassificationOfInventoryToPropertyAndEquipmentNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_CashlessExerciseOfPrefundedWarrants" xlink:label="loc_rwlkCashlessExerciseOfPrefundedWarrants" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_rwlkCashlessExerciseOfPrefundedWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_InitialRecognitionOfOperatingLeaseRightofuseAssets" xlink:label="loc_rwlkInitialRecognitionOfOperatingLeaseRightofuseAssets" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_rwlkInitialRecognitionOfOperatingLeaseRightofuseAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_InitialRecognitionOfOperatingLeaseLiabilities" xlink:label="loc_rwlkInitialRecognitionOfOperatingLeaseLiabilities" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_rwlkInitialRecognitionOfOperatingLeaseLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaapSupplementalCashFlowInformationAbstract" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_SupplementalCashFlowCashAndCashEquivalents" xlink:label="loc_rwlkSupplementalCashFlowCashAndCashEquivalents" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_rwlkSupplementalCashFlowCashAndCashEquivalents" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_RestrictedCashIncludedInOtherNoncurrentAssets" xlink:label="loc_rwlkRestrictedCashIncludedInOtherNoncurrentAssets" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_rwlkRestrictedCashIncludedInOtherNoncurrentAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_CashAndCashEquivalentsRestrictedCashAndRestrictedCashEquivalent" xlink:label="loc_rwlkCashAndCashEquivalentsRestrictedCashAndRestrictedCashEquivalent" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_rwlkCashAndCashEquivalentsRestrictedCashAndRestrictedCashEquivalent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_SupplementalDisclosuresOfCashFlowInformation" xlink:label="loc_rwlkSupplementalDisclosuresOfCashFlowInformation" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_rwlkSupplementalDisclosuresOfCashFlowInformation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaid" xlink:label="loc_us-gaapIncomeTaxesPaid" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkSupplementalDisclosuresOfCashFlowInformation" xlink:to="loc_us-gaapIncomeTaxesPaid" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet" xlink:label="loc_us-gaapInterestPaidNet" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkSupplementalDisclosuresOfCashFlowInformation" xlink:to="loc_us-gaapInterestPaidNet" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://rewalk.com/role/ConsolidatedStatementsOfCashFlowsParenthetical" xlink:title="00000008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_BestOfferingMember" xlink:label="loc_rwlkBestOfferingMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_rwlkBestOfferingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_RegisteredDirectMember" xlink:label="loc_rwlkRegisteredDirectMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_rwlkRegisteredDirectMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaapPrivatePlacementMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapPrivatePlacementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_InvestmentAgreementMember" xlink:label="loc_rwlkInvestmentAgreementMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_rwlkInvestmentAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_AtmOfferingProgramMember" xlink:label="loc_rwlkAtmOfferingProgramMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_rwlkAtmOfferingProgramMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_WarrantExerciseMember" xlink:label="loc_rwlkWarrantExerciseMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_rwlkWarrantExerciseMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfStockIssuanceCosts" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsOfStockIssuanceCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_IssuanceExpensesOfOfferingSharesAmount" xlink:label="loc_rwlkIssuanceExpensesOfOfferingSharesAmount" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_rwlkIssuanceExpensesOfOfferingSharesAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_LongTermLoanConversionAmount" xlink:label="loc_rwlkLongTermLoanConversionAmount" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_rwlkLongTermLoanConversionAmount" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://rewalk.com/role/General" xlink:title="00000009 - Disclosure - GENERAL">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://rewalk.com/role/SignificantAccountingPolicies" xlink:title="00000010 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaapSignificantAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSignificantAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://rewalk.com/role/PrepaidExpensesAndOtherCurrentAssets" xlink:title="00000011 - Disclosure - PREPAID EXPENSES AND OTHER CURRENT ASSETS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrentAbstract" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_PrepaidExpenseAndOtherAssetsDisclosureTextBlock" xlink:label="loc_rwlkPrepaidExpenseAndOtherAssetsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:to="loc_rwlkPrepaidExpenseAndOtherAssetsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://rewalk.com/role/Inventories" xlink:title="00000012 - Disclosure - INVENTORIES">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="loc_us-gaapInventoryDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://rewalk.com/role/PropertyAndEquipmentNet" xlink:title="00000013 - Disclosure - PROPERTY AND EQUIPMENT, NET">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://rewalk.com/role/LoanAgreementWithKreosAndRelatedWarrantToPurchaseOrdinaryShares" xlink:title="00000014 - Disclosure - LOAN AGREEMENT WITH KREOS AND RELATED WARRANT TO PURCHASE ORDINARY SHARES">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_DisclosureofTermLoansandWarrantstoPurchaseOrdinarySharesTextBlock" xlink:label="loc_rwlkDisclosureofTermLoansandWarrantstoPurchaseOrdinarySharesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_rwlkDisclosureofTermLoansandWarrantstoPurchaseOrdinarySharesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://rewalk.com/role/CommitmentsAndContingentLiabilities" xlink:title="00000015 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://rewalk.com/role/ShareholdersEquity" xlink:title="00000016 - Disclosure - SHAREHOLDERS&apos; EQUITY">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://rewalk.com/role/ResearchCollaborationAgreementAndLicenseAgreement" xlink:title="00000017 - Disclosure - RESEARCH COLLABORATION AGREEMENT AND LICENSE AGREEMENT">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentAbstract" xlink:label="loc_us-gaapResearchAndDevelopmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:label="loc_us-gaapResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapResearchAndDevelopmentAbstract" xlink:to="loc_us-gaapResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://rewalk.com/role/PaycheckProtectionProgramLoan" xlink:title="00000018 - Disclosure - PAYCHECK PROTECTION PROGRAM LOAN">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="loc_us-gaapDebtDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://rewalk.com/role/IncomeTaxes" xlink:title="00000019 - Disclosure - INCOME TAXES">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaapIncomeTaxDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://rewalk.com/role/FinancialExpensesNet" xlink:title="00000020 - Disclosure - FINANCIAL EXPENSES, NET">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract" xlink:label="loc_us-gaapOtherIncomeAndExpensesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:label="loc_us-gaapOtherIncomeAndOtherExpenseDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract" xlink:to="loc_us-gaapOtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://rewalk.com/role/GeographicInformationAndMajorCustomerAndProductData" xlink:title="00000021 - Disclosure - GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="loc_us-gaapSegmentReportingDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapSegmentReportingDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://rewalk.com/role/SubsequentEvents" xlink:title="00000022 - Disclosure - SUBSEQUENT EVENTS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaapSubsequentEventsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://rewalk.com/role/SignificantAccountingPoliciesPolicies" xlink:title="00000023 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaapUseOfEstimates" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapUseOfEstimates" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="loc_us-gaapForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaapConsolidationPolicyTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapConsolidationPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="loc_us-gaapInventoryPolicyTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapInventoryPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_RelatedPartiesTransactionsAndBalancesPolicyTextBlock" xlink:label="loc_rwlkRelatedPartiesTransactionsAndBalancesPolicyTextBlock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_rwlkRelatedPartiesTransactionsAndBalancesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_OtherLongTermAssetsPolicyTextBlock" xlink:label="loc_rwlkOtherLongTermAssetsPolicyTextBlock" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_rwlkOtherLongTermAssetsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="loc_us-gaapRevenueFromContractWithCustomerPolicyTextBlock" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="loc_us-gaapShareBasedCompensationOptionAndIncentivePlansPolicy" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ClassOfWarrantOrRightPolicyTextBlock" xlink:label="loc_rwlkClassOfWarrantOrRightPolicyTextBlock" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_rwlkClassOfWarrantOrRightPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="loc_us-gaapResearchAndDevelopmentExpensePolicy" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapResearchAndDevelopmentExpensePolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaapIncomeTaxPolicyTextBlock" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIncomeTaxPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StandardProductWarrantyPolicy" xlink:label="loc_us-gaapStandardProductWarrantyPolicy" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStandardProductWarrantyPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="loc_us-gaapConcentrationRiskCreditRisk" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapConcentrationRiskCreditRisk" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PostemploymentBenefitPlansPolicy" xlink:label="loc_us-gaapPostemploymentBenefitPlansPolicy" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapPostemploymentBenefitPlansPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="loc_us-gaapFairValueMeasurementPolicyPolicyTextBlock" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaapEarningsPerSharePolicyTextBlock" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapEarningsPerSharePolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesPolicyTextBlock" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCommitmentsAndContingenciesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_GovernmentGrantsPolicyTextBlock" xlink:label="loc_rwlkGovernmentGrantsPolicyTextBlock" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_rwlkGovernmentGrantsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://rewalk.com/role/SignificantAccountingPoliciesTables" xlink:title="00000024 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaapScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" xlink:label="loc_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ScheduleOfTradeReceivablesAndDeferredRevenuesTableTextBlock" xlink:label="loc_rwlkScheduleOfTradeReceivablesAndDeferredRevenuesTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_rwlkScheduleOfTradeReceivablesAndDeferredRevenuesTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:label="loc_us-gaapScheduleOfProductWarrantyLiabilityTableTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:label="loc_us-gaapSchedulesOfConcentrationOfRiskByRiskFactorTextBlock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://rewalk.com/role/PrepaidExpensesAndOtherCurrentAssetsTables" xlink:title="00000025 - Disclosure - PREPAID EXPENSES AND OTHER CURRENT ASSETS (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:label="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:label="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://rewalk.com/role/InventoriesTables" xlink:title="00000026 - Disclosure - INVENTORIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="loc_us-gaapScheduleOfInventoryCurrentTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://rewalk.com/role/PropertyAndEquipmentNetTables" xlink:title="00000027 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://rewalk.com/role/CommitmentsAndContingentLiabilitiesTables" xlink:title="00000028 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:label="loc_us-gaapScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://rewalk.com/role/ShareholdersEquityTables" xlink:title="00000029 - Disclosure - SHAREHOLDERS&apos; EQUITY (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="loc_us-gaapScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://rewalk.com/role/IncomeTaxesTables" xlink:title="00000030 - Disclosure - INCOME TAXES (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:label="loc_us-gaapScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="loc_us-gaapScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:label="loc_us-gaapSummaryOfValuationAllowanceTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapSummaryOfValuationAllowanceTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="loc_us-gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://rewalk.com/role/FinancialExpensesNetTables" xlink:title="00000031 - Disclosure - FINANCIAL EXPENSES, NET (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract" xlink:label="loc_us-gaapOtherIncomeAndExpensesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:label="loc_us-gaapScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract" xlink:to="loc_us-gaapScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataTables" xlink:title="00000032 - Disclosure - GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:label="loc_us-gaapRevenueFromExternalCustomersByGeographicAreasTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapRevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:label="loc_us-gaapLongLivedAssetsByGeographicAreasTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapLongLivedAssetsByGeographicAreasTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:label="loc_us-gaapScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://rewalk.com/role/GeneralDetails" xlink:title="00000033 - Disclosure - GENERAL (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_GeneralTextualAbstract" xlink:label="loc_rwlkGeneralTextualAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_rwlkGeneralTextualAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkGeneralTextualAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkGeneralTextualAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkGeneralTextualAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkGeneralTextualAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaapProceedsFromWarrantExercises" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkGeneralTextualAbstract" xlink:to="loc_us-gaapProceedsFromWarrantExercises" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://rewalk.com/role/SignificantAccountingPoliciesDetails" xlink:title="00000034 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaapComputerEquipmentMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapComputerEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_MachineryAndLaboratoryEquipmentMember" xlink:label="loc_rwlkMachineryAndLaboratoryEquipmentMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_rwlkMachineryAndLaboratoryEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_FieldServiceUnitsMember" xlink:label="loc_rwlkFieldServiceUnitsMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_rwlkFieldServiceUnitsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:label="loc_us-gaapPropertyPlantAndEquipmentEstimatedUsefulLives" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentEstimatedUsefulLives" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://rewalk.com/role/SignificantAccountingPoliciesDetails1" xlink:title="00000035 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details 1)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_RevenueObligationAxis" xlink:label="loc_rwlkRevenueObligationAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_rwlkRevenueObligationAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_RevenueObligationDomain" xlink:label="loc_rwlkRevenueObligationDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkRevenueObligationAxis" xlink:to="loc_rwlkRevenueObligationDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_UnitsPlacedMember" xlink:label="loc_rwlkUnitsPlacedMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkRevenueObligationDomain" xlink:to="loc_rwlkUnitsPlacedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_SparePartsAndWarrantiesMember" xlink:label="loc_rwlkSparePartsAndWarrantiesMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkRevenueObligationDomain" xlink:to="loc_rwlkSparePartsAndWarrantiesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://rewalk.com/role/SignificantAccountingPoliciesDetails2" xlink:title="00000036 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details 2)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenue" xlink:label="loc_us-gaapDeferredRevenue" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapDeferredRevenue" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://rewalk.com/role/SignificantAccountingPoliciesDetails3" xlink:title="00000037 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details 3)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtRangeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharePrice" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://rewalk.com/role/SignificantAccountingPoliciesDetails4" xlink:title="00000038 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details 4)">
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_SignificantAccountingPoliciesDetails4Abstract" xlink:label="loc_rwlkSignificantAccountingPoliciesDetails4Abstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkSignificantAccountingPoliciesDetails4Abstract" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://rewalk.com/role/SignificantAccountingPoliciesDetails5" xlink:title="00000039 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details 5)">
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_SignificantAccountingPoliciesDetails1Abstract" xlink:label="loc_rwlkSignificantAccountingPoliciesDetails1Abstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:label="loc_us-gaapMovementInStandardProductWarrantyAccrualRollForward" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkSignificantAccountingPoliciesDetails1Abstract" xlink:to="loc_us-gaapMovementInStandardProductWarrantyAccrualRollForward" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StandardProductWarrantyAccrual" xlink:label="loc_us-gaapStandardProductWarrantyAccrual" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMovementInStandardProductWarrantyAccrualRollForward" xlink:to="loc_us-gaapStandardProductWarrantyAccrual" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StandardProductWarrantyAccrualWarrantiesIssued" xlink:label="loc_us-gaapStandardProductWarrantyAccrualWarrantiesIssued" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMovementInStandardProductWarrantyAccrualRollForward" xlink:to="loc_us-gaapStandardProductWarrantyAccrualWarrantiesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StandardProductWarrantyAccrualPayments" xlink:label="loc_us-gaapStandardProductWarrantyAccrualPayments" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMovementInStandardProductWarrantyAccrualRollForward" xlink:to="loc_us-gaapStandardProductWarrantyAccrualPayments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StandardProductWarrantyAccrual" xlink:label="loc_us-gaapStandardProductWarrantyAccrual_2" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMovementInStandardProductWarrantyAccrualRollForward" xlink:to="loc_us-gaapStandardProductWarrantyAccrual_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://rewalk.com/role/SignificantAccountingPoliciesDetails6" xlink:title="00000040 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details 6)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis" xlink:label="loc_srtMajorCustomersAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtMajorCustomersAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_CustomerAMember" xlink:label="loc_rwlkCustomerAMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_rwlkCustomerAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_CustomerBMember" xlink:label="loc_rwlkCustomerBMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_rwlkCustomerBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_CustomerCMember" xlink:label="loc_rwlkCustomerCMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_rwlkCustomerCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_CustomerDMember" xlink:label="loc_rwlkCustomerDMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_rwlkCustomerDMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_CustomerEMember" xlink:label="loc_rwlkCustomerEMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_rwlkCustomerEMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_CustomerFMember" xlink:label="loc_rwlkCustomerFMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_rwlkCustomerFMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_CustomerGMember" xlink:label="loc_rwlkCustomerGMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_rwlkCustomerGMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_CustomerHMember" xlink:label="loc_rwlkCustomerHMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_rwlkCustomerHMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_CustomerIMember" xlink:label="loc_rwlkCustomerIMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_rwlkCustomerIMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_CustomerJMember" xlink:label="loc_rwlkCustomerJMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_rwlkCustomerJMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_CustomerKMember" xlink:label="loc_rwlkCustomerKMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_rwlkCustomerKMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_CustomerLMember" xlink:label="loc_rwlkCustomerLMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_rwlkCustomerLMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://rewalk.com/role/SignificantAccountingPoliciesDetails7" xlink:title="00000041 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details 7)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_us-gaapEarningsPerShareBasicAndDiluted" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapEarningsPerShareBasicAndDiluted" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://rewalk.com/role/SignificantAccountingPoliciesDetailsTextual" xlink:title="00000042 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details Textual)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTable" xlink:label="loc_us-gaapConcentrationRiskTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapConcentrationRiskTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="loc_us-gaapConcentrationRiskLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_us-gaapConcentrationRiskLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_srtProductOrServiceAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ReStoreProductMember" xlink:label="loc_rwlkReStoreProductMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_rwlkReStoreProductMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_SCIProductsMember" xlink:label="loc_rwlkSCIProductsMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_rwlkSCIProductsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_srtTitleOfIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_EmployeesAndNonEmployeesMember" xlink:label="loc_rwlkEmployeesAndNonEmployeesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_rwlkEmployeesAndNonEmployeesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="loc_us-gaapAdjustmentsForNewAccountingPronouncementsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_us-gaapAdjustmentsForNewAccountingPronouncementsAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaapTypeOfAdoptionMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsForNewAccountingPronouncementsAxis" xlink:to="loc_us-gaapTypeOfAdoptionMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201609Member" xlink:label="loc_us-gaapAccountingStandardsUpdate201609Member" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfAdoptionMember" xlink:to="loc_us-gaapAccountingStandardsUpdate201609Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_YaskawaElectricCorporationMember" xlink:label="loc_rwlkYaskawaElectricCorporationMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_rwlkYaskawaElectricCorporationMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_SignificantAccountingPoliciesTextualAbstract" xlink:label="loc_rwlkSignificantAccountingPoliciesTextualAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskLineItems" xlink:to="loc_rwlkSignificantAccountingPoliciesTextualAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWriteDown" xlink:label="loc_us-gaapInventoryWriteDown" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkSignificantAccountingPoliciesTextualAbstract" xlink:to="loc_us-gaapInventoryWriteDown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="loc_us-gaapImpairmentOfLongLivedAssetsHeldForUse" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkSignificantAccountingPoliciesTextualAbstract" xlink:to="loc_us-gaapImpairmentOfLongLivedAssetsHeldForUse" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_RelatedPartyTransactionOwnershipPercentage" xlink:label="loc_rwlkRelatedPartyTransactionOwnershipPercentage" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkSignificantAccountingPoliciesTextualAbstract" xlink:to="loc_rwlkRelatedPartyTransactionOwnershipPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkSignificantAccountingPoliciesTextualAbstract" xlink:to="loc_us-gaapConcentrationRiskPercentage1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromRelatedParties" xlink:label="loc_us-gaapRevenueFromRelatedParties" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkSignificantAccountingPoliciesTextualAbstract" xlink:to="loc_us-gaapRevenueFromRelatedParties" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkSignificantAccountingPoliciesTextualAbstract" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_AllowanceForSalesReturns" xlink:label="loc_rwlkAllowanceForSalesReturns" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkSignificantAccountingPoliciesTextualAbstract" xlink:to="loc_rwlkAllowanceForSalesReturns" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkSignificantAccountingPoliciesTextualAbstract" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_RevenueRecognitionRecognized" xlink:label="loc_rwlkRevenueRecognitionRecognized" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkSignificantAccountingPoliciesTextualAbstract" xlink:to="loc_rwlkRevenueRecognitionRecognized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_CumulativeEffectOnRetainedEarningsNetOfTax" xlink:label="loc_rwlkCumulativeEffectOnRetainedEarningsNetOfTax" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkSignificantAccountingPoliciesTextualAbstract" xlink:to="loc_rwlkCumulativeEffectOnRetainedEarningsNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaapAllocatedShareBasedCompensationExpense" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkSignificantAccountingPoliciesTextualAbstract" xlink:to="loc_us-gaapAllocatedShareBasedCompensationExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement" xlink:label="loc_us-gaapIncomeTaxExaminationLikelihoodOfUnfavorableSettlement" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkSignificantAccountingPoliciesTextualAbstract" xlink:to="loc_us-gaapIncomeTaxExaminationLikelihoodOfUnfavorableSettlement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_SeverancePayMonthlyDepositByEmployeesPercentage" xlink:label="loc_rwlkSeverancePayMonthlyDepositByEmployeesPercentage" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkSignificantAccountingPoliciesTextualAbstract" xlink:to="loc_rwlkSeverancePayMonthlyDepositByEmployeesPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PostemploymentBenefitsPeriodExpense" xlink:label="loc_us-gaapPostemploymentBenefitsPeriodExpense" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkSignificantAccountingPoliciesTextualAbstract" xlink:to="loc_us-gaapPostemploymentBenefitsPeriodExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_RoyaltyBearingGrantsExpenses" xlink:label="loc_rwlkRoyaltyBearingGrantsExpenses" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkSignificantAccountingPoliciesTextualAbstract" xlink:to="loc_rwlkRoyaltyBearingGrantsExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RoyaltyExpense" xlink:label="loc_us-gaapRoyaltyExpense" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkSignificantAccountingPoliciesTextualAbstract" xlink:to="loc_us-gaapRoyaltyExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionsQuantification" xlink:label="loc_rwlkNewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionsQuantification" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkSignificantAccountingPoliciesTextualAbstract" xlink:to="loc_rwlkNewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionsQuantification" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LessorOperatingLeaseDescription" xlink:label="loc_us-gaapLessorOperatingLeaseDescription" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkSignificantAccountingPoliciesTextualAbstract" xlink:to="loc_us-gaapLessorOperatingLeaseDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingTerm" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkSignificantAccountingPoliciesTextualAbstract" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingTerm" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://rewalk.com/role/PrepaidExpensesAndOtherCurrentAssetsDetails" xlink:title="00000043 - Disclosure - PREPAID EXPENSES AND OTHER CURRENT ASSETS (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:label="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_PrepaidExpensesToGovernmentInstitutionsCurrent" xlink:label="loc_rwlkPrepaidExpensesToGovernmentInstitutionsCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="loc_rwlkPrepaidExpensesToGovernmentInstitutionsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="loc_us-gaapPrepaidExpenseCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Supplies" xlink:label="loc_us-gaapSupplies" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="loc_us-gaapSupplies" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="loc_us-gaapOtherAssetsCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="loc_us-gaapOtherAssetsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://rewalk.com/role/InventoriesDetails" xlink:title="00000044 - Disclosure - INVENTORIES (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoods" xlink:label="loc_us-gaapInventoryFinishedGoods" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryFinishedGoods" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterials" xlink:label="loc_us-gaapInventoryRawMaterials" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryRawMaterials" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://rewalk.com/role/PropertyAndEquipmentNetDetails" xlink:title="00000045 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaapComputerEquipmentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapComputerEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_MachineryAndLaboratoryEquipmentMember" xlink:label="loc_rwlkMachineryAndLaboratoryEquipmentMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_rwlkMachineryAndLaboratoryEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_FieldServiceUnitsMember" xlink:label="loc_rwlkFieldServiceUnitsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_rwlkFieldServiceUnitsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://rewalk.com/role/PropertyAndEquipmentNetDetailsTextual" xlink:title="00000046 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details Textual)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_PropertyAndEquipmentNetTextualAbstract" xlink:label="loc_rwlkPropertyAndEquipmentNetTextualAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_rwlkPropertyAndEquipmentNetTextualAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://rewalk.com/role/LoanAgreementWithKreosAndRelatedWarrantToPurchaseOrdinarySharesDetails" xlink:title="00000047 - Disclosure - LOAN AGREEMENT WITH KREOS AND RELATED WARRANT TO PURCHASE ORDINARY SHARES (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaapDebtInstrumentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtInstrumentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaapDebtInstrumentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapDebtInstrumentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaapLongtermDebtTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapLongtermDebtTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuredDebtMember" xlink:label="loc_us-gaapSecuredDebtMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_us-gaapSecuredDebtMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapDebtInstrumentAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_FirstAmendmentMember" xlink:label="loc_rwlkFirstAmendmentMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_rwlkFirstAmendmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_SecondAmendmentMember" xlink:label="loc_rwlkSecondAmendmentMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_rwlkSecondAmendmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_srtStatementScenarioAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_PreFundedMember" xlink:label="loc_rwlkPreFundedMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_rwlkPreFundedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_LoanAgreementWithKreosAndRelatedWarrantToPurchaseOrdinarySharesTextual" xlink:label="loc_rwlkLoanAgreementWithKreosAndRelatedWarrantToPurchaseOrdinarySharesTextual" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_rwlkLoanAgreementWithKreosAndRelatedWarrantToPurchaseOrdinarySharesTextual" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:label="loc_us-gaapProceedsFromIssuanceOfLongTermDebt" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTerm" xlink:label="loc_us-gaapDebtInstrumentTerm" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_DebtInstrumentProceedsfromIssuanceofCommonStockRequiredforRepaymentPeriodtobeExtended" xlink:label="loc_rwlkDebtInstrumentProceedsfromIssuanceofCommonStockRequiredforRepaymentPeriodtobeExtended" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_rwlkDebtInstrumentProceedsfromIssuanceofCommonStockRequiredforRepaymentPeriodtobeExtended" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_LongtermDebtMaturitiesPortionofPrincipalSubjecttoRepaymentExtension" xlink:label="loc_rwlkLongtermDebtMaturitiesPortionofPrincipalSubjecttoRepaymentExtension" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_rwlkLongtermDebtMaturitiesPortionofPrincipalSubjecttoRepaymentExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseDebt" xlink:label="loc_us-gaapInterestExpenseDebt" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapInterestExpenseDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfDebt" xlink:label="loc_us-gaapRepaymentsOfDebt" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapRepaymentsOfDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesOther" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesOther" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://rewalk.com/role/CommitmentsAndContingentLiabilitiesDetails" xlink:title="00000048 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInTwoYears" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInThreeYears" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInFourYears" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ImputedInterest" xlink:label="loc_rwlkImputedInterest" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_rwlkImputedInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PresentValueOfFutureMinimumLeasePaymentsSaleLeasebackTransactions" xlink:label="loc_us-gaapPresentValueOfFutureMinimumLeasePaymentsSaleLeasebackTransactions" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapPresentValueOfFutureMinimumLeasePaymentsSaleLeasebackTransactions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaapOperatingLeaseWeightedAverageRemainingLeaseTerm1" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://rewalk.com/role/CommitmentsAndContingentLiabilitiesDetailsTextual" xlink:title="00000049 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES (Details Textual)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCommitmentsTable" xlink:label="loc_us-gaapOtherCommitmentsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOtherCommitmentsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCommitmentsLineItems" xlink:label="loc_us-gaapOtherCommitmentsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherCommitmentsTable" xlink:to="loc_us-gaapOtherCommitmentsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherCommitmentsTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_IsraelInnovationAuthorityMember" xlink:label="loc_rwlkIsraelInnovationAuthorityMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_rwlkIsraelInnovationAuthorityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_IsraelUSBinationalIndustrialResearchAndDevelopmentFoundationMember" xlink:label="loc_rwlkIsraelUSBinationalIndustrialResearchAndDevelopmentFoundationMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_rwlkIsraelUSBinationalIndustrialResearchAndDevelopmentFoundationMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_RrlAndRrgMember" xlink:label="loc_rwlkRrlAndRrgMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_rwlkRrlAndRrgMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherCommitmentsTable" xlink:to="loc_srtRangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherCommitmentsTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="loc_us-gaapConvertiblePreferredStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapConvertiblePreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherCommitmentsTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaapIPOMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapIPOMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_CommitmentsAndContingenciesLiabilitiesTextualAbstract" xlink:label="loc_rwlkCommitmentsAndContingenciesLiabilitiesTextualAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherCommitmentsLineItems" xlink:to="loc_rwlkCommitmentsAndContingenciesLiabilitiesTextualAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligation" xlink:label="loc_us-gaapPurchaseObligation" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkCommitmentsAndContingenciesLiabilitiesTextualAbstract" xlink:to="loc_us-gaapPurchaseObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_OperatingLeasesMaximumPenaltiesPayableOnEarlyReleaseOfAgreement" xlink:label="loc_rwlkOperatingLeasesMaximumPenaltiesPayableOnEarlyReleaseOfAgreement" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkCommitmentsAndContingenciesLiabilitiesTextualAbstract" xlink:to="loc_rwlkOperatingLeasesMaximumPenaltiesPayableOnEarlyReleaseOfAgreement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRoyaltiesReceived" xlink:label="loc_us-gaapProceedsFromRoyaltiesReceived" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkCommitmentsAndContingenciesLiabilitiesTextualAbstract" xlink:to="loc_us-gaapProceedsFromRoyaltiesReceived" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ResearchAndDevelopmentRoyaltyBearingGrants" xlink:label="loc_rwlkResearchAndDevelopmentRoyaltyBearingGrants" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkCommitmentsAndContingenciesLiabilitiesTextualAbstract" xlink:to="loc_rwlkResearchAndDevelopmentRoyaltyBearingGrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRoyalties" xlink:label="loc_us-gaapPaymentsForRoyalties" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkCommitmentsAndContingenciesLiabilitiesTextualAbstract" xlink:to="loc_us-gaapPaymentsForRoyalties" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ResearchAndDevelopmentAmountReceivedInConsiderationOfConvertiblePreferredShares" xlink:label="loc_rwlkResearchAndDevelopmentAmountReceivedInConsiderationOfConvertiblePreferredShares" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkCommitmentsAndContingenciesLiabilitiesTextualAbstract" xlink:to="loc_rwlkResearchAndDevelopmentAmountReceivedInConsiderationOfConvertiblePreferredShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:label="loc_us-gaapConvertiblePreferredStockSharesIssuedUponConversion" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkCommitmentsAndContingenciesLiabilitiesTextualAbstract" xlink:to="loc_us-gaapConvertiblePreferredStockSharesIssuedUponConversion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_RoyaltyFeesPercentage" xlink:label="loc_rwlkRoyaltyFeesPercentage" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkCommitmentsAndContingenciesLiabilitiesTextualAbstract" xlink:to="loc_rwlkRoyaltyFeesPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConversionOfStockDescription" xlink:label="loc_us-gaapConversionOfStockDescription" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkCommitmentsAndContingenciesLiabilitiesTextualAbstract" xlink:to="loc_us-gaapConversionOfStockDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ContingentLiabilityRelatedToGrantsReceived" xlink:label="loc_rwlkContingentLiabilityRelatedToGrantsReceived" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkCommitmentsAndContingenciesLiabilitiesTextualAbstract" xlink:to="loc_rwlkContingentLiabilityRelatedToGrantsReceived" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_PercentageOfGrantReceivedConsideredToDetermineRoyaltyFees" xlink:label="loc_rwlkPercentageOfGrantReceivedConsideredToDetermineRoyaltyFees" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkCommitmentsAndContingenciesLiabilitiesTextualAbstract" xlink:to="loc_rwlkPercentageOfGrantReceivedConsideredToDetermineRoyaltyFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RoyaltyExpense" xlink:label="loc_us-gaapRoyaltyExpense" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkCommitmentsAndContingenciesLiabilitiesTextualAbstract" xlink:to="loc_us-gaapRoyaltyExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_GuarantorObligationsCollateralPledged" xlink:label="loc_rwlkGuarantorObligationsCollateralPledged" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkCommitmentsAndContingenciesLiabilitiesTextualAbstract" xlink:to="loc_rwlkGuarantorObligationsCollateralPledged" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DescriptionOfLessorLeasingArrangementsOperatingLeases" xlink:label="loc_us-gaapDescriptionOfLessorLeasingArrangementsOperatingLeases" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkCommitmentsAndContingenciesLiabilitiesTextualAbstract" xlink:to="loc_us-gaapDescriptionOfLessorLeasingArrangementsOperatingLeases" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLongTermDebt" xlink:label="loc_us-gaapOtherLongTermDebt" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkCommitmentsAndContingenciesLiabilitiesTextualAbstract" xlink:to="loc_us-gaapOtherLongTermDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet" xlink:label="loc_us-gaapOperatingLeasesRentExpenseNet" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkCommitmentsAndContingenciesLiabilitiesTextualAbstract" xlink:to="loc_us-gaapOperatingLeasesRentExpenseNet" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://rewalk.com/role/ShareholdersEquityDetails" xlink:title="00000050 - Disclosure - SHAREHOLDERS&apos; EQUITY (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://rewalk.com/role/ShareholdersEquityDetails1" xlink:title="00000051 - Disclosure - SHAREHOLDERS&apos; EQUITY (Details 1)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_EmployeeStockOptionAndRestrictedStockUnitsRsuMember" xlink:label="loc_rwlkEmployeeStockOptionAndRestrictedStockUnitsRsuMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_rwlkEmployeeStockOptionAndRestrictedStockUnitsRsuMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingRollForwardAbstract" xlink:label="loc_rwlkShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingRollForwardAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_rwlkShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingRollForwardAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstandingNumber" xlink:label="loc_rwlkSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstandingNumber" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingRollForwardAbstract" xlink:to="loc_rwlkSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingRollForwardAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingRollForwardAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingRollForwardAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstandingNumber" xlink:label="loc_rwlkSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstandingNumber_2" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingRollForwardAbstract" xlink:to="loc_rwlkSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstandingNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingWeightedAverageExercisePriceRollForwardAbstract" xlink:label="loc_rwlkShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingWeightedAverageExercisePriceRollForwardAbstract" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_rwlkShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingWeightedAverageExercisePriceRollForwardAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_SharebasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeOutstandingOptionsAndEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice" xlink:label="loc_rwlkSharebasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeOutstandingOptionsAndEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingWeightedAverageExercisePriceRollForwardAbstract" xlink:to="loc_rwlkSharebasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeOutstandingOptionsAndEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsGrantedInPeriodWeightedAverageExercisePrice" xlink:label="loc_rwlkShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsGrantedInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingWeightedAverageExercisePriceRollForwardAbstract" xlink:to="loc_rwlkShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsGrantedInPeriodWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsvestedInPeriodWeightedAverageExercisePrice" xlink:label="loc_rwlkShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsvestedInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingWeightedAverageExercisePriceRollForwardAbstract" xlink:to="loc_rwlkShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsvestedInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsForfeitedInPeriodWeightedAverageExercisePrice" xlink:label="loc_rwlkShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsForfeitedInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingWeightedAverageExercisePriceRollForwardAbstract" xlink:to="loc_rwlkShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsForfeitedInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_SharebasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeOutstandingOptionsAndEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice" xlink:label="loc_rwlkSharebasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeOutstandingOptionsAndEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice_2" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingWeightedAverageExercisePriceRollForwardAbstract" xlink:to="loc_rwlkSharebasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeOutstandingOptionsAndEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://rewalk.com/role/ShareholdersEquityDetails2" xlink:title="00000052 - Disclosure - SHAREHOLDERS&apos; EQUITY (Details 2)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="loc_us-gaapAwardTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaapEmployeeStockOptionMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapEmployeeStockOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ExercisePriceRangeOneMember" xlink:label="loc_rwlkExercisePriceRangeOneMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_rwlkExercisePriceRangeOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ExercisePriceRangeTwoMember" xlink:label="loc_rwlkExercisePriceRangeTwoMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_rwlkExercisePriceRangeTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ExercisePriceRangeThreeMember" xlink:label="loc_rwlkExercisePriceRangeThreeMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_rwlkExercisePriceRangeThreeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ExercisePriceRangeFourMember" xlink:label="loc_rwlkExercisePriceRangeFourMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_rwlkExercisePriceRangeFourMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ExercisePriceRangeFiveMember" xlink:label="loc_rwlkExercisePriceRangeFiveMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_rwlkExercisePriceRangeFiveMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ExercisePriceRangeMember" xlink:label="loc_rwlkExercisePriceRangeMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_rwlkExercisePriceRangeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_InvestmentOptionsExercisePrices" xlink:label="loc_rwlkInvestmentOptionsExercisePrices" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_rwlkInvestmentOptionsExercisePrices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://rewalk.com/role/ShareholdersEquityDetails3" xlink:title="00000053 - Disclosure - SHAREHOLDERS&apos; EQUITY (Details 3)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="loc_us-gaapClassOfWarrantOrRightTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapClassOfWarrantOrRightTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="loc_us-gaapClassOfWarrantOrRightLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightTable" xlink:to="loc_us-gaapClassOfWarrantOrRightLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandFifteenMember" xlink:label="loc_rwlkWarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandFifteenMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_rwlkWarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandFifteenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwoThousandSixteenMember" xlink:label="loc_rwlkWarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwoThousandSixteenMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_rwlkWarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwoThousandSixteenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandSixteenMember" xlink:label="loc_rwlkWarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandSixteenMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_rwlkWarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandSixteenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenMember" xlink:label="loc_rwlkWarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_rwlkWarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenOneMember" xlink:label="loc_rwlkWarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenOneMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_rwlkWarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentyFiveTwoThousandNineteenMember" xlink:label="loc_rwlkWarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentyFiveTwoThousandNineteenMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_rwlkWarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentyFiveTwoThousandNineteenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenMember" xlink:label="loc_rwlkWarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_rwlkWarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenOneMember" xlink:label="loc_rwlkWarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenOneMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_rwlkWarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveAndSixTwoThousandNineteenMember" xlink:label="loc_rwlkWarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveAndSixTwoThousandNineteenMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_rwlkWarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveAndSixTwoThousandNineteenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveTwoThousandNineteenMember" xlink:label="loc_rwlkWarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveTwoThousandNineteenMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_rwlkWarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveTwoThousandNineteenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTweleveTwoThousandNineteenMember" xlink:label="loc_rwlkWarrantsToPurchaseOrdinarySharesIssuedOnJuneTweleveTwoThousandNineteenMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_rwlkWarrantsToPurchaseOrdinarySharesIssuedOnJuneTweleveTwoThousandNineteenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTenTwoThousandNineteenMember" xlink:label="loc_rwlkWarrantsToPurchaseOrdinarySharesIssuedOnJuneTenTwoThousandNineteenMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_rwlkWarrantsToPurchaseOrdinarySharesIssuedOnJuneTenTwoThousandNineteenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyMember" xlink:label="loc_rwlkWarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_rwlkWarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyOneMember" xlink:label="loc_rwlkWarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyOneMember" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_rwlkWarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyMember" xlink:label="loc_rwlkWarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_rwlkWarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyOneMember" xlink:label="loc_rwlkWarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyOneMember" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_rwlkWarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberThreeTwoThousandTwentyMember" xlink:label="loc_rwlkWarrantsToPurchaseOrdinarySharesIssuedOnDecemberThreeTwoThousandTwentyMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_rwlkWarrantsToPurchaseOrdinarySharesIssuedOnDecemberThreeTwoThousandTwentyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberThreeTwoThousandTwentyOneMember" xlink:label="loc_rwlkWarrantsToPurchaseOrdinarySharesIssuedOnDecemberThreeTwoThousandTwentyOneMember" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_rwlkWarrantsToPurchaseOrdinarySharesIssuedOnDecemberThreeTwoThousandTwentyOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ClassOfWarrantOrRightExercisable" xlink:label="loc_rwlkClassOfWarrantOrRightExercisable" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_rwlkClassOfWarrantOrRightExercisable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_WarrantsExpitationDate" xlink:label="loc_rwlkWarrantsExpitationDate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_rwlkWarrantsExpitationDate" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://rewalk.com/role/ShareholdersEquityDetails4" xlink:title="00000054 - Disclosure - SHAREHOLDERS&apos; EQUITY (Details 4)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="loc_us-gaapScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember" xlink:label="loc_us-gaapCostOfSalesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapCostOfSalesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaapResearchAndDevelopmentExpenseMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapResearchAndDevelopmentExpenseMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingAndMarketingExpenseMember" xlink:label="loc_us-gaapSellingAndMarketingExpenseMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapSellingAndMarketingExpenseMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="loc_us-gaapGeneralAndAdministrativeExpenseMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapGeneralAndAdministrativeExpenseMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaapAllocatedShareBasedCompensationExpense" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="loc_us-gaapAllocatedShareBasedCompensationExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://rewalk.com/role/ShareholdersEquityDetailsTextual" xlink:title="00000055 - Disclosure - SHAREHOLDERS&apos; EQUITY (Details Textual)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable" xlink:label="loc_us-gaapScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionLineItems" xlink:label="loc_us-gaapShareBasedGoodsAndNonemployeeServicesTransactionLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable" xlink:to="loc_us-gaapShareBasedGoodsAndNonemployeeServicesTransactionLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_AgreementAxis" xlink:label="loc_rwlkAgreementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable" xlink:to="loc_rwlkAgreementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_AgreementDomain" xlink:label="loc_rwlkAgreementDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkAgreementAxis" xlink:to="loc_rwlkAgreementDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_SecuritiesPurchaseAgreementsMember" xlink:label="loc_rwlkSecuritiesPurchaseAgreementsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkAgreementDomain" xlink:to="loc_rwlkSecuritiesPurchaseAgreementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_EquityExchangeProgramMember" xlink:label="loc_rwlkEquityExchangeProgramMember" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkAgreementDomain" xlink:to="loc_rwlkEquityExchangeProgramMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_TimwellCorporationLimitedMember" xlink:label="loc_rwlkTimwellCorporationLimitedMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_rwlkTimwellCorporationLimitedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_KreosCapitalMember" xlink:label="loc_rwlkKreosCapitalMember" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_rwlkKreosCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_WarrantsToPurchaseOrdinarySharesIssuedMember" xlink:label="loc_rwlkWarrantsToPurchaseOrdinarySharesIssuedMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_rwlkWarrantsToPurchaseOrdinarySharesIssuedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaapPrivatePlacementMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapPrivatePlacementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_AtmOfferingProgramMember" xlink:label="loc_rwlkAtmOfferingProgramMember" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_rwlkAtmOfferingProgramMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_CommonUnitsAndPreFundedUnitsMember" xlink:label="loc_rwlkCommonUnitsAndPreFundedUnitsMember" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_rwlkCommonUnitsAndPreFundedUnitsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_CommonUnitsMember" xlink:label="loc_rwlkCommonUnitsMember" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_rwlkCommonUnitsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_PreFundedUnitsMember" xlink:label="loc_rwlkPreFundedUnitsMember" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_rwlkPreFundedUnitsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_CommonUnitsAndPreFundedUnits1Member" xlink:label="loc_rwlkCommonUnitsAndPreFundedUnits1Member" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_rwlkCommonUnitsAndPreFundedUnits1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_PurchaseAgreementWithCertainInstitutionalInvestorsMember" xlink:label="loc_rwlkPurchaseAgreementWithCertainInstitutionalInvestorsMember" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_rwlkPurchaseAgreementWithCertainInstitutionalInvestorsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable" xlink:to="loc_us-gaapAwardTypeAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaapRestrictedStockUnitsRSUMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockUnitsRSUMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaapEmployeeStockOptionMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapEmployeeStockOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable" xlink:to="loc_deiLegalEntityAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_KreosCapitalVMember" xlink:label="loc_rwlkKreosCapitalVMember" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_rwlkKreosCapitalVMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_TypeofCurrencyAxis" xlink:label="loc_rwlkTypeofCurrencyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable" xlink:to="loc_rwlkTypeofCurrencyAxis" order="70" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_TypeofCurrencyDomain" xlink:label="loc_rwlkTypeofCurrencyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkTypeofCurrencyAxis" xlink:to="loc_rwlkTypeofCurrencyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_IsraeliMember" xlink:label="loc_rwlkIsraeliMember" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkTypeofCurrencyDomain" xlink:to="loc_rwlkIsraeliMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="80" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_AdditionallyWarrantsIssuedMember" xlink:label="loc_rwlkAdditionallyWarrantsIssuedMember" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_rwlkAdditionallyWarrantsIssuedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ShareholdersEquityTextualAbstract" xlink:label="loc_rwlkShareholdersEquityTextualAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedGoodsAndNonemployeeServicesTransactionLineItems" xlink:to="loc_rwlkShareholdersEquityTextualAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="loc_us-gaapStockholdersEquityReverseStockSplit" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkShareholdersEquityTextualAbstract" xlink:to="loc_us-gaapStockholdersEquityReverseStockSplit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_CommonStockAggregateOfferingPriceAuthorizedUnderEquityDistributionAgreement" xlink:label="loc_rwlkCommonStockAggregateOfferingPriceAuthorizedUnderEquityDistributionAgreement" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkShareholdersEquityTextualAbstract" xlink:to="loc_rwlkCommonStockAggregateOfferingPriceAuthorizedUnderEquityDistributionAgreement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_CommonStockIssuanceCostsUnderEquityDistributionAgreementAsPercentOfGrossProceeds" xlink:label="loc_rwlkCommonStockIssuanceCostsUnderEquityDistributionAgreementAsPercentOfGrossProceeds" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkShareholdersEquityTextualAbstract" xlink:to="loc_rwlkCommonStockIssuanceCostsUnderEquityDistributionAgreementAsPercentOfGrossProceeds" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkShareholdersEquityTextualAbstract" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkShareholdersEquityTextualAbstract" xlink:to="loc_us-gaapSharesIssuedPricePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkShareholdersEquityTextualAbstract" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkShareholdersEquityTextualAbstract" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_StockIssuedDuringPeriodPricePerShare" xlink:label="loc_rwlkStockIssuedDuringPeriodPricePerShare" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkShareholdersEquityTextualAbstract" xlink:to="loc_rwlkStockIssuedDuringPeriodPricePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_StockIssuedDuringPeriodValueNewIssuesGross" xlink:label="loc_rwlkStockIssuedDuringPeriodValueNewIssuesGross" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkShareholdersEquityTextualAbstract" xlink:to="loc_rwlkStockIssuedDuringPeriodValueNewIssuesGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkShareholdersEquityTextualAbstract" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_FixedCommissionRate" xlink:label="loc_rwlkFixedCommissionRate" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkShareholdersEquityTextualAbstract" xlink:to="loc_rwlkFixedCommissionRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_FixedCommissionAmount" xlink:label="loc_rwlkFixedCommissionAmount" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkShareholdersEquityTextualAbstract" xlink:to="loc_rwlkFixedCommissionAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfStockIssuanceCosts" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkShareholdersEquityTextualAbstract" xlink:to="loc_us-gaapPaymentsOfStockIssuanceCosts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkShareholdersEquityTextualAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkShareholdersEquityTextualAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkShareholdersEquityTextualAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkShareholdersEquityTextualAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkShareholdersEquityTextualAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkShareholdersEquityTextualAbstract" xlink:to="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_AggregateNumberOfOrdinaryShares" xlink:label="loc_rwlkAggregateNumberOfOrdinaryShares" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkShareholdersEquityTextualAbstract" xlink:to="loc_rwlkAggregateNumberOfOrdinaryShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_SharebasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsVestedAndOptionsNetBasisOfCommonStock" xlink:label="loc_rwlkSharebasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsVestedAndOptionsNetBasisOfCommonStock" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkShareholdersEquityTextualAbstract" xlink:to="loc_rwlkSharebasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsVestedAndOptionsNetBasisOfCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkShareholdersEquityTextualAbstract" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkShareholdersEquityTextualAbstract" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkShareholdersEquityTextualAbstract" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkShareholdersEquityTextualAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkShareholdersEquityTextualAbstract" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable" xlink:label="loc_us-gaapClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkShareholdersEquityTextualAbstract" xlink:to="loc_us-gaapClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_WarrantsExercisableDescrition" xlink:label="loc_rwlkWarrantsExercisableDescrition" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkShareholdersEquityTextualAbstract" xlink:to="loc_rwlkWarrantsExercisableDescrition" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCollateralAmount" xlink:label="loc_us-gaapDebtInstrumentCollateralAmount" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkShareholdersEquityTextualAbstract" xlink:to="loc_us-gaapDebtInstrumentCollateralAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpensesRelatedParty" xlink:label="loc_us-gaapCostsAndExpensesRelatedParty" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkShareholdersEquityTextualAbstract" xlink:to="loc_us-gaapCostsAndExpensesRelatedParty" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockPlans" xlink:label="loc_us-gaapProceedsFromStockPlans" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkShareholdersEquityTextualAbstract" xlink:to="loc_us-gaapProceedsFromStockPlans" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare" xlink:label="loc_us-gaapAcceleratedShareRepurchasesFinalPricePaidPerShare" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkShareholdersEquityTextualAbstract" xlink:to="loc_us-gaapAcceleratedShareRepurchasesFinalPricePaidPerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction" xlink:label="loc_us-gaapSaleOfStockPercentageOfOwnershipAfterTransaction" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkShareholdersEquityTextualAbstract" xlink:to="loc_us-gaapSaleOfStockPercentageOfOwnershipAfterTransaction" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PartnersCapitalLimitationOfLiability" xlink:label="loc_us-gaapPartnersCapitalLimitationOfLiability" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkShareholdersEquityTextualAbstract" xlink:to="loc_us-gaapPartnersCapitalLimitationOfLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_FeesAndOtherRelatedExpenses" xlink:label="loc_rwlkFeesAndOtherRelatedExpenses" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkShareholdersEquityTextualAbstract" xlink:to="loc_rwlkFeesAndOtherRelatedExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_NetAggregateProceedsOfAfterDeductingFeesAndOtherRelatedExpenses" xlink:label="loc_rwlkNetAggregateProceedsOfAfterDeductingFeesAndOtherRelatedExpenses" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkShareholdersEquityTextualAbstract" xlink:to="loc_rwlkNetAggregateProceedsOfAfterDeductingFeesAndOtherRelatedExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuritiesLoanedMeasurementDifferenceDescription" xlink:label="loc_us-gaapSecuritiesLoanedMeasurementDifferenceDescription" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkShareholdersEquityTextualAbstract" xlink:to="loc_us-gaapSecuritiesLoanedMeasurementDifferenceDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="loc_us-gaapWarrantsAndRightsOutstanding" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkShareholdersEquityTextualAbstract" xlink:to="loc_us-gaapWarrantsAndRightsOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_PrefundedWarrantsToPurchaseAggregateOrdinarySharesExercised" xlink:label="loc_rwlkPrefundedWarrantsToPurchaseAggregateOrdinarySharesExercised" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkShareholdersEquityTextualAbstract" xlink:to="loc_rwlkPrefundedWarrantsToPurchaseAggregateOrdinarySharesExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_DescriptionOfUnderwritingAgreement" xlink:label="loc_rwlkDescriptionOfUnderwritingAgreement" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkShareholdersEquityTextualAbstract" xlink:to="loc_rwlkDescriptionOfUnderwritingAgreement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_DescriptionOfUnderwritersWarrantsToPurchase" xlink:label="loc_rwlkDescriptionOfUnderwritersWarrantsToPurchase" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkShareholdersEquityTextualAbstract" xlink:to="loc_rwlkDescriptionOfUnderwritersWarrantsToPurchase" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkShareholdersEquityTextualAbstract" xlink:to="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_DescriptionOfWainwrightOrItsDesigneesWarrantsToPurchase" xlink:label="loc_rwlkDescriptionOfWainwrightOrItsDesigneesWarrantsToPurchase" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkShareholdersEquityTextualAbstract" xlink:to="loc_rwlkDescriptionOfWainwrightOrItsDesigneesWarrantsToPurchase" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_StockIssuedDuringPeriodShareOrdinaryShares" xlink:label="loc_rwlkStockIssuedDuringPeriodShareOrdinaryShares" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkShareholdersEquityTextualAbstract" xlink:to="loc_rwlkStockIssuedDuringPeriodShareOrdinaryShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_OrdinarySharesExercisePrice" xlink:label="loc_rwlkOrdinarySharesExercisePrice" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkShareholdersEquityTextualAbstract" xlink:to="loc_rwlkOrdinarySharesExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkShareholdersEquityTextualAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_DescriptionOfEquityExchangePrograms" xlink:label="loc_rwlkDescriptionOfEquityExchangePrograms" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkShareholdersEquityTextualAbstract" xlink:to="loc_rwlkDescriptionOfEquityExchangePrograms" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_WarrantsToPurchaseOrdinaryShares" xlink:label="loc_rwlkWarrantsToPurchaseOrdinaryShares" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkShareholdersEquityTextualAbstract" xlink:to="loc_rwlkWarrantsToPurchaseOrdinaryShares" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://rewalk.com/role/ResearchCollaborationAgreementAndLicenseAgreementDetails" xlink:title="00000056 - Disclosure - RESEARCH COLLABORATION AGREEMENT AND LICENSE AGREEMENT (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentAbstract" xlink:label="loc_us-gaapResearchAndDevelopmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:label="loc_us-gaapScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapResearchAndDevelopmentAbstract" xlink:to="loc_us-gaapScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:label="loc_us-gaapResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:to="loc_us-gaapResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_AgreementAxis" xlink:label="loc_rwlkAgreementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:to="loc_rwlkAgreementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_AgreementDomain" xlink:label="loc_rwlkAgreementDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkAgreementAxis" xlink:to="loc_rwlkAgreementDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_LicenseAgreementAndCollaborationAgreementMember" xlink:label="loc_rwlkLicenseAgreementAndCollaborationAgreementMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkAgreementDomain" xlink:to="loc_rwlkLicenseAgreementAndCollaborationAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ResearchCollaborationAgreementAndLicenseAgreementTextualAbstract" xlink:label="loc_rwlkResearchCollaborationAgreementAndLicenseAgreementTextualAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="loc_rwlkResearchCollaborationAgreementAndLicenseAgreementTextualAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentPeriodicPayment" xlink:label="loc_us-gaapDebtInstrumentPeriodicPayment" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkResearchCollaborationAgreementAndLicenseAgreementTextualAbstract" xlink:to="loc_us-gaapDebtInstrumentPeriodicPayment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkResearchCollaborationAgreementAndLicenseAgreementTextualAbstract" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkResearchCollaborationAgreementAndLicenseAgreementTextualAbstract" xlink:to="loc_us-gaapDebtInstrumentMaturityDate" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://rewalk.com/role/PaycheckProtectionProgramLoanDetailsTextual" xlink:title="00000057 - Disclosure - PAYCHECK PROTECTION PROGRAM LOAN (Details Textual)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaapDebtInstrumentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtInstrumentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaapDebtInstrumentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapDebtInstrumentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapDebtInstrumentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_PaycheckProtectionProgramLoanMember" xlink:label="loc_rwlkPaycheckProtectionProgramLoanMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_rwlkPaycheckProtectionProgramLoanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_deiLegalEntityAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_SiliconValleyBankMember" xlink:label="loc_rwlkSiliconValleyBankMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_rwlkSiliconValleyBankMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnsecuredDebt" xlink:label="loc_us-gaapUnsecuredDebt" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapUnsecuredDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTerm" xlink:label="loc_us-gaapDebtInstrumentTerm" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentTerm" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://rewalk.com/role/IncomeTaxesDetails" xlink:title="00000058 - Disclosure - INCOME TAXES (Details)">
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_IncomeTaxesDetailsAbstract" xlink:label="loc_rwlkIncomeTaxesDetailsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkIncomeTaxesDetailsAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkIncomeTaxesDetailsAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkIncomeTaxesDetailsAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://rewalk.com/role/IncomeTaxesDetails1" xlink:title="00000059 - Disclosure - INCOME TAXES (Details 1)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentIncomeTaxExpenseBenefit" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapCurrentIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_DeferredIncometax" xlink:label="loc_rwlkDeferredIncometax" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_rwlkDeferredIncometax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_TaxesOnIncome" xlink:label="loc_rwlkTaxesOnIncome" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_rwlkTaxesOnIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:label="loc_us-gaapFederalIncomeTaxExpenseBenefitContinuingOperations" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapFederalIncomeTaxExpenseBenefitContinuingOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" xlink:label="loc_us-gaapForeignIncomeTaxExpenseBenefitContinuingOperations" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapForeignIncomeTaxExpenseBenefitContinuingOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_TaxesIncome" xlink:label="loc_rwlkTaxesIncome" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_rwlkTaxesIncome" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://rewalk.com/role/IncomeTaxesDetails2" xlink:title="00000060 - Disclosure - INCOME TAXES (Details 2)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGrossAbstract" xlink:label="loc_us-gaapDeferredTaxAssetsGrossAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsGrossAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:label="loc_us-gaapDeferredTaxAssetsInProcessResearchAndDevelopment" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsInProcessResearchAndDevelopment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:label="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset" xlink:label="loc_us-gaapFinanceLeaseRightOfUseAsset" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapFinanceLeaseRightOfUseAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesAbstract" xlink:label="loc_us-gaapDeferredTaxLiabilitiesAbstract" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxLiabilitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_RightofuseLiability" xlink:label="loc_rwlkRightofuseLiability" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_rwlkRightofuseLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaapDeferredTaxAssetsGross" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://rewalk.com/role/IncomeTaxesDetails3" xlink:title="00000061 - Disclosure - INCOME TAXES (Details 3)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ValuationAllowanceDeferredTaxAssetChangesDuetoAmendmentsinTaxLawsandExchangeRateDifferencesAmount" xlink:label="loc_rwlkValuationAllowanceDeferredTaxAssetChangesDuetoAmendmentsinTaxLawsandExchangeRateDifferencesAmount" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_rwlkValuationAllowanceDeferredTaxAssetChangesDuetoAmendmentsinTaxLawsandExchangeRateDifferencesAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ValuationAllowanceDeferredTaxAssetAdjustmentsAmount" xlink:label="loc_rwlkValuationAllowanceDeferredTaxAssetAdjustmentsAmount" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_rwlkValuationAllowanceDeferredTaxAssetAdjustmentsAmount" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="loc_us-gaapValuationAllowanceDeferredTaxAssetChangeInAmount" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance_2" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://rewalk.com/role/IncomeTaxesDetails4" xlink:title="00000062 - Disclosure - INCOME TAXES (Details 4)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaapIncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:label="loc_us-gaapIncomeTaxReconciliationForeignIncomeTaxRateDifferential" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:label="loc_us-gaapIncomeTaxReconciliationNondeductibleExpense" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationNondeductibleExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapIncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:label="loc_us-gaapIncomeTaxReconciliationChangeInEnactedTaxRate" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationChangeInEnactedTaxRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="loc_us-gaapIncomeTaxReconciliationOtherAdjustments" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationOtherAdjustments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherTaxExpenseBenefit" xlink:label="loc_us-gaapOtherTaxExpenseBenefit" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapOtherTaxExpenseBenefit" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://rewalk.com/role/IncomeTaxesDetailsTextual" xlink:title="00000063 - Disclosure - INCOME TAXES (Details Textual)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ScheduleOfIncomeTaxTable" xlink:label="loc_rwlkScheduleOfIncomeTaxTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_rwlkScheduleOfIncomeTaxTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ScheduleOfIncomeTaxLineItems" xlink:label="loc_rwlkScheduleOfIncomeTaxLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkScheduleOfIncomeTaxTable" xlink:to="loc_rwlkScheduleOfIncomeTaxLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkScheduleOfIncomeTaxTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ReWalkRoboticsIncMember" xlink:label="loc_rwlkReWalkRoboticsIncMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_rwlkReWalkRoboticsIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_ReWalkRoboticsGMBHMember" xlink:label="loc_rwlkReWalkRoboticsGMBHMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_rwlkReWalkRoboticsGMBHMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkScheduleOfIncomeTaxTable" xlink:to="loc_srtRangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis" xlink:label="loc_us-gaapIncomeTaxAuthorityNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkScheduleOfIncomeTaxTable" xlink:to="loc_us-gaapIncomeTaxAuthorityNameAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityNameAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IsraelTaxAuthorityMember" xlink:label="loc_us-gaapIsraelTaxAuthorityMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityNameDomain" xlink:to="loc_us-gaapIsraelTaxAuthorityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_IncomeTaxesTextualAbstract" xlink:label="loc_rwlkIncomeTaxesTextualAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkScheduleOfIncomeTaxLineItems" xlink:to="loc_rwlkIncomeTaxesTextualAbstract" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkIncomeTaxesTextualAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCutsAndJobsActOf2017ChangeInTaxRateDeferredTaxAssetIncomeTaxExpense" xlink:label="loc_us-gaapTaxCutsAndJobsActOf2017ChangeInTaxRateDeferredTaxAssetIncomeTaxExpense" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkIncomeTaxesTextualAbstract" xlink:to="loc_us-gaapTaxCutsAndJobsActOf2017ChangeInTaxRateDeferredTaxAssetIncomeTaxExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_BeneficiaryEnterprisefromProductiveActivityTaxExemptionPeriod" xlink:label="loc_rwlkBeneficiaryEnterprisefromProductiveActivityTaxExemptionPeriod" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkIncomeTaxesTextualAbstract" xlink:to="loc_rwlkBeneficiaryEnterprisefromProductiveActivityTaxExemptionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_BeneficiaryEnterprisefromProductiveActivityMaximumTimefromPeriodofElectionforTaxExemption" xlink:label="loc_rwlkBeneficiaryEnterprisefromProductiveActivityMaximumTimefromPeriodofElectionforTaxExemption" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkIncomeTaxesTextualAbstract" xlink:to="loc_rwlkBeneficiaryEnterprisefromProductiveActivityMaximumTimefromPeriodofElectionforTaxExemption" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_BeneficiaryEnterprisefromProductiveActivityTaxRateonDividendDistributionsfromTaxExemptIncome" xlink:label="loc_rwlkBeneficiaryEnterprisefromProductiveActivityTaxRateonDividendDistributionsfromTaxExemptIncome" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkIncomeTaxesTextualAbstract" xlink:to="loc_rwlkBeneficiaryEnterprisefromProductiveActivityTaxRateonDividendDistributionsfromTaxExemptIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaapOperatingLossCarryforwards" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkIncomeTaxesTextualAbstract" xlink:to="loc_us-gaapOperatingLossCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_DescriptionOfIncomeTaxLawForEncouragementOfCapitalInvestments" xlink:label="loc_rwlkDescriptionOfIncomeTaxLawForEncouragementOfCapitalInvestments" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkIncomeTaxesTextualAbstract" xlink:to="loc_rwlkDescriptionOfIncomeTaxLawForEncouragementOfCapitalInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_NetOperatingCarryForwardLossesTerms" xlink:label="loc_rwlkNetOperatingCarryForwardLossesTerms" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkIncomeTaxesTextualAbstract" xlink:to="loc_rwlkNetOperatingCarryForwardLossesTerms" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://rewalk.com/role/FinancialExpensesNetDetails" xlink:title="00000064 - Disclosure - FINANCIAL EXPENSES, NET (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract" xlink:label="loc_us-gaapOtherIncomeAndExpensesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfBankDebt" xlink:label="loc_us-gaapRepaymentsOfBankDebt" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract" xlink:to="loc_us-gaapRepaymentsOfBankDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_BankCommissions" xlink:label="loc_rwlkBankCommissions" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract" xlink:to="loc_rwlkBankCommissions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_FinancialExpensesIncomeNet" xlink:label="loc_rwlkFinancialExpensesIncomeNet" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract" xlink:to="loc_rwlkFinancialExpensesIncomeNet" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails" xlink:title="00000065 - Disclosure - GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:label="loc_us-gaapScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:label="loc_us-gaapEntityWideRevenueMajorCustomerLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:to="loc_us-gaapEntityWideRevenueMajorCustomerLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:to="loc_srtStatementGeographicalAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_IL" xlink:label="loc_countryIL" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryIL" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US" xlink:label="loc_countryUS" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryUS" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EuropeMember" xlink:label="loc_srtEuropeMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_srtEuropeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_AsiaPacificMember" xlink:label="loc_srtAsiaPacificMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_srtAsiaPacificMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LatinAmericaMember" xlink:label="loc_srtLatinAmericaMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_srtLatinAmericaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_AfricaMember" xlink:label="loc_srtAfricaMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_srtAfricaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEntityWideRevenueMajorCustomerLineItems" xlink:to="loc_us-gaapRevenues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails1" xlink:title="00000066 - Disclosure - GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA (Details 1)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="loc_srtStatementGeographicalAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_IL" xlink:label="loc_countryIL" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryIL" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US" xlink:label="loc_countryUS" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryUS" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_DE" xlink:label="loc_countryDE" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryDE" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails2" xlink:title="00000067 - Disclosure - GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA (Details 2)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:label="loc_us-gaapScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:label="loc_us-gaapEntityWideRevenueMajorCustomerLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:to="loc_us-gaapEntityWideRevenueMajorCustomerLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis" xlink:label="loc_srtMajorCustomersAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:to="loc_srtMajorCustomersAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_CustomerAMember" xlink:label="loc_rwlkCustomerAMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_rwlkCustomerAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaapSalesRevenueNetMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapSalesRevenueNetMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEntityWideRevenueMajorCustomerLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetailsTextual" xlink:title="00000068 - Disclosure - GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA (Details Textual)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_GeographicInformationAndMajorCustomerAndProductDataTextualAbstract" xlink:label="loc_rwlkGeographicInformationAndMajorCustomerAndProductDataTextualAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_rwlkGeographicInformationAndMajorCustomerAndProductDataTextualAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments" xlink:label="loc_us-gaapNumberOfReportableSegments" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkGeographicInformationAndMajorCustomerAndProductDataTextualAbstract" xlink:to="loc_us-gaapNumberOfReportableSegments" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://rewalk.com/role/SubsequentEventsDetails" xlink:title="00000069 - Disclosure - SUBSEQUENT EVENTS (Details)">
      <link:loc xlink:type="locator" xlink:href="rwlk-20201231.xsd#rwlk_SubsequentEventsDetailsAbstract" xlink:label="loc_rwlkSubsequentEventsDetailsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rwlkSubsequentEventsDetailsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaapProceedsFromWarrantExercises" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromWarrantExercises" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>image0.jpg
<TEXT>
begin 644 image0.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 0O!WH# 2(  A$! Q$!_\0
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M>Y; P*3%.HI#"BFL<4BMF@!]%%% !1110 4444 %%%% !1110 4444 %%%%
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M\97$+1116EA!11118 HHHI@%%%% !1110 4444 %%%% !1110 4444 %%%%
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MY->QAZK;,90+P-.J->E/%>W1E<P8^BDIU=T=20HHHK004444 %%%% !1110
MAIIIU--85&-$;FJ<[\5:D/%49C7BXBI9F\(W*K.<TSS,4DIJ M7C8BM8WC"Y
M8\WWH\VJFXYIVZN!XBYJH%GS?>CS:J[C1N.:S>(8^0L^8:/--0YXIJGFLOK#
M#E+2R^](TAJLSXZ4Y6R*TAB"' E,IQ3HI3GK54GFE#8KMHX@7(:\4F:MHU9-
MO(:T(VKTL/6O(QE#0NJ:?4:'BI*^EH2O$YF%+24M=*9(4444P"BBB@ HHHH
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M.::LI!I+<H[NRU0MC+5OV=[N(YKS>TO"I'-='8W^,<T"._CD!4<T^L*SO@X
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MTL-,YIHT+<<"M*+I5"W%:$8XKZC NZ.6IH3"GTP4ZOHJ3T.=BT445L(****
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MM]RHS766<^]!S7F6GW)#+S7::7> JHS0P1U .12U%%)N45+2&%%%% !1110
M4444 %%%% !1124F[ +124M"=P"BBBF QJA>IS4$@KS<5'0T@4IAQFLV9AG%
M:LP^6L>8'>:^4QD=SLIL8#@T_.:B-.4\5\[61U(<QI@ZT-UI*P4;%I#V.10#
M@4VC%6UH%@/6ESQ3>]%9,=ARFG$U&*7M6]%ZB8]7^:KT!Z5F#.ZKT#5[V%=K
M'-49K1'-65JG :MBOJ<)+2YPU%J2BBD%+7LQ=T8A1113 *2EI*E@%+24M"W
M****H!IJ)^E2FH7Z5YV*=D7$ISMP:RY6YK0N.]9<AY-?(8Z1WTHZ#,9IPX&*
M1:#UKYNH[R.I!WS2D\48XIAJ$]1[BT4#FBM[W0PH!P:*2HD X\TH.*0<4G>L
MKZB'$4QJDQQ49'-=%*9+9)#Q5N,\U32K4745ZV%E[QG/8TX3Q5M>E48.U75Z
M5]=A7[J//J;DE+312UZD&8CJ***Z$(**** "BBDI, HHHJ1B&H9*F-025PXF
M5D5'<IS/C-9LQR:NW&:SWZU\SBZAV4MQA-(#00:3%?-5Y79VQV) :0GBD6FL
M.:XUN%M0!YIQ.1312UM$;%!IIZTM)3: =G(Q4;\4]>#22#<.*F"NQ-V&IR:T
M;<<51A3%:, YKV<)3U.6HR_$.*LK4,0XJ=17U^"AH<4V/%+2"EKVH[&04444
MV E%%%0ABT4458@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HI*6D@"BBBF AIC5)3&KGK[#1!)TK.N!C)K0?I5"YY4U\KCGN=-,SG.33
M!\M.P0](XSTKYBON=L=@Z\T!J0=*;@YK@>Y:1+FFGFD/(I5XIQ*#.!3>]*13
M:=BD2 TI.*C'%*>:A;BL)GFI,_+4=%=5):@T6K8_-6M$<BL>VY-:\ XKZ? 1
MT."MN6.U5+CI5OM52XZ5Z6)7N&,-S)F&2:B'%3R=34#<U\;BU[QWTQ^::3F@
M'BF]Z\ZQLD XIX--/- XH =FG U'U-/[570ECB:9G% IK"I6X1$[T_/%,I<5
MTPW*8JGFM*T-98Y-:=F.E>[@GJCCJHU8^E2BHH^E2BOM,*_=1PRW%H%%+7>C
M.P4444#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"*;[M0)WJ:7[
MM0+WH$CD/$I^9JXF8C?7:^).K5PT^?,JGL,D2GOTJ)#Q2YS4@2(>*:1\U(,T
M_M0)B'I0E-.:*8(<PYH[4HZ<TTT!N"]:EXJ&GJ:=@>PIIG>ALYI1TIDICQ2&
MF@\T-0]P8'K2]J11Q1WH'N '-!I3TI!S2 !TI,<TIS2XXH #TI![T#K01Z4
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M-RBO-]$N,,.:[NQFRHYH0[:FQ13$.13Z0PHHHH **** "BBB@ HHHH ****
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M24M)4L I:2BA,!:***=P"BBD-,!:*2B@5Q:*2B@+BT444#"BDHS2N M%%%,
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MI,T2#'%-QBG9XIN<UBMQH4?-2$8-*.*.O-:IV0PQQ2 9-*3QBF@X-.X"L,4
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M>I0OIBG>H;:X)D'-0ZP^TFJ=C/\ O%YK$L[>U;,0IEW)L6DL3F$55U9RL9H
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MM!G%?2834XZVY8/W:HSU>/2J-QWKU*Z_=F=/<SWZU&2*D<<U V<U\?B?B.R
M'K2GI0.E-[UY\MS="KUI6H(IM..J 2E'6C%)38Q['BF"@T"I3LP' 4K#BE4<
M4IIN5V1(;&,&M2UK-7KQ6E:]J^@RYZHY*C-./I4U01]*F'2ONL(_<.&6XM%%
M(:ZF2(::32FF$UQUIV*2&L:@E/!J1S561^#7B8JKH;011G?FJQ;-/G)+U#7S
MU>KJ=D%H+UJ113%%25YM6K<UL!IC$8I3TJ,YKE<BTAN::>30U*M"9H/ XHHH
M-6M26-)J12,5'B@9S5F;'XYJ5>::!Q3XE.ZN[#4^8QFR>*.KT25%$E746O>P
MU#4YI2T'H.*D I *>*^AP].R.=L44M%%>BMB I,T&D%%Q7%(XJK)'EJMTA44
MQD$<0':I\<48I:5@*TJ9-.C3BIBN: ,4P(3$#VH\H#M4V*,4 0%!4J**:XIR
M=* 'T444 %%%% $4WW:K)WJS-]VJR]Z!6.4\1]6KA[C_ %E=QXAZM7#W/^LI
M)!L-2GFHUJ0<U2!CAR.:;WH)Q3ATHZC ]*1>>M)GG%*>*8K@W7BE[4#D4A/.
M*!@#S3Z90#0*^@M,[TK'FCM0F+81P,5H:7]\?6LTG)Q6GIOWQ0A(]%T7_5#Z
M5MUAZ'_JA6Y4EA1110 444UC@4 ,D< 5E7LP"GFK5Q+@=:P-1N< \U0F<[K$
MV7/-<^6R]:&I3;F/-8X8^93N*]B[_#4+X!J0GY*@))-2#)%Z4W^*@$T=Z:"Q
M)VI!0*1CB@ )YI<<4SK3AFEL Y>M.IO2@&F'0?GBHB?FH=JCR>M(+DPK5TU<
ML*R(LDUN:<AW+0-;';:2GR"MU/NUDZ2G[H9K7'2D"5@)Q6;>SA0>:N3MM%<Y
MJ=SM#<T S(U.ZR6YKE[J3>YJYJ%R2YYK*8DG- QNWG-2KBHZ:6(Z4]P)R:0D
M8J,-Q3-QW55@9*.M(U':E S42$"@4\5$3@T;N*E")6P*52#UJ'<306(K:+T&
MM25L9I,"H=YIR,2:)+0UCH2;<U7G3TJX%.*1H2PZ5Y>(1HC&D2H GS5IRP'=
MTJ(VQ SBO"KZ&B*VSBC9Q5@1-Z4QT([5P<VILEH56'-&T8J1E-1\YJTQ(2BD
M:D% 6L.H7K2=Z?C H(8/35ZTA)-)G%;4W9DWL78<9K1CQBL>-SFK\$A->G1D
M0S10BF2 $U$SD#BE5LCFO7HNZ.:;%3"MFMS3;G# 9KGF8@U:LIBKBMF2CTS3
M)]P'-;0.17(:)<9VY-=2CY%9RE8T2'RGBLZ8\FK<K?+6?(V37AXVHG<Z*:*T
MG-14Z4U&#Q7Q^,>IU1 XIE&>:<1Q7EO<Z(C:>M,I0:<M44R2FOBESQ41)S3I
MD,DCZU;1>*IIUJ_",K7?3B[&<W9#2O%1,*LL*@E&!6DHDQ9 ?:@4#FFL<&N:
M9JF.-( *"?EIBGFN.2&/-**:QI5J!@13<\T\U"YKJP[]X.A>MVK4A/%8UH:U
MH37U.$D<%5:EM:E%1)4HKZ;";'+(=1117HD"4TTM--<U1C1&YXK/N#UJ[*<"
MLNX;FOF\PE8ZJ2U*;_>IE.;K25\Q6E<[XH44T]:,TX#-<$F7L(1Q2+UI_:FG
MBLKZB0C&G+S4=*#5#L24AH/2D!YI)$M:"XI4'S4UCBI8ADUZF%6QBW8T+<=*
MT(QQ5"W%7UX%?7Y<MCDJ[DO:H9!4R]*8XKU,9&\#".C,Z9<UGR)S6K.O%4&7
MFOAL=!\QW4WH5=M,QS4[#%1D<5X[B[G3%B'[M-6FDTF:EIE)Z#S2K2+R*3.#
M4J+8KDM,<4XGBFCFMJ<&2V- HIY%)BNN-&X<PF*<HSUI0I-*5(INB)R&,.:,
M#%."DBF-G.*ATA7 =:<:9TJ1>>M9NE8I,0=*;WI7.*;FL90+3'D<5'2YIC5F
M4D.IV*8M2+5PL# #FAN*<1@5&32E:XEJ/'(IA'- -.QQ4WL&PRBB@UM"5A20
M]#AA6G;MQ64O6K\#=*]K!5$<U1&I&<U-5>(\"I^U?349W@<4EJ12=*H35=D-
M5)Q\N:\S%LU@C/D%1"GN>341.*^:Q9VP6@IZT_M31R*4'G%<$=S0!UH;BE/2
MHS3>XT/'2FGK1FDH0Q:<.:11FGXQ2DQ,B;(-**<P&*BSS6^'U9)=MNM:T72L
M>W/-:T!XKZ7!G%6W+!^[5*:KI^[5&>O3Q'\,RI[E*6H.*E<\U QKX_$_$=D$
M(>M.%(.12 \UYTS?H/IAZTI--IP0T.'2F@<TH-*>E-@(PH6@<T'BIN'D/IKG
MBC/%,ZFE%79+)(.O-:EOVK,08K2M3D5]!ERU1R5#2BZ5,*ACZ5,*^[PC]TX9
M;BTAHI":ZI2LA"&HR:5CQ4#-S7E8BH:10DC 5G3R\U+=2X%9CR%J^>Q=70Z(
M0'.0:C'6F[CFG'@5\W6JOF.J"T)!1FHT:E8\URR;9HD/IK"C/%)G)J1H9BC%
M/84*.*=RKC:5>M(1S2=*T3![$N!28%(IS2,3FK2;,&2Q\G%7(X^,U4@!+5J1
M)\HKWLNI-G-.5F/A6K:BHHUQ4XKZ>A2L<\F. IPI!2UZL(V1D+1116R$-[TH
MHQ2T"2"BBBF,**** "BBB@ HHHH 0C- &*6B@ HHHH **** (;@X6JL1R34\
MIRM0QC&: .3\2'#&N)GY>NV\2#):N&N#B3% #D%2[<5"AXJ93F@&&W--SSBE
M8XI/>FA;"D<9IHYI<YXI.E,&+G%'O3":4-VIB8O4TC?+2].::QS2 >@W4K#
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M%"T^BEKWHP2.=L6BBEKIB(****T$%%%% !1110 4444 %%%% !1110 4444
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M,:>QS3HH\D4GL!:M(-S#BNGT^TZ'%9^G6F2#BNKLK;"CBJB7$M6<& .*T1&
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M (!S5^UCW,*I]>E:>GCYAFD]A'3Z7"-HXKI;>'"CBL;2TX%=)"N$%$66ARC
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MG%6W+!Z52G%7>U5+CI7J5W^[,J;U,J7K4:^]32#FH&X-?'XE^\=L-@(YI>U
MZ4WO7G2-T*M#=:4BFTXZ@.'2D[T@ZTXCBA@.&*:>M"TU\YJ;$L<*<>E(OW::
M:TBA10A-&ZF/2)FK;LBR0GBF)]ZG45+D,>W2A:;25#%8=WI3TH[4T]:%J Y*
M&IM!K1/H'43-*O)J,]:>E92*:T)<4F!3NU,;K4Q1 =Z>>E-[4W/-=M!ZDR+5
MNW-:,1K*A.#6E"U?082H<U1%Y#Q4HJ%#Q4HKZ7#SNCBD/HI!3J].&QFQO>G4
MWO3JL2"BBB@84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MVA]*4VA]*\R56S.B)B?9SGI3C;G'2MD6?M2_8\=J7MC2QB+;D=J?]G/I6O\
M9,]J>+3CI3=4&M#'\GC&*:+<YZ5M&R.<XH^R>U1[6Q+6ABM;D]J?' 16L;3'
M:GI:9/2MJ5;4R:*,5N?2IY(24Z5JQ6?'2GM9''2O557W1-'*7%N0:GLX#D5K
M7%D3VI;:UVD<5Y6*JZ#BC0T].@KH(D(05EV4."#6TN-@KPZDM3:  9IV<"FJ
M:&/-97-1&'>F8S4N>*:!S63&*ORT[&XTTC-21\'FNN@C)EJW7I6I$.*H05HQ
M]*^LRU''69,*"*44M?3P6AQL;BEHI*4@0C=*S[D=:T&Z52GZ5YV*V-Z3U,B<
M54VX-7IEYJLPKY''K4[X,5*<:8O%/KYZ>YK<85I,9IY(Q31UJ^A28Y1BF.N:
MDS2$C%3%ZDLA7[U78!BJ@'S9JW"U>KA78QD7X^14I/%11'BGN>*]B,O=.=[E
M68U0D.35R=N*H,>:\S$NYT4T.04\TU:<W2O(J;FPT')I^*C4?-4I/%9 R,BF
M5)FF'K6T=AH2DQFEH4XJ)(H<!2JOS49S4J=:Z\(O>.>;+EOT%:,8XJC;K6@O
M05]C@?A.*;$>JTIXJP[8%4IGK3%R]T*:*<IYJLW-2RMFHAP:^4Q#U.U(!P*8
M1DYIQYH!Q7G5&:V CY:15P:?VH!KG 8U-[4YJ2M(Z%H9CFG@9HIRBJD#8W%&
M*<PYI0>U*.HKC0*=2XI0,UZ%&GH)LFB3(J3R^:EMU^6I=GS5Z5+#WU.64]2)
M(ZE$>:F6/BI$2O3HX<QE.Y (J41<U:VBEVBN^-#0RYROLXHV58VTPBL:M"R!
M2*SKQ5*8<5H/TJE-7@8JG8Z*;,\C#4AYI\IYJ-:\6JK'7$7H*;CG-.-+VKG2
M*8=13<8IPX-#&M(C&XI*>#Q33UJ7N-"4N,TE.6A[ +CY:A"_O*LXR*AR-]:4
M/B,V:%OVK1B'%9UMVK2CZ5]9@O@.*JQS_=K.N.:T7Z5GS=:K%;$4]RCC!IK<
MU(YR:CZ5\SB3T([" <48YIU&:X$4!'%-'%/J,\U0(",TE.!P*;GYJ:&.'%(>
M:4G(H'%#$,QBEH- -;X?<);%FW&36K ,"LNV/-:T1XKZ7!G#6W)^U4[@\5;/
MW:HW%>KB%^[,J>YGR'!J C-2R]:C''6OCL3\1VP&8I0,4$\T[/%>?(W#K3<8
MIR\4,:< $ YIY'%(IIU*0F, IK#)J3-%9MZ@QH'%-(YJ2FGFA,$- S2D8I5X
MI&.36R>@^H =Z4\\4N>*8.M)H-P48I&'-24T\5%G<S;$!XQ1BF]ZDSQ32U*3
M$ S2D8I5XI&/-;W*ZB =Z4\TN>*0=:R8"#B@\T,:53Q46 .V*0#!I.].)XH2
M #S3>E.2AZZJ+LR&A4.&K1MY,\5E!JM6SX:O?PLSFFC<C/%3@U3B?(JRK5]+
MA:NAQS1+2TT&G5ZT)71D%%%%6 4444 %)2T4 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110!%-]VJJ]ZL7!^6JL/4T <MXBZM7$W'^LKM/$OWFKB
M9C\] ""I$'K3$J;M0#&-UI1TI:9WIH QS2M3N,44[DO<:#Q2=Z#UIPIH!".*
M$.*=3&XJ6"8K\]*9MIZX(YIW&:$-D0%:VF_>%9QQBM+3?O"D,] T4_NQ6T.E
M8.D?<%;J=* (YUW+7+ZO;Y!XKK2,BL75(=RFF@/.;Z':QXK./!KHM2AP3Q7/
M3##TP&TM)FG+1L)C@>*3O0>M.[4 D(:04#K0:!#6S0O6G <4F.:$"''I4>.:
MD)R*$%'0:)8^%JO-4V[%,?!%(5[,KQ$AJZ#3;@J1DUAHO-7(I=C#%4AK4]#T
MRYW <UT$1RM</H]U]WFNQM) T8J7N,MT444@(+H?NFKA=:0[FKNKC_5FN.UE
M0=U4F)LXB<8<U$*LW*XD-5N] EJ+SFI.U(!Q1WH !UYH:E-(*& RG+F@CFER
M,4^@[C9.13$4U(O)YJ4**5P2$'"U"YYJ=CA:J9R]"&7;0$M73:?!NQQ7/68&
M177Z0H(%)=@-."T&SI4ALP>U:5O&-M6/)%(##^Q#TI?L?'2MOR%H\E:!)& ;
M+YNE/-G\O2MOR%]*#"*)/0:,%;+VJO<6.>@KI/(45$\"GM7G5T:IG'S6'M5)
MK'YNE=?/;+Z5GRVZ^E?.8N5C>!SWV+VI/L7M6\L"YH>!:\2I4U.F*,+['[4-
M9\=*VO)6CR16'M=35:&(EGSTI_V3GI6SY"^E'DK5>V!F3]D&WI3/L?/2MD1#
M-/,*XJ75):,)[3VJ2*S]JU3",U+'"M:4ZMF2XE.*T]JFDM!MZ5I1Q#%2&-<5
MZD:WNF/4YN2S&>14(M<-P*WIXA4*Q+WKS\34N:(KP1;5Z5/S3P *4XQ7FN5S
M6(RBBB@U%&<TX]*.U(O6I2NR1R^]*/O<4C>U/B&2*[\-'4SFR];CBM"(54MQ
MQ5]!Q7UN71T."K(D%+2"@U]'!:',Q.]+1BBHD@0T]*J3"KAJM*.#7!B5H:TW
MJ9<R\53(P:OS#FJ<M?(8]:GH0V(Z7M35I]?.S6IHD,.<TE2'&*8.M7T-$Q5I
MC9S4M-;%97U)8WM4T&<U /O583 KOPTK&<HE^,\4]CQ4$34YFKU%4T,''4KS
M53;K5R7&VJ@'S5Q5YF\14XIYHXHS7F3U+0F*,T45D,:U-J2HVZUK%E(*:<TM
M.4525P8J"IXQ\U1@<U9A7FO0PD=3FJ%Z!>!5L=*AA'%6*^NP<?=.*;U*\V:S
MIB:TI<8K-GZUAC9V1K3*9SNIK"I#C-(<5\G7G[QUQ&+TYIA^]3B<&EXQ7')F
ME@SQ0M(.M*U0D4#<TVGKTIIZUK$!5'-/Q2#&*>M3-DMC".*CYW5*U(,9ITE=
MD.1(!D4]$I(^M6U45[N$IW(<R6%>*G"4D*\58"U]#A\/<XYSU&A:>%IP%. K
MTZ6'L8MC<48I^**Z?8Z"N1D4QA4N*8U<=:GH-,J2U1G/%:$O2LR<\U\UC(:G
M73*;'YJ2E;K2I7@5XZG9%B@<4WO4E-.*XGN4F(>E-IPZT-5Q&-I*>.E-[U+W
M&)BBGGI2+UI= N2K]RJW/FU/GBHQC?6^'W,FB];]JT8NE9]MU%:"U]7@?A..
MH/?I6?<=ZOG[M49NM/%+0F&Y1YS37]JD?&>*C^M?,XD[XB#I2=Z?2'I7#$H0
MGBA?>D%*?:J&(U-IXZ4WO0@!:5J4CBD%$A(8:0=:5NM. KHP[U!LL6_6M:#.
M*R[;K6M%C%?28,X:VY,?NU1N*OG[M4;@5ZN(7[LRI[F<_6H&]JEEZU&OO7QV
M)7O'; 92C-!QFG=J\^1N!IM.7K0U. #1UIY/% Z4WO0T +3Z**R8@/2H^]24
MUJ2! :;2K0>M:1T&)S14@ Q32*WA"X7!32.,FDS4BC-:^Q,VQNWY::.#4V*C
M; K.5*Q*D!Z4RG*:&ZUD]#6+$%//2D'2D'6IN,0TE/:FU:C<$)12T4<HQR4D
ME*IIK<FB#LR);D>#FK$)P::%XI%X:O4P]6QC,U8)*O1MFLB%ZT87XKW\+7.2
M:+H-/%0J:E%?18>?,CG8ZBBBNU$A1110 4444 %)2T4K %%%%, HHHH ****
M "BBB@ HHHH **** "BBB@"M)R*A3C-3SC"U6C.<T <MXBY+5PER<2UW/B,X
M+5Q$XS)F@!%Z5*AS4:"G]*:"XK'F@4H&::>#0A, >:5C28XI5YIBW #BDSS3
M\8II%%P%)XJ,TY>32LN*:0TB/=BEW4F*!UI;!8<"36KIOWEK,*X%:6F??%2#
M/0=&&8Q6V!@5C:-_JQ6U0,*I7D>]35VHI5W T <+J\&">*Y*[0AC7HNJ6NX,
M<5Q6H08<\4[ 8BD[JEI63::%&:;8APZ4F>:#Q2]LT" ]*1>:.M. Q2 :>#2D
M<4[;01Q3N#(E.33SQ2$8H'-"$A"U-!)-.(YIP2AC:N)C IN\@U+BH7&#0F"9
MO:7<%67FNXTVXW(.:\WLI-K"NNTJZY49H*.T1LK3ZJ6\FY!5H4A)D-Q_JS7'
M:L#EJ[.89C-<OJT7#&F@9PMX,,:HKUK3O5^<UGXP:!( :?VI .*,\XH 0=:4
M\48Q0.:$ ?PU#D[JF/I2;.],! <"I4;(J*E#8I-%"R$U6_BJUC<*A*8-) 7;
M)N177:5)C%<9;MM-=/I4OW>:-A-'<VC905<%9-C+E16JARM#0QU%%%( HHHI
M/8!AIC4\U&W2O/Q#T+15G'!K+E^]6I-TK-G&,U\QC6=,"N3B@'(J,GFDW8KY
M^M*QUP6@\]:<>E(O-.KD<S0:M#4AXH'-/G'YCATI W-(33<XYIWN%AS^U2PU
M"#NJ13BJ4M3.6Q<4TK/Q5??Q3!)DUZ%.I[IGRCW.:KN<&IB:C89KEK2N6B+=
M2YIO\52$<5R&JL-HI**+E#@:?CBD44^G%ZDMC1S4T8Y%0GBK, R17K8579A,
MOVXXJ\G2JT*\5:4<5]?E\-#@J/4?112U[D48B4E+25#W&(:KRU9-0R#BN/$Q
MT+@]3-N!Q6<V2U:DPS5*1 *^0S!:G=!Z%?&*7-*:B)YKYR:]XVB*32=*D R*
M"M-Z(T3&J:8Q.:D I"O-87U$QH%2(>::*<!BNJC*Q!:C;BG,>*BC/%*QKM4]
M#.UV1NW-0OQ4CFH<[C7-4D:10Y#Q03S2=*7&1FN4T0HI:9GFGUDP8QC3:D(I
MG>KBQH2ESBGXXI ,UO!7$WH.0U<A'-4NAK1M1D5[&#IZG)49>BZ5/42#BI>U
M?4896B<<MRK.369.U:DPR#6/<'YL5YV.E=,VIH@W'=2N>*,=Z#S7R->7O'9$
MCSFG TA&*<!Q7/<VZ"]J;2@\TI%7$! :0T45KL *3FI,\4W&**PDS-@3FF@G
M=2TY5YK;#_$0V3QU=A&:JPC)K1A3@5]/@H7,)RLBQ&M3 4U!4@KZG#4[(XY,
M,4M%%=RBD0%,[T^FXJAH*8U24QJY*Z5AHJR]*S+CO6G+T-9EQU-?+XW1G72*
M'\5.Z4C#!IR\U\WB-SM30N>*83\U*W%&.]<+W*:%[4W-.'/%##%5$:&YI*>!
MQ33UJ>HPS244H&:'L [^&H03YE3XXJ,+\]:X=^\9R-"W[5H1\UGVU:48XKZO
M!? <=5CF^[6=<=ZT7^[6?/R:K%;&=/<HYR::_%/88-,ZU\SB3T(B \4F>:?B
MDQ7 BKB$8% YIQ&:8>*JX(":;3P,BFXYIH8X<TC<4I&!0.:&!'3A01@TM;X?
M<4D3V_6M: \5EVPR:UHA@5]+@SAK;D_:J=P.*N'[M4K@\5ZF(3]F8T]S-DZU
M W%32GFH@,U\=B5[QW0&4H-!'-.Q@5P2-P/%-IPYH88IP 0&E(XI5%+CBE(3
M8U30U.QBC&:D+C1TIO>I,4TC%2-"'BDI1S01S6D%J Y:60?+2J.*7[W%>E1I
MW,Y,KH"35E%-/CAYJTL/%>@J%T8RF4V!Q5=LYK2>.JDL>!7/6HV0*16SBGKR
M*:!DU*!BO)JQLS9,9WI:7'-+6%]2[D>::3S4A&*;BNB!28#I12T&G) -IX&:
M:!FI!Q7.W9B84U^!3J:_2NBE4LS"2%B?FM&"2LE3@UH6[<5[>'JV9BXFM&V1
M5A36=%)SBKZ'BOJ<%4NCDFM22EI*6O9B[F044450!1110 4444 %%%%+J 44
M44P"BBB@ HHHH **** "BBB@ HHHH BG&5JHJX)JU.<+5:,[B: .3\1+DFN*
MN.'KN/$0P37$7/\ K* (P<5(/FJ-1FI,;:: "=M&,C-&-U&<<4 )GM2]*7;W
MH(S3)V8 YII/-'2E II '2C.:7&:3&VIN"V&GK3@O&:,9YI<]J"D,9NU:&F-
M\X^M9SKWK0TI<N/K32T$>C:(<QBMRL31!B,5MU(PI".*6B@#,O8=R-7$ZM!M
M9CBO0ITW(:Y75;3=NXJD!P<@^<BHV^6M"\M_*8FL\G<:0GL)G-&ZD(Q2A<TR
M0!IX.:3;1TICW%+8IPIN,\T9P<4F#''FF'BG$\4WK2$ARC/-.Z4T'%+FF-C6
M.*B)S4AYINW% D.BDV.*Z/2KCYAS7,A><U?LKGRW'- STRPFW*O-:H/%<=I-
M_G:,UU5O+O44@)W^X:Y_54RAKH2,K63J<7[HF@&CSK4EVLU9 ;)K<U=?F:L1
M5YIH2%W=J=CO2;.:D R,4 ,SFCI3RFT5$QS0QAFG*<TRG@8YH>PQ)/E%0JV3
M4[?/Q4>S;2N#)%;M2LO&:C6GELBFT D9P:V].FVD<UA#@U=MIMK"DP1Z'ILF
MY1S6]$?EKAM+O\8&:ZVTN-Z#F@9HT4U3D4ZD 4444GL PTQA4AIC5Q5XZ%(J
MS#BLR;DXK6E'RUESK@YKYG&PN=5(HR#%,49J5OF-"KBOFJ\;,ZDQ@;!Q3\\4
M&/O3">U<,EJ:QU G- .*;3PN:=BQII.M.(I,8K2*9+ '%2J<BH:C>?8.M4HN
MY,D6"_.*0G'-9K7?S=:EBN/,.,UV)-(1?1MU#G%-C&!0YS7/50TM1G>GYXIH
MZTK# KG+LAK'% --ZTH%)E]"16IY.!3%6I,9%.&YE(9G)JY;]JID8-7[5,XK
MW<'&YSU7H:4/2K*U!&,"IUK[# K0X)@33E.:0BE Q7K(CH%%%%2T AJ-^E24
MQA7+73<1HH3C%4)&R:TYUR*RYAM)KY+'QU.RFRNYQ474T\_-2A*^<J*TCK@T
M"FGFF[<49K&>Q=A:C+<U)32F>:P0@SQ0K9-+CC%- P:UIL5BS'THD-,1N*:[
M5TJ>A*CJ,+9.*3&.:4+SFE(XKGG,M"#FD)QQ1TI<9YJ5J4 %.IH-.J9"8TFF
M9IY%,Z4XC0[=2BF4]>:ZZ*N*6B#JU:-JV *I+'S6C;1\5[^#@<=1EY.E/--0
M<4\U[].+43D>Y4G;BLF?KFM2XK*F/.*\?';,WID&[G%+FDV\YI<9KY&M\1V1
M <TA.*7I1C-9&HT=:=G--I16T1BTE+25J]A &IU-"XIXYKFGN9L8:<C<XI&%
M"#YJZ<-N9-FC M:$705GV[5HQ]*^KP!SU2PM/IBT^OJ:#5CD84&BBNJY(4S=
MS3Z85YHN-"YXIC&G&HG.*\W$SL7%%>9NM9LYJ],:SYJ^8QM2YV4T5"<FE!Q3
M3P:<.:^=Q$M3L5AW6DSVIP'%)CFN)/4H,8YI"<T_'%,(Q6D009IM.QFD[TGN
M,2E!Q2D<4@&:.@$HY6J^[]YBIP<+BH]GSYK6A:YBV7K8]*THCD5FVXK3B&!7
MUF!^$Y*@Y^E9TYQFM%^E9\XS1BMB:>Y1)R::W%/(P:8W-?-8D[X@#Q2;N:4#
MBDQCFN!%#B>*;UHSFCI5 )G%)GFG8S3>]-#0[.:<!BD"XIU*0F-85%NYJ1C3
M-O.:Z,,M1="U;'!K5A.165;#)K6A&!7TN#.*MN3G[M4;BKQ^[5&XKU<1_#,J
M>YG2#)J$G;4TIP:A^]7QV)OS';!C<Y-.!S3<<T[&*\^1N+TI"<TO6D(Q3@ H
M:G$\4T#O1GM1(0 YI2<4**",U*W#2XO:HR:=TXI"O>CE&AH.*<#FD"YIX3%=
M%*&I,G9B@\5)$,M3DAS5F&#!KW<+1,)S1+%'TJR(\"EC3 J8+7LT\.<DIE.2
M/C-9UQ6S(N5K.FAS7)BJ%D73D9><&GJ<T^2+%0YVFOG,3"QTQ9+2$XIRC(I"
M*\SJ;)D><TM(1BE%=$"@/2F9YI])LQ5R8T .*>#Q3 ,TO2N66XF(6YH8\4;<
MG-.VY%5%ZF<D-09-6$?;4(&VESFO6P\]3.Q?@?+5JQ'Y16%;O\];,+?**^GP
M%4Y*L2R*<*8#3A7T%*=SF:'4445TB"BBB@ HHI*3 6BDHI7 6BDI:: ****8
M!1110 4444 %%%% !1110!#.,K56(8)JY+]VJH[T <MXB.2U<)<M^\KM_$+8
M+5PMR,RT .0U(3NJ)1Q4J\4T  XI.^:5AFBA"8H;B@G%,Z4X\T["W$ZTH-*!
MQ32.::8#\TTG-&<B@#%*P+8 <48[TT\FGYXI#0UCD8K1TOY7'UK-QS6GIXRP
MH3&>AZ*<QCZ5MUAZ&,1BMRA@%%%%(!&&161?P90G%;%5KM-T9II@>=ZK!DMQ
M7..OEL:[C4[7ECBN0U&':33>XBEG<:F7I4$8Q5@=*&A-",=M,#;C22GBF1<&
M@"RO"U$WWJG RM0-]ZC<8N<T#BD Q2GFA" C-&>U*.E-QS0P%'%!YI32#B@!
M"<"FHV'S2L,U'THN*YTFCS_..:[FPF^4<UYKIDVQQS7;:==9"\TAHZI&R*JZ
M@NZ$_2GV\F5I]P-\=#*/.M8@PS'%<[C!KM]9M<AN*X^XC\LFGT)L5]U.4XYJ
M GFI >*0B1WR*@I30!FF]BD.5:">,4X<"HVZTM0L*IP:5CFF44(89HIVVFT-
M@%.1L&DQ3>]%P-BQF*N#FNPTV\X S7!6\NTBMZPN]I'-.P'H$4V5'-65;-<[
M:7P8#FM6&Y![T@+]%,5\BG9I !IAIYIIKFK*Z&B"0<5FW SFM1QQ5"=<<U\_
MC*9TTF9;?*: ^:6?VJN&Q7S>(I7.N):W<8J%AWI U#2#%>9.FTS9:"4\-@5#
MOQ4;S"B,+CW)7DQ4#W0'>JLUR .M9DUW@]:Z(4P-<W@'>J5Q=9[UEM>>]5I+
MOCK6T:3$V7&NLOC-:%C+EA7,B;,O6MW3GR16\H61)TZ-E10:CA^Z*>>M<-0I
M#@.]*_(IP^[49ZUS6&M2/H:>O--84].!6<BWL/![4_-1=\T[.>*NDKLSD+]X
MUI6@PHJ@B\UI6PXKZ3!1.2J7DJ85$E3"OKL''0XI"T445Z) E%%%0QA3#3Z:
M:QK+0:*TO2LJY&<UK2CBLV9>M?+YA$Z:3,[[IJ0'(ILHYI%/&*^8KQU.N(I;
MM2 4F#G-2=JY)[&J8E.!XIM+BN<&(33>M*:0<5I :%'%)UYH/-*#@5K<! :4
MFFXYI2.*P>X"=:4' Q0HH(YJHO48F.]*#1VH HEJ I--QFE84#I2B(93TIG>
MGJ*]'#QNR)%J/DUI0<"L^$5HPBOH\'$XZC+*TX]*1>E*:]^,;1.;J4;GO63,
M/FK8N%SFLN9:^?S#J=%-E;=VI>E-QAJ"<U\C67O'; .M+GM2J*0CFL303%%.
MSQ3<8K2# 6DHHK7H N[-.'%,"G-28XK">YFT-:D5N:4BF ?-6U!V9FT7H#S6
MG"W%94-:$38KZG U+&%1%X&G@U"C9IX-?1T:VARM$F:7-,S1FNI5M";#LTA-
M-S32:SG7L@L*S5 [9I7>JS2XKRL3B-#:$2*9L52D-33/DU69NU?-XJK<ZH(@
M;K2J<4NWFC;7B5)79U)#\TF>:!TI,<UB@'YXIK'-.QQ3",5M#8$*#Q3>]&*2
MI>Y0_.12=*!Q2MS28@I0>: .*0#YJUH?$9R2+MN>16E&>*S(!6E$.*^MP/PG
M'4)&Z51G&.:O-5*X^Z:,5L33W,YSDXIG2G$8:FOS7S6).^(9I"<\4 <4F.:X
M$4*.*#S2D<4@XJP#.!BF]Z4C-)0AHD!S03BFCBD/-#%80GFEIN,4HKHP^X2+
M5L<-6M"<BLBW&36K ,"OI,&<-;<LG[M4;G@9J]VJE=<K7J8A_NS&&YD2MDTQ
M3BG./F-,QFOD,5\1WP6@_&>:,]J!P,4F.:\Z1JA1Q2$YI>M-QBG 8X'BDQWH
M YIQ'%$F(4&@G%,'%*>:4=PL(3S3LY%,IP&*TL-B_=J6,;C4>-U6(%QUKLP\
M+LQFRU$E6XTJ*):M(.*^FP5*YQ5)#@*?B@"G8KWZ=*R,&R)QQ5245>8<55E2
MN+%T;HN#,R850D'S5IS)5"1.:^6QE$ZH,5#\M!-- P*"<U\_.+4CIB(3FDHQ
MBE S6D=#0,TXG(IE.4428,3I0>:5A2#BL6 H.*=G%1XYIQY%$5J)H0G- I ,
M4M>A2E8EK0DBX?-;$#_**QHS@UHV[U[N$JV.6K$TU-2 U71LBIE-?1X:M<XV
MB04M-%.KU8.Z,PHHHJP"DI:2DP"BBBI&+1115B"BBB@ HHHH **** "BBB@
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M0E&:*2G(9(*4U&#3F-8O<FPHI<#%-4T$\U4-P$QS2G@4O:F$UHQ[CAS32.:
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MO4H4]"+DB*2:M+'\M-B2K:+Q7I0I:&-295\OFHIHZT2G%02**B=$A3N99&*
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M94U0B;.*NQFOJ<%(Y*B+ I:8#3Z^AIRNC!A1116HA**6DJ>H"T4450!1110
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MHC I]% " 8I:** "BBB@ HHHH **** "BBB@ HHHH 3%!%+10 S8*4H*=10
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MH **** (+G[E5K;[]3S'*U%;KAJI+0"\.E%%%2 4444 %%%% !1110 4444
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MYI:*8PHHHH 2BEI*E[@+1115 %%%% !1110 44E%2V M%%)FG<!:3%&:6G<
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M3>:2FGK1N"W$+'-*6XHQQ333#<4,:1FIIH%)AU%W4T,<T4N*&&X%C3=U%,-
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M44 %%%% !1110 4444 %%%%*P!1113 04M%%) %%%%, HHHH **** "BBB@
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M0 4444 %%%% !1110!6F.5J.W7#5),,+4=NV6H NT444 %%%% !2'I2TAZ4
M1$Y.*.E+C!S2=: &DYHI2,4AX% ",<"F?>H)SQ0!MH "=M,8TK'--/2J0# W
M-*QQ3<8-'6@ QD5 S8;%3YP*@89:BX"DX%"MF@CBF?=HZ *[8J(\FI"-U1G@
MU(!36.#2DXIGWJ: >IS3&;G%&<4A7/- #<TI.:;10P&EL&ESQ32O>DSVI] &
MLV: <4I6DQFBV@",<U$34K"H]O-) -Z4A.:D*\5&5Q0MQ(;NP*83WJ3;FF%:
M?4GJ-W9HW8HVXHVYI]1]0SFFE^U.Q@4QEJ7N"W$SBFL<T[&::RXIL'N,W8I2
M>*-N:".*&#(]V:-V*-N*0C-'0.@$TS=S3J;M[T(?0,XI.M+C-)TH$MAA..*C
M)J4KGFHRM(2$W9I:3;BEIL&&VC':C=VI"<<T,;$9<5&13R^:B9L4T/<#3&&.
M:-](7W<4GH+8;NS1NQ2;<4NW-/H'0,YIA-/QVI"O&:&#&9Q1G-(1FE Q2#H-
M)HIVWO2X[4 -ZTQN*?C%-(S0#T&49IV*7;B@")N*;UJ1AFF@8I@]!N>U'3FG
M;>]!%)@-ZT=*<%Q05S20=1N.]-+=JDQQ497!I]1=0!Q3NM- S3NE'4IC2W:@
M&@KGF@"@2'=:7.*0<4N,T(:&9^:GYR*9CFI%6D-D3#!K8TQ,LM9;+DUNZ2G*
MT6$CK=/&(Q4NHOB+\*2U7;$#5;4I,H10%CC=7DRS5A[^:U]4^\:QPN32&7(#
MR*Z/1QEQ7.6JY?%=9HT&"#5"1TT3;(_PK%U67*M6O)\J5SFIR<,*G89R]S)N
MG(K5TF'+@XK*=,SY]ZZ+1HLLM.P'5V"[8_PK-U:?&X5KPKLB_"N?U8Y<T@,1
M1NN<^]=7HXQMKFK:/=/^-=?ID.U0:8DQ^I2;5-<=J+Y)KJ]7.%-<7J$G)%%K
MB9B3M\]1%MM.EY>FE=U(HB9\FKUHNX@52,>&K:TVWW%3BBPD:-O8[E!Q5I=/
MSVK5LK7* 8K32QXZ4#.8;3\#I5"XL]H)Q7;O8Y'2LR[L/E/% 6.#N$VDBJ1.
MTUT5_8[23BL.6'YC18+#%?-#4@3::?M^7- 6$@;:^:ZS1;C)49KCT/SXKI-'
M;:PH$CT.R?*BK]96F-N45JT#"BBB@ HII-1/+@=: )LT9J@UV >M,^V =Z!7
M- M2[JS#>#UI!?#.,T!<U<TM9PNACK4R7&>]($RW140DS4@.13'<6BBB@ HH
MHH KW)PE<EK$V U=3>MA#7%ZNV[=0(Y>\DW,:JKUJ2Z^]42=:!CYCA*2S^=_
MQI91N6I].A^<4R=V=9HT>-M=G:#$8KE]*CP%KIH&VI2L46Z:S8JM)<;1UJF]
MZ,]:&A,U5:G9K'6_P<9JPEV&'6D*YHT56CFW=ZL TRA:*** "BBB@ HHHH *
M**0F@!:,U$TF*A>X [T!<LEJ3=6?)=@=ZC%Z#WI"N:H/%+FLU;P>M.^UC'6@
M&:.:*STNPQZU:23/>F,FHI <TM !1110 4444 %-8X4TA;%4KJYV*>::0&=J
MEWL5AFN&U*YRYYK=U6ZW;N:Y"[DW.:$!5DDWDU)",&H0O-685Y%-BV-C3%S,
MM>AZ<H\A:X#3?ED6NYL9PL*\TK#-=1BG9JE]I'K3&NP.]%@+V[FG#I5*.?<>
MM6T;BA@/I#2U$[8I"9)VJ*1 XJ W&#C-/$X(ZTP(C;#/2D^S#/2I'F'K3!<C
M/6BPRQ'$%%3 5'&^X5+0 4444@"BBFL<"@!U&:KF;'>HFN0.] %S-(36>UV!
MWIOVP'O2$:(:G9K+-Z%[TY+P-WIL&:6:6J(NAZU)YXQUH&6J*ACDW5-0 444
M4 %%,=L5"9L=Z +.:3(JDUUCO437H'>@#1+4!JRC? ]Z!?#UH U-W-.S66+S
MOFI8[L,>M &A157S_>I4?(H EHIF[FGT %%%% !1110 4444 %%%% !1110
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M$XJ_4$XRA%(#C-3C'/%<M<IM8UVFIPGDUR&H\$TT!F,<FG9^7%1CDTIXHMJ
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MJ )'-;,%R''6O/[.\/'-=)87G3F@:T.E#TX&JL+[Q5I>E "T444 %%%(3@4
M#'%0238'6H[BX"#K6-=:FJYYH M7-\$/6LV74QZUD7FH;R<-65+=DGK1:XFC
M>EU,>M0KJ>#]ZN<DN&]:B%PWK0"V.O74O>G'4QC&ZN42Z..M.^T-ZTF#.L@U
M'YNM:]M?AL<UP4-R0>M:MK?;2,FF,[V&;<*G#9K L+T,HYK7BE#4"1:HI!TH
M)Q0,"<"HVDJ*:X""LV6_53UH$R]/<!!UK!OKO(/-,O-3!'6L.XO<@\U2=D,J
MZA<9)&:PG^:3-6KN4LYYJLO6D@#9Q4B'::>!Q4+_ 'J -BSDP0:Z"WU *@&:
MY&";:O6K*W)!ZT"1UAU(#O49U'<>M<TURQ'6FBZ*GDT[V0SM+6^!(&:VX)MR
MBN"L;HM(.:[*P):,&D!K!LBLR^NQ%GFKV=JUR^N3D,<&A .DU(;NM"ZL.FZN
M4FO"#C-0K=-GK38'82:H/[U,34 S#FN3DNV]:EM;LEAS0F!Z#9W88#FM1&W+
MFN5TQBX!S72P?<%#0%BBBD)P*D )P*J3S[1UI+BZ" \UBWFH 9YH GGO@F>:
MH2:B/6LB[OMV<&LQ[P^M KZF])J@!^]4?]J@?Q5S3SLS=:C:5\=:!G3MJH8_
M>J:+4\=ZX]9F!Y-3I<-ZTF)G9IJ(/>K U $=:XZ.[([U86]/K3&CM[.\#'K6
MM')N%</I][R.:ZJRFWJ.: -,4UFP*3=A<U3NKD(IYH 2XN ,\UES7X4]:J7N
MH@9YK"N+_+=: -R74,#.:HR:IS]ZL:2\)7K5!IF+=:0D=$=4Q_%2C4\_Q5S$
MDK>M"3MZTQG6KJ8/&ZK4%_SG-<:D[ YS5R.\QWH [(:@#WK1M[L,.M<,E]CO
M6E:ZH!@;J .R27)JRIS6!:7PD(YK9A;<!0!8HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH K7!^6H+8_/4D^=M1VOWJ - =**** "BBB@!":,\5&^<TX?=
MH 1JCQ3AG-#=* &TG%+VJ(YW4 2]JC?%.)^6HCF@!***1NE.X#7(Q34/K33G
M-&<46 <]1,W%.)R*A.=U(!1UI6]J4C IJ^]5Y@*O3FHFZT]^O%1MTI=0 $9I
M348SFE<^E# 0]:7(Q2#I33G- D-[T4&D%/H%]0XHIC9S3OX:0#7Q35I#G-%%
MABM4;8Q3CTJ/G-" !UH;FE;I35]Z+B8< 5&>M*V<T=J9(AZ4G%%,;-&X)ZB-
MUI>U '%,.<T,>[$I#2FFT V(:;WH/6E/2@-A&-,HYS2&@%L(:::4FF=Z0(44
M&E- I@)QBHSUIS9S3:5P0&FDTM,-/<6X=Z4GB@=*8>M P)IA-*::>E-@V.R,
M4TTPDYI2>*3!B,: :;2'-'0&M!6II-+VJ+G-.P^@^FM0:!2%?0.U)WI#UIQZ
M4K@(<4REIIIK8>PG>EXIIIHSFA"0XFF$T.::*$)$G:F@<T@ZTYNE%QO00XI1
MTIG-+S1T!;"XYIQZ4=J:.M%P'+[T[BFGVH!XH![ >E(O6D[TX]*$&P[BD.*1
M32'.:0=1-O-.;[O%&.*2BPTR>T&6&:[/1T&T5R%JF6&*[71T.P9II#-F4A;?
M\*X[6I?O<UU=V^V UPVM29+8H2 PW;+&F?Q4Q"2U2HI+BD]Q&MI*9F6O0+ !
M8E^E<9I,7S+Q7:6H*QB@"+4G 0YK@=6<&4XKL=8E(5JX._DW3?C0T,ETY=UP
M*[_2XP$7BN'TJ,F4&N\L1MC7Z4@&ZF<*<5RTYW3?C72ZDW!S7-2?-.,>M/H!
ML:9'\P-=(IVQ#Z5BZ;%\H-:[G;'0A7.;UV3[U<?<')KH]?DY-<PYR*&,KG&:
M>AJ YWU(#2 N1#<PKI])C^[7-V8RPKK=)3[M6D!U%FF$%7QTJ"U7$8JQ4 %1
M2=#4M0S'"&F@,/5=OE&N!U-OG:NSU>7Y6KA=2?<QIL"I'S2.<&DAZ4R7.ZD)
M;CXSEJW]+'S"N=ASNKIM(0Y%%@1V^E#Y16P3A<UE:<-JBKD\P6,\T-!<BNKD
M*O6N<U"^VYYIU_>X8\UR^I7A.<&A 6)KXMG!K-GN"3UJHL['J:8[DFA@.,AS
MUIK/FF&D%2*VI,C<4QS3<T4QW&[C4\4I!ZU'MHP10%C3ANB&'-=!I][T&:X]
M9-IJ_9W1$@YH!'I-G<!@.:U4<,*X_3;K('-=+:R;@*!EZF2G"4^H;@XC- &#
MJLGRFN'U*3YC76:I)]ZN*U-\L<4TA,H_>IIP*?",K4;YWT):C+5K]^MZV95
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M?//K2QW+B0#-5%;UJ2(9F6@#L]'D=BO-=I:YV"N/T-.%KM;=<1B@"?M1110
M4444 %%%% !1110 4444 %%%% !1110!6N!\M06WWZFE.138!AJ +@Z4444
M%%%% #2*7'%,8X-*#\M #6XI%YI">:0'% #FJ,@4\FHB><4 (.M*X%+C S3"
M<T -HIC'!IP/%4]@&N!BHN].8\TE) )28&:7M4>[YJ-P),<5$_%/8_+4).30
M!(O(J-AS2AL4QC2 :>*1>>M(#DTK<4[@!ZTN.*!R*:Q[4 ,/6B@T T=!=1"!
M3,\T,W-';-"!@P&*CIQ--H0PII%./2H\\T  ZT-Q2D8%1DYHW <!D4TT9I&/
M%.PDA#2  TP-DTI;%/J+J.(IC8Q2YXJ)FYI,743O0:*2BXV(:;WIK-S1GBA
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M:?;'>O% '3:-&0%XKKX1^[%8.EV^U <5T"#"T .HHHH **** "BBB@ HHHH
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M"]4D<UY_97C#&36O!?'>.:3"^IWL,H9>*GK"T^\#(,FMA)012:&2T4@.:6D
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %.?.VH[7[U3W ^6H+;
M[] &A10.E% !1110!$],J9A41H 3-,>GTA&: &+[TG>@\&G8XS0 'I45.+4V
MG8"-NM+VIQ%,SS3 8<YJ-ZG(XS41&:2 :IXJ-R<TX\&EQD4P(J7ZTH'-.<8H
M>X%=NM.[4N,TN*&!$.M*W2E88I%YJ0(Z7-*XP:;0 U^E,'-2$9I",4">Q&>*
M2GD4T=::!,3)I*D8<5'0,#TJ)B:D/6D(XH6@KD5)2]Z2J8R)B<TO:GE13:&2
MR(YIIJ1A3*+CW0RG"DIW:D2AC]*CJ4U&1215QA-+GBC%(O6GL+86F/4Q'%1D
M9HN-#.U,/6G'@T$<4"V&&BG 4C<4!U(F)S2]J=C-(:;!C!S37IYXI ,T@9&!
MQ2&GFFF@&M"-JCJ8BHV%"W!,9DTIZ48I%ZTPV 4&GL,"F#FD T]*;WIYI","
M@$-- Z4#F@\4@&,3FCM3\9%,-,$)G-,:GFDQFC8:&XXI!UI]-/% A#2@<4+S
M3L4 ]AF>:4]*"*0<F@-P%!XI^,4A%%PV8E--*.M.(XH&D1T&G**0]:;8#.]+
M3\<4@'-)"!*20XIQXIC<T"2$@YDKKM$C)9:Y6S7,X%=UHT. II ]#;/R1_A7
M-ZO-PU=/.,1_A7&ZS)\Q% [Z',739E-1I3YN7S21]:8F:%HFYA7<:,F(A]*Y
M&PCRRUV^EIB'\*0#[YL0FN*U.3YFKL-1;$9KB-3;YFH&D9Z9,@^M=AHR'RQ7
M)6:[Y!]:[K2(<0CCM0)[EN9L15S]Z^2:WKT[8C7,3/ND(]ZIC9<TU-S"NJMA
MMAK TF/.*Z4+MA/TI!U,/59/D-<3>-F1JZO5Y/O"N.NV^<T;@T5R:C+8I\?(
MJ*7AJ MH/5LFG.A(IL0R:TH+??CBBP6,^*!O2I'1E7I6Y'8<=*@N;3:AXH;!
M& &(>IBQ(IKIB:GL/EHN/<8IJU$N:KJ*M08W"ALDUM-MP9!Q7::?; *.*YK2
MU&X5V-F!M%(:19$ ]*DV[13Q39/NT#9EZFW[HUP.K-EFKMM4D^0UP>J/EFID
M[F,>M'\-/09I&%%[%)$(R6K5T],L*ST7FMW28LL*&)[G8:-%\HR*Z&,8%9>E
MQ[5%:ZCBD-CJ***0PJ*?_5FI:AG/R&@#E=7;AJX?4'^8UVNM$!6KAKP[G--,
M&01<BAQ21\5*1\M#$A+8?/75:63Q7,6P_>5U.FC % S;,F(C7,ZI)\QKH7.(
MC]*Y34W_ 'A%.Q-C(8DR&D;@4['S4CT;BW$C&6%='I,9W+7/0#,@^M=EH\(*
MJ<46"QU%BF(UK4'052M5P@JZ.E#*%HHHJ1B&L;5&PIK7D.!6!JK_ "FF)['&
M:JV7-8;YS6KJ;YD-9I (H;!$(&*E0YJ,BG)U%#&:EFI+"NGMCMA%8>G1;@#B
MMW&R&BX&;JTO[LURKG+&MW59.#6$G)I"2&]J0=:>_%-'6JW!ERU3YA76Z1'T
MKF+!<N*[+2H\!:5AG16HPM7!TJO;K\M6: "BBBD R0_(:Y[56^0UORGY37.Z
MLP\LT["N<3J7WFK,3WK0OCEVK.S@T@N-<<T@J7&1FF ?-0"1LZ.3Y@KT#3/N
MBN"TA?G%=]I8^04#-"<XB-<?JLGS-75W;8B-<1JTN&:F*YSFHGDXJG;U-<MO
M8U'&,46&+(>U+:)F6FOR:M6"9E%/8#K=%0_+78VRX45SNC0\+73QK@4,2)**
M**D84444 03G"&N3UB3Y6KJKLXA-</J\OS,,TTA,Y2_;+FJT6:EO#EC1;+E:
M=PN,?I2V:DS42_>Q5O3XP911<-SL-#CP%K<N3B(_2L_1HL*M6]2?9&WTI CB
M-8D_?&L)^6K4U9\S&LQ>6IL!T?%*S<TK# J/.6I;@D:%BF9!7<Z3&=JUR6E1
M;I%KO=-A C6AC-:,845)2*,"EI %%%% !1110 4444 %4+R/<AJ_4<B;E- F
M<%JMN<GBN5O(2I/%>DZC9AE)Q7(W]D=QXH&<Q&2#S4PD-/G@*$\5 * W)6Y6
MJXSNJ4')Q2E>,U2)N2Q2%:MQ7)##FJ"4UI"KBG<+G8:=?'(&:ZFVNMR#FO.+
M&Y((YKJ+&\X&30-'90ONJ>LRPE#@<UIU PHHHH **** "BBB@ HHHH ****
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MHHH K3G*U%;KAJED'%-AZT 6Z0]*6B@"$C!S3U:E84U1@T *S8J(\U(XJ.@
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M&:3O0113N/<#S33Q3A3'I-A:XP]:=D8IM-IV!CCUIII33:&##/%,[T'K0>E
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MM\M5<"@"48-*<5&"14<CFD*Q*LA$@Q75Z//PN37&QG+ UOZ?/LQS0V!Z#;W
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MOIF>BTF@.+DMV!Z5&("3C%=3-I;9^[446DMO^[3L!AI9MZ5=@T\L1Q6\NE$
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M;KZ5/BEH @^SKZ4TVZYZ59I,4 5Q;KCI1Y"^E6:3% %;[.OI2_9U]*L8I<4
M5C;KZ4GV=?2K.*,4 0K"*E5 *7%+0 UAD57:$,>E6J3% $"6ZCM2FW7TJ>B@
M"N(@#4X'%&*6@!C1ANM,\A<=*FHH KB$!NE3@8%&*6@"M,FXTD4(]*L%<TH&
M*=]  * *-M+12 C:(&HC;KGI5FDQ0!"+=?2D:V4]JL44 51 J]JF1 *?BEH
M**** "BBB@ HHHH :5!IAA4]JEHH A\A?2FFW7TJQ10!6%LI[4"$*:L8HQ0
MBC IU%% !2$9I:* (FA5NU1FU0]JLT4 5#9IZ5";)-W2M&F[: *7V- .E*EL
MOI5W;2!<4[B1!Y(':I50"GXI:!A1112 *;3J*!,84!J)X%/:K%% RLMLOI3C
M;KZ5/10! B8-3TF*6@ J-H@:DHH J/;J>U0&T4]JT2*;LH SQ9)GI4Z6B#M5
MK;2@4 1B%0*>% IU% !1110 4444 %%%% !4;YJ2D(S0 U.E!C!IP&*6@"I+
M;*1TJO\ 8U]*TB,TW90!GBR3/2IULT Z5:VTN* *WV9?2@6ZCM5G%&* (TC
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
%110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>image1.jpg
<TEXT>
begin 644 image1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 0T!V\# 2(  A$! Q$!_\0
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MHE+110,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_OJOD1]9OV_Y>)/SJ,ZCJ#?\O$GYFG9@?7O_  FFG_\ />/_ +ZII\:Z>/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MDG5R*N1:4QY\TT:AJ:L?EKT8&K<4@!XK,BTXI_RT)J[%&4]Z+A<V;=\XK4A
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M"MBW6'C.*YN.3GK5N.3_ &Z8SI EOC^&D9+?'1:Q%D/]XT[S']32U%J6KE8
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M.U+DGM3R3_=I,M_=HU"R&[<TA2I.?2C\*!7(2IH&?2I<G^[1N/\ =H'J(M2
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M#-EMLGI35@VGI5I[GVJ!KGVI@2* !4<AJ%I\TGF9I 02!B>E$8;/2K(8&G@
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M#3T"Y8:4!:S;J7@\5<\AR.AJ-[(MUHL(YZYD;GBLZ5I.RUU;:6IZT@TF/VI
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHI,T +13"QI-YIV DHI@8T[-%@$)--W'TI2:3<?2F@%
M#'TI<TW)]*=BD+4"U,\PTI%,(-(8[S*<&%18/I1M-,"?(I:A -/&:+"N/I#T
MHS0>E(+E6XZ5BWB\'BMJ<G!K'NV.#Q3L,Y'5T^5N*\YUR/EJ]*U9B5;BO/=:
M7):BP' 7<8\PU5V 5I7J .:S)&9>@IJP#U ]*G15K/$TF?NU8CD8]15"+P50
M*0MCM4:DD4_FG=@-,Q]*B:;/:IBI/:F&'- $)8&G*5I3;4GD,.@I: 2J!Z4\
M(#VJ$"0?PFGAI!_#0!*(AZ4X1@=J8)&]*7S&]* )-N.U%1[G_NTX*[=J %R/
M6E\S'>E%L6I3:$4  GQ4\<Y/:JWD,.U21HP[46"QH1OFI>U5HCCK5D.H'6@"
M-R?[M4IRV/NUHF5/45!++'CJ*D+G/70<D_+6<T<A;[IKH9Y8>Y%4_.@!^\*-
M0,U(I?[AJ7R9B/N'\JTH[N =UJP+Z#'5:-1:G/26TQ_A-0-9S>AKIS=VY[K4
M;3V_]Y:-0L<S]EF'\)I1!*/X370--#V(J%IX_:G89E+"_<&I1#ZU9>X3VJL]
MROJ*5D,"@%1D@5&]QGI4#2,:$@+.X4 CUJL"34BK3%<MH15I"OM6<,BGB9EH
MT T2J&F&WB/\59[73U$UT],#6%K%_>%2""(=Q6']L<4X7\E*P&O)%'CJ*HRQ
M+V:H1=2/VJ01O)V-*P6(A$,_>JQ'&/[U.6Q<\X-3K9..QIW0R2%%]:T(0G]Z
ML_R'7L:0LR=S2N(WT\O'WZD!3^]7-?;"O\5']I$=Z+AJ=*67UJ-MO]ZN>.K/
M4;:J].X&\X']^JDJ#^]60=3<U&=0D/:E8-2]+&/6JDD2^M0&[F;^$TPO*_\
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MJ.-[(W6+]*;Y[-_!^E.^U0'^):/M,']X4!H-^]U2G"!6ZC%)]JB[,*:;F/\
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MT))[T=@*J"\^?H*'A![U"8,&BP7->UN$)&<5NV<T'&6%<:N].F:4WDL8XS2
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M0=M\48I2-TB?G6Q;>/[67&9D_.OEQ5NXC_&*LQZA=1?Q-^=+0#ZNA\664O\
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ME)./6K"W*C^(4@-$-FEK/^VJ/XA2'4E'<4 :!7--,6>]4/[57U%)_:R_WA3
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M2BPQ0:>"*C!IXQZT6#0?D4F3Z4W@=Z-^*!:"DGTIAI?,-)G-,8E+DTE+D^E
M#@[>E+N-("WI2[2>U+40N:,T;<4TR*G4T6'H+N([4OG8J!KI/45 \V[I1<-"
M\;L#O4+W1/2J!61CP#4L=O.?X#1<>@]IG;M3-CO_  U<BLYS_P LS^5:$%A(
M<;D- &*MFS'I5R"Q(_AKH(=.7N*NI8(*!6,:"U(Q\M:$46.U:*6B"I!:K3N2
M5X]H%/:4*.*E^R"F-9GWHNAE62[8=*I37[^E:#V+>AJM)IK'^$TK 8\VHR9J
MM_:<H-:\FCY[&J<NC[>QIA8KKK,P[5,-<G]*JRV3IT4U69)%_AHN(UQK4IZT
M[^UY#WK"+,.HI/.(H WO[4D--.H.U8@G:GK</Z4!8UC,7ZTW />J*SM4GV@X
MH$6\8Z4&0BJ1NF'2HVNY3T6F,O-<E:B:^(JB3/)T0TJ65U(W$;4@99.H/V%-
M-_<'HE7[/0+N4C]RWY5T5CX.NI2,P-^5"%J<;]HNG_Y9FG!+Q^D1KU?3_ +/
MC?$P_"NIL/AU:\%P1^%.XU<\$33=1E^[ Q_"K4?AO6)#\MHY_"OI.T\#V4&"
M /RK9M]#M8,8C4_A2Y@L?,UMX.U=\;K20?A6U;>!;UL;[=Q^%?1BVD"](E_*
MG>3$.D:_E2YA'@L7P\E;[T3C\*MQ_#3=U1ORKV\K&/X1^5,+1KV%.[ \>C^%
MD+?>#5:C^$=FWWF:O4WO+>/[S**KOKFGQ?>F0?C1=CT//%^#^G]W:I/^%1Z:
MH^^:[&?Q5ID?2Y3\ZR+KQM8IG;<)^=-,6ASES\+=.B7[YKGK[P%809P_2NEO
M_'$# A9E/XUR.I^*O-SM<'\:=P,*^\-6D&=KUSE[:1P9VG-:=]K,LI.*Y^[N
M9I,_+3O<92EN7C; %(NHRC^&H769FR4-/C0C[PHLA6+*ZE-_<IW]H2G^&FJ$
MQ36QVH"S)/MCGM3A<DU5(?L* K]Q19BLRV)Z=YU50AIV"*+"LRSYQ]*7SC5;
M+>E&6/:BS'=EGSJ0SU7PQII#>E,HL&Y/I2?:">U53YGI1F3^[0!9\S-*'JL-
M_I3AN]*9-RR)#3O-;TJN&;TIVYO2D,F\T^E+YIJ+=3A0,D\YO2G"5SVIJ@^E
M2*#Z46%H*"Q[5(JGTH7/I4@DVTK"'*C?W:NVJ-N'RU0^W*G4BK%OJ\8<?,*0
M:G7::C<?+77Z<IX^6N'T[6(N/F%==INJ1''S"@:9VM@.G%=):?=%<KIUZCXP
MPKJ+.4,HQ4-#NC0%+30>*7-2%PVTW92EC3=[4QAY8H\H>M&\TX&I=P$$8]:7
M:*6DR:0KB[13?+%+DTN:87&^7[TX+BEI*+C%HI**+@+24M%&H"44M)D46 **
M-P]:,BBP"T4E(2:8#J*9N/I2@F@=AU%)2T""BBB@"+<WI1DGM1N;TI<GTJA!
MMS2;:=11<+C>129/I3B329/I2&)1Q2XS1M%-"$R>U*"WI1R*,GTHL,<,FG 4
MT$T[-(6@8I:3-&32"Z%I"**.:!C3&#49@%.9F'05&9)/2FK@+Y86C>5I-S'J
M*<%!ZT"U 2FG!V/:@(M/ %%P5Q 3Z4,"13N*,BBXS)O;3S0>*Y>_T/S,G::[
MIL&H9(%8=*+ >1WVCM!DA37.W4TELQP.E>RW^D"8'Y:Y'4?")E)(0T6 X[3M
M9<. :[[1=5#!<L*Y&?PO):$LJ-Q54W=UIYPJGBD![5;7T;(/F%6Q<!NAKQ6S
M\8W$;8? KJ=.\90L!YLJC\:8'HH<FG=>U<]:^*-/E4?Z0F?K6I#JMM-]R531
M8"VT2N.156738I.HJVDBN,@T^D!SE[H,+*<"N/U7P\>=BFO4&0,.:K2V$<G4
M4#1X7=Z%.CY"M4,=I- >5->SWFC0;22*Y+5=/@B!Z4] T.,,[*N"M9UT'F!P
MF:U[L0(_+"FP2VF?FD%,5CCKK3)I,D1'\JQKC39TS^[(_"O7(SIKC!E6FRZ5
MIER/]8O-%V%CQ&:&5#R"*@V,>N:]DN/!VG3 D/7/7_A"VB!*$T:@>>B%#U-.
M%M%ZUKWVCM"3L4FLA[>9#]TU("_9H_6HW@4=#3295Z@TWS)/2JT C=7'04P>
M:>H-3>9+_=I=\O\ <HLAV$5">HJ3R5[TW=)_=I"9/[M(0_RTH\N/N:A/G'^$
MTWRYF_A-4A$_E0]WI#%;_P!^HOLDC=0:<-.<^M)A<0K$.C4TE/6IAIK^AIXT
MU_[II68:%7*T97UJY_9A[@T'3L>M&H613W>E&YO2K#6C+T!J%DF7HE4@&X8]
MJ3RS06G'\%1F68?PT!8DW,O04GVJ1?X:A,TO=:3S&[B@"4W$C=J:=S4J-GK5
ME0A[T[$LK#<*D65EJ1@HZ57=B.E *Q96Y/>IUNU[D5DEF/:FX<^M!6ALFY1A
MU%1,P;H:H)%(>@-6H[>8]%- :",F:A:'ZU>%K-C[AIWV23NIH S1 ?>IEB(]
M:N&V<?PTTJZ_PT: ,C##M5R*5E[565F[BK$9'>@"T+EL=*#,Q[4P>7CK1E>Q
MI, +L>U-R:7<:;NJ4&H4N[%)FDJ@'^8?2DWDTE%(89HHHH ,FCFC)HR:!A1D
MT44Q#MY%!<TW)HR:D>@9H!HHIZB'ACZ4NYO2F;S2^8?2B[ 0DTE+NS2$TQ"[
MB*7S#41+4FYO2E89+NI":9R>M+BB]A:B%C2;F]*4Y':DW-Z4[@*":>#3 Q]*
M7-)L!^[%+O-1$FDW-Z4;C)]]+N%0 MZ4ZBPK#R_I49E;L*=BBA(+#?,8]J4$
MFEXI,CUI@+BEVFDWBG>93 3:?2DP:?O--S0 E&#13@Q%  $)[4X1TGFD4GG@
M=: '^6!2=*C-ROK33.#0!+YI%'V@#K58R$U&REJ +37 (QFJL@9^E"6[$]ZO
MP6K<<4(#*%I(S=#5R"R;N#6W#:-C[M6TM#_=I@9L%H!U%:,, ':K26GM5A+<
MCM2 CB3'\(JRJ?[-/6)AVJ4(WI560#5C%/$=. (H+XI6  A]*7D=J8;DBH7O
M*0%KS,4UKG;6=)>^XJK)>GUH U&O\>E0MJ7TK%DNV-56N'- &^VI+[5$UXC]
MQ6 7<TWS)!0!N,4?TJ"2VC:LP74J]J=]OD'45(7)I-/C/>JS:;&.].-^>]1M
M>YZ&@!/L,:]Z0VZ#O43W$K?=&:BW7)/"&GH%RP81VH%N['@$TQ!='_EF:O6W
MVH,#Y1_*E<"%--N9/NQ$_A5ZV\/WTC#_ $=ORK8L+N>/&8OTKI+36Y(@,QK^
M5(+&3IOA&YD(WP-^5=AIO@?H6B/Y5'#XMDA_@6KB^/YHQPJT]0L='8>$XX<?
MN_TKHK72H8 ,H./:O-9/B5?*/D135.7XEZNW"PBDP/8LVT(Y*BF'5+&+K*H_
M&O%7\:ZW=?\ + \U7;4=:N?^6+\T#/;FU_3U_P"7A/SJ%_$NGK_R\)^=>*BW
MUF7_ )8R5*ND:Q)UADIV$[GJMSXOM8\[)E/XUB77CWR\['4UR4'A?4)<>9'(
M*U+?P*TN/,#BC0%<;=?$>]&?+4&L:Y^(^LDD)#FNNA^'=O\ Q;JT(?A[9#K1
M=#/,CXRUV[.# W/M2B35[X_-$XS7KD/@BRBQ@?I6A#X<M8>@'Y4[H#QN+PU?
M7/+K(,U>A^'[S??,E>R)IL*=%'Y5.MLB]A2N!X[_ ,*QC(R6>HW^&4*]WKV<
MH@'05#(L..2*+@>&W?P^BA4D!JYK4/#:VV<*>*][U-8/+/(KSO7EB^;!%4)G
MD5W;&(D!:R9O,'1:Z[5 H<XKF[EPI-,5S*)EW=#4T1D[BFO<?-VJ2.>C4+EI
M-V.E/P?2FI*<=*?OS1<5QNVC%!:D+&FFAV%Y]*,^U,W-Z4;F]*8#\BC(IE&3
M2N*X_/M1^%,W-Z4;F]*8Q^!1@4W)I13)N+@^E+@^E 9O2G!V]* N((\TNS%*
M']:=N7UI@1^8Z]!3EN)/[M.R*>H!-(8Y)6;J*5P"M31P;JG%GD=#2T P[B$G
MIFJR6TF_C-=(=.)[&I8=.PV2M*P:E+3X)@1@&NNTM)P5X-0V4$4>-Q KH[&>
MTCQEU%(1NZ/YXV_*:[G3GFVCY37&V.L646/WJ_G706WB>S0?ZY/SI =7&\A'
M(J=<]ZYD>*[7M*GYTO\ PE,)Z2+2LQW1U&*,"N8_X253T=:</$)/0BERL=T=
M+BC%<Z-?'=A3QK\7=Q1RL+HWZ*PO^$@@_P">B_G2?\)#!_ST7\Z.5BN;U%8B
MZ_;G_EHOYU*NN6IZRK^=)Q&F:]%9RZQ:M_RU7\ZD&I6[=)!^=*Q1=HJL+V$_
MQBI!<1GHPH EHI@D4]Z=N'K0 8II0&GT4 1^4/6E"8I]%*P"4M%%%@"BBBF
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M#\C<*XS4]<DESSFN:OM9N'E(%4Q<W4Q^X35")KNZDE8Y%9[Q>9UJ^MO=2?\
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M5Q0S>E.!--!/I3@:+#%IISZ4N::2: &G/I3"N:>2WI2<GM1<"/RQ3@E. -/
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M5S4JO1=!H:B2FK44IK(24BK*7#4]!:FU%(.]78Y%]:P$N#5E+@>M)V%J;Z3
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MYI%*[&2;3364TW[0U(9B:5@&L*A<FIB<U$PI@5V9O2A=QJ0JWI2A6]*=P%5
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MW#O3M<1:#CUIP<U5#CUIWF&GHAEKS#2AQ57>32@FDV(NHPJPC-VK/1L5;CG
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M0:D5F?-327']RH_-N.ZU],'X2:.?6F_\*AT?WIW0['S4&F/\-/!E_NU])?\
M"H=']Z4?"+1QZT7&?-P,_933O])_N'\J^DA\)M('K3O^%4Z3Z4K@?-6VX/\
M :0QW']PU]+?\*ITGTI1\*M)':G<#YF\F[[1G\J3R+X](C^5?3H^%VE#M3Q\
M,=*':E<#Y>^RWQ_Y9G\J;]CO?^>9KZC_ .%9:5Z4?\*RTKTIIH#Y;-G?]HC^
M5)]CU'_GD?RKZG'PTTL=J7_A6VE^E.Z ^5_L.H=XF_*G#3[_ /YY-^5?4W_"
MMM+]*/\ A6VE^E+05CY<&GZCVA;\JD%CJO:W;\J^HU^'>F+_  U*O@+3E_A'
MY4M L?+'V'5_^?=ORH^PZO\ \^[?E7U3_P ()IW]T?E1_P ()IW]T?E3T"Q\
MKBPU?_GW;\J>-.U@_P#+LWY5]3#P+IP_A'Y5(/!6GC^$?E1H%CY8&EZP?^79
MORIW]D:P?^7=ORKZG'@VP_N#\J7_ (0^Q_N#\J- L?*_]C:R>ELWY4AT/6ST
MM6_*OJL>$;$?P#\JD'A:R'\ _*C0+'R=_P (_KI_Y=7_ "H_X1S73_RZO^5?
M6G_"-68_@'Y4?\(Y9_W!^5%QGR8/#.N_\^K_ )5*OAG7O^?1_P J^L!X>LQ_
M OY4\:%:#^!?RHN(^4D\,:__ ,^C_E4R^%]>_P"?1_RKZK&C6H_@7\J7^RK8
M?P+^5%PL?+ \):Z_6T?\J=_P@FM2];5_RKZG&GVP_@7\JE6T@'1%_*B[&?*R
M?#359#\UM)^57X/A9>L1OMW_ "KZ>\B(=$7\J:R =$'Y5('SU:?"J4$%H7_*
MNHT[X=B#&8S^5>M<CH@_*E!;^Z/RIW8'(6'A.. #*?I6Y;Z3%#CY:U@6]*"N
M>M("*)(XQVJP)$]:C\I3UH$2^M,";>II,J::(Q2[*0K@0M,.!TI^P4NP4] N
M0%V'04"1SVJ?RQ2;,4AC ">M/\L&DY'04 MZ4 +Y0I/* IX)I<T"L1[2*0EO
M2I"PI-PH"Y$6?TIGSGJM6<BEIW&5?(#=5%-;3X7'*C\JM'--);THN*QGR:+;
M/U4?E563PU9OU K68R>E-_>>E(9A2>#+&3K59_A_I[]2:ZE=W>I 30!Q;?#;
M36[FHV^&.F'N:[5G<=!4)DF["G8#C#\,].7IFD'P[LEZ UVJR2]Q4H9^XIWL
M!R$/@:TC_AK2@\*VD?\  /RK=+-Z4W?)Z4FP**:#:IT4?E5A=,@3HH_*IPTA
MZBI!N[TA$2VD2] *E6)!T I^** U# %'%-9L5 TQ% RUFBJ8G)-3)(30(EQ2
M%!2@\4A8"@8TQBFE*<T@[5"TK]A3L _:13@:K>9,3]VI%,AZBBP$X84[<*C5
M?6G[0*- %(!J)H%;K3F<(,YJE/J<4/5P* ([NPC9#7$ZYI*$-Q717OB2VC4_
MO1^=<;J_B>$AML@IV X76M&&6XKB[[3-A/%=AJVO[RVUA7)WNHO*3BGJ+4YN
MYMMA-51E36C<&60GBJGV>4G[M :@L[BI!=/0+9^ZTIMR.U(8X7!-+YN:A,6*
M4#;3T%<EY-(5([4+(12LY-,")GVU&9_>GM&S=JC^S-Z4 +]H;M2B:0TY;=AV
MJ00D=J6I28U68]:E5<]:381VH^8=!3N.Z)EA4U*+9*J^9*.@H^T3^E%V2RU]
MF2FF",=Z@\^4]11O<]J-1$C*J]*C,A7I2?-Z4FTGM5) /%RPJ5;TBHEASUJ9
M;,&@6I/'?FKD>HGVJFE@3T!J==.E[*:>HKM%^/4?7%6%OT(ZBLP:?,.JFG?9
M''4&F*Y>DNE8<$53DD+=*:867M3/F':G8!/F]*>,T@+>E2JN>M+00T4\$T_8
M.U&QNPI:#%4FIE-1!7]*E53WI#%9N*K22'-6&7BJDF :0:#HI6W5L6DAR,UA
MQL-U:UH>12&=9IC_ ##FNZT=ONUY_IGWA7>Z-GY:3"QW-BQV"M($XK,L,[!6
MFN<5(#Z*04M(H**** "BBB@"+<_I1D]Z,MZ49/>@!/K1Q2\=Z,#M5"L)D]J,
MMWHY[49:D,7ZT8%)]:.*8KA]*,M1SVHRU(84<4OUHP*8K"?2C+4OTI,M2&'U
MI<"DY[T<4T*XOTI,M11EJ3&'/>CBCGO2X'>FA"?2C+4O':DR>U)C%W&EW>M)
MS1M]:!"[J3<:7;2<T[!H +4X9[T@)]*<#2L&@4WFG9I"330:"9;TI0329:E&
M:  FHVW=JEQ33FD"N1?/Z4]=U.RWI2C-,=QK D53F@9@>*T!0:5P.4U&T?8W
MRUY[K]JP#9%>O7Z@Q-Q7G?B&#<&XIW \=U2(!S]:QSP:ZK6;3YVXKF+B,H3Q
M2T :)"*/,-4WE932I,3UIV MDYJ-X]W:I(L-5^&UWXP*=A&(]JQ[56>W9>U=
MDFE,XX6HI]$<C[AI@<4S%::)2:Z"YT*3GY#6=)I4D7\)I:@55W&G>6Q[4C+)
M%VIHN&'6F &$TY82.U.6X!ZFI5E0]Z !%8=JF#,!TIH?TI<L: '>9ZTGF"HS
MD]:0+2U%J2[SVH!8]J:HJ5<TPN*H)ZBI G%"FG;AB@8PC%-WFE=O2H2S9H%8
MF#&I%-0+GO4RT 68VJRDAJFIQ4@<TQ,M;R::>:B\PTN^F22<TX%JC$E*)30*
MY84MWJ56JL)&-/!)H'<L%Q49<U&349<BD,M(YS5E"<5GQR'-7(Y!B@"23I5&
M8MZ5==ABJ,S'M0!1E9N>*JMR>15F0OGI5=@Q/2@"S91!I!79Z/IX?;\M<A8
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M?PFF!H;4;J:/(B/>L_\ TH?PFG W7]TT!J7O(C]:3RD%5E%T?X34@BN3U4T
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M#4W&=W9R*0*U8X%E'2N.L[U^,&NGTZZ=L9IV O'1DE7[M95_X>&#A*[*R97
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MYI>*A!8T\!J5@),+2C%,"FE^:BP#^:0EJ3+4F\=Z5A"[FI,M1YB^M'F#M3U
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MB2AI6*.4DAQ4.P UK7%N4)W#%4&\L-UI:@1JK=A4R[_2E0CM4PS3%J(N>]2
MBDQZT86@!2WI32S4A('2DW&D $M2<T\ FE\L^E-,+C!FG M048=J:=X[4[BY
MA^6I<TS+4X9HN(<,TX%J:,TX%J.80\%J<*CW/1N-%V,G%.!/:J^\THD>C499
MW-1N]:@\QZ7<3UIZ@3[A1DU$#3@6[4[@DA^6HQZT@+U*JYZTK@R$IQ4+QMV%
M7B@Q43!AT%%T)%!HYA_#3?WH[5;=I?2J[M)W%%V4-$L@IZW#U"2V>:5<T78B
MQ]H?%,:8GK33TJ"0F@9,'R>M6X.<5C^80:NVT^".:+L#?@4FK:Q&L^VN1QS6
MG%.I[T[@+Y+>]1O#+V!J_&P-2X]J+@8;QW78&F>5>'L:W]I]*<%/I1<# %O>
M>AJ=(KM>QK<'TH)]J0&;'+=IZU.+ZZ4<YJ9C49 - "?VE<#J33AK$Z_Q&F>0
M&I#: ]J>@%A?$%RO1C4Z>)[M?XJSOL1]*3[$WI18#;C\5W(ZO5J/Q?./XZYK
M['CJ*7[*HI =:GC*<?QU9C\:S#^.N(\@#I2>4PZ4[ >@IXVE[O5J/QLW>05Y
MEMD]Z0F8=,TFD!ZW%XU]9!5R/QFG>05XFT]VOW<U$;Z_7H#18#WI/&4/>4?G
M5A/%]L>LH_.OGO\ M+41ZT#5=1'K18#Z-C\46C?\M15N/7[5O^6@KYK7Q!J$
M?<U,GB[4(_XC2L@/I5=7M6_Y:"GC4+9OXQ7SE%XXOAU>KL7CV['62E89]""X
M@;HPIX$3=#7A$/Q"N!C,E:4'Q'E'6446 ]G\A#2?94KRN#XD9QNE%:<'Q!@;
M[TP_.G9@>@?9D%'EA>E<E!XWLY.LR_G6E#XHL9/^6PI6$;>2*3S,53CUBRE'
M$@_.K"7%O)]UA0%B7S:42$T*D9Z&I BTM L-RQH\O/6GX]*8Q?M0&HGD"CRL
M4W=+3@[=Z>HPVD4A/K3]W'-1.PI +N'K2AJKD\T]2:=P)P32X)IJEJ?DTK@)
MM%-(QTI^13&)[4"U&%W%*&<]::=_84JA_2BXR4#/6G;*:N>](\P7J:+@28Q4
M;S*G6JTM_&@Y:L>]U:, X>@5C8EU").K"LF]UB( X<5RU_K(R</7/7.JLQ.&
MIZ#.BU#6>NUZYF\U:1B?FK/FNY7Z52<RL>11H 75[(^>367),V3R:OF+/WA4
M3VZ4]!6*7GD=30;D8Y-/D@6JDD0HL ]KB,]34+3Q?WJ@D1:K.J^M 6+37$8Z
M&HC<IZU4:,GI3!"^>E %[S@U&<U!&F.M65,8'6F F[%'G>],D9>QJLQ;/% %
MW<K=31Y<9[U35F!YJ97'K0!.$1>E/\TKTJ#);[M*(9VZ T6 D:X>HVGDJQ%8
M3OU4U>AT=VZK3T QQ),>E. N6Z UTD6B8_AJ['I 7^&BZ Y1+>Y;JIJU'ITK
M=5-=1]C2/J*:9(8NI%%P,--&+=5-64T$'JM7VU&%?NL*B;5V'W#0 Q?#L?=:
ME&@6XZBJSZU<=JKOK-T:0&I_8UHG:FFSMX^F*QCJMTU-^V7+TF!LEXX^F*8;
M]4]*R@T[]14JP;_O5.H7+C:SM[BH'UL?WA4;6<&,DU1GAM4_BH&7&UE3_%3?
M[5C/5ZQ9#:YP&I@B23[AHLP-X:A W5Z>+B!_XZPUT^5N5!J5;.=.QIW8KFVH
MA;^*I%MX3WK&0RIUS5J*Z*]35 :BV<1J06BCH*J1WR#JU6!>J?NF@"81LO04
MN91_#40N)#]VG![ANU%V _S)1VI?/D]*:$G/\-!CE'44]0'^>W>E$Z]S5<Y'
M6HV9?6G8"\)X/XFI&EMNS5F,$/>HCM'0T[ :#NI^Z:KMO-5#,R]*3[5+4Z@6
M2K=Z:4J(3N>M/\PTRK,"".E(=_I09#2>::6@F'S4TJQI_FCO2^:GK3N3J1&-
MC3&A?TJT)!VI&9B.!3N,S)8F]*I2)ZUK2ACU%4)D-#$[E%@!3-V*=*I%5'+@
MT)"+R.*M(RUD([9YJW')ZFBP71I#!Z4;">@JNDH]:L++Q0&C&E#Z5&PJ9I*K
MNXHN%B-ZK.#VJ5F%0LYI78KE>0-59U]:LR2&JSR#/)I7 1(@35^WM02.*JP$
M,W%;EE;2/C:M(I(T](L_G7BO3/#UOM"\5QNDZ?<;E.PUZ'HEK*@7*TF4=KIT
M8$8K3"C%4+%2(Q5[+8J0'8HQ4>6IP+4@%VTNV@9I: N)BEHHH **** (LM1S
M1EJ.:L!*..U+Q1Q0*P<T<T<]J.:!A]:,"DHXH%<7Z4<TG/:ER:!B4<4OUHP*
M!6$I>:/I1S0,/K1@4G-'% KB_2CFDI>:!AS2<4O/>C H$)2\T<=J.:!ASWHX
MHYI*!"\4<TE+S0 <TE+S1QWH 3BEYHP*.>U !S1]:.:2@8O%'TI.*.:!"Y:F
MG-.^:EP30,93A2[*0\4M )!05!J+<12>8:5@)-@I=@J,2&G!C18!DR94UR^J
MV7F!N*ZL\BJ4\"OG(I >3:MHI;<=E<7J.DM'N^6O<[[3XV4\5P^N:>H#86BP
M'C=[$\9/%9+N^:[#6;0AFP*YI[<[N13L24MQJ:.Z:+H:F^SKWJ-[=>U589:A
MUV:+HU:]GXIE&,O7*/;GL*8(W0TK >GV?BS@;I!6E_PE$;K_ *P5Y(L[IWI_
M]H2+T:BX6/4)==C?^(5DWFHQR \BN#.J7 Z&HSJ5T]/4#:OY(W)YK$>*,OUI
MAEGDZT"*4G.*- N68HDJV$4"J*+(O:I@TF*D-21P!5=S3SN/6F&,FF@U(&9N
MU,#RYJUY1]*!$?2F+49&\G>K2N<4Q5 ZU(&0=Z !F:HF+^E2%AVIAW=J:8K#
M?FIPS1\U+S1:XK!FG;B*8<TTEZ7*!+O-)DFH\O3AFG8!U*&-)13 ?O-.#5'S
M12'8F#"GAZKTX%J!V+(<T\2U4W-2[CWH'<N>;[TA<GI58/3U8]J!:#V+^E0M
MGN*EW-BHG8]Z!D+"F$XIS.*8>>E 6&ES4;,#UJ0JU0NIHT 3"5+'M[55(P:D
M1L&@#2B8CI6E;R,,5BQ2XJ_#/TYH WX)CBKBS^]8L,_O5E9O>@#5$_O3O/K,
M$AJ56- %[S2:<&)JNE3+FF!((\T\0U&'<=*=YDE%V!*(U%!VBH/,>FEF-.P$
MQD(Z5&T[5$?,/05&RR^E.P$K3^IJ,SKZU Z/WJ(HU%@+/G#L:!*:JX:G+NHU
M N*X/6IEVFJB9J=<TK 3>2K=J=]C#=J8'8=*>+B44; ']G@_PTO]FQGJ*474
MG>E^UMWI,"%])A/:H&T2 ]JN_:2:3SR:%8#..A0>E,.AQ=@:UUDSU-2JR'J:
M&!S[:*HZ U"VD2#H#74$QTTLM*P'*'3KA>@-,-O>)T!KK"RU&?*[XIV Y=9=
M0BZ9J=-8U2+IFMXI :9]G@:@"C!XKU:(]36I;^/=4BQEJA%A;M3AI5LU%@-J
MW^).H# 9ZU;?XD3G[\@KD&T:#L*A?1\?=!I6 ])M_B&A^_**U+?Q]9-C?./S
MKQF32K@?=!JI)87R_=#460'T)#XUTN3_ );KGZU>B\1Z?-]V4'\:^: -3A.0
M&JS%KNIVO<C%2T,^FDO[:7[KBI0T+]#7SG:^/;^$@,]=!8_$:7CS)14@>W>4
MAZ4&/'2O-;+XB0-C?,*W;7QO9RXS,/SI@=6=X[4F]AUK,@\264P_UHJXFH6D
MW1Q3 F\X9Y-/65#WJ,+#)R#05C7O0!9##%-:0+5-[I(Q]ZLR[U>- <N*+,#7
MENU4=:Q[W4< X:L&\\10KG,@K#N?$4+YQ)0!J7VJ2#.#7/76IRDG+55N-563
M.&K/DN!)WH =/?%CR:KK,K'DTC(KTBP*#Q18"]$(V%3M%'BJ2 KTJ0R/B@5Q
MDR**H3<=*MR,3526@9FSNXZ5GRO+6I-5*3K1J*Y0;S#UJ+8Q-6VJ//-- 1+'
M)V%/$<WI4RE^PJ4>=V%,"F8I?2F&&3TK1V3G^&E$$I/W: ,S[/,>@I19W1Z(
M:VXX)!_#5R)&'44 <XNFWC?P&K$>BWA_Y9FNHBD5?O8JXE[ HY(H YB#1KE<
M90UIP:=*O5*TWU.(#Y2*J/JA_A(H E2W9.HJ=6V5G_VA(U/$[,.:I :(N<4[
M[9[UCRR2 <50FN;D=*>@&]/=;AUK'N6+GK6<][<C[U1'46'WC1H!:$)8]ZMQ
M6N>M8YU9%_BH_P"$@"='%2P.@^Q#'2H7L6["LF/Q+D_?%7(M=1^KBD!,+)\_
M=JS%9-W%0_VO'C(85#)K17[I%%P->.S'<586S3O7*R>(9UZ&J<GBJY3^*IN!
MVSZ?"RUGW&BQ25R/_"8W.[!:K4/BR5NK4#-1O#<9;.#5NVT*.,]*SXO$98<L
M*LKKV?XA0!NPV$2C&*D;34<<"L:/6\_Q5=AUH?WJ>H#Y=$R"0M8]YIS0@X%=
M"-7W+U%4+N<S XIB..N9)(34<6HR*>M:MW8/+DA:RY-.E0YVF@#2M]5?CFM:
MWU-CU-<B5EC/2IHKMTZF@#NX;W<.HI\EQD<5R,.IE>K5<74P1]ZGJ!I3.QZ5
M38O31>;N](9<T[L +>M-+#UIC-FHSD]*.8!Y:D!YJ/:_:E"R>E*X%I".]2_+
MBJJAN]2#I2'=DAQVIAI#GM3#OIB%('>D 3/6FD-2;6HNP+*;>U2YXJFH<=*D
MS+Z4[MDL=(:I2BK)$AZBHFB8]J ,V5:I.ISTK6DMV]*JO;/Z52"Q15/6IT5>
M]2?9W'44HAQUIBL.4#M3QN[4P+BG[B*E@*2W>HSCO2M(:A=Z0A'*^M5I&]*6
M1ZK.Y[46*0CDFJS(2:F!8FIXXBQY%*PW86P@.\<5VNCV[_+A:P]-M<L.*[O1
MK-OEPM (W=*@D 7Y:[+38V&W(K+TVS<*ORUTEI"RXXJ64:EL#M%6>:BB&%J7
MFI&A.:49I.:7F@!:0YI:6@1'EJ4%J?11<!!FEHHI 1?-1S1EJ.:L!*..U+Q1
M@4"L'-'-'/:CF@8<=Z,"D^M'% KB_2CYJ3GM2_-0,3ZT<4OUHP*!6$I?FH^E
M'S4##ZT<4G/>CB@5Q?I1S2?2E^:@8<]Z3BEY[T8% A*7FCCM1S0 <T<4<TG%
M "\4<TG%+S0 <TE+S1QWH&)Q2\]J,"CGM0(.:/K1S2?6@8O%-)]*7BC% A-[
M4\,:;M-. -*P#J::4YJ%V-(!U+M!J#S&S3U<FG<9,$%.VTU2:?2%<3%1LF:F
MI,4@L9]Q;AE/%<?K-AN#86N\D4$5AZA &!XIW8SQK6=*<EL+7'W=A)&3E:]F
MU.Q#;OEKB=6T_&[Y:=V!YO.3&3FJ9N#GK6WJ=F06XK >!E/2EJ _S&/2@ASV
MIJAQVJ0,W>G9 1F(GK3?(%6@R]Z1F3M0*Y4\D4Y8U%/?/:HL24PN6D$8ZT\O
M&!50;N]!&14V&/DN .AJ WASUIKQ9IH@YYHU F6Y8U()2:;'$@ZU95(<=:+,
M"+S#1YC5(RIVJ,H>U.P!DFEVYINUJ7#4"U'!:=R*:-U+DT"%YHHW4FX52$+1
M3<TGS4PLQ]%,^:G<TA6%I<-2 TX,:8!M:C%+O/>C>O>E<I,*7FDWIZT;_2BX
M7%^:FDF@N::6]: U' \U*I/:H RYJ9&]* U)<OBHG!/6I=QQ3&R:+BLRLRTW
MI4K*:C(-.X(:7(J)Y/6I&JM)2T*&LXIN^HGIO/:BX%I9&JW#*WK6:N_-6(V8
M=:=P-J&8^M7$F-8D<I%6XYCVI ;*2-5N)B>M8L<LG:KT,K]Z+L#:BV]ZL#;C
MBLV&8=S5M95/0T[@3\]J/FI@8GI3@7II@. />EVT@8]Z4L*=QZC22*8TAIQ(
MJ)J>@AC/ZU$66G,!496C0=T&12BF[&[4H1_2E<"9:D%0KD=:D#@=Z+B)>:=\
MU0^<!TI/M#4#L3<]Z0@5%YK&C+FE8=A6#=JB8S#H*4M(.E,,THH :99UJ,WD
MRTXS-_%49>(_>-&XK@=1E'>F_P!IR^M&VW;O2BVA;I0(!J3GJ:D6\SU--^Q(
M>@I18GL*+C2)TG![U91LU36U=>U3HCK286+JU*K&JBN1UJ99!W-%V(M"1A2^
M>U0>:GK33,OK1=@6OM#=Z7SP>N*SWN5'>JLFHQKU:BX&NYB<8.*IS6$4W:LF
M36HDZ/523Q*$^Z]*X&E+H*MR%JE+H<B?=4U5'BR0MC?5ZWU]INK4M!E%K"\B
M/R@TY)]0@Z9XK=CNTE'.*1Q&]*[ H0>(=1@(Y-;5GXSOHR,O68UK&QZ5(FG1
MGM2U%<ZZV\?W*CF2I7^(-P1_K*Y5-*C/:GG38%ZT[,9M3>.KM^CUEW/BF\FS
M\U53:V:]33"MDO1A0*Y6FU"[F)Y/-,C%TYY!JUYEJO0BI8[N%>A%(80VEPP&
M0:M?8YEZK2QZFBC@BE?5@1]X4["N,*.G45&9BM12ZDA_B%49;L-T-%PN:!OB
MO>D&H$]36)(\S?=JN?M8/2J0'3K<*_4TX^6PZUROVJY3K2'5+A>] '2/"AJN
M]JE<^VKW78U"^L7E2V,W7MHN]1>1 #UKGGUBY[FH?[6F)Y-%V!U:+ .]3H\(
M[BN134)6[U92YF:JU$=6LUOW(J43VH_B%<S&+AZL+:W+=C0!NFZMQT85&UY%
MV-97V.X]#1]DF[@T@+[7D9_BJ%KF,_Q57^RMW%.%JG>F XSH>AI!)Z5*EI'4
MZVBT: 1Q2>M78IH^YJ+[,@ZTOE1#O3T O*T#]34GV>W<5FY0?=-*))1]V@"6
M[L8L':*YR^LF!.T5T:&5_O5:2S@D'ST@/-+BUF!/!K/EBE!Y!KU.ZTBT9?E%
M<WJ&B\GRUHN!Q09U-6([IU[U=GTBX5C\AJJUFT?WA0!:@O&/!-:=NRR=36!E
M(Z<-0:/[IH ZU+*&0<T-H<$G:N;AUJ<' -:MKK$S8R:5@)I?#<(&0M9ESIGD
M?=%=#'?O(O)H=$F^]2U&<7(\T38&:DBO)L\FNH?2H'YQ5631XQ]T4M0*$%X_
M<UJ6\[MC!JJ-,96X6K]K:NA'%-"N:5MYK8K8MH"V-PK-@8QBI6U$Q#@U0'11
M64##YJK76GVV#C%<[)XAD3.&JA-XDN&Z-0!HWFG1\X%94EBJGI5.;6[MLX-4
M9-3O6IV TF@5:%V+WK#>\O6[&HQ/>GL:+ =,DRKWJ87*^M<NKWY[&ID:\'W@
M: .D$ZGO3Q*OK6 DTH^]5N*XSWIV0&P'%/#52B<MTJTH8BEH5=$NX4;Q494T
MW:QZ4A,DW^E-,AIODRGH*/LER>BFJ38@,M)YHIXT^Y;^$U(NE7!_@-,+$0E/
M:GB1ZL)I-Q_<JRFE3CJM&@6*:ESVIX0GM6DFGLOWA4ZVL2CYJ5R68C1'TJ!X
MF]*Z%H[=>IJM)]F'<4TQ69STB,.U57)%;TS6OJ*H3&T_O4,-3*+FFF0U8F,'
M\)JA*_\ =I /:0U"SU'N<FEV,:+CL1.U5V9L\5:>$^E0,A!I7$+ '8]*V;.V
M+D9%9UHA+#BNGTZ G'% :FGI5AR.*[[1K @+A:Y_2;8@KQ7>:1$0%XH923-J
MQM'"#Y:UHH6'446H(0<5;&:ALH100*#FG<TTDT@$RU*,TW+4H+47 >,TM(,T
MM( HHHH **** (OGI/FI?F]*.:JP#>>]%.I.*8@YI>:3GM1EJ5QBTG%)S24Q
M#N:,M1S2Y-*PQO-)3_K2<4Q"#-.RU)]*,M2N,7ZTG%)S24T*PZCYJ09IWS4K
M#$YI*=S2<4T(09I?FH^E'S=J38"\TG%'S4AH0Q>.U'-(*7YJ+"#YJ3FG<T4(
M8VEYHXHY[4[B%YHI,M2<TDQB\4OTIM*,TQ"Y-)YA%'--(I# R@TPDMTI=@IZ
MJ*+H"'RVIZJ14X%&VD*XT-BGAA3"E-/%(";-+5?S<4X2YH&2,,BL^Y@+YXK0
M!S367- '*7NGNP/RUQ^K::P#?+7J4T.5/%<SJMGN#<56H'BNK6)!;(KE[BWV
MD\5ZIJ^F9+?+7&7^F[2?EI7%J<=(K+VJN2U:]W;E,\5F,IS3T&19-+3MM!%.
MXKC<FEW&HVW=J;EZ+ 2YHI@SWIXI6&)@]J-K^E/&>U+\U&HK$>#WI:?]:3BF
M @S3P6I/I1\U*X#MQ[TN\4SYN]&VEN%QV[TIOS&C!'2E^:J20;AM/>C8*4%N
M].I#&[<=*3YNU/--RU-  W4N*0%J49H$&*0[J?1S0!'\U&W/6I.:*0QFP4F"
M.E/IIW4(!/FHQGK1\]+SWIL0!13P".E- IXSVJ0U' O3QN[TT;Z>,]Z=F,".
M*@>K':HG%*PK%1\U6?-7'0U5D4U06*K4T9I["FC-%AC@7J52U1#=4JEJ6H$Z
M9JQ&Q%5U-3*:>HM"[',PJW%<-WK,4M5B/?3 UXIE[FK:3+V-9$>:M)F@#52X
M/:IUF<UFQ[JM1EJ=@+RDMUI^P8J&-JFWC'6G= -*U$W%.9CVJO(7IW0".ZBH
MC,H[U'(&-5V1JG4"U]I'8T?:C5$H_84;9/2F!H"?/6G;U/>L\%QUIV]A2N!>
MRM&X50,K"F&=Z+@:7F@=Z7[2!WK,\UCU-+O]33N!H_:,]#2%V-41)CO3Q<$=
MZ+@3LI/6HC #UIOVKU---T/6@"00@5(/EJDUX!T-0M?-V- &N)BM/%Z%[U@F
M\D;O2>;(U+4#=;4?0U7?4'[&L^-':K<=J6[4) 'V^;/6G"^D[FIA8^U*;,#M
M5: 1?;W[FHVU$C^*GRVHQQ6?/:OV%&@#YM4X^]63<ZB3GYJ=-9S'H#5&73;@
MG[II,",W!E?&:MP6#7'8FJ\.EW(?.PUT>FVD\>,K4V&1VOAEI"#L-;]EX8VX
MRAK1L=Z@9%;EO+TS2T$9L.@!$^[3)M+9!PM=*LR[:JW$@(XI706.5DMY4/ I
MJO*G6M6X)YK-F8B@+B_;74=:H76HRX.#39IL9YK+N)LTKC(KG4+C)P:JB[N6
M-1RNQ-+$6S5: 6DDG:K*>?38:NH>*+@,43TK>;WJ<.:9*YQ4BL4W=AUIJS<]
M:2;)JJ20:86-1)SVIS3L164)RO>GBY)ZFBXR>60FJ<C5-O5NM(40TM1:E)W;
MM5:222M)H0>E5I(#CI3"YER2-WJ#S.:NS0^U4VC -&H%F&6M*WFY%88)7I4\
M<[@]: .NM)^G-;$,XQ7&6UX1C)K6@U#C[U 7.C,I/2HF9S6?'>[N]65E9J+@
M#EJ@9C5K:S4TVS'M0%B%92*F6X>FFU<=J9Y4@[4P+0D=Z>(&;M4,>Y>M78YT
M4<FG<"N;=EZ"HF:5.E7WN8B.M5)9%/0T 0?;)5I1J,@ZFH9"*JNRCO0!JI?E
M^IJPC>97/K<(AZU:CU-$_BH U9;)9!TK*N='5\_+4_\ ;<8'WQ4,FM1G^*E<
M#%N=#49.VL>XTPIG KI9M31^C5FSS^9G%,#GC Z-TJW!(R=:FDC=CTIGD/Z4
M 7XKW:.M6TU >M8WE/Z4A2;L* .@74%_O5(-13NU<V$N3V-3);7#=C0!O_VC
M%_>%-.HC^$UFQZ=.W535V+2I.ZF@!QU&0]#2BY,GWC5J/2&/\-65T.1NB&@#
M-\N!_O&C[% ?NULIX=G/1#5V'P],.J&@#F/[.S]U:E32B>JUV<.AL.J5<315
M_NT <4FD1'JM3#1X?X5KM5T1/[M/&E0Q]12 X?\ L=OX4H_L69O^6==SY5I%
MU(J-[NQC_B% '%?\([(W5*<OAN0=$-=3)J]BG\8JG+XBLTZ2"G<#(30[A.B5
M,NF7*]4I\WBN!>D@JC+XQC[2"@"^-/<?>6I5LHU^]7/R>+@?^6@JG+XJ)Z/2
M"YV21VZ=<5*)K1.I%>=2^)9S]UZJ2:]=MT:F%SU'^T;).K"F-KE@G\8KRIM5
MNGZL:C-W</U)H%<]1D\2VB_=D%4Y?%<(Z2"O.-\[=S1LE/7- ;G<S>+!V<5G
MR^*F/1ZY@0,>M.%LO>F+8VW\12OT:H6UB=_XJS/)4=*/N]*!W9?-[._>F^;*
MW6J?FL*<+EA30%@F2F$O4?GL:=N8T:"T'JY'6IEF'K5-B:B,A!J6AHT3(&Z5
M&49CP*KPL6-:UK;NY'%*P#K"T=F'%=II.GL=ORU1TK3W)7*UWVCZ:<+E:&(G
MTS3B ORUUVGVVP#BDLM/"J.*V(;<+VJ1HM0+A14]1H,"G%J10IIISVHWT;J!
M7&_-1N/>G$U&U,5QWF"C?FHN].6@+C\M3ANI5IU%RA.:6BBD!%\])\U+\U'-
M58!O/>BG4G%,0#-+S2<]J/FI7&+]:3BDYI*8AW-'S4<TO-*PQO-)3_K2<4Q7
M$&:=\U)1\U*XQ?K2<4G-)30AU'S4G-+DTK '-)3N:3BF%Q!FE^:BCYNU)L8O
M-)Q1\U)S0A"\=J.:2EYHL ?-2<T[)HH07&TO-'%'--L!>:/K2?-2<TKC%XI"
M3124Q6#<U+]:2EP:06%XII)'2EVFEVFC0"/=)3U=N]!!IA+"C09+NXJ*3<>E
M,WFG*^>M%@(&63/2GHK]ZLKMIXVTK -0'O3^:7BEH @?<165>0EP<BMLBJLT
M6[M1<#B;_3PP/RUQVJZ8!NPM>J75D6!XKDM8L'PV%IV0K'C^J694M@5S<L#!
MCQ7?:S9S!FPM<C<03!CD4"LS),1]*:4-7&5AUJ!J!V*S"F5,RDU$4:@8E**3
M!%**8APS2_-2#-+\U Q#FFTXYIM A032@M3<FEW&DPU'C/>G8I@?UI^]:5F
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M!'5)>S4W^U9_6BR [274<=#5&757'1JYL7\S]34JN[]:8C4?6)1T:H6UJ?\
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MA1111884X$4VC;0!)N%&?2F;31@B@+#B6IA![TNXTH.: (R@I0GI4NT48Q3
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MB8[<5VFFRRG&:=@L=C:.[ 9J^,XK*L6; S6CO(%242'-02;^U-:X([TP7&:
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M\DZD+-7)ZGK[W6</G-.S0R]J_C"YRP\RN-U'Q#-<9!:JUZ9IF)K+D@D[BB[
MKW-PTK9)JNO6K#0'/(I!#[4M0!2*D!/:D$1I=C4Q:C@6I<GO3-KTTB2C45V2
M_+WI,+VJ [Z3<]*S*)MA[4>6:B$DE+YK]Z+ 3;*-M1>?ZT>>OK3L39DN&[4O
MS5%YX]:7SQZT6&39-&:C$Z=S2^;'ZT6#4#F@!LTN\'I3E)-,0]%/>IU%,0,:
ME"MB@>@8-+\U'(I,F@5A?K1\M*%)IXA/I18! /2GA&IPB8=J=\XIV 9M:DIY
MD ZTPSQ=S0 TYI/GIV]6^[1Y<AZ"J0QH+=Z>".]'E2=Q2JG/-#:"P]5!Z59B
MMF8\"G6\&[&!6W9V$K$86E=$L?IEBY*_+7<:5IV0N5K.TO3)<KE:[G2M/8!<
MK0"U+-A8!0/EKI+. *!Q3+6TV@<5I11;>U2RDB=.!3BPH XI#BI0,-U)D]J.
M*<,4Q#?FIPSWIU%2,3-(2>U!!IIW4Q789:C!--RU*&/>D%V+M%."TFX4;O2F
M&HZEYJ/+4[YJ+#L/HI!FEI#(OGI/FI<M2?-30"<T4<T50"_-2\TGS4?-2N M
M)Q2<T4Q"\T?-2<TOS5(Q.:.:.:*I +S2_-3>:7YJ5P%^M'%)S24Q"_2CYJ3/
MI1N-)CL'-%&31FA '-+EJ2E^:AB#YJ2EYI*$ 4OS4F:,FAC%^:DYHW&C-" *
M.:*.:& N6I.:7YJ3FA""DP:6C)I@)AJ<%-)DTX-4ZBLPVTQ@>U2;A4;$]J>H
M]1GST]=U,^>GKNHU&2C.*8V:>,XIC9I 1'=FG+NIIW4JEN],"<9I#FD#4C,:
M0#3F@9II+4GS4Q6)@13PPJ 9IXHT"P\GBJ-VF0:O"HI$!%(9RM_;;@>*XW6+
M/AOEKTVXME8'BN7U>R7:V!5)@>,:S;,"W%<=<PMO/%>HZY8G+86N$OK1P[<4
MQ'/>5SR*54 -6Y8F7J*JDD&E89*A(Z5-O;%5 S=J<'>IL23-N-,*&E#GO3]X
MII,:(]K"E^>G%L]*3YJ>HQ.>])Q3MI[TNP4KBL,^E+\_:EVXZ4?-VIH!1NIP
MIOS4X4#%S1N-&VEV-2L ;C2Y%)L:DQBBPK#^.U'S=J8,TX;J=@'?-1M]:4;Z
M4 ]Z+ -VTF&[5)BFG=VHL+43YZ,>M'STX ]Z+#$VK3@!1BF$D=*5@U)*C:F%
MVIADH&.(INUNU D&:E1A3T @9),=*K2AQ6KU%5I4!HLA&:C,'%=#I=PRE>:Q
MC$H:KUK,L1'-&@'HVDWKC;S7=:3=LVWFO';+5Q$1\U=7IOBB.(KF2@9[9ITA
M8#)K7"AEKRJP\;V\8&916H/'UL!Q,*5@.^:!33?LZ"N ;Q_#VF%0/\08A_RV
MIZ@>D"*,4NU/:O+7^(L0_P"6]0GXC)VGI >LX':C;]*\D/Q$<_=FII^(<_\
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M(\Y!WI1,O8T :1U.[/0TPZC>GO502$]*>"YH D-_>GO3#>7YZ&EVR4UA..E
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M&:08I>*6H7"D+"EXI"HH&)N6E#"DVK2A10+07-&X"C%&T&@8F\4FZEV"C:*
M#)I>:3%+S18D6BBB@HI_/2_-3OFI>:JXKB#-+112L,3FCFD^:D^>G85A]%(,
MTM(8G-'-.I*!6#FEI*6GH,*,FCFC!I: &31FC!HQ3U *,&BC)I:@&#1BC)HS
M30!1DT48-+0 R:,T8-&*: *,&BC)HU ,&C%&31FD 49-%&#3T ,FC-&#1BD
MA-,)?M4E+Q3U BS(:<%)ZU)Q3=X%%A7#REH,:BD,OI32S'I19C%P!3P0*BP]
M'S#K2L!/N%(23TJ+>!2&6F K!ZA9'I_G&E#%J *I1J>@(JT(\TX0CTHN!&C8
MJ3?3O+44C&->I%*XM1"14;;_ .&D>Z@3JPJG/KUC;_?<<4#)F^T_PTB_:N]8
MUSX\TBW!W2CBN>U#XH::@(BFHL!Z&GF8^8TR5E Y(_.O$M1^*LF3Y$YK!E^)
M6L3L1',U.P'NUU)$ <D5RVKO"5;D5Y;_ ,)7XBNONR,<TUK[Q#-RY;!IV$7M
M<CC8MBN%O8%60D"NF>._D_UV:ISV&1\PYH#4Y1I1'3/MO.,UJW5@@SQ65):!
M6X%("19?,J40[JIB-U^[4@>X7I189:^R'TI?LC#M4 FN!WIXGG/4TM@'% G6
MF^?$M+DM]ZCR(CU%&HK"B=#TIX+'I31"@^[3@&'2J0#MK'K2[!0-].&:8#=G
MI3<-VIYS3</30 -U.&:;AZ<,T,!<4[::;FG;C2 -AI,$4N]J3/K18!**7K1M
M-.P"44[8U)M/>BP"4T[NU/Q119@1$O2%G[U*:C:C4!N\TNYC332C/:F [YZ.
M>] WTX*>]%@&_+2$KVJ38,5"Z'M2L NXCI3UG*]35-Q+VJ(^=2 UUO%'4U,M
M^GK6!^\J1!)570'0B^4]Z9)<AN]9<:2&K*6\C=J0".58T^)%S4J64A[5+]CD
M7M1J!9MPHQ6O;,@QFN?_ 'L=*+R5.]%F!VUO+ .N*T([BW ZBO/!JDJ_Q5*N
MKS=FI68'H@O(1T(IKWZ <$5PB:E<-T:ITN[E^IH ZB74E]:IOJ8SPU92>8_W
MJG2VSU%%@+1U)ST---_,>]-6U]J>;?CI19@0M=L?O&H)+A".34LD(]*J21#T
MHLP*\\X[&LV:=NQK0DASVJJ]J3VH S);R1>]5'U*4=ZV&L%/45&=+A/5: ,?
M^T)&[T?:7;O6L=)C[+33I+=EH R3(3UJ,E#UK7.CR?W:8=%E_NT 90,8IWF)
M5YM&E_NU%_9$^?NT 4W8-TJJ]O(QX%;T.D2YY6M.WT8<;EI6 XU+"Y)^5:N0
MZ;J'\*UW,.E0IC*BKT4%M'U HL!Q-OIFI\?+6O;Z;?X&5KI#<6L8XQ5:35H4
MZ,*=@,\Z9>%>5JG/HUVW\-:C:ZN<!JC.JL_1J ,"30[G/*U"=(F7JM=$UW,_
M0U"_GO2 PA8RJ>!4B17B?<K1>*<<U7>XDBZT6 C\S4E'7BF->72_ZQJ9+JI
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M&GB)3VI4C.>:LI&O>F! (4]*>$ Z"K82/%-9%[4K@09Q36D0=:=(I JA.V*
M)9;B("LNYNP,X-1W$V.]9=Q-[T686'3WK@\&J;WS=S5::1L]:JLQ-,"]]NYZ
MU*E[[UD]ZEC!H VXKMB>M:5O.3C)KGX0^16G;;^* .@B*D<TDK*!56)F JM=
M3, <&@!TUP!WJD]P#WK+N[F4$X-4A<RD\FBXS;+(:0;1TK.CF8]35A68T"+R
MR,.E3)=.O4UG R]J")J -I-2"]6J4ZJ".&KG"),TZ,/GF@#<>^E;[II@GNF/
M6JL.>]:$72@!T9G/6ILR*,T]*63.WB@"L]W+'T-0MJD^<;JKW?F<XK.'G%Z
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M/0TQO--/\N05(H]: *FR4TX0R&KORXJ-F/\ #0!$()*<(2.M1L\_8TPO<>M
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M<GO3A.H[U,LZGO2NQE8I<4TK.*T!(II"T?>GJ!G;IA4BSS#O5EC%4;&/M1<
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M-*FF',-R:7FC::< :!7$&ZG;32C-+FBX7&[*3:>U/S33F@+C<-3AFD^:E -
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MPYL4QN@%%P/!_LVH7'0'FGKX:U*X/W#S7T5!X&T^/_EB*T8?"MA'C$0_*E=
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MSTF-<=')#)TJTEJD@X%,#7G\<7_:8UES^-]4[3M^=-;19)?NBH&\*W<GW5H
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M&HR3THPU,!PSWI::-U.J6QB'--(:G'/:FD-30#3N'>DW&E.ZFTP'AS4@8U"
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MA5=XR>E.X:B&<CO2B?/4U7>WD[&F"*1>M(=R\)%-1R,.U0!B.M!?-.XKC2[
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MD\U7@0E^:+#U)8Q<-T-6DL[J3IFM+3X$.,BNJTZTMSC*B@+G$KH-_+T!I_\
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MCK3M]#5$::L!)NS1\QZ&H^:< WK2=@$(:FD&I.>]&1WH C&:< U.R.U&#VH
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MG/>C*^E%P& &G -ZTN1VHPW8T &#WHRO<4NUO6E"#O0 W*]A1SVIQ0=J3:U
M";6]:<%]:;\P[TN_'6@0[:*;M-&^DR3T-.X!\PI=^.M)M;UI=OK2;&&\&FD%
MJ?M%+Q2O<",1-4BQD=:7)IAW]C2 E*X%0N6'2CY_6E />BX%<O)GK2B1^]6@
MJ]Q2[4]*>H$*R^M2!E-*53TJ-D/:E9@2[4I#M'2JY27/!I0K]S3L \R8H$II
M0H[T_:OI2T%83=FFM DGWAFG[/2G!#2&4WTJUD'S1@UGW/AFTESB)?RK? H(
M- '#7?@FW<$B):YC4O!4<>XB-:]9D5\=:Y[5E;#9JKB/%-3\/I 6P@KF+FR"
M,<"O3]:"Y;(KB+[9N/%.P'+R1,O2JQW ]:U+G'.*S9 <TK,+C<^M2I(!58JU
M)M<'K2L,U8KMEZ-5D:C*!]\UB L.]/#-ZT["U--]5D'\1JN^JN?XC53:6ZT>
M2#0,F-Z[_P 5,+NW>F^21TI0C4Q";6-)Y1J0 T^C4"$1FG;6'>GG--PWK32
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MF':NW-_IY'$8JO)>69^ZE '-0:<Z'D5KVT*I]X4^2YA["JSWBCI1<#4,D83
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MQU:@"+^S@.H%'V1%[4-J*KU.:A?5HNF#0!)L1>U = >E4GU!7Z U&MSENAH
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MC#>M'7I1AO6D =.M&5]*.G6C*^E, ^E&&]:.O2C#>M( Z=:,KZ4=.M&5]*:
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M!7-1E/K4>QB>M937<G]XTL=W)NZFC4#86VD;H:D^P3$?>JO:SN<<FM6-V*T
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MN'4TK,2.#3MAHV4AE5TF;HU1>1<9^_6CMI<"@5RDD$G<U.L/K4I%-*MV- 6
M1+W%+Y2>@J,H_8TFR3UI7 >8O2F&*3L:>JMW-2CIS0,@VR#O2Y8=:E)%-++Z
M4 -W4NY?2DX-)L- K@1GI3?*<]#3\$4X/B@8Q8G'>I54CK0'%.S0 M,?I3BV
M*AEE % &+JG1JX'6"<MS7;ZK)E6P:\_UDL2V#3 Y'46Y;)KE[UUR<UMZGORW
M-<G?LX)YIV A9TW4Y&'8UE,TC,<&I8X9VZ-3L(UTY[U81%-9L-I<=VJ_##(O
M4TP+(1<=*0\=*<.!S3&H0$;,WK5=]QJQWYIRE!U%58#.:-C2>0YK7#P_W12[
MX?[M*PS)^RR>M'V=Q6H9(\=*B>9/2J H>4PIP1JF:=/2F>8#TH$*BL#UJ[ 2
M.IJDH9CP:NP0.Q'-+4#2AD Q5U'!JK!92''-7DM'6F Y5)I_E$TY8RM2;P.M
M0P(#![5&\-6_/0=JC9U?H* *+1'-3V\))I3;.YX-6[6PFR,F@"_9VN<5T=A9
M<CBL^QM77&:Z:PBQCBI=QFKI]I@#BNBM[<A16=8KC%;D/W:+L 6,BI,4ZDI
M-(/K3=K>M.(/K3=K>M( VGO3L"D -.IB# HQ2TM 6$Q2T44AA1110 A--WT[
M HVBGH W?FESFEVBC H%8.:*6BD%@HHI*!BT4E% KBT444#"BBB@ HHHH **
M** "FD&G44 1[6I=II]%.X" 48I:*0%38_K2%6]:78_K2%6]:L!I!S24I!S2
M4Q#PK>M+M;UI K>M+M;UI#&$&DQ3B#3:!#MA-+Y9IF32[CZT[,!=N*;1DT4
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MD^M&12 7)-+AO6FTN&]:!B[3WI=HI.11OH%8-M&T^M&[-&&]: 0!3ZTX(*:
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MCBBUL9&QP:W[+2I&QQ2N%R.TL,XXKH;&PQCBI[+192!6];:1(@&31= +8P;
M*VHQ\HJO#:,G6K:K@5(Q<&DP?6E(/K28/K3 < :6F@&G4F M%%%( HHHH :0
M:;@^M.(--P?6J ,'UIP-( ?6EQ0+47-)00:;M/K2"P^BFA33@#0%@(--*FG4
M47 9M-. -+11< HH(--(- #J*9M/K3@#0%AU)2T4AB8-%+10*P4444#"BBB@
M HHHH **** "BBB@"IL;UI-K>M-W-ZT9/K6EF("#29HHI@&3ZTNX^M)10 9-
M%%%( HHHI@%%%%( HII!I-K>M-(!]%-VFG"DP"BBB@ HHHH **0@TW:WK32
M?13-I]:<!0T M%%%( HHHH **0TW:?6FD ^BF;6]:4 T- .HHHI %%%% !11
M28I +D^M&33<'UI<4K +FDI:3%/4!,&EP:3!]:7!]:!"T444##GUHR:*2D,*
MD6HQ4BTQ$HZ52O.AJZ.E5KD#!J1G)ZBHYXKDM23KQ7<WR*<\5RVI1 @\4P//
MM1B.37/RQL&/-=;J<!).*YJ>!@QYIV%J55XZTI88Z4[;CK3&(I6"Y#)STJN4
M.:L,:B(-,+C E."CTI1FE%*P#@OI3MK>M(%)I=C>M&HQ"#ZTVG%6'>FX.::
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MF^M0/&3WH C\[FIDE4U$+5F/6K45@YH >C*>U3K'NZ"K%MI;L16Y9Z*S8XI
M8*6<C=,U932KA^F:[>QT#.,J*Z6P\.IQF,?E0!Y;%H-TW3-7X?#M]Q@FO:++
MPY!QF)?RK:M_#]J,9A7\J /#8?#NH]F:KL?AW4.Y:O=XM%LQ_P L5_*K(TBS
M_P">*_E1<9X5'X>O.^:N1>&KANHKVK^R;0?\LE_*E_LRV'2-?RI7$>0P^$Y3
MU6M>T\)E2,J*]'_L^(=%%.6T1>@% K'+V?AM$QE!6U!H\<8^Z*U%C IQXI7'
M8@BM5CZ 5/C II)IN33L,<2:;DTNX4NX47 3GUIP!]:3KTHP?6BX#P#2TWD4
MN:0KBT4WFDVGUHL ^BF@&G4#$(--VGUI]%%Q#0#3@#111<84448-(3"BC%%
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M3/+S0 S?ZTX,/2E\NG;1Z4R6P&#4@0GO3,>E.&?6@0[8?6C;29/K3MXJM1B
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M TN*!6(231N-2X%(<>E.XQ@DHW9I<CTI P]*0!@FC8:>"*6BX#=E&T4ZD(-
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M33@#0 M%%%( HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M=[T;O>B_<1%Y;_WJ3RI/[U3CGO3@F>]/0I%<1R#^*G@..IJ?RO\ :H\OWI7
MC#&GAZ78/6CR_>@+(7>*3>O]VE\L#O28 IV'83<G]VDX/04[*^E/"@T:BU(P
MI]:E4$=Z=Y?O32"*5V(F0^]6H_K5!6(-68B:=QZ%[''6JLV!4HSCK5>8'UI:
M!H5BPW=*T;,Y(Q69CYJU;%>13L@L=#8HQ(YKJ]-1N.:YO3X^G-=9IR#CFD["
M.DL00!6B7(%4[,# JU(N1Q4%6('N".],$V[O4$T3$\&H51@>M4D*QHJ U!C
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M:+,8FP^M&T^M&">]*%-%@% HQ3@*6BXM2/::7::=Q2YHN,: :=112 ***,T
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MB[AZ4X,*BQ1S3L!."*6J^3ZTX,:5@)J*CWTNZBS ?129I:0!1110 449I,T
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MS8J!W:@"C_9Z ]!4BZ>I["I?,.>E3Q@M0!&FG#VJW%9JOI4B0G^]4P3;_%0
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M8?6F@#!]:=2!3ZTZ@0TC--V9[T\BF[3ZT( ">].Q3=I]:<*3&-9<U&8B>]6
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M8/K1C-&#ZT#$HS[4O2C<*!6$I<'UHZT8/K0,.E&1Z4=*,CTH .M&/>C-)^-
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MT KH]M)L-,5CEV\,+[5$WA8>WY5UNPT;*0'%/X6/;%57\*OV-=_Y8IODJ>U
MSSP^&)1WIA\.2CN:]&\A?04GD1_W10!YLV@S#N:B;1KA?XC7I9M8S_"*C:PC
M/\(H"YYH=,NE_B:FFTNE_B:O23IL9_A%)_9<7]P4Q,\W\NZ'=J</M8_B:O0S
MI$1_@'Y5&=&C/\(I"NSA%ENQ_$U3+=7(ZLU=D=#3T'Y4G]B)Z"D,Y9+^X'=J
MLIJ,W^U70?V*GH*7^QD]!0,QTU*7_:J==5D'K6C_ &0H]*0Z4H]*!6*J:LQ[
M&K,>H%J3^S0*<-./8T[(982YW=ZE$_O506##^.GBT=?XJ+"N7!-[T\2^]5!$
MP[T\(?6@9;$@I?,%5PA]:78?6D*Q/YHIOFYJ'8?6C8?6F!-N]Z-WO4.P^M."
MGUI#)0].$E1 4M $VX4;A4'/K1SZT["N3%Z:9*912&*6S29/K11QZT &3ZT9
M/K110 9/K1GWII7WINP^M $P>E$E1!?>EQ0!,'%+N'K4!!]:9M/]Z@"WD>M&
M1ZU5 /K3AGUH L9%&14//K2A3ZT 39HJ,+[TX?6@!U%)D>M&10 M%&110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!%M]Z,>]-S[TF?>
MJU 7%%)FBBX#L>]&/>D_&C\:+B%S1D4E%,!U&T^M-HS[T +BDQ1FB@ Q2X/K
M1CWHV^]*X!1FC'O24PL+UHV^])2X]Z5@#;[TF*6C-,+B 4NT^M'6EQ[T &*,
MT8I*!BYHQ24N*!";3ZTA%.Q[TF: $I<>]&:6@ P?6D(I=OO28H&)1CWHHH8"
M[?>DQ[T<^M%)( HQ[T4N/>F N#ZT4FT^M&/>E< R*.M)13L(7:?6C:?6DYHY
MI6&&***2F(7\:/QIN*,4@'9III:0TKC$*^])M]Z"#ZTW!]:=Q7'X%'%,S1OH
ML+4=M]Z-OO3-WO29]Z-1C\XHW#TJ/-)NH"Y+UHV^]19]Z,GUI7"Y+TI,U%OQ
M2>95!8FS1^-0YSWHP?6D%B?..]+OJOG'>CS,46 G+@TTD5"7IN2>]4D!,6Q3
M=_M4>:<''I3L NXFC#'O3@P]*<"*+ ,V-ZTH6G9 IID I ."BGA/>JQF J,W
M'O0!>QC^*EWX[UG?:3ZTOGD]Z+#+S2 U ^#WJN934+2'UHY1"S0ANXK+N+-&
MSTJW(Y_O51FD/K2L@,V?3$8]JSYM"#]& K3EG(JE)>,OK3 S7\-,3_K*C_X1
MEO[]7CJ+YZ&I$U$]P:G49F?\(TW]ZFGPR?6MY+\'M3Q=*W:B[ Y]?# SU%7(
M/"Z=P/RK86935B.<"G=B*5OX8B'55_*M:V\.PKCY5_*GQ70K0AN0>] $EOHT
M"X^5?RJ_'I\*?PBHXI0?XJGW<?>I7&3+#&G84XE%]*K?,>],96/>E9@63.HI
MOVH54,3'O3ECQU-%A7+/VC/:D\S/:D7:.I%290]"*0#-N:!%[TI7/0TW8P[T
M[L9(%QWH.34?(I1)3 &C8]ZC,#G^*IQ*OM3_ #4]11<"G]F;UH%J?6KGFIZB
MD\Q?44@*ZVY'>I!$?[U*2#WII4_WJ8#]@]:78OJ*BV-ZTNQO6C06HK0@]ZC-
MM_M4\1-ZT[R6]: (Q"5[U(!BCRV'>C!%*XQU+MS28I=OO2 3;1BG!?>G8JD*
MY'BEVGUI^*3::=P #WI:38:<%I %)M-/HI7"Q'L/K3@IIU%%QA1128I +128
MHQ0(#32/>G8I"M-#&[?>E"^])M/K2A3ZTP%VT;:4"EI7 CV'UI0AI]%%P&[:
M-M.HHN!'L-*$-/HHN @%+112 **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I,4M% 6$Q1BEHH%8;MI-
ME/HH'8C\LTGEU+10!%Y5-,)J>B@"OY!]:40GUJ>BG<"+RJ0PU-12 KF ^M)Y
M1'>K-%.X%?:11M)J? HP*+H"OY1/>CRCZU9HHN!6VD4O/I4^!1@4@*^#1@U8
MP*,"G<5B#FDQ5C I-HI#*Q4TFP^M62E-\N@"(*:=BI0E+M% %<J33=A]:L[*
M;Y= $'(H\SVJ?RJ/*% $&2:-A]:G\JCRZ (,$4;\=JG\JCRA0!$']J<&-/\
M*H\J@!F3ZT9/K3_+H\J@!O)[TH4^M.$=."T -"'UIX%+10 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110!4V'^]1MQWH\L_WJ-N.]6 M+FF
M[L4;\U-A#OQHQ[TW&>]&WWIV"P^BF9Q1O/I1J,=^-&/>FX)[T;?>@5A_XTM1
MYQWH\RF!)1SZTT/FG9%%D,**:6Q2>9[4"'XI=OO48>G ^]%ACMOO24N?>C-
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M@ZDQZ1&E86IO17+?WJOPW/JU<D+]R?ND5=M[AWQDD4K,=SL(IU[D5.'1NXK
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M3S/:BXA]%1^9[4>9[4#)**C\SVH\SVHL!)13-_M2AJ0#J*** "BBB@ HHHH
M*3%+10 F*,4M% K!1128H&+128HQ0(6BBB@84444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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8 !1110 4444 %%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>image2.jpg
<TEXT>
begin 644 image2.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 0T!VP# 2(  A$! Q$!_\0
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M7XY58=:E!'K7GUGXK+8%;]GK9FQQ18+G2"EJI!<>8,U:!R*0Q:*** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@!#TJI</@5;;I5"[/RF@#(O+K;FN;O]0P#
M6KJ+XS7):C(>: ,;5;_.[FN&U2YW%N:Z/4F)W5Q^H*2318#(FE!8U&)!39(S
MN-,"D4M )MX]*8S#TI*:31= ,8TT4I(I 1ZTP)% I^!Z4Q2*D[4K@,.*C8BG
ML*A9?>@ R*,TT+CO3UP*-0#\*7GTIV\>E*6'I1J RC%+FDHL 49I*6@ HHHH
M0!1FBBF E(033J*D"/8?6C::DQ24:@-Q3@!Z4W=[4F\^E/4"4**78*C#-Z4H
M+468$FS%'3M3033@_M3U -WM29]J=O'I32P/:F*PE)BEI*8PHHS29H%="TGX
MTA!I-A]:0:"TF[VI-IHSCM0.PN[VI0?:DW>U*#[4[ .%+24N* %W#THW"DS2
M&D*PI(II^M(5)I-A]: L%)N]J<%IXQZ4: 1[O:E!]JDROI29'I0 E%%%%AA1
M1^%'/I3 ,48HHQ0 N<4[>/2F@XIV\>E)@+N]J.M)Y@]*0M0A#L>])3<TH-4P
MU';O:E#CTIN_VHW^U2,D#"G9%09-)\U%F!*6%,+CTIN32[O:@EH3=[4G6G;A
MZ49IH$AF*,4ZDIV'83-&:,^U&?:@0M%%%(H7-+N]J*4'VHL(,Y[48I01Z4N1
M1J2)M-&,4[-)FBX#<CTHR/2EW>U-W>U%T.P4VES250PI,^U+29I"#-+29I:!
MBY-.W4VES[4,!V\>E&[-)N]J-WM2T#47%(5]Z3)I,FF &FY]J7-)F@0F:,TN
M:2D(,T9HHS[4@%S[4X<TW/M2Y/I3&/VTA6DYI.:-1C6%,S@]*D+>U-+CTIA8
M57QVJ42BH-P]*:6HL@+?G@4PW(':JI;WJ)GHL!<:Z7TJ)K@'M50O29)I6"Q,
MTN:;YE1[2:D1#Z46860X.?2EW$]JD2/VJ=8Q_=IZ@5>3VHV,:NB(>E+Y(H S
M_+--*&M(Q4TQCTIV SMI]*:4;TK1V?[-+Y0/:E9 9GEM2>4_O6L(!Z5*D"_W
M:+(9B^2_H:40R?W370)&@_@J78G_ #SI7 Y]87]#4HB8=JV2D?\ = J)DC]J
M0C-Y6E%R5[59D5/454DP*+ 3)?'-6XKT5CEL=J3SB*8SI8[M?6K"WZ+WKDQ<
MO[U*L\A]:=Q'6#5D6@ZV!T%<U&97/W36M8Z?+<, 4- RR^NOV4T1ZU.[ !6K
MI-,\&M=XRO6NQT[X8AP"5I <1ITL]P1\K<UV6F:/+/MX-==8_#Y+;!VCBNEL
M]"2U ^4<4(#F+#PW(,$@UTEEI#18K;BB1!C;5A=O]VA@0V\)115L4@IU2 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !32U.I,4 -WT>93L"C:* $#4M&*6
M@ HHHH ***3(]: %HI-R^M)YB_WA0 ZBF>;'_>%)Y\7]\?G0!)147VB+_GHO
MYT?:(?\ GHOYT 2T5'Y\7]\?G2^='_?% #Z*9YB?WA2[U]10 ZBF[AZTF\4
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M HHHH 3-+112U ****8!1110 44446 2BEHI60!1113 **** "BBB@ HHHH
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MLP/_ !K^=+E86-2BJ:ZA$W1A^=3"X1NA%%F!-13!(#WIP(-*P"T444 %%%%
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MY%3Y'K4C%HI*0@T .HS3-II-K4[ 244S!IV#0 M%%%( HHHH **** "BBB@
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M!V+12V!^Z* (!V%8KW#YZT@NG]:6@K&^OD^@J>/R?05SRW;5:BNS1<-3H42
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M=C6.M6"]4%1-XCTY?^68K,.BR'J:9_8)/7%-1$7I?%%E_ E49O$ZG[@(IRZ
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M2$9H 8744GGJ*1HR:B,#4@)Q.IIX<&JZPL*E5"!0!)FEI *6@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH *,444 -**>HIAMXVZBI:* *K6$#]5%5WT
M2SD^\@_*M*B@#$?POITG6(?E5=_!NF-_RQ'Y5T=% ')OX(TP_P#+$?E5:3P'
MIYZ0C\J[6B@#SV7X?69Z1#\JI2?#J ](A^5>G%A3=XH \M_X5PG:/]*!\.E'
M_+/]*]2WBE!!I6 \P7X>)WC_ $JU'\/K?^*(?E7HU+18#@D\ 6/\4(_*I?\
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M32'8MB4]C3A*Q[U2W-2K(PI:@7@2>M+L!JLLX'6I!=)3N YHQ492G&Y0TPS
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M^%:+B/,LSGUHV3GL:]+?3=+'11562RT\= *+DL\\:"4]0:@>V;N*[V:VLAG
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MBLAA5?2F%%I68=JC+&BXK 5%-.*<#GK4@5.]%PV(,BCBK.R.F%%[4[A<B%.
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M?OT0_E7TC%X-TZ+[J#\JN1^';./HH_*G<#YVM_ FH-C]V?RK9L_A]>9&Z/\
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MU&K&A::0TQ'%=#8^#_/QE:R;'5!$1S75:;XE6+'(H*)HOAXKKDI^E4;WP*D
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M% !1110 4444 %%%% !1110 4C=*6D;I0!0NSA37,:DX&:Z2].$-<=JTF-U
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M&BPBQTJ"6RC':K>YZC=O6@+F1/:H*SIHE6M^3RC]XU1F2W(ZTAF!*RK51K@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M[D'I3%8:1ZU$P3O0[LW2H&5S2*!Q%W-0D0^M.:%CUJ,VU M!<Q]C3@X[4SR
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MFF+4V!;6_P#>%.$, _B%9 ,GO4BF3WIW'9FL$A]13PL'J*R0TGO2[F]32 V
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M0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M%2++5,.:D5R:>HB\K^]2JP]:J)SWJ=$'K3$3AZ=O/I344>M2@"@")B3VJNZ
MU<8"JTBCUH&4WA7UJN\8'>K3J/6J[@>M [E9N*C)J1ZB-(!M*![TF*4*,]:
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M:I$ER-_>K*2UGIQWJ=&Q3%J7?,S36YJ)6S4RC/>@-2!T]ZJRJ16BR#'6JDP
MH S9&([5"7]JL2N!VJJS@T##=3E/O4?![TJISUI%)(M1_6K*BJT0Q5M#[4@
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M8I/+%/*Y[TW;[T<H#"HI,>U/X'>DW"GJ%QNWVI?+IP84\$>M-$C!'4BC':E
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MV.:\TL[M@1S76:7=$E>:3*/0K.7=CFM9#D5SFFR$A:Z&(Y%2,FHHHI %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %)FEHH 86I/,]J?@4;10 W?[4X&C
MI: "@]**#TH I77W#7&ZST:NRN_N&N*UL\-S0!Y]K&,MS7(71 )KJ-9;EN:X
MZZ;D\T 5)9,53DEJ60U5>@")_F[U6>+=_%4K@^M5W#>M,")X/]JH&CP>M2N&
M]:@;.>M $T"9<5TFFV^XCFN:M_OBNFTQN5YH [+3+#=MYKLM,T_&WYJY'2Y/
MN_-79:9)]WYJH#K]-MMH'-;HB_=8K$TYN!S70Q+NCJ0,._M"X-<S=Z8Q)YKO
M)[4N*R[C32<TTP.1AM3"V:V+2]$&*?/8%,UGRCRS3T$=-;ZXH %:,6J"2N%B
MN0'Q6W8W )%%D,ZR.;S*F )K/M'R!6DG2IN N*6BBD 4444 %(W2EI&Z4 96
MH?<-</K(^]S7<7X^0UP^LJ3NH X+4T^8\U@3(<]:Z#4XVW&N?F5@:=@*CQU"
M4J9V(J%I/:E8=V)MH_&F%LTG/K18>@\FFEJ3'O2XIAH&ZE!-* *<%HT%H(,^
MM/&?6D">].">] :#A2FC%!I"(SFF\^M.--Q0,<,^M/%1 T\/1<+#S3"?>@MF
MFE">].XK#2?>F%_>G& ^M1F$CO3L@#S*/-IA4BDP:=D(F$A]:7S3ZU"%-.\L
M^M2&I+YY'>C[7BHO*-)Y5-")OMM'VTU7,=,,9IA<N_;3ZTHO/>LXJ1WI,D4[
M!<U!=BGBX!K)\PBE$QHLB37#Y[TX#/>LI;@^M2K<'UIV"[-''O2U268GO4ZR
M46"Y/BEP?6HU;-2 9[U<42. ;^]4BDCO30GO4JI5VL)H42&EWYI0HH(%.Y(W
MD]Z38?6@_6FY]Z-1V%*>])MHW>]&X>M ]!,4F?>D8CUJ,GWI 39]Z<%SWJNO
MUJ=#[T6 D\JF-%4X/%1R&E8=R!EQWI />F29]:B&0>M%D%RZ@%3*!5)'([U.
MDM%A7+044[9[U"KYJ49/>E8=P*>]0L"*L;3ZTTK0T!2?/I4#@UHE1Z5&T(/:
MIL,RW0U79#ZUK-:YJ)K+WICL9+*:B(Q6JUG436=,#-R12>815\V?M49LZ5Q%
M3SB*<+DBIS:>U--M[47 :+H^E2+=&F?9_:G"W-.X$RW!]:E6X/K586Y]:>(2
M.](=BVMR?6I%N:IA"*D4&BXK(N"8FI Q-5XUS5E(_>F%@R::7J0QU$RXHL A
MDJ,G-*13<55@&E2>])Y9]:?@T8]Z8AOETOEBEI12T"P".G"(^M**>![TQ6$"
M$=Z>.*!]:<"* L+D>E'6C<*.M(!"OO32OO3MI]::5/K3)&FB@T4 %+B@+FG>
M7[TAZ$3"HV J8I[U&5I#L0E0:88\U,13"II!:Q"8?>F^7CO4I4^M,(QWH%<9
MTIN[VIQ--R/2E<8FZC<?6EQFE\OWI7*&9-)4GETNVBXKD=+M)J3%&*0)C0A]
M:<%/K1CWI<>](JPHIU-I13NP' >].">]-"^]."GUJD(>$]ZE5:8JGUJ113"Q
M*@JRGUJNHJ95/K0*R)^W6HI/K3MA]:8R&BX616<"H2H-6FC-1F,T7$5C%GO2
M>4?6IS&?6HV4^M%@N1;<4TL!2MQWJ!WJ6&HR:05G3/5J5LU3E7-*X%<L2>M/
M0$TSRSFI47%%V.Y*L=!CIZT&B['=$##%,)Q4K+GO4)C]Z+E)AYN*#./2F%,5
M&10,<T@:H&3=4F*,4#Y2$0G-6(UVT 5(M%PL2H^.U2AZA!]J>.:8B8$&GC%0
MA?>GA#ZT[(EDZL*D#CTJNHJ5:5D0RRK U*I%5EJ91[T6%S%A3BIEE JK^-+N
MQ18?,S7MKH!AQ75Z5>#*\5PUO(-PKJ]*D&5I-#4F>CZ7>C"\5TT%WD"N-TIE
MPO(KJ;8I@<BH<2TV:BS9J4-FJL9'K5A:EHI#Z***0PHHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "@]**.U %*['R&N*UN,D-7<7"Y4US.IV
MA<&@#R36K=B6KCKN!@37JVJ:06W5Q^H:.RYXH X:4%>M4Y),5NWUD8R:P+A2
MK8H A9\U"P)[T[!)H\ICWII@5V0^M1%:MM"WK4+1D55T%A(N&K9LIMI'-8H^
M4U8CN-O>BZ$=OI]Z01\U=CI%Z3M^:O*+6_VD<UUNC:ERO-%QGM.D7&X+S78V
MAW1CFO,-"O\ (7FN_P!/NP8QS2 V_+R*AEM\BGQSY%2;MU*X&!?6Y -<O?1,
M">#7>7$.\=*Q[K3PY/RT7 X=0XDZ&MO3V((S5J33 ISMJ,0^5TIW#0Z.QD4
M9-:T<JXZBN+2[:,_>J];W[''S46 ZH.#WIU9-O<%L<UHQMD4K 2T444@"D;I
M2TC=* ,V]7*&N0U6#=NKL[L?*:Y?44SFFD!Y_J5F2QKG;FTP37:ZA'R:YN\C
MQFG8+HYN:(#M5)P,]*U+H8)K+DZTK 0E<TWRV]:D)I,^](>@P1MZTX*14BXJ
M0 4 0T9J8J*B=/>@0FX^M.#>]0E#ZTJJ?6@"P'I=V:C7BI 1Z4QB8S2>73Z3
M!]:+ ,V4=*4BFDTAZ"TN/>FYI0#ZT78.PNT^M(5]Z7:?6D*GUIW)&%11M%+B
MDI *$IPC]Z9S2@GUIV8$H2EV4U6-2!_:FKDNPQHZA:*K6<TAC+50M"@T-0LF
M*TC;L>]0M;&F(S6XIF36@UO[5"T'M0+4JYIRL?6E>(U"5([T#+B28[U824>M
M9)<KWH%T132):-]) >]3HV>]8$=Y[U<BNO>K6@6-M0?6I5^M9D=S_M5:CG'K
M3N#+HI"*C28&I-P-!)$R'UJ(HWK5K;GO33$?6B[&5#N'>F%R*LM%4+)1<=B!
MI349E/K3Y$JLZ'-(+$RS<]:LQS^]9H1L]:L1J:=PL::W Q37F!JNN<4Q\T$Z
M#G;/>HL^]0/N]:B&[/6D/0T%;WJ=7K-1R.]6$EHN&AH*]3*WO5!),U84D]Z+
MCNBX&]Z7=4"@^M3+BE<-!=WM1C-/&*7BBX:$1B)[TPPGUJ<J?6F,C>M!5R Q
MXJ,@5,P-0MFF!&0*C.*D9":C,+'O2L W HVKZ4>2WK2["*5D FQ?2D*#TI^#
M32#3L SRZ/+]Z4J?6FE6]:!#PHIP"U!R.] )]:!EM<5(#[U47)[U,JGUH FW
M>]-+BF[3ZTT@U2$.+CTII(IN#1M-.PA*3%/V'UHV'UH$,I<TNVC%%A@*<,^M
M)M-&P^M%F*['\^M.!J/:1WHY%&H79*&I>M1;J<&HU#4EVGUI"I]:9D^M&3ZT
M]1#CQ29%)24KA<=FCGUIF#ZTF#ZT:#T'DTTL*:<^M-- : 7![4P\TI-1FI"P
M%3ZTPJ?6@Y]:82?6@5F!6DQ2%J-U2PLPVTNT^M)R>]&T^M*[+0O([T;L4F".
M])D47 =OI<YIFX4HH!,=@^M+BDP?6CIWI7*'4HIF[%*'H"S) I]:<%/K488T
MX9]:I"LR4<=ZD#XJ 9IXJ@+"R5,LGO505(H/K0(N*Q]:>*JH#ZU9C%)B;'8]
MJ8R^U6544UU%224'6JT@]ZNRI5&53ZT[L=RK(V.]59)<5)-D=ZI2/B@0K/FH
MRN:;O%/4YI ,\NG 8J3%-(HT*2#>!2%P:::;3T&A3S3"#ZTN/>FE3ZU-RAIX
MIA84K"HS310[(-&,TS%* ?6C0!X3WIZI3 I]:E6BZ!C@*>!2*:>*$2 0^M."
MGUI #3@IJD*R%&14@>FA:D 'I3)=AZMFIE!/>HE6IE4^M,D>$/K2[?>@(?6E
MVGUI,1-",,*Z#3Y"".:Y^+J*VK)L$5#*1V>G7+C'S5TUG=N<?-7$V,PXYKI+
M*8<<U#N6CKK69CCFM:%LBN?LI <<UNVY^6IU+1:%+2"EI#"BBB@ HHHH ***
M* "BBB@ HHHR* "BC(HH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHS10!%(N167=6Q<'BMC&::8
MP>U '%WNFLP/%<KJFE, >#7J\MLA'2L#5+!&4_+0!X7J]@REN#7&7T!5SQ7M
M.M:1NW82N#U+0VW'Y#0!P+#!Z4WS,5O7.D,I/!K+GL2E-6 J;\TTIN[T/$5[
MU"S,O>GH YK?WJ%XBO>@S-3,LU "HS*W6NATBZ*,N6KGA$Q/6K<#M%WH ]<T
M/550+EA7H.F:W'L4;A^=?/-KK308^;I71Z;XJ8,HWTQ'T1:ZFCXP16O!.''6
MO'=%\1>:5R]>A:3J2R!?F%)H9U&W<*B>$'M2PSHPZBIMRF@#*N80%/%8%\VS
M/%=?*BLM9%W9H^>*=PL<1/>LK=#5BSOF)'!K6GTR,G[HID=G%$?NB@+&GI\Y
M8"N@@;*BN<@GBBQTK1BU2,<<4K ;=%4([]7Z5:24-TI6 EI#TH%!Z4@*-W]T
MUS&HJ<'FNGNONFN9U$'GFF@.1U!#D\US-[E<\UU&H Y/-<O?+UYJ@L<]=S8)
MK)DN 2>*U+Q1DUE.@W5+3 ;N+4H1CWI52I@A]:!Z$:H1WJ0-B@C'>HR^*0B;
M?FFE2W>H?-%.$E "F%CWI1$1WHWGUI=Q]: '#BE\P5'24 2^8*3?[U%M-)M/
MK1<HDW>])FF;33@*!,=3@I]::*< ?6@0NT^M,)([T_:?6F%#ZT R,RXI/.'I
M2E!2;1Z52(NQP?-.7FF@"G#BF43**E514 ?%/$P':@31. *7BH?.S1N)H1-B
M;\:3&:C"GUJ55]ZH!ACS436Y-75 I^T&G<#'>S8]*KO8M70>4#3&M\B@5SF9
M+)A59K5A7326IJI)9GTI@8'E,*<-X[UIO:$=JK/ 13 BCE<'K5V*X;UJGY>#
M4J<4 :L5S5I+C-9*2 5.LH]:.85C767/>I-WO66LA]:D$C>M%QE\GWIIQ53S
M&]:/,-%Q-,F:,&H6ML]Z3S#3?,;UJ>8+,/LI'>G"/;3=Y]:>#GO1S#L+NQVJ
M)VS4P -+Y:FGS 9[@FH]C5J?9@:8UMBG<"DHQUJ9<4/%MJ+D&E<1:4U,N?6J
M:$^M64!]::L+4L+N'>I%<CO4(4^M.&:>@)EA9:D63-50:>&I:#T+8;/>G&JH
M8^M.W'UH))2!3"HIF^D\RF- R5$8CZT_<31@GO2'=D7EGUHVXI^UO6DVF@5V
M-XIIQ3]II-AHL/4B-1D&K'EFFF,T6'8K'--JP4I-E.P#5!J95/K30AIX4^M
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M\U2V:(]&TUR<<UU-H?E%<+I,QPN37964WR"I9:-8=*6HDD!%2!LU-ABT444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
MTH#UIU% $+6Z,.E4KG3$E4@+6G11<#AM2\*O< [5_2N1U'X?7<N2J_I7L],=
M PZ4[@?.-]X"O(<DJ?RKF[WP_+;$[D/'M7T_=Z8LX.5ZUSM]X/BN,DQ_I33
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MT[$= %3::-C^M62!VJ,ANU [D6QZ,$4\AJ3GO0&XVBEXHXH"PE%%% @HHHH
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M4[71I4QD5MVMBZ8R*5BD:-N3M%6ATJ&*,J*G%24%%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% ##GM49$G:IZ* *V):< _>IZ* &#/>G;0>M+10!&T2D=*H7=@)4(
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "D(I:*
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M*M1W('>LOYZ4,U,3-M+I?6K"70]:Y]7:IE=Z>@C?%T/6G?:A6&'DIWF/WIZ
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MV>WBN@M,8%2QHUHONBIZABZ5-6904444 %%%% !1110 4444 %%%% !1110
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M4BG&*XG3U;BNLT\' I,=SI(2-HJ>JT'W15D=*D84444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MD:%14PS4>6IPW4ACZ*3FEH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M7UJ02)ZTKC.2N?!UE@D(OY5A7GAJ"'.U!^5>DOL<8JC/8I+VI<S$>4SZ7L.
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M!3A2*2%HHHI#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MH7I_A-0\'4'[0]<NW7!KG[V1>:\\D^(]W)U!JE-XYN9.H-3]5DA.HSK+ZYV
MXKE]0UB2+.,UD7/BF:4<BL.[U=I<YI?5V3SLUW\3SI)C<>OK6WI7BEBR[G/Y
MUYO+<;FSFI8+EE/!-"P[#G9] Z1XC@8+NE_6NMMM=LV4?OA^=?,]MJMQ'C:S
M?G6BGB*^C'!?\ZM89=Q\[/I-=7LVZ2BGC4K4_P#+05\V_P#"8ZE'T#_G2_\
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M<*<"?2@I,%)]*F4TP'VIXJ&:)CJ6DHJ"A:***!A1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M.IJ02 _Q5+SF78?LS4^V@=J3^T!Z5G@@]Z#&3TJ'F[?0/9E_^T4[XH_M&/\
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MJ&:)!BEHHJ2[!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MW904OGDFKD+8QFD:,CH*@<NO0&G= ;,4L0'.*=)-#CC%<ZTT@]:;]HD]ZJZ
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M4M24@HHI,TABT4W)I<TKBN+1113&%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M;2&29I<TP+3@*0PHI:*0Q**6B@5@HHHH&%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MZ[>RNT9!\PJ&-,UZ*B692.HJ0,#2*%HHI,B@!:*3(]:,B@!:*** "BBDS2N
MM%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH ***3- "T4TM3?,]J 'DTTN?2D#^U.Z]J
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M'Q,C@ L*Z&UU**<#.#7AFE:BV1^\KO=&OB0OST/4+GHIAAG3[HYK%U#P['<
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M*&SVJ( ^E3(P'44 .&?2GC/I3UF0=12FZ0#H* &AB.U!D/I3&O4':HC>J>U
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M0U+FD%Q:***!A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?:A!9L792[12"3/:G YJTT2TPP/2C ]*7%+5$V8VEI>*.* L%+112*"BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M;J@J,Z/:'_EF*OTM(9F'1;7_ )YBD_L:V[1BM2B@#.72H%Z(*G2RB7HM6J*
M(A @[4\(!VIU% "8%+2%@*K2WJ1=: +#'BLK4)RB$YJ.X\06\8.2/SKG]3\2
MVSH0"/SI7 Q];UAX=V&K@=1\2RAR-];&MWZ7&[;WKB;NSDFDX!ZT!8TX=4>Z
M;!;.:V[/3/M>"5SFL;1]*DWKE3^5>F:%IP 7*T60&=8^%ER#Y?Z5U&GZ$(<?
M+716=G&$'RUH+"@' HL!3M+;RP.*T%&!0% I:8!1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M 6/N*>$B]*-!Z%(&G9-71%'Z4>6GI1H(I[J<"OI4Y$8[4W=&.U&@# JGM3A
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MT: 527[4 R&M!8%[TCM#%][%+F0TBD%D/6I A'6FRZQ90#YB/SK(O?%UA&I
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M=);>((9 ,-^M(JYTM%9\.H))C!JZCAA2&/HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBDS0 M%-W@4AE44 /HJ$W"#O3#>Q#O0!9HJH=0A'>D_M&#UH N452.I0^M
M,.HQ]C0!H45EG4!V-1G4#ZT ;%%89U,CO3#JI]:+@;]%<\=5;L:3^TY>QI7
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MJW'IT\?04["L9 T)%&0M(=-,?05T MK@=12_9G/WA3L!S+6T@X JO)IDTO\
M#77"U3^(5/&D"=:=A'G[^%YY?X?TIB^$)D.2GZ5Z:MS:(.<5!=:C:!>"*+ <
M'%H7D?>6K(@BB'(J]J&J0\[37.7.I;FX-'*(ORSHG2J;:BRGY3519O-/-6X;
M5)#S2Y!EZPU.8L.:[32+R9MO-<O8Z>@(P*ZO38?+Q@4N4#L;"65E%:T;/CFL
M.RD95%:T,I(YI68K%U3ZT[*TQ"IZU(0N*5V.PPD4E(X]*C^;-.X6+"A>]2JD
M?>JR9[U93'>ES@.*14PK'4N$I#&II<XTB'"YJ1=M+Y0HVXHYD.R)5Q0<]JBW
M8I?,HYD%A&9^U1;I*EW49%4FA<I&.>M2!8N])E>])F.F2T3JL-2J$[564Q]J
MG0KVII,G4D[5$[&I>,5&V.]4(KM(:0,QI[;*!M[4[@*H<U((WH4GM4JEJ-1\
MHT1GO4,Z+M.:M@$]:BFC!7FBXN4XK6T3:U>8:[&F6KUS5[="&S7G6MV<9+<5
M2%RL\MO84WM5 PC/%=/J%HBLV*P+D>63BJ0N5A;PG<*[#1$8%:X1;MU?@UU>
MB7LA9>:JX<K/7M#=@%KN+29M@S7G.@W)(7-=Y92 H*5B;LV X/6@[*C0@U*%
M4U(B%]@J!F45:>-:KO"*I!H,5US5B-E-5_)YJ15Q3:"Z19^3%4[C;BINU0R(
M&J>5CYT8UV5P:YC4\$&NSGM5(-<YJEH IQ1=ASH\TUB'=NKB[ZU)<X%=_K<9
M3=BN%U!Y YQ1<+F.;>0'BG*LXZ5)YDA-2(7HN-7"+S\\UI0!SUJM%N[U>B;U
MI-E:EE(P1S3C"E(L@ I&E%*XQC6\=-^SPBD::F;\TTPY281VXZT\?9A4 3=3
MO(%4F0XEE6@'2I!)'VJB8RM,WLM5<5F:)?/2HV#GI5,787K4HU2!/O&E<5F.
M*2U&7D3K1)K5KM^]6;=:Q"<[32N-19>:[9>IJI-=ANIK$GU(N?E-1QM/,>,T
M717*R],\;GFJX2/=5F#2KJ?HIK2A\+WSX(0_E4NP:E&W '2M.)W XJY!X1U'
MC$9_*M*#PCJ?'[L_E2&KF([R8JI)O)Z5WEMX,O&QYD9_*MNU\"HV/,3]*5AG
ME4$+L_ -=#IUA.Y&T&O3K7P-9)@E.?I6W:^&+.#&U1^5'*!P6GZ/=G& :ZFP
MTVYCQN!KK(-.AA' %3%$0<4N4"G9(T8&ZMN&X0  FLEW --6;GK2L6CH1<(>
M]/$BFL>&7-7HCFDT,N;A1FHUQ3Q2 =1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MIU%(8F*6BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MLJ'I4\3.3TK5NXX 3@BH8Q"#U%%T&@L*,15KR>.34T'DXZBKH2%AUHN,Q9$
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MK:>%+;O)30C 98&Z$5"T,1Z$5TTGAJUC&1)6;<:9%#]UJ8C'-NO8TWR,59=
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M!U]: )$L U6XM.I\,B<<UH0RI0!#'IY]*M)9$=JN12K4WF T:BN4UMP.M/\
M(3'-3L5-1D#UH"Y"UI&WI4+:9&WI5DY'2F%Y!T%%A7*QTB/VI!I2 ]:L&64=
MJ;]H<=118+EFRTU1(.:[;1;785Q7%6UZ5<9KJ-,UE8R,FE8=SU#20RA>*Z6%
MWQTKSW3?$L:A?F%=):^(XY /F%2%SIPQIU9D&IK+T-7TE##-(9+1110,****
M $II)I]% $>YJ S5)BB@!H)IU%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2$XI:8W2E<!#)BHGN
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MK1S(+,N1-Z&KL;FJ$46WO5Z(X[4KE)%E7:I 34:O[5(&I,8\4M(*6I ****
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MV:I>1,?6C[-+ZFG=BLB[Y5N.FVC;".F*IBVE]33OL\OO1=A9%K]W[4GR>HJ
M6\OH:46LA]:5PL2_+_>HW =Z8+23WIWV5_>BXQ?-([TAF-'V=_2G?9F/:E=
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
+ **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>image3.jpg
<TEXT>
begin 644 image3.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 0G!W,# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHI*3 ****E +1115@%%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4AI:2DP"@44M) %%%%4 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4E+128"4M)2TD 44450!1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444E)@%%%%2@
M%HHHJP"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** $HHHJ0"EHHIH HHHI@%%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 E%%%0 M%%%4@"BBBF 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 )1114@%+1130!1113 **** "BB
MB@ HHHH **** "BBB@ I*6DJ6 M%)2TT 4444P"BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 2EI**D!
M:***H HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHHL 4444 %%%% !1110 4444 %%)128!2TE%*X"T4E+5 %%%)F@!
M:*** "BBB@ HHHH **** "BBB@ I***FX"T444T 4444P"BBB@ HHHH ****
M "DI:*3 2EI*6D@"BBBJ **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBBBP!1110 4444 %%%% !111
M0 444E "T444 %%)2T %%%%( HHHI@%%%% !1110 4E%%2V 4M)2TT 4444P
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I*6DJ6
M 4M)10F M%%%4 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 444AI, I:2EI( HHHJ@"BBB@!M%%)4LD6BBDI#N+2TVEJD
M),6BBDJ@8M+24M(:"BBB@84444 %%%% !24M)4L HHHI#"EI**:$+1115 %%
M%% !1110 4444 %%%% !11118 HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *2BBI 6BB
MBJ **** "DI:2DP"EI*6A %%%%, HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBDH **2BF2+110:!A124M D+24M)4,H*6DHI7 6BBBJN 4E+
M24I, HI*6H3&%%%%5<!:*2EJDQ!1113 ***2DP"BBBIN,6BDI:I""BBBF 4E
M%%1< I:2BFF M%%%4 4444 %%%% "4445#&%%%% !2TE+5(04444P"BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***0TF 4M)2TD 44450!
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4K %%%%, HHHH 2DIU)28F-HHI*1(4M)10 ZBD%.%-#04M%%,H***2DP"EI*
M*28"T4450!11118 HHHI6 ****+ %%%%, HHHH **** "BBB@ HHHH ****
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MQ!1113 *2EI#4M %%%%)#%HHHJA!1113 **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH ****5@"BBBF 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !24M)4L!:*2EII@%)112
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MFJ=$$-)III:0UYDJNINHC2:4&F&G+4.J7RCA3P::**S=4.4>33:04\5*JDM
M.*=NIIIN:VA6U%84G)JQ;]:K5:@ZU[6$J:F,XFM;GBK:FJ4'2KBFOJ,-*Z.2
M2)!2T@I:]%;&04444P"BBB@ HHHH *2EI*F0#3333C4;5P5I6+1%)5.6K<E5
M):\:O,W@BA-51NM7)JJ$<UXE>K9FZB(!4BBD44_%>;*MJ6HCLTUJ6@U+K#L1
M$4RI2*B:I58=@S2TT4\5UTJI+05/%UJ&IHAS7KX>9C)&C *NH*J0"KJ"O:H,
MRDR5:DIBTX5ZM-F#'44E+72B0HHHI@%%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 E--.IIK"HM!H::C:GFHVZ5Y5<T14G/!
MK-E;FM"XZ&LR7K7S.-.RB,ZTF*!3L5\_5>IU)B9I0:8: :Q95B2@FDI#20K
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M&DI"N/HI!2TQA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MP=16A&>*SX:O1GBOK<#L<51%@4ZF+3Z]R&Q@PI*6BJ8A****G884E%(:SE(
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M3 ZFBBBI- HHHH **** "JMU]PU:JK=?<- ',:C_ !5RU[WKJ=1_BKE[WJ:
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MVG<+D6*,5*5INVF%R.BI,4A% 7(Z*4T"I* 4\"@"G"E<EC2*9CFI::16D)$
MIJ4-4/2EW5Z-"6IG(FWU8A;FJ0-6(37T&&J:&4MC5B;BK -4HFXJRIKU*<[G
M-*))3&I_:F-15V(15FZ5GR'FM":L^3K7S^+.FF1TA%%!KQ*CU.J)&:04\BFU
MSLTN.%%-S2@UE)!86BBFYJ '44T&GUT4T1)"5)'UJ(U)$>:]7#HYY(T(NE6!
MTJ"'I5D#BO9A'W3%L8_2J,]7W'%4IA7%BUH53W*)ZTE.;K49-?/U5J=D4/HI
MH-.KGL6%--!-)FBP(2E6EQ15H8[-,:ES1UK1,EH9BGH.:4+3U'->AAGJ9R9=
MMA6I%TK-MQ6G%TK[#+]CAJO4E%.IHIU>]#8YV%%%)5MB U$QI[&H7:N#%5.5
M%Q1'(U5)'J25ZI2/7S>)Q!TP0V1JKM4A.:C(KPZ]2YV4R,TVGD4RO,F]39"T
M44TU(Q:*:#3UJ6#' 4_'%(!3NU.+,V1M4=2M3,5W48W,V %3QK4:BK42UZ^'
M@839-$E7(DID25:1:]W#TCEDQZK3P* *=7K4X6,V H/2EHKK@B2!Q4#+5MEJ
M(I6J8%4K3=M62E)LH8[E5D.*K21YK3,=0O#4B,DQ<T>4:T?(YZ4X6_M2N!GB
M(U((JO"W]J<(/:F)HS_*HK1\GVHIDV-&BBBD6%%%% !1110 55NON&K55;K[
MAH YC4?XJY>\ZFNHU'^*N6O>IH Q)_O5&O6GW!^:HTZTRKDXHQ0*6BQ(F**6
MC%%@)$I_:F+4G:F!"PI!4A%-Q4@&>*A<U(34+FF0T2V_WZZ&P[5SMO\ >K?L
M6Z4".IL>U=#;?=KF[!NE=';?=H*1;HI**0[BT4E+0,CD^[65=MC-:DI^4UCW
MIZTT!AW\G!KEKY_F-=!?OP:Y:^?DU3)96+<THJ -DU,O2A B04[BH\TNZDQ,
MDIII,TA- (:::32DTV@;8X&I14(J0&@0IIG>G$TWO3*0]!S6WI8^85C1CFMS
M3!\PJ6,[C2_NBMD=*Q],^Z*V!TI (QP*J32X%3S' K(NY]N>:I 4M1GX/-<?
MJ,V2>:VK^YR#S7+WLF6-#)9GSN2357!+5:(W&@1<TT-"1+5I!3%3%2#BK0KD
M@/%,<T9XJ-C38P'6IT%5UY-6HQQ6+!CQQ06%#G JJ\N*S8(=(:K-UIY?--(K
M"H]"T0L*@D%62*A<5X]=:FL447ZU&:L.M0L*X)&T!E+3:7%1<V%I,TAIN>::
M'8DI<4B<U*%H$0%:0BIRM1L*N*U,Y#5ZU>@-41UJY":]"@C"1>'2FD'-*AR*
ME"9KV*1@PA<K6M9W6&'-8S?+3H)]L@YKHN(]$TNYSCFNDAE!45P.E773FNLM
M;C*CFN:HRD;&[-,:HXWR*>W2O(Q#-(D$E4I35R3I5"8U\[BV=5,A)YI,TPMS
M2BO J[G4AU!/%)32:S0["&D%%%4D42+3JC!J1:U42&+BG 4H%%14B3<::B-2
MM435SB$%.IF:,U2+2%(IN*=UHQ6T'J5<*2C-%>C19$B2(\UJ6YX%9<?6M" X
MQ7OX)ZG)41IH>*E%5HVJ=37T=%Z')(?11175<D2FFG4PUSU7H-#6J%S4C&H'
M->)BJAK%%>4\50F-7)6K/F;FOG<3*YVTD1&@4T'-2 5X]0Z113A3>E -9":'
MBEI!2U1(AIC5)49JX:L!!UJ>.H!UJ5#S7LX2!E,O15=0<50@-:$?2O=I4]#D
MFQV*BD'%3XJ-Q3G E,SY5JI(M:4B52F7%>9B(Z'1!E,]:5:1^M(#7A5HZG2F
M3 T^H0:=NKB<!V!JB/6GL:C--0*6@\4ZH@:>#3Y!-CZ<*8*"<4>S);),BF$B
MF%Z:7HY&),E!J0&JP:G!ZI4V#9,2*;3-])NJN0:)*::;NHS2:&A#0!2XIP%9
M,NXHHHHJ"0HI#32U7$3 TRG=:"*[J3L9L :GB:JQXJ2)N:]>A,AHTXFJVAK/
MB:KD9KUJ-0PFBT.E(U /%!KIE*Z,2K-TK/EZUH3=*SY>M>'C#HID5%%!KPJN
MYU1"F&@FF$USW-$@-**;2@U+*L/S3#1FDJ4@2'+4F>*B%.S7331$@:GP]:B)
MJ2'K7JT-S"1J0=*M=JJ0=*M"O:A\)RRW$?I5&:KS]*H3FN'%K0TI;E-ZB-/<
M\U$:^=J[G?%#EJ2HUJ0=*P$QC4@IY%)B@=Q12&C-%.PAO>G"C%%6@;'BGKUJ
M(&I4ZUZ&&W,9EZWK2CZ5G6]:,?2OLLO>APU-R844@I:]V.Q@%!HIA-1.=D"0
MCGBJLC5-(W%4I7KP\=6T-H(BE>J4C<U+(^:KL:^5Q-74Z5$ :7/%1YHW5Y\I
MW-XH5J93^M--8-ZFR8E,-!-%!:0@J5:C J05+0I$HHIH-.JX0NS)L::0"G&E
M09->KAZ1#>@]$JW"G2HXDS5V),5[>&I:G)-DT2\58 IB"I17OT*>AS-BBEHH
MKOC$D*6BBM$(3%-(I](:H"(K0%IY% %.X";:8R"IJ0BH8$'EBGB,4_%. I6
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M1:9&F*L**]NA1L<TY#E%/%(!3J]:G"R,6%+1170D2%%%%, HHHH 3%&*6B@
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MQ312!5J85&.*=FJ&*:8U-+TW=FI:$T(:512XS2@8I"'BEQ30:<*=@"D)%#'
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M5]!A:&AR3D*JU(!0!2U[%*G8Q;%HIN:<*ZTM"1:***8@HHHH **** "BBB@
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MJD58=36HS335(:&F@#F@TJ]:;*-C34RPKLM/B&T5Q^F?>6NST]OD%8R&:\2
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MAIIM/-1FN)/4V@@I<TS-&:IHUL2BE(I@-.S4-$M#2*%ZT[%'2JB@;T'BD(I
M:4<UV4H&3D"CFK<4>:BC3FKT*5[>$I&$Y#DCJPBT*M3*M?18>B<TI"J*E%-
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M5<Z.@A6HS4A-1FN%@ H/2DH)XJH[E(B:G1<FFMS3X1S7JX7<F1?A7-7HUJK
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M:9CFM:9#' U/%UJ 5/%UKTJ&YSS+\-65JM"*L@5[M)>Z8,1^E9UP:T7Z5GW
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MSO0!AW'WJC2I)^M1KUIE$PZ4A%*.E+33)(R*;GFGM4?>F(L1U,.E01U/VHL
MTFD!I&H6@!_:J\E6.U02T,3"#[]=!8KTK @^_70V':I).DL!TKHK;[M<_8]J
MZ&V^[0RD6".*HWB94UH=JJW"Y6@=CD-0@R3Q7.W-O@GBNUO(,YXKG[R#&>*H
M+'+R18--"XJ[<)AJJFD2%&*3-.!H0T)BEI33:;!ABD(IU(:FXT1&I$&:8:EC
MJAC]G%5I5J[D8JM**D3*Z\&KD$F"*ID8-/1\&@2.KTV;D<UU=G-\HYK@["?!
M'-=1970P.:11U$3Y%/?I5*UEW 5=/(H H7"\&N8U1.#763K\IKFM37@U:%8X
MRZ3YS53I6E>#YC6<]#!B T_&140ZU*IJ;D#&%1]ZF89IFWFDV,<HJ0"FJ,5)
MFLRT+VJ)ZDS3#S51!D0ZU9B?!%0$4JG!K:*%8Z339>1786#Y45P>FR885V6G
M3?**IHAHZ!#Q4PJG#)D5;4\5FRD+28IU)6;10W%,(J6FFN>I$I%=EJNZU<85
M"XKR<3$U@S/D2JKKS6A**IR#FOF\7H=<"L12 5(12 5XU2;N: %I=M/44IJ5
M48)$>*3%/-&*M5&4,Q0!3\4VM8U&2T2QBK"KQ59' J82"NF%0S8YEJ%TJ4N#
M32PISGH-7*S14W9BK!Q3&KSZDBT1TTTXTE<S9JA *<**6JB#8E.0<TE.3K7L
MX1'-49<A%7HQ5.&KT8KZ7"Q.61,M24Q:?7O4EH8L6DI:*WL2--1M4AIC5Q5X
MZ%(JR+5.1:O/562OE\;$ZJ;*;BH34\E0&OFZRU.R+&$4T\4\U&U<K1=Q,TE-
M[THJ4AH6E'6BE K2)1/'5C/%5D.*FW<5UTYV1A,&-,)I&--!HG+0@=BFD4^F
MM7!-ZFB&4445F6(:3-!IM:1*2'=:,4+3JVBM2&1]ZLP=:@QS5F <UZN&6IG-
MZ%^)>*L 5'$.*FKW8+0XY/4C;I562K3U3E:N/%/0NF5I*JOUJRYS5=A7A57J
M=D!E%+BBN66IJ&:6FTHK%H+#@*<*04M1<D*:13J2M(DMV&'BE0\TC4B#YJ]+
M#QN839?AYJ_&M4;?M6C'7TF$IHY9LF1:E IJ5(*]^C25C%L,44M%=?+8D2EH
MHH ::ADZ5*:AD/%>=BI:%Q*DM4I*MS&J;FOD<;+4[*>Q7>F8I[4E>'.6IT(;
MBCI3J8:R-$+2XIHIXH&Q*,T&FTT@'8II%.%(U7#<AC!UJW *J#K5R"O4P^YA
M,O1K4P%1Q]*F%>M#8YV0R#BJ<@J])5.2N#%FM,JMQ4>:D>HN]>/4.N*T"E H
M%.KE8PI"*6BD W%)3C3#5Q&.I<4T4^MHDL;4T1YJ$U)%UKT:#,Y;&C#TJR*K
MPU8%>S3?NG'+<:_2L^XZUH/TK/GKEQ3T-:.Y1;K1FANM-KP*NYW(?2XIHIXK
M%$L***2AF8ZBDI:S9:"DQ2T4T W%-IYIM;PU*0H%/"4BU.!7=3IW,Y,8%IP6
MGA:D1*ZE1,VR/RZ8T>*NA.*C=*4J5B%+4HE:;MJPR<TPBN.K$V3(,8HS3VJ(
MUQ21HB0&EI@-/J+ QIH%(:!56&/III<TAH1-B,T4XBFUTTYV!HFC-7(GJ@IJ
M:-^:]*A6,)Q-:)\U:0\5FPO5^-N*^BPE4Y)Q+ IU1J:>*]ZE.Z,&AU)1174B
M&)112TQ!2TE+2*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "JMU]TU:JK=?=- ',:CWKE[WO73ZD>M<M>GK0!B7!^:HTI]Q]ZHTZT#N3C
MI2$TO:F&J0@SF@#FFBI%%#8$J"INU1I4@II@-(I *>128I7 :>E025.:KR47
M(8Z#[];UBW2L"#[U;MEVI".IL&Z5T=K]VN9T_M72VGW:"D7*BD7(J6D(S2*,
MVX@R#Q7/ZC!@'BNND0$5@ZE%P>*=P.%O%PQK/>MJ_A.XUCS+M)H0K$.:<&J$
MMS3A5@2@TZF"GYXJ6%A":;FAC3<T) .IP.*:#030(DWTP\TRG"@;(W%0EL&K
M$E5'ZTB30MI]I'-;UC=\@9KDXV(-:EE,0XYH"YZ'ITVX#FMU.5%<CI4_ YKI
MX)05%!2'S+\M<UJB\&NH<Y6N=U1,@T7&<5>CYS69(*V+V,[C63*,47 @IX:H
M\\TX4$LF49I^RF1\5-D8J9"(3Q3=U.>H:R+1)NIPYJ(5*M:1 4KQ41X-3GI5
M9SS6R)9I6,F"*ZJPN, <UQ=L^TUO6=SC'-5<D[:UESWK5C.17+6-V..:WH+D
M%1S6;*1?HJ-7#5)4E"4TTZD-8U%H-##43"I33&%>77B:)E*:J,G6K\_2LZ3K
M7S&.B=5-C<9HQ0*=7@5%J;B4$TA--S2464D.I14>ZCS *I18-DAJ%FQ37G J
MI)<@=ZU461<M&7'>D^T>]9CW8]:A^U\]:WBF%KFXL^>]2>963%/GO5M7S2E<
MT446]]&[-0!J>#7',KE'TE HKG8"BEIM+FM*>XF!-"'YJ::5!\U>_@XG-4-*
MWK00<50MATK10<5]+AHG+)DBTZFBG5[-/8Q8M%%%;"$-1M4E,:N:LKHI%:2J
M<AJY+5.05\UCHG53*LE0,:GDJNU?-UXZG3%C"U,)I328KADC5#:6EQ1BLKFB
M'"G 4T5(.E4F)AG%&^FFFUO%F;1)FE%,%.I2EH18=F@FFT9KEEN:)!11FBI&
M--,J0TPU<2D -/!J*G*:[:4;D2) .:M0CI5=!FKD(KU</#4YYLNQ=*EJ.,<5
M+7M06ARO<AEZ5G3-R:T)NE9<_4UPXQ:&U(B+9I"*:.M.%?/UMSK0TBFT\TRN
M<T0E%%)4,8X&G TP4\5FT)BTF:6FU4#&84Y%YI!4B]:]3#/4Q9:AJ]$:H1U<
MBKZ7!R,)(NH>*EJ&.I:^@I/0YV.HI*7-=%Q"&D)H)II-8U)I#2 FH)#Q3RU0
M2MQ7D8FJK&D44YVJFS5/.:J$\U\IC)79U0 FDS29I#7CRW.B*%S2TRGBD:AC
M%&:4TPFF@0$TE%+BK2&)FC-(1241W(8X=:M0U5'6K,5>GA]S&:+\;5.IXJK'
M5E>E>Q#8Y6-D/%4I#S5R7I5&3K7GXLVI$+4PBGFFFO&J'4AG2E!IIH%<[*L2
M4TFE!XIIJ4A(,TN*:.M/%6-B4F:5JC[UK AD@YJ:(<U M68J]"AN9R+L72K
M-5HZL"O9I['+('Z5G7'>M%^E9]Q7+B]C2CN4&ZTE.8<TVO J/4[T**<#3*45
MD)HD%%(*4TR+:C<TH---**5BN@^D)I>U,-%A(,T4VG 5T4HC)4J=142+5E$K
MVL/2NC&;'*M3*E*B5,$KTHT-#FE,8%ICK5C;366HJ4-"%+4HNM5W&*OR+5.4
M5Y6(I6-XR*K5&:E8<U$17E5(V.F# 4X&F4X5D6QV*0\4X4C4"(]U.!S41ZU(
ME!36@\BF&I.U1M34C,;FI$;FHC2KUKLHS,Y(T87J_&U94+5?B:O?PE4YYQ-!
M#4HJM&U6 :^EP]2Z.22'T4"EKTHO0S8E)2TE62Q:6FTHI#0M%%% PHHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "JEU]PU;JI=?<- '*ZF>M<M>'
MDUT^I]6KEKSJ: ,>?[U,2G3?>IJ4 3CI2$4HZ4M #,4\4E**8$JU(.E1*:>&
MXHN ^DI,T9I (PJO)5@FJ\E#):"'[U;MEVK"@^]6]8]J28)'2Z>.E=-:_=KF
MM/[5TMK]VF46Z*** &MTK*OH]P-:QZ53N$R#0!QU_;=>*YF^CVDUWM[!E3Q7
M'ZI"06XIH#G"WS5/'S4#(0YJQ%Q5-@28P*3-*349-0 XG---&::QJT ;J<IS
M5<GFI(S4BL3XH/%.!XJ-J+@QK'-1%<U)WHQ31*1$%Q5JV;#BH"*=$V&I,JQU
MFFSXQS73VESD#FN%LY\8YKH["XSCFD,ZQ&W+65J"9!J[;2;DJ*Z7<#0!QM]#
MR:Y^Z&TFNPOX.#Q7*ZA'@FF@,L'FIT7BJPX:K49XIL!<[:3S*20\5!SFI%8L
M9S2%:1*>:BPKC,4Y3330#5Q11(3Q5=SS4I-1-6@@1]M7H+K:1S68<BA7(-)L
M+'6V=]C'-=!9WV<<UP-M<$=ZW+&[((YJ;B._M9MP'-:"GBN:T^[&!S6RETN.
MM%BD7:0U7%ROK1YXJ)("8TQNE1^>*0RBN"O'0M%>X[UF2GFKUQ*,&LJ:89KY
MG&P.FFR0-3MU5!,*7SQZUX4Z>IT199)J-FQ4)N!ZU"]R/6G&D:$SR8JM)<8[
MU!+<CUK/FNO>M%1)9<FN\=ZSIK[WJG/==>:RY[DYZUM"B9W-.2^]Z8EYENM8
M;W!]:6&<EQS6ZHJQ29V%I/NQS6O$^17,Z>Y.*Z&W/RBN6K"QHF7UJ45#'4XK
MS:B-+BBEHHKF8AIINZE:HSUK:DM2&R0<U/&G-0QBKD0KZ/ QT,)ER!<5>3I5
M2$5<7I7TN'B<DQXI:!17J16ADPHHHJQ!3#3Z8:PJ[%(@<55E6KK"J\HXKP,7
M&YM!F;**K-5J>JIZU\UB(ZG3%C,4;:=2UYE0WBQF*,4^BN9LTN-Q1F@TS-4F
M/<?1BD%/%7S$M" 4M+12<A6$IIIU,8U-BD&:<*CIX-2T-H=32*<*#51W)N0-
MQ0AYHDIB=:]3#QN929>B%7HA5. 5H1+7LX>&IS3990<4^FITI]>NHZ&!7F'%
M9DXK4EZ5G3BO+QJT-Z3*1XI,TYZBSS7SE;<ZXDG6@BD4TXURMED1H%!ZTJTK
MCN. IV*!2U+"X4F*6BDF2U<;2J>:::13S7=0G9D.)>B-7(ZSXFJ[&XKZ'"53
MGG$O(:F!JHCU,'KWZ-70Y91)J,TS=2%JZI5;(FPXFF$TTM4;/7!6KE) [55D
M>G2/55WKQ<3B#:,2.4YJLU2NU0M7S]>I=G3&(W-**93UKC9LAV**6F,:12U%
M)IM)FE[TT58<!3L4BT\55R6QA6F,,5-Q43TX[DD>>:M0FJ7>K<%>GAMS.>QH
M1U97I5:+H*LKTKV%L<C&2=*IR"KLE5)*\[%&M,K-41-225":\BH=<1#0*2BN
M=F@X&EIHIXI"88HIW:HS5(0IIM&:6M8(&@%6(CS5>IHNM>C06IC-&E%5@"J\
M'2K0Z5[=->Z<<MQC]*H3BM!^E49JX\8M#2D]3/<<TPU*]1&OGJFYW18"G8I!
M3^U8,&-HS2&D%4@'XHI12&F(,TE)WI15) ]!<4Y10*>O6NRC'4R<B>)<U<CC
MXJ" 5H1KQ7TV"HW1RU)B*E2!:>%I^*]R&'5CG<B/;3&6I\4PBIJX=6$I%61>
M*I2K6C(O%4Y17A8NA8WA(H,M0D59<5"PKYRO"QU0D1XI<4M!KB9LF)FFDT&D
MI%H;BG#BBBJ&/S28S2 TX4F0QA%-'6I33.]:TW8ADT9J[$U4%-68VKV<-4L8
MS1I1M5E35")ZMHU?1X6J<LT60:=4:FI*]VG*Z.=H6DI:*W$)2T44 %%%% !1
M110 4444 %%%% !24M)4L HHHI7&+1115B"BBB@ HHHH *J77W#5NJMU]TT
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M+B=!IJ\"ND@'RBL#3QTKH8/NBO/K,T3+*BI *:@J2O'JO4M,;2&EQ2&L08E
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MEHHL E%%%38 HHHH: ***6FD 4444[ %%%%%@"BBBBP!1113 **** "BBB@
MI*6DJ6 4444@%HI*6J3 ****8!1110 4444 )12T5+0"4F*6BH<1A11132L
M444M.PA*,4M)0XC$Q2T44E$ HHHHL 4M(*6K0@I#2TAIB8VG"FTHHN2AU%%%
M!84444 %%%% !1110 E(:=25$HW&-I*=3:P< N&*,4"G4E3"XW%+115JF*X8
MI<4M%6H#N%%&*6J2$(:9NH<XJ!I.:=AI%@&G9JNL@J3>,4P'%J U0M)35?GK
M56"Q:!I:8IS3Z0A**6BI: 2BEHH2 2BEI,4.(!12T4N4!**6BA1 2FD4^DIM
M"8W%+2T4N4$)BBEHJ>4H***6JY0$HHQ2T*(@HHHJK %%%%%@$HHI*+"N+24M
M%%@&THI:*+ D%)3J2HDBAM)BG4E82@,3%%.Q2&A4P$I:::45HHC'44"EI\A(
ME%&:-PI\H"TM,W"EW"J0AU%)D4N:L HHHH ***2DP"DI:*AZC"BBEII )BEH
MHJK""BBBBP!11118 HHHHL E%+12<0&XHQ2T5'(,**6BJY1"44M%-( HHHJ@
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH 2C-(33<T[ /S2TP&G9H ,T9II- - #Z3-&::30 ZEIF:=F@!:3-)FDS2
M=FBFYHS0 [-&:9NI=U KCZ3-)FDW4#'9I:9NI<T"0ZC--S29I-C'44W=06J0
M'45'NI0U%Q#Z3-)NII:K6HQ^:7-1!J=N%.PFQ^:3-,+4FX4[ 29HS4>\4A>B
MPR7=0#4.^G!ZD5R7-)NINZF%Q2N%R3=2YJ#?3M]%QHDS2YJ'?2;Z+BN3YHS4
M8>D9ZI(9)NHW57,E*)*30$^:-U0[Z:9*BY+98W49J 24N\8II@F3;J3?5=I!
M3?-JD%RUNI=U5A)2^8*=BBQNHW56\RE\RD!8W4F^H#)33+3L)LL[J7=542T[
MS*+ F6-U&ZJ_F4"2DQEC-(6J(.*8T@J&*Y/OIP.:IB7GK4\;YI(+D]+2 T$U
M:&(32;JC=\5'Y@S3 L@TZH$?-2@T .J-FQ3B>*K2OBF@)?,YIZMFL\3?-UJU
M$^:;0%BDS29II:H8KDE%,!I](:84$TF::6HN [-)NJ,N*C,@]:+BN6-U+FJH
MD&:E#BFF,E)INZF,XJ/S!FAH"R#3J@1Q4H84P'4AHR*,T -I112U(K!2TE+3
M3&%%%%, HHI*5P%HHHI@%%%% "4VG48J;"8T4ZBBA($)24ZBG85@%+113*"F
M,V*<U5Y'P*!,CFFP.M9TMV%/6B\GV@\USEW>[2>:129T"WX!ZU+_ &@,=:XP
MZD0>M.&IG^]2 ZXWH/>I8;C<>M<E'?DGK6K97.XCFM%L4=7"V14]4+1\J*O#
MI4D"T444 %%%% !1110 4E+2&@ S13,TH-(JPZDS2TPFJ2)'9I:8#3Q0T 49
MII-)FI*L/I::*=3)"BBB@ HHHH **** $I*6BF38*6BBD4%%%% !24M%)@)1
M2TE2XC"D-.I#3L!&1S2@4N*4"BP[AG%1M)BG.<"L^XEQGFJ))WN0.]5VO0.]
M9=Q=[<\UD3ZC@_>J6!TYU >M*M^">M<8VJ'/WJ=%J>6^]0@.ZCN@W>K"RYKE
M[.]W8YK9@FR!S5 :@.:=4,9R*FH *2EHI,!**6BE8 HHHIH HHHI@%%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "9I,TA-,S0
M!+F@FF@TC&@!=U :H"_-.5J )LTFZF;N*86H FW4;JK[Z-] $Y>D\RJS24SS
M:5P+F^CS*J>936EI@6_-H\VL\S4>=0!H>;1YM9_G>]'G>] %XR4WS*I^=[TA
ME]Z: O"6CSJSC/[TWS_>@#2\VCSA6;Y_O33<>]4!J>>*3SJROM/O2BX]Z0C4
M\[WI?/'K64;CWIIN?>D*YK>>*3SQZUD_:O>D^T^](=S6^T#UH^T#UK&-U[TW
M[6?6F)LV?M ]:/M(]:QOM7O33=^] D;GVD>M(;D>M87VSWH^V'UH13-S[2/6
ME^U#UK!^V>])]M/K0]!(Z#[4/6D^TCUK!%[[T?;/>H*1O?:AZTANAZUSYO?>
MF_;O>D!T'VH>M'VL>M<]]M]Z:;[WI6$=']L'K33=CUKG/MY]:47I]:TCH-G0
M_:AZTX78]:YS[;[T?;O>K).B-V/6F_:QZUSWV[WIIOO>@9T7VP>M(;P>M<V;
M\^M)]O/K0P.D^UCUIPO!ZUS7V[WI#?D=ZALDZ<WH]:8;P>M<S_:)]:3[>?6H
M&=+]L&>M+]M'K7,_;SZTG]H'UH'L=/\ ;!ZT?;!ZUS'V_P!Z#?GUJDB6SJ/M
MH]::UZ/6N7.HGUIAU$^M:)#N=.;T9ZTHO1ZURW]H>])_:)]:)";.K^W#UIIO
MAZURO]I'UI/[1/K6+1#9U8OAZTOV\>M<E_:)]:3^TC_>II#1UAO1ZTS[:/6N
M8&HD]Z#?^]6AG4B^'K1]N'K7)G43ZT?VD?6F4F=9]N'K1]N'K7*?VB?6C^T3
MZT)#9U9OAZTTWP]:Y7^T3ZT?V@?[U-BW.J%\/6G?;AZUR?\ :)]:/[2/K0&Q
MUOVT>M*+T>M<HNH^]..H>]2QW.J^WC'6HWOQZURIU(_WJC;4C_>K-DG5I>@M
MUK1M[@'O7#0:@2_6N@L+K<!S0D,Z;S>*C>X '6J)GPO6J<]W@'FK&B[-> =Z
MJ_;QNZUAW=_C/-9HU(^9]Z@9W,-V#WJXDX-<A9WQ('-:\-UD=:8KFT9>*H7,
M^,\TWS_EZUF7EQC/-- 6%N?GZUI6TV0*Y1+K]YUK:LIL@4-BN;;2X%0M/SUJ
MO+-A:H/<_-UK-B9MQRYJ??@5D6T^[O5UY,1TT4A\EP%[U6>] [UFW=WMSS61
M-J.,\TK#9T+7X]:B-^/6N6?4CG[U1?VD?[U(@ZT7P]:E74!ZUQO]I'UI?[4(
M_BII%7.Q;4!ZU%]O&>M<B=4/]ZD_M(Y^]5I#.TCOQZU86_'K7#KJ9]:L1ZF?
M[U.P':B\![U*EP#WKD(M1SWK4MKS=CFE8=CHE?-/S5&"7(ZU;5JEB)****6P
M"T4E+3N E%%%2,6BBBJ$%%)2T7 ****8!1110 E%%% KBT4E+0,8_2J,[X!J
M[(?EK*NGP#28F9.HS8!YKD+^X.X\UT6I2<&N/U"3YC2N)$#7!SUI4G)/6J1?
MFI83EJ"TC8MW)QS70Z<3D5SUHN<5TNG)R*M#N=58?=%:0Z5GV(^45H#I2)%H
MHHH *2@TS- TA]+3 :=0#%IIIU)0"(S3AUHQ2@4AW TPU)32*I$C13Q2 4ZA
M@---IY%)BI*3%'2G4E+3$PHI*6E<04444P$HI#3<T#2'TM-!IU ,****!!2$
MT$U&S4 /S2YJ'?3@U.Q+D24M,!IU%@3%HI*6D4%%%% $,QPM8=[+C/-;-R?D
MKFM1DQFF@,F]N<9YKGKNZ.3S5V^FZ\USUW,<FDT ][LYZU);W9,G6L:28YJ2
MTE/F"A(#O=,G+8YKJ;1\@5Q6D/D+7861X%# W8#Q5FJMOT%6J "BBB@ HHHH
M 3-)FD--S56 DS2TP4^D 444E( S1FDI,TKBN.S2TVEHN"%HI**+C%HHHI@%
M%%% !1124FP%HI*6A %%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ I#2T4 1M3.]2D4S%  #Q37-+33S0!"W6
ME6G%:;TH ?GBHV-*3330 W-!:D-,)H &-1Y.:?UI,5#"XW)IC$T\BF$528$1
M)IN34A6F$4Q7$W&C<:,48H&+N-(6-(:830 ,QJ/<?6G&F$4(!V\XJ-G-!IAK
M1 &\YI0Y]:9BBDQ,D+FHF<^M+32*D@3>:#(:::830 -(:9O/K0::10 [S#ZT
MPR'UIIIM#&A?,.>M+YA]:;BDQ0BQQD/K3#(?6C%)BB1#8X2'UI3*<=:CQ2&I
M*0-(?6F>8?6E(S3"*5ACO-/K3&D;UIII,50!YC9ZTX2GUINVDQ0B6R0RGUIA
ME/K3:3%4A(=YI]:0RGUIAIIIW*%:5O6FB4^M(128H8$GFGUIC2MZTVD(K%DB
M>:WK2^<?6F$4PT#3)O./K2>:WK40IX% -C_-;UI#,?6F$4RM(DBM*WK3?.;U
MI,4TBM$ [SF]::9F]:8:;28A_G-ZT><WK49%,-1RBL2F=O6F^<WK45&*=BDB
MRLY]:<9SCK544[-%ADAF;UI/.;UIN*:13L")?/;UH\YO6H*<!3!LD\UO6E\Y
MO6F%:8:8(E,S>M'G-ZU$*7%0P9.LY'>@W!]:JLV*9OI"++3MZTSS6/>HQS3U
M3-*Q1:M'8N.:ZW3"=HKE[./YQ77Z9'\HI@:$A(2LB[F(SS6S<+A*YN_?!- ;
M&1?3GGFLM)6,O6K5TV<U3A7,M%AW.BT]F('-;T+$ 5BZ;'P*W%7:*9).9<+U
MK*O9NO-6I), UDW;YS1<9#'(3+UKH]/8[17+P',M=/IP^45+%8O7#$*:QY)#
MYG6M:Z^X:PIC^\_&E8$;-BY)%:4S?NJR-./(K5G_ -33L6CFM3F()YKG+BX.
M3S6SJSX+5S,SY- ,:\[9ZTT3-ZU$>33E%"1!(96]:C:=O6G,O%5G%58I(D^T
M-ZTHG;UJN!3P*$-EE9V]:GCG;/6J0%2KQ5"-:"Y/'-;5E=<CFN71\5?M[G:>
MM26=S:W8P.:U89PU<3:WW(YK?L[G=CFAH31T2MD4X&JD,F0*LJ<U#0A]+244
M@"BDI*0KCZ*2EJAB4"EHI) %%%%4 4444 )24M%,FP4M%%(HAF^[6->-UK9F
M^[6'>GK4L3.<U%N#7(WV=QKJ[_G-<Q>+\QI;@C+[U9MQEJB*\U:M%RXJDB[F
MY819Q73V$.,5DZ7#D#BNIM(, <55B6:-HN%%7ATJO N!5BD 4444 -/2F&I*
M;BD4F ZTX4@%.IB84444"$Q2TE+2N 48HHI@&**** "DQ2T4 %%%% "4"EHJ
M4@"BBBJ ::9WJ2FXI%)@*<*;2T$MCJ0FBHG;%, >3 JG+<A>]-N)L U@WM[M
MSS2N)FO]N&>M2+>CUKCCJ?S=:FBU(D]:M$-':1W :K2-D5S5E=[R.:W[=MRT
M,%H6:6D%+4EH****!E:Y^X:Y?4D)S75S#*UAWL&[/%4@.%OHCS7/749R:[>^
MM.O%<Y=6OS'BFQ7.;:%B:L6=LWF"M5++<>E:%IIWS#BDF!=TF C;786:$ 5D
MZ?9[<<5T5O%@"DQEZ <59J&(8%34@"BBB@ I#2T4 1FF]ZD(IN*I,!13Z:!3
MJ3 *::=24F)C:*7%&*FPK"4ZBBBPT%%&*6BPPHHHJ@"BBB@ I*6BDP$I:**$
M 4444P"BBB@ HHHH **** "BBDI7 6BDHHN M%%%, HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH 2FF@FF$T (:;3C3#0 O:HVI2U-)H :31FD--)H &-
M1D\TI--H <*4]*9FC=4LD#333J8U);CZ"&F&@M3<UH2A**0TTFD7<5C41IQ-
M-- "4A-(33<T (:;3Z0BK3%<;332YHH$-HIQIA-2%AK5&14E!6@1%BFL*D(I
MAIB(2*3%2E::1BD-#:2EI*!MB4E*:8302!III<TAHL6A*:U*33":+#&GK0*#
M24FA,?VJ-J=FFFA(D;29H-,)IB%-,I<TE!:"@TTFF[JKH# T9I":86J'$FPY
MJC:C=1UI6'8%J0'BH^E&ZBP6'-3*7.:0U2$%-:@FF$U28A#244E4 AJ-J>33
M"*=AV&TO:BBE8:$I1244$LF%(U-!I<YH 9CFGK1MHZ4K@./2HR*=FC&:8"**
M<>E&,4A/%2T,KR5$.M3N,U%BD!(AJU$,U24\U?MN<4RNAI64?S"NMTU<**YN
MR3D5T]CPHI"2+%X<1GZ5R&I2<FNJOW_=GZ5Q>IR?,:0VC+G?)--MAF05#(^3
M4UGS**=P2.LTM,J*V)%VK6?I*Y45J7(PE!+,>XDQFLV8[JLW;X8U54;C2!"6
MZ'S*Z;3QA16-;P_-FMNU^4"A%,L71^0U@S ^9^-;4YRM9<B9>K2$B]IW!%:E
MP?W%9MD,5<N7_<U+'<Y'6&^9JYF1OFKH]6.2U<U+UJ0N-!YJ>,9JH&YJY!S5
M(E$I3(J!X2:THX]PJ9;7=VIFB,06YJ06Y':ML6/M2M9X'2@&81CQ3>E:%Q#M
M[5GOP:!)"[JD64CO5?-(6Q0BS6MKD[AS73Z;,3CFN(MY?G'-=5I4GW:;$=I;
M/E15^,UE6C?**TXC68K$_:BE%)4M"&T4ZDHL2**6DI:HH**** "BBB@ HHHH
M **** "BBB@""<_+7/W[XS6[<G"&N7U*3&:B0F8E](.:YVZ89-:=[-UK!N9<
ML:41)C#UJY9#,@K/5LFM2P&9!6J*N=GH\>0M=7!& HXKF]&7A:ZN$?**8$J#
M I]-%.I %%)FEI %)2T4 %%%(: #-&:830#0 ^B@4M38 HHHJ@"BDS1F@!:*
M3-+0 4444 %%%% !1110 4F*6B@!II*=24B0[55G? -66Z5G7;X!I%(S[V?"
MGFN2U.Y()YK;OY^#S7(:E-DGFD@*INF+]:N6\K$CFL6-LR5M629Q6B8'3Z6Q
M)%==9_<%<KID>,5UEH,(*;9+1;[4M(*0FD-"YHS3,TH-%A@XR*H3Q9K0/(J%
MTS30'.7EMD'BN?N;++'BNVG@W=JSI;$$]*&R6CF8;'GI6K;60&.*T8['!Z5<
MBM<=JD:([6W"XXK3C3 IL<6*L*M QRC%/I!2T %%%% !1110 4F**,T +129
MHS0 M%%% !1112 **** "BBBF 4444 %%%% !1110 4444 %%%)2N M%%%,
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M#02&::QI"::6I -8TW-!II- QQZ5&U+FF]:=A""I1TJ/%.S2 &J,T\FF&FD
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M4D!J4<UCVMSOQS6K&<BFBA^*2G4QC3 "V!4,DH%)+)@5DW=UMSS0T#1/<W0
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M>I WC>G/6K]A=%F'-<F+G)ZUKZ9-EQS5H1Z'82945:D? K+TU_D%6KB7"U2
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MCR*YK58\!J=RCA;Y<,:RWX-;.H+\YK(D7FFR18&^:MZQDZ5@0K\U;-GP14V
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MH **** "BBB@ II%*::30 AIA-.)IAH 7-(:;FD)H 0FF9H--- "T4S-.!H
M6C%%(30 UA49J0FHS0 W%-(IV:8S4 ,)I!0U(* 9)CBF,*=FFFDB".C%*:3-
M4%AI%1FGDTPT -I#2TTF@!II*4TE!84AI<TAJB6)28I::34DC6%1FGL:C-,
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M+FJ9Y-,2)H^36G9QY<5GP+R*VK)/F%(HZ;2H^!74P)\HKGM+7@5TT(^44 /
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M/85&10 E%%% !1BBC- #"*8:D)J,T ,-)MIU(30!&>*;FG-S3,4 )333J::
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MAH0QF:<*3'-.%,5@Q333R:C-2,44['%-6GYXH 8PIHIS4T=:8#P*4BE!H-"
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M>*D5JQA?#/6K"7@/>@#4S2$U2%T/6@W(]: )I,5DWZC::MO=#'6LN]N@5/-
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MT)H K[J-U2>2:3RC0 S=1NI_E&CRC0*Q$3335CRC36A- 6*Q:FYJ9H33?)-
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M@"-US52>+(-7L4QU!% ',WMINSQ6%<6/)XKM)X0<\5F3VH/:I XR6RQVJO\
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M2KD=L!VH SX+/&.*TX(,=JG2$#M5A$ H $3 J910!3J "BBB@ HHHH ****
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M\L4X(*5@(%CQ4RBG;:7%,"-UR*JR0YJ\132@H R7M<]J@:S]JVS&*3R1Z4K
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MP@I=M $86G@4[%&* %HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
#/__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>image00004.jpg
<TEXT>
begin 644 image00004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" !? %D# 2(  A$! Q$!_\0
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MS\#\JR[C4KJ?(:4JO]U.!7S.-XPR_#75-NH_+;[W^ESJA@JDM]#IKB\M[?\
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1W[=N[:,9QVJY0 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>image5.jpg
<TEXT>
begin 644 image5.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 0G!UP# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ I#2TAH **** "BBB@!**** "BBB@ H
MHHH **** "DI:2@ HHHH *<.E-IPZ4 %%%%,04444 %%%% !1110 M%%%(84
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %!Z44AZ4 )1110 4444 %%%% !1110 M%)2T %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1113$%%%% "4444 %%%% "9/K1D^M)WHH 7)]:,GUI** #)]:,GU-
M%)0 N3ZFC)]3244 +D^IHR?4TE% "Y/J:,GU-)10 N3ZFC)]3244 2T444AA
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 )1110 4444 %+24M !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4AZ4M(>E #:***
M"BBB@!:*** "BBB@ I:2EH **** "EI*6@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I#TI:0]* &T444Q!1110!
M$6.X\]Z3<WK0WWC]:2@!=S>M&YO6DHH '=@.#3/-?U_2E?[OXU'0 _S7]?TH
M\U_7]*910 _S7]?TJ/SY/[WZ4M14 2>?)_>_2CSY/[WZ5'10!)Y\G][]*//D
M_O?I4=% &K1112&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M!Z444 -Q1BEHH 3%&*6B@ Q1BEHH 3%&*6B@!,44M)0 4444 %+24M !1110
M 4444 %%%% !1110 E%%% !1110 $TFXT'K24 +N-&XTE% "[C2;C124 +N-
M&XTE% "[C4;3,K$ "GU!)]\T /\ /;T%'GMZ"HJ*8B7SV]!2&=L=!4=(>E #
M_/;T%'GMZ"HJ* )?/;T%'GMZ"HJ* $:=MQX'6D\]O05&WWC]:2@"7SV]!1Y[
M>@J*B@![SMMZ#K4?GMZ"D?[OXU'0!+Y[>@H\]O05%10!+Y[>@J+SV]!14= $
MGGMZ"CSV]!4=% $GGMZ"CSV]!4=% '0T444AA1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MTAQPWY55IK4 6?M*>C4?:4]&JK10!:^TIZ-1]I3T:JM% $WF#T-'F#T-144
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M'TI]% #,'TI,'TJ2B@"/!]*,'TJ2B@"/!]*,'TJ2B@#=HHHI#"BBB@ HHHH
M**** "BBB@ HHHH *2EI* "BBB@ HHHH **** "BBB@!:*** "BBB@ HHHH
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MBB@ HHHH **** "BBB@ HHHH ***2@!:*2B@!:*2B@!:*2B@!:*2B@!:***
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!**** "
MBBB@!**6B@!**6B@!*2G44 -HIU% #:*=10 VBG44 -HIU% "44ZB@!M%.HH
M ;12T4 )12T4 -;I3:>:,#TH 913\#THP/2@!E.[4N!Z44 )12T4 )3EI**
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MT /HJ/)]:,GUH DHJ/)]:,GUH DHJ/)]:,GUH DHJ/)]:,GUH ?13,GUHR:
M'T4S)HR: 'TE-R:6@!:*2B@!:6FTTDYZT 245'D^IHR?4TQ$E%1Y/J:,GU-
M$E%,R?6C)]: 'T4S)]:,GUH ?13:* '44VB@!U%)10 M%)10 M)110 4444
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MOZ_I1YK^OZ4 6*1ONFH/-?U_2D,CXZ_I0!)14.]O6C>WK0!-14.]O6C>WK0
M]NM)3-Q]:-Q]: 'T4S<?6C<?6@!S=*;2$G%)DT .HIN31DT .IO>C)IN3F@!
MU%-R:,F@!U!IN31DT +129-&30 M%)DT9- #J*2B@!:*2B@!U%(*6@ HHHH
M***6@!**6B@!**6B@!**6B@!**6B@ HIN31DT .HIN31DT '>BDHH 6BDHH
M6DHI* %HI** %HI*,F@!:*3)HR: %I#1DTF: %HI** %HI** %HHHH ****
M"BE%+@4 -HIV!1@4 -I:7 HP* $HI<"C H 2FGK3\"EVJ>U $5%2[%]*-B^E
M,1%14NQ?2E"+GI0!%14VQ?2C8OI0!#14VQ?2C8OI0!'VHJ81KCI2^6OI0!!1
M4_EKZ4>6OI0!!2U.(TST_6E\I/3]: *]%6/*3T_6CRD]/UH KT58\I/3]:=Y
M2?W?UH JT5:\I/[OZT>4G]W]: *M%6O*3^[^M'E)_=_6@#4HI:*0Q**6B@!!
M2T44 %%%% !1110 4444 %)2TE !1110 4444 %%%% !1110 M%%% !1110
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M/FMZ"CS6]!0!-14/FMZ"CS6]!0 M%-W&C<: '44W<:-QH &ZTE&<T4 %%%%
M!VIM.I,4 )12XHQ0 E+1BB@ HHHH **** "BDHH 6BDHH >.E%(.E+0 4444
M %)2TE !1110 4E+24 %%%% !1110 4444 %%%% #J*6B@!**6B@ '2EH%%
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M[;[T;?>@!M%.V^])M]Z &T4[;[T;?>@!M%.V^]&WWH !TI: .*,4 %%&*,4
M%)3L9I=GO0 RBG[/>C9[T ,I*DV>]'E>_P"E $=%2>5[_I1Y7O\ I0!'14GE
M>_Z4HAS_ !?I0!%14WV?_:_2C[/_ +7Z4 0T5-]G_P!K]*/L_P#M?I0 RBI_
MLW^W^E'V;_;_ $H @HJ?[-_M_I1]F_V_TH AHJP+7C[_ .E'V7_;_2@"O15C
M[+_M_I1]E_V_TH KTE6OLG^W^E+]B_Z:?^.T 5**M_8O^FG_ ([1]B_Z:?\
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M I:**0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M1110 4444 %%%% !1110 4E+24 %%%% !1110 4444 %%%% "44M)0 4444
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MTHADS]W]:?Y,G]W]: (Z*D\F3^[^M'DR?W?UH CIPZ4[R9/[OZTX0R8^[^M
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 )1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 +11D49%
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MK3O+?^XWY4HC?/W&_*@!**=Y;_W&_*CRW_N-^5 #:*=Y;_W&_*CRW_N-^5
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I*6DH **** "EI*6@ HHHH
M **** "BBB@ HHHH 91110 4444 1R?>_"F4^3[WX4R@ HHHH 1ONGZ5#4S?
M=/TJ&@ HHHH *C?[WX5)4;_>_"@!M%%% !2-TI:1NE #**** "BBB@!****
M"BBB@ I*6DH **** "GCI3*>.E !1110 4HI*44 %%%% !1110 ZBBB@ HHH
MH <O2G4U>E.H ****  =:?3!UI] !1110 5(OW14=2+]T4 +1110 4J]:2E7
MK0 ^BBB@ HHHH <.E% Z44 %%%% !1110 4444 %+24M !1110 4HI*44 %%
M%% !1110 M%%% !1110 HZ4M(.E+0 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% "'K24IZTE !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 E%%% !1110 4E+24 %%%% !1110 4444 %*O6DI5ZT /
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH 0]:2E/6DH **** "BBB@ HHHH *
M*** "BBB@ J*?^&I:BG_ (: (:*** "BBB@!M%%% !1110 Q^M-IS]:;0 44
M44 !Z4RGGI3* "BBB@ HHHH **** "E7K24J]: 'T444 %%%% $B_=%+2+]T
M4M !1110 J]:?3%ZT^@ HHHH **** "BBB@ HHHH **** "BBB@!U%%% !11
M10 HZ4M(.E+0 4444  ZT^F#K3Z "BBB@ IPZ4VG#I0 M%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "4444 %
M%%% !1110 4444 %)2TE !1110 4444 %%%% !1110 4444 %%%% "T444 %
M%%% !1110 4444 %+24M !1110 4444 %%%% !1110 4444 %%%% "4444 %
M%%% !24M)0 4444 %%%% !1110 4HZTE*.M "T444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2&EI#UH 2BBB@ H)
M.**0]* $R?4T9/J:2B@!<GU-&3ZFDHH 0DYZFC)]32'K10 N3ZFC)]3244 &
M3ZFC)]3124 +D^IHR?4TE% "Y/J:3<?4T4E "[CZFC<?4TE% "[CZFF2$\<F
MG4R3M0 RBBB@ HHHH 6BBB@ HHHH ,#T%&T>@_*EHH 3:/0?E1M'H/RI:* $
MVCT'Y4NQ?[H_*CO3J &[%_NC\J-B_P!T?E3J* &[%_NC\J<$3'W5_*BG+TH
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M#T%+10 F!Z"EP/2BB@ P/2C ]*** # ]*2EI* "BBB@ HHHH **** "BBB@
MHHHH **** "EI*6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH *2EI* "BBB@ HHHH **** "BBB@!**** "BBB@!:*** "BBB@
MHHHH **** "EI*6@ HHHH **** "BBB@ HHHH 2BBB@ HHHH 6BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HQ110 F!1@4M% "8%&!2T4 )@48%+10
MF!1@4M% "=.E&30>E)0 N31DTE% "Y-&3244 +DT9-)10 N31DTE% "Y-&32
M44 +DT9-)10 M%%% !1110 4E%% !1110 4N3244 +DT9-)10 N31DTE% "Y
M-&3244 +DT9-)10 N31DTE% "Y-&3244 +1@444 &!1@444 )12TE !1110
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M])0 W9[T;/>G44 -V>] 3GK3J* #%&*6B@!,48I:* $HHHH **** "C%%+0
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M!:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M E%-HH =13:* '"EI%I: "BBB@ [4VE/0TR@!U%-HH =2CI3*<O2@!U%)10
MM(S!5RQ 'J314%W_ ,>K_A_.@"3SHO\ GJG_ 'T*/.B_YZI_WT*QZ* -CSHO
M^>J?]]"CSHO^>J?]]"L>B@"W/=VRS,#<1 ^A<5']LM?^?F'_ +[%<WJ'_'])
M^'\A5:@#K?MEK_S\P_\ ?8H^V6O_ #\P_P#?8KDJ* .O6\M<_P#'S#_W\%.^
MVVO_ #\P_P#?P5QU% '8_;;7_GYA_P"_@H^VVO\ S\P_]_!7'44 =C]MM?\
MGYA_[^"G"]M,?\?4/_?P5QE.[4 =E]MM/^?J'_OX*/MMI_S]0_\ ?P5QM% '
M9?;;3_GZA_[^"GI?V8SF[@'UD%<53).U '=?VA9?\_EO_P!_5_QH_M"R_P"?
MRW_[^K_C7!44 =[_ &A9?\_EO_W]7_&C^T++_G\M_P#OZO\ C7!44 =[_:-C
M_P _EO\ ]_5_QH_M&Q_Y_+?_ +^K_C7G]% 'H']HV/\ S^6__?U?\:/[1L?^
M?RW_ ._J_P"->?T4 >@?VA9?\_EO_P!_5_QH_M"R_P"?RW_[^K_C7 KTI: .
M]_M"R_Y_+?\ [^K_ (T?VA9?\_EO_P!_5_QK@J* .]_M"R_Y_+?_ +^C_&E^
MWV?_ #]P?]_!7!+]X?6IJ .W^WV?_/W!_P!_!1]OL_\ G[@_[^"N(HH [?[?
M9_\ /W!_W\%'V^S_ .?N#_OX*XBFMUH [G[?9_\ /W!_W\%'V^S_ .?N#_OX
M*X2B@#N_M]G_ ,_<'_?P4U[^SV'_ $N#_OX*X:FO]PT =M]OL_\ G[@_[^"C
M[?9_\_<'_?P5PE% '=_;[/\ Y^X/^_@H^WV?_/W!_P!_!7"44 =^M]:%1BZ@
M_P"_@I?MMI_S]0_]_!7$Q?ZI:?0!V?VVT_Y^H?\ OX*/MMI_S]0_]_!7&44
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M ':_;;3_ )^H?^_@H^VVG_/U#_W\%<910!V?VVT_Y^H?^_@I5OK3=_Q]0?\
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M_?8I5O+4-DW,('_705R5-D^X: .R^WV?_/W!_P!_!1]OL_\ G[@_[^"N&HH
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M_'G!_P!<U_E7%UUUG_QXV_\ US7^5 %RBHJ* ):F@_BJI5BU_B_"@"Q1110
M4444 0T5-10!#14U% #4^[^-.HHH **** #M3:4]#3* '44VB@!U+3*4=* '
M44E% "T4E*.M "T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% #:*6B@!**6B@
M %+2"EH **** $/0TRGGH:CH 6BDHH 6E'2FT].E !13J* &U5U'_CPD_#^8
MJY574?\ CQD_#^8H Y^BGT4 ,HI]% ''ZU_R%I_^ _\ H(JA5W7?^0S<?\!_
M]!%9U $E%1T4 .?I3*&Z4R@!]%,HH ?2U'10!)14=% $E(:93T[T %%.HH ;
M13J* &44M% "44M% "KTI:;10 ZBFT4 /'45)4%% $]%044 3U')][\*93'Z
MT /HJ*B@"6D;I4=(W2@!U%144 2T5%10!?B_U2T^J2_=%+0!<HJG10!IVG^M
M/^[5RL.+[WX5-0!K45DT4 :U>BZ;_P @JS_ZX)_Z"*\DKT+3O^07:?\ 7%/_
M $$4 ='16+10!M5R_C#_ )<O^!_^RU>J"X_A_&@#D**ZBB@#EZ*ZBB@#S>BK
MU% %&BKU% %1>E+2W'^L'TJ&@"6BHJ* )AU%255I* +=%5** +=+5.E'2@"W
M156B@"U2'I5:B@">BH:* )J*AHH ]"\._P#(!MO^!?\ H1K4KB-._P"/"+\?
MYFK5 '6T5R5% ';67^N/^[5ZN3\-_P#(1D_ZY'^8KJ* )**CHH DIO>FU*/N
MCZ4 ,HJ2B@".G+WIU1R]J )**KT4 6**KT4 8=%8E% &W16)10!1\2_\A&/_
M *XC^9K&J_JW_'TO^X/YFJ% !1110 U_N-]*J5</0U'0!7HJQ10!7JU%_JEI
MM.'2@!]%-HH =3)O]4U+2'I0!4HJS10!6HJS10! .E+5M/N"G4 4J*NT4 /T
M?_C[?_KF?YBMRH?#7_(1D_ZXG^8KJ: .<HKHZ* .<KKK/_CQM_\ KFO\JJ5M
M0?\ 'O'_ +@_E0!7HJY10!3JQ:_Q?A4E.7O0 ZBBB@ HHHH **** "BBB@ H
MI** %HI**  ]#3*>>E,H **** "E'2DI: %HI** %I1UIM*.M #J*** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MT5!N;U/YT;F]3^= $]>A:=_R"[3_ *XI_P"@BO-MS>I_.M6*^NUA15NIPH4
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MVF?_ )[R?]]FC[3/_P ]Y/\ OLT =%17._:9_P#GO)_WV:/M,_\ SWD_[[-
M%K5O^/I?]P?S-4*9/)([@L[,<=2<U'N;U/YT 3T5!N;U/YT;F]3^= $QZ&HZ
M;N.>IIU !1110 4X=*;43LP8@$_G0!8HJKN;^\?SHW-_>/YT 6J0]*K;F_O'
M\Z<C,7 ))_&@"6BEHH 2BEHH D3[@IU:-E%&UG&6C4GGDCW-6/(B_P">2?\
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M0 M%)10 M5K_ /X\I/P_F*L57OO^/.3\/YB@#%HI:* $HI:* .*UW_D,W'_
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MMN.QJA@4 -HIV!1@4 -JS%_JQ4&!5F(#RQ0 M%+@48% "4Z/[XI,"C[O(ZT
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MK=T#2K*?1+>22'<YW9.]O[Q]ZT?[%T__ )]__'V_QH Y&BNN_L73_P#GW_\
M'V_QH_L73_\ GW_\?;_&@#,\+_\ (3D_ZXG^:UUE9UII]K9RF2WBV,5VD[B>
M/Q-7-S>M $M%1;F]:-S>M $M%1;F]:>"<4 .HI,FC)H 6FMVI<FCKUH 913]
MH]*-H]* &44_:/2C:/2@!:*** "BBB@!C]:;4A /6C:/2@".BI-H]*-H]* &
M#J*DI-H]*6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@!****8@HHHH !2T@I:0PHHHH **** "BBB@ I*6DH ****8@JO??\
M><GX?S%6*KWW_'G)^'\Q0!C4444 %%%% '#^(/\ D.7'_ ?_ $$5F5I^(/\
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M-^8_PH_L.V_OS?F/\* ,5/N"G5L_V/;KP'E_,?X4?V3!_?D_,?X4 8U%;/\
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MLBWE:*0LH&<8YJS]LD_NK^5 %ZBJ/VR3^ZOY4?;)/[J_E0!>KT/3?^07:?\
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M E%+BC% "4\=!3<4\#B@ HI:* $I110* %HHHH **** "BBB@ HHHH ****
M"BBB@ HHI* %HI** %HI** %HI** %HI** %HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MOUH ?4B_=%0>9[?K5^VM?.MUDWXSGC'O0!!15S[#_P!-/_':/L/_ $T_\=H
MIU=TG_D)P_\  OY&D^P_]-/_ !VK^C:=OU:!?-QG=_#_ +)]Z -BBM3^Q_\
MIO\ ^.?_ %Z/['_Z;_\ CG_UZ ,NBM3^Q_\ IO\ ^.?_ %Z/['_Z;_\ CG_U
MZ -'2O\ D&P_C_,U<J&RM_(M(X]V[;GG&.YJQM]Z0QM%.V^]&WWH ;2TNWWI
M=OO0 VBG;?>C;[T -IXZ4FWWI<4 %%&*,4 % HQ2T %%%% !1110 4444 %%
M%% !1129H 6BDS1F@!:2C-&: "BC-&: "BC-&: "BC-&: "BC- ZT +1110
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MGLB?]5<?]\K_ (T[_A);/_GE/_WR/\:0S9HK&_X26S_YY3_]\C_&C_A);/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M6GU36_ML_P"M_P#'33_[0M?^>O\ XZ?\* +-%5O[0M?^>O\ XZ?\*/[0M?\
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MR/44Y2-W6@!]%%% !1110!$WWC24KGYC29% !11D49% "CK2T@ZTM !1110
M5L0_ZB/_ '1_*L>M6&1!#&"Z_='>@":BF^;'_?7\Z/-C_OK^= #JZ3PG_P O
MG_ /_9JYGS8_[Z_G73>$6#?;-I!QLZ'_ 'J .EHI<'THP?2@!**7!]*,'TH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M%%% !4J_=%15*OW10 M%%%(84AZ4M(>E "4444""BBB@!1TI:0=*6@84444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !24M)0 4444 %%%% "T444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M "4444""BBB@ %+2"EH&%%%% !1110 4444 %)2TE !1110(*KWW_'G)^'\Q
M5BJ]]_QYR?A_,4 8U%%%, HHHH X?Q!_R'+C_@/_ *"*S*T_$'_(<N/^ _\
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MCM?^?:'_ +]BLJ#_ (^(O]\?SK<H @^QVO\ S[0_]^Q1]CM?^?:'_OV*GHH
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MQ_\ ?(IR11IG8BKGK@8IU H ,#T%&!Z"EHI#$P/048'H*6B@!M%%%,04444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M$<Z+-G_GX;_T%:Z7 KFO _\ R!9O^OAO_05KIJ0"8%&!2T4   R*DJ,=14E
M!1110 4444 %%%% !1110 M%%% PHHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M[XH W_\ A);W_GE!_P!\G_&C_A);W_GE!_WR?\:QJ* -G_A);W_GE!_WR?\
M&C_A);W_ )Y0?]\G_&L:B@#4?Q+>;C^Z@_[Y/^-)_P )+>?\\H/^^3_C60WW
MC3: -G_A);S_ )Y0?]\G_&C_ (26\_YY0?\ ?)_QK&HH VT\2WF?]5!_WR?\
M:?\ \)+>_P#/*#_OD_XUAIUI] &S_P )+>_\\H/^^3_C1_PDM[_SR@_[Y/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MFN5\ _\ ("G_ .OEO_05KJJ0PHHHH *3%+10 F*,4M% "8HQ2T4 )BC%+10
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MC:WI4E% $84YZ4[!IU% #<&C!IU% #<&EI:;WH =D49%-HH =D4UB**:W:@
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M !]?\:ZNB@#DSH]_G_4?^/K_ (TG]CW_ /SP_P#'U_QKJVZTE '*_P!CW_\
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M_8U__P \/_'U_P :/[&O_P#GA_X^O^-=910!R?\ 8U__ ,\/_'U_QIK:-?\
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M!R?V2Y_Y]YO^^#4HM+G _P!'E_[X-=/3NU '+_9+G_GWE_[X-'V2Y_Y]Y?\
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M%%% "CI2T@Z4M(84444 %%%% !1110 444E "T4E% "T4E H 6BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 2BEHH 2BEHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH ;13:* '44VB@!XI::O>G4 %%%% "'H:CJ0_=
M/TJ*@!:*2B@!:>G2HZ<O2@"2BF44 /HIE*.M #J*** "BBB@"E/_ *YJCK1H
MH SJ*T:* *EM_K#]*M4'I24 +1244 +59OOM]:L4[M0!4HJW10!4IK5=IC]J
M *E%6:* *U%6:* '44^B@!E%/HH @D^]^%,J=^M-H BHJ6B@"*BI>].H @HJ
M>B@""GITJ2G+TH CHJ6B@"*D/2IJ1ONF@""BG44 -HIU% "#I2U*OW12T 0T
M5-10!#2U+24 1T5)10!'3NU.I: &44^B@!E,D[5-4<O:@"*BEHH 2BEHH ;1
M5JB@"K15JB@"%/N_C3JBN/\ 6#Z5#0!;HJI10!<'44^J2?ZQ?J*NT %%%% !
M2'K2U"_WS0!)14-% $U%0TY/OB@"2BG44 -HIU% ##UI*9)_K#3* )J*AHH
MFHIL7WS]*FH CHJ2B@".BI*@;[Q^M #Z*CHH DIC]J2GQ]Z8$=%6** *]%6*
M* &T4ZB@!M%.HH ;137^]^%-H DHJ.B@"0=:?4%%(">BH** )Z0]:AJ1?NB@
M!:*6B@!**6B@!**=10 VBG44 (.E+4$GWS3: +-%5J* +-%0Q?>_"IJ "BBB
M@ I*6F'K0 ZBFT4 .H%-H% #Z*;10 ZBFT4 .HHHH **** "BD/6DH =13:*
M '44WO3J "BBB@ HHI#UH 6BFT4 .HIM% #J*910 ^BF44 /HIE% #Z*910
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M]31D^IH BN/]8/I4-7 H898 _44NQ/[B_E0!2HJ[L3^XOY4;$_N+^5 %1/\
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MJ_F/Z_I1YC^OZ4 6*F7[H^E4?,?U_2G^=)C[WZ4 7**I^?)_>_2CSY/[WZ4
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M*-H]* (^U-J4J-IX[5#0 M%)10 M2I]P5#4+SR(Y56P![4 7J*S_ +3-_?\
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M[A0!)1110 4444 %%%% !1110 4E+10 E%+10 E%+24 %%%% !1110 M%%%
M!1110 R3M4=2LH/6DV#WH CHJ38/>C8/>@!B_>'UJ:F!!GO3Z "BBB@ HHHH
M **** "HY_\ 4M4E5[YS'9R.,9&.OU% %:BL_P"W2_W4_(T?;I?[J?D: -"B
ML_[=+_=3\C1]NE_NI^1H L2?ZPTVL2\UJYBNG14B(&.H/I]:@_MZZ_YYP_\
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M['^1_P :LV&HS->Q@JG?L?0^] '5450^VR_W4_(T?;9?[J?D: +]%4/MLO\
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MJ+S&]!1YC>@H EHJ+S&]!1YC>@H **K?:']%H^T/Z+0!9HJM]H?T6C[0_HM
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M>UW_ (_D_P"N8_F:TO[3_P"F/_CW_P!:L+6K[?>(?+Q^['\7N: *]%5OM?\
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M]:@"[15+^T/^F7_CW_UJ/[0_Z9?^/?\ UJ +M96L_P#+#_@7]*L?VA_TR_\
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M_D7_ .M2_P#"0^9\WV7&>WF?_6H V:*QO[>_Z=O_ ")_]:C^WO\ IV_\B?\
MUJ -FGQ?ZU:P_P"WO^G;_P B?_6J2#7=TRC[-Z_Q_P#UJ .BHK+_ +9_Z8?^
M/_\ UJ/[9_Z8?^/_ /UJ -2BLO\ MG_IA_X__P#6H_MG_IA_X_\ _6H VD^X
M*=6'_;^SY?LV<?\ 33_ZU'_"0_\ 3K_Y$_\ K4 ;E%8?_"0_].O_ )$_^M1_
MPD/_ $Z_^1/_ *U &K=_ZH?[U4ZI3:]YB ?9L<Y_UG_UJ@_MC_IA_P"/_P#U
MJ -2BLO^V/\ IA_X_P#_ %J/[8_Z8?\ C_\ ]:@#4J%OO'ZU1_MC_IA_X_\
M_6K/D\2;977[)G#$?ZS_ .M0!NT5S_\ PDW_ $Z?^1?_ *U'_"3?].G_ )%_
M^M0!T%7M/_Y:?A_6N1_X2;_IT_\ (O\ ]:MSP]JOV_[3^Y\O9M_CSG.?;VH
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MM%97]L_]._\ X_\ _6H_MG_IW_\ '_\ ZU &K5M/N+]*Y_\ MG_IW_\ '_\
MZU)_PE.SY?L>=O&?-_\ K4 ='17-_P#"5_\ 3E_Y%_\ K4?\)7_TY?\ D7_Z
MU '24UNU<[_PE?\ TY?^1?\ ZU6+?Q!]JW?Z+MVX_P"6F?Z4 ;%%9O\ :O\
MTQ_\?_\ K4?VK_TQ_P#'_P#ZU &E16;_ &K_ -,?_'__ *U']J_],?\ Q_\
M^M0!/163_;7_ $[_ /C_ /\ 6H_MK_IW_P#'_P#ZU &M163_ &U_T[_^/_\
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M0!8HJO\ :X_1ORH^UQ^C?E0!8K&U;_CZ7_<'\S6C]KC]&_*LO4I!+<*R@_<
MY^IH IT444 %6;#_ (_8_P ?Y&JU6M/&;Z,?7^1H VJ*=L/M1L/M0 VBG;#[
M4;#[4 59/]8:;4DBGS#3=IH ;13MIHVF@!M)39Y! @9@2"<<57^WQ?W7_(4
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MZ1I 0&Z>E0_:$]&H FHJ'[0GHU'VA/1J +=M_P ?4/\ OC^==#7-6<RO>VZ
M'+2*!GZUUOV.3U7\Z *]%6/L<GJOYT?8Y/5?SH KUS.K?\A.;_@/\A77?8Y/
M5?SKE=8A9=5F4D<;?_010!G44_RS[4>6?:@!E7]&_P"0K#_P+_T$U3\L^U7M
M&C/]K0<C^+_T$T =314GE-ZBCRF]10!'14GE-ZBCRF]10!YKJ7_(5O/^N[_^
MA&JM7M2A;^U;SD?Z]_\ T(U6\AO44 145+Y#>HH\AO44 ;/A+_D*R_\ 7 _^
MA+79UR/A.%AJLO(_U!_]"6NQ\IO44 ,HI_E-ZBCRF]10 RN>N?\ CZF_WS_.
MND\IO45RUW.JWDZD'(D8?K0 45#]I3T:C[2GHU $U6+;^+\*H_:4]&J6&\C3
M=E7Y]!0!H454_M"+^Z_Y#_&C^T(O[K_D/\: +=%5/[0B_NO^0_QH_M"+^Z_Y
M#_&@"U15?[9'Z-^5'VR/T;\J +%%5_MD?HWY4?;(_1ORH JZA_Q\+_N_U-5*
MEOKA&G4@-]W^IJKYZ^AH EHJ+SU]#1YZ^AH L0_Z^/\ WA_.M>L6VD#W4* '
M+. ,_6NB^QR>J_G0!7HJQ]CD]5_.C[')ZK^= %>NETK_ )!L/X_S-87V.3U7
M\ZW]-C*6$2G&1GI]30!:HI<48H 2G1_?%)BG(/G% $U%%% !1110!*/NCZ4M
M(.@^E+0 4444 %%)FC- "T4F:,T +3:7-)0 4444 %%%% #**=L/M1L/M0 V
MBG;#[4;#[4 "=Z?31\O6EW"@!:*3<*-PH &^Z?I4%3$Y!'K3/+/M0 RBG^6?
M:CRS[4 ,J6/[OXTWRS[4Y3L&#0 ^BF[Q[T;Q[T .J"]_X]'_  _G4N\>]07C
M@VC]>W\Z ,JBDS1F@!:*3-&: .*U_P#Y#=Q_P'_T$5FUJ:ZA;6;@C'\/_H(K
M.\IO44 ,HI_E-ZBCRF]10!H:%_Q_/_US/\Q70US^C#RKQV;_ )YD<?45M^>O
MH: ):*B\]?0T>>OH: ):Y:[_ ./R?_KHW\ZZ3SU]#7.7*EKN8CN[']: (**=
ML/M1L/M0 VNA\+_\O7_ /_9JP-A]JZ#PR,?:L_[']: .@HHHH **** .7HJ'
M[2GHU'VE/1J )J*A^TIZ-1]I3T:@#9T[_CW;_?\ Z"K=95E?Q1PL"K_>SP![
M59_M*'^[)^0_QH N453_ +2A_NR?D/\ &C^TH?[LGY#_ !H L7'_ ![2_P"X
M?Y5@UIRZA$\+J%?)4@<#_&LK<* '44W<*-PH =5.[_UH_P!VK6X52O) )AU^
M[0!%13/,'H:/,'H: 'U:T[_C_B_'^1JEY@]#5O39 =0B'/?^1H Z&BDS1F@!
M:*3-&: ()?\ 6&F4^3_6&F4 %%%% %/4O^/=?]_^AK+K4U(?Z.O^_P#T-9F*
M $HI<48H 2NTL?\ CPMO^N2_R%<9BNPLI +&W&#Q$O\ *@"U13/-7T-'FKZ&
M@!]96M?\L/\ @7]*TO-7T-9FKG?Y..V[K^% &513MIHVF@!M%.VFC:: )J*C
M\]?0T>>OH: )**C\]?0T>>OH: -G3/\ CV;_ 'S_ "%7:SM,F7[,W!^^?Y"K
MOG+Z&@"2BH_.7T-'G+Z&@"/4/^0;=?\ 7%_Y&N#KN+Z0-I]RH!R8F'Z&N+\A
MO44 1T5)Y#>HH\AO44 1UU.D?\@N'_@7_H1KFO(;U%=;HUI(VDP$%?XN_P#M
M&@":BK'V.3^\OYT?8Y/[R_G0!7J.;_4M5S[')_>7\ZAN[=XK9W8K@8Z?6@#.
MHIN\>]&\>] #J*;O'O1O'O0!0NO^/A_P_E4-2W)S<,?I_*HJ "BBB@#3T+_C
M^?\ ZYG^8KH:YW1&"WKD_P#/,_S%;_FKZ&@!]%,\U?0T>:OH: 'UQ=]_Q_W/
M_75OYFNQ\U?0UQ5],O\ :%SP?]:W\S0 RBH_/7T-'GKZ&@"2NN\#_P#+_P#]
ML_\ V:N-\]?0UUW@>=?]/X/_ "S_ /9J .SHJ+[0GHU'VA/1J ):*B^T)Z-1
M]H3T:@!E%5_MD?HWY4?;(_1ORH L457^V1^C?E1]LC]&_*@#E?%O_(5B_P"N
M _\ 0FK!K9\53J^J1D _ZD=?]YJP_,'O0 ^BF>8/>CS![T /[4VDWCWHS0 M
M%)FC- "UV_A__D"6_P#P+_T(UP^:[;0) -$MQS_%_P"A&@#5HIGF#T-'F#T-
M #ZEM_\ 7K^/\JK^8/0U+;RKYZ\'O_*@#2HIGFKZ&CS5]#0 ^BF>:OH:/-7T
M- '):W_R&)_^ _\ H(K/J_K1W:M.1_L_^@BJ% !1110!)#]\_2IZ@A^^?I4]
M !1110 5S5U_Q]S?]=&_G72USMS$QNICD<N?YT 5Z*D\IO44>4WJ* (ZO:=_
MRU_#^M5?*;U%7+%2GF9[XZ?C0!=HI-PHW"@!:*3<*-PH R**9Y@]Z/,'O0 ^
MBF>8/>CS![T -D^]^%,J4J9.1].:3R6]10!'14GDMZBCR6]10!+IW_(3M/\
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M_$/[H]ZH_P!EWO\ SQ_\>'^- %.BKG]EWO\ SQ_\>'^-']EWO_/'_P >'^-
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M/#_&C^S+S_GC_P"/#_&@#.?[YIM77TR\WG]S_P"/#_&F_P!F7G_/'_QX?XT
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M !H_L;4/^??_ ,?7_&@"@.M/JY_8U_G_ (]__'U_QIW]CW__ #P_\?7_ !H
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M'^-6K+2KV3?LASC&?F'^- $=%7_[&U#_ )]__'U_QH_L;4/^??\ \?7_ !H
MH45?_L;4/^??_P ?7_&C^QM0_P"??_Q]?\: .4HJ]_8]_P#\\/\ Q]?\:/['
MO_\ GA_X^O\ C0!1HJ]_8]__ ,\/_'U_QH_L>_\ ^>'_ (^O^- %>+[A^M25
M833+Q%PT.#G^\/\ &G?V==?\\O\ QX?XT 5:*M?V==?\\O\ QX?XT?V==?\
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M9>?\\?\ QX?XT 5**M_V9>?\\?\ QX?XT?V9>?\ /'_QX?XT 3:/_P ?;_\
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M(H **,BC(H @N?X?QJO5BX!;;M!/7I4.Q_[C?E0 VBG;'_N-^5&Q_P"XWY4
M"?ZQ?J*NU41&#J2IZ^E6LCUH 6BDR/6C(]: %I#UHR/6@T )1110 4U_N&G4
MC@[3Q0!#12[3Z'\J-I]#^5 "44NT^A_*C:?0_E0!AW__ !^R?A_(56JY?0RM
M>2%8G(XY"GT%5_L\_P#SQD_[Y- $=%2?9Y_^>,G_ 'R:/L\__/&3_ODT .MO
M]8?I5NH+:"82',4G3^Z:M>3+_P \G_[Y- #**?Y,O_/)_P#ODT>3+_SR?_OD
MT ,J%OO'ZU9\F7_GD_\ WR:B-O-N/[F3K_=- $5%2?9Y_P#GC)_WR:/L\_\
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MF_\ WR:/)E_YYO\ ]\F@"W14?VB'_GM'_P!]"C[1#_SVC_[Z% $E%1_:(?\
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M3QTH\F7_ )YO_P!\FGB&7'^K?_ODT ,HI_DR_P#/-_\ ODT>3+_SS?\ [Y-
M#*9)VJ;R9?\ GF__ 'R:9)!*<8B?_ODT 045)Y$W_/*3_ODT>1-_SRD_[Y-
M$=%2>1-_SRD_[Y-'D3?\\I/^^30!HT4[8_\ =;\J-C_W6_*@!M%.V/\ W6_*
MC8_]UORH R]0_P"/A?\ =_J:J5?OH)GG4K$Y&WLI]357[-<?\\)?^^#0!%14
MOV:X_P">$O\ WP:/LUQ_SPE_[X- !:_\?</_ %T7^==-7/6UO.+J$F&0 .,D
MJ?6NBP?2@!**7!]*,'TH 2GKTIN#Z4X=* %HHHH **** "BBB@ HHHH ****
M "BBB@ I*6DH **** "EI*6@ HHHH **** &4444 %%%% #EI:1:6@ HHHH
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M %;$/^HC_P!T?RK'K8A_U$?^Z/Y4 /HHHH *MV/_ "T_#^M5*MV/_+3\/ZT
M7**** "BBB@">BBB@ HHHH @G^^/I452S_?'TJ*@ HHHH 4=14E1CJ*DH **
M** "I4^X*BJ5/N"@!U%%% !39/N&G4V3[AH @HHHH **** 'KTI:1>E+0 44
M44 %)2TE !1110 4\=!3*>.@H 6BBB@ I#2TAH 2BBB@ HHHH **** "BBB@
M#F/$?_(0C_ZY#^9K'K8\1_\ (0C_ .N0_F:QZ "BBB@">Q_X_P"V_P"NJ_S%
M=I7%V/\ Q_VW_75?YBNTH **** "BBB@ HHHH *@O/\ CT?\/YU/4%Y_QZ/^
M'\Z ,FBBB@ HHHH F7[H^E+2+]T?2EH **** +%G_K3_ +M7:I6?^M/^[5V@
M HHHH *>.E,IXZ4 %%%% !2&EI#0 4444 %%%% #Z*** "BBB@!#UI*4]:2@
M HHHH 4?>'UJ6HA]X?6I: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@!**** "BBB@ %+2"EH ****  ]*93
MSTIE !1110 4AZTM(>M "4444 %-D^X:=39/N&@""BBB@ HHHH S;K_CY?\
M#^50U-=?\?+_ (?RJ&@ HHHH DA^^?I4]00_?/TJ>@ HHHH *D'05'4@Z"@
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M3_=%/ID7^I3_ '13Z "BBB@"]I7_ !]-_N'^8K8K'TK_ (^F_P!P_P Q6Q0
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M!GE(YX+GT-9M7=)_Y"</_ O_ $$T =5YTO\ ST?_ +Z-'G2_\]'_ .^C3**
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M?7(D8"3H3_"*FJA)_K&^IH G^WW/_/7_ ,=%'V^Y_P">O_CHJM10!9^WW/\
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MZFGT4 ,\L>IKH?"_[O[5COLZ_P# JP:WO#?_ "]?\ _K0!T/F'VH\P^U,HH
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M-HHVBEHH R/LD?JWYT?9(_5OSJ>B@"#[)'ZM^='V2/U;\ZGHH X?Q9"J:I$
M3_J!_P"A-6%L'O70^+O^0M%_UP'_ *$U8% #=@]Z-@]Z=10 ZWB5[F)23@N
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M +N-&XTE% "[C2CI3:<.E "T444 %%%% !1110 4444 %%%% !1110 4444
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MP_D*K4 97]C?]/'_ (Y_]>C^QO\ IX_\<_\ KUJT4 8TNA>8@7[3CG/^K_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_3;_ ,=_^O1_9G_3;_QW_P"O5^B@#*DT?>V?/QQ_<_\ KTW^Q/\ IX_\<_\
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M)_Z;_P#CG_UZTZ* ,S^R?^F__CG_ ->I(]-\O/[W.?\ 9_\ KU?HH J?8O\
MII_X[1]B_P"FG_CM6Z* *GV+_II_X[1]B_Z:?^.U;HH S/[)_P"F_P#XY_\
M7H_LG_IO_P".?_7K3HH S/[)_P"F_P#XY_\ 7H_LG_IO_P".?_7K3HH SAI>
MWCSO_'?_ *]']F_]-?\ QW_Z]:!ZTE %#^S?^FO_ ([_ /7H_LW_ *:_^.__
M %ZOT4 4H]/V2*_FYVD'&W_Z]7LTE% "YHS244 +FLN[TW[1=/+YNW=CC;GM
M]:TZC;[QH RO['_Z;_\ CG_UZ/['_P"F_P#XY_\ 7K4HH R_['_Z;_\ CG_U
MZEMM+\JX5_.SC/&WV^M7Z<GWQ0 W[/\ [7Z4?9_]K]*GHH @^S_[7Z4?9_\
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M0!!]F_V_TJK+8[I2?,QG_9K1J)_OF@"A_9__ $U_\=_^O1_9_P#TU_\ '?\
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M_P =_P#KT?V9NX\[&?\ 9_\ KU?I5^\* ,_^QO\ IO\ ^.?_ %Z/[&_Z;_\
MCG_UZU** ,O^QO\ IO\ ^.?_ %Z/[&_Z;_\ CG_UZU** **V&U0OF]!C[M.^
MP_\ 33_QVK=% %3[#_TT_P#':/L/_33_ ,=JW10!!!;>4Y;?G(QTJQB@=:6@
M!,48I:* $Q32>:?49ZF@ S1FDHH 7-(312&@ S1FDHH 7-&:2B@">BBB@ HH
MHH 0T9H/6DH 7-&:2B@!:6F]Z=0 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 )N%&X4VB@!VX4;A3:* ' YI
M:1:6@ HHHH #TIFTT^DH ;M-&TTZB@!NTTNTTM+0 W::-IIU% #=IHQCFG4A
MZ4 &X4;A3:* ';A1N%-HH ",G-&TTX=** &[31M-.HH 11@TZDI: "BBB@ I
MN.:=24 )BC%+10 F*!Q2TAH 7<*-PIM% #MPHW"FT4 /HHHH **** "DI:*
M$HI:* $Q3=II]% #-IHVFGT4 ,VFD/!J2HW^]^% "9HS244 +F@_,,#O24J_
M>% ">4WJ*/*;U%344 0^4WJ*/*;U%344 1A@@VGJ/2E\U?0U')]\TV@";S5]
M#1YJ^AJ&B@"7<).!]>:/+/M38OO?A4U $?EGVH\L^U244 1^6?:GC@8I:;WH
M 7-&:2B@!<T;A24AH =N%&X4RB@!^X4;A3** )**** "BBB@!I/-)FANM)0
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MH\P>AJ*B@"7S!Z&CS!Z&HJ* 'E"YW#&#2>4WJ*D3[@IU $/E-ZBCRF]14U%
M$2J8SD_3BG>8/>B3[OXU'0!)Y@]Z/,'O4=% $GF#WI.O-,IXZ4 %%%% !3E[
MTVG+WH =1110 4444 0^4WJ*/*;U%344 0^4WJ*/*;U%344 1K^[&#]>*7S!
M[TDGWOPIE $GF#WH\P>]1T4 2AP3CFG5"OWA]:FH **** "F,I)S3Z* (]A]
MJ-A]JDHH CV'VI0A!SQ3Z* $HI:* $HI:* &%AFC<*:?O'ZTE #]PHW"F44
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4AHHH
M**** "BBB@!:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH *2BB@ HHHH *6BB@ HHHH **** "BBB@ HHHH ***
<* "BBB@ HHHH **** "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>image6.jpg
<TEXT>
begin 644 image6.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" '8 WT# 2(  A$! Q$!_\0
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M*\)^+O\ R4#]EO\ [+MXA_\ 69?VBZ /=J*** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "O"?B[_P E _9;_P"R[>(?_69?VBZ]VKPG
MXN_\E _9;_[+MXA_]9E_:+H ]VHHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BOF;]I#]LW]E+]C^'X?W'[4/[07PJ^!4?Q4\5VO@OX>+\2?%VE^
M&YO%FO7&H:1IMR-*MKR9;A]&T&XU_19/%_BB6*+POX(T_5++5O&&L:'I<Z7A
MZ?XU_M/_ +-7[-</ABX_:,_:&^!OP!M_&U[>Z;X,G^-?Q:\ _"N'Q=J.FK9O
MJ.G^&)?'6OZ$FO7NGIJ&GO>VNE-=SVJWUFT\<8N82X![E17B/CW]IG]F_P"%
M7Q%\ _"#XH?M _!'X;_%KXK7-C9_"[X7>/?BMX$\'_$7XDW>IZLN@Z;:^ ?!
M/B'7M.\2^,;G4-<=-&L8/#NF:C+=ZLZZ=;K)>,(2>/?VF?V;_A5\1? /P@^*
M'[0/P1^&_P 6OBM<V-G\+OA=X]^*W@3P?\1?B3=ZGJRZ#IMKX!\$^(=>T[Q+
MXQN=0UQTT:Q@\.Z9J,MWJSKIUNLEXPA(![=7A/Q=_P"2@?LM_P#9=O$/_K,O
M[1=>[5X3\7?^2@?LM_\ 9=O$/_K,O[1= 'NU%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110!_$-_P<U> ?V6I?VRO@9\6O&/QJ_9VU7X]:3\"_A'\/
M-=_8\_;/\'_$;P]\#_&O[.U[^U)=^*=4^+WPS_:!T)=(TWP/\2XM=@UWX;_$
MO3_!M[XN^(@^#>JZOKECI?A2'0AJ>M9O[:OQ._X)-_'K]E;X"VGQ?^!6E?LK
M?'OQQ_P0UT3XD_LN^-_VS=8\2_&+X.>'/V>TL+TO^S'^S1\0?B7\;+""3]N)
M+Y+>?X1?M(7GP(\;?%Z/PG?^"_&\OAGXC6FIZ;\)+[^O+]I7]C/]E+]L?3?!
M&C_M3_L^_"KX]Z9\-_%=GXT\#V?Q-\(Z7XGB\.Z]:7>GWDQL_M\+M)HVN-I6
MG6OB[PO=-<>%_&NEVD.B^+]'UO2 ;$]7\:OV9_V;_P!I.T\.:?\ M%?L_?!'
MX^6'@[4KC6/"-E\:OA1X$^*=IX5U>[BA@N]5\.6WCG0==AT/4KJ&WMX;B^TQ
M+6YFB@ACDE9(D"@'^<C\9/&'[(GC[]FO_@J?XQ^/W@?2OAK^TCK_ .Q-_P $
M6;W_ ()D> _CWK^A^+?VEO"W@;_A0_PRAT;2/V5_%UOHWASQ_P"+]3M_'$4Y
M^*?B[X8>&O#,_BG1VDU_XF^&O#V@:CXDT:Q^I?\ @J+_ ,* _P"$V_X+[_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M=>[5X3\7?^2@?LM_]EV\0_\ K,O[1= 'NU%%% !1110 4444 %%%% !1110
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MK2&&*WABM[>*."""-(8((46*&&&)0D<44:!4CCC151$10J* J@  5X;\7?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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ML\8VNEB3X@>)]3L?L-CX3UF"&Z2?1VN_#/Q"_5G]GG]GKX.?LI_!GP!^S[\
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M5:^*O[6'Q*\83^'OV,?@O\ - ^!_['/@'P5\3;;6/#'QF\4_$HZ)XO\ CO\
M&_X@>%_#NJ36UKJ?A;7-%MOA?X<TWQ1 SW5OH]GXATVSM9--BU#4?UCKYG_8
MV_98^'/[$G[+GP0_92^$\<__  @OP1\":9X/TR^O%5=0U_4E>?4_%'B[541F
MACUCQGXKU'6_%FL1VVVTCU36;M+2.*V6*)/IB@ HHHH **** "BBB@ HHHH
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M?LC>)]+^'_@O1I?&^I:?K_@#XD_!S]J3P9XFT6VT/7KW6-,_>C]G7]@SX6^
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M4>EV\W@OQQX/O9;VZN_TZHH _'K]G?\ X(^_!#X<?$C0OBI\9?!?[(WC;4_
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M);OK]]HO@;PIYO[&_LX?";_@H1^V<OQUNO\ @K9\)_V:_AY^RE\5_">G>#_
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M5Q:Z58(1/JFMZCY"Z?H>CVN^]UC5[JRTNQCEO+N")_SNG_84_;9^(O[(=G\
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MUY'<7&^9OG?_ (*B>(?V3OASX ^'_P 1/CW^Q%\-OVY/B0WBN30_A1\+M?\
MA+\,_B7\1!H7AO1-;^*7QD\4^"9/'_ACQ)-IUO\ #3X/^"O'?Q$FL--CM7\5
M:_HOA[P%8W=IXC\:Z%-0!YU_P3&^(]Q8_L@_M+_%CX5_!?Q4/@?IOQ>^)OQ
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M5_%'B;Q#\8-2T31?@IK'@_XE?#WQ=X<\:>.]6TJ#Q!=>&O&GBC0M5YG]E/\
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M (;#0K>UU&SM],T+5KS2=1DU-M2?3-.GMK>VC^K/V>OV-?AK^S?X]^*/Q/\
M#/C/XW>/O'WQAT+X?>&_&_B;XR_%[Q;\3[^]T;X7S>,9_!UM:KX@NGM;2733
MX[\0PM?+;MJ$]G-:6+W7V*PM;>/ZUH _*GX[_P#!,3Q=^T3\+?V>/AYXL_X*
M8_\ !3#X7:W\#/!]YX<\2?$K]F'X^^%_V?\ QE\>M9OX=(27QA\8+CP]\-=5
MM]8U:R?2Y!H]O81V-E90:EJ NH]1U"XDU)_P$7X*_!/]I/P+XKUOXR_\%,?^
M"H'P%\>:WIOB_P#9N_LK4/AG\6_&WC;XA?LB_#MK[X=_"KPM^U7)JW[--YI_
MQ-\5>.\?$;XZ>.K%;G3M,_MK]H3Q/X0U?3[K^P;26W_M1HH _FE_9]^('_!7
MGQ?^S3\.M&_8:^+'[/OQDO/V//&'Q"_9W^)5Y^W3\'OCM\,]2_;#\'^%CX8\
M1?!#XL^"/'EA8Z%K.C>(;WX+^(_#OA;QC%JVB-:6OQDT?QD_B3Q9XHMXTO'^
MY?VC?^"MW@']@C3_ (#6W[?WP.^//PFG^)'PIT/QE\4_C7\'?AAXL^/W[)/P
M4\>32-I_B+X:>)_B]X3TZ#Q<^MZ?J%O<WNG+;_#"XCO_  \]IJ27#^:5K]=:
M:Z)*CQ2HLD<BLDD;J'1T<%71T8%65E)5E8$,"000: /./!OQB^%GQ!C\*'P=
MX_\ "NMW7CCP!X?^*GA71H-7M+?Q+K'PY\56R7?A[QG#X6O9+;Q'#X?U2%P+
M?4+K2[>(7"36DICNH)H8_P 3/VU-%^%7['/Q&\"^ O /QP_;:^$_PI_:,\?>
M*?B1^T3\)/V;_B3\)]!^$WP&^$?BCQOX?\-?%O\ :<U#5/B!\&OB'\8O@IX&
MU#XU_%[P*GC'2/V=_BM\&8H&\9?$OXP^'UT^[\$>-+RY^U/VT?\ @D9^P+^W
MUXMT#XE_M%_!$:C\8/"6DV&A>%/C3X \:>./A3\5M TC2[J_O-.TZW\7_#SQ
M#X>N]2L;";5=4-A9>((]8M+#^T;MK*"WD=9%_GV\<_"G]GK]M3QS\;/CS\;/
M^"@__!2S]D*_^+=KJO[.,?[./PJ^'GQL_P"$<A_8Y^%%SX@^'GPV\$?%.V\8
M_LY?$&_\3>)OBAI]QXQ^,?CVSUGQ)K6EVNK_ !DUOP[J.EW>HVFKW^H@']>7
MPV^''P\^!_PW\'?"WX:^'=)\"?#7X<>&]+\*^$O#FG-)%IF@^']&MH[.QMA<
M7L\]U<RB-!)>:EJ5W=:EJ=[+/J&IWEW?W5Q<R_GQ^U!_P6(_8=_93^/FA_LH
M>*_&7CWXG?M3:[?>%;:/]GCX _"KQS\8OB=I-GXP33;K2M8\267A?29="\.V
M(TG6-,U^6TU?7K37IM OK35=.T:_M;F!Y/S2_9Q_X)K_ +(O_!3WPW'XL_;(
MO?VJ_P!HH_LI>(S^ROX<TSXD_$O]HCX6? SXU> OA/#I_B+X+_'2/X872_#F
M\U3QWXL^&'B[P79_&G48'CT;5OC'X<\<PW>F7,(-UJ7]*&E>#O">AZG=ZUHW
MAG0=+UO4-.TK1]1UNQTBPMM9U+2M"A:WT73M1U:*!=0O[/28'>+3K>\N9HK-
M'=;=8P[9 /S,^*GB?_@L/XT_:\A\"_ SX9_L=_!']BSP7XO\!WOB'X\_&/Q5
MXS^*_P 8_C3X--OHFK^.-)^&_P *? EUX9TOX?:F+B76O!X;X@ZKG9:1^)-)
MU=OM4-E%^2&I>#/A#XU_X*H?'+]JS]JG]O#_ (*3>!K/]E_]HI/"G[+/P \,
M:)\:_#OPPD\+:%8> =>^,-IJ]E\./@)JFG^(_@%\2?B-X?L/!]EX7TWQ):W7
MQ)\(?#6W\3^.?$?B[2_%7A^WT;^L6B@#^5K_ ()\_P#!/7]D?XC?MH?'_P >
M?#GXF_MSV.C?L]?&_P"%OQP_9^GT+XH_M+?!O]G_ %/X2>,8Y];\*?L_WWPV
M\::'X8T:ZTGX)>-O GC#P!=^ =%\G1-1^"4WPLCU..Z?6O$,)_4[5?\ @F;X
M_;]KM?VJ/"W_  4S_P""C/AS0=0^*VC_ !,\2?LO7WQF\,^+OV:+W3=-U"PO
M;[X7^'/ 'B+P)<S>#?AOKUO92:7J6DZ9JD^HP6.HW[Z5JNG7[6U[:_JO10!^
M4=[^SC_P5ATG]K]/BCX;_P""DOPM\4_L@ZU\6+#Q%J_[+?C_ /8X\#:=XB\%
M_"(ZE!+K/PW\%?&?P5XCTWQ5X@UUM(2ZLM#\;^,(_/L;^YM]1U32M:@L9=-U
M'\Y/VDO '_!2O_@H'^WIXY_8Y^*/@O\ 89^)/_!.+X ?%CPSXE^)_P#PA7BS
MX]> /BI!X3^-'@;QWHO@+P_XZU35;+Q)X<\3?M*_!#X<^(+3]H/1?"W@RRT#
MP3I'CGQ!\ /'<_B;3[U-,CT;^G>OSVF_X)O?"JV\9?%'QKX1^-W[87PUO/C%
M\2O$GQ<\=:-\./VGOB3X4\-:AX\\5I80:QJ]OHUI?R0V:FQTK2=)T^RB?[)I
M&AZ1I&A:7#::1I6GV5L ? /[('[;7_!7'7?CC<?LR?$K]@WX7_%;P!^SS\9]
M&_9F_:!_:STC]JWP=X%\9Q6FB^'?"NIQ_M$ZM\ ?$OAJ;Q%J,7Q/\ >(_#?Q
MLT3PIX7OI(+_ $WQ;'X;L]5M-6TW5(]/^LHOVZ/VUX/VN)/@%K'_  2=^/EO
M\#[CXL2> ](_:TT;XW? K7O UQX&_MA-/@^,>K^"DUNQ\2Z%X7?3)$\1S^'I
M;N\\96^FB73UT2?Q)#)H8^H/V>OV-?AK^S?X]^*/Q/\ #/C/XW>/O'WQAT+X
M?>&_&_B;XR_%[Q;\3[^]T;X7S>,9_!UM:KX@NGM;2733X[\0PM?+;MJ$]G-:
M6+W7V*PM;>/ZUH _*6/_ (*.?'4_M=']FJ3_ ();?MTI\/?^%MR?#(?M4+H?
MPUD^"AT)=5;2HOBZ;P^.4OA\-9$":^]SSXFC\-LT@\-R>(U'AAOB?]J/]K+]
MIO\ :\_;1\/_ /!+A?\ @G'\9;']GZW^-'@CQG^U'\8O$GQ*^$4/ACXA?L?^
M$OB!JMMI^NQ>%AJ\]S!\)_C/X^\(Z;'JFC:MJI\8?$GX5>&OBG\-M,\$7.LW
MWB8>$OZ,J^%?'_\ P3_^%WCKXT?$;X]V'Q7_ &HOAA\0/BQ8>!M,\>2?"#]H
M;Q_\/M"UNR^'&BW&@^#[<Z%I-Z;"RM](LK[5)X;.Q2VL3JNM:]K)MO[5UW5[
MN\ /R]_8JU3_ (*R>!?VN]7_ &#7NOV.OA]^QK^Q9XBLY]!NO'T_Q:^(O[5_
MQK_8D\;>)OB/IO[,EUX1U"PO-%^'EI_PC'A#P@_PGU_Q'K##7]#\8_#B;^W]
M.\20W"7?BO[.^$O_  2'^!_@7]L*]_;I^*/QM_:L_:B_:!TOQAX]\3?""]^/
M_P ;-6UWP%^SYIOCVUUW1[WPE\'_ (9^%++PCX-T;0+#POXBU+PW96NM:9KL
M,%G-]LM(+/4E2[3Z)^#_ .PI\,?@_P#&NT_:"A^)/[1WQ,^)VG?#7Q/\)=,U
M7XS?';QQ\2K'3O!'B_Q'X1\5ZYI=OI.MWGV&1IM<\$:#>6DUW%<G39([UM/6
MVDU&\DE^U: ,3P_X:\.>$M-71O"OA_1/#.D+<WEXNE>']*L-&TU;S4;J6]U"
M[6QTV"VM1<WUY/-=WDXB\VYNII9YV>61W/+^(OA%\)_&&J2ZWXM^%_P\\4:U
M-'##-J_B+P5X:UO5)8;=!%;Q2ZAJ>F7-W)'!&!'#&TI6) $0*HQ7H=% '!^%
M_A9\,?!%_-JO@OX<> _"&J7%H]A/J7A?PAX>T"_GL99H+B6RFO-)TZTN)+22
M>VMIWMGD:%YK>"1D+Q1LO>444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 <[XD\(>$_&4.DVWB_POX=\
M56^@^(M"\7Z';^)-$TW7(=&\6>%]0BU;PSXHTF+4[:ZCT[Q%X=U2"#4M"UNS
M6'4M(U"&*\T^YM[B-)!T5%% !1110 5^27Q)_P""7?\ P3^T/QG^S?INB?LM
M?#31=,UGXU^(K#4-,TB#6=+TV6Q;]G[X^^(39PZ?8ZO!9V=L-9TVQOU@LH+>
M-)K9 BK'N1OUMKPGXN_\E _9;_[+MXA_]9E_:+H _)/]J7_@AK\(KO5-#_:0
M_P"";>O0_L ?MZ_#![O4_A]\:O ?]IW?@CXEQRV]C%=?##]H[P9?2ZS9_$#X
M;>(K?2K'3+J6XT_4=2T&..WNUT[Q)IEE)X7U'T#]@/\ X*NWOQ@^*%]^PU^W
ME\,X?V.O^"DW@73EFU;X1:Q>$_#+]H30[6*8'XK_ ++'C6[N;JQ\=>$M8CL[
MO4Y?"<.K:IXE\.1P:I:)=^)+?PYX@U;3_P!HJ^#_ -OO_@G1^S=_P47^%MEX
M ^.6A:GI7BWP=?GQ)\%_CIX OSX6^-GP'\=PO;W&G^-/A?XZM$.HZ/>V]]9:
M?>7VD3FZ\/ZV^G6#:KIEQ<Z=IEU8@'WA17\X'P6_X*'_ +3/_!,SXH^#_P!C
M+_@LUJUEX@^''BO5H_"7[+7_  52T;2WTCX1?%R,#9H?@3]J2!6FM?@W\9H[
M*/;=>(]4N5\.:ZEO=ZCJ>HW=EI>J?$?7OZ.;>XM[RW@N[2>&ZM;J&*XMKFWE
M2>WN+>=%EAG@FB9HYH9HV62*6-F21&5T8J0: )J*** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ KPGXN_\E _9;_[+MXA_]9E_:+KW:O"?B[_R4#]E
MO_LNWB'_ -9E_:+H ]VHHHH \M^-7P2^$G[1GPO\8_!;XZ?#WPO\4OA7X_TF
M71?%W@?QAID.J:)K%C(RRQL\4F)K/4+"ZC@U#2-8T^:TU?1-5M;/5M'OK'4K
M.UNX?X0OV1?V*O"G_!+W]E+]D_\ ;"_:"_81_9I_X*4_\$VOVE_V;?V??CS\
M<_&'BK]DKX'_ !*_;"_88\:?%SX4>#_&WC;Q4=5U?P+?:]\8_P!FVRUG7+ZY
M>VOKZXUGP'H4<<8ET==$FN_B-_H'U^;OA_\ X)1?LB^$O".B?#_PEK/[:WA3
MP!X9\.:;X.\,^!/"_P#P5 _X*:^'?!7AKP?HVF0Z)HWA+P[X3T;]KNR\/Z%X
M6T;1;:VT;2/#NE:=::/IFDVUOIMC9064$4" ''_\$8=?^$7BC]@O1M?_ &?S
MX4'P(U7]JO\ X*-ZA\%(/ FD6_AWP3:?""^_X*,_M67GPOL_!WANTL=+M?#?
MA.W\!S^'H_#'A^VTO2[;1] &G6%MIUE;016T?ZI5_,?X\_X)[_M _P#!%_Q)
MJ7[4/_!'?PSXN^+'[+5PT&L?M6_\$N/$WCOQGXYF\6:?8010ZU\9?V5/&?CO
M5_%WC+2_C7:Z7;"XUCPGJFI>()_'L=L+2RBU^XLO#'@VV_;C]BC]N#]G/_@H
M%\#-!^/_ .S5XVC\4^$M2E?2O$6@ZA$FE>._AKXRLXXVUKX??$OPH\\U[X4\
M9:%)*J7FGW+36E]:R6NM:#J&L>'M2TO5[T ^N**** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M"7COQ/H>K:6ECJ=CJDL5V$C]\H **** "BB@G )/ '))X  ZDF@ K^,[P/\
MM4_\$0]!U_XY_#GXK?L!^$O^"B/[<EW^W)_P4GUWXC^#_@1_P3M\'?M@?'I?
M#VH?\%$OVG'^&NH^-/&NL>!VL=0M9OAK-X03PK:W'CO4;VP\&P:!:P6=EI0T
M:&7[2^-'[1?QX_X+5_'/XA?L1?L%_$#Q/\&/^"?'P>\3R>"?VX_^"@G@.]%E
MXE^+GB"Q4/X@_9;_ &1M?5)[2=KNVGM[;X@_%2S-U86VE7+21"Y\*7VA:9\8
MOOOX'_\ !$O_ ()_?LU>$#X%^ &@_M3?!7PM/<QZCJFA_"'_ (*)?\%#/A/H
MFMZX+2"SN?$6J^'?AI^U%X3\-S:Y?Q6T1O;Z#1[;S& 6..*%8XD /RM_X)B_
M\%;O^"77P)^-G[;/[.FN^'[W_@E_%\3/VO?#OQ"^#'[.'[1WP!7]C_0_"6A7
M'[%?[&?P_P#$NE7^D6&GQ?"'X6^(M8^)7@KQ;XYN_#VK^(="O-<TOQWX>\<;
M+RX\7W+Q_P!5UI=VM_:VU]8W-O>V-[;PW=G>6DT=S:W=K<QK-;W-M<0L\,]O
M/"Z2PS1.\<L;JZ,RL"?BFQ_X)Q?L8K\(_B?\#?%GP97XR_#GXS^-Y_B3\4++
M]I/X@?%/]J3Q-XQ\>R^ O!GPOM_%NI?$;]HWQO\ %+XCQZYH_P /_AWX'\+>
M&;ZR\66LOA33/"^D)X9.DRVJRG\<]:_9A_;4_P""'FHW/Q0_8'/Q._;8_P""
M:%FTM_\ %;_@GOXP\37WC/X[?LW^'UFENM2\9?L8>+]<>XU;Q1X;T*U>:ZN_
M@MK5U=W]^L,QAFUO5]:N_&7A, _IJHKYC_9#_;%_9W_;I^"'AC]H/]F3XBZ3
M\1?AUXE0P2RVK&T\0^$O$%O%"^J^#/'?ANX*ZKX1\9:&\\::IH.KP07"Q2VN
MHV37NCZAINHWGTY0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7S/^
MT/\ L9_LI?M:WWPNU/\ :8_9]^%7QPU#X*^*I?&GPLO?B/X0TOQ+<^"]>NOL
M']I'2IKZ%W;1M<?2-#G\1^%[PW7ACQ+=>'O#=WK^CZE<^'-$EL/IBB@#PCXS
M_LM_LR?M'WG@S4/VA_V<_@1\>;_X<7.J7GP\OOC/\(OA_P#%&\\!WFN2Z-/K
M5UX,N?''A[7)O"]SK$WASP]-JD^AO8RZA+H.C27;3/I=B8+/C#]F?]F_XA_%
M7P5\=?'_ .S]\$?'/QO^&UM9V?PZ^,GC#X4>!/$WQ5\ VFG7^HZKI]KX*^(>
MM:#>^+O"UM8ZIJ^K:E9P:%J]A%;7^J:C>0*EQ>W,DOMU% !7A/Q=_P"2@?LM
M_P#9=O$/_K,O[1=>[5X3\7?^2@?LM_\ 9=O$/_K,O[1= 'NU%%% !1110 44
M44 %? 5Y_P $SOV7)]8\7ZQI>K?M=^"%\=>._B%\3/$7ASX6?\%%_P#@H=\(
M? +>-_BQXV\0?$CXCZYHOPT^%O[4GA#X>>%&\8>/?%?B7Q9K.G^%?#&BZ5/K
MFN:G?)8QRW<I;[]HH _&/4_^#>O_ ((YZ]HNL:/XG_8H\+>,;KQ!XFU+Q?KO
MC/QQ\3_COXW^*^L:[JUCI^GWDVI?&;Q;\4]9^+5[8&WTRU>UT.X\:R:%I]Z]
M]J6GZ;:ZCJFIW5WXX/\ @V1_X)&:7D>!?A+\;?A?$O\ Q[6_@#]K7]IG3X;/
M)*M]F&K_ !0UQUWVY^QOYCRYM@%&),RG]_Z* /Y_V_X-QOV,; $^"OVC/^"D
M'PUG7Y;2Z\"_MQ?%.QN-/2/_ (]8[,ZP-;C5+$<6@FBF*#_6&6OQU_9=^$'[
M7'[-G[+?[."?L^?\%+O^"R?P3^,OACX!?!RT^(7[,?[4/_!(?]OG]L3]GKP1
M\1=*^'OARV\:?!7P-JEM^QT8_ OPF\(>(H-1\&^#Y?AWJ?C*WT'PII>GQ^&=
M;UJWCM-4F_N*HH _D?\ V%O^"K_[07_!/OX06/AO_@K+^QE\8/@C\$OB7^T1
M^U9\1O#?[>7P_P#A?\5(/@M/X@^//[7WQH^)^NW7QC^!?Q!\)^'/VB/V9/"^
MN>,?'.L:C\)8?BAX/@\:>(_ASJG@^^U/P5I<Z:MJ)_JJ^'/Q*^'OQ@\#^&OB
M9\*/''A/XD_#OQEID.L^$_''@;7]+\4>%/$>E7&X17^C:]HUS>:;J%LSH\;2
M6UQ((YHY(9-LL;HO0:]H.A^*=$U;PUXGT72?$?AS7].O-(UW0->TZSU?1-:T
MG4('M;_2]6TK4(;BQU'3KZVEDM[RRO()K:Y@D>&:)XW93_/O\0?^"07QT_8M
M\=>(_P!HC_@B!\9]$_9TU;7M3G\2_$S]@+XQR:WXE_88^-E\0)+Q_#>AVUQ)
MKWP"\97ZQK;VFL>!KBVTD)!I7AZPD\"^%X;X3@']#U%?@+\)/^"^OP7\&^+=
M-^!'_!4/X-?$S_@EQ^TF?-LFL_CSIUSJO[-WQ O+':EYK'PA_:7T"SF\!>(?
M#3_-.^J:])H&CV,K'2+?Q!KMW ;B?COV5OC9;?%7]B[]F?\ :4^.O_!?;XG?
M"WQA\5/V<_@]\5OBQI":_P#\$>_!_A#P)X^\9_#70?%GQ \+VEGXU_83U?7/
M#NG>$_$EYKFCQZ-XH\0:MX@T6#2WL-=U.]U*SO+J0 _HKK^<;]N_]HWXQ_\
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M>VOBS2(Y[/2OAY\;)Q/?2Z!\3]+?2(K_ %N\N)=>U'1+K7O%'BC4?.?V&_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M:;J\UG>3306%]-%'"SQ6=RZK"X!]545X3_PMWX@?]&M_';_PH?V9?_HBZ/\
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M_P")#KVJ!?@'XNCM/[*L+$QZG_5)_P +=^('_1K?QV_\*']F7_Z(NOB/XM?
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MH>K>#-:_:3UN;_A$?!NE33WWAK2CKOB.UC_L/3=:_I%_X6[\0/\ HUOX[?\
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MOA1/HQG\?:5XT\#=-^UU_P $(/V+/VO_ !UX0\9:YXK_ &EO@;I&D_"7X?\
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MPOD\8^%_BE\%K_PMX<^/_P $OB?X!\;_  Q^)_P@\5^+-#DUW0[+Q%X1\?\
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M[2OT/H *X+XG?"OX8?&SP-KWPP^,WPW\!?%SX:>*4L(_$_P\^)W@_P />/?
MWB./2M4L=<TN/7O"7BK3M6T#5TTW6],TW6+!=0T^X6SU33['4+<1W=I;S1][
M7X,?\%H/V]?C1^RI_P ,R>%OAG\:-)_9%^#OQPLOC3XB^)7[?>J?L]Z]^U;X
M7^$MQ\+O!6C^*/AW\.K7X:>&K;4-*2Z^-%_JMV9/&OBO;I6F>%?#&NGPY!J&
ML327^@ 'W7'_ ,$HO^"6T,D<L7_!-?\ 8#BEB=9(I8_V.?V=TDCD1@R21NOP
MY#(Z, RLI#*P!!!%??E?BQ_P2G_X*O/^V9I'@']GW]I'X2?%[]G/]O'3?V:?
M 7QX\??#WXJ_";4_A;X8^*W@W65T;1=9^,'P)_M'6=:N=6^'Y\4:M8Z9?6&M
M_P!AZ_HNLW=UIT6DWFGZ;-J0_:>@ K@OB=\*_AA\;/ VO?##XS?#?P%\7/AI
MXI2PC\3_  \^)W@_P]X]\#>(X]*U2QUS2X]>\)>*M.U;0-733=;TS3=8L%U#
M3[A;/5-/L=0MQ'=VEO-'WM?C#_P4S_;R_:(^"/QC_8\_9/\ V0+_ /98\'_&
M#]K]OCCJ.@?'']L;6?&MK^S_ *"GP(TKPS>WOPXTR'X>3V>J^(_BCX\U+Q/#
M8:59?VW:1:%9:/J3MI6N:IJ.G6EJ ?44?_!*+_@EM#)'+%_P37_8#BEB=9(I
M8_V.?V=TDCD1@R21NOPY#(Z, RLI#*P!!!%??E?B[_P2$_X*XZ;_ ,%']"^*
M/PT^)_P_T_X*_M<_L\ZO?Z/\6OA[H.KS^(_AOXXT'3_%WB/P'!\9O@-XONE6
M3QE\*M9\6^$M?T*2YCEU)O#>N68TJ?6M<L[S1]=U?]HJ "L+Q1X7\,^./#/B
M+P7XT\.Z%XO\'>+]"U?POXL\)^*-(L-?\,^*/#.OZ?<:3KWAWQ%H.K6]WI>M
MZ%K>EW=UINKZ1J5K<Z?J6GW-Q9WEO-;S21MNU^.?_!4/]O'XZ_LZ^-_V-_V;
MOV5;K]F[PO\ &3]M7Q[\8/!OA;XZ_M9ZKXN@_9P^&MY\%O#>E:UJ/@_Q / 4
MUIK&J?%#XF:QK5OX.^&F@'6;&.77M+UZ.YLM4N++^SZ /HW_ (=._P#!++_I
M&G^P!_XAO^SK_P#.YK[B\+^%_#/@?PSX=\%^"_#NA>$/!WA#0M(\+^$_"?A?
M2+#0/#/A?PSH&GV^DZ#X=\.Z#I-O::7HFA:)I=I:Z;I&D:;:VVGZ;I]M;V=G
M;PV\,<:_C1_P21_X*ZK^W]JWQJ_9V^.'@/PW\'_VT/V9M<\5Z/\ $CPOX%UN
M^\2?!KXP>%?!/Q)\1_!S7?CA^SEXJU4#4/%'PMB^)_A'7?".IEKC6T\.:M_9
M%G)XGUR35%DM_P!M* "O(OCI\"_AK^TA\--5^$GQ;TK7=6\$ZOKO@3Q3+'X6
M\=^/OAAXHTSQ1\,/'WACXI?#WQ-X9^(7PM\3^#/B#X/\1^#_ (@^#/"_BO0M
M=\*>*-%U6QU71;22.[\OS8I/7:_)?_@JC^W;\4OV2_"_[-/@K]GN7X"Z3\6?
MVM_VC;7]FSPA\8?VFM:\1:=^SC\'/$#^%?$_BF>_^(L_@V6WUC5/$FN2>&9/
M!_@7PA%K&AMJ7BO44GOKN2ST>\TN^ /3/%'_  2J_9-\<>&?$7@KQQX@_;<\
M:^"_&&A:OX6\7^#?&'_!47_@IQXI\(^+?"_B#3[C2=?\,^*?#.N_M>W^A^(O
M#FO:3=W>E:WH6LV%[I6KZ9=W6GZC:7-I<30O^CE?A+_P2T_X*[^)?VKOC?\
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M5[75)K+PUXS\-:K9:M<>';^=?$&@?0WP=_9'\,?\%1O@W\#/&W@_QO\ $?\
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M/CWP1^TE:VVO:+\,_A)H>DZ_;^,=9^*FJ_$W2]5U/XH6%_>0:%;7<$.C0^*
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MNKNXA@B4%I)%'-;-?@M\4O$_[-?_  78TWP_\%?@I\;]#G\%?L5_\%!M%?\
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M]_H[W^D6^K:#>ZSINEZO?7* 'SG_ ,%0?B;\3_&6G_$__@G/I_@CP9X>MO\
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MPSXD^-GP9\'^*_"JOXFT/Q!\3_A?I?B?PE:-H"/JNLQ:E<>&K1?,UO@ R?\
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MU?ZWJ#ZSK6N>*]<U*34=7U)HK33;*Q_2"BOS:_X*Z>#OVKO'O_!/C]H+PO\
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MK.RFUKQ!?Z;\3?2_CA\"OBK_ ,$G[CXW_!^UL?V=OCM_P3'_ &Q/C?\ LJ_
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M &B?VJ?C%X&\#?\ !1O_ ()T_M?_ +3O[0?Q^_;P_83T+28/BAHOP?\  WQ
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MXB?'KX;_  CO/CEJ7PIAT'QGXK^&^C:I-IWBK5OA5HWB72+KXPZEX'M8M.U
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M2T?3O!MS;7-_X4N!/>VMDW[B44 <3\-_AOX!^#W@'PA\+/A9X/\ #_@#X<^
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M:KX2L?A%XQ\3)<&2RMO#_A/QWK6KZCJ-K?Z=IUG=WVG7]O;@'Z?45_*MJ_\
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MN>%-9\-6'BGPWXAT;3+]K_P6^_X)37O[5Z?L2VW[:7PQD_:,D\9/\.XO#/\
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M_%WP19?M.:Q8?$SQ!X)_:+^,/[3OQ.^!?A34OV2_VJ+;2?BU\,O!GP*_9O\
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MCH>MZ3KRV1M=$:74'?L)_P#!.[]K?X/_ /!>[]H]]4^$_BNS_9!_9!?]M/\
M:0_8<\;^)O OB/1?@Q<_$7]O33_AG+=_"SP#X_ETJW\.:I8^&=)U[Q1H.NV/
MAR\GUWPS-X;\1V6K7=PMW!$G]H=% '^;?\,OV?\ _@HK\5OBS_P2O\5?&#]D
M#_@I9X)\7_LB_P#!4#X$W_[1?PMT3]E+X4?L_?\ !,OX)?#^Z_:G\8^/]*\=
M_LM? 3]G;P3H.K?$[5;?1+#Q7K_QS_:OF\,Z]I>E6E_H^A^,/'^L:7XJ^%VL
MZ][[=_L'?MG>,?\ @WS_ &&_V:].^!/[4WPQ^.$7_!82R\5Z]9:-\%/BK9?&
M'X*^ =8\;?'BWA^/=[X2@T?2/%WAGPSX0C\0Z-XHM/&UXVA:+:M)I-XOB"Q6
M[M+NO]!.B@#\"/\ @AU\$_BW^P';_M2_\$M_'_PK^(*_"W]F?XO:[\2OV3OV
MH;GX;7>E_#[X_P#[/?QRO3XQT_1O$'Q,TK0--\*>*OV@/A;XFOM5T'XD6LLU
MAJ(TV]T'2_#>BCPGX/BNQ^<?QU_X(F?#3_@I?_P6+_X*[:C^UG\#OB_H'@+6
M_@%^RG8?LF_M.1Z9\4?"G@_0?B9)\#?#OAGQ9XC^'FK6FH>'?AG\8M2\&ZII
M&G6_B7PAKDOBG3K&6PN-,N[?1KVXENH_[$Z* /X#=$_8X_;;M_\ @F7\.OV2
M=8_X)SZM+\6/^"/7_!2WX4?M-_%CX7>!?@[?>#?A1_P5%_9S^&6F>)X;_P"(
M7PO\977A:P\(_M"_&G7_  U"GAGQ3X7L;CQ1X^\6^%M,\.B/2=7^(7B#2_AO
M99/_  4T^"O[7_\ P5!US_@HC^WS\%/^"=/[9?[-WP^@_P"">WP<_8WT/X6_
M&GX$:KX,_:V_:M^,%K^VC\"OC)JVM6O[/OA)_%?BS7/!/@;X?V<,3^-HWUV"
M6#X<:!9V>L7T6C:]H/PW_P! BB@#^/GX2^'?VE?VZ_\ @HW_ ,$B-5T/_@GC
M^U3_ ,$^?#W_  2X_9X^/O@[]HGXI_&_X7Z/\/? ]_K7C[X"^&_@QX5^%'[,
MOC7P[=-HGQK\"^$O%FE:LGA75M+GT+3I_!/BC7?$9\$^'K-9=+US\XW_ &9_
MVTM/_P""4'B;_@WCE_X)5_M#ZQ^UKJG[24M[;_MNGX>:9)^PCJ>D77QHT[X^
M0?M.:E^U6+J2TM_%X^$4/_"I6T1;,^*+?0(+;P!JMY-\01J?P/E_T(J* /XU
M?VVOA5^TG\%O^"F__!1748?V5_VQ/VB?!O[;'_!%GQ+^S#\,?CC\%/@5X@^*
M?@2'XP:3\)O$.G-!\5_$WAN\NX_"6H^)-8\!2:=:Z1Y.I>+;[Q%XM\+);>&I
M]%URSUZ7Q;]FSX8_M5?\$Z?BQ_P2>_;^^)/[!'[9/[2WPQT'_@D'X<_8E\9_
M"?\ 9[^!VH?$7]IG]FKX[VGCKQ%\1)-7UWX&^)+SPWXG\-Z;KGAJ[NO"VI>(
M97\,Q::VKZ[H^M7R7UWH^A>+/[DZ* /XS_VV/@QXG^*W[(G_  3.^.]]_P $
M=?VW_P!B.P^&WC;X\>,]!\&_\$=/B]X+\._MM?L0Z7\9-&2WT5S^SIX;_9V\
M':3KP_:+&GZ!XH^+N@:)=_#;Q[\$I=/BT?Q]XHT[Q+J?C+P)JGZG?\&\V@?M
MC:)^Q9\1+S]L7X2V_P )M;\5?M._%KQ5\*(]<_9A^%'[&_QC^(/PNOHO#EA9
M_$[X^?LZ_!W3=.\-^ OBEXN\2Z7XBGU3^W)-5\9:O8V]C?ZGXC\8:(_AKQMX
MF_>*B@ HHHH **** /RE_:=_X)5_\--?M 7?Q]_X>0?\%6_V?/M<?A*/_A2O
M[,7[8'_"J/V?[;_A$K&RL=]I\./^%=Z_Y,GB;[%]L\6M_;+?VS?7=[<8MO/V
M))^U!_P2O_X:=^/TOQ[_ .'CO_!5?]GKS;?PG;_\*6_9?_:^_P"%3? &/_A%
M+:VMO/B^'/\ PKS7]EQXE^S>?XLD_MD_VS<SW,NVV\W:OZK44 ?S-_\ !8K]
MB.[^+7[3/P,\0Z_^TG_P6-TSX%?'.]US3OVD_A/^R%J_QK^*O[+_ (<^%GPH
M\!06UEX3E^ /P8^"GQ+GL/'?QQ\?ZYX/^U:MXT>_\'7_ (7\/?%34+K39=;B
MT"T?S_X+_P#!/F3]J7]KO]INX\$?M<?\%S?V.OV=?#^M>#/C%\!O _PX\7?'
MO]B3]GZSG^*OB+QIXH^,GPDL_A7\>O@5ITNKZKH'Q8M]>\=/<>#_ "_"(^''
MQ8\(>"K6QL[OP1J4]]_5)10!^4W[3W_!*Z3]IKX_W/Q]7_@I%_P59_9Z:>+P
ME%'\%_V8?VNK?X5? "S/A*SL[02VWPUE^&OB*)IO$CVAO?%K7>JW2ZW>7=XS
MI#!*MO'Z#\2O^"=TGQ)_;%\)?MA#]NW_ (*,> /^$2UGP'JZ_LM_#7]I6U\+
M_L=>(X_ T5K%)HWBWX(MX!U#^W=&\;?9I)/'D$WB>.ZUR6]NGMKW3<6HM?T8
MHH _GF_X*P?LT^,_V@O^"IW_  0YN6^!WC?XM_ 'PQ??\%&?"W[1VM:7X!\3
M>*OAGX.\%_%KX"?#'P?8Z7\6_$>DZ9=:#X.T?X@QIKGA[2/^$GU'2HO$,T&H
MV&F/<W%O.D?X"?"']E/_ (*/?\$K_P#@HQ^U_?\ AGX%_M,?M'?"S]D;_@E]
M^T%\#?\ @G/\6? GP/\ BO\ %72_%^B_$OXR:=\6?V=_A5)K_AO0M?'B/QK\
M,_B#\9?$GA_QAX:MI;?4-#\)^ -;U/3-)M_ &BZ9J\G^@I10!_ )XS_X(<_\
M%9/@I_P29^ GC[P7^VIKOQ*\=?LI>(?A;_P4$^$G_!/[2OV'?"C_ !5\)?M.
M7?B>T^(GB_1['X_Z%XDU7]H+QI\1_!D_CCQK=3Z+?^&]0C\8>(="L_"*:)HM
MK%H>I>'_ -O/^"L_BWXD?'/X!?L3^*?BO_P2K\3_ +>/[!GQ?T>S\7?MA?L[
M:!\&OB?<_P#!0S]G?QQXB\%Z1J'PP\0_!3PEIOCSX>>-_!/B?PWK6N^)/"7Q
M3CL],T[Q3I6C6NM^%M4\5^&-"\5ZG>)_1_10!_G)W/[*G[:/PQ_8V\(>+?AC
M^Q+_ ,%$+;]BSX>?\%Z?V9/VG?V.OV'O&7PO\<?%+]L'X+_LW?#3P=^TQKGQ
MLU:[^$UG_:WB+P!X.\1^+]7\,:9X1TSQ?K-MI]SXGN3K6M>,O$E[XY/Q-\=?
MLU\>?C9^T)_P5>_:I_8>\=^%?^"<?_!03]F']F;_ ()K_%/6_P!NGXW>*_VO
M/V>;_P"$OQ/^)WC'X9^%=7U7X4?!S]G3X4:1KWB[Q%\7?%'BO6="N=-O;?PM
M=7]Y8SZQIR7^BI,^A67BO^M*B@#^!?X9_P#!$C_@J[^US_P3+_:P^(_Q2_;$
MU+X#^)?V]/&GQH_;'^,'_!//XA?L-^%-8\;^)/C?HGB[4?$?PQ\,:Y\:_'GB
M+3?CE\*+OQ3>_#[P.=%TSPWX9BC\!:%K,5I%X:U]KO7=.UGZ\^'7B#_@H#\&
M?CG^PG_P6[\7?L3?M7_'Q_'G_!-_3/V"_P!O_P#9S\(?"'7=+_;,^&7Q%\$?
M%JSU*3XR^$/@#X['A;QGX^T3XE^-O#?A_7+?3].B4:7X3.N>,=8UZP\.:KID
MMK_9910!_%G^P1^T7^V5^W__ ,%Q?V6?CA^W-^ROX^_85F_9Z_9$_:.\&?!#
M1_BW\$OC1\";S]K#QIJNK?8?&VN^ ?#?Q3TW7M,T&YT;X=>,M(\5^(/A!I_Q
M9^)&N^"(="OM5M?'OCS0[C4[O0OU0_X*^_ ?]H_PI^U9_P $W_\ @J;^S;\&
M_%G[3=S_ ,$__$GQZT?XU?LX_#G[#/\ %KQG\%_V@_ARG@/Q1XP^$&C7FQO&
M7C;P)I:Z[+:_#O3_ +5KWC;4=9\/6FB#3(]/U?41^_E% '\U_C#]I7]O[_@K
MM\-/V[_V9/A=_P $]?C[^Q?^S%X__8=^,'PQ\'_&#]NOP]?_ +.7QQ\4?M->
M-O#=WI.A^"=-^%GVWQ>-0^$7B71]9DT#Q#XJL3=:?H]@FO:K>^)_[972_AYJ
MWYD> OA]^U3^V/X<_P""(W[ ?AO_ ()=?M1_L;_$7_@EA\??@5\4OVF/VI_C
M+\+M'^'/P!T+PO\ LNV^F>#/BA:_LW?&"#4[VR^.-_\ M(^,3I_CVXL?#!GN
MO%&NZ;H_BH77Q"\$Z?XJ^*.A?W#T4 ?P"?&7]B3]JG4_^"4/_!P[X-TO]D7]
MH'4/BU\</^"P6L_$/X0>%;#X!_$:[^(OQ?\ A7:_M)?"W7](\<_#?0[?PG)X
ME^('P_M]&G\6:UIOB;PQ:ZMX<ATR;Q%J5K>K:R:E,?JC_@HA^SO\6/!_[9W[
M8OQ3T;X%_$3PM^SYH'_!JA^TO\%Y?B-IGPQ\2Z)\&]$\<Z+X6^(]S9_">3Q?
M:Z):^"=-\6:3H%CIMQ;>!&U"'6+#2+.QEBTJ*RMX&3^U.O/_ (L?"WP)\<?A
M9\2_@I\4M"_X2CX9?&#X?^,OA;\1?#7]IZSHG_"1>!/B!X<U+PGXNT+^V?#N
MH:1X@TC^U_#^KZAI_P#:>A:KIFL6'VC[5IFH65[%!<Q@'\'7[.GA7]H?_@H!
M^S'_ ,$"OV-O@Y^P)^TI^S;KG[&GQ2^!?[4OC[]NK5_ACX;T#]F.T^#.D:$?
M'%]XI^!/QR\/ZO);^//'OQT@\5>%/'OCGP'"WAKQ-9_&*PN_#GC#3];U?POX
ME\0>&\)/V9_VTM0_X)0>&?\ @WCB_P""5?[0^C_M:Z7^TE%>W'[;H^'FF1_L
M(Z9I%K\:-1^/D_[3FF_M5FZCM+CQ>?A%-_PJ5=$:S'BBXT">Y\ :5>0_$$Z9
M\#XO[T_@K\&OAM^SO\)/AQ\"O@[X;_X0_P"%?PD\':%X ^'WA;^V->\0?\(_
MX2\,V$.F:)I/]N>*=4UOQ'JOV*Q@B@^WZWJ^I:G<[/,N[R>9FD/I] '\)G_!
M7_\ 9U_:'\#_ +9G[7_C[X"?L>?\%0HOCI\=/AC\!]'\%?$K]FGP%\,/V_\
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M5U;/)!("CFOWNHHH _GF_P""L'[-/C/]H+_@J=_P0YN6^!WC?XM_ 'PQ??\
M!1GPM^T=K6E^ ?$WBKX9^#O!?Q:^ GPQ\'V.E_%OQ'I.F76@^#M'^(,::YX>
MTC_A)]1TJ+Q#-!J-AICW-Q;SI'^ GPA_93_X*/?\$K_^"C'[7]_X9^!?[3'[
M1WPL_9&_X)??M!? W_@G/\6? GP/^*_Q5TOQ?HOQ+^,FG?%G]G?X52:_X;T+
M7QXC\:_#/X@_&7Q)X?\ &'AJVEM]0T/PGX UO4],TFW\ :+IFKR?Z"E% '\
MGC/_ ((<_P#!63X*?\$F?@)X^\%_MJ:[\2O'7[*7B'X6_P#!03X2?\$_M*_8
M=\*/\5?"7[3EWXGM/B)XOT>Q^/\ H7B35?V@O&GQ'\&3^./&MU/HM_X;U"/Q
MAXAT*S\(IHFBVL6AZEX?_;S_ (*S^+?B1\<_@%^Q/XI^*_\ P2K\3_MX_L&?
M%_1[/Q=^V%^SMH'P:^)]S_P4,_9W\<>(O!>D:A\,/$/P4\):;X\^'GC?P3XG
M\-ZUKOB3PE\4X[/3-.\4Z5HUKK?A;5/%?AC0O%>IWB?T?T4 ?YR=S^RI^VC\
M,?V-O"'BWX8_L2_\%$+;]BSX>?\ !>G]F3]IW]CK]A[QE\+_ !Q\4OVP?@O^
MS=\-/!W[3&N?&S5KOX36?]K>(O '@[Q'XOU?PQIGA'3/%^LVVGW/B>Y.M:UX
MR\27OCD_$WQU^S7QY^-G[0G_  5>_:I_8>\=^%?^"<?_  4$_9A_9F_X)K_%
M/6_VZ?C=XK_:\_9YO_A+\3_B=XQ^&?A75]5^%'P<_9T^%&D:]XN\1?%WQ1XK
MUG0KG3;VW\+75_>6,^L:<E_HJ3/H5EXK_K2HH _@7^&?_!$C_@J[^US_ ,$R
M_P!K#XC_ !2_;$U+X#^)?V]/&GQH_;'^,'_!//XA?L-^%-8\;^)/C?HGB[4?
M$?PQ\,:Y\:_'GB+3?CE\*+OQ3>_#[P.=%TSPWX9BC\!:%K,5I%X:U]KO7=.U
MGZ\^'7B#_@H#\&?CG^PG_P %N_%W[$W[5_Q\?QY_P3?TS]@O]O\ _9S\(?"'
M7=+_ &S/AE\1?!'Q:L]2D^,OA#X ^.QX6\9^/M$^)?C;PWX?URWT_3HE&E^$
MSKGC'6->L/#FJZ9+:_V644 ?Q9_L$?M%_ME?M_\ _!<7]EGXX?MS?LK^/OV%
M9OV>OV1/VCO!GP0T?XM_!+XT? F\_:P\::KJWV'QMKO@'PW\4]-U[3-!N=&^
M'7C+2/%?B#X0:?\ %GXD:[X(AT*^U6U\>^/-#N-3N]"_0S_@LM^R/XY_:Q_X
M*-_\$9O#D7PF^(WCGX$'1O\ @IQ\-/VB/'7A?P#XD\5>!OACX1^.O[-_P\^'
MNFR?$GQ'I>G7/A[P=;>+A-K>E^'/^$IU+28?$-]8WMAITEQ/;SI'_2!10!_F
MD?"S_@G3_P %&M3_ &-?#7Q%^/?[,_[1VN?'WPI_P5&_X)I?LT^&?!,/P8^*
M%_KGA+]D']@CX,?$/P5I?Q(\/>'CX=FUFW^"-S=^-[1+_P")2V5OX)UC6M(E
MU2*^MQ<B,]KX_P#^"77[38^*G[8G[&/QD_9T_P""V?QD\4_M(_MX>/OBYX9M
M?V:/V@_!GP7_ ."2OQ?^'?Q&\8:/XRT7XZ?'?XH>+?@7\=O"7@GXL:'9:%;:
MQK=IXA\&>+=?:\\+>"O#9_X1_P 4V.EZ>?\ 2"HH _CJ^./A3]HG]AK_ (*$
M?\%BKC6/^"=G[5__  4&\'?\%3/V:O@?X$_9S^)GP;^&-E\6O"%A>^!?V?O%
M/P2\4?"/]J3QOJ]U9V?PI\%^+?$NK:3#XPU>[N-4AF\&^%]$\20>"M;AFM]+
MT'\O?V'/^";7[<WC;1_A7\)+S]G/X\_!W7O&?_!M_P#MJ?LNIXH^*WPF^)/P
MT\'>&OCO\2/V[_VMM?\ "7P@\?\ BOQ)X?TC3O!WB3Q?X4\5^'=8N?#VLSQ:
MW_P@/BFT\5C0]2T&]M_MO^BO10!_*;_P3>^-OQOU;P]_P3\_9%3_ ((6?%[P
M5\=_V$_V7/&'PT\7_MC?MA_"[PC\'/A3\#OB!\/?A5H7PZN_$'[*_P 5)?!G
MC+6/C,?VH/'>FRP>.;7X=^)OA?J5WI&MKXJN-6\?^#(O$GB_0/PN^!O[/O\
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M^'WQ=\"-J]JER_A?XC>"I;W46\,^+=(=FM-8TD:A?Q6MU&ZPWEU"8YG]2HH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
9HHH **** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>image00007.jpg
<TEXT>
begin 644 image00007.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 0L!WT# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I#2TE !WH-%+0
M4@I:* "D[TM% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%)0 "EHHH ***0T +10** "BBB
M@ HI*6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ I*6D- "]Z*3O2T %)2T@H 6BBB@ HHI.] !2T44 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4E+24 '>EI*6@!.]+2=Z6@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** &2R"
M-,FHUG#(3Z55UF;R;(M69:7FZQF<GH* -.;44C4$GJ:?/>I%&K$]1FO/];UA
MHK:-@W5P*N^(=5-OIMJ^[&Z,&@#N[>43PAQT-.FD$41<]JR/"MS]KT.&7.<U
M-X@N1;:5*^<8% %JUNEG; -6ZXWPC?F[F;G/%=E0 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &
M%XI?9IA^M8*R^1HDSD]4K<\5H7TW ]:YO6LVWAIS_P!,Z .?N+=K_1XI!S\]
M1>.IS#I%N,_=C K<\)PB]\,1L>?FKGOB5$R:4Q'15H [[X;3>=X0MGSUK/\
MB/JPLM/DBW8W+4?PCNQ+X/MH\\BN1^-EZ\,R(IX*T ==\-E,EFL_]X5Z'7"?
M"Q0WA*TD[E:[N@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 9N ;
M%/K U'4Q;7>S=CG%;<#[X4;U% $E%)2T %%%% !1110 4444 %%%% !1110
M444E "T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444AH 6BBB@!.]+2=Z
M6@ HI*6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "D[TM)0 M%%% !0**!0 4444 %%%% !1110 4
M4AHH .]+2=Z6@"CJ=O\ :+?;CO7(>-X_(\.3#TC-=X1FN+^(BYT.=1W0T 9O
MPR_?^%8\^IJO\3;#_BGKE\=$J]\*H]GAB,'U-:?Q MO/\,W:X_@- '"?!:_+
MVBVV?N@\5E_&T%[A3Z"F?!HF+Q'/;'^%3Q6W\7--,UH\VW[HH ZKX4G_ (HR
MS'^S7=UY[\*9/^*9MH_1:]"H **** "BBB@ HHHH **** "BBB@ HHHH ***
M* $[4M)2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !24M-?A2: /+/%NJ&/7Q"K<[Q7I6FMNTZ!O5!7A/BN_,GQ!>#/1Q_.O==
M*_Y!=O\ [@H N444E "T44E "TG>EI* %I!2TG>@!:*** "BBB@ I.]+24 +
M124M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%)0 "EHHH *0T&EH ****
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M5Z=0 4444 %%)1WH !0:6DH 6BBB@ HHHH **** "D-+10 G>EI** %HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *K7TODV<C^@J
MS6+XGNA;:+<,3@[#0!\^WLIOOBC,0<C<*^D=,&--MQZ(*^9/#<@O/B'*YYYK
MZ>L1BRA'^R* )S12TAH 6DI:* $H%!I: "D[TM(: %HH[44 %%%% !12&B@
M[TM%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M"G*@T=Z %HHHH **** "BBB@ I*6B@!,\49!JK?W MK8N3BJNE:@+PN <XH
MU:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** (;IQ';
M2,>RFOESQ[?->>(&C!R Y%?2?B"X^SZ7*V<?*:^8KI/[0UF[EZ[)#0!)X#AV
M^+< >E?4]E_QYP_[HKYI\ P[O&3#T%?3%L,6T8]!0!*:6DI: "D[TN:2@!:3
MM2TE !2TE&1ZT +1110 4444 %%%)D4 +1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L[7)/+T>Z/_3,_RK0%
M8?BN3R]$N/>,_P J /G3PM')>>-6DR2!*?YU[$UDR13-C^&N!^%NG?:=5GG*
MYQ,?YU[/>V(2QG;'\!H \"N+ESXE6#<>37IOV)I-,AX/W:\M(W?$..+U)KZ
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MFM6N+\?7WD:8%!P=PH ZK3Y?.M(W]15JLKP\Y?1K9CW05JT %%(:6@ HHHH
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MPNOOM.A0IG.U!0!Z#2444 ***** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M;_KH?YU[Y\%!_H1_W: /7^U+110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MEK*3G*T ;UY>K ^TGM7 #5?)UV9BW!:M'Q9J?V?5$C#=17G&NW[VTWG D9-
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M*_\ 'B?]P5X7K8$CW#C_ )Z'^=>\?!>(IIVX]T% 'K=%)WI: "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M!MSIWCIB1BOH+PXWVCPK:D\[HA7B7C:$6WC?Y>.: .^T^W+W5K)ZD&O2XO\
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M@KYIM9=UO)%ZO7U7\.8/*\,VAQUC% '9T44AH 6BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M'6,4 =@.E+0** "BBB@ HHHH **** "FO]QOI3J:_P!QOI0!\L_$(X\9(?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M=?\ EC_NU[39OYELC>U>,_')<M#_ +M '%^$8T&F0.>N:ZE[<ZEXRTUL950
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MC+-NU.V3U%>YI@0G'I7SY\9)MNM6QSTH \^T>'S?$4<>.C@U]<Z*FS2;8?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M5W&@#Z*\.0>5H-NN.=@KPSQY^Z^(@8^HKZ$T^+RK"-/1:^??BDAA\9B7MD4
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M<0W!&>*]MA79"J^@KSSPSIFS5HI67M7H^,4 >:_&W_D2)/K7F_P+_P"/J?\
MWJ](^-O_ ")$GUKSKX$)NN+@^C4 ?1W\/X5Y1\5M&^U63S[<[5KU@=!7/>,+
M%;O0KE=N25H ^;_#MP;**1>F5(KK/AKHQEUX7A7I)G-8XT*2.0@*1S7K'PYT
MD6MJS,O.<T >BCA0/:O%/C-IGGS?: /NK7ME<)\0M-%[ITGRY.* /"-&O3#9
M209ZKBNW^&>@$WRWA7^+K7*0:%*EV5"G&:]Q\ Z6MKI()7#9H [*(;8E'H*\
M%^,=MLOS<XZ$5[Z.!7D_Q8TLWEDQ5<G- '$V%Z=4DTJ+.=F!7OVC0^1I\:8Z
M"O!_ ^D2#4K;>#A&%?0L2A(E ]* 'T444 %)WI:2@!:***  T444 %%%% !1
M110 4G>EI* %K,UV7R-+D?.,"M.N=\:S>3X<G?T% 'S?JVKM>^,EAW$@38KZ
M$T'2P=/B8K_"*^9=+4W?CD-U_?#^=?7.D1"/3XA_LB@#+U'30\!7':O)O'NE
M_9-->95Q7NEQ'O7&*\[^(VG^9H#\4 >!^!)F_P"$VLQZRBOL6'_5+]!7R-X
MLRWC6$X^Y-7US$,1+]* 'TR5-ZXI]% $42;!BI#12T )WI:2EH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M=V!M[UZ+*H9"*RQ:#S]V.] !8:>()%<#H*UZ:HP!3J /,_C=_P B1)]:X?X
M1;C=MZ&NX^-W_(D2?[U<I\ (L079Q0![N.E5KV#[1:O&1G(JS10!P4OAQ/M'
MW!UKJ='L!9P[0,59>$&7.*M*,+0 =ZS]4LA=PLA&<UH4$9H \^7PT@O"=@ZU
MV>F6HM+4(!BG" >>6Q5P# H 6L#Q%I:W]L5*YK?J.9 R8H XSP_H*V]QNVXV
MFNV' JK:0B-FXZU;H **** $-+110 AI:** "BBB@ I!2T4 %%%% !2"EHH
M*Y?Q\A?PM<*O7%=16/XF@^T:+-'C.10!\J>&R(O&@#=I17UOICB2QB(_NBOD
M)]UCX[8= )J^JO"]XLVD1-N'04 ;Q&:X[XA[(_#LA-=?YBXSFO/?BU>"/PJQ
M4\YH \H^&-GY_B>24#A9:^FUX0?2O _@K9&6:YG8?QYKWT=* "BBB@ HHHH
M04M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "=
MZ6BB@ HHHH *.U%% !VHHHH **** "BBB@ I ,4M% !2$9I:* "BBB@ HHHH
M **** $QS2T44 %%%% !1110 F*6BB@ HHHH 2EHHH .M)CBEHH *0C-+10
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M 4444 %%%% !1110 4AI:0T ))_JV^AKYX_MCR?B!/%N_P"6^*^AY/\ 5/\
M0U\K:I#-%\29'YVFXH ]'\:S_;9H[?.<X->B>$[;[/H\(QCY!7FMU"]UX@B!
MY&T5Z[I<0BT^%1V6@"[1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4G:EI* .5\1Z,+V&0E<\5P5MHWV:3:%Q
MS7L4\8>)ACJ*Y>73<S9V]Z ,J:TSINW'\-9>D:()[A<IWS7:O99MMN.U+H]B
M(9<D4 ;5G%Y-LB>@Q4]'2B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 )5>6U61MQ%6*.U $20*K
M9 J:DHH 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ I*6B@ I!2TG>@ I32&EH 04M%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 )2]J04M ""BEHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@!*6DI: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **!10 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4AI:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@!#2T44 %%%% !1110 @I:**
M"BBB@!!2TE+0 444E  :*6DH 6D%+10 G>@TM% !VI!110 M%%% "&EHHH *
M*2EH **** "D-+10 4444 %%%)0 &EI*6@ HHHH **** $-':BEH **** "B
MBB@ HHHH **** "BBB@ HHHH **** $-+110 44E+0 4444 %%%% ""EHHH
M0TM)2T %%)2T %%%% !112&@ %+110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M10 M%)FES0 G>@4M% !12&CO0 M(*6B@ I!0:6@!!2T44 (*6BB@ HI.]+0
M4AI:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M!I@& ]:7S1F@"6EJ'S13&N #C- %FBJ[SA11YXV@YH L45'$^\9J2@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **2EH **** "BBB@ HHHH **** "BD-+0 4444  I
M*44E "T@I:2@!:*** "BBD- "T444 )2TE+0 4AI:0T +24M(: %HHHH ***
M* "DI:2@!:*2EH **** "BBB@ HHHH *3O2TG>@ I:2EH *3O2TE "T444 %
M%%% !1110 4444 %%%% !1110 44@I: "BBB@ HHI* %HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MF^"K53X<AX[5Q7C&P9?B'I;H. >: /7;<Y@4^U2U!:_\>Z?2IMV* %HHI.]
M!2TA.** .1\>PE_#5Z?2,UYQ\&AMNL>YKU;QG&&\+7Y/_/(UY;\(!B^Q[F@#
MW*D-%+VH 2EI!2T %%%)0 =Z6DH!S0 M>+_'2(M:0$=@:]HKR3XUH&TU#Z*:
M +_P5_Y$N'ZUZ7WKS7X+?\B9%_O&O2A0 =Z6D)YI: "BBB@ HI <T"@#G/%M
MG]KL]N,\5%X+L?L6F[,8^:NAN8!.F#26ENMO'M6@"S112$T +1110 4E&:*
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH *2EI* %I*6CM0 E'>CM0* %I**!0 M)WI:* $I:0
M4M !24&EH **3O2T %%(:6@ I#2T4 (*6D% H #11WH% "T4AI: "BBB@ HI
M#1WH *.]+2=Z  TM%)VH *6DI: "BD%+0 4AH-% "T444 %)2T4 %%)WI: "
MBBB@ I*.]'>@!:2EJ&294?:30!-135.1FG4 (*.]+10 444AH .]+14#W"JV
MTF@":EI!R,TM !2&EHH 3M2TG:CM0 M%)2T %%%% "4M)WH[T !I:*04 +12
M"EH 2EHI#0 M%(*6@!*6D%+0!3U,XLG^E?-/C#3=^HWDV.Y-?2>KG&GN:\<U
M[3O/M;Z7;T4F@#I?@HW_ !2&/1Z]-KR3X+W0716M\_\ +0\5ZW0!QGCEM^GM
M'7SYJ=C]D\56+8QN?->[^,ILS&//>O(/%T83Q'I1 ZD4 ?0?A;G0X?I6PYVJ
M36-X3_Y ,/TJWJMT+:W9B<8% "_:!YN,U?4Y45YV/$2_;"N_OZUVNE78NK?<
M#F@#0J"20!NM+<2>7$S>@KEYM:7>WS=* /-_B7=^;XCTQ,])A7LNB\:9#_NB
MOG_QM<>?XITYLY_?"O?M*;;I,1_V!_*@"^7&[%25RJ:VK:GY&[^+%=2#\H/M
M0 V1@J$U!'*">M4M6OA;1G)QQ6-#K \M6W=30!UX.139&"BJ]C/Y\(;/:J&K
M:@+8=<4 :,<H+=:LUR5OK W9W5T]K+YMNK^M 'BOQ=/_ !-5'L*]1\%_\BI8
M_P#7,5Y9\7?^0NOT%>I^"_\ D5+'_KF* -^N6\2Z6+[4K*7&?+;-=34,T0=E
M)'2@!8%VPJ/05Y%\7#C5[&O81P*\<^+W_(7L: /0/ _/AN"J^N:2+KQ#:W.W
M.RI_ W_(M05OR1!I Q'(H =&-L0'I4,DH!ZTZZE$,6>E<Q>:P$#'=TH ZR)@
MR T[O6-H>H"\3AL\5KRMM4F@!LKA<4Y&!%<_?:H$?&[H:?INJB>X$>[- #_&
M)_XI34/^N1KRKX0<WI^IKU3Q?SX4U#_KD:\K^$7RWA^IH ]N9P& S3^U<QJ.
MM+;W\<6[&3706LOFVP?VH GR,TC$ 5CRZF$U!(=W4U-J]Z+2U#DXS0!I*P(X
MIU8>B:F+U"0V<&MR@".1@JTR&0,:RM5U$6]QY6[&152UU4&95W=30!T]>3?&
MD_\ $L7_ '37JR'<@->4?&G_ )!J?[IH O\ P6_Y$N+_ 'C7I5>:_!;_ )$N
M+_>->C7$GEPLWH* (Y) 'QFK"D%17+SZJ/,^]6IIM\+A>#F@#4[TV1@JTZL3
M5-1$$FS=C- &K%(&/6IA7,VNJ@R8W5MPW(>11GK0!:)P.:2-@PXJCJUV+2U9
MR<8%4_#VIC4+<N&SS0!NU!)( V*ED;:A/I7.W>IA)R-U '1*P(%*>!63IM^+
MC@'.*OW<OE0EO:@!/-&_K4X((KE&U@ L=W0ULZ5?"Z08.: -2BBB@ I*6DH
M^>OB8VWQZOX5[AX:.?#]F?\ IF*\+^*)QX\7\*]S\,?\BY9?]<Q0!KFDH-!Z
M4 >;_$+4?(:%,_\ +4?SKO-*;?I5LWK&*\7^*-__ ,3B*$-TE7C\:]@T.3.C
MV?\ UR'\J -3M3"PW8IL\GEIFLAM2'VH+NH \Y^+\0-WI9]9A_.O3O#Z[=)@
M'^P/Y5YC\4YA-=Z6/^FP_G7JFCKMTR#_ '!_*@"]2TE+0 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH CE<(N335G4KG-4=;N/L
M]J&SCFL>WU/=:2-NZ4 =2CAQQ3F.!FLS2;H3Q YJ[=/LMV:@!L$ZR3,H/(J>
M1PBY-<GX>U+[3K=U%G.TUO:S/]GT]Y,XQ0!+;7"RR. <XJQ+((UR:Y+PEJ7V
MV\N%W9VFMK7[G[+8[\XYH TT<.,BB1@JY-9^CW'VBV5LYXJ759O)LV;..* )
M(+A9 Q!Z5.K!AD5R&@:I]HM[UMWW#70Z7<":W5LT :-1&90^W-2=JYN?4-NI
MF//>@#I,TO:JPD&Y!GJ*L]J &.X1<FDC</R*I:Q/]GL6?.,4W2;@30!L]10!
MIT4FX44  ICR!" 34E8>LWGV>XC7.,T ;0.Y<BG55L91):JV>M6<B@ )P":J
MI<H\VT&I+I]EK(WHI-<;H>K_ &G5C'NS\Q% ';NP52344,ZR]#46I2^592/Z
M+7.^&=4^V2,-V?F(H ZZH7G5&VDU-7*:UJ?V?4?+SB@#J0<@$=Z1W"#FHK-_
M,M(V]15+6;G[/"ISC)H U <C-+4-J^^VC;U%2]Z $=MJDFHXYED. :CU"3RK
M-W]!6'H6H?:;Z1,YQ0!TI.!FFJX8X%-N'V0EJH:?="6=USTH U*C=P@R:?G-
M96MW/V:V+9QQ0!IQ2"1<BG&LCP[=?:[#?G/-;%  >E1+*I;&:?(<1L?05S]G
M?B2^9,]&Q0!T5%)D8I: (I95BQDXS3T8,,BN?\3WWV..$YQN;%:FF3B:U5L]
M10!-?-MLIF]%-?/LE\T_Q)CBSFO?M4.-,N#_ +!KYUT@?:/BO$/<T ?1FG#%
MA$/]FK+' S45N D"+Z"BX?;"Q]J $@E$C, >E3&N?\/WOVF[NESG:U= 30 9
MH%1HX)/-29% $=P<0,?:O";.=[CXE7D796KW2[/^C/\ 2O$_#-OY_P 4-1/H
M: /;K?B",?[(J6F1X"*/04^@ IK,%(![TO>J%]<"*:)<]30!H44U6&T4[M0!
M ;A1-LSS4V>,UR$NJ[?$[V^[I75[O]'#>U #PX)Q2&0!MN:I6T^^X9<]*K3W
M874HX\]: -9W"#FG*<BLS5KGR(XSG&35NSD\R -0!9S142."Y&:ES0 A.!0I
MR,U#=2;(R:;92^9#NH L"EI 110 "EHHH **0TM &=K8SIDOTKQKP=*7U[6X
MB?45[/K SILOTKP_P,V?&.L)ZN: ,W3YO[.^):<X%?0L4^[35ESU7-?-GBV0
MZ?\ $.-AQTKWZRN-W@^.;/\ RRS0!YK%/]I^*$XSGY#7%>,>/&UF/22NE\,R
M&Y^)<\G4;#7-^,R#XYM0.TM 'T!X<./#:'T6O*]2N3-X^M>>%>O4M!./"X/H
MA_E7C"2F;QEOZ[9#0![#J,L9TFYZ9\H_RKP#X=7;?\+ \O/!F;^=>PW=RS6%
MRO/^J/\ *O%/A]#(GQ&5B#@RG^= '9_%^Y9KVUB4]90*](\ 60A\.@,.2,UY
M3\27^T^)[6(<XG'\Z]T\/VPMM%A4#K&/Y4 ?/7C)-GC^V_Z^!_.OH>U&=$0?
M],OZ5X!XY7'CNT/_ $\#^=?0=B,Z0@_Z9_TH ^>+.,Q_$AO>X_K7OGB"7R="
M9O\ 8_I7B#1[/B(I];C^M>P^,Y?*\-$_[']* /$? L3WOC2>0Y(6>O6?B9 /
M^$: 45P'PAM1<:S?RD=):]0\?P&;0PH&: .,^#Z,NCZ@#_>-<<K%_BC=(>@8
M?SKT?X9V9M]-O 1C+&N#2T<?%*[?:<;J /3_ !W$%\"2D#G8*POA-.7AV$]%
MKH/'DBCP/*I/\ KDOA Y,\H[;: *'Q=_Y"R_05ZEX+_Y%2Q_ZYBO+?B[_P A
M9?H*]2\%_P#(J6/_ %S% &_2"EHH *\<^+O_ "%K&O8Z\;^+O_(7L* ._P#
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M<KXD!QUD'\Z]?\*VS+:V;8_@%><_$Z +X@3_ *ZC^=>S:!:A-'M&Q_RR'\J
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M^H^9''I^>HVXH ]#^%EF8O##,1@G->3>*4"^/8<=YJ]_\)V'V#P\8\8^4FO
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MIZ3C^=?2^G#&GP?[@_E0!:I!2T4 %%%% !1110 4444 %%%% !1110 4444
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M^=?15]_QXS?[AKPOP?#M\8W!_P"FY_G0!W_BS2E70Y#@<(?Y5R?P4&U+]?\
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MM$OHH% '*W?A]$TZ;Y1]TUXMHD7V/XFQ1CCFOI&_4?8)AC^$U\]0QX^+$(H
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M/-T"W;U% 'DOQ2_Y'RR_W:V_%J[O ]M[)6+\4>?'EG_NUTGB2+S/ L/'2,T
M'P4;/AN8?]-#7=^)#CP]>G_IF:\]^"4F-!G0GGS37?>*W">&[[/_ #R- 'S]
M\,(]_P 1_,]S7H/QJ_Y!J?[IKC?A+;E_%1GQ_$>:[/XT_P#(-3_=- %OX._\
MB*OXUQ.LGR_B/8^\U=O\&_\ D1D^IKB/%P,'Q"TYNG[V@#W^%MT*'V%>'?'0
MXFC'^S7M6FRB2RC8'M7B'QT;=>0J/[M '??#7_DG%O\ ]<S7F$D./B3!(O0,
M:]0^'(,?PX@SVC/\J\^MU67Q>)?[KF@"WXVLY+Z\LP,D"05ZOX8MA;:3&F,?
M**YA=/2]NE+ ':<UW-E&(K=5'84 >?\ Q<_Y I_W36;\%?\ D6F_WC6C\7/^
M0+_P$UG?!3_D6F_WS0!R7Q'40^,]-?\ Z;5[AX=<3:3$WL*\2^+:F+Q'I\GI
M)FO7? UR)_#\1SGB@#>GN!#(JGO1.X-L<]Q6%KU\(M1MT#=35V[N/+L(R3U.
M* /%?B9H1FN3(B^]7_@W,8-0>V8_=7I7H'B'1%OK+S-N?EKS?X?G[)X^O+;I
MM'2@#WHOC%.!R*S[BX$;H">HJ["VZ($4 /[TM)10!\^_$@?\7 7\*]O\.?\
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M3)1'X;M8_6%?Y5UWPBBV^&K=_5:X+XLRE+&QB'>%>/PKTSX5P>7X,LV(Y*T
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M54U<XTJY/^P:N#@5GZXP71KK_KF: /"?"-LTWQ-CN.P)KU[QT^SPU=_]<S7
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MVC'\J ,7P_JXN=:NHMWW6Q7:BO%O ]\S>,M2C)Z25[2OW!]* %HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ JM=R^6A-6:PO$5X+6V9B<<4 >-?$>[^V:O# #G$P_G
M7M>B#R] MO\ KD/Y5X%?J^J^*@PY4.#^M?0%N/)T*(>D8_E0!Y+&/.^(=U[-
M7JFM2^1X?9O1*\OT1?/^(-X?>O1?&+F+PK,1V6@#S;X9GSO&>I2>IKO_ ![=
MBV\.3-GM7!_"J,IK%_<-W&:O?$O6UDT&:%6YS0!B_".#S=:OIL?>;-=[\3I_
M)\,$Y[US?P<L3'%+,P^^,UJ?&&79X7(!_B% "_#%=FGS2_WAFL'XIW/VJ".
M'/[P5T'@/_1_"K3'_GEFN(URY_M?6%B4YPXH ]6\&6_V?0(..L8KR35;3[?\
M4[A,9VD&O;M(B$&B0+CI&*\HTJ,3?%K4"PR N: ,7XJQ^9K&G6W_ $S KU_P
M%;_9O"EI'C&%KR7QR1?>/=/C'('%>V^'X?(TB&,#&!0!QOQ=GV^%+B//6KWP
MQBV>%+-O5*POB\Y;3GA'<5T'@N9;#P58EN/DH \[^+4GF^(DM_4"O3M)'D^
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M=J -.L#Q9<"'1YAGJAJ>_P!7CM)-K$5R'BO65O+(Q(PR1B@"O\,8=\,DN/\
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M>(+5M(U<JHQE\5Z%X%TK[7+'=,N3ZTWQGX;-UJBNJ?QYKN/!>F?8K)%*X(H
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MKG2C*1_'7HWBK_D7;Q?6,T >3_"FSWZJUT1_$>:]QKR_X5V?EV328_C->H4
M>9?&>/?X7^C5YM\,M4:%I(]W\6*]7^*T'G>&F&.]>+>"(C#<S'T:@#TCX@:V
M;;P\C!L%CBHOA!;?:89;DCG?G-<UX^F-SI$$(.?G%>C?">P^QZ(V1C=@T =]
M<Q>;'C%-LX?)C(QWJS2=* *]U#YH7CI4-P1;6+GI@5>ZU@^+[O['H4TN<8%
M'B\_BAQXR, DX\['6IOB%JC37$=N&SG'%<'"S7'C#S^QES77:O;G4?$<28SP
M* /1!+_9W@F*3."8<UYGXB8WWAA+@\Y?K7=>,9_LGAZRM,X+1XQ7)ZM9F'P#
M;DCK)0!W7P>CV:5)]*]/K@/A?!Y.D9QU KOZ *MW!YHZ4J 06N.F!5G&:S-:
MN/LUB[9QP: /)_'WB(V>I;%?''K7*Z1K;ZIJ"0ELY;%9?C6]-_J;,#G!(JQX
M L&?5HV(_B% 'K^N,-%\%R./E.,UXN=8;5]8MHBV[Y\5ZG\5[WR/"S0 X^45
MXUX&MFN]=@8C.'% 'U!X7M/L>CQH!CC-:EZ^RSD;T%)8ILM(U_V15;79/*T:
MX?T0T >$^,/$3?VT]N'ZG&,UZ3\,K;R=/DDQC?S7@^H.VH^,"!S\W]:^DO!U
MK]FTB(8QE10!PWQA.^WM$_Z;C^=,\2Z@=)T"UP=N80?TJQ\3(OM$]NG7$P/Z
MUS?Q7E,.E6B#C]R/Y4 <Z/%[^3GS/UKIO ERVLZG'*QW8.*\<DW+81M_>KVK
MX+V1-KYQ'1J .Q\?WYTS2$ ..*XOPA*VL0DM\WS5M?&&7%G!&#]XXJ/X7Z88
M]/#D=6S0!Z5HMF+6W  QQ6/\0)O)\.2-FNJB7;&!7$_%!]GAAO=J .%^'8,.
MF:U/Z@G-5O 0-WX^EF/.16WX3LS;^$-2DQ]^+-4/A?;G_A(6E(]: /;A\J?0
M5X%K[?:?B5-%UVL#^M>\W3^7;LWH*\)M(_MWQ4NSUQS0!Z+XHOOL/AQ2#@B,
M?RKR;PW,^MZ[(C?, :[?XCW?EVT=J#]Y,8K)^&VAM%>FY9?O"@#UK0K,6=D$
M Q6K3(U"QJ!Z4^@ J*X.V!SZ"I:JZ@VVQF/HM 'B2?Z1\8/7Y:]JDAWVRI[5
MXSH<?G?%+S?:O;]O"T 1V<7DP!:Y[X@)N\(WW^Y74CBN=\;KO\*7H_V#0!YM
MX5N1:>#%(.#M-<CX9D?4O&2%LD"0U/I>I[=,^Q;N1D8K?\!: T>LK<E?X\T
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ /2J<MFLC9(JY2=Z *26*JP.*NC@8I:* "BDI:
M "BBB@ HHHH **** $ P:6D[TM "&EI*6@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *3O2TE "T4E+0 E+12=Z %HHHH *
M*** "BBB@!.]+2"CO0 "EHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH *.]%)WH **.]+0 444&@ I*7M2"@!:*** "BBB@ HHH
MH 2EI.]+0 G>EI.]+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 )WI:3O2T %%%% !2=Z6D[T +1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
@4 %%%% !1110 4444 %%%% !1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>image00008.jpg
<TEXT>
begin 644 image00008.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 0A!W8# 2(  A$! Q$!_\0
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1124 +2&BB
M@!**6B@ I:2EH *0G%+4<IP* &-)B@251FFP>M-2?WH TPV:<*JQ/FK2]* '
M4444 %)2TE !2TE+0 4AHHH *6DI: "BBB@ HHHH **2EH **2EH 2BBB@!:
M*2EH ***2@!:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ I*6DH **2EH *,4M% !1110 56N7PIJ9VQ69?W&U#S0!FW=SA^
MM1Q7()ZUA:AJ(60\]ZCM]1!(YH [>UEW8K43I7,Z9<[\<UTD1R@H DHHHH 2
MBBB@!:*** $HHHH 6BBB@ HHHH *2EI* "CM11VH **** %I*6B@!**** "B
MBB@!:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ I*6B@!**6B@ HHHH 2BBB@"O</M%<SK%WLC;FMZ^?:IKA/$-WMC;F@#D=
M7U7;,?F[U#9:KEA\U<EKNHD7!Y[U'IM^69>: /;] N_,*\UWEN<Q ^U>5>%)
MRY3FO4K0Y@7Z4 6*6DH% !12T4 %%%% "44M)0 4M)2T %%%% !1110 E+11
M0 E%+10 4444 )12TE !112T %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 444E "T4E+0 444E !2'I2TQCQ0!CZM+L1N:
M\P\37GR,,UZ!X@FV1MSVKQWQ+>_,PS0!Y]K<Y:Y//>K.C LRUE:@_F7'XUT'
MA^#<5XH ]7\((04KUJS_ -0OTKS/PM!MV5Z;:#]ROTH GH%%+0 44E% "T44
M4 %)2TE !2TE+0 44E+0 44E% "T444 %%)10 M%%% !24M)0 4M)2T %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4E+24
M %+24M !24M)0 5!*V!4QZ5FWDVP'F@#EO%-QMB?GM7A_B*[S,PS7JOBN\_=
MOSVKQ769M]RW- &&P,EP/K7<^&;;.WBN3M+;S)EX[UZ5X8LN%XH ]$\/0;0O
M%=[;#$0^E<KH\&P+Q760C$8H DHHHH 2BBB@!:*** "BBB@ HHHH 2BBB@ H
MHHH 6BBB@!**** %HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@!***6@ HI** %IKG"TZHISB,T 9=]<;%/-><>);[AN:Z_6+K8K<UY5X
MFO\ AN: .*UV[W._-<S;-NNQ]:LZI=;I&YJA8MFY'UH ]4\,=4KV#P\/E6O'
M?##<I7L7AT_*M '8(/E%.I$^Z*=0 E H[TM !1110 4444 %%%% !1124 +1
M110 4E+10 E+24M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@XYK;M;@,!S7F=AJNYE^:NRTN[W@<T =6C9J6J<#Y JV.E "T4G>EH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MF>'[O>J\UX1I%X?-3FO6_"]SE4YH ]7M'RHK27I6'I\FY5K;3[M #J!1WH%
M"T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4E+24 +1244 %+2
M4M "-TJC<R80U<D.%K'OIL(W/:@#BO$MUM#<UY=J<_F2-S7<>*KG[W->;RN9
M)C]: +6D0;KL''>O9/#<.VW7CM7E^A6V9U.*]@T*';;#CM0!:NGV1GZ5Y1XT
MGRK\UZ;JC[$;Z5Y!XQFR'YH \IU)\SM]:9IO-P*AOGS.WUJ;2^9Q]: /5/#
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%)0
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M3X5N:\]UZ?<&&: /*/$(+3-]:YEHSGI78:M#YDI^M9B:>6/2@#-MBRGH:O\
MGOCO6C#I1/\ #5K^R&Q]V@#!-P_O4;W#X[UOMH[?W:ADTA@I^6@#F)YF/K6;
M,Y-='=Z>4SQ6'=0E2>* *D7+5U&@+^_7ZUR\?#5TV@-_I"_6@#V_PK&-B?2O
M2-.7 %>;^%'^1/I7I.GG@4 :XZ4M(.E+0 5#<?ZH_2IJKW1_=-]* .$\0GAJ
M\9\4'[]>O^(Y,!J\:\3/G?0!YQ=_Z]OK4VG<S"H+O_7-]:L:9S,* /2/#D>6
M2O8O#4/RK7E'AB/)CKV/PXF%6@#L(4P@J?'%)&/D%/H C*9IACJ;%&* (U7
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !24M% "4USA:=4%PV(S0!GW=SL!YKDM5U#&>:T]5NM@;FO/]9U'!
M;F@!UU>>:Q&:IK#YC]*S+>[,LO7O73Z=;^9@XH +.PR1Q73Z?9;<<4ZQL.!Q
M6];6FW'% $UG  !Q6LD8Q5>&/;5P=* &&,53O(QY35?-5KL?NFH \S\21#YZ
M\>\2)@M7M7B->'KQKQ,O+4 >>2C]\?K6WH2?Z0M9#C,Q^M=%H$>9U^M 'L7A
M./Y$^E>H:6N%%>=^%(OD3Z5Z3IZX H UATI:!THH :YPM9.HR8A;Z5J2G"U@
MZI)B)OI0!YGXKEY>O(=9?+-7I_BN7EZ\GU63+-0!SSC,AK8T6+-PM90&9*Z+
M08LW"T >N>$X?ECXKU32DVJM>?>$X/D3BO2M/3 % &NOW:=2+TI: "BBB@ H
MHHH RM4&8S7F?B5/D>O3M2_U9KSGQ&!Y;4 >(^(D_?-]:IZ8GSBM3Q$G[YOK
M5;2XOF'% 'I?A$;6CKU-)=MF.>U>8>&%VE*] >7%H/I0!A:W<95AFO,-<'F.
MU=UK$Q)89KB[V/S'- '.)8&1^E=?X<TS:Z?+4>GZ=O8<5W6B:6%V_+0!T6BV
MFV->*Z^TCVK67I]ML1>*VX5P* ),<55GZ&K1Z55G^Z: . \6']V]>'>(3^^>
MO</%I_=O7AOB _OFH XJ\^^:AB7+"IKO[YHMURXH ZK0H-S+Q7KOA6VVE.*\
MW\-V^XKQ7L'AVVVA.* /0],&+=:NR?=JM8C$(JQ+]TT 9%^^$:O)_&$W#\UZ
M=JDF$:O'_&,_#\T >6:M+F5OK6 _S/6AJ,N9F^M4(QN>@#1TN',Z_6O9O!\'
MRIQ7E6CP9F7CO7M/A"W^5.* /1],CPJUT,?W1658Q[56M9/NT .HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MG_EN?K75>'1^_7ZT >V^%4_=I]*]#LA@"N"\*C]TGTKO[0<"@#0'2EI!TI:
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MMDPHJZ.E01+A14XH 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBCO0 4444 %%%% !1110 4444 %%%'>@
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M'$%'2@!ZC J2D I: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@!**.]% "T444 %%%% "4444 %%%'>@!:*** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH 0T4&CO0 "EI!2T %%%% !1110 4444
M%)2TG>@ %+2"EH **** $H%'>@4 +1110 4444 %%%% !1110 4444 %%%%
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MIQ0!W_A^+9"O':NB[5DZ5'LC'TK6H 6BDI: "DI:2@!:*2EH **** "BBB@
MHHHH **** "BBB@ HHHH **** "DHHH **** "BBB@!:*** $HI:* $HI:2@
M I:2B@!:*** "BBB@!*6DHH 6BBB@!*6DH% "T444 %%%% !1110 4E+24 %
M+244 +1110 4444 %%%% !24M% "4M)10 M%%% "44M)0 M%)2T %%%% !11
M10 4E%% "T444 %%%% !1110 4444 %)0:* "BBB@!:*2EH **** "BBB@ H
MHHH **** "BBB@ HHHH *2EHH 2EHHH **** "BBB@ I*6DH 6BDI: "DI:2
M@ HHI: "BBB@ HHHH *2BB@!:*** "BBB@ HHHH **** "DHHH 6BBB@!***
M* %HHHH *2EHH 2EHHH *2EHH 2EHHH **** "DI:* $I:** "BBB@ HHHH
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M*6@!**** "BBB@!*6BB@!:*2EH **** "BBB@!**** %HHHH **** $HHHH
M6BBB@!M**** %HHHH ***2@!:*** "BBB@!**** %HHI* %HHHH **** "BB
MB@!**** %HHHH *2BB@ %+24M !1110 4444 )1110 M%%% !1110 44E+0
M4444 (:*6DH **** "EI*6@ HHHH **** "BDI: "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ I*6DH *6DI: "DI:2@ I:2EH ***2@!:*** $HHHH
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M1VHMP5DKI)])/]VJ8TTA^E &MHLY61.:]<\,3DJO->3:99E95XKU?PO"0%H
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M**6DH *6DI: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MDVNP#B@#;M8\ 5H+TJ&), 5,.E &=JPS :\D\4PYW\5Z]J0S":\R\2095^*
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M72BL@^6O0]2T;S&/RU'I^B[&'RT 7]!L]@3BO0;!-L0KG]-LO+"\5T]LNU*
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M0 M%)2T %%%% !1124 +1110 AHI:2@ %+124 +2&B@T '>@4=Z!0 M)110
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M@ I*6DH *6DI: "DI:2@ HHHH ***6@ HHHH **** "DI:2@ I:2EH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** $I*6C% !1VHHH **** %HHHH **** "DI:2@ H[44=J "BBB@ HHHH .
MU%':B@ I:2EH 0T=Z#10 44"B@ I:2EH **** "BBB@ HHHH **** "BBB@
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M2EI* "EHHH **** "BDI: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@!**6DH 6BBB@ HHHH **** "BBB@ HHHH *2EI* "
MEHHH **** $HHHH 6BBB@ HHHH ***2@!:*** $HHHH 6BBB@ HHHH ****
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M $Y<4>8*H//@]:9]I]Z -+S!1Y@K-^T^]'VCWH T?,%-,H]:H&XXZU&]S[T
M7FF'K2QR@GK6-)=\]:GMKG<>M &XIXI<U!&^5IS-Q0 XN*4-FJ4DV#UI\4N:
M +F:3-,+<4S?0!-FES4 >I5- #Z3-)FF%J 'YI<U#OIX- $E%)0: #--+4UF
MJ%Y,4 3%Q2>8*HO/@]:9]HYZT ::L#4E4H)=U6P>* %S29II-,W4 345&&IV
M: '9HIN:,T /I,T5&S4 29HS40:G9H ?13<T9H 7-+FHBU(&H FS1FFYHS0
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M4 2YHS30:": '9HS3<T9H ?13<TM "TF:0TPM0 _-&:AWT;Z )\T9J(-2[J
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M %JZO\$\U1_M+G[U9-]>$$\UE?;CGK0!URZC_M5*+\XZUR,5\2>M7$N21UH
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M $F-W>H-;ORA;FN&N]6(G^]WH ]1L=5# ?-6H-0X^]7F>DZF6 ^:NA%_QUH
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M?I1K@_O5YM_:[?WJ/[8/]Z@#TK^W!_>_6E_MP?W_ -:\T_MD_P!ZC^V3_>H
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M/>E,OO0!8=Z=:R8D%4VDI8I=K9H [;3[A0HK3^U+MKC+:_V <U;_ +4&/O4
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MGD'I5=K$^E &;OD]:-\GK6D+$^E!L3Z4 9P:0]S4B^8>YK0CL"3TJ]#IA/\
M#0!B;),=35::21.YKKSI!\LG;7/:G9F(GB@#,6=R>M3HTC=S45O 6;I6W:6!
M;'% % +)CJ:C;S!W-=0NDG9G;5.?32O:@#GR\GK2>9)ZFM1[$CM4?V(^E %
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M'2EFMLKTH Y"2VP^<5+#E6 K7GM.3Q5(6Q$G2@#1L^0*LRQY%)90' J^T/%
M'/W$'7BJ2IL?-=!<0\'BLJ6+F@"Q;W908S5Q9#(*R$C;=6O:1' H CD7%9UT
M,@UN2P\5FSVY.>* .?:++U<@MN^*M)9$OTK4AL3LZ4 4X9#"*F:X+CK3+FW*
MFHX8F)H AN1QFJ,?$M;$UN2E4%MCYM &Q8MA16CYV!UJA:1$**EE)% %2_\
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M"*73P.U.M]/!/2MR:(>E.MHAGI0!7ATP8'RT^;3Q'&3BMZ!%P.*;?*OV=N*
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MK'EFFF.@"#%+BI?+-*(Z (MM&VI_+-'EF@"#;1BIS'3?+- $6VEVU,(S1Y=
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MOY ]*3[./2K5% %;R!Z4ODCTJ>B@"#R1Z4>2/2K%% %8P#TI/('I5FB@"OY
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MM3?L_M0!EBW]JBEM_:MK[/[5&]MGM0!R]S:Y[52CL_WG2NIFM,]JKI8_/TH
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MFSW=J .(:R.3Q2I9GTKIFT_GI0-/]J ,2&U.>E:T%K\O2KD=A@]*T(;3 Z4
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M6.>U5FT_GI0!S8M3Z5&UD3VKIQI_M1_9_M0!RXL<=J>+,CM72_V?[4?V?[4
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M4H?-8IOAGK4\-WNQS0!K@TM5HY,BK Z4 !J-ES4M)B@"'93PM/Q10 "EHHH
M*0FEJ&1\4 /+8IOF"J,USM[U3^WC=C- &X&S3@:S8;G=WJ[&^: )J2CM10 M
M%%% "4444 +1110 E+24M !24M)0 M%%% !112&@ )Q3"XJ.:3:*SI;S:>M
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M38* ,?[$/2E^Q>U:WEBC8* ,G[$/2E%GSTK5\L4;!0!2CM\=JE,/M5G;2XH
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M"C8* ,K[%[4GV+VK6V"C8* ,G[$/2C[$/2M;8*/+% &5]B]J/L7M6KL%&P4
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M*JFX'K0+@>M %JBH!,#WI?-'K0!-14!F [TS[0,]: +5%0I(&[U-0 4E+24
M+1110 4444 )2TE+0 4444 %%%% !1110 4444 %%%% "'I69J,NQ35Z20**
MYS6KL*C<T 4UO?\ 2,9KI-/DWH*\YCOLWF,]Z[O19-\8^E &Y1110 4E+24
M+1110 4444 %%%% !1110 4E+24 +1110 4444 %%%% !1110 4444 %%%%
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MO/*!YKA=;U<$,-U:WBB^\E6YKR75]:)D8;J -VRO]][U[UZQX<DWPK]*^?\
M1K_S+T<]Z]V\)2;K=/I0!V':B@=** "DI:* "BBB@ HI** %HHHH **** "D
MI:* "BBB@ HHHH **** "BBB@ HHHH **** "FL<4ZHY#@4 9VI2[8&KRWQ!
M>[9FY[UZ+K$NVW:O&/%-[MG;GO0!T>B:C\P^:N_TZ\WJO->):+J7SCYJ]+T*
M]WA.: /0H6W+4PJE9ONC%710 M%%% !1110 44E% "T444 %%%% !1110 44
M44 %)2T4 )12T4 %%%% "'I63?M@&M8]*P]4; - '+ZG<[-W-<^FH_Z3C=4^
MO7.P-S7$KJ1^VXSWH ]AT>ZWJO-=1;OD"O.O#EWO1>:[RR?(% &H.E%(.E+0
M 4E%% "T444 %%%% !1110 4444 %%)10 M%%% !1110 4444 %%%%  :B=L
M"I#TJK,V%- %6YN=F>:SVU  _>JGJEWLSS7-2ZF0Y^:@#K6U( ?>JL^K ?Q5
MR,VK8'WJS)M:(/WJ .^&KC/WJTK._$F.:\H76SN^]75Z)J)D*\T >C12;@*L
M \5E6<NY!6FA^6@!])110 4M%% !124M !1244 +1110 4E+10 E+244 %!Z
M4M-?[M %6>7:#7/:E?[ >:TK^;:#S7 Z_J/EAN: +AU4&3&ZM"RO=[#FO,EU
M@FX(W=ZZ?1[_ 'LO- 'J&GR;E%:=86CR;T6MT=* "DI:* "BBB@ HHI* %HI
M*6@ HHHH **** "DHHH *"**6@#*U-?W9KS3Q&N%>O3]1&8S7G7B*+Y'H \6
M\0N5D:L:SNRK]:VO$Z8D>N5B;:] 'J/AB])9.:]AT2?="O->">&+C$B<U[/X
M?N,Q+S0!Z!:G*U:JA8-E!5^@ HHHH *9)]VGU',<(: ,;4)=J-S7D_B^[VA^
M:])U>;:C<UX]XPN,[^: .%FNRUPW/>M_P^2UPOUKD%;=<GZUVGAJ/,RF@#VK
MPM'^Y7Z5V<:X KE?"Z8A7Z5UJCB@!]%%% !1110 4E+24 %+24M !1110 44
M44 %%%%  >E5+@\&K9Z53N>AH XGQ0^(6^E>(:Y-_I9^M>U^*O\ 4M]*\-UP
M_P"EGZT 2Z;)F5?K7K_@\Y"5XUIG^M7ZU['X.Z)0!ZC!_JA]*J:A_JS5N#_5
M#Z57O5RAH \\\09\MJ\BUT-]I/!ZU[9K5L71N*\TU?2BTY.WO0 SPJ&W+Q7K
MVCYV)]*\\\.Z<8V7Y:],TR':J_2@#HH/]6*EJ.$805)0 4M)2T %%%% !111
M0 4444 %)110 4M)2T (:.]!HH 6BBB@ JC>'Y35ZJ%[]TT <-XF?$#5X+XH
MF/VEOK7NWBC_ %#5X#XI/^DM]: ,^QE)D%>P^!VRT=>+Z>?W@KV7P-]Z.@#W
M"P_X]D^E6^]5-/\ ^/9/I5N@ %+2"EH *HWCX4U<)K*U*3:AH Y77[G;"W->
M/Z[?,+HX)ZUZ3K]QE&&:\LU6,R7/XT ;_AZY9MO6O0[&1MHK@?#5J?EXKT:R
MMR$'% #;Z0B+\*X36KEE#=:]!OH#Y1X[5P.OVY",<4 >>:EJ3+*>3UJ;3M19
MB.36-K65G/UJQHP+,* /0M-NF8+UK<,S>5WK#TB D+Q73&T/DCCM0!S>I7+*
MAKC+K466Z R>M=KK%L1$W%>;ZEE;S\: /8O EV9-G->QVYS"OTKPWX>,3L_"
MO<;7_4+]* )J6DI: "DI:2@ I:2EH **** $HHHH 6BBB@ HHHH **** "HY
M_P#5&I*BN/\ 5'Z4 >1>.[HQJ_->%ZGJ3&X<9[U[-\1&PLE?/^HR'[4_UH Z
M?PU=%KU>>]?2/@MMULGTKY?\+-_IJ_6OISP/_P >T?TH [L=*6D'2EH ****
M "BBB@!**** %HI*6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "H9NE35%*,B@#F-=8BV>O!?&%P5G?ZU[YKZ?Z*]?/?C7BX?ZT 4-'O#O'->
MJ^&+DL4YKQG26/F#ZUZQX4;)CH ]BTULPK6DM96E_P"H6M5>E #J*** "BBB
M@!**** %HHHH **** "BBB@ HHHH **** "BBB@ HHHH 1ONUSNKMA6KHF^[
M7-:T?E:@#S/Q-,0'KSA;EO[0_&O0?$O(>O/DA)O^G>@#U/PI*2B5Z7IQR!7F
MOA2(A$KTO3EP!0!LKTI:1>E% !WH%% H 6BBB@ HHHH **** "BBB@!****
M%HHHH **** "BBB@ HHHH 1NE4;D_*:O-TJE<+E30!PVNRE=U<-=7;*YYKO-
M>B)#5YSJBF-FH JW.HD \UBW&I-NZU!>W.&(S64TI>2@#9AO79QR:] \,3LQ
M7.:\]TVV,C+Q7IGAJT*[>* /2-.8F-:VX_NUD:?'B-:UXQ\M #Z*** %I#2T
ME !WH%% H **** %HHHH **** $HHHH 6F2?<-/IDGW#0!S6JN0K5Y3XKNB@
M?FO5=67Y6KR#QB" ] '#Q:@WVLC/>N\\/719UYKRZ)C]L/UKT'PT_P ZT >V
M^'WW1K]*Z8=*Y7PV<QK]*ZH=* %HHHH **** "DI:2@ I:2B@!:*** "BBB@
M!**2EH 6BBB@"E?#*&N$\019B>N^NAE*X_78LPM0!X/XJBP[UP[?*]>C^+(?
MF?BO.;D;7H Z;PY-B1:]D\-W&47FO#-!DQ(M>O\ AF?(7F@#U[2VW1CZ5JUB
MZ,V8A]*VJ "BBB@ J&X.(S4U5[L_NFH XK79MJOS7C?BN?=OYKU;Q')@/7C?
MB:0DM0!RMK\US^->A^&8OWBUYWI_-S^->H>&$&Y: /8?#:XA7Z5U KG/#XQ$
MOTKI!TH 2BB@4 +1110 4444 )2T44 %%%% !1110 E+2=Z!0 M4[GH:N54N
M.AH X7Q5_J6^E>&ZX/\ 2S]:]R\5?ZEOI7AVN?\ 'V?K0 S3/]:OUKV3P=T2
MO'-,_P!:OUKV/P=T2@#U"#_5+]*;.NY:=!_JE^E/89H YV^M-ZGBN6O=&#R9
MVUZ%) &JG)8*QZ4 <MIFEB,CY:ZJU@V <4^*S5.U74C"T /086G4#I2T %%%
M% !1110 4444 %%%(: "DHHH 6EI*6@ I.]+10 4444 %4+W[IJ_5"]^Z: .
M"\4?ZAJ\ \4_\?+?6O?_ !1_J&KP#Q3_ ,?+?6@#)T__ %B_6O9O WWHZ\;T
M[_6+]:]E\#?>CH ]OT__ (]D^E6N]5=/_P"/9?I5N@ HHHH C<\5@:Q)M1JW
M9.E<UKI/EM0!Y]K4^YF&:Y22V\V<''>M_4R3.15>UMM\J\=Z -SPY88"\5W]
MM:80<5A^'[0 +Q7:10 ** ,:\MLQGBN'\16?[ECBO3;F$%37&^(X!]F:@#YZ
M\11;;EN.]6O#\.YEXH\4IB[;ZU=\,QY9: /1M#M,A>*ZW[#^Y'':LS0( 52N
MS%L/('':@#SK7;+$+<5X_K<6V]_&OH#7[0?9VXKQ/Q#:G[:>.] ';?#L<QU[
ME:_ZA?I7B?P_B*E.*]MM?]2OTH FHHHH 2BBB@ [44M)0 M%%% !24M)0 4M
M)WI: "BBB@ HHHH *BN/]2WTJ6HI_P#5'Z4 >)_$4?+)7S[J(_TI_K7T3\0(
M2ZR<5X%JELRW+\=Z +WA7_C]7ZU].>!_^/:/Z5\R^&!B^7ZU]->!_P#CVC^E
M '>#I2T@Z4M "4M)2T %)2TE !110: "EI.] H 6BBB@ I*6D[T +12"EH *
M*** "BBB@ I*#10 M%%% "4444 +3'&13Z0B@#G]>C_T1_I7SOXX7%P_UKZ0
MUQ?]#?Z5\Z>.A_I$GUH Y32O]8/K7JWA/[T=>5:9_K!]:]5\)_>2@#V+2O\
MCW6M5>E96E?\>ZUJKTH =1110 4444 )2T44 %%%% !1110 4444 %%%% !1
M110 4444 %%%% "-]TUS&M]&KIV^[7,ZTI(:@#S+75W%ZY&"US>YQWKNM5@+
M,W%8EO9'[2#CO0!V'AF#:B<5W]DN *Y/0+?:B\5V5LN * +HZ444"@ I:**
M"BBB@ HHHH **** "BBB@!**6DH *6DI: "DI:3O0 4M)2T )111WH .U03+
ME34]-<?+0!R&L0;@W%>9>(HO+WFO7=3B!5J\N\6IM62@#RG4)\3$9JM;'?,*
MBU.0BY8>].TSYKA?K0!Z'X>L?,VG%>H:+8; O%<=X1M@ZIQ7J6GVP55XH T;
M6+:@J\HXJ.-,+4HH *6BB@!***!0 4M)2$XH 6C-0M(!2>:/6@">EJ)7!J3M
M0 44&B@!:2EHH *;)]TTZFO]V@#G]33*M7D/C./"O7LFH+E6KR/QJGRO0!Y$
M@Q>'ZUWWAK[ZUPN/],/UKN?#?^L6@#VOPU_JEKK!TKDO#/\ JDKK1TH 6BBB
M@ HHHH **** $HI:3O0 4M)2T %%%% "444M !1110!!.,K7,ZU%F!JZB49%
M86K1Y@:@#PWQ;#\S\5YA?IAS7K_BR'YGXKRK4XL.: $T9L2K]:]9\+R\I7D6
ME_+*/K7J/A>3YUH ]NT(YA7Z5OUSGAYLPK]*Z(=* %HHHH 0U5O#^Z:K+52O
M&_=-0!Y[XD/#UXYXD/+5[#XBY#UX]XD'+4 <SIO_ !\_C7J?A?JM>6:=_P ?
M/XUZCX8/S+0![-X?_P!4OTKH^U<YX?\ ]4OTKHQTH 2BEHH ***2@ HII-)N
MH ?2TP-3@: %HHHH **** $H%'>C- "U3N>AJV3Q5.Y/!H X?Q5_J6^E>':Y
M_P ?9^M>X>*C^Y;Z5X=KG_'V?K0 :9_K5^M>Q>#NB5X[IG^M7ZU['X/Z)0!Z
M?!_JE^E2U%!_JE^E2T )BDV"G4F: $VBEQ1FEH **** "BBB@ I*0FDW4 /H
MI :6@ I#2T4 )1110 449II- "YI:CW4\&@!U%(#2T %4+W[IJ_5"]^Z: ."
M\4?ZAJ\ \4_\?+?6O?\ Q1_J&KP#Q3_Q\M]: ,O3O]8OUKV7P-]Z.O&M._UB
M_6O9? WWHZ /;]/_ ./9?I5NJFG_ /'LOTJW0 4444 0R=*YS6URC5TCUAZJ
MFY#0!YG?P9G/%265M\Z\5I7=MF8\5-:6V&'% '1Z)%M"\5U:#Y16!I4>T"NA
M7[HH KW ^6N0\2+_ **_TKL+C[M<CXD_X]7^E 'SYXL_X_&^M7?"P^9:I^+/
M^/QOK5WPM]Y: /9/#Z_*E=NB9A'TKBO#_P!U*[F$9A% '/:U!N@;BO(=>T_=
M=D[>]>WZE#NB/%>?:KIVZ<G'>@ \%VOEE>*]8M^(E^E<+X<M/**\5WD0Q&*
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M7Z5;H **** (VK*U!-RFM=JHW29!H X^XMLR=*EMK?##BM*6WR_2I(;?!'%
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M$F+E>:[>T^Z* -->E*335.%J.63:* &2N #6'?W&,\U9NKT*#S7-W]Z&S@T
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MUU'$RC=WKU#PK=>8J\T =Y(^$K!U.]\M3S6I<28B_"N)\17GEHW/:@#.O]:
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MYKCDOR+S&>] 'MFA7N]5YKL;67<!7E?AF]W*G->C:;+N44 ;@Z4M-4\4%L4
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M>F.(R:HZ5_Q[K5F\;; QH YO5KP(&YKSO6[O>6P:Z#Q%?^6S#-<-=7/G,>:
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MWUJ?2?\ CX3ZU!JG_'VWUJ?2?^/A/K0![9X.^XE>H6?W17E_@[[B5ZA9_=%
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M<_(M;HZ4 %%%% "4"BEH **** "BBB@ HHHH **** "BBB@!**** .?\1?\
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MZU]!^,+7S(GX[5XW<:6?[0)V]Z .D\,,1LKUW0#E%KR_P_9%"O%>IZ%'M5:
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MZ5HUN&C7CM7F.@R_.HKUGP^0T:T %Y997I7):K9X#<5Z/<1 KTKEM6M<AN*
M.%MH=MQT[UW&CC"K7/Q66)^G>NJTR':!Q0!T]CT%:0Z5GV:X K0'2@ HHHH
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M?ZU?K7L7@_HE>.Z9_K5^M>Q>#^B4 >GP?ZH?2J&J?ZLU?@_U0^E4-4_U9^E
M'FOB+E6KR?6(\W/XUZSX@Z-7F&IIFY_&@#K/!4'*UZQ$NR$?2O-_!,7W*],F
M&V ?2@#EO$L^+=AGM7AOB";-T?K7L'BB;$3<]J\1UR7-V?K0!8TWYI5^M>R>
M"UQLKQK1^9$^M>T^#1]R@#U>U_U*_2H+Y-\9J>V_U*_2EF3<* .#U;3_ #-W
M%<A>:)NDSMKU6YL]^>*R9M*#-]V@#E]%TKRR/EKM+>VVH.*2ST\1XXK72#"]
M* ,2_M=\1&*XN]TG=/G;WKTN>WW+TK(FTX,^=M &!I>G>7CBNE@C\M:=!:!!
MTJ60;10!BZU>>5$W/:O,=;UCYV&ZNT\4SE(GY[5XMK=^?M##- $TM[YEQU[U
MUWA]]VVO,X+DM..>]>C>&6W;: /5M$'"UT<W^I_"N>T4<+70S_ZK\* .'\4?
M\>[5\_\ BG_CY;ZU] >*/]0U?/\ XI_X^6^M &7IW^L7ZU[+X&^]'7C6G?ZQ
M?K7LO@;[T= 'M^G_ /'LOTJW533_ /CV7Z5;H 2BEI* "EI*6@!*6BB@ HHH
MH K7'2N1\2?\>KUUUQTKD?$G_'J] 'S[XL_X_&^M7O"WWEJCXL_X_&^M7O"W
MWEH ]F\/_=2N]M?]4*X+P_\ =2N]M?\ 5"@"?O11WHH BD^Z:XWQ)]QJ[&7[
MIKC/$C?(] 'EVIC,S52MXL3 U?OCF=JCAC^;- '6Z+<>4J\UTL=_D=:XFSD*
M 5K0W!XYH V[A_.!KF-8L-R$XKHK3]YBI+^RW0$X[4 >/S:=_IG3O7=>'+'"
M+Q5&?3_]+Z=Z['0[/;$.* %F/DI7G_BVZW1N,UWNLGRD->5>)[C=O&: .8T=
MLZKGWKZ-\%_\>J?2OF_0N=3'UKZ0\%_\>J?2@#M>U1N.*D[4TB@#D_$%IYJ-
MQ7GLVBYNB=O>O7+ZW\Q3Q6"VE RYVT 8&E:9L*\5VVF0[%%5K:P"8XK8MXM@
M% %@_<KSGQX?]'D^E>AR-A37F_CI\P2?2@#PS&=8_&O:O!D.84^E>,1\ZS_P
M*O=O!,6;=/I0!W%K'A127<>Y35J),**)4RIH \I\:P8ADX[5X7>/Y6I$^]?0
MGCF+$$G':OG37&V7[?6@#T#PQJWEF,;J]D\.7OG*O-?-&AWY6=!GO7O/@FY,
MB)S0!Z>.4K@O'(_T:3Z5WJ<QCZ5P?CG_ (]I/I0!\\7Z[M6/UKTCPC:;ECXK
MSNZ&=8_&O7/!D(,4?TH ]!T>#8JUTB_=K*L(PJBM8=* ,'71^Z;Z5Y5KBYE:
MO5]<_P!4WTKRW61^]:@#E1%FX'UKTKPDF%6N!1/WX^M>B^%UPJT =/?/MA_"
MO,_%LV8WY[5Z-JC8A/TKRKQ7+\KT >2:FV;X_6NB\/CYT^M<U?'-[^-=1X>'
MSI0![/X3'"5Z/#_JQ]*\[\*CA:]$A_U8H 9.N17*^((,VK\5USC(K!U^+_1'
M^E 'S=XSCVSO]:Y.SFV2#GO7:^.4Q-)]:\]63;)^- 'K_@RYR\?->XZ.^;9:
M^>/!$^9(^:]_T-\VJ4 6]9/^A/\ 2OG?QW_Q\2?6OH?6/^/%_I7SQX[_ ./B
M3ZT <IIG^L%>K>$OO1UY5IG^L%>K>$OO1T >M69VVJ_2L37;G%N_/:M>$XLQ
M]*Y/Q#/B%^: /(/%LVZX;GO4OA9-[K67XFEW7+?6MSP8FYUH ]<T*#")Q7;V
M@Q$*YK1X<1)QVKJ(!A!0!+BHKC_4M]*FJ*X_U+?2@#Q+XACB2O%@/]+;ZU[;
M\05R)*\6*8NF^M ':^%S^^7ZU[GX?_X]!]*\+\,<3+]:]S\/G_1!]* (-;^X
MWTKQCQ?_ !U[/K?W&KQCQ?U>@#B=-CWW?XUZOX8L_NG%>9:(FZ\'UKVCPS;C
MRT.* .^TF/9;CZ50UG[K5L6*[8/PK(UG[K4 >,^,/XZY#0O^/[_@5=AXP_CK
MD-"_X_A_O4 >X>&!^Y6O1-/'R"O//#'^I6O0]/\ NB@#0?[AKBO$D>Y6KMF^
M[7):\F5:@#R74X/WK<53T^/%T/K6[JD/SMQ679IBZ'UH ],\-\1I]*[.,_)7
M&^'>$6NPC_U= '+>)9MB-7D>M7N)'YKT[Q=)MC>O$M<NOWS\T 5&OL3]:W].
MU?8!\U<!+='S>M7+:]8 <T >H0Z[@#YJLC7^/O5YLFHM_>J8:DW]Z@#K-7UG
MS(C\W:O/[VYWW&<]ZMW=ZSKUK$8EY<T =)I$O[U/K7LOA%LQK7BNCJ?-3ZU[
M1X/'[M: +?BX9MF^E>+WORWC?6O;/%@S;-]*\4U4;;EC[T :VB7&)E&:]E\+
MR[HDKP72;C;=+SWKVKPC<9C3F@#NG7<M9%]:[P>*V$8,HIDD(<=* .333_WN
M<5LV=MM XJX+,;LXJS%!M[4 26ZX JV*B1<5(* %HHHH *1NE+2-TH Q=1^Z
MU>7>,/N25ZCJ/W6KR[QA]R2@#Q/5/^/MOK4^D_\ 'POUJ#5/^/MOK4^D_P#'
MPOUH ]L\'?<2O4+/[HKR_P '?<2O4+/[HH U%Z4M(O2EH **** "BBB@#.U,
M_N37F'B-\;Z].U7_ %!KRGQ*WWZ /-M8D_>FMSPH<R+7-:NW[T_6NB\(<R)0
M![1HR_NDKIXN(ZYO1A^Y3Z5T:\1T 4=3DQ;O]*\2\:S?._->R:L^+=_I7AOC
M:3]X] '$QMOE_&NX\*Q_O4^M<)9?-+^->D>%8OG3ZT >QZ"F+=?I6X1\M96B
M+BW7Z5KM]V@#&U!?E->6^+N%>O5KX?*:\J\9<*] 'FB28NS]:[?P_+\ZUY]O
M_P!,/UKM?#TGSK0![/H#9C6NE'2N6\.',:UU(Z4 +1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 <_P"(O^/=OI7B'B'_ (^F^M>W^(O^/=OI7A_B
M'_CY;ZT 4K'_ %B_6O3O"W\->86/^L7ZUZ=X6_AH [N4?N!]*X7Q6O[AOI7=
MO_J!]*X;Q7_J&^E '@6O?\?Q^M;GAL\I6)KX_P!//UK<\-CE* /8O#C?*M:V
MN'-L?I6-X>.%6M;63FW/TH \TO4W71^M:6FVV77BH)HMUV?K71Z59Y"G% &_
MIB;(?PK@O'I^1Z]'@C\N'\*\T\=GY7H \EB_X_#]:]"\,_?6O/8?^/P_6O0O
M#/WUH ]I\._ZE?I72G[M<UX=_P!2OTKI&^[0!@ZK)M5J\[UZX^]S7<ZY)M5J
M\M\0W6"_- &&L^Z\Z]Z[SP^NX+7ED%UNONO>O5?"_P R)]* .\TZ/@5L;.*S
M[!<**U,<4 0&,4SR1Z5:(I,4 5C ,=*J7";4-:9'%9]W]TT >7^,ON/7D,PS
M=M]:]>\8\J]>4.F;L_6@#?\ #\7[Y>*]L\++B)/I7D&@1?O5XKV3PVN(UH Z
ML?=JG<]#5S^&J=ST- '#>*?]2WTKQ#7/^/L_6O;_ !3_ *EOI7B&N?\ 'V?K
M0 :9_K5^M>P^#^B5X[IG^M7ZU[%X/Z)0!Z?!_JA]*H:I_JS]*OP?ZH?2J&J?
MZL_2@#S;Q!T:O,]2/^D_C7IGB'[K5Y=JC8NOQH ]$\$?PUZ1=\6_X5YKX%;.
MRO2KS_CV_"@#SCQ4W[MOI7B6LG_3#]:]J\5_ZM_I7BFL_P#'X?K0!HZ)_K$^
MM>U^#NB5XIHGWT^M>U^#OX* /5;;_4K]*E/-16W^I7Z5+0!$T>:@:$>E6\4T
MB@"&.(#M4^WB@"G4 1.M5I(Q5QJJSG"&@"E)($JM)-N!JI?76QCS5>"XW]Z
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M_P#X]E^E6Z "BBB@ HHHH **** "BBB@"M<=*Y'Q)_QZO77W'2N0\2?\>KT
M?/OBS_C\;ZU>\*_>6J/BS_C\;ZU>\*_>6@#V?P_]U*[VU_U0K@O#_P!U*[VU
M_P!4* )Z0]*6D/2@"A='Y37EGC>3;')7J5W]TUY3XZ_U<E 'D:SYU C/>O1?
M#IW!:\O#8U$_6O2/#,O*4 >IZ1;AE7BMP6@QTK,T'YD6NDV<4 5(H-O:K1CR
MN*<JU)CB@"@;8%LXJ0Q[8S]*M;:9*/W9^E 'G7BKHU>2ZMS(WUKUGQ7T>O(]
M6;$C?6@!- 4?;1]:]]\*#_1E^E?/^@2?Z:/K7O\ X3.;9?I0!UE%%% "&DQ3
MJ:QP* $S2,?D-0M)@T[=E#0!R?B"7:K5X]XIN,[^:]8\2G"M7C7B5N7H YC2
M3G5!]:^C/ __ ![)]*^<=&_Y"8^M?1W@?_CVC^E '>#I0>E Z4'H: //?'?_
M ![2?2OF_6AG4F^M?2'CO_CVD^E?..K\ZFWUH V?#\&94XKW'PA'M1*\<\.)
M\Z5[7X57"I0!WB?ZO\*X/QU_Q[2?2N\3[GX5P?CK_CVD^E 'SGJAQJA^M=KX
M7F(V5Q6J_P#(4/UKL?#"\I0![-X>DW*M=DGW*XKPX,*M=HGW* ,37/\ 5-]*
M\HUXXD:O5M<_U3?2O*-?^^U ')M)BY'UKTWP>V46O+'/^DCZUZ?X-/R+0!UF
MK_ZD_2O)_%/1Z]8U?_4'Z5Y/XIZ/0!Y1>?\ 'Y^-=;X=^\E<E=_\?OXUUOAW
M[R4 >T>%>BUZ'#_JQ7GOA;[JUZ%#_JQ0!)63KO\ QYO]*UJR==_X\V^E 'SI
MX[_ULE>7R_ZS\:]0\>?ZV2O+Y?\ 6?C0!Z!X%_UT=?1&@_\ 'JGTKYW\"_ZZ
M.OHC0?\ CU3Z4 7]7_X\6^E?/'CO_CXD^M?0^K_\>+?2OGCQW_Q\2?6@#E=+
M_P!8/K7K'A'[T=>3Z7_K!]:]8\(_>CH ]2'_ !Y#Z5P?B4?(]=\@S9#Z5Q/B
M2+]T] 'B.O\ _'R?K78>!/OI7)^(EQ<GZUUG@3[Z4 >ZZ7_J$^E;<?W:Q-,_
MU"?2MN/[M #Z9)]PT^FR?<- '"^)(=P:O*-:M]KOQ7L.O+D-7EFOI@O0!SFD
MG%Z/K7M/AQO]$7Z5XKIO%^/K7LWAHYME^E %G51E&KQ[Q@OWZ]IU"+=&WTKR
M+QE#@/Q0!P&DMMN_QKU_PQ/\J#->.6;>7=?C7I7AF\^91F@#VG3FS;_A63K3
M?*U7-'DW6H/M63KLF U 'DOBWYMU<KH2'[:/K76>(AYA:LC0K3_2P<=Z /6?
M#*_NEKT/3_N"N(\.P;8EXKNK)<** +S?=KF=:/RM73-]VN3UY\*U '!:J?F:
ML:V/^E#ZUH:I+\[<UE6CYNA]: /2] ^XM=='_JZY'P]]Q?I771_ZN@#SOQP?
MW;UX3JG-TWUKW3QS_JWKPK4O^/MOK0 NEQ;[E:];\,Z<'C3BO+=%7-RM>W^$
MH08DX[4 :T6DC ^6IO[)']VM^* 8'%2^0/2@#F_[)']VI$T@9^[70" >E2+"
M/2@#%BTP*1\M:MO;"->E65B J7;@4 <CXCCS&U>.^([<[WXKV_6H=ZM7F.OZ
M?N+<4 >.W"%;GIWKH=&N"A6DOM,(FSM[U+:6QC(XH ]"T2]^[S7>Z;=@A>:\
MGTZX\K'-==INJ8V_-0!Z=;S J.:M*V:Y2PU$, -U;]M-O7K0!>I:8II] !11
M10 4C?=I:1ONT 8NH=#7EWC#[DE>HZAT->7>,/N24 >):I_Q]M]:L:1_Q\)]
M:KZI_P ?;?6K&D_\?"_6@#VSP=]Q*]1L_NBO+O!WW$KU&S^Z* -->E+2+TI:
M "BBB@ HHHH H:E_J37FOB%?OUZ5J/\ J37G6OCAZ /+-73]Z:V/"PQ(M9NL
M#]X:U?#'^L6@#UW1S^Z2NB_Y95SFC_ZI*Z$G]S0!@ZNW[I_I7CWBKF1J]:UE
M\1/7D'BB3]XU &/I4>917IGAV/&RO-=&.917J/AX<)0!Z/I@Q"*OO]VJ6F_Z
MD5=?[M &1??=->3>-?NO7K-_]TUY+XT^[)0!Y+_R^'ZUVWAS_6+7$_\ +X?K
M7;>'/]8M 'M7AG_5K]*ZP=*Y/PS_ *M?I76#I0 M%%% !1110 4444 %%%%
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MM7ZU[#X/Z)7CVE_ZU?K7L7@_HE 'IT'^J'TJCJ?^K/TJ]!_JA]*HZG_JS]*
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M;=?I7C&G<WX^M>S^%A^X3Z4 =#<0[HCQVKR;QO!A7XKV9H\PGZ5Y3X[C 5Z
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MK]*ZP=*Y/PU_JU^E=8.E "TE+24 +1110 4444 %%%% !1110 4444 %%%%
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M=XP7$CT 97A]\2K]:]@\-R95*\6T-\2CZUZ[X8ER$H ]9TTYA%7G^[6=I1S
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M5S>MP[U:NE/2LG48MRF@#QSQ+9XW'%>;LC)J ^M>T^([+*MQ7EE]9E+S..]
M'H/@ZY"1IDUZ3;7Z[1\U>,:)>_9U49QBNK@UP #YOUH ]&-^F/O5AZU?*83@
M]JYXZZ,??_6LW4-7$J$;J ,VXNR;X8/>O0?"[EHUS7EJ/YEX#[UZAX5'[M*
M.FNH@T9^E>8>-;7]W)@5ZS(N8Z\_\7VV^-^* / C$8]1)QWKT7PW=^6%&:Y&
M_M/+O&..]:&G7?D,!F@#VS1[]=J_-70"\4KUKR?2]9"A?FKI(=9##[U %KQ-
M=9B;!KS(S.U\?K78:Q=^=&W-<I!;E[S..] '9Z%DJN:[:T.(_P *Y;0[?:B\
M5TJMLC_"@#F_$TH"-S7C/B.4%GKU#Q5=85N:\;UVZW2/S0!1T4_\3(?6OHWP
M0W^C1_2OFS0WSJ"GWKZ)\$RXMT^E 'HX.5K(U!L UHQOE:R]2^ZU 'F'C)SY
M<GTKQ2\/_$P/UKV?QC_JY/I7B>H-B^/UH [?PW* R<U[3X8<%5KP+P_=;94&
M:]P\(3;T3F@#T9?N5P?CK_CVD^E=XG^KK@_'7_'M)]* /GB__P"0L?K7I7A%
MAMCKS/4CC53]:] \*38$?- 'LFD'*K71K]VN5T.3<JUU*_=H P=>.(F^E>5:
MRX\X_6O4O$+8A;Z5X]KD^)VY[T 0PLOG#GO7HWA@C:M>20WG[]>>]>H>$I]Z
MIS0!V]TN8OPKSOQ;!^Z?CM7I,B[HOPKB?%-ONA;CM0!\ZZ[$1=MQWJ+3'*SK
M]:W/$5IBX8X[U@6X\NX7ZT >Y^!ILA*]?MFS$OTKQ#P--@)S7LME+F)?I0!H
M,V!6!KTX^R.,UJW,NR/-<;K]]^Y89H \8\:_/</]:YG3K8LXXKIO$G[Z=OK4
M6BV&YAQ0!VGA&U*M'Q7LFEIBW6O._#=ELV<5Z58KMA H K:W_P >3_2OG3QW
M_P ?$GUKZ+UO_CR?Z5\Z>._^/B3ZT <MI7^L'UKU?PGUCKR?2_\ 6#ZUZOX3
M^]'0![#IG_'LM,UA,VC_ $I^E_\ 'NM/U)=ULP]J /GOQO;DS.<5R%@3%(/K
M7IGB^RWNYQ7G4T/DO0!Z+X5N\L@S7K^DS!K=>:\#\+W6)5&:]FT2ZW0+S0!U
MBG(J.X/[IOI387W+3;IOW3?2@#R'QY*0'KQN21GN6'O7KGCTY#UY/!%ONS]:
M .F\-PDSJ<=Z]S\,IMMU^E>3>&K/YU.*]BT*/9 /I0!JW+8B;Z5XSX_DXDKU
MR_EVQM]*\7\=RY#\T >=Z7@WW/\ >KU[PTB;%KQG39=M[_P*O5_#=X J\T >
MMZ85$8^E7)55JQ=*N08QSVK1><>M #O+05+$%!K/DN@.].M[H,W6@#<3&*?5
M>%]RU8% "/\ <-<#XJ^Z]=\_W#7!^*ONO0!Y'J/^O;ZTFEL/M(HU4XF;ZU4T
MR7_2Q]: /:?#!_=K]*[./[E<+X6?,:?2NXA.4H Y/Q-%O1J\;\16I#N<5[KK
M4'F(W%>6^(]/^^<4 >5P*4OA]:]<\)702-,FO,I[;RKO..]=9H=]Y.T9H ]M
MT^\4J.:V4N%(ZUYQI>J@@?-72P:@& YH WIYP%ZUCW-T,]:BNK["=:P)]0S)
MC- &H\^3UIR.36;!-YA'-:<"9% %"_F**:R[>\S-C/>K6N-Y:-7)6]]_I6,]
MZ /3=/D#J.:V$B#)7*:-<[E7FNNM3NCH Y[5K52&XKRKQ5;A0^!7LFJ+\K5Y
M9XKBRKT >6VN1?'ZUZGX88X6O.;>W_TX\=Z]-\-0X"\=J /3]%)*+70CI6!H
MRX1:WQTH *.]%% "TC=*6D;I0!CW_P!TUY=XQ^Y)7J-_]TUY=XQ_U<E 'B6J
M?\?;?6K&D?\ 'PGUJMJG_'VWUJSI'_'PGUH ]N\&CY$KU"T^Z*\O\&_<2O4+
M7[HH T%Z4M(O2EH CF.$-<UJ<^W=S717)Q$3[5PVNW6S=S0!SNK7V">:IZ3>
M%IQSWK&U:^R6YIN@W.ZX'/>@#U6!RUL/I6'JRY1JV+#YK4?2L_5(_P!VU 'E
MNMC$AJ_X9/[Q:J:^N)&J7PX^)%H ]AT=OW25T8YBKE-%DS&E=7#S%0!S^LQY
M@?Z5X=XS@/F/Q7OVJ19@?Z5XUXOL]SOQ0!YUI8*2C/K7J/AB?E.:\WCB\J3\
M:['PW<XD49[T >ZZ/*# O-:Y.5KEM"N<P+S71H^4H S[\_(U>3>,V^62O5-1
M;"-7D?C.3Y9* /+\_P"F'ZUVOAP_O%K@R_\ IA^M=KX<D_>K0![AX:/[I?I7
M4%P!7)^&F_<K]*WKF?8O6@":2Y5>]1"]7/6N>OM2$>?FK*36@9,;J .\2X5N
M]64;-<G9:B'Q\U=#:2[P* +U%%% !1110 4444 %%%% !1110 55N#@&K54[
MKH: .-\42?N&^E>#^))3]J;ZU[IXF4M"WTKP[Q#:NURW'>@#*LICO'UKTKPQ
M.<KS7G%I:N'''>O0O#<3*5H ]7TV;,:\UMH<I7-Z7G8M=%!]P4 4=43-NWTK
MQGQ;;YE;BO;[],V[?2O*O$UF6D;B@#B-+M\2#BO2O#L>"E<CI]B0_2N\T* J
M5XH [VPX@%.NFPAI+,8A%-N_]6: ./UJ;"MS7CWBN0MOKUK7%8AJ\H\1VS/N
MXH \Z3(N#]:ZS1)2K+6$+%_//'>N@TNU=6'% 'I>AW9"+S776ET3CFN#TA'4
M+7666[B@#K[.3=BI;Z+S(NG:J>GYXK8=-R4 ><:[I_RL=M>9ZQ!Y4K<=Z]QU
MFT!A;BO)_$5D=[X% '*PWQ@[U9_MMA_%6/>0R(3BLT^;F@#K%U@N?O5?L[HR
MN.:XVV$I:NHT:)S*N: .\TBV\PJ<5WVDV^Q1Q7,>'[;Y5R*[BSB"@<4 .N8M
MR5PGB>TS&W':O1G3*URGB*V#1-QVH ^?-=MML[''>L6&0QS#ZUW'B&P)E; K
MC9;1UFZ=Z .]\,W9PO-=_#=$QCGM7F?AV-U"UWEL&V"@"CXCF)@;Z5XQKCG[
M2?K7L>NQ,T#?2O)=9LW-P>.] &?I\A$R_6O7O!TQ^3FO*+*S<2KQWKU3PE"R
M[* /8-.DS&OTI=5/^CGZ5!IF=B_2I]4&;<_2@#RCQ,Y^:O*-68_:#]:]9\20
MLQ:O,=4LW,QX[T ;OA.8JR\U[+H5P61.>U>,^';=T9:];\/A@$S0!WD8WPBL
M;6+;= W%;=J,PBH-2B#0-Q0!X1XJM/G<XK@9LQ,:]>\466XOQ7F&J63*6P*
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M+=D9.* /;-+;_1D^E:Z=*Q=+!%NGTK:CZ4 /HHHH **** "BBB@!C=*S[I\
MU??I67>YP: ,#4K@@'FN"U^Z)C89KL=4W8-<%K<;LK4 >8:XQ:X/UJ]H#%66
MH]4LW:8\=ZO:/:.K+Q0!ZSX6D)V5ZG8?ZA?I7E?A:)E*5ZI8?ZA?I0!;HHHH
M *IW,>X&KE,9<T <7KEGNC;BO+=:LMDK''>O;=5MPT9XKS3Q#9X#'% 'G<EV
M;<XSC%+'K9'\59FN[HI&Q7/K<29ZT =R=<./O4+JAE.-U<<LLC=ZU-/61G%
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M.I?=-6K3[HJ#4%RIH \J\8#Y)/I7B&K9%X?K7O/BRW+(_':O%M8L7^TL<=Z
M(]&G*W"#/>O>_ TNY(Z\$TRU=;E..]>\>!(V5(\T >KQ_P"J%<)XY_X]I/I7
M=Q_ZH5PWC=<VS_2@#YRU7C5#]:[/PQ*04KDM6A/]IGZUU?AN)@R4 >R>'7RJ
MUV2?<KBO#BD*M=JGW* .:\3'$#?2O$/$4Q6=OK7M_B9286^E>&>)X6$K'WH
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MTD*?NT 9.GV!4#BNAM+8C'%6;>PVXXK1AML8XH GL8\8K7 ^6JEO'C%70.*
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M#70%'SUXY87YC YK836& ^]0!ZJ-?&/O_K2_V^/[_P"M>7?VTW]ZC^VF_O4
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MAZ5IJ,+4:)BIATH 0BF[:DI,4 ,VTH%.Q1B@ I:** "DI:2@ I:2EH ****
M"DI:* &XI,4^DQ0 S;1MI^** $ IU)2T %%%% !1110 5#,NY*FI&&10!S=[
M9;V/%5$TX9^[72R1 GI3! /2@#.M;/81Q6O$F%H2,#M4P&* % I:** "BBB@
M"M<IN6N=O[ /GBNI<9%4YH01TH X*XTD%ONU/9Z4%(^6NGEM03TIT%L >E $
M-E:;,<5N0KM6H8HP.U65&!0 ZDI:* &$4W;4F*,4 ,"TX"EQ2T )2T44 (13
M"M24F* (MM/44[%% "U3NX]ZFKE1R+F@#GC9_O<XK5M8=@'%/\H;NE6(UQ0
M\"G444 (:IWD>^,BKM12KE: .)O]-#S9V]ZT-*LO*QQ6G-;@MTJ>WA"]J +4
M2X45.*8HXI] !4<HRA%24UN10!Q^LV7F[N*Y271QN/RUZ/=PAL\5E/9C/2@#
MF=.TO9(/EKN--@V1CBJ-M:@-TK=MDVK0!.@Q3Z04M !6;J4>^,BM*JURNY:
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MEHH 2EI*6@ I*** "EI*6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M***2@ HHHH 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I#2T4 )
M1110 M%%% !1110 4E+24 %+24M !1110 4444 %%%% !1110 E%+24 +111
M0 E%%% "T444 )BC%+10 E%+24 %+24M !1110 444E "T444 %%%% !1110
M 4444 %%%% !1110 4444 )BEHHH **** "BDI: $Q1BEHH 3%+110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% "4444 +1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %)2TE !2TE+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !2&EI#0 4M)2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% "4444 +1110 4AI:0T %+24M !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 )WH%'>@4 +1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% "4M%% "4444 +4<HRAJ2D89% '-:
MC:[R>*PI=-R>E=K-;[NU5'LAZ4 <!>Z7D'Y:PI=(_>?=KTVYL 0>*R9--&[I
M0!Q2:3_LU,FE<_=KKUTT>E/&GC/2@#'T_3]I'%=38V^T#BF6UD%QQ6M;PX H
M MP)A:M**9&N!4@H 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HI*6@!**6DH 6BDI: "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ I*6DH *6DHH 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH *2BB@ I:** "BBB@ HHI* %HI*6@ HHHH **** "BBB@ HHHH **2B@!:*
M** "BDHH 6BBB@ HHHH ***2@ HHI: "BBB@ I*6DH *6BB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** $H%%+0 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%)0 9I:2B@!:*** $HI:2@!:*** &E:C9!4U-- %*:(
M&J+VXW=*UW7-5VCYH SQ;CTI1 /2KWET>70!7CBQVJY&F*%2I56@"11Q3J04
MM !1110 4444 %%%% !1110 4444 %%%% !1110 44E% "T444 %%%% !111
M0 4444 %%%% !1110 44E% "T444 %%%% !1110 4444 %%%)0 M%)2T %%%
M% !1110 4444 %%%% !1110 44E+0 4444 %%%% !1110 4444 %%)2T %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2&EI#0 =Z
M6D[TM !24M)0 "EI!2T %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 E%%% "T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %(:6D- !WH
M%'>@4 +1110 4444 %)2TE !2TE+0 4444 %%%% !1110 4444 )1WHH[T +
M1110 E%%% "T444 %%%% "&CO0:.] "T444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !24M)0 E%%% #J*** "BBB@ HHHH **** &D4S94M%
M$6RC94M% $86G 4ZB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M $H%% H 6BBB@ HHHH **** "BBB@ HHHH **** $[T4=Z* %HHHH **** "
MBBB@ HHHH *2EI* "EI*6@ HHHH **** "BBB@ HHHH *0TM(: #O0*.] H
M6BBB@ HHHH **** "BBB@!.] H[T"@!:*** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "D-%% !WI:** "DHHH !2T44 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 E%%% "T444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %(:** #O0*** %HHHH **** "DHHH *6BB@ HHHH
M**** "BBB@ HHHH 2CO110 M%%% "4444 +1110 4444 (:.]%% "T444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !2444 )1110 ZBBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** $H%%% "T444 %%%% !1110 4444 %%%% !1110 G>BBB@!:**
M* "BBB@ HHHH **** "DHHH *6BB@ HHHH **** "BBB@ HHHH *0T44 '>@
L444 +1110 4444 %%%% !1110 G>@444 +1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>image00010.jpg
<TEXT>
begin 644 image00010.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 0I!V@# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "DI:*5@$HHHJ1A2TE+30@HHHJ@"BBB@
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M]Z"C1WBC>/6L[[3[TGVGWH T=X]:-XK.^TCUI/M7O0!I;Z-XK,^U>]+]J]Z
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4E+24A,;12T8I""EI*6F-!12TE,!**6DIBL%%%)0(,TTM36.*KO)BDQDY<4P
MRCUJF]QCO55[K'>IN%C2:8>M1M./6LE[WWJN]][TTRDC9:X'K437(]:Q6O\
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M1DT.%.H%%,5A:***8PHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M!R$@-.S46:7=3%R$A--I,TM%P4!*44N**.8?(*#3@:CS1NI#Y"7-&:CW4[-
M<@[-+FFTM <H[-+FF9HS1<=AV:3-)FBES!R7#-&:*::5P]F+NHW4PFDW4PY"
M3=2[JC!I0:!<@_-+FF49HN-1),TA-1[J3=04HCR:831FBD'*)DTH-&*2BXN4
MDS1FH\TFZBXN0>6IA:DS3:=P]F.W4X-4=.!IAR$H-+NJ+-+NH#D'$TPFC-)2
M#V8FXT;J2DIW%R#MU&ZF44^87(/W4;C3:*5Q\@\,:D#5#3@:0^0L!J"U0[J7
M=05RCRU,+&DS118?()DT9HI*+!R"YI<TREH%RCLT4"EQ2#E$I,TI%--%PL+F
MC-,)H!H3$XDF:7--%+5HRE 8QJ!S4SU7DJD82@,W5-&:K$\U-$:=S"<31A-:
M5OVK,@K6MATH.2<39LNU='8]JY^S'2NBLATIHYI1-^UZ"M*/I6;:]!6C'6B9
MC(M)4RU E3K5HQ8ZEHHJR0HHHI@%%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 E%+14V 2EHHII %%%% "44M%*P"4M%%-(!*0TM%,8RDI^*,55Q
MW$%.%&**0FPI:**0@I#2TAH 814$@XJP:B<<5#&F9%Z/E-<MJ0ZUUMXO!KF-
M17@U)K!G&:@O6N;NEZUU>H)UKG;I.32.J#,"=>M4)%YK8G2L^1.:1T195C7F
MK\ Z565>:N0BE<Z(%^&K0-5(JLJ:#L@A])12U+.B*&44XTPU)I8,TF::329J
M;!8DS1FH\T9I!8<33#1FBE8+##0*=BC%'*.PHIXIE+FE8+#\T$U'NII:BP6)
M=U+NJONHWT^45BQNHW57WT;ZJP6)B:::9NI<T6"P&DIV*7%%AV&TM+BBBPQ*
M2G8HQ18!E%.Q2&BQ-AM%!IN:+!86FD4M. HL-$>*,5+MHVTK#&4M!%)2Y1"Y
MHS3<T9HY16'9I<TVC-'*.P_-+FH\T;J!CR:3-,S1FBP#LT\&H\TX&CE)L3"G
M5$#3P:.4+"FFFG4E.Q20VE%+BBBP["BBDI,U-B6@-,-.HHL*Q'BBGXI,4U$=
MAM%!I#56'R@:;FE--I6)<0S2YI*2E87*/S1FF9I<U-BDAU)0*=BG8T2$%/%)
MBG"G8NPX4M)1FGRA8#333J2G88VBE-,)IV 7-&:830#18!U)BG#FG@5+1+(\
M4X"G[:3%*Q#$H-%%!#8PTTBI<4;:!<Q#BG 5)LI,4@YAM%+BC%%@&$4F*DQ1
MMH*1'BG 4_;1B@&-Q1BGXHQ185B+%)@U-MHVT%)$0%/ I^VC%(8F*0T[%&*+
M"(B*:14V*3;3 BQ3A3MM)5(3%HS3:,T[$V'9HS3,TN:=@L2 T\&H0:4-4M#L
M3YHS40:G TK#Y1324ZC%.Q5AM.S3332V*"6B;=1NJOOJ16I$V):*1:DQ4A8;
M12FFDT<HT+FFFDS29JN4H0TE.HQ3L.PT4^DHI-$M#LTTFDS29I6%8":2EHIC
M%%.%-I<T6$QU--&::31R@D(329I":2EREI#J6D%.%-(+"8HI^*,4[!8913L4
MAIV$)29H)IN:+"'9I*;FE%*P!BC%. IV*7**PW%+BEQ2T[#&T4IIIIV&&:7-
M-HS3Y1V'@TZHP:>*?* M)BE%. I\HFR/%+BI-M&*7*2V,%+0::34.)-QQIAI
M<TN*7*!&10!4NVC;1R@,%.S2'BFDU:B2Q'JL]3L:B;FG8PF08YJ:(4W;4\:T
M['+,NP5JVQZ5E0UI6YZ4['-,W[/M7167:N:LCTKI+'H*?*<LS?M>@K2CK/M>
M@K2C'%4HG/(G2IEJ)14HJT8L?12"EJT0%%%%, HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** &YHS3,T9I%6)**9FGBF*PM%)2T""BDHJ;@+124M.
MX!1113 **** "BBB@ HHI* %I**2@5PJ-^E25&_2I8&9>?=-<SJ/0UTU[]TU
MRVI'AJDTB<M?GK7.W)Y-;NH-R:YRY?DT'3!E"<U0DJU,U49&J6CI@(.M6(S5
M0'FIXS4V.RFB_&U6%:J4;580TCM@60:?42FI!4LZ8BFHVJ0U&U2:$9IM.--I
M7$%%*!3L4#L,HIQIAH06%S2YJ+-*&JA$E%-!IU38!IJ,FI&J%J:0"%J3--)I
M :NP#\TZD%/ I6'804X&D--)HL%B8-2[JK;Z<'HL(L9I:C5J>*0"TE*:832
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MVIX%:49XK)M3P*THC5HYY%U34JU70U.M.QA(DHI!2TR HHHI@%%%% !1110
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MR8&G U$M2"I;*4R534R-5<4X-4MFL97+BO2EJJAZ<'J39$IYJ)A3@<TM.XR
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M72_]FI5TO_9KK!8#TJ06 ]*"N<Y,:9_LT'3/]FNN%B/2C["/2E<?M#CCI?\
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MMHFR*"T=):7)R.:W[2X/'-<Q:1-Q6]:1MQ0,Z*"<D#FKT<N:R;=#@5HQ*:3
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M6P_-3QM6:LN3UJW$],1HQFK JI$:L@\5+&.-12=*>6JO*_%(#-OS\AKB]7?
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M*M,Q8ZEHHIH@****8!1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 44E%3< HHHI#"BBBF(6DHHH ****0PI:2EIH044450!24M)0
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M""BBBF 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M3\5HC"17,8IA458:H'-6C-D#@"JDIJS(U4IFX-,AE.9JSY6YJW,U4)3S3)9
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M3H+0<"M*,<5G6O05I)3,VB0"GBFBGTS-BT444R0HHHH **** "BBB@ HHHH
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MF"UL<]*$MCGI6T;<>E*MN/2J3)L4(;?VK0B@Q4T<(%6DC JKCY2%8J=LQ5C
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M110 4444 %%%% !1110 4F*6BE8 HHHI@%%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MZZ9[5TB6'M5A+$?W:"'4.7&F?[-']G8[5UOV(8Z5&]D/2F+VAR;6..U5Y;7
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M%&* N5_+IWEU-BC%%@N0^71Y=38HQ0%R'RZ4)4N*,46"XP+3P*6B@0E+110
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M%*X!2444F 4444AA2TE+3$%%%%4 4444 %%%% !1110 4444 %%%% !1110
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M*K,>J$_Q5Q*79SUJ[#=^]-%6.S34<_Q4YK\XZUS,5U[U8$^1UJA6->343ZU
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MH **** "BBB@ HHHH **2BE< HHHI %%%%(84M)13$+1113 ****8!1129I
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M.X!1113 **2BE< HHHI %%%%( I:2BG<!:***8!1113 **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "DQ2T4 ,*TPQ ]JFI*!E&6!
M2.E8M_;#!XKI)!D5E7D>0:3*3.#U*T'/%<E?VG)XKT6_M\YXKF;VSSGBLVC>
M+."N+7D\5F36^.U=E=677BL>YM,9XJ;'1&1S#PXI%3!K4FM\'I59HL&@Z(S(
MTXJRC5!C%*&Q4-&T:A?1ZG1A6<LE3I)4V-%*YH B@XJNLE/#YHL:H5J813^M
M+MH-(D8IXHQ2=*#>(^@TS=1F@V0IIN*=1BD:) !3Q3*-U%AV)<T9J'?1OHL)
MHD+4TM3=U-)JTC&0K&HR:&:HF:F82'9I0:AW<TX-3N<TR=>M6[?[PJDAYJ[;
M_>%4CFFSH+#M74V':N6L3R*ZBP/ JD<DV=';?=%:$>,5FVS?**O(W%6CEG(M
MKBD<C%1AZ:[\4SFDR"<BLR<BKL[\5F3/5&+*LO4U5>II&YJ F@DB-.C'-&*E
MC7F@"W;CI6K;BL^W6M2!>E:)C1>B%7(Q5>):MQBFV4BQ'4XJ%*F%9,M#J:W2
MG4UNE2,S[O[IKF=1/6NFN_NFN:U =:!'):@>M<S>$\UT^H+UKF;Q>M2*Q@W1
M/-9,YY-:]TO6LB<'-4A$,9YK2MFZ5F(#FK]OGBFQ&]:/TKH;"3D5S%J3Q706
M!Y%18=CLM.?I73VC<"N1TYNE=/:-\HIHI(O3R86L#4+C /-:MU)A:Y;4Y\ \
MTQF7?7A!/-8-Q>9[T[4+DY/-8,UR2>M KEJ:Y)SS5-Y2>]0&4FA22:5A$J@M
M5F.V+=J6UBW$<5T%E8[\<46!(RH]/9NU6%TMO[M==::1NQ\M:2:+_LTRC@QI
M9_NTITLX^[7?_P!C ?PU&^D<?=IB:/-KG32 ?EK$N[$C/%>HW>E  _+7.7^F
M8S\M!-CSB>U8'I421%374W>GX)XK+DM=IZ4 5X"5K4MIL8YK,*E:<DQ4T".N
MLKD#'-=-878XYKSVTNB".:Z&QO3QS5(9Z):78P.:TDNQZUQ5I>G YK2CO3ZU
M0CJ!=#UIWVD>M<ZMZ?6I!>'UJ638W3<CUJ-KD>M8IO#ZU&UX?6I'8V'N1ZU3
MFN%]:S'O3ZU2FO3ZT#+\]PO-9=Q.O/-4I[X\\UF3WI]:I,"2\E!S7/7C9)JW
M/<EN]9LS%JJXF9LH):GQ*<U(8R6JS!!D]*9-B:W0\5L6R'BH;:VZ<5M6MKTX
MI%I$UK&>*W+6-N*@M+3IQ6[:6G3BE<=A]O&V!6C%&:E@M>.E74M\=J=Q6(8T
M-3[>*E6'%.V<4[B*<B\53D6M*1:IR+1<DSI%JLZ5?D6JSK0-(IL@J%D%6G%0
MM3N6B';24\TPU+9HF*#4BM4.:-U2;19:#\4R1^*A\SBHI).*1O%E>Y?K6-<M
MUJ_<2=:R+A^M2T=$2C.W)JA*:M3-S5*0UFSI@02&H#UJ5S47>LVSJ@QPJ1:C
M%2K2.B(X4ZD%+4V-T.I:;FC-2T6I"FDHS12L%QM)3J2A(EB4"BDS5HAL>*=3
M :7-,QE(4FHF:E9JKR/3,7,&>H':FO)46_-%C*4Q'YJ$J2:GQFGK%DU2.><R
M*&(DUJ6T&<<4V"WYZ5KVMMTXJCEG(?;6W3BMJUM.G%-M;;IQ6W:VW3BJ.:3'
MVEITXK;M;4<<4VTMNG%;5M;].*9DV,AM@.U:$,..U21PX'2K*QXID7"-,5,!
M2**>*8@Q2T44""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!**,4M
M38!*6BBFD 4444 )12T4K )2T44T@"BBBBP"44M%*P"4M%%-( HHHI@%%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M>+$>E;0MO:GBV]J0K&,MD/2K,=F!VK3%O[5(L'M04D5([8#M5I(0.U3+'BI
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M%)&GYWO2>=[UFF?WH\_WJ6AFGYWO2B;WK+$_O3Q/[TAFF)O>E\ZLT3T[SJ+
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44E%3<!:*2EII@%%%
M%, HHHH **** "BBBD 44E%*X"T4E+33 ****8!1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBBD 4F:**5P%HI*6F@"BBBF 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** $HHHJ!A2TE+5(04444P"BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHI
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MHI:* L)2T44#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@!****@84M)2U2$%%%%, HHHH **** "BBBDP$HHHJ0"EI*6
MJ0!1113 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0(2DI:2I$+2TE+3&A:***8PHHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHI %%%% !1113 **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** $HHHJ!A2T452$%%%%, HHHH
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MFG8I,4B@IPI,4Z@3"EI*6F2%%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%)FC-(!:*** "BBBF 4444 %
M%%% !1110 444F:5P%HHHI@%%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ I,4M% !1110 4444 %%%% !1110 4E+10 F*,4M% "44M% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 E%%%1884M%%4A!1113 **** "BBB@ HHHI,!**6DI6 *6BBF
M@"BBBF 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1244K@+1111< HHHI@%%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH ****0"44M%*P"4M%%-( HHHI@%%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %)2TE "&F$4^D-(5R%DJ%H_:K1%-VTB2F81Z4PP#TJ]LI-GM3L!GFV'
MI2?9AZ5H>7[4>72L!G?91Z4OV8>E:'ET>718"DMN/2I5@'I5D)3@M $2Q#TI
MXC'I4@%+0 T(*4+3J*87#%+244#N.I:9FES1<=QU%)2TQA1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%)12N M%%%%P"BBBF 4444 %%%% !11
M10 44E%*X"T4447 ****8!1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %)110*X4E%%%A7$HI:,4K )1BEHII"$Q1BEI:8#<48IU
M)0,3%&*#29I$MBXHQ29I:07"BEHHL4)12TE,0444M# 2BEQ2XI6'8***6@84
M444QA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 E%%%9C"EI*6J0@HHHJ
M@"BBB@ HHHH ****3 2BBBI&%+24M-""BBBJ **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "DI:2@ I*6DID,2EI*6@$+1112*"DI:2F2
MPI:2EH!!0:*#2*8PTE*:;2,V+2BFTX4 A]%%%,T"DI:2F2PI:2EH&@I:04M(
MH**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
G **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140286959602664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Feb. 16, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_DocumentAndEntityInformationAbstract', window );"><strong>Document and Entity Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ReWalk Robotics Ltd.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001607962<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27,393,283<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,445,454<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-36612<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">L3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_DocumentAndEntityInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_DocumentAndEntityInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140286961093832">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>CURRENT ASSETS:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 20,350<span></span>
</td>
<td class="nump">$ 16,253<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Trade receivable, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">684<span></span>
</td>
<td class="nump">794<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">672<span></span>
</td>
<td class="nump">903<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,542<span></span>
</td>
<td class="nump">3,123<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">25,248<span></span>
</td>
<td class="nump">21,073<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsNoncurrentAbstract', window );"><strong>LONG-TERM ASSETS</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Restricted cash and other long term assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,033<span></span>
</td>
<td class="nump">1,061<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,349<span></span>
</td>
<td class="nump">1,737<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">437<span></span>
</td>
<td class="nump">501<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Total long-term assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,819<span></span>
</td>
<td class="nump">3,299<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">28,067<span></span>
</td>
<td class="nump">24,372<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>CURRENT LIABILITIES:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current maturities of long-term loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">5,438<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current maturities of operating leases liability</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">660<span></span>
</td>
<td class="nump">637<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Trade payables</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,268<span></span>
</td>
<td class="nump">2,698<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Employees and payroll accruals</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">867<span></span>
</td>
<td class="nump">670<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">441<span></span>
</td>
<td class="nump">323<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">432<span></span>
</td>
<td class="nump">402<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,668<span></span>
</td>
<td class="nump">10,168<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>LONG-TERM LIABILITIES</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long term loan, net of current maturities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,527<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueNoncurrent', window );">Deferred revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">667<span></span>
</td>
<td class="nump">521<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Non-current operating leases liability</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">923<span></span>
</td>
<td class="nump">1,315<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">35<span></span>
</td>
<td class="nump">61<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Total long-term liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,625<span></span>
</td>
<td class="nump">3,424<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,293<span></span>
</td>
<td class="nump">13,592<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">COMMITMENTS AND CONTINGENT LIABILITIES</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders' equity:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Share capital Ordinary share of NIS 0.25 par value-Authorized: 60,000,000 shares at December 31, 2020 and 2019; Issued and outstanding: 25,332,225 and 7,319,560 shares at December 31, 2020 and December 31, 2019, respectively</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,827<span></span>
</td>
<td class="nump">504<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">201,392<span></span>
</td>
<td class="nump">178,745<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(181,445)<span></span>
</td>
<td class="num">(168,469)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders' equity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">21,774<span></span>
</td>
<td class="nump">10,780<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and shareholders' equity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 28,067<span></span>
</td>
<td class="nump">$ 24,372<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Balance presented net of unrecognized revenues that were not yet collected.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140286973383176">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - &#8362; / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Ordinary shares, par value (in NIS per share)</a></td>
<td class="nump">&#8362; 0.25<span></span>
</td>
<td class="nump">&#8362; 0.25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Ordinary shares, authorized</a></td>
<td class="nump">60,000,000<span></span>
</td>
<td class="nump">60,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ordinary shares, issued</a></td>
<td class="nump">25,332,225<span></span>
</td>
<td class="nump">7,319,560<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ordinary shares, outstanding</a></td>
<td class="nump">25,332,225<span></span>
</td>
<td class="nump">7,319,560<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140286961121976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 4,393<span></span>
</td>
<td class="nump">$ 4,873<span></span>
</td>
<td class="nump">$ 6,545<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of revenues</a></td>
<td class="nump">2,204<span></span>
</td>
<td class="nump">2,147<span></span>
</td>
<td class="nump">3,720<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">2,189<span></span>
</td>
<td class="nump">2,726<span></span>
</td>
<td class="nump">2,825<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development, net</a></td>
<td class="nump">3,459<span></span>
</td>
<td class="nump">5,348<span></span>
</td>
<td class="nump">7,349<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Sales and marketing</a></td>
<td class="nump">5,754<span></span>
</td>
<td class="nump">6,167<span></span>
</td>
<td class="nump">7,897<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">4,980<span></span>
</td>
<td class="nump">5,259<span></span>
</td>
<td class="nump">6,793<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">14,193<span></span>
</td>
<td class="nump">16,774<span></span>
</td>
<td class="nump">22,039<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating loss</a></td>
<td class="num">(12,004)<span></span>
</td>
<td class="num">(14,048)<span></span>
</td>
<td class="num">(19,214)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_FinancialExpensesIncomeNet', window );">Financial expenses, net</a></td>
<td class="nump">921<span></span>
</td>
<td class="nump">1,496<span></span>
</td>
<td class="nump">2,466<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income taxes</a></td>
<td class="num">(12,925)<span></span>
</td>
<td class="num">(15,544)<span></span>
</td>
<td class="num">(21,680)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Taxes on income (tax benefit)</a></td>
<td class="nump">51<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (12,976)<span></span>
</td>
<td class="num">$ (15,551)<span></span>
</td>
<td class="num">$ (21,675)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Net loss per ordinary share, basic and diluted</a></td>
<td class="num">$ (0.82)<span></span>
</td>
<td class="num">$ (2.70)<span></span>
</td>
<td class="num">$ (14.72)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted average number of shares used in computing net loss per ordinary share, basic and diluted</a></td>
<td class="nump">15,764,980<span></span>
</td>
<td class="nump">5,763,317<span></span>
</td>
<td class="nump">1,472,499<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_FinancialExpensesIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the aggregate amount of financial expense or income from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_FinancialExpensesIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140286962892216">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2"><div>Ordinary Share</div></th>
<th class="th"><div>Additional paid-in capital [Member]</div></th>
<th class="th"><div>Accumulated deficit [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2017</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 84<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 134,843<span></span>
</td>
<td class="num">$ (131,220)<span></span>
</td>
<td class="nump">$ 3,707<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Dec. 31, 2017</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,200,146<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet', window );">Cumulative effect to accumulated deficit from adoption of a new accounting standard</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="num">(23)<span></span>
</td>
<td class="num">(23)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation to employees and non-employees</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,766<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">2,766<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of ordinary shares upon exercise of options to purchase ordinary shares and RSUs by employees and non-employees</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of ordinary shares upon exercise of options to purchase ordinary shares and RSUs by employees and non-employees, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">17,181<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInInvestingAgreementNetOfIssuanceExpenses', window );">Issuance of ordinary shares in investing agreement, net of issuance expenses in an amount of $830</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">$ 12<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4,283<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">4,295<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInInvestingAgreementNetOfIssuanceExpenses', window );">Issuance of ordinary shares in investing agreement, net of issuance expenses in an amount of $830, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">164,715<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_StockIssuedDuringPeriodValueNewIssuesTwo', window );">Issuance of ordinary shares in at-the-market offering, net of issuance expenses in the amount of $236</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">$ 4<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,113<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,117<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_StockIssuedDuringPeriodSharesNewIssuesTwo', window );">Issuance of ordinary shares in at-the-market offering, net of issuance expenses in the amount of $236, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">49,882<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_StockDuringPeriodOrdinarySharesAndWarrantsValuePurchaseOrdinarySharesInFollowOnPublicOfferingTwo', window );">Issuance of ordinary shares, warrants and pre-funded warrants in follow-on public offering, net of issuance expenses in an amount of $1,505</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">$ 49<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">11,528<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">11,577<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_StockDuringPeriodOrdinarySharesAndWarrantsSharesPurchaseOrdinarySharesInFollowOnPublicOfferingTwo', window );">Issuance of ordinary shares, warrants and pre-funded warrants in follow-on public offering, net of issuance expenses in an amount of $1,505, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">728,019<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Modification of warrants to purchase ordinary shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">18<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_ExerciseOfPreFundedWarrantsValue', window );">Exercise of pre-funded warrants</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">$ 44<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">119<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">163<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_ExerciseOfPreFundedWarrantsShares', window );">Exercise of pre-funded warrants, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">653,144<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_StockIssuedDuringPeriodValueOrdinaryShares', window );">Issuance of ordinary shares in a "best effort" offering, net of issuance expenses in the amount of $686</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="num">(21,675)<span></span>
</td>
<td class="num">(21,675)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2018</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 193<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">154,670<span></span>
</td>
<td class="num">(152,918)<span></span>
</td>
<td class="nump">1,945<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Dec. 31, 2018</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,813,087<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation to employees and non-employees</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,108<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,108<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of ordinary shares upon exercise of options to purchase ordinary shares and RSUs by employees and non-employees</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 2<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of ordinary shares upon exercise of options to purchase ordinary shares and RSUs by employees and non-employees, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">47,473<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_StockIssuedDuringPeriodValueOrdinaryShares', window );">Issuance of ordinary shares in a "best effort" offering, net of issuance expenses in the amount of $686</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">$ 52<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,632<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">3,684<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_StockIssuedDuringPeriodSharesOrdinaryShares', window );">Issuance of ordinary shares in a "best effort" offering, net of issuance expenses in the amount of $686, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">760,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_ExerciseOfPrefundedWarrantsAndWarrantsValue', window );">Exercise of pre-funded warrants and warrants</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">$ 40<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,461<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,501<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_ExerciseOfPreFundedWarrantsAndWarrantsShares', window );">Exercise of pre-funded warrants and warrants, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">584,087<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses', window );">Issuance of ordinary shares in a "Registered Direct" offering, net of issuance expenses in the amount of $ 1,125</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">$ 115<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">8,010<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">8,125<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses', window );">Issuance of ordinary shares in a "Registered Direct" offering, net of issuance expenses in the amount of $ 1,125, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">1,650,248<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses', window );">Issuance of ordinary shares in a "Warrant exercise" agreement, net of issuance expenses in the amount of $ 1,019</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">$ 102<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">9,864<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">9,966<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses', window );">Issuance of ordinary shares in a "Warrant exercise" agreement, net of issuance expenses in the amount of $ 1,019,shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,464,665<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="num">(15,551)<span></span>
</td>
<td class="num">(15,551)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2019</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 504<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">178,745<span></span>
</td>
<td class="num">(168,469)<span></span>
</td>
<td class="nump">10,780<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Dec. 31, 2019</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">7,319,560<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation to employees and non-employees</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">749<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">749<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of ordinary shares upon exercise of options to purchase ordinary shares and RSUs by employees and non-employees</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 3<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(3)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of ordinary shares upon exercise of options to purchase ordinary shares and RSUs by employees and non-employees, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">63,111<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_StockIssuedDuringPeriodValueOrdinaryShares1', window );">Issuance of ordinary shares in a "Best Efforts" offering, net of issuance expenses in the amount of $ 1,056</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">$ 290<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,720<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">4,010<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_StockIssuedDuringPeriodSharesOrdinaryShares1', window );">Issuance of ordinary shares in a "Best Efforts" offering, net of issuance expenses in the amount of $ 1,056, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">4,053,172<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_StockIssuedDuringPeriodValueOrdinaryShares', window );">Issuance of ordinary shares in a "best effort" offering, net of issuance expenses in the amount of $686</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_ExerciseOfPrefundedWarrantsAndWarrantsValue', window );">Exercise of pre-funded warrants and warrants</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">$ 244<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,979<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">4,223<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_ExerciseOfPreFundedWarrantsAndWarrantsShares', window );">Exercise of pre-funded warrants and warrants, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">3,378,328<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1', window );">Issuance of ordinary shares in a "registered direct" offering, net of issuance expenses in the amount of $ 1,019</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">$ 357<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">7,624<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">7,981<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1', window );">Issuance of ordinary shares in a "registered direct" offering, net of issuance expenses in the amount of $ 1,019, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">4,938,278<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_StockIssuedDuringPeriodValuePrivatePlacement', window );">Issuance of ordinary shares in a private placement, net of issuance expenses in the amount of $ 993</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">$ 429<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">6,578<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">7,007<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_StockIssuedDuringPeriodSharesPrivatePlacement', window );">Issuance of ordinary shares in a private placement, net of issuance expenses in the amount of $ 993, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">5,579,776<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="num">(12,976)<span></span>
</td>
<td class="num">(12,976)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 1,827<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 201,392<span></span>
</td>
<td class="num">$ (181,445)<span></span>
</td>
<td class="nump">$ 21,774<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Dec. 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">25,332,225<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="6"></td></tr>
<tr><td colspan="6"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Represents an amount lower than $1.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">See note 8b.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">See note 8f.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_ExerciseOfPreFundedWarrantsAndWarrantsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares exercise of pre-funded warrants and warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_ExerciseOfPreFundedWarrantsAndWarrantsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_ExerciseOfPreFundedWarrantsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares exercise of pre-funded warrants and warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_ExerciseOfPreFundedWarrantsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_ExerciseOfPreFundedWarrantsValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of exercise of pre-funded warrants and warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_ExerciseOfPreFundedWarrantsValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_ExerciseOfPrefundedWarrantsAndWarrantsValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of exercise of pre-funded warrants and warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_ExerciseOfPrefundedWarrantsAndWarrantsValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_StockDuringPeriodOrdinarySharesAndWarrantsSharesPurchaseOrdinarySharesInFollowOnPublicOfferingTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Issuance of ordinary shares, warrants and pre-funded warrants in follow-on public offering, net of issuance expenses shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_StockDuringPeriodOrdinarySharesAndWarrantsSharesPurchaseOrdinarySharesInFollowOnPublicOfferingTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_StockDuringPeriodOrdinarySharesAndWarrantsValuePurchaseOrdinarySharesInFollowOnPublicOfferingTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Issuance of ordinary shares, warrants and pre-funded warrants in follow-on public offering, net of issuance expenses in an amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_StockDuringPeriodOrdinarySharesAndWarrantsValuePurchaseOrdinarySharesInFollowOnPublicOfferingTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInInvestingAgreementNetOfIssuanceExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Issuance of ordinary shares in investing agreement, net of issuance expenses in an amount of shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInInvestingAgreementNetOfIssuanceExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issuance of ordinary shares in a "Warrant exercise" agreement, net of issuance expenses in the amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issuance of ordinary shares in a "Registered Direct" offerings , net of issuance expenses in the amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of further shares issuance of ordinary shares in a registered direct offerings, net of issuance expenses in the amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_StockIssuedDuringPeriodSharesNewIssuesTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Issuance of ordinary shares in at-the-market offering, net of issuance shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_StockIssuedDuringPeriodSharesNewIssuesTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_StockIssuedDuringPeriodSharesOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issuance of ordinary shares in a "best efforts" offering, net of issuance expenses in the amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_StockIssuedDuringPeriodSharesOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_StockIssuedDuringPeriodSharesOrdinaryShares1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of further shares issuance of ordinary shares in a "best efforts" offering, net of issuance expenses in the amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_StockIssuedDuringPeriodSharesOrdinaryShares1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_StockIssuedDuringPeriodSharesPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period under private placement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_StockIssuedDuringPeriodSharesPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInInvestingAgreementNetOfIssuanceExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Issuance of ordinary shares in investing agreement, net of issuance expenses in an amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInInvestingAgreementNetOfIssuanceExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of issuance of ordinary shares in a "Warrant exercise" agreement, net of issuance expenses in the amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of issuance of ordinary shares in a "Registered Direct" offerings , net of issuance expenses in the amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of further issuance of ordinary shares in a registered direct offerings, net of issuance expenses in the amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_StockIssuedDuringPeriodValueNewIssuesTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Issuance of ordinary shares in at-the-market offering, net of issuance expenses in the amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_StockIssuedDuringPeriodValueNewIssuesTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_StockIssuedDuringPeriodValueOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of issuance of ordinary shares in a "best efforts" offering, net of issuance expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_StockIssuedDuringPeriodValueOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_StockIssuedDuringPeriodValueOrdinaryShares1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of further issuance of ordinary shares in a "best efforts" offering, net of issuance expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_StockIssuedDuringPeriodValueOrdinaryShares1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_StockIssuedDuringPeriodValuePrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period under private placement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_StockIssuedDuringPeriodValuePrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in additional paid in capital (APIC) resulting from a tax benefit (deficiency) associated with an share-based compensation plan other than an employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326096&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109126253&amp;loc=d3e4724-112606<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140286961109784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=rwlk_BestOfferingMember', window );">Best Offering [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Issuance expenses, amount</a></td>
<td class="nump">$ 1,056<span></span>
</td>
<td class="nump">$ 686<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=rwlk_RegisteredDirectOfferingMember', window );">Registered Direct [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Issuance expenses, amount</a></td>
<td class="nump">1,019<span></span>
</td>
<td class="nump">1,125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Issuance expenses, amount</a></td>
<td class="nump">$ 993<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=rwlk_WarrantExerciseMember', window );">Warrant Exercise [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Issuance expenses, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=rwlk_InvestmentAgreementMember', window );">Investment Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Issuance expenses, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 830<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=rwlk_AtmOfferingProgramMember', window );">Atm Offering Program [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Issuance expenses, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">236<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=rwlk_PublicStockOfferingMember', window );">Follow-on Public Offering [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Issuance expenses, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,505<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=rwlk_BestOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=rwlk_BestOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=rwlk_RegisteredDirectOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=rwlk_RegisteredDirectOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=rwlk_WarrantExerciseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=rwlk_WarrantExerciseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=rwlk_InvestmentAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=rwlk_InvestmentAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=rwlk_AtmOfferingProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=rwlk_AtmOfferingProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=rwlk_PublicStockOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=rwlk_PublicStockOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140286962621416">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows used in operating activities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (12,976)<span></span>
</td>
<td class="num">$ (15,551)<span></span>
</td>
<td class="num">$ (21,675)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">285<span></span>
</td>
<td class="nump">321<span></span>
</td>
<td class="nump">463<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation to employees and non-employees</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">749<span></span>
</td>
<td class="nump">1,108<span></span>
</td>
<td class="nump">2,766<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(44)<span></span>
</td>
<td class="num">(57)<span></span>
</td>
<td class="num">(107)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain on PPP forgiveness</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(392)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_GainsLossesOnInducementOfDebt1', window );">Loss on inducement of debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_FinancialExpensesRelatedToLongTermLoan', window );">Financial expenses related to long term loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">224<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in assets and liabilities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Trade receivables, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">110<span></span>
</td>
<td class="num">(36)<span></span>
</td>
<td class="nump">322<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses, operating lease right-of-use assets and other assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">166<span></span>
</td>
<td class="nump">64<span></span>
</td>
<td class="nump">734<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(469)<span></span>
</td>
<td class="num">(1,221)<span></span>
</td>
<td class="nump">1,403<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableTrade', window );">Trade payables</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(506)<span></span>
</td>
<td class="nump">370<span></span>
</td>
<td class="nump">492<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities', window );">Employees and payroll accruals</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">197<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="num">(222)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredLiabilities', window );">Deferred revenues and advance from customers</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">264<span></span>
</td>
<td class="nump">176<span></span>
</td>
<td class="nump">283<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities', window );">Operating lease liabilities and other liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">27<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="num">(57)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(12,589)<span></span>
</td>
<td class="num">(14,815)<span></span>
</td>
<td class="num">(14,774)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows used in investing activities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(73)<span></span>
</td>
<td class="num">(22)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(73)<span></span>
</td>
<td class="num">(22)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayment of long-term loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(6,965)<span></span>
</td>
<td class="num">(1,722)<span></span>
</td>
<td class="num">(3,866)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from PPP loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">392<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_IssuanceOfOrdinarySharesInInvestmentAgreement', window );">Issuance of ordinary shares in investment agreement, net of issuance expenses in an amount of $830</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">4,295<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Issuance of ordinary shares in at-the-market offering, net of issuance expenses paid in the amount of $211</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,142<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_ProceedsFromIssuanceofPreFundedWarrants', window );">Issuance of ordinary shares and exercise of pre-funded warrants into ordinary shares in follow-on offering, net of issuance expenses in an amount of $1,505 and net of long-term loan conversion in the amount of $3,600</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[3]</sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">8,140<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_ProceedsFromStockOne', window );">Issuance of ordinary shares in a "best effort" offering, net of issuance expenses in the amount of $686</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">3,684<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_ProceedsFromStockTwo', window );">Issuance of ordinary shares in a "registered direct" offering, net of issuance expenses in the amount of $1,035</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">8,125<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_ProceedsFromOfferingCost', window );">Issuance of ordinary shares in a "best effort" offering, net of issuance expenses in the amount of $1,056</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">4,010<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_ProceedsFromIssuanceOfRegistrationCost', window );">Issuance of ordinary shares in a "registered direct" offering, net of issuance expenses in the amount of $977</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">8,023<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_IssuanceOfOrdinarySharesInWarrantExerciseAgreementNetOfIssuanceExpensesInAmountOf10191', window );">Issuance of ordinary shares in a "warrant exercise" agreement, net of issuance expenses in the amount of $1,019</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">9,966<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Issuance of ordinary shares in a private placement, net of issuance expenses in the amount of $959</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">7,041<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_ExerciseOfPreFundedWarrants', window );">Exercise of pre-funded warrants and warrants</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">4,223<span></span>
</td>
<td class="nump">1,429<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">16,724<span></span>
</td>
<td class="nump">21,482<span></span>
</td>
<td class="nump">9,711<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect', window );">Increase (decrease) in cash, cash equivalents, and restricted cash</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,062<span></span>
</td>
<td class="nump">6,645<span></span>
</td>
<td class="num">(5,076)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, and restricted cash at beginning of period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">16,992<span></span>
</td>
<td class="nump">10,347<span></span>
</td>
<td class="nump">15,423<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, and restricted cash at end of period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">21,054<span></span>
</td>
<td class="nump">16,992<span></span>
</td>
<td class="nump">10,347<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Supplemental disclosures of non-cash flow information</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_RegisteredDirectOfferingsIssuanceCostIncurredNotYetPaid', window );">Expenses related to offerings not yet paid</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">76<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_RepaymentOfLongTermLoanByIssuanceOfUnitsAndPrefundedUnits', window );">Repayment of long-term loan by issuance of units and pre-funded units</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">3,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_CommonStockIssuanceCostsIncurredNotYetPaid', window );">At-the-market offering expenses not yet paid</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_ClassificationOfOtherCurrentAssetsToPropertyAndEquipmentNet', window );">Classification of other current assets to property and equipment, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">98<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">236<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_ClassificationOfInventoryToOtherCurrentAssets', window );">Classification of inventory to other current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">164<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_ClassificationOfInventoryToPropertyAndEquipmentNet', window );">Classification of inventory to property and equipment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">50<span></span>
</td>
<td class="nump">174<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_CashlessExerciseOfPrefundedWarrants', window );">Cashless exercise of pre-funded warrants</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">72<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_InitialRecognitionOfOperatingLeaseRightofuseAssets', window );">Initial recognition of operating lease right-of-use assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">2,099<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_InitialRecognitionOfOperatingLeaseLiabilities', window );">Initial recognition of operating lease liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="num">(2,249)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosures of cash flow information:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_SupplementalCashFlowCashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">20,350<span></span>
</td>
<td class="nump">16,253<span></span>
</td>
<td class="nump">9,546<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_RestrictedCashIncludedInOtherNoncurrentAssets', window );">Restricted cash included in other long term assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">704<span></span>
</td>
<td class="nump">739<span></span>
</td>
<td class="nump">801<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_CashAndCashEquivalentsRestrictedCashAndRestrictedCashEquivalent', window );">Total Cash, cash equivalents, and restricted cash</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">21,054<span></span>
</td>
<td class="nump">16,992<span></span>
</td>
<td class="nump">10,347<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_SupplementalDisclosuresOfCashFlowInformation', window );"><strong>Supplemental disclosures of cash flow information:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Cash paid for income taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">13<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 862<span></span>
</td>
<td class="nump">$ 1,499<span></span>
</td>
<td class="nump">$ 1,501<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">See note 6.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">See note 10.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">See note 8b.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_CashAndCashEquivalentsRestrictedCashAndRestrictedCashEquivalent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of total cash, cash equivalents, and restricted cash for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_CashAndCashEquivalentsRestrictedCashAndRestrictedCashEquivalent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_CashlessExerciseOfPrefundedWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cashless exercise of pre-funded warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_CashlessExerciseOfPrefundedWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_ClassificationOfInventoryToOtherCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Classification of inventory to other current assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_ClassificationOfInventoryToOtherCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_ClassificationOfInventoryToPropertyAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Classification of Inventory to Property and Equipment, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_ClassificationOfInventoryToPropertyAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_ClassificationOfOtherCurrentAssetsToPropertyAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Classification of other net current assets to property and equipment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_ClassificationOfOtherCurrentAssetsToPropertyAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_CommonStockIssuanceCostsIncurredNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common Stock Issuance Costs Incurred but Not yet Paid</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_CommonStockIssuanceCostsIncurredNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_ExerciseOfPreFundedWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise of pre-funded warrants and warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_ExerciseOfPreFundedWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_FinancialExpensesRelatedToLongTermLoan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Financial expenses related to long term loan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_FinancialExpensesRelatedToLongTermLoan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_GainsLossesOnInducementOfDebt1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss on inducement of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_GainsLossesOnInducementOfDebt1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_InitialRecognitionOfOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Initial recognition of operating lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_InitialRecognitionOfOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_InitialRecognitionOfOperatingLeaseRightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Initial recognition of operating lease right-of-use assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_InitialRecognitionOfOperatingLeaseRightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_IssuanceOfOrdinarySharesInInvestmentAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Issuance of ordinary shares of investment agreement, net of issuance expenses in the amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_IssuanceOfOrdinarySharesInInvestmentAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_IssuanceOfOrdinarySharesInWarrantExerciseAgreementNetOfIssuanceExpensesInAmountOf10191">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Issuance of ordinary shares of warrant exercise, net of issuance expenses in the amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_IssuanceOfOrdinarySharesInWarrantExerciseAgreementNetOfIssuanceExpensesInAmountOf10191</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_ProceedsFromIssuanceOfRegistrationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Issuance of ordinary shares of registered direct, net of issuance expenses in the amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_ProceedsFromIssuanceOfRegistrationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_ProceedsFromIssuanceofPreFundedWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Issuance of ordinary shares and exercise of pre-funded warrants into ordinary shares in follow-on offering, net of issuance expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_ProceedsFromIssuanceofPreFundedWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_ProceedsFromOfferingCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Issuance of ordinary shares in a offering, net of issuance expenses in the amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_ProceedsFromOfferingCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_ProceedsFromStockOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from issuance of stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_ProceedsFromStockOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_ProceedsFromStockTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from issuance of stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_ProceedsFromStockTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_RegisteredDirectOfferingsIssuanceCostIncurredNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>"Registered direct" offerings issuance cost incurred not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_RegisteredDirectOfferingsIssuanceCostIncurredNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_RepaymentOfLongTermLoanByIssuanceOfUnitsAndPrefundedUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Repayment of long term loan by issuance of units and pre-funded units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_RepaymentOfLongTermLoanByIssuanceOfUnitsAndPrefundedUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_RestrictedCashIncludedInOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of restricted cash included in other long term assets for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_RestrictedCashIncludedInOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_SupplementalCashFlowCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents for the preiod.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_SupplementalCashFlowCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_SupplementalDisclosuresOfCashFlowInformation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Supplemental Disclosures of Cash Flow Information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_SupplementalDisclosuresOfCashFlowInformation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableTrade">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableTrade</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change during the period in carrying value for all deferred liabilities due within one year or operating cycle.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140286967685304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Issuance expenses paid</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 1,505<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_IssuanceExpensesOfOfferingSharesAmount', window );">Issuance expenses in an amount</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">3,600<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=rwlk_BestOfferingMember', window );">Best Offering [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Issuance expenses paid</a></td>
<td class="nump">1,056<span></span>
</td>
<td class="nump">686<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=rwlk_RegisteredDirectMember', window );">Registered Direct [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Issuance expenses paid</a></td>
<td class="nump">977<span></span>
</td>
<td class="nump">1,035<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Issuance expenses paid</a></td>
<td class="nump">959<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=rwlk_InvestmentAgreementMember', window );">Investment Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Issuance expenses paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">830<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=rwlk_AtmOfferingProgramMember', window );">Atm Offering Program [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Issuance expenses paid</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 211<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=rwlk_WarrantExerciseMember', window );">Warrant Exercise [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Issuance expenses paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_IssuanceExpensesOfOfferingSharesAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Issuance expenses of offering shares amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_IssuanceExpensesOfOfferingSharesAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=rwlk_BestOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=rwlk_BestOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=rwlk_RegisteredDirectMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=rwlk_RegisteredDirectMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=rwlk_InvestmentAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=rwlk_InvestmentAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=rwlk_AtmOfferingProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=rwlk_AtmOfferingProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=rwlk_WarrantExerciseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=rwlk_WarrantExerciseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140286962171640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GENERAL<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">GENERAL</a></td>
<td class="text"><div style="font: 10pt/1.25 Times New Roman, Times, Serif"><font style="font-weight: bold">NOTE&#160;1:-</font>&#160;&#160;&#160;&#160; <font style="font-weight: bold">GENERAL</font></div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
  <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z73c0f9ba04994c84a372c43778daec8f" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"><br />
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top">a.</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify">
          <div style="font: 10pt Times New Roman, Times, Serif">ReWalk Robotics Ltd. (&#8220;RRL&#8221;, and together with its subsidiaries, the &#8220;Company&#8221;) was incorporated under the laws of the State of Israel on June&#160;20, 2001 and commenced operations on the&#160;same&#160;date.</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 5.65pt">&#160;</div>
  <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zc22defa361944b118ba6d1e12f0f7460" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"><br />
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top">b.</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify">
          <div style="font: 10pt Times New Roman, Times, Serif">RRL has two wholly owned subsidiaries: (i)&#160;ReWalk Robotics Inc. (&#8220;RRI&#8221;) incorporated under the laws of Delaware on February&#160;15, 2012 and (ii)&#160;ReWalk Robotics GMBH. (&#8220;RRG&#8221;) (formerly Argo Medical Technologies GmbH) incorporated under the laws
            of Germany on January&#160;14, 2013.</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif"><br style="line-height: 1.25" />
  </div>
  <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z33476b6ad2094d83a4499124edf1bbae" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"><br />
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top">c.</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify">
          <div style="font: 10pt Times New Roman, Times, Serif">The Company is designing, developing, and commercializing robotic&#160;exoskeletons that allow individuals with mobility impairments or other medical conditions the ability to stand and walk once again. The Company has developed and is continuing
            to commercialize the ReWalk, an exoskeleton designed for individuals with paraplegia that uses its patented tilt-sensor technology and an on-board computer and motion sensors to drive motorized legs that power movement. The ReWalk system
            consists of a light wearable brace support suit which integrates motors at the joints, rechargeable batteries, an array of sensors and a computer-based control system to power knee and hip movement. Additionally, the Company developed and, in
            June 2019, started to commercialize the ReStore following receipt of European Union CE mark and United States Food and Drug Administration (&#8220;FDA&#8221;). The ReStore is a powered, lightweight soft exo-suit intended for use in the rehabilitation of
            individuals with lower limb disability due to stroke. The Company markets and sells its products directly to institutions and individuals and through third-party distributors. The Company sells its products directly primarily in Germany and the
            United States, and primarily through distributors in other markets. In its direct markets, the Company has established relationships with rehabilitation centers and the spinal cord injury community, and in its indirect markets, the Company&#8217;s
            distributors maintain these relationships. RRI markets and sells products mainly in the United States. RRG sell the Company&#8217;s products mainly in Germany and Europe.</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: -36pt; margin-left: 36pt"> <br />
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">During the second quarter of 2020, we have finalized two separate agreements to distribute additional product lines in the U.S. market.
    The Company will be the exclusive distributor of the MediTouch Tutor movement biofeedback systems in the United States and will also have distribution rights for the MYOLYN MyoCycle FES cycles to U.S. rehabilitation clinics and personal sales through
    the U.S. Department of Veterans Affairs (&#8220;VA&#8221;) hospitals. These new products will improve our product offering to clinics as well as patients within the VA as they both have similar clinician and patient profiles.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 5.65pt">&#160;</div>
  <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zd8d054c208944b989ab9ecba87bbe556" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"><br />
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top">d.</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify">
          <div style="font: 10pt Times New Roman, Times, Serif">The Company depends on one contract manufacturer, Sanmina. Reliance on this vendor makes the Company vulnerable to possible capacity constraints and reduced control over component availability, delivery schedules, manufacturing yields and
            costs.</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif"><br style="line-height: 1.25" />
  </div>
  <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zb9e19c9d63534b00a0e37875220c4a2f" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"><br />
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top">e.</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify">
          <div style="font: 10pt Times New Roman, Times, Serif">The worldwide spread of COVID-19 has resulted in a global economic slowdown and is expected to continue to disrupt general business operations until the disease is contained. This has had a negative impact on the Company's sales and results
            of operations during 2020, and the Company expects that it will continue to negatively affect its sales and results of operations, but the Company is currently unable to predict the scale and duration of that impact. As of the date of issuance
            of these financial statements, the Company is not aware of any specific event or circumstance that would require an update of its accounting estimates or judgments or revision of the carrying value of its assets or liabilities. This
            determination may change as new events occur and additional information is obtained. Actual results could differ from our estimates and judgments, and any such differences may be material to our financial statements.</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;<br /></div>
  <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zc4e92d2381e3411498c1d949f78ba407" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"><br />
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top">f.</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify">
          <div style="font: 10pt Times New Roman, Times, Serif">
            <div style="font: 10pt/1.25 Times New Roman, Times, Serif">
              <div style="font: 10pt/1.25 Times New Roman, Times, Serif">For the full year ended December 31 ,2020 the Company incurred a consolidated net loss of $13 million and has an accumulated
                deficit in the total amount of $181.4 million. The Company&#8217;s negative operating cash flow for the full year ended December 31, 2020 was $12.6 million. Our cash and cash equivalent on December 31, 2020 totaled $20.3 million and in subsequent
                warrants exercise transactions the Company received a total of additional $13.2 million in the beginning of 2021. The Company has sufficient funds to support its operation for more than 12 months following the approval of its consolidated
                financial statements for the fiscal year ended December 31, 2020.</div>
            </div>
            <div style="font: 10pt/1.25 Times New Roman, Times, Serif"><br style="line-height: 1.25" />
            </div>
            <div style="font: 10pt/1.25 Times New Roman, Times, Serif">
              <div style="font: 10pt/1.25 Times New Roman, Times, Serif">The Company expect to incur future net losses and our transition to profitability is dependent upon, among other things, the successful development and commercialization of the Company&#8217;s products and product candidates, the achievement of a level of revenues adequate to support
                  the cost structure.&#160;&#160;Until the Company achieve profitability or generate positive cash flows, it will continue to need to raise additional cash. The Company intend to fund future operations through cash on hand, additional private and/or
                  public offerings of debt or equity securities, cash exercises of outstanding warrants or a combination of the foregoing. In addition, the Company may seek additional capital through arrangements with strategic partners or from other
                  sources and will continue to address its cost structure. Notwithstanding, there can be no assurance that the Company will be able to raise additional funds or achieve or sustain profitability or positive cash flows from operations.</div></div></div></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140286965115688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text"><div style="font: 10pt/1.25 Times New Roman, Times, Serif"></div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif"><font style="font-weight: bold">NOTE&#160;2:-</font>&#160;&#160;&#160;&#160; <font style="font-weight: bold">SIGNIFICANT ACCOUNTING POLICIES</font></div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 18pt">The consolidated financial statements are prepared according to United States generally accepted accounting principles (&#8220;U.S. GAAP&#8221;),
    applied on a consistent basis, as follows:</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">&#160;</div>
  <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z0a33e389668f457b9b7e6bf33704bbef" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"><br />
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top">a.</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify">
          <div style="font: 10pt Times New Roman, Times, Serif">Use of Estimates</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">
    <div style="font: 10pt/1.25 Times New Roman, Times, Serif">The preparation of the consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates, judgments, and
      assumptions. The Company&#8217;s management believes that the estimates, judgments, and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts
      of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
      On an ongoing basis, the Company&#8217;s management evaluates estimates, including those related to inventories, fair values of share-based awards and warrants, contingent liabilities, provision for warranty, allowance for doubtful account and sales return
      reserve. Such estimates are based on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. <br />
    </div>
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>

  <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zc0dba15ad360421690d3148bb5e25a82" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"><br />
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top">b.</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify">
          <div style="font: 10pt Times New Roman, Times, Serif">Financial Statements in U.S. Dollars:</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">Since 2015, most of the Company&#8217;s expenses were denominated in United States dollars (&#8220;dollars&#8221;) and the remaining expenses were denominated in New Israeli Shekel (&#8220;NIS&#8221;) and Euros.
    Until 2018 most of the Company&#8217;s revenues were denominated in U.S. dollars and the remainder of our revenues was denominated in euros and British pound whereas in the last two years our Euro revenues are higher than the ones in dollars.&#160; &#160;however, the
    selling prices are linked to the Company&#8217;s price list which is determined in dollars, the budget is managed in dollars, financing activities including loans and cash investments, are made in U.S. dollars and the Company&#8217;s management believes that the
    dollar is the primary currency of the economic environment in which the Company and each of its subsidiaries operate. Thus, the dollar is the Company&#8217;s and its subsidiaries&#8217; functional and reporting currency.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif"><br style="line-height: 1.25" />
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">Accordingly, transactions denominated in currencies other than the functional currency are re-measured to the functional currency in accordance with Accounting Standards Codification
    (&#8220;ASC&#8221;) No. 830, &#8220;Foreign Currency Matters&#8221; at the exchange rate at the date of the transaction or the average exchange rate in the relevant reporting period. At the end of each reporting period, financial assets and liabilities are re-measured to the
    functional currency using exchange rates in effect at the balance sheet date. Non-financial assets and liabilities are re-measured at historical exchange rates. Gains and losses related to re-measurement are recorded as financial income (expense) in
    the consolidated statements of operations as appropriate.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif"><br style="line-height: 1.25" />
  </div>
  <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z3d72edf84d57490a93185381c32117fb" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"><br />
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top">c.</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify">
          <div style="font: 10pt Times New Roman, Times, Serif">Principles of Consolidation:</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 54pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">
    <div style="font: 10pt/1.25 Times New Roman, Times, Serif">
      <div style="font: 10pt/1.25 Times New Roman, Times, Serif">The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, RRI and RRG. All
        intercompany transactions and balances have been eliminated upon consolidation.</div>
    </div>
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center">&#160;&#160;</div>
  <div style="font: 10pt Times New Roman, Times, Serif; clear: both; margin-top: 10pt; margin-bottom: 10pt">


  </div>
  <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zd955c270d10444e99907c61dd04aa49f" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"><br />
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top">d.</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify">
          <div style="font: 10pt Times New Roman, Times, Serif">Cash Equivalents:</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">Cash equivalents are short-term highly liquid investments that are readily convertible to cash with original maturities of three months or less, at the date acquired.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 36pt">&#160;</div>
  <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z5788efea516d48349aa7e6fb3ab915c9" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"><br />
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top">e.</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify">
          <div style="font: 10pt Times New Roman, Times, Serif">Inventories:</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">Inventories are stated at the lower of cost or market value. Inventory reserves are provided to cover risks arising from slow-moving items or technological obsolescence.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">The Company periodically evaluates the quantities on hand relative to historical, current and projected sales volume. Based on this evaluation, an impairment charge is recorded when
    required to write-down inventory to its market value.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-indent: 36pt">Cost is determined as follows:</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">Finished products - on the basis of raw materials and manufacturing costs on an average basis.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">Raw materials - The weighted average cost method.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">
    <div style="font: 10pt/1.25 Times New Roman, Times, Serif">The Company regularly evaluates the ability to realize the value of inventory based on a combination of factors, including historical usage rates and forecasted sales according
      to outstanding backlogs. Purchasing requirements and alternative usage are explored within these processes to mitigate inventory exposure. When recorded, the reserves are intended to reduce the carrying value of inventory to its net realizable value.
      In the years ended December&#160;31, 2020, 2019 and 2018, the Company wrote off inventory in the amount of $215 thousand, $64 thousand, and $562 thousand, respectively. The write off inventory were recorded in cost of revenue. If actual demand for the
      Company&#8217;s products deteriorates, or market conditions are less favorable than those projected, additional inventory reserves may be required.</div>
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">&#160;</div>
  <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z4aa8c8c1d0024f7b92595ce5d2e64e86" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"><br />
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top">f.</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify">
          <div style="font: 10pt Times New Roman, Times, Serif">Related parties transactions and balances:&#160;</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">The Company has a related party shareholder named Yaskawa Electric Corporation (&#8220;YEC&#8221;).</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">In September 2013, the Company entered into a share purchase agreement and a strategic alliance with YEC, pursuant to which YEC has agreed to distribute the Company&#8217;s products, in
    addition to providing sales, marketing, service and training functions, in Japan, China (including Hong-Kong and Macau), Taiwan, South Korea, Singapore and Thailand.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">
    <div style="font: 10pt/1.25 Times New Roman, Times, Serif">
      <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: left">As of December 31, 2020, and 2019, the related party receivable were 0% of trade receivable, net, in both years. Revenues from YEC during
        the years ended December&#160;31, 2020, 2019, and 2018 amounted to $0 thousand, $41 thousand, and $13, respectively.</div>

    </div>
  </div>
  <div style="font: 10pt Times New Roman, Times, Serif; clear: both; margin-top: 10pt; margin-bottom: 10pt">

  &#160;
  <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z05a82daea43b40e2b33b8f576d65c3b7" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"><br />
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top">g.</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify">
          <div style="font: 10pt Times New Roman, Times, Serif">Property and Equipment:</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets at
    the following annual rates:&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
  <table cellspacing="0" cellpadding="0" border="0" align="right" id="z251bfdcae9e14e5e93cd117615991b47" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 75.84%; vertical-align: bottom">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; width: 24.16%; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">%</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 75.84%; vertical-align: top; background-color: #CCEEFF">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Computer equipment</div>
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 24.16%; vertical-align: top; background-color: #CCEEFF">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center">20-33 (mainly 33)</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 75.84%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Office furniture and equipment</div>
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 24.16%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center">6 - 10&#160;(mainly 10)</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 75.84%; vertical-align: top; background-color: #CCEEFF">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Machinery and laboratory equipment</div>
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 24.16%; vertical-align: top; background-color: #CCEEFF">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center">15</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 75.84%; vertical-align: bottom">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Field service units</div>
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 24.16%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center">50</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 75.84%; vertical-align: top; background-color: #CCEEFF">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Leasehold improvements</div>
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 24.16%; vertical-align: top; background-color: #CCEEFF">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center">Over&#160;the&#160;shorter&#160;of&#160;the&#160;lease<br />
            term or estimated useful life</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center; clear: both">&#160;</div>
  <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z9443fa13dcbe4ce6b1b64bf17f939507" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"><br />
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top">h.</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify">
          <div style="font: 10pt Times New Roman, Times, Serif">Impairment of Long-Lived Assets:</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">The Company&#8217;s long-lived assets are reviewed for impairment in accordance with ASC No.&#160;360, &#8220;Property, Plant and Equipment&#8221; whenever events or changes in circumstances indicate that
    the carrying amount of an asset (or asset group) may not be recoverable. Recoverability of assets (or asset group) to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted cash flows expected to be
    generated by the assets. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. During the years ended December&#160;31, 2020,
    2019 and 2018, no impairment losses have been recorded.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif"><br style="line-height: 1.25" />
  </div>
  <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z6146e80aa19e400b986403f2498b419f" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"><br />
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top">i.</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify">
          <div style="font: 10pt Times New Roman, Times, Serif">Restricted cash and Other long-term assets:</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">Other long-term assets include long-term prepaid expenses and restricted cash deposits for offices and cars leasing based upon the term of the remaining restrictions.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">&#160;</div>
  <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z67e623d200a64464ac03f67293e01e52" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"><br />
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top">j.</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify">
          <div style="font: 10pt Times New Roman, Times, Serif">Revenue Recognition:&#160;</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">The Company generates revenues from sales of products. The Company sells its products directly to end customers and through distributors. The Company sells its products to private
    individuals (who finance the purchases by themselves, through fundraising or reimbursement coverage from insurance companies), rehabilitation facilities and distributors.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: -13.5pt; margin-left: 31.5pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">On January 1, 2018, the Company adopted Topic 606 using the modified retrospective method for contracts that were not completed as of January 1, 2018. Under the modified
    retrospective method, the Company recognized the cumulative effect of initially applying the new revenue standard as an adjustment to the opening balance of retained earnings. This adjustment did not have a material impact on the Company consolidated
    financial statements. Results for reporting periods beginning after January 1, 2018 are presented under Topic 606, while prior period amounts are not adjusted and continue to be reported in accordance with the Company historic accounting under Revenue
    Recognition (&#8220;Topic 605&#8221;).</div>
  <div style="font: 10pt Times New Roman, Times, Serif; clear: both; margin-top: 10pt; margin-bottom: 10pt">

  <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 34.2pt">The adoption of Topic 606 represents a change in accounting principle that will provide financial statement readers with enhanced
    revenue recognition disclosures. In accordance with Topic 606, revenue is recognized when obligations under the terms of a contract with the Company customer are satisfied; generally this occurs with the transfer of control of the Company products or
    services. Revenue is measured as the amount of consideration to which the Company expect to be entitled in exchange for transferring products or providing services. To achieve this core principle, the Company applies the following five steps:</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: -13.5pt; margin-left: 31.5pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">1. Identify the contract with a customer</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 72pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt">A contract with a customer exists when (i) the Company enters into a written agreement with a customer that defines each party&#8217;s rights regarding the products or services to be
    transferred and identifies the payment terms related to these products or services, (ii) both parties to the contract are committed to perform their respective obligations, (iii) the contract has commercial substance, and (iv) the Company determines
    that collection of substantially all consideration for products or services that are transferred is probable based on the customer&#8217;s intent and ability to pay the promised consideration. The Company applies judgment in determining the customer&#8217;s
    ability and intention to pay, which is based on a variety of factors including the customer&#8217;s payment history or, in the case of a new customer, published credit and financial information pertaining to the customer.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: -40.5pt; margin-left: 72pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">2. Identify the performance obligations in the contract</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 40.5pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt">Performance obligations promised in a contract are identified based on the products or services that will be transferred to the customer that are both capable of being distinct,
    whereby the customer can benefit from the product or service either on its own or together with other resources that are readily available from the Company, and are distinct in the context of the contract, whereby the transfer of the products or
    services is separately identifiable from other promises in the contract.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 40.5pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">3. Determine the transaction price</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 40.5pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt">The transaction price is determined based on the consideration to which the Company will be entitled in exchange for transferring products or services to the customer. To the
    extent the transaction price is variable, revenue is recognized at an amount equal the consideration to which the Company expects to be entitled. This estimate includes customer sales incentives which are accounted for as a reduction to revenue and
    estimated using either the expected value method or the most likely amount method, depending on the nature of the program.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 40.5pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt">As a result of the Company&#8217;s adoption of this standard, the majority of the amounts that were historically classified as bad debt expense, primarily related to self-payers
    customers, are now considered an implicit price concession in determining net revenue. Accordingly, the Company recognized uncollectible balances associated with self-payers customers as a reduction of the transaction price and therefore as a reduction
    in net revenues when historically these amounts were classified as bad debt expense within general and administrative expenses.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 40.5pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt">Shipping and handling costs charged to customers are included in net sales. Determining the transaction price requires significant judgment, which is discussed by revenue category
    in further detail below.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 40.5pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt">
    <div style="font: 10pt/1.25 Times New Roman, Times, Serif">In practice, the Company does not offer extended payment terms beyond one year to customers.</div>
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif"><br style="line-height: 1.25" />
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">4. Allocate the transaction price to performance obligations in the contract</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: -40.5pt; margin-left: 72pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt">If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. Contracts that contain multiple
    performance obligations require an allocation of the transaction price to each performance obligation based on a relative standalone selling price basis unless a portion of the variable consideration related to the contract is allocated entirely to a
    performance obligation. The Company determines standalone selling price based on the price at which the performance obligation is sold separately.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: -40.5pt; margin-left: 72pt">&#160;&#160;</div>
  <div style="font: 10pt Times New Roman, Times, Serif; clear: both; margin-top: 10pt; margin-bottom: 10pt">

  &#160;<br />
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: -40.5pt; margin-left: 72pt">5. Recognize revenue when or as the Company satisfies a performance obligation</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 40.5pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt">The Company generally satisfies performance obligations at a point in time, once the customer has obtained the legal title to the items purchased or service provided.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 40.5pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt">
    <div style="font: 10pt/1.25 Times New Roman, Times, Serif">For systems sold to rehabilitation facilities, the Company includes training and considers the elements in the arrangement to be a single performance obligation. In accordance
      with ASC 606, the Company has concluded that the training is essential to the functionality of the Company&#8217;s systems. Therefore, the Company recognizes revenue for the system and training only after delivery in accordance with the agreement delivery
      terms to the customer and after the training has been completed.</div>
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 40.5pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt">
    <div style="font: 10pt/1.25 Times New Roman, Times, Serif">For sales of Personal systems to end users, and for sales of Personal or Rehabilitation systems to third party distributors, the Company does not provide training to the end
      user as this training is completed by the Rehabilitation centers or by the distributor that have previously completed the ReWalk Training program. Therefore, the Company recognizes revenue in such sales upon delivery.</div>
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 40.5pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt">Revenue is recognized based on the transaction price at the time the related performance obligation is satisfied by transferring a promised product or service to a customer.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 40.5pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt">The Company generally does not grant a right of return for its products. There have been isolated cases in which the Company experienced a return of its products. Therefore, the
    Company records reductions to revenue for expected future product returns based on the Company&#8217;s historical experience.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 40.5pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt"><u>Disaggregation of Revenues (in thousands)</u></div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 40.5pt">&#160;</div>
  <table cellspacing="0" cellpadding="0" border="0" align="right" id="z244734cb0e59414b81b34ea77097c036" style="font: 10pt Times New Roman, Times, Serif; width: 93%; color: #000000; text-align: left">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="10" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">Year Ended December 31,</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"> 2020</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">2019</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">2018</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Units placed</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">3,620</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">4,385</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">6,237</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Spare parts and warranties</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">773</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">488</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">308</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Total Revenues</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">4,393</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">4,873</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">6,545</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 90pt; clear: both">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt"><u>Units placed</u></div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt">&#160;<br />
    The Company currently offer five products: (1) ReWalk Personal, (2) ReWalk Rehabilitation, (3) ReStore, (4) MyoCycle and (5) MediTouch.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif"><br style="line-height: 1.25" />
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt">ReWalk Personal and ReWalk Rehabilitation are units for spinal cord injuries (&#8220;SCI Products&#8221;). SCI Products are currently designed for everyday use by paraplegic individuals at
    home and in their communities, and are custom fitted for each user, as well as for use by paraplegia patients in the clinical rehabilitation environment, where they provide individuals access to valuable exercise and therapy. ReWalk Rehabilitation
    current design is dated and will not be produced in the future.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif"><br style="line-height: 1.25" />
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt">ReStore is a powered, lightweight soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation
    environment.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif"><br style="line-height: 1.25" />
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt">MyoCycle which uses Functional Electrical Stimulation (&#8220;FES&#8221;) technology and MediTouch tutor movement biofeedback devices (&#8220;Distributed Products&#8221;).&#160; The Company markets the
    Distributed Products in the United States for use at home or in clinic.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt"> <br />
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt">&#160;&#160;&#160;Units placed includes revenue from sales of SCI Products, ReStore and Distributed Products.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt"> <br />
  </div>
  <div style="font: 10pt Times New Roman, Times, Serif; clear: both; margin-top: 10pt; margin-bottom: 10pt">
      <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt"> <br />
  </div>
  <br />
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt">For units placed, the Company recognizes revenues when it transfers control and title has passed to the customer.&#160; Each unit placed is considered an independent, unbundled
    performance obligation. The Company also offers a rent-to-purchase model in which the Company recognizes revenue ratably according to the agreed rental monthly fee.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif"><br style="line-height: 1.25" />
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt"><u>Spare parts and warranties</u></div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt">Spare parts are sold to private individuals, rehabilitation facilities and distributors. Revenue is recognized when the Company satisfies a performance obligation by transferring
    control over promised goods or services to the customer. Each part sold is considered an independent, unbundled performance obligation.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif"><br style="line-height: 1.25" />
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt">Warranties are classified as either assurance type or service type warranty. A warranty is considered an assurance type warranty if it provides the consumer with assurance that the
    product will function as intended for a limited period of time.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif"><br style="line-height: 1.25" />
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt">In the beginning of 2018, the Company updated its service policy for SCI Products to include a five- year warranty compared to a period of two years that were included in the past
    for parts and services. The first two years are considered as assurance type warranty and the additional period is considered an extended service arrangement, which is a service type warranty. An assurance type warranty is not accounted for as separate
    performance obligations under the revenue model. A service type warranty is either sold with a unit or separately for units for which the warranty has expired. Revenue is then recognized ratably over the life of the warranty.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif"><br style="line-height: 1.25" />
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt">The ReStore device is offered with a two-year warranty which is considered as assurance type warranty.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif"><br style="line-height: 1.25" />
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt">The Distributed Products are offered with assurance type warranty ranging between one year to ten years depending on the specific product and part.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif"><br style="line-height: 1.25" />
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt">
    <div style="font: 10pt/1.25 Times New Roman, Times, Serif"><u>Contract balances</u><u> (in thousands)</u></div>
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 40.5pt">&#160;</div>
  <table cellspacing="0" cellpadding="0" border="0" align="right" id="z5c799b2fe8f0464797acfbb534d43627" style="font: 10pt Times New Roman, Times, Serif; width: 93%; color: #000000; text-align: left">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">&#160;</td>
        <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">December 31,</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">&#160;</td>
        <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">December 31,</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"> 2020</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">2019</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Trade receivable, net (1)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">684</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">794</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Deferred revenues (1) (2)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">1,108</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">844</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 72pt; clear: both">&#160;</div>
  <table cellspacing="0" cellpadding="0" border="0" align="right" id="z17cb99861cfd43fcbaa9360391eba714" style="font: 10pt Times New Roman, Times, Serif; width: 93%; color: #000000; text-align: left">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 3.85%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(1)</div>
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 96.15%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">Balance presented net of unrecognized revenues that were not yet collected.</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 72pt; clear: both">&#160;</div>
  <table cellspacing="0" cellpadding="0" border="0" align="right" id="z3161792d8d93450192807264069a7a74" style="font: 10pt Times New Roman, Times, Serif; width: 93%; color: #000000; text-align: left">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 3.85%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(2)</div>
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 96.15%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">$330 thousand of December&#160;31, 2019 deferred revenues balance were recognized as revenues during the year ended December 31, 2020.</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 40.5pt; clear: both">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt"><u>Typical timing of payment</u></div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 43.2pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt">Deferred revenue is comprised mainly of unearned revenue related to service type warranty but also includes other offerings for which the Company has been paid in advance and earns
    revenue when the Company transfers control of the product or service.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif"><br style="line-height: 1.25" />
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt">The Company&#8217;s unfilled performance obligations as of December 31, 2020 and the estimated revenue expected to be recognized in the future related to the service type warranty
    amounts to $1,108 thousand, which is fulfilled over one to five years. &#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt">&#160;</div>
  <div style="font: 10pt Times New Roman, Times, Serif; clear: both; margin-top: 10pt; margin-bottom: 10pt">

  &#160;
  <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z6ad9a3b4411a480fb5186fe382453b4c" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"><br />
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top">k.</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify">
          <div style="font: 10pt Times New Roman, Times, Serif">Accounting for Share-Based Compensation:</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">The Company accounts for share-based compensation in accordance with ASC No.&#160;718, &#8220;Compensation-Stock Compensation&#8221; (&#8220;ASC No. 718&#8221;). ASC No. 718 requires companies to estimate the
    fair value of equity-based payment awards on the date of grant using an Option-Pricing Model (&#8220;OPM&#8221;). The value of the portion of the award that is ultimately expected to vest is recognized as an expense over the requisite service periods in the
    Company&#8217;s consolidated statements of operations.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">The Company recognizes compensation expenses for the value of its awards granted based on the straight-line method over the requisite service period of each of the awards.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">Effective as of January 1, 2017, the Company adopted Accounting Standards Update 2016-09, &#8220;Compensation-Stock Compensation (Topic 718)&#8221; (&#8220;ASU 2016-09&#8221;) on a modified, retrospective
    basis. ASU 2016-09 permits entities to make an accounting policy election related to how forfeitures will impact the recognition of compensation cost for stock-based compensation: to estimate the total number of awards for which the requisite service
    period will not be rendered or to account for forfeitures as they occur. Upon adoption of ASU 2016-09, the Company elected to change its accounting policy to account for forfeitures as they occur. The change was applied on a modified, retrospective
    basis with a cumulative-effect adjustment to retained earnings of $11 thousand (which increased the accumulated deficit) as of January 1, 2017.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">ASU 2016-09 also eliminates the requirement that excess tax benefits be realized as a reduction in current taxes payable before the associated tax benefit can be recognized as an
    increase in paid in capital. The implementation resulted with no cumulative-effect adjustment to retained earnings as of January 1, 2017.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"> <br />
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 36pt">Additionally, ASU 2016-09 addresses the presentation of excess tax benefits and employee taxes paid on the statement of cash flows. The Company is now required to present excess tax benefits as an
    operating activity on the statement of cash flows rather than as a financing activity. The Company adopted this change prospectively.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif"><br style="line-height: 1.25" />
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">In June 2018, the FASB issued ASU No.&#160;2018-07 Compensation&#8212;Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting. ASU 2018-07 was issued to
    simplify several aspects of the accounting for nonemployee share-based payment transactions resulting from expanding the scope of Topic 718, "Compensation &#8211; Stock Compensation", to include share-based payment transactions for acquiring goods and
    services from nonemployees. The amendments specify that Topic 718 applies to all share-based payment transactions in which a grantor acquires goods or services to be used or consumed in a grantor&#8217;s own operations by issuing share-based payment awards.
    As a result of ASU 2018-07, grants awarded to non-employees are accounted for under ASC 718. The Company adopted ASU 2018-07 as of January 1, 2019. The adoption did not have a material impact on the consolidated financial statements.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">The Company selected the Black-Scholes-Merton option pricing model as the most appropriate fair value method for its share-option awards. The option-pricing model requires a number
    of assumptions, of which the most significant are the fair market value of the underlying ordinary share, expected share price volatility and the expected option term. Expected volatility was calculated based upon certain peer companies that the
    Company considered to be comparable. The expected option term represents the period of time that options granted are expected to be outstanding. The expected option term is determined based on the simplified method in accordance with Staff Accounting
    Bulletin No.&#160;110, as adequate historical experience is not available to provide a reasonable estimate. The simplified method will continue to apply until enough historical experience is available to provide a reasonable estimate of the expected term.
    The risk-free interest rate is based on the yield from U.S. treasury bonds with an equivalent term. The Company has historically not paid dividends and has no foreseeable plans to pay dividends.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">Following the IPO in September 2014, the fair value of ordinary shares is observable as they are publicly traded.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"> <br />
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">The fair value of Restricted Stock Units (RSUs) granted is determined based on the price of the Company&#8217;s ordinary shares on the date of
    grant.<br />
    <div style="font: 10pt Times New Roman, Times, Serif"><br />
    </div>
  </div>
  <div style="font: 10pt Times New Roman, Times, Serif; clear: both; margin-top: 10pt; margin-bottom: 10pt">

  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">The fair value for options granted in 2019, 2018 is estimated at the date of grant using a Black-Scholes-Merton option pricing model with the following assumptions:</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
  <table cellspacing="0" cellpadding="0" border="0" align="right" id="zcfac848f1c7c4ec8be5afff37beb22e7" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="6" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">Year Ended December 31,</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"> 2019</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">2018</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: #CCEEFF; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Expected volatility</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">57.5</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">%</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">57% - 61</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">%</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Risk-free rate</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">2.22</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">%</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">2.74% - 2.83</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">%</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: #CCEEFF; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Dividend yield</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#8212;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">%</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#8212;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">%</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Expected term (in years)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">6.11</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">6.11</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: #CCEEFF; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Share price</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">5.37</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">25.5 - $28.75</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; clear: both">&#160;&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">There were no options granted during the twelve months ended December 31, 2020.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"> <br />
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">The Company accounts for options granted to consultants and other service providers under ASC No. 718.        The fair value of
    these options was estimated using a Black-Scholes-Merton option-pricing model.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">
    <div style="font: 10pt/1.25 Times New Roman, Times, Serif">The non-cash compensation expenses related to employees and non- employees for the years ended December&#160;31, 2020, 2019 and 2018 amounted to $749 thousand, $1,108 thousand, and
      $2,766 thousand, respectively.</div>
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">
    <font lang="AR-SA" dir="rtl" style="font: 10pt Times New Roman,serif; mso-fareast-font-family: Times New Roman">&#160;</font>
    <table cellspacing="0" cellpadding="0" border="0" class="MsoNormalTable" style="font: 10pt Times New Roman, Times, Serif; width: 100%; width: 100%; mso-padding-alt: 0cm 0cm 0cm 0cm">

        <tr style="font: 10pt Times New Roman, Times, Serif; mso-yfti-irow: 0; mso-yfti-firstrow: yes; mso-yfti-lastrow: yes">
          <td style="font: 10pt Times New Roman, Times, Serif; padding: 0cm; width: 24px; vertical-align: top; width: 18pt">
            <p class="MsoNormal" style="font: 10pt/normal Times New Roman, Times, Serif; margin-bottom: 0cm; margin-bottom: 0pt"><font dir="ltr"></font><font dir="ltr"></font><font style="font: 10pt Times New Roman,serif; mso-fareast-font-family: Times New Roman"><font dir="ltr"></font><font dir="ltr"></font>&#160;</font></p>
          </td>
          <td style="font: 10pt Times New Roman, Times, Serif; padding: 0cm; width: 24px; vertical-align: top; width: 18pt">
            <p class="MsoNormal" style="font: 10pt/normal Times New Roman, Times, Serif; margin-bottom: 0cm; margin-bottom: 0pt"><font style="font: 10pt Times New Roman,serif; mso-fareast-font-family: Times New Roman">l.</font></p>
          </td>
          <td style="font: 10pt Times New Roman, Times, Serif; padding: 0cm; vertical-align: top">
            <p class="MsoNormal" style="font: 10pt/normal Times New Roman, Times, Serif; margin-bottom: 0cm; margin-bottom: 0pt"><font style="font: 10pt Times New Roman,serif; mso-fareast-font-family: Times New Roman">Warrants to Acquire
                Ordinary Shares:</font></p>
          </td>
        </tr>

    </table>
    <p class="MsoNormal" style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0cm 0cm 0pt 36pt"><font lang="AR-SA" dir="rtl" style="font: 10pt Times New Roman,serif; mso-fareast-font-family: Times New Roman">&#160;</font></p>
    <p class="MsoNormal" style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0cm 0cm 0pt 36pt"><font style="font: 10pt Times New Roman,serif; mso-fareast-font-family: Times New Roman">D</font><font style="font: 10pt Times New Roman,serif; mso-fareast-font-family: Times New Roman; mso-bidi-language: HE">uring
    the twelve-month ended</font><font style="font: 10pt Times New Roman,serif; mso-fareast-font-family: Times New Roman"> 31,
    2020, and 2019, respectively, the Company issued warrants to acquire up to </font><font dir="rtl"></font><font dir="rtl"></font><font lang="HE" dir="rtl" style="font: 10pt Times New Roman,serif; mso-fareast-font-family: Times New Roman; mso-bidi-language: HE"><font dir="rtl"></font><font dir="rtl"></font>11,389,555</font><font dir="ltr"></font><font dir="ltr"></font><font style="font: 10pt Times New Roman,serif; mso-fareast-font-family: Times New Roman"><font dir="ltr"></font><font dir="ltr"></font>
    and </font><font dir="rtl"></font><font dir="rtl"></font><font lang="HE" dir="rtl" style="font: 10pt Times New Roman,serif; mso-fareast-font-family: Times New Roman; mso-bidi-language: HE"><font dir="rtl"></font><font dir="rtl"></font>2,522,284</font><font dir="ltr"></font><font dir="ltr"></font><font style="font: 10pt Times New Roman,serif; mso-fareast-font-family: Times New Roman"><font dir="ltr"></font><font dir="ltr"></font>
    ordinary shares. The Company assessed the warrants pursuant to ASC 480 "Distinguishing Liabilities from Equity" and ASC 815
    "Derivatives and Hedging" and determine that the warrants should be accounted for as equity and not as a derivative
    liability. Refer to Note </font><font dir="rtl"></font><font dir="rtl"></font><font lang="HE" dir="rtl" style="font: 10pt Times New Roman,serif; mso-fareast-font-family: Times New Roman; mso-bidi-language: HE"><font dir="rtl"></font><font dir="rtl"></font>8</font><font style="font: 10pt Times New Roman,serif; mso-fareast-font-family: Times New Roman; mso-bidi-language: HE">f</font><font style="font: 10pt Times New Roman,serif; mso-fareast-font-family: Times New Roman">
    for additional information.<font style="mso-spacerun: yes">&#160;&#160; </font></font></p>
    </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"> <br />
  </div>
  <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z8db205dbbcfb4efaa93a391fce4c3d64" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"><br />
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top">m.</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify">
          <div style="font: 10pt Times New Roman, Times, Serif">Research and Development Costs:</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">Research and development costs are charged to the consolidated statement of operations as incurred and are presented net of the amount of any grants the company receive for research
    and development in the period in which the grant was received.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">&#160;</div>
  <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z842b410387424176bf5d892651c42ab0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"><br />
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top">n.</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify">
          <div style="font: 10pt Times New Roman, Times, Serif">Income Taxes</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">The Company accounts for income taxes in accordance with ASC No.&#160;740, &#8220;Income Taxes&#8221; (&#8220;ASC No. 740&#8221;), using the liability method whereby deferred tax assets and liability account
    balances are determined based on the differences between financial reporting and the tax basis for assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The
    Company provides a valuation allowance, if necessary, to reduce deferred tax assets to the amounts that are more likely-than-not to be realized.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">ASC No. 740 contains a two-step approach to recognizing and measuring a liability for uncertain tax positions. The first step is to evaluate the tax position taken or expected to be
    taken in a tax return by determining if the weight of available evidence indicates that it is more likely than not that, on an evaluation of the technical merits, the tax position will be sustained on audit, including resolution of any related appeals
    or litigation processes. The second step is to measure the tax benefit as the largest amount that is more than 50% likely to be realized upon ultimate settlement. The Company accrues interest and penalties related to unrecognized tax benefits in its
    taxes on income. As of December 31, 2020, and 2019, the Company did not identify any significant uncertain tax positions.&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">&#160;&#160;</div>
  <div style="font: 10pt Times New Roman, Times, Serif; clear: both; margin-top: 10pt; margin-bottom: 10pt">

  </div>
  &#160;
  <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="ze6bf0cf2a2aa4cc3b679ca44928b857c" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"><br />
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top">o.</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify">
          <div style="font: 10pt Times New Roman, Times, Serif">Warranty:</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">The Company provided a two-year standard warranty for its products. In the beginning of 2018, we updated our service policy for new devices sold to include five-year warranties.&#160; The
    Company determined that the first two years of warranty is an assurance-type warranty and records a provision for the estimated cost to repair or replace products under warranty at the time of sale. Factors that affect the Company&#8217;s warranty reserve
    include the number of units sold, historical and anticipated rates of warranty repairs and the cost per repair.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <table cellspacing="0" cellpadding="0" border="0" align="right" id="z24e95ed7a2ee4f738f16153ac66d9200" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">US Dollars<br />
            in<br />
            thousands</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 88%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Balance at December 31, 2019</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">227</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 88%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Provision</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">125</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 88%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Usage</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(212</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 88%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Balance at December 31, 2020</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">140</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; clear: both">&#160;</div>
  <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z1a8f598a777d49a5b354da4c89c73b12" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"><br />
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top">p.</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify">
          <div style="font: 10pt Times New Roman, Times, Serif">Concentrations of Credit Risks:</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash, cash equivalents and trade receivables.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">The Company&#8217;s cash and cash equivalents are deposited in major banks in Israel, the United States and Germany. Such deposits in the United States may be in excess of insured limits
    and are not insured in other jurisdictions. The Company maintains cash and cash equivalents with diverse financial institutions and monitors the amount of credit exposure to each financial institution.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">Concentration of credit risk with respect to trade receivable is primarily limited to a customer to which the Company makes substantial sales.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <table cellspacing="0" cellpadding="0" border="0" align="right" id="z6023b00ba79a4ef29192bf73408506a9" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="6" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">December 31,</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"> 2020</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">2019</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">Customer A</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">15</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">%</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">*</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Customer B</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">15</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">%</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">*</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">Customer C</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">15</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">%</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">*</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">Customer D</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">14</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">%</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">*</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">Customer E</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">12</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">%</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">12</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">%</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">Customer F</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">11</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">%</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">*</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">Customer G</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">*</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">14</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">%</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Customer H</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">*</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">13</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">%</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Customer I</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">*</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">13</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">%</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">Customer J</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">*</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">12</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">%</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">Customer K</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">*</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">12</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">%</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Customer L</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">*</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">12</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">%</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-indent: 36pt; clear: both">&#160;</div>
  <table cellspacing="0" cellpadding="0" border="0" align="right" id="z134b78bbeb3144378ee804552ff51346" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 3.85%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">*)</div>
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 96.15%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">Less than 10%</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-indent: 36pt; clear: both">&#160;&#160;</div>
  <div style="font: 10pt Times New Roman, Times, Serif; clear: both; margin-top: 10pt; margin-bottom: 10pt">

  </div>
  &#160;
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">The Company&#8217;s trade receivables are geographically diversified and derived primarily from sales to customers in various countries, mainly in the United States and Europe.
    Concentration of credit risk with respect to trade receivables is limited by credit limits, ongoing credit evaluation and account monitoring procedures. The Company performs ongoing credit evaluations of its distributors based upon a specific review of
    all significant outstanding invoices. The Company writes off receivables when they are deemed uncollectible and having exhausted all collection efforts. As of December 31, 2020, and 2019 trade receivables are presented net of $102 thousand and $31
    thousand allowance for doubtful accounts, respectively, and net of sales return reserve of $0 thousand and $86 thousand, respectively.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">&#160;</div>
  <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z4e14dd2dffa44865bb3145074fd5b07a" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"><br />
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top">q.</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify">
          <div style="font: 10pt Times New Roman, Times, Serif">Accrued Severance Pay:</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">Pursuant to Israel&#8217;s Severance Pay Law, Israeli employees are entitled to severance pay equal to one month&#8217;s salary for each year of employment, or a portion thereof. All of the
    employees of the RRL elected to be included under section 14 of the Severance Pay Law, 1963 (&#8220;section 14&#8221;). According to this section, these employees are entitled only to monthly deposits, at a rate of 8.33% of their monthly salary, made in their name
    with insurance companies. Payments in accordance with section 14 release the Company from any future severance payments (under the above Israeli Severance Pay Law) in respect of those employees; therefore, related assets and liabilities are not
    presented in the balance sheet.&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">Total Company expenses related to severance pay amounted to $125 thousand, $156 thousand and $169 thousand for the years ended December&#160;31, 2020, 2019 and 2018, respectively.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">&#160;</div>
  <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z6bf8ea3b08384d14b0ccf4afddd571ac" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"><br />
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top">r.</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify">
          <div style="font: 10pt Times New Roman, Times, Serif">Fair Value Measurements:</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the
    asset or liability in an orderly transaction between market participants on the measurement date.&#160; The Company uses a three-tier fair value hierarchy to classify and disclose all assets and liabilities measured at fair value on a recurring basis, as
    well as assets and liabilities measured at fair value on a non-recurring basis, in periods subsequent to their initial measurement.&#160; The hierarchy requires the Company to use observable inputs when available, and to minimize the use of unobservable
    inputs when determining fair value. If a financial instrument uses inputs that fall in different levels of the hierarchy, the instrument will be categorized based upon the lowest level of input that is significant to the fair value calculation. The
    three-tiers are defined as follows:</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt Times New Roman, Times, Serif">
    <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zdcbd6ac918d047b7b0ce02f1923b2381" style="font: 10pt Times New Roman, Times, Serif; width: 100%">

        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
          <td style="font: 10pt Times New Roman, Times, Serif; width: 36pt">&#160;</td>
          <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 27pt">
            <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: left">&#9679;</div>
          </td>
          <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: auto">
            <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: left"><font style="font-weight: bold">Level 1.&#160;</font>Observable inputs based on unadjusted quoted prices in active markets for identical assets or liabilities;</div>
          </td>
        </tr>

    </table>
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
  <div style="font: 10pt Times New Roman, Times, Serif">
    <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zd17ba00465ad44acbc00c8c632d833f1" style="font: 10pt Times New Roman, Times, Serif; width: 100%">

        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
          <td style="font: 10pt Times New Roman, Times, Serif; width: 36pt">&#160;</td>
          <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 27pt">
            <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: left">&#9679;</div>
          </td>
          <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: auto">
            <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: left"><font style="font-weight: bold">Level 2.&#160;</font>Inputs, other than quoted prices in active markets, that are observable either directly or indirectly; and</div>
          </td>
        </tr>

    </table>
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
  <div style="font: 10pt Times New Roman, Times, Serif">
    <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z7971363fdc984e908a793fa67f2f12af" style="font: 10pt Times New Roman, Times, Serif; width: 100%">

        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
          <td style="font: 10pt Times New Roman, Times, Serif; width: 36pt">&#160;</td>
          <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 27pt">
            <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: left">&#9679;</div>
          </td>
          <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: auto">
            <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: left"><font style="font-weight: bold">Level 3.&#160;</font>Unobservable inputs for which there is little or no market data requiring the Company to develop its own assumptions.</div>
          </td>
        </tr>

    </table>
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">The carrying amounts of cash and cash equivalents, short term deposits, trade receivables and trade payables approximate their fair value due to the short-term maturity of such
    instruments.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;&#160;</div>
  <div style="font: 10pt Times New Roman, Times, Serif; clear: both; margin-top: 10pt; margin-bottom: 10pt">

  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center"><br />
  </div>
  <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z147735070f9745478837e094cfe351cf" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"><br />
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top">s.</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify">
          <div style="font: 10pt Times New Roman, Times, Serif">Basic and Diluted Net Loss Per Share:</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">Basic net loss per share is computed by dividing the net loss by the weighted-average number of shares of ordinary shares outstanding during the period.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">Diluted net loss per share is computed by giving effect to all potential shares of ordinary shares, including stock options, convertible preferred share warrants, to the extent
    dilutive, all in accordance with ASC No.&#160;260, &#8220;Earning Per Share&#8221;.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">The following table sets forth the computation of the Company&#8217;s basic and diluted net loss per ordinary share (in thousands, except share and per share data):</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <table cellspacing="0" cellpadding="0" border="0" align="right" id="zf3292f75d1664a6e9a65631d4d24c1c5" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="10" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">Year ended December 31,</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"> 2020</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">2019</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">2018</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Net loss</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(12,976</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(15,551</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(21,675</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Net loss attributable to ordinary shares</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(12,976</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(15,551</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(21,675</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Shares used in computing net loss per ordinary shares, basic and diluted</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">15,764,980</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">5,763,317</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">1,472,499</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Net loss per ordinary share, basic and diluted</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(0.82</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(2.70</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(14.72</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt; clear: both">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">
    <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: left">Basic and diluted net loss per share was the same for each period presented as the inclusion of all potential shares of ordinary shares and
      warrants outstanding would have been anti-dilutive.</div>
    <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
  </div>
  <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z84c18d6253bf4238bc62601cb23e7efb" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"><br />
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top">t.</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify">
          <div style="font: 10pt Times New Roman, Times, Serif">Contingent liabilities</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">The Company accounts for its contingent liabilities in accordance with ASC No.&#160;450, &#8220;Contingencies&#8221;. A provision is recorded when it is both probable that a liability has been
    incurred and the amount of the loss can be reasonably estimated.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">With respect to legal matters, provisions are reviewed and adjusted to reflect the impact of negotiations, estimated settlements, legal rulings, advice of legal counsel and other
    information and events pertaining to a particular matter.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"> <br />
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">See note 7e for further information.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif"><br style="line-height: 1.25" />
  </div>
  <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z4e6e8ddef3724ce7868cf6b53b989b16" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"><br />
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top">u.</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify">
          <div style="font: 10pt Times New Roman, Times, Serif">Government grants</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">Government grants received by the Company relating to categories of operating expenditures are credited to the consolidated statements of operations during the period in which the
    expenditure to which they relate is charged. Royalty and non-royalty-bearing grants from the Israel Innovation Authority, or the IIA, (formerly known as the Israeli Office of the Chief Scientist), from the Israel-U.S. Binational Industrial Research and
    Development Foundation (&#8220;BIRD&#8221;) and from the Israeli Fund for Promoting Overseas Marketing for funding certain approved research and development projects and sales and marketing activities are recognized at the time when the Company is entitled to such
    grants, on the basis of the related costs incurred, and are included as a deduction from research and development or sales and marketing expenses (see Note&#160;7c).</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">No royalty-bearing grants were recorded for the years ended December 31, 2020, and December 31, 2019, the Company received royalty-bearing grants in the amount of $198 thousand for
    the year ended December 31, 2018, as part of the research and development expenses.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif"><br style="line-height: 1.25" />
  </div>
  <div style="font: 10pt Times New Roman, Times, Serif; clear: both; margin-top: 10pt; margin-bottom: 10pt">

  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;<br />
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">Total Company expenses related to royalties amounted to $46 thousand, $15 thousand for the years ended December&#160;31, 2020, 2019, respectively, no royalty expenses were recorded for
    the year ended December&#160;31, 2018.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif"><br style="line-height: 1.25" />
  </div>
  <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zedb0b2f971494d55a06e892aae3c3b76" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"><br />
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top">v.</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify">
          <div style="font: 10pt Times New Roman, Times, Serif">New Accounting Pronouncements</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: italic 10pt/1.25 Times New Roman, Times, Serif; text-indent: 36pt">Recently Implemented Accounting Pronouncements</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif"><br style="line-height: 1.25" />
  </div>
  <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z53e58c161f4e4c0d9e1cfc8d00371b44" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 72pt"><br />
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 36pt; vertical-align: top">i.</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top">
          <div style="font: 10pt Times New Roman, Times, Serif">Leases:</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">In February 2016, the FASB&#160;issued Accounting Standard Update, or ASU, No. 2016-02, Leases (Topic 842), to enhance the transparency and comparability of financial reporting related to
    leasing arrangements. The Company adopted the standard effective January 1, 2019. At the inception of an arrangement, the Company determines whether the arrangement is or contains a lease based on the unique facts and circumstances present. Operating
    lease liabilities and their corresponding right-of-use assets are recorded based on the present value of lease payments over the expected lease term. The interest rate implicit in lease contracts is typically not readily determinable. As such, the
    Company utilizes its incremental borrowing rate, which is the rate incurred to borrow on a collateralized basis over a similar term an amount equal to the lease payments in a similar economic environment.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">Prior to the Company&#8217;s adoption of ASU 2016-02, when its lease agreements contained rent payment relief and rent escalation clauses, the Company recorded a deferred rent asset or
    liability equal to the difference between the rent expense and the future minimum lease payments due. Operating leases are recognized on the balance sheet as right-of-use assets, current maturities of operating leases and noncurrent operating lease
    liabilities.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">The Company used the modified retrospective transition method, under which the Company applied the standard as a cumulative effect adjustment to each lease that had commenced as of
    the beginning of January 1, 2019 and did not apply the standard to comparative historical periods. In addition, the Company elected to apply the package of practical expedients permitted under the transition guidance, which among other things, allowed
    the Company to carry forward the historical lease classification. The Company has elected, as of the adoption date, not to reassess whether expired or existing contracts contain leases under the new definition of a lease, not to reassess the lease
    classification for expired or existing leases, and not to reassess whether previously capitalized initial direct costs would qualify for capitalization under ASC 842.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">
    <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Leases with an initial term of 12 months or less are not recorded on the balance sheet. The Company recognizes the lease expense
      for such leases on a straight-line basis in the statement of operations over the lease term. As a result, the Company no longer recognizes deferred rent on the balance sheet.</div>
    <div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 36pt"> <br />
    </div>
    <div style="font: 10pt/1.25 Times New Roman, Times, Serif">The Company has elected to apply the practical expedient and combine lease and non-lease components.&#160; <br />
    </div>
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">Upon adoption of this
  standard on January 1, 2019, the Company recorded right&#8211;of&#8211;use assets and corresponding lease liabilities
  of&#160;$2,099&#160;thousand and&#160;$2,249 thousand, respectively. As of&#160;December&#160;31, 2020, the
  right&#8211;of&#8211;use assets and corresponding lease liabilities in the Company&#8217;s consolidated balance sheets
  were&#160;$1,349 thousand&#160;and&#160;$1,583 thousand, respectively. The adoption of this standard did not have a material impact
  on the Company&#8217;s consolidated statements of operations or cash flows. See also note 7b - Lease commitment.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif"><br style="line-height: 1.25" />
  </div>
  <div style="font: 10pt Times New Roman, Times, Serif; clear: both; margin-top: 10pt; margin-bottom: 10pt">

  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif"><br style="line-height: 1.25" />
  </div>
  <div style="font: italic 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt">Recent Accounting Pronouncements Not Yet Adopted</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif"><br style="line-height: 1.25" />
  </div>
  <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z50e182fa759e4e5db0765d46b3042523" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 70.8pt"><br />
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 36pt; vertical-align: top">i.</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top">
          <div style="font: 10pt Times New Roman, Times, Serif">Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif"><br style="line-height: 1.25" />
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">In August 2020, the FASB issued ASU No. 2020-06, Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity (ASU&#160; 2020-06), which simplifies the accounting for
    certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts in an entity&#8217;s own equity.&#160; Among other changes, ASU 2020-06 removes from GAAP the liability and equity separation model for
    convertible instruments with a cash conversion feature and a beneficial conversion feature, and as a result, after adoption, entities will no longer separately present in equity an embedded conversion feature for such debt. Similarly, the embedded
    conversion feature will no longer be amortized into income as interest expense over the life of the instrument. Instead, entities will account for a convertible debt instrument wholly as debt unless (1) a convertible instrument contains features that
    require bifurcation as a derivative under ASC Topic 815, Derivatives and Hedging, or (2) a convertible debt instrument was issued at a substantial premium. Additionally, ASU 2020-06 requires the application of the if-converted method to calculate the
    impact of convertible instruments on diluted earnings per share (EPS). ASU&#160; 2020-06 is effective for fiscal years beginning after December 15, 2021, with early adoption permitted for fiscal years beginning after December 15, 2020 and can be adopted on
    either a fully retrospective or modified retrospective basis. The adoption of this standard is not expected to result in a material impact to the Company&#8217;s financial statements.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif"><br style="line-height: 1.25" />
  </div>
  <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z70dbcad0e59447bfa3b078cc6c5a1e76" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 70.8pt"><br />
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 36pt; vertical-align: top">ii.</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top">
          <div style="font: 10pt Times New Roman, Times, Serif">Financial Instruments&#160;</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif"><br style="line-height: 1.25" />
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">In June 2016, FASB issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. ASU 2016-13 amends the impairment
    model to utilize an expected loss methodology in place of the currently used incurred loss methodology, which will result in the more timely recognition of losses. Topic 326 was adopted by the Company on January 1, 2020. The adoption did not have a
    material impact on the Company&#8217;s consolidated financial statements.</div></div></div></div></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140286962149464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PREPAID EXPENSES AND OTHER CURRENT ASSETS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract', window );"><strong>Prepaid Expense and Other Assets, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_PrepaidExpenseAndOtherAssetsDisclosureTextBlock', window );">PREPAID EXPENSES AND OTHER CURRENT ASSETS</a></td>
<td class="text"><div style="font: 10pt/1.25 Times New Roman, Times, Serif"><font style="font-weight: bold">NOTE&#160;3:-</font>&#160;&#160;&#160; <font style="font-weight: bold">PREPAID EXPENSES AND OTHER CURRENT ASSETS</font></div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-indent: 36pt">The components of prepaid expenses and other current assets are as follows (in thousands):</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
  <table cellspacing="0" cellpadding="0" border="0" align="right" id="zc6efca7e7e844e46a25c6bd8d55ca9ea" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="6" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">December 31,</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"> 2020</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">2019</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Government institutions</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">87</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">175</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Prepaid expenses</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">311</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">318</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Advances to vendors</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">241</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">246</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Other assets</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">33</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">164</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">672</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">903</div></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_PrepaidExpenseAndOtherAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for prepaid expenses and other current assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_PrepaidExpenseAndOtherAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140286962080952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">INVENTORIES</a></td>
<td class="text"><div style="font: 10pt/1.25 Times New Roman, Times, Serif"><font style="font-weight: bold">NOTE&#160;4:-</font>&#160;&#160;&#160;&#160; <font style="font-weight: bold">INVENTORIES</font></div>
  <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-indent: 36pt">The components of inventories are as follows (in thousands):</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-indent: 36pt">&#160;</div>
  <table cellspacing="0" cellpadding="0" border="0" align="right" id="z4334ea3338be48a1a507c3302b556507" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="6" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">December 31,</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"> 2020</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">2019</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Finished products</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">2,764</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">2,394</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Raw materials</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">778</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">729</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">3,542</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">3,123</div></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140286962240632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT, NET<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">PROPERTY AND EQUIPMENT, NET</a></td>
<td class="text"><div style="font: 10pt/1.25 Times New Roman, Times, Serif"><font style="font-weight: bold">NOTE&#160;5:-</font>&#160;&#160;&#160; <font style="font-weight: bold">PROPERTY AND EQUIPMENT, NET</font></div>
  <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-indent: 36pt">The components of property and equipment, net are as follows (in thousands):</div>
  <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
  <table cellspacing="0" cellpadding="0" border="0" align="right" id="z40bab54ebb0e4397aeb5637d012e1e87" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="6" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">December 31,</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"> 2020</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">2019</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Cost:</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Computer equipment</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">725</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">723</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Office furniture and equipment</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">298</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">293</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Machinery and laboratory equipment</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">612</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">604</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Field service units</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">1,626</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">1,420</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Leasehold improvements</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">333</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">333</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">3,594</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">3,373</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; clear: both">&#160;</div>
  <table cellspacing="0" cellpadding="0" border="0" align="right" id="z840539bb6b7f46bea160bf1f1c4d9228" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="6" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">December 31,</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"> 2020</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">2019</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Accumulated depreciation</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">3,157</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">2,872</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Property and equipment, net</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">437</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">501</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; clear: both">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt">Depreciation expenses amounted to $285 thousand, $321 thousand, and $463 thousand for the years ended December&#160;31, 2020, 2019 and 2018, respectively.&#160;</div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140286966557688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LOAN AGREEMENT WITH KREOS AND RELATED WARRANT TO PURCHASE ORDINARY SHARES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_DisclosureofTermLoansandWarrantstoPurchaseOrdinarySharesTextBlock', window );">LOAN AGREEMENT WITH KREOS AND RELATED WARRANT TO PURCHASE ORDINARY SHARES</a></td>
<td class="text"><div style="font: bold 10pt/1.25 Times New Roman, Times, Serif">NOTE&#160;6: -&#160;&#160; LOAN AGREEMENT WITH KREOS AND RELATED WARRANT TO PURCHASE ORDINARY SHARES</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt">On December 30, 2015, the Company entered into the loan agreement (the &#8220;Loan Agreement&#8221;) with Kreos Capital V (Expert Fund) Limited (&#8220;Kreos&#8221;), pursuant to which Kreos extended a line
    of credit to us in the amount of $20 million, with interest payable monthly in arrears on any amounts drawn down at a rate of 10.75% per year from the applicable drawdown date through the date on which all principal is repaid. As of June 30, 2017, the
    Company raised more than $20 million in connection with the issuance of its share capital and, therefore, in accordance with the terms of the Loan Agreement, the repayment period was extended from 24 months to 36 months. The principal was also reduced
    in connection with the issuance of the Kreos Convertible Note on June 9, 2017. Pursuant to the Loan Agreement, we granted Kreos a first priority security interest over all of our assets, including certain intellectual property and equity interests in
    its subsidiaries, subject to certain permitted security interests.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif"><br style="line-height: 1.25" />
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-indent: 36pt">Pursuant to the terms of the warrant, in connection with the $20.0 million drawdown under the Loan Agreement on January 4, 2016, we issued to Kreos the warrant to purchase up to 4,771 of our ordinary
    shares at an exercise price of $241.0 per share, increased to 6,679 ordinary shares on December 28, 2016. Subject to the terms of the warrant, the warrant is exercisable, in whole or in part, at any time prior to the earlier of (i) December 30, 2025,
    or (ii) immediately prior to the consummation of a merger, consolidation, or reorganization of us with or into, or the sale or license of all or substantially all our assets or shares to, any other entity or person, other than a wholly-owned subsidiary
    of us, excluding any transaction in which our shareholders prior to the transaction will hold more than 50% of the voting and economic rights of the surviving entity after the transaction.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-indent: 36pt"><br style="line-height: 1.25" />
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-indent: 36pt">On June 9, 2017, the Company and Kreos entered into the First Amendment, under which $3.0 million of the outstanding principal under the Loan Agreement became subject to repayment pursuant to the senior
    secured Kreos Convertible Note issued on June 9, 2017.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif"><br style="line-height: 1.25" />
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt">&#160;On November 20, 2018, the Company and Kreos entered into the Second Amendment of the Loan Agreement, in which the Company repaid Kreos the $3.6 million other related payments,
    including prepayment costs and end of loan payments, terminating the Kreos Note, by issuing to Kreos 192,000 units and 288,000 pre-funded units as part of an underwritten public offering at the public offering prices, and the parties agreed to revise
    the principal and the repayment schedule under the Kreos Loan. Additionally, Kreos and the Company entered into the Kreos Warrant Amendment, which amended the exercise price of the warrant to purchase 6,679 ordinary shares currently held by Kreos from
    $241.0 to $7.50.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt">On June 5, 2019 and June 6, 2019, the Company entered into warrant exercise agreements with certain institutional investors of warrants to purchase the Company&#8217;s ordinary shares,
    pursuant to which, Kreos agreed to exercise in cash their November 2018 warrants at the existing exercise price of $7.50 per share. Under the exercise agreements, the Company also agreed to issue to Kreos new warrants to purchase up to 480,000 ordinary
    shares at an exercise price of $7.50 per share and exercise period of five years.&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;<br />
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt">On December 29, 2020, the Company repaid in full the remaining loan principal amount to Kreos including the end of loan payments, and by that discharged all of its obligations to
    Kreos and as of December 31, 2020, the outstanding principal amount under the Kreos Loan Agreement was zero.&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif"><br style="line-height: 1.25" />
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt">The Company recorded interest expense in the amount of $907 thousand during the fiscal year ended December&#160;31, 2020.</div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_DisclosureofTermLoansandWarrantstoPurchaseOrdinarySharesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of Term Loans and Warrants to Purchase Ordinary Shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_DisclosureofTermLoansandWarrantstoPurchaseOrdinarySharesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140286966597096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENT LIABILITIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENT LIABILITIES</a></td>
<td class="text"><div style="font: 10pt/1.25 Times New Roman, Times, Serif"><font style="font-weight: bold">NOTE&#160;7:-</font>&#160;&#160;&#160;&#160; <font style="font-weight: bold">COMMITMENTS AND CONTINGENT LIABILITIES</font></div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
  <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z71631782f67c4ba1a807e8892c46a8cd" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"><br />
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top">a.</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify">
          <div style="font: 10pt Times New Roman, Times, Serif">Purchase commitment:</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">The Company has contractual obligations to purchase goods from its contract manufacturer as well as raw materials from different vendors. Purchase obligations do not include
    contracts that may be canceled without penalty. As of December&#160;31, 2020, non-cancelable outstanding obligations amounted to approximately $0.7 million.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z7114fb01bfff49ba95b76036a53bccf9" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"><br />
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top">b.</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify">
          <div style="font: 10pt Times New Roman, Times, Serif">Operating lease commitment:</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: -18pt; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt Times New Roman, Times, Serif">
    <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z98b9924a313d4ceea15de6d760b03ddd" style="font: 10pt Times New Roman, Times, Serif; width: 100%">

        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
          <td style="font: 10pt Times New Roman, Times, Serif; width: 36pt">&#160;</td>
          <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 18pt">
            <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: left">(i)</div>
          </td>
          <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: auto">
            <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"><font style="font-family: Times New Roman,Times,serif">The Company operates from leased facilities in Israel, the United States and Germany. These leases expire between 2021 and 2023. A
                portion of the Company&#8217;s facilities leases is generally subject to annual changes in the Consumer Price Index (CPI). The changes to the CPI are treated as variable lease payments and recognized in the period in which the obligation for
                those payments was incurred.</font></div>
          </td>
        </tr>

    </table>
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 36pt">&#160;&#160;</div>
  <div style="font: 10pt Times New Roman, Times, Serif">
    <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zcbd9492150d64f1f856ef88201ec8098" style="font: 10pt Times New Roman, Times, Serif; width: 100%">

        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
          <td style="font: 10pt Times New Roman, Times, Serif; width: 36pt">&#160;</td>
          <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 18pt">
            <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: left">(ii)</div>
          </td>
          <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: auto">
            <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify"><font style="font-family: Times New Roman,Times,serif">RRL and RRG lease cars for their employees under cancelable operating lease agreements expiring at various dates in between 2021 and
                2023. A subset of the Company&#8217;s cars leases is considered variable. The variable lease payments for such cars leases are based on actual mileage incurred at the stated contractual rate. RRL and RRG have an option to be released from these
                agreements, which may result in penalties in a maximum amount of approximately $26 thousand as of December&#160;31, 2020.</font></div>
          </td>
        </tr>

    </table>
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: -18pt; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">The Company&#8217;s future lease payments for its facilities and cars, which are presented as current maturities of operating leases and non-current operating leases liabilities on the
    Company&#8217;s consolidated balance sheets as of&#160;December&#160;31, 2020&#160;are as follows (in thousands):</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <table cellspacing="0" cellpadding="0" border="0" align="right" id="zdb7695d55aa043a5a1fe0885ee1a4249" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">2021</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">710</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 88%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">2022</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">676</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 88%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">2023</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">491</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 88%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Total lease payments</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">1,877</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 88%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Less: imputed interest</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(294</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 88%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Present value of future lease payments</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">1,583</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Less: current maturities of operating leases</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(660</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 88%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Non-current operating leases</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">923</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Weighted-average remaining lease term (in years)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">2.69</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 88%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Weighted-average discount rate</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">12.6</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">%</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt; clear: both">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">Total rent expenses for the years ended December&#160;31, 2020, 2019 and 2018 were $764 thousand, $739 thousand, and $695 thousand, respectively.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt; margin-left: 36pt">&#160;</div>
  <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zf560b39bfd6e411487b434ff352a82c6" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"><br />
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top">c.</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify">
          <div style="font: 10pt Times New Roman, Times, Serif">Royalties:</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">The Company&#8217;s research and development efforts are financed, in part, through funding from the IIA and BIRD. Since the Company&#8217;s inception through December&#160;31, 2020, the Company
    received funding from the IIA and BIRD in the total amount of $1.97 million and $500 thousand, respectively. Out of the $1.97 million in funding from the IIA, a total amount of $1.57 million were royalty-bearing grants (as of December&#160;31, 2020, the
    Company paid royalties to the IIA in the total amount of $88 thousand), while a total amount of $400 thousand was received in consideration of 209 convertible preferred A shares, which converted after the Company&#8217;s initial public offering in September
    2014 into ordinary shares in a conversion ratio of 1 to 1. The Company is obligated to pay royalties to the IIA, amounting to 3% of the sales of the products and other related revenues generated from such projects, up to 100% of the grants received.
    The royalty payment obligations also bear interest at the LIBOR rate. The obligation to pay these royalties is contingent on actual sales of the applicable products and in the absence of such sales, no payment is required.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"> <br />
  </div>

  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">Additionally, the License Agreement requires the Company to pay Harvard royalties on net sales, See note 9 below for more information about the Collaboration Agreement and the
    License Agreement.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif"><br style="line-height: 1.25" />
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">Royalties expenses in cost of revenue were&#160;$46 thousand and $15 thousand&#160;for the years ended December&#160;31, 2020, and 2019 respectively, no royalties&#8217; expenses recorded for the year
    ended December&#160;31, 2018.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">As of December&#160;31, 2020, the contingent liability to the IIA amounted to $1.6 million. The Israeli Research and Development Law provides that know-how developed under an approved
    research and development program may not be transferred to third parties without the approval of the IIA. Such approval is not required for the sale or export of any products resulting from such research or development. The IIA, under special
    circumstances, may approve the transfer of IIA-funded know-how outside Israel, in the following cases:</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">(a)&#160;the grant recipient pays to the IIA a portion of the sale price paid in consideration for such IIA-funded know-how or in consideration for the sale of the grant recipient itself,
    as the case may be, which portion will not exceed six times the amount of the grants received plus interest (or three times the amount of the grant received plus interest, in the event that the recipient of the know-how has committed to retain the
    R&#38;D activities of the grant recipient in Israel after the transfer); (b)&#160;the grant recipient receives know-how from a third party in exchange for its IIA-funded know-how; (c)&#160;such transfer of IIA-funded know-how arises in connection with certain
    types of cooperation in research and development activities; or (d)&#160;If such transfer of know-how arises in connection with a liquidation by reason of insolvency or receivership of the grant recipient.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif"><br style="line-height: 1.25" />
  </div>
  <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z67642dacf86542d184c5e455ae2e25fb" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"><br />
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top">d.</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify">
          <div style="font: 10pt Times New Roman, Times, Serif">Liens</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt; margin-left: 36pt">&#160;&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 36pt; text-align: justify">As part of the
  Company&#8217;s other long-term assets and restricted cash, an amount of $704 thousand has been pledged as security in
  respect of a guarantee granted to a third party. Such deposit cannot be pledged to others or withdrawn without the consent of
  such third party.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif"><br style="line-height: 1.25" />
  </div>

  <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z2e53269c7f3c45bd88bece20968e6c92" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"><br />
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top">e.</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify">
          <div style="font: 10pt Times New Roman, Times, Serif">Legal Claims:</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: -18pt; margin-left: 36pt">&#160;&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">As previously disclosed,
  between September 2016 and January 2017, eight putative class actions on behalf of alleged shareholders that purchased or
  acquired the Company&#8217;s ordinary shares pursuant and/or traceable to its registration statement on Form F-1 (File No.
  333-197344) used in connection with the Company&#8217;s initial public offering (the &#8220;IPO&#8221;) were commenced in the
  following courts: (i) the Superior Court of the State of California, County of San Mateo; (ii) the Superior Court of the
  Commonwealth of Massachusetts, Suffolk County; (iii) the United States District Court for the Northern District of
  California; and (iv) the United States District Court for the District of Massachusetts. The actions involved claims under
  various sections of the Securities Act and the Exchange Act against the Company, certain of its current and former directors
  and officers, the underwriters of the Company&#8217;s IPO and certain other defendants. The four actions commenced in the
  Superior Court of the State of California, County of San Mateo were dismissed in January 2017 for lack of personal
  jurisdiction, and the action commenced in the United States District Court for the Northern District of California was
  voluntarily dismissed in March 2017. Additionally, the two actions commenced in the Superior Court of the Commonwealth of
  Massachusetts, Suffolk County (he &#8220;Superior Court,&#8221;), were consolidated in December 2017, and voluntarily dismissed with
  prejudice in November 2018, after the District Court for the District of Massachusetts partially dismissed the related claims
  in that court and the parties in the Superior Court entered a stipulation of dismissal with prejudice.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif"><br style="line-height: 1.25" />
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 36pt; text-align: justify">
    <div style="font: 10pt/1.25 Times New Roman, Times, Serif">The action commenced in the United States District Court for the District of Massachusetts (the &#8220;District Court&#8221;), alleging
      violations of Sections 11 and 15 of the Securities Act and Sections 10(b) and 20(a) of the Exchange Act, was partially dismissed in August 2018. In particular, the District Court granted the motion to dismiss the claims under Sections 11 and 15 of
      the Securities Act, finding that the plaintiff failed to plead a false or misleading statement in the IPO registration statement. In May 2019, the court subsequently denied the plaintiff&#8217;s motion to amend to pursue Exchange Act claims and the
      complaint was dismissed. Thereafter, the plaintiff timely appealed to the United States Court of Appeals for the First Circuit, which subsequently affirmed the dismissal and the denial of the plaintiff&#8217;s motion to amend in August 2020. The plaintiff
      did not file a petition for certiorari for appeal of the case to the Supreme Court of the United States by the deadline on November 24, 2020. Thus, as of December 31, 2020, all eight actions had been dismissed, with such judgments being final and non-appealable.</div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140286968623304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHAREHOLDERS' EQUITY<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">SHAREHOLDERS' EQUITY</a></td>
<td class="text"><div style="font: bold 10pt/1.25 Times New Roman, Times, Serif">NOTE&#160;8: - &#160; SHAREHOLDERS&#8217; EQUITY&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
  <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zbce2f39981044abe95f83348d9a27c09" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"><br />
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top">a.</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify">
          <div style="font: 10pt Times New Roman, Times, Serif">Reverse share split:&#160;</div>
        </td>
      </tr>

  </table>
  <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">
    <div style="font: 10pt/1.25 Times New Roman, Times, Serif">On&#160;March&#160;27, 2019, the&#160;Company&#8217;s shareholders approved (i) a reverse share split within a range of 1:8 to 1:32, to be effective at the ratio and on a date to be determined by
      the Board of Directors, and (ii) amendments to the Company&#8217;s Articles of Association authorizing an increase in the Company&#8217;s authorized share capital (and corresponding authorized number of ordinary shares, proportionally adjusting such number for
      the reverse share split) by up to NIS 17.5 million. Following the shareholder approval, an authorized committee of the Board of Directors of the Company approved a one-for-twenty-five reverse share split of the Company&#8217;s ordinary shares, and the
      Company filed the Third Amended and Restated Articles of Association of the Company with the Israeli Corporations Authority to effect the reverse share split and to increase the Company&#8217;s authorized share capital after the effect of the reverse share
      split. The reverse share split became effective on April 1, 2019. Additionally, effective at the same time, the total number of ordinary shares the Company is authorized to issue changed from 250,000,000 shares to 60,000,000 shares, the par value per
      share of the ordinary shares changed to NIS 0.25 and the authorized share capital of the Company changed from NIS 2,500,000 to NIS 15,000,000. All share and per share data included in these consolidated financial statements, for periods before
      December 31, 2019, give retroactive effect to the reverse stock split.</div>
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">Upon the effectiveness of the reverse share split, every twenty-five shares were automatically combined and converted into one ordinary share. Appropriate adjustments were also made
    to all outstanding derivative securities of the Company, including all outstanding equity awards and warrants.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">No fractional shares were issued in connection with the reverse share split. Instead, all fractional shares (including shares underlying outstanding equity awards and warrants) were
    rounded down to the nearest whole number.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;&#160;</div>
  <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z23594874992e43fc97f02f13de087636" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"><br />
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top">b.</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify">
          <div style="font: 10pt Times New Roman, Times, Serif">Equity raise:</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
  <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z964929ec1f6f4ccb991d72651bfdec3f" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"><br />
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top">1.</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify">
          <div style="font: 10pt Times New Roman, Times, Serif">At-the-market offering program:</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">On May 10, 2016, the Company entered into an equity distribution agreement (the &#8220;Equity Distribution Agreement&#8221;) with Piper Jaffray &#38; Co. (&#8220;Piper Jaffray&#8221;), as amended on May 9,
    2019, pursuant to which it may offer and sell, from time to time, ordinary shares having an aggregate offering price of up to $25 million, through Piper Jaffray acting as its agent. Subject to the terms and conditions of the Equity Distribution
    Agreement, Piper Jaffray will use its commercially reasonable efforts to sell on the Company&#8217;s behalf all of the ordinary shares requested to be sold by the Company, consistent with its normal trading and sales practices. Piper Jaffray may also act as
    principal in the sale of ordinary shares under the Equity Distribution Agreement. Sales may be made under the Company&#8217;s shelf registration statement on Form S-3, which was declared effective by the&#160;SEC on&#160;May 9, 2016, or the Company&#8217;s shelf
    registration statement on Form S-3, which was declared effective by the SEC on May 23, 2019 (the &#8220;Form S-3&#8221;), in what may be deemed &#8220;at-the-market&#8221; equity offerings as defined in Rule 415 promulgated under the Securities Act of 1933, as amended (the
    &#8220;ATM Offering Program&#8221;). Sales may be made directly on or through the NASDAQ Capital Market, the existing trading market for the Company&#8217;s ordinary shares, to or through a market maker other than on an exchange or otherwise, in negotiated transactions
    at market prices prevailing at the time of sale or at prices related to such prevailing market prices, and/or any other method permitted by law, including in privately negotiated transactions. Piper Jaffray is entitled to compensation at a fixed
    commission rate of 3.0% of the gross sales price per share sold through it as agent under the Equity Distribution Agreement. Where Piper Jaffray acts as principal in the sale of ordinary shares under the Equity Distribution Agreement, such rate of
    compensation will not apply, but in no event will the total compensation of Piper Jaffray, when combined with the reimbursement of Piper Jaffray for the out-of-pocket fees and disbursements of its legal counsel, exceed 8.0% of the gross proceeds
    received from the sale of the ordinary shares. The Company is not required to sell any of its ordinary shares at any time.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">
    <div style="font: 10pt/1.25 Times New Roman, Times, Serif">From the inception of the ATM Offering Program in May 2016 until December 31, 2020, the Company had sold 302,092 ordinary shares under the ATM Offering Program for gross
      proceeds of $15.7 million and net proceeds to the Company of $14.5 million (after commissions, fees, and expenses). Additionally, as of that date, the Company had paid Piper Jaffray compensation for the fixed commission rate of 3.0% in the aggregated
      amount of $471 thousand and had incurred total expenses (including such commissions) of approximately $1.2 million in connection with the ATM Offering Program.</div>
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z0e6420828f00419fb2d007983c5ac23b" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"><br />
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top">2.</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify">
          <div style="font: 10pt Times New Roman, Times, Serif">Follow-on offerings&#160;&#160;&#160;</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">&#160;&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">In November 2018, the Company entered into an underwriting agreement with H.C. Wainwright &#38; Co., LLC (&#8220;H.C. Wainwright&#8221;), in connection with the Company&#8217;s follow-on public
    offering of 496,055 units, each consisting of one ordinary share and one common warrant to purchase one ordinary share with an exercise price of $7.5 per warrant. Each unit was sold to the public at a price of $7.50 per unit. On November 18, 2018, H.C.
    Wainwright exercised in full its option to purchase 231,964 ordinary shares for $7.25 per share and/or common warrants to purchase up to an additional 231,964 ordinary shares for $0.25 per warrant.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;&#160;&#160;&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">
    <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Additionally, the Company issued and sold 1,050,372 pre-funded units at a price to the public of $7.25 per unit. Each unit containing one pre-funded warrant with an exercise
      price of $0.25 per share and one warrant to purchase one ordinary share with an exercise price of $7.50 per warrant. The total gross proceeds received from the November 2018 follow-on public offering, before deducting commissions, discounts, and
      expenses, were $13.1 million (including proceeds from the exercise of 90,691 pre-funded warrants at the closing of the offering). As of December&#160;31, 2018, additional pre-funded warrants to purchase an aggregate 562,466 ordinary shares had been
      exercised, for additional proceeds of $140,617. During the year ended December 31, 2019 additional 288,000 pre-funded warrants and 296,087 warrants to purchase an aggregate 584,087 ordinary shares had been exercised, for additional proceeds of $1.5
      million. As compensation for their role in the offering, the Company also issued to the Underwriters warrants to purchase up to 106,680 ordinary shares, which became immediately exercisable starting on November 20, 2018 until November 15, 2023 at
      $9.375 per share.</div>
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">&#160;&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">In February 2019, the Company entered into an exclusive placement agent agreement with H.C. Wainwright, on a reasonable best-efforts basis in connection with a public offering of
    760,000 ordinary shares at a price of $5.75 per share.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">
    <div style="font: 10pt/1.25 Times New Roman, Times, Serif">The total gross proceeds received from the February 2019 follow-on public offering, before deducting commissions, discounts, and expenses, were $4.37 million. The Company also
      issued to H.C Wainwright and/or its designees warrants to purchase up to 45,600 ordinary shares, which are immediately exercisable starting on February 25, 2019 until February 21, 2024 at $7.1875 per share.</div>
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">In April 2019, the Company entered into securities purchase agreements with certain institutional purchasers whereby the Company issued 816,914 ordinary shares at $5.2025 per
    ordinary share and warrants to purchase up to 408,457 ordinary shares with an exercise price of $5.14 per share, exercisable from April 5, 2019 until October 7, 2024, in a private placement that took place concurrently with the Company&#8217;s registered
    direct offering of ordinary shares in April 2019. Additionally, the Company issued warrants to purchase up to 49,015 ordinary shares, with an exercise price of $6.503125 per share, exercisable from April 5, 2019 until April 3, 2024, to representatives
    of H.C. Wainwright as compensation for its role as the placement agent in the Company&#8217;s April 2019 registered direct offering and concurrent private placement of warrants.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">On June 5, 2019 and June 6, 2019, the Company entered into warrant exercise agreements with certain institutional investors whereby the Company issued warrants to purchase up to
    1,464,665 ordinary shares with an exercise price of $7.50 per share, exercisable from June 5, 2019 or June 6, 2019 until June 5, 2024 or June 6, 2024, respectively. Additionally, the Company issued warrants to purchase up to 87,880 ordinary shares,
    with an exercise price of $9.375 per share, exercisable from June 5, 2019 until June 5, 2024, to certain representatives of H.C. Wainwright as compensation for its role as the placement agent in the Company&#8217;s June 2019 warrant exercise agreement and
    concurrent private placement of warrants.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif"><br style="line-height: 1.25" />
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">On June 12, 2019, the Company entered into a purchase agreement with certain institutional investors for the issuance and sale of 833,334 ordinary shares, par value NIS 0.25 per
    share&#160;at $6.00 per ordinary share and warrants to purchase up to 416,667 ordinary shares with an exercise price of $6.00 per share, exercisable from June 12, 2019 until December 12, 2024, in a private placement that took place concurrently with the
    Company&#8217;s registered direct offering of ordinary shares in June 2019. Additionally, the Company issued warrants to purchase up to 50,000 ordinary shares, with an exercise price of $7.50 per share, exercisable from June 12, 2019 until June 10, 2024, to
    certain representatives of H.C. Wainwright as compensation for its role as the placement agent in the Company&#8217;s June 2019 registered direct offering and concurrent private placement of warrants.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif"><br style="line-height: 1.25" />
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">
    <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: left">On February 10, 2020, the Company closed a &#8220;best efforts&#8221; public offering whereby the Company issued an aggregate of 5,600,000 of common
      units and pre-funded units at a public offering price of $1.25 per common unit and $1.249 per pre-funded unit. As part of the public offering, the Company entered into a securities purchase agreement with certain institutional purchasers. Each common
      unit consisted of one ordinary share, par value NIS 0.25 per share, and one common warrant to purchase one ordinary share. Each of the 1,546,828 pre-funded unit consisted of one pre-funded warrant to purchase one ordinary share and one common
      warrant. Additionally, the Company issued warrants to purchase up to 336,000 ordinary shares, with an exercise price of $1.5625 per share, to representatives of H.C. Wainwright as compensation for its role as the placement agent in the Company&#8217;s
      February 2020 offering.&#160; During the three months ended March 31, 2020, all pre-funded warrants to purchase ordinary shares were exercised.</div>
    <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">
    <div style="font: 10pt/1.25 Times New Roman, Times, Serif">As of December 31, 2020, a total of 1,831,500 common warrants to purchase ordinary shares were exercised.</div>
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif"><br style="line-height: 1.25" />
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">On July 6,2020, the Company entered into a purchase agreement with certain institutional investors for the issuance and sale of (i) 4,938,278 ordinary shares, par value NIS 0.25 per
    share, at a price of $1.8225 per ordinary share and (ii) warrants to purchase up to 2,469,139 ordinary shares with an exercise price of $1.76 per share, exercisable from July 6, 2020 until January 6, 2026. Additionally, the Company issued warrants to
    purchase up to 296,297 ordinary shares, with an exercise price of $2.2781 per share, exercisable from July 6, 2020 until July 2, 2025, to certain representatives of H.C. Wainwright as compensation for its role as the placement agent in its July 2020
    registered direct offering.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif"><br style="line-height: 1.25" />
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">On December 3,2020, the Company entered into a purchase agreement with certain institutional investors for the issuance and sale of (i) 5,579,776 ordinary shares, par value NIS 0.25
    per share, at a price of $1.4337 per ordinary share and (ii) warrants to purchase up to 4,184,832 ordinary shares with an exercise price of $1.34 per share, exercisable from December 8, 2020 until June 8, 2026. Additionally, the Company issued warrants
    to purchase up to 334,787 ordinary shares, with an exercise price of $1.7922 per share, exercisable from December 8, 2020 until June 8, 2026, to certain representatives of H.C. Wainwright as compensation for its role as the placement agent in its
    December 2020 registered direct offering.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif"><br style="line-height: 1.25" />
  </div>
  <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zf1a1ca111b0c4711a3ec7bf9ad55065d" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"><br />
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top">3.</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify">
          <div style="font: 10pt Times New Roman, Times, Serif">Investment agreement</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">On March 6, 2018, the Company entered into an investment agreement with Timwell Corporation Limited, a Hong Kong corporation (&#8220;Timwell&#8221;), as amended on May 15, 2018 (the &#8220;Investment
    Agreement&#8221;), pursuant to which the Company agreed to issue to Timwell, in three different tranches, an aggregate of 640,000 ordinary shares in return for aggregate gross proceeds of $20 million. The closing of each tranche is subject to certain closing
    conditions. The closing of the first tranche (the &#8220;First Tranche Closing&#8221;) took place on May 15, 2018, upon which Timwell received 160,000 ordinary shares for an aggregate purchase price of $5,000,000, and Timwell and the Company signed a registration
    rights agreement in the form attached to the Investment Agreement. The net aggregate proceeds of the First Tranche Closing after deducting fees and other related expenses in the amount of approximately $705 thousands were approximately $4.3 million.
    The remaining investment is to occur in two tranches, including $10 million for the issuance to Timwell of 320,000 ordinary shares (the &#8220;Second Tranche&#8221;) and $5 million for the issuance to Timwell of 160,000 ordinary shares (the &#8220;Third Tranch&#8221;). The
    closing of the second and third tranches is subject to specified closing conditions, including, with respect to the second tranche, the signing of a license agreement and a supply agreement and the formation of the China JV (the &#8220;China JV&#8221;) based on
    the JV Framework Agreement, and, with respect to the third tranche, the successful production of certain ReWalk products by the China JV. The second tranche closing was initially expected to occur by July 1, 2018 and the third tranche closing was
    initially expected to occur by December 31, 2018 and no later than April 1, 2019.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">In late March 2020, Timwell notified the Company that it would not invest the second and third tranches under the Investment Agreement. In response, in early April 2020, the
    Company&#8217;s Board of Directors also removed Timwell&#8217;s designee, who was appointed pursuant to the Investment Agreement, from the Board of Directors, due to this breach pursuant to the terms of the Investment Agreement. As the Company continues to view
    China as a market with key opportunities for products designed for stroke patients, the Company continues to evaluate potential relationships with other groups to penetrate the Chinese market.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif"><br style="line-height: 1.25" />
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">In May 2018, the Company entered into a fee and release agreement with Canaccord Genuity LLC (&#8220;Canaccord Genuity&#8221;) requiring the Company to pay to Canaccord Genuity, in connection
    with a settlement, in addition to certain cash amounts, (i) $125 thousand in ordinary shares of the Company after the First Tranche Closing of the Timwell transaction and (ii) $225 thousand in ordinary shares of the Company after the closing of the
    Second Tranche of the Timwell transaction (or such lower amount if the Second Tranche Closing is less than $10.0 million). The price per share used for calculation of the number of ordinary shares issued by the Company to Canaccord Genuity is based on
    the volume weighted average price of the Company&#8217;s ordinary shares as reported on the Nasdaq Capital Market for the five consecutive trading days prior to the date of issuance. The Company is also obligated to pay $100 thousand in cash following the
    closing of the Third Tranche of $5.0 million (or such lower amount if the Third Tranche Closing is less than $5.0 million). Following the First Tranche Closing on May 15, 2018, the Company issued 4,715 ordinary shares to Canaccord Genuity.&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt; margin-left: 36pt">&#160;</div>
  <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="za59e12d1ab6b42a189bf8ea686629c55" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"><br />
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top">c.</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify">
          <div style="font: 10pt Times New Roman, Times, Serif">Share option plans:</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">On March&#160;30, 2012, the Company&#8217;s board of directors adopted the ReWalk Robotics Ltd. 2012 Equity Incentive Plan.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt; margin-left: 72pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">On August 19, 2014, the Company&#8217;s board of directors adopted the ReWalk Robotics Ltd. 2014 Incentive Compensation Plan or the &#8220;Plan&#8221;. The Plan provides for the grant of stock
    options, stock appreciation rights, restricted stock awards, restricted stock units, cash-based awards, other stock-based awards and dividend equivalents to the Company&#8217;s and its affiliates&#8217; respective employees, non-employee directors and consultants.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt; margin-left: 72pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">Starting in 2014, the Company&#160;grants to directors and employees also Restricted Stock Units (&#8220;RSUs&#8217;&#8217;) under this Plan. An RSU award is an agreement to issue shares of the company&#8217;s
    ordinary shares at the time the award is vested.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif"><br style="line-height: 1.25" />
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">As of December 31, 2020, and 2019, the Company had reserved 604,320 and 12,409 shares of ordinary shares, respectively, available for issuance to employees, directors, officers, and
    non-employees of the Company.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt; margin-left: 36pt">&#160;&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">The options generally vest over four years, with certain options granted to non-employee directors during the fiscal year ended December&#160;31, 2019, vesting over&#160;one&#160;year.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt; margin-left: 72pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">Any option that is forfeited or canceled before expiration becomes available for future grants under the Plan.</div>

  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt; margin-left: 72pt">&#160;<br />
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">
    <div style="font: 10pt/1.25 Times New Roman, Times, Serif">
      <div style="font: 10pt/1.25 Times New Roman, Times, Serif">A summary of employee and non-employee&#160;shares options activity during the fiscal year ended 2020 is as follows:</div>
    </div>
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 72pt">&#160;</div>
  <table cellspacing="0" cellpadding="0" border="0" align="right" id="z333a780dd513489ea483da9d96b10a52" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">Number</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">Average</div>
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">exercise</div>
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">price</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">Average</div>
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">remaining</div>
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">contractual</div>
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">life (years)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">Aggregate</div>
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">intrinsic</div>
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">value (in</div>
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">thousands)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 52%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Options outstanding at the beginning of the year</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">74,713</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">41.6</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">6.34</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">135</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 52%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Granted</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#8212;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#8212;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#8212;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#8212;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 52%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Exercised</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#8212;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#8212;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#8212;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#8212;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 52%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Forfeited</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(5,107</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">91.59</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#8212;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#8212;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 52%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 52%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Options outstanding at the end of the year</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">69,606</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">37.9</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">5.59</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#8212;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 52%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 52%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Options exercisable at the end of the year</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">52,997</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">43.76</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">4.94</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#8212;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 72pt; clear: both">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">
    <div style="font: 10pt/1.25 Times New Roman, Times, Serif">
      <div style="font: 10pt/1.25 Times New Roman, Times, Serif">A summary of employee and non-employee RSUs activity during the fiscal year ended 2020 is as follows:</div>
    </div>
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">&#160;</div>
  <table cellspacing="0" cellpadding="0" border="0" align="right" id="z08c2cc9952cf4a269ef65b9e027ffd67" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">Number of</div>
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">shares underlying</div>
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">outstanding</div>
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">RSUs</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">Weighted-</div>
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">average</div>
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">grant date</div>
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">fair value</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Unvested RSUs at the beginning of the year</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">62,378</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">44.61</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Granted</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">1,266,185</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">1.44</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Vested</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(63,111</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">7.83</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Forfeited</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(14,141</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">6.05</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Unvested RSUs at the end of the year</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">1,251,311</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">3.20</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; clear: both">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">The weighted average grant date fair values of options granted during the fiscal year ended December&#160;31, 2019, 2018 were $2.98, $15.25, respectively. The weighted average grant date
    fair values of RSUs granted during the fiscal year ended December&#160;31, 2020, 2019 and 2018, were $1.44, $4.67and $26.75, respectively.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">The aggregate intrinsic value in the table above represents the total intrinsic value that would have been received by the option holders had all option holders, which hold options
    with positive intrinsic value, exercised their options on the last date of the exercise period. During the years ended December&#160;31, 2020 and December&#160;31, 2019, no options were exercised. Total fair value of shares vested during the year ended
    December&#160;31, 2020, 2019 and 2018 were $676 thousand, $1,175 thousand, and $2,918 thousand, respectively. As of December&#160;31, 2020, there were $2 million of total unrecognized compensation cost related to non-vested share-based compensation arrangements
    granted under the 2014 Plan. This cost is expected to be recognized over a period of approximately 3.2 years.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 54pt">&#160;</div>
  <br />
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">The number of options and RSUs outstanding as of December&#160;31, 2020 is set forth below, with options separated by range of exercise price:</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 54pt">&#160;</div>
  <table cellspacing="0" cellpadding="0" border="0" align="right" id="z6f11344252224499ad65c066a0b989e8" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif">Range of exercise&#160;price</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">Options and RSUs<br />
            Outstanding as of<br />
            December 31,<br />
            2020</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">Weighted</div>
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">average</div>
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">remaining</div>
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">contractual</div>
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">life (years) (1)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">Options Exercisable as of December 31,<br />
            2020</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">Weighted</div>
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">average</div>
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">remaining</div>
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">contractual</div>
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">life (years) (1)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 52%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">RSUs only</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">1,251,311</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#8212;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#8212;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#8212;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 52%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$5.37</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">12,425</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">8.24</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">5,435</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">8.24</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 52%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$20.42- $33.75</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">36,292</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">5.26</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">27,598</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">4.60</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 52%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$37.14-$38.75</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">9,992</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">2.99</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">9,992</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">2.99</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 52%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$50-$52.5</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">8,231</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">6.43</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">7,306</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">6.44</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 52%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$182.5-$524.25</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">2,666</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">4.84</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">2,666</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">4.84</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 52%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">1,320,917</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">5.59</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">52,997</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">4.94</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; clear: both">&#160;</div>
  <table cellspacing="0" cellpadding="0" border="0" align="right" id="z0880807c2442494481d433b408f422c8" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 3.85%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(1)</div>
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 96.09%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">Calculation of weighted average remaining contractual term does not include the RSUs that were granted, which have an indefinite contractual term.</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; clear: both">&#160;</div>
  <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zf8331be665c64e619344e46cc4d93093" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"><br />
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top">d.</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify">
          <div style="font: 10pt Times New Roman, Times, Serif">Equity compensation issued to consultants:</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">The Company granted 6,680 fully vested RSUs during the fiscal year ended December&#160;31, 2019 to non-employee consultants. As of December&#160;31, 2020, there are no outstanding options or
    RSUs held by non-employee consultants.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif"><br style="line-height: 1.25" />
  </div>
  <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zd31e7a8bb09f4dd380ed3659c480e191" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"><br />
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top">e.</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify">
          <div style="font: 10pt Times New Roman, Times, Serif">Share-based compensation expense for employees and non-employees:</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif"><br style="line-height: 1.25" />
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">
    <div style="font: 10pt/1.25 Times New Roman, Times, Serif">The Company recognized non-cash share-based compensation expense in the consolidated statements of operations as follows (in thousands):</div>
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif"><br style="line-height: 1.25" />
  </div>
  <table cellspacing="0" cellpadding="0" border="0" align="right" id="zedd6cc7efe2d49be877f8a188016ed3a" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="10" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">Year Ended December 31,</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"> 2020</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">2019</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">2018</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Cost of revenues</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">8</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">13</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">16</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Research and development, net</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">136</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">204</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">435</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Sales and marketing, net</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">163</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">166</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">467</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">General and administrative</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">442</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">725</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">1,848</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Total</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">749</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">1,108</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">2,766</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; clear: both"><br style="line-height: 1.25" />
  </div>
  &#160;
  <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zece8f1ea1f6d4bc0a3b21fc81312ccac" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"><br />
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top">f.</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify">
          <div style="font: 10pt Times New Roman, Times, Serif">Warrants to purchase ordinary shares:</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 36pt">The following table summarizes information about warrants outstanding and exercisable as of December&#160;31, 2020:</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-indent: 36pt">&#160;</div>
  <table cellspacing="0" cellpadding="0" border="0" align="right" id="z10fa5c8f5fd64ea58708475ca56d3205" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif">Issuance date</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">Warrants<br />
            outstanding</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">Exercise price per warrant</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">Warrants outstanding and exercisable</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">Contractual<br />
            term</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">(number)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">(number)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center">&#160;</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">December 31, 2015 (1)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">4,771</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">7.500</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">4,771</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center">See footnote (1)</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 32%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">November 1, 2016 (2)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">97,496</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">118.750</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">97,496</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 32%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center">November 1, 2021</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">December 28, 2016 (3)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">1,908</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">7.500</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">1,908</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center">See footnote (1)</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 32%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">November 20, 2018 (4)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">126,839</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">7.500</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">126,839</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 32%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center">November 20, 2023</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">November 20, 2018 (5)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">106,680</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">9.375</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">106,680</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center">November 15, 2023</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 32%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">February 25, 2019 (6)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">45,600</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">7.187</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">45,600</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 32%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center">February 21, 2024</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">April 5, 2019 (7)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">408,457</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">5.140</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">408,457</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center">October 7, 2024</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 32%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">April 5, 2019 (8)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">49,015</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">6.503</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">49,015</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 32%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center">April 3, 2024</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">June 5, 2019 and June 6, 2019 (9)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">1,464,665</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">7.500</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">1,464,665</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center">June 5, 2024</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 32%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">June 5, 2019 (10)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">87,880</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">9.375</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">87,880</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 32%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center">June 5, 2024</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">June 12, 2019 (11)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">416,667</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">6.000</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">416,667</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center">December 12, 2024</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 32%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">June 10, 2019 (12)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">50,000</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">7.500</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">50,000</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 32%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center">June 10, 2024</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">February 10, 2020 (13)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">3,768,500</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">1.250</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">4,343,500</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center">February 10, 2025</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 32%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">February 10, 2020 (14)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">336,000</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">1.5625</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">336,000</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 32%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center">February 10, 2025</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">July 6, 2020 (15)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">2,469,139</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">1.76</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">2,469,139</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center">July 2, 2025</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 32%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">July 6, 2020 (16)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">296,297</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">2.2781</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">296,297</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 32%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center">July 2, 2025</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">December 3, 2020 (17)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">4,184,832</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">1.34</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">4,184,832</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center">June 8, 2026</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 32%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">December 3, 2020 (18)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">334,787</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">1.7922</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">334,787</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 32%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center">June 8, 2026</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">14,249,533</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">14,249,533</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center">&#160;</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt Times New Roman, Times, Serif; clear: both"><br />
  </div>
  <table cellspacing="0" cellpadding="0" border="0" align="right" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 3.88%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(1)</div>
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 96.12%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">Represents warrants for ordinary shares issuable upon an exercise price of $7.5 per share, which were granted on December 31, 2015 to Kreos Capital V (Expert) Fund Limited, or Kreos, in
            connection with a loan made by Kreos to us and are currently exercisable (in whole or in part) until the earlier of (i) December 30, 2025 or (ii) immediately prior to the consummation of a merger, consolidation, or reorganization of us with or
            into, or the sale or license of all or substantially all the assets or shares of us to, any other entity or person, other than a wholly-owned subsidiary of us, excluding any transaction in which the Company&#8217;s shareholders prior to the
            transaction will hold more than 50% of the voting and economic rights of the surviving entity after the transaction. None of these warrants had been exercised as of December 31, 2020.</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; clear: both"></div>
  <table cellspacing="0" cellpadding="0" border="0" align="right" id="ze5403d3ed0b34b878e19f68e7a78deb7" style="font: 10pt Times New Roman, Times, Serif; width: 100%; color: #000000; text-align: left">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; width: 5%; vertical-align: top">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 4%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(2)</div>
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 91%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">Represents warrants issued as part of the Company&#8217;s follow-on offering in November 2016. At any time, the board of directors may reduce the exercise price of the warrants to any amount and for
            any period of time it deems appropriate.</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; width: 5%; vertical-align: top">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 4%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(3)</div>
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 91%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">Represents common warrants that were issued as part of the $8.0 million drawdown under the Loan Agreement which occurred on December 28, 2016. See footnote 1 for exercisability terms.</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; width: 5%; vertical-align: top">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 4%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(4)</div>
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 91%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">Represents common warrants that were issued as part of the Company&#8217;s follow-on offering in November 2018. As of September 30, 2019, warrants to purchase an aggregate 1,651,537 ordinary shares
            had been exercised.</div>
        </td>
      </tr>

  </table>
  <table cellspacing="0" cellpadding="0" border="0" align="right" style="font: 10pt Times New Roman, Times, Serif; width: 100%; color: rgb(0, 0, 0); text-align: left; clear: both">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; width: 5%; vertical-align: top">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 4%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(5)</div>
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 91%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">Represents common warrants that were issued to the underwriters as compensation for their role in the Company&#8217;s follow-on offering in November 2018.</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; width: 5%; vertical-align: top">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 4%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(6)</div>
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 91%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">Represents warrants that were issued to the exclusive placement agent as compensation for its role in the Company&#8217;s follow-on offering in February 2019.</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; width: 5%; vertical-align: top">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 4%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(7)</div>
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 91%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">Represents warrants that were issued to certain institutional purchasers in a private placement in the Company&#8217;s registered direct offering of ordinary shares in April 2019.</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; width: 5%; vertical-align: top">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 4%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(8)</div>
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 91%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">Represents warrants that were issued to the placement agent as compensation for its role in the Company&#8217;s April 2019 registered direct offering.</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; width: 5%; vertical-align: top">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 4%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(9)</div>
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 91%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">Represents warrants that were issued to certain institutional investors in a warrant exercise agreement on June 5, 2019 and June 6, 2019, respectively.</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; width: 5%; vertical-align: top">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 4%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(10)</div>
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 91%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">Represents warrants that were issued to the placement agent as compensation for its role in the Company&#8217;s June 2019 warrant exercise agreement and concurrent private placement of warrants.</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; width: 5%; vertical-align: top">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 4%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(11)</div>
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 91%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">Represents warrants that were issued to certain institutional investors in a warrant exercise agreement in June 2019.</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; width: 5%; vertical-align: top">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 4%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(12)</div>
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 91%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">Represents warrants that were issued to the placement agent as compensation for its role in the Company&#8217;s June 2019 registered direct offering and concurrent private placement of warrants.</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; width: 5%; vertical-align: top">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 4%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(13)</div>
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 91%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">Represents warrants that were issued to certain institutional purchasers in a private placement in the Company&#8217;s best efforts offering of ordinary shares in February 2020.</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; width: 5%; vertical-align: top">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 4%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(14)</div>
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 91%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">Represents warrants that were issued to the placement agent as compensation for its role in the Company&#8217;s February 2020 best efforts offering.</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; width: 5%; vertical-align: top">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 4%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(15)</div>
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 91%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">Represents warrants that were issued to certain institutional purchasers in a private placement in our registered direct offering of ordinary shares in July 2020</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; width: 5%; vertical-align: top">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 4%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(16)</div>
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 91%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">Represents warrants that were issued to the placement agent as compensation for its role in the Company&#8217;s July 2020 registered direct offering.</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; width: 5%; vertical-align: top">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 4%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(17)</div>
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 91%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">Represents warrants that were issued to certain institutional purchasers in a private placement in our private placement offering of ordinary shares in December 2020</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; width: 5%; vertical-align: top">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 4%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(18)</div>
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 91%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">Represents warrants that were issued to the placement agent as compensation for its role in the Company&#8217;s December 2020 private placement.</div></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140286959685128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESEARCH COLLABORATION AGREEMENT AND LICENSE AGREEMENT<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentAbstract', window );"><strong>Research and Development [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock', window );">RESEARCH COLLABORATION AGREEMENT AND LICENSE AGREEMENT</a></td>
<td class="text"><div style="font: 10pt/1.25 Times New Roman, Times, Serif"><font style="font-weight: bold">NOTE&#160; 9:-&#160; RESEARCH COLLABORATION AGREEMENT AND LICENSE AGREEMENT</font></div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt">On May 16, 2016, the Company entered into a Research Collaboration Agreement (&#8220;Collaboration Agreement&#8221;) and an Exclusive License Agreement (&#8220;License Agreement&#8221;) with Harvard. The
    Research Collaboration Agreement was amended on May 1, 2017 and April 1, 2018 (as amended, the &#8220;Collaboration Agreement&#8221;), and the Exclusive License Agreement was amended on April 1, 2018 (as amended, the &#8220;License Agreement&#8221;), to extend the term of the
    Collaboration Agreement by one year to May 16, 2022 and reallocate the Company&#8217;s quarterly installment payments to Harvard through such date, and to make certain technical changes. On April 30, 2020, the Company and Harvard amended the Collaboration
    Agreement, which included certain adjustments to the quarterly installments and extended the term an additional three quarters until February 2023.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt">Under the Collaboration Agreement, Harvard and the Company have agreed to collaborate on research regarding the development of lightweight &#8220;soft suit&#8221; exoskeleton system technologies
    for lower limb disabilities, which are intended to treat stroke, multiple sclerosis, mobility limitations for the elderly and other medical applications. The Company has committed to pay in quarterly installments for the funding of this research,
    subject to a minimum funding commitment under applicable circumstances. The Collaboration Agreement will expire on February 16, 2023.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt">Under the License Agreement, Harvard has granted the Company an exclusive, worldwide royalty-bearing license under certain patents of Harvard relating to lightweight &#8220;soft suit&#8221;
    exoskeleton system technologies for lower limb disabilities, a royalty-free license under certain related know-how and the option to obtain a license under certain inventions conceived under the joint research collaboration.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt">The License Agreement requires the Company to pay Harvard an upfront fee, reimbursements for expenses that Harvard incurred in connection with the licensed patents, royalties on net
    sales and several milestone payments contingent upon the achievement of certain product development and commercialization milestones. The Harvard License Agreement will continue in full force and effect until the expiration of the last-to-expire valid
    claim of the licensed patents. As of December 31,2020, the Company achieved three of the milestones which represent all development milestones under the License Agreement. The Company continues to evaluate the likelihood that the other milestones will
    be achieved on a quarterly basis.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt">The Company&#8217;s total payment obligation under the Collaboration Agreement and the Harvard License Agreement is $7.2 &#160;&#160;million, some of which is subject to a minimum funding commitment
    under applicable circumstances as indicated above.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt">The Company has recorded expenses in the amount of $0.8 million, $1.6 million, and $0.9 million for the years ended December&#160;31, 2020, 2019, and 2018, respectively, which are part of
    the total payment obligation indicated above, as research and development expenses related to the Harvard License Agreement and to the Collaboration Agreement. No withholding tax was deducted from the Company&#8217;s payments to Harvard in respect of the
    Collaboration Agreement and License Agreement since this is not taxable income in Israel in accordance with Section 170 of the Israel Income Tax Ordinance 1961-5721.</div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for research, development, and computer software activities, including contracts and arrangements to be performed for others and with federal government. Includes costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility and in-process research and development acquired in a business combination consummated during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 730<br> -URI http://asc.fasb.org/subtopic&amp;trid=2197926<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140286977419144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PAYCHECK PROTECTION PROGRAM LOAN<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">PAYCHECK PROTECTION PROGRAM LOAN</a></td>
<td class="text"><div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">NOTE 10: - PAYCHECK PROTECTION PROGRAM LOAN</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif"><br style="line-height: 1.25" />
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt">On April 21, 2020, RRI received an unsecured loan in the principal amount of $392 under the Paycheck Protection Program (the &#8220;PPP&#8221;)
    administered by the U.S. Small Business Administration, or the SBA, pursuant to the Coronavirus Aid, Relief, and Economic Security Act (the &#8220;CARES Act&#8221;), or the PPP loan. The terms of the PPP Loan were subsequently revised in accordance with the
    provisions of the Paycheck Protection Flexibility Act of 2020, or the PPP Flexibility Act, which was enacted on June 5, 2020. The PPP loan provides for an interest rate of 1.00% per year and matures two years after the date of initial disbursement,
    with initial principal and interest payments coming due late in fiscal 2021. The PPP loan may be used for payroll costs, costs related to certain group health care benefits and insurance premiums, rent payments, utility payments, mortgage interest
    payments and interest payments on any other debt obligation that were incurred before February 15, 2020. Under the terms of the CARES Act and the PPP Flexibility Act, the Company may apply for and be granted forgiveness for all or a portion of loan
    granted under the PPP loan, with such forgiveness to be determined, subject to limitations (including where employees of the Company have been terminated and not re-hired by a certain date), based on the use of the loan proceeds for payment of payroll
    costs and any payments of mortgage interest, rent, and utilities. The terms of any forgiveness may also be subject to further requirements in regulations and guidelines adopted by the SBA.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif"><br style="line-height: 1.25" />
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt">On September 29, 2020, the Company applied for loan forgiveness and on November 6, 2020 the Company received confirmation of its PPP Note
    forgiveness.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif"><br style="line-height: 1.25" />
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt">
    <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Forgiveness is booked as other income within the marketing and
    sales expenses because it was  granted and used for payroll, rent, and utility costs related to sales efforts.</div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140286961063384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text"><div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">NOTE 11: - INCOME TAXES</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 18pt">The Company&#8217;s subsidiaries are separately taxed under the domestic tax laws of the jurisdiction of incorporation of each entity.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">&#160;</div>
  <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z495f2ff54edb43c9b12ed00e41577015" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"><br />
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top">a.</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify">
          <div style="font: 10pt Times New Roman, Times, Serif">Corporate tax rates in Israel:</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">Presented hereunder are the tax rates relevant to the Company in the years 2018-2020:</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">The Israeli statutory corporate tax rate and real capital gains were 23% in the years 2018-2020.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt">&#160;</div>
  <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z563e6c146a774b7c840fb8537d035ac8" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"><br />
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top">b.</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify">
          <div style="font: 10pt Times New Roman, Times, Serif">Income (loss) before taxes on income is comprised as follows (in
          thousands):</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 36pt">&#160;</div>
  <table cellspacing="0" cellpadding="0" border="0" align="right" id="z2ba3a7d1752c4363bc6e2cd6ff3d455b" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="10" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">Year Ended December 31,</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"> 2020</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">2019</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">2018</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Domestic</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(12,992</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(15,599</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(21,784</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Foreign</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">67</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">55</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">104</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(12,925</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(15,544</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(21,680</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 36pt; clear: both">&#160;</div>
  <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z081375363046492ba85434cf4fe097b1" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"><br />
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top">c.</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify">
          <div style="font: 10pt Times New Roman, Times, Serif">Taxes on income are comprised as follows (in thousands):&#160;</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
  <table cellspacing="0" cellpadding="0" border="0" align="right" id="zcdc58fc524c440858a57748de7edc2b3" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="10" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">Year Ended December 31,</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"> 2020</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">2019</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">2018</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Current</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">95</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">64</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">102</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Deferred</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(44</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(57</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(107</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">)<br />
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">51</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">7</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(5</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; clear: both">&#160;</div>
  <table cellspacing="0" cellpadding="0" border="0" align="right" id="zdf4592310e5f4e58871a824057235746" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="10" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">Year Ended December 31,</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"> 2020</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">2019</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">2018</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Domestic</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#8212;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#8212;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#8212;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Foreign</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">51</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">7</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(5</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">51</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">7</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(5</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; clear: both">&#160;</div>
  <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zab90f7c8c6824db28e51a5ff35678e0b" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"><br />
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top">d.</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify">
          <div style="font: 10pt Times New Roman, Times, Serif">Deferred income taxes (in thousands):</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts
    used for income tax purposes. The Company&#8217;s deferred tax assets as of December&#160;31, 2020 and 2019 are derived from temporary differences.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">In assessing the realization of deferred tax assets, the Company considers whether it is more likely than not that all or some portion of the deferred tax assets will not be
    realized. Based on the Company&#8217;s history of losses, the Company established a full valuation allowance for RRL.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif"><br style="line-height: 1.25" />
  </div>

  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">Undistributed earnings of certain subsidiaries as of December&#160;31, 2020 were immaterial. The Company intends to reinvest these earnings indefinitely in the foreign subsidiaries. As a
    result, the Company has not provided for any&#160;deferred income taxes.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <table cellspacing="0" cellpadding="0" border="0" align="right" id="za1a0ca5d98ce48fcbd64c50f98f02c7d" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="6" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">December 31,</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"> 2020</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">2019</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Deferred tax assets:</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Carry forward tax losses</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">41,941</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">35,051</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Research and development carry forward expenses-temporary differences</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">946</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">1,294</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Accrual and reserves</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">341</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">290</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">
            <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Lease liabilities</div>
          </div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">390</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">433</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Total deferred tax assets</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">43,618</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">37,068</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Deferred tax liabilities:</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">
            <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Right-of-use asset</div>
          </div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(390</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(433</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Net deferred tax assets</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">43,228</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">36,635</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Valuation allowance</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(42,941</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(36,392</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Net deferred tax assets</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">287</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">243</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt; clear: both">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">The net changes in the
  total valuation allowance for each of the years ended December&#160;31, 2020, 2019 and 2018, are comprised as follows (in
  thousands):</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt; margin-left: 36pt">&#160;</div>
  <table cellspacing="0" cellpadding="0" border="0" align="right" id="z35a053d4f75348c6b77902f0ea14916a" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="10" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">Year Ended December 31,</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"> 2020</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">2019</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">2018</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Balance at beginning of year</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(36,392</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(29,655</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(26,311</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Changes due to amendments to tax laws and exchange rate differences</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(2,929</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(2,055</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">1,393</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Adjustment previous year loss</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#8212;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(735</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#8212;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Additions during the year</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(3,620</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(3,947</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(4,737</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Balance at end of year</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(42,941</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(36,392</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(29,655</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt; margin-left: 36pt; clear: both">&#160;</div>

  <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z51e8a038c406441d816c571ae27c4ac3" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"><br />
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top">e.</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify">
          <div style="font: 10pt Times New Roman, Times, Serif">Reconciliation of the theoretical tax expenses:</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">A reconciliation between the theoretical tax expense, assuming all income is taxed at the statutory tax rate applicable to income of the Company, and the actual tax expense (benefit)
    as reported in the consolidated statements of operations is as follows (in thousands):</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">&#160;</div>
  <table cellspacing="0" cellpadding="0" border="0" align="right" id="z4ab1a317623746aa8f3e7b4ad9ead3cd" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="10" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">Year Ended December 31,</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"> 2020</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">2019</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">2018</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Loss before taxes, as reported in the consolidated statements of operations</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(12,925</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(15,544</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(21,680</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Statutory tax rate</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">23.0</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">%</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">23.0</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">%</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">23.0</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">%</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Theoretical tax benefits on the above amount at the Israeli statutory tax rate</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(2,973</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(3,575</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(4,986</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Income tax at rate other than the Israeli statutory tax rate</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">3</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(1</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">5</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Non-deductible expenses including equity-based compensation expenses and other</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">185</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">255</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">631</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Operating losses and other temporary differences for which valuation allowance was provided</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">3,620</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">3,947</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">4,737</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Permanent differences</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(706</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(651</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(427</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">)</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Other</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(78</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">32</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">35</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Actual tax expense</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">51</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">7</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(5</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; clear: both">&#160;&#160;</div>
  <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z791cb6555109419f8bfa57802578bca1" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"><br />
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top">f.</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify">
          <div style="font: 10pt Times New Roman, Times, Serif">Foreign tax rates:</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-indent: 36pt; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 36pt">Taxable income of RRI was subject to tax at the rate of 21% in 2020, 2019 and 2018.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-indent: 36pt">&#160;&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-indent: 36pt">Taxable income of RRG was subject to tax at the rate of 30% in 2020, 2019, and 2018.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 54pt">&#160;</div>
  <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z43d53d1b59844e8196d75da61ea03d04" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"><br />
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top">g.</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify">
          <div style="font: 10pt Times New Roman, Times, Serif">Tax benefits under the Law for the Encouragement of Capital Investments, 1959 (the &#8220;Investment Law&#8221;):&#160;</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">Conditions for entitlement to the benefits:</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">Under the Investment Law, in 2012 the Company elected &#8220;Beneficiary Enterprise&#8221; status which provides certain benefits, including tax exemptions and reduced tax rates. Income not
    eligible for Beneficiary Enterprise benefits is taxed at a regular rate.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">Income derived from Beneficiary Enterprise from productive activity will be exempt from tax for ten years from the year in which the Company first has taxable income, providing that
    12 years have not passed from the beginning of the year of election. In the event of a dividend distribution from income that is exempt from company tax, as aforementioned, the Company will be required to pay tax of 10%- 25% on that income.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">In the event of distribution of dividends from the said tax-exempt income, the amount distributed will be subject to corporate tax at the rate ordinarily applicable to the
    Beneficiary Enterprise&#8217;s income. Tax-exempt income generated under the Company&#8217;s &#8220;Beneficiary Enterprise&#8221; program will be subject to taxes upon dividend distribution or complete liquidation.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt; margin-left: 36pt">&#160;</div>

  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">The entitlement to the above benefits is conditional upon the Company&#8217;s fulfilling the conditions stipulated by the Law and regulations published thereunder.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">On December 29, 2010, the Knesset approved an additional amendment to the Law for the Encouragement of Capital Investments, 1959. According to the amendment, a reduced uniform
    corporate tax rate for exporting industrial enterprises (over 25%) was established. The reduced tax rate will not be program dependent and will apply to the industrial enterprise&#8217;s entire income. The tax rates for industrial enterprises have been
    reduced. In August 2013, the Israeli Knesset approved an amendment to the Investment Law, pursuant to which the rates for development area A will be 9% and for the rest of the country- 16% in 2014 and thereafter. The Amendment also prescribes that any
    dividends distributed to individuals or foreign residents from a preferred enterprise&#8217;s earnings as above will be subject to taxes at a rate of 20% (subject to tax treaty benefits)</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">In December 2016, the Economic Efficiency Law (Legislative Amendments for Applying the Economic Policy for the 2017 and 2018 Budget Years), 2016 which includes Amendment 73 to the
    Law for the Encouragement of Capital Investments (&#8220;the Amendment&#8221;) was published. According to the Amendment, a preferred enterprise located in development area A will be subject to a tax rate of 7.5% instead of 9% effective from January 1, 2017 (and
    thereafter the tax rate applicable to preferred enterprises located in other areas remains at 16%).</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">The Company has examined the effect of the adoption of the Amendment on its financial statements, and as of the date of the publication of the financial statements, the Company
    estimates that it will not apply the Amendment. The Company&#8217;s estimate may change in the future.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">&#160;</div>
  <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zf1b0aeaf3ca64a2486b1d0930669f1c3" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"><br />
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top">h.</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify">
          <div style="font: 10pt Times New Roman, Times, Serif">Tax assessments:</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 36pt">RRL has had final tax assessments up to and including the 2015 tax year.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 36pt">Each RRI and RRG have not had a final tax
  assessment since its inception.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">&#160;</div>
  <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zdab1f9ce80b04eac8acaec28821c7cce" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"><br />
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top">i.</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify">
          <div style="font: 10pt Times New Roman, Times, Serif">Net operating carry-forward losses for tax purposes:</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">As of December&#160;31, 2020, RRL has carry-forward losses amounting to approximately $182.4 million, which can be carried forward for an indefinite period, and RRI has carry-forward
    losses amounting to approximately $291 thousands, which can be carried forward for a period of 20 years.</div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140286964989464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL EXPENSES, NET<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other Income and Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock', window );">FINANCIAL EXPENSES, NET</a></td>
<td class="text"><div style="font: bold 10pt/1.25 Times New Roman, Times, Serif">NOTE&#160;12: - FINANCIAL EXPENSES, NET</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">The components of
  financial expenses, net were as follows (in thousands):</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 36pt">&#160;</div>
  <table cellspacing="0" cellpadding="0" border="0" align="right" id="z5c91740d842e4334816c9648efa53c90" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="10" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">Year Ended December 31,</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"> 2020</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">2019</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">2018</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Foreign currency transactions and other</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(9</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(34</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">42</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Financial expenses related to loan agreement with Kreos</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">907</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">1,499</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">2,398</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Bank commissions</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">23</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">31</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">26</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">921</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">1,496</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">2,466</div></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other income or other expense items (both operating and nonoperating). Sources of nonoperating income or nonoperating expense that may be disclosed, include amounts earned from dividends, interest on securities, profits (losses) on securities, net and miscellaneous other income or income deductions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -URI http://asc.fasb.org/topic&amp;trid=2122503<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 610<br> -URI http://asc.fasb.org/topic&amp;trid=49130413<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140286973341176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA</a></td>
<td class="text"><div style="font: bold 10pt/1.25 Times New Roman, Times, Serif">NOTE 13: -&#160; GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt">Summary information about geographic areas:</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt">ASC 280, &#8220;Segment
  Reporting&#8221; establishes standards for reporting information about operating segments. Operating segments are defined as
  components of an enterprise about which separate financial information is available that is evaluated regularly by the chief
  operating decision maker in deciding how to allocate resources and in assessing performance. The Company manages its business
  on the basis of one reportable segment and derives revenues from selling systems and services (see Note 1 for a brief
  description of the Company&#8217;s business). The following is a summary of revenues within geographic areas (in thousands):</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt">&#160;</div>
  <table cellspacing="0" cellpadding="0" border="0" align="right" id="zec3d7aa5328f4b0f84320dfdfed923e6" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="10" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">Year Ended December 31,</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"> 2020</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">2019</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">2018</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Revenues based on customer&#8217;s location:</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 9pt">Israel</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#8212;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">2</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#8212;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 9pt">United States</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">1,746</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">2,003</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">3,558</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 9pt">Europe</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">2,631</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">2,832</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">2,807</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 9pt">Asia-Pacific</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">8</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">36</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">22</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 9pt">Latin America</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">6</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#8212;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">58</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 9pt">Africa</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">2</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#8212;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">100</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Total revenues</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">4,393</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">4,873</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">6,545</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; clear: both">&#160;</div>
  <table cellspacing="0" cellpadding="0" border="0" align="right" id="z2ef27552142e4f388dcac51bf5575d3f" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="6" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">December 31,</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"> 2020</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">2019</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Long-lived assets by geographic region:</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 9pt">Israel</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">145</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">179</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 9pt">United States</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">249</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">244</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 9pt">Germany</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">43</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">78</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">437</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">501</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; clear: both">&#160;</div>
  <table cellspacing="0" cellpadding="0" border="0" align="right" id="zf6398c4ec5504e8a93132307dffabbba" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 3.88%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(*)</div>
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 96.12%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">Long-lived assets are comprised of property and equipment, net.</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; clear: both">&#160;&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 36pt">Major customer data as a percentage of total revenues:</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
  <table cellspacing="0" cellpadding="0" border="0" align="right" id="zbbad66930d1b49dbb2d56aacfee26f04" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="10" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">Year Ended December 31,</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"> 2020</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">2019</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">2018</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Customer A</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">10.0</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">%</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">15.0</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">%</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">38.0</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">%</div></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140286965075560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">SUBSEQUENT EVENTS</a></td>
<td class="text"><div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">NOTE&#160;14: - SUBSEQUENT EVENTS</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif">
    <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">&#160;</div>
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif">
    <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt">
      <div style="font: 10pt/1.25 Times New Roman, Times, Serif">
        <div style="font: 10pt/1.25 Times New Roman, Times, Serif">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">
            <div style="font: 10pt/1.25 Times New Roman, Times, Serif">
              <div style="font: 10pt/1.25 Times New Roman, Times, Serif">
                <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Following December 31, 2020, a total of 9,372,954 outstanding warrants with exercise prices ranging from $1.25 to $1.79 were
                  exercised, for total gross proceeds to us of approximately $13.2 million.</div></div></div></div></div></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140286962476904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z0a33e389668f457b9b7e6bf33704bbef" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"><br />
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top">a.</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify">
          <div style="font: 10pt Times New Roman, Times, Serif">Use of Estimates</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">
    <div style="font: 10pt/1.25 Times New Roman, Times, Serif">The preparation of the consolidated financial statements in conformity with U.S. generally accepted accounting principles
      requires management to make estimates, judgments, and assumptions. The Company&#8217;s management believes that the estimates, judgments, and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of
      assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. On
      an ongoing basis, the Company&#8217;s management evaluates estimates, including those related to inventories, fair values of share-based awards and warrants, contingent liabilities, provision for warranty, allowance for doubtful account and sales return
      reserve. Such estimates are based on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. </div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Financial Statements in U.S. Dollars</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zc0dba15ad360421690d3148bb5e25a82" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"><br />
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top">b.</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify">
          <div style="font: 10pt Times New Roman, Times, Serif">Financial Statements in U.S. Dollars:</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">Since 2015, most of the Company&#8217;s expenses were denominated in United States dollars (&#8220;dollars&#8221;) and the remaining expenses were denominated in New Israeli Shekel (&#8220;NIS&#8221;) and Euros.
    Until 2018 most of the Company&#8217;s revenues were denominated in U.S. dollars and the remainder of our revenues was denominated in euros and British pound whereas in the last two years our Euro revenues are higher than the ones in dollars.&#160; &#160;however, the
    selling prices are linked to the Company&#8217;s price list which is determined in dollars, the budget is managed in dollars, financing activities including loans and cash investments, are made in U.S. dollars and the Company&#8217;s management believes that the
    dollar is the primary currency of the economic environment in which the Company and each of its subsidiaries operate. Thus, the dollar is the Company&#8217;s and its subsidiaries&#8217; functional and reporting currency.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif"><br style="line-height: 1.25" />
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">Accordingly, transactions denominated in currencies other than the functional currency are re-measured to the functional currency in accordance with Accounting Standards Codification
    (&#8220;ASC&#8221;) No. 830, &#8220;Foreign Currency Matters&#8221; at the exchange rate at the date of the transaction or the average exchange rate in the relevant reporting period. At the end of each reporting period, financial assets and liabilities are re-measured to the
    functional currency using exchange rates in effect at the balance sheet date. Non-financial assets and liabilities are re-measured at historical exchange rates. Gains and losses related to re-measurement are recorded as financial income (expense) in
    the consolidated statements of operations as appropriate.</div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z3d72edf84d57490a93185381c32117fb" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"><br />
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top">c.</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify">
          <div style="font: 10pt Times New Roman, Times, Serif">Principles of Consolidation:</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 54pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">
    <div style="font: 10pt/1.25 Times New Roman, Times, Serif">The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, RRI and RRG. All
      intercompany transactions and balances have been eliminated upon consolidation.</div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash Equivalents</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zd955c270d10444e99907c61dd04aa49f" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"><br />
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top">d.</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify">
          <div style="font: 10pt Times New Roman, Times, Serif">Cash Equivalents:</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">Cash equivalents are short-term highly liquid investments that are readily convertible to cash with original maturities of three months or less, at the date acquired.</div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventories</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z5788efea516d48349aa7e6fb3ab915c9" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"><br />
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top">e.</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify">
          <div style="font: 10pt Times New Roman, Times, Serif">Inventories:</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">Inventories are stated at the lower of cost or market value. Inventory reserves are provided to cover risks arising from slow-moving items or technological obsolescence.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">The Company periodically evaluates the quantities on hand relative to historical, current and projected sales volume. Based on this evaluation, an impairment charge is recorded when
    required to write-down inventory to its market value.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-indent: 36pt">Cost is determined as follows:</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">Finished products - on the basis of raw materials and manufacturing costs on an average basis.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">Raw materials - The weighted average cost method.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">
    <div style="font: 10pt/1.25 Times New Roman, Times, Serif">The Company regularly evaluates the ability to realize the value of inventory based on a combination of factors, including
      historical usage rates and forecasted sales according to outstanding backlogs. Purchasing requirements and alternative usage are explored within these processes to mitigate inventory exposure. When recorded, the reserves are intended to reduce the
      carrying value of inventory to its net realizable value. In the years ended December&#160;31, 2020, 2019 and 2018, the Company wrote off inventory in the amount of $215 thousand, $64 thousand, and $562 thousand, respectively. The write off inventory were recorded in cost of revenue. If actual demand for the Company&#8217;s products deteriorates, or market conditions are less favorable than those projected,
      additional inventory reserves may be required.</div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_RelatedPartiesTransactionsAndBalancesPolicyTextBlock', window );">Related parties transactions and balances</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z4aa8c8c1d0024f7b92595ce5d2e64e86" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"><br />
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top">f.</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify">
          <div style="font: 10pt Times New Roman, Times, Serif">Related parties transactions and balances:&#160;</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">The Company has a related party shareholder named Yaskawa Electric Corporation (&#8220;YEC&#8221;).</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">In September 2013, the Company entered into a share purchase agreement and a strategic alliance with YEC, pursuant to which YEC has agreed to distribute the Company&#8217;s products, in
    addition to providing sales, marketing, service and training functions, in Japan, China (including Hong-Kong and Macau), Taiwan, South Korea, Singapore and Thailand.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">
    <div style="font: 10pt/1.25 Times New Roman, Times, Serif">As of December 31, 2020, and 2019,
      the related party receivable were 0% of trade receivable, net, in both years. Revenues from YEC during the years ended December&#160;31, 2020, 2019, and 2018
      amounted to $0 thousand, $41 thousand, and $13, respectively.</div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z05a82daea43b40e2b33b8f576d65c3b7" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"><br />
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top">g.</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify">
          <div style="font: 10pt Times New Roman, Times, Serif">Property and Equipment:</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets at
    the following annual rates:&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
  <table cellspacing="0" cellpadding="0" border="0" align="right" id="z251bfdcae9e14e5e93cd117615991b47" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 75.84%; vertical-align: bottom">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; width: 24.16%; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">%</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 75.84%; vertical-align: top; background-color: #CCEEFF">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Computer equipment</div>
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 24.16%; vertical-align: top; background-color: #CCEEFF">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center">20-33 (mainly 33)</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 75.84%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Office furniture and equipment</div>
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 24.16%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center">6 - 10&#160;(mainly 10)</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 75.84%; vertical-align: top; background-color: #CCEEFF">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Machinery and laboratory equipment</div>
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 24.16%; vertical-align: top; background-color: #CCEEFF">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center">15</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 75.84%; vertical-align: bottom">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Field service units</div>
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 24.16%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center">50</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 75.84%; vertical-align: top; background-color: #CCEEFF">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Leasehold improvements</div>
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 24.16%; vertical-align: top; background-color: #CCEEFF">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center">Over&#160;the&#160;shorter&#160;of&#160;the&#160;lease<br />
            term or estimated useful life</div></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment of Long-Lived Assets</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z9443fa13dcbe4ce6b1b64bf17f939507" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"><br />
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top">h.</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify">
          <div style="font: 10pt Times New Roman, Times, Serif">Impairment of Long-Lived Assets:</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">The Company&#8217;s long-lived assets are reviewed for impairment in accordance with ASC No.&#160;360, &#8220;Property, Plant and Equipment&#8221; whenever events or changes in circumstances indicate that
    the carrying amount of an asset (or asset group) may not be recoverable. Recoverability of assets (or asset group) to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted cash flows expected to be
    generated by the assets. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. During the years ended December&#160;31, 2020,
    2019 and 2018, no impairment losses have been recorded.</div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_OtherLongTermAssetsPolicyTextBlock', window );">Restricted cash and Other long term assets</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z6146e80aa19e400b986403f2498b419f" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"><br />
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top">i.</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify">
          <div style="font: 10pt Times New Roman, Times, Serif">Restricted cash and Other long-term assets:</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">Other long-term assets include long-term prepaid expenses and restricted cash deposits for offices and cars leasing based upon the term of the remaining restrictions.</div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z67e623d200a64464ac03f67293e01e52" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"><br />
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top">j.</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify">
          <div style="font: 10pt Times New Roman, Times, Serif">Revenue Recognition:&#160;</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">The Company generates revenues from sales of products. The Company sells its products directly to end customers and through distributors. The Company sells its products to private
    individuals (who finance the purchases by themselves, through fundraising or reimbursement coverage from insurance companies), rehabilitation facilities and distributors.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: -13.5pt; margin-left: 31.5pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">On January 1, 2018, the Company adopted Topic 606 using the modified retrospective method for contracts that were not completed as of January 1, 2018. Under the modified
    retrospective method, the Company recognized the cumulative effect of initially applying the new revenue standard as an adjustment to the opening balance of retained earnings. This adjustment did not have a material impact on the Company consolidated
    financial statements. Results for reporting periods beginning after January 1, 2018 are presented under Topic 606, while prior period amounts are not adjusted and continue to be reported in accordance with the Company historic accounting under Revenue
    Recognition (&#8220;Topic 605&#8221;).</div>

  <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 34.2pt">The adoption of Topic 606 represents a change in accounting principle that will provide financial statement readers with enhanced
    revenue recognition disclosures. In accordance with Topic 606, revenue is recognized when obligations under the terms of a contract with the Company customer are satisfied; generally this occurs with the transfer of control of the Company products or
    services. Revenue is measured as the amount of consideration to which the Company expect to be entitled in exchange for transferring products or providing services. To achieve this core principle, the Company applies the following five steps:</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: -13.5pt; margin-left: 31.5pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">1. Identify the contract with a customer</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 72pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt">A contract with a customer exists when (i) the Company enters into a written agreement with a customer that defines each party&#8217;s rights regarding the products or services to be
    transferred and identifies the payment terms related to these products or services, (ii) both parties to the contract are committed to perform their respective obligations, (iii) the contract has commercial substance, and (iv) the Company determines
    that collection of substantially all consideration for products or services that are transferred is probable based on the customer&#8217;s intent and ability to pay the promised consideration. The Company applies judgment in determining the customer&#8217;s
    ability and intention to pay, which is based on a variety of factors including the customer&#8217;s payment history or, in the case of a new customer, published credit and financial information pertaining to the customer.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: -40.5pt; margin-left: 72pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">2. Identify the performance obligations in the contract</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 40.5pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt">Performance obligations promised in a contract are identified based on the products or services that will be transferred to the customer that are both capable of being distinct,
    whereby the customer can benefit from the product or service either on its own or together with other resources that are readily available from the Company, and are distinct in the context of the contract, whereby the transfer of the products or
    services is separately identifiable from other promises in the contract.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 40.5pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">3. Determine the transaction price</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 40.5pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt">The transaction price is determined based on the consideration to which the Company will be entitled in exchange for transferring products or services to the customer. To the
    extent the transaction price is variable, revenue is recognized at an amount equal the consideration to which the Company expects to be entitled. This estimate includes customer sales incentives which are accounted for as a reduction to revenue and
    estimated using either the expected value method or the most likely amount method, depending on the nature of the program.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 40.5pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt">As a result of the Company&#8217;s adoption of this standard, the majority of the amounts that were historically classified as bad debt expense, primarily related to self-payers
    customers, are now considered an implicit price concession in determining net revenue. Accordingly, the Company recognized uncollectible balances associated with self-payers customers as a reduction of the transaction price and therefore as a reduction
    in net revenues when historically these amounts were classified as bad debt expense within general and administrative expenses.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 40.5pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt">Shipping and handling costs charged to customers are included in net sales. Determining the transaction price requires significant judgment, which is discussed by revenue category
    in further detail below.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 40.5pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt">In practice, the Company does not offer extended payment terms beyond one year to customers.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif"><br style="line-height: 1.25" />
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">4. Allocate the transaction price to performance obligations in the contract</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: -40.5pt; margin-left: 72pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt">If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. Contracts that contain multiple
    performance obligations require an allocation of the transaction price to each performance obligation based on a relative standalone selling price basis unless a portion of the variable consideration related to the contract is allocated entirely to a
    performance obligation. The Company determines standalone selling price based on the price at which the performance obligation is sold separately.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: -40.5pt; margin-left: 72pt">&#160;&#160;</div>

  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: -40.5pt; margin-left: 72pt">5. Recognize revenue when or as the Company satisfies a performance obligation</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 40.5pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt">The Company generally satisfies performance obligations at a point in time, once the customer has obtained the legal title to the items purchased or service provided.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 40.5pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt">
    <div style="font: 10pt/1.25 Times New Roman, Times, Serif">For systems sold to rehabilitation facilities, the Company includes training and considers the elements in the arrangement to be
      a single performance obligation. In accordance with ASC 606, the Company has concluded that the training is essential to the functionality of the Company&#8217;s systems. Therefore, the Company recognizes revenue for the system and training only after delivery in accordance with the agreement delivery terms to the customer and after the training has been completed.</div>
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 40.5pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt">
    <div style="font: 10pt/1.25 Times New Roman, Times, Serif">For sales of Personal systems to end users, and for sales of Personal or Rehabilitation systems to third party distributors, the
      Company does not provide training to the end user as this training is completed by the Rehabilitation centers or by the distributor that have previously completed the ReWalk Training program. Therefore, the Company recognizes revenue in such sales upon delivery.</div>
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 40.5pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt">Revenue is recognized based on the transaction price at the time the related performance obligation is satisfied by transferring a promised product or service to a customer.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 40.5pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt">The Company generally does not grant a right of return for its products. There have been isolated cases in which the Company experienced a return of its products. Therefore, the
    Company records reductions to revenue for expected future product returns based on the Company&#8217;s historical experience.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 40.5pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt"><u>Disaggregation of Revenues (in thousands)</u></div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 40.5pt">&#160;</div>
  <table cellspacing="0" cellpadding="0" border="0" align="right" id="z244734cb0e59414b81b34ea77097c036" style="font: 10pt Times New Roman, Times, Serif; width: 93%; color: #000000; text-align: left">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="10" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">Year Ended December 31,</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"> 2020</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">2019</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">2018</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Units placed</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">3,620</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">4,385</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">6,237</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Spare parts and warranties</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">773</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">488</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">308</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Total Revenues</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">4,393</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">4,873</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">6,545</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 90pt; clear: both">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt"><u>Units placed</u></div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt">&#160;<br />
    The Company currently offer five products: (1) ReWalk Personal, (2) ReWalk Rehabilitation, (3) ReStore, (4) MyoCycle and (5) MediTouch.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif"><br style="line-height: 1.25" />
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt">ReWalk Personal and ReWalk Rehabilitation are units for spinal cord injuries (&#8220;SCI Products&#8221;). SCI Products are currently designed for everyday use by paraplegic individuals at
    home and in their communities, and are custom fitted for each user, as well as for use by paraplegia patients in the clinical rehabilitation environment, where they provide individuals access to valuable exercise and therapy. ReWalk Rehabilitation
    current design is dated and will not be produced in the future.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif"><br style="line-height: 1.25" />
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt">ReStore is a powered, lightweight soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation
    environment.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif"><br style="line-height: 1.25" />
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt">MyoCycle which uses Functional Electrical Stimulation (&#8220;FES&#8221;) technology and MediTouch tutor movement biofeedback devices (&#8220;Distributed Products&#8221;).&#160; The Company markets the
    Distributed Products in the United States for use at home or in clinic.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt"> <br />
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt">&#160;&#160;&#160;Units placed includes revenue from sales of SCI Products, ReStore and Distributed Products.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt"> <br />
  </div>

  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt">For units placed, the Company recognizes revenues when it transfers control and title has passed to the customer.&#160; Each unit placed is considered an independent, unbundled
    performance obligation. The Company also offers a rent-to-purchase model in which the Company recognizes revenue ratably according to the agreed rental monthly fee.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif"><br style="line-height: 1.25" />
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt"><u>Spare parts and warranties</u></div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt">Spare parts are sold to private individuals, rehabilitation facilities and distributors. Revenue is recognized when the Company satisfies a performance obligation by transferring
    control over promised goods or services to the customer. Each part sold is considered an independent, unbundled performance obligation.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif"><br style="line-height: 1.25" />
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt">Warranties are classified as either assurance type or service type warranty. A warranty is considered an assurance type warranty if it provides the consumer with assurance that the
    product will function as intended for a limited period of time.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif"><br style="line-height: 1.25" />
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt">In the beginning of 2018, the Company updated its service policy for SCI Products to include a five- year warranty compared to a period of two years that were included in the past
    for parts and services. The first two years are considered as assurance type warranty and the additional period is considered an extended service arrangement, which is a service type warranty. An assurance type warranty is not accounted for as separate
    performance obligations under the revenue model. A service type warranty is either sold with a unit or separately for units for which the warranty has expired. Revenue is then recognized ratably over the life of the warranty.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif"><br style="line-height: 1.25" />
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt">The ReStore device is offered with a two-year warranty which is considered as assurance type warranty.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif"><br style="line-height: 1.25" />
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt">The Distributed Products are offered with assurance type warranty ranging between one year to ten years depending on the specific product and part.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif"><br style="line-height: 1.25" />
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt">
    <div style="font: 10pt/1.25 Times New Roman, Times, Serif"><u>Contract balances</u><u> (in thousands)</u></div>
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 40.5pt">&#160;</div>
  <table cellspacing="0" cellpadding="0" border="0" align="right" id="z5c799b2fe8f0464797acfbb534d43627" style="font: 10pt Times New Roman, Times, Serif; width: 93%; color: #000000; text-align: left">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">&#160;</td>
        <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">December 31,</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">&#160;</td>
        <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">December 31,</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"> 2020</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">2019</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Trade receivable, net (1)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">684</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">794</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Deferred revenues (1) (2)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">1,108</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">844</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 72pt; clear: both">&#160;</div>
  <table cellspacing="0" cellpadding="0" border="0" align="right" id="z17cb99861cfd43fcbaa9360391eba714" style="font: 10pt Times New Roman, Times, Serif; width: 93%; color: #000000; text-align: left">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 3.85%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(1)</div>
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 96.15%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">Balance presented net of unrecognized revenues that were not yet collected.</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 72pt; clear: both">&#160;</div>
  <table cellspacing="0" cellpadding="0" border="0" align="right" id="z3161792d8d93450192807264069a7a74" style="font: 10pt Times New Roman, Times, Serif; width: 93%; color: #000000; text-align: left">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 3.85%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(2)</div>
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 96.15%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">$330 thousand of December&#160;31, 2019 deferred revenues balance were recognized as revenues during the year ended December 31, 2020.</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 40.5pt; clear: both">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt"><u>Typical timing of payment</u></div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 43.2pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt">Deferred revenue is comprised mainly of unearned revenue related to service type warranty but also includes other offerings for which the Company has been paid in advance and earns
    revenue when the Company transfers control of the product or service.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif"><br style="line-height: 1.25" />
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 43.2pt">The Company&#8217;s unfilled performance obligations as of December 31, 2020 and the estimated revenue expected to be recognized in the future related to the service type warranty
    amounts to $1,108 thousand, which is fulfilled over one to five years.</div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Accounting for Share-Based Compensation</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z6ad9a3b4411a480fb5186fe382453b4c" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"><br />
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top">k.</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify">
          <div style="font: 10pt Times New Roman, Times, Serif">Accounting for Share-Based Compensation:</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">The Company accounts for share-based compensation in accordance with ASC No.&#160;718, &#8220;Compensation-Stock Compensation&#8221; (&#8220;ASC No. 718&#8221;). ASC No. 718 requires companies to estimate the
    fair value of equity-based payment awards on the date of grant using an Option-Pricing Model (&#8220;OPM&#8221;). The value of the portion of the award that is ultimately expected to vest is recognized as an expense over the requisite service periods in the
    Company&#8217;s consolidated statements of operations.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">The Company recognizes compensation expenses for the value of its awards granted based on the straight-line method over the requisite service period of each of the awards.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">Effective as of January 1, 2017, the Company adopted Accounting Standards Update 2016-09, &#8220;Compensation-Stock Compensation (Topic 718)&#8221; (&#8220;ASU 2016-09&#8221;) on a modified, retrospective
    basis. ASU 2016-09 permits entities to make an accounting policy election related to how forfeitures will impact the recognition of compensation cost for stock-based compensation: to estimate the total number of awards for which the requisite service
    period will not be rendered or to account for forfeitures as they occur. Upon adoption of ASU 2016-09, the Company elected to change its accounting policy to account for forfeitures as they occur. The change was applied on a modified, retrospective
    basis with a cumulative-effect adjustment to retained earnings of $11 thousand (which increased the accumulated deficit) as of January 1, 2017.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">ASU 2016-09 also eliminates the requirement that excess tax benefits be realized as a reduction in current taxes payable before the associated tax benefit can be recognized as an
    increase in paid in capital. The implementation resulted with no cumulative-effect adjustment to retained earnings as of January 1, 2017.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"> <br />
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 36pt">Additionally, ASU 2016-09 addresses the presentation of excess tax benefits and employee taxes paid on the statement of cash flows. The Company is now required to present excess tax benefits as an
    operating activity on the statement of cash flows rather than as a financing activity. The Company adopted this change prospectively.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif"><br style="line-height: 1.25" />
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">In June 2018, the FASB issued ASU No.&#160;2018-07 Compensation&#8212;Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting. ASU 2018-07 was issued to
    simplify several aspects of the accounting for nonemployee share-based payment transactions resulting from expanding the scope of Topic 718, "Compensation &#8211; Stock Compensation", to include share-based payment transactions for acquiring goods and
    services from nonemployees. The amendments specify that Topic 718 applies to all share-based payment transactions in which a grantor acquires goods or services to be used or consumed in a grantor&#8217;s own operations by issuing share-based payment awards.
    As a result of ASU 2018-07, grants awarded to non-employees are accounted for under ASC 718. The Company adopted ASU 2018-07 as of January 1, 2019. The adoption did not have a material impact on the consolidated financial statements.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">The Company selected the Black-Scholes-Merton option pricing model as the most appropriate fair value method for its share-option awards. The option-pricing model requires a number
    of assumptions, of which the most significant are the fair market value of the underlying ordinary share, expected share price volatility and the expected option term. Expected volatility was calculated based upon certain peer companies that the
    Company considered to be comparable. The expected option term represents the period of time that options granted are expected to be outstanding. The expected option term is determined based on the simplified method in accordance with Staff Accounting
    Bulletin No.&#160;110, as adequate historical experience is not available to provide a reasonable estimate. The simplified method will continue to apply until enough historical experience is available to provide a reasonable estimate of the expected term.
    The risk-free interest rate is based on the yield from U.S. treasury bonds with an equivalent term. The Company has historically not paid dividends and has no foreseeable plans to pay dividends.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">Following the IPO in September 2014, the fair value of ordinary shares is observable as they are publicly traded.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"> <br />
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">The fair value of Restricted Stock Units (RSUs) granted is determined based on the price of the Company&#8217;s ordinary shares on the date of
    grant.<br />
    <div style="font: 10pt Times New Roman, Times, Serif"><br />
    </div>
  </div>

  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">The fair value for options granted in 2019, 2018 is estimated at the date of grant using a Black-Scholes-Merton option pricing model with the following assumptions:</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
  <table cellspacing="0" cellpadding="0" border="0" align="right" id="zcfac848f1c7c4ec8be5afff37beb22e7" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="6" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">Year Ended December 31,</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"> 2019</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">2018</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: #CCEEFF; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Expected volatility</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">57.5</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">%</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">57% - 61</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">%</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Risk-free rate</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">2.22</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">%</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">2.74% - 2.83</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">%</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: #CCEEFF; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Dividend yield</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#8212;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">%</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#8212;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">%</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Expected term (in years)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">6.11</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">6.11</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: #CCEEFF; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Share price</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">5.37</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">25.5 - $28.75</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; clear: both">&#160;&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">There were no options granted during the twelve months ended December 31, 2020.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"> <br />
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">The Company accounts for
  options granted to consultants and other service providers under ASC No. 718. The fair value of these options was estimated
  using a Black-Scholes-Merton option-pricing model.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">
    <div style="font: 10pt/1.25 Times New Roman, Times, Serif">The non-cash compensation expenses related to employees and non- employees for the years ended December&#160;31, 2020, 2019 and 2018
      amounted to $749 thousand, $1,108 thousand, and $2,766 thousand, respectively.</div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_ClassOfWarrantOrRightPolicyTextBlock', window );">Warrants to Acquire Ordinary Shares</a></td>
<td class="text"><div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">    <table cellspacing="0" cellpadding="0" border="0" class="MsoNormalTable" style="font: 10pt Times New Roman, Times, Serif; width: 100%; width: 100%; mso-padding-alt: 0cm 0cm 0cm 0cm">

        <tr style="font: 10pt Times New Roman, Times, Serif; mso-yfti-irow: 0; mso-yfti-firstrow: yes; mso-yfti-lastrow: yes">
          <td style="font: 10pt Times New Roman, Times, Serif; padding: 0cm; width: 24px; vertical-align: top; width: 18pt">
            <p class="MsoNormal" style="font: 10pt/normal Times New Roman, Times, Serif; margin-bottom: 0cm; margin-bottom: 0pt"><font dir="ltr"></font><font dir="ltr"></font><font style="font: 10pt Times New Roman,serif; mso-fareast-font-family: Times New Roman"><font dir="ltr"></font><font dir="ltr"></font>&#160;</font></p>
          </td>
          <td style="font: 10pt Times New Roman, Times, Serif; padding: 0cm; width: 24px; vertical-align: top; width: 18pt">
            <p class="MsoNormal" style="font: 10pt/normal Times New Roman, Times, Serif; margin-bottom: 0cm; margin-bottom: 0pt"><font style="font: 10pt Times New Roman,serif; mso-fareast-font-family: Times New Roman">l.</font></p>
          </td>
          <td style="font: 10pt Times New Roman, Times, Serif; padding: 0cm; vertical-align: top">
            <p class="MsoNormal" style="font: 10pt/normal Times New Roman, Times, Serif; margin-bottom: 0cm; margin-bottom: 0pt"><font style="font: 10pt Times New Roman,serif; mso-fareast-font-family: Times New Roman">Warrants to Acquire
                Ordinary Shares:</font></p>
          </td>
        </tr>

    </table>
    <p class="MsoNormal" style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0cm 0cm 0pt 36pt"><font lang="AR-SA" dir="rtl" style="font: 10pt Times New Roman,serif; mso-fareast-font-family: Times New Roman">&#160;</font></p>
    <p class="MsoNormal" style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0cm 0cm 0pt 36pt"><font style="font: 10pt Times New Roman,serif; mso-fareast-font-family: Times New Roman">D</font><font style="font: 10pt Times New Roman,serif; mso-fareast-font-family: Times New Roman; mso-bidi-language: HE">uring
    the twelve-month ended</font><font style="font: 10pt Times New Roman,serif; mso-fareast-font-family: Times New Roman"> 31,
    2020, and 2019, respectively, the Company issued warrants to acquire up to </font><font dir="rtl"></font><font dir="rtl"></font><font lang="HE" dir="rtl" style="font: 10pt Times New Roman,serif; mso-fareast-font-family: Times New Roman; mso-bidi-language: HE"><font dir="rtl"></font><font dir="rtl"></font>11,389,555</font><font dir="ltr"></font><font dir="ltr"></font><font style="font: 10pt Times New Roman,serif; mso-fareast-font-family: Times New Roman"><font dir="ltr"></font><font dir="ltr"></font>
    and </font><font dir="rtl"></font><font dir="rtl"></font><font lang="HE" dir="rtl" style="font: 10pt Times New Roman,serif; mso-fareast-font-family: Times New Roman; mso-bidi-language: HE"><font dir="rtl"></font><font dir="rtl"></font>2,522,284</font><font dir="ltr"></font><font dir="ltr"></font><font style="font: 10pt Times New Roman,serif; mso-fareast-font-family: Times New Roman"><font dir="ltr"></font><font dir="ltr"></font>
    ordinary shares. The Company assessed the warrants pursuant to ASC 480 "Distinguishing Liabilities from Equity" and ASC 815
    "Derivatives and Hedging" and determine that the warrants should be accounted for as equity and not as a derivative
    liability. Refer to Note </font><font dir="rtl"></font><font dir="rtl"></font><font lang="HE" dir="rtl" style="font: 10pt Times New Roman,serif; mso-fareast-font-family: Times New Roman; mso-bidi-language: HE"><font dir="rtl"></font><font dir="rtl"></font>8</font><font style="font: 10pt Times New Roman,serif; mso-fareast-font-family: Times New Roman; mso-bidi-language: HE">f</font><font style="font: 10pt Times New Roman,serif; mso-fareast-font-family: Times New Roman">
    for additional information.<font style="mso-spacerun: yes">&#160;&#160; </font></font></p></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development Costs</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z8db205dbbcfb4efaa93a391fce4c3d64" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"><tr style="font: 10pt Times New Roman, Times, Serif"><td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"><br />
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top">m.</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify">
          <div style="font: 10pt Times New Roman, Times, Serif">Research and Development Costs:</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">Research and development costs are charged to the consolidated statement of operations as incurred and are presented net of the amount of any grants the company receive for research
    and development in the period in which the grant was received.</div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z842b410387424176bf5d892651c42ab0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"><br />
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top">n.</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify">
          <div style="font: 10pt Times New Roman, Times, Serif">Income Taxes</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">The Company accounts for income taxes in accordance with ASC No.&#160;740, &#8220;Income Taxes&#8221; (&#8220;ASC No. 740&#8221;), using the liability method whereby deferred tax assets and liability account
    balances are determined based on the differences between financial reporting and the tax basis for assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The
    Company provides a valuation allowance, if necessary, to reduce deferred tax assets to the amounts that are more likely-than-not to be realized.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">ASC No. 740 contains a two-step approach to recognizing and measuring a liability for uncertain tax positions. The first step is to evaluate the tax position taken or expected to be
    taken in a tax return by determining if the weight of available evidence indicates that it is more likely than not that, on an evaluation of the technical merits, the tax position will be sustained on audit, including resolution of any related appeals
    or litigation processes. The second step is to measure the tax benefit as the largest amount that is more than 50% likely to be realized upon ultimate settlement. The Company accrues interest and penalties related to unrecognized tax benefits in its
    taxes on income. As of December 31, 2020, and 2019, the Company did not identify any significant uncertain tax positions.&#160;</div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyPolicy', window );">Warranty</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" class="DSPFListTable" id="ze6bf0cf2a2aa4cc3b679ca44928b857c" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"><br />
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top">o.</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify">
          <div style="font: 10pt Times New Roman, Times, Serif">Warranty:</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">The Company provided a two-year standard warranty for its products. In the beginning of 2018, we updated our service policy for new devices sold to include five-year warranties.&#160; The
    Company determined that the first two years of warranty is an assurance-type warranty and records a provision for the estimated cost to repair or replace products under warranty at the time of sale. Factors that affect the Company&#8217;s warranty reserve
    include the number of units sold, historical and anticipated rates of warranty repairs and the cost per repair.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <table cellspacing="0" cellpadding="0" border="0" align="right" id="z24e95ed7a2ee4f738f16153ac66d9200" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">US Dollars<br />
            in<br />
            thousands</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 88%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Balance at December 31, 2019</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">227</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 88%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Provision</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">125</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 88%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Usage</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(212</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 88%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Balance at December 31, 2020</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">140</div></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentrations of Credit Risks</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z1a8f598a777d49a5b354da4c89c73b12" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"><br />
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top">p.</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify">
          <div style="font: 10pt Times New Roman, Times, Serif">Concentrations of Credit Risks:</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash, cash equivalents and trade receivables.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">The Company&#8217;s cash and cash equivalents are deposited in major banks in Israel, the United States and Germany. Such deposits in the United States may be in excess of insured limits
    and are not insured in other jurisdictions. The Company maintains cash and cash equivalents with diverse financial institutions and monitors the amount of credit exposure to each financial institution.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">Concentration of credit risk with respect to trade receivable is primarily limited to a customer to which the Company makes substantial sales.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <table cellspacing="0" cellpadding="0" border="0" align="right" id="z6023b00ba79a4ef29192bf73408506a9" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="6" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">December 31,</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"> 2020</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">2019</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">Customer A</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">15</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">%</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">*</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Customer B</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">15</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">%</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">*</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">Customer C</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">15</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">%</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">*</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">Customer D</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">14</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">%</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">*</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">Customer E</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">12</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">%</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">12</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">%</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">Customer F</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">11</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">%</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">*</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">Customer G</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">*</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">14</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">%</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Customer H</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">*</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">13</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">%</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Customer I</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">*</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">13</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">%</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">Customer J</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">*</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">12</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">%</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">Customer K</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">*</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">12</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">%</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Customer L</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">*</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">12</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">%</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-indent: 36pt; clear: both">&#160;</div>
  <table cellspacing="0" cellpadding="0" border="0" align="right" id="z134b78bbeb3144378ee804552ff51346" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 3.85%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">*)</div>
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 96.15%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">Less than 10%</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-indent: 36pt; clear: both">&#160;&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">The Company&#8217;s trade receivables are geographically diversified and derived primarily from sales to customers in various countries, mainly in the United States and Europe.
    Concentration of credit risk with respect to trade receivables is limited by credit limits, ongoing credit evaluation and account monitoring procedures. The Company performs ongoing credit evaluations of its distributors based upon a specific review of
    all significant outstanding invoices. The Company writes off receivables when they are deemed uncollectible and having exhausted all collection efforts. As of December 31, 2020, and 2019 trade receivables are presented net of $102 thousand and $31
    thousand allowance for doubtful accounts, respectively, and net of sales return reserve of $0 thousand and $86 thousand, respectively.</div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PostemploymentBenefitPlansPolicy', window );">Accrued Severance Pay</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z4e14dd2dffa44865bb3145074fd5b07a" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"><tr style="font: 10pt Times New Roman, Times, Serif"><td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"><br />
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top">q.</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify">
          <div style="font: 10pt Times New Roman, Times, Serif">Accrued Severance Pay:</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">Pursuant to Israel&#8217;s Severance Pay Law, Israeli employees are entitled to severance pay equal to one month&#8217;s salary for each year of employment, or a portion thereof. All of the
    employees of the RRL elected to be included under section 14 of the Severance Pay Law, 1963 (&#8220;section 14&#8221;). According to this section, these employees are entitled only to monthly deposits, at a rate of 8.33% of their monthly salary, made in their name
    with insurance companies. Payments in accordance with section 14 release the Company from any future severance payments (under the above Israeli Severance Pay Law) in respect of those employees; therefore, related assets and liabilities are not
    presented in the balance sheet.&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">Total Company expenses related to severance pay amounted to $125 thousand, $156 thousand and $169 thousand for the years ended December&#160;31, 2020, 2019 and 2018, respectively.</div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z6bf8ea3b08384d14b0ccf4afddd571ac" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"><br />
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top">r.</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify">
          <div style="font: 10pt Times New Roman, Times, Serif">Fair Value Measurements:</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the
    asset or liability in an orderly transaction between market participants on the measurement date.&#160; The Company uses a three-tier fair value hierarchy to classify and disclose all assets and liabilities measured at fair value on a recurring basis, as
    well as assets and liabilities measured at fair value on a non-recurring basis, in periods subsequent to their initial measurement.&#160; The hierarchy requires the Company to use observable inputs when available, and to minimize the use of unobservable
    inputs when determining fair value. If a financial instrument uses inputs that fall in different levels of the hierarchy, the instrument will be categorized based upon the lowest level of input that is significant to the fair value calculation. The
    three-tiers are defined as follows:</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt Times New Roman, Times, Serif">
    <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zdcbd6ac918d047b7b0ce02f1923b2381" style="font: 10pt Times New Roman, Times, Serif; width: 100%">

        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
          <td style="font: 10pt Times New Roman, Times, Serif; width: 36pt">&#160;</td>
          <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 27pt">
            <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: left">&#9679;</div>
          </td>
          <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: auto">
            <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: left"><font style="font-weight: bold">Level 1.&#160;</font>Observable inputs based on unadjusted quoted prices in active markets for identical assets or liabilities;</div>
          </td>
        </tr>

    </table>
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
  <div style="font: 10pt Times New Roman, Times, Serif">
    <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zd17ba00465ad44acbc00c8c632d833f1" style="font: 10pt Times New Roman, Times, Serif; width: 100%">

        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
          <td style="font: 10pt Times New Roman, Times, Serif; width: 36pt">&#160;</td>
          <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 27pt">
            <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: left">&#9679;</div>
          </td>
          <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: auto">
            <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: left"><font style="font-weight: bold">Level 2.&#160;</font>Inputs, other than quoted prices in active markets, that are observable either directly or indirectly; and</div>
          </td>
        </tr>

    </table>
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
  <div style="font: 10pt Times New Roman, Times, Serif">
    <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z7971363fdc984e908a793fa67f2f12af" style="font: 10pt Times New Roman, Times, Serif; width: 100%">

        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
          <td style="font: 10pt Times New Roman, Times, Serif; width: 36pt">&#160;</td>
          <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 27pt">
            <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: left">&#9679;</div>
          </td>
          <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: auto">
            <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: left"><font style="font-weight: bold">Level 3.&#160;</font>Unobservable inputs for which there is little or no market data requiring the Company to develop its own assumptions.</div>
          </td>
        </tr>

    </table>
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">The carrying amounts of cash and cash equivalents, short term deposits, trade receivables and trade payables approximate their fair value due to the short-term maturity of such
    instruments.</div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Basic and Diluted Net Loss Per Share</a></td>
<td class="text"><div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center"></div>
  <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z147735070f9745478837e094cfe351cf" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"><br />
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top">s.</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify">
          <div style="font: 10pt Times New Roman, Times, Serif">Basic and Diluted Net Loss Per Share:</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">Basic net loss per share is computed by dividing the net loss by the weighted-average number of shares of ordinary shares outstanding during the period.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">Diluted net loss per share is computed by giving effect to all potential shares of ordinary shares, including stock options, convertible preferred share warrants, to the extent
    dilutive, all in accordance with ASC No.&#160;260, &#8220;Earning Per Share&#8221;.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">The following table sets forth the computation of the Company&#8217;s basic and diluted net loss per ordinary share (in thousands, except share and per share data):</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <table cellspacing="0" cellpadding="0" border="0" align="right" id="zf3292f75d1664a6e9a65631d4d24c1c5" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="10" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">Year ended December 31,</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"> 2020</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">2019</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">2018</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Net loss</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(12,976</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(15,551</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(21,675</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Net loss attributable to ordinary shares</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(12,976</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(15,551</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(21,675</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Shares used in computing net loss per ordinary shares, basic and diluted</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">15,764,980</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">5,763,317</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">1,472,499</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Net loss per ordinary share, basic and diluted</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(0.82</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(2.70</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(14.72</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt; clear: both">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">
    <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: left">Basic and diluted net loss per share was the same for each period presented as the inclusion of all potential shares of ordinary shares and
      warrants outstanding would have been anti-dilutive.</div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock', window );">Contingent liabilities</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z84c18d6253bf4238bc62601cb23e7efb" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000"><tr style="font: 10pt Times New Roman, Times, Serif">
    <td>&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top">t.</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify">
          <div style="font: 10pt Times New Roman, Times, Serif">Contingent liabilities</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">The Company accounts for its contingent liabilities in accordance with ASC No.&#160;450, &#8220;Contingencies&#8221;. A provision is recorded when it is both probable that a liability has been
    incurred and the amount of the loss can be reasonably estimated.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">With respect to legal matters, provisions are reviewed and adjusted to reflect the impact of negotiations, estimated settlements, legal rulings, advice of legal counsel and other
    information and events pertaining to a particular matter.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"> <br />
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">See note 7e for further information.</div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_GovernmentGrantsPolicyTextBlock', window );">Government grants</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z4e6e8ddef3724ce7868cf6b53b989b16" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"><br />
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top">u.</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify">
          <div style="font: 10pt Times New Roman, Times, Serif">Government grants</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">Government grants received by the Company relating to categories of operating expenditures are credited to the consolidated statements of operations during the period in which the
    expenditure to which they relate is charged. Royalty and non-royalty-bearing grants from the Israel Innovation Authority, or the IIA, (formerly known as the Israeli Office of the Chief Scientist), from the Israel-U.S. Binational Industrial Research and
    Development Foundation (&#8220;BIRD&#8221;) and from the Israeli Fund for Promoting Overseas Marketing for funding certain approved research and development projects and sales and marketing activities are recognized at the time when the Company is entitled to such
    grants, on the basis of the related costs incurred, and are included as a deduction from research and development or sales and marketing expenses (see Note&#160;7c).</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">No royalty-bearing grants were recorded for the years ended December 31, 2020, and December 31, 2019, the Company received royalty-bearing grants in the amount of $198 thousand for
    the year ended December 31, 2018, as part of the research and development expenses.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif"><br style="line-height: 1.25" />
  </div>


  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">Total Company expenses related to royalties amounted to $46 thousand, $15 thousand for the years ended December&#160;31, 2020, 2019, respectively, no royalty expenses were recorded for
    the year ended December&#160;31, 2018.</div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New Accounting Pronouncements</a></td>
<td class="text"><div style="font: 10pt/1.25 Times New Roman, Times, Serif"></div>
  <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zedb0b2f971494d55a06e892aae3c3b76" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"><br />
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top">v.</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify">
          <div style="font: 10pt Times New Roman, Times, Serif">New Accounting Pronouncements</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: italic 10pt/1.25 Times New Roman, Times, Serif; text-indent: 36pt">Recently Implemented Accounting Pronouncements</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif"><br style="line-height: 1.25" />
  </div>
  <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z53e58c161f4e4c0d9e1cfc8d00371b44" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 72pt"><br />
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 36pt; vertical-align: top">i.</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top">
          <div style="font: 10pt Times New Roman, Times, Serif">Leases:</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">In February 2016, the FASB&#160;issued Accounting Standard Update, or ASU, No. 2016-02, Leases (Topic 842), to enhance the transparency and comparability of financial reporting related to
    leasing arrangements. The Company adopted the standard effective January 1, 2019. At the inception of an arrangement, the Company determines whether the arrangement is or contains a lease based on the unique facts and circumstances present. Operating
    lease liabilities and their corresponding right-of-use assets are recorded based on the present value of lease payments over the expected lease term. The interest rate implicit in lease contracts is typically not readily determinable. As such, the
    Company utilizes its incremental borrowing rate, which is the rate incurred to borrow on a collateralized basis over a similar term an amount equal to the lease payments in a similar economic environment.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">Prior to the Company&#8217;s adoption of ASU 2016-02, when its lease agreements contained rent payment relief and rent escalation clauses, the Company recorded a deferred rent asset or
    liability equal to the difference between the rent expense and the future minimum lease payments due. Operating leases are recognized on the balance sheet as right-of-use assets, current maturities of operating leases and noncurrent operating lease
    liabilities.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">The Company used the modified retrospective transition method, under which the Company applied the standard as a cumulative effect adjustment to each lease that had commenced as of
    the beginning of January 1, 2019 and did not apply the standard to comparative historical periods. In addition, the Company elected to apply the package of practical expedients permitted under the transition guidance, which among other things, allowed
    the Company to carry forward the historical lease classification. The Company has elected, as of the adoption date, not to reassess whether expired or existing contracts contain leases under the new definition of a lease, not to reassess the lease
    classification for expired or existing leases, and not to reassess whether previously capitalized initial direct costs would qualify for capitalization under ASC 842.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">
    <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Leases with an initial term of 12 months or less are not recorded on the balance sheet. The Company recognizes the lease expense
      for such leases on a straight-line basis in the statement of operations over the lease term. As a result, the Company no longer recognizes deferred rent on the balance sheet.</div>
    <div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 36pt"> <br />
    </div>
    <div style="font: 10pt/1.25 Times New Roman, Times, Serif">The Company has elected to apply the practical expedient and combine lease and non-lease components.&#160; <br />
    </div>
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">Upon adoption of this
  standard on January 1, 2019, the Company recorded right&#8211;of&#8211;use assets and corresponding lease liabilities
  of&#160;$2,099&#160;thousand and&#160;$2,249 thousand , respectively. As of&#160;December&#160;31, 2020, the
  right&#8211;of&#8211;use assets and corresponding lease liabilities in the Company&#8217;s consolidated balance sheets
  were&#160;$1,349 thousand&#160;and&#160;$1,583 thousand, respectively. The adoption of this standard did not have a material impact
  on the Company&#8217;s consolidated statements of operations or cash flows. See also note 7b - Lease commitment.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif"><br style="line-height: 1.25" />
  </div>
  <div id="DSPFPageBreakArea" style="font: 10pt Times New Roman, Times, Serif; clear: both; margin-top: 10pt; margin-bottom: 10pt">

  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif"><br style="line-height: 1.25" />
  </div>
  <div style="font: italic 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt">Recent Accounting Pronouncements Not Yet Adopted</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif"><br style="line-height: 1.25" />
  </div>
  <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z50e182fa759e4e5db0765d46b3042523" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 70.8pt"><br />
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 36pt; vertical-align: top">i.</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top">
          <div style="font: 10pt Times New Roman, Times, Serif">Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif"><br style="line-height: 1.25" />
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">In August 2020, the FASB issued ASU No. 2020-06, Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity (ASU&#160; 2020-06), which simplifies the accounting for
    certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts in an entity&#8217;s own equity.&#160; Among other changes, ASU 2020-06 removes from GAAP the liability and equity separation model for
    convertible instruments with a cash conversion feature and a beneficial conversion feature, and as a result, after adoption, entities will no longer separately present in equity an embedded conversion feature for such debt. Similarly, the embedded
    conversion feature will no longer be amortized into income as interest expense over the life of the instrument. Instead, entities will account for a convertible debt instrument wholly as debt unless (1) a convertible instrument contains features that
    require bifurcation as a derivative under ASC Topic 815, Derivatives and Hedging, or (2) a convertible debt instrument was issued at a substantial premium. Additionally, ASU 2020-06 requires the application of the if-converted method to calculate the
    impact of convertible instruments on diluted earnings per share (EPS). ASU&#160; 2020-06 is effective for fiscal years beginning after December 15, 2021, with early adoption permitted for fiscal years beginning after December 15, 2020 and can be adopted on
    either a fully retrospective or modified retrospective basis. The adoption of this standard is not expected to result in a material impact to the Company&#8217;s financial statements.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif"><br style="line-height: 1.25" />
  </div>
  <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z70dbcad0e59447bfa3b078cc6c5a1e76" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 70.8pt"><br />
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 36pt; vertical-align: top">ii.</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top">
          <div style="font: 10pt Times New Roman, Times, Serif">Financial Instruments&#160;</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif"><br style="line-height: 1.25" />
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">In June 2016, FASB issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. ASU 2016-13 amends the impairment
    model to utilize an expected loss methodology in place of the currently used incurred loss methodology, which will result in the more timely recognition of losses. Topic 326 was adopted by the Company on January 1, 2020. The adoption did not have a
    material impact on the Company&#8217;s consolidated financial statements.</div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_ClassOfWarrantOrRightPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for warrants or rights.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_ClassOfWarrantOrRightPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_GovernmentGrantsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for government grants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_GovernmentGrantsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_OtherLongTermAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for other long term assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_OtherLongTermAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_RelatedPartiesTransactionsAndBalancesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for related parties transactions and balances.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_RelatedPartiesTransactionsAndBalancesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 450<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6491354&amp;loc=d3e6052-115624<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 450<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491354&amp;loc=d3e6049-115624<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=108315417&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI http://asc.fasb.org/topic&amp;trid=2175825<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226317&amp;loc=d3e202-110218<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011434&amp;loc=d3e125687-122742<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32847-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491622&amp;loc=d3e9504-115650<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32840-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116657188&amp;loc=SL116659661-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e32280-109318<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116846552&amp;loc=d3e543-108305<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PostemploymentBenefitPlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for postemployment benefits. Postemployment benefits are benefits provided to former or inactive employees, their beneficiaries, and covered dependents after employment but before retirement, except for: a) benefits provided through a pension or postretirement benefit plan, b) individual deferred compensation arrangements, c) special or contractual termination benefits, and d) stock compensation plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 712<br> -URI http://asc.fasb.org/topic&amp;trid=2197446<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PostemploymentBenefitPlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for standard warranties including the methodology for measuring the liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140286980318520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock', window );">Schedule of property and equipment estimated useful lives</a></td>
<td class="text"><div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets at
    the following annual rates:&#160;</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
  <table cellspacing="0" cellpadding="0" border="0" align="right" id="z251bfdcae9e14e5e93cd117615991b47" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 75.84%; vertical-align: bottom">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; width: 24.16%; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">%</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 75.84%; vertical-align: top; background-color: #CCEEFF">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Computer equipment</div>
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 24.16%; vertical-align: top; background-color: #CCEEFF">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center">20-33 (mainly 33)</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 75.84%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Office furniture and equipment</div>
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 24.16%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center">6 - 10&#160;(mainly 10)</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 75.84%; vertical-align: top; background-color: #CCEEFF">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Machinery and laboratory equipment</div>
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 24.16%; vertical-align: top; background-color: #CCEEFF">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center">15</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 75.84%; vertical-align: bottom">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Field service units</div>
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 24.16%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center">50</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 75.84%; vertical-align: top; background-color: #CCEEFF">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Leasehold improvements</div>
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 24.16%; vertical-align: top; background-color: #CCEEFF">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center">Over&#160;the&#160;shorter&#160;of&#160;the&#160;lease<br />
            term or estimated useful life</div></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock', window );">Schedule of disaggregation of revenues</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" border="0" align="right" id="z244734cb0e59414b81b34ea77097c036" style="font: 10pt Times New Roman, Times, Serif; width: 93%; color: #000000; text-align: left"><tr style="font: 10pt Times New Roman, Times, Serif"><td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"><div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="10" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">Year Ended December 31,</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"> 2020</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">2019</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">2018</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Units placed</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">3,620</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">4,385</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">6,237</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Spare parts and warranties</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">773</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">488</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">308</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Total Revenues</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">4,393</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">4,873</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">6,545</div></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_ScheduleOfTradeReceivablesAndDeferredRevenuesTableTextBlock', window );">Schedule of trade receivables and short and long term deferred revenues</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" border="0" align="right" id="z5c799b2fe8f0464797acfbb534d43627" style="font: 10pt Times New Roman, Times, Serif; width: 93%; color: #000000; text-align: left"><tr style="font: 10pt Times New Roman, Times, Serif"><td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom"><div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">&#160;</td>
        <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">December 31,</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">&#160;</td>
        <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">December 31,</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"> 2020</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">2019</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Trade receivable, net (1)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">684</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">794</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Deferred revenues (1) (2)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">1,108</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">844</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 72pt; clear: both">&#160;</div>
  <table cellspacing="0" cellpadding="0" border="0" align="right" id="z17cb99861cfd43fcbaa9360391eba714" style="font: 10pt Times New Roman, Times, Serif; width: 93%; color: #000000; text-align: left">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 3.85%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(1)</div>
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 96.15%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">Balance presented net of unrecognized revenues that were not yet collected.</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 72pt; clear: both">&#160;</div>
  <table cellspacing="0" cellpadding="0" border="0" align="right" id="z3161792d8d93450192807264069a7a74" style="font: 10pt Times New Roman, Times, Serif; width: 93%; color: #000000; text-align: left">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 3.85%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(2)</div>
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 96.15%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">$330 thousand of December&#160;31, 2019 deferred revenues balance were recognized as revenues during the year ended December 31, 2020.</div></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Black-Scholes-Merton option pricing model assumptions</a></td>
<td class="text"><div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">The fair value for options granted in 2019, 2018 is estimated at the date of grant using a Black-Scholes-Merton option pricing model with the following assumptions:</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
  <table cellspacing="0" cellpadding="0" border="0" align="right" id="zcfac848f1c7c4ec8be5afff37beb22e7" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="6" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">Year Ended December 31,</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"> 2019</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">2018</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: #CCEEFF; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Expected volatility</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">57.5</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">%</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">57% - 61</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">%</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Risk-free rate</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">2.22</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">%</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">2.74% - 2.83</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">%</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: #CCEEFF; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Dividend yield</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#8212;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">%</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#8212;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">%</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Expected term (in years)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">6.11</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">6.11</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: #CCEEFF; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Share price</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">5.37</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">25.5 - $28.75</div></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock', window );">Schedule of product warranty liability</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" border="0" align="right" id="z24e95ed7a2ee4f738f16153ac66d9200" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left"><tr style="font: 10pt Times New Roman, Times, Serif"><td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"><div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">US Dollars<br />
            in<br />
            thousands</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 88%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Balance at December 31, 2019</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">227</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 88%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Provision</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">125</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 88%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Usage</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(212</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 88%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Balance at December 31, 2020</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">140</div></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock', window );">Schedule of concentration of credit risk</a></td>
<td class="text"><div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">Concentration of credit risk with respect to trade receivable is primarily limited to a customer to which the Company makes substantial sales.</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <table cellspacing="0" cellpadding="0" border="0" align="right" id="z6023b00ba79a4ef29192bf73408506a9" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="6" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">December 31,</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"> 2020</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">2019</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">Customer A</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">15</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">%</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">*</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Customer B</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">15</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">%</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">*</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">Customer C</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">15</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">%</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">*</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">Customer D</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">14</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">%</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">*</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">Customer E</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">12</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">%</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">12</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">%</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">Customer F</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">11</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">%</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">*</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">Customer G</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">*</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">14</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">%</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Customer H</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">*</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">13</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">%</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Customer I</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">*</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">13</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">%</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">Customer J</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">*</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">12</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">%</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">Customer K</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">*</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">12</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">%</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Customer L</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">*</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">12</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">%</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-indent: 36pt; clear: both">&#160;</div>
  <table cellspacing="0" cellpadding="0" border="0" align="right" id="z134b78bbeb3144378ee804552ff51346" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 3.85%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">*)</div>
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 96.15%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">Less than 10%</div></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of basic and diluted net loss per ordinary share</a></td>
<td class="text"><div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">The following table sets forth the computation of the Company&#8217;s basic and diluted net loss per ordinary share (in thousands, except share and per share data):</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <table cellspacing="0" cellpadding="0" border="0" align="right" id="zf3292f75d1664a6e9a65631d4d24c1c5" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="10" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">Year ended December 31,</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"> 2020</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">2019</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">2018</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Net loss</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(12,976</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(15,551</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(21,675</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Net loss attributable to ordinary shares</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(12,976</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(15,551</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(21,675</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Shares used in computing net loss per ordinary shares, basic and diluted</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">15,764,980</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">5,763,317</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">1,472,499</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Net loss per ordinary share, basic and diluted</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(0.82</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(2.70</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(14.72</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_ScheduleOfTradeReceivablesAndDeferredRevenuesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of trade receivables and short and long term deferred revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_ScheduleOfTradeReceivablesAndDeferredRevenuesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of expected timing for satisfying remaining performance obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of public utility physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, deprecation expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 980<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84167750&amp;loc=d3e42232-110370<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13537-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13531-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6327-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6442-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140286968837048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PREPAID EXPENSES AND OTHER CURRENT ASSETS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract', window );"><strong>Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock', window );">Schedule of prepaid expenses and other current assets</a></td>
<td class="text"><div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-indent: 36pt">The components of prepaid expenses and other current assets are as follows (in thousands):</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
  <table cellspacing="0" cellpadding="0" border="0" align="right" id="zc6efca7e7e844e46a25c6bd8d55ca9ea" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="6" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">December 31,</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"> 2020</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">2019</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Government institutions</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">87</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">175</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Prepaid expenses</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">311</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">318</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Advances to vendors</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">241</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">246</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Other assets</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">33</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">164</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">672</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">903</div></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140286968848968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of inventories</a></td>
<td class="text"><div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-indent: 36pt">The components of inventories are as follows (in thousands):</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-indent: 36pt">&#160;</div>
  <table cellspacing="0" cellpadding="0" border="0" align="right" id="z4334ea3338be48a1a507c3302b556507" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="6" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">December 31,</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"> 2020</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">2019</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Finished products</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">2,764</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">2,394</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Raw materials</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">778</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">729</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">3,542</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">3,123</div></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140286965021048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT, NET (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of components of Property and Equipment, Net</a></td>
<td class="text"><div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-indent: 36pt">The components of property and equipment, net are as follows (in thousands):</div>
  <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
  <table cellspacing="0" cellpadding="0" border="0" align="right" id="z40bab54ebb0e4397aeb5637d012e1e87" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="6" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">December 31,</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"> 2020</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">2019</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Cost:</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Computer equipment</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">725</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">723</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Office furniture and equipment</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">298</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">293</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Machinery and laboratory equipment</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">612</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">604</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Field service units</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">1,626</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">1,420</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Leasehold improvements</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">333</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">333</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">3,594</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">3,373</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; clear: both">&#160;</div>
  <table cellspacing="0" cellpadding="0" border="0" align="right" id="z840539bb6b7f46bea160bf1f1c4d9228" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="6" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">December 31,</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"> 2020</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">2019</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Accumulated depreciation</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">3,157</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">2,872</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Property and equipment, net</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">437</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">501</div></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140286965178200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENT LIABILITIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock', window );">Schedule of future minimum lease commitments</a></td>
<td class="text"><div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">The Company&#8217;s future lease payments for its facilities and cars, which are presented as current maturities of operating leases and non-current operating leases liabilities on the
    Company&#8217;s consolidated balance sheets as of&#160;December&#160;31, 2020&#160;are as follows (in thousands):</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">&#160;</div>
  <table cellspacing="0" cellpadding="0" border="0" align="right" id="zdb7695d55aa043a5a1fe0885ee1a4249" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">2021</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">710</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 88%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">2022</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">676</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 88%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">2023</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">491</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 88%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Total lease payments</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">1,877</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 88%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Less: imputed interest</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(294</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 88%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Present value of future lease payments</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">1,583</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Less: current maturities of operating leases</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(660</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 88%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Non-current operating leases</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">923</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Weighted-average remaining lease term (in years)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">2.69</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 88%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Weighted-average discount rate</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">12.6</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">%</div></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121573735&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140286962258456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHAREHOLDERS' EQUITY (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock', window );">Schedule of employee and non-employee shares options activity</a></td>
<td class="text"><div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"><div style="font: 10pt/1.25 Times New Roman, Times, Serif">A summary of employee and&#160;non-employee shares options activity during the fiscal year ended 2020 is as follows:</div>
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 72pt">&#160;</div>
  <table cellspacing="0" cellpadding="0" border="0" align="right" id="z333a780dd513489ea483da9d96b10a52" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">Number</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">Average</div>
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">exercise</div>
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">price</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">Average</div>
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">remaining</div>
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">contractual</div>
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">life (years)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">Aggregate</div>
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">intrinsic</div>
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">value (in</div>
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">thousands)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 52%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Options outstanding at the beginning of the year</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">74,713</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">41.6</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">6.34</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">135</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 52%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Granted</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#8212;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#8212;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#8212;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#8212;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 52%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Exercised</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#8212;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#8212;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#8212;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#8212;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 52%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Forfeited</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(5,107</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">91.59</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#8212;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#8212;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 52%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 52%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Options outstanding at the end of the year</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">69,606</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">37.9</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">5.59</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#8212;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 52%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 52%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Options exercisable at the end of the year</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">52,997</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">43.76</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">4.94</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#8212;</div></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock', window );">Schedule of employee and non-employee RSUs activity</a></td>
<td class="text"><div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt"><div style="font: 10pt/1.25 Times New Roman, Times, Serif">A summary of employee and&#160;non-employee RSUs activity during the fiscal year ended 2020 is as follows:</div>
  </div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">&#160;</div>
  <table cellspacing="0" cellpadding="0" border="0" align="right" id="z08c2cc9952cf4a269ef65b9e027ffd67" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">Number of</div>
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">shares underlying</div>
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">outstanding</div>
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">RSUs</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">Weighted-</div>
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">average</div>
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">grant date</div>
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">fair value</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Unvested RSUs at the beginning of the year</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">62,378</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">44.61</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Granted</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">1,266,185</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">1.44</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Vested</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(63,111</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">7.83</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Forfeited</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(14,141</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">6.05</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Unvested RSUs at the end of the year</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">1,251,311</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">3.20</div></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock', window );">Schedule of options and RSUs outstanding</a></td>
<td class="text"><div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">The number of options and RSUs outstanding as of December&#160;31, 2020 is set forth below, with options separated by range of exercise price:</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 54pt">&#160;</div>
  <table cellspacing="0" cellpadding="0" border="0" align="right" id="z6f11344252224499ad65c066a0b989e8" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif">Range of exercise&#160;price</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">Options and RSUs<br />
            Outstanding as of<br />
            December 31,<br />
            2020</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">Weighted</div>
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">average</div>
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">remaining</div>
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">contractual</div>
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">life (years) (1)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">Options Exercisable as of December 31,<br />
            2020</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">Weighted</div>
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">average</div>
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">remaining</div>
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">contractual</div>
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">life (years) (1)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 52%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">RSUs only</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">1,251,311</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#8212;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#8212;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#8212;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 52%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$5.37</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">12,425</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">8.24</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">5,435</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">8.24</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 52%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$20.42- $33.75</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">36,292</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">5.26</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">27,598</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">4.60</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 52%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$37.14-$38.75</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">9,992</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">2.99</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">9,992</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">2.99</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 52%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$50-$52.5</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">8,231</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">6.43</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">7,306</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">6.44</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 52%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$182.5-$524.25</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">2,666</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">4.84</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">2,666</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">4.84</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 52%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">1,320,917</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">5.59</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">52,997</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">4.94</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; clear: both">&#160;</div>
  <table cellspacing="0" cellpadding="0" border="0" align="right" id="z0880807c2442494481d433b408f422c8" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 3.85%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(1)</div>
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 96.09%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">Calculation of weighted average remaining contractual term does not include the RSUs that were granted, which have an indefinite contractual term.</div></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of non-cash share-based compensation expense</a></td>
<td class="text"><div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">The Company recognized
non-cash share-based compensation expense in the consolidated statements of operations as follows (in thousands):</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif"><br style="line-height: 1.25" />
  </div>
  <table cellspacing="0" cellpadding="0" border="0" align="right" id="zedd6cc7efe2d49be877f8a188016ed3a" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="10" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">Year Ended December 31,</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"> 2020</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">2019</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">2018</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Cost of revenues</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">8</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">13</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">16</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Research and development, net</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">136</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">204</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">435</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Sales and marketing, net</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">163</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">166</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">467</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">General and administrative</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">442</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">725</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">1,848</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Total</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">749</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">1,108</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">2,766</div>
        </td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock', window );">Schedule of warrants outstanding and exercisable</a></td>
<td class="text"><div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 36pt">The following table summarizes information about warrants outstanding and exercisable as of December&#160;31, 2020:</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-indent: 36pt">&#160;</div>
  <table cellspacing="0" cellpadding="0" border="0" align="right" id="z10fa5c8f5fd64ea58708475ca56d3205" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif">Issuance date</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">Warrants<br />
            outstanding</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">Exercise price per warrant</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">Warrants outstanding and exercisable</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">Contractual<br />
            term</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">(number)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">(number)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center">&#160;</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">December 31, 2015 (1)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">4,771</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">7.500</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">4,771</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center">See footnote (1)</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 32%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">November 1, 2016 (2)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">97,496</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">118.750</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">97,496</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 32%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center">November 1, 2021</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">December 28, 2016 (3)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">1,908</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">7.500</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">1,908</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center">See footnote (1)</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 32%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">November 20, 2018 (4)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">126,839</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">7.500</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">126,839</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 32%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center">November 20, 2023</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">November 20, 2018 (5)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">106,680</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">9.375</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">106,680</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center">November 15, 2023</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 32%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">February 25, 2019 (6)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">45,600</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">7.187</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">45,600</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 32%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center">February 21, 2024</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">April 5, 2019 (7)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">408,457</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">5.140</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">408,457</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center">October 7, 2024</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 32%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">April 5, 2019 (8)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">49,015</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">6.503</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">49,015</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 32%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center">April 3, 2024</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">June 5, 2019 and June 6, 2019 (9)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">1,464,665</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">7.500</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">1,464,665</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center">June 5, 2024</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 32%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">June 5, 2019 (10)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">87,880</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">9.375</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">87,880</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 32%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center">June 5, 2024</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">June 12, 2019 (11)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">416,667</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">6.000</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">416,667</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center">December 12, 2024</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 32%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">June 10, 2019 (12)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">50,000</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">7.500</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">50,000</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 32%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center">June 10, 2024</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">February 10, 2020 (13)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">3,768,500</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">1.250</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">4,343,500</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center">February 10, 2025</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 32%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">February 10, 2020 (14)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">336,000</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">1.5625</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">336,000</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 32%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center">February 10, 2025</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">July 6, 2020 (15)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">2,469,139</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">1.76</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">2,469,139</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center">July 2, 2025</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 32%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">July 6, 2020 (16)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">296,297</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">2.2781</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">296,297</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 32%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center">July 2, 2025</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">December 3, 2020 (17)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">4,184,832</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">1.34</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">4,184,832</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center">June 8, 2026</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 32%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">December 3, 2020 (18)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">334,787</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">1.7922</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">334,787</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 32%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center">June 8, 2026</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">14,249,533</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">14,249,533</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 32%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: center">&#160;</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt Times New Roman, Times, Serif; clear: both"><br />
  </div>
  <table cellspacing="0" cellpadding="0" border="0" align="right" style="font: 10pt Times New Roman, Times, Serif; width: 100%; color: #000000; text-align: left">

      <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="width: 5%">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 4%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(1)</div>
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 91%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">Represents warrants for ordinary shares issuable upon an exercise price of $7.5 per share, which were granted on December 31, 2015 to Kreos Capital V (Expert) Fund Limited, or Kreos, in
            connection with a loan made by Kreos to us and are currently exercisable (in whole or in part) until the earlier of (i) December 30, 2025 or (ii) immediately prior to the consummation of a merger, consolidation, or reorganization of us with or
            into, or the sale or license of all or substantially all the assets or shares of us to, any other entity or person, other than a wholly-owned subsidiary of us, excluding any transaction in which the Company&#8217;s shareholders prior to the
            transaction will hold more than 50% of the voting and economic rights of the surviving entity after the transaction. None of these warrants had been exercised as of December 31, 2020.</div>
        </td>
      </tr>

  </table>

  <table cellspacing="0" cellpadding="0" border="0" align="right" id="ze5403d3ed0b34b878e19f68e7a78deb7" style="font: 10pt Times New Roman, Times, Serif; width: 100%; color: #000000; text-align: left">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; width: 5%; vertical-align: top">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 4%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(2)</div>
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 91%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">Represents warrants issued as part of the Company&#8217;s follow-on offering in November 2016. At any time, the board of directors may reduce the exercise price of the warrants to any amount and for
            any period of time it deems appropriate.</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; width: 5%; vertical-align: top">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 4%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(3)</div>
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 91%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">Represents common warrants that were issued as part of the $8.0 million drawdown under the Loan Agreement which occurred on December 28, 2016. See footnote 1 for exercisability terms.</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; width: 5%; vertical-align: top">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 4%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(4)</div>
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 91%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">Represents common warrants that were issued as part of the Company&#8217;s follow-on offering in November 2018. As of September 30, 2019, warrants to purchase an aggregate 1,651,537 ordinary shares
            had been exercised.</div>
        </td>
      </tr>

  </table>
  <table cellspacing="0" cellpadding="0" border="0" align="right" style="font: 10pt Times New Roman, Times, Serif; width: 100%; color: rgb(0, 0, 0); text-align: left; clear: both">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; width: 5%; vertical-align: top">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 4%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(5)</div>
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 91%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">Represents common warrants that were issued to the underwriters as compensation for their role in the Company&#8217;s follow-on offering in November 2018.</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; width: 5%; vertical-align: top">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 4%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(6)</div>
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 91%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">Represents warrants that were issued to the exclusive placement agent as compensation for its role in the Company&#8217;s follow-on offering in February 2019.</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; width: 5%; vertical-align: top">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 4%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(7)</div>
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 91%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">Represents warrants that were issued to certain institutional purchasers in a private placement in the Company&#8217;s registered direct offering of ordinary shares in April 2019.</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; width: 5%; vertical-align: top">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 4%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(8)</div>
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 91%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">Represents warrants that were issued to the placement agent as compensation for its role in the Company&#8217;s April 2019 registered direct offering.</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; width: 5%; vertical-align: top">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 4%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(9)</div>
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 91%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">Represents warrants that were issued to certain institutional investors in a warrant exercise agreement on June 5, 2019 and June 6, 2019, respectively.</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; width: 5%; vertical-align: top">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 4%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(10)</div>
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 91%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">Represents warrants that were issued to the placement agent as compensation for its role in the Company&#8217;s June 2019 warrant exercise agreement and concurrent private placement of warrants.</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; width: 5%; vertical-align: top">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 4%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(11)</div>
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 91%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">Represents warrants that were issued to certain institutional investors in a warrant exercise agreement in June 2019.</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; width: 5%; vertical-align: top">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 4%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(12)</div>
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 91%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">Represents warrants that were issued to the placement agent as compensation for its role in the Company&#8217;s June 2019 registered direct offering and concurrent private placement of warrants.</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; width: 5%; vertical-align: top">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 4%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(13)</div>
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 91%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">Represents warrants that were issued to certain institutional purchasers in a private placement in the Company&#8217;s best efforts offering of ordinary shares in February 2020.</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; width: 5%; vertical-align: top">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 4%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(14)</div>
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 91%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">Represents warrants that were issued to the placement agent as compensation for its role in the Company&#8217;s February 2020 best efforts offering.</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; width: 5%; vertical-align: top">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 4%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(15)</div>
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 91%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">Represents warrants that were issued to certain institutional purchasers in a private placement in our registered direct offering of ordinary shares in July 2020</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; width: 5%; vertical-align: top">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 4%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(16)</div>
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 91%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">Represents warrants that were issued to the placement agent as compensation for its role in the Company&#8217;s July 2020 registered direct offering.</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; width: 5%; vertical-align: top">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 4%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(17)</div>
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 91%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">Represents warrants that were issued to certain institutional purchasers in a private placement in our private placement offering of ordinary shares in December 2020</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; width: 5%; vertical-align: top">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 4%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(18)</div>
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 91%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">Represents warrants that were issued to the placement agent as compensation for its role in the Company&#8217;s December 2020 private placement.</div></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for stock options and stock appreciation rights that were outstanding at the beginning and end of the year, exercisable at the end of the year, and the number of stock options and stock appreciation rights that were granted, exercised or converted, forfeited, and expired during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 50<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6784392&amp;loc=d3e188667-122775<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140286962016744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Schedule of loss before taxes on income</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z563e6c146a774b7c840fb8537d035ac8" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"><br />
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top"></td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify">
          <div style="font: 10pt Times New Roman, Times, Serif">Income (loss) before taxes on income is comprised as follows (in
          thousands):</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 36pt">&#160;</div>
  <table cellspacing="0" cellpadding="0" border="0" align="right" id="z2ba3a7d1752c4363bc6e2cd6ff3d455b" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="10" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">Year Ended December 31,</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"> 2020</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">2019</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">2018</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Domestic</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(12,992</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(15,599</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(21,784</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Foreign</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">67</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">55</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">104</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(12,925</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(15,544</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(21,680</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of taxes on income</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z081375363046492ba85434cf4fe097b1" style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: left; color: #000000">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 17pt"><br />
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 19pt; vertical-align: top"></td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: auto; vertical-align: top; text-align: justify">
          <div style="font: 10pt Times New Roman, Times, Serif">Taxes on income are comprised as follows (in thousands):&#160;</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
  <table cellspacing="0" cellpadding="0" border="0" align="right" id="zcdc58fc524c440858a57748de7edc2b3" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="10" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">Year Ended December 31,</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"> 2020</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">2019</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">2018</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Current</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">95</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">64</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">102</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Deferred</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(44</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(57</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(107</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">)<br />
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">51</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">7</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(5</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; clear: both">&#160;</div>
  <table cellspacing="0" cellpadding="0" border="0" align="right" id="zdf4592310e5f4e58871a824057235746" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="10" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">Year Ended December 31,</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"> 2020</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">2019</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">2018</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Domestic</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#8212;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#8212;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#8212;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Foreign</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">51</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">7</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(5</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">51</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">7</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(5</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of deferred income taxes</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" border="0" align="right" id="za1a0ca5d98ce48fcbd64c50f98f02c7d" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left"><tr style="font: 10pt Times New Roman, Times, Serif"><td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"><div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="6" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">December 31,</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"> 2020</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">2019</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Deferred tax assets:</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Carry forward tax losses</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">41,941</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">35,051</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Research and development carry forward expenses-temporary differences</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">946</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">1,294</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Accrual and reserves</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">341</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">290</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">
            <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Lease liabilities</div>
          </div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">390</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">433</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Total deferred tax assets</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">43,618</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">37,068</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Deferred tax liabilities:</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">
            <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Right-of-use asset</div>
          </div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(390</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(433</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Net deferred tax assets</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">43,228</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">36,635</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Valuation allowance</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(42,941</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(36,392</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Net deferred tax assets</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">287</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">243</div></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SummaryOfValuationAllowanceTextBlock', window );">Schedule of net changes in total valuation allowance</a></td>
<td class="text"><div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">The net changes in the
total valuation allowance for each of the years ended December&#160;31, 2020, 2019 and 2018, are comprised as follows (in
thousands):</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt; margin-left: 36pt">&#160;</div>
  <table cellspacing="0" cellpadding="0" border="0" align="right" id="z35a053d4f75348c6b77902f0ea14916a" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="10" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">Year Ended December 31,</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"> 2020</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">2019</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">2018</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Balance at beginning of year</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(36,392</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(29,655</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(26,311</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Changes due to amendments to tax laws and exchange rate differences</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(2,929</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(2,055</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">1,393</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Adjustment previous year loss</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#8212;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(735</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#8212;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Additions during the year</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(3,620</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(3,947</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(4,737</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Balance at end of year</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(42,941</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(36,392</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(29,655</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of reconciliation between the theoretical tax expense and the actual tax expense (benefit)</a></td>
<td class="text"><div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">A reconciliation between the theoretical tax expense, assuming all income is taxed at the statutory tax rate applicable to income of the Company, and the actual tax expense (benefit)
    as reported in the consolidated statements of operations is as follows (in thousands):</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">&#160;</div>
  <table cellspacing="0" cellpadding="0" border="0" align="right" id="z4ab1a317623746aa8f3e7b4ad9ead3cd" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="10" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">Year Ended December 31,</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"> 2020</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">2019</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">2018</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Loss before taxes, as reported in the consolidated statements of operations</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(12,925</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(15,544</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(21,680</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Statutory tax rate</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">23.0</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">%</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">23.0</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">%</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">23.0</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">%</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Theoretical tax benefits on the above amount at the Israeli statutory tax rate</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(2,973</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(3,575</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(4,986</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Income tax at rate other than the Israeli statutory tax rate</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">3</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(1</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">5</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Non-deductible expenses including equity-based compensation expenses and other</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">185</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">255</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">631</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Operating losses and other temporary differences for which valuation allowance was provided</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">3,620</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">3,947</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">4,737</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Permanent differences</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(706</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(651</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(427</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">)</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Other</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(78</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">32</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">35</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Actual tax expense</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">51</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">7</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(5</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfValuationAllowanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of valuation allowances to reduce deferred tax assets to net realizable value, including identification of the deferred tax asset more likely than not will not be fully realized and the corresponding amount of the valuation allowance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfValuationAllowanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140286965285624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL EXPENSES, NET (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other Income and Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock', window );">Schedule of financial expenses, net</a></td>
<td class="text"><div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; margin-left: 36pt">The components of
financial expenses, net were as follows (in thousands):</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 36pt">&#160;</div>
  <table cellspacing="0" cellpadding="0" border="0" align="right" id="z5c91740d842e4334816c9648efa53c90" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="10" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">Year Ended December 31,</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"> 2020</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">2019</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">2018</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Foreign currency transactions and other</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(9</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(34</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">)</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">42</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Financial expenses related to loan agreement with Kreos</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">907</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">1,499</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">2,398</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Bank commissions</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">23</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">31</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">26</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">921</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">1,496</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: #000000 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">2,466</div></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140286965237960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock', window );">Schedule of revenues within geographic areas</a></td>
<td class="text"><div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt">The following is a summary
of revenues within geographic areas (in thousands):</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; text-indent: 36pt">&#160;</div>
  <table cellspacing="0" cellpadding="0" border="0" align="right" id="zec3d7aa5328f4b0f84320dfdfed923e6" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="10" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">Year Ended December 31,</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"> 2020</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">2019</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">2018</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Revenues based on customer&#8217;s location:</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 9pt">Israel</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#8212;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">2</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#8212;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 9pt">United States</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">1,746</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">2,003</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">3,558</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 9pt">Europe</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">2,631</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">2,832</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">2,807</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 9pt">Asia-Pacific</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">8</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">36</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">22</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 9pt">Latin America</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">6</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#8212;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">58</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 9pt">Africa</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">2</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#8212;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">100</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Total revenues</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">4,393</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">4,873</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">6,545</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; clear: both">&#160;</div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock', window );">Schedule of long-lived assets by geographic region</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" border="0" align="right" id="z2ef27552142e4f388dcac51bf5575d3f" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left"><tr style="font: 10pt Times New Roman, Times, Serif"><td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"><div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="6" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">December 31,</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"> 2020</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">2019</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Long-lived assets by geographic region:</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 9pt">Israel</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">145</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">179</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 9pt">United States</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">249</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">244</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 9pt">Germany</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">43</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">78</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 76%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 4px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">437</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">$</div>
        </td>
        <td colspan="1" style="border-bottom: rgb(0, 0, 0) 4px double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">501</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
      </tr>

  </table>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify; clear: both">&#160;</div>
  <table cellspacing="0" cellpadding="0" border="0" align="right" id="zf6398c4ec5504e8a93132307dffabbba" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 3.88%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">(*)</div>
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 96.12%; vertical-align: top">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif; text-align: justify">Long-lived assets are comprised of property and equipment, net.</div></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock', window );">Schedule of major customer data as a percentage of total revenues</a></td>
<td class="text"><div style="font: 10pt/1.25 Times New Roman, Times, Serif; margin-left: 36pt">Major customer data as a percentage of total revenues:</div>
  <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
  <table cellspacing="0" cellpadding="0" border="0" align="right" id="zbbad66930d1b49dbb2d56aacfee26f04" style="font: 10pt Times New Roman, Times, Serif; width: 95%; color: #000000; text-align: left">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="10" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">Year Ended December 31,</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">&#160;</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center"> 2020</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">2019</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        <td colspan="2" style="border-bottom: #000000 2px solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom">
          <div style="font: bold 10pt/1.25 Times New Roman, Times, Serif; text-align: center">2018</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; background-color: #CCEEFF; width: 64%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">Customer A</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">10.0</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">%</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">15.0</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">%</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; width: 1%">&#160;</td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">38.0</div>
        </td>
        <td colspan="1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; background-color: #CCEEFF; vertical-align: bottom; width: 1%">
          <div style="font: 10pt/1.25 Times New Roman, Times, Serif">%</div></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-lived assets, excluding financial instruments, long-term customer relationships of a financial institution, mortgage rights, deferred policy acquisition costs, and deferred tax assets, by geographic areas located in the entity's country of domicile and foreign countries in which the entity holds assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph b<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph a<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the extent of the entity's reliance on its major customers, if revenues from transactions with a single external customer amount to 10 percent or more of entity revenues, including the disclosure of that fact, the total amount of revenues from each such customer, and the identity of the reportable segment or segments reporting the revenues. The entity need not disclose the identity of a major customer or the amount of revenues that each segment reports from that customer. For these purposes, a group of companies known to the entity to be under common control is considered a single customer, and the federal government, a state government, a local government such as a county or municipality, or a foreign government is each considered a single customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140286889533160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GENERAL (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 02, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_GeneralTextualAbstract', window );"><strong>General (Textual)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (181,445)<span></span>
</td>
<td class="num">$ (168,469)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Negative cash flow from operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12,589)<span></span>
</td>
<td class="num">(14,815)<span></span>
</td>
<td class="num">$ (14,774)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12,976)<span></span>
</td>
<td class="num">(15,551)<span></span>
</td>
<td class="num">$ (21,675)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,350<span></span>
</td>
<td class="nump">$ 16,253<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_GeneralTextualAbstract', window );"><strong>General (Textual)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Proceeds from warrants exercise</a></td>
<td class="nump">$ 13,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_GeneralTextualAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_GeneralTextualAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromWarrantExercises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from holders exercising their stock warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromWarrantExercises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140286961056504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives', window );">Property and equipment estimated useful lives</a></td>
<td class="text">Over&#160;the&#160;shorter&#160;of&#160;the&#160;lease  term or estimated useful life<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=rwlk_MachineryAndLaboratoryEquipmentMember', window );">Machinery and laboratory equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives', window );">Property and equipment estimated useful lives</a></td>
<td class="text">15%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=rwlk_FieldServiceUnitsMember', window );">Field service units [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives', window );">Property and equipment estimated useful lives</a></td>
<td class="text">50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Computer equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives', window );">Property and equipment estimated useful lives</a></td>
<td class="text">20%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Office furniture and equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives', window );">Property and equipment estimated useful lives</a></td>
<td class="text">6%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Computer equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives', window );">Property and equipment estimated useful lives</a></td>
<td class="text">33%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Office furniture and equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives', window );">Property and equipment estimated useful lives</a></td>
<td class="text">10%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Describes the periods of time over which an entity anticipates to receive utility from its property, plant and equipment (that is, the periods of time over which an entity allocates the initial cost of its property, plant and equipment).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 35<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=68071081&amp;loc=d3e1205-110223<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=rwlk_MachineryAndLaboratoryEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=rwlk_MachineryAndLaboratoryEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=rwlk_FieldServiceUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=rwlk_FieldServiceUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140286959795064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Details 1) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">$ 4,393<span></span>
</td>
<td class="nump">$ 4,873<span></span>
</td>
<td class="nump">$ 6,545<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_RevenueObligationAxis=rwlk_UnitsPlacedMember', window );">Units Placed [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">3,620<span></span>
</td>
<td class="nump">4,385<span></span>
</td>
<td class="nump">6,237<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_RevenueObligationAxis=rwlk_SparePartsAndWarrantiesMember', window );">Spare parts and warranties [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">$ 773<span></span>
</td>
<td class="nump">$ 488<span></span>
</td>
<td class="nump">$ 308<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_RevenueObligationAxis=rwlk_UnitsPlacedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_RevenueObligationAxis=rwlk_UnitsPlacedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_RevenueObligationAxis=rwlk_SparePartsAndWarrantiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_RevenueObligationAxis=rwlk_SparePartsAndWarrantiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140286962185480">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Details 2) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Trade receivable, net (1)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 684<span></span>
</td>
<td class="nump">$ 794<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenue', window );">Deferred revenues (1) (2)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="nump">$ 1,108<span></span>
</td>
<td class="nump">$ 844<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Balance presented net of unrecognized revenues that were not yet collected.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">$330 thousand of December 31, 2019 deferred revenues balance were recognized as revenues during the year ended December 31, 2020.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140286959969928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Details 3) - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.22%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">0 years<span></span>
</td>
<td class="text">6 years 1 month 9 days<span></span>
</td>
<td class="text">6 years 1 month 9 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.74%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.83%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 28.75<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140286964989464">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Details 4) - shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_SignificantAccountingPoliciesDetails4Abstract', window );"><strong>Significant Accounting Policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to acquire common stock</a></td>
<td class="nump">11,389,555<span></span>
</td>
<td class="nump">2,522,284<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_SignificantAccountingPoliciesDetails4Abstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_SignificantAccountingPoliciesDetails4Abstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140286962219320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Details 5)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInStandardProductWarrantyAccrualRollForward', window );"><strong>Warranty provision:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyAccrual', window );">Balance at December 31, 2019</a></td>
<td class="nump">$ 227<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued', window );">Provision</a></td>
<td class="nump">125<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyAccrualPayments', window );">Usage</a></td>
<td class="num">(212)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyAccrual', window );">Balance at December 31, 2020</a></td>
<td class="nump">$ 140<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInStandardProductWarrantyAccrualRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInStandardProductWarrantyAccrualRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyAccrual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount as of the balance sheet date of the aggregate standard product warranty liability. Does not include the balance for the extended product warranty liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)(1),(c)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyAccrual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyAccrualPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in the standard product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard product warranty. Excludes extended product warranties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph ((c)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyAccrualPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in the standard product warranty accrual from warranties issued. Excludes extended product warranties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph ((c)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyAccrualWarrantiesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140286959639400">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Details 6)<br></strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th" colspan="2"><div>Dec. 31, 2020</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=rwlk_CustomerAMember', window );">Customer A [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration of credit risk</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">15.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=rwlk_CustomerBMember', window );">Customer B [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration of credit risk</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">15.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=rwlk_CustomerCMember', window );">Customer C [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration of credit risk</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">15.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=rwlk_CustomerDMember', window );">Customer D [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration of credit risk</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">14.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=rwlk_CustomerEMember', window );">Customer E [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration of credit risk</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">12.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">12.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=rwlk_CustomerFMember', window );">Customer F [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration of credit risk</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">11.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=rwlk_CustomerGMember', window );">Customer G [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration of credit risk</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">14.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=rwlk_CustomerHMember', window );">Customer H [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration of credit risk</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">13.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=rwlk_CustomerIMember', window );">Customer I [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration of credit risk</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">13.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=rwlk_CustomerJMember', window );">Customer J [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration of credit risk</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">12.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=rwlk_CustomerKMember', window );">Customer K [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration of credit risk</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">12.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=rwlk_CustomerLMember', window );">Customer L [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration of credit risk</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">12.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Less than 10%</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=rwlk_CustomerAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=rwlk_CustomerAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=rwlk_CustomerBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=rwlk_CustomerBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=rwlk_CustomerCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=rwlk_CustomerCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=rwlk_CustomerDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=rwlk_CustomerDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=rwlk_CustomerEMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=rwlk_CustomerEMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=rwlk_CustomerFMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=rwlk_CustomerFMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=rwlk_CustomerGMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=rwlk_CustomerGMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=rwlk_CustomerHMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=rwlk_CustomerHMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=rwlk_CustomerIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=rwlk_CustomerIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=rwlk_CustomerJMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=rwlk_CustomerJMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=rwlk_CustomerKMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=rwlk_CustomerKMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=rwlk_CustomerLMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=rwlk_CustomerLMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140286961289400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Details 7) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">$ (12,976)<span></span>
</td>
<td class="num">$ (15,551)<span></span>
</td>
<td class="num">$ (21,675)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net loss attributable to ordinary shares</a></td>
<td class="num">$ (12,976)<span></span>
</td>
<td class="num">$ (15,551)<span></span>
</td>
<td class="num">$ (21,675)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Shares used in computing net loss per ordinary shares, basic and diluted</a></td>
<td class="nump">15,764,980<span></span>
</td>
<td class="nump">5,763,317<span></span>
</td>
<td class="nump">1,472,499<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Net loss per ordinary share, basic and diluted</a></td>
<td class="num">$ (0.82)<span></span>
</td>
<td class="num">$ (2.70)<span></span>
</td>
<td class="num">$ (14.72)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140286960116664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Details Textual) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_SignificantAccountingPoliciesTextualAbstract', window );"><strong>Significant Accounting Policies (Textual)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWriteDown', window );">Wrote off inventory amount</a></td>
<td class="nump">$ 215<span></span>
</td>
<td class="nump">$ 64<span></span>
</td>
<td class="nump">$ 562<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for doubtful accounts</a></td>
<td class="nump">102<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_AllowanceForSalesReturns', window );">Net of sales return reserve</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Deferred revenue recognized</a></td>
<td class="nump">$ 330<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_RevenueRecognitionRecognized', window );">Revenue recognition description</a></td>
<td class="text">The estimated revenue expected to be recognized in the future related to the service type warranty amounts to $1,108 thousand, which is fulfilled over one to five years.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Non-cash compensation expenses</a></td>
<td class="nump">$ 749<span></span>
</td>
<td class="nump">1,108<span></span>
</td>
<td class="nump">2,766<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement', window );">Maximum percentage of likely to be realized upon ultimate settlement</a></td>
<td class="text">50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_SeverancePayMonthlyDepositByEmployeesPercentage', window );">Percentage of monthly deposit by employees</a></td>
<td class="nump">8.33%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PostemploymentBenefitsPeriodExpense', window );">Severance pay expense</a></td>
<td class="nump">$ 125<span></span>
</td>
<td class="nump">156<span></span>
</td>
<td class="nump">169<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_RoyaltyBearingGrantsExpenses', window );">Royalty-bearing grants expenses</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">198<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RoyaltyExpense', window );">Royalty expenses</a></td>
<td class="nump">$ 46<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LessorOperatingLeaseDescription', window );">Lease, description</a></td>
<td class="text">Upon adoption of this standard on January 1, 2019, the Company recorded right&#8211;of&#8211;use assets and corresponding lease liabilities of $2,099 thousand and $2,249 thousand, respectively. As of December 31, 2020, the right&#8211;of&#8211;use assets and corresponding lease liabilities in the Company&#8217;s consolidated balance sheets were $1,349 thousand and $1,583 thousand, respectively.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=rwlk_YaskawaElectricCorporationMember', window );">YEC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_SignificantAccountingPoliciesTextualAbstract', window );"><strong>Significant Accounting Policies (Textual)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment losses</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Related party receivables as a percent of trade receivables, net</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromRelatedParties', window );">Revenues from related party</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 41<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201609Member', window );">Accounting Standards Update 2016-09 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_SignificantAccountingPoliciesTextualAbstract', window );"><strong>Significant Accounting Policies (Textual)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_CumulativeEffectOnRetainedEarningsNetOfTax', window );">Cumulative-effect adjustment to retained earnings/accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=rwlk_EmployeesAndNonEmployeesMember', window );">Employees and non- employees [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_SignificantAccountingPoliciesTextualAbstract', window );"><strong>Significant Accounting Policies (Textual)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Non-cash compensation expenses</a></td>
<td class="nump">$ 749<span></span>
</td>
<td class="nump">$ 1,108<span></span>
</td>
<td class="nump">$ 2,766<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rwlk_ReStoreProductMember', window );">ReStore product [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_SignificantAccountingPoliciesTextualAbstract', window );"><strong>Significant Accounting Policies (Textual)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Service policy</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rwlk_SCIProductsMember', window );">SCI Products [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_SignificantAccountingPoliciesTextualAbstract', window );"><strong>Significant Accounting Policies (Textual)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Service policy</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_AllowanceForSalesReturns">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Allowance for Sales Returns</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_AllowanceForSalesReturns</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_CumulativeEffectOnRetainedEarningsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cumulative-effect adjustment to retained earnings/accumulated deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_CumulativeEffectOnRetainedEarningsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_RevenueRecognitionRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue Recognition Recognized</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_RevenueRecognitionRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_RoyaltyBearingGrantsExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the expenses related to royalty bearing grants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_RoyaltyBearingGrantsExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_SeverancePayMonthlyDepositByEmployeesPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the percentage of monthly deposit required by employees as per the severance pay law.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_SeverancePayMonthlyDepositByEmployeesPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_SignificantAccountingPoliciesTextualAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_SignificantAccountingPoliciesTextualAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121599878&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2921-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the likelihood that an uncertainty in income taxes will not be sustained as a result of the examination by the taxing authority.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 15<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877542&amp;loc=d3e27249-109313<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4542-108314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeaseDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of lessor's operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121576215&amp;loc=SL77919359-209981<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeaseDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PostemploymentBenefitsPeriodExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period expense related to postemployment benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PostemploymentBenefitsPeriodExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07.1(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401555&amp;loc=SL114874292-224272<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1(e))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RoyaltyExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RoyaltyExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=rwlk_YaskawaElectricCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=rwlk_YaskawaElectricCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201609Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201609Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=rwlk_EmployeesAndNonEmployeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=rwlk_EmployeesAndNonEmployeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rwlk_ReStoreProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rwlk_ReStoreProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rwlk_SCIProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rwlk_SCIProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140286962854472">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>PREPAID EXPENSES AND OTHER CURRENT ASSETS (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract', window );"><strong>Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_PrepaidExpensesToGovernmentInstitutionsCurrent', window );">Government institutions</a></td>
<td class="nump">$ 87<span></span>
</td>
<td class="nump">$ 175<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses</a></td>
<td class="nump">311<span></span>
</td>
<td class="nump">318<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Supplies', window );">Advances to vendors</a></td>
<td class="nump">241<span></span>
</td>
<td class="nump">246<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other assets</a></td>
<td class="nump">33<span></span>
</td>
<td class="nump">164<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">$ 672<span></span>
</td>
<td class="nump">$ 903<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_PrepaidExpensesToGovernmentInstitutionsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance to government institutions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_PrepaidExpensesToGovernmentInstitutionsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6787-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=68074540&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Supplies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration paid in advance for supplies that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(7)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=68074540&amp;loc=d3e5879-108316<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6787-107765<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Supplies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140286966573160">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INVENTORIES (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Finished products</a></td>
<td class="nump">$ 2,764<span></span>
</td>
<td class="nump">$ 2,394<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterials', window );">Raw materials</a></td>
<td class="nump">778<span></span>
</td>
<td class="nump">729<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">$ 3,542<span></span>
</td>
<td class="nump">$ 3,123<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterials">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterials</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140286961226904">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT, NET (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">$ 3,594<span></span>
</td>
<td class="nump">$ 3,373<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation</a></td>
<td class="nump">3,157<span></span>
</td>
<td class="nump">2,872<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">437<span></span>
</td>
<td class="nump">501<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">725<span></span>
</td>
<td class="nump">723<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Office furniture and equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">298<span></span>
</td>
<td class="nump">293<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=rwlk_MachineryAndLaboratoryEquipmentMember', window );">Machinery and laboratory equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">612<span></span>
</td>
<td class="nump">604<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=rwlk_FieldServiceUnitsMember', window );">Field service units [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">1,626<span></span>
</td>
<td class="nump">1,420<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">$ 333<span></span>
</td>
<td class="nump">$ 333<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=rwlk_MachineryAndLaboratoryEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=rwlk_MachineryAndLaboratoryEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=rwlk_FieldServiceUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=rwlk_FieldServiceUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140286965152920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT, NET (Details Textual) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_PropertyAndEquipmentNetTextualAbstract', window );"><strong>Property and Equipment, Net (Textual)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expenses</a></td>
<td class="nump">$ 285<span></span>
</td>
<td class="nump">$ 321<span></span>
</td>
<td class="nump">$ 463<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_PropertyAndEquipmentNetTextualAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_PropertyAndEquipmentNetTextualAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140286963158136">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>LOAN AGREEMENT WITH KREOS AND RELATED WARRANT TO PURCHASE ORDINARY SHARES (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jan. 04, 2016</div></th>
<th class="th"><div>Dec. 30, 2015</div></th>
<th class="th"><div>Nov. 20, 2018</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Jun. 06, 2019</div></th>
<th class="th"><div>Jun. 09, 2017</div></th>
<th class="th"><div>Dec. 28, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from long term loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 392<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrant to purchase ordinary shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,389,555<span></span>
</td>
<td class="nump">2,522,284<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rwlk_SecondAmendmentMember', window );">Second Amendment [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Units issued</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">192,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rwlk_SecondAmendmentMember', window );">Second Amendment [Member] | Pre-Funded [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Units issued</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">288,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Secured Debt [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from long term loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Loan term</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">24 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">36 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Annual interest rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_DebtInstrumentProceedsfromIssuanceofCommonStockRequiredforRepaymentPeriodtobeExtended', window );">Required proceeds from issuance of common stock required for repayment period to be extended</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 907<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrant to purchase ordinary shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,771<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">480,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,679<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 241.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Secured Debt [Member] | First Amendment [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_LongtermDebtMaturitiesPortionofPrincipalSubjecttoRepaymentExtension', window );">Portion of principal subject to repayment extension</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="10"></td></tr>
<tr><td colspan="10"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">See note 10.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_DebtInstrumentProceedsfromIssuanceofCommonStockRequiredforRepaymentPeriodtobeExtended">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Proceeds from Issuance of Common Stock Required for Repayment Period to be Extended</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_DebtInstrumentProceedsfromIssuanceofCommonStockRequiredforRepaymentPeriodtobeExtended</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_LongtermDebtMaturitiesPortionofPrincipalSubjecttoRepaymentExtension">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-term Debt, Maturities, Portion of Principal Subject to Repayment Extension</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_LongtermDebtMaturitiesPortionofPrincipalSubjecttoRepaymentExtension</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rwlk_SecondAmendmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rwlk_SecondAmendmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=rwlk_PreFundedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=rwlk_PreFundedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rwlk_FirstAmendmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rwlk_FirstAmendmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140286962610440">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENT LIABILITIES (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent', window );">2021</a></td>
<td class="nump">$ 710<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears', window );">2022</a></td>
<td class="nump">676<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears', window );">2023</a></td>
<td class="nump">491<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">1,877<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_ImputedInterest', window );">Less: imputed interest</a></td>
<td class="num">(294)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PresentValueOfFutureMinimumLeasePaymentsSaleLeasebackTransactions', window );">Present value of future lease payments</a></td>
<td class="nump">1,583<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Less: current maturities of operating leases</a></td>
<td class="num">(660)<span></span>
</td>
<td class="num">$ (637)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Non-current operating leases</a></td>
<td class="nump">$ 923<span></span>
</td>
<td class="nump">$ 1,315<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted-average remaining lease term (in years)</a></td>
<td class="text">2 years 8 months 9 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted-average discount rate</a></td>
<td class="nump">12.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_ImputedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Less: imputed interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_ImputedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121573735&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121580752&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121573735&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121580752&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121580752&amp;loc=d3e38371-112697<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121573735&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121573735&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121580752&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PresentValueOfFutureMinimumLeasePaymentsSaleLeasebackTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of minimum lease payments for sale-leaseback transactions accounted for using the deposit method or as a financing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121616839&amp;loc=d3e45280-112737<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PresentValueOfFutureMinimumLeasePaymentsSaleLeasebackTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140286960200680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENT LIABILITIES (Details Textual) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_CommitmentsAndContingenciesLiabilitiesTextualAbstract', window );"><strong>Commitments and Contingent Liabilities (Textual)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligation', window );">Non-cancelable outstanding obligations</a></td>
<td class="nump">$ 700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_OperatingLeasesMaximumPenaltiesPayableOnEarlyReleaseOfAgreement', window );">Maximum penalties payable on early release of agreement</a></td>
<td class="nump">26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RoyaltyExpense', window );">Royalties expenses</a></td>
<td class="nump">$ 46<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DescriptionOfLessorLeasingArrangementsOperatingLeases', window );">Lease expiration, term</a></td>
<td class="text">These leases expire between 2021 and 2023.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLongTermDebt', window );">Other long-term assets</a></td>
<td class="nump">$ 704<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesRentExpenseNet', window );">Rent expenses</a></td>
<td class="nump">$ 764<span></span>
</td>
<td class="nump">$ 739<span></span>
</td>
<td class="nump">$ 695<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_CommitmentsAndContingenciesLiabilitiesTextualAbstract', window );"><strong>Commitments and Contingent Liabilities (Textual)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockDescription', window );">Description of conversion ratio</a></td>
<td class="text">Ordinary shares in a conversion ratio of 1 to 1.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=rwlk_IsraelInnovationAuthorityMember', window );">Israel Innovation Authority [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_CommitmentsAndContingenciesLiabilitiesTextualAbstract', window );"><strong>Commitments and Contingent Liabilities (Textual)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRoyaltiesReceived', window );">Total fund received</a></td>
<td class="nump">$ 1,970<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_ResearchAndDevelopmentRoyaltyBearingGrants', window );">Royalty bearing grants</a></td>
<td class="nump">1,570<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRoyalties', window );">Royalties paid</a></td>
<td class="nump">$ 88<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_RoyaltyFeesPercentage', window );">Percentage of obligation to pay royalties</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_ContingentLiabilityRelatedToGrantsReceived', window );">Contingent liability</a></td>
<td class="nump">$ 1,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_PercentageOfGrantReceivedConsideredToDetermineRoyaltyFees', window );">Percentage of grant received</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=rwlk_IsraelInnovationAuthorityMember', window );">Israel Innovation Authority [Member] | Convertible preferred A shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_CommitmentsAndContingenciesLiabilitiesTextualAbstract', window );"><strong>Commitments and Contingent Liabilities (Textual)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_ResearchAndDevelopmentAmountReceivedInConsiderationOfConvertiblePreferredShares', window );">Amount received in consideration of preferred shares</a></td>
<td class="nump">$ 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion', window );">Convertible preferred shares</a></td>
<td class="nump">209<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=rwlk_IsraelUSBinationalIndustrialResearchAndDevelopmentFoundationMember', window );">Israel US Binational Industrial Research And Development Foundation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_CommitmentsAndContingenciesLiabilitiesTextualAbstract', window );"><strong>Commitments and Contingent Liabilities (Textual)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRoyaltiesReceived', window );">Total fund received</a></td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=rwlk_RrlAndRrgMember', window );">RRL and RRG [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_CommitmentsAndContingenciesLiabilitiesTextualAbstract', window );"><strong>Commitments and Contingent Liabilities (Textual)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DescriptionOfLessorLeasingArrangementsOperatingLeases', window );">Lease expiration, term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">RRL and RRG lease cars for their employees under cancelable operating lease agreements expiring at various dates in between 2021 and 2023.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_CommitmentsAndContingenciesLiabilitiesTextualAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_CommitmentsAndContingenciesLiabilitiesTextualAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_ContingentLiabilityRelatedToGrantsReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the contingent liability related to grant received as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_ContingentLiabilityRelatedToGrantsReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_OperatingLeasesMaximumPenaltiesPayableOnEarlyReleaseOfAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the maximum amount of penalties payable on early release of lease agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_OperatingLeasesMaximumPenaltiesPayableOnEarlyReleaseOfAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_PercentageOfGrantReceivedConsideredToDetermineRoyaltyFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the percentage of grant received considered to determine royalty fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_PercentageOfGrantReceivedConsideredToDetermineRoyaltyFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_ResearchAndDevelopmentAmountReceivedInConsiderationOfConvertiblePreferredShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the portion of aggregate amount received in consideration of convertible preferred shares by the entity to fund research and development activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_ResearchAndDevelopmentAmountReceivedInConsiderationOfConvertiblePreferredShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_ResearchAndDevelopmentRoyaltyBearingGrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the portion of aggregate amount received as royalty bearing grants by the entity to fund research and development activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_ResearchAndDevelopmentRoyaltyBearingGrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_RoyaltyFeesPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the percentage of royalty fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_RoyaltyFeesPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique description of a noncash or part noncash stock conversion. The description would be expected to include sufficient information to provide an understanding of the nature and purpose of the conversion. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for each share of convertible preferred stock that is converted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21506-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DescriptionOfLessorLeasingArrangementsOperatingLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A general description of the nature of the existing leasing arrangements of a lessor for all operating leases including, but not limited to: (1) guarantees or indemnities; (2) restrictions imposed by lease arrangements; (3) unusual provisions or conditions; (4) contingent rentals; and (5) lease expiration dates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121555071&amp;loc=d3e37045-112695<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DescriptionOfLessorLeasingArrangementsOperatingLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesRentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121573735&amp;loc=d3e41499-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesRentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRoyalties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid for royalties during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRoyalties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRoyaltiesReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received for royalties during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRoyaltiesReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of purchase arrangement in which the entity has agreed to expend funds to procure goods or services from a supplier.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RoyaltyExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RoyaltyExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=rwlk_IsraelInnovationAuthorityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=rwlk_IsraelInnovationAuthorityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=rwlk_IsraelUSBinationalIndustrialResearchAndDevelopmentFoundationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=rwlk_IsraelUSBinationalIndustrialResearchAndDevelopmentFoundationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=rwlk_RrlAndRrgMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=rwlk_RrlAndRrgMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140286961168232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHAREHOLDERS' EQUITY (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number, Options outstanding at the beginning of the period</a></td>
<td class="nump">74,713<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number, Granted</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Number, Exercised</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Number, Forfeited</a></td>
<td class="num">(5,107)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number, Options outstanding at the end of the period</a></td>
<td class="nump">69,606<span></span>
</td>
<td class="nump">74,713<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Number, Options exercisable at the end of the period</a></td>
<td class="nump">52,997<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Average exercise price, Options outstanding at the beginning of the period</a></td>
<td class="nump">$ 41.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Average exercise price, Granted</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Average exercise price, Exercised</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Average exercise price, Forfeited</a></td>
<td class="nump">91.59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Average exercise price, Options outstanding at the end of the period</a></td>
<td class="nump">37.9<span></span>
</td>
<td class="nump">$ 41.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Average exercise price, Options exercisable at the end of the period</a></td>
<td class="nump">$ 43.76<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Average remaining contractual life (in years), Options outstanding at the beginning of the period</a></td>
<td class="text">5 years 7 months 2 days<span></span>
</td>
<td class="text">6 years 4 months 2 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Average remaining contractual life (in years), Options exercisable at the end of the period</a></td>
<td class="text">4 years 11 months 8 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate intrinsic value (in thousands), Options outstanding</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 135<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate intrinsic value (in thousands), Options exercisable at the end of the period</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140286962957560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHAREHOLDERS' EQUITY (Details 1) - Employee Stock Option And Restricted Stock Units Rsu [Member]<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2020 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingRollForwardAbstract', window );"><strong>Number of shares underlying outstanding RSUs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstandingNumber', window );">Unvested RSUs at the Beginning of the period | shares</a></td>
<td class="nump">62,378<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted', window );">Granted | shares</a></td>
<td class="nump">1,266,185<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested | shares</a></td>
<td class="num">(63,111)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures', window );">Forfeited | shares</a></td>
<td class="num">(14,141)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstandingNumber', window );">Unvested RSUs at the end of the period | shares</a></td>
<td class="nump">1,251,311<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingWeightedAverageExercisePriceRollForwardAbstract', window );"><strong>Weighted average grant date fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_SharebasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeOutstandingOptionsAndEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice', window );">Unvested RSUs at the Beginning of the period | $ / shares</a></td>
<td class="nump">$ 44.61<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsGrantedInPeriodWeightedAverageExercisePrice', window );">Granted | $ / shares</a></td>
<td class="nump">1.44<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsvestedInPeriodWeightedAverageExercisePrice', window );">Vested | $ / shares</a></td>
<td class="nump">7.83<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsForfeitedInPeriodWeightedAverageExercisePrice', window );">Forfeited | $ / shares</a></td>
<td class="nump">6.05<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_SharebasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeOutstandingOptionsAndEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice', window );">Unvested RSUs at the end of the period | $ / shares</a></td>
<td class="nump">$ 3.20<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingRollForwardAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingRollForwardAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingWeightedAverageExercisePriceRollForwardAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingWeightedAverageExercisePriceRollForwardAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsForfeitedInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsForfeitedInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsGrantedInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsGrantedInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsvestedInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options vested.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsvestedInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Options and Equity Instruments Other than Options, Outstanding, Number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_SharebasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeOutstandingOptionsAndEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation, Shares Authorized under Stock Options Plans, Exercise Price Range, Outstanding Options and Equity Instruments Other than Options, Weighted Average Exercise Price</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_SharebasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeOutstandingOptionsAndEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net number of non-option equity instruments granted to participants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=rwlk_EmployeeStockOptionAndRestrictedStockUnitsRsuMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=rwlk_EmployeeStockOptionAndRestrictedStockUnitsRsuMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140286960159272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHAREHOLDERS' EQUITY (Details 2) - Employee Stock Option [Member]<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr><th class="th" colspan="2">
<div>Dec. 31, 2020 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options outstanding</a></td>
<td class="nump">1,320,917<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Options outstanding weighted average remaining contractual life (years)</a></td>
<td class="text">5 years 7 months 2 days<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options outstanding and exercisable</a></td>
<td class="nump">52,997<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2', window );">Options exercisable weighted average remaining contractual life (years)</a></td>
<td class="text">4 years 11 months 8 days<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">5.37 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_InvestmentOptionsExercisePrices', window );">Exercise price | $ / shares</a></td>
<td class="nump">$ 5.37<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options outstanding</a></td>
<td class="nump">12,425<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Options outstanding weighted average remaining contractual life (years)</a></td>
<td class="text">8 years 2 months 27 days<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options outstanding and exercisable</a></td>
<td class="nump">5,435<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2', window );">Options exercisable weighted average remaining contractual life (years)</a></td>
<td class="text">8 years 2 months 27 days<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">$20.42- $33.75 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Range of exercise price, minimum | $ / shares</a></td>
<td class="nump">$ 20.42<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Range of exercise price, maximum | $ / shares</a></td>
<td class="nump">$ 33.75<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options outstanding</a></td>
<td class="nump">36,292<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Options outstanding weighted average remaining contractual life (years)</a></td>
<td class="text">5 years 3 months 4 days<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options outstanding and exercisable</a></td>
<td class="nump">27,598<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2', window );">Options exercisable weighted average remaining contractual life (years)</a></td>
<td class="text">4 years 7 months 6 days<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">$37.14-$38.75 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Range of exercise price, minimum | $ / shares</a></td>
<td class="nump">$ 37.14<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Range of exercise price, maximum | $ / shares</a></td>
<td class="nump">$ 38.75<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options outstanding</a></td>
<td class="nump">9,992<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Options outstanding weighted average remaining contractual life (years)</a></td>
<td class="text">2 years 11 months 26 days<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options outstanding and exercisable</a></td>
<td class="nump">9,992<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2', window );">Options exercisable weighted average remaining contractual life (years)</a></td>
<td class="text">2 years 11 months 26 days<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">$50-$52.5 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Range of exercise price, minimum | $ / shares</a></td>
<td class="nump">$ 50<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Range of exercise price, maximum | $ / shares</a></td>
<td class="nump">$ 52.5<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options outstanding</a></td>
<td class="nump">8,231<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Options outstanding weighted average remaining contractual life (years)</a></td>
<td class="text">6 years 5 months 5 days<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options outstanding and exercisable</a></td>
<td class="nump">7,306<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2', window );">Options exercisable weighted average remaining contractual life (years)</a></td>
<td class="text">6 years 5 months 9 days<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">$182.5-$524.25 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Range of exercise price, minimum | $ / shares</a></td>
<td class="nump">$ 182.5<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Range of exercise price, maximum | $ / shares</a></td>
<td class="nump">$ 524.25<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options outstanding</a></td>
<td class="nump">2,666<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Options outstanding weighted average remaining contractual life (years)</a></td>
<td class="text">4 years 10 months 3 days<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options outstanding and exercisable</a></td>
<td class="nump">2,666<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2', window );">Options exercisable weighted average remaining contractual life (years)</a></td>
<td class="text">4 years 10 months 3 days<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">RSUs only [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">RSUs outstanding</a></td>
<td class="nump">1,251,311<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Options outstanding weighted average remaining contractual life (years)</a></td>
<td class="text">0 years<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2', window );">Options exercisable weighted average remaining contractual life (years)</a></td>
<td class="text">0 years<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Calculation of weighted average remaining contractual term does not include the RSUs that were granted, which have an indefinite contractual term.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_InvestmentOptionsExercisePrices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_InvestmentOptionsExercisePrices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term of exercisable stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=rwlk_ExercisePriceRangeOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=rwlk_ExercisePriceRangeOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=rwlk_ExercisePriceRangeTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=rwlk_ExercisePriceRangeTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=rwlk_ExercisePriceRangeThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=rwlk_ExercisePriceRangeThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=rwlk_ExercisePriceRangeFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=rwlk_ExercisePriceRangeFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=rwlk_ExercisePriceRangeFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=rwlk_ExercisePriceRangeFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=rwlk_ExercisePriceRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=rwlk_ExercisePriceRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140286888910712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHAREHOLDERS' EQUITY (Details 3)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr><th class="th" colspan="2">
<div>Dec. 31, 2020 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding</a></td>
<td class="nump">14,249,533<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_ClassOfWarrantOrRightExercisable', window );">Warrants outstanding and exercisable</a></td>
<td class="nump">14,249,533<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandFifteenMember', window );">December 31, 2015 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding</a></td>
<td class="nump">4,771<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price per warrant | $ / shares</a></td>
<td class="nump">$ 7.500<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_ClassOfWarrantOrRightExercisable', window );">Warrants outstanding and exercisable</a></td>
<td class="nump">4,771<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_WarrantsExpitationDate', window );">Contractual term</a></td>
<td class="text">Dec. 30,  2025<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwoThousandSixteenMember', window );">November 1, 2016 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding</a></td>
<td class="nump">97,496<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price per warrant | $ / shares</a></td>
<td class="nump">$ 118.750<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_ClassOfWarrantOrRightExercisable', window );">Warrants outstanding and exercisable</a></td>
<td class="nump">97,496<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_WarrantsExpitationDate', window );">Contractual term</a></td>
<td class="text">Nov.  01,  2021<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandSixteenMember', window );">December 28, 2016 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding</a></td>
<td class="nump">1,908<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price per warrant | $ / shares</a></td>
<td class="nump">$ 7.500<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_ClassOfWarrantOrRightExercisable', window );">Warrants outstanding and exercisable</a></td>
<td class="nump">1,908<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_WarrantsExpitationDate', window );">Contractual term</a></td>
<td class="text">Dec. 30,  2025<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenMember', window );">November 20, 2018 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding</a></td>
<td class="nump">126,839<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price per warrant | $ / shares</a></td>
<td class="nump">$ 7.500<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_ClassOfWarrantOrRightExercisable', window );">Warrants outstanding and exercisable</a></td>
<td class="nump">126,839<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_WarrantsExpitationDate', window );">Contractual term</a></td>
<td class="text">Nov. 20,  2023<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenOneMember', window );">November 20, 2018 One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding</a></td>
<td class="nump">106,680<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price per warrant | $ / shares</a></td>
<td class="nump">$ 9.375<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_ClassOfWarrantOrRightExercisable', window );">Warrants outstanding and exercisable</a></td>
<td class="nump">106,680<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_WarrantsExpitationDate', window );">Contractual term</a></td>
<td class="text">Nov. 15,  2023<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentyFiveTwoThousandNineteenMember', window );">February 25, 2019 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding</a></td>
<td class="nump">45,600<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[6]</sup></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price per warrant | $ / shares</a></td>
<td class="nump">$ 7.187<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[6]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_ClassOfWarrantOrRightExercisable', window );">Warrants outstanding and exercisable</a></td>
<td class="nump">45,600<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[6]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_WarrantsExpitationDate', window );">Contractual term</a></td>
<td class="text">Feb. 21,  2024<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[6]</sup></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenMember', window );">April 5, 2019 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding</a></td>
<td class="nump">408,457<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[7]</sup></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price per warrant | $ / shares</a></td>
<td class="nump">$ 5.140<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[7]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_ClassOfWarrantOrRightExercisable', window );">Warrants outstanding and exercisable</a></td>
<td class="nump">408,457<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[7]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_WarrantsExpitationDate', window );">Contractual term</a></td>
<td class="text">Oct.  07,  2024<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[7]</sup></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenOneMember', window );">April 5, 2019 One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding</a></td>
<td class="nump">49,015<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[8]</sup></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price per warrant | $ / shares</a></td>
<td class="nump">$ 6.503<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[8]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_ClassOfWarrantOrRightExercisable', window );">Warrants outstanding and exercisable</a></td>
<td class="nump">49,015<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[8]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_WarrantsExpitationDate', window );">Contractual term</a></td>
<td class="text">Apr.  03,  2024<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[8]</sup></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveAndSixTwoThousandNineteenMember', window );">June 5, 2019 and June 6, 2019 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding</a></td>
<td class="nump">1,464,665<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[9]</sup></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price per warrant | $ / shares</a></td>
<td class="nump">$ 7.500<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[9]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_ClassOfWarrantOrRightExercisable', window );">Warrants outstanding and exercisable</a></td>
<td class="nump">1,464,665<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[9]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_WarrantsExpitationDate', window );">Contractual term</a></td>
<td class="text">Jun.  05,  2024<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[9]</sup></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveTwoThousandNineteenMember', window );">June 5, 2019 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding</a></td>
<td class="nump">87,880<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[10]</sup></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price per warrant | $ / shares</a></td>
<td class="nump">$ 9.375<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[10]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_ClassOfWarrantOrRightExercisable', window );">Warrants outstanding and exercisable</a></td>
<td class="nump">87,880<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[10]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_WarrantsExpitationDate', window );">Contractual term</a></td>
<td class="text">Jun.  05,  2024<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[10]</sup></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTweleveTwoThousandNineteenMember', window );">June 12, 2019 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding</a></td>
<td class="nump">416,667<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[11]</sup></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price per warrant | $ / shares</a></td>
<td class="nump">$ 6.000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[11]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_ClassOfWarrantOrRightExercisable', window );">Warrants outstanding and exercisable</a></td>
<td class="nump">416,667<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[11]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_WarrantsExpitationDate', window );">Contractual term</a></td>
<td class="text">Dec. 12,  2024<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTenTwoThousandNineteenMember', window );">June 10, 2019 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding</a></td>
<td class="nump">50,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[12]</sup></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price per warrant | $ / shares</a></td>
<td class="nump">$ 7.500<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[12]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_ClassOfWarrantOrRightExercisable', window );">Warrants outstanding and exercisable</a></td>
<td class="nump">50,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[12]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_WarrantsExpitationDate', window );">Contractual term</a></td>
<td class="text">Jun. 10,  2024<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[12]</sup></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyMember', window );">February 10, 2020 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding</a></td>
<td class="nump">3,768,500<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[13]</sup></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price per warrant | $ / shares</a></td>
<td class="nump">$ 1.250<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[13]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_ClassOfWarrantOrRightExercisable', window );">Warrants outstanding and exercisable</a></td>
<td class="nump">4,343,500<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[13]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_WarrantsExpitationDate', window );">Contractual term</a></td>
<td class="text">Feb. 10,  2020<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[13]</sup></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyOneMember', window );">February 10, 2020 One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding</a></td>
<td class="nump">336,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[14]</sup></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price per warrant | $ / shares</a></td>
<td class="nump">$ 1.5625<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[14]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_ClassOfWarrantOrRightExercisable', window );">Warrants outstanding and exercisable</a></td>
<td class="nump">336,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[14]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_WarrantsExpitationDate', window );">Contractual term</a></td>
<td class="text">Feb. 10,  2020<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[14]</sup></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyMember', window );">July 6, 2020 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding</a></td>
<td class="nump">2,469,139<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[15]</sup></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price per warrant | $ / shares</a></td>
<td class="nump">$ 1.76<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[15]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_ClassOfWarrantOrRightExercisable', window );">Warrants outstanding and exercisable</a></td>
<td class="nump">2,469,139<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[15]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_WarrantsExpitationDate', window );">Contractual term</a></td>
<td class="text">Jul.  06,  2020<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[15]</sup></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyOneMember', window );">July 6, 2020 One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding</a></td>
<td class="nump">296,297<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[16]</sup></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price per warrant | $ / shares</a></td>
<td class="nump">$ 2.2781<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[16]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_ClassOfWarrantOrRightExercisable', window );">Warrants outstanding and exercisable</a></td>
<td class="nump">296,297<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[16]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_WarrantsExpitationDate', window );">Contractual term</a></td>
<td class="text">Jul.  06,  2020<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[16]</sup></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberThreeTwoThousandTwentyMember', window );">December 3, 2020 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding</a></td>
<td class="nump">4,184,832<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[17]</sup></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price per warrant | $ / shares</a></td>
<td class="nump">$ 1.34<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[17]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_ClassOfWarrantOrRightExercisable', window );">Warrants outstanding and exercisable</a></td>
<td class="nump">4,184,832<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[17]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_WarrantsExpitationDate', window );">Contractual term</a></td>
<td class="text">Dec.  03,  2020<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[17]</sup></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberThreeTwoThousandTwentyOneMember', window );">December 3, 2020 One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding</a></td>
<td class="nump">334,787<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[18]</sup></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price per warrant | $ / shares</a></td>
<td class="nump">$ 1.7922<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[18]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_ClassOfWarrantOrRightExercisable', window );">Warrants outstanding and exercisable</a></td>
<td class="nump">334,787<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[18]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_WarrantsExpitationDate', window );">Contractual term</a></td>
<td class="text">Dec.  03,  2020<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[18]</sup></td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Represents warrants for ordinary shares issuable upon an exercise price of $7.5 per share, which were granted on December 31, 2015 to Kreos Capital V (Expert) Fund Limited, or Kreos, in connection with a loan made by Kreos to us and are currently exercisable (in whole or in part) until the earlier of (i) December 30, 2025 or (ii) immediately prior to the consummation of a merger, consolidation, or reorganization of us with or into, or the sale or license of all or substantially all the assets or shares of us to, any other entity or person, other than a wholly-owned subsidiary of us, excluding any transaction in which the Company's shareholders prior to the transaction will hold more than 50% of the voting and economic rights of the surviving entity after the transaction. None of these warrants had been exercised as of December 31, 2020.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Represents warrants issued as part of the Company's follow-on offering in November 2016. At any time, the board of directors may reduce the exercise price of the warrants to any amount and for any period of time it deems appropriate.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Represents common warrants that were issued as part of the $8.0 million drawdown under the Loan Agreement which occurred on December 28, 2016. See footnote 1 for exercisability terms.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top">Represents common warrants that were issued as part of the Company's follow-on offering in November 2018. As of September 30, 2019, warrants to purchase an aggregate 1,651,537 ordinary shares had been exercised.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[5]</td>
<td style="vertical-align: top;" valign="top">Represents common warrants that were issued to the underwriters as compensation for their role in the Company's follow-on offering in November 2018.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[6]</td>
<td style="vertical-align: top;" valign="top">Represents warrants that were issued to the exclusive placement agent as compensation for its role in the Company's follow-on offering in February 2019.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[7]</td>
<td style="vertical-align: top;" valign="top">Represents warrants that were issued to certain institutional purchasers in a private placement in the Company's registered direct offering of ordinary shares in April 2019.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[8]</td>
<td style="vertical-align: top;" valign="top">Represents warrants that were issued to the placement agent as compensation for its role in the Company's April 2019 registered direct offering.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[9]</td>
<td style="vertical-align: top;" valign="top">Represents warrants that were issued to certain institutional investors in a warrant exercise agreement on June 5, 2019 and June 6, 2019, respectively.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[10]</td>
<td style="vertical-align: top;" valign="top">Represents warrants that were issued to the placement agent as compensation for its role in the Company's June 2019 warrant exercise agreement and concurrent private placement of warrants.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[11]</td>
<td style="vertical-align: top;" valign="top">Represents warrants that were issued to certain institutional investors in a warrant exercise agreement in June 2019.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[12]</td>
<td style="vertical-align: top;" valign="top">Represents warrants that were issued to the placement agent as compensation for its role in the Company's June 2019 registered direct offering and concurrent private placement of warrants.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[13]</td>
<td style="vertical-align: top;" valign="top">Represents warrants that were issued to certain institutional purchasers in a private placement in the Company's best efforts offering of ordinary shares in February 2020.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[14]</td>
<td style="vertical-align: top;" valign="top">Represents warrants that were issued to the placement agent as compensation for its role in the Company's February 2020 best efforts offering.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[15]</td>
<td style="vertical-align: top;" valign="top">Represents warrants that were issued to certain institutional purchasers in a private placement in our registered direct offering of ordinary shares in July 2020</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[16]</td>
<td style="vertical-align: top;" valign="top">Represents warrants that were issued to the placement agent as compensation for its role in the Company's July 2020 registered direct offering.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[17]</td>
<td style="vertical-align: top;" valign="top">Represents warrants that were issued to certain institutional purchasers in a private placement in our private placement offering of ordinary shares in December 2020</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[18]</td>
<td style="vertical-align: top;" valign="top">Represents warrants that were issued to the placement agent as compensation for its role in the Company's December 2020 private placement.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_ClassOfWarrantOrRightExercisable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Class of Warrant or Right, Exercisable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_ClassOfWarrantOrRightExercisable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_WarrantsExpitationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants Expitation Date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_WarrantsExpitationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandFifteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandFifteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwoThousandSixteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwoThousandSixteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandSixteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandSixteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentyFiveTwoThousandNineteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentyFiveTwoThousandNineteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveAndSixTwoThousandNineteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveAndSixTwoThousandNineteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveTwoThousandNineteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveTwoThousandNineteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTweleveTwoThousandNineteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTweleveTwoThousandNineteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTenTwoThousandNineteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTenTwoThousandNineteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberThreeTwoThousandTwentyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberThreeTwoThousandTwentyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberThreeTwoThousandTwentyOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=rwlk_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberThreeTwoThousandTwentyOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140286962868104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHAREHOLDERS' EQUITY (Details 4) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Non-cash share-based compensation expense</a></td>
<td class="nump">$ 749<span></span>
</td>
<td class="nump">$ 1,108<span></span>
</td>
<td class="nump">$ 2,766<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of revenues [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Non-cash share-based compensation expense</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development, net [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Non-cash share-based compensation expense</a></td>
<td class="nump">136<span></span>
</td>
<td class="nump">204<span></span>
</td>
<td class="nump">435<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember', window );">Sales and marketing, net [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Non-cash share-based compensation expense</a></td>
<td class="nump">163<span></span>
</td>
<td class="nump">166<span></span>
</td>
<td class="nump">467<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Non-cash share-based compensation expense</a></td>
<td class="nump">$ 442<span></span>
</td>
<td class="nump">$ 725<span></span>
</td>
<td class="nump">$ 1,848<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140286878692808">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>SHAREHOLDERS' EQUITY (Details Textual)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="9">1 Months Ended</th>
<th class="th" colspan="5">12 Months Ended</th>
<th class="th" colspan="1">36 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 03, 2020 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jul. 06, 2020 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 12, 2019 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 06, 2019 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 05, 2019 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 30, 2019 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th"><div>Mar. 27, 2019</div></th>
<th class="th">
<div>Feb. 28, 2019 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th"><div>Nov. 30, 2018</div></th>
<th class="th"><div>May 31, 2018</div></th>
<th class="th">
<div>Mar. 06, 2018 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Feb. 10, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2015 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>&#8362; / shares</div>
</th>
<th class="th">
<div>Dec. 03, 2020 </div>
<div>&#8362; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jul. 06, 2020 </div>
<div>&#8362; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Feb. 10, 2020 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Feb. 10, 2020 </div>
<div>&#8362; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>&#8362; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 28, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 10, 2016 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_ShareholdersEquityTextualAbstract', window );"><strong>Shareholders' Equity (Textual)</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityReverseStockSplit', window );">Reverse share split, description</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The Company&#8217;s shareholders approved (i) a reverse share split within a range of 1:8 to 1:32, to be effective at the ratio and on a date to be determined by the Board of Directors, and (ii) amendments to the Company&#8217;s Articles of Association authorizing an increase in the Company&#8217;s authorized share capital (and corresponding authorized number of ordinary shares, proportionally adjusting such number for the reverse share split) by up to NIS 17.5 million. Following the shareholder approval, an authorized committee of the Board of Directors of the Company approved a one-for-twenty-five reverse share split of the Company&#8217;s ordinary shares, and the Company filed the Third Amended and Restated Articles of Association of the Company with the Registrar of Companies of the State of Israel to effect the reverse share split and to increase the Company&#8217;s authorized share capital after the effect of the reverse share split. The reverse share split became effective on April 1, 2019. Additionally, effective at the same time, the total number of ordinary shares the Company is authorized to issue changed from 250,000,000 shares to 60,000,000 shares, the par value per share of the ordinary shares changed to NIS 0.25 and the authorized share capital of the Company changed from NIS 2,500,000 to NIS 15,000,000. All share and per share data included in these consolidated financial statements, for periods before December 31, 2019, give retroactive effect to the reverse stock split.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Par value of shares | &#8362; / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 0.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 0.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Issuance expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 1,505<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted (in shares) | shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of warrants issued | shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,389,555<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,389,555<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,522,284<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term of shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">0 years<span></span>
</td>
<td class="text">6 years 1 month 9 days<span></span>
</td>
<td class="text">6 years 1 month 9 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrant exercised</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,651,537<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,651,537<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_DescriptionOfUnderwritingAgreement', window );">Description of underwriting agreement</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The Company entered into an underwriting agreement with H.C. Wainwright & Co., LLC (&#8220;H.C. Wainwright&#8221;), in connection with the Company&#8217;s follow-on public offering of 496,055 units, each consisting of one ordinary share and one common warrant to purchase one ordinary share with an exercise price of $7.5 per warrant. Each unit was sold to the public at a price of $7.50 per unit. On November 18, 2018, H.C. Wainwright exercised in full its option to purchase 231,964 ordinary shares for $7.25 per share and/or common warrants to purchase up to an additional 231,964 ordinary shares for $0.25 per warrant.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_DescriptionOfUnderwritersWarrantsToPurchase', window );">Description of underwriters warrants to purchase</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The Company issued and sold 1,050,372 pre-funded units at a price to the public of $7.25 per unit. Each unit containing one pre-funded warrant with an exercise price of $0.25 per share and one warrant to purchase one ordinary share with an exercise price of $7.50 per warrant. The total gross proceeds received from the November 2018 follow-on public offering, before deducting commissions, discounts and expenses, were $13.1 million (including proceeds from the exercise of 90,691 pre-funded warrants at the closing of the offering). As of December 31, 2018, additional pre-funded warrants to purchase an aggregate 562,466 ordinary shares had been exercised, for additional proceeds of $140,617. During the year ended December 31, 2019 additional 288,000 pre-funded warrants and 296,087 warrants to purchase an aggregate 584,087 ordinary shares had been exercised, for additional proceeds of $1.5 million. As compensation for their role in the offering, the Company also issued to the Underwriters warrants to purchase up to 106,680 ordinary shares, which became immediately exercisable starting on November 20, 2018 until November 15, 2023 at $9.375 per share.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Total gross proceeds received from the follow-on public offering</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,041<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_WarrantsToPurchaseOrdinaryShares', window );">Warrants to purchase ordinary shares | shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,680<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=rwlk_KreosCapitalVMember', window );">Kreos Capital V [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_ShareholdersEquityTextualAbstract', window );"><strong>Shareholders' Equity (Textual)</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable', window );">Warrants grant date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Dec. 31,  2015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_WarrantsExercisableDescrition', window );">Warrants exercisable, description</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Currently exercisable (in whole or in part) until the earlier of (i) December 30, 2025 or (ii) immediately prior to the consummation of a merger, consolidation, or reorganization of us with or into, or the sale or license of all or substantially all the assets or shares of us to, any other entity or person, other than a wholly-owned subsidiary of us, excluding any transaction in which the Company&#8217;s shareholders prior to the transaction will hold more than 50% of the voting and economic rights of the surviving entity after the transaction.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_ShareholdersEquityTextualAbstract', window );"><strong>Shareholders' Equity (Textual)</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value, restricted stock units (in USD per share) | $ / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.44<span></span>
</td>
<td class="nump">$ 4.67<span></span>
</td>
<td class="nump">$ 26.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value, options (in USD per share) | $ / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.98<span></span>
</td>
<td class="nump">$ 15.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_ShareholdersEquityTextualAbstract', window );"><strong>Shareholders' Equity (Textual)</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares reserved for future issuance (in shares) | shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">604,320<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">604,320<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,409<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized cost of shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term of shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years 2 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Total fair value of shares vested | shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">676<span></span>
</td>
<td class="nump">1,175<span></span>
</td>
<td class="nump">2,918<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_ShareholdersEquityTextualAbstract', window );"><strong>Shareholders' Equity (Textual)</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of ordinary shares (in shares) | shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">760,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Issuance expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 959<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare', window );">Sale of stock price per share | $ / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Total gross proceeds received from the follow-on public offering</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,370<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_DescriptionOfWainwrightOrItsDesigneesWarrantsToPurchase', window );">Description of wainwright or its designees warrants to purchase</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The Company also issued to H.C Wainwright and/or its designees warrants to purchase up to 45,600 ordinary shares, which are immediately exercisable starting on February 25, 2019 until February 21, 2024 at $7.1875 per share.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=rwlk_AtmOfferingProgramMember', window );">Atm Offering Program [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_ShareholdersEquityTextualAbstract', window );"><strong>Shareholders' Equity (Textual)</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_CommonStockAggregateOfferingPriceAuthorizedUnderEquityDistributionAgreement', window );">Aggregate offering price</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_CommonStockIssuanceCostsUnderEquityDistributionAgreementAsPercentOfGrossProceeds', window );">Stock issuance costs under equity distribution agreement as a percent of gross proceeds</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of ordinary shares (in shares) | shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">302,092<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_StockIssuedDuringPeriodValueNewIssuesGross', window );">Issuance of ordinary shares in an ATM offering of ordinary shares, gross of issuance expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of ordinary shares in an ATM offering of ordinary shares, net of issuance expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_FixedCommissionRate', window );">Fixed commission rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_FixedCommissionAmount', window );">Fixed commission amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 471<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Issuance expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 211<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_FeesAndOtherRelatedExpenses', window );">Fees and other related expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=rwlk_CommonUnitsAndPreFundedUnitsMember', window );">Common units and pre-funded units [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_ShareholdersEquityTextualAbstract', window );"><strong>Shareholders' Equity (Textual)</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of ordinary shares (in shares) | shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Par value of shares | &#8362; / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 0.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Warrant to purchase one ordinary share | shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,546,828<span></span>
</td>
<td class="nump">1,546,828<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price per share | $ / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.5625<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of warrants issued | shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">336,000<span></span>
</td>
<td class="nump">336,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=rwlk_CommonUnitsMember', window );">Common units [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_ShareholdersEquityTextualAbstract', window );"><strong>Shareholders' Equity (Textual)</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares issued price per share | $ / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=rwlk_PreFundedUnitsMember', window );">Pre-funded units [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_ShareholdersEquityTextualAbstract', window );"><strong>Shareholders' Equity (Textual)</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares issued price per share | $ / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.249<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=rwlk_CommonUnitsAndPreFundedUnits1Member', window );">Common units and pre-funded units one [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_ShareholdersEquityTextualAbstract', window );"><strong>Shareholders' Equity (Textual)</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrant exercised</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,831,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,831,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=rwlk_PurchaseAgreementWithCertainInstitutionalInvestorsMember', window );">Purchase agreement with certain institutional investors [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_ShareholdersEquityTextualAbstract', window );"><strong>Shareholders' Equity (Textual)</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of ordinary shares (in shares) | shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,579,776<span></span>
</td>
<td class="nump">4,938,278<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares issued price per share | $ / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 1.4337<span></span>
</td>
<td class="nump">$ 1.8225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Par value of shares | &#8362; / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 0.25<span></span>
</td>
<td class="nump">&#8362; 0.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price per share | $ / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 1.34<span></span>
</td>
<td class="nump">$ 1.76<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of warrants issued | shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,184,832<span></span>
</td>
<td class="nump">2,469,139<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,184,832<span></span>
</td>
<td class="nump">2,469,139<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=rwlk_PurchaseAgreementWithCertainInstitutionalInvestorsMember', window );">Purchase agreement with certain institutional investors [Member] | Additionally Warrants Issued [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_ShareholdersEquityTextualAbstract', window );"><strong>Shareholders' Equity (Textual)</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price per share | $ / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 1.7922<span></span>
</td>
<td class="nump">$ 2.2781<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of warrants issued | shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">334,787<span></span>
</td>
<td class="nump">296,297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">334,787<span></span>
</td>
<td class="nump">296,297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=rwlk_TimwellCorporationLimitedMember', window );">Timwell Corporation Limited [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_ShareholdersEquityTextualAbstract', window );"><strong>Shareholders' Equity (Textual)</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_AggregateNumberOfOrdinaryShares', window );">Aggregate number of ordinary shares | shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">640,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockPlans', window );">Gross proceeds</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_FeesAndOtherRelatedExpenses', window );">Fees and other related expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">705<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_NetAggregateProceedsOfAfterDeductingFeesAndOtherRelatedExpenses', window );">Net aggregate proceeds of after deducting fees and other related expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuritiesLoanedMeasurementDifferenceDescription', window );">Description of tranche consisting</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The Company entered into a fee and release agreement with Canaccord Genuity LLC (&#8220;Canaccord Genuity&#8221;) requiring the Company to pay to Canaccord Genuity, in connection with a settlement, in addition to certain cash amounts, (i) $125 thousand in ordinary shares of the Company after the First Tranche Closing of the Timwell transaction and (ii) $225 thousand in ordinary shares of the Company after the closing of the Second Tranche of the Timwell transaction (or such lower amount if the Second Tranche Closing is less than $10.0 million). The price per share used for calculation of the number of ordinary shares issued by the Company to Canaccord Genuity is based on the volume weighted average price of the Company&#8217;s ordinary shares as reported on the Nasdaq Capital Market for the five consecutive trading days prior to the date of issuance. The Company is also obligated to pay $100 thousand in cash following the closing of the Third Tranche of $5.0 million (or such lower amount if the Third Tranche Closing is less than $5.0 million). Following the First Tranche Closing in May 15, 2018, the Company issued 4,715 ordinary shares to Canaccord Genuity.<span></span>
</td>
<td class="text">The Company entered into an investment agreement with Timwell Corporation Limited, a Hong Kong corporation (&#8220;Timwell&#8221;), as amended on May 15, 2018 (the &#8220;Investment Agreement&#8221;), pursuant to which the Company agreed to issue to Timwell, in three different tranches, an aggregate of 640,000 ordinary shares in return for aggregate gross proceeds of $20 million. The closing of each tranche is subject to certain closing conditions. The closing of the first tranche (the &#8220;First Tranche Closing&#8221;) took place on May 15, 2018, upon which Timwell received 160,000 ordinary shares for an aggregate purchase price of $5,000,000, and Timwell and the Company signed a registration rights agreement in the form attached to the Investment Agreement. The net aggregate proceeds of the First Tranche Closing after deducting fees and other related expenses in the amount of approximately $705 thousands were approximately $4.3 million. The remaining investment is to occur in two tranches, including $10 million for the issuance to Timwell of 320,000 ordinary shares (the &#8220;Second Tranche&#8221;) and $5 million for the issuance to Timwell of 160,000 ordinary shares (the &#8220;Third Tranch&#8221;). The closing of the second and third tranches is subject to specified closing conditions, including, with respect to the second tranche, the signing of a license agreement and a supply agreement and the formation of the China JV (the &#8220;China JV&#8221;) based on the JV Framework Agreement, and, with respect to the third tranche, the successful production of certain ReWalk products by the China JV. The second tranche closing was initially expected to occur by July 1, 2018 and the third tranche closing was initially expected to occur by December 31, 2018 and no later than April 1, 2019.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=rwlk_KreosCapitalMember', window );">Kreos Capital [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_ShareholdersEquityTextualAbstract', window );"><strong>Shareholders' Equity (Textual)</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price per share | $ / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCollateralAmount', window );">Drawdown amount under loan agreement</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_AgreementAxis=rwlk_SecuritiesPurchaseAgreementsMember', window );">Securities Purchase Agreements [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_ShareholdersEquityTextualAbstract', window );"><strong>Shareholders' Equity (Textual)</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price per share | $ / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of warrants issued | shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">416,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">408,457<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_WarrantsExercisableDescrition', window );">Warrants exercisable, description</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Exercisable from June 12, 2019 until December 12, 2024.<span></span>
</td>
<td class="text">Exercisable from June 5, 2019 or June 6, 2019 until June 5, 2024 or June 6, 2024.<span></span>
</td>
<td class="text">Exercisable from June 5, 2019 or June 6, 2019 until June 5, 2024 or June 6, 2024.<span></span>
</td>
<td class="text">Exercisable from April 5, 2019 until October 7, 2024.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_StockIssuedDuringPeriodShareOrdinaryShares', window );">Issuance of ordinary shares, shares | shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">833,334<span></span>
</td>
<td class="nump">1,464,665<span></span>
</td>
<td class="nump">1,464,665<span></span>
</td>
<td class="nump">816,914<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_OrdinarySharesExercisePrice', window );">Exercise price ordinary shares | $ / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.00<span></span>
</td>
<td class="nump">$ 7.50<span></span>
</td>
<td class="nump">$ 7.50<span></span>
</td>
<td class="nump">$ 5.2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_AgreementAxis=rwlk_SecuritiesPurchaseAgreementsMember', window );">Securities Purchase Agreements [Member] | Israeli [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_ShareholdersEquityTextualAbstract', window );"><strong>Shareholders' Equity (Textual)</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_OrdinarySharesExercisePrice', window );">Exercise price ordinary shares | $ / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_AgreementAxis=rwlk_SecuritiesPurchaseAgreementsMember', window );">Securities Purchase Agreements [Member] | Warrants To Purchase Ordinary Shares[Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_ShareholdersEquityTextualAbstract', window );"><strong>Shareholders' Equity (Textual)</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_WarrantsExercisableDescrition', window );">Warrants exercisable, description</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Exercisable from June 12, 2019 until June 10, 2024.<span></span>
</td>
<td class="text">Exercisable from June 5, 2019 until June 5, 2024.<span></span>
</td>
<td class="text">Exercisable from June 5, 2019 until June 5, 2024.<span></span>
</td>
<td class="text">Exercisable from April 5, 2019 until April 3, 2024.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_StockIssuedDuringPeriodShareOrdinaryShares', window );">Issuance of ordinary shares, shares | shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="nump">87,880<span></span>
</td>
<td class="nump">87,880<span></span>
</td>
<td class="nump">49,015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_OrdinarySharesExercisePrice', window );">Exercise price ordinary shares | $ / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.50<span></span>
</td>
<td class="nump">$ 9.375<span></span>
</td>
<td class="nump">$ 9.375<span></span>
</td>
<td class="nump">$ 6.503125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_AgreementAxis=rwlk_EquityExchangeProgramMember', window );">Equity Exchange Program [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_ShareholdersEquityTextualAbstract', window );"><strong>Shareholders' Equity (Textual)</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpensesRelatedParty', window );">Compensation payment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="26"></td></tr>
<tr><td colspan="26"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">See note 8b.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_AggregateNumberOfOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of ordinary shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_AggregateNumberOfOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_CommonStockAggregateOfferingPriceAuthorizedUnderEquityDistributionAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Aggregate Offering Price Authorized Under Equity Distribution Agreement</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_CommonStockAggregateOfferingPriceAuthorizedUnderEquityDistributionAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_CommonStockIssuanceCostsUnderEquityDistributionAgreementAsPercentOfGrossProceeds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issuance costs under equity distribution agreement as a percent of gross proceeds.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_CommonStockIssuanceCostsUnderEquityDistributionAgreementAsPercentOfGrossProceeds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_DescriptionOfUnderwritersWarrantsToPurchase">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of underwriters warrants to purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_DescriptionOfUnderwritersWarrantsToPurchase</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_DescriptionOfUnderwritingAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of underwriting agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_DescriptionOfUnderwritingAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_DescriptionOfWainwrightOrItsDesigneesWarrantsToPurchase">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of wainwright or its designees warrants to purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_DescriptionOfWainwrightOrItsDesigneesWarrantsToPurchase</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_FeesAndOtherRelatedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of fees and other related expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_FeesAndOtherRelatedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_FixedCommissionAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fixed commission amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_FixedCommissionAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_FixedCommissionRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fixed commission rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_FixedCommissionRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_NetAggregateProceedsOfAfterDeductingFeesAndOtherRelatedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net aggregate proceeds of the first tranche closing after deducting fees and other related expenses in the amount of approximately.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_NetAggregateProceedsOfAfterDeductingFeesAndOtherRelatedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_OrdinarySharesExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price ordinary shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_OrdinarySharesExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_ShareholdersEquityTextualAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_ShareholdersEquityTextualAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_StockIssuedDuringPeriodShareOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Issuance of ordinary shares, shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_StockIssuedDuringPeriodShareOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_StockIssuedDuringPeriodValueNewIssuesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Value, New Issues, Gross</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_StockIssuedDuringPeriodValueNewIssuesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_WarrantsExercisableDescrition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants exercisable, description.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_WarrantsExercisableDescrition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_WarrantsToPurchaseOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants to purchase ordinary shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_WarrantsToPurchaseOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Final price paid per share for the purchase of the targeted number of shares, determined by an average market price over a fixed period of time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 25<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6405686&amp;loc=d3e22802-112653<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date the warrants or rights are exercisable, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Costs of sales and operating expenses for the period incurred from transactions with related parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpensesRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCollateralAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets pledged to secure a debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=75038535&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCollateralAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the stock plan during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuritiesLoanedMeasurementDifferenceDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of measurement difference between recognized amounts and resulting measurement differences for securities loaned.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20225997-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuritiesLoanedMeasurementDifferenceDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options vested.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityReverseStockSplit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 4.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187143-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityReverseStockSplit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=rwlk_KreosCapitalVMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=rwlk_KreosCapitalVMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=rwlk_AtmOfferingProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=rwlk_AtmOfferingProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=rwlk_CommonUnitsAndPreFundedUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=rwlk_CommonUnitsAndPreFundedUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=rwlk_CommonUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=rwlk_CommonUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=rwlk_PreFundedUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=rwlk_PreFundedUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=rwlk_CommonUnitsAndPreFundedUnits1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=rwlk_CommonUnitsAndPreFundedUnits1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=rwlk_PurchaseAgreementWithCertainInstitutionalInvestorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=rwlk_PurchaseAgreementWithCertainInstitutionalInvestorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=rwlk_AdditionallyWarrantsIssuedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=rwlk_AdditionallyWarrantsIssuedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=rwlk_TimwellCorporationLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=rwlk_TimwellCorporationLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=rwlk_KreosCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=rwlk_KreosCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_AgreementAxis=rwlk_SecuritiesPurchaseAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_AgreementAxis=rwlk_SecuritiesPurchaseAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_TypeofCurrencyAxis=rwlk_IsraeliMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_TypeofCurrencyAxis=rwlk_IsraeliMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=rwlk_WarrantsToPurchaseOrdinarySharesIssuedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=rwlk_WarrantsToPurchaseOrdinarySharesIssuedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_AgreementAxis=rwlk_EquityExchangeProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_AgreementAxis=rwlk_EquityExchangeProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140286966912488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESEARCH COLLABORATION AGREEMENT AND LICENSE AGREEMENT (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_ResearchCollaborationAgreementAndLicenseAgreementTextualAbstract', window );"><strong>Research Collaboration Agreement and License Agreement (Textual)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="nump">$ 3,459<span></span>
</td>
<td class="nump">$ 5,348<span></span>
</td>
<td class="nump">$ 7,349<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_AgreementAxis=rwlk_LicenseAgreementAndCollaborationAgreementMember', window );">License Agreement and Collaboration Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_ResearchCollaborationAgreementAndLicenseAgreementTextualAbstract', window );"><strong>Research Collaboration Agreement and License Agreement (Textual)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPayment', window );">Total payment obligation</a></td>
<td class="nump">7,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="nump">$ 800<span></span>
</td>
<td class="nump">$ 1,600<span></span>
</td>
<td class="nump">$ 900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Research collaboration agreement expire date</a></td>
<td class="text">Feb. 16,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_ResearchCollaborationAgreementAndLicenseAgreementTextualAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_ResearchCollaborationAgreementAndLicenseAgreementTextualAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments including both interest and principal payments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=75038535&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_AgreementAxis=rwlk_LicenseAgreementAndCollaborationAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_AgreementAxis=rwlk_LicenseAgreementAndCollaborationAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140286962112968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PAYCHECK PROTECTION PROGRAM LOAN (Details Textual) - Paycheck Protection Program Loan [Member] - Silicon Valley Bank [Member]<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
</tr>
<tr><th class="th">
<div>Apr. 21, 2020 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredDebt', window );">Unsecured promissory note</a></td>
<td class="nump">$ 392<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Initial period of loan</a></td>
<td class="text">2 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnsecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of uncollateralized debt obligations (with maturities initially due after one year or beyond the operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnsecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rwlk_PaycheckProtectionProgramLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rwlk_PaycheckProtectionProgramLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=rwlk_SiliconValleyBankMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=rwlk_SiliconValleyBankMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140286965078200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_IncomeTaxesDetailsAbstract', window );"><strong>Income Taxes (Textual)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">Domestic</a></td>
<td class="num">$ (12,992)<span></span>
</td>
<td class="num">$ (15,599)<span></span>
</td>
<td class="num">$ (21,784)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Foreign</a></td>
<td class="nump">67<span></span>
</td>
<td class="nump">55<span></span>
</td>
<td class="nump">104<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income loss before taxes</a></td>
<td class="num">$ (12,925)<span></span>
</td>
<td class="num">$ (15,544)<span></span>
</td>
<td class="num">$ (21,680)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_IncomeTaxesDetailsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_IncomeTaxesDetailsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140286962750136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details 1) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Current</a></td>
<td class="nump">$ 95<span></span>
</td>
<td class="nump">$ 64<span></span>
</td>
<td class="nump">$ 102<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_DeferredIncometax', window );">Deferred</a></td>
<td class="num">(44)<span></span>
</td>
<td class="num">(57)<span></span>
</td>
<td class="num">(107)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_TaxesOnIncome', window );">Taxes on income</a></td>
<td class="nump">51<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations', window );">Domestic</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations', window );">Foreign</a></td>
<td class="nump">51<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_TaxesIncome', window );">Taxes on income</a></td>
<td class="nump">$ 51<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
<td class="num">$ (5)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_DeferredIncometax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Income Tax.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_DeferredIncometax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_TaxesIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Taxes on income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_TaxesIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_TaxesOnIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Taxes on income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_TaxesOnIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current and deferred federal income tax expense (benefit) attributable to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current and deferred foreign income tax expense (benefit) attributable to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140286963192056">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INCOME TAXES (Details 2) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGrossAbstract', window );"><strong>Deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Carry forward tax losses</a></td>
<td class="nump">$ 41,941<span></span>
</td>
<td class="nump">$ 35,051<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment', window );">Research and development carry forward expenses-temporary differences</a></td>
<td class="nump">946<span></span>
</td>
<td class="nump">1,294<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals', window );">Accrual and reserves</a></td>
<td class="nump">341<span></span>
</td>
<td class="nump">290<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Lease liabilities</a></td>
<td class="nump">390<span></span>
</td>
<td class="nump">433<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Total deferred tax asset</a></td>
<td class="nump">43,618<span></span>
</td>
<td class="nump">37,068<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesAbstract', window );"><strong>Deferred tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_RightofuseLiability', window );">Right-of-use liability</a></td>
<td class="num">(390)<span></span>
</td>
<td class="num">(433)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Net deferred tax assets</a></td>
<td class="nump">43,228<span></span>
</td>
<td class="nump">36,635<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(42,941)<span></span>
</td>
<td class="num">(36,392)<span></span>
</td>
<td class="num">$ (29,655)<span></span>
</td>
<td class="num">$ (26,311)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Net deferred tax assets</a></td>
<td class="nump">$ 287<span></span>
</td>
<td class="nump">$ 243<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_RightofuseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Right-of-use liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_RightofuseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGrossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGrossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from in-process research and development costs expensed in connection with a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140286981497384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details 3) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Balance at beginning of year</a></td>
<td class="num">$ (36,392)<span></span>
</td>
<td class="num">$ (29,655)<span></span>
</td>
<td class="num">$ (26,311)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_ValuationAllowanceDeferredTaxAssetChangesDuetoAmendmentsinTaxLawsandExchangeRateDifferencesAmount', window );">Changes due to amendments to tax laws and exchange rate differences</a></td>
<td class="num">(2,929)<span></span>
</td>
<td class="num">(2,055)<span></span>
</td>
<td class="nump">1,393<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_ValuationAllowanceDeferredTaxAssetAdjustmentsAmount', window );">Adjustment previous year loss</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(735)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Additions during the year</a></td>
<td class="num">(3,620)<span></span>
</td>
<td class="num">(3,947)<span></span>
</td>
<td class="num">(4,737)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Balance at end of year</a></td>
<td class="num">$ (42,941)<span></span>
</td>
<td class="num">$ (36,392)<span></span>
</td>
<td class="num">$ (29,655)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_ValuationAllowanceDeferredTaxAssetAdjustmentsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Valuation Allowance, Deferred Tax Asset, Adjustments, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_ValuationAllowanceDeferredTaxAssetAdjustmentsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_ValuationAllowanceDeferredTaxAssetChangesDuetoAmendmentsinTaxLawsandExchangeRateDifferencesAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Valuation Allowance, Deferred Tax Asset, Changes Due to Amendments in Tax Laws and Exchange Rate Differences, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_ValuationAllowanceDeferredTaxAssetChangesDuetoAmendmentsinTaxLawsandExchangeRateDifferencesAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140286963272856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details 4) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Loss before taxes, as reported in the consolidated statements of operations</a></td>
<td class="num">$ (12,925)<span></span>
</td>
<td class="num">$ (15,544)<span></span>
</td>
<td class="num">$ (21,680)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Statutory tax rate</a></td>
<td class="nump">23.00%<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Theoretical tax benefits on the above amount at the Israeli statutory tax rate</a></td>
<td class="num">$ (2,973)<span></span>
</td>
<td class="num">$ (3,575)<span></span>
</td>
<td class="num">$ (4,986)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential', window );">Income tax at rate other than the Israeli statutory tax rate</a></td>
<td class="nump">3<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpense', window );">Non-deductible expenses including equity-based compensation expenses and other</a></td>
<td class="nump">185<span></span>
</td>
<td class="nump">255<span></span>
</td>
<td class="nump">631<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Operating losses and other temporary differences for which valuation allowance was provided</a></td>
<td class="nump">3,620<span></span>
</td>
<td class="nump">3,947<span></span>
</td>
<td class="nump">4,737<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate', window );">Permanent differences</a></td>
<td class="num">(706)<span></span>
</td>
<td class="num">(651)<span></span>
</td>
<td class="num">(427)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherAdjustments', window );">Other</a></td>
<td class="num">(78)<span></span>
</td>
<td class="nump">32<span></span>
</td>
<td class="nump">35<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherTaxExpenseBenefit', window );">Actual tax expense</a></td>
<td class="nump">$ 51<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
<td class="num">$ (5)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e32059-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140286962977352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details Textual) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 29, 2010</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_IncomeTaxesTextualAbstract', window );"><strong>Income Taxes (Textual)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Statutory tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_BeneficiaryEnterprisefromProductiveActivityTaxExemptionPeriod', window );">Beneficiary enterprise from productive activity, tax exemption period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_BeneficiaryEnterprisefromProductiveActivityMaximumTimefromPeriodofElectionforTaxExemption', window );">Beneficiary enterprise from productive activity, maximum time from period of election for tax exemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Carry-forward losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 291<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_DescriptionOfIncomeTaxLawForEncouragementOfCapitalInvestments', window );">Description of income tax law for encouragement of capital investments</a></td>
<td class="text">The Knesset approved an additional amendment to the Law for the Encouragement of Capital Investments, 1959. According to the amendment, a reduced uniform corporate tax rate for exporting industrial enterprises (over 25%) was established. The reduced tax rate will not be program dependent and will apply to the industrial enterprise&#8217;s entire income. The tax rates for industrial enterprises have been reduced. In August 2013, the Israeli Knesset approved an amendment to the Investment Law, pursuant to which the rates for development area A will be 9% and for the rest of the country- 16% in 2014 and thereafter. The Amendment also prescribes that any dividends distributed to individuals or foreign residents from a preferred enterprise&#8217;s earnings as above will be subject to taxes at a rate of 20% (subject to tax treaty benefits)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The Economic Policy for the 2017 and 2018 Budget Years), 2016 which includes Amendment 73 to the Law for the Encouragement of Capital Investments (&#8220;the Amendment&#8221;) was published. According to the Amendment, a preferred enterprise located in development area A will be subject to a tax rate of 7.5% instead of 9% effective from January 1, 2017 (and thereafter the tax rate applicable to preferred enterprises located in other areas remains at 16%).<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_IsraelTaxAuthorityMember', window );">Israel Tax Authority [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_IncomeTaxesTextualAbstract', window );"><strong>Income Taxes (Textual)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Statutory tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_IncomeTaxesTextualAbstract', window );"><strong>Income Taxes (Textual)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_BeneficiaryEnterprisefromProductiveActivityTaxRateonDividendDistributionsfromTaxExemptIncome', window );">Beneficiary enterprise from productive activity, tax rate on dividend distributions from tax exempt income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_IncomeTaxesTextualAbstract', window );"><strong>Income Taxes (Textual)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_BeneficiaryEnterprisefromProductiveActivityTaxRateonDividendDistributionsfromTaxExemptIncome', window );">Beneficiary enterprise from productive activity, tax rate on dividend distributions from tax exempt income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=rwlk_ReWalkRoboticsIncMember', window );">ReWalk Robotics Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_IncomeTaxesTextualAbstract', window );"><strong>Income Taxes (Textual)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Statutory tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Carry-forward losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 182,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_NetOperatingCarryForwardLossesTerms', window );">Net operating carry-forward losses, terms</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=rwlk_ReWalkRoboticsGMBHMember', window );">ReWalk Robotics GMBH [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_IncomeTaxesTextualAbstract', window );"><strong>Income Taxes (Textual)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Statutory tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_BeneficiaryEnterprisefromProductiveActivityMaximumTimefromPeriodofElectionforTaxExemption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Beneficiary Enterprise from Productive Activity, Maximum Time from Period of Election for Tax Exemption</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_BeneficiaryEnterprisefromProductiveActivityMaximumTimefromPeriodofElectionforTaxExemption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_BeneficiaryEnterprisefromProductiveActivityTaxExemptionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Beneficiary Enterprise from Productive Activity, Tax Exemption Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_BeneficiaryEnterprisefromProductiveActivityTaxExemptionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_BeneficiaryEnterprisefromProductiveActivityTaxRateonDividendDistributionsfromTaxExemptIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Beneficiary Enterprise from Productive Activity, Tax Rate on Dividend Distributions from Tax Exempt Income</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_BeneficiaryEnterprisefromProductiveActivityTaxRateonDividendDistributionsfromTaxExemptIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_DescriptionOfIncomeTaxLawForEncouragementOfCapitalInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of income tax law for encouragement of capital investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_DescriptionOfIncomeTaxLawForEncouragementOfCapitalInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_IncomeTaxesTextualAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_IncomeTaxesTextualAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_NetOperatingCarryForwardLossesTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net operating carry-forward losses, terms.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_NetOperatingCarryForwardLossesTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_IsraelTaxAuthorityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_IsraelTaxAuthorityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=rwlk_ReWalkRoboticsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=rwlk_ReWalkRoboticsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=rwlk_ReWalkRoboticsGMBHMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=rwlk_ReWalkRoboticsGMBHMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140286973336952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL EXPENSES, NET (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other Income and Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency transactions and other</a></td>
<td class="num">$ (9)<span></span>
</td>
<td class="num">$ (34)<span></span>
</td>
<td class="nump">$ 42<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfBankDebt', window );">Financial expenses related to loan agreement with Kreos</a></td>
<td class="nump">907<span></span>
</td>
<td class="nump">1,499<span></span>
</td>
<td class="nump">2,398<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_BankCommissions', window );">Bank commissions</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_FinancialExpensesIncomeNet', window );">Financial expenses, net</a></td>
<td class="nump">$ 921<span></span>
</td>
<td class="nump">$ 1,496<span></span>
</td>
<td class="nump">$ 2,466<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_BankCommissions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of bank commissions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_BankCommissions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_FinancialExpensesIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the aggregate amount of financial expense or income from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_FinancialExpensesIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfBankDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to settle a bank borrowing during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfBankDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140286960212760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">$ 4,393<span></span>
</td>
<td class="nump">$ 4,873<span></span>
</td>
<td class="nump">$ 6,545<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IL', window );">Israel [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">1,746<span></span>
</td>
<td class="nump">2,003<span></span>
</td>
<td class="nump">3,558<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">2,631<span></span>
</td>
<td class="nump">2,832<span></span>
</td>
<td class="nump">2,807<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember', window );">Asia Pacific [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_LatinAmericaMember', window );">Latin America [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">6<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">58<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AfricaMember', window );">Africa [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">$ 2<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EntityWideRevenueMajorCustomerLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EntityWideRevenueMajorCustomerLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AsiaPacificMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_LatinAmericaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_LatinAmericaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AfricaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AfricaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140286878634856">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA (Details 1) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Long-lived assets</a></td>
<td class="nump">$ 437<span></span>
</td>
<td class="nump">$ 501<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IL', window );">Israel [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Long-lived assets</a></td>
<td class="nump">145<span></span>
</td>
<td class="nump">179<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Long-lived assets</a></td>
<td class="nump">249<span></span>
</td>
<td class="nump">244<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_DE', window );">Germany [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Long-lived assets</a></td>
<td class="nump">$ 43<span></span>
</td>
<td class="nump">$ 78<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_DE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_DE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140286981492072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA (Details 2) - Customer A [Member]<br></strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=rwlk_CustomerAMember', window );">Sales Revenue, Net [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">38.00%<span></span>
</td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Less than 10%</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EntityWideRevenueMajorCustomerLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EntityWideRevenueMajorCustomerLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=rwlk_CustomerAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=rwlk_CustomerAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140286965044936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA (Details Textual)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2020 </div>
<div>segment</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rwlk_GeographicInformationAndMajorCustomerAndProductDataTextualAbstract', window );"><strong>Geographic Information and Major Customer and Product Data (Textual)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments</a></td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rwlk_GeographicInformationAndMajorCustomerAndProductDataTextualAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rwlk_GeographicInformationAndMajorCustomerAndProductDataTextualAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rwlk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140286973424072">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Jan. 02, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 02, 2021 </div>
<div>&#8362; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,249,533<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,372,954<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Proceeds From Warrant Exercises | $</a></td>
<td class="nump">$ 13,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price | &#8362; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 1.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price | &#8362; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 1.79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromWarrantExercises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from holders exercising their stock warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromWarrantExercises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>95
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MXJKL=LN!D1O7_V&)CMVDNUP#3T#9"?A\*:79#:R#^C^'\=]02P,$%     @
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M_@!A$O3YDG/U&I@1U;Z1DC]02P,$%     @ A$A24DMOEWNQ!   L!   !@
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M38L&[/M5PAQ5?2@4U/\[P=7_ %!+ P04    " "$2%)2_BS+/TD#   ,"P
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M&AKZL"&CW=0CY]1G2R;X4(7;.4J*E<Q!9:V&LA]?K;/BA?,2R?V.\B(?[IY
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MF'U-]PQ^P7:Z?O?=I?*NK;46Q5.JS/;P K: 0!, O?DP(F;W&B CF([-#@U
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M0/Z^**2AFB]J@-T[X5?_!U!+ P04    " "$2%)2?Y=>$FH#  !X#   &
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ME-/T,\+Z\?1CS'OIP(4>E53@Z,'DEV=[:;OI/P3;\H\*&.^#;?BRPJRJ'#V
M[PMK0_^!% R_,IW\%U!+ P04    " "$2%)26NQSV#PL   WA@  &0   'AL
M+W=O<FMS:&5E=',O<VAE970Q,"YX;6RM/=ENVUB6[_P*(IT:V -)L>0UKE0
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MNA7,^D9UT1:>U*D "]"&B'-835X3I0&)UD"B>>/H#30+U',9\CCW QR9&6>
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M1V=GT>'!6?2U:F&YNB >Y>4A_7MV>DBC'1\=Q_Z42@Z6 5!^+%_K45Y22\(
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MMAUGA6=.>4$&-!UT 7F.2XS>,P9N!0XPIHV^5VM#4&40X/,D4F>@<X7W#(%
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M[GMTI14\)MM].[Y-AE[01&_EC-^;>4VI\%B#HR4DKUZTKU^]R!OXD\+_=?4
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M;4IC%*4QH.\[(?3I8!PT@WG\$U!+ P04    " "$2%)2-9DK%EH"  #G!
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M@D!G)=9,W\@&!>T44M7,D*KV@6X4LMPYU540A^$XJ!D7_G+NUC9J.9>MJ;C
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MIB7]8%!9 ]HOI#0GQ0;H?UG+?P%02P,$%     @ A$A24AWV*S7C!P  VA,
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MX[W)^.=220!&![ _-V#^\H$4U)_S+OX+4$L#!!0    ( (1(4E)H$^Q_N@T
M +,D   9    >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;*U:VW(;-Q)]GZ]
M:9TMJ8JB2$K6Q;<J6;83;EFR2E(V#UO[ ,Z ).*9P03 F.9^_9YN8"Z42"79
M[(M$#H%&]^GNT]T@WZR,_>J62GGQO<A+]W9OZ7WUZNC(I4M52#<TE2KQR=S8
M0GJ\M8LC5UDE,]Y4Y$>3T>CTJ)"ZW'OWAI_=VG=O3.US7:I;*UQ=%-*NWZO<
MK-[NC?>:!W=ZL?3TX.C=FTHNU+WR/U>W%N^.6BF9+E3IM"F%5?.W>Y?C5^]/
M:#TO^*=6*]=[+<B2F3%?Z<TT>[LW(H54KE)/$B3^?5-7*L])$-3X+<K<:X^D
MC?W7C?1/;#MLF4FGKDS^B\[\\NW>^9[(U%S6N;\SJY]4M.<ER4M-[OBO6(6U
M+R=[(JV=-T7<# T*78;_\GO$H;?A?+1CPR1NF+#>X2#6\H/T\MT;:U;"TFI(
MHQ=L*N^&<KHDI]Q[BT\U]OEW5U^NKZ</UQ]O'N[%Y<T'<?7EYF%Z\R/>B\_3
MR_?3S].'Z<?[-T<>9]&.HS3*?1_D3G;('4_$M2G]THF/9::R30%'4++5=-)H
M^G[RK,0/*AV*X_% 3$:3T3/RCEO+CUG>\2[+35%HC_CR3L@R$U=05Y<+5:9:
M.?%!NS0WKK9*_.MRYKQ%^/S[F5-/VE-/^-23_SO>S\N]^?+P49R].A1_[(!$
M#I/;VJ9+!+1(6R1>B8>E A)%)<NUP(?XK&3;:YD+,\OU0E(R.>&-J)K]"V,R
M)^;6%$+[;@O"M*SGM-<J*R!KA=RC_U:N\)E75LL\[LOT?*XL-!#?5)D9ZX:B
M5:]_;&9$:;S099K7F4J:HZ#/4M*!:S&#/;),D?894LDO040"#"9SOQZ*2R?,
M7""25#&#3DTT#2"T/ S;Y"S'D;5W'D&!>-@X7A:F+CTDPWQ95=9\UV1(OA8O
M1L,SY&>>8]TPF0V3+Y6RD@)*Y.H1R,F^/DCZ0!M>JR(6O#X30$[GVE,PZE),
MG94J'\!.)7XN->EP[WD/Q>Z/"@15PD!(Q5DLP0GUO=*(WYGR*Z5*LG3,J_'B
M&%@DE;',C(#$=]K\_6_GD_'9:]=7( K43B _H&L.BUT]^Q74RE"4)<4'W(7\
M876#O!)4#YAOK4Z5F(('OHO]J]OI >O9+H< 7GX[%1+J>M06,@^!\DTB1,@?
M <)*KKMTM2HUBU+_!ROC>0!1&WZW6NITR<\ZYPD4L 3AT)>SDJ1L6ENKLB&\
M K?<W7UF\7=W/S:.D];19I*GK5!%E9NU@MXU#+*B'S6/7"X75JEP$KN"/D&4
MDE6F1BRS^Z#N8P<ET4$$L4-=WN$?5JSS#'+!:6@$0!K< LZ[4"2;7 V@^H+(
M S..OU RR:\(:X4"W4)%1I!"SK.C^A1!83P4?1"7\AN00)!5[ 4X&QEJ51/D
M%/">@C;IT!I$!U(Z6^507PFED,0Q'2350%W414Q)PNA10DY.!66_(T7D]KP?
M]NFNB_N:&&L;6L1NO:P@R81=HR]AA\[(J3+&+\-5$B]!8M@#-1Z%29##!!27
M/UF0PW_-H8:#/7D2#/"^R77&'IG)G*)2<%O@=EG/^DJR+$=KYL0^YU% S!V\
MHB@<)R^2L_&(7DZ2T[-3CLSDY&*</!@/=V]BE(P'YV=GR6?EW"NABZKVG)P@
M>N5\LC^Y.$D.DML $*(RKQ7IM15NB'IY?AQ%_3$8D_W3TQ$.N'D&29AS 0-^
MX5Y-98>(34N1;17UKUWF0N6"\5@K^/<@F0Q/+Y[NRM C</!1U"=C+$I^$ $8
M/AU)C^Y5M>P1I E%#=&V(C09C2\B08_/42V!RHNSTY/6*0.\/;[HO:6U+TXO
M7O8> =U*<:>;KX=).DSNS#JDS:NMP4[>D):"%[(RA6VF*ECY.;3V@1#FNJ1X
M@GC*0VD]U2%KZL42W@M5LDED,9U>LJSWT[L/0W&O*0ZWL1=]$"DABMJ"2&]C
M L)7,"M[_LBF&'AV0T<.+\;#B[9 !^!>CD:[@!-?ZI9V-W="_+;SX8MM1[[L
M-K([+3MC?3@#YB1B825QR_Z.#!WT4QW ZRQ*T%W9).-WV7Q^WAIXP"2%(K!%
MSY,>$%P36Z@AN"DKLFD5)J,+>H@<\)JJ"A@/K1N5!12L)<*EY<.XBKAPCHS:
M$09(:*A3U:C4*>1#%B&#D^\1'XP'6&=\0D1BA+& 'L-C/"F4@G!.&!-)3=)R
M3/B,-PB>BF3L!T('5U%]V8+G(()#>N#I\0]-*#B9!^[A=L.:K$YC-V+PQ%)9
M8]D6>536JNF6?%/HN-IB'_5-0*FN6,G1J#T@QD.#_Y"[Q!@T#3=N-J2YHX(J
M;<NS37'^/'W_Y2[6XX?-3BB:SF6W!T#H(<(,Y'OE?\-J%%GX20;']P"((2C1
ML%#&8S4;RWNIO6ZUUV3>;[6FEDM<9IDFE:BA#-G^&:TB.%-<-MU L]KUPZ<Q
MX2=IT=WTLP)JEVB9XKGW2M&\H,0%0$*18R8NC*5>)EQH,!O,:$@(XG.T<B8&
M>Z<#64BI^$0[]#KMT2W=<]8XSJT8"9',3_HM"5'0N*/N/UHD8GVXV" L1K@%
M(297IQ#URI;D]<](MAXQ/G]F2J*MO1!IVI)UGXOZ(Q(8\+0=BC@*PQBCQ5V_
M['SHE9W/F T16-] .7&H^UJ:U>$2OHO5":)#YXVFDEL^)$JRLXSA<R15P;TD
M38XS&C!DZ2)EL>(:$415C9S8C(PQUB&=!M]Y8QXJ&H5U^PFBF:0V$=T"3/$'
MLB(7H(IR=TH,WF1,Z&K;(L*ITIJ ;3T+(F[$2L%L\CH8,TFU3>N"QM240IT,
MC'"$8A"MI+.Q^Y"J%A1LT:01%R"W@V5,X- ,DF8I-4RO4)L..FJB2-*59F#E
M>J,&2?%HG&0(*A[]N'(]J27M_+%5/;M]0P?N?*M::-%5/A\D,O %&1&O!9JJ
MU*BY0ERR\]3W5.%HI[\+KXM(-%UYW,++HLIKUS'N/NL%1GA^_X[M+?1$%3[$
M/+WM;(I"6FS"O0Q=)\0\L\K+("2Y^[LLJM<?PFUGVRMO1:JY5.A5YR9H#EZ+
M_=EVOT<C7*<.A[#LY=&:9 -5GN_;P6F+EW%*>A!BX/?"%?U22ZUE&:]T*5E%
MBA8#UB=^705C4Q/;_M"N[:2&#J+7%&[[V8&8SI]J\P=4D*!"$$ 6SIS1U"I=
MR 1-8QD<FZ[IC B>=4M=[?#+,$'9_XQ7CGB8X(P+GXQ\H>?(3;DXY'E%.J?:
MRQ'GD7D\G4NW'#!7=@W?V:@;*CB:9G3]4.4J6X3!U:F4)BUR9!+K#'.86-22
MU%51[7@3UO=]9,A,5<9I3]<CD78;\=3%D>:. "'X,BM7Y0;Q4MJ'P$^".WKB
M$P5XU +<>Y5+78"A"";46;I3P=R?A8M;#"M)<Z_2-I)4WTX9H'_(LJ8V$@_.
M!H('.[2@7E(Y%6D.*#D\J,4BCZJES.>,0)XK,H+;SZ7),[*#4[:Y#44O:!.9
MQGJPK>5]W,-BIZMEZ#*.B$JL3!5W6(!*,^TL--U <W3QI4L1.S3Z8D)\.AR+
M_4_4V]^887)\?'PXOC@[/CDY$+5K>_B->/TSC?@^+:95D]'KZ>T7?C5^?1 Z
M&F(AZO>:_B_IE0]38WQ$_="!1^YKOI^S.+AN8SK<8=*;*YEK,$6IY8!6E(@]
M/+U'W%YCA0%3Z.<$47(4IEPI=$!+>G8-%\IT"00\M=KW-<;9_&L4S=*BN,W+
MU \Z)$X4WE2<&]0,A&S9?8[0[%1^S3&UK[_]"9$]29O*AH+?1)\NOQ%_9!24
MB/;0 R3-%:)339!&.$/>$NM?IFW;*CXV7,P/%V!+Y_M!,&A(E!G+=Q=7L2^E
M2]P,\9QZ8UW"\\Y\CL).5U\DAI5:X6#.ZNVWE8B=<&'6G,3LE6%V+#,JKL'L
M.3!J;7\277\MAD+(@A\*[6)B]&F /9/+]"MMPCF.QI+D5^#I,LT:#5I @X9/
M%/S?@ZFG.TW@"9P._>'EP&B=QM=<RDC?;=.37YF=Z.W(P$>)DSR;.&*_(X--
M<8.&& 8-,_3N(Z% .TT$QB4@M]M(!)6 SW^M,VH=L?4&+6VS]7S0ZU;^;&:%
M)I^_O.C."ZU6F-M#CB6,%RB=*:SU>3,A;$=3<3>'X@F"UE6=M]<E\229!^IM
M+0NS_5\*I-V&]DE[<W/G)BYE8.H$E3.7+8W<-Y0R#E\6843=32[=XA'UBV$V
MI8DA;ND3SX"OEK:Y #9?UHL:G!3FSVFX9-0I8+2#;:YNFP]\5)CF4B-*#"U$
MCRZWVY0\M6E -YU\M]=VX17D8."=S\5<ZCS>&^5*DJ?G,G<\Y>%4>D0;N_(<
M/4F\M[V LZ'7DMGGHAFNR3K^VN>W&DL()E7J:&FK2TNJG>T2$K/XK:RK'U%^
M!*.YQ4"T!5'LD=8/S,#H7"F_!H^,I\$FYP$31-',S8_#M.652U[6W7M_TA;.
MO:*!5?MF#MNP4J*>H,P$.[N4:7*/0.CF\-_'H1]1S=<\[:XDTQD/?O-P'UHI
MK]OYDLH3LAJLQ&^#P<W!/$U&TY'_%F[<)---/&;KJ+S,Z.MZ:M@Z+COIOH*J
MP;,[;X"1*[$_;8A]B>#CAKWUW"!P"_?*8)=%^,9JIOB" ;UFWG[%%.SA[P:W
M_9CAJ/=#$A3]!?]<ADH)B#K\IJ1]VOXBYS+\$*5;'G[.@T(%=J'O%>?8.AJ>
MO=P3-OQ$)KSQIN*?I<R,]Z;@ETL@I2PMP.=S8WSSA@YH?Z?T[K]02P,$%
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M]&N^O?[QZLVK'W_]Z?M7;Z[_VWGU]W>OW_[CZ^<-C(S?GV_4*-_Q*,&14?S
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MP?M'@ON$#1N'AG&MD*K..V>35X^M,]SU'E+(/*7CB"[K3Q!7U1:!*@L-"_-
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MKC];B NQ\KUX-6IX8A$H*VWPYRMW/IL#R.'"6XD81SL;C6.'F(^,$P?N:K5
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MY,UGX@Q4NA]=GH5+;+4"_1P(D- K^]>S>'9Y%@<>C.P&H0]*)PK%P@UG:,J
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MD;QT2I_ /#WKT4YCF^J[Q,527IW@7#GSV.L);G8 E!>'H?TKF6F=1V=$(VK
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M1/1#4Q[HSQJMRZ8I]_3K3H+;6F$#^(X6JW[ "<S?N?KV_P%02P,$%     @
MA$A24GF?U7#U!@  /A(  !D   !X;"]W;W)K<VAE971S+W-H965T,3<N>&UL
MM5A;;]LV%'[WKR"\8MB Q+<T3=HF 9S470.T29%DV\.P!UHZMMA0HDI2<;Q?
MO^^0DJPT<5H,&!#$$D6>RW>^<Y&.5L;>NHS(B_M<%^ZXGWE?OAD.79)1+MW
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M5'%8R<U.Y2S.X=0=UC?B>&[X5L^UV1H,T92]'=,>R/1HO=+9BM;*$Y=@+VP
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M&TKDX8/,C3 %/W&J$2'Z^J1DJ>'SX.*,''_)ZEL.J=!&FLH4Y9.(GXDB9)Z
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M9=^NM\OM;Q1^DN6*$C!32VP=#6>3$U':]_[VBRFV_*Y]41A3;/AR#=A0)2W
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MHP[$E38R;XR)02Z*NN=?&AU>&(R]-PR"QB!PO&M'CN4E-_S\5,D-*'N:T.S
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M89%PE6@@!_3*=[I_ZY#JD.)N3]? N@?3;]8L&?LJ28T$N&:QS$M9N!VY EX
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MV0.TOY+T%IN)==#^UIW_ U!+ P04    " "$2%)2=^*3>&P"   C!0  &0
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M4#L'VL^4LON%.Z!_%Y>_ %!+ P04    " "$2%)2&L,<YZPS  "9I@  &0
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M<> T,EA5,W[^YC[)6]J;!WO O[Q->6DX1V5R0G) O:R C31EE>%SZR2K8AR
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MPB7_U0(7EY,!8X-%*'"L[)[.TG&ZB3!<MF-@S7\"<S5JT=R7>;N!65^KV=+
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M>1+F5$\1^5UQ>#E(%^/1H2DD/@9VE]XP/WX$[*0Z$*$":N[SW#TRRI\(W]Y
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MDMSCM+H:Q:A/>YZSQY 5/BNF>($231H>]'Y<(=FS#/&ELP,O_0Y):95L"9,
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M+ED)C3\J?1.J#3>2&!UU^*X%.("!V:+.;*_B-S$A:.00=$H(*E#6P(_7)RJ
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M/^_HBG9\ 'Y?EZ"NR0><X*&LOM'R?OM?4$L#!!0    ( (1(4E+$T_ CQP8
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M>#0Y#8GNUJI3K*K]**^5Q<7PQQ)?(M#. >V%4G:KN 3#VS;_ U!+ P04
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MI30X0=RRQ)$-RAK@>2&EV2J6H/L)3/X!4$L#!!0    ( (1(4E)"H7HK/@,
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MN^*PG;[$,XEMB/R\( C0V%/#]O!WV?[Q%YCB @UX[L1*C_.)-[5W;F358"S
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M)XG.VD&D7VBY,K^%N)=:R](\+@7&5D4$^)XZUGY!"H8?Q[S\'U!+ P04
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MB^5\^CA9T6F\BNG9BJT+T.=#UZ A%LY-]DJO&Z7!*TK]@,ZD,+FF-R*%]$<
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M$.:"/H\Y5QO#!*@FZ^Y?4$L#!!0    ( (1(4E+@DTN=L0(  ($'   9
M>&PO=V]R:W-H965T<R]S:&5E=#,U+GAM;*5576_:,!3]*U;4AU;:FD\26@$2
MA+9#6BDJL#U,>S#)A5A-;&8;Z/[];"=DE"\A]27QQSGGWGL2^[8VC+^)#$"B
M]R*GHFUE4B[O;5LD&118W+(E4+4S9[S 4DWYPA9+#C@UI"*W/<<)[0(3:G5:
M9FW$.RVVDCFA,.)(K(H"\[\]R-FF;;G6=N&5+#*I%^Q.:XD7, 8Y78ZXFMFU
M2DH*H((PBCC,VU;7O>]'&F\ /PALQ,X8Z4IFC+WIR2!M6XY."')(I%; ZK6&
M&/)<"ZDT_E2:5AU2$W?'6_5'4[NJ988%Q"S_25*9M:VFA5*8XU4N7]GF&U3U
M-+1>PG)AGFA38L,["R4K(5E1D54&!:'E&[]7/NP0W/ $P:L(WCXA.$'P*X)_
M*2&H"(%QIBS%^-#'$G=:G&T0UVBEI@?&3,-6Y1.J/_M8<K5+%$]VQH.GX>!Q
M$'>'$]2-XY?I<#(8/J'1R_=!/'@8H^L^2$QR@=P;]!5-QWUT?76#KA"A:)*Q
ME< T%2U;JDRTGIU447ME5.]$5-=#SXS*3* 'FD+Z4<!6)=1U>-LZ>MY9Q3XD
MM\AWOR#/\9PC"<47T]V[(_3^Y?3FF6K\^JOX1B\XH3=A$N?H%=9 5W#4WY+?
M,'Q]M->=P+_S6_9ZM^8CH&:T!^H?@L)&T*A!'_(/ZOR#L_E/*9$"C7*<0(I^
M/4,Q _[[C"^-6K?Q25]*?KA3C1_J'^*#+X>@P&\V]GPY!(6>'QWW):SS#\_F
M/UYB#D@]E#OJY* -YAQ324!<XE)41XD^Z5)T\,VC_?\B/L0$S>:>1X<8WVGN
M663O7$X%\(6YY 5*V(K*\GS7JW4?Z9KK<V^]I_I+V0[^RY3-Z1GS!:$"Y3!7
MDLYMI#+BY85?3B1;FBMPQJ2Z4,TP4ST2N :H_3EC<CO1 >JNV_D'4$L#!!0
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ML@9I%/#[2@C]>C$.ZO4_^@-02P,$%     @ A$A24G4SY>Z, P  C0T  !D
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MX)RN4W7/MY]QGU##\,UX*NTO;(NQK8X'L[54/-N#M8*,Y<4_?=I/Q!& -$\
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M1''V+QJ*K^QI>,J5/EO;QZ6^+Z$P _3[.>?JN6$"E#>P_B]02P,$%     @
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M^J4%?:L%#]L+&_8-J/0%2_5UG15VP,<%150J!B2\X1=]28':X8'B:+;IIN8
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M@^Y8HJR"L@[X?2FEV1HV0"_4Z0M02P,$%     @ A4A24J.#:Z%#!0  R10
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MP#>(80YB JY)+/A'V2F_KS8TYXA$?&@*Z88RQ@PKDR>ER7"/R6>(' "K_Q%
MRW8U\&D[?(K# ]"S"KBC@<_:X1?T_D!""[BG@9^\8GQ.:NT##?QS%^-M!8>6
M!G[:&6[[&OB\@_&6NQ=^U@7N[_7]2P?CH:=;=U-F?9WZL$Y]6,CK[96W$F!.
MN&"YK!$"?#N7$\!<X)1_;Q'?J\7W"O']/>(7C(881QRL&4U!0LDM$)BI+T0T
MSA^W2_MF?]=E2PER"I"JGO>CG@^'YOUV2K0*5B7[D&<HQ$>&K,D<LWMLC$"+
M__W:_WZKQ3>(,23#*BC(<A9N9-T#E$4QD96[(@6=1Z50=\LCV^YYON,XS]QZ
M.1$Z$$*O7\_;,=NIS79:S5[BD)((C&5*1&5:?,7I"K.VE'!KV>Y;9-R@%C_H
M%''\B%D8RW!G+ ZQCN)*.?Y6[ 8'CCYN7JW<:U4>X S]5%[I5G7FO<Q3U[+T
M&OU:H]^JL2@G(.8\QY%.I_\RDWQYTMRCU;::BFG]7H: ?\""X4\G.8EPU"5O
M[*TJ;;]%YM@-%]KP/P6S@N]L-\_;'\V&)>UV8I/1S)D,5^%AEY@U_&/WWR1F
M#5/8[51Q(ED3H)3F1&B/(<Z+I%?IMR]B#8G8[O]96":5N*YV-&QCM]/-N=17
M:-8ZWXZ%?9!2(C8ZLCAY!=MSM=A=+QK:LMMY:TQ(CA)Y))6>8"X 0T)'F=-7
MQ-C6P<#YH\VBAM;L=EX+\(\\5ELBVUEHM3<1D1E'UR"DJ0P!D/>#\$Y>;*OY
M\H(M&Q4-@PRSF$:J_*ZP+ D"*U;2AMO_E?R #4_"=IZ</X44/V;R#JZ+ZN=*
MQ+9NWQKLT=RP);3?X.@QJ:1N<UQ_,+!WSQUSW2QO)U[E858SSW4'_A[?M@ZM
M[43=N<A/*D$[Z]I_X4TYR>MR%( -J</?('59'D]B)O/AE\Y6L.%[^"9\#QN^
MA^U\OZ"L> :2&U &G81Q)HF#YZN_<5CD6K/WBNVF7IUTER3XLB[T]F\W519V
M>QJ"ANU$J;\S'+^"6F(,"!482$K3A<W<>FQ(,;LMWL.XI"19!LO;4=U;O[D=
M%X\5S_NA>W@&7<V(-%&.% \U9J.B?.3[BMAM3#A(\%JJ4ZQK %:^FY4-0;/B
MN6-%A:!I\;G!*,),39#C:RJ=JQI*0?UZ.?H74$L#!!0    ( (5(4E(S4@1Z
M0@,  '8)   9    >&PO=V]R:W-H965T<R]S:&5E=#0X+GAM;)66;6_:,!#'
MO\HIVJ16&LT3)*0"I!;V@-2R:K#MQ;07;G* M21FM@/MM]\YH2D;(>W>0)SX
M?[__76Q?!CLA?ZDUHH:'+,W5T%IKO;FT;16O,6/J0FPPIR=+(3.F:2A7MMI(
M9$DIRE+;<YS SAC/K=&@O'<G1P-1Z)3G>"=!%5G&Y.,UIF(WM%SKZ<87OEIK
M<\,>#39LA7/47S=WDD9V'27A&>:*BQPD+H?6E7LY=CTC*&=\X[A3!]=@4KD7
MXI<93).AY1A'F&*L30A&?UL<8YJ:2.3C]SZH53.-\/#Z*?J',GE*YIXI'(OT
M.T_T>FCU+4APR8I4?Q&[3[A/J&?BQ2)5Y2_LJKEAUX*X4%ID>S$YR'A>_;.'
M?2$.!-XI@;<7>/\(W%,"?R_PRT0K9V5:$Z;9:"#%#J293=',15F;4DW9\-R\
MQKF6])233H_&GV]OIXO;][/%'*YF$QA_GBVFLX\TAIOIU?7T9KJ8OI_#V00U
MXZDZAPY\G4_@[,TYO &>PV(M"L7R1 UL379,4#O>HZ\KM'<"/<'X GSW'7B.
MYS3(QZ^6N]'?<IN*4%?"JROAE?'\4Y406<8UK5"M@!*"L<@USU>8QQP53+B*
M4Z$*B?#CZEYI2>OO9PO5KZE^2>V>H%+N;E/I*E6O5)FMN!V%+A5IVX#JUJCN
M2RBO"56I@@-4$ ;-J%Z-ZKV$\IM0O2-4-W*;44&-"EI1"Z%9"BG25H8->RS?
M7Q,Z.$*[_3!L9H<U.VQEWZ!2E\"S3:$QH=V@4:+23?3PB-[QHFXSO5_3^ZWT
M.X)1MK!E:8$@EK LM%F?+]>B?UR+7M]O=A/5;J)7U"(NI#2>Z'PM)-=FYY Q
M:CJ2F<U4>6OT%!U7* B>5WQU(D1'NZ(3^"=>HNL\'X%.J_69R#M/QE]C=1_N
MT$;D^?]8;9CD^F[OA->#X]IM]?J][$N8=-B6C*Z06JEIUK5AH#68P1F=S(_(
MI#IO]-^.\"HI]"&C(W"M((*$/:J6P\Y]/F-=[__L)W2NBH(*3U7'1K/M 5WO
M(G#>-GFS#YJB^2*Y97+%<T5E6E(DYR*D5R.K)E\-M-B4??)>:.JZY>6:/HQ0
MF@GT?"F$?AJ8UEM_:HW^ %!+ P04    " "%2%)2M5!:/TX%  #P$P  &0
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MU-4K=.G+8#,*N@'V!O;F $6_IN@?1?%7Y0+Y.N"E7B. OM5NQ(I$,+34M26
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ML;FPGV[OV5$U$CFA&-A[C5H&/"GZ5Z&.Y#J798]3K]8]\KCH#%^MW^K>N6@
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MO2V9<=1J<J?FV?T$6#>2#W!-:;#PA]!&AH"HHGB!FHGAD['M37.(N7=$"T5
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MU*X?H&+;X :!?GJ HAT-]/-XH1ZCO7][ +C1./[^ .D>#?2/$4"ELG.E]/1
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M:""*4.C$D5B5:\PI\00ZQK$$A^,H!$&7A2@"\0;E4V@3X-(L3?(TCN9<4!>
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M/((0!QSATES*.8#S$S8!&!P"]IF2CPGY 'XN5TNF"#_AWS:]*VE%2BXVX!X
M#4@J!*0^&0K&/'#MC@^#]A^&ID[-FP#:',#C)FGR!C@1 J S7WEV^B&,<HB2
M/IHE:]:RX^:CE@/&D7UX]ZX,_1!7#6>3FP24'<Y/$^3.F%@>!39"*++AT0$7
MPSISFUP7K);$$*Q6D@)B6P!SN=@FK ZU%%"-!!H=+G(@WT6TC:9L7U5>^FV6
MYCF&E3/&P(6$H(U%=Z4_B].NA!@%>'@A3TKO$R:[F?&%RX/#'+?3857/HWR6
M;I"=.*_2NYJ0+:@JLF]:4[.,0]'50$<8051X5>A4TX.)!<;$#<P>*N=E8#*+
MTUSJ$!X 2&2?@R?.0[:VJPPKM+8@^@#7N8#+YQ;TZ2W&?(Y+)[;K=E;/,IP#
M:9ABS%PX[8UQY"R16:8-LX*XG!QOLC(41Y-)1.S:<>X;*]CW>>312Q$@.T5-
MZWMC9N/;O.4WSZ:>7P":@TP@YT6(+?,444:R-*Z2*$JB&FF#.$_+]2L7Y/4N
M;2&UG&FX$]<WNOF"[3*"A2O#WVBU8G.(_5E\7TXNO(DQ)@HS88>2^EH0X@*K
MOH X62EZOF-$+92__6!J>;4%K=68*F%H4KTZ&[=J!]=ICP;]:<>0_S#_V;O_
M03M.DF?89M.3.M?#?D"0\QT -4FN4JBF/N/YN4^TV@M#%V9(^/6HP 6!'/ E
M571MZL/K7S*6YN1(YB4^D7^\YT+X3]VD51QL.D^3F395A&GJ0\R*KCS&Y/G<
MWETF/91RT^!__O(7W&C28::"25,?35:8U13!KK3YQ0Z81YLL [>[I5TPK-XN
M4?N!+H3/:U VSZ56X>8NS.)(!+:83E?:7VR].-B-Y[3KZ@LL/VI6H271D\8*
MN-+'"LF*9;<LF]2R2_!J@I! H++;,(G^7;7>Y,*QX-@5*6\E,GX"95 M:,@Y
M8'!>4ZR_NP&5"1,0">I8S"/,<X:.;5:N%P$;(:)V3Z$-6K@"I4QDM'*.$W]>
M+-$V<3K%]S^D6\SSXS 13!A6( <%<</7TFM B 4P, ]%6,)IC*J^+S1I[%TT
M*%<'L04;1K 5A*T9$Q@YQE]+Q^(N%<$5NC9 UG0%&I<[^%5B.-]D=]$=-I*S
M5*G;VCA:&Z&2!:8^QL;<-CA_F"^XY!D]7E!"GEU<7N?/1ZD)%72;P=.H":I"
M9JH/;3_S,D=TV^]8%MZRFKH@BS"2*<8)"&\U:Y''%(X\KC#<L*OL,.:OM-O1
M'R5"?CW\G]IVR[+UM+*G;BN3\&M/*^I.O8'L'%61$]6'-6.IDLH\WL/)<"XQ
M:* ^#?SV!+NM3&<P#TMK.Z-ZK^-DM8[3>\:D"(M\Y!CAI<JP4^N)A%?9:*JW
MT9="VTF/9,Y=WL6FV( .B<I4\]C4JARJX488MD6-5O)J9+O?>]J9U#:" <XI
MUX'J<^C7"?BCZ6TB=PCS0I^PI-WT-84@ICVI':V:N"H?A.J]AP<D5G= LF1B
MDXK$9DY,NBNU295#0O7.@_#ZU;JN;:C<@=K;D>:FW:RTZ[EM==:7X_:<]FKO
M27 'IC_ !F6QJ-YBG6?1'6JN\Q@\>)Z='+/0E96B3V2E+&6E++V5JC:.>O8[
M1R[PMW*(.G$]UQB4<DL9"TMO+$;M:DD8]146. /*P%)JW-*K\4ON*"ZD218Y
M*97CVF&"WDK@=>/B#!I/JU84LZ.&Y?L'T6_ED'7RV98WQ#IE0"R] 6EE2+<J
M=8PN.?@W$)5$MPECHQ.F;W>,>#6<=3F;'M63US+/O!L+F8BQG0F(\U >!N5A
M3!+FE-UD&^Q.97FN#)?4<U'>9_,DC#<U_;%9&$N9.$MOX@Z+%?E8;F&<9RDX
M7ZLQ*LM2ALERGTAE*:-BZ8W*897MJW9C^/KLK8Z3L!KVUQE634KS6WK-+[R[
MRA="=R$7^P"$B4G/L=PFNMF( JQJ^RK,,4$/(H)?8&4T5W/_'/2H6%/#^*N.
MLLK>6/J]R.]@##[*(>K&P#*H$=!^BMO*4MF/MU18E)>0PZOWC0VZSH(5M(8W
MT1C#(O%IUB=X0Z)C*ZMFC[1JCY](PHKQT^C:1]-V!J>A+*2MMY"GT=>RDBX7
M9P_[$V$?=\#9);ZV,H^VWCQV, I7N'73BU./U?/, 9+4ZH;T)FB4OZ*'\8#,
ML@344&WFT!R4B;#U)N(4C2'?P^,YK(S%O(I+.R.G)R ;%#!E2FQ]9'(D]H'E
MOB;6G;4W.T=8+EN9%=M[&LME*Z-AZS7U=]"O'^00=6([W-D>HK?2_K9>^S^Z
M[.TW"7AD29O2^,Z.#-JX'60-M3X[W=#$=&S7IZUTT&\C&C9GH=2]HU?W)\V-
M[=%!Q&<)U[0:^3S''22L4MV.7N4^JNKLLP3:L.R6VTEY_+:[71-MI=\=O7YO
M*(01:]]1BMNQGV;M.[4"3;U>E1DU2><'RX+3D]H=% 2E8AV]BCU_A$9UE$9U
MGDBC.DJC.CO<\&^CJ@!NTB99[8'L@:-4J:-7I;M-%^JQ$<1VE;)TC:<AMJLT
MF;LC=S^F5-'M<3=]RW0ZF5'9T-4T;.*IU)NK5V_G56E(LVAPQC*L<@(G.R^B
M8B/K/J($4Y%XXF,,/Y2R<I\H2>\JK>6.=#<?[TX<N=UDNN-X@=?.LQ[W-+0#
MRZ?>@(%TE69TGU S'DG@+2MI6^W:V./^ACX=TJ)NK>1\AQ9]K.-T+0'K#PQ\
MVM6JB;92SZX^C_)8Q^1(PFT:(\MNT[NO54VLFE@KC>_J-?ZC?)<CM^LUVZ9O
M^Q9M8]UM2&TW,*V@V?!Z+,1/(R V2:&LC+O#8?]&/0<4JQ^0(E7YR!M!T!'Z
MT%/VR7LB^^0I^^0]C:=]Y/5ZVEY V]+1UY!.00<.A-V>LEG>$[CD1UZ?JVU[
M?EOW];2C@4N#5KOKD? ^[8;7)(.RFMZ.'8YHM65Q3([2;)UFHISG7;2*BI'B
MJ&RG]T0>OZ?LFK<CV5[EJ8>/%&J8^][KIE5<>SC0]Y2]\O3VZN==*>?W$D![
MUWIHY-II)[W)>7ARZ;W7W;GUA@Z)><J*>#NL""MJ5</UTE]1WZ2JP1>/0-GO
MV5(;))Y2]YY>W;>VU+#\:B8+Y<21D[[+2W; '#Y_@Q/G\X89LQXC<Q0FX6P&
M\DQ^9@E?/?6#-YVWY=$;  =KK:H0+\?&%$_(_W1Z]A[6"4G.BB+F^/ &92$W
M@BCMWRS,ES('G$]X'>*^21T85UQ-A-W:Z[%]Z+LJ=CN-LKP@5Y+F1\WZ_%)K
MU2OOJE/[^_2Q8[9. 5QBB=Z\PD$S]C->SSA;DCC=XBEX3@(2]8(IIQ+E)&9Y
M+DH$]TUC:I0%\,_%N8NV4=WDLBYH%L:S3=PX?3ZL\*11D]<=U-C?E2? "&\1
MY-<FB&+%>+-B9-NN(*L.C(PX;(_;;QG#JP@4W ]A/@__K J2WX?9%] .Y64$
M_'0_KC$VV_ CR$!H7JV)13+-PLNY/$-?;LL(NM5/C..V='H31[=<ATBA!V(;
M#0'A<KMH7&K0$@5Q+T!-$O8=Q2\]^YM=^[GO-)C?O%ZA?R$ UORF$:<\CM(\
M*\]Y;D\\T^D>JN]A_;17JSY6DR72]17;KTTMIO$W)J!DSE*8VR\I/Q2D&I1*
M3G96IPIQ;U?>U9 V"4*>(4%DOS<*G<,2'05DO<E0?'C:NU/^*_"O73@ 'R0:
M$W$0!5Z3>82;APA?&HE\TCPF Q(#K@0_<].S YFQ8I.)8RZJ2ZOJ!&6.&NJ,
MS%532/EAR-)"@7#EFYM_R8/[E7:6K5$;<=6==Z"(]8?R5H*JD[%7$BL[4Z3I
M%[+&NJPV+R9DLT[+TNI2 *HJ&M/MIPNG1IV&U9:$.K!6W9@@[O0H8;?O]^ E
M)W-^QXRXDX-+E:R[5@(JSQ7AC;(D+ J@J#I#U"="@GS)H&<SO'H?Z/.4F$G%
M@DX37H[R-5J)"IA]<- JA9:+HW*M%O;4:LI.QE;R &)ML49</:2SV88?,BBV
M:4V@U6D[4*"5[BO5=K4UKA8((FK1?N[6Y:II("N!0GKL.V,'&A*C^D!U55P.
MT[L&<H&1D"/L4U*AM;3R-9M%BP@WP3N+JT:PB=!]>(E/[3(-.8@$+30X2JK$
M(ZS.3-1J61 I0&"]CN];CTO);5Y*LP1:D+>?&E0H'U:$;AA]:'R:@5+%&XN5
MJ//UU3^-!H'D+#:S&1BWQ88?\N-"+G J5=$%^QS&7\J7>>6=2,P$3YKTJ2B,
MAZQ!<.6Y$5;5Y99R"[#>;N"-/*A9$:>!YT.@=<Y^<I!)2G"1RD,GS6MP--&L
MK_(WOGXSMGEJ:T0L[JN\C6\^32SNJ_2*OZ,J_Y&IH0L)-ZB'G].!\--7:0Y?
MG^8XSL+M/-V6%2JR<"Q.PT1[F\(??K=LQ1\,RWV5#/%W5/N#;XOW+(!"J7**
MU5H;M2_BJZR(_T0']'R5W_!W%<<_CMDG?C?MT=H&.9--FI6]YM U*2HQXC_!
M/3 G?C<W8INNVS[,<];7SO!M9R!=Y]>N=]&G41YSX/!D!\R36OTL+VE^NTE8
M=>.N+)JME*!X3NV^D.'T42.5U;E@W_EWMS&P:D+M9I-^''[^+\#A[*$X"//1
M+%/^."M2)+C7.TY3?E1*RW]TP>ED1(KTQ.\6F_H6_-?:BSKM:6?:KNVZK:VV
MG\<V/.L;V72#(4T0*#L;Z.UL2WEU$\9Z%19TBU9;*NPTZ![MJYLT08@QC<YD
MH\9VB#/%\[T#5% N0:#?RAEID8 <XL+":(R1"I2[$#S1_::!<@$"O0OPK7RV
M.OP9WA,.E"<0?!=/ -"K5/]5JII^+&<A]O3'\$0Y#L$3.0Z!<AR"D2?['V+.
M=L <9<[$,T-CRAXUBC-H-GI-U7]@C+.'CM%GBL0S:[<A"I3_%>C]KV\U1$'7
MPW*,3FGD:4\SW_-]HZU\1S4[ZVEF!_PNB5XEH+RZ8)0_\&C5Y.\V':=!3^D=
MOWBF38IQ[<[*=G;=\$T=PS('E6+MACZ]ER)US<E7<6GJ0PY.F4;]BKTGJI P
MC=K%98;>L![5+S):A_<#D>9E":?N2 S=_&*@76T]JMU28^@-8?\U/3_MZG;)
M&$G2@A'_IE<%'-1^_(3?'(*_9X47.8$.$?>05T^K7\WZB?_<3.>Y05_\@9/L
MOD,L\1W_ 9D#-8SXJ:[W878;);BSLH AC2ENZ&?BMZ_$ER)=\Y]@N4F+(EWQ
MCTL6 O^Q ;Q?I#!!^04'J'Z#[/7_ U!+ P04    " "%2%)2FZ-:30D#  #N
M"   &0   'AL+W=O<FMS:&5E=',O<VAE970U-BYX;6S%5LMNXC 477>^PHJZ
M:*4.(0]>%2 %0J>5@%9 9Q:C69CD0J(F<<8VC_[]V$Y(0WD,BY%F [9SS_$Y
M]SJ^:6\(?6,! $?;.$I81PLX3^]UG7D!Q)A52 J)>+(@-,9<3.E29RD%["M0
M'.EFM5K78QPF6K>MUEYHMTU6/ H3>*&(K>(8T_<>1&33T0QMMS )EP&7"WJW
MG>(E3(&_IB]4S/2"Q0]C2%A($D1AT=$<X]YMR7@5\#V$#2N-D70R)^1-3I[\
MCE:5@B "CTL&+/[6T(<HDD1"QN^<4RNVE,#R>,?^H+P++W/,H$^B'Z'/@X[6
MU) /"[R*^(1L'B'W4Y-\'HF8^D6;/+:J(6_%.(ESL% 0ATGVC[=Y'DH HWX"
M8.8 \S/ /@&P<H!U*<#. ;;*3&9%Y<'%''?;E&P0E=&"30Y4,A5:V \36?8I
MI^)I*'"\.QE,!\ZD_XCZS\.ATWN>.+.GYS%RODT&@]%@/$/.V$7#I_Y@/!V4
M5F]<X#B,V"WZBEZG+KJYOD77*$S0+" KAA.?M74NY,E-="^7TLNDF">D&"8:
MD80'# T2'_Q] EWX*LR9.W,]\RRC"UX%6<8=,JMF]8B@_L5PHW4$[EX.;YYQ
M8Q6ELA2?=:I4P !3+T#BC$=X3BA6;XZSI #B1>1(I!T-0T^\DU!:O9G!EJ]P
M='M&@EU(L)4$^V\2Y%8^K,6MD:I-8)O*;8]6/:.L*4IY"ZV[EET3^5R7*W$8
M5+/LYGZ0>QC4L.P/ICU+M<)2[:REPX1);Z=2_',$\1SHKS.YK!<;U_]7.1N%
MA,99[S/"<812_*Z8R3P*ETK$L2IF3/5R[D5K.9[[9K%_\]\?I^;!(6B6=&2G
MZ3#&J'\.<@^#6J<,M0I#K<L,>7LUQ47UA+&0 O(QAV/>SK,_P+R"C/K=EZLK
M<:%9QPZ 7NH$,="EZJA,R%DE/+LWB]6B:3NJ5WU:[XEFGO7>#YKL2V"$Z3),
M&(I@(2BKE8;((,VZ:S;A)%7]9DZXZ%YJ&(@/$J R0#Q?$,)W$[E!\8G3_0-0
M2P,$%     @ A4A24K]!D2V6 @  U 4  !D   !X;"]W;W)K<VAE971S+W-H
M965T-3<N>&ULA51M;]HP$/XKIVB36FDC(2ULJP")EVY%*RT"VFFJ^L$D!['P
M2V8[I?S[V4Z:,@G8E^1LW_/<<V??=;92;72&:."5,Z&[069,?A6&.LF0$]V0
M.0I[LI**$V.7:AWJ7"%)/8BS,(ZB=L@)%4&OX_>FJM>1A6%4X%2!+C@G:C=
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M#%.RLX\CV<!425.5UYIK13C<2B+@:8)\B>K9^LXIHXD]?R2,X0X&1&S>CS\
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M-B7J[EM/%-_:?K3B2G<W.RST@P7" /3^FG-UF)@ [1.8_@-02P,$%     @
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M"6W+T/#?16U"ZD5M(DX5=50Y'KWW[SAJ'-Z&\R:D[KR):#BW#]I4#GQEVKU
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M^JO8_P8-H<CH2T2NJBO9-UAW1))2:5$TPNA!P7A]IX<F$$<"7GQ&P&\$_*Y
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M@=]UW((Y4XR>_^JV/^CV5:++IN4VU67EX/<:7C>N-Q9,=Q=9(.,N ^=H4BQ
M;JJ)6V$?P,9?SU_M:CO57U6S;&?]VDS[U03ZJJ;^5;BG<L.X(CFL4:5[,4&'
M9#U]UR]:;*MY="4T3K?58X9_+" - +^OA= O+\9 ^P^T^!=02P,$%     @
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M/X/F5M1%JIF#==N>=U 7HAUQXV_';1C?*XWO-1)=BD1,92"QP()(K-"IED;
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M*VSY9IC@+0Y"!^#[)>=J-]$)JO\%@[]02P,$%     @ A4A24H/%V3JV P
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M0UM%Q+,)+GN0;*=GFE<FE3#Z=JNF7N"I@7J_9DR^/:0.BCEZ\!]02P,$%
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M:._VX<X#V6Q%HVA1N4G<"VV:Y<3"/"0HK8,Y/PBASXI-T#U-T3]02P,$%
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M+0BS6K.93E', JWM4V:V?:J$GJ4:IP;3V=5T_&TV_GH/XP?=3N%\A(K05%[
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M]=?N>O?4C<(E,:PN,G6B<M<=.!^DXWN1OW"G=BRGXMI>V)XC1327,HX(H 8
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M;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( (1(4E)6D %J6@0  '\0   8
M          " @0X(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4
M    " "$2%)24_CTN-H&  "#&P  &               @(&>#   >&PO=V]R
M:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%     @ A$A24I@2J3*  @  G08
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M965T-RYX;6Q02P$"% ,4    " "$2%)2?Y=>$FH#  !X#   &
M    @(&?-   >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#%     @
MA$A24H-.(#U%"P  <1H  !@              ("!/S@  'AL+W=O<FMS:&5E
M=',O<VAE970Y+GAM;%!+ 0(4 Q0    ( (1(4E):['/8/"P  #>&   9
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M970Q-"YX;6Q02P$"% ,4    " "$2%)2:!/L?[H-  "S)   &0
M    @($>@0  >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4 Q0    (
M (1(4E+'CJ>W AX  /-J   9              " @0^/  !X;"]W;W)K<VAE
M971S+W-H965T,38N>&UL4$L! A0#%     @ A$A24GF?U7#U!@  /A(  !D
M             ("!2*T  'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q02P$"
M% ,4    " "$2%)2YU%;@6P%    #   &0              @(%TM   >&PO
M=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    ( (1(4E+,ZB"QC@P
M (@A   9              " @1>Z  !X;"]W;W)K<VAE971S+W-H965T,3DN
M>&UL4$L! A0#%     @ A$A24I4"4[6T @  FP4  !D              ("!
MW,8  'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q02P$"% ,4    " "$2%)2
M$ XBAYT$  #B"0  &0              @(''R0  >&PO=V]R:W-H965T<R]S
M:&5E=#(Q+GAM;%!+ 0(4 Q0    ( (1(4E)WXI-X; (  ",%   9
M      " @9O.  !X;"]W;W)K<VAE971S+W-H965T,C(N>&UL4$L! A0#%
M  @ A$A24AK#'.>L,P  F:8  !D              ("!/M$  'AL+W=O<FMS
M:&5E=',O<VAE970R,RYX;6Q02P$"% ,4    " "$2%)2Q-/P(\<&  !T$0
M&0              @($A!0$ >&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+
M 0(4 Q0    ( (1(4E)@4ESTO0(  )X%   9              " @1\, 0!X
M;"]W;W)K<VAE971S+W-H965T,C4N>&UL4$L! A0#%     @ A$A24G2D<H5?
M @  YP0  !D              ("!$P\! 'AL+W=O<FMS:&5E=',O<VAE970R
M-BYX;6Q02P$"% ,4    " "$2%)204WUV^8"   0!@  &0
M@(&I$0$ >&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4 Q0    ( (1(
M4E)"H7HK/@,  .$&   9              " @<84 0!X;"]W;W)K<VAE971S
M+W-H965T,C@N>&UL4$L! A0#%     @ A$A24@,.6:DE"P  *",  !D
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M=#,S+GAM;%!+ 0(4 Q0    ( (1(4E),YIW=!@,  &4+   9
M  " @<<S 0!X;"]W;W)K<VAE971S+W-H965T,S0N>&UL4$L! A0#%     @
MA$A24N"32YVQ @  @0<  !D              ("!!#<! 'AL+W=O<FMS:&5E
M=',O<VAE970S-2YX;6Q02P$"% ,4    " "$2%)28ZKSM H#   *"   &0
M            @('L.0$ >&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;%!+ 0(4
M Q0    ( (1(4E)U,^7NC ,  (T-   9              " @2T] 0!X;"]W
M;W)K<VAE971S+W-H965T,S<N>&UL4$L! A0#%     @ A$A24NB!E5X< @
M=P0  !D              ("!\$ ! 'AL+W=O<FMS:&5E=',O<VAE970S."YX
M;6Q02P$"% ,4    " "$2%)2/*Y.4U\"  #$!0  &0              @(%#
M0P$ >&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4 Q0    ( (5(4E)?
M0F6+U@,  +06   9              " @=E% 0!X;"]W;W)K<VAE971S+W-H
M965T-# N>&UL4$L! A0#%     @ A4A24F>)@RD& P  @P@  !D
M     ("!YDD! 'AL+W=O<FMS:&5E=',O<VAE970T,2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( (5(4E)O!KC=80(  +0%   9              "
M@3E= 0!X;"]W;W)K<VAE971S+W-H965T-#8N>&UL4$L! A0#%     @ A4A2
M4J.#:Z%#!0  R10  !D              ("!T5\! 'AL+W=O<FMS:&5E=',O
M<VAE970T-RYX;6Q02P$"% ,4    " "%2%)2,U($>D(#  !V"0  &0
M        @(%+90$ >&PO=V]R:W-H965T<R]S:&5E=#0X+GAM;%!+ 0(4 Q0
M   ( (5(4E*U4%H_3@4  / 3   9              " @<1H 0!X;"]W;W)K
M<VAE971S+W-H965T-#DN>&UL4$L! A0#%     @ A4A24BZ7]! 5!   71
M !D              ("!26X! 'AL+W=O<FMS:&5E=',O<VAE970U,"YX;6Q0
M2P$"% ,4    " "%2%)2ZZMWY$ #  #^"0  &0              @(&5<@$
M>&PO=V]R:W-H965T<R]S:&5E=#4Q+GAM;%!+ 0(4 Q0    ( (5(4E*:QPQO
M3 8  .$E   9              " @0QV 0!X;"]W;W)K<VAE971S+W-H965T
M-3(N>&UL4$L! A0#%     @ A4A24G&;6.JY#@  >V0  !D
M ("!CWP! 'AL+W=O<FMS:&5E=',O<VAE970U,RYX;6Q02P$"% ,4    " "%
M2%)2+C42TWD#   N#0  &0              @(%_BP$ >&PO=V]R:W-H965T
M<R]S:&5E=#4T+GAM;%!+ 0(4 Q0    ( (5(4E*&N+GYZA8  (]L   9
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M970U.2YX;6Q02P$"% ,4    " "%2%)2<(DWYE0#   W"P  &0
M    @(%+L@$ >&PO=V]R:W-H965T<R]S:&5E=#8P+GAM;%!+ 0(4 Q0    (
M (5(4E)M=J="-0,  %()   9              " @=:U 0!X;"]W;W)K<VAE
M971S+W-H965T-C$N>&UL4$L! A0#%     @ A4A24GQH5OD8!   #PT  !D
M             ("!0KD! 'AL+W=O<FMS:&5E=',O<VAE970V,BYX;6Q02P$"
M% ,4    " "%2%)2'4@[ $ &  ##%P  &0              @(&1O0$ >&PO
M=V]R:W-H965T<R]S:&5E=#8S+GAM;%!+ 0(4 Q0    ( (5(4E*$\>@;\0(
M ",(   9              " @0C$ 0!X;"]W;W)K<VAE971S+W-H965T-C0N
M>&UL4$L! A0#%     @ A4A24H/%V3JV P  4P\  !D              ("!
M,,<! 'AL+W=O<FMS:&5E=',O<VAE970V-2YX;6Q02P$"% ,4    " "%2%)2
M6%PIV,X"   9"0  &0              @($=RP$ >&PO=V]R:W-H965T<R]S
M:&5E=#8V+GAM;%!+ 0(4 Q0    ( (5(4E++RH+SXP(  . (   9
M      " @2+. 0!X;"]W;W)K<VAE971S+W-H965T-C<N>&UL4$L! A0#%
M  @ A4A24O]U#79' @  I@0  !D              ("!/-$! 'AL+W=O<FMS
M:&5E=',O<VAE970V."YX;6Q02P$"% ,4    " "%2%)22H3WAJT"  #C!P
M&0              @(&ZTP$ >&PO=V]R:W-H965T<R]S:&5E=#8Y+GAM;%!+
M 0(4 Q0    ( (5(4E+*+N-,AP(  &P/   -              "  9[6 0!X
M;"]S='EL97,N>&UL4$L! A0#%     @ A4A24I>*NQS     $P(   L
M         ( !4-D! %]R96QS+RYR96QS4$L! A0#%     @ A4A24HW&&0PK
M!0  QBT   \              ( !.=H! 'AL+W=O<FMB;V]K+GAM;%!+ 0(4
M Q0    ( (5(4E*7=W+D+ (  /8H   :              "  9'? 0!X;"]?
M<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( (5(4E+62",N]P$
M "LH   3              "  ?7A 0!;0V]N=&5N=%]4>7!E<UTN>&UL4$L%
3!@    !- $T $A4  !WD 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>279</ContextCount>
  <ElementCount>460</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>105</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>6</UnitCount>
  <MyReports>
    <Report instance="rwlk-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rewalk.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="rwlk-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rewalk.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="rwlk-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rewalk.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="rwlk-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rewalk.com/role/ConsolidatedStatementsOfOperations</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="rwlk-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rewalk.com/role/StatementsOfChangesInShareholdersEquity</Role>
      <ShortName>STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="rwlk-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Statement - STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rewalk.com/role/StatementsOfChangesInShareholdersEquityParenthetical</Role>
      <ShortName>STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="rwlk-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00000007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rewalk.com/role/ConsolidatedStatementsOfCashFlows</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="rwlk-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00000008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rewalk.com/role/ConsolidatedStatementsOfCashFlowsParenthetical</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="rwlk-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>00000009 - Disclosure - GENERAL</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rewalk.com/role/General</Role>
      <ShortName>GENERAL</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="rwlk-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>00000010 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rewalk.com/role/SignificantAccountingPolicies</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="rwlk-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>00000011 - Disclosure - PREPAID EXPENSES AND OTHER CURRENT ASSETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rewalk.com/role/PrepaidExpensesAndOtherCurrentAssets</Role>
      <ShortName>PREPAID EXPENSES AND OTHER CURRENT ASSETS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="rwlk-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>00000012 - Disclosure - INVENTORIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rewalk.com/role/Inventories</Role>
      <ShortName>INVENTORIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="rwlk-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>00000013 - Disclosure - PROPERTY AND EQUIPMENT, NET</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rewalk.com/role/PropertyAndEquipmentNet</Role>
      <ShortName>PROPERTY AND EQUIPMENT, NET</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="rwlk-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>00000014 - Disclosure - LOAN AGREEMENT WITH KREOS AND RELATED WARRANT TO PURCHASE ORDINARY SHARES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rewalk.com/role/LoanAgreementWithKreosAndRelatedWarrantToPurchaseOrdinaryShares</Role>
      <ShortName>LOAN AGREEMENT WITH KREOS AND RELATED WARRANT TO PURCHASE ORDINARY SHARES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="rwlk-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>00000015 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rewalk.com/role/CommitmentsAndContingentLiabilities</Role>
      <ShortName>COMMITMENTS AND CONTINGENT LIABILITIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="rwlk-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>00000016 - Disclosure - SHAREHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rewalk.com/role/ShareholdersEquity</Role>
      <ShortName>SHAREHOLDERS' EQUITY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="rwlk-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>00000017 - Disclosure - RESEARCH COLLABORATION AGREEMENT AND LICENSE AGREEMENT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rewalk.com/role/ResearchCollaborationAgreementAndLicenseAgreement</Role>
      <ShortName>RESEARCH COLLABORATION AGREEMENT AND LICENSE AGREEMENT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="rwlk-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>00000018 - Disclosure - PAYCHECK PROTECTION PROGRAM LOAN</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rewalk.com/role/PaycheckProtectionProgramLoan</Role>
      <ShortName>PAYCHECK PROTECTION PROGRAM LOAN</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="rwlk-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>00000019 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rewalk.com/role/IncomeTaxes</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="rwlk-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>00000020 - Disclosure - FINANCIAL EXPENSES, NET</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rewalk.com/role/FinancialExpensesNet</Role>
      <ShortName>FINANCIAL EXPENSES, NET</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="rwlk-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>00000021 - Disclosure - GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rewalk.com/role/GeographicInformationAndMajorCustomerAndProductData</Role>
      <ShortName>GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="rwlk-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>00000022 - Disclosure - SUBSEQUENT EVENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rewalk.com/role/SubsequentEvents</Role>
      <ShortName>SUBSEQUENT EVENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="rwlk-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>00000023 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rewalk.com/role/SignificantAccountingPoliciesPolicies</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="rwlk-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>00000024 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rewalk.com/role/SignificantAccountingPoliciesTables</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://rewalk.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="rwlk-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>00000025 - Disclosure - PREPAID EXPENSES AND OTHER CURRENT ASSETS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rewalk.com/role/PrepaidExpensesAndOtherCurrentAssetsTables</Role>
      <ShortName>PREPAID EXPENSES AND OTHER CURRENT ASSETS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://rewalk.com/role/PrepaidExpensesAndOtherCurrentAssets</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="rwlk-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>00000026 - Disclosure - INVENTORIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rewalk.com/role/InventoriesTables</Role>
      <ShortName>INVENTORIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://rewalk.com/role/Inventories</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="rwlk-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>00000027 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rewalk.com/role/PropertyAndEquipmentNetTables</Role>
      <ShortName>PROPERTY AND EQUIPMENT, NET (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://rewalk.com/role/PropertyAndEquipmentNet</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="rwlk-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>00000028 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rewalk.com/role/CommitmentsAndContingentLiabilitiesTables</Role>
      <ShortName>COMMITMENTS AND CONTINGENT LIABILITIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://rewalk.com/role/CommitmentsAndContingentLiabilities</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="rwlk-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>00000029 - Disclosure - SHAREHOLDERS' EQUITY (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rewalk.com/role/ShareholdersEquityTables</Role>
      <ShortName>SHAREHOLDERS' EQUITY (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://rewalk.com/role/ShareholdersEquity</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="rwlk-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>00000030 - Disclosure - INCOME TAXES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rewalk.com/role/IncomeTaxesTables</Role>
      <ShortName>INCOME TAXES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://rewalk.com/role/IncomeTaxes</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="rwlk-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>00000031 - Disclosure - FINANCIAL EXPENSES, NET (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rewalk.com/role/FinancialExpensesNetTables</Role>
      <ShortName>FINANCIAL EXPENSES, NET (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://rewalk.com/role/FinancialExpensesNet</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="rwlk-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>00000032 - Disclosure - GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataTables</Role>
      <ShortName>GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://rewalk.com/role/GeographicInformationAndMajorCustomerAndProductData</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="rwlk-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>00000033 - Disclosure - GENERAL (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rewalk.com/role/GeneralDetails</Role>
      <ShortName>GENERAL (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://rewalk.com/role/General</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="rwlk-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>00000034 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rewalk.com/role/SignificantAccountingPoliciesDetails</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://rewalk.com/role/SignificantAccountingPoliciesTables</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="rwlk-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>00000035 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rewalk.com/role/SignificantAccountingPoliciesDetails1</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://rewalk.com/role/SignificantAccountingPoliciesTables</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="rwlk-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>00000036 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rewalk.com/role/SignificantAccountingPoliciesDetails2</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Details 2)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://rewalk.com/role/SignificantAccountingPoliciesTables</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="rwlk-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>00000037 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details 3)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rewalk.com/role/SignificantAccountingPoliciesDetails3</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Details 3)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://rewalk.com/role/SignificantAccountingPoliciesTables</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="rwlk-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>00000038 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details 4)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rewalk.com/role/SignificantAccountingPoliciesDetails4</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Details 4)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://rewalk.com/role/SignificantAccountingPoliciesTables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="rwlk-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>00000039 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details 5)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rewalk.com/role/SignificantAccountingPoliciesDetails5</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Details 5)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://rewalk.com/role/SignificantAccountingPoliciesTables</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="rwlk-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>00000040 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details 6)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rewalk.com/role/SignificantAccountingPoliciesDetails6</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Details 6)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://rewalk.com/role/SignificantAccountingPoliciesTables</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="rwlk-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>00000041 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details 7)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rewalk.com/role/SignificantAccountingPoliciesDetails7</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Details 7)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://rewalk.com/role/SignificantAccountingPoliciesTables</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="rwlk-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>00000042 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rewalk.com/role/SignificantAccountingPoliciesDetailsTextual</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://rewalk.com/role/SignificantAccountingPoliciesTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="rwlk-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>00000043 - Disclosure - PREPAID EXPENSES AND OTHER CURRENT ASSETS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rewalk.com/role/PrepaidExpensesAndOtherCurrentAssetsDetails</Role>
      <ShortName>PREPAID EXPENSES AND OTHER CURRENT ASSETS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://rewalk.com/role/PrepaidExpensesAndOtherCurrentAssetsTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="rwlk-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>00000044 - Disclosure - INVENTORIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rewalk.com/role/InventoriesDetails</Role>
      <ShortName>INVENTORIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://rewalk.com/role/InventoriesTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="rwlk-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>00000045 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rewalk.com/role/PropertyAndEquipmentNetDetails</Role>
      <ShortName>PROPERTY AND EQUIPMENT, NET (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://rewalk.com/role/PropertyAndEquipmentNetTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="rwlk-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>00000046 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rewalk.com/role/PropertyAndEquipmentNetDetailsTextual</Role>
      <ShortName>PROPERTY AND EQUIPMENT, NET (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://rewalk.com/role/PropertyAndEquipmentNetTables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="rwlk-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>00000047 - Disclosure - LOAN AGREEMENT WITH KREOS AND RELATED WARRANT TO PURCHASE ORDINARY SHARES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rewalk.com/role/LoanAgreementWithKreosAndRelatedWarrantToPurchaseOrdinarySharesDetails</Role>
      <ShortName>LOAN AGREEMENT WITH KREOS AND RELATED WARRANT TO PURCHASE ORDINARY SHARES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://rewalk.com/role/LoanAgreementWithKreosAndRelatedWarrantToPurchaseOrdinaryShares</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="rwlk-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>00000048 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rewalk.com/role/CommitmentsAndContingentLiabilitiesDetails</Role>
      <ShortName>COMMITMENTS AND CONTINGENT LIABILITIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://rewalk.com/role/CommitmentsAndContingentLiabilitiesTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="rwlk-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>00000049 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rewalk.com/role/CommitmentsAndContingentLiabilitiesDetailsTextual</Role>
      <ShortName>COMMITMENTS AND CONTINGENT LIABILITIES (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://rewalk.com/role/CommitmentsAndContingentLiabilitiesTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="rwlk-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>00000050 - Disclosure - SHAREHOLDERS' EQUITY (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rewalk.com/role/ShareholdersEquityDetails</Role>
      <ShortName>SHAREHOLDERS' EQUITY (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://rewalk.com/role/ShareholdersEquityTables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="rwlk-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>00000051 - Disclosure - SHAREHOLDERS' EQUITY (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rewalk.com/role/ShareholdersEquityDetails1</Role>
      <ShortName>SHAREHOLDERS' EQUITY (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://rewalk.com/role/ShareholdersEquityTables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="rwlk-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>00000052 - Disclosure - SHAREHOLDERS' EQUITY (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rewalk.com/role/ShareholdersEquityDetails2</Role>
      <ShortName>SHAREHOLDERS' EQUITY (Details 2)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://rewalk.com/role/ShareholdersEquityTables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="rwlk-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>00000053 - Disclosure - SHAREHOLDERS' EQUITY (Details 3)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rewalk.com/role/ShareholdersEquityDetails3</Role>
      <ShortName>SHAREHOLDERS' EQUITY (Details 3)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://rewalk.com/role/ShareholdersEquityTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="rwlk-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>00000054 - Disclosure - SHAREHOLDERS' EQUITY (Details 4)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rewalk.com/role/ShareholdersEquityDetails4</Role>
      <ShortName>SHAREHOLDERS' EQUITY (Details 4)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://rewalk.com/role/ShareholdersEquityTables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="rwlk-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>00000055 - Disclosure - SHAREHOLDERS' EQUITY (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rewalk.com/role/ShareholdersEquityDetailsTextual</Role>
      <ShortName>SHAREHOLDERS' EQUITY (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://rewalk.com/role/ShareholdersEquityTables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="rwlk-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>00000056 - Disclosure - RESEARCH COLLABORATION AGREEMENT AND LICENSE AGREEMENT (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rewalk.com/role/ResearchCollaborationAgreementAndLicenseAgreementDetails</Role>
      <ShortName>RESEARCH COLLABORATION AGREEMENT AND LICENSE AGREEMENT (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://rewalk.com/role/ResearchCollaborationAgreementAndLicenseAgreement</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="rwlk-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>00000057 - Disclosure - PAYCHECK PROTECTION PROGRAM LOAN (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rewalk.com/role/PaycheckProtectionProgramLoanDetailsTextual</Role>
      <ShortName>PAYCHECK PROTECTION PROGRAM LOAN (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://rewalk.com/role/PaycheckProtectionProgramLoan</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="rwlk-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>00000058 - Disclosure - INCOME TAXES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rewalk.com/role/IncomeTaxesDetails</Role>
      <ShortName>INCOME TAXES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://rewalk.com/role/IncomeTaxesTables</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="rwlk-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>00000059 - Disclosure - INCOME TAXES (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rewalk.com/role/IncomeTaxesDetails1</Role>
      <ShortName>INCOME TAXES (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://rewalk.com/role/IncomeTaxesTables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="rwlk-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>00000060 - Disclosure - INCOME TAXES (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rewalk.com/role/IncomeTaxesDetails2</Role>
      <ShortName>INCOME TAXES (Details 2)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://rewalk.com/role/IncomeTaxesTables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="rwlk-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>00000061 - Disclosure - INCOME TAXES (Details 3)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rewalk.com/role/IncomeTaxesDetails3</Role>
      <ShortName>INCOME TAXES (Details 3)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://rewalk.com/role/IncomeTaxesTables</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="rwlk-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>00000062 - Disclosure - INCOME TAXES (Details 4)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rewalk.com/role/IncomeTaxesDetails4</Role>
      <ShortName>INCOME TAXES (Details 4)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://rewalk.com/role/IncomeTaxesTables</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="rwlk-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>00000063 - Disclosure - INCOME TAXES (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rewalk.com/role/IncomeTaxesDetailsTextual</Role>
      <ShortName>INCOME TAXES (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://rewalk.com/role/IncomeTaxesTables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="rwlk-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>00000064 - Disclosure - FINANCIAL EXPENSES, NET (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rewalk.com/role/FinancialExpensesNetDetails</Role>
      <ShortName>FINANCIAL EXPENSES, NET (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://rewalk.com/role/FinancialExpensesNetTables</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="rwlk-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>00000065 - Disclosure - GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails</Role>
      <ShortName>GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataTables</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="rwlk-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>00000066 - Disclosure - GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails1</Role>
      <ShortName>GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataTables</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="rwlk-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>00000067 - Disclosure - GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails2</Role>
      <ShortName>GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA (Details 2)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataTables</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="rwlk-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>00000068 - Disclosure - GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetailsTextual</Role>
      <ShortName>GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataTables</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="rwlk-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>00000069 - Disclosure - SUBSEQUENT EVENTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rewalk.com/role/SubsequentEventsDetails</Role>
      <ShortName>SUBSEQUENT EVENTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://rewalk.com/role/SubsequentEvents</ParentRole>
      <Position>69</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>rwlk-20201231.xml</File>
    <File>rwlk-20201231.xsd</File>
    <File>rwlk-20201231_cal.xml</File>
    <File>rwlk-20201231_def.xml</File>
    <File>rwlk-20201231_lab.xml</File>
    <File>rwlk-20201231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/country/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>100
<FILENAME>0001178913-21-000678-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001178913-21-000678-xbrl.zip
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ML#L(!-/3*P3FQ[0(APF[^0+%M334RC98.&&SNGUHZ9O5K:^<Y1U"P)^>OB'
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M:"-Q>X79J7T[RO3F=6G::(/H&Z)OFEZ$]=HV)-H\B+@.1V6&)9L';?T=XX
MT6E$IXT?T,1I-VJ=)HX+ D2G$9TV>D 31P<!]&" [K]E93- 7]J6#'2-(+85
M8KT YLT:F,M3U[* H40CFV,RWE<@%A3##P*03\W5RC1P[L"T\1;&^08]%<[_
MXT*Z(7]KTT#82K;V2/"]4Z_KF',E<J&S4%4-I03(^JVLJ9?&7N5P5X11H0P(
MI.I"Z@XXLF8 ]5RV#,UXFOCAM2:6LIDG(.HF([5P$@CP1@:\J>2HM@8>V43'
MO(D># S),6 ,QX#QP:V\^-R%!G3U'E@OF@)P]OE^X.?6,J'$G,VM#H_C"T-%
M,,*M1S]MMKFE?F)KI@!V":31%HG+!%)@_%\!V0;/IJY>KM86ZA<Q_>NK6F@*
M\YCSY4! 51=42/&[#K!"B?NN5MMROG_1#&WE[DDMJ%H0RY%*-XY7U$7P3C:>
M_#'1/V.2)B#N%,3R&P'Q,"".2IJ N"Z(+UP+6D>NA4KI7VAOZ"^;*&/X<+Y@
MB#Z>)I0/5B7O LI$*[<XO7^1E6?- -8&3MB5_(B*?)G6)K&C'@2$\5F^DC@(
MR+*N]<3(M9Z8O"E6%-.%/!M/]XYLJ+*EVE_7*B0!/4O/]P-E"_7?<$WAP_J%
M:5V#URW7$( &_-/K=9UT?E>1S4Z]DF(3KZ0X0"'Y>;5CTM2!-<RAJ,<(IQX+
M%.<@(=\..2@PM#'']@(/Q,J9C)6S6X206ZQQW&+M>-\@5U"CNX(:"A%A%RO4
M_4:,=+&B][=8\\@K)B?:6>&)J7<*\6>PGU/()1K@?_@SH$0PDB52 J#=VQ0)
M)/249\%$(YN98S9:1L,TU$3Y\ZG/?FZM]TQN=ZH]_*FIISW\.>S5;985#>]C
MYL[2X3Y]9SU-&RWY'1,3#.X8(&.+=+\X0VZT_^&_/9Q-N=#1^+R'6+ S+-AP
M9[XT%',%'N2WA>L\FQ9D]EI>Q3=O+V,P^HA_Y1?N[NZC#?[C0EF=O\#_2N_^
M\>^GO:J#/2!?<%L[($]R9,'7W1' 7[+^X\Y\-!U-L3]_^?2O:8.H8&O(X91
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M:_/]\FJJZ$"1\*&E_!F@*LOK9TT)$K%\!C]<7A%0U 7%U_L]!\77>P**JJ!
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MN"8@9_O]/]OOMJ<,.9@?RL%\&C@CI^KIG:JGC2RBO<9^))X&OLAY=MKGV7U
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M"<K:H:P6E?EYH5X%D9)9VE?,AULVP\;<R31'M.=^:,_$ELW4]Q_Y@.@_2HZ
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M!?+BI)/YY.45L?C[EA?/Q1+.!Z*\1X#%CTB#;*U,(LFG-VYV([9V!\M;RU0
M4&UD"J+<;-E ^8@0!2]PQ[_59043VDMB85AO@\4E#GN@M'K*8)06ID]:YKBX
M=A#C#O]F9^&E;O+WU3+84$)?!-W52.N,H2K![5'ALBFKD^:9#AC 1P"ON,"9
M"Y?*DV?\X_5E1\\'@:*KZ@!L<"?5Z#23H::!W>&)+G_+Z9T=_TCF6@,QE*S_
MR9P(=8R.CME)BO/.W,BZLQDP93N^_<7'KT%=TVP67JPP/G8#7&@&7.WPF.E_
M:7N)7->@GPTH(29^[A%:0DH3BAOGKO-BSS35G\XYR]0A:>M-0%\\R&_^DY^
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M")5F4L]:L3L^:R)4H#N&:'RSB;1'K$46,^]8(^20U085 B]*O>[4(97-5J?
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MRKL_ ANX,!.17"W)"Y38K;Q!&NS!DM5!-BZIJG:-$M8!.XVK-LVK;EZ]$-Q
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M:2ZZYAL2'3_#0'-'=U4<-HLVF6U_D\&26B5N'K7R:Q#7$5M-(32CF3$0WB
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MP'K1%. %B]T!Q7PR\%O^E/5!&ORD:@#WS=-.9=A97>(#E5(?BG(<#+5I+DC
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M71<.00=#!/+Q737E&*X >6#9:1]^(^S["A*A \\8 Y%%'W$2"R<*'"_QZO:
M%IV^^+QZD^FSZTWF%@N(*/\TB/ 5>6L P0*,T:EYPB_I!+QT'+T/856PA'<D
M]";@NP^\:P<PQ19[[E(]"JI=;0_C2ICY#->MJME>E6DO/,(_D!]Y9^R?&.Z$
MV6ZKVP-R2%=(3L@>9&Q.'XES)D/*=E (+;&=!\3"S7:![<'4D>0H"OFL%T=G
M(>95$43VB!?%U/IXEJ$5!L!V8E2O2%ALG(AOBN$A5XQT0GD)^9CN#9!17 PB
M)%5,++9&9S-\=L^4"!0[BW3I3*K"S8S'3[;F)EK/<(&<QMN(L\#TTRS*0K%/
MOG-FBZB8M8Y,.G_]^@LRJB"*]!A#BT?B+.71./(=:7ZYO6CH5#0V"^[-EK?3
M&-&UX)]@O?O K2KW[GPYA+^?YB><%%G0Q3HQ4\GE*\?M)G%C73HV_ ZYYD!%
M1=G@3BBF1Q.3 ;>MZ*[E;S!(BZH!747SPPM'8MKA%$P/TFU5YN8"/%HN^CD;
MOXK??L[X40IH;J039E8Z.=6%7+E]<WG:7KO(K-)XVAD#529?H75S=A+?KAEL
M=*E?H9 7S51I\MVG3%H$;'78QGR<'/8SZS-I-BLI[S.T3.J$:TUSUOL.SYK(
MK#<.UBKGCX/_MVL%/W#45GG-PO)*7F4RB7\5*ZC?=2IV<=2->+)MEIM/4TO:
M&YL=91%#*%UA9-2WA%S9; DTQPS <V.;H9A^Y#L8&>V]SA<^M W!<+.M?AR3
M-=PF/H[)&G #&\4$-^'7:["@U62(/JFC&F.EE![+2RD]YI12^C/29N9FF6O)
M%%9::U/Z*%8]N0=>=B2O:-0W<L!W)2]VSB3+F^V)P.81@759>HI)55GL26"Q
MS(<\55>_#5/>PA'#HUO9F)6RV^M=!U?3Z#=&X U^>#4?_&B#>^W- 2!__C05
M"L8T'5S8)KW-2?Q<+$F!+[@%'Y#UX':B$>M<!NO,G"XK.#U:SB^T947.^0S.
M*Y2W& ?G6[BCKE$1_L]Q_% E 0A94\^*L]*R0Q,1P8V1WW!O*P4Q2PJTI_0F
M((7@IL63PH7V B*2N-8,4!$,4M9J0!U&)B$%',':G/E9%O-5RL^-G_MJBV">
M)0#O?F8"_*/,4,3^ F]\C2# T%EJ(/#E3T@&S;AG,KCW??83X1WJ/QTT93_+
M_JM4@W-$_ .C&>]9!F"RR?5PK%>Y8&/YN<!QDYB9<'>.S8ZW5U>8FRP3E9/$
MF3"1;;F(_4H;$Y-EHU8J&SH. :!<GOB65'GNL^S2:E5!Q\UZM7G/,D<KU?,<
M!_/AP10EV#:9_4R+M%+1SBD(H!H&LHS22D4W.Q8!@[UF[+:@HOMH@_^XD)'S
MEQHM-N><Q,Z%LM+F>8D)F0_GU?G;J2N-S7.E5>)C5TRW=**EF?:<:%/CN8[[
M+,VSYSX;-<_=.,XRIMMWG$V;^:HNLPS^Z<@]P5CY[\Y9EH%]SUDV:OY;N\DR
MV/;=9)/ENZJ#+(/U2 #S6#GOQC66L=QC8:YCY[ZI4RS-=S20=<Q<MW2'98#=
M=X>-G_/FCK TU]$0UJ&8KN,"&_5LM'9^9:"0XSEA]-ML%VZO-.^!VVO4K+=R
M>*5Y#AU>DV2ZJJLK@V_?U35JMCMP<F7M,[Z3:\*L5W5O9:UQS[U5G_F \O,W
M5.@%A9"=U>\2WIV'*.H0PL5860;7"6 2D61Q<L? 48E;(.H%\!CCL*68#)&;
M#&,1L$9/^!'>PD/.V'BK=9R/GMX]YGCLK1PK(JN<U:-'\X G!O5AFR!/F3B<
M;Z<*_H<;*5N5#]G1,W7(&,K#&3ECE5AB)L-2^>$X>A8.%Q8+_S-FK@H/OM%S
M;F2>F+'N6^5W$]&K"(\CKQ?4A#C*-9JX27!4Y8 ?/<][//F-9"?(4]86Q0B3
M8*OL7!X]AH?\H':N$^,G<XJD2;!4[3@=/3T'7.'&J)/D*G.ZY@T8V_8H007V
M</;6G[+NQKDZ[:)Q?4;%28'FXP%I"2)J$5FK5.>,E2J-C"5X:X&UK 4M&19^
MHX8%;@]XIMFH;)MK03/BS?FDPQ=432#[^'?=^5757BC;V>C@MW=+^+,/%$.O
MG?<,*J[WH*V 35V#5^K.7,G&D??!$74/+&WY[N]/SJ_H!>A7T3<<>Y5P/U"/
MIJ[BIZYO'LYQ+<R_,2+]*_?A&/WL/7H6OR/\)NLOJMH0MW?GMXO+,^K\?V_/
MK^_/[ZG%]1EU\_"O\SOJ].O=W?GU [6XOS]_N(\/C?X!!8#__AO#_4I1[46R
M9:+;M_]*H3D]U@P5H%]QXMK! ^(Z\N9J;1HHRQB5D5M[<-G6\=^6^%>\AII!
M:TD9%4X,*HK:N+%F6,__'Q]V(A['<_@!7;?7LJ(93[^]@XL8_7N-JN;Y_WXT
M+158^$]9UYZ,W][APF.>,OJO(H*E(DM  C.>![PHLX(B/JHS51 4>0[D=VGZ
MRV3_JJG.\P=J+OS\*Y2V;EH?J+]Y;8K\><%D?*!TL/2FQ6<),A7\X?-GU1T\
M_KKP/6I])EZ Y6B*K ?$/IH.W!'R/_<E?NS]^P/%KM_2Q/0-BNT8[QTU3Q1P
M2B!<( R8!G/;F5CB;%2@5@RI]0 =OM+'%GHUA?O-_DKUQ4_E&7W$-6!K*2M_
M( 574<8#10MRCFJR7Y\U!QPCG0,^4(;Y:LGK[A'@?6IE?$K4 E$+(;7LP:D%
M5&J4'M4L#Z(/"%"G!E14>>3P<+H?^]:CK/QXLDS74(\#$_[T]/S\XB(T[R7Q
MYUYVLL\FI,GPN[W9CN:XN%3,J("4"S!/-,S/60*TGAY_86G^B&(YU)9!$/XQ
M KU7,,^E3/8R_3^-:J(;B">J#/%!>WL@[D=B,VE4(LM4LNUA-DKK@*QWLMX'
M7^^,)(Q*9KM9\/MA9O5L2]TFO-NCPLU>*/X1TSBX8N(89E0 JW7<F\*,$AHG
MNS)FA[(R]F-?WIW[8Z&^H,:SN)O5"S!4TYK8KGU 1Z&ID3^XWF/Y"5@$$\<!
M69 CF8AI+$B1+,@]L5&VALAP808XF-*/B!L5D"IHP3XNGA-7N4BMTD<4^L\_
MAKC/[5(![IR5X4]EW*@@W.Q0-K6 "K(@)\/*\#<;(G_0*W(_[)+=^4XF%@1)
M3FCC)[]<!^Z4(^+0(,ME3.23Y;*WVWJ1NX$G60TE)B#?\]D&OI]23?=1!P,>
M;D8<"K9[60U^>A(E=E2KI*O34Q=+AZQYLN;W<<W/Z;@/,R*SB-&!_T2YXNA?
M?J6)FG42DM4=+@W4%<2T-I.KJ<#7JJE0N[K"Y?6?Y]</-W>7Y\WJ)]3)O!I+
M$07-!X,&!BZ3D$?B()43>([C@<QQW.P1\#.9D05:4CB.9A\%081_D\H)+5,L
M#_LP02HGD,H)AWR-0-0"24@GE1/ZF7H"U'$#E51.F.Z^M;OK[PO-T.QGH%)K
MRU1=97H1>@=SK3=B)]I(KPV[CH,^DJ80:S3Q"V2RY,F2']&2Y^9DR>^+E;6+
MY(<[^95:R=!&UV1]<K85";8>-RN#ZT-)VH><]*EY1<B*G PKPZ](=L).'Y+^
ML'/_S\1N,@[Q%#@U\DD\-UDN9+F0Y4(<#B3]@81"3\>ENWM9#5_-X4C@20($
M6?5DU1_6JF?8!BD05=(8DBD/MY:YAFQO;G79<!:&>OX?5UNC/A632X$0^FDK
M>7-[?O?P#;>3//^?KY>W7\ZO'XZHZ_.'^&!IO+<.I!I+(L3:APCN(@D"?!Q1
M!G Z2HSH7BJ=I$+0C_*CP(/'1QKPW%R2P:,@<I)*,RQ@P(RD0I"8YU[$0E(A
M2"K$ ?@>B%H@$>8D%8*D0APB4$DJQ'3WK>KW5!UO9*>F[60=J<:WA_5XE<=.
MF_R=K=F)\$00=7B(VH]MH><PJ%-SM7:A^;!UP$UB)QA3Z,/TKT+VZ(I#8B?0
M[W./4#T%&LG*&V;E[4.'B(.T+'9X^+Q9+C4%4$O7,C3'1;=^T<O 40%J?V)-
M]Y^3(NVW0[2S\_U((YLX.@@GX^-DM"MV'ZP:XE49UJOR15:>-0-87FR3+C^:
MEHP"YZ9JV8Q8;TR!QN&KVS/[$-P]XADE-$YU9= 3*&M#O!0C\U)<:$"'O +K
M!3DK7$,CY0())_MUT&&.1'8"[<[W'Q^$D_%Q,MHURT\Y+I6X)YKDS_<5SWX%
M9!L\HRA4;;6VS!> W!23,W-(G;!QLS)\SBNW'P[<:07QDQ4Y&5;(BB25^Z;J
MEYE8#M[^'(CVAY.NCG;3";#?G[DCG(R/$[*>B!NCBAN#E $LLR=)0;#RV28%
MP=J6 9Q"FY<=+1ZRZLFJW\]5STG[Z8*INGBRS"O_#^^KH/AAY,/F!?$4'<@6
MIO]YN"IS,YX6N/GCH_@H+7GQ$<APO,<ELV047IVS[(Q4F:NV.DDYJ7IB(57F
M2)6Y SC:$K70LUHXO.)=I,H< >HD@$JJS$UWWZK4<&VX[6VA*.[*U64'J)0*
MUA90--G13&-4\&H6"S#09<<02F>GO:E&RN NFC<(TJC61><=LJ9F1! %0!3
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M$U86=U "\"M_5TWW%H24.)A_]SA,(0N_6SG1D02@=+P;O#QK&159Y;>=T/S
M?M[__(;'2[Y#XY(+!8"_5FN3@Y0T$IT0$$=<*IV4YRRLHY-=BET<3G]YA]Y@
M>%,633923V'S:C& DIXWOU@G[@^80JXLJ^9(PLTT#7.'+P%2$RYNB>G6P +P
M.D]['7'*CR09 K?25,<Q&DO:X!RB&PAM@#8E7?*[I2"#E\@"(A$_;M2B%?%^
M0>8\\;6Y?9"^LCZ]!\R)@1D!I>F+E[L(@,@R(4 AXL<!'WAW^#))UC2;A\L-
M6]=:=^W9J=+Q9.P,?.8%T_$(?K"GCC?BSFC$^( /1H%K4J6M3)7ZAYDJ_0C"
M]M@2PXYF2;?GAS0<EFW:.O#,T6I(K2??WI26$GF<*(FO3ZG8"?0)+U'4LQS\
M$,*T9=F\1^YSE5";]*N3*[*I+H+Y+B/N7PL0T8Q[>-D +9><@ S%R*FUK@N&
MNIA+G2S;[N@F3[K,/E\F69@CY+#TP]5+,#^&\\]0VZ-M\%-V&]<\<72%A!,@
MYR LCO:2]EF ES0# SX:#L8S;Q(,/6?D^M.I"U9QT)^-IWSLS0;&#+32#/ #
M-0/\&D+?MQ$+%YT_-'LH4'0KXE*T!RF_00#VZ([JM:(DX[X*^!04>WD2@<FL
M,5F!?["XP/,'^&#2LTB)6<LB9YA0$XJ'?'S,R:,WSN<L"DC!1Q%''4WG%O,D
M\E%-4W2F6LWY5MEU@WDR"[+I]&3U& 3&R HF$K)_P?@Q91XG70DV(:18\QHT
MH0Q0")E](9/[[Q,P<^]/;>OD/1X5?4K4H<-P.#RU9Y.AX[RQBJP\&*K%'H\]
MW3G!!]0W!Q#R?/E<_F;_\D:<H&$PBH<'ZC!!SD=+I"1%FF<_6R?A&YK!54']
M3%*82E$:>=$+!G]Y"SP!$6(<LAY^(P83#)]>@?G^';X!XH]]$C8/5'D+BR2^
MY2R"=<-??H>M9MX<*)/C6<Y5$< $O\D7T)ART'IKFG>A\"+D*U0RXE.2HN6.
MJ[^7%KJ:_B_$@2?AS2,&UL:K3UFDPQ2OAO$-1HH^LC H(Y$ADQ-0G0HRKAA;
M$E@X-)@(./?*LP#K0D7E].$UA,M9KC-*3T71%*'F%;JZ[!R,;7!\X'XO3]),
M"00>L05!"$]F(HM*$[R%UY.[L[D- G"8P'=7[R0'S^<!CWW,P@@R!$"SDA8;
M^.]Y7"98&S3-(LRD,.FJA/8K8MXW? C>D^'9CWSQGT#ES ]I=KV2S&*V:Y-]
M.KMI*\ #8;7Y201K 0X0>K*:_>^4W\"YGUGKQU7Y;;*1GALHN2)@\OWWBIEU
M4E<G]8%[NFKI*=VB0>K#=%2R7NIS)&[SBE'=R2F!Y?BS\#$C"0-\2F[* :8]
M+>'U6'D4B7.DH/96D;D3A\I",N4<B))@/$@5ECRA<N_-=.:4(H18! Q N"RB
M\G1?O@_T-2GU<GTMC 5V&#-67M5SE_SUN>*ZF6E6#6I]@+H D L"]E-S(L$#
MBEBIU*^4@K=%4S1[=(^JK[[</W'?R//%$_9&/:*;@1Y5F#0Q.%#AO+@&JHOC
M0NN#J$@*/6#/M-<D2&5T#']:)*J.08XH8ES-A#6O2:/ ^NIZ6"!%U3]E\GP)
M(\; &($5L#"2Q2,19RA+ 8LR.J&"]^-'^&#E8,E=1BO4[(+1DG]G9 5FZH 0
MUTD=?OY=P%>08#P.Y9K+N=3,7$4)!J/ZLH5Q5JR88TF:U6-[;#*\$ /33I7[
M0]8QY:35>BNDP-.)B([(0&6K$\!5ABXU_#E]K2H2?A^FL.EO\<@MS-5A2FW-
M#.P]. -BU96*4KH.25*=*#Z,*CJW#?K"]%=/5M3P0Y_.<@)1/+7D>5@>':$C
M 3H5[ /]*I:OID$'1)(0H'U3V.*ZD:M3Q[V32V$^*D)TQRM[XO3*61:@3NKU
M8Y9VLA]%,@Y1!G<.C$G9IW(?>T*S4[('=/NU:(7C<CHXA4@B*GO7B/50>ZB:
M\M5^_NM?BNSTFK'ESV_+]K/9>>R_50?;'DC2.Q%3%2G_"OKUMRCQOOWMO_\+
MB?M7];0ZPM9.KVD4PKM+KY(@OX7@IF$@.D*'7RYY\.NK]VFR0$*<]FWX)T_H
M9WMP.K1?_>U%C!4^I8]P>BO-E0M1G+A'_OGK11776K.?3[7?+B^N+LXOW_Z/
M]?;SQX_GOWV^//_ZX?,GZ_SOEQ<7OU]\^FJ=?WIG??SP]N+3U47U*=$;W[9*
M_!<SPSN.P]=2QS2+ST+WV6,J%QG7JD)+?X4*_UA5\;"I&.E$LX,;OE,+-D6!
M#2K(J,@P?%^OL=*'7/MK/7)%^9)E5Z18JK/3'\T;-2[I)]%6C0C2$U$!3O%\
M":ZH_&1*=:3RRX):CUMT3P_3-BY[948/G\&]-.JA9@0VX'(&E&"OQ=C61AJ!
MIDQB47R$HU1,,QC(Y#RHP<3#6&Q3)/AO"+;@E1$FX,'\1M%"%B (90BCJJHY
M5;Y,ZA)#!4FU!-S';[P,)7/NS6-,&ZKVK&?69T6L8;^ASIE&42]1]%TKKRMI
M4:Y>F<<PABW#9]0,F(_R5<X?AVI<I;#X@O1<(SZ>8)2AFRPZD .@_Y3#0MYS
M-Y51ZF"XG8"@%9KH#_(6[ZEU[%4[%]<2<[*'(7Z/>,0KGR>#7I8"@/_'4NE7
M\EI1 ,A A"9%&!9=GC(P@L"&H2Y'L(])]HU'/$<_\BX#/U*P8A(EUUC&I_B'
M4@K)+9YGA0L7G8&R^YS>Z0XK1P1;)**A,! [3;X!TR^PM K\7 LL,$^3+,2J
MJ$16K,&882YC!^74<4QK1G=:133X;R0ALER8OEXOREXK/\'Z5>#M#8RL7J4J
M]$E_A-7-AZIF1V^Z#,YY3+T?U6->Z;FH6KBJGKE6!Z8FNT%U8]6/["F-N50E
M+%(W'8? K"G]2E1P<_6 K5*$6+PC[ _P8I)&_BW6SJU>GHCDT++)JE1[2Q M
MY 78^[+0&9,DLE[_$;)4%;+>+U/WRQ(KYQV@!FV>M$KC5!4]4HU4K4\35VCU
M#2.$,99TR91:+(N_BG(;_DQ"*N61ZL;3678G%?8M8LZO3ZZ8!\XLED&*/G_
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M^/=0)CO.A?82NZM-<>4[2O&CQN0Q(X4)(_VC ,=]U-,.G=3RJIMZ=)845[>
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MNV!Q+LU5#,$ 98@Q:7-#!JY*5O5DSDR4"L#^_,D]RB!1T<!-$A4+V,[?5#U
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M>]4Y1KFLN<2;O<,G>WVKAQ%?)$;Q%_AV#H]=*)CBO7J+?;SDX#/.G*'K]/G
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M%M/^ -;BWT4(D;NX#!R'XHJ_LCZU^]T!"U,"WJ*KH?A<?B>7*#U!BX&!0<
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M[^*-1@(M#_9@8X(^&9I6E<*OP(JIUQLY1DL\UZ&<SC)B7MET6YT#56.+R<$
M= "4,<3]?P\.>)(JUU7XV)M J,N1,'N4:DW0%/WPP:J57$$@V$CCG@YK3^$
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MI(8:,[@X69%F2R7I4 4):(Y.@1(/J.-]B'B,<<),! -+$'U/=8;W0M2-AJ=
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M@*O.!;(Y,'N:WZNS8D=<3UQ_2*Z?.!JH81WK6M6+]4R1UIO/;QV[-BQJ;.%
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M_6HMWVLUAO7A<:J; UA7@UL_E-C*^.]1$LW+^1?X#8L_LZ6HI_^09I]@758
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MW0=\OHC3)><&2X*58$G2Y+SYY,O5'[G!*NP809EAICVZ'<(H!Z(5W@?T1O#
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M('1@2ZU&3&M.#\28BAP$,28Q)C&F@@=!C*D;8_;#LC^P^?[#Z,)6:\2@#L)
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M+N$5Z>(@7'CV?U\_EPN??4SNA6EUL\6M=+^C8H9E0-GI?)%%.;R9AL8B2Q<
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M!+D05A!H2-G2\,LL S5H65,1^K/AB'V#)S=1EB9B48!%(J4%@-1S&;P)OXQ
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MM# K)6HA%-Y*N,7IK8P ^"+ @''K[!LO9&CZPJA_O*SC[G4"9'H3!=+)XZ=
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M76@EE=X+#2G!CNX5&^2;+=\3.0! Z#MEXH&-&+>&$SZF^RG<CZFT &3']:0
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MJGQQ;5;5O.^T-,'AR]]"!J[&I3N/0YZ>_\F3#)6B0/]21FQ$ 5AA=<,'<%*
M"Y(8?D8W1 D32;\;J8'JYA$-RL$D\=$&BZ_.Z^.7D2DF_9E*%_I4A&I!;\'R
MX7/EW! \6'<?BTIAW(E)*X[@$I6\Z\$D(M3PELY6L4(MTA^!:E;Q(_I,".#&
M=8Q&&96*+P^-BN?DXH N%SWC??&M\@;*8Y>%KK3_!4/FZ"VY@&N&IB+GB1J-
M:U9[+)MU5&7-A)@05071>!5870<48%7:'-+VJ96"%).)QZO "JZ\<086YUF:
M";%^QUS8^(#C7V2DUN,S0@&A7R:)9$U@]#)COJ]HMA(%O^5AR.&;NL:UK#[U
MC6 >4 Y2(M@Q("#I[!SA2P(>B=IQ5%?PF@4A6?IDAXEF$"C^&';@H-8/TK$6
M*UR%F+QD/*@-(M$Q '7!K8&PPH11G%_--X/P\.D+,JVV (FKQ 7"E@3ICW,_
MX9PJ?B88Z$RH[&U:Q_IMP$-/Z+KOO<L>:":8+@=RG\615[B]$85V@4-(=Q$A
MJ]("S[FK5<%Z$9ED"U.)71X)%4O/@0^#3E3*.:UH&8(BI/6RV^II+8W??(A#
M,-D+&^GCE\_(#9<<="3%<4 3.F8EPTKA59=6*55%G*'M0-@NHB(DN/)9&+@A
M91AXZ_/]CLLC?*0JK./U*\<ZB*YHX8 6J&@\</;U\GOZJA2+=T@WH2<DWZX[
M)&CN7/W I.1MFJJW]OST.6>%&P=\1GF_?1WE'X@JT(1IZD7@4;11R5*=4/'8
M,G5$J.SU!V"/,+%((!/?EP)",7S6G>4^WQW?1R:MZS-WXDQ\RQV[#G<G,SX$
M3>\/QC,^LVW^G***PRYGTNZV*LN6$W!;6D_K0)661B=7N^@?F!O\?B4W^/2(
M85V.C)8E6I;H.FB/*=AWBH70CG()IT>]:/^?'O$>L=I[4&F_G2C"-2'C[E*6
M<K]\+^6U6EC%Z(C6M/?:"L-Q;]A^XF]=N;5?VH\S+3"TP-B)P/C%.#=&5OL9
MH/-"XXB-OQU;>%_+LUIJ8M=Z4NVLQ#HZP/<N3^V>;1\-@6HKJ_,,T%G #\"Y
M8P=M(;LW&1P-H6J3Y_CB7>]D%IA(33L"4M6>ZQ&L:>_R6KD8TGX>Z+SSJN5&
M^TCB*-:DY<91RXTCM@#W=:Q)]T*PPSC5+VM77XG3\$4["_C^>WCUK X<)1S=
M/FO -6>U&EV/V^<C-AH.%S:ZK*[C'@$=G;KOMV7BV&9+F_;@;/_9%+W!^"@Q
MV5D]K06&%A@M%ACVL#<TSHV7]J0W/HG$S5;UQKJCC44K:AQ\FV/+$=E_:.4N
MM=)S)+OAX376<8FR>?J8YB-[6PK-U+(*!FNK4#>QC#4VL894F(EB3MA AHK$
ME65P12&2)%6J-\E*T;V"45?J)93$#4.EO)P4*]U4-^(?</F]7O]'EP51I,9S
M13/N&=;KHO* ZTLL*S5KE:I>D4?O*5\5I9@I@-M@SV8+(KLO&Q'A.%0E0;2]
M$-.\'#M3I>O%2AL,M5"; 6K%'(]&RL\)O[\RX:YW;G6;<$PC9%@&X>+K^>7%
M"\,+DE]?)%GX$'V6RGJ6:7SN,RS.DYWCT_!A$82WKYO/KZ-5?'X%JD<7;9!]
M+_Y,XT_81"64C2^>W)*!.EK4/N :BZMG+(3A^NY"_;=IHJP:"X\.GXA);_TL
M. ^2^ :F5+[Q@R3-Z-M;GBK? R+*KS>934^)P,BUT[I+U-C.\N>&'A(%\B9-
MX: "LES9N#5[]I>(?KD75_62+ 1F\SNEPP<1/M%ZF"7EMQ4Y/N*1'?')=H#<
MP&WX8;F!/-:9NYIP]K#ETH@X^"8]L&'@,6_%WT4#+"K_=B$*GJZL'O_WN:B,
M12%>6>/HR1NX(?BNJL85-VQ7NZ!H.,!I9>2URFA81?!AD+&;5;_;D[X13\X"
M#\V'Z"IG5_RU\?M[@H$<7=5ED@[O.3F\PJ#>IUJDFCT%.,)DE];ZM&YCU]LV
MR)K2-PI;RSK&1K[$3W<H5J3K>W3OW8\(5@&$[I)/[MK$[:S'LLS!9&H.A\,G
MFTI=MZ8*PD.2TQ1S[R.V.;1MTYXX)T\PC0J:C?KBV-NA:+=2BJAEGJ0Y$ZTS
M,+#E3/K&BW=!BJ6%\R"=8^CICX#-L.H&5EZF.KGOJ<W9"R)0?&EB#4L87KP#
M/%PS%(\B5/([]T"W78FGR^*@90GG"I1T'N>AAY64ZS73,61&$\K(2R8Z-WCE
M/.7<H03TMF=\Q5ZXHD= QC47W?_(I 5F@+]7WBNHAFBL;(MB!!&UR,5/O28(
M. &=F"1YI 0_UIPJK)+<??;D7L)RCXC2/[L7[,2;V?VA-YNY_LSA/F/3 1M,
M+=_ECCOP1H[N!=O*7K"+X^P%^Y6GG"788R3"V#P8[_&2&GZ\C=-L;=G@N_9@
MG0^]NV/,SAW2U)#M*<C&[GVB+XH+)LI5U1A\?8?0>H-0U/M!1)W)/!I9Y+M1
MYP;X)N)9V:J'3E2H)P98/K)-BYBF;*[)L7,CROY$ ENSNU6@94=SV1:B;%:#
MWXDBUGBJ)T?<3QGYAVWU\R6X8\\<JS^8C!W;L<:CF3_T)E-[-+1<QV:SOI;@
MK93@T7%*\(\1<"\WOF&C.2VN]Y(K$0B4B]Y^#^K2[?1K[6MK>W9?2VZGK_:G
M-65Z!(K9TK$KV\Q@XLSL%EN%<E('V"40/5R9P5&](-=3;ON,A0B_4$*;>E5X
M@0_C<GINQK,;SB.E:5;"J=4V->X6[C3U**0NJ<)A78$CD,XP3KJ@_C)E^@>U
ML8F86W323*B-)[W,;F2K(^JJ,Z.FF;+I)2!@%=1F4Z($&]FEHE=/B8!BHV5:
M"[K2F+0B,A\8ME1 _)A&X(-&Q0Z,++DUQ6A>[O*U*)=*7*A="3,M%;N%AL$/
M'MZ>8\_%<_3>1;>DHO>H3FE1&8!:)[$ ;1TCNP%G,^-+T4@,.W#3)HC&J@7U
M"6(2:405T8M6<T7S+-RH99P&HLNZR%7"@WV#1@]$<WM! [PDY^(%^/ #2 T&
MK+>[JJ+U]#MUWR/RY5F>1 ;QIF N!"X0=MD--;$DNZQL]<2IV 4V@(H\4"NB
MARTVK:?&] H%B:Z=1$'PNTF]BZ,"<*7Q?<;=>43=I1:P%5EJKJZIX*<4-D9T
MB\7!<B^ 844?100:#,,XS(NAA=DH\H%@1X!\4R7P9B"37S'9KR1VJ9.J;)(%
M6Q9Y*K*E!*A$AVR>*[O'A6@98P,Y8<4*;$A4$ Z&_5]*G-28231-PTZ3U"0+
M>#,3S70;H4#737*2Z+(Q%E+2$H102()*R7K*(Z63;ZT3*VPX_)]"!:@BJ'<P
M2OP>]DT$I*WD**H'*>K12='%$&D!>870K7:LVT3.^V7AK621/B)K];EM@9H@
M5?!NT4W@X!CT7=]F-F..ZPYFH_'498XSM2>SR7#L:C>AE6Y"?)QN@DRJN-4A
MG9WY"-)T]*21@EFO!K6^9$EY^GU;=CB%I[&Q/&C#C\)DG7$8G\P"T!"B<_0-
MGI"+X$^<*ZG7<1BX8J0(UN!QT0$XQ08%2LMC'[O!$Q1R<M!BBF)8:_XJIG]Y
M%"6L(EB23.3%'JK%:K ]942=QA*TC\^SVR6O?D6EAIHRP4:/ C\IF@)%8G"5
M\XT1,&'(+3%?G.)/RY")/'/"DTPSK\86P,$ U#<M9=C+] ,X#'%2F-K")]C4
M6*\<"2-=B7)>5N /7Q3M9'&"G!K[(8Y-M54GN2^ 6C=8TD*$GZ*B2"PI+;TB
M6NJ2)_*'=EOZVVCA9CM\.N3>F-F<._YX,/&MD34<,'<T\J9V_QGQLN-LX7;
M#DL;^Y:TM.N2;E%30^566M1\OS3>Q2%X6^E&PTQ(R3M_+BY?/#8FV:([M*?1
M[>;I%1LFD]U<#OU-Q")1PS<<Y98U_CJ>R]?ZGO6VT;/_*]6V+L%P++)WQP+V
M2^&(M8I@NE"#H\LP[ETB678'2CMHL?-(DV]_G7Z_I^RJ736['F#PK4'.GJS
M??BG!RVAU-(%[EVNGME6!WKM/(=4]B=C'EM6^#@$_5W2W-D1IC=[]7:_5=3\
M!.ITMM#$NR'=4$'T30/_>87C&UZ<ST*^NR#C#B7U =:R?V/7:1<5/[5:X%-)
MNP7GQ'>4-7O.X=8=*1X6F_C#Z82-QV//F;+A;#!T/.:XDZD['LPL6Z=XM#+%
M8WF<*1YOXPB/<8IK(;%OO$VX%V0&]A'5=WFV"\6',N\YB-(LR3&=4.8=+.,,
ML_58&-X::3[[5R,)09;6:VR5*[8J@:VB6S\!)@DD081Y!3@0/L+2N4G_I9N_
MURSD16D^&,GC\K(-[DO:[JR"?:?FU/(^"(&(M%5,4NX[)5%RNM&T8/^*$_!D
MHA^4V?DQ31@/18;F]X@>NLS*O/2_\@0 ONT9E[D[+\9)BVM2]><7[+9(7/^)
M2;&XO4!'E/\>!@LUA;3(CZ<T4/D(O">*,?XK!X+Q E?)82ZH;,$"F3.]><%T
M6P$V ]/AE4Q^I.@@R^7M,DRGC@%ZD5>CWB*3-,M_PE(I<3<V."9DKQU)4V1=
M0#>9GO9"%E&AFP,-EL94*Q (,'( XH"(1"0C,\.%:>.%N-A?7<*K".$')H?E
M,\Q%0[%$N5(MEQ#;R#L:]>W!K-^?L?&4.=RWI];4GOGC@=.?#/LC-M5Y1ZW)
M.SKM'*/1R>48J1&@5FVV3A#28J$M8N'T4@_;%PS>BSS0A-HU0FU=*J+66UO,
M<MA!*[+- <"WA?-VT2J"TKFM+4GGZD)&@M6!1*_6I3BWJQ6]YG?-[P\FW?^W
M5:3;#78_Z4RC735W+8VGWUI%D5V0,UV&41LX3\]D/VTKIL5$W048M:71%KX[
M37.BK;&;MZTB4^W+M42,=L&7ZX)ITSIGKF-6C^;WUH*O+:H.L/MI&EL'M:C>
MM8I,NR!\N@SC :YKM8J^6N18=LRT:3%1=P%&;7ZTA>].T\9H:T#G?:O(5#MX
M+1&C77#PCKTXB+9Z-+^W&'S-[\?([\=A;1W4I/K0*C+M@O3I,HS[%X-6J^BK
M19YEQVR;%A-U%V#4$9VV\)V.Z+0IHO/75I&I]O!:(D:[X.%U0,*VSL%[K/#5
M[*[9O27LWH6SZ=;QNP[H[ "II?'T>ZLHL@N"ILLP:@.GJRZDINDNP[A_2V/0
M*OIJ$>.=ICEQD-A-W=+XV"J*U'Y;2T1F%_RV#E@QK7/;.F;@:'9O+?C:>.H"
MOY^F7770@Z^_M8I,NR!]N@RCMGK:XD)VS+1I,4UW 4:=]ML:QCM-&Z.M>3?_
MTRHRU1Y>2^1H%SR\#I@VK7/P.F;U:'9O+?C:HNH"OY^FL;6OT[ _6D6171 T
M7891&SAM<2$[9L6TF*:[ *.V-%K#>-LP)^0?XJ?M=RD/(H_C6]C,]HWAAIPE
MA)WY.@JOKX0V<0N=;:V!,QM/9C,^&UB.,QA/.)_TG>'0]OTA_#9Z FT<16=;
MN8A!;X++:%)P%B]WHT6?K"V>O$NCGK6G%6Z.\/V!?<NS.8M@J&-BVR>U"K\/
M!&6^LB<V[)9XN?Q&R%CQY5HF6P=2!>_6<%7?[4U-O)5N\P*(B6V-WZ0KG<M3
MZE]_Q>,K4"QSI-?P5G:=#_R >]1B'J0=?.,I+<[])%Z(5N78U[SH<9X:061<
MPQ-QGH*@RJ,L"1!\;'</+\&/V/O\>T3=T2\SEG'1POY]GL1+WBL1^JQ>["DV
M8R]:L,]NBW?I&X ECJYB$.3%U_R:A;F8!R%A+H%M+&( ,D[PP642N]S+8<:>
MH6#56/+$CY-%NGG$%$&'20&?*6!BEL.(J3%C*0"6+W%& U<!>'8!_NL MCWV
M2R3 3A@I;#7^S "D.,^P23QJ(<#D=1RX38AND@ Q&OM^#1TW<TZ(OZ6M]CA?
MX/P1*)(04!B@QL.ES]DU#LU_SAEL)^X\ % \!,!R'Y:;P907M"ZU2S2UAC5I
M%&R^N8'(EH!"[-+I&1'/<(B75M\&P(!8"/7P[\N!5:Z_^B$,XQL&%&$  (87
MY[/,S\-BJV!+)3$ B8:W @HY@2#0A&=Y$N%3/+GF-'&_,>UD5'Y1'Z[W&#GS
M+(F])=O$#5F:_OKBW>67#W\ U7W#EZ1AXG#+\3S;\WWF.)/1<(8&RK _=GQO
M..N/V=,-$ZO?_V75$FG:*FVW3*QQ(=AAG%EB_&5?%H,U136SR5[X=V]'TS*0
M1VNGO8-('VB[/&#G+EPWR5$-<(" N/L+NWW=?E/E8>KW:8;*MJ'XDB=ICKH#
MU.3'-&$\K-D"-=0;?[ ;4SX5&'RQ#.-;+B4W2.T@"V&S8)RT?&D)+_%_YRS$
MK^.(H]+,YK490 "SY);D-F?NW+@%0PL%L!A^ >."0DY #RY!M:"2 365\-@'
M)0/*!QZ$S^7&5C")'XRO7_\P.*HG =F,@UYTP]PC]08V"\ J5)?E%*^L6;(U
M'0V,LP)LN_^F>JO\TGKS"D "A9.0^D6K8PY6AGS2Q*%3O@EI,=H^\ JA!ZTK
MOHQ3LD58!DL'*X>4TJ0W&/PBX0R2\FF!0K2A/"XM*/@U8HL*,601!5&:BY6Y
M9 X$:!W (A')9)<Q I^>H!<4Y"2 1;!*"$.%,4$6'OV1@_KD]7T7@YX)+.-;
M;!:#:BVH9P7+KQ" PF:C)<8JOMZ(?0<RX:A^0T;F1YKR3-B'8<!F01AD@41M
M%&?EXBNK0IJ7,T 83IW..<]Z[6#$=D#Q+<Z 68L-YC^7/$K)/A((7V%NMD #
M2_SRT@)0*AOII34<-6PH:S2MOD&.Q\U AD^!%9 G"XNQ0D9E.I+9*.W'R?&:
M8*.9/^%L,.M/!A/'LYQ9WW5]A_F>YPW'%G.U"=9*$RPY3A/L P--\K_@K7+C
M3Y#_(.5)KFLC;*M0$):O"<M@,GC<#R+2;B0?^4]WSJ(K=([!G\>(76;<Q'GH
MH34C'&@NI"F+A$9$>VG) D^&/J+4YVA %2KRUCB#)_G/(!-#OBK4(GR*W& )
M"B!&XR(%T\.[!MN077&,U@#L/V!P*;>K($0Q934^FA*102%PM&L0!"8LB1G/
M;CB/BK&6#,D:ID1;0=AVQJ*B,\,#K:/HYUHH(T?%Q."5A/-ST/N)X5=HG,-G
MEKASLJI(V@+Z1: J2-T030N,76PP("0('EI?RJ 4C@&,YPE%?68L#=!"2RLK
MB].83QDVBJ/SE:$!CTL@IM@#.S*?I6!)<V&I"PLOB&!<V"T%8TUD57A(X.T@
MX6G-@H.A (U&/,.X!VFN(%KFF0P(L6L6A/BMB)B@?0I3+H+_"#.0WO3!CJY>
M+S&A#N/QC"?X)BRL6G;/^.C#NH'4P9C 58!UFB4Y;3MMK1R"Z-W'S0)L>($/
MM(R/A&"&A*697RZ3[&QUJ)L W@1&<8&2KN($8/?4\!H^'<8W/)4C4C@.)Q;S
MH@&OQ-<$YM6] Y'LYB&%\BC0IH2F"K),94RM9&H_QFC56AGZ/(FS31'W&*V^
M%;O'<V?>B+E3:^+UG?%L#'8/[]N^-;4',WLP><IYJ6+W-/7BJH9^M&7SJ..;
MYYR&;=C(-:;&]A*HR+Z0 -CCYFG&O9;%HQ5D=2Q)BYR.QM-UY'J?B;<;!* )
MMC\$P) XCCKF^0W'TV,\?PH]>7B'PLIJ^J[X,/[\>46@"YD'$B^/F/<O$;W_
M=QYGXLC&Y=+_1W]**N>4-'V IVZ(F$*I*8H>=-I3-FE#"J$J3=8:A%N4E9O/
M#(_OKU8+?6L\8_V^,QHRSW&8.W/[?7?BC@:V-QD,?"WTM=#70K\A].U-0O\C
M27K3B#%2*C([[I'PIK!RT3Y57  >T  >> MN!OX;:H&H^/0&70$M]-O^5YN%
M_G@ZM@:C@>^YTXG#I_T)&T\'/AN-?3#W;>9KH:^%OA;Z=:$_V"3TOT>KP1NT
MVV_F@3L79V8BV2G+X 'X(8J+X)O',B;#0G1B68\+>3AOO*3DI/B&(HOY8DDY
M2^N.6SH@_SL8&,80GLN2Y!8W2)RU4<S+9>F<8G+T!V[A-0LY93JE\SC)#(RX
M*:?(:[*M,*!'WR[9K?QJN4SBG\$"#YM%@%$)='GPKPQ_T0SG- ,\FR<8\<5,
MJMR=*_&_(@*WEEH.L8U=RPO=&HHP3Y(GF\[,=G6.:3GC\6#8'_?]Z=@9.N/)
M9##F_:GC^GPPM-QG:GE]CKFC<\ST.,\Q?V-IX)+0>Q>$.?I$GT #_A&GJ?$%
M?)W+.?A [3[4;+.:$MC%C-H0,;K$O"K$*%H>F&J4RSQK ";P"ENC?!Q^P,_"
M\N'>.<,$DRMX(*?D850M.!@I/LJNPGRQXBLEX]G+2SM&G)JU1?,<$(J"VN_?
MFZM Y';[ODR:QR.W99QA^)>%F[? E!EU^'*:Q>X/(Q96H@G#1\3OJ$F6"?=Y
M@H>?8O8;L&H8&2S2JH UP50E(WD(>'"-1X_BZ*^9FW9Q^=;X%"MFL3WJFX:2
MH_>>)73D6/*WDJJG*8-,2W$224Q#ZCZ54?^,/ =)'JRX89%MN"\R*V6KMX[:
MZO1BG%&R@<@! \#Y3Y>#!!>_X1@5@:)_\FK[IZ3;W*EM7 ;T!_;4]L=#SQJ-
M'#;B4S8:C@:6YWBVXUKN\%0O S[V%K#$>&ELV\N?.[DN>"=1/,ARV^OEZ(UH
M>?Q5[GX)KJ#H<DQ)7#BVD<9AX+TQ=K6@!V\I!E">[2_] Y/1ZZFI>)FI51O_
MJ-O?3Z6&#>$;+2*TB%"AM4].0E!R>JMV>2_R0!-JUP@5KT]H.M5TV@$ZG9P>
MG1Z'?75_#>.1\\O^S+!/,@S1*G)Z0$G3-?C94YW3?0B9UI7 ?+E%^F@I O=>
M(>W,LLWI>-0JSMMZ0=;]2;*.U3/4(DR+L",084-S.+1:Q7E:A&D1ID585Q&X
M?Q%F6^9H/&P5YYV0"#L.I[[RW/5923?J87<!QOMEX4'!?DY)[5;B6\.HZ;:+
M^-8P:KI]'KZ/PPI[T-'*3D]1#):)"M64\XCU/.N)P-TRWW3CN-:"KP\K.M,]
MKG-!/<WT+05?A_<UTVNFUTRO ^+'P?3'X74=(FOM4MRTS%-1KUY<PL,[>G?<
MJH,!5F[AM8K(GW.*L[V35!3[?=/ ?U[M(W-VFP+ZX$O9?Y?-H3D>.>9TTN'[
M%3NF;\V8FC'WSYC(EP-S8(TU7VJ^U'S9&KZT3&=LF\ZTP_>\MD#>Q^%Y'.Z\
MIZL).3K.TUKPNWCXW/%=TNS2DHW0[-*%7=+LTI*-T.RBLY[VEGO^:7-$O?,!
M]190?O<O$AU1<."LWYO8K4+-<W(^3SNE0?-VJ_?I &D-O?$Q'))IWM:\W?)]
M.D">HM,;:\6]P[0D^8?XZ0"-R&M=1.X/P>\#I/I>;6_&LN#T;W?7#"]JQ(MN
MU2E;<&IJQ)D[E[7]L:!\BE7CRC[I5(8^E;7*6?B@XO74S*ZBCJ(H?:VM@.BU
M/F?7W)AAZW)X(#@ORM.O;X6TVS.8#5\]NV/+Q'&MB3>RAX.9[]B#R<P=V:.^
MY<[L 1]S?Z8[MK2R8TMVG!U;WL+#0+34Z[WJ-WP$XKY%$OZ;TO(-^VM0>S'J
M^IQA<Y!U&_"@5AS.L-Z*H]Q+%[=0:<-A7( <CZ\#$MM!BAW*,&O# Q,#)&V0
MX7>H%?&IF;AW2 U+2XAN03"G))?+_04]D%.C$6IQ!BL4?=.*#A:D8UP6P4LP
M'4OC",:]-3@@"CN?Z:8QV9N_XZ:"=ES*3C AOP(E"MC)> (#ECN64N?8A%\'
M_$;BN^PM#J\EW ]I!%3.0&0N[4'$KV)0RK)%3(EV[#V2A7PAFMB)&9,\!*J!
MC\R[#H#8X&WQ U)JRD.:D;K=*IL/Y+N@T>E7?HT#HLV0L8#:P6!G&V/)4*CE
M(4ODL@ZZZ\8:A7)(>"XY![,^X\98F%U^GE!'8 6YV\:7JE?E^[#W_'PNVV'B
M""_VTK?.X2,^\3SN#\:VX_+Q9#1Q_=$,C*+I9#JS1MH*:J45E!^G%?37&&:.
M4"H:5^2:: -HFU"LH%?V2!4MT=2.N D/62;UAPL*ZRI. NE2@G(1/_&?2PX^
M8Y:39PFJT04S))#:4#34BBCK5"B\#/Z/])TR"BK5E3YV:'.5_7S+;51FP_'+
M!R2LHL$;>+E78-, HFY9"-82ZL0HCLX3\?E\QAE-)E?O)_&")OZ8)@P4[,<H
MBJ^%-KW(LWF,O5Y-["),SWR\,(TS5 D\ 0OJ1R3:!"OO!\9GWY>:FY Y#[AO
M7((5"/9@FKTRFQ.>?^]=]HS?P$7'.1D"X,$.)NC$?P5_GR7NO.:SOQ-=BFD'
M/^!QN@#V3#$^?_OX]9UB<[XB'#3F#8P/.7X+*_L"O\2TG9^!-F#*U/B3^B7C
M5T(;BKB *VP*T387*291 "S:)Q-@\/N_P! 237=35K3?793#@FD47 OS6EA4
M;GP5!?]!FTJ83V D<6$3JS0)&XR(!+.)**S6@/=*=M>+Q2MXF)T6VR#H X.#
M:9:6]K(I#+A$1E(\$5EAL!(O=PFKA+2-JP34K%L;D6D*7Y^E8%9\ K.B8OVQ
M^TJ;VV\^@:F\GAUON*0&\HE\R7>W\%"ZIBL5M:(1N]CXVIJ:#6$FA=R&>8.H
MX3B]M*:3LFL? E+260'0>GBLB8E$A.9V17P;Z*<@E-::ED_0X6UM$+V&^EOD
M?WR+,Y#W!;&6 J006UG!+R0OB4;%MR^=44FD)M#LL$:R&WFGPD/%1()GI \,
MK!*"VHM*/JU@6N'0^QBC.9DU:2V]/]N5XMZL/[/]Z=ARIHXW'+(^N%93FS$^
M< >SL7:EVNE*71^G*X6_78@@)[4%3N((_G:%"7ZZ;E4 LC9P'PE, #(M4N?]
MRK&%$W@!'Q=+$<4#F?<8;!^'Q!L.^'#B6B/+=[CC]KTIMUS?G7C]_F!LS1SG
MU"7>V#Z0Q!/G[)LD7K!WB;=MX?8'^*D\7=<LNRUBK$4.U\?(^,!G28YY &"!
MC81S].'B\K<*OB!-\[H(N\2$ )9XQO<E!G H#')Q^=W$HR\:YKQOFX;8"./L
M6[P$J3IQ[%?4X9Y'<SHO(V<>G"R0+PF/7!&0P1(O+"D.M,!/\H,(GL:@1\*7
M<4+35]9ON57@6J04/L"LA2LA6GM&[5#/BY?T$F91%/!SWQ=&K?$W%A$2I)/8
M,RZR(I6"+XNV[RQ2)Z@[DA[/>+( 69MB=((."<AQK)['( 4@"@\368 G1@0U
M!20 +AF=R*/@WSDW?%8$2=P@<?,%0NS"T#+5HV=\+D)M-13PVOFD//4+<,X$
M#?A8A&LH6>L\]L]S> $$.+:Z9ZKQ7H-(3FE<LS"7!T\XT9+=RHC=M5PJ>@(N
MHE@\@.@06Q!@1T.>9D9"L3A0BX&+!YJ1?!(QDM"" 4/9[1(%!.C/*,[P6-(+
MP@J[R(6P-RE%>,Q:$+#8B#R#]?\'CV=%1"<AY ,!S0 )\0TA@(A6A D#$:43
MH!7GI4"FXFE$ D/-@A27L) B43*"A.MF1AHL CP\0_B(0$2D@/\[AREEL+.!
M,8R4E>\!SJ-X 0S"H^L 3 -\1$>"WGQ) O138Y7'BM"E-7Z3"GZ6? FRIQ([
M\KP\E5AG5PF7L67)>12?Q%BDV \4)QB+16ZA[WD*]">"IV#? (^D*R$CP288
M$/0Y$0R]2*QD*(YO=31?(P<O +&#,@_3J+(;+F.9B1+Z*4_L_9RBVD#ZP2)?
M-"G)R[DB"L2O*X'3,NX9DMQ-YYPCK.O$@&D0 P <"P;S"C%2"^P74XC@>?%T
MX_<5! 3;CV5UD*95=40US7!;%C&00T DE"5Q$601FC$@(ER -HD]$U2#!Q*G
M/-RH--L2!&I3LU&\&A1'CI0,XPE-)Y,2B.Q1%6,2H936F$PR9Z2!%TB:-$3L
MUX(X,PZKHM0!H(F&QI09C!Z);03IM@X0'A8)Y4[PS,%=B!.4]/)D!]0U&"/H
M6^"BZQS'0Z%8,&&A'!G<DA_LBC32$K4'C87LXP5%HL,BR/ U@;C2WA!8O<H#
MRMLI] #(;5R75-PRV2(,XQONU7!0P$2'7PFLWX^3&UK@O+8JJ=K008+]=46J
M0,TBP70=N3)3(%M8#(5@$Z85HI,R2)!#T\JX@)4&*'DP%_0G3$OG,*4BE:*N
M8-<* Q'0,4@M$">E42,>6IVIU%SE^NNK$7FH:\ 0DYI22*P'?XFY,G&>PF:Z
M;$F>]W^HRE] ::H># KD*HYE1-HI2E!@+IJU?$4 (I:'N5=@9>Y6T"CMF=LA
M5+:7:2OM=<IC T.FV HR;(!.+!MD593-R8@-<2]1SP@C32K$=9JF3O.E6E+(
MJ]!YBC>&>XP67D&_9(6E0-NDLC"B(8TP>3Q3'B WSH]+VU0U22]0-((]FH<-
M$SZ*C1"$ +RB@%E7\6M7N/7$Y\=D1ZV-X&R!&C9(JH8,7A6\A1LWPTV2)I@\
M:2^L_04X(N2@51STX)5I*^+[$KE!L7Y!6Z42B%+;PB\-_;S!AB4CL#2LK3>@
M\:L/JG](NZIZD2O^IH2A& 'Q]-(V^]-I];D\A,+$!?4IVYDJYU7J81/QJSKF
M76=5E3^XQ7450F:=%U)+8ZE)A0(=>"RF+-4R!\I2JQ_J"+',X62P$2'?5"M!
M$D"U]84-1M<T&!KRG))&1-YIL4D/7-+&S!Q2PNG<\,%" M,-\R19F,8R67)F
MG(OP#YF30;8+IU8?9N\3)T\Z&VD*M+L.3#8?D6"FC/$/\%DO1 BOK3A[_I%)
MGUL3VV?CX90[?.C-^N/1T'-&LT'?L8?VX.2/3/J]B3XTV<FAB<)\:'N_C2.:
M% GZ8P2&=RXX$;7EVRI:BQ<+C/>8=U=7(9]OX.M_Y_AUVT]A=J4_=G!0<Y%?
MP3.5I4/'-$9Q.G/Y79Z^V/WS_L@T=K6CQAE,I1CN<L)711PEI?B^'T@/C]7
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MQ$:'KFQ-*CR+$_7J]N*Z]4O7S>Z8Z]8":=IE&/=_$;MO=L+4ZO*F=A#&H_:
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M?,KBR\.8YPCEP6#T:*EL]8:C.@Y7/;W=RU0%$_4:]56YWZK8E'+:D<V!] Q
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M]616BN( R2$4Y%M>J[_'D7)S"T=JR1:W3-I?8'E46;^,@NYD1/@\H  (!G*
MT[ PM"P\P7\N WFX/^,@6%%DUKC3S[,\D1:(&I'?:&JV;2<:ON)Q9,,W'*WG
M9=8;:;Y8H+3&-(6"D<615\79%5(+,2\E ;4@I(X;=S$\Y><%%(\3D:X-#F4[
M[B\\G*D?%O>9@4+D"?U)\_[Z@LQS&?H9# 9L/.E[WM :.),I9\YDX+&I-QW-
MK#X;VD\/_4R'OS3C/!MNM[4Q\M,,?H"_E<6+S=]+C)^+SZ\->_GS47&1K40:
M'A2+@BT!<@$RL)ZPMUM#2WT9#X"VHD1!T.60DK9P:(.:G;XQ=K6>!^_H8SJ)
MUYG"I=,ST>"1#CE:M<TW<]#EYRAM^&N0T#<)6^YC[S6EMIM2+\0)V492W>7<
M9?710TQ.1X*:0S6':@[=/'>9+'J0V3$'"-N?Y2P\R/QAX'/CC,(9K[2DT)*B
M]9*BR$H_"+<$P*Q!E ;N0687ESW/@N@@LY>Y^"<H)]:=V'<O"#!C[H\KZFQ_
M7@0^WKY]__[#AS(H,K1_V4E8X+,,B,5YEF9 0TKWP!F_"J)(2>1"7=0J"MM(
M>3()YI=UF$VN9F=VWS$->X!7@(?#5RU02'<0P+V+[";XJBRCN&(5_]L-I8\Q
MI6_0*OI=*R$[3@J:)ZN-V#(%OVP5\7:!YQVK-VH5TC3''S?'=PW\O7/DJ#=P
M-$=JCM0Z^%0XWAH,6X6SPS#\<<0I=AR,^*O(SVL5N1R%O&\QC'N71V4&MMVN
M3)A'A4N[L+,:1LTAFD.Z3GU=@%%SB.80#:/FD,-RR'&X>(<[BGY?=#-H%<'H
M6%I+1%L78EV=DGH=IP?-F"W9",V8FC$U8[9P(S1C:L;4C-G"C=",V37&/ [?
MOG+@5Q/NG1W=._]0%/)H%14]0!1N1- S1$?C+A#*UKYIX#^O<'S#B_-9R'=W
M(VB;8O#P:]F[3#P;FE9_W"I"?EH\<W_LWZXK29KMCV M>V?[J=4;3EM%QUOG
M^K;[)9HKV[X6[:!HWM2\V<ZU:-X\$&\>1]C@<"D!'2M:IP.I[0?_?EEXT!7I
M<P?-+FT"7[.+9A?-+II=VKM+FEU:LA&:7?19\V'/FN\H9H:]GCI<QDS'V-J^
MEOU74IF:HWX'JAOIT'?72+D[%50.CZN]L_U@W--GT9KIM2YN$U,.=8*(9DJM
MB4^+Z?4AM[K&KL<K]"&WCJOJN.HQQU4UNVAVT>S2DEW2[-*2C=#LTH5=TNS2
MDHW0[*(/N=MQR"W[UU(K=WW(W=ZXE ZL/R>P;IO3Z9'?N&Z[87$2;*E#ZVUB
M>V?0&^O4%LWU6AFWBBM[TP[T[M),V35"UJJXQ4RO3[G5-=8#%O(/\1,ZXLJO
MST%\?9O_E:=9X-^^,18LN0JB\Y#[,-387L+>NR'X^;3.^?UGR;L&:3!:9G4:
M?#[UU3?@66-=&&F^ (!O,4;"%\LPON7<8)$'Y!.=EU]\O?R>&LS-@NL@NS6\
M/,%;!!A2\8,42(LB*QAIX9YA]^V^$<#3*7!\&,8WZ>NU/+)A+W:]/0^C"")<
MP^4A,JD+B_WU1?\%?9:L0I^%Y*,_:9)?7Y#T>6$$WJ\O_M.?N+;K3J=#V_4=
M9H^FW!\-9U/>M\>^[XW&3^#[0JH-@6>+$&2?_E=?*Y+>BW5<60J@#L43F\+)
MWE$,L6,I)QO1\FBSQ]ZDRB5MX=!&&H>!MSLE_N =G<6A]S0!X/(HXPE-]"E?
MS'@"(F_C3N]R]G3.$G@M!W&9A+>PAP>!0KD/=I#Y4:6TBM$>93QMC_NTK&BW
MK/@[1YW.O?.#< D#%+ K?I"YK[#SK.&Q[##3^RQ(C&L6YING/UHQ<1PGP?>G
M#X]'NW'0OT?7/ 6FE8Z+. F><7#+(O1<.GP>K#-:6@K^_N\ZV^9@/&D5_>HL
M,\V3;0)__Z=!3F]D:98\$OMEQT;*7]&^[EH/D!8(@B[#N'>)9)GV:&1:DV&K
MR$SWY-8PMH0_>LXQY&^<D%8^7%3A?RFFT"IJT=Y)2P1:%[R3L]' M*R3\$^V
MC+G.=>S23-]2\/?.]./>9- JZM41B6U$)'2S4IT8W/FU[-\"LAS3<CI@ 3V'
MO$_=]M%\W_:U[/^LM-<_A@"HKD=WJ-!/QY*#M2?8?O!U"13-+II=-+OHJ,8A
MHAIK,T1UK: 6.@O:\7E>^L?0,@==./31-0JZ1LV:,Y_3LZ9G]T^:*=?9+NI%
M\#T4#VAGI8!O8'[<R%MGAKP 9E27L8SJ8E2*UDHL:Q]>B732NV_GO^,NQ[NO
MU4H'%C@U?6M*_YW Q DW7MJ]*?@Z+ZTAK,PT$IXN.5[^Y^%MS[@'O'(O&V"2
MG?4L&.V^@)3*$R"PIH06<[@ 6J<W&N-/+^U1;]P$>Q\;VC(:8E=7";]"B@FB
M#/"=!J[8#_A,J!=5#M@LON: K"7@BT=9*GZ*,]B4YGO9' SEFS@//6,..V_,
M.(_@39<#CCUC=DNO"GHTYG$((CV%!X%*PK#QM8GBQIW3QX*"2\JY";*YL8S3
M />N"819%/F$&6$ZH+&" 6*QJI"EDE&D*5\\;RP!C;'7,]Y5U(=DE]Y+=T1Q
M=[%.%)=0$$F6( *[$"8K9D"HY UPZ8%X=7 $-"4R'LP-DAE&XQ$,%><I?(\L
M;%KCH?*%8!!S"L]77]89_(+X]:YY =2$%Z+"6 1AB%N+Z*;%YA'01'P5!?_A
MJ*L62QZEC';?C6%O$AXR7'<64Y$1B07"R?F,I<UW6 )"XXHOD#9+K!2"A"[1
M$^H !8[Q)6012J@@%5,%6!(6ER:FFR&=EY !V2<&DU2!T+/E,HE_!@N +KPU
M0$$+\MB+[)!?!K >'&KH%&5C[A,GL\3XRZ$D3%3442BI'\F+)'VMW>P]!(7;
ME/(,K+L$&'_&P_C&%$*@&#;E2Y80T8"0(7*@>C4E8R<!&"VMWJ9M5)09^98U
M<!Q[:-NVXTRGS!L-W?YHQ/JSZ63*)\=54>8NGV"+509V4DU 5+AHTFE%)$2P
MK;+^#U@Z8E<[VX[Z$9\;DG&-S*[^][DI->]\NI"H!@C2.Q]$(=LJ:M.U5C3#
MW%=P92/![G+R0]9;2?B"!=&AZC&Y,%3"W"QGX4'F#P.?&V=D<+\RSJQV99UI
M>:7EU7T*_KW:>Z3F\6C]K.G]>.A=ZV>MGT]2/Q]'LLWA>CJ+N&#T_[=WI<^.
MVT;^^U;M_\":C&N?J_0TO$11=IRJR1Q>)Y-Q:F;B5#YM020D,4.1"H_W1O[K
MMQL@J8O4.T12@ 27[=+3T00:_>L+0'>X%DITU)G 2SX3>+W':227!@5+019"
M!EA*U8]#<GE0P!1D(10P%3 5, 5<" 5,V8!Y&9%]Q^'[R]'0$JOKL S*0.8Q
M]A]>FP/;O(2+^@(OJAJCI.!PA^;55"I58B?S&'N'QFA@6\IL7+W<R3!&9394
M@6MA=VA?FOK0-F^UEY8U'(NE4%5V2Q#%)D-VRW(&YL042GY5QEEA4J3A]^^C
M#TU'(5(A4B%2%$2:X\%HHAI(*DPJ3 J#27OH2' 31&W("K$A:XV'AGW[TG*E
M"]8%T 8RC[%WM3093&2(IV5>4S5&2;%A#B<3!8UK%SL9QJC,AL*&&J,@V+@F
MLW$9X=P9]V5'^NW+D3F4+,I3B2UAA]__,92!::E;LPJ2"I+"0-(9VJHSL$*D
M0J0PB!P/+%T=DE"05) 4!I)@)"4X/JTV9)^X(7ND"EC;L;OA0N".X;L]%.QN
MXR,481>U'<]<+;&OOE6]3*7_M.7 <21P4<XDV@J3"I/G.#3F2N"C*$A*)L<*
MDLI,*DR*)<@*D\I,J@+6#V_#]]=(_FCGM_/)UC/$"#C44^9S3_<4'>=:[O1\
MUN2HJ#,\0\5LR]0'$T.LRG&M)U$OJS>]4@-*#;1]^WLDP6E'I0&4!E :H",-
M8 XF$^4%*!T@"T*4#N@@ S.1( -S'@U0EYPI7O"/L+'DUJ>G+$9#:WLOI"1A
MDUH\G-I@R])"4WO==757'WNF;9OVQ+9=P[<M:VKK[LPV3>_"FMH_>1+6T,5I
M[ M>%J\Z0>@)C?V>O4S.4)_T,\5:N6</>4-"+P\)=G+%SJWW18]+K>@WJ56]
M'[6M/HQ +5F""H<'1G&F!9$7YC[5L@756*^[;$$R()50;9Z0",@-4.%X"VT!
M9#42P2]\.@.R&3T@.WSB,ERN^O!"DJ8_O7C[^>_O/P1I]@5_5.B.F6M9QI0Z
MSLAS;.H8$\NVJ>UXGNU/+'UB/5]W&+K^W:&RV%<GHBL/8[PJ%%S8T'VX(TP;
MDU76C&A_V-%C29[%M8]M!OYCM<LC5N[=?_(@6X.(+%<T2KDN"=(T!S62Q0CP
M- \ST /I#[)A^W%P;EF=+$DR#Z);Q!V80:>0Y"^@7-\ ATFT+K6JY@P<5]=F
M>1BN8?%3?(OI7S]/4&.C/IX%*4B$ANUK-0I:UZ^:<V^F91D0T>C&!%<KBJ-;
MNER%\9K2[:4;:J]W6GOO_]K4!_@\4/D$_HMB+<ZS%'Z)VDR+BT[A<5(M(QOG
M@H:^-ETW/[1EAF^KA.+W81#1VP6S>D &*+S8419=*7#?,NB8N-.I/IG9OF^Y
M.O4M9S3Q;'AE3)[CZBL%WKT"IY>IP#\O +2W4Y)2?U>+TV_X&K1(#-JC &@*
M#IR_ UFA]7IKF.]%RV_8<>J4M^U%0KUX'@6_4[YN'DD76OK0F@<1,R"HCO%$
M#$'K AH]HTL*JAEM0;R"&(%K=I*"C(1A?)]J-^R'<9Z"F*3?UXF&W%K]>%1/
M?1_<\#&=4=.W)U/JCL<SEQ@0ZQL.J'ARK5']4S.T?=U2D>P42XMG^_2'TK0]
M'(9[])).8_ 4GZ5P/=!6-&$/^A<ZP>]VG& -O%>A%OY)1^.N^SR<4A$=JPCS
MZC0$"V2%6N5>]($25-D$%=,U2DZ5G$H@IQ(T6E#^U?/N&SAV-\<EWL1IA@F&
MA-[1**>I4!*DJJALS@:UO.XOA5IH&0X62:!<):_5H^"NX"X,W U5MU#A7>']
M>O N02D%58+M*?JCJY#I$TTI2;P%VYSW(6X*XQ5NU ZTB&9""=%%& &!QW@&
MIT0"+27SBJHQ2HH,< D5,JY=ZF088_\7XBRQ*L*J'D#";@9\)F%QYG1)DJ\T
M"Z*YA$[M%64-9!O^&:)ZE<93@%2 % B0$D2PDLN! J0@"R$#(&WGP@OF7%'D
ML D/^JM-^C.-:$)"%C40?QE$09KA5:4[*I18G:FNTK$*R.W6YNF]Q- 9YM*_
M<K0OH;7X994,NP Y5I@\I8&A8!VN%"85)@6;RQDJ<+NV!.=C.Q3NRP@@SK?U
M(-G-3Y5*$7_X#VO!L\Y(91X57$0:OH*+@HN"BX*+2J.?(XW^)<Y(*)OK>Q69
M (%OYIR?5_UG_VR)BW&H[)^H<JPP+S#FC8&A7W=V4:%>H?[:4&\.QC*<%>QY
M3Z%XP3]JM2;_06N-\,0ROYO9;;YS<C5WZE%W9E!BS!S?GGHZL::F,?-<PS),
MSR.>JN8N9#7WV656<_\G2; _1(KM'%9YXBU(2C50U4%$DC6O^RU!Q?;NFFXT
M]]?@)<Q9ZPRF$M)\"5\.?@=J032+DR5A%=+)-,XS[;YD\W:G"SQP2+_1Q M2
M1H$\T#2CJ3SZB<7FL;]2M#V[7CJ:&?J,C#QW-IKYCDW)R!WKKCT>>63D^):I
MCRZK]ODQ[T?6.HZ,Z"]IFI/(HQK6_!?*UVEZOX<*G1>QO(UE.DN3T6B?\9\M
M/2>45*C2LTJPFP3[';?%5%LE 6BT%4U*NZU$6(FP%"+\ST?XF5<LS-<H$F_B
MJF?J48N-_51;"/3.GT=H3>E<]P%15<G^^9B[B7(,X9_=)?H"5*WTLMJM)(IW
MM$I)@M):5Z^U+L'9:%S?9SL@E^'G/7PUR#*[V0C>;B"(S;-'VHTA%LK4.>Y+
M/L?=LCC;@_'8$$I\U=6*RX:DP.>:K@/RX^%(EZ#7I8+\Q4!>MN$K*WQN2%YF
M -$8S7VF> 8ISJ(XH\^()RXCINLX</L8W_' C<=MCG9C2A:W":!,91YC[UI]
M,A[8DTLX-"[PHDHXQHL.@(0!GV&XP_%(@CCG@B1;C5$6=%RI:9+8AVV,'7;]
M6O.I8>1EQ X"[ >9;AE76)+%%2H3)>SPSW"[?2+#[7;))4%!\DK"(1D@K_:#
M%.25%18*DLH*[\WI,@,(M1\DPGZ0J;/ S=5N;,D"-P&TJ<QC[%^MF\[ M2ZA
M9*# JRKA&"\Z!!(&?9+$.1<DUVJ,LF#C6BV3Q$[LPQM"W+$UG]IS_#*BA_/M
M"-4$%B/) @N5BQ)V^/V;!MT9.*X$CI/DLJ! >24!D0R@GPRML02-317D+P;R
ML@U?V>'S@_(R@XA'G/0;77%@UW'T]IY.DQSK99N,R<9$NW$DB]X$4*@RC['_
MVY^C@:,RTTKPKBD($@9\XZ'ACH5BC<*>&J,8V+A2PR2Q"]L8.VS<6GY-R+[*
MV.%\FT*O5TD0:E5(,98LI%")*&&'W[]5T-V!/9+ 9Y)<%A0HKR06D@'THZ%A
M2^ )*LA?#.1E&[ZRP^<'Y64&$(U!W:]>%N-^T/B*0[I^XS97LKA- %4J\QC[
MU^F3@6Y(</!&YD65<(P7'?X( SYG.-*?>J9"8>_2L2?D&)5A4EM!SXT:N$MK
M77',<+YMH+_D$:VB">SERMYPRO!B(EEXH=)1P@[_##5K;,<>.(X$1D)R:5"P
MO)+(2 ;82U)504'^8B OV_"5)18!EI<95#0&>9M XTICO#X#N1M#ERQP$T"3
MRCS&WE6Z.QZX,MS]E'E1)1SC14<_PH!/DF((%R37:HRR8.-*#9/$[JL*&82*
MX#:L-\PJG'ARQ6^5?5+9)T$L@FTX \=1QY(5*-4NT-6 WAGJ:A=(05[987$@
MJ>SPE400C0%=U9J41Q97&M7U$KKI5>AF2A:Z":!-91YC_Q>Q]8$4KI;,BRKA
M&"\Z A(&?)(<=KL@N59CE 4;5VJ8)/9?C^\$<9_V2H.&\VT%587Z"O[K$%-8
MDL44*@TE[/![-PO68.RX RG<)LFE0<'R2L(A&6"/7U.05Y!7EE@82-H#R[:4
M)=Z=TV5&$@^7 2^BBZ<>:[Z,Z.X,(9PM60@G@$Z5>8S]AUF6<Y7I-R5Y5QP(
M"8,^8SARGFQ+%?@N'7Q"CE&9)K4SI.('^6*Z8F<N7/-R<2RJ&$D65:ATE+##
M[]TLF /;F0P,:R*4"*LL\67#\J+C(1E@;PS'CE!,4XB_;,3+-GQEB$6 Y67&
M$$=._$%<85YQ2-=OW.9(%K<)H$EE'F/_*GWB#,R)!'<_95Y5-499T3$TQZZA
MP''M@B?#&)7I4+LURJN7*LC:K;U@54[_6#*G7^6(A!W^&<X.&ZX]<"U3*!%6
MJ5L%2Y&&?X;-%.NI]W,5(A4B)5T(&1"I#.75^/G'RR>XS.]_ZE;W981=&Y[_
MJ*V([P?1_)9_]H-FKK[U%7"YT@5<C<PZ0>].X\2G2442#9,^T/#?[Y&^EL9A
MX/^HR9!F._M4SG!VVAZ,W4O(QG4CW-*B4@W\2>#JSXX8P_'$E,![N[CE5V90
MFJDH,WA.5%Z:^Z[BJ)/"VL,ULCLRC7L2*@H0GX$YX%!/2;L]7?T'G?V# ]#\
M.)^&M T]?=:\GJ@S[#\9;P],>S(86990\&@]]W=$X<CF6/:G!\X+<E&7K&58
MBSI-!4$1("BJH5*F6)GB\^F!*PIB&@/-9P<V=6%F\8)_1 !T6Y\VCOZA@7LA
M)0GCZ8*/& A-$^W5'NV]H;,EQB' 9$.49P\X_-,+_07[N^ X^YMK#O:2L>>G
M%PRGSY#]$M@C6--RO;D>VF5_2&?9BSK&5;)YQD"]%,RAZWYW*-E9O.I$:]T\
MO^WOLY?)&1IF/U/<7?Y_YVD6S-;L(9_H*J$IP#'5[DF2$'PQBQ,-9#*(L-A,
MNB#P!2U(TYQ)<[Z*(XU$&OU&$R](J;9* H]J\4Q[.1Z.M!5-^$\&J'&]A79/
M$ZK-D3#U-?CI9J_88'V[1C!?[:\)C5/M#5D%&0FUW[2;=]^ 4/:]]AY4E_8A
M6(+N]@<P*/[-@19$>]S10."CB'I9 ,^X#[*%1K0PAG$NB4^UZ;IX!#PK3V'X
MO@9#U+P\26#JX;J<#9OA30 4%C&\@N?!ZQ7!D>11%H1:MJ ::(,P@ G E&^"
M[[<F5)3EP9_=!/!)L%Q2/R 9A0< E^!M>#Q2@*&F^7))V&"!#-&6-)G39, ^
MP0PR^XA-&(:=S$D4_%Y]&R; )A@G!SP(HBQFO\*GI(1/(83UB5*V1"0,\9TT
MGZ89K$@ ?Z_9F_A]DJ845C].RC7GST**)%IKH/Y@DL"N(%OCEV"!4C9&]GZV
M %X3QK=P?1O?1[#:^)@ & !2Q$@-@,U>F*/B8Q0SD(J4\"5C/$=YP9&\B9=@
M_]?<-+BF,?XQY6,"ZJ JTQUN'C!AF^Q] )/#7VG+&!:<C7*D?X?CP0?=Q1D?
MC*]18'V\##SN)*7E-](\N0ON\$O%S,DLHYR_6\\9:A_CB!:_ 5974%H07YM2
MNH$+"!ZCO0<#4Q^>R_P]2GW4V<#V#5[@__3B=SJR=<NWJ*]/+7OJCEUJ3&:.
M2\=D[/IT.GZ^731T72##>)*76\QH=,Q\=.:%%@^W^S3/SV_M^&SS;(AHF]$.
M<R6"9JG44G4*<P::.+Z_939C!@\"%09*]F-\Q_4.F%YGJ+W.N":&\0P8I6E,
M$A_)^D$"UC0&9;LD:[!"?NY1;OX.##^^6PT0E#)2)$N(.C*F66<UA@J_ @8D
MB-FS\/%:D&D^I4NPSJM5$@-Q,)QM*$4%W+,"]_G]DRX"N%Z\7*(?4L%C03+N
M$]<C^:4[U+4E>"WHO?@)N??!EP+GTR^<C@_HT[Z>)X 4H%_X3+''/-E=_]ID
MN[<(\L^4 @CC+(HSJAG,O:_\W2!$IP9<FF6JP"8]V)Y?Z?XJP?8\L^F"V60^
M_&>ZRK9#/V,RV+&#JSSQ%@0L)89&<\#LG"  !\[(&(RL\7Z,?6 D#X.'/H*$
M,R6M=ISS[6-5AQYZ33BBW'6Q%-'SB^->AR(J$D',KM\G089)#<)^MZ)1RE,]
M,Y['"1(MP604:*%3=)8R[K)CZOF%RRX"4P^"B247T^ .(M.0>-P_)G/V_QID
M!4#I>;BJZK"CQ5>XDAY7SZ\-<OFX\F"0),#T//PVRQ$])*P<6S!: 6;]5TEP
MAZ[M!G='0 5N<)""P8,'\!S3!ES@4Q_L.T&T"^1#!;;+ -OS[X5>/M@0,6V9
MK@UHC@!.X4EZ/$T4GIYHO(+HCJ9L8X/9KH+"9EN#5,E5@!N[!C/BR1VVF<'>
M<,IL#PQCA6<.[FBX5F"2'DR&KM#4BW5B*&*8.@(_A)L71\4AG1HG$]S%<L0*
M?/*#[PPG\*0!WZFF+(@VF%-8D1\KZCA,WX;J2-I"&:KK M^5'VGI.V$X!1NG
MT1E EAW+/9HKW,K-MW.D5F'MO%B[\A,MO1FZ'>#40T[!27XX7?FYC*Y,5YPG
M3]_7XATB &X*5]+C2IW-Z"L>*S"C=K4N&D_J3$9G=JHN/7'43FUN%"A;=0G8
M4D<P^K%5.[@YA-VNF=IB_!9DPNTS^G]\E:>W<T)6/WS.8N]K<1?ZW7_R(%M_
MC#/Z-DB],$[SA'X!+OPYA._\Z;__"WGZQ_*'OVY=)7^S?=7\=>3_G3.(_?GK
M[#UH@<@+2/@9WF'C36OH8]H36?Z)SGYZ\3Z)ESC56]V ?[.8O3;,6\MX\:>3
MQ18)X*^V*=S>4[QS@/< 0I]]Z^.O7]YMT&K\<,LXB-_=P_'15]KC'O;SNX_O
M/KW^L/N(0V2=/O5C%5(8,A]U8\,+29K^].+MY[^__P">TQ?\47'E>FQY^FPR
M);H]F=B>:Q-K;'JV-1Z[/J&>.SOU5D?-!8Z=2]BBUR(QQJNLJ?1+IXK3F*RR
M9LU)AAT]EN197/O89@7[6"W^B)7[1/])PJ_P\32&YZ?:A\P?:C>E:C7U'S]]
M^E#]9?PX8/LO63RGK! %*XV!ZKFJ/A$@>5326R3V]#60^1X, [H[7IRLXH1@
MM9+-K<N0W%<5(9A"Q#]^21-"P_*4T :E)KL,IAO%OM 2E*>'=S-7-&'*-<6?
M8.&*ZA<I66[]Y;=T\7E+0[1<#6))DGD0W2*4P7,:.J,2'IUK*L\T?3HCEF-,
M;'MJ&.Z4.+Y!#7.FS\:VHRM-):2FFEZHIOKT08.82\ONXZ+RC;97^09TSP]8
M)6B#C'WM]DOD[6NW7W;4T@,JZ2V%5UC,*-[L?FVY0/SLHLET$18E:A[(SW_[
M\__NC^3GG9'<@.>[I G,\G4RC[6_41^9KGVAWB("E,QALMK/R^G_'AWS'OLU
MG,//-%FR$D.@2DFT-P.;S< 262-N(Z[X?1A$]'91N(Q(X45[!>..Z$?+LL?.
MU"&^J4]LW[6(#2Z=8=K4GQG3*:%*/PJI'[W+U(]?-I$QQ-B:3U-X&DCQ %[>
MT3!>L=>5FY1@O!G\CIFHA&NEC1J@W^+T*PUIAOX3B]P)WLT#30.#"_R<A$55
MM&5<U+0(X+E!PB)7+%?&RY0M"YT%<:L?<&>,E3XKZV#$&A9&\]F8[E$]QN"[
M:61.@FBH;4\'U7XQ"<J_'J0L&@ZB'"9PH.4P;[<U1UY*AZO@ 2^G5\VOX!/U
M>:9A?X(KDI!52.<!X7S(4TS395C9(*.LREX6A-DMQ/(I7B NE?.:5[V+8$:W
MO,@/)C5R+&:&'RQCEMO@OV+5"_P$KU+"^W$"X_4![O."\ZOX'EF)UXLQC\'X
M4EB3=)UF='DP>RQK!YHJY<7N0M2*VCV%B:"ZFR;$PT)K*S 8$'+G05G6)(#9
MS-&&I'P8J08/1[[].X:/4CQ^[RW %:6<#,E@,LS9QWH+24)8V;ER1FSVU9QO
MIP1KL>&")7%8#)O5;&!S^QI1RGZQ"%9;$WWM<Z$!T5L/MO,^NZ)06YZP.DDV
M0!%+LB*76R,3GS,L5<?OGC(L4(\&*W:*[%V>P$-@>O^(<+7>O$-7_"L;*;R#
M-%ETDFKOXYA+Y=LDG\.XET$$_.?QQXZ-?__V];:-+Q>3CP%$FG".8/5%MFP\
M"Z*E\0S/F<:W;+EPH<#(<X$%>2RS8@E=<&21HG;A 5<.I#MD_ ^#Y53S-_5I
M_)QR;";Q5[H+1&0 EBW$R:9H.#D6DMC//7C!]X9"!NVMA#G__O;361"Y2.)\
MCC4(@\2_Q4HA:QQ%E@33'.5O]\G'GK9* AA8 *^ %:5[PQ]Q6+!P9^FX/MS\
MOAS3]CA8*I_K,S[[(;B1;"3%5ECQ]JZ,HLJB*;H80;J YR7@.3)>@) 7W-];
M,%ZFM^0-8!04-E.>"?+NWWFR9@*<P_C7@X*C;!C(V,:!;"=)#WBQ,\TEJ%VV
MU<&K*NX,>*B!HURS^M5:X(\Y__'9.SS&W_[,OM^8O*TAL[V,'(@B^Z2U!KYX
M$Y:'(JE;RT&O9"><Q[>8\=9J7*26TYL-8ZP?S]N<[5$Q.<1BG;[VGQSU*"O$
MBKGF 9@4$'(P6C,44V:T,#)+*9K,;.LX/+=OI:3!!Y5>+]==0_\]K81G^'E8
MB-JP6KAM5<#*C$[+^GAE&8(M62Z31Q@S?8ES,&Y?V-NE;=&F03RCU,>"W84U
M2FM%EWLF^#A06C&?;O4<Q&Q1OK0H'J+][5^_?OC71^UOZ_C-V@,K^?[=9\W#
M5XP';&+[H(>I8SS(U!"K\0ILP5JR::F+*A94O'F++,[*L\Z_45@5 CKV]6P&
M+EBZ8W!^V[$WVB).6=%?KEL!Y!&(2@4^-E%PY!)@4[%YR9>GVK)$&UH.&+Z/
MD&9%GK* ;_: 5BO8^-MK_ 1>K5G=(,ZZ-%@&(4D*&@$Z#CAM_G-\VBR B=?A
M7-8,FN_Z^LCV3-W%#-K$G9#IA'I3XHZG4SH:.2I"%#)"]"\_0O3I"KQ(EAW'
M8LK,-R?,AXCR&;S($ZR0_9E$X,P2,.$T!+QZE&?3P56]@U^C2B5?:;KC^-SE
M841YK,$\_#0-&(@((BA;L^@$'H4Q!8,_+W:ZB0Y ^20L<H!AX7[P'0&=P3U3
MC&1#T/5X8,(#IRH/<7Z;$:.*6@<T]!GEFK@H;>=*R.5GMD!+&1-OXCO6R+*G
MNDYT:HW=\0ALBF<34^U1BJFWZ.7JK?LX"7T8#<9%"26LDO&;7W_[Y>VM,6'!
M5D+3/$37C1W(FH?Q%#RIJLY\"J$N*^Y:)(_H-RPE4*8%6"*)%GYJDL.@YA25
M&+B9X%R";YIN;RANFA/ MRE):9F- J5&?72M@I0-"4M*$O"QY@2+%K <F9<5
M^Y&EOOR?M'#WN"[$.=1F[;>>[W--Q[WP,EHLU2^?6)$[PN0..G7;,RR'@[T(
MP*_S,KY_NS^&W6<.@!'9SG-PRE5#ASRJ]'V".3_^U=3#G@A($T9<)B6*@3%6
ME*4]&2N+?5[6^@(,31T/>& Z*P_+8&JG."TSV!];%(/IX#LU,U;_&DM'!#.0
M!'K''&>P,4'BY4O,0+):VW@\*<Y#9,!_<HBG,:^5KZIAH;7R/"RSS=H3@)PO
M680 A/Z=^_,J\YG0NR"MIHIV+TG6^),[$N8;4E7W!S"KS+@%-.62<QBDHX./
M5IAQ$.N#>PL2S;&%!//?V8127I:8)]XV 580X2X2_R5P)9Z6,OH:["5\7BZV
MQV;N!^CH:[,D7C+_?S-+)%M-<U D-X&I&%OQ7^&V.Z]>#I$9_BC!%0*)0$)U
M2R:^(=Z)#BHEW]5>NTTGIF]:KD$MVS#LB>L9_L2>S,;NE-CZR8T8E,7MQ.+.
M+M/B'BBAT]&T3[$%FN^+M,LL!QNWI@0;YF!B?*O=BS9@YT%WK$-4U&\G6PV
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M@?IHAL=P"6$E>#8: W^XJP_XOBE^&55!N;!;<56Y^<>>"<Q>L-WEG>T*?JL
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ML[J8H=K!-<0Q4'6.^F9'?-8PSKUW/\ ?\,D?7^$(@A_P__#G_P-02P,$%
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M7,09+2@7<SP3.1?D-XZ9^3OD*^*RV;VZ6'29B'OWI,=Q2Y=O5NI1A^B&G=C
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M!.('_(+VTC.16C(2&9D)\X$3Y][?D^=\%TWE4F*,E^^IYKQ*C,U" HDYEJ@
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MLAHO#JG8/+7+'=ZP7 '>U11Y"9R_35\NT2R,T-:-$]8+C*)P?=.9#1)+EQZ
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MIF]#EN@J=<N21I*[IN^+@A8AF5,4H0%)V]I??P!)R9+(!$ *)$"7-C9Z7#8
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M89)K@F+3L;"#N]A^1,'KI6VOWS#WX@WRPF#[F]CA>/WV(KV2]^_IKV<[PJD
M48_^N(/+L^^0%W][EC;.:_O& -+C/!@)LM-VQR0_*U&;;(E/[:_D(I<8_5_F
MV ^IVEE>_#6Z<*#E?O+U@N"54)ZI[#"7@WT!4T)>M3"A2OKKJXNWS[1X.$#.
MKZ]"$N6PK .E9 IU\&J-_?B\XLF5T;7\;DHQS'5719@=0@'@Q>,Y!SZM0!W1
MVDV=8 @@H+E28+(NN0@5KL"Q# ,0.)=O&X_.["*'!U4 ;=W34VWAJ0C&3$(@
MOM,+(CNMQ?XDQ//O-^F^#0(PTW2F'+O##22 "W^68#'-9AJ[MN/$<K.]D>TZ
M/;]CK]W0]D2H<+M5,+V40R1F ,1++V!C%A+SD6/9Q'?]92!"*K_]+,^*&P81
MAW)P;=*+33SC<S=*>7[=<=O9!SV8%/"^<TDVT[ EJ5?#*(S+!5']X4!QW-1\
M)'(I!F>%YA7FGU$09V9-,6!U=\>8UF*!YN$UE4O,X95-MV[,6%#?*@ZA[-T"
MS5N3E'[(>"6H@E_07S1$A0*0U9BONV.^QHC:J< -T021!W>.1HBXV!FC.5XF
M,,;EL&1TJIHO-TC)*A0 I'7O]:_FO2"(D-.-"$N_CSF(R<Z?18+5OM!8QFM&
M298@K#^8B'6RSBH"FS=84]$6\@3!_;$DW-F< ?8;[EQEOV:'2\/%85I^SV<W
M/P*6*+Y+NZ3KX'"Q[;!-6LI!FGVTTF^:JQ#UL [IS:=:]":EN%[%4?311FJ.
M2MXAU?G9>!\VOB!WFC,:#V&N"I3B! +T<WUKR  ]QG\)IH^XQ'*PW]U<< IS
MP3M^K<U*EX<FV[^1V !L&!J_YBF8P/X)NYH+7R$.0.3T!O*XZE<.NKV^3<7N
MF 40O+(A-)Y-W"?DT&5J^]M;R4&L7?DWDWO^-?8\_#CT1]&=Y\Z'BP5B(PI,
M:86?-5<-:N,>U*"RX;"3-2CY1?TJ5/*[+T6'3F$?5"*]<389QS]E/S&UI^V&
M#H8R5RU.X@A$6G&(S7I"9.Y2/5R,"+J.6$KQ@;$#9KNHF[FH2%,/(J X6,4A
MYK#:M3P$2;_&8K!'/@A"V; / $(G6D6>';H/*#E3G>+8H&>BW^RLM>W@-?MY
MN*"[L^<R3I/X 2.29]O8)Q1^P6Q@53,*JH#B0%&6;DI0\CNZ-Z#2G;NA2OA+
MC=XTZ,LS"::]U!.%2C;O!\[9!<_SE1O!;/B*,@)"5#865290>!)&N4,T$B28
M$Q"ELG&GDR?2R?.HD0A!?(#X5!%:DE.<TR=1(Q$"&0$A4AR[.?")%P<^\7$0
M2F93P!_!;(B*,@)"5#8R4GRWEHGQ%-^X989H$$@RG( H&9$X-$9+-P@1H9U<
M0MW7ZM.&I+YHM@Y4S3BH,F;D#%6@,TH^V4BE4<<YJ#6*XT85:G^9[>:IGVRD
MUJCC'-2:>G*2E*A_J1WP#ZDW"EF'%*?TA6REYB8F//7&MBY;I6Z-S <;J3*J
M^ ;UI<[(69T*H^*+C=0898R#*E-C&&]$W <JBY%GSP_>72U@-(Z':"2H,"<@
M2G4&\TZ#*7^,1N+$804$2N_M1&H.DMN]?1QPRD<=-#,7&I!:4/I[T;J_O3EB
MA'[FN\[R>!(%##^>7"LO4]?0@-)F&7S/M?/.M?-4H!3=!:[C,F_(]JAO%%MQ
M0=T\N(OA-?-$O!I7:>69S(&]HC].J8L:V/&S(*+R;#)]-572$\* "W,"1HWT
M5F.K%D"CB^TI![F:JGN ;W^%@G";^ W6 6,MLPTU5=$K,$NPB'S5UA 0\G%P
M3TK@_$ZZ"N25D[X$+R 4>E>FX_V<J%9>?GM=M?**HR5F UR!%$^:HS@5=Z[D
MMM6V52TU16 6((%_4"SPI$!"_'#!MD("5^A@^]G')@F>SP8D_(^*A=\.5UNC
MF+Z#QY4]U'SVJ4FBYW(!2?Z38LDGE]]BTJ769;#][.<FR9[/!B3\GW67&I8H
M)?<<GMV>;71P$'+V^:>,2GT7PP.BIW,'*<-;'?%3Z(V4CAW<7WOX$7@BY9/\
M$RF=]N1KZ[H__%;+LS6Y/$A$?W\NP] YX'L.^)X#ON> [SG@>P[XF@S@.>!K
M9,"W43%'@'[E<4;)F&^A6&_3HH8"'I2'#(V*[38FS"AFHWFAQD;%N_ALU!7P
M4A5J;%2XB\N%\FA794<:GYLD<Y@%2."?-2\(]B:-Q.P"8A+A0UZOV86N-5QV
MBR^F7B+\IV1-.$I$'RZV$S:M:K=BE5N@!4*JL\%H%&5"];8> *6/_>44D54?
MVWX'T^6+L#T4%PI>%\,!$),.>K(Z0N%?D(\(%!_^S-Z1=P,6CHL(HO_X8@VL
M<;M?54Q[XBY]=^'.J<%_+K(TPIX[=U%^3/[B[3&)D]Z70>^ZUVD/IJUVIS.\
M'4Q[@R^MT;#?Z_2LRL+Q(X+6MNMLIUW;=^):O)V(L%AY.PA0"'!P<<S!:&R-
MVKUNR_K'R!I,K$FK/>BVAM.OUKC5N1V/+<;89&)-*^.%N9@^G=V@T"^/2>X-
M_J!D#<>5"ABO$0DW5+(LNWV=/KZ03^"[K$S9H_73/V-9LL3U$3O9^*_6P)I6
M13 S #L7_9L;WO].$&:*,49Q>;'4LYGB_,JJ^8R]/V:L/VP/6NTO8RL^JFE]
MZTV_MGX?6\-$:\96/S[+^=8>C]F$F Y;H]MQYVM[8K6&XVYOT![_F:3V5WA.
MM5JYR=$AY9U:1#:G8R-JW[D>_0#$ZH=C5CO#FYO>-#F18LQUAO'49FSW>^VK
M7K\WK5#_LM<K\LG^F#%(T,V)JB@=HP#1=>6^@SVZK&(2%R_<:2(%H>_.F9':
M_2J?D4_'C% EL=I4>:C@^_WVU7#<GO:&^\K'0*%6EAFMY]]69@_LS?P>S;]3
MNQ"B>!.1[LG8O,OGZ.>,56C_V?EJ=7YGYF%J=6)VZ(]?QNV;>&)59V#3]Q A
MW<\LO+T!U7ZK-6W_HSH-OZ;6QY^[MK==Q"#S>IE9=*^I)1ET>NW^;M&JU+1^
M00SI];T[[_D+3%:)AOO.C?U/3)?<(*32)?3?5".<:!YV[=#.9R2S]GZQ&/JC
MK[T.%?GU<'R3ZCC5[)OV;T.V D^F%(EQ_"NJ*]W;SK35;4_;E=F=Z"Y _XKH
M-+78JIRO,)>9%7ER>S6A9H9-2XNMS=7919[/QO7=+C.KM,!W:_UE.]Y_:N$F
M/CT%>,DLS$)>DM$JXT3&(>4QE%E^I=W2REG;\T]Y'&16XCTOM0;QY[JK/'HS
M"R['::V<?@FWC<=+9JF5<]XJ9ROKQ?&XR"S#G%NPE>O\SF7@4/PNLS+O.PZ5
M$YGG0?"HS2R_@!]1.>$E' H>7YG5N+Q;40/K<0"HBT+;]0!^,@MU&@=J_27M
M=DX"/"<!ON@DP#T/?$J_)TX!S.U@?@(@AT_CTO^RY J3QN N^I+]>"(7 F1Z
MAI]"C$S/YU. 8S5)?)5 *<ISRFVN+1E-.'&X &FXN)IZ95.JA)'MM>^"D-AS
MZ+0TO_'LO<G'I!R:(1GKU?\Q\W1]Y%@V\>E6.,@^% -/!G'?VL&2PP"78<-,
M=X%N1=G5*+J#>W#IWNAJ<TN]RYX_I$Z4';_H/@_=AX/CJ-PJ9I)C- +/@NR
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M#)?].M+0@ZTD C3_:8D?WCC(3="C/QR#1G\UZZ.E[5GQJ_1 /@%ME6FD+9.
M+V ,4US%R4!A82<$@2?5M,EABYK3!#ARPP"%E>0$5"Q7(P_]"\N^UA/^7D!L
MY/5\'S_$US/;47B/Z;YTPSWQ%_2J.Y4;4EY<B&+5AH0K\=O)55KDWJ94.1'U
M=%W;&Z, T4_?4Z^IBQZ0A^-KB]<X\AWQP[FG#UQ[C11IX$[F2L;S5U)ZG'@L
M"X$LN5 =M9I],D_N>22"4<KZ<R;'K"XRG">Y]V>S/9I#6FLY(I>7+ZC#6ZJW
M#>K/>LP*#>>35HD?4[U,C71EY.5N]"6U;0IF&IF-@T?\"U*<+F:;%S']($@F
MG"_$=(JNX^2UU7-)2BSFW*.!'"Z-NR5U&B!&6C-EH)EL[#K8?T D=*EM&-%A
M$2'(B4D7E[WD=M1UQ8HS93+O6 OI!^>:WI3$2707N([+LI5M5F599H&"NS1C
M@1*QK"Z131%&SV2R&VC#Q938?F#/X])7 OLHTU?3 B:$ 1?FQ- %K5H C5[P
ME(-L\@+8&PU%2]VNB:Z*F@6F$>90#EI*Q3$NX'B7/8VS=\)[]$H.$ DK-=;L
M0I/W(7UJ>")K$)*:Z^5O[U+=>>X2>N%M>RDDT[9^T-2 @*7XJNGPX/!UL.#&
M?G)7T6J$?-N+\X'M#7.RAKYE$V\S1AYK-5SL;LH!D_#$41N.K#()U!*]/>F.
M6O+&)&5HC.;(?<B]:9%SJRO3K>&(R[.H.CH&G1KE'F3EO=X*'2A)#]!PZ,HP
M:^8.<I3FF%YCLE,^SG3,:=UP*(6<0;@IOIN4KT[)Y>.M->CYE%&Z:XI7">P/
M%[GAI3C=M- ,+?V5AF-?F40@G=%[O0D,1B:D)YG+MVOL)PV!ZVZBR"8\6,.U
MY53&(:4H>[N*_^S\-:(.(^^*\M[+[(=M&PZ3@"\(!<TWF7:ZLCU5D'F'FM>K
MX2A*<PCA6?9V$AAM.KX^L$F+O$QQXN5Q-C.)9&0':#AR99@%XQ:J*TGMC,%P
M$=.Q)6.[OC,"NXA=<79]M&=% %!+C_<",#Z1=Q!RO;5T4CK3J]&PZ3ULUW X
M.3R!,"FN2/8ELID.8?(<T@PZV&,V@]C>R$/.$C2M4GT;#E%!/D'8=-?4V:W>
MPT4?!0$F+-1)9=)F5X^7R5ML1V%0>!*6&J[ABG ZZZ!NZ(U$Q:=:<D7+,DU?
M!J8 6R!>92-0BO ZU*UQ7.0E7CFXSY%QN[T0',4L@ICN18CJNP(>1R[8BYAT
MJ\6>*0LWO!O?']X>WXB.']GZ.NQWK?'D/^PU#OX:OT\V_;/Z2]X@Z1?YM%\4
MI[UUH?/J=LS@%=4CASV=394HN3CV;.2O-L]-TBAV^]$F3E]\QUO%V#J3I^;W
MR(GBI!41(P'$B> "N<)/&'/I7)U&':=HJ<:CCAOM"IYUC>G>B%Y4.VJF+2%6
M/4J8QZ?JE)2:K"K(^C-[OL,>(95YJJ6:K^E)SLV'%]? +YC8HCF%M_&J9'*:
ML"YUJ[7\@;5:>WB#4'S",5RG[U6/$;M?/@_3X\5;BD8P#B+NE>X2(VEZ\:Y2
M&X%/EHCJ90MZ_JBL+Y9P$J3O2H>;YRIE2:6QZ;WMIVT&[ PMH*P.HS (;=^A
M.],Q]KQK3&)Q\E.C#:)0UVTO]0ZSB8*%-%ZQK8MYNA.S?7<"VWO<)H5.>;I=
M-RVU:['!RG8\';1@T= ="H08A2%A-R..^)26EVU=W3?/2@\%BRN6.;AI:J9R
M"_'X(P:CYR>E5RM0]8(4G!5?N>*700#<R35S&L!SGXI_@=PPRD\!K\[F['WW
MK/(UVOICN4.*KOC!'5WB_H9897KDM!\0L9?HH("]^7O:@M2?][NZA [-HK+W
M-PKMA9-[!&EIT/]!SJU/O[T7O@I8T"LXY(/)<(_G B+CB:?0MMD<LG^H!>@$
M]1;NO@V#%)J5BB_0E(I,'P644Y;2G=C6%2T[UVHGYCR#RLT@/4!!\Z+LE:;J
MY\7#P0Y-[[20I^4\*W3.BH(X09-"\;TPA0RF6SE3YD4A<LY30^?4* X5+[_.
MH/SCR_PDWLL22;R7YB7QBMQKP+O.[+)E WRG?\_@9%\IYJXV6?9.S  ^];N&
MIP6KTM&"J<)JT#SG#VO('U8$W3FI^)Q4?$XJ;JXJG9.*ZTHJ5J-Q.7FRHHK%
M8)<7G%(LPWJ35J?2J[7@)8 J/O9CN3P5XM6,=+"26X]RB]V)']/T4$*%*J),
M&44(-<3W:HXVFNQY-5ICZ[T3ECU5]^%G^^*;3G /HQPR-58#2S.N>LV3!FSZ
MB L"MNM1^QNXNA$[Y!STH*O'C+8O.LWV^IB5LE<';D>\@Y.M<N2N<40* O?<
M999GOE\R;D>L@ZM:];"Y#T7GVW,7;4\E:8/MD'4(MO>5PU80LJUM_]',XS[?
M\**F&*U>G++ _/ T/^" +JB6K:#7[.+#"\ ./)>4E@"$HHE[5A67J78),.!-
MZLKO<QV1\,(U48\X7US,.D?B^!&15/8KEU.BLLJO_LC*JU*"/T @^W:]UJ"O
M1U\]ZZL:"8(;K)>CK\ER,EQD;__4I+HP 6<M5BY,<.NI7Z$+WV.3OL9VE%<]
M1DP'Z)]9S6B6ZAW9'JO=?2E0>/T$_D 3PA1A0Q-&;Q7W2FQ&^I?XL5HM*T"6
M@!](X>L2)J30>A\Y5#KGLZP;M@*4)_ 'FA"F"!N:,'OWUPVX<_4N_\[5NQ)W
MKM[IO'/5\>P@&"Z^V2QD%@[)F$&5T9><1Q4%_72^$IE'FN#^$J^/,7>/Y+ Z
M?AM2*(UFW/_)Y8.?7LOIHBU)5@(."?Q,OM^32[ HP8_;24_:J%CP$D 9GL2I
M&BN3DRH5XEEKBF-*0##%HXC,[ZF7-B1T>VV3Y&0K?4I[Z'?1/'8IIX]X>H^C
M@&["K]U%B!!\0X6-KVIX3<F3,K,.5\.M:O-[(OX#_'!,\L1]4H:_:'A=N9@5
M*8 4NZ &:%*!'*U5J0*BX76E==9G [+L@@N[=BM U\+-'NE6O =7;@RX7]&5
M+UJY31!S#7H'INJ%Z-Z$^@_I2DO5I1V'C(,G@YH4Y!K=D8C^-B&?9=#NL3!P
M?:3,>!3XTDQ3]+4B%2G*.7@8IDE'VFOB>E6JAO@#LX\O2B,D&08/D0Q4!%4+
MB=0W9I]^&'4XY!D\)=&D$;]%?GSMHAT[R579!\FOS'Y^45I1A&M(+W[6K!=5
M:P0LE<\O4A?X_$):\%FC%E"GQT/5*H+H$[.+MR].&>1XAD_Z=&H$\BO5!L[P
MLXN7%:Z4XQ>.5^K>=!Z0GFR/U.XUP0]HNVU9]1Y3P#&H"[HBESS"5>TII+XQ
MNWA98<L"3(-*H2ML^5OD;0Y]7H7&@3_X[.)EQ2=EN 7QUQ65A(A691"$XVM+
M *U9"XX8!A5!5^AQ=QC'*JE48PYD/C&[>%GQ1WF>08W0%8/DDZ[*0$A^97;Q
ML@*1A=@&5:-T,++"[+:]"TH%4]SV>L[>F11A[)=) <YP Z%H8(;BP:6#W1^#
M]*_!14%@1<.] +3E6 0GLEH+SZ,02--G_43=&@*3/"M@;E$U"Z[UM';#^.9/
MUPXA$/(;-TCT/ ; I!VCKAZ]WQ%Z</7H?8FK1^]U7CW:58='Y(%:):"4CQ=3
M0'\:+L9HCI<^NXJ6O-_5P4$89,#F5.!7]2$C'GA2PY7TNTY*/V?,E:J*=!!\
MQZD"T)IQ?:OG4\.&)M3BQLCT4P;Y%[BXG0QXYZ *-+&\!%2[:Y4B+;I5).BF
MYPZ8C/BE #/\'E@5F)E\%TPQKB:_6,1,S' QL3T4B%XJRC35=*=+;@YA,>UF
M&L@Q"A"EYK[M.UWT@#R\9ES2_0A5;CAHF?:6Z*SK)E89V&39@3,7]'KCR*-C
M+BGU-S;YCD+ZLR2.HIZZ[E*5 5&*%W#ETXO@%^0C8GN4]K:SHL)ECU&'[@.2
MA%&JNZYK4&6PE&<(7._T IJZV\C)]\93/F!$Y?IK.P>L9\-:1 @2YP8&!,VF
M=)C(]O)#9Q]*A,[2 <UX+_T+QDY Y^P ^^A008(IL2EJ\U2T\D^B%Q[2B*!8
M4?I+/&M>:&!C ETGZXK$T^0E1%YU\ HX\F@O"8H%!\2?6*.C-@:$FTZ3- 99
MJ^G8;_=5,*QP0)NFR \LGSP!5A;742E#(R,Q9>1<:]V="9I'A H(!=M4F1TU
M<"2%]11WK'V'SM-97)ARY9MQZ#VEV(&SGB@E_A*-"%X2>\5_4@GN,;NL.YU7
M4NA"FD';4CHI5U4<RV-;A)%-PLW>JA-<;?;_PC_A*3+&2UF!2[ .JH Q"B Z
M*LAKJ^=,IX3<8> ,/]<Y#2$C_8;J4*S5NYBZJT?D>1U,UIC8R8YKY5*"N.N;
MH)>F\QK.A,"%:*]I(_([03CHV"S_R^.*.]MP]DY3GK><C"&"0:TV,4.[>45]
MJW$02E3^U?M.TKGR[[GRKXF^PLNN_*O@FM,+K. J$Z[0_ IB=!>XCLOHMN.E
M@[VLP5_[.%U>V-HG%(YQ3ZH]DSFP5_3'/49%9E6FKYZ54 P#+LR)H0MBM0":
MO#RJ!]GD?,@1<1_H3FKDV?-8/J(,G_SVNBK,%9A@6)8-""C5)>/:X6JX6"#B
M^DN96#[47%MYEN*R%[,!^B:J"ZYT\&J%_5LJ(K8PCPBZCEA23?P++@SBCK/W
MFJJJE0-$EB'0SU!=,FV/(%DDMG1J\MA/%OP^_:"<51\G%E#Z?*W0E));3MHP
M"Z# 55?^XLVTB])&YV++BZ;R3.JMS@%'(#JJ2S!ECOB_N>%]!Y&0<M#S@] -
M(\:2[?7\!Q304053IN1PL_>Z7M@L-ZU.8A,$MW19)45)TX\V<:;T*_SXPU&S
M%Q9SR!5"3O%]_0_W9A.^64ALF23J7&V>VXSL39Q>Q3A[9H_:'\_VF=(+-[:5
M?$U/+",?7IF7H=5(U[R(1^-5R>2HBBYU,SGV,J8K(G'G[%X)6W9CYV<\N96X
M\PAWTU:FLU);D;DE*1( &$C0G"2XNZ_T_&ZX"&ZPB[9+5S5"+6 >A+ET%48F
MH6 KH@#-?UKBAS<.<A.(Z0_'R-)?S?IH:7N63[U=*+^3MLHT>BG^8AYO$# ?
MZX0E(0A<B6F3PQ8U.V(<N6& PDI<IXKE:J174ECVM68Z[.>M_2&=DO?'-DN^
M[@,!2$V!3+P#.D&-5AWQ9ZL.7G0B0I _A\QTG)B9T_"EF&J(/PB%3U5BP+VS
ME=]4P^4WCKA H=9]#>Y$N1IIH4^3?:WFNA<0&WDNUU ?M)F]J_N(4*BCF$LJ
M+$G-26/;8AYITIQ,TAC<Y:58>3&G$)X_FY"$&],IF7M[T%934IA0S+GIM#E<
M&A<2/0T0(Y<59:#5NL*T'<=-SM&\S3;A5R+=6=1M]E[O,PUY<P 7)1\\1/RD
MN#!XMIA.6O2F?<?*0LU#  5AO]D'7:D4JJJ@%& 3@DOSX0_3Q /BQ^B!_IP$
M'B=KS\U#=V=,A)WKA[@X),?>@R138 RVBNR9Q$XOEP0MJ0%_SB2DBMJ.PGM,
M6&6O6Y\2D):[8A7;W+LX"6&7H\#-LE'RA0;!70GGH#]3F4ZP=<'VYRBNYR8B
MLAV,J&].?Q@NOA <!"."YP@Y4$1(]6>:JQT*V0==)_WK0.)C=*-8_>,J@<E5
MJ@%ZC/_$W5W*]&^0 I3@"W3(]*=WI.YC;-,H!_'O!#D:>5T:B!^?%0@RO<E=
M>X9G9),AB3=MSA^V%TF )]&Y>3!*,U7%^6M%MZP'$9,5W0SNJFUUZ(8/.5<;
MRY[?'[85AA_*#]U 95##<DUG/\ *(C+%L9 DNC8(OF(LJ0[5%H,G-BV[]3UV
MXXJ!E#/ RX *9 P"[+.)CNTA%X7]VL/N#0*V.%M@F$-QJ/?:?8KSZE9NP"+=
M8_CMP9R6#4* RP$H;,5!I2,"VBL<@>&AW+;-%O@^#Z#(]9[PIMFCV\."@P $
M;*YXO1H$F30W('B:HRFB1&$H3SC)]*6K:GSDXR=6&?(^9+.2BW^L>:I2F1!
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M@=[ =<'3^6/FE&4Z' _\0G2C*,.@ENB-D$N]7SS <?$TE)3/".)-U?[?V4'
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M_S%P'&398E46-UB0N^CY17:EW(+>Z<&O2>W6B:^*V#N2;#44CFL8/4I7J.1
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MMO2OA77L>*-AX4V4X'$FFE[-@/.> 9W4VWUZM'%<_M/?L*X#51+0A^^Y _T
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MGW HTTI8BO=L,*!DC2+? ++#CF?8&+=*K6'33F2!#!OKE!8#CR<PV26W:!G
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MX7NT"0AZ98).9]O\)271/W#X(_K]NY-W[_C_+U@R%.3H B_Y,]+HX_L3Q #
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M"W*?L^WY7]A;/+J/8\$&[_2AC]+=;T<9BA>*V/A0C 4PA@)IAE%U/^D>+^E
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M0MI-I3M<G+-8802CZSCA %G>\3F2 >)J'I\6(O?)I<VJNOQ,J'ZBI%.5;VK
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M:9%!U*NHAH_8-"L6%!6S]A*X;[NSU#MHD4'3JZ@&37<R.A]03C/3.[HTK18
M+35/AS"/!LDVS=M+"XO2IWV%!U!C/1S@D:'ZKP/E%R\J]*UL'\-H@*QKV\21
M_\:/D4>%WZIM_K& LIL7,:I6BH\?8)Z3O(!EV6WX1-O6IAW$."'LT+1C QC6
MWH%8[L@*\AI2OF2%V@!BX[<%R<T]HO@M$WEXU$WZ@J'KS+[VB);$Z!%M:CH
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MLF <+54,Z[G6!,LN8F18]&O:LUPUO=1B7IJZP2V-H-)#VGJTO?\[,G2,RFF
M+.Y%L8G%!Z?'UI^O[N0-;UL.ED:!R]QMZC4-SNB((G1K<7]-@R*BLY5XQ>O!
M>[D/8WJ74T..;A<Q,ASZ-=4@D2RP'1),A'$18".<#PD\#Y"290,-)T0/2UW+
M[CN7^OVUMTR*7#T0EWLO3CX,56\>4B^@XDP0NI/Q@QQQ!"=7@!GO9_M=VQ&R
ML$)\:$>TJ'=O641>6@]YA^ #D"Y/L[AX_@'+UDDJZFY5YQ6!.@Q-9:MNG(6M
M^N.@[^$W(Q4R@#M4U.943HOD[3>FC"KL4R;AR.S5UM5&+PLZ;.ST-0 E&:OJ
M8A6K8]B>*)1(H7-O]S&)\W6TNZ;;) OSRUV9[MYQ=SV0'QN@AR@_*,-P(\2R
M:9++9;/D/XL0ILOECE1% CS^(#5GSY1.D!].(N_9S7P*-UN7S$_A(3[8/XIS
MTY2_ILV]]G)7T<S%!6YU:"[">D5YC=LD7=&0/Y\TYX?97RF<&M!@"AU]I-V)
MY:X40>:H;JW0]'C%0CS!PYV77X:J>S O)\_KT%_+%]7A06!(GO2Y\]>2;>#M
M1K;@S$!!/B1J.1CJ4?:5TGCL(^&#>%W>]3@8H,:;'07#;>!V# @1HQ\!4"O?
M_0"PU^+-^O]@$[AU?Z&N.^]?=AC=8/,I%)N#RI;Y#M*04PYK]H5W K+31:\^
MT9PQA1F$-8$).#YFOW^]]A%Z_*MWONGK@E<D_4N'+(L]J)Q!#&6!;*VU;%I+
MVH191[,;#WAY6'NQI)D5>98S2X3QXZ?"O*MWH<4XW?8<)M#.'J"A"]X2J6M#
M:NK M%NGDRH1KM.$R!;Y !!ZD9IBA&O&]JYL=I>4C*72;D*$?GA&A'S223Q_
M]R=$)P<TK7\=Y\R"^[7!%F"J6J<& #5\E8-8X3&,,W36LAV2$_G2 *ET)Q#C
MGA*N?3D.N?X34A:FXVT1WH>]D7?(P"W7=;(_C5:<#.(M,PHDF0 >LL9#V%I&
MM),:F?M:J*KY#O#PA!D!ZW/)YO88&1STNH!@$K&EV"^\5?4O$W\PO^1Q%XLL
M_UDL<OQ5:N##<Z+C?.X6D?G**W5W0/6,254:I9&24RN94JN.LA5U&RS*;;A<
M0UO;^8L7%?0U_?BP!L?JQD?U%H470W&9V&7-&&YLZ#H-ZB;G'W+V3VY,LS_V
M,"'T*3N-M:\I7U<)7B*8B>">R%75'%9?( $1@%R?_2%A"Z.!=11@MNL]:*B[
M_K"T="SK>ZB6D7>_(3H(_^.;&X_/G*RO \N*A4JX[;/ Y:<"*,;GI\VJ'F?U
M4JO&WH2/#NFI]@X%/W:KW&DOE=Y8">\O6IF5OY0+G8R@KH_7:=]/])G_E+4N
MP&TX1^10!K6'ED7,+QBB%QLO_<9!;UOM8IVICE@>96-='YD5/\&TL&2?,D)7
MJR2%+.]1U,MLL1/?5;[::NLTK8W" 4_:U5=;:XW(-;F]Y.&(.I,_DU_:-/46
MG') /[60 )"\YU^MDZ=Z6EJ%#/S%UDM'.8.>=!]PBK;>@J,>LPL8X*EO;O7/
M^UZNA3^D23;,]?99Q^-)1KV'G'UR*1/"Y B";$*X*+38#MC8:8PCQ/7LV[J1
MC.W#=GD&UO'X@-4>;\"D/W1OY\8'BNTVXDLF+X*"7+=1\@S_.XUY?2Z(;7GR
M(FJJ6F?/BLP'ANK=7GZ,UQR#RTW^#UIQ5E7&4NJJREB]GU5&.L3ERD[?58GI
MG>#V,>.%UU)S[0->$T%J,@!RD$) #*G)<8+O@_<"2U@H):#!5_L-%SJZ8GK:
M_ M8.I95$MR9=A9W&5?]BM"\#=50&CC</-,HNDK2;2)JP=Z'&\A$;(D][*%'
M!H*5LAHL@HO4V(CD<QJ ^, ,E:S$0W_^SEBI4B=!!DB;?AH&C)!/\I*4_ ;$
MG68_HD;EOEKM!2K-=*]6G;)+S187P%B7LD/#7C=P5Y*2UW>?1Y[?.C5J%+C,
MWJ9>T^:<C@A"I_,=[/!$5A$$)L(.357_81].7I9X&OQ19#F/]!=; 0V3 V3@
M0NWP#I@VS#(M2HF:$"6,5RKCXB:D)I#]!Q>)$_ZK->2#9-<%S9.R0E 6QE"K
MS7O.V';PYL7G- LOI]<A;/PIO)YRL+,<V>+87.LTW3W8$67SA+4/%3TK#>!<
MAY?68TJ(S!^I!@$]2$T1EP[<N'9K^6H8J7 Y2I>*6M*\O I4Q$XV-2K 7BH!
MU=VN:>:GH?&$I9,:)1*=JK8@4B9T ].$!)QMZ^S,I.K)-A3]O69#MP.;.AE6
M4 PZMJ)141,@=PK"0V+.0FF%HXT!)S ]VK9"Q+XY6U7+#D/Q@[[^B.N4[N^,
M%?.X8#1HW@KI0U*5)U129$JRRZV.71=G\72;AM%M^$0?GI.'=5+ $NQ3&-.<
MTO@HW&U$C]$K!O1+NUP"1O+W"7G_P[M_.-T(GZ*KL[AG 7H:Z6_/1YI=ZW83
M1CT*5[FF/E>RUN';<'6"::1/\#@=Q+)772N)ML^."D^"=:!LA;!FB&J'R(;&
MZE:?PY?SN-6>X#?C5J9>G<6M9$.C<*M;NDP+]M>'9V;UW7G6/P/:&*>S#>]@
MT^^4!/)^3*NBGXJ80F^G?'"=WG$LY8_3:89UKNDPP%TNC6#2X7_XKQ$ZS_G<
MYHTZS%&N,A;/>*#Q>1RC2_!X_<*B5T:W>/?#V/SBF4;T7)-&G_ 1^X==S\P^
M\GY$/O(I>9+K?EB*U?I[PRL3'NTFEO+'Z2G#.J>EADMNYBS<8?[[;3C,\<=[
M]DV\4;?I.^C3/6<LAWU5UT]\*M,G>.R><LY3F=*=T)W*_.IEW[QG[R:B/CRK
M4 N#;G&7/@9<;F"I;1/>7V^NW)>?M4J8>Z<!-( 7%U;#%6]-$UP5*:\%_5;2
M!>V+Y%C[@Y%Y% [1I7E[<2#E$O]?).B@:@S#YIEC&QN%'YZRI\?/9&E5["+@
M[56U+L;HLR<I)#AP,OR7\-J3=O5TT^T;<U]1[3L-G[R<\NP:@&K0%-ID'H5S
M=6G>]!7Y@$>XV7H<;8[DDYKW8OHLGU +Q2XJ$!5=Y(NTK"WYE,A6M$:VJCE,
M;M WV$Y9!.T4;8W"R4[8T1/4DGQCY="$$0^=N<S<(_(JR[FK\I.1S5/-K[MZ
M:J(<3E=)EM_%/J3@!I^2_%>:S[TPT/ _4 XN3SBN$TV?J)>;"[1R<^44X#.9
M4 .""R5QDI,=FR2V3*X;ATAV7I3O;O<>AM?A-E$A [-#Q4$OW*="$%E11Z<]
M<V_GKZG_;9XF.?,BUE_VK\?4V]PG7MNIK 4/+KCL%6Z"ISA)Q4HD+P%FMP>W
M810R&K8.CNCNTHN_M;WJ9J;#A5&WDEKY)D%-!#D!^E%<F)6ADGL!*^+F\%1A
MIJVB<0%^\GZU!I6**)_W/XS>0XZ_B[>2_O;\I.\&7G>5L=S _U1$N_WXV9-,
M)MUBQ^D@5GW20\"BG8@K'LG\T=;+X^>.7LEORRWZYHP]SQC+=%'F!:U32D\]
M:=@('Z>/#.A9TTW*'*F_C6@2Z>[O\5.)I?RWZ"Q]TXKF+ZZGEJMDLTEB7KMM
M&@?SE-[R%U[Y'UK<H)\%%[+6^C;!$HRDX(7M&B_@BC\B0:X?*.2XV,/@TN)6
MHP/_>!@P N9('5X;Q^\.F*O>803'7N'ALU7B^%NC/JSE0V=?PWQ]1=/<"^.[
M.,O#O "S>)%X$BU)6\?8@8)P07UD+[2QJF+'RTMC\LP$$E]()&%=I'P8CLET
MZA'3( B%0M%.+< ZJU'U,>!"V%);K31,C8V4Z0$R!<#I#!QY658&1,S2!:3
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MA_Y0&8@&\\&J'PR],9VDU07J?[IG_V)_5G]B_P].(MA?_@]02P,$%     @
MA4A24I:Y@<1.70  ^P@& !4   !R=VQK+3(P,C Q,C,Q7W!R92YX;6SMO6US
MXSBR+OA](_8_Z/:-/3$GXE1WNZI?IGMF]H8LRRY-RY)&DKNF]TL'34$RIRA2
M0U)V:7[] B I\0U @@0$R.T3]_:X; !$YI-()!*)S+_^GR];O_>,HM@+@[]]
M=?7UMU_U4."&*R_8_.VKA\6[_F(P&GW5BQ,G6#E^&*"_?16$7_V?__?__K]Z
M^/_^^K_>O>O=>LA?_=R["=UWHV =_J4W<;;HY]X="E#D)&'TE]ZOCK\GOPG_
M>3T?XW^FG_NY]_W7/SSVWKT##/8K"E9A]# ?'0=[2I+=S]]\\_+R\G40/CLO
M8?0Y_MH-M[#Q%N$^<M%QL/FG\2^]J_?OO^U=??O+UU_6>,XW3H+_\/[;]U?_
MS_N;;]_C_US]>7GUX>?WW_W\_H?_#_B5Q$GV\?$KWW[Y-ON_M/M??2_X_#/Y
MSZ,3HQY&(HA__A)[?_NJ0-S+AZ_#://-^V^_O?KFG_?CA?N$MLX[+R"(N.BK
MO!<9I:G?U4\__?0-_6O>M-;RRV/DY]_X\$T^G>/(^*\>IWUA)K'W<TRG-PY=
M)Z$")?Q,C]F"_.M=WNP=^=6[J_?O/EQ]_25>?94SGW(P"GTT1^L>^5\L(L>O
M1NC%\3\3H?B&_.D;#,]^BX*D'ZR&0>(E!X)5M*53Q=.G8SU%:/VWKZ(7_S/^
MY/MOK]ZG'_S?D+[)88>71^QM=SYFQS>MYC@(@SCTO166OM6UXQ/.+IX02F+1
M!(4=M<YNYD28.4\H\5S';SW5QE%4SYLL2D2@C*?KZ8ZH* RA%'OY(ZB8;_$+
M@R<GV*!X%"R>,'N>0G^%U>?PWWLL@Z))2PYSQIE+R4N7,75*S\")GV[]\*6U
M\-0&.,ML6Z]5^&@JZ$CM!^$$*\V4R+"W";PUI@>K>]<-]UC?!YL9YH+K(2'6
MH,XJ9CF+T,[Q5L,O.Q3$*,8;TQ3#$ WV$0&D'\> 34-F#!5S'@7/>-PP O"Q
MH:D:KH588R<'LH]CK;$CXCQ!B9A1W&XJ9C8.G:"_B1!=89^\Y.F7"(4$DCGR
MR>K[Y$01%JIE.,.FZQ.VB:81MM*=Z$ UH9"?BH97HZ&V6R^AB@1_'VL8LD3P
MO\:>\^CY7@*0#HDAE&@$^:U7ZRX[1S%R,$R#T/>=QS"U0([H8HZ,/9>LZ..O
M1--M/:"2->D<\+'!_8P768)<\F7\TR9RMD1FA2L3TEF-[L(_HJ7S!:*[:DU5
MS. 6K\? ]1P_U]< Q<7KHV:7)LS>/7ENX4"$Y>7>^5>(]Y$XP8R(\+\Q**N]
MF^!3M2/>T5L/J62M[Q]C].\]EO$AV8'$&SZCO79+1(E%HL,RX7YPZ3SZ'>=<
M'N)<MA1LXO(C*;:K8--D=M!H8T$9".A\)BL$-F/I@?18),"%)>BG>*>$2B.C
M@ZY=$S8M<4]#.RAL^IT'5GB*OT&)X_F *3>UUKXG 6<G,\:YYGRE8M)7YY[U
M>Q6S?G_N67]0,>L/YY[U=RIF_=VY9_V]BEE_?^Y9_Z!BUC^<>]8_JICUC^>>
M]1)]2?: RP/YH<YUH@!N.RV&4GRF $Z4W4/CJ0+,1$AO_?,$2JW4(!9XGX$H
MJ/W*F4Z!0-KD1SKO_(&2UWI /:=:J&DNZJAU=F(C7-A3Z_S$YK:PI];YB0UK
M84^M\Q.;T,*>6N<'-86 _8W<4 $7>M=QM=]72>[S\D,I]M"!;3M6#SWS$:I4
M3A<],Q(J44X7/3,2JDU.%STS$BI*3A<],P*N0V%'79YHX/(#=#7DBP9[=KN.
M;)8^H3Y2,+19"H7Z3<'09BD$Z@)E'] 1C0 ]#_&[\6:VPP=MW(52/<:_*'7!
M!*)@A5;Y0&2.G>+M\:_)"-F[B*O>NU[>J_BC$ZQZZ1"]XAC9O/.9^Z%;FJQ/
MGB&$D8A7Y#>_\^;:?XR3R'&/<3/8\$0^'?YWTA?6]9LVDR6,C3%GZ<N(&+E?
M;\+G;U;(^X800'Z@E+S[]BI[%_&_\:]^3R<Q1QN/?#M(R%N4AJGCILTMJS,M
M"D0_<GMAA \0&+)\3&R.E\2@_I0C:_'-CL8*OW.?//\H0>LHW,KR,N-;*""D
MR%X\A?-C,,"41(X_PBOFRR_HP .AUA2(PI5],#"H-H)#'U.Q(I3<^LZFF?^5
M)D"^O[>)[XU4&N%W=BEQZ\6NX_^&3^K#8$5>TC6SGMT:B,('FU 0T6X$D)R6
M)1ZW&81R"R#CO[.)\4TT&F7V#$5>N.**/J,ID/W?V\C^1JJ-XI NQ71>M_AW
M,1^+AN9 /'ZP$0\F]19@0M0C&)%"8R >/]J+1XUR@_;I)^3[OP3A2[! 3AP&
M:#6*XSV*FC$1= $B\V>;D %QP2 ^OX;^'K,P.MQZ/HH8:X71%(C'3_;AP:#:
MY#DNM>SF:!=&Y#H\S>O /<XQ>H!/=?;!PF>"072HF RPS;$)(^X9N](0BH6%
M1^Q&D@U"L'C".G00;G=.P$6@W X*@%5G;3;!)OF_=7S_>A][ 8JY>JG2$(J
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M _/##OAN,HMWCIY1L!<O+E9[<R$P;8'B4VX'.M1Y)K.DF!W =\'6X".@W0Z
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MX7-Z)RVZ$N%V,ATR)2&=U>@I,2_L4)SDX=0^0=&1-!%@S ZF@YK:@R7@@1U
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M"@/\HYLFLN17%)8<YI*48SL*"SXC@^@N\0>FZ_XJI&E=1-4SFUO;@54K.:U
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M'2@UC09/I 35*"@V\ +7V_FY27V,U(G_L2<I[@GAY)^,A:7K8U#([73KZ(7
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MU-D.1"4D%PIFD4@K$I:04,P]MHV/,Q2E*&%V,'U D)#*VILX+@_L."K<[J/
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M1^UADO,!XP\E=1\BA<RU6 I4'1N WX#*PJ5Y(J58;'Q3\ ]E4U:A0A -#A6
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M,2YX;6Q02P$"% ,4    " "%2%)2*J<WY-4;  "@10$ $0
M@ %\U0$ <G=L:RTR,#(P,3(S,2YX<V102P$"% ,4    " "%2%)22_3RT*X3
M   =_@  %0              @ & \0$ <G=L:RTR,#(P,3(S,5]C86PN>&UL
M4$L! A0#%     @ A4A24MA P&:Z/P  :.X# !4              ( !804"
M ')W;&LM,C R,#$R,S%?9&5F+GAM;%!+ 0(4 Q0    ( (5(4E(X;KQZ59L
M -&4"  5              "  4Y% @!R=VQK+3(P,C Q,C,Q7VQA8BYX;6Q0
M2P$"% ,4    " "%2%)2EKF!Q$Y=  #[" 8 %0              @ '6X (
K<G=L:RTR,#(P,3(S,5]P<F4N>&UL4$L%!@     &  8 B@$  %<^ P    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
